orf_id	symbol	nt_change	aa_change	ensembl_gene_id	chr	chr_pos_38	spdi	ccsb_allele_id	ccsb_mutation_id	mutation_id_rc4	mutation_id_cegs2	mutation_id_edgotyping3	entry_plate	entry_well	collection	sequence	#AlleleID	Type	Name	GeneID	GeneSymbol	HGNC_ID	ClinicalSignificance	ClinSigSimple	LastEvaluated	RS# (dbSNP)	nsv/esv (dbVar)	RCVaccession	PhenotypeIDS	PhenotypeList	Origin	OriginSimple	Assembly	ChromosomeAccession	Chromosome	Start	Stop	Cytogenetic	ReviewStatus	NumberSubmitters	Guidelines	TestedInGTR	OtherIDs	SubmitterCategories	VariationID	PositionVCF	ReferenceAlleleVCF	AlternateAlleleVCF	SomaticClinicalImpact	SomaticClinicalImpactLastEvaluated	ReviewStatusClinicalImpact	Oncogenicity	OncogenicityLastEvaluated	ReviewStatusOncogenicity	SCVsForAggregateGermlineClassification	SCVsForAggregateSomaticClinicalImpact	SCVsForAggregateOncogenicityClassification	clinvar_nt_change	clinvar_aa_change	RefSeq_mRNA	StarStatus	clinvar_clnsig_clean	chrom	ref	alt	varid	gnomad_af	clinvar_id	#chr	pos(1-based)	ref_dbnsfp	alt_dbnsfp	aaref	aaalt	rs_dbSNP	hg19_chr	hg19_pos(1-based)	hg18_chr	hg18_pos(1-based)	aapos	genename	Ensembl_geneid	Ensembl_transcriptid	Ensembl_proteinid	Uniprot_acc	Uniprot_entry	HGVSc_snpEff	HGVSp_snpEff	HGVSc_VEP	HGVSp_VEP	APPRIS	GENCODE_basic	TSL	VEP_canonical	MANE	cds_strand	refcodon	codonpos	codon_degeneracy	Ancestral_allele	AltaiNeandertal	Denisova	VindijiaNeandertal	ChagyrskayaNeandertal	SIFT_score	SIFT_converted_rankscore	SIFT_pred	SIFT4G_score	SIFT4G_converted_rankscore	SIFT4G_pred	Polyphen2_HDIV_score	Polyphen2_HDIV_rankscore	Polyphen2_HDIV_pred	Polyphen2_HVAR_score	Polyphen2_HVAR_rankscore	Polyphen2_HVAR_pred	MutationTaster_score	MutationTaster_converted_rankscore	MutationTaster_pred	MutationTaster_model	MutationTaster_trees_benign	MutationTaster_trees_deleterious	MutationAssessor_score	MutationAssessor_rankscore	MutationAssessor_pred	PROVEAN_score	PROVEAN_converted_rankscore	PROVEAN_pred	VEST4_score	VEST4_rankscore	MetaSVM_score	MetaSVM_rankscore	MetaSVM_pred	MetaLR_score	MetaLR_rankscore	MetaLR_pred	Reliability_index	MetaRNN_score	MetaRNN_rankscore	MetaRNN_pred	M-CAP_score	M-CAP_rankscore	M-CAP_pred	REVEL_score	REVEL_rankscore	MutPred_score	MutPred_rankscore	MutPred_protID	MutPred_AAchange	MutPred_Top5features	MVP_score	MVP_rankscore	gMVP_score	gMVP_rankscore	MPC_score	MPC_rankscore	PrimateAI_score	PrimateAI_rankscore	PrimateAI_pred	DEOGEN2_score	DEOGEN2_rankscore	DEOGEN2_pred	BayesDel_addAF_score	BayesDel_addAF_rankscore	BayesDel_addAF_pred	BayesDel_noAF_score	BayesDel_noAF_rankscore	BayesDel_noAF_pred	ClinPred_score	ClinPred_rankscore	ClinPred_pred	LIST-S2_score	LIST-S2_rankscore	LIST-S2_pred	VARITY_R_score	VARITY_R_rankscore	VARITY_ER_score	VARITY_ER_rankscore	VARITY_R_LOO_score	VARITY_R_LOO_rankscore	VARITY_ER_LOO_score	VARITY_ER_LOO_rankscore	ESM1b_score	ESM1b_rankscore	ESM1b_pred	AlphaMissense_score	AlphaMissense_rankscore	AlphaMissense_pred	PHACTboost_score	PHACTboost_rankscore	MutFormer_score	MutFormer_rankscore	MutScore_score	MutScore_rankscore	Aloft_Fraction_transcripts_affected	Aloft_prob_Tolerant	Aloft_prob_Recessive	Aloft_prob_Dominant	Aloft_pred	Aloft_Confidence	CADD_raw	CADD_raw_rankscore	CADD_phred	DANN_score	DANN_rankscore	fathmm-XF_coding_score	fathmm-XF_coding_rankscore	fathmm-XF_coding_pred	Eigen-raw_coding	Eigen-raw_coding_rankscore	Eigen-phred_coding	Eigen-PC-raw_coding	Eigen-PC-raw_coding_rankscore	Eigen-PC-phred_coding	GERP++_NR	GERP++_RS	GERP++_RS_rankscore	GERP_91_mammals	GERP_91_mammals_rankscore	phyloP100way_vertebrate	phyloP100way_vertebrate_rankscore	phyloP470way_mammalian	phyloP470way_mammalian_rankscore	phyloP17way_primate	phyloP17way_primate_rankscore	phastCons100way_vertebrate	phastCons100way_vertebrate_rankscore	phastCons470way_mammalian	phastCons470way_mammalian_rankscore	phastCons17way_primate	phastCons17way_primate_rankscore	bStatistic	bStatistic_converted_rankscore	1000Gp3_AC	1000Gp3_AF	1000Gp3_AFR_AC	1000Gp3_AFR_AF	1000Gp3_EUR_AC	1000Gp3_EUR_AF	1000Gp3_AMR_AC	1000Gp3_AMR_AF	1000Gp3_EAS_AC	1000Gp3_EAS_AF	1000Gp3_SAS_AC	1000Gp3_SAS_AF	TOPMed_frz8_AC	TOPMed_frz8_AN	TOPMed_frz8_AF	gnomAD2.1.1_exomes_flag	gnomAD2.1.1_exomes_controls_AC	gnomAD2.1.1_exomes_controls_AN	gnomAD2.1.1_exomes_controls_AF	gnomAD2.1.1_exomes_controls_nhomalt	gnomAD2.1.1_exomes_non_neuro_AC	gnomAD2.1.1_exomes_non_neuro_AN	gnomAD2.1.1_exomes_non_neuro_AF	gnomAD2.1.1_exomes_non_neuro_nhomalt	gnomAD2.1.1_exomes_non_cancer_AC	gnomAD2.1.1_exomes_non_cancer_AN	gnomAD2.1.1_exomes_non_cancer_AF	gnomAD2.1.1_exomes_non_cancer_nhomalt	gnomAD2.1.1_exomes_controls_AFR_AC	gnomAD2.1.1_exomes_controls_AFR_AN	gnomAD2.1.1_exomes_controls_AFR_AF	gnomAD2.1.1_exomes_controls_AFR_nhomalt	gnomAD2.1.1_exomes_controls_AMR_AC	gnomAD2.1.1_exomes_controls_AMR_AN	gnomAD2.1.1_exomes_controls_AMR_AF	gnomAD2.1.1_exomes_controls_AMR_nhomalt	gnomAD2.1.1_exomes_controls_ASJ_AC	gnomAD2.1.1_exomes_controls_ASJ_AN	gnomAD2.1.1_exomes_controls_ASJ_AF	gnomAD2.1.1_exomes_controls_ASJ_nhomalt	gnomAD2.1.1_exomes_controls_EAS_AC	gnomAD2.1.1_exomes_controls_EAS_AN	gnomAD2.1.1_exomes_controls_EAS_AF	gnomAD2.1.1_exomes_controls_EAS_nhomalt	gnomAD2.1.1_exomes_controls_FIN_AC	gnomAD2.1.1_exomes_controls_FIN_AN	gnomAD2.1.1_exomes_controls_FIN_AF	gnomAD2.1.1_exomes_controls_FIN_nhomalt	gnomAD2.1.1_exomes_controls_NFE_AC	gnomAD2.1.1_exomes_controls_NFE_AN	gnomAD2.1.1_exomes_controls_NFE_AF	gnomAD2.1.1_exomes_controls_NFE_nhomalt	gnomAD2.1.1_exomes_controls_SAS_AC	gnomAD2.1.1_exomes_controls_SAS_AN	gnomAD2.1.1_exomes_controls_SAS_AF	gnomAD2.1.1_exomes_controls_SAS_nhomalt	gnomAD2.1.1_exomes_controls_POPMAX_AC	gnomAD2.1.1_exomes_controls_POPMAX_AN	gnomAD2.1.1_exomes_controls_POPMAX_AF	gnomAD2.1.1_exomes_controls_POPMAX_nhomalt	gnomAD2.1.1_exomes_non_neuro_AFR_AC	gnomAD2.1.1_exomes_non_neuro_AFR_AN	gnomAD2.1.1_exomes_non_neuro_AFR_AF	gnomAD2.1.1_exomes_non_neuro_AFR_nhomalt	gnomAD2.1.1_exomes_non_neuro_AMR_AC	gnomAD2.1.1_exomes_non_neuro_AMR_AN	gnomAD2.1.1_exomes_non_neuro_AMR_AF	gnomAD2.1.1_exomes_non_neuro_AMR_nhomalt	gnomAD2.1.1_exomes_non_neuro_ASJ_AC	gnomAD2.1.1_exomes_non_neuro_ASJ_AN	gnomAD2.1.1_exomes_non_neuro_ASJ_AF	gnomAD2.1.1_exomes_non_neuro_ASJ_nhomalt	gnomAD2.1.1_exomes_non_neuro_EAS_AC	gnomAD2.1.1_exomes_non_neuro_EAS_AN	gnomAD2.1.1_exomes_non_neuro_EAS_AF	gnomAD2.1.1_exomes_non_neuro_EAS_nhomalt	gnomAD2.1.1_exomes_non_neuro_FIN_AC	gnomAD2.1.1_exomes_non_neuro_FIN_AN	gnomAD2.1.1_exomes_non_neuro_FIN_AF	gnomAD2.1.1_exomes_non_neuro_FIN_nhomalt	gnomAD2.1.1_exomes_non_neuro_NFE_AC	gnomAD2.1.1_exomes_non_neuro_NFE_AN	gnomAD2.1.1_exomes_non_neuro_NFE_AF	gnomAD2.1.1_exomes_non_neuro_NFE_nhomalt	gnomAD2.1.1_exomes_non_neuro_SAS_AC	gnomAD2.1.1_exomes_non_neuro_SAS_AN	gnomAD2.1.1_exomes_non_neuro_SAS_AF	gnomAD2.1.1_exomes_non_neuro_SAS_nhomalt	gnomAD2.1.1_exomes_non_neuro_POPMAX_AC	gnomAD2.1.1_exomes_non_neuro_POPMAX_AN	gnomAD2.1.1_exomes_non_neuro_POPMAX_AF	gnomAD2.1.1_exomes_non_neuro_POPMAX_nhomalt	gnomAD2.1.1_exomes_non_cancer_AFR_AC	gnomAD2.1.1_exomes_non_cancer_AFR_AN	gnomAD2.1.1_exomes_non_cancer_AFR_AF	gnomAD2.1.1_exomes_non_cancer_AFR_nhomalt	gnomAD2.1.1_exomes_non_cancer_AMR_AC	gnomAD2.1.1_exomes_non_cancer_AMR_AN	gnomAD2.1.1_exomes_non_cancer_AMR_AF	gnomAD2.1.1_exomes_non_cancer_AMR_nhomalt	gnomAD2.1.1_exomes_non_cancer_ASJ_AC	gnomAD2.1.1_exomes_non_cancer_ASJ_AN	gnomAD2.1.1_exomes_non_cancer_ASJ_AF	gnomAD2.1.1_exomes_non_cancer_ASJ_nhomalt	gnomAD2.1.1_exomes_non_cancer_EAS_AC	gnomAD2.1.1_exomes_non_cancer_EAS_AN	gnomAD2.1.1_exomes_non_cancer_EAS_AF	gnomAD2.1.1_exomes_non_cancer_EAS_nhomalt	gnomAD2.1.1_exomes_non_cancer_FIN_AC	gnomAD2.1.1_exomes_non_cancer_FIN_AN	gnomAD2.1.1_exomes_non_cancer_FIN_AF	gnomAD2.1.1_exomes_non_cancer_FIN_nhomalt	gnomAD2.1.1_exomes_non_cancer_NFE_AC	gnomAD2.1.1_exomes_non_cancer_NFE_AN	gnomAD2.1.1_exomes_non_cancer_NFE_AF	gnomAD2.1.1_exomes_non_cancer_NFE_nhomalt	gnomAD2.1.1_exomes_non_cancer_SAS_AC	gnomAD2.1.1_exomes_non_cancer_SAS_AN	gnomAD2.1.1_exomes_non_cancer_SAS_AF	gnomAD2.1.1_exomes_non_cancer_SAS_nhomalt	gnomAD2.1.1_exomes_non_cancer_POPMAX_AC	gnomAD2.1.1_exomes_non_cancer_POPMAX_AN	gnomAD2.1.1_exomes_non_cancer_POPMAX_AF	gnomAD2.1.1_exomes_non_cancer_POPMAX_nhomalt	gnomAD4.1_joint_flag	gnomAD4.1_joint_AC	gnomAD4.1_joint_AN	gnomAD4.1_joint_AF	gnomAD4.1_joint_nhomalt	gnomAD4.1_joint_POPMAX_AC	gnomAD4.1_joint_POPMAX_AN	gnomAD4.1_joint_POPMAX_AF	gnomAD4.1_joint_POPMAX_nhomalt	gnomAD4.1_joint_AFR_AC	gnomAD4.1_joint_AFR_AN	gnomAD4.1_joint_AFR_AF	gnomAD4.1_joint_AFR_nhomalt	gnomAD4.1_joint_AMI_AC	gnomAD4.1_joint_AMI_AN	gnomAD4.1_joint_AMI_AF	gnomAD4.1_joint_AMI_nhomalt	gnomAD4.1_joint_AMR_AC	gnomAD4.1_joint_AMR_AN	gnomAD4.1_joint_AMR_AF	gnomAD4.1_joint_AMR_nhomalt	gnomAD4.1_joint_ASJ_AC	gnomAD4.1_joint_ASJ_AN	gnomAD4.1_joint_ASJ_AF	gnomAD4.1_joint_ASJ_nhomalt	gnomAD4.1_joint_EAS_AC	gnomAD4.1_joint_EAS_AN	gnomAD4.1_joint_EAS_AF	gnomAD4.1_joint_EAS_nhomalt	gnomAD4.1_joint_FIN_AC	gnomAD4.1_joint_FIN_AN	gnomAD4.1_joint_FIN_AF	gnomAD4.1_joint_FIN_nhomalt	gnomAD4.1_joint_MID_AC	gnomAD4.1_joint_MID_AN	gnomAD4.1_joint_MID_AF	gnomAD4.1_joint_MID_nhomalt	gnomAD4.1_joint_NFE_AC	gnomAD4.1_joint_NFE_AN	gnomAD4.1_joint_NFE_AF	gnomAD4.1_joint_NFE_nhomalt	gnomAD4.1_joint_SAS_AC	gnomAD4.1_joint_SAS_AN	gnomAD4.1_joint_SAS_AF	gnomAD4.1_joint_SAS_nhomalt	ALFA_European_AC	ALFA_European_AN	ALFA_European_AF	ALFA_African_Others_AC	ALFA_African_Others_AN	ALFA_African_Others_AF	ALFA_East_Asian_AC	ALFA_East_Asian_AN	ALFA_East_Asian_AF	ALFA_African_American_AC	ALFA_African_American_AN	ALFA_African_American_AF	ALFA_Latin_American_1_AC	ALFA_Latin_American_1_AN	ALFA_Latin_American_1_AF	ALFA_Latin_American_2_AC	ALFA_Latin_American_2_AN	ALFA_Latin_American_2_AF	ALFA_Other_Asian_AC	ALFA_Other_Asian_AN	ALFA_Other_Asian_AF	ALFA_South_Asian_AC	ALFA_South_Asian_AN	ALFA_South_Asian_AF	ALFA_Other_AC	ALFA_Other_AN	ALFA_Other_AF	ALFA_African_AC	ALFA_African_AN	ALFA_African_AF	ALFA_Asian_AC	ALFA_Asian_AN	ALFA_Asian_AF	ALFA_Total_AC	ALFA_Total_AN	ALFA_Total_AF	clinvar_clnsig	clinvar_trait	clinvar_review	clinvar_hgvs	clinvar_var_source	clinvar_MedGen_id	clinvar_OMIM_id	clinvar_Orphanet_id	Interpro_domain	aaref_3	aaalt_3	#AlleleID_dbnsfp	Type_dbnsfp	Name_dbnsfp	GeneID_dbnsfp	GeneSymbol_dbnsfp	HGNC_ID_dbnsfp	ClinicalSignificance_dbnsfp	ClinSigSimple_dbnsfp	LastEvaluated_dbnsfp	RS# (dbSNP)_dbnsfp	nsv/esv (dbVar)_dbnsfp	RCVaccession_dbnsfp	PhenotypeIDS_dbnsfp	PhenotypeList_dbnsfp	Origin_dbnsfp	OriginSimple_dbnsfp	Assembly_dbnsfp	ChromosomeAccession_dbnsfp	Chromosome_dbnsfp	Start_dbnsfp	Stop_dbnsfp	Cytogenetic_dbnsfp	ReviewStatus_dbnsfp	NumberSubmitters_dbnsfp	Guidelines_dbnsfp	TestedInGTR_dbnsfp	OtherIDs_dbnsfp	SubmitterCategories_dbnsfp	VariationID_dbnsfp	PositionVCF_dbnsfp	ReferenceAlleleVCF_dbnsfp	AlternateAlleleVCF_dbnsfp	SomaticClinicalImpact_dbnsfp	SomaticClinicalImpactLastEvaluated_dbnsfp	ReviewStatusClinicalImpact_dbnsfp	Oncogenicity_dbnsfp	OncogenicityLastEvaluated_dbnsfp	ReviewStatusOncogenicity_dbnsfp	SCVsForAggregateGermlineClassification_dbnsfp	SCVsForAggregateSomaticClinicalImpact_dbnsfp	SCVsForAggregateOncogenicityClassification_dbnsfp	clinvar_nt_change_dbnsfp	clinvar_aa_change_dbnsfp	RefSeq_mRNA_dbnsfp	StarStatus_dbnsfp	clinvar_clnsig_clean_dbnsfp	symbol_right	ensembl_gene_id_right	orf_id_wt	mutation_id_old	ccsb_mutation_id_right	ccsb_allele_id_right	nt_change_right	aa_change_right	collection_right	entry_plate_orig	entry_well_orig	entry_plate_conso	entry_well_conso	entry_seq_pool	db_plate	db_well	n2h_plate	n2h_well	dualip_plate	dualip_well	mislocalization_plate	mislocalization_well	entry_sequenced	entry_sequence_confirmation_class	db_sequenced	db_sequence_confirmation_class	n2h_sequenced	n2h_sequence_confirmation_class	dualip_sequenced	dualip_sequence_confirmation_class	mislocalization_sequenced	mislocalization_sequence_confirmation_class	gene_variant	chr_num	Chrom	nuc_loc	ref_allele	alt_allele
71569	OTC	240G>T	Lys80Asn	ENSG00000036473	X	38369819	NC_000023.11:38369819:G:T	ALE00005236	CCSBVarC005236	NULL	205820	NULL	GDEhDisVCh_40048	B07	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAATTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103032.0	single nucleotide variant	NM_000531.6(OTC):c.240G>T (p.Lys80Asn)	5009.0	OTC	HGNC:8512	Pathogenic	1.0	-	72554333.0	-	RCV000083371	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38369819.0	38369819.0	Xp11.4	no assertion criteria provided	1.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224512	2.0	97140.0	38369819.0	G	T	-	-	-	-	-	-	SCV000115457	-	-	240G>T 	Lys80Asn	NM_000531.6		1_Pathogenic	chrX	G	T	X-38369819-G-T		97140	X	38369819	G	T	K	N	rs72554333	X	38229072	X	38114016	80	OTC	ENSG00000036473	ENST00000713758	ENSP00000519059	P00480	OTC_HUMAN	.	.	c.240G>T	p.Lys80Asn	principal1	Y	.	.	.	+	AAG	3	2	G	G/G	G/G	G/G	G/G	.	0.72322	.	.	0.76775	.	0.997	0.70687	D	0.866	0.61572	P	.	0.87956	.	.	.	.	3.65	0.94095	H	.	0.68915	.	.	0.97550	1.0887	0.99186	D	0.9680	0.98983	D	10	.	0.99738	.	0.718615	0.97717	D	.	0.92267	0.947	0.99343	P00480	K80N	Loss of ubiquitination at K80 (P = 0.0224)| Loss of methylation at K80 (P = 0.0674)| Loss of MoRF binding (P = 0.087)| Loss of glycosylation at K80 (P = 0.1149)| Gain of catalytic residue at S81 (P = 0.1359)	.	0.97441	.	0.99555	.	0.81855	0.781181156635	0.79068	T	0.971608	0.99695	D	0.264885	0.79831	D	0.142713	0.79571	D	0.991074621677399	0.81182	D	.	0.75707	.	0.9880877	0.99653	0.9315401	0.97160	0.9880877	0.99653	0.9315401	0.97160	-9.311	0.69755	D	.	0.79045	.	0.991757379582947	0.89177	0.99680674	0.98169	0.981	0.99334	.	.	.	.	.	.	3.806327	0.54957	23.5	0.99834288680513605	0.91548	.	.	.	.	.	.	.	.	.	5.88	2.11	0.26229	2.44	0.45176	1.797	0.38543	0.720000	0.21086	0.674	0.70877	1.0	0.71675	0.996000	0.32869	0.999	0.91597	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided	no_assertion_criteria_provided	NC_000023.11:g.38369819G>T	ClinGen:CA224512	CN517202	.	.	Aspartate/ornithine carbamoyltransferase, carbamoyl-P binding	Lys	Asn	103032	single nucleotide variant	NM_000531.6(OTC):c.240G>T (p.Lys80Asn)	5009	OTC	HGNC:8512	Pathogenic	1	-	72554333	-	RCV000083371	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38369819	38369819	Xp11.4	no assertion criteria provided	1	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224512	2	97140	38369819	G	T	-	-	-	-	-	-	SCV000115457	-	-	240G>T 	Lys80Asn	NM_000531.6		1_Pathogenic	OTC	ENSG00000036473	71569	205820	CCSBVarC005236	ALE00005236	240G>T	Lys80Asn	CEGS2	CegsMutGDEh1027	C08	GDEhDisVCh_40048	B07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Lys80Asn	23	X	38369819	G	T
7918	MSH2	2060T>C	Leu687Pro	ENSG00000095002	2	47476421	NC_000002.12:47476421:T:C	ALE00003015	CCSBVarC003015	NULL	202694	NULL	GDEhDisVCh_40060	F07	CEGS2	ATGGCGGTGCAGCCGAAGGAGACGCTGCAGTTGGAGAGCGCGGCCGAGGTCGGCTTCGTGCGCTTCTTTCAGGGCATGCCGGAGAAGCCGACCACCACAGTGCGCCTTTTCGACCGGGGCGACTTCTATACGGCGCACGGCGAGGACGCGCTGCTGGCCGCCCGGGAGGTGTTCAAGACCCAGGGGGTGATCAAGTACATGGGGCCGGCAGGAGCAAAGAATCTGCAGAGTGTTGTGCTTAGTAAAATGAATTTTGAATCTTTTGTAAAAGATCTTCTTCTGGTTCGTCAGTATAGAGTTGAAGTTTATAAGAATAGAGCTGGAAATAAGGCATCCAAGGAGAATGATTGGTATTTGGCATATAAGGCTTCTCCTGGCAATCTCTCTCAGTTTGAAGACATTCTCTTTGGTAACAATGATATGTCAGCTTCCATTGGTGTTGTGGGTGTTAAAATGTCCGCAGTTGATGGCCAGAGACAGGTTGGAGTTGGGTATGTGGATTCCATACAGAGGAAACTAGGACTGTGTGAATTCCCTGATAATGATCAGTTCTCCAATCTTGAGGCTCTCCTCATCCAGATTGGACCAAAGGAATGTGTTTTACCCGGAGGAGAGACTGCTGGAGACATGGGGAAACTGAGACAGATAATTCAAAGAGGAGGAATTCTGATCACAGAAAGAAAAAAAGCTGACTTTTCCACAAAAGACATTTATCAGGACCTCAACCGGTTGTTGAAAGGCAAAAAGGGAGAGCAGATGAATAGTGCTGTATTGCCAGAAATGGAGAATCAGGTTGCAGTTTCATCACTGTCTGCGGTAATCAAGTTTTTAGAACTCTTATCAGATGATTCCAACTTTGGACAGTTTGAACTGACTACTTTTGACTTCAGCCAGTATATGAAATTGGATATTGCAGCAGTCAGAGCCCTTAACCTTTTTCAGGGTTCTGTTGAAGATACCACTGGCTCTCAGTCTCTGGCTGCCTTGCTGAATAAGTGTAAAACCCCTCAAGGACAAAGACTTGTTAACCAGTGGATTAAGCAGCCTCTCATGGATAAGAACAGAATAGAGGAGAGATTGAATTTAGTGGAAGCTTTTGTAGAAGATGCAGAATTGAGGCAGACTTTACAAGAAGATTTACTTCGTCGATTCCCAGATCTTAACCGACTTGCCAAGAAGTTTCAAAGACAAGCAGCAAACTTACAAGATTGTTACCGACTCTATCAGGGTATAAATCAACTACCTAATGTTATACAGGCTCTGGAAAAACATGAAGGAAAACACCAGAAATTATTGTTGGCAGTTTTTGTGACTCCTCTTACTGATCTTCGTTCTGACTTCTCCAAGTTTCAGGAAATGATAGAAACAACTTTAGATATGGATCAGGTGGAAAACCATGAATTCCTTGTAAAACCTTCATTTGATCCTAATCTCAGTGAATTAAGAGAAATAATGAATGACTTGGAAAAGAAGATGCAGTCAACATTAATAAGTGCAGCCAGAGATCTTGGCTTGGACCCTGGCAAACAGATTAAACTGGATTCCAGTGCACAGTTTGGATATTACTTTCGTGTAACCTGTAAGGAAGAAAAAGTCCTTCGTAACAATAAAAACTTTAGTACTGTAGATATCCAGAAGAATGGTGTTAAATTTACCAACAGCAAATTGACTTCTTTAAATGAAGAGTATACCAAAAATAAAACAGAATATGAAGAAGCCCAGGATGCCATTGTTAAAGAAATTGTCAATATTTCTTCAGGCTATGTAGAACCAATGCAGACACTCAATGATGTGTTAGCTCAGCTAGATGCTGTTGTCAGCTTTGCTCACGTGTCAAATGGAGCACCTGTTCCATATGTACGACCAGCCATTTTGGAGAAAGGACAAGGAAGAATTATATTAAAAGCATCCAGGCATGCTTGTGTTGAAGTTCAAGATGAAATTGCATTTATTCCTAATGACGTATACTTTGAAAAAGATAAACAGATGTTCCACATCATTACTGGCCCCAATATGGGAGGTAAATCAACATATATTCGACAAACTGGGGTGATAGTACCCATGGCCCAAATTGGGTGTTTTGTGCCATGTGAGTCAGCAGAAGTGTCCATTGTGGACTGCATCTTAGCCCGAGTAGGGGCTGGTGACAGTCAATTGAAAGGAGTCTCCACGTTCATGGCTGAAATGTTGGAAACTGCTTCTATCCTCAGGTCTGCAACCAAAGATTCATTAATAATCATAGATGAATTGGGAAGAGGAACTTCTACCTACGATGGATTTGGGTTAGCATGGGCTATATCAGAATACATTGCAACAAAGATTGGTGCTTTTTGCATGTTTGCAACCCATTTTCATGAACTTACTGCCTTGGCCAATCAGATACCAACTGTTAATAATCTACATGTCACAGCACTCACCACTGAAGAGACCTTAACTATGCTTTATCAGGTGAAGAAAGGTGTCTGTGATCAAAGTTTTGGGATTCATGTTGCAGAGCTTGCTAATTTCCCTAAGCATGTAATAGAGTGTGCTAAACAGAAAGCCCTGGAACTTGAGGAGTTTCAGTATATTGGAGAATCGCAAGGATATGATATCATGGAACCAGCAGCAAAGAAGTGCTATCTGGAAAGAGAGCAAGGTGAAAAAATTATTCAGGAGTTCCTGTCCAAGGTGAAACAAATGCCCTTTACTGAAATGTCAGAAGAAAACATCACAATAAAGTTAAAACAGCTAAAAGCTGAAGTAATAGCAAAGAATAATAGCTTTGTAAATGAAATCATTTCACGAATAAAAGTTACTACG	96348.0	single nucleotide variant	NM_000251.3(MSH2):c.2060T>C (p.Leu687Pro)	4436.0	MSH2	HGNC:7325	Pathogenic/Likely pathogenic	1.0	Jan 08, 2025	587779133.0	-	RCV000160600|RCV000524374|RCV000586744|RCV003452885|RCV004700382	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MeSH:D003123,MedGen:C0009405|MedGen:C3661900|MONDO:MONDO:0007356,MedGen:C2936783,OMIM:120435,Orphanet:144|MONDO:MONDO:0018630,MedGen:C1333990,OMIM:PS120435,Orphanet:443909	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|not provided|Lynch syndrome 1|Hereditary nonpolyposis colon cancer	germline;unknown	germline	GRCh38	NC_000002.12	2	47476421.0	47476421.0	2p21	criteria provided, multiple submitters, no conflicts	8.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA019927	2.0	90873.0	47476421.0	T	C	-	-	-	-	-	-	SCV000211196|SCV000212848|SCV000548193|SCV000696233|SCV001344423|SCV002047290|SCV004186739|SCV005413359	-	-	2060T>C 	Leu687Pro	NM_000251.3	2.0	1_Pathogenic	chr2	T	C	2-47476421-T-C		90873	2	47476421	T	C	L	P	rs587779133	2	47703560	2	47557064	687	MSH2	ENSG00000095002	ENST00000233146	ENSP00000233146	P43246	MSH2_HUMAN	c.2060T>C	p.Leu687Pro	c.2060T>C	p.Leu687Pro	principal1	Y	1	YES	Select	+	CTC	2	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.32	0.98311	H	-6.77	0.92803	D	0.995	0.99931	1.0134	0.97410	D	0.8846	0.96162	D	10	0.9753079	0.97244	D	0.485595	0.94905	D	0.945	0.98886	0.866	0.96082	P43246	L687P	Gain of catalytic residue at L687 (P = 0.0515)| Loss of stability (P = 0.1074)| Gain of phosphorylation at T682 (P = 0.346)| Loss of MoRF binding (P = 0.3674)| Loss of helix (P = 0.3949)	0.978712159248	0.97827	0.9834343819709838	0.98328	0.0291571377522	0.02906	0.878514230251	0.93751	D	0.925096	0.98673	D	0.483117	0.93759	D	0.456188	0.93680	D	0.99940550327301	0.97246	D	0.980102	0.93270	D	0.9933494	0.99911	0.97947365	0.99801	0.990999	0.99811	0.9833847	0.99894	-13.772	0.92308	D	0.9941	0.97393	P	0.999981312536684	0.99579	0.99933410	0.99303	1	0.99985	.	.	.	.	.	.	5.402576	0.90478	31.0	0.99931912474580209	0.99439	0.951098	0.96523	D	1.00826820325586	0.95972	14.18431	0.942200809007903	0.97147	15.68519	6.08	6.08	0.98980	4.03	0.76886	7.674	0.83188	7.908000	0.73922	0.609	0.47831	1.0	0.71675	1.000000	0.68239	0.997	0.79771	929	0.16852	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	not_provided|Hereditary_cancer-predisposing_syndrome|Lynch_syndrome_1|Hereditary_nonpolyposis_colorectal_neoplasms	criteria_provided,_conflicting_classifications	NC_000002.12:g.47476421T>C	ClinGen:CA019927	C3661900|C0027672|C2936783|C0009405	120435	140162|144	DNA mismatch repair protein MutS, C-terminal|DNA mismatch repair protein MutS, C-terminal|DNA mismatch repair protein Msh2, ATP-binding cassette domain	Leu	Pro	96348	single nucleotide variant	NM_000251.3(MSH2):c.2060T>C (p.Leu687Pro)	4436	MSH2	HGNC:7325	Pathogenic/Likely pathogenic	1	Jan 08, 2025	587779133	-	RCV000160600|RCV000524374|RCV000586744|RCV003452885|RCV004700382	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MeSH:D003123,MedGen:C0009405|MedGen:C3661900|MONDO:MONDO:0007356,MedGen:C2936783,OMIM:120435,Orphanet:144|MONDO:MONDO:0018630,MedGen:C1333990,OMIM:PS120435,Orphanet:443909	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|not provided|Lynch syndrome 1|Hereditary nonpolyposis colon cancer	germline;unknown	germline	GRCh38	NC_000002.12	2	47476421	47476421	2p21	criteria provided, multiple submitters, no conflicts	8	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA019927	2	90873	47476421	T	C	-	-	-	-	-	-	SCV000211196|SCV000212848|SCV000548193|SCV000696233|SCV001344423|SCV002047290|SCV004186739|SCV005413359	-	-	2060T>C 	Leu687Pro	NM_000251.3	2	1_Pathogenic	MSH2	ENSG00000095002	7918	202694	CCSBVarC003015	ALE00003015	2060T>C	Leu687Pro	CEGS2	CegsMutGDEh1038	A11	GDEhDisVCh_40060	F07	2	CegsMutGDDh1038	A11	NULL	NULL	VUSMutpDEST2_07	F04	NULL	NULL	1	1	1	1	0	NULL	1	1	0	NULL	MSH2_Leu687Pro	2	2	47476421	T	C
359	CBS	1009A>C	Met337Leu	ENSG00000160200	21	43062341	NC_000021.9:43062341:T:G	ALE00007310	CCSBVarC007315	NULL	NULL	262	GDEhDisVCh_40013	H05	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCCTGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210419.0	single nucleotide variant	NM_000071.3(CBS):c.1009A>C (p.Met337Leu)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Nov 29, 2012	372822486.0	-	RCV000199004|RCV001276187	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394	not provided|Classic homocystinuria	germline	germline	GRCh38	NC_000021.9	21	43062341.0	43062341.0	21q22.3	criteria provided, single submitter	2.0	-	N	ClinGen:CA323553	2.0	212858.0	43062341.0	T	G	-	-	-	-	-	-	SCV000249701	-	-	1009A>C 	Met337Leu	NM_000071.3	1.0	4_VUS	chr21	A	C	21-43062341-A-C		212858	21	43062341	T	G	M	L	rs372822486	21	44482451	21	43355520	337	CBS	ENSG00000160200	ENST00000352178	ENSP00000344460	P35520	CBS_HUMAN	c.1009A>C	p.Met337Leu	c.1009A>C	p.Met337Leu	principal1	Y	1	.	.	-	ATG	1	0	T	T/T	T/T	T/T	T/T	0.027	0.46673	D	0.018	0.60067	D	0.001	0.07480	B	0.006	0.12129	B	.	.	.	.	.	.	-0.985	0.01194	N	-1.17	0.29897	N	0.384	0.42390	-0.0463	0.81200	T	0.5692	0.84341	D	10	0.44655436	0.58097	D	0.171349	0.84825	D	0.512	0.78984	0.496	0.58390	P35520	M337L	Loss of loop (P = 0.2237)| Loss of phosphorylation at T333 (P = 0.2689)| Gain of relative solvent accessibility (P = 0.2751)| Loss of helix (P = 0.3949)| Gain of solvent accessibility (P = 0.4496)	0.556891854595	0.55018	.	0.78528	.	0.34961	0.598840355873	0.52674	T	0.818532	0.95502	D	0.123323	0.66466	D	0.16507	0.80975	D	0.213451108219942	0.20873	T	0.973003	0.90270	D	0.60739166	0.72805	0.18332592	0.41174	0.5202491	0.67971	0.20886981	0.45043	-2.723	0.07505	T	0.0882	0.11852	B	0.626157392886746	0.64629	0.99426850	0.97510	0.725	0.84761	.	.	.	.	.	.	2.32782	0.29868	18.24	0.91650268886590203	0.21190	0.751827	0.69140	D	-0.454124378525553	0.23333	1.268497	-0.232769585219129	0.30053	1.709353	5.28	5.28	0.74083	2.92	0.53394	2.503	0.45168	3.967000	0.40874	0.58	0.29757	1.0	0.71675	1.000000	0.68239	0.137	0.19879	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109326	9.146950e-06	0	2	207618	9.633080e-06	0	2	236630	8.452010e-06	0	0	7156	0.000000e+00	0	0	17094	0.000000e+00	0	0	2314	0.000000e+00	0	1	9046	1.105460e-04	0	0	13388	0.000000e+00	0	0	42730	0.000000e+00	0	0	15684	0.000000e+00	0	1	9046	1.105460e-04	0	0	16170	0.000000e+00	0	0	30496	0.000000e+00	0	0	6188	0.000000e+00	0	2	13412	1.491200e-04	0	0	16726	0.000000e+00	0	0	89180	0.000000e+00	0	0	30590	0.000000e+00	0	2	13412	1.491200e-04	0	0	14876	0.000000e+00	0	0	34234	0.000000e+00	0	0	9562	0.000000e+00	0	2	17692	1.130450e-04	0	0	21558	0.000000e+00	0	0	102580	0.000000e+00	0	0	30510	0.000000e+00	0	2	17692	1.130450e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	not_provided|Classic_homocystinuria	criteria_provided,_single_submitter	NC_000021.9:g.43062341T>G	ClinGen:CA323553	CN517202|C0751202	236200	394	Tryptophan synthase beta chain-like, PALP domain	Met	Leu	210419	single nucleotide variant	NM_000071.3(CBS):c.1009A>C (p.Met337Leu)	875	CBS	HGNC:1550	Uncertain significance	0	Nov 29, 2012	372822486	-	RCV000199004|RCV001276187	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394	not provided|Classic homocystinuria	germline	germline	GRCh38	NC_000021.9	21	43062341	43062341	21q22.3	criteria provided, single submitter	2	-	N	ClinGen:CA323553	2	212858	43062341	T	G	-	-	-	-	-	-	SCV000249701	-	-	1009A>C 	Met337Leu	NM_000071.3	1	4_VUS	CBS	ENSG00000160200	359	262	CCSBVarC007315	ALE00007310	1009A>C	Met337Leu	Edgotyping3	VUSMutGDEh010	C12	GDEhDisVCh_40013	H05	1	VUSMutGDDh010	C12	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	5	0	NULL	0	NULL	0	NULL	CBS_Met337Leu	21	21	43062341	T	G
359	CBS	34C>T	Pro12Ser	ENSG00000160200	21	43072160	NC_000021.9:43072160:G:A	ALE00007356	CCSBVarC007368	NULL	NULL	329	GDEhDisVCh_40013	E12	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGTCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210453.0	single nucleotide variant	NM_000071.3(CBS):c.34C>T (p.Pro12Ser)	875.0	CBS	HGNC:1550	Conflicting classifications of pathogenicity	0.0	Jul 19, 2022	558259739.0	-	RCV000197083|RCV002229439|RCV002336521	MedGen:CN169374|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	not specified|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection	germline	germline	GRCh38	NC_000021.9	21	43072160.0	43072160.0	21q22.3	criteria provided, conflicting classifications	3.0	-	N	ClinGen:CA321523	2.0	212840.0	43072160.0	G	A	-	-	-	-	-	-	SCV000249674|SCV000833973|SCV002618684	-	-	34C>T 	Pro12Ser	NM_000071.3	1.0	3_Conflicting	chr21	C	T	21-43072160-C-T		212840	21	43072160	G	A	P	S	rs558259739	21	44492270	21	43365339	12	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.34C>T	p.Pro12Ser	c.34C>T	p.Pro12Ser	principal1	Y	1	.	.	-	CCC	1	0	G	./.	./.	./.	./.	1.0	0.00968	T	0.662	0.06574	T	0.0	0.02950	B	0.0	0.01384	B	.	.	.	.	.	.	-1.13	0.00937	N	0.11	0.05678	N	0.13	0.12427	0.3196	0.87819	D	0.7643	0.91955	D	10	0.025771528	0.00759	T	0.09967	0.77073	D	0.357	0.67610	0.081	0.00689	P35520	P12S	Gain of glycosylation at P12 (P = 0.0063)| Gain of phosphorylation at P12 (P = 0.0489)| Loss of relative solvent accessibility (P = 0.1807)| Loss of solvent accessibility (P = 0.1813)| Gain of catalytic residue at P12 (P = 0.2318)	0.232513804876	0.22479	.	0.14630	.	0.36618	0.304598122835	0.11083	T	0.325231	0.69419	T	-0.141087	0.29363	T	-0.25891	0.48603	T	0.0169604222991762	0.00445	T	.	0.19669	.	0.07125109	0.15616	0.034633152	0.02577	0.072464526	0.15973	0.032634035	0.02038	-3.096	0.11261	T	.	0.01962	.	0.0166690487046361	0.27964	0.97898430	0.95420	0.063	0.17447	.	.	.	.	.	.	-1.196273	0.00535	0.012	0.38576503882430407	0.02624	0.077676	0.15462	N	-1.95328655407844	0.00265	0.0114165	-2.01153728762329	0.00288	0.01278436	5.48	-11.0	0.00133	-5.19	0.04199	-2.711	0.00887	-1.260000	0.05909	-0.206	0.0855	0.0	0.06393	0.000000	0.08389	0.006	0.0734	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	108562	9.211330e-06	0	2	202268	9.887870e-06	0	2	231792	8.628430e-06	0	0	6994	0.000000e+00	0	0	17010	0.000000e+00	0	0	2278	0.000000e+00	0	0	8998	0.000000e+00	0	0	13338	0.000000e+00	0	0	42392	0.000000e+00	0	1	15654	6.388140e-05	0	1	15654	6.388140e-05	0	0	14876	0.000000e+00	0	0	30328	0.000000e+00	0	0	6008	0.000000e+00	0	0	13344	0.000000e+00	0	0	16656	0.000000e+00	0	0	85794	0.000000e+00	0	2	30540	6.548790e-05	0	2	30540	6.548790e-05	0	0	13682	0.000000e+00	0	0	34082	0.000000e+00	0	0	9422	0.000000e+00	0	0	17638	0.000000e+00	0	0	21178	0.000000e+00	0	0	99820	0.000000e+00	0	2	30464	6.565130e-05	0	2	30464	6.565130e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_specified|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_conflicting_classifications	NC_000021.9:g.43072160G>A	ClinGen:CA321523	C4707243|CN169374|C3150344	PS607086	91387	.	Pro	Ser	210453	single nucleotide variant	NM_000071.3(CBS):c.34C>T (p.Pro12Ser)	875	CBS	HGNC:1550	Conflicting classifications of pathogenicity	0	Jul 19, 2022	558259739	-	RCV000197083|RCV002229439|RCV002336521	MedGen:CN169374|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	not specified|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection	germline	germline	GRCh38	NC_000021.9	21	43072160	43072160	21q22.3	criteria provided, conflicting classifications	3	-	N	ClinGen:CA321523	2	212840	43072160	G	A	-	-	-	-	-	-	SCV000249674|SCV000833973|SCV002618684	-	-	34C>T 	Pro12Ser	NM_000071.3	1	3_Conflicting	CBS	ENSG00000160200	359	329	CCSBVarC007368	ALE00007356	34C>T	Pro12Ser	Edgotyping3	VUSMutGDEh011	D07	GDEhDisVCh_40013	E12	1	VUSMutGDDh011	D07	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	5	0	NULL	0	NULL	0	NULL	CBS_Pro12Ser	21	21	43072160	G	A
52861	F9	1136G>A	Arg379Gln	ENSG00000101981	X	139561821	NC_000023.11:139561821:G:A	ALE00004388	CCSBVarC004388	NULL	204382	NULL	GDEhDisVCh_40052	C02	CEGS2	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCAAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT	25652.0	single nucleotide variant	NM_000133.4(F9):c.1136G>A (p.Arg379Gln)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Nov 21, 2024	137852259.0	-	RCV000011359|RCV001000156|RCV000851995|RCV004799740|RCV001851792	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|not specified|Hereditary factor VIII deficiency disease|not provided|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561821.0	139561821.0	Xq27.1	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA255394,UniProtKB:P00740#VAR_006597,OMIM:300746.0056	3.0	10613.0	139561821.0	G	A	-	-	-	-	-	-	SCV000899436|SCV001156642|SCV002137345|SCV002765920|SCV005421306	-	-	1136G>A 	Arg379Gln	NM_000133.4	2.0	1_Pathogenic	chrX	G	A	X-139561821-G-A	9.1059e-7	10613	X	139561821	G	A	R	Q	rs137852259	X	138643980	X	138471646	379	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1136G>A	p.Arg379Gln	c.1136G>A	p.Arg379Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.052	0.39251	T	0.067	0.44850	T	0.985	0.61134	D	0.274	0.40038	B	0.89	0.91795	A	simple_aae	11.0	89.0	0.15	0.08820	N	-3.0	0.62369	D	0.313	0.73254	0.1942	0.85750	D	0.5944	0.85464	D	10	0.93273604	0.92526	D	0.603	0.96505	D	0.631	0.85753	0.951	0.99425	P00740	R379Q	Loss of sheet (P = 0.1158)| Loss of solvent accessibility (P = 0.2073)| Loss of MoRF binding (P = 0.2243)| Loss of phosphorylation at T381 (P = 0.2702)| Loss of loop (P = 0.2897)	0.995206253788	0.99508	0.9879215220694736	0.98782	1.44713708483	0.86008	0.352929472923	0.18333	T	0.835829	0.96094	D	0.253373	0.78760	D	0.126177	0.78484	D	0.958440780639648	0.65052	D	0.768423	0.39558	T	0.80942816	0.84316	0.69568026	0.81875	0.78737503	0.82899	0.5809159	0.75462	-3.268	0.13996	T	0.178	0.53911	B	0.983118799619526	0.86112	0.99996996	0.99978	0.901	0.94783	.	.	.	.	.	.	3.557492	0.50121	22.9	0.9994734402814196	0.99913	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	5.168	0.64897	9.997000	0.83047	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.974	0.5568	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	20	264690	7.556009E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1211705	8.252830e-07	0	1	895503	1.116690e-06	0	0	57750	0.000000e+00	0	0	689	0.000000e+00	0	0	46022	0.000000e+00	0	0	22040	0.000000e+00	0	0	33836	0.000000e+00	0	0	46886	0.000000e+00	0	0	4354	0.000000e+00	0	1	895503	1.116690e-06	0	0	56974	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|not_specified|Hereditary_factor_VIII_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561821G>A	ClinGen:CA255394|OMIM:300746.0056|UniProtKB:P00740#VAR_006597	C0008533|C2749016|CN169374|C0019069	306900|300807|134500|306700	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Gln	25652	single nucleotide variant	NM_000133.4(F9):c.1136G>A (p.Arg379Gln)	2158	F9	HGNC:3551	Pathogenic	1	Nov 21, 2024	137852259	-	RCV000011359|RCV001000156|RCV000851995|RCV004799740|RCV001851792	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|not specified|Hereditary factor VIII deficiency disease|not provided|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561821	139561821	Xq27.1	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA255394,UniProtKB:P00740#VAR_006597,OMIM:300746.0056	3	10613	139561821	G	A	-	-	-	-	-	-	SCV000899436|SCV001156642|SCV002137345|SCV002765920|SCV005421306	-	-	1136G>A 	Arg379Gln	NM_000133.4	2	1_Pathogenic	F9	ENSG00000101981	52861	204382	CCSBVarC004388	ALE00004388	1136G>A	Arg379Gln	CEGS2	CegsMutGDEh1011	C10	GDEhDisVCh_40052	C02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	F9_Arg379Gln	23	X	139561821	G	A
359	CBS	670C>T	Arg224Cys	ENSG00000160200	21	43065269	NC_000021.9:43065269:G:A	ALE00007321	CCSBVarC007329	NULL	NULL	282	GDEhDisVCh_40013	F07	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACTGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210431.0	single nucleotide variant	NM_000071.3(CBS):c.670C>T (p.Arg224Cys)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Mar 28, 2024	139456571.0	-	RCV000726462|RCV000556147|RCV002310758|RCV002517164|RCV003330558	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:C3150344|MedGen:CN169374	not provided|Classic homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not specified	germline	germline	GRCh38	NC_000021.9	21	43065269.0	43065269.0	21q22.3	criteria provided, multiple submitters, no conflicts	9.0	-	N	ClinGen:CA322963	2.0	212851.0	43065269.0	G	A	-	-	-	-	-	-	SCV000249689|SCV000318560|SCV000344856|SCV000649845|SCV001715597|SCV001748029|SCV001781421|SCV004039504	-	-	670C>T 	Arg224Cys	NM_000071.3	2.0	4_VUS	chr21	C	T	21-43065269-C-T		212851	21	43065269	G	A	R	C	rs139456571	21	44485379	21	43358448	224	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.670C>T	p.Arg224Cys	c.670C>T	p.Arg224Cys	principal1	Y	1	.	.	-	CGC	1	0	G	G/G	G/G	G/G	G/G	0.018	0.50835	D	0.05	0.48432	T	0.443	0.35957	B	0.133	0.33075	B	0.76	0.85499	D	simple_aae	24.0	76.0	2.06	0.56495	M	-4.8	0.80714	D	0.857	0.85414	1.1103	0.99867	D	0.9469	0.98263	D	10	0.9168539	0.90944	D	0.829068	0.98671	D	0.833	0.94713	.	.	.	.	.	0.893698342419	0.89183	.	0.90272	.	0.58649	0.716107010841	0.69427	T	0.958106	0.99436	D	0.268062	0.80121	D	0.459655	0.93741	D	0.510450065135956	0.32702	D	.	0.94110	.	0.81778246	0.84878	0.5497225	0.73713	0.83060294	0.85761	0.54815805	0.73625	-10.423	0.76479	D	.	0.44519	.	0.992089069143965	0.89336	0.99931800	0.99296	0.964	0.98523	.	.	.	.	.	.	5.763684	0.9345	33.0	0.99942733626700431	0.99848	0.936923	0.93370	D	0.32609883839065	0.57273	3.916688	0.384006054105913	0.60365	4.246965	4.84	3.92	0.44459	.	.	6.64	0.74237	8.217000	0.76856	0.578	0.29426	1.0	0.71675	1.000000	0.68239	0.935	0.4738	988	0.02004	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	.	.	.	.	14	109370	1.280060e-04	0	41	208026	1.970910e-04	0	48	236882	2.026330e-04	0	0	7154	0.000000e+00	0	0	17098	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13390	0.000000e+00	0	11	42760	2.572500e-04	0	3	15690	1.912050e-04	0	11	42760	2.572500e-04	0	1	16200	6.172840e-05	0	2	30502	6.556950e-05	0	0	6212	0.000000e+00	0	0	13408	0.000000e+00	0	0	16730	0.000000e+00	0	31	89504	3.463530e-04	0	6	30608	1.960270e-04	0	31	89504	3.463530e-04	0	1	14890	6.715920e-05	0	2	34236	5.841800e-05	0	0	9572	0.000000e+00	0	0	17690	0.000000e+00	0	0	21622	0.000000e+00	0	38	102726	3.699160e-04	0	6	30526	1.965540e-04	0	38	102726	3.699160e-04	0	.	31	1394598	2.222860e-05	10	2	57294	3.490770e-05	1	0	65706	0.000000e+00	0	0	770	0.000000e+00	0	0	55296	0.000000e+00	0	0	25718	0.000000e+00	0	0	44640	0.000000e+00	0	2	57294	3.490770e-05	1	0	5342	0.000000e+00	0	28	1000904	2.797470e-05	9	1	83606	1.196090e-05	0	48	177964	2.6971747094918074E-4	0	354	0	0	4498	0	1	8930	1.1198208286674133E-4	0	796	0	0	968	0	0	1842	0	0	276	0	5	17346	2.882508935777701E-4	1	9284	1.0771219302024989E-4	0	6340	0	54	212974	2.535520767793252E-4	Uncertain_significance	Classic_homocystinuria|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_provided|not_specified|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43065269G>A	ClinGen:CA322963	C0751202|C4707243|C3661900|CN169374|C3150344	236200|PS607086	394|91387	Tryptophan synthase beta chain-like, PALP domain	Arg	Cys	210431	single nucleotide variant	NM_000071.3(CBS):c.670C>T (p.Arg224Cys)	875	CBS	HGNC:1550	Uncertain significance	0	Mar 28, 2024	139456571	-	RCV000726462|RCV000556147|RCV002310758|RCV002517164|RCV003330558	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:C3150344|MedGen:CN169374	not provided|Classic homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not specified	germline	germline	GRCh38	NC_000021.9	21	43065269	43065269	21q22.3	criteria provided, multiple submitters, no conflicts	9	-	N	ClinGen:CA322963	2	212851	43065269	G	A	-	-	-	-	-	-	SCV000249689|SCV000318560|SCV000344856|SCV000649845|SCV001715597|SCV001748029|SCV001781421|SCV004039504	-	-	670C>T 	Arg224Cys	NM_000071.3	2	4_VUS	CBS	ENSG00000160200	359	282	CCSBVarC007329	ALE00007321	670C>T	Arg224Cys	Edgotyping3	VUSMutGDEh011	D02	GDEhDisVCh_40013	F07	1	VUSMutGDDh011	D02	NULL	NULL	NULL	NULL	NULL	NULL	1	5	1	5	0	NULL	0	NULL	0	NULL	CBS_Arg224Cys	21	21	43065269	G	A
2803	HMBS	518G>A	Arg173Gln	ENSG00000256269	11	119091432	NC_000011.10:119091432:G:A	ALE00005166	CCSBVarC005166	NULL	200932	NULL	GDEhDisVCh_40054	G05	CEGS2	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAGCTTGCTCGCATACAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGGACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCTTGAACATGCCCTGGAGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCGAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTCGGGGAAACCTCAACACCCAGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACCGGGTGGGGCAGATCCTGCACCCTGAGGAATGCATGTATGCTGTGGGCCAGGGGGCCTTGGGCGTGGAAGTGCGAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCTGCATCGCTGAAAGGGCCTTCCTGAGGCACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATGGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCGTAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACGATGCCCAT	16486.0	single nucleotide variant	NM_000190.4(HMBS):c.518G>A (p.Arg173Gln)	3145.0	HMBS	HGNC:4982	Pathogenic	1.0	Mar 17, 2023	118204096.0	-	RCV000001512|RCV001851550|RCV003764511	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704	Acute intermittent porphyria|not provided|Encephalopathy, porphyria-related	germline	germline	GRCh38	NC_000011.10	11	119091432.0	119091432.0	11q23.3	criteria provided, single submitter	2.0	-	N	ClinGen:CA251797,UniProtKB:P08397#VAR_003653,OMIM:609806.0006	3.0	1447.0	119091432.0	G	A	-	-	-	-	-	-	SCV002239477	-	-	518G>A 	Arg173Gln	NM_000190.4	1.0	1_Pathogenic	chr11	G	A	11-119091432-G-A	1.42921e-6	1447	11	119091432	G	A	R	Q	rs118204096	11	118962142	11	118467352	173	HMBS	ENSG00000256269	ENST00000652429	ENSP00000498786	P08397	HEM3_HUMAN	c.518G>A	p.Arg173Gln	c.518G>A	p.Arg173Gln	principal2	Y	.	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	0.999	0.92348	D	.	0.99291	.	.	.	.	4.47	0.98862	H	.	0.73186	.	.	0.99110	0.9241	0.96005	D	0.9976	0.99940	D	9	.	0.99848	.	0.821559	0.98609	D	.	0.98634	0.995	0.99946	P08397	R173Q	Loss of MoRF binding (P = 0.0536)| Loss of ubiquitination at K176 (P = 0.0896)| Gain of methylation at K176 (P = 0.0989)| Loss of catalytic residue at R173 (P = 0.1174)| Gain of disorder (P = 0.1932)	.	0.98920	0.9591060731281039	0.95871	.	.	0.699745595455	0.67052	T	0.996674	0.99995	D	0.586753	0.97309	D	0.605054	0.97265	D	0.999946236610413	0.99828	D	0.994301	0.98139	D	0.9701812	0.98248	0.9275634	0.96882	0.97552854	0.98729	0.8991726	0.94848	-13.148	0.90849	D	0.9954	0.96786	P	0.999852158607011	0.98365	0.35481197	0.78420	0.997	0.99892	.	.	.	.	.	.	6.149691	0.94679	34.0	0.99937155143951062	0.99661	0.906816	0.85955	D	1.12239435646449	0.98520	18.53718	1.01935734208314	0.98962	20.07949	5.95	5.95	0.96408	5.91	0.96850	9.934	0.98847	11.823000	0.97301	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	228	0.91137	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1551720	1.288890e-06	0	2	1146970	1.743720e-06	0	0	73184	0.000000e+00	0	0	912	0.000000e+00	0	0	51000	0.000000e+00	0	0	28652	0.000000e+00	0	0	40930	0.000000e+00	0	0	59902	0.000000e+00	0	0	5990	0.000000e+00	0	2	1146970	1.743720e-06	0	0	84064	0.000000e+00	0	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Encephalopathy,_porphyria-related|Acute_intermittent_porphyria|not_provided	criteria_provided,_single_submitter	NC_000011.10:g.119091432G>A	ClinGen:CA251797|OMIM:609806.0006|UniProtKB:P08397#VAR_003653	CN376852|C0162565|C3661900	620704|176000	79276	Porphobilinogen deaminase, N-terminal	Arg	Gln	16486	single nucleotide variant	NM_000190.4(HMBS):c.518G>A (p.Arg173Gln)	3145	HMBS	HGNC:4982	Pathogenic	1	Mar 17, 2023	118204096	-	RCV000001512|RCV001851550|RCV003764511	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704	Acute intermittent porphyria|not provided|Encephalopathy, porphyria-related	germline	germline	GRCh38	NC_000011.10	11	119091432	119091432	11q23.3	criteria provided, single submitter	2	-	N	ClinGen:CA251797,UniProtKB:P08397#VAR_003653,OMIM:609806.0006	3	1447	119091432	G	A	-	-	-	-	-	-	SCV002239477	-	-	518G>A 	Arg173Gln	NM_000190.4	1	1_Pathogenic	HMBS	ENSG00000256269	2803	200932	CCSBVarC005166	ALE00005166	518G>A	Arg173Gln	CEGS2	CegsMutGDEh1040	H06	GDEhDisVCh_40054	G05	2	CegsMutGDDh1040	H06	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	HMBS_Arg173Gln	11	11	119091432	G	A
8459	ASPA	584T>G	Met195Arg	ENSG00000108381	17	3489292	NC_000017.11:3489292:T:G	ALE00001385	CCSBVarC001385	15707	NULL	NULL	GDEhDisVCh_40040	E04	RC4	ATGACTTCTTGTCACATTGCTGAAGAACATATACAAAAGGTTGCTATCTTTGGAGGAACCCATGGGAATGAGCTAACCGGAGTATTTCTGGTTAAGCATTGGCTAGAGAATGGCGCTGAGATTCAGAGAACAGGGCTGGAGGTAAAACCATTTATTACTAACCCCAGAGCAGTGAAGAAGTGTACCAGATATATTGACTGTGACCTGAATCGCATTTTTGACCTTGAAAATCTTGGCAAAAAAATGTCAGAAGATTTGCCATATGAAGTGAGAAGGGCTCAAGAAATAAATCATTTATTTGGTCCAAAAGACAGTGAAGATTCCTATGACATTATTTTTGACCTTCACAACACCACCTCTAACATGGGGTGCACTCTTATTCTTGAGGATTCCAGGAATAACTTTTTAATTCAGATGTTTCATTACATTAAGACTTCTCTGGCTCCACTACCCTGCTACGTTTATCTGATTGAGCATCCTTCCCTCAAATATGCGACCACTCGTTCCATAGCCAAGTATCCTGTGGGTATAGAAGTTGGTCCTCAGCCTCAAGGGGTTCTGAGAGCTGATATCTTGGATCAAAGGAGAAAAATGATTAAACATGCTCTTGATTTTATACATCATTTCAATGAAGGAAAAGAATTTCCTCCCTGCGCCATTGAGGTCTATAAAATTATAGAGAAAGTTGATTACCCCCGGGATGAAAATGGAGAAATTGCTGCTATCATCCATCCTAATCTGCAGGATCAAGACTGGAAACCACTGCATCCTGGGGATCCCATGTTTTTAACTCTTGATGGGAAGACGATCCCACTGGGCGGAGACTGTACCGTGTACCCCGTGTTTGTGAATGAGGCCGCATATTACGAAAAGAAAGAAGCTTTTGCAAAGACAACTAAACTAACGCTCAATGCAAAAAGTATTCGCTGCTGTTTACAT																																															chr17	T	G	17-3489292-T-G	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																													ASPA	ENSG00000108381	8459	15707	CCSBVarC001385	ALE00001385	584T>G	Met195Arg	RC4	RC4_Mut_GDEh1016	F01	GDEhDisVCh_40040	E04	2	RC4_Mut_GDDh1016	F01	NULL	NULL	NULL	NULL	NULL	NULL	1	2	1	1	0	NULL	0	NULL	0	NULL	ASPA_Met195Arg	17	17	3489292	T	G
8459	ASPA	71A>G	Glu24Gly	ENSG00000108381	17	3476230	NC_000017.11:3476230:A:G	ALE00001383	CCSBVarC001383	15684	NULL	NULL	GDEhDisVCh_40040	C04	RC4	ATGACTTCTTGTCACATTGCTGAAGAACATATACAAAAGGTTGCTATCTTTGGAGGAACCCATGGGAATGGGCTAACCGGAGTATTTCTGGTTAAGCATTGGCTAGAGAATGGCGCTGAGATTCAGAGAACAGGGCTGGAGGTAAAACCATTTATTACTAACCCCAGAGCAGTGAAGAAGTGTACCAGATATATTGACTGTGACCTGAATCGCATTTTTGACCTTGAAAATCTTGGCAAAAAAATGTCAGAAGATTTGCCATATGAAGTGAGAAGGGCTCAAGAAATAAATCATTTATTTGGTCCAAAAGACAGTGAAGATTCCTATGACATTATTTTTGACCTTCACAACACCACCTCTAACATGGGGTGCACTCTTATTCTTGAGGATTCCAGGAATAACTTTTTAATTCAGATGTTTCATTACATTAAGACTTCTCTGGCTCCACTACCCTGCTACGTTTATCTGATTGAGCATCCTTCCCTCAAATATGCGACCACTCGTTCCATAGCCAAGTATCCTGTGGGTATAGAAGTTGGTCCTCAGCCTCAAGGGGTTCTGAGAGCTGATATCTTGGATCAAATGAGAAAAATGATTAAACATGCTCTTGATTTTATACATCATTTCAATGAAGGAAAAGAATTTCCTCCCTGCGCCATTGAGGTCTATAAAATTATAGAGAAAGTTGATTACCCCCGGGATGAAAATGGAGAAATTGCTGCTATCATCCATCCTAATCTGCAGGATCAAGACTGGAAACCACTGCATCCTGGGGATCCCATGTTTTTAACTCTTGATGGGAAGACGATCCCACTGGGCGGAGACTGTACCGTGTACCCCGTGTTTGTGAATGAGGCCGCATATTACGAAAAGAAAGAAGCTTTTGCAAAGACAACTAAACTAACGCTCAATGCAAAAAGTATTCGCTGCTGTTTACAT	17653.0	single nucleotide variant	NM_000049.4(ASPA):c.71A>G (p.Glu24Gly)	443.0	ASPA	HGNC:756	Likely pathogenic	1.0	Dec 13, 2023	104894551.0	-	RCV000002732	MONDO:MONDO:0010079,MedGen:C0206307,OMIM:271900,Orphanet:141	Spongy degeneration of central nervous system	germline;unknown	germline	GRCh38	NC_000017.11	17	3476230.0	3476230.0	17p13.2	criteria provided, single submitter	2.0	-	N	OMIM:608034.0010,ClinGen:CA252362,UniProtKB:P45381#VAR_016782	3.0	2614.0	3476230.0	A	G	-	-	-	-	-	-	SCV004202426	-	-	71A>G 	Glu24Gly	NM_000049.4	1.0	1_Pathogenic	chr17	A	G	17-3476230-A-G	6.84072e-7	2614	17	3476230	A	G	E	G	rs104894551	17	3379524	17	3326274	24	ASPA	ENSG00000108381	ENST00000263080	ENSP00000263080	P45381	ACY2_HUMAN	c.71A>G	p.Glu24Gly	c.71A>G	p.Glu24Gly	principal1	Y	1	YES	Select	+	GAG	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.9	0.92286	A	simple_aae	10.0	90.0	3.445	0.92067	M	-6.61	0.92107	D	0.98	0.99026	1.0773	0.98795	D	0.9998	0.99987	D	9	0.993685	0.99892	D	0.560225	0.95975	D	0.972	0.99695	0.987	0.99867	P45381	E24G	Loss of stability (P = 0.0574)| Gain of catalytic residue at L25 (P = 0.1775)| Loss of helix (P = 0.2662)| Loss of disorder (P = 0.4304)| Loss of glycosylation at T20 (P = 0.4416)	0.994473814415	0.99434	0.9930298597615689	0.99297	0.444316458929	0.44059	0.588556230068	0.51223	T	0.98839	0.99940	D	0.560027	0.96202	D	0.566663	0.96142	D	0.999348104000092	0.97016	D	0.915108	0.77362	D	0.91941285	0.93089	0.91032493	0.95651	0.9544493	0.96667	0.8993103	0.94858	-11.895	0.84380	D	0.9808	0.91280	P	0.998952539306041	0.95387	0.99120400	0.96923	0.983	0.99413	.	.	.	.	.	.	5.532113	0.91891	32.0	0.99926947653275833	0.99164	0.963960	0.98594	D	0.93346184918611	0.93263	11.94884	0.869394993080095	0.94063	12.502	5.44	5.44	0.79319	3.48	0.63010	9.065	0.9338	11.191000	0.88680	0.731	0.85655	1.0	0.71675	1.000000	0.68239	0.981	0.58703	754	0.51253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614172	6.195130e-07	0	1	91090	1.097820e-05	0	0	75058	0.000000e+00	0	0	912	0.000000e+00	0	0	60024	0.000000e+00	0	0	29602	0.000000e+00	0	0	44880	0.000000e+00	0	0	64016	0.000000e+00	0	0	6062	0.000000e+00	0	0	1180022	0.000000e+00	0	1	91090	1.097820e-05	0	0	76	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	106	0	0	434	0	0	34	0	0	656	0	Likely_pathogenic	Spongy_degeneration_of_central_nervous_system	criteria_provided,_single_submitter	NC_000017.11:g.3476230A>G	ClinGen:CA252362|OMIM:608034.0010|UniProtKB:P45381#VAR_016782	C0206307	271900	141	.	Glu	Gly	17653	single nucleotide variant	NM_000049.4(ASPA):c.71A>G (p.Glu24Gly)	443	ASPA	HGNC:756	Likely pathogenic	1	Dec 13, 2023	104894551	-	RCV000002732	MONDO:MONDO:0010079,MedGen:C0206307,OMIM:271900,Orphanet:141	Spongy degeneration of central nervous system	germline;unknown	germline	GRCh38	NC_000017.11	17	3476230	3476230	17p13.2	criteria provided, single submitter	2	-	N	OMIM:608034.0010,ClinGen:CA252362,UniProtKB:P45381#VAR_016782	3	2614	3476230	A	G	-	-	-	-	-	-	SCV004202426	-	-	71A>G 	Glu24Gly	NM_000049.4	1	1_Pathogenic	ASPA	ENSG00000108381	8459	15684	CCSBVarC001383	ALE00001383	71A>G	Glu24Gly	RC4	RC4_Mut_GDEh1016	D01	GDEhDisVCh_40040	C04	2	RC4_Mut_GDDh1016	D01	NULL	NULL	NULL	NULL	NULL	NULL	1	7	1	1	0	NULL	0	NULL	0	NULL	ASPA_Glu24Gly	17	17	3476230	A	G
359	CBS	1109G>A	Cys370Tyr	ENSG00000160200	21	43060477	NC_000021.9:43060477:C:T	ALE00007305	CCSBVarC007309	NULL	NULL	254	GDEhDisVCh_40013	B05	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTACGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	410876.0	single nucleotide variant	NM_000071.3(CBS):c.1109G>A (p.Cys370Tyr)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Sep 16, 2024	757920190.0	-	RCV000482454|RCV003155205|RCV003464007|RCV003495133	MedGen:C3661900|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344	not provided|Homocystinuria|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;unknown	germline	GRCh38	NC_000021.9	21	43060477.0	43060477.0	21q22.3	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA16621012	2.0	420089.0	43060477.0	C	T	-	-	-	-	-	-	SCV000568648|SCV003844249|SCV004213854|SCV004281679	-	-	1109G>A 	Cys370Tyr	NM_000071.3	2.0	1_Pathogenic	chr21	G	A	21-43060477-G-A		420089	21	43060477	C	T	C	Y	rs757920190	21	44480587	21	43353656	370	CBS	ENSG00000160200	ENST00000398165	ENSP00000381231	P35520	CBS_HUMAN	c.1109G>A	p.Cys370Tyr	c.1109G>A	p.Cys370Tyr	principal1	Y	1	YES	Select	-	TGC	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	0.996	0.84488	D	1.0	0.99291	A	simple_aae	0.0	100.0	2.975	0.85240	M	-9.84	0.98705	D	0.947	0.95504	1.1004	0.99677	D	0.9459	0.98229	D	10	0.99154735	0.99680	D	0.846484	0.98812	D	0.958	0.99315	0.881	0.96866	P35520	C370Y	Gain of phosphorylation at C370 (P = 0.0517)| Loss of catalytic residue at V372 (P = 0.0772)| Loss of sheet (P = 0.0817)| Gain of disorder (P = 0.1155)| Gain of MoRF binding (P = 0.1946)	0.924946054921	0.92360	0.9619133811296562	0.96155	1.48192362878	0.86652	0.810161828995	0.83488	D	0.981121	0.99850	D	0.48326	0.93762	D	0.539258	0.95366	D	0.999585807323456	0.98005	D	.	0.96681	.	0.98742336	0.99613	0.9593627	0.98920	0.9907052	0.99796	0.96293586	0.99113	-16.061	0.97855	D	.	0.83458	.	0.998930983132326	0.95346	0.99972278	0.99643	0.983	0.99413	.	.	.	.	.	.	4.874884	0.79937	27.2	0.99712561999427363	0.81441	0.963631	0.98552	D	0.803834029992883	0.86270	8.855725	0.716804924230221	0.83567	8.078992	4.9	4.9	0.63598	.	.	7.501	0.80483	7.385000	0.58543	0.469	0.21904	1.0	0.71675	1.000000	0.68239	0.646	0.32626	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	107470	9.304920e-06	0	3	204546	1.466660e-05	0	2	234566	8.526380e-06	0	0	7138	0.000000e+00	0	0	17098	0.000000e+00	0	0	2320	0.000000e+00	0	0	9038	0.000000e+00	0	0	11556	0.000000e+00	0	1	42736	2.339950e-05	0	0	15688	0.000000e+00	0	1	42736	2.339950e-05	0	0	16030	0.000000e+00	0	1	30474	3.281490e-05	0	0	6162	0.000000e+00	0	0	13314	0.000000e+00	0	0	14892	0.000000e+00	0	2	88256	2.266130e-05	0	0	30604	0.000000e+00	0	1	30474	3.281490e-05	0	0	14830	0.000000e+00	0	0	34244	0.000000e+00	0	0	9552	0.000000e+00	0	0	17684	0.000000e+00	0	0	19790	0.000000e+00	0	2	102350	1.954080e-05	0	0	30522	0.000000e+00	0	2	102350	1.954080e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6062	0	0	8	0	0	26	0	0	586	0	0	0	0	0	0	0	0	30	0	0	0	0	1	2276	4.393673110720562E-4	0	594	0	0	56	0	1	8988	1.1125945705384957E-4	Pathogenic/Likely_pathogenic	Homocystinuria|Hereditary_breast_ovarian_cancer_syndrome|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|not_provided|Classic_homocystinuria	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43060477C>T	ClinGen:CA16621012	C0019880|C0677776|C3150344|C3661900|C0751202	236200	145|394	Tryptophan synthase beta chain-like, PALP domain	Cys	Tyr	410876	single nucleotide variant	NM_000071.3(CBS):c.1109G>A (p.Cys370Tyr)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Sep 16, 2024	757920190	-	RCV000482454|RCV003155205|RCV003464007|RCV003495133	MedGen:C3661900|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344	not provided|Homocystinuria|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;unknown	germline	GRCh38	NC_000021.9	21	43060477	43060477	21q22.3	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA16621012	2	420089	43060477	C	T	-	-	-	-	-	-	SCV000568648|SCV003844249|SCV004213854|SCV004281679	-	-	1109G>A 	Cys370Tyr	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	254	CCSBVarC007309	ALE00007305	1109G>A	Cys370Tyr	Edgotyping3	VUSMutGDEh010	E11	GDEhDisVCh_40013	B05	1	VUSMutGDDh010	E11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	5	0	NULL	0	NULL	0	NULL	CBS_Cys370Tyr	21	21	43060477	C	T
52861	F9	804T>G	Cys268Trp	ENSG00000101981	X	139560821	NC_000023.11:139560821:T:G	ALE00004381	CCSBVarC004381	NULL	204367	NULL	GDEhDisVCh_40052	B03	CEGS2	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGGGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT	25638.0	single nucleotide variant	NM_000133.4(F9):c.804T>G (p.Cys268Trp)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Sep 01, 1989	137852246.0	-	RCV000011345	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139560821.0	139560821.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255363,UniProtKB:P00740#VAR_017313,OMIM:300746.0040	1.0	10599.0	139560821.0	T	G	-	-	-	-	-	-	SCV000031577	-	-	804T>G 	Cys268Trp	NM_000133.4		1_Pathogenic	chrX	T	G	X-139560821-T-G		10599	X	139560821	T	G	C	W	rs137852246	X	138642980	X	138470646	268	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.804T>G	p.Cys268Trp	c.804T>G	p.Cys268Trp	principal1	Y	1	YES	Select	+	TGT	3	2	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.82	0.88440	A	simple_aae	18.0	82.0	4.215	0.97851	H	-10.32	0.98976	D	0.939	0.95034	1.0605	0.98348	D	0.9649	0.98877	D	10	0.99231	0.99766	D	0.910024	0.99327	D	0.828	0.94525	0.992	0.99914	P00740	C268W	Gain of MoRF binding (P = 0.0431)| Loss of catalytic residue at H267 (P = 0.1073)| Gain of sheet (P = 0.1451)| Gain of loop (P = 0.2754)| Loss of glycosylation at T264 (P = 0.2896)	0.999785564942	0.99978	0.9999343672497478	0.99993	1.9161241583	0.92915	0.590369582176	0.51479	T	0.972905	0.99716	D	0.636315	0.99872	D	0.676246	0.99871	D	0.999935746192932	0.99780	D	0.825917	0.49905	T	0.98821485	0.99661	0.97395056	0.99619	0.9833401	0.99342	0.96807534	0.99369	-13.591	0.91669	D	0.993	0.95230	P	0.999868267252352	0.98431	0.99999190	0.99996	0.961	0.98360	.	.	.	.	.	.	2.107523	0.26863	17.25	0.9891336906416559	0.48514	.	.	.	.	.	.	.	.	.	5.84	-1.12	0.09280	-3.7	0.06893	0.016	0.13313	-0.210000	0.10908	0.609	0.47831	0.008	0.17977	0.001000	0.17376	0.472	0.28435	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139560821T>G	ClinGen:CA255363|OMIM:300746.0040|UniProtKB:P00740#VAR_017313	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Trp	25638	single nucleotide variant	NM_000133.4(F9):c.804T>G (p.Cys268Trp)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852246	-	RCV000011345	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139560821	139560821	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255363,UniProtKB:P00740#VAR_017313,OMIM:300746.0040	1	10599	139560821	T	G	-	-	-	-	-	-	SCV000031577	-	-	804T>G 	Cys268Trp	NM_000133.4		1_Pathogenic	F9	ENSG00000101981	52861	204367	CCSBVarC004381	ALE00004381	804T>G	Cys268Trp	CEGS2	CegsMutGDEh1017	E01	GDEhDisVCh_40052	B03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	F9_Cys268Trp	23	X	139560821	T	G
3689	GCK	907C>T	Arg303Trp	ENSG00000106633	7	44146575	NC_000007.14:44146575:G:A	ALE00006691	CCSBVarC006693	NULL	214847	NULL	GDEhDisVCh_40037	C05	CEGS2	ATGCTGGACGACAGAGCCAGGATGGAGGCCGCCAAGAAGGAGAAGGTAGAGCAGATCCTGGCAGAGTTCCAGCTGCAGGAGGAGGACCTGAAGAAGGTGATGAGACGGATGCAGAAGGAGATGGACCGCGGCCTGAGGCTGGAGACCCATGAAGAGGCCAGTGTGAAGATGCTGCCCACCTACGTGCGCTCCACCCCAGAAGGCTCAGAAGTCGGGGACTTCCTCTCCCTGGACCTGGGTGGCACTAACTTCAGGGTGATGCTGGTGAAGGTGGGAGAAGGTGAGGAGGGGCAGTGGAGCGTGAAGACCAAACACCAGATGTACTCCATCCCCGAGGACGCCATGACCGGCACTGCTGAGATGCTCTTCGACTACATCTCTGAGTGCATCTCCGACTTCCTGGACAAGCATCAGATGAAACACAAGAAGCTGCCCCTGGGCTTCACCTTCTCCTTTCCTGTGAGGCACGAAGACATCGATAAGGGCATCCTTCTCAACTGGACCAAGGGCTTCAAGGCCTCAGGAGCAGAAGGGAACAATGTCGTGGGGCTTCTGCGAGACGCTATCAAACGGAGAGGGGACTTTGAAATGGATGTGGTGGCAATGGTGAATGACACGGTGGCCACGATGATCTCCTGCTACTACGAAGACCATCAGTGCGAGGTCGGCATGATCGTGGGCACGGGCTGCAATGCCTGCTACATGGAGGAGATGCAGAATGTGGAGCTGGTGGAGGGGGACGAGGGCCGCATGTGCGTCAATACCGAGTGGGGCGCCTTCGGGGACTCCGGCGAGCTGGACGAGTTCCTGCTGGAGTATGACCGCCTGGTGGACGAGAGCTCTGCAAACCCCGGTCAGCAGCTGTATGAGAAGCTCATAGGTGGCAAGTACATGGGCGAGCTGGTGTGGCTTGTGCTGCTCAGGCTCGTGGACGAAAACCTGCTCTTCCACGGGGAGGCCTCCGAGCAGCTGCGCACACGCGGAGCCTTCGAGACGCGCTTCGTGTCGCAGGTGGAGAGCGACACGGGCGACCGCAAGCAGATCTACAACATCCTGAGCACGCTGGGGCTGCGACCCTCGACCACCGACTGCGACATCGTGCGCCGCGCCTGCGAGAGCGTGTCTACGCGCGCTGCGCACATGTGCTCGGCGGGGCTGGCGGGCGTCATCAACCGCATGCGCGAGAGCCGCAGCGAGGACGTAATGCGCATCACTGTGGGCGTGGATGGCTCCGTGTACAAGCTGCACCCCAGCTTCAAGGAGCGGTTCCATGCCAGCGTGCGCAGGCTGACGCCCAGCTGCGAGATCACCTTCATCGAGTCGGAGGAGGGCAGTGGCCGGGGCGCGGCCCTGGTCTCGGCGGTGGCCTGTAAGAAGGCCTGTATGCTGGGCCAG	44928.0	single nucleotide variant	NM_000162.5(GCK):c.907C>T (p.Arg303Trp)	2645.0	GCK	HGNC:4195	Likely pathogenic	1.0	Oct 20, 2023	193922336.0	-	RCV000029927|RCV000711788|RCV002371788	MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:C3661900|Human Phenotype Ontology:HP:0004904,MONDO:MONDO:0018911,MedGen:C0342276,OMIM:606391,Orphanet:552	Maturity-onset diabetes of the young type 2|not provided|Maturity onset diabetes mellitus in young	germline	germline	GRCh38	NC_000007.14	7	44146575.0	44146575.0	7p13	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA213862	2.0	36264.0	44146575.0	G	A	-	-	-	-	-	-	SCV000052582|SCV000842185|SCV002688544|SCV004295150	-	-	907C>T 	Arg303Trp	NM_000162.5	2.0	1_Pathogenic	chr7	C	T	7-44146575-C-T		36264	7	44146575	G	A	R	W	rs193922336	7	44186174	7	44152699	303	GCK	ENSG00000106633	ENST00000403799	ENSP00000384247	P35557	HXK4_HUMAN	c.907C>T	p.Arg303Trp	c.907C>T	p.Arg303Trp	principal1	Y	1	YES	Select	-	CGG	1	2	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.996	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.91	0.96121	H	-7.43	0.95620	D	0.984	0.99346	1.0240	0.97601	D	0.9827	0.99470	D	10	0.9946202	0.99953	D	0.874274	0.99037	D	0.971	0.99671	0.983	0.99835	P35557	R303W	Gain of catalytic residue at L301 (P = 0.0054)| Loss of MoRF binding (P = 0.2334)| Loss of methylation at R303 (P = 0.529)| Loss of helix (P = 0.5596)| Loss of disorder (P = 0.704)	0.990771566325	0.99056	.	0.99530	.	0.96238	0.825230181217	0.85806	D	0.963923	0.99552	D	0.535654	0.95277	D	0.531653	0.95208	D	0.999597728252411	0.98050	D	0.99598	0.98629	D	0.9196614	0.93114	0.86529386	0.92441	0.9396137	0.95135	0.86898375	0.92699	-14.04	0.93199	D	0.9475	0.89484	P	0.999429393664456	0.96550	0.99983537	0.99792	0.981	0.99334	.	.	.	.	.	.	5.83412	0.9376	33.0	0.999174190492922	0.98519	0.892615	0.82911	D	0.801043153705935	0.86095	8.800712	0.663109094355815	0.79479	7.114674	4.77	3.78	0.42561	1.37	0.32764	3.129	0.5029	3.042000	0.36167	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.956	0.50825	712	0.56407	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1612312	6.202270e-07	0	1	62198	1.607770e-05	0	0	75046	0.000000e+00	0	0	912	0.000000e+00	0	0	60032	0.000000e+00	0	0	29602	0.000000e+00	0	0	44862	0.000000e+00	0	1	62198	1.607770e-05	0	0	6062	0.000000e+00	0	0	1180014	0.000000e+00	0	0	91086	0.000000e+00	0	0	7040	0	0	84	0	0	118	0	0	2642	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2726	0	0	142	0	0	11338	0	Likely_pathogenic	not_provided|Maturity-onset_diabetes_of_the_young_type_2|Maturity_onset_diabetes_mellitus_in_young	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.44146575G>A	ClinGen:CA213862	C3661900|C0342277|C0342276	125851|606391	552|552	Hexokinase, C-terminal	Arg	Trp	44928	single nucleotide variant	NM_000162.5(GCK):c.907C>T (p.Arg303Trp)	2645	GCK	HGNC:4195	Likely pathogenic	1	Oct 20, 2023	193922336	-	RCV000029927|RCV000711788|RCV002371788	MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:C3661900|Human Phenotype Ontology:HP:0004904,MONDO:MONDO:0018911,MedGen:C0342276,OMIM:606391,Orphanet:552	Maturity-onset diabetes of the young type 2|not provided|Maturity onset diabetes mellitus in young	germline	germline	GRCh38	NC_000007.14	7	44146575	44146575	7p13	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA213862	2	36264	44146575	G	A	-	-	-	-	-	-	SCV000052582|SCV000842185|SCV002688544|SCV004295150	-	-	907C>T 	Arg303Trp	NM_000162.5	2	1_Pathogenic	GCK	ENSG00000106633	3689	214847	CCSBVarC006693	ALE00006691	907C>T	Arg303Trp	CEGS2	CegsMutGDEh1045	B08	GDEhDisVCh_40037	C05	1	CegsMutGDDh1045	B08	VUSN2Hmut_GDN2h_09	E10	VUSMutpDEST2_03	D09	VUSmut_GDEh09	E10	1	1	1	1	1	1	1	4	1	1	GCK_Arg303Trp	7	7	44146575	G	A
14613	BRCA1	346G>A	Glu116Lys	ENSG00000012048	17	43104217	NC_000017.11:43104217:C:T	ALE00003298	CCSBVarC003298	NULL	218399	NULL	GDEhDisVCh_40059	G09	CEGS2	ATGGATTTATCTGCTCTTCGCGTTGAAGAAGTACAAAATGTCATTAATGCTATGCAGAAAATCTTAGAGTGTCCCATCTGTCTGGAGTTGATCAAGGAACCTGTCTCCACAAAGTGTGACCACATATTTTGCAAATTTTGCATGCTGAAACTTCTCAACCAGAAGAAAGGGCCTTCACAGTGTCCTTTATGTAAGAATGATATAACCAAAAGGAGCCTACAAGAAAGTACGAGATTTAGTCAACTTGTTGAAGAGCTATTGAAAATCATTTGTGCTTTTCAGCTTGACACAGGTTTGGAGTATGCAAACAGCTATAATTTTGCAAAAAAGGAAAATAACTCTCCTAAACATCTAAAAGATGAAGTTTCTATCATCCAAAGTATGGGCTACAGAAACCGTGCCAAAAGACTTCTACAGAGTGAACCCGAAAATCCTTCCTTGCAGGAAACCAGTCTCAGTGTCCAACTCTCTAACCTTGGAACTGTGAGAACTCTGAGGACAAAGCAGCGGATACAACCTCAAAAGACGTCTGTCTACATTGAATTGGGATCTGATTCTTCTGAAGATACCGTTAATAAGGCAACTTATTGCAGTGTGGGAGATCAAGAATTGTTACAAATCACCCCTCAAGGAACCAGGGATGAAATCAGTTTGGATTCTGCAAAAAAGGCTGCTTGTGAATTTTCTGAGACGGATGTAACAAATACTGAACATCATCAACCCAGTAATAATGATTTGAACACCACTGAGAAGCGTGCAGCTGAGAGGCATCCAGAAAAGTATCAGGGTGAAGCAGCATCTGGGTGTGAGAGTGAAACAAGCGTCTCTGAAGACTGCTCAGGGCTATCCTCTCAGAGTGACATTTTAACCACTCAGCAGAGGGATACCATGCAACATAACCTGATAAAGCTCCAGCAGGAAATGGCTGAACTAGAAGCTGTGTTAGAACAGCATGGGAGCCAGCCTTCTAACAGCTACCCTTCCATCATAAGTGACTCTTCTGCCCTTGAGGACCTGCGAAATCCAGAACAAAGCACATCAGAAAAAGTATTAACTTCACAGAAAAGTAGTGAATACCCTATAAGCCAGAATCCAGAAGGCCTTTCTGCTGACAAGTTTGAGGTGTCTGCAGATAGTTCTACCAGTAAAAATAAAGAACCAGGAGTGGAAAGGTCATCCCCTTCTAAATGCCCATCATTAGATGATAGGTGGTACATGCACAGTTGCTCTGGGAGTCTTCAGAATAGAAACTACCCATCTCAAGAGGAGCTCATTAAGGTTGTTGATGTGGAGGAGCAACAGCTGGAAGAGTCTGGGCCACACGATTTGACGGAAACATCTTACTTGCCAAGGCAAGATCTAGAGGGAACCCCTTACCTGGAATCTGGAATCAGCCTCTTCTCTGATGACCCTGAATCTGATCCTTCTGAAGACAGAGCCCCAGAGTCAGCTCGTGTTGGCAACATACCATCTTCAACCTCTGCATTGAAAGTTCCCCAATTGAAAGTTGCAGAATCTGCCCAGAGTCCAGCTGCTGCTCATACTACTGATACTGCTGGGTATAATGCAATGGAAGAAAGTGTGAGCAGGGAGAAGCCAGAATTGACAGCTTCAACAGAAAGGGTCAACAAAAGAATGTCCATGGTGGTGTCTGGCCTGACCCCAGAAGAATTTATGCTCGTGTACAAGTTTGCCAGAAAACACCACATCACTTTAACTAATCTAATTACTGAAGAGACTACTCATGTTGTTATGAAAACAGATGCTGAGTTTGTGTGTGAACGGACACTGAAATATTTTCTAGGAATTGCGGGAGGAAAATGGGTAGTTAGCTATTTCTGGGTGACCCAGTCTATTAAAGAAAGAAAAATGCTGAATGAGCATGATTTTGAAGTCAGAGGAGATGTGGTCAATGGAAGAAACCACCAAGGTCCAAAGCGAGCAAGAGAATCCCAGGACAGAAAGATCTTCAGGGGGCTAGAAATCTGTTGCTATGGGCCCTTCACCAACATGCCCACAGGGTGTCCACCCAATTGTGGTTGTGCAGCCAGATGCCTGGACAGAGGACAATGGCTTCCATGCAATTGGGCAGATGTG	69560.0	single nucleotide variant	NM_007294.4(BRCA1):c.346G>A (p.Glu116Lys)	672.0	BRCA1	HGNC:1100	Uncertain significance	0.0	Jan 25, 2022	397509071.0	-	RCV000577079|RCV002453364	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Familial cancer of breast|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000017.11	17	43104217.0	43104217.0	17q21.31	criteria provided, single submitter	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002236	3.0	54893.0	43104217.0	C	T	-	-	-	-	-	-	SCV002612990	-	-	346G>A 	Glu116Lys	NM_007294.4	1.0	4_VUS	chr17	G	A	17-43104217-G-A		54893	17	43104217	C	T	E	K	rs397509071	17	41256234	17	38509760	116	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.346G>A	p.Glu116Lys	c.346G>A	p.Glu116Lys	principal2	Y	1	YES	Select	-	GAA	1	0	C	./.	./.	./.	./.	0.001	0.78662	D	0.015	0.61973	D	0.956	0.54679	P	0.275	0.40079	B	0.99	0.97926	D	simple_aae	1.0	99.0	2.455	0.71058	M	-0.56	0.54726	N	0.665	0.73073	1.0626	0.98399	D	0.9333	0.97797	D	10	0.75375986	0.75596	D	0.687104	0.97412	D	0.698	0.89052	.	.	.	.	.	0.936910906656	0.93576	.	0.48618	.	0.25914	0.455957233906	0.32716	T	0.167623	0.51184	T	0.458962	0.92824	D	0.42149	0.92735	D	0.960671126842499	0.65652	D	.	0.90678	.	0.30580968	0.53088	0.31052214	0.56841	0.29307255	0.51944	0.32331142	0.58036	-4.132	0.26444	T	0.103	0.24020	B	0.315487270864402	0.54793	0.99916387	0.99185	0.137	0.36038	.	.	.	.	.	.	3.863469	0.56124	23.7	0.99917023792078985	0.98450	0.588432	0.58423	D	0.519732155081613	0.68091	5.192408	0.544271718873321	0.70840	5.588604	5.32	5.32	0.75341	.	.	2.768	0.47428	3.839000	0.40112	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.994	0.71086	462	0.78630	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	17708	0	0	292	0	0	84	0	2	7360	2.717391304347826E-4	0	146	0	0	610	0	0	24	0	0	94	0	0	1904	0	2	7652	2.6136957658128593E-4	0	108	0	2	28222	7.086669973779322E-5	Uncertain_significance	Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast	criteria_provided,_single_submitter	NC_000017.11:g.43104217C>T	ClinGen:CA002236	C0027672|C0346153	114480	140162|227535	.	Glu	Lys	69560	single nucleotide variant	NM_007294.4(BRCA1):c.346G>A (p.Glu116Lys)	672	BRCA1	HGNC:1100	Uncertain significance	0	Jan 25, 2022	397509071	-	RCV000577079|RCV002453364	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Familial cancer of breast|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000017.11	17	43104217	43104217	17q21.31	criteria provided, single submitter	2	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002236	3	54893	43104217	C	T	-	-	-	-	-	-	SCV002612990	-	-	346G>A 	Glu116Lys	NM_007294.4	1	4_VUS	BRCA1	ENSG00000012048	14613	218399	CCSBVarC003298	ALE00003298	346G>A	Glu116Lys	CEGS2	CegsMutGDEh1028	G06	GDEhDisVCh_40059	G09	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	BRCA1_Glu116Lys	17	17	43104217	C	T
71569	OTC	479T>G	Ile160Ser	ENSG00000036473	X	38401367	NC_000023.11:38401367:T:G	ALE00005246	CCSBVarC005246	NULL	205856	NULL	GDEhDisVCh_40048	F07	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTAGCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103106.0	single nucleotide variant	NM_000531.6(OTC):c.479T>G (p.Ile160Ser)	5009.0	OTC	HGNC:8512	Pathogenic	1.0	-	67954347.0	-	RCV000083453	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38401367.0	38401367.0	Xp11.4	no assertion criteria provided	1.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224632,UniProtKB:P00480#VAR_012651	2.0	97214.0	38401367.0	T	G	-	-	-	-	-	-	SCV000115539	-	-	479T>G 	Ile160Ser	NM_000531.6		1_Pathogenic	chrX	T	G	X-38401367-T-G		97214	X	38401367	T	G	I	S	rs67954347	X	38260620	X	38145564	160	OTC	ENSG00000036473	ENST00000039007	ENSP00000039007	P00480	OTC_HUMAN	c.479T>G	p.Ile160Ser	c.479T>G	p.Ile160Ser	principal1	Y	1	YES	Select	+	ATC	2	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	0.975	0.58089	D	0.923	0.65825	D	0.96	0.95575	A	simple_aae	4.0	96.0	3.98	0.96573	H	-5.71	0.87487	D	0.885	0.88339	1.0160	0.97456	D	0.9846	0.99532	D	10	0.99582183	0.99993	D	0.927443	0.99470	D	0.934	0.98488	0.976	0.99775	P00480	I160S	Gain of disorder (P = 0.0099)| Gain of glycosylation at I160 (P = 0.052)| Loss of stability (P = 0.0693)| Loss of sheet (P = 0.0817)| Gain of phosphorylation at S156 (P = 0.1381)	0.998099356442	0.99805	0.9974565587897993	0.99744	0.700501834841	0.60838	0.444618612528	0.31169	T	0.976265	0.99773	D	0.721492	0.99946	D	0.798597	0.99946	D	0.993813633918762	0.84652	D	0.957904	0.84136	D	0.9825449	0.99285	0.9691135	0.99417	0.9825449	0.99286	0.9691135	0.99417	-15.897	0.97607	D	0.9541	0.87330	P	0.998918626271355	0.95306	0.99859830	0.98864	0.997	0.99892	.	.	.	.	.	.	4.935173	0.81438	27.5	0.99445567173450045	0.65068	.	.	.	.	.	.	.	.	.	5.97	5.97	0.96929	.	.	7.628	0.82424	7.798000	0.69116	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.997	0.79771	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided	no_assertion_criteria_provided	NC_000023.11:g.38401367T>G	ClinGen:CA224632|UniProtKB:P00480#VAR_012651	CN517202	.	.	Aspartate/ornithine carbamoyltransferase, carbamoyl-P binding	Ile	Ser	103106	single nucleotide variant	NM_000531.6(OTC):c.479T>G (p.Ile160Ser)	5009	OTC	HGNC:8512	Pathogenic	1	-	67954347	-	RCV000083453	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38401367	38401367	Xp11.4	no assertion criteria provided	1	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224632,UniProtKB:P00480#VAR_012651	2	97214	38401367	T	G	-	-	-	-	-	-	SCV000115539	-	-	479T>G 	Ile160Ser	NM_000531.6		1_Pathogenic	OTC	ENSG00000036473	71569	205856	CCSBVarC005246	ALE00005246	479T>G	Ile160Ser	CEGS2	CegsMutGDEh1028	G03	GDEhDisVCh_40048	F07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Ile160Ser	23	X	38401367	T	G
359	CBS	401G>C	Gly134Ala	ENSG00000160200	21	43066293	NC_000021.9:43066293:C:G	ALE00007330	CCSBVarC007341	NULL	NULL	297	GDEhDisVCh_40013	B09	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGCGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210439.0	single nucleotide variant	NM_000071.3(CBS):c.401G>C (p.Gly134Ala)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Aug 27, 2021	766958673.0	-	RCV000198867|RCV001231415|RCV002517163	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43066293.0	43066293.0	21q22.3	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA323396	2.0	212845.0	43066293.0	C	G	-	-	-	-	-	-	SCV000249681|SCV001403935	-	-	401G>C 	Gly134Ala	NM_000071.3	2.0	4_VUS	chr21	G	C	21-43066293-G-C		212845	21	43066293	C	G	G	A	rs766958673	21	44486403	21	43359472	134	CBS	ENSG00000160200	ENST00000352178	ENSP00000344460	P35520	CBS_HUMAN	c.401G>C	p.Gly134Ala	c.401G>C	p.Gly134Ala	principal1	Y	1	.	.	-	GGG	2	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.004	0.76775	D	1.0	0.90580	D	0.998	0.88579	D	0.84	0.89397	D	simple_aae	16.0	84.0	4.215	0.97851	H	-5.97	0.89297	D	0.87	0.86807	0.9590	0.96521	D	0.9916	0.99788	D	10	0.99140644	0.99664	D	0.897938	0.99228	D	0.874	0.96234	0.858	0.95637	P35520	G134A	Gain of helix (P = 0.0425)| Loss of loop (P = 0.0512)| Loss of relative solvent accessibility (P = 0.0676)| Loss of disorder (P = 0.1194)| Loss of ubiquitination at K137 (P = 0.1388)	0.937295271682	0.93616	.	0.89777	.	0.79480	0.57268255949	0.48990	T	0.989589	0.99951	D	0.401941	0.89954	D	0.339584	0.89829	D	0.997305274009705	0.91167	D	0.990687	0.97749	D	0.90824765	0.92017	0.7678897	0.86122	0.91777414	0.92931	0.7867385	0.87287	-12.838	0.88710	D	0.3259	0.59727	B	0.997835490041568	0.93609	0.99977595	0.99714	0.938	0.97019	.	.	.	.	.	.	3.555826	0.5009	22.9	0.99673257517440006	0.78740	0.912715	0.87325	D	0.700298128477774	0.79542	7.123037	0.49272765384763	0.67330	5.093294	5.23	5.23	0.72532	.	.	6.845	0.75251	7.398000	0.58622	0.524	0.24207	1.0	0.71675	1.000000	0.68239	0.041	0.14402	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Uncertain_significance	HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|not_provided|Classic_homocystinuria	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43066293C>G	ClinGen:CA323396	C3150344|CN517202|C0751202	236200	394	Tryptophan synthase beta chain-like, PALP domain	Gly	Ala	210439	single nucleotide variant	NM_000071.3(CBS):c.401G>C (p.Gly134Ala)	875	CBS	HGNC:1550	Uncertain significance	0	Aug 27, 2021	766958673	-	RCV000198867|RCV001231415|RCV002517163	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43066293	43066293	21q22.3	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA323396	2	212845	43066293	C	G	-	-	-	-	-	-	SCV000249681|SCV001403935	-	-	401G>C 	Gly134Ala	NM_000071.3	2	4_VUS	CBS	ENSG00000160200	359	297	CCSBVarC007341	ALE00007330	401G>C	Gly134Ala	Edgotyping3	VUSMutGDEh011	H03	GDEhDisVCh_40013	B09	1	VUSMutGDDh011	H03	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	5	0	NULL	0	NULL	0	NULL	CBS_Gly134Ala	21	21	43066293	C	G
2803	HMBS	754G>A	Ala252Thr	ENSG00000256269	11	119092506	NC_000011.10:119092506:G:A	ALE00005175	CCSBVarC005175	NULL	200943	NULL	GDEhDisVCh_40054	B07	CEGS2	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAGCTTGCTCGCATACAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGGACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCTTGAACATGCCCTGGAGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCGAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTCGGGGAAACCTCAACACCCGGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACCGGGTGGGGCAGATCCTGCACCCTGAGGAATGCATGTATGCTGTGGGCCAGGGGGCCTTGGGCGTGGAAGTGCGAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCTGCATCGCTGAAAGGACCTTCCTGAGGCACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATGGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCGTAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACGATGCCCAT	16511.0	single nucleotide variant	NM_000190.4(HMBS):c.754G>A (p.Ala252Thr)	3145.0	HMBS	HGNC:4982	Uncertain significance	1.0	Mar 26, 2024	118204113.0	-	RCV000001537|RCV002512652	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900	Acute intermittent porphyria|not provided	germline	germline	GRCh38	NC_000011.10	11	119092506.0	119092506.0	11q23.3	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA251832,UniProtKB:P08397#VAR_003667,OMIM:609806.0032	3.0	1472.0	119092506.0	G	A	-	-	-	-	-	-	SCV001265198|SCV003441181|SCV004807413	-	-	754G>A 	Ala252Thr	NM_000190.4	2.0	4_VUS	chr11	G	A	11-119092506-G-A	0.0000102609	1472	11	119092506	G	A	A	T	rs118204113	11	118963216	11	118468426	252	HMBS	ENSG00000256269	ENST00000652429	ENSP00000498786	P08397	HEM3_HUMAN	c.754G>A	p.Ala252Thr	c.754G>A	p.Ala252Thr	principal2	Y	.	YES	Select	+	GCC	1	0	G	G/G	G/G	G/G	G/G	.	0.45552	.	.	0.47688	.	0.4	0.34869	B	0.403	0.44587	B	.	0.99291	.	.	.	.	2.575	0.75110	M	.	0.44100	.	.	0.87898	1.1749	0.99960	D	0.9285	0.97634	D	9	.	0.97710	.	0.362793	0.92538	D	.	0.93165	0.938	0.99125	P08397	A252T	Loss of catalytic residue at A252 (P = 0.1094)| Loss of stability (P = 0.2551)| Gain of phosphorylation at A252 (P = 0.3641)| Loss of methylation at R255 (P = 0.3976)| Loss of MoRF binding (P = 0.6116)	.	0.98612	0.768717101170805	0.76691	.	.	0.614813685417	0.54929	T	0.89818	0.97962	D	0.506263	0.94420	D	0.504921	0.94682	D	0.792380094528198	0.45558	D	0.977502	0.92076	D	0.5682572	0.70672	0.34421596	0.59888	0.53617907	0.68882	0.3964207	0.64034	-4.688	0.33297	T	0.2987	0.55045	B	0.979279035390397	0.85142	0.13817188	0.69646	0.829	0.90573	.	.	.	.	.	.	4.301771	0.65751	24.9	0.99861774711109397	0.94006	0.881987	0.80906	D	0.308101625705982	0.56340	3.821246	0.376068987627135	0.59878	4.193178	5.24	4.32	0.50841	4.78	0.87641	6.62	0.74156	9.654000	0.81207	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	228	0.91137	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	0	109388	0.000000e+00	0	1	208108	4.805200e-06	0	1	236824	4.222550e-06	0	0	7162	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13380	0.000000e+00	0	0	42768	0.000000e+00	0	0	15688	0.000000e+00	0	.	.	.	.	0	16214	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16720	0.000000e+00	0	1	89554	1.116640e-05	0	0	30606	0.000000e+00	0	1	89554	1.116640e-05	0	0	14900	0.000000e+00	0	0	34258	0.000000e+00	0	0	9568	0.000000e+00	0	0	17692	0.000000e+00	0	0	21618	0.000000e+00	0	1	102646	9.742220e-06	0	0	30524	0.000000e+00	0	1	102646	9.742220e-06	0	.	17	1614090	1.053230e-05	0	8	6084	1.314920e-03	0	1	74932	1.334540e-05	0	0	912	0.000000e+00	0	0	60008	0.000000e+00	0	0	29608	0.000000e+00	0	1	44900	2.227170e-05	0	0	64026	0.000000e+00	0	8	6084	1.314920e-03	0	5	1180044	4.237130e-06	0	1	91088	1.097840e-05	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Uncertain_significance	not_provided|Acute_intermittent_porphyria	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.119092506G>A	ClinGen:CA251832|OMIM:609806.0032|UniProtKB:P08397#VAR_003667	C3661900|C0162565	176000	79276	Porphobilinogen deaminase, C-terminal|Porphobilinogen deaminase, dipyrromethane cofactor binding site	Ala	Thr	16511	single nucleotide variant	NM_000190.4(HMBS):c.754G>A (p.Ala252Thr)	3145	HMBS	HGNC:4982	Uncertain significance	1	Mar 26, 2024	118204113	-	RCV000001537|RCV002512652	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900	Acute intermittent porphyria|not provided	germline	germline	GRCh38	NC_000011.10	11	119092506	119092506	11q23.3	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA251832,UniProtKB:P08397#VAR_003667,OMIM:609806.0032	3	1472	119092506	G	A	-	-	-	-	-	-	SCV001265198|SCV003441181|SCV004807413	-	-	754G>A 	Ala252Thr	NM_000190.4	2	4_VUS	HMBS	ENSG00000256269	2803	200943	CCSBVarC005175	ALE00005175	754G>A	Ala252Thr	CEGS2	CegsMutGDEh1042	D01	GDEhDisVCh_40054	B07	2	CegsMutGDDh1042	D01	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	HMBS_Ala252Thr	11	11	119092506	G	A
2013	KCNE1	20C>T	Thr7Ile	ENSG00000180509	21	34449615	NC_000021.9:34449615:G:A	ALE00000217	CCSBVarC000217	3288	NULL	NULL	GDEhDisVCh_40065	D09	RC4	ATGATCCTGTCTAACACCATAGCGGTGACGCCCTTTCTGACCAAGCTGTGGCAGGAGACAGTTCAGCAGGGTGGCAACATGTCGGGCCTGGCCCACAGGTCCCCCCGCAGCGGTGACGGCAAGCTGGAGGCCCTCTACGTCCTCATGGTACTGGGATTCTTCGGCTTCTTCACCCTGGGCATCATGCTGAGCTACATCCGCTCCAAGAAGCTGGAGCACTCGAACGACCCATTCAACGTCTACATCGAGTCCGATGCCTGGCAAGAGAAGGACAAGGCCTATGTCCAGGCCCGGGTCCTGGAGAGCTACAGGTCG	28515.0	single nucleotide variant	NM_000219.6(KCNE1):c.20C>T (p.Thr7Ile)	3753.0	KCNE1	HGNC:6240	Pathogenic	1.0	Nov 01, 1997	28933384.0	-	RCV000014418|RCV000119076|RCV004777562	MONDO:MONDO:0012871,MedGen:C2676723,OMIM:612347,Orphanet:768,Orphanet:90647|MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:101016,Orphanet:768|MONDO:MONDO:0013372,MedGen:C1867904,OMIM:613695,Orphanet:101016,Orphanet:768	Jervell and Lange-Nielsen syndrome 2|Congenital long QT syndrome|Long QT syndrome 5	germline;not applicable	germline	GRCh38	NC_000021.9	21	34449615.0	34449615.0	21q22.12	no assertion criteria provided	3.0	-	N	ClinGen:CA256863,UniProtKB:P15382#VAR_008897,OMIM:176261.0002	3.0	13476.0	34449615.0	G	A	-	-	-	-	-	-	SCV000034667	-	-	20C>T 	Thr7Ile	NM_000219.6		1_Pathogenic	chr21	C	T	21-34449615-C-T		13476	21	34449615	G	A	T	I	rs28933384	21	35821913	21	34743783	7	KCNE1	ENSG00000180509	ENST00000621601	ENSP00000483895	P15382	KCNE1_HUMAN	c.20C>T	p.Thr7Ile	c.20C>T	p.Thr7Ile	principal1	Y	4	.	.	-	ACA	2	0	G	G/G	G/G	G/G	G/G	.	0.68399	.	0.0	0.92967	D	0.999	0.77914	D	0.999	0.92348	D	.	0.97926	.	.	.	.	2.8	0.81458	M	.	0.56814	.	0.567	0.76569	1.0516	0.98148	D	0.8889	0.96305	D	10	0.8340558	0.82382	D	0.148119	0.82960	D	.	0.83333	0.32	0.29768	P15382	T7I	Loss of disorder (P = 0.0702)| Loss of loop (P = 0.0986)| Gain of sheet (P = 0.1208)| Loss of phosphorylation at T10 (P = 0.1404)| Loss of helix (P = 0.1706)	0.958254064319	0.95744	.	0.89180	.	0.44239	0.451426267624	0.32098	T	0.870876	0.97186	D	0.334797	0.85383	D	0.326001	0.89269	D	0.972129225730896	0.69376	D	.	0.36985	.	0.41131204	0.61185	0.36616728	0.61710	0.42471084	0.62083	0.35140076	0.60497	-6.462	0.50056	T	.	0.65866	.	0.975235727869839	0.84263	0.99918479	0.99198	0.542	0.74109	.	.	.	.	.	.	3.540905	0.49807	22.8	0.99690111473343856	0.79863	0.616498	0.60162	D	0.46893528966639	0.65103	4.803355	0.307317754279631	0.55737	3.75977	4.82	4.82	0.61594	.	.	6.281	0.72726	9.421000	0.80785	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.021	0.11764	900	0.24584	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109396	9.141100e-06	0	1	207908	4.809820e-06	0	1	236802	4.222940e-06	0	0	7162	0.000000e+00	0	1	17110	5.844540e-05	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13394	0.000000e+00	0	0	42762	0.000000e+00	0	0	15690	0.000000e+00	0	1	17110	5.844540e-05	0	0	16178	0.000000e+00	0	1	30514	3.277180e-05	0	0	6206	0.000000e+00	0	0	13400	0.000000e+00	0	0	16734	0.000000e+00	0	0	89408	0.000000e+00	0	0	30608	0.000000e+00	0	1	30514	3.277180e-05	0	0	14882	0.000000e+00	0	1	34254	2.919370e-05	0	0	9562	0.000000e+00	0	0	17690	0.000000e+00	0	0	21620	0.000000e+00	0	0	102650	0.000000e+00	0	0	30526	0.000000e+00	0	1	34254	2.919370e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic	Congenital_long_QT_syndrome|Jervell_and_Lange-Nielsen_syndrome_2	no_assertion_criteria_provided	NC_000021.9:g.34449615G>A	ClinGen:CA256863|OMIM:176261.0002|UniProtKB:P15382#VAR_008897	C1141890|C2676723	PS192500|612347	101016|768|768|90647	.	Thr	Ile	28515	single nucleotide variant	NM_000219.6(KCNE1):c.20C>T (p.Thr7Ile)	3753	KCNE1	HGNC:6240	Pathogenic	1	Nov 01, 1997	28933384	-	RCV000014418|RCV000119076|RCV004777562	MONDO:MONDO:0012871,MedGen:C2676723,OMIM:612347,Orphanet:768,Orphanet:90647|MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:101016,Orphanet:768|MONDO:MONDO:0013372,MedGen:C1867904,OMIM:613695,Orphanet:101016,Orphanet:768	Jervell and Lange-Nielsen syndrome 2|Congenital long QT syndrome|Long QT syndrome 5	germline;not applicable	germline	GRCh38	NC_000021.9	21	34449615	34449615	21q22.12	no assertion criteria provided	3	-	N	ClinGen:CA256863,UniProtKB:P15382#VAR_008897,OMIM:176261.0002	3	13476	34449615	G	A	-	-	-	-	-	-	SCV000034667	-	-	20C>T 	Thr7Ile	NM_000219.6		1_Pathogenic	KCNE1	ENSG00000180509	2013	3288	CCSBVarC000217	ALE00000217	20C>T	Thr7Ile	RC4	RC4_Mut_GDEh1010	E07	GDEhDisVCh_40065	D09	1	RC4_Mut_GDDh1010	E07	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	KCNE1_Thr7Ile	21	21	34449615	G	A
3774	TP53	704A>G	Asn235Ser	ENSG00000141510	17	7674259	NC_000017.11:7674259:T:C	ALE00004865	CCSBVarC004865	NULL	214900	NULL	GDEhDisVCh_40053	G05	CEGS2	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAGCTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACCGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	133278.0	single nucleotide variant	NM_000546.6(TP53):c.704A>G (p.Asn235Ser)	7157.0	TP53	HGNC:11998	Benign	0.0	Aug 05, 2024	144340710.0	-	RCV000115733|RCV000122177|RCV000148915|RCV000590586|RCV000663295|RCV000989714|RCV000991139|RCV003952552|RCV001798339	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|Human Phenotype Ontology:HP:0002859,MONDO:MONDO:0005212,MeSH:D012208,MedGen:C0035412,Orphanet:780|MedGen:C3661900|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MONDO:MONDO:0010150,MeSH:D000077195,MedGen:C1168401,OMIM:275355,Orphanet:67037|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524||MedGen:CN221562	Hereditary cancer-predisposing syndrome|not specified|Rhabdomyosarcoma|not provided|Li-Fraumeni syndrome 1|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome|TP53-related disorder|Breast and/or ovarian cancer	germline;unknown	germline	GRCh38	NC_000017.11	17	7674259.0	7674259.0	17p13.1	reviewed by expert panel	24.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000343,UniProtKB:P04637#VAR_045186	2.0	127821.0	7674259.0	T	C	-	-	-	-	-	-	SCV001142532	-	-	704A>G 	Asn235Ser	NM_000546.6	3.0	2_Benign	chr17	A	G	17-7674259-A-G		127821	17	7674259	T	C	N	S	rs144340710	17	7577577	17	7518302	235	TP53	ENSG00000141510	ENST00000269305	ENSP00000269305	P04637	P53_HUMAN	c.704A>G	p.Asn235Ser	c.704A>G	p.Asn235Ser	principal1	Y	1	YES	Select	-	AAC	2	0	T	T/T	T/T	T/T	T/T	0.201	0.25683	T	0.343	0.25427	T	0.186	0.90580	B	0.144	0.92348	B	0.57	0.75656	D	simple_aae	43.0	57.0	1.115	0.28553	L	-2.59	0.60060	D	0.922	0.92789	1.0418	0.97942	D	0.9811	0.99418	D	10	0.36727762	0.52838	D	0.563617	0.96019	D	0.593	0.83722	.	.	.	.	.	0.879868673219	0.87776	0.24076455901994082	0.23800	0.107495780972	0.11903	0.525174260139	0.42295	T	0.909511	0.98266	D	-0.071271	0.40777	T	-0.0341756	0.67860	D	0.121167317032814	0.14360	T	.	0.88587	.	0.793036	0.83255	0.62665206	0.77999	0.82270104	0.85214	0.6272676	0.78034	-10.62	0.78519	D	0.1437	0.42988	LB	0.701797727734414	0.67088	0.99983019	0.99778	0.867	0.92766	.	.	.	.	.	.	4.404252	0.68134	25.2	0.99796990224571303	0.88204	0.431663	0.49212	N	0.149286571644596	0.48531	3.085956	0.234448370534166	0.51517	3.356646	4.62	4.62	0.56895	.	.	4.163	0.58057	7.841000	0.70574	0.661	0.55789	1.0	0.71675	1.000000	0.68239	1.0	0.97202	433	0.80635	.	.	.	.	.	.	.	.	.	.	.	.	35	264690	1.3223015E-4	.	17	109406	1.553850e-04	0	32	208132	1.537490e-04	0	42	236946	1.772560e-04	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	15	42768	3.507300e-04	0	0	15690	0.000000e+00	0	15	42768	3.507300e-04	0	0	16218	0.000000e+00	0	0	30522	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	3	16732	1.792970e-04	0	27	89558	3.014810e-04	0	0	30608	0.000000e+00	0	27	89558	3.014810e-04	0	0	14902	0.000000e+00	0	0	34258	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	6	21628	2.774180e-04	0	34	102748	3.309070e-04	0	0	30526	0.000000e+00	0	34	102748	3.309070e-04	0	.	400	1613414	2.479210e-04	0	36	63952	5.629220e-04	0	6	74746	8.027190e-05	0	0	912	0.000000e+00	0	0	59942	0.000000e+00	0	0	29600	0.000000e+00	0	0	44852	0.000000e+00	0	36	63952	5.629220e-04	0	0	6084	0.000000e+00	0	341	1179786	2.890350e-04	0	0	91074	0.000000e+00	0	68	180078	3.7761414498161907E-4	0	360	0	0	2710	0	0	9432	0	0	796	0	0	968	0	0	682	0	0	280	0	4	15600	2.564102564102564E-4	0	9792	0	0	3392	0	72	210906	3.413843133907997E-4	Benign	Li-Fraumeni_syndrome_1|Squamous_cell_carcinoma_of_the_head_and_neck|not_provided|Li-Fraumeni_syndrome|Breast_and/or_ovarian_cancer|Hereditary_cancer-predisposing_syndrome|not_specified|Rhabdomyosarcoma|TP53-related_disorder	reviewed_by_expert_panel	NC_000017.11:g.7674259T>C	ClinGen:CA000343|UniProtKB:P04637#VAR_045186	C1835398|C1168401|C3661900|C0085390|CN221562|C0027672|CN169374|C0035412	151623|275355|PS151623	524|67037|524|140162|780	p53, DNA-binding domain|p53, DNA-binding domain	Asn	Ser	133278	single nucleotide variant	NM_000546.6(TP53):c.704A>G (p.Asn235Ser)	7157	TP53	HGNC:11998	Benign	0	Aug 05, 2024	144340710	-	RCV000115733|RCV000122177|RCV000148915|RCV000590586|RCV000663295|RCV000989714|RCV000991139|RCV003952552|RCV001798339	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|Human Phenotype Ontology:HP:0002859,MONDO:MONDO:0005212,MeSH:D012208,MedGen:C0035412,Orphanet:780|MedGen:C3661900|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MONDO:MONDO:0010150,MeSH:D000077195,MedGen:C1168401,OMIM:275355,Orphanet:67037|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524||MedGen:CN221562	Hereditary cancer-predisposing syndrome|not specified|Rhabdomyosarcoma|not provided|Li-Fraumeni syndrome 1|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome|TP53-related disorder|Breast and/or ovarian cancer	germline;unknown	germline	GRCh38	NC_000017.11	17	7674259	7674259	17p13.1	reviewed by expert panel	24	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000343,UniProtKB:P04637#VAR_045186	2	127821	7674259	T	C	-	-	-	-	-	-	SCV001142532	-	-	704A>G 	Asn235Ser	NM_000546.6	3	2_Benign	TP53	ENSG00000141510	3774	214900	CCSBVarC004865	ALE00004865	704A>G	Asn235Ser	CEGS2	CegsMutGDEh1019	E03	GDEhDisVCh_40053	G05	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	TP53_Asn235Ser	17	17	7674259	T	C
359	CBS	616G>A	Val206Met	ENSG00000160200	21	43065437	NC_000021.9:43065437:C:T	ALE00007324	CCSBVarC007332	NULL	NULL	285	GDEhDisVCh_40013	A08	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGATGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210434.0	single nucleotide variant	NM_000071.3(CBS):c.616G>A (p.Val206Met)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	May 31, 2024	369220569.0	-	RCV000200147|RCV000648123|RCV002517997|RCV003278691	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection	germline	germline	GRCh38	NC_000021.9	21	43065437.0	43065437.0	21q22.3	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA324707	2.0	212849.0	43065437.0	C	T	-	-	-	-	-	-	SCV000249687|SCV000769937|SCV004008115	-	-	616G>A 	Val206Met	NM_000071.3	2.0	4_VUS	chr21	G	A	21-43065437-G-A		212849	21	43065437	C	T	V	M	rs369220569	21	44485547	21	43358616	206	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.616G>A	p.Val206Met	c.616G>A	p.Val206Met	principal1	Y	1	.	.	-	GTG	1	0	C	C/C	C/C	C/C	C/C	0.013	0.54059	D	0.014	0.62681	D	0.969	0.56783	D	0.854	0.60860	P	0.83	0.88920	D	simple_aae	17.0	83.0	1.875	0.49735	L	-2.61	0.56171	D	0.877	0.87459	1.0207	0.97541	D	0.9075	0.96927	D	10	0.9345856	0.92710	D	0.613325	0.96625	D	0.788	0.92964	.	.	.	.	.	0.938040257409	0.93691	.	0.83617	.	0.75467	0.8022595644	0.82276	T	0.96461	0.99566	D	0.263931	0.79742	D	0.248999	0.85472	D	0.860499143600464	0.50830	D	.	0.90506	.	0.6719479	0.76274	0.37531948	0.62434	0.68797046	0.77145	0.44820967	0.67616	-8.019	0.61273	D	0.2916	0.52282	LB	0.952908122148564	0.80792	0.99964249	0.99561	0.912	0.95445	.	.	.	.	.	.	3.788488	0.54597	23.5	0.99898149283079285	0.97050	0.910881	0.86891	D	0.594089151071777	0.72658	5.863861	0.541767229445711	0.70666	5.562694	4.65	4.65	0.57575	2.66	0.48641	6.582	0.74004	4.609000	0.44106	0.513	0.23433	1.0	0.71675	1.000000	0.68239	0.744	0.35612	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	109314	2.744390e-05	0	4	207586	1.926910e-05	0	4	235712	1.696990e-05	0	0	7150	0.000000e+00	0	0	17080	0.000000e+00	0	0	2320	0.000000e+00	0	0	9042	0.000000e+00	0	0	13388	0.000000e+00	0	3	42758	7.016230e-05	0	0	15664	0.000000e+00	0	3	42758	7.016230e-05	0	0	16112	0.000000e+00	0	0	30472	0.000000e+00	0	0	6190	0.000000e+00	0	0	13390	0.000000e+00	0	0	16728	0.000000e+00	0	4	89264	4.481090e-05	0	0	30582	0.000000e+00	0	4	89264	4.481090e-05	0	0	14886	0.000000e+00	0	0	34210	0.000000e+00	0	0	9526	0.000000e+00	0	0	17684	0.000000e+00	0	0	21626	0.000000e+00	0	4	101678	3.933990e-05	0	0	30498	0.000000e+00	0	4	101678	3.933990e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	9690	1.0319917440660474E-4	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	1	14050	7.117437722419929E-5	Uncertain_significance	Classic_homocystinuria|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_provided|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43065437C>T	ClinGen:CA324707	C0751202|C4707243|C3661900|C3150344	236200|PS607086	394|91387	Tryptophan synthase beta chain-like, PALP domain	Val	Met	210434	single nucleotide variant	NM_000071.3(CBS):c.616G>A (p.Val206Met)	875	CBS	HGNC:1550	Uncertain significance	0	May 31, 2024	369220569	-	RCV000200147|RCV000648123|RCV002517997|RCV003278691	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection	germline	germline	GRCh38	NC_000021.9	21	43065437	43065437	21q22.3	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA324707	2	212849	43065437	C	T	-	-	-	-	-	-	SCV000249687|SCV000769937|SCV004008115	-	-	616G>A 	Val206Met	NM_000071.3	2	4_VUS	CBS	ENSG00000160200	359	285	CCSBVarC007332	ALE00007324	616G>A	Val206Met	Edgotyping3	VUSMutGDEh011	G02	GDEhDisVCh_40013	A08	1	VUSMutGDDh011	G02	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	5	0	NULL	0	NULL	0	NULL	CBS_Val206Met	21	21	43065437	C	T
359	CBS	146C>T	Pro49Leu	ENSG00000160200	21	43072048	NC_000021.9:43072048:G:A	ALE00000042	CCSBVarC000042	994	NULL	323	GDEhDisVCh_40013	G02	RC4	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCTGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210450.0	single nucleotide variant	NM_000071.3(CBS):c.146C>T (p.Pro49Leu)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Feb 02, 2025	148865119.0	-	RCV000200523|RCV000410155|RCV002229028|RCV002310761	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection	germline;unknown	germline	GRCh38	NC_000021.9	21	43072048.0	43072048.0	21q22.3	criteria provided, multiple submitters, no conflicts	12.0	-	N	ClinGen:CA325105,UniProtKB:P35520#VAR_008049	2.0	212872.0	43072048.0	G	A	-	-	-	-	-	-	SCV000249719|SCV000317366|SCV000543521|SCV000893557|SCV001472722|SCV001713879|SCV002016939|SCV004213842|SCV004847929|SCV005051295|SCV005052058	-	-	146C>T 	Pro49Leu	NM_000071.3	2.0	1_Pathogenic	chr21	C	T	21-43072048-C-T		212872	21	43072048	G	A	P	L	rs148865119	21	44492158	21	43365227	49	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.146C>T	p.Pro49Leu	c.146C>T	p.Pro49Leu	principal1	Y	1	.	.	-	CCG	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.008	0.83643	D	0.977	0.58547	D	0.692	0.53858	P	1.0	0.99291	A	simple_aae	0.0	100.0	3.165	0.88471	M	-7.36	0.96705	D	0.787	0.78271	1.0891	0.99201	D	0.9773	0.99294	D	10	0.9457127	0.93828	D	0.639053	0.96913	D	0.864	0.95865	.	.	.	.	.	0.94052500168	0.93943	.	0.74110	.	0.44147	0.493413418531	0.37861	T	0.943753	0.99126	D	0.333256	0.85278	D	0.54547	0.95521	D	0.547446891953106	0.34070	D	.	0.84186	.	0.88651955	0.90072	0.64787984	0.79179	0.8733611	0.88980	0.63119227	0.78252	-5.537	0.42265	T	.	0.14168	.	0.962803492659164	0.82124	0.99981695	0.99765	0.949	0.97673	.	.	.	.	.	.	3.985133	0.58691	24.0	0.99887169769619488	0.96206	0.796384	0.72251	D	0.717515815183183	0.80675	7.370829	0.681475325225945	0.80868	7.419574	5.64	5.64	0.86461	0.949	0.28759	5.359	0.65911	6.357000	0.55569	0.59	0.31918	1.0	0.71675	1.000000	0.68239	0.43	0.27499	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11	109388	1.005590e-04	0	33	207310	1.591820e-04	0	34	236450	1.437940e-04	0	0	7160	0.000000e+00	0	0	17110	0.000000e+00	0	0	2318	0.000000e+00	0	0	9044	0.000000e+00	0	0	13390	0.000000e+00	0	11	42762	2.572380e-04	0	0	15690	0.000000e+00	0	11	42762	2.572380e-04	0	0	16200	0.000000e+00	0	0	30514	0.000000e+00	0	0	6188	0.000000e+00	0	0	13412	0.000000e+00	0	0	16730	0.000000e+00	0	32	88808	3.603280e-04	0	0	30606	0.000000e+00	0	32	88808	3.603280e-04	0	0	14896	0.000000e+00	0	0	34254	0.000000e+00	0	0	9562	0.000000e+00	0	0	17690	0.000000e+00	0	0	21626	0.000000e+00	0	33	102284	3.226310e-04	0	0	30524	0.000000e+00	0	33	102284	3.226310e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	42	170326	2.4658595869098083E-4	0	246	0	0	2626	0	0	6222	0	0	650	0	0	358	0	0	656	0	0	182	0	9	15046	5.981656254153928E-4	0	6468	0	0	3282	0	51	196312	2.5979053751171605E-4	Pathogenic/Likely_pathogenic	Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_provided|Classic_homocystinuria|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43072048G>A	ClinGen:CA325105|UniProtKB:P35520#VAR_008049	C4707243|C3661900|C0751202|C3150344	PS607086|236200	91387|394	.	Pro	Leu	210450	single nucleotide variant	NM_000071.3(CBS):c.146C>T (p.Pro49Leu)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Feb 02, 2025	148865119	-	RCV000200523|RCV000410155|RCV002229028|RCV002310761	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection	germline;unknown	germline	GRCh38	NC_000021.9	21	43072048	43072048	21q22.3	criteria provided, multiple submitters, no conflicts	12	-	N	ClinGen:CA325105,UniProtKB:P35520#VAR_008049	2	212872	43072048	G	A	-	-	-	-	-	-	SCV000249719|SCV000317366|SCV000543521|SCV000893557|SCV001472722|SCV001713879|SCV002016939|SCV004213842|SCV004847929|SCV005051295|SCV005052058	-	-	146C>T 	Pro49Leu	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	323	CCSBVarC000042	ALE00000042	146C>T	Pro49Leu	Edgotyping3	VUSMutGDEh011	F06	NULL	NULL	NULL	VUSMutGDDh011	F06	NULL	NULL	NULL	NULL	NULL	NULL	0	NULL	1	5	0	NULL	0	NULL	0	NULL	CBS_Pro49Leu	21	21	43072048	G	A
359	CBS	146C>T	Pro49Leu	ENSG00000160200	21	43072048	NC_000021.9:43072048:G:A	ALE00000042	CCSBVarC000042	994	NULL	323	GDEhDisVCh_40013	G02	RC4	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCTGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210450.0	single nucleotide variant	NM_000071.3(CBS):c.146C>T (p.Pro49Leu)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Feb 02, 2025	148865119.0	-	RCV000200523|RCV000410155|RCV002229028|RCV002310761	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection	germline;unknown	germline	GRCh38	NC_000021.9	21	43072048.0	43072048.0	21q22.3	criteria provided, multiple submitters, no conflicts	12.0	-	N	ClinGen:CA325105,UniProtKB:P35520#VAR_008049	2.0	212872.0	43072048.0	G	A	-	-	-	-	-	-	SCV000249719|SCV000317366|SCV000543521|SCV000893557|SCV001472722|SCV001713879|SCV002016939|SCV004213842|SCV004847929|SCV005051295|SCV005052058	-	-	146C>T 	Pro49Leu	NM_000071.3	2.0	1_Pathogenic	chr21	C	T	21-43072048-C-T		212872	21	43072048	G	A	P	L	rs148865119	21	44492158	21	43365227	49	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.146C>T	p.Pro49Leu	c.146C>T	p.Pro49Leu	principal1	Y	1	.	.	-	CCG	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.008	0.83643	D	0.977	0.58547	D	0.692	0.53858	P	1.0	0.99291	A	simple_aae	0.0	100.0	3.165	0.88471	M	-7.36	0.96705	D	0.787	0.78271	1.0891	0.99201	D	0.9773	0.99294	D	10	0.9457127	0.93828	D	0.639053	0.96913	D	0.864	0.95865	.	.	.	.	.	0.94052500168	0.93943	.	0.74110	.	0.44147	0.493413418531	0.37861	T	0.943753	0.99126	D	0.333256	0.85278	D	0.54547	0.95521	D	0.547446891953106	0.34070	D	.	0.84186	.	0.88651955	0.90072	0.64787984	0.79179	0.8733611	0.88980	0.63119227	0.78252	-5.537	0.42265	T	.	0.14168	.	0.962803492659164	0.82124	0.99981695	0.99765	0.949	0.97673	.	.	.	.	.	.	3.985133	0.58691	24.0	0.99887169769619488	0.96206	0.796384	0.72251	D	0.717515815183183	0.80675	7.370829	0.681475325225945	0.80868	7.419574	5.64	5.64	0.86461	0.949	0.28759	5.359	0.65911	6.357000	0.55569	0.59	0.31918	1.0	0.71675	1.000000	0.68239	0.43	0.27499	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11	109388	1.005590e-04	0	33	207310	1.591820e-04	0	34	236450	1.437940e-04	0	0	7160	0.000000e+00	0	0	17110	0.000000e+00	0	0	2318	0.000000e+00	0	0	9044	0.000000e+00	0	0	13390	0.000000e+00	0	11	42762	2.572380e-04	0	0	15690	0.000000e+00	0	11	42762	2.572380e-04	0	0	16200	0.000000e+00	0	0	30514	0.000000e+00	0	0	6188	0.000000e+00	0	0	13412	0.000000e+00	0	0	16730	0.000000e+00	0	32	88808	3.603280e-04	0	0	30606	0.000000e+00	0	32	88808	3.603280e-04	0	0	14896	0.000000e+00	0	0	34254	0.000000e+00	0	0	9562	0.000000e+00	0	0	17690	0.000000e+00	0	0	21626	0.000000e+00	0	33	102284	3.226310e-04	0	0	30524	0.000000e+00	0	33	102284	3.226310e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	42	170326	2.4658595869098083E-4	0	246	0	0	2626	0	0	6222	0	0	650	0	0	358	0	0	656	0	0	182	0	9	15046	5.981656254153928E-4	0	6468	0	0	3282	0	51	196312	2.5979053751171605E-4	Pathogenic/Likely_pathogenic	Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_provided|Classic_homocystinuria|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43072048G>A	ClinGen:CA325105|UniProtKB:P35520#VAR_008049	C4707243|C3661900|C0751202|C3150344	PS607086|236200	91387|394	.	Pro	Leu	210450	single nucleotide variant	NM_000071.3(CBS):c.146C>T (p.Pro49Leu)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Feb 02, 2025	148865119	-	RCV000200523|RCV000410155|RCV002229028|RCV002310761	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection	germline;unknown	germline	GRCh38	NC_000021.9	21	43072048	43072048	21q22.3	criteria provided, multiple submitters, no conflicts	12	-	N	ClinGen:CA325105,UniProtKB:P35520#VAR_008049	2	212872	43072048	G	A	-	-	-	-	-	-	SCV000249719|SCV000317366|SCV000543521|SCV000893557|SCV001472722|SCV001713879|SCV002016939|SCV004213842|SCV004847929|SCV005051295|SCV005052058	-	-	146C>T 	Pro49Leu	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	994	CCSBVarC000042	ALE00000042	146C>T	Pro49Leu	RC4	RC4_Mut_GDEh1026	F05	GDEhDisVCh_40013	G02	1	RC4_Mut_GDDh1026	F05	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	CBS_Pro49Leu	21	21	43072048	G	A
71569	OTC	299G>A	Gly100Asp	ENSG00000036473	X	38381342	NC_000023.11:38381342:G:A	ALE00005237	CCSBVarC005237	NULL	205846	NULL	GDEhDisVCh_40048	F01	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGACTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103055.0	single nucleotide variant	NM_000531.6(OTC):c.299G>A (p.Gly100Asp)	5009.0	OTC	HGNC:8512	Pathogenic	1.0	-	72554349.0	-	RCV000083396	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38381342.0	38381342.0	Xp11.4	no assertion criteria provided	1.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA285806,UniProtKB:P00480#VAR_004868	2.0	97163.0	38381342.0	G	A	-	-	-	-	-	-	SCV000115482	-	-	299G>A 	Gly100Asp	NM_000531.6		1_Pathogenic	chrX	G	A	X-38381342-G-A	0.0	97163	X	38381342	G	A	G	D	rs72554349	X	38240595	X	38125539	100	OTC	ENSG00000036473	ENST00000039007	ENSP00000039007	P00480	OTC_HUMAN	c.299G>A	p.Gly100Asp	c.299G>A	p.Gly100Asp	principal1	Y	1	YES	Select	+	GGC	2	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.001	0.83643	D	1.0	0.90580	D	0.999	0.92348	D	0.91	0.92786	A	simple_aae	9.0	91.0	3.96	0.96448	H	-5.49	0.85795	D	0.935	0.94087	1.0043	0.97253	D	0.9878	0.99643	D	9	0.9944922	0.99947	D	0.993545	0.99981	D	0.979	0.99840	0.966	0.99665	P00480	G100D	Gain of catalytic residue at G100 (P = 0.0867)| Gain of phosphorylation at T97 (P = 0.1291)| Gain of disorder (P = 0.2291)| Loss of MoRF binding (P = 0.3606)| Loss of helix (P = 0.3949)	0.994559445019	0.99443	0.9980761451723724	0.99806	1.34399655542	0.83846	0.837670862675	0.87718	D	0.977168	0.99788	D	0.682498	0.99917	D	0.742584	0.99917	D	0.998704552650452	0.94873	D	0.963804	0.86602	D	0.99539727	0.99970	0.9930161	0.99993	0.99539727	0.99970	0.9930161	0.99994	-15.139	0.96178	D	0.9928	0.94557	P	0.999694462344425	0.97521	0.99829440	0.98716	0.985	0.99487	.	.	.	.	.	.	4.973959	0.82375	27.8	0.99853406444131498	0.93284	.	.	.	.	.	.	.	.	.	5.8	5.8	0.92070	5.0	0.89963	5.633	0.67575	11.588000	0.93396	-0.105	0.15707	1.0	0.71675	1.000000	0.68239	0.84	0.39676	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided	no_assertion_criteria_provided	NC_000023.11:g.38381342G>A	ClinGen:CA285806|UniProtKB:P00480#VAR_004868	CN517202	.	.	Aspartate/ornithine carbamoyltransferase, carbamoyl-P binding	Gly	Asp	103055	single nucleotide variant	NM_000531.6(OTC):c.299G>A (p.Gly100Asp)	5009	OTC	HGNC:8512	Pathogenic	1	-	72554349	-	RCV000083396	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38381342	38381342	Xp11.4	no assertion criteria provided	1	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA285806,UniProtKB:P00480#VAR_004868	2	97163	38381342	G	A	-	-	-	-	-	-	SCV000115482	-	-	299G>A 	Gly100Asp	NM_000531.6		1_Pathogenic	OTC	ENSG00000036473	71569	205846	CCSBVarC005237	ALE00005237	299G>A	Gly100Asp	CEGS2	CegsMutGDEh1010	H05	GDEhDisVCh_40048	F01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Gly100Asp	23	X	38381342	G	A
359	CBS	296T>A	Phe99Tyr	ENSG00000160200	21	43068529	NC_000021.9:43068529:A:T	ALE00007345	CCSBVarC007357	NULL	NULL	317	GDEhDisVCh_40013	B11	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTACGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	404307.0	single nucleotide variant	NM_000071.3(CBS):c.296T>A (p.Phe99Tyr)	875.0	CBS	HGNC:1550	Conflicting classifications of pathogenicity	0.0	Dec 14, 2023	112029370.0	-	RCV000459701|RCV000497848|RCV001704553|RCV002525534|RCV002436393	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:CN169374|MedGen:C3661900|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Classic homocystinuria|not specified|not provided|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection	germline	germline	GRCh38	NC_000021.9	21	43068529.0	43068529.0	21q22.3	criteria provided, conflicting classifications	6.0	-	N	ClinGen:CA16616548	2.0	405376.0	43068529.0	A	T	-	-	-	-	-	-	SCV000543516|SCV000589389|SCV000602919|SCV001781420|SCV002749720|SCV005410140	-	-	296T>A 	Phe99Tyr	NM_000071.3	1.0	3_Conflicting	chr21	T	A	21-43068529-T-A		405376	21	43068529	A	T	F	Y	rs112029370	21	44488639	21	43361708	99	CBS	ENSG00000160200	ENST00000398165	ENSP00000381231	P35520	CBS_HUMAN	c.296T>A	p.Phe99Tyr	c.296T>A	p.Phe99Tyr	principal1	Y	1	YES	Select	-	TTC	2	0	A	A/A	A/A	A/A	A/A	1.0	0.02319	T	1.0	0.04939	T	0.0	0.02950	B	0.002	0.06938	B	0.07	0.21442	N	simple_aae	93.0	7.0	0.355	0.11881	N	0.4	0.03443	N	0.337	0.37578	0.2752	0.87101	D	0.7284	0.90677	D	10	0.019435287	0.00431	T	0.145456	0.82716	D	0.243	0.54707	.	.	.	.	.	0.288352970974	0.28040	0.7618642488328979	0.76003	0.393819959556	0.40268	0.522314071655	0.41892	T	0.63546	0.88641	D	-0.282512	0.10170	T	-0.184443	0.55805	T	0.0144167181623514	0.00289	T	.	0.49081	.	0.116353385	0.27202	0.03586995	0.02934	0.08557036	0.19674	0.03571664	0.02887	-5.512	0.42031	T	.	0.05295	.	0.192316754054814	0.49526	0.98257690	0.95787	0.078	0.22017	.	.	.	.	.	.	0.989232	0.13688	10.21	0.79814335663967206	0.13121	0.191169	0.31625	N	-1.30257201737864	0.03606	0.1632357	-1.24855689625397	0.05072	0.2448237	4.81	-3.74	0.04101	-4.1	0.06067	0.67	0.24927	2.580000	0.33493	-0.198	0.09038	0.975	0.34813	0.663000	0.26107	0.329	0.25228	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13	109404	1.188260e-04	0	28	208056	1.345790e-04	0	27	236860	1.139910e-04	0	11	7162	1.535880e-03	0	2	17112	1.168770e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42766	0.000000e+00	0	0	15690	0.000000e+00	0	11	7162	1.535880e-03	0	26	16208	1.604150e-03	0	2	30522	6.552650e-05	0	0	6210	0.000000e+00	0	0	13414	0.000000e+00	0	0	16734	0.000000e+00	0	0	89496	0.000000e+00	0	0	30608	0.000000e+00	0	26	16208	1.604150e-03	0	24	14894	1.611390e-03	0	2	34258	5.838050e-05	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	1	102672	9.739750e-06	0	0	30526	0.000000e+00	0	24	14894	1.611390e-03	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2764	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2878	0	0	112	0	0	14030	0	Conflicting_classifications_of_pathogenicity	Familial_thoracic_aortic_aneurysm_and_aortic_dissection|Classic_homocystinuria|not_provided|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|not_specified	criteria_provided,_conflicting_classifications	NC_000021.9:g.43068529A>T	ClinGen:CA16616548	C4707243|C0751202|C3661900|C3150344|CN169374	PS607086|236200	91387|394	Tryptophan synthase beta chain-like, PALP domain	Phe	Tyr	404307	single nucleotide variant	NM_000071.3(CBS):c.296T>A (p.Phe99Tyr)	875	CBS	HGNC:1550	Conflicting classifications of pathogenicity	0	Dec 14, 2023	112029370	-	RCV000459701|RCV000497848|RCV001704553|RCV002525534|RCV002436393	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:CN169374|MedGen:C3661900|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Classic homocystinuria|not specified|not provided|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection	germline	germline	GRCh38	NC_000021.9	21	43068529	43068529	21q22.3	criteria provided, conflicting classifications	6	-	N	ClinGen:CA16616548	2	405376	43068529	A	T	-	-	-	-	-	-	SCV000543516|SCV000589389|SCV000602919|SCV001781420|SCV002749720|SCV005410140	-	-	296T>A 	Phe99Tyr	NM_000071.3	1	3_Conflicting	CBS	ENSG00000160200	359	317	CCSBVarC007357	ALE00007345	296T>A	Phe99Tyr	Edgotyping3	VUSMutGDEh011	H05	GDEhDisVCh_40013	B11	1	VUSMutGDDh011	H05	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	CBS_Phe99Tyr	21	21	43068529	A	T
52861	F9	509G>A	Cys170Tyr	ENSG00000101981	X	139548480	NC_000023.11:139548480:G:A	ALE00002181	CCSBVarC002181	24671	NULL	NULL	GDEhDisVCh_40052	C12	RC4	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTATGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT	800231.0	single nucleotide variant	NM_000133.4(F9):c.509G>A (p.Cys170Tyr)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Jun 28, 2019	1603265500.0	-	RCV001001432	MedGen:CN169374	not specified	germline	germline	GRCh38	NC_000023.11	X	139548480.0	139548480.0	Xq27.1	criteria provided, single submitter	1.0	-	N	ClinGen:CA414439424	2.0	811517.0	139548480.0	G	A	-	-	-	-	-	-	SCV001158668	-	-	509G>A 	Cys170Tyr	NM_000133.4	1.0	1_Pathogenic	chrX	G	A	X-139548480-G-A		811517	X	139548480	G	A	C	Y	rs1603265500	X	138630639	X	138458305	170	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.509G>A	p.Cys170Tyr	c.509G>A	p.Cys170Tyr	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	4.73	0.99523	H	-9.32	0.98352	D	0.88	0.95970	0.9074	0.95765	D	0.9985	0.99959	D	9	0.9941932	0.99929	D	0.833338	0.98706	D	0.971	0.99671	0.989	0.99885	P00740	C170Y	Gain of phosphorylation at C170 (P = 0.048)| Loss of disorder (P = 0.0766)| Loss of glycosylation at S169 (P = 0.0882)| Gain of ubiquitination at K168 (P = 0.1008)| Loss of methylation at K168 (P = 0.1771)	0.998542052572	0.99850	0.9999921642813904	0.99999	2.12843697498	0.95120	0.562821447849	0.47599	T	0.964843	0.99570	D	0.720938	0.99946	D	0.797801	0.99946	D	0.99992847442627	0.99730	D	0.919108	0.70775	D	0.9961493	0.99983	0.9921017	0.99990	0.9964981	0.99988	0.99270505	0.99993	-14.847	0.95493	D	0.9818	0.94596	P	0.999918678679179	0.98806	0.99999344	0.99996	0.995	0.99826	.	.	.	.	.	.	4.801854	0.78068	26.8	0.99425548895376659	0.64033	.	.	.	.	.	.	.	.	.	5.08	5.08	0.68332	4.69	0.86632	7.385	0.7908	11.769000	0.95819	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.965	0.52907	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic	not_specified	criteria_provided,_single_submitter	NC_000023.11:g.139548480G>A	.	CN169374	.	.	.	Cys	Tyr	800231	single nucleotide variant	NM_000133.4(F9):c.509G>A (p.Cys170Tyr)	2158	F9	HGNC:3551	Pathogenic	1	Jun 28, 2019	1603265500	-	RCV001001432	MedGen:CN169374	not specified	germline	germline	GRCh38	NC_000023.11	X	139548480	139548480	Xq27.1	criteria provided, single submitter	1	-	N	ClinGen:CA414439424	2	811517	139548480	G	A	-	-	-	-	-	-	SCV001158668	-	-	509G>A 	Cys170Tyr	NM_000133.4	1	1_Pathogenic	F9	ENSG00000101981	52861	24671	CCSBVarC002181	ALE00002181	509G>A	Cys170Tyr	RC4	RC4_Mut_GDEh1022	D11	GDEhDisVCh_40052	C12	2	RC4_Mut_GDDh1022	D11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	F9_Cys170Tyr	23	X	139548480	G	A
3774	TP53	818G>A	Arg273His	ENSG00000141510	17	7673802	NC_000017.11:7673802:C:T	ALE00004872	CCSBVarC004872	NULL	214905	NULL	GDEhDisVCh_40053	H09	CEGS2	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCATGTTTGTGCCTGTGCTGGGAGAGACCGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	27405.0	single nucleotide variant	NM_000546.6(TP53):c.818G>A (p.Arg273His)	7157.0	TP53	HGNC:11998	Pathogenic	1.0	Aug 05, 2024	28934576.0	-	RCV000013163|RCV000013164|RCV000115738|RCV001257517|RCV003492292|RCV000254693|RCV000431361|RCV000441169|RCV004797590|RCV003466853|RCV000785345|RCV001527470|RCV005003353|RCV003162246|RCV000422097|RCV000463420|RCV001358389|RCV001527484	Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|Human Phenotype Ontology:HP:0011779,MONDO:MONDO:0006468,MeSH:D065646,MedGen:C0238461,Orphanet:142|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002859,MONDO:MONDO:0005212,MeSH:D012208,MedGen:C0035412,Orphanet:780|MedGen:CN221562|MedGen:C3661900|Human Phenotype Ontology:HP:0030078,MONDO:MONDO:0005061,MeSH:D000077192,MedGen:C0152013|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651||MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0005575,MedGen:C0346629,OMIM:114500;Human Phenotype Ontology:HP:0006775,MONDO:MONDO:0009693,MeSH:D009101,MedGen:C0026764,OMIM:254500,Orphanet:29073,Orphanet:85443|12 conditions|Human Phenotype Ontology:HP:0012126,MONDO:MONDO:0001056,MeSH:D013274,MedGen:C0024623,OMIM:613659|MONDO:MONDO:0010150,MeSH:D000077195,MedGen:C1168401,OMIM:275355,Orphanet:67037|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535	Li-Fraumeni syndrome 1|Thyroid gland undifferentiated (anaplastic) carcinoma|Hereditary cancer-predisposing syndrome|Rhabdomyosarcoma|Breast and/or ovarian cancer|not provided|Lung adenocarcinoma|Neoplasm|TP53-related disorder|Adrenocortical carcinoma, hereditary|Ovarian neoplasm|Colorectal cancer;Multiple myeloma|12 conditions|Gastric cancer|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome|Malignant tumor of breast|Familial cancer of breast	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7673802.0	7673802.0	17p13.1	reviewed by expert panel	37.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000434,UniProtKB:P04637#VAR_005995,OMIM:191170.0020	3.0	12366.0	7673802.0	C	T	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV001142550	-	SCV005094393	818G>A 	Arg273His	NM_000546.6	3.0	1_Pathogenic	chr17	G	A	17-7673802-G-A		12366	17	7673802	C	T	R	H	rs28934576	17	7577120	17	7517845	273	TP53	ENSG00000141510	ENST00000714357	ENSP00000519624	P04637	P53_HUMAN	.	.	c.818G>A	p.Arg273His	principal1	Y	.	.	.	-	CGT	2	0	C	C/C	C/C	C/C	C/C	.	0.60085	.	.	0.56104	.	0.831	0.90580	P	0.516	0.78402	P	.	0.99291	.	.	.	.	2.08	0.57221	M	.	0.80543	.	.	0.97550	0.9393	0.96226	D	0.9921	0.99806	D	9	.	0.84138	.	0.516858	0.95378	D	.	0.96013	.	.	.	.	.	.	0.99672	.	0.79135	.	0.28691	0.680267095566	0.64247	T	0.994624	0.99987	D	0.487327	0.93879	D	0.525881	0.95078	D	0.909091472625732	0.56142	D	.	0.60013	.	0.8545731	0.87508	0.63635963	0.78537	0.70529693	0.78097	0.64109737	0.78801	-12.599	0.87675	D	.	0.93277	.	0.99568204115679	0.91519	0.99997449	0.99978	0.994	0.99793	.	.	.	.	.	.	4.139481	0.62078	24.4	0.99836463733182734	0.91720	0.929822	0.91586	D	0.382783734256881	0.60284	4.238356	0.333000780386941	0.57264	3.914811	4.92	4.92	0.64102	5.51	0.94414	7.905	0.86513	7.724000	0.67499	0.596	0.33565	1.0	0.71675	1.000000	0.68239	0.98	0.58201	432	0.80699	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	.	.	.	.	4	109260	3.660990e-05	0	4	207842	1.924540e-05	0	4	236592	1.690670e-05	0	0	7150	0.000000e+00	0	0	17078	0.000000e+00	0	1	2314	4.321520e-04	0	0	9036	0.000000e+00	0	0	13390	0.000000e+00	0	3	42710	7.024120e-05	0	0	15670	0.000000e+00	0	3	42710	7.024120e-05	0	0	16194	0.000000e+00	0	0	30460	0.000000e+00	0	1	6204	1.611860e-04	0	0	13412	0.000000e+00	0	0	16730	0.000000e+00	0	3	89416	3.355100e-05	0	0	30576	0.000000e+00	0	3	89416	3.355100e-05	0	0	14880	0.000000e+00	0	0	34194	0.000000e+00	0	1	9564	1.045590e-04	0	0	17680	0.000000e+00	0	0	21600	0.000000e+00	0	3	102572	2.924770e-05	0	0	30494	0.000000e+00	0	3	102572	2.924770e-05	0	.	18	1613942	1.115280e-05	0	2	29602	6.756300e-05	0	1	75012	1.333120e-05	0	0	912	0.000000e+00	0	0	59968	0.000000e+00	0	2	29602	6.756300e-05	0	0	44856	0.000000e+00	0	0	64016	0.000000e+00	0	0	6062	0.000000e+00	0	14	1179946	1.186490e-05	0	1	91066	1.098100e-05	0	7	98880	7.079288025889968E-5	0	176	0	0	2708	0	0	4178	0	0	436	0	0	928	0	0	656	0	0	280	0	0	4286	0	0	4354	0	0	3364	0	7	112528	6.220673965590786E-5	Pathogenic	Lung_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Brainstem_glioma|Gastric_cancer|Neoplasm_of_the_large_intestine|Malignant_tumor_of_breast|Uterine_carcinosarcoma|Malignant_neoplasm_of_body_of_uterus|Prostate_adenocarcinoma|Ovarian_serous_cystadenocarcinoma|Gastric_adenocarcinoma|Adrenal_cortex_carcinoma|Squamous_cell_lung_carcinoma|Acute_myeloid_leukemia|Carcinoma_of_esophagus|Breast_and/or_ovarian_cancer|Thyroid_gland_undifferentiated_(anaplastic)_carcinoma|Pancreatic_adenocarcinoma|Rhabdomyosarcoma|Breast_neoplasm|B-cell_chronic_lymphocytic_leukemia|Li-Fraumeni_syndrome|Familial_cancer_of_breast|Medulloblastoma|Colorectal_cancer|Basal_cell_carcinoma,_susceptibility_to,_7|Li-Fraumeni_syndrome_1|Adrenocortical_carcinoma,_hereditary|Bone_marrow_failure_syndrome_5|Hepatocellular_carcinoma|Nasopharyngeal_carcinoma|Carcinoma_of_pancreas|Choroid_plexus_papilloma|Glioma_susceptibility_1|Bone_osteosarcoma|Neoplasm_of_brain|Ovarian_neoplasm|Malignant_melanoma_of_skin|Multiple_myeloma|Glioblastoma|Small_cell_lung_carcinoma|Hereditary_cancer-predisposing_syndrome|not_provided|Squamous_cell_carcinoma_of_the_head_and_neck|Neoplasm	reviewed_by_expert_panel	NC_000017.11:g.7673802C>T	ClinGen:CA000434|OMIM:191170.0020|UniProtKB:P04637#VAR_005995	C0152013|C0279680|C0677865|C0024623|C0009404|C0006142|C0280630|C0153574|C0007112|C0279663|C0278701|C0206686|C0149782|C0023467|C0152018|CN221562|C0238461|C0281361|C0035412|C1458155|C0023434|C0085390|C0346153|C0025149|C0346629|C3553606|C1835398|C1859972|C4748488|C2239176|C2931822|C0235974|C0205770|C2750850|C0585442|C0006118|C0919267|C0151779|C0026764|C0017636|C0149925|C0027672|C3661900|C1168401|C0027651	613659|601626|151400|PS151623|114480|155255|114500|614740|151623|202300|618165|114550|607107|260500|137800|259500|254500|182280|275355	1501|519|70482|142|780|67038|524|227535|616|524|1501|88673|150|1333|217074|251899|2807|668|29073|85443|360|70573|140162|67037	p53, DNA-binding domain|p53, DNA-binding domain	Arg	His	27405	single nucleotide variant	NM_000546.6(TP53):c.818G>A (p.Arg273His)	7157	TP53	HGNC:11998	Pathogenic	1	Aug 05, 2024	28934576	-	RCV000013163|RCV000013164|RCV000115738|RCV001257517|RCV003492292|RCV000254693|RCV000431361|RCV000441169|RCV004797590|RCV003466853|RCV000785345|RCV001527470|RCV005003353|RCV003162246|RCV000422097|RCV000463420|RCV001358389|RCV001527484	Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|Human Phenotype Ontology:HP:0011779,MONDO:MONDO:0006468,MeSH:D065646,MedGen:C0238461,Orphanet:142|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002859,MONDO:MONDO:0005212,MeSH:D012208,MedGen:C0035412,Orphanet:780|MedGen:CN221562|MedGen:C3661900|Human Phenotype Ontology:HP:0030078,MONDO:MONDO:0005061,MeSH:D000077192,MedGen:C0152013|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651||MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0005575,MedGen:C0346629,OMIM:114500;Human Phenotype Ontology:HP:0006775,MONDO:MONDO:0009693,MeSH:D009101,MedGen:C0026764,OMIM:254500,Orphanet:29073,Orphanet:85443|12 conditions|Human Phenotype Ontology:HP:0012126,MONDO:MONDO:0001056,MeSH:D013274,MedGen:C0024623,OMIM:613659|MONDO:MONDO:0010150,MeSH:D000077195,MedGen:C1168401,OMIM:275355,Orphanet:67037|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535	Li-Fraumeni syndrome 1|Thyroid gland undifferentiated (anaplastic) carcinoma|Hereditary cancer-predisposing syndrome|Rhabdomyosarcoma|Breast and/or ovarian cancer|not provided|Lung adenocarcinoma|Neoplasm|TP53-related disorder|Adrenocortical carcinoma, hereditary|Ovarian neoplasm|Colorectal cancer;Multiple myeloma|12 conditions|Gastric cancer|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome|Malignant tumor of breast|Familial cancer of breast	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7673802	7673802	17p13.1	reviewed by expert panel	37	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000434,UniProtKB:P04637#VAR_005995,OMIM:191170.0020	3	12366	7673802	C	T	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV001142550	-	SCV005094393	818G>A 	Arg273His	NM_000546.6	3	1_Pathogenic	TP53	ENSG00000141510	3774	214905	CCSBVarC004872	ALE00004872	818G>A	Arg273His	CEGS2	CegsMutGDEh1027	A03	GDEhDisVCh_40053	H09	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	TP53_Arg273His	17	17	7673802	C	T
71569	OTC	422G>A	Arg141Gln	ENSG00000036473	X	38401310	NC_000023.11:38401310:G:A	ALE00002760	CCSBVarC002760	35490	NULL	NULL	GDEhDisVCh_40048	G11	RC4	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCAAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	26026.0	single nucleotide variant	NM_000531.6(OTC):c.422G>A (p.Arg141Gln)	5009.0	OTC	HGNC:8512	Pathogenic	1.0	Aug 15, 2024	68026851.0	-	RCV000011734|RCV000083434	MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664|MedGen:C3661900	Ornithine carbamoyltransferase deficiency|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	38401310.0	38401310.0	Xp11.4	criteria provided, multiple submitters, no conflicts	8.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224600,UniProtKB:P00480#VAR_004879,OMIM:300461.0002	3.0	10987.0	38401310.0	G	A	-	-	-	-	-	-	SCV000230943|SCV000894489|SCV001212429|SCV001802043|SCV002033219|SCV005381012	-	-	422G>A 	Arg141Gln	NM_000531.6	2.0	1_Pathogenic	chrX	G	A	X-38401310-G-A		10987	X	38401310	G	A	R	Q	rs68026851	X	38260563	X	38145507	141	OTC	ENSG00000036473	ENST00000039007	ENSP00000039007	P00480	OTC_HUMAN	c.422G>A	p.Arg141Gln	c.422G>A	p.Arg141Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.87	0.90832	A	simple_aae	13.0	87.0	4.24	0.97965	H	-3.92	0.73186	D	0.991	0.99781	0.9955	0.97105	D	0.9992	0.99972	D	10	0.9958034	0.99993	D	0.979866	0.99892	D	0.956	0.99253	0.995	0.99946	P00480	R141Q	Gain of sheet (P = 0.1208)| Loss of stability (P = 0.2015)| Loss of loop (P = 0.2237)| Loss of ubiquitination at K144 (P = 0.2248)| Gain of disorder (P = 0.2263)	0.999483916749	0.99946	0.9913628209556475	0.99130	1.24856909382	0.81659	0.540151119232	0.44402	T	0.984146	0.99893	D	0.740285	0.99969	D	0.825592	0.99969	D	0.999841570854187	0.99303	D	0.957304	0.83895	D	0.9925527	0.99881	0.98080575	0.99837	0.9925527	0.99881	0.98080575	0.99837	-11.615	0.82977	D	0.9576	0.87737	P	0.999949925457097	0.99079	0.99878650	0.98964	0.972	0.98934	.	.	.	.	.	.	4.882109	0.80113	27.2	0.99958513863383269	0.99990	.	.	.	.	.	.	.	.	.	5.97	5.11	0.69146	5.17	0.91630	9.543	0.97194	9.811000	0.81777	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.995	0.73271	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Ornithine_carbamoyltransferase_deficiency|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.38401310G>A	ClinGen:CA224600|OMIM:300461.0002|UniProtKB:P00480#VAR_004879	C0268542|C3661900	311250	664	Aspartate/ornithine carbamoyltransferase, carbamoyl-P binding	Arg	Gln	26026	single nucleotide variant	NM_000531.6(OTC):c.422G>A (p.Arg141Gln)	5009	OTC	HGNC:8512	Pathogenic	1	Aug 15, 2024	68026851	-	RCV000011734|RCV000083434	MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664|MedGen:C3661900	Ornithine carbamoyltransferase deficiency|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	38401310	38401310	Xp11.4	criteria provided, multiple submitters, no conflicts	8	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224600,UniProtKB:P00480#VAR_004879,OMIM:300461.0002	3	10987	38401310	G	A	-	-	-	-	-	-	SCV000230943|SCV000894489|SCV001212429|SCV001802043|SCV002033219|SCV005381012	-	-	422G>A 	Arg141Gln	NM_000531.6	2	1_Pathogenic	OTC	ENSG00000036473	71569	35490	CCSBVarC002760	ALE00002760	422G>A	Arg141Gln	RC4	RC4_Mut_GDEh1017	G11	GDEhDisVCh_40048	G11	2	RC4_Mut_GDDh1017	G11	NULL	NULL	NULL	NULL	NULL	NULL	1	3	1	99	0	NULL	0	NULL	0	NULL	OTC_Arg141Gln	23	X	38401310	G	A
14613	BRCA1	1942G>C	Ala648Pro	ENSG00000012048	17	43057075	NC_000017.11:43057075:C:G	ALE00003308	CCSBVarC003308	NULL	218439	NULL	GDEhDisVCh_40059	C08	CEGS2	ATGGATTTATCTGCTCTTCGCGTTGAAGAAGTACAAAATGTCATTAATGCTATGCAGAAAATCTTAGAGTGTCCCATCTGTCTGGAGTTGATCAAGGAACCTGTCTCCACAAAGTGTGACCACATATTTTGCAAATTTTGCATGCTGAAACTTCTCAACCAGAAGAAAGGGCCTTCACAGTGTCCTTTATGTAAGAATGATATAACCAAAAGGAGCCTACAAGAAAGTACGAGATTTAGTCAACTTGTTGAAGAGCTATTGAAAATCATTTGTGCTTTTCAGCTTGACACAGGTTTGGAGTATGCAAACAGCTATAATTTTGCAAAAAAGGAAAATAACTCTCCTGAACATCTAAAAGATGAAGTTTCTATCATCCAAAGTATGGGCTACAGAAACCGTGCCAAAAGACTTCTACAGAGTGAACCCGAAAATCCTTCCTTGCAGGAAACCAGTCTCAGTGTCCAACTCTCTAACCTTGGAACTGTGAGAACTCTGAGGACAAAGCAGCGGATACAACCTCAAAAGACGTCTGTCTACATTGAATTGGGATCTGATTCTTCTGAAGATACCGTTAATAAGGCAACTTATTGCAGTGTGGGAGATCAAGAATTGTTACAAATCACCCCTCAAGGAACCAGGGATGAAATCAGTTTGGATTCTGCAAAAAAGGCTGCTTGTGAATTTTCTGAGACGGATGTAACAAATACTGAACATCATCAACCCAGTAATAATGATTTGAACACCACTGAGAAGCGTGCAGCTGAGAGGCATCCAGAAAAGTATCAGGGTGAAGCAGCATCTGGGTGTGAGAGTGAAACAAGCGTCTCTGAAGACTGCTCAGGGCTATCCTCTCAGAGTGACATTTTAACCACTCAGCAGAGGGATACCATGCAACATAACCTGATAAAGCTCCAGCAGGAAATGGCTGAACTAGAAGCTGTGTTAGAACAGCATGGGAGCCAGCCTTCTAACAGCTACCCTTCCATCATAAGTGACTCTTCTGCCCTTGAGGACCTGCGAAATCCAGAACAAAGCACATCAGAAAAAGTATTAACTTCACAGAAAAGTAGTGAATACCCTATAAGCCAGAATCCAGAAGGCCTTTCTGCTGACAAGTTTGAGGTGTCTGCAGATAGTTCTACCAGTAAAAATAAAGAACCAGGAGTGGAAAGGTCATCCCCTTCTAAATGCCCATCATTAGATGATAGGTGGTACATGCACAGTTGCTCTGGGAGTCTTCAGAATAGAAACTACCCATCTCAAGAGGAGCTCATTAAGGTTGTTGATGTGGAGGAGCAACAGCTGGAAGAGTCTGGGCCACACGATTTGACGGAAACATCTTACTTGCCAAGGCAAGATCTAGAGGGAACCCCTTACCTGGAATCTGGAATCAGCCTCTTCTCTGATGACCCTGAATCTGATCCTTCTGAAGACAGAGCCCCAGAGTCAGCTCGTGTTGGCAACATACCATCTTCAACCTCTGCATTGAAAGTTCCCCAATTGAAAGTTGCAGAATCTGCCCAGAGTCCAGCTGCTGCTCATACTACTGATACTGCTGGGTATAATGCAATGGAAGAAAGTGTGAGCAGGGAGAAGCCAGAATTGACAGCTTCAACAGAAAGGGTCAACAAAAGAATGTCCATGGTGGTGTCTGGCCTGACCCCAGAAGAATTTATGCTCGTGTACAAGTTTGCCAGAAAACACCACATCACTTTAACTAATCTAATTACTGAAGAGACTACTCATGTTGTTATGAAAACAGATGCTGAGTTTGTGTGTGAACGGACACTGAAATATTTTCTAGGAATTGCGGGAGGAAAATGGGTAGTTAGCTATTTCTGGGTGACCCAGTCTATTAAAGAAAGAAAAATGCTGAATGAGCATGATTTTGAAGTCAGAGGAGATGTGGTCAATGGAAGAAACCACCAAGGTCCAAAGCGACCAAGAGAATCCCAGGACAGAAAGATCTTCAGGGGGCTAGAAATCTGTTGCTATGGGCCCTTCACCAACATGCCCACAGGGTGTCCACCCAATTGTGGTTGTGCAGCCAGATGCCTGGACAGAGGACAATGGCTTCCATGCAATTGGGCAGATGTG	70150.0	single nucleotide variant	NM_007294.4(BRCA1):c.5254G>C (p.Ala1752Pro)	672.0	BRCA1	HGNC:1100	Pathogenic/Likely pathogenic	1.0	Mar 04, 2025	80357074.0	-	RCV000112581|RCV000563666|RCV001326888|RCV004819215|RCV003321495	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Breast-ovarian cancer, familial, susceptibility to, 1|not provided	germline;not applicable	germline	GRCh38	NC_000017.11	17	43057075.0	43057075.0	17q21.31	criteria provided, multiple submitters, no conflicts	6.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003394	2.0	55483.0	43057075.0	C	G	-	-	-	-	-	-	SCV000665879|SCV001517941|SCV004026748|SCV005440545	-	-	5254G>C 	Ala1752Pro	NM_007294.4	2.0	1_Pathogenic	chr17	G	C	17-43057075-G-C		55483	17	43057075	C	G	A	P	rs80357074	17	41209092	17	38462618	1752	BRCA1	ENSG00000012048	ENST00000357654	ENSP00000350283	P38398	BRCA1_HUMAN	c.5254G>C	p.Ala1752Pro	c.5254G>C	p.Ala1752Pro	principal2	Y	1	YES	Select	-	GCA	1	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.002	0.79703	D	0.979	0.73231	D	0.382	0.68055	B	0.9	0.97016	A	simple_aae	10.0	90.0	1.905	0.50677	L	-0.87	0.67509	N	0.785	0.91505	0.7267	0.93483	D	0.7512	0.91494	D	10	0.8884573	0.88051	D	0.528347	0.95543	D	0.687	0.88535	.	.	.	.	.	0.916468186789	0.91499	.	0.90554	.	0.14300	0.402806550264	0.25430	T	0.363985	0.72793	T	0.394069	0.89495	D	0.328277	0.89363	D	0.873226821422577	0.52047	D	.	0.85727	.	0.751786	0.80741	0.29994422	0.55811	0.6752999	0.76456	0.36229545	0.61397	-13.432	0.91505	D	0.97	0.92260	P	0.996970231371041	0.92647	0.99981004	0.99752	0.86	0.92357	.	.	.	.	.	.	3.172499	0.43113	21.7	0.99755420600979217	0.84629	0.754999	0.69359	D	0.376284195546614	0.59932	4.199692	0.382146778878571	0.60252	4.234296	5.07	4.08	0.46818	3.31	0.60027	3.194	0.50801	1.458000	0.26744	0.593	0.32293	1.0	0.71675	1.000000	0.68239	0.998	0.85369	518	0.74567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Hereditary_cancer-predisposing_syndrome|not_provided|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.43057075C>G	ClinGen:CA003394	C0027672|C3661900|C0677776|C2676676	604370	140162|145|145	.	Ala	Pro	70150	single nucleotide variant	NM_007294.4(BRCA1):c.5254G>C (p.Ala1752Pro)	672	BRCA1	HGNC:1100	Pathogenic/Likely pathogenic	1	Mar 04, 2025	80357074	-	RCV000112581|RCV000563666|RCV001326888|RCV004819215|RCV003321495	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Breast-ovarian cancer, familial, susceptibility to, 1|not provided	germline;not applicable	germline	GRCh38	NC_000017.11	17	43057075	43057075	17q21.31	criteria provided, multiple submitters, no conflicts	6	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003394	2	55483	43057075	C	G	-	-	-	-	-	-	SCV000665879|SCV001517941|SCV004026748|SCV005440545	-	-	5254G>C 	Ala1752Pro	NM_007294.4	2	1_Pathogenic	BRCA1	ENSG00000012048	14613	218439	CCSBVarC003308	ALE00003308	1942G>C	Ala648Pro	CEGS2	CegsMutGDEh1021	A08	GDEhDisVCh_40059	C08	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	BRCA1_Ala648Pro	17	17	43057075	C	G
359	CBS	352G>A	Val118Met	ENSG00000160200	21	43066342	NC_000021.9:43066342:C:T	ALE00007337	CCSBVarC007348	NULL	NULL	307	GDEhDisVCh_40013	A10	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCATGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	336884.0	single nucleotide variant	NM_000071.3(CBS):c.352G>A (p.Val118Met)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Jun 09, 2022	763385546.0	-	RCV000368495|RCV002523181	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344	Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43066342.0	43066342.0	21q22.3	criteria provided, multiple submitters, no conflicts	2.0	-	N	ClinGen:CA10644745	2.0	340090.0	43066342.0	C	T	-	-	-	-	-	-	SCV000436229|SCV003291446	-	-	352G>A 	Val118Met	NM_000071.3	2.0	4_VUS	chr21	G	A	21-43066342-G-A		340090	21	43066342	C	T	V	M	rs763385546	21	44486452	21	43359521	118	CBS	ENSG00000160200	ENST00000398165	ENSP00000381231	P35520	CBS_HUMAN	c.352G>A	p.Val118Met	c.352G>A	p.Val118Met	principal1	Y	1	YES	Select	-	GTG	1	0	C	C/C	C/C	C/C	C/C	0.001	0.91343	D	0.001	0.83643	D	0.999	0.77914	D	0.953	0.69273	D	0.67	0.80805	D	simple_aae	33.0	67.0	2.8	0.81458	M	-2.76	0.58599	D	0.932	0.93732	1.0907	0.99266	D	0.9420	0.98095	D	10	0.92550987	0.91808	D	0.539457	0.95697	D	0.917	0.97849	0.714	0.84890	P35520	V118M	Loss of methylation at K119 (P = 0.0193)| Gain of disorder (P = 0.0238)| Gain of catalytic residue at V118 (P = 0.0394)| Gain of ubiquitination at K119 (P = 0.0544)| Gain of helix (P = 0.132)	0.953373632049	0.95248	0.8556524161156026	0.85440	1.11752430456	0.78084	0.853418111801	0.90114	D	0.973046	0.99719	D	0.469279	0.93255	D	0.451796	0.93571	D	0.945095360279083	0.61963	D	.	0.97756	.	0.7370298	0.79884	0.56771576	0.74724	0.7595509	0.81201	0.57430625	0.75093	-11.264	0.81146	D	.	0.62609	.	0.998128105855292	0.93995	0.99976164	0.99689	0.974	0.99029	.	.	.	.	.	.	5.198594	0.87222	29.2	0.99892026751995922	0.96592	0.901069	0.84676	D	0.867498419301583	0.90025	10.24448	0.81363973995668	0.90673	10.53977	5.26	5.26	0.73443	2.86	0.52289	6.845	0.75251	7.399000	0.58628	0.524	0.24207	1.0	0.71675	1.000000	0.68239	0.985	0.61072	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	109204	1.831430e-05	0	3	207714	1.444290e-05	0	2	236612	8.452660e-06	0	0	7162	0.000000e+00	0	0	17104	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	1	13206	7.572320e-05	0	1	42764	2.338420e-05	0	0	15690	0.000000e+00	0	1	42764	2.338420e-05	0	0	16196	0.000000e+00	0	0	30514	0.000000e+00	0	0	6210	0.000000e+00	0	0	13404	0.000000e+00	0	1	16546	6.043760e-05	0	2	89376	2.237740e-05	0	0	30608	0.000000e+00	0	2	89376	2.237740e-05	0	0	14892	0.000000e+00	0	0	34244	0.000000e+00	0	0	9566	0.000000e+00	0	0	17690	0.000000e+00	0	1	21444	4.663310e-05	0	1	102630	9.743740e-06	0	0	30526	0.000000e+00	0	1	102630	9.743740e-06	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	4462	4.4822949350067237E-4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8	0	0	0	0	0	0	0	2	4470	4.4742729306487697E-4	Uncertain_significance	HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Classic_homocystinuria	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43066342C>T	ClinGen:CA10644745	C3150344|C0751202	236200	394	Tryptophan synthase beta chain-like, PALP domain|Cysteine synthase/cystathionine beta-synthase, pyridoxal-phosphate attachment site	Val	Met	336884	single nucleotide variant	NM_000071.3(CBS):c.352G>A (p.Val118Met)	875	CBS	HGNC:1550	Uncertain significance	0	Jun 09, 2022	763385546	-	RCV000368495|RCV002523181	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344	Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43066342	43066342	21q22.3	criteria provided, multiple submitters, no conflicts	2	-	N	ClinGen:CA10644745	2	340090	43066342	C	T	-	-	-	-	-	-	SCV000436229|SCV003291446	-	-	352G>A 	Val118Met	NM_000071.3	2	4_VUS	CBS	ENSG00000160200	359	307	CCSBVarC007348	ALE00007337	352G>A	Val118Met	Edgotyping3	VUSMutGDEh011	G04	GDEhDisVCh_40013	A10	1	VUSMutGDDh011	G04	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	5	0	NULL	0	NULL	0	NULL	CBS_Val118Met	21	21	43066342	C	T
71569	OTC	717G>C	Glu239Asp	ENSG00000036473	X	38408795	NC_000023.11:38408795:G:C	ALE00005256	CCSBVarC005256	NULL	205935	NULL	GDEhDisVCh_40048	H04	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGACAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103194.0	single nucleotide variant	NM_000531.6(OTC):c.717G>C (p.Glu239Asp)	5009.0	OTC	HGNC:8512	Likely pathogenic	1.0	Feb 06, 2024	66851495.0	-	RCV000083548|RCV000990790	MedGen:C3661900|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664	not provided|Ornithine carbamoyltransferase deficiency	germline;unknown	germline	GRCh38	NC_000023.11	X	38408795.0	38408795.0	Xp11.4	criteria provided, multiple submitters, no conflicts	3.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224759	2.0	97302.0	38408795.0	G	C	-	-	-	-	-	-	SCV001141827|SCV005201830	-	-	717G>C 	Glu239Asp	NM_000531.6	2.0	1_Pathogenic	chrX	G	C	X-38408795-G-C		97302	X	38408795	G	C	E	D	rs66851495	X	38268048	X	38152992	239	OTC	ENSG00000036473	ENST00000039007	ENSP00000039007	P00480	OTC_HUMAN	c.717G>C	p.Glu239Asp	c.717G>C	p.Glu239Asp	principal1	Y	1	YES	Select	+	GAG	3	2	G	G/G	G/G	G/G	G/G	0.084	0.33072	T	0.137	0.34224	T	0.181	0.29130	B	0.093	0.30106	B	0.94	0.94378	A	simple_aae	6.0	94.0	1.835	0.48050	L	-1.67	0.39882	N	0.427	0.46403	0.9636	0.96591	D	0.9315	0.97736	D	10	0.9239547	0.91653	D	0.890488	0.99167	D	0.669	0.87667	0.836	0.94325	P00480	E239D	Loss of phosphorylation at Y236 (P = 0.083)| Gain of ubiquitination at K243 (P = 0.1181)| Loss of disorder (P = 0.1359)| Loss of methylation at K238 (P = 0.1644)| Loss of helix (P = 0.2662)	0.996576498332	0.99648	0.8060954068835287	0.80451	0.519031115311	0.49446	0.362168908119	0.19681	T	0.826975	0.95797	D	0.476142	0.93509	D	0.446168	0.93428	D	0.573432147502899	0.35055	D	0.822018	0.47982	T	0.58106476	0.71376	0.426277	0.66155	0.6039107	0.72618	0.4427263	0.67257	-5.447	0.41419	T	0.1437	0.31710	B	0.995092416091971	0.91086	0.99315417	0.97277	0.825	0.90346	.	.	.	.	.	.	5.003279	0.83063	27.9	0.99347649071077404	0.60509	.	.	.	.	.	.	.	.	.	5.74	5.74	0.90056	.	.	4.746	0.61912	9.700000	0.81329	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.923	0.4591	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Ornithine_carbamoyltransferase_deficiency|not_provided	criteria_provided,_single_submitter	NC_000023.11:g.38408795G>C	ClinGen:CA224759	C0268542|CN517202	311250	664	Aspartate/ornithine carbamoyltransferase, Asp/Orn-binding domain	Glu	Asp	103194	single nucleotide variant	NM_000531.6(OTC):c.717G>C (p.Glu239Asp)	5009	OTC	HGNC:8512	Likely pathogenic	1	Feb 06, 2024	66851495	-	RCV000083548|RCV000990790	MedGen:C3661900|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664	not provided|Ornithine carbamoyltransferase deficiency	germline;unknown	germline	GRCh38	NC_000023.11	X	38408795	38408795	Xp11.4	criteria provided, multiple submitters, no conflicts	3	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224759	2	97302	38408795	G	C	-	-	-	-	-	-	SCV001141827|SCV005201830	-	-	717G>C 	Glu239Asp	NM_000531.6	2	1_Pathogenic	OTC	ENSG00000036473	71569	205935	CCSBVarC005256	ALE00005256	717G>C	Glu239Asp	CEGS2	CegsMutGDEh1019	F11	GDEhDisVCh_40048	H04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Glu239Asp	23	X	38408795	G	C
14613	BRCA1	2T>C	Met1Thr	ENSG00000012048	17	43124095	NC_000017.11:43124095:A:G	ALE00003294	CCSBVarC003294	NULL	218377	NULL	GDEhDisVCh_40059	F04	CEGS2	ACGGATTTATCTGCTCTTCGCGTTGAAGAAGTACAAAATGTCATTAATGCTATGCAGAAAATCTTAGAGTGTCCCATCTGTCTGGAGTTGATCAAGGAACCTGTCTCCACAAAGTGTGACCACATATTTTGCAAATTTTGCATGCTGAAACTTCTCAACCAGAAGAAAGGGCCTTCACAGTGTCCTTTATGTAAGAATGATATAACCAAAAGGAGCCTACAAGAAAGTACGAGATTTAGTCAACTTGTTGAAGAGCTATTGAAAATCATTTGTGCTTTTCAGCTTGACACAGGTTTGGAGTATGCAAACAGCTATAATTTTGCAAAAAAGGAAAATAACTCTCCTGAACATCTAAAAGATGAAGTTTCTATCATCCAAAGTATGGGCTACAGAAACCGTGCCAAAAGACTTCTACAGAGTGAACCCGAAAATCCTTCCTTGCAGGAAACCAGTCTCAGTGTCCAACTCTCTAACCTTGGAACTGTGAGAACTCTGAGGACAAAGCAGCGGATACAACCTCAAAAGACGTCTGTCTACATTGAATTGGGATCTGATTCTTCTGAAGATACCGTTAATAAGGCAACTTATTGCAGTGTGGGAGATCAAGAATTGTTACAAATCACCCCTCAAGGAACCAGGGATGAAATCAGTTTGGATTCTGCAAAAAAGGCTGCTTGTGAATTTTCTGAGACGGATGTAACAAATACTGAACATCATCAACCCAGTAATAATGATTTGAACACCACTGAGAAGCGTGCAGCTGAGAGGCATCCAGAAAAGTATCAGGGTGAAGCAGCATCTGGGTGTGAGAGTGAAACAAGCGTCTCTGAAGACTGCTCAGGGCTATCCTCTCAGAGTGACATTTTAACCACTCAGCAGAGGGATACCATGCAACATAACCTGATAAAGCTCCAGCAGGAAATGGCTGAACTAGAAGCTGTGTTAGAACAGCATGGGAGCCAGCCTTCTAACAGCTACCCTTCCATCATAAGTGACTCTTCTGCCCTTGAGGACCTGCGAAATCCAGAACAAAGCACATCAGAAAAAGTATTAACTTCACAGAAAAGTAGTGAATACCCTATAAGCCAGAATCCAGAAGGCCTTTCTGCTGACAAGTTTGAGGTGTCTGCAGATAGTTCTACCAGTAAAAATAAAGAACCAGGAGTGGAAAGGTCATCCCCTTCTAAATGCCCATCATTAGATGATAGGTGGTACATGCACAGTTGCTCTGGGAGTCTTCAGAATAGAAACTACCCATCTCAAGAGGAGCTCATTAAGGTTGTTGATGTGGAGGAGCAACAGCTGGAAGAGTCTGGGCCACACGATTTGACGGAAACATCTTACTTGCCAAGGCAAGATCTAGAGGGAACCCCTTACCTGGAATCTGGAATCAGCCTCTTCTCTGATGACCCTGAATCTGATCCTTCTGAAGACAGAGCCCCAGAGTCAGCTCGTGTTGGCAACATACCATCTTCAACCTCTGCATTGAAAGTTCCCCAATTGAAAGTTGCAGAATCTGCCCAGAGTCCAGCTGCTGCTCATACTACTGATACTGCTGGGTATAATGCAATGGAAGAAAGTGTGAGCAGGGAGAAGCCAGAATTGACAGCTTCAACAGAAAGGGTCAACAAAAGAATGTCCATGGTGGTGTCTGGCCTGACCCCAGAAGAATTTATGCTCGTGTACAAGTTTGCCAGAAAACACCACATCACTTTAACTAATCTAATTACTGAAGAGACTACTCATGTTGTTATGAAAACAGATGCTGAGTTTGTGTGTGAACGGACACTGAAATATTTTCTAGGAATTGCGGGAGGAAAATGGGTAGTTAGCTATTTCTGGGTGACCCAGTCTATTAAAGAAAGAAAAATGCTGAATGAGCATGATTTTGAAGTCAGAGGAGATGTGGTCAATGGAAGAAACCACCAAGGTCCAAAGCGAGCAAGAGAATCCCAGGACAGAAAGATCTTCAGGGGGCTAGAAATCTGTTGCTATGGGCCCTTCACCAACATGCCCACAGGGTGTCCACCCAATTGTGGTTGTGCAGCCAGATGCCTGGACAGAGGACAATGGCTTCCATGCAATTGGGCAGATGTG	69412.0	single nucleotide variant	NM_007294.4(BRCA1):c.2T>C (p.Met1Thr)	672.0	BRCA1	HGNC:1100	Pathogenic/Likely pathogenic	1.0	May 05, 2024	80357111.0	-	RCV000111545|RCV001017950|RCV001387017	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43124095.0	43124095.0	17q21.31	criteria provided, multiple submitters, no conflicts	6.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA001954	2.0	54745.0	43124095.0	A	G	-	-	-	-	-	-	SCV000325520|SCV000785479|SCV001179120|SCV001587504	-	-	2T>C 	Met1Thr	NM_007294.4	2.0	1_Pathogenic	chr17	T	C	17-43124095-T-C		54745	17	43124095	A	G	M	T	rs80357111	17	41276112	17	38529638	1	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	c.2T>C	p.Met1?	c.2T>C	p.Met1?	principal2	Y	1	.	.	-	ATG	2	0	A	./.	./.	./.	./.	.	0.91343	.	.	0.92967	.	0.967	0.56423	D	0.916	0.65195	D	.	0.99291	.	.	.	.	.	.	.	.	0.71435	.	.	0.96886	0.4652	0.90013	D	0.7036	0.89769	D	9	0.98665875	0.98978	D	0.950787	0.99662	D	.	0.89789	0.987	0.99867	E9PFC7	M1T	Loss of stability (P = 2e-04)| Gain of catalytic residue at M1 (P = 0.0208)| Gain of glycosylation at M1 (P = 0.121)| Gain of disorder (P = 0.1374)| Gain of helix (P = 0.2684)	0.883389812914	0.88134	.	0.29790	.	.	.	.	.	0.298644	0.66936	T	0.3844	0.88912	D	0.314388	0.88772	D	0.991858303546906	0.82073	D	0.9	0.64967	D	0.9435044	0.95537	0.71842754	0.83181	0.9426614	0.95450	0.7257	0.83606	-9.871	0.82067	D	.	.	.	0.999999935724936	0.99831	0.99948680	0.99428	.	.	.	.	.	.	.	.	3.997208	0.58947	24.0	0.97714747887968068	0.35682	0.056815	0.10376	N	0.358832926107613	0.58998	4.098281	0.311400030491244	0.55978	3.783919	3.83	3.83	0.43219	2.37	0.44186	4.168	0.58094	11.022000	0.84990	0.634	0.51995	1.0	0.71675	1.000000	0.68239	0.255	0.23438	469	0.78193	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.43124095A>G	ClinGen:CA001954	C0677776|C0027672|C2676676	604370	145|140162|145	.	Met	Thr	69412	single nucleotide variant	NM_007294.4(BRCA1):c.2T>C (p.Met1Thr)	672	BRCA1	HGNC:1100	Pathogenic/Likely pathogenic	1	May 05, 2024	80357111	-	RCV000111545|RCV001017950|RCV001387017	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43124095	43124095	17q21.31	criteria provided, multiple submitters, no conflicts	6	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA001954	2	54745	43124095	A	G	-	-	-	-	-	-	SCV000325520|SCV000785479|SCV001179120|SCV001587504	-	-	2T>C 	Met1Thr	NM_007294.4	2	1_Pathogenic	BRCA1	ENSG00000012048	14613	218377	CCSBVarC003294	ALE00003294	2T>C	Met1Thr	CEGS2	CegsMutGDEh1015	F12	GDEhDisVCh_40059	F04	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	BRCA1_Met1Thr	17	17	43124095	A	G
3774	TP53	1031T>C	Leu344Pro	ENSG00000141510	17	7670678	NC_000017.11:7670678:A:G	ALE00004879	CCSBVarC004879	NULL	214911	NULL	GDEhDisVCh_40053	G07	CEGS2	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACCGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCCGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	27414.0	single nucleotide variant	NM_000546.6(TP53):c.1031T>C (p.Leu344Pro)	7157.0	TP53	HGNC:11998	Likely pathogenic	1.0	Aug 05, 2024	121912662.0	-	RCV000013174|RCV002390102|RCV000991141|RCV003473083|RCV003996091	Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501|Human Phenotype Ontology:HP:0002889,Human Phenotype Ontology:HP:0006744,Human Phenotype Ontology:HP:0006759,MONDO:MONDO:0006639,MeSH:D018268,MedGen:C0206686,Orphanet:1501	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Adrenal cortex carcinoma	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7670678.0	7670678.0	17p13.1	reviewed by expert panel	7.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000021,UniProtKB:P04637#VAR_045546,OMIM:191170.0031	3.0	12375.0	7670678.0	A	G	-	-	-	-	-	-	SCV001142539	-	-	1031T>C 	Leu344Pro	NM_000546.6	3.0	1_Pathogenic	chr17	T	C	17-7670678-T-C		12375	17	7670678	A	G	L	P	rs121912662	17	7573996	17	7514721	344	TP53	ENSG00000141510	ENST00000503591	ENSP00000426252	P04637	P53_HUMAN	c.*4551T>C	.	c.1031T>C	p.Leu344Pro	principal1	.	5	.	.	-	CTG	2	0	A	A/A	A/A	A/A	A/A	.	0.78662	.	.	0.83643	.	0.995	0.67505	D	0.967	0.71532	D	.	0.95575	.	.	.	.	2.89	0.83536	M	.	0.80031	.	.	0.94679	1.0500	0.98113	D	0.8994	0.96656	D	9	.	0.99285	.	0.593641	0.96393	D	.	0.95791	0.933	0.98984	P04637	L344P	Loss of stability (P = 0.1061)| Loss of MoRF binding (P = 0.1941)| Gain of methylation at R342 (P = 0.2115)| Gain of glycosylation at L344 (P = 0.3431)| Loss of helix (P = 0.3949)	.	0.99043	.	0.88224	.	0.46248	0.570193588734	0.48638	T	0.981663	0.99858	D	0.503596	0.94338	D	0.485604	0.94258	D	0.992141008377075	0.82416	D	.	0.23420	.	0.9833371	0.99342	0.97173697	0.99531	0.9830403	0.99321	0.96479404	0.99209	-14.526	0.94651	D	.	0.96154	.	0.975627823965943	0.84342	0.99986780	0.99835	0.97	0.98836	.	.	.	.	.	.	4.775765	0.77402	26.7	0.99895217226213961	0.96821	0.964093	0.98610	D	0.714305134819387	0.80462	7.323566	0.648487460311545	0.78381	6.888421	5.43	5.43	0.78977	4.46	0.83695	8.183	0.89672	11.159000	0.87608	0.756	0.943	0.932	0.32434	0.998000	0.34068	0.99	0.65338	450	0.79381	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614076	6.195500e-07	0	1	91074	1.098010e-05	0	0	75024	0.000000e+00	0	0	910	0.000000e+00	0	0	60000	0.000000e+00	0	0	29604	0.000000e+00	0	0	44874	0.000000e+00	0	0	64024	0.000000e+00	0	0	6062	0.000000e+00	0	0	1179994	0.000000e+00	0	1	91074	1.098010e-05	0	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Likely_pathogenic	Adrenocortical_carcinoma,_hereditary|Li-Fraumeni_syndrome_1|Adrenal_cortex_carcinoma|Li-Fraumeni_syndrome|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.7670678A>G	ClinGen:CA000021|OMIM:191170.0031|UniProtKB:P04637#VAR_045546	C1859972|C1835398|C0206686|C0085390|C0027672	202300|151623|PS151623	1501|524|1501|524|140162	p53, tetramerisation domain	Leu	Pro	27414	single nucleotide variant	NM_000546.6(TP53):c.1031T>C (p.Leu344Pro)	7157	TP53	HGNC:11998	Likely pathogenic	1	Aug 05, 2024	121912662	-	RCV000013174|RCV002390102|RCV000991141|RCV003473083|RCV003996091	Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501|Human Phenotype Ontology:HP:0002889,Human Phenotype Ontology:HP:0006744,Human Phenotype Ontology:HP:0006759,MONDO:MONDO:0006639,MeSH:D018268,MedGen:C0206686,Orphanet:1501	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Adrenocortical carcinoma, hereditary|Adrenal cortex carcinoma	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7670678	7670678	17p13.1	reviewed by expert panel	7	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000021,UniProtKB:P04637#VAR_045546,OMIM:191170.0031	3	12375	7670678	A	G	-	-	-	-	-	-	SCV001142539	-	-	1031T>C 	Leu344Pro	NM_000546.6	3	1_Pathogenic	TP53	ENSG00000141510	3774	214911	CCSBVarC004879	ALE00004879	1031T>C	Leu344Pro	CEGS2	CegsMutGDEh1021	C10	GDEhDisVCh_40053	G07	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	TP53_Leu344Pro	17	17	7670678	A	G
7918	MSH2	1865C>T	Pro622Leu	ENSG00000095002	2	47475130	NC_000002.12:47475130:C:T	ALE00001280	CCSBVarC001280	14330	NULL	NULL	GDEhDisVCh_40060	E12	RC4	ATGGCGGTGCAGCCGAAGGAGACGCTGCAGTTGGAGAGCGCGGCCGAGGTCGGCTTCGTGCGCTTCTTTCAGGGCATGCCGGAGAAGCCGACCACCACAGTGCGCCTTTTCGACCGGGGCGACTTCTATACGGCGCACGGCGAGGACGCGCTGCTGGCCGCCCGGGAGGTGTTCAAGACCCAGGGGGTGATCAAGTACATGGGGCCGGCAGGAGCAAAGAATCTGCAGAGTGTTGTGCTTAGTAAAATGAATTTTGAATCTTTTGTAAAAGATCTTCTTCTGGTTCGTCAGTATAGAGTTGAAGTTTATAAGAATAGAGCTGGAAATAAGGCATCCAAGGAGAATGATTGGTATTTGGCATATAAGGCTTCTCCTGGCAATCTCTCTCAGTTTGAAGACATTCTCTTTGGTAACAATGATATGTCAGCTTCCATTGGTGTTGTGGGTGTTAAAATGTCCGCAGTTGATGGCCAGAGACAGGTTGGAGTTGGGTATGTGGATTCCATACAGAGGAAACTAGGACTGTGTGAATTCCCTGATAATGATCAGTTCTCCAATCTTGAGGCTCTCCTCATCCAGATTGGACCAAAGGAATGTGTTTTACCCGGAGGAGAGACTGCTGGAGACATGGGGAAACTGAGACAGATAATTCAAAGAGGAGGAATTCTGATCACAGAAAGAAAAAAAGCTGACTTTTCCACAAAAGACATTTATCAGGACCTCAACCGGTTGTTGAAAGGCAAAAAGGGAGAGCAGATGAATAGTGCTGTATTGCCAGAAATGGAGAATCAGGTTGCAGTTTCATCACTGTCTGCGGTAATCAAGTTTTTAGAACTCTTATCAGATGATTCCAACTTTGGACAGTTTGAACTGACTACTTTTGACTTCAGCCAGTATATGAAATTGGATATTGCAGCAGTCAGAGCCCTTAACCTTTTTCAGGGTTCTGTTGAAGATACCACTGGCTCTCAGTCTCTGGCTGCCTTGCTGAATAAGTGTAAAACCCCTCAAGGACAAAGACTTGTTAACCAGTGGATTAAGCAGCCTCTCATGGATAAGAACAGAATAGAGGAGAGATTGAATTTAGTGGAAGCTTTTGTAGAAGATGCAGAATTGAGGCAGACTTTACAAGAAGATTTACTTCGTCGATTCCCAGATCTTAACCGACTTGCCAAGAAGTTTCAAAGACAAGCAGCAAACTTACAAGATTGTTACCGACTCTATCAGGGTATAAATCAACTACCTAATGTTATACAGGCTCTGGAAAAACATGAAGGAAAACACCAGAAATTATTGTTGGCAGTTTTTGTGACTCCTCTTACTGATCTTCGTTCTGACTTCTCCAAGTTTCAGGAAATGATAGAAACAACTTTAGATATGGATCAGGTGGAAAACCATGAATTCCTTGTAAAACCTTCATTTGATCCTAATCTCAGTGAATTAAGAGAAATAATGAATGACTTGGAAAAGAAGATGCAGTCAACATTAATAAGTGCAGCCAGAGATCTTGGCTTGGACCCTGGCAAACAGATTAAACTGGATTCCAGTGCACAGTTTGGATATTACTTTCGTGTAACCTGTAAGGAAGAAAAAGTCCTTCGTAACAATAAAAACTTTAGTACTGTAGATATCCAGAAGAATGGTGTTAAATTTACCAACAGCAAATTGACTTCTTTAAATGAAGAGTATACCAAAAATAAAACAGAATATGAAGAAGCCCAGGATGCCATTGTTAAAGAAATTGTCAATATTTCTTCAGGCTATGTAGAACCAATGCAGACACTCAATGATGTGTTAGCTCAGCTAGATGCTGTTGTCAGCTTTGCTCACGTGTCAAATGGAGCACCTGTTCCATATGTACGACTAGCCATTTTGGAGAAAGGACAAGGAAGAATTATATTAAAAGCATCCAGGCATGCTTGTGTTGAAGTTCAAGATGAAATTGCATTTATTCCTAATGACGTATACTTTGAAAAAGATAAACAGATGTTCCACATCATTACTGGCCCCAATATGGGAGGTAAATCAACATATATTCGACAAACTGGGGTGATAGTACTCATGGCCCAAATTGGGTGTTTTGTGCCATGTGAGTCAGCAGAAGTGTCCATTGTGGACTGCATCTTAGCCCGAGTAGGGGCTGGTGACAGTCAATTGAAAGGAGTCTCCACGTTCATGGCTGAAATGTTGGAAACTGCTTCTATCCTCAGGTCTGCAACCAAAGATTCATTAATAATCATAGATGAATTGGGAAGAGGAACTTCTACCTACGATGGATTTGGGTTAGCATGGGCTATATCAGAATACATTGCAACAAAGATTGGTGCTTTTTGCATGTTTGCAACCCATTTTCATGAACTTACTGCCTTGGCCAATCAGATACCAACTGTTAATAATCTACATGTCACAGCACTCACCACTGAAGAGACCTTAACTATGCTTTATCAGGTGAAGAAAGGTGTCTGTGATCAAAGTTTTGGGATTCATGTTGCAGAGCTTGCTAATTTCCCTAAGCATGTAATAGAGTGTGCTAAACAGAAAGCCCTGGAACTTGAGGAGTTTCAGTATATTGGAGAATCGCAAGGATATGATATCATGGAACCAGCAGCAAAGAAGTGCTATCTGGAAAGAGAGCAAGGTGAAAAAATTATTCAGGAGTTCCTGTCCAAGGTGAAACAAATGCCCTTTACTGAAATGTCAGAAGAAAACATCACAATAAAGTTAAAACAGCTAAAAGCTGAAGTAATAGCAAAGAATAATAGCTTTGTAAATGAAATCATTTCACGAATAAAAGTTACTACG	16792.0	single nucleotide variant	NM_000251.3(MSH2):c.1865C>T (p.Pro622Leu)	4436.0	MSH2	HGNC:7325	Pathogenic	1.0	Sep 05, 2013	28929483.0	-	RCV000001823|RCV000076307|RCV000566777|RCV000630204|RCV002460877	MONDO:MONDO:0007356,MedGen:C2936783,OMIM:120435,Orphanet:144|MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MeSH:D003123,MedGen:C0009405|MedGen:C3661900	Lynch syndrome 1|Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|not provided	germline	germline	GRCh38	NC_000002.12	2	47475130.0	47475130.0	2p21	reviewed by expert panel	6.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA019478,UniProtKB:P43246#VAR_004482,OMIM:609309.0001	3.0	1753.0	47475130.0	C	T	-	-	-	-	-	-	SCV000107329	-	-	1865C>T 	Pro622Leu	NM_000251.3	3.0	1_Pathogenic	chr2	C	T	2-47475130-C-T	6.84054e-7	1753	2	47475130	C	T	P	L	rs28929483	2	47702269	2	47555773	622	MSH2	ENSG00000095002	ENST00000233146	ENSP00000233146	P43246	MSH2_HUMAN	c.1865C>T	p.Pro622Leu	c.1865C>T	p.Pro622Leu	principal1	Y	1	YES	Select	+	CCA	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.94	0.94956	A	simple_aae	6.0	94.0	4.925	0.99800	H	-9.64	0.98562	D	0.994	0.99956	1.0471	0.98052	D	0.9773	0.99294	D	9	0.9936495	0.99889	D	0.369384	0.92693	D	0.960	0.99376	0.976	0.99775	P43246	P622L	Gain of sheet (P = 0.0827)| Gain of MoRF binding (P = 0.0876)| Loss of phosphorylation at Y619 (P = 0.1085)| Gain of ubiquitination at K627 (P = 0.1306)| Loss of loop (P = 0.2237)	0.98579228348	0.98548	0.9524720838409222	0.95202	0.0349925845809	0.03574	0.649595737457	0.59865	T	0.941035	0.99064	D	0.577713	0.96932	D	0.592068	0.96882	D	0.999973893165588	0.99958	D	0.981385	0.94194	D	0.9423729	0.95420	0.8355323	0.90421	0.95604885	0.96830	0.8418747	0.90844	-13.236	0.90331	D	0.8924	0.90713	P	0.999512044730862	0.96835	0.99983501	0.99778	0.978	0.99209	.	.	.	.	.	.	5.108564	0.85413	28.6	0.99879844472914814	0.95656	0.815228	0.73629	D	1.11949178929837	0.98471	18.39482	1.00760891282676	0.98762	19.31339	5.76	5.76	0.90713	3.77	0.69307	7.205	0.77446	7.684000	0.65502	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.988	0.63383	939	0.14250	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614110	6.195360e-07	0	1	1180028	8.474380e-07	0	0	75028	0.000000e+00	0	0	912	0.000000e+00	0	0	60008	0.000000e+00	0	0	29606	0.000000e+00	0	0	44874	0.000000e+00	0	0	64010	0.000000e+00	0	0	6062	0.000000e+00	0	1	1180028	8.474380e-07	0	0	91076	0.000000e+00	0	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Lynch_syndrome|Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|Lynch_syndrome_1|not_provided	reviewed_by_expert_panel	NC_000002.12:g.47475130C>T	ClinGen:CA019478|OMIM:609309.0001|UniProtKB:P43246#VAR_004482	C4552100|C0027672|C0009405|C2936783|C3661900	120435	144|140162|144	DNA mismatch repair protein MutS, core	Pro	Leu	16792	single nucleotide variant	NM_000251.3(MSH2):c.1865C>T (p.Pro622Leu)	4436	MSH2	HGNC:7325	Pathogenic	1	Sep 05, 2013	28929483	-	RCV000001823|RCV000076307|RCV000566777|RCV000630204|RCV002460877	MONDO:MONDO:0007356,MedGen:C2936783,OMIM:120435,Orphanet:144|MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MeSH:D003123,MedGen:C0009405|MedGen:C3661900	Lynch syndrome 1|Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|not provided	germline	germline	GRCh38	NC_000002.12	2	47475130	47475130	2p21	reviewed by expert panel	6	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA019478,UniProtKB:P43246#VAR_004482,OMIM:609309.0001	3	1753	47475130	C	T	-	-	-	-	-	-	SCV000107329	-	-	1865C>T 	Pro622Leu	NM_000251.3	3	1_Pathogenic	MSH2	ENSG00000095002	7918	14330	CCSBVarC001280	ALE00001280	1865C>T	Pro622Leu	RC4	RC4_Mut_GDEh1031	B01	GDEhDisVCh_40060	E12	2	RC4_Mut_GDDh1031	B01	NULL	NULL	VUSMutpDEST2_07	F02	NULL	NULL	1	7	1	99	0	NULL	1	6	0	NULL	MSH2_Pro622Leu	2	2	47475130	C	T
359	CBS	215A>T	Lys72Ile	ENSG00000160200	21	43068610	NC_000021.9:43068610:T:A	ALE00007348	CCSBVarC007360	NULL	NULL	320	GDEhDisVCh_40013	E11	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAATATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210447.0	single nucleotide variant	NM_000071.3(CBS):c.215A>T (p.Lys72Ile)	875.0	CBS	HGNC:1550	Conflicting classifications of pathogenicity	0.0	Jan 30, 2025	192232907.0	-	RCV000196407|RCV001086812|RCV002229442|RCV002277462|RCV002315525|RCV003330559|RCV003907714	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|MONDO:MONDO:0003900,MedGen:C0009782|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:CN169374|	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Connective tissue disorder|Familial thoracic aortic aneurysm and aortic dissection|not specified|CBS-related disorder	germline	germline	GRCh38	NC_000021.9	21	43068610.0	43068610.0	21q22.3	criteria provided, conflicting classifications	9.0	-	N	ClinGen:CA320825	2.0	212883.0	43068610.0	T	A	-	-	-	-	-	-	SCV000249734|SCV000649830|SCV000738498|SCV001298525|SCV001471787|SCV002566472|SCV004039503	-	-	215A>T 	Lys72Ile	NM_000071.3	1.0	3_Conflicting	chr21	A	T	21-43068610-A-T		212883	21	43068610	T	A	K	I	rs192232907	21	44488720	21	43361789	72	CBS	ENSG00000160200	ENST00000352178	ENSP00000344460	P35520	CBS_HUMAN	c.215A>T	p.Lys72Ile	c.215A>T	p.Lys72Ile	principal1	Y	1	.	.	-	AAA	2	0	T	T/T	T/T	T/T	T/T	0.211	0.28905	T	0.203	0.37239	T	0.0	0.02950	B	0.002	0.06938	B	0.04	0.13669	N	simple_aae	96.0	4.0	2.095	0.57934	M	-1.79	0.56814	N	0.4	0.44226	0.8238	0.94687	D	0.9009	0.96706	D	10	0.007154703	0.00160	T	0.223733	0.87886	D	0.363	0.68150	.	.	.	.	.	0.679255775376	0.67400	.	0.61952	.	0.56058	0.336756229401	0.15937	T	0.556335	0.84932	D	-0.162068	0.26097	T	0.00224358	0.70264	D	0.018580592940585	0.00571	T	0.808619	0.51365	T	0.6786452	0.76636	0.18975048	0.42193	0.6786452	0.76637	0.18975048	0.42192	-6.713	0.51974	T	0.1071	0.26171	B	0.708614554905754	0.67322	0.99744403	0.98379	0.405	0.65014	.	.	.	.	.	.	1.50869	0.19412	14.24	0.98209283735102826	0.39333	0.203654	0.32805	N	-0.595557985032734	0.18846	0.9957292	-0.594395571633558	0.19337	1.054566	4.81	3.62	0.40547	1.89	0.38396	1.016	0.29676	2.030000	0.30333	0.58	0.29757	0.244	0.24874	0.130000	0.23061	0.19	0.21645	988	0.02004	11	0.002196485623003195	0	0.0	0	0.0	0	0.0	10	0.00992063492063492	1	0.0010224948875255625	.	.	.	.	80	109246	7.322920e-04	0	113	207566	5.444050e-04	0	145	236542	6.129990e-04	0	0	7144	0.000000e+00	0	1	17100	5.847950e-05	0	0	2316	0.000000e+00	0	70	9034	7.748510e-03	0	0	13334	0.000000e+00	0	1	42740	2.339730e-05	0	7	15668	4.467700e-04	0	70	9034	7.748510e-03	0	0	16140	0.000000e+00	0	1	30506	3.278040e-05	0	0	6182	0.000000e+00	0	94	13394	7.018070e-03	0	0	16674	0.000000e+00	0	2	89236	2.241250e-05	0	14	30586	4.577260e-04	0	94	13394	7.018070e-03	0	0	14856	0.000000e+00	0	1	34244	2.920220e-05	0	0	9558	0.000000e+00	0	124	17680	7.013570e-03	0	0	21564	0.000000e+00	0	4	102532	3.901220e-05	0	14	30504	4.589560e-04	0	124	17680	7.013570e-03	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	24638	1.217631301241984E-4	0	108	0	0	84	0	0	2776	0	0	500	0	0	628	0	0	24	0	0	94	0	0	4748	0	0	2884	0	0	108	0	3	33600	8.928571428571429E-5	Conflicting_classifications_of_pathogenicity	Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_provided|CBS-related_disorder|Classic_homocystinuria|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Connective_tissue_disorder|not_specified	criteria_provided,_conflicting_classifications	NC_000021.9:g.43068610T>A	ClinGen:CA320825	C4707243|C3661900|C0751202|C3150344|C0009782|CN169374	PS607086|236200	91387|394	.	Lys	Ile	210447	single nucleotide variant	NM_000071.3(CBS):c.215A>T (p.Lys72Ile)	875	CBS	HGNC:1550	Conflicting classifications of pathogenicity	0	Jan 30, 2025	192232907	-	RCV000196407|RCV001086812|RCV002229442|RCV002277462|RCV002315525|RCV003330559|RCV003907714	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|MONDO:MONDO:0003900,MedGen:C0009782|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:CN169374|	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Connective tissue disorder|Familial thoracic aortic aneurysm and aortic dissection|not specified|CBS-related disorder	germline	germline	GRCh38	NC_000021.9	21	43068610	43068610	21q22.3	criteria provided, conflicting classifications	9	-	N	ClinGen:CA320825	2	212883	43068610	T	A	-	-	-	-	-	-	SCV000249734|SCV000649830|SCV000738498|SCV001298525|SCV001471787|SCV002566472|SCV004039503	-	-	215A>T 	Lys72Ile	NM_000071.3	1	3_Conflicting	CBS	ENSG00000160200	359	320	CCSBVarC007360	ALE00007348	215A>T	Lys72Ile	Edgotyping3	VUSMutGDEh011	C06	GDEhDisVCh_40013	E11	1	VUSMutGDDh011	C06	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	5	0	NULL	0	NULL	0	NULL	CBS_Lys72Ile	21	21	43068610	T	A
359	CBS	1265C>T	Pro422Leu	ENSG00000160200	21	43058927	NC_000021.9:43058927:G:A	ALE00007300	CCSBVarC007304	NULL	NULL	246	GDEhDisVCh_40013	D04	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCTGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	15168.0	single nucleotide variant	NM_000071.3(CBS):c.1265C>T (p.Pro422Leu)	875.0	CBS	HGNC:1550	Uncertain significance	1.0	Sep 17, 2021	28934892.0	-	RCV000000152|RCV000522394|RCV000675050|RCV002444412	MedGen:C3150344|MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not provided|Classic homocystinuria|Familial thoracic aortic aneurysm and aortic dissection	germline;unknown	germline	GRCh38	NC_000021.9	21	43058927.0	43058927.0	21q22.3	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA113898,UniProtKB:P35520#VAR_021802,OMIM:613381.0013	3.0	129.0	43058927.0	G	A	-	-	-	-	-	-	SCV000617613|SCV000800491|SCV000914971|SCV002681405|SCV003271519	-	-	1265C>T 	Pro422Leu	NM_000071.3	2.0	4_VUS	chr21	C	T	21-43058927-C-T		129	21	43058927	G	A	P	L	rs28934892	21	44479037	21	43352106	422	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.1265C>T	p.Pro422Leu	c.1265C>T	p.Pro422Leu	principal1	Y	1	.	.	-	CCG	2	0	G	G/G	G/G	G/G	G/G	0.072	0.35129	T	0.096	0.39683	T	0.9	0.49610	P	0.408	0.44732	B	0.99	0.97926	D	simple_aae	1.0	99.0	2.29	0.65064	M	-8.44	0.97214	D	0.975	0.98940	-0.3939	0.72095	T	0.3576	0.71881	T	10	0.98175466	0.98197	D	0.293267	0.90615	D	0.771	0.92267	0.825	0.93622	P35520	P422L	Loss of phosphorylation at T424 (P = 0.0907)| Loss of glycosylation at T424 (P = 0.1748)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.2045)| Gain of catalytic residue at S420 (P = 0.2065)	0.877245150884	0.87509	.	0.79183	.	0.58986	0.628612756729	0.56882	T	0.949296	0.99249	D	0.462344	0.92975	D	0.426348	0.92887	D	0.99376255273819	0.84579	D	.	0.63411	.	0.756464	0.81017	0.5347184	0.72858	0.72243124	0.79054	0.43402806	0.66681	-13.256	0.90410	D	0.383	0.58564	A	0.95438190065085	0.80977	0.99831260	0.98725	0.946	0.97496	.	.	.	.	.	.	3.88071	0.5648	23.7	0.99526564431471021	0.69629	0.953249	0.96927	D	0.217513876557353	0.51809	3.38155	0.176934521710306	0.48322	3.072543	4.71	4.71	0.58959	.	.	9.462	0.96818	9.450000	0.80878	0.586	0.30628	1.0	0.71675	1.000000	0.68239	0.009	0.08693	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	Familial_thoracic_aortic_aneurysm_and_aortic_dissection|Classic_homocystinuria|not_provided|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43058927G>A	ClinGen:CA113898|OMIM:613381.0013|UniProtKB:P35520#VAR_021802	C4707243|C0751202|C3661900|C3150344	PS607086|236200	91387|394	CBS domain|CBS domain|CBS domain|Cystathionine beta-synthase, C-terminal domain	Pro	Leu	15168	single nucleotide variant	NM_000071.3(CBS):c.1265C>T (p.Pro422Leu)	875	CBS	HGNC:1550	Uncertain significance	1	Sep 17, 2021	28934892	-	RCV000000152|RCV000522394|RCV000675050|RCV002444412	MedGen:C3150344|MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not provided|Classic homocystinuria|Familial thoracic aortic aneurysm and aortic dissection	germline;unknown	germline	GRCh38	NC_000021.9	21	43058927	43058927	21q22.3	criteria provided, multiple submitters, no conflicts	7	-	N	ClinGen:CA113898,UniProtKB:P35520#VAR_021802,OMIM:613381.0013	3	129	43058927	G	A	-	-	-	-	-	-	SCV000617613|SCV000800491|SCV000914971|SCV002681405|SCV003271519	-	-	1265C>T 	Pro422Leu	NM_000071.3	2	4_VUS	CBS	ENSG00000160200	359	246	CCSBVarC007304	ALE00007300	1265C>T	Pro422Leu	Edgotyping3	VUSMutGDEh010	H10	GDEhDisVCh_40013	D04	1	VUSMutGDDh010	H10	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	5	0	NULL	0	NULL	0	NULL	CBS_Pro422Leu	21	21	43058927	G	A
3172	CBS	1058C>T	Thr353Met	ENSG00000160200	21	43060528	NC_000021.9:43060528:G:A	ALE00003755	CCSBVarC003755	NULL	214531	NULL	GDEhDisVCh_40055	D04	CEGS2	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTCCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCATGGTGGCGGTGGCCGTGAAGGCCGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	15170.0	single nucleotide variant	NM_000071.3(CBS):c.1058C>T (p.Thr353Met)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Oct 24, 2024	121964972.0	-	RCV000000154|RCV000169466|RCV002227961|RCV002271361|RCV000078106|RCV004018522	MedGen:C4017308|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3661900|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Homocystinuria, pyridoxine-nonresponsive|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria|not provided|Familial thoracic aortic aneurysm and aortic dissection	germline;unknown	germline	GRCh38	NC_000021.9	21	43060528.0	43060528.0	21q22.3	criteria provided, multiple submitters, no conflicts	11.0	-	N	ClinGen:CA113902,UniProtKB:P35520#VAR_008082,OMIM:613381.0015	3.0	131.0	43060528.0	G	A	-	-	-	-	-	-	SCV000220905|SCV000225481|SCV000249706|SCV000319360|SCV000769936|SCV001430903|SCV002555838|SCV004033913|SCV004213883	-	-	1058C>T 	Thr353Met	NM_000071.3	2.0	1_Pathogenic	chr21	C	T	21-43060528-C-T		131	21	43060528	G	A	T	M	rs121964972	21	44480638	21	43353707	353	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.1058C>T	p.Thr353Met	c.1058C>T	p.Thr353Met	principal1	Y	1	.	.	-	ACG	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.002	0.79703	D	0.059	0.23066	B	0.038	0.23362	B	1.0	0.99291	A	simple_aae	0.0	100.0	0.875	0.21401	L	-1.21	0.30729	N	0.47	0.50358	1.0925	0.99339	D	0.9341	0.97825	D	9	0.9363066	0.92882	D	0.779439	0.98258	D	0.606	0.84430	.	.	.	.	.	0.845099770423	0.84239	.	0.81512	.	0.61003	0.324749410152	0.14128	T	0.880939	0.97482	D	0.116455	0.65771	D	0.25147	0.85588	D	0.138191738329402	0.15916	T	.	0.93592	.	0.43559173	0.62797	0.1315766	0.31507	0.43643323	0.62852	0.16446294	0.37974	-7.017	0.54227	T	.	0.29563	.	0.959632978814147	0.81671	0.99879320	0.98964	0.775	0.87544	.	.	.	.	.	.	2.236505	0.28608	17.84	0.99720562724395423	0.82002	0.858441	0.77513	D	-0.273326906406384	0.29901	1.680548	-0.306985076292533	0.27554	1.549767	5.05	3.2	0.35749	0.0291	0.21753	4.579	0.60732	1.837000	0.29244	0.526	0.24477	1.0	0.71675	0.008000	0.19814	0.017	0.10969	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	101252	9.876350e-06	0	7	196044	3.570630e-05	0	6	226208	2.652430e-05	0	1	6882	1.453070e-04	0	0	16988	0.000000e+00	0	0	2300	0.000000e+00	0	0	8902	0.000000e+00	0	0	6312	0.000000e+00	0	0	42406	0.000000e+00	0	0	15608	0.000000e+00	0	1	6882	1.453070e-04	0	6	15262	3.931330e-04	0	1	30316	3.298590e-05	0	0	6052	0.000000e+00	0	0	13116	0.000000e+00	0	0	9644	0.000000e+00	0	0	86418	0.000000e+00	0	0	30514	0.000000e+00	0	6	15262	3.931330e-04	0	5	14288	3.499440e-04	0	1	34092	2.933240e-05	0	0	9474	0.000000e+00	0	0	17546	0.000000e+00	0	0	14452	0.000000e+00	0	0	100386	0.000000e+00	0	0	30438	0.000000e+00	0	5	14288	3.499440e-04	0	.	3	47414	6.327250e-05	0	2	2854	7.007710e-04	0	2	2854	7.007710e-04	0	0	0	.	0	1	4036	2.477700e-04	0	0	1052	0.000000e+00	0	0	3562	0.000000e+00	0	0	1340	0.000000e+00	0	0	190	0.000000e+00	0	0	24414	0.000000e+00	0	0	7552	0.000000e+00	0	0	6146	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	250	0	0	0	0	0	0	0	0	6396	0	Pathogenic/Likely_pathogenic	Homocystinuria|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_provided|Classic_homocystinuria|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Homocystinuria,_pyridoxine-nonresponsive	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43060528G>A	ClinGen:CA113902|OMIM:613381.0015|UniProtKB:P35520#VAR_008082	C0019880|C4707243|C3661900|C0751202|C3150344|C4017308	PS607086|236200	91387|394	Tryptophan synthase beta chain-like, PALP domain	Thr	Met	15170	single nucleotide variant	NM_000071.3(CBS):c.1058C>T (p.Thr353Met)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Oct 24, 2024	121964972	-	RCV000000154|RCV000169466|RCV002227961|RCV002271361|RCV000078106|RCV004018522	MedGen:C4017308|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3661900|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Homocystinuria, pyridoxine-nonresponsive|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria|not provided|Familial thoracic aortic aneurysm and aortic dissection	germline;unknown	germline	GRCh38	NC_000021.9	21	43060528	43060528	21q22.3	criteria provided, multiple submitters, no conflicts	11	-	N	ClinGen:CA113902,UniProtKB:P35520#VAR_008082,OMIM:613381.0015	3	131	43060528	G	A	-	-	-	-	-	-	SCV000220905|SCV000225481|SCV000249706|SCV000319360|SCV000769936|SCV001430903|SCV002555838|SCV004033913|SCV004213883	-	-	1058C>T 	Thr353Met	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	258	CCSBVarC007312	ALE00003755	1058C>T	Thr353Met	Edgotyping3	VUSMutGDEh010	H11	GDEhDisVCh_40013	E05	1	VUSMutGDDh010	H11	NULL	NULL	NULL	NULL	NULL	NULL	1	3	1	1	0	NULL	0	NULL	0	NULL	CBS_Thr353Met	21	21	43060528	G	A
3172	CBS	1058C>T	Thr353Met	ENSG00000160200	21	43060528	NC_000021.9:43060528:G:A	ALE00003755	CCSBVarC003755	NULL	214531	NULL	GDEhDisVCh_40055	D04	CEGS2	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTCCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCATGGTGGCGGTGGCCGTGAAGGCCGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	15170.0	single nucleotide variant	NM_000071.3(CBS):c.1058C>T (p.Thr353Met)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Oct 24, 2024	121964972.0	-	RCV000000154|RCV000169466|RCV002227961|RCV002271361|RCV000078106|RCV004018522	MedGen:C4017308|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3661900|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Homocystinuria, pyridoxine-nonresponsive|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria|not provided|Familial thoracic aortic aneurysm and aortic dissection	germline;unknown	germline	GRCh38	NC_000021.9	21	43060528.0	43060528.0	21q22.3	criteria provided, multiple submitters, no conflicts	11.0	-	N	ClinGen:CA113902,UniProtKB:P35520#VAR_008082,OMIM:613381.0015	3.0	131.0	43060528.0	G	A	-	-	-	-	-	-	SCV000220905|SCV000225481|SCV000249706|SCV000319360|SCV000769936|SCV001430903|SCV002555838|SCV004033913|SCV004213883	-	-	1058C>T 	Thr353Met	NM_000071.3	2.0	1_Pathogenic	chr21	C	T	21-43060528-C-T		131	21	43060528	G	A	T	M	rs121964972	21	44480638	21	43353707	353	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.1058C>T	p.Thr353Met	c.1058C>T	p.Thr353Met	principal1	Y	1	.	.	-	ACG	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.002	0.79703	D	0.059	0.23066	B	0.038	0.23362	B	1.0	0.99291	A	simple_aae	0.0	100.0	0.875	0.21401	L	-1.21	0.30729	N	0.47	0.50358	1.0925	0.99339	D	0.9341	0.97825	D	9	0.9363066	0.92882	D	0.779439	0.98258	D	0.606	0.84430	.	.	.	.	.	0.845099770423	0.84239	.	0.81512	.	0.61003	0.324749410152	0.14128	T	0.880939	0.97482	D	0.116455	0.65771	D	0.25147	0.85588	D	0.138191738329402	0.15916	T	.	0.93592	.	0.43559173	0.62797	0.1315766	0.31507	0.43643323	0.62852	0.16446294	0.37974	-7.017	0.54227	T	.	0.29563	.	0.959632978814147	0.81671	0.99879320	0.98964	0.775	0.87544	.	.	.	.	.	.	2.236505	0.28608	17.84	0.99720562724395423	0.82002	0.858441	0.77513	D	-0.273326906406384	0.29901	1.680548	-0.306985076292533	0.27554	1.549767	5.05	3.2	0.35749	0.0291	0.21753	4.579	0.60732	1.837000	0.29244	0.526	0.24477	1.0	0.71675	0.008000	0.19814	0.017	0.10969	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	101252	9.876350e-06	0	7	196044	3.570630e-05	0	6	226208	2.652430e-05	0	1	6882	1.453070e-04	0	0	16988	0.000000e+00	0	0	2300	0.000000e+00	0	0	8902	0.000000e+00	0	0	6312	0.000000e+00	0	0	42406	0.000000e+00	0	0	15608	0.000000e+00	0	1	6882	1.453070e-04	0	6	15262	3.931330e-04	0	1	30316	3.298590e-05	0	0	6052	0.000000e+00	0	0	13116	0.000000e+00	0	0	9644	0.000000e+00	0	0	86418	0.000000e+00	0	0	30514	0.000000e+00	0	6	15262	3.931330e-04	0	5	14288	3.499440e-04	0	1	34092	2.933240e-05	0	0	9474	0.000000e+00	0	0	17546	0.000000e+00	0	0	14452	0.000000e+00	0	0	100386	0.000000e+00	0	0	30438	0.000000e+00	0	5	14288	3.499440e-04	0	.	3	47414	6.327250e-05	0	2	2854	7.007710e-04	0	2	2854	7.007710e-04	0	0	0	.	0	1	4036	2.477700e-04	0	0	1052	0.000000e+00	0	0	3562	0.000000e+00	0	0	1340	0.000000e+00	0	0	190	0.000000e+00	0	0	24414	0.000000e+00	0	0	7552	0.000000e+00	0	0	6146	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	250	0	0	0	0	0	0	0	0	6396	0	Pathogenic/Likely_pathogenic	Homocystinuria|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_provided|Classic_homocystinuria|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Homocystinuria,_pyridoxine-nonresponsive	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43060528G>A	ClinGen:CA113902|OMIM:613381.0015|UniProtKB:P35520#VAR_008082	C0019880|C4707243|C3661900|C0751202|C3150344|C4017308	PS607086|236200	91387|394	Tryptophan synthase beta chain-like, PALP domain	Thr	Met	15170	single nucleotide variant	NM_000071.3(CBS):c.1058C>T (p.Thr353Met)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Oct 24, 2024	121964972	-	RCV000000154|RCV000169466|RCV002227961|RCV002271361|RCV000078106|RCV004018522	MedGen:C4017308|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3661900|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Homocystinuria, pyridoxine-nonresponsive|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria|not provided|Familial thoracic aortic aneurysm and aortic dissection	germline;unknown	germline	GRCh38	NC_000021.9	21	43060528	43060528	21q22.3	criteria provided, multiple submitters, no conflicts	11	-	N	ClinGen:CA113902,UniProtKB:P35520#VAR_008082,OMIM:613381.0015	3	131	43060528	G	A	-	-	-	-	-	-	SCV000220905|SCV000225481|SCV000249706|SCV000319360|SCV000769936|SCV001430903|SCV002555838|SCV004033913|SCV004213883	-	-	1058C>T 	Thr353Met	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	3172	214531	CCSBVarC003755	ALE00003755	1058C>T	Thr353Met	CEGS2	CegsMutGDEh1032	E07	GDEhDisVCh_40055	D04	1	CegsMutGDDh1032	E07	NULL	NULL	NULL	NULL	NULL	NULL	1	5	1	1	0	NULL	0	NULL	0	NULL	CBS_Thr353Met	21	21	43060528	G	A
359	CBS	233C>G	Pro78Arg	ENSG00000160200	21	43068592	NC_000021.9:43068592:G:C	ALE00007347	CCSBVarC007359	NULL	NULL	319	GDEhDisVCh_40013	D11	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCGAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	187063.0	single nucleotide variant	NM_000071.3(CBS):c.233C>G (p.Pro78Arg)	875.0	CBS	HGNC:1550	Conflicting classifications of pathogenicity	1.0	Mar 15, 2023	786204608.0	-	RCV000169367|RCV002444679|RCV003226232|RCV002515196	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:CN169374|MedGen:C3150344	Classic homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|not specified|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;unknown	germline	GRCh38	NC_000021.9	21	43068592.0	43068592.0	21q22.3	criteria provided, conflicting classifications	4.0	-	N	ClinGen:CA274218,UniProtKB:P35520#VAR_002171,ClinVar:2501029	2.0	188988.0	43068592.0	G	C	-	-	-	-	-	-	SCV000220742|SCV002732600|SCV002978951|SCV003922487	-	-	233C>G 	Pro78Arg	NM_000071.3	1.0	3_Conflicting	chr21	C	G	21-43068592-C-G		188988	21	43068592	G	C	P	R	rs786204608	21	44488702	21	43361771	78	CBS	ENSG00000160200	ENST00000352178	ENSP00000344460	P35520	CBS_HUMAN	c.233C>G	p.Pro78Arg	c.233C>G	p.Pro78Arg	principal1	Y	1	.	.	-	CCA	2	0	G	G/G	G/G	G/G	G/G	0.025	0.47480	D	0.09	0.41254	T	0.981	0.59690	D	0.875	0.62099	P	1.0	0.99291	A	simple_aae	0.0	100.0	3.145	0.88167	M	-4.71	0.84343	D	0.899	0.89904	1.0844	0.99026	D	0.9719	0.99116	D	10	0.9449192	0.93747	D	0.583423	0.96269	D	0.946	0.98921	0.746	0.87676	P35520	P78R	Gain of MoRF binding (P = 0.0014)| Gain of glycosylation at K75 (P = 0.0593)| Gain of helix (P = 0.0696)| Loss of methylation at K82 (P = 0.0714)| Loss of catalytic residue at P78 (P = 0.0821)	0.932931052682	0.93172	.	0.81103	.	0.75467	0.562999725342	0.47624	T	0.871415	0.97202	D	0.55692	0.95999	D	0.562201	0.95937	D	0.985645055770874	0.76407	D	0.961304	0.87234	D	0.8072316	0.84171	0.59515435	0.76253	0.7717094	0.81932	0.6571012	0.79697	-7.983	0.61028	D	0.1383	0.34361	B	0.96042823826272	0.81781	0.99973756	0.99666	0.96	0.98304	.	.	.	.	.	.	4.8523	0.79365	27.1	0.99777405807318165	0.86444	0.942721	0.94748	D	0.821396718332232	0.87356	9.213447	0.769095491747813	0.87508	9.269862	4.81	4.81	0.61353	.	.	8.498	0.90348	9.467000	0.80897	0.59	0.31918	1.0	0.71675	1.000000	0.68239	0.993	0.69292	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109360	0.000000e+00	0	0	207904	0.000000e+00	0	1	236766	4.223580e-06	0	0	7154	0.000000e+00	0	0	17108	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13382	0.000000e+00	0	0	42758	0.000000e+00	0	0	15680	0.000000e+00	0	.	.	.	.	0	16184	0.000000e+00	0	0	30516	0.000000e+00	0	0	6194	0.000000e+00	0	0	13410	0.000000e+00	0	0	16722	0.000000e+00	0	0	89418	0.000000e+00	0	0	30598	0.000000e+00	0	.	.	.	.	0	14882	0.000000e+00	0	0	34254	0.000000e+00	0	0	9566	0.000000e+00	0	0	17690	0.000000e+00	0	0	21620	0.000000e+00	0	0	102626	0.000000e+00	0	0	30516	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Classic_homocystinuria|not_specified|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Familial_thoracic_aortic_aneurysm_and_aortic_dissection	criteria_provided,_conflicting_classifications	NC_000021.9:g.43068592G>C	ClinGen:CA274218|UniProtKB:P35520#VAR_002171	C0751202|CN169374|C3150344|C4707243	236200|PS607086	394|91387	.	Pro	Arg	187063	single nucleotide variant	NM_000071.3(CBS):c.233C>G (p.Pro78Arg)	875	CBS	HGNC:1550	Conflicting classifications of pathogenicity	1	Mar 15, 2023	786204608	-	RCV000169367|RCV002444679|RCV003226232|RCV002515196	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:CN169374|MedGen:C3150344	Classic homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|not specified|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;unknown	germline	GRCh38	NC_000021.9	21	43068592	43068592	21q22.3	criteria provided, conflicting classifications	4	-	N	ClinGen:CA274218,UniProtKB:P35520#VAR_002171,ClinVar:2501029	2	188988	43068592	G	C	-	-	-	-	-	-	SCV000220742|SCV002732600|SCV002978951|SCV003922487	-	-	233C>G 	Pro78Arg	NM_000071.3	1	3_Conflicting	CBS	ENSG00000160200	359	319	CCSBVarC007359	ALE00007347	233C>G	Pro78Arg	Edgotyping3	VUSMutGDEh011	B06	GDEhDisVCh_40013	D11	1	VUSMutGDDh011	B06	NULL	NULL	NULL	NULL	NULL	NULL	1	3	1	5	0	NULL	0	NULL	0	NULL	CBS_Pro78Arg	21	21	43068592	G	C
71569	OTC	590G>A	Gly197Glu	ENSG00000036473	X	38403667	NC_000023.11:38403667:G:A	ALE00002761	CCSBVarC002761	35556	NULL	NULL	GDEhDisVCh_40048	B12	RC4	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGAGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103153.0	single nucleotide variant	NM_000531.6(OTC):c.590G>A (p.Gly197Glu)	5009.0	OTC	HGNC:8512	Pathogenic	1.0	-	72556302.0	-	RCV000083503	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38403667.0	38403667.0	Xp11.4	no assertion criteria provided	1.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224696,UniProtKB:P00480#VAR_004902	2.0	97261.0	38403667.0	G	A	-	-	-	-	-	-	SCV000115589	-	-	590G>A 	Gly197Glu	NM_000531.6		1_Pathogenic	chrX	G	A	X-38403667-G-A		97261	X	38403667	G	A	G	E	rs72556302	X	38262920	X	38147864	197	OTC	ENSG00000036473	ENST00000039007	ENSP00000039007	P00480	OTC_HUMAN	c.590G>A	p.Gly197Glu	c.590G>A	p.Gly197Glu	principal1	Y	1	YES	Select	+	GGG	2	0	G	G/G	G/G	G/G	G/G	0.003	0.68399	D	0.002	0.79703	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.97016	A	simple_aae	2.0	98.0	4.365	0.98493	H	-6.53	0.91762	D	0.994	0.99902	1.0118	0.97382	D	0.9865	0.99597	D	10	0.9937301	0.99895	D	0.963256	0.99763	D	0.987	0.99952	0.919	0.98524	P00480	G197E	Gain of sheet (P = 0.1208)| Gain of catalytic residue at G197 (P = 0.2043)| Loss of MoRF binding (P = 0.267)| Gain of solvent accessibility (P = 0.3089)| Loss of helix (P = 0.3949)	0.994313477609	0.99418	0.9930783613449486	0.99302	1.34946530569	0.83970	0.850276589394	0.89640	D	0.967942	0.99628	D	0.723893	0.99950	D	0.802046	0.99950	D	0.998715281486511	0.94902	D	0.991501	0.97334	D	0.99001044	0.99761	0.98799324	0.99961	0.99001044	0.99761	0.98799324	0.99962	-12.084	0.85298	D	0.9894	0.93397	P	0.999156324658706	0.95829	0.99874560	0.98943	0.995	0.99826	.	.	.	.	.	.	5.116945	0.85595	28.6	0.99849760455849479	0.92930	.	.	.	.	.	.	.	.	.	5.91	5.91	0.95233	4.91	0.89049	9.543	0.97194	11.705000	0.94567	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.997	0.79771	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided	no_assertion_criteria_provided	NC_000023.11:g.38403667G>A	ClinGen:CA224696|UniProtKB:P00480#VAR_004902	CN517202	.	.	Aspartate/ornithine carbamoyltransferase, Asp/Orn-binding domain	Gly	Glu	103153	single nucleotide variant	NM_000531.6(OTC):c.590G>A (p.Gly197Glu)	5009	OTC	HGNC:8512	Pathogenic	1	-	72556302	-	RCV000083503	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38403667	38403667	Xp11.4	no assertion criteria provided	1	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224696,UniProtKB:P00480#VAR_004902	2	97261	38403667	G	A	-	-	-	-	-	-	SCV000115589	-	-	590G>A 	Gly197Glu	NM_000531.6		1_Pathogenic	OTC	ENSG00000036473	71569	35556	CCSBVarC002761	ALE00002761	590G>A	Gly197Glu	RC4	RC4_Mut_GDEh1017	B12	GDEhDisVCh_40048	B12	2	RC4_Mut_GDDh1017	B12	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	OTC_Gly197Glu	23	X	38403667	G	A
14613	BRCA1	131G>A	Cys44Tyr	ENSG00000012048	17	43115729	NC_000017.11:43115729:C:T	ALE00003296	CCSBVarC003296	NULL	218386	NULL	GDEhDisVCh_40059	D03	CEGS2	ATGGATTTATCTGCTCTTCGCGTTGAAGAAGTACAAAATGTCATTAATGCTATGCAGAAAATCTTAGAGTGTCCCATCTGTCTGGAGTTGATCAAGGAACCTGTCTCCACAAAGTGTGACCACATATTTTACAAATTTTGCATGCTGAAACTTCTCAACCAGAAGAAAGGGCCTTCACAGTGTCCTTTATGTAAGAATGATATAACCAAAAGGAGCCTACAAGAAAGTACGAGATTTAGTCAACTTGTTGAAGAGCTATTGAAAATCATTTGTGCTTTTCAGCTTGACACAGGTTTGGAGTATGCAAACAGCTATAATTTTGCAAAAAAGGAAAATAACTCTCCTGAACATCTAAAAGATGAAGTTTCTATCATCCAAAGTATGGGCTACAGAAACCGTGCCAAAAGACTTCTACAGAGTGAACCCGAAAATCCTTCCTTGCAGGAAACCAGTCTCAGTGTCCAACTCTCTAACCTTGGAACTGTGAGAACTCTGAGGACAAAGCAGCGGATACAACCTCAAAAGACGTCTGTCTACATTGAATTGGGATCTGATTCTTCTGAAGATACCGTTAATAAGGCAACTTATTGCAGTGTGGGAGATCAAGAATTGTTACAAATCACCCCTCAAGGAACCAGGGATGAAATCAGTTTGGATTCTGCAAAAAAGGCTGCTTGTGAATTTTCTGAGACGGATGTAACAAATACTGAACATCATCAACCCAGTAATAATGATTTGAACACCACTGAGAAGCGTGCAGCTGAGAGGCATCCAGAAAAGTATCAGGGTGAAGCAGCATCTGGGTGTGAGAGTGAAACAAGCGTCTCTGAAGACTGCTCAGGGCTATCCTCTCAGAGTGACATTTTAACCACTCAGCAGAGGGATACCATGCAACATAACCTGATAAAGCTCCAGCAGGAAATGGCTGAACTAGAAGCTGTGTTAGAACAGCATGGGAGCCAGCCTTCTAACAGCTACCCTTCCATCATAAGTGACTCTTCTGCCCTTGAGGACCTGCGAAATCCAGAACAAAGCACATCAGAAAAAGTATTAACTTCACAGAAAAGTAGTGAATACCCTATAAGCCAGAATCCAGAAGGCCTTTCTGCTGACAAGTTTGAGGTGTCTGCAGATAGTTCTACCAGTAAAAATAAAGAACCAGGAGTGGAAAGGTCATCCCCTTCTAAATGCCCATCATTAGATGATAGGTGGTACATGCACAGTTGCTCTGGGAGTCTTCAGAATAGAAACTACCCATCTCAAGAGGAGCTCATTAAGGTTGTTGATGTGGAGGAGCAACAGCTGGAAGAGTCTGGGCCACACGATTTGACGGAAACATCTTACTTGCCAAGGCAAGATCTAGAGGGAACCCCTTACCTGGAATCTGGAATCAGCCTCTTCTCTGATGACCCTGAATCTGATCCTTCTGAAGACAGAGCCCCAGAGTCAGCTCGTGTTGGCAACATACCATCTTCAACCTCTGCATTGAAAGTTCCCCAATTGAAAGTTGCAGAATCTGCCCAGAGTCCAGCTGCTGCTCATACTACTGATACTGCTGGGTATAATGCAATGGAAGAAAGTGTGAGCAGGGAGAAGCCAGAATTGACAGCTTCAACAGAAAGGGTCAACAAAAGAATGTCCATGGTGGTGTCTGGCCTGACCCCAGAAGAATTTATGCTCGTGTACAAGTTTGCCAGAAAACACCACATCACTTTAACTAATCTAATTACTGAAGAGACTACTCATGTTGTTATGAAAACAGATGCTGAGTTTGTGTGTGAACGGACACTGAAATATTTTCTAGGAATTGCGGGAGGAAAATGGGTAGTTAGCTATTTCTGGGTGACCCAGTCTATTAAAGAAAGAAAAATGCTGAATGAGCATGATTTTGAAGTCAGAGGAGATGTGGTCAATGGAAGAAACCACCAAGGTCCAAAGCGAGCAAGAGAATCCCAGGACAGAAAGATCTTCAGGGGGCTAGAAATCTGTTGCTATGGGCCCTTCACCAACATGCCCACAGGGTGTCCACCCAATTGTGGTTGTGCAGCCAGATGCCTGGACAGAGGACAATGGCTTCCATGCAATTGGGCAGATGTG	68866.0	single nucleotide variant	NM_007294.4(BRCA1):c.131G>A (p.Cys44Tyr)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	80357446.0	-	RCV000077486|RCV000235119|RCV000509871|RCV001386839	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43115729.0	43115729.0	17q21.31	reviewed by expert panel	12.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00114,ClinGen:CA000861	2.0	54199.0	43115729.0	C	T	-	-	-	-	-	-	SCV000244299	-	-	131G>A 	Cys44Tyr	NM_007294.4	3.0	1_Pathogenic	chr17	G	A	17-43115729-G-A		54199	17	43115729	C	T	C	Y	rs80357446	17	41267746	17	38521272	44	BRCA1	ENSG00000012048	ENST00000494123	ENSP00000419103	P38398	BRCA1_HUMAN	c.131G>A	p.Cys44Tyr	c.131G>A	p.Cys44Tyr	principal2	Y	1	.	.	-	TGC	2	0	C	C/C	C/C	C/C	C/C	0.016	0.91343	D	0.0	0.92967	D	0.994	0.66535	D	0.84	0.60164	P	.	0.99291	.	.	.	.	4.005	0.96727	H	-2.52	0.98949	D	.	0.95504	1.0538	0.98195	D	0.9802	0.99389	D	10	0.99267334	0.99802	D	0.72305	0.97758	D	0.853	0.95458	0.99	0.99894	E9PFC7	C44Y	Loss of disorder (P = 0.0407)| Loss of helix (P = 0.1299)| Loss of catalytic residue at I42 (P = 0.1404)| Loss of stability (P = 0.2362)| Loss of ubiquitination at K45 (P = 0.2592)	0.998941922364	0.99891	.	0.91966	.	0.18552	0.729841411114	0.71433	T	0.47499	0.93038	T	0.562886	0.96259	D	0.57077	0.96199	D	0.987259089946747	0.77622	D	.	0.90786	.	0.92106634	0.93252	0.6351263	0.78468	0.91385037	0.92549	0.69650024	0.81922	-13.581	0.94506	D	0.9966	0.97393	LP	0.999496437666765	0.96769	0.99973255	0.99655	0.94	0.97139	.	.	.	.	.	.	5.096311	0.85159	28.5	0.99228087188246783	0.56189	0.829447	0.74743	D	0.895383086000917	0.91485	10.93124	0.837834818254792	0.92242	11.33957	5.97	5.97	0.96929	.	.	3.475	0.52993	7.600000	0.61593	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.996	0.76032	464	0.78507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided|Hereditary_cancer-predisposing_syndrome|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43115729C>T	BRCA1-HCI:BRCA1_00114|ClinGen:CA000861	C3661900|C0027672|C0677776|C2676676	604370	140162|145|145	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type, conserved site|Zinc finger, RING-type|Zinc finger, RING-type	Cys	Tyr	68866	single nucleotide variant	NM_007294.4(BRCA1):c.131G>A (p.Cys44Tyr)	672	BRCA1	HGNC:1100	Pathogenic	1	Aug 10, 2015	80357446	-	RCV000077486|RCV000235119|RCV000509871|RCV001386839	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43115729	43115729	17q21.31	reviewed by expert panel	12	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00114,ClinGen:CA000861	2	54199	43115729	C	T	-	-	-	-	-	-	SCV000244299	-	-	131G>A 	Cys44Tyr	NM_007294.4	3	1_Pathogenic	BRCA1	ENSG00000012048	14613	218386	CCSBVarC003296	ALE00003296	131G>A	Cys44Tyr	CEGS2	CegsMutGDEh1010	C05	GDEhDisVCh_40059	D03	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	7	0	NULL	0	NULL	0	NULL	0	NULL	BRCA1_Cys44Tyr	17	17	43115729	C	T
2803	HMBS	100C>A	Gln34Lys	ENSG00000256269	11	119088647	NC_000011.10:119088647:C:A	ALE00005158	CCSBVarC005158	NULL	200923	NULL	GDEhDisVCh_40054	E04	CEGS2	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAGCTTGCTCGCATAAAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGGACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCTTGAACATGCCCTGGAGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCGAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTCGGGGAAACCTCAACACCCGGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACCGGGTGGGGCAGATCCTGCACCCTGAGGAATGCATGTATGCTGTGGGCCAGGGGGCCTTGGGCGTGGAAGTGCGAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCTGCATCGCTGAAAGGGCCTTCCTGAGGCACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATGGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCGTAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACGATGCCCAT	16494.0	single nucleotide variant	NM_000190.4(HMBS):c.100C>A (p.Gln34Lys)	3145.0	HMBS	HGNC:4982	Pathogenic	1.0	Sep 01, 1992	118204105.0	-	RCV000001520	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276	Acute intermittent porphyria	germline	germline	GRCh38	NC_000011.10	11	119088647.0	119088647.0	11q23.3	no assertion criteria provided	1.0	-	N	ClinGen:CA251811,UniProtKB:P08397#VAR_003641,OMIM:609806.0017	1.0	1455.0	119088647.0	C	A	-	-	-	-	-	-	SCV000021675	-	-	100C>A 	Gln34Lys	NM_000190.4		1_Pathogenic	chr11	C	A	11-119088647-C-A		1455	11	119088647	C	A	Q	K	rs118204105	11	118959357	11	118464567	34	HMBS	ENSG00000256269	ENST00000652429	ENSP00000498786	P08397	HEM3_HUMAN	c.100C>A	p.Gln34Lys	c.100C>A	p.Gln34Lys	principal2	Y	.	YES	Select	+	CAG	1	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	0.998	0.88579	D	.	0.97016	.	.	.	.	4.47	0.98862	H	.	0.72746	.	.	0.99974	0.9038	0.95714	D	0.9962	0.99912	D	9	.	0.99628	.	0.666812	0.97207	D	.	0.99695	0.988	0.99876	P08397	Q34K	Gain of catalytic residue at Q34 (P = 0.0293)| Gain of MoRF binding (P = 0.0502)| Gain of phosphorylation at T35 (P = 0.1359)| Gain of disorder (P = 0.1863)| Gain of methylation at Q34 (P = 0.1955)	.	0.98290	0.98746795927839	0.98736	.	.	0.668422341347	0.62552	T	0.996415	0.99995	D	0.580589	0.96975	D	0.5962	0.96926	D	0.999150395393372	0.96329	D	0.949805	0.88094	D	0.9930165	0.99899	0.9686536	0.99395	0.99230266	0.99870	0.9659788	0.99268	-18.924	0.99796	D	0.975	0.91467	P	0.999930232982536	0.98982	0.40520808	0.79716	1	0.99985	.	.	.	.	.	.	5.269885	0.88506	29.6	0.98478870246162831	0.42080	0.860229	0.77724	D	1.01097472279383	0.96050	14.27046	0.895296341151146	0.95337	13.55232	4.96	4.96	0.65108	.	.	6.969	0.75938	7.664000	0.64459	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.999	0.91597	228	0.91137	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Acute_intermittent_porphyria	no_assertion_criteria_provided	NC_000011.10:g.119088647C>A	ClinGen:CA251811|OMIM:609806.0017|UniProtKB:P08397#VAR_003641	C0162565	176000	79276	Porphobilinogen deaminase, N-terminal	Gln	Lys	16494	single nucleotide variant	NM_000190.4(HMBS):c.100C>A (p.Gln34Lys)	3145	HMBS	HGNC:4982	Pathogenic	1	Sep 01, 1992	118204105	-	RCV000001520	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276	Acute intermittent porphyria	germline	germline	GRCh38	NC_000011.10	11	119088647	119088647	11q23.3	no assertion criteria provided	1	-	N	ClinGen:CA251811,UniProtKB:P08397#VAR_003641,OMIM:609806.0017	1	1455	119088647	C	A	-	-	-	-	-	-	SCV000021675	-	-	100C>A 	Gln34Lys	NM_000190.4		1_Pathogenic	HMBS	ENSG00000256269	2803	200923	CCSBVarC005158	ALE00005158	100C>A	Gln34Lys	CEGS2	CegsMutGDEh1039	A04	GDEhDisVCh_40054	E04	2	CegsMutGDDh1039	A04	NULL	NULL	NULL	NULL	NULL	NULL	1	6	1	1	0	NULL	0	NULL	0	NULL	HMBS_Gln34Lys	11	11	119088647	C	A
359	CBS	253G>A	Gly85Arg	ENSG00000160200	21	43068572	NC_000021.9:43068572:C:T	ALE00007346	CCSBVarC007358	NULL	NULL	318	GDEhDisVCh_40013	C11	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCAGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210446.0	single nucleotide variant	NM_000071.3(CBS):c.253G>A (p.Gly85Arg)	875.0	CBS	HGNC:1550	Pathogenic	1.0	Jan 25, 2024	863223435.0	-	RCV000195506|RCV001063052|RCV002228834	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;unknown	germline	GRCh38	NC_000021.9	21	43068572.0	43068572.0	21q22.3	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA319849,UniProtKB:P35520#VAR_008051	2.0	212874.0	43068572.0	C	T	-	-	-	-	-	-	SCV000249722|SCV001227885|SCV002784826|SCV003827506|SCV004213880	-	-	253G>A 	Gly85Arg	NM_000071.3	2.0	1_Pathogenic	chr21	G	A	21-43068572-G-A		212874	21	43068572	C	T	G	R	rs863223435	21	44488682	21	43361751	85	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.253G>A	p.Gly85Arg	c.253G>A	p.Gly85Arg	principal1	Y	1	.	.	-	GGG	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.001	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.455	0.98813	H	-7.76	0.95831	D	0.999	0.99995	1.0732	0.98675	D	0.9709	0.99082	D	10	0.9933187	0.99862	D	0.642919	0.96955	D	0.940	0.98707	0.967	0.99678	P35520	G85R	Gain of MoRF binding (P = 0.0256)| Gain of solvent accessibility (P = 0.0456)| Gain of phosphorylation at T87 (P = 0.0896)| Loss of methylation at K83 (P = 0.1131)| Gain of disorder (P = 0.1268)	0.936124493805	0.93496	.	0.96260	.	0.81188	0.663791716099	0.61890	T	0.984975	0.99903	D	0.570911	0.96591	D	0.582297	0.96535	D	0.999729573726654	0.98666	D	.	0.96149	.	0.93975097	0.95149	0.89119345	0.94274	0.96367913	0.97610	0.90246725	0.95085	-11.825	0.84034	D	.	0.78584	.	0.999851858739197	0.98365	0.99986637	0.99835	0.994	0.99793	.	.	.	.	.	.	5.186666	0.86996	29.1	0.99920568129113618	0.98722	0.907519	0.86114	D	0.790904520017775	0.85453	8.604383	0.592038373512724	0.74225	6.125103	4.81	4.81	0.61353	2.97	0.54324	6.695	0.7448	5.671000	0.49331	0.524	0.24207	1.0	0.71675	1.000000	0.68239	0.924	0.46023	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109390	9.141600e-06	0	1	208054	4.806440e-06	0	1	236856	4.221970e-06	0	0	7162	0.000000e+00	0	0	17108	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13390	0.000000e+00	0	1	42766	2.338310e-05	0	0	15684	0.000000e+00	0	1	42766	2.338310e-05	0	0	16202	0.000000e+00	0	0	30520	0.000000e+00	0	0	6210	0.000000e+00	0	0	13414	0.000000e+00	0	0	16730	0.000000e+00	0	1	89512	1.117170e-05	0	0	30602	0.000000e+00	0	1	89512	1.117170e-05	0	0	14888	0.000000e+00	0	0	34256	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21628	0.000000e+00	0	1	102688	9.738240e-06	0	0	30520	0.000000e+00	0	1	102688	9.738240e-06	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	23860	4.191114836546522E-5	0	84	0	0	84	0	0	2230	0	0	500	0	0	628	0	0	24	0	0	94	0	0	4558	0	0	2314	0	0	108	0	1	32062	3.118957020772254E-5	Pathogenic	HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Classic_homocystinuria|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43068572C>T	ClinGen:CA319849|UniProtKB:P35520#VAR_008051	C3150344|C0751202|C3661900	236200	394	Tryptophan synthase beta chain-like, PALP domain	Gly	Arg	210446	single nucleotide variant	NM_000071.3(CBS):c.253G>A (p.Gly85Arg)	875	CBS	HGNC:1550	Pathogenic	1	Jan 25, 2024	863223435	-	RCV000195506|RCV001063052|RCV002228834	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;unknown	germline	GRCh38	NC_000021.9	21	43068572	43068572	21q22.3	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA319849,UniProtKB:P35520#VAR_008051	2	212874	43068572	C	T	-	-	-	-	-	-	SCV000249722|SCV001227885|SCV002784826|SCV003827506|SCV004213880	-	-	253G>A 	Gly85Arg	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	318	CCSBVarC007358	ALE00007346	253G>A	Gly85Arg	Edgotyping3	VUSMutGDEh011	A06	GDEhDisVCh_40013	C11	1	VUSMutGDDh011	A06	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	5	0	NULL	0	NULL	0	NULL	CBS_Gly85Arg	21	21	43068572	C	T
3172	CBS	1397C>T	Ser466Leu	ENSG00000160200	21	43058215	NC_000021.9:43058215:G:A	ALE00003758	CCSBVarC003758	NULL	214536	NULL	GDEhDisVCh_40055	E09	CEGS2	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTCCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCCGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTTGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	15169.0	single nucleotide variant	NM_000071.3(CBS):c.1397C>T (p.Ser466Leu)	875.0	CBS	HGNC:1550	Conflicting classifications of pathogenicity	1.0	Nov 11, 2024	121964971.0	-	RCV000000153|RCV000675119|RCV002390082|RCV003226154	MedGen:C3150344|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:CN169374	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Classic homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|not specified	germline;unknown	germline	GRCh38	NC_000021.9	21	43058215.0	43058215.0	21q22.3	criteria provided, conflicting classifications	7.0	-	N	ClinGen:CA113900,UniProtKB:P35520#VAR_008091,OMIM:613381.0014	3.0	130.0	43058215.0	G	A	-	-	-	-	-	-	SCV000800673|SCV002128242|SCV002702257|SCV002782907|SCV003922491|SCV004213886	-	-	1397C>T 	Ser466Leu	NM_000071.3	1.0	3_Conflicting	chr21	C	T	21-43058215-C-T		130	21	43058215	G	A	S	L	rs121964971	21	44478325	21	43351394	466	CBS	ENSG00000160200	ENST00000352178	ENSP00000344460	P35520	CBS_HUMAN	c.1397C>T	p.Ser466Leu	c.1397C>T	p.Ser466Leu	principal1	Y	1	.	.	-	TCG	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.006	0.70891	D	0.376	0.34257	B	0.117	0.32017	B	0.94	0.94378	D	simple_aae	6.0	94.0	3.08	0.87122	M	-4.39	0.77256	D	0.856	0.86483	0.9268	0.96044	D	0.8588	0.95289	D	10	0.97071606	0.96627	D	0.426043	0.93877	D	0.822	0.94297	0.817	0.93090	P35520	S466L	Loss of disorder (P = 0.053)| Gain of helix (P = 0.132)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.2754)| Loss of catalytic residue at S466 (P = 0.3734)	0.891810618394	0.88991	.	0.71929	.	0.40758	0.549852132797	0.45771	T	0.948343	0.99229	D	0.404985	0.90130	D	0.407602	0.92299	D	0.958893304414527	0.65172	D	0.976502	0.91830	D	0.6766013	0.76525	0.61432356	0.77315	0.6842936	0.76943	0.61038023	0.77097	-12.517	0.87309	D	0.1763	0.41635	B	0.944859074248624	0.79866	0.99918312	0.99198	0.978	0.99209	.	.	.	.	.	.	4.493764	0.70285	25.5	0.99883847249634716	0.95973	0.859573	0.77646	D	0.367363435421357	0.59455	4.147524	0.391879163051237	0.60854	4.301397	4.62	4.62	0.56895	1.58	0.35008	6.422	0.73331	8.200000	0.76837	0.522	0.23977	1.0	0.71675	1.000000	0.68239	0.922	0.45799	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	109404	1.828090e-05	0	3	208044	1.442000e-05	0	3	236924	1.266230e-05	0	0	7162	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	2	42768	4.676390e-05	0	0	15690	0.000000e+00	0	2	42768	4.676390e-05	0	0	16200	0.000000e+00	0	0	30522	0.000000e+00	0	0	6208	0.000000e+00	0	0	13414	0.000000e+00	0	0	16734	0.000000e+00	0	3	89496	3.352110e-05	0	0	30608	0.000000e+00	0	3	89496	3.352110e-05	0	0	14890	0.000000e+00	0	0	34258	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	3	102734	2.920160e-05	0	0	30526	0.000000e+00	0	3	102734	2.920160e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Classic_homocystinuria|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|not_specified|Familial_thoracic_aortic_aneurysm_and_aortic_dissection	criteria_provided,_conflicting_classifications	NC_000021.9:g.43058215G>A	ClinGen:CA113900|OMIM:613381.0014|UniProtKB:P35520#VAR_008091	C0751202|C3150344|CN169374|C4707243	236200|PS607086	394|91387	CBS domain|CBS domain|CBS domain|Cystathionine beta-synthase, C-terminal domain	Ser	Leu	15169	single nucleotide variant	NM_000071.3(CBS):c.1397C>T (p.Ser466Leu)	875	CBS	HGNC:1550	Conflicting classifications of pathogenicity	1	Nov 11, 2024	121964971	-	RCV000000153|RCV000675119|RCV002390082|RCV003226154	MedGen:C3150344|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:CN169374	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Classic homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|not specified	germline;unknown	germline	GRCh38	NC_000021.9	21	43058215	43058215	21q22.3	criteria provided, conflicting classifications	7	-	N	ClinGen:CA113900,UniProtKB:P35520#VAR_008091,OMIM:613381.0014	3	130	43058215	G	A	-	-	-	-	-	-	SCV000800673|SCV002128242|SCV002702257|SCV002782907|SCV003922491|SCV004213886	-	-	1397C>T 	Ser466Leu	NM_000071.3	1	3_Conflicting	CBS	ENSG00000160200	359	238	CCSBVarC007298	ALE00003758	1397C>T	Ser466Leu	Edgotyping3	VUSMutGDEh010	B10	GDEhDisVCh_40013	F03	1	VUSMutGDDh010	B10	NULL	NULL	NULL	NULL	NULL	NULL	1	4	1	5	0	NULL	0	NULL	0	NULL	CBS_Ser466Leu	21	21	43058215	G	A
3172	CBS	1397C>T	Ser466Leu	ENSG00000160200	21	43058215	NC_000021.9:43058215:G:A	ALE00003758	CCSBVarC003758	NULL	214536	NULL	GDEhDisVCh_40055	E09	CEGS2	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTCCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCCGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTTGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	15169.0	single nucleotide variant	NM_000071.3(CBS):c.1397C>T (p.Ser466Leu)	875.0	CBS	HGNC:1550	Conflicting classifications of pathogenicity	1.0	Nov 11, 2024	121964971.0	-	RCV000000153|RCV000675119|RCV002390082|RCV003226154	MedGen:C3150344|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:CN169374	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Classic homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|not specified	germline;unknown	germline	GRCh38	NC_000021.9	21	43058215.0	43058215.0	21q22.3	criteria provided, conflicting classifications	7.0	-	N	ClinGen:CA113900,UniProtKB:P35520#VAR_008091,OMIM:613381.0014	3.0	130.0	43058215.0	G	A	-	-	-	-	-	-	SCV000800673|SCV002128242|SCV002702257|SCV002782907|SCV003922491|SCV004213886	-	-	1397C>T 	Ser466Leu	NM_000071.3	1.0	3_Conflicting	chr21	C	T	21-43058215-C-T		130	21	43058215	G	A	S	L	rs121964971	21	44478325	21	43351394	466	CBS	ENSG00000160200	ENST00000352178	ENSP00000344460	P35520	CBS_HUMAN	c.1397C>T	p.Ser466Leu	c.1397C>T	p.Ser466Leu	principal1	Y	1	.	.	-	TCG	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.006	0.70891	D	0.376	0.34257	B	0.117	0.32017	B	0.94	0.94378	D	simple_aae	6.0	94.0	3.08	0.87122	M	-4.39	0.77256	D	0.856	0.86483	0.9268	0.96044	D	0.8588	0.95289	D	10	0.97071606	0.96627	D	0.426043	0.93877	D	0.822	0.94297	0.817	0.93090	P35520	S466L	Loss of disorder (P = 0.053)| Gain of helix (P = 0.132)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.2754)| Loss of catalytic residue at S466 (P = 0.3734)	0.891810618394	0.88991	.	0.71929	.	0.40758	0.549852132797	0.45771	T	0.948343	0.99229	D	0.404985	0.90130	D	0.407602	0.92299	D	0.958893304414527	0.65172	D	0.976502	0.91830	D	0.6766013	0.76525	0.61432356	0.77315	0.6842936	0.76943	0.61038023	0.77097	-12.517	0.87309	D	0.1763	0.41635	B	0.944859074248624	0.79866	0.99918312	0.99198	0.978	0.99209	.	.	.	.	.	.	4.493764	0.70285	25.5	0.99883847249634716	0.95973	0.859573	0.77646	D	0.367363435421357	0.59455	4.147524	0.391879163051237	0.60854	4.301397	4.62	4.62	0.56895	1.58	0.35008	6.422	0.73331	8.200000	0.76837	0.522	0.23977	1.0	0.71675	1.000000	0.68239	0.922	0.45799	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	109404	1.828090e-05	0	3	208044	1.442000e-05	0	3	236924	1.266230e-05	0	0	7162	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	2	42768	4.676390e-05	0	0	15690	0.000000e+00	0	2	42768	4.676390e-05	0	0	16200	0.000000e+00	0	0	30522	0.000000e+00	0	0	6208	0.000000e+00	0	0	13414	0.000000e+00	0	0	16734	0.000000e+00	0	3	89496	3.352110e-05	0	0	30608	0.000000e+00	0	3	89496	3.352110e-05	0	0	14890	0.000000e+00	0	0	34258	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	3	102734	2.920160e-05	0	0	30526	0.000000e+00	0	3	102734	2.920160e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Classic_homocystinuria|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|not_specified|Familial_thoracic_aortic_aneurysm_and_aortic_dissection	criteria_provided,_conflicting_classifications	NC_000021.9:g.43058215G>A	ClinGen:CA113900|OMIM:613381.0014|UniProtKB:P35520#VAR_008091	C0751202|C3150344|CN169374|C4707243	236200|PS607086	394|91387	CBS domain|CBS domain|CBS domain|Cystathionine beta-synthase, C-terminal domain	Ser	Leu	15169	single nucleotide variant	NM_000071.3(CBS):c.1397C>T (p.Ser466Leu)	875	CBS	HGNC:1550	Conflicting classifications of pathogenicity	1	Nov 11, 2024	121964971	-	RCV000000153|RCV000675119|RCV002390082|RCV003226154	MedGen:C3150344|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:CN169374	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Classic homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|not specified	germline;unknown	germline	GRCh38	NC_000021.9	21	43058215	43058215	21q22.3	criteria provided, conflicting classifications	7	-	N	ClinGen:CA113900,UniProtKB:P35520#VAR_008091,OMIM:613381.0014	3	130	43058215	G	A	-	-	-	-	-	-	SCV000800673|SCV002128242|SCV002702257|SCV002782907|SCV003922491|SCV004213886	-	-	1397C>T 	Ser466Leu	NM_000071.3	1	3_Conflicting	CBS	ENSG00000160200	3172	214536	CCSBVarC003758	ALE00003758	1397C>T	Ser466Leu	CEGS2	CegsMutGDEh1042	A08	GDEhDisVCh_40055	E09	1	CegsMutGDDh1042	A08	NULL	NULL	NULL	NULL	NULL	NULL	1	6	1	1	0	NULL	0	NULL	0	NULL	CBS_Ser466Leu	21	21	43058215	G	A
52861	F9	1151G>C	Arg384Pro	ENSG00000101981	X	139561836	NC_000023.11:139561836:G:C	ALE00004389	CCSBVarC004389	NULL	204384	NULL	GDEhDisVCh_40052	D02	CEGS2	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCCATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT	25699.0	single nucleotide variant	NM_000133.4(F9):c.1151G>C (p.Arg384Pro)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Aug 04, 2016	137852283.0	-	RCV000011413	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561836.0	139561836.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255463,OMIM:300746.0111	1.0	10660.0	139561836.0	G	C	-	-	-	-	-	-	SCV000031645	-	-	1151G>C 	Arg384Pro	NM_000133.4		1_Pathogenic	chrX	G	C	X-139561836-G-C		10660	X	139561836	G	C	R	P	rs137852283	X	138643995	X	138471661	384	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1151G>C	p.Arg384Pro	c.1151G>C	p.Arg384Pro	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.113	0.30937	T	0.126	0.35539	T	0.811	0.45417	P	0.626	0.51596	P	0.91	0.92786	A	simple_aae	9.0	91.0	1.8	0.47294	L	-2.95	0.61611	D	0.576	0.88450	-0.2094	0.77327	T	0.6380	0.87292	D	10	0.953725	0.94661	D	0.656409	0.97099	D	0.614	0.84859	0.867	0.96136	P00740	R384P	Gain of glycosylation at T381 (P = 0.0458)| Loss of catalytic residue at R384 (P = 0.0607)| Loss of MoRF binding (P = 0.1287)| Loss of helix (P = 0.1299)| Gain of ubiquitination at K387 (P = 0.1696)	0.999870480019	0.99986	0.9930344317450107	0.99298	1.87772444659	0.92541	0.347094744444	0.17476	T	0.844472	0.96374	D	0.41848	0.90875	D	0.363341	0.90761	D	0.955869972705841	0.64392	D	0.864914	0.58713	D	0.9766411	0.98823	0.92917997	0.96996	0.97375035	0.98574	0.86487466	0.92413	-8.889	0.67458	D	0.7086	0.83164	P	0.999433055132211	0.96580	0.99998236	0.99989	0.776	0.87600	.	.	.	.	.	.	3.756788	0.53962	23.4	0.99434905878668101	0.64520	.	.	.	.	.	.	.	.	.	5.66	2.91	0.32820	3.27	0.59264	1.5	0.35396	4.414000	0.43370	0.676	0.76753	0.035	0.20792	1.000000	0.68239	0.988	0.63383	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561836G>C	ClinGen:CA255463|OMIM:300746.0111	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Pro	25699	single nucleotide variant	NM_000133.4(F9):c.1151G>C (p.Arg384Pro)	2158	F9	HGNC:3551	Pathogenic	1	Aug 04, 2016	137852283	-	RCV000011413	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561836	139561836	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255463,OMIM:300746.0111	1	10660	139561836	G	C	-	-	-	-	-	-	SCV000031645	-	-	1151G>C 	Arg384Pro	NM_000133.4		1_Pathogenic	F9	ENSG00000101981	52861	204384	CCSBVarC004389	ALE00004389	1151G>C	Arg384Pro	CEGS2	CegsMutGDEh1012	G04	GDEhDisVCh_40052	D02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	F9_Arg384Pro	23	X	139561836	G	C
3172	CBS	572C>T	Thr191Met	ENSG00000160200	21	43065481	NC_000021.9:43065481:G:A	ALE00003751	CCSBVarC003751	NULL	214526	NULL	GDEhDisVCh_40055	E07	CEGS2	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTCCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGATGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCCGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	15171.0	single nucleotide variant	NM_000071.3(CBS):c.572C>T (p.Thr191Met)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Dec 24, 2024	121964973.0	-	RCV000000155|RCV000195441|RCV000576767|RCV000589097|RCV002227962|RCV004018523|RCV003914787	MedGen:C4017308|MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|	Homocystinuria, pyridoxine-nonresponsive|not provided|Classic homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection|CBS-related disorder	germline;unknown	germline	GRCh38	NC_000021.9	21	43065481.0	43065481.0	21q22.3	criteria provided, multiple submitters, no conflicts	14.0	-	N	ClinGen:CA113904,UniProtKB:P35520#VAR_008068,OMIM:613381.0016	3.0	132.0	43065481.0	G	A	-	-	-	-	-	-	SCV000249685|SCV000677987|SCV000695307|SCV000769933|SCV002016940|SCV002512726|SCV002790934|SCV003677654|SCV003841740|SCV004213858|SCV005331353	-	-	572C>T 	Thr191Met	NM_000071.3	2.0	1_Pathogenic	chr21	C	T	21-43065481-C-T		132	21	43065481	G	A	T	M	rs121964973	21	44485591	21	43358660	191	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.572C>T	p.Thr191Met	c.572C>T	p.Thr191Met	principal1	Y	1	.	.	-	ACG	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.95	0.96383	H	-5.69	0.87331	D	0.966	0.98079	1.0159	0.97454	D	0.9876	0.99636	D	9	0.9910051	0.99614	D	0.935087	0.99532	D	0.956	0.99253	0.898	0.97671	P35520	T191M	Loss of phosphorylation at T191 (P = 0.0306)| Loss of disorder (P = 0.127)| Gain of MoRF binding (P = 0.1325)| Gain of sheet (P = 0.1451)| Gain of loop (P = 0.2754)	0.946093818666	0.94509	.	0.90049	.	0.78830	0.743441224098	0.73432	T	0.99434	0.99986	D	0.323638	0.84618	D	0.543263	0.95414	D	0.995535731315613	0.87499	D	.	0.98577	.	0.9192799	0.93076	0.8814906	0.93580	0.95037234	0.96245	0.89804995	0.94766	-13.49	0.91298	D	0.7502	0.75011	LP	0.998430861309326	0.94452	0.99985027	0.99806	0.989	0.99628	.	.	.	.	.	.	5.331047	0.89477	30.0	0.99902462664609826	0.97428	0.964437	0.98651	D	0.840295495566379	0.88486	9.620101	0.663087580219915	0.79475	7.11431	4.65	3.74	0.42041	.	.	8.355	0.90006	9.473000	0.80904	0.578	0.29426	1.0	0.71675	1.000000	0.68239	0.747	0.35717	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4	109202	3.662940e-05	0	12	207260	5.789830e-05	0	15	235092	6.380480e-05	0	0	7132	0.000000e+00	0	4	17062	2.344390e-04	0	0	2318	0.000000e+00	0	0	9040	0.000000e+00	0	0	13380	0.000000e+00	0	0	42710	0.000000e+00	0	0	15652	0.000000e+00	0	4	17062	2.344390e-04	0	0	16054	0.000000e+00	0	11	30432	3.614620e-04	0	0	6190	0.000000e+00	0	0	13384	0.000000e+00	0	0	16718	0.000000e+00	0	0	89090	0.000000e+00	0	0	30556	0.000000e+00	0	11	30432	3.614620e-04	0	0	14858	0.000000e+00	0	13	34168	3.804730e-04	0	0	9504	0.000000e+00	0	0	17682	0.000000e+00	0	0	21576	0.000000e+00	0	0	101246	0.000000e+00	0	0	30474	0.000000e+00	0	13	34168	3.804730e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic/Likely_pathogenic	Homocystinuria|Homocystinuria,_pyridoxine-nonresponsive|Classic_homocystinuria|not_provided|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|CBS-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43065481G>A	ClinGen:CA113904|OMIM:613381.0016|UniProtKB:P35520#VAR_008068	C0019880|C4017308|C0751202|C3661900|C4707243|C3150344	236200|PS607086	394|91387	Tryptophan synthase beta chain-like, PALP domain	Thr	Met	15171	single nucleotide variant	NM_000071.3(CBS):c.572C>T (p.Thr191Met)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Dec 24, 2024	121964973	-	RCV000000155|RCV000195441|RCV000576767|RCV000589097|RCV002227962|RCV004018523|RCV003914787	MedGen:C4017308|MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|	Homocystinuria, pyridoxine-nonresponsive|not provided|Classic homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection|CBS-related disorder	germline;unknown	germline	GRCh38	NC_000021.9	21	43065481	43065481	21q22.3	criteria provided, multiple submitters, no conflicts	14	-	N	ClinGen:CA113904,UniProtKB:P35520#VAR_008068,OMIM:613381.0016	3	132	43065481	G	A	-	-	-	-	-	-	SCV000249685|SCV000677987|SCV000695307|SCV000769933|SCV002016940|SCV002512726|SCV002790934|SCV003677654|SCV003841740|SCV004213858|SCV005331353	-	-	572C>T 	Thr191Met	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	287	CCSBVarC007333	ALE00003751	572C>T	Thr191Met	Edgotyping3	VUSMutGDEh011	H02	GDEhDisVCh_40013	B08	1	VUSMutGDDh011	H02	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	CBS_Thr191Met	21	21	43065481	G	A
3172	CBS	572C>T	Thr191Met	ENSG00000160200	21	43065481	NC_000021.9:43065481:G:A	ALE00003751	CCSBVarC003751	NULL	214526	NULL	GDEhDisVCh_40055	E07	CEGS2	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTCCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGATGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCCGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	15171.0	single nucleotide variant	NM_000071.3(CBS):c.572C>T (p.Thr191Met)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Dec 24, 2024	121964973.0	-	RCV000000155|RCV000195441|RCV000576767|RCV000589097|RCV002227962|RCV004018523|RCV003914787	MedGen:C4017308|MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|	Homocystinuria, pyridoxine-nonresponsive|not provided|Classic homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection|CBS-related disorder	germline;unknown	germline	GRCh38	NC_000021.9	21	43065481.0	43065481.0	21q22.3	criteria provided, multiple submitters, no conflicts	14.0	-	N	ClinGen:CA113904,UniProtKB:P35520#VAR_008068,OMIM:613381.0016	3.0	132.0	43065481.0	G	A	-	-	-	-	-	-	SCV000249685|SCV000677987|SCV000695307|SCV000769933|SCV002016940|SCV002512726|SCV002790934|SCV003677654|SCV003841740|SCV004213858|SCV005331353	-	-	572C>T 	Thr191Met	NM_000071.3	2.0	1_Pathogenic	chr21	C	T	21-43065481-C-T		132	21	43065481	G	A	T	M	rs121964973	21	44485591	21	43358660	191	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.572C>T	p.Thr191Met	c.572C>T	p.Thr191Met	principal1	Y	1	.	.	-	ACG	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.95	0.96383	H	-5.69	0.87331	D	0.966	0.98079	1.0159	0.97454	D	0.9876	0.99636	D	9	0.9910051	0.99614	D	0.935087	0.99532	D	0.956	0.99253	0.898	0.97671	P35520	T191M	Loss of phosphorylation at T191 (P = 0.0306)| Loss of disorder (P = 0.127)| Gain of MoRF binding (P = 0.1325)| Gain of sheet (P = 0.1451)| Gain of loop (P = 0.2754)	0.946093818666	0.94509	.	0.90049	.	0.78830	0.743441224098	0.73432	T	0.99434	0.99986	D	0.323638	0.84618	D	0.543263	0.95414	D	0.995535731315613	0.87499	D	.	0.98577	.	0.9192799	0.93076	0.8814906	0.93580	0.95037234	0.96245	0.89804995	0.94766	-13.49	0.91298	D	0.7502	0.75011	LP	0.998430861309326	0.94452	0.99985027	0.99806	0.989	0.99628	.	.	.	.	.	.	5.331047	0.89477	30.0	0.99902462664609826	0.97428	0.964437	0.98651	D	0.840295495566379	0.88486	9.620101	0.663087580219915	0.79475	7.11431	4.65	3.74	0.42041	.	.	8.355	0.90006	9.473000	0.80904	0.578	0.29426	1.0	0.71675	1.000000	0.68239	0.747	0.35717	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4	109202	3.662940e-05	0	12	207260	5.789830e-05	0	15	235092	6.380480e-05	0	0	7132	0.000000e+00	0	4	17062	2.344390e-04	0	0	2318	0.000000e+00	0	0	9040	0.000000e+00	0	0	13380	0.000000e+00	0	0	42710	0.000000e+00	0	0	15652	0.000000e+00	0	4	17062	2.344390e-04	0	0	16054	0.000000e+00	0	11	30432	3.614620e-04	0	0	6190	0.000000e+00	0	0	13384	0.000000e+00	0	0	16718	0.000000e+00	0	0	89090	0.000000e+00	0	0	30556	0.000000e+00	0	11	30432	3.614620e-04	0	0	14858	0.000000e+00	0	13	34168	3.804730e-04	0	0	9504	0.000000e+00	0	0	17682	0.000000e+00	0	0	21576	0.000000e+00	0	0	101246	0.000000e+00	0	0	30474	0.000000e+00	0	13	34168	3.804730e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic/Likely_pathogenic	Homocystinuria|Homocystinuria,_pyridoxine-nonresponsive|Classic_homocystinuria|not_provided|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|CBS-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43065481G>A	ClinGen:CA113904|OMIM:613381.0016|UniProtKB:P35520#VAR_008068	C0019880|C4017308|C0751202|C3661900|C4707243|C3150344	236200|PS607086	394|91387	Tryptophan synthase beta chain-like, PALP domain	Thr	Met	15171	single nucleotide variant	NM_000071.3(CBS):c.572C>T (p.Thr191Met)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Dec 24, 2024	121964973	-	RCV000000155|RCV000195441|RCV000576767|RCV000589097|RCV002227962|RCV004018523|RCV003914787	MedGen:C4017308|MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|	Homocystinuria, pyridoxine-nonresponsive|not provided|Classic homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection|CBS-related disorder	germline;unknown	germline	GRCh38	NC_000021.9	21	43065481	43065481	21q22.3	criteria provided, multiple submitters, no conflicts	14	-	N	ClinGen:CA113904,UniProtKB:P35520#VAR_008068,OMIM:613381.0016	3	132	43065481	G	A	-	-	-	-	-	-	SCV000249685|SCV000677987|SCV000695307|SCV000769933|SCV002016940|SCV002512726|SCV002790934|SCV003677654|SCV003841740|SCV004213858|SCV005331353	-	-	572C>T 	Thr191Met	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	3172	214526	CCSBVarC003751	ALE00003751	572C>T	Thr191Met	CEGS2	CegsMutGDEh1040	B04	GDEhDisVCh_40055	E07	1	CegsMutGDDh1040	B04	NULL	NULL	NULL	NULL	NULL	NULL	1	6	1	5	0	NULL	0	NULL	0	NULL	CBS_Thr191Met	21	21	43065481	G	A
2803	HMBS	1075G>A	Asp359Asn	ENSG00000256269	11	119093272	NC_000011.10:119093272:G:A	ALE00005179	CCSBVarC005179	NULL	200947	NULL	GDEhDisVCh_40054	H07	CEGS2	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAGCTTGCTCGCATACAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGGACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCTTGAACATGCCCTGGAGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCGAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTCGGGGAAACCTCAACACCCGGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACCGGGTGGGGCAGATCCTGCACCCTGAGGAATGCATGTATGCTGTGGGCCAGGGGGCCTTGGGCGTGGAAGTGCGAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCTGCATCGCTGAAAGGGCCTTCCTGAGGCACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATGGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCGTAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACAATGCCCAT	171132.0	single nucleotide variant	NM_000190.4(HMBS):c.1075G>A (p.Asp359Asn)	3145.0	HMBS	HGNC:4982	Benign/Likely benign	0.0	Jan 01, 2025	144949995.0	-	RCV000148507|RCV001356682	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900	Acute intermittent porphyria|not provided	germline;unknown	germline	GRCh38	NC_000011.10	11	119093272.0	119093272.0	11q23.3	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA272871	2.0	161249.0	119093272.0	G	A	-	-	-	-	-	-	SCV001259472|SCV002447753	-	-	1075G>A 	Asp359Asn	NM_000190.4	2.0	2_Benign	chr11	G	A	11-119093272-G-A	0.0000649879	161249	11	119093272	G	A	D	N	rs144949995	11	118963982	11	118469192	359	HMBS	ENSG00000256269	ENST00000652429	ENSP00000498786	P08397	HEM3_HUMAN	c.1075G>A	p.Asp359Asn	c.1075G>A	p.Asp359Asn	principal2	Y	.	YES	Select	+	GAT	1	0	G	G/G	G/G	G/G	G/G	.	0.65576	.	.	0.57446	.	0.979	0.62341	D	0.527	0.50892	P	.	0.10877	.	.	.	.	2.14	0.59685	M	.	0.38141	.	.	0.77038	1.0459	0.98026	D	0.9846	0.99532	D	10	.	0.30896	.	0.746723	0.97973	D	.	0.87667	.	.	.	.	.	.	0.91579	0.39072444537365264	0.38784	.	.	0.512455224991	0.40508	T	0.432739	0.77879	T	-0.170586	0.24805	T	-0.0682527	0.65505	T	0.104062861534229	0.12635	T	0.910309	0.68120	D	0.3453892	0.56375	0.3170101	0.57454	0.37713367	0.58781	0.32851937	0.58510	-4.539	0.33492	T	0.1264	0.27406	B	0.948487344713086	0.80270	0.03907438	0.56847	0.765	0.86988	.	.	.	.	.	.	4.645467	0.74048	26.1	0.99903784978921351	0.97503	0.952613	0.96811	D	0.622631496984238	0.74470	6.161659	0.651979823880355	0.78641	6.941212	4.99	4.99	0.65898	.	.	9.075	0.93427	11.804000	0.96740	0.66	0.55068	1.0	0.71675	1.000000	0.68239	0.972	0.54981	228	0.91137	1	1.9968051118210862E-4	1	7.564296520423601E-4	0	0.0	0	0.0	0	0.0	0	0.0	113	264690	4.269145E-4	.	8	109344	7.316360e-05	0	24	207970	1.154010e-04	1	22	236602	9.298320e-05	1	8	7164	1.116690e-03	0	0	17102	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13358	0.000000e+00	0	0	42750	0.000000e+00	0	0	15690	0.000000e+00	0	8	7164	1.116690e-03	0	20	16212	1.233650e-03	0	0	30502	0.000000e+00	0	0	6212	0.000000e+00	0	0	13412	0.000000e+00	0	0	16696	0.000000e+00	0	1	89468	1.117720e-05	0	0	30604	0.000000e+00	0	20	16212	1.233650e-03	0	19	14900	1.275170e-03	0	0	34234	0.000000e+00	0	0	9564	0.000000e+00	0	0	17692	0.000000e+00	0	0	21582	0.000000e+00	0	1	102490	9.757050e-06	0	0	30522	0.000000e+00	0	19	14900	1.275170e-03	0	.	151	1614106	9.355020e-05	1	110	75040	1.465880e-03	0	110	75040	1.465880e-03	0	0	910	0.000000e+00	0	4	60026	6.663780e-05	0	0	29606	0.000000e+00	0	0	44870	0.000000e+00	0	0	64012	0.000000e+00	0	6	6036	9.940360e-04	1	20	1180020	1.694890e-05	0	0	91080	0.000000e+00	0	5	156854	3.1876777130325014E-5	0	352	0	0	2686	0	8	8770	9.122006841505131E-4	0	442	0	0	950	0	0	652	0	0	280	0	1	9042	1.1059500110595002E-4	8	9122	8.770006577504934E-4	0	3338	0	14	180028	7.776568089408314E-5	Benign/Likely_benign	Acute_intermittent_porphyria|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.119093272G>A	ClinGen:CA272871	C0162565|C3661900	176000	79276	.	Asp	Asn	171132	single nucleotide variant	NM_000190.4(HMBS):c.1075G>A (p.Asp359Asn)	3145	HMBS	HGNC:4982	Benign/Likely benign	0	Jan 01, 2025	144949995	-	RCV000148507|RCV001356682	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900	Acute intermittent porphyria|not provided	germline;unknown	germline	GRCh38	NC_000011.10	11	119093272	119093272	11q23.3	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA272871	2	161249	119093272	G	A	-	-	-	-	-	-	SCV001259472|SCV002447753	-	-	1075G>A 	Asp359Asn	NM_000190.4	2	2_Benign	HMBS	ENSG00000256269	2803	200947	CCSBVarC005179	ALE00005179	1075G>A	Asp359Asn	CEGS2	CegsMutGDEh1042	H08	GDEhDisVCh_40054	H07	2	CegsMutGDDh1042	H08	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	2	0	NULL	0	NULL	0	NULL	HMBS_Asp359Asn	11	11	119093272	G	A
14613	BRCA1	1684T>C	Tyr562His	ENSG00000012048	17	43067686	NC_000017.11:43067686:A:G	ALE00003302	CCSBVarC003302	NULL	218423	NULL	GDEhDisVCh_40059	H03	CEGS2	ATGGATTTATCTGCTCTTCGCGTTGAAGAAGTACAAAATGTCATTAATGCTATGCAGAAAATCTTAGAGTGTCCCATCTGTCTGGAGTTGATCAAGGAACCTGTCTCCACAAAGTGTGACCACATATTTTGCAAATTTTGCATGCTGAAACTTCTCAACCAGAAGAAAGGGCCTTCACAGTGTCCTTTATGTAAGAATGATATAACCAAAAGGAGCCTACAAGAAAGTACGAGATTTAGTCAACTTGTTGAAGAGCTATTGAAAATCATTTGTGCTTTTCAGCTTGACACAGGTTTGGAGTATGCAAACAGCTATAATTTTGCAAAAAAGGAAAATAACTCTCCTGAACATCTAAAAGATGAAGTTTCTATCATCCAAAGTATGGGCTACAGAAACCGTGCCAAAAGACTTCTACAGAGTGAACCCGAAAATCCTTCCTTGCAGGAAACCAGTCTCAGTGTCCAACTCTCTAACCTTGGAACTGTGAGAACTCTGAGGACAAAGCAGCGGATACAACCTCAAAAGACGTCTGTCTACATTGAATTGGGATCTGATTCTTCTGAAGATACCGTTAATAAGGCAACTTATTGCAGTGTGGGAGATCAAGAATTGTTACAAATCACCCCTCAAGGAACCAGGGATGAAATCAGTTTGGATTCTGCAAAAAAGGCTGCTTGTGAATTTTCTGAGACGGATGTAACAAATACTGAACATCATCAACCCAGTAATAATGATTTGAACACCACTGAGAAGCGTGCAGCTGAGAGGCATCCAGAAAAGTATCAGGGTGAAGCAGCATCTGGGTGTGAGAGTGAAACAAGCGTCTCTGAAGACTGCTCAGGGCTATCCTCTCAGAGTGACATTTTAACCACTCAGCAGAGGGATACCATGCAACATAACCTGATAAAGCTCCAGCAGGAAATGGCTGAACTAGAAGCTGTGTTAGAACAGCATGGGAGCCAGCCTTCTAACAGCTACCCTTCCATCATAAGTGACTCTTCTGCCCTTGAGGACCTGCGAAATCCAGAACAAAGCACATCAGAAAAAGTATTAACTTCACAGAAAAGTAGTGAATACCCTATAAGCCAGAATCCAGAAGGCCTTTCTGCTGACAAGTTTGAGGTGTCTGCAGATAGTTCTACCAGTAAAAATAAAGAACCAGGAGTGGAAAGGTCATCCCCTTCTAAATGCCCATCATTAGATGATAGGTGGTACATGCACAGTTGCTCTGGGAGTCTTCAGAATAGAAACTACCCATCTCAAGAGGAGCTCATTAAGGTTGTTGATGTGGAGGAGCAACAGCTGGAAGAGTCTGGGCCACACGATTTGACGGAAACATCTTACTTGCCAAGGCAAGATCTAGAGGGAACCCCTTACCTGGAATCTGGAATCAGCCTCTTCTCTGATGACCCTGAATCTGATCCTTCTGAAGACAGAGCCCCAGAGTCAGCTCGTGTTGGCAACATACCATCTTCAACCTCTGCATTGAAAGTTCCCCAATTGAAAGTTGCAGAATCTGCCCAGAGTCCAGCTGCTGCTCATACTACTGATACTGCTGGGTATAATGCAATGGAAGAAAGTGTGAGCAGGGAGAAGCCAGAATTGACAGCTTCAACAGAAAGGGTCAACAAAAGAATGTCCATGGTGGTGTCTGGCCTGACCCCAGAAGAATTTATGCTCGTGCACAAGTTTGCCAGAAAACACCACATCACTTTAACTAATCTAATTACTGAAGAGACTACTCATGTTGTTATGAAAACAGATGCTGAGTTTGTGTGTGAACGGACACTGAAATATTTTCTAGGAATTGCGGGAGGAAAATGGGTAGTTAGCTATTTCTGGGTGACCCAGTCTATTAAAGAAAGAAAAATGCTGAATGAGCATGATTTTGAAGTCAGAGGAGATGTGGTCAATGGAAGAAACCACCAAGGTCCAAAGCGAGCAAGAGAATCCCAGGACAGAAAGATCTTCAGGGGGCTAGAAATCTGTTGCTATGGGCCCTTCACCAACATGCCCACAGGGTGTCCACCCAATTGTGGTTGTGCAGCCAGATGCCTGGACAGAGGACAATGGCTTCCATGCAATTGGGCAGATGTG	70018.0	single nucleotide variant	NM_007294.4(BRCA1):c.4996T>C (p.Tyr1666His)	672.0	BRCA1	HGNC:1100	not provided	0.0	-	397509215.0	-	RCV000577034|RCV001072947	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1	germline;not applicable	germline	GRCh38	NC_000017.11	17	43067686.0	43067686.0	17q21.31	no classification provided	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003144	3.0	55351.0	43067686.0	A	G	-	-	-	-	-	-	SCV000679566|SCV001238417	-	-	4996T>C 	Tyr1666His	NM_007294.4		5_Others	chr17	T	C	17-43067686-T-C		55351	17	43067686	A	G	Y	H	rs397509215	17	41219703	17	38473229	1666	BRCA1	ENSG00000012048	ENST00000494123	ENSP00000419103	P38398	BRCA1_HUMAN	.	.	c.4996T>C	p.Tyr1666His	principal2	Y	1	.	.	-	TAC	1	0	A	A/C	A/A	A/A	A/A	.	0.20412	.	.	0.25056	.	0.0	0.02950	B	0.002	0.06938	B	.	0.97926	.	.	.	.	-1.32	0.00693	N	.	0.11118	.	.	0.76663	-0.9205	0.45292	T	0.2066	0.56350	T	10	.	0.22735	.	0.1115	0.78865	D	.	0.69364	.	.	.	.	.	.	0.58533	.	0.34422	.	0.11644	0.342471420765	0.16791	T	0.100186	0.40283	T	0.154414	0.69459	D	-0.0159712	0.69070	D	0.131434166552965	0.15319	T	.	0.52040	.	0.1621493	0.35975	0.09023593	0.21118	0.16839896	0.36995	0.07757455	0.17278	-1.322	0.04147	T	.	0.14538	.	0.000593738237608634	0.07418	0.99559280	0.97823	0.02	0.02966	.	.	.	.	.	.	1.651542	0.21102	15.04	0.87432290807886215	0.17471	0.082972	0.16607	N	-0.699590856538156	0.15836	0.8133621	-0.532633688972598	0.20959	1.149792	5.24	4.27	0.49950	1.35	0.32557	3.369	0.52185	5.083000	0.47360	-0.322	0.05858	1.0	0.71675	1.000000	0.68239	0.228	0.22726	546	0.72541	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	Familial_cancer_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	no_classification_provided	NC_000017.11:g.43067686A>G	ClinGen:CA003144	C0346153|C2676676	114480|604370	227535|145	BRCT domain|BRCT domain|BRCT domain	Tyr	His	70018	single nucleotide variant	NM_007294.4(BRCA1):c.4996T>C (p.Tyr1666His)	672	BRCA1	HGNC:1100	not provided	0	-	397509215	-	RCV000577034|RCV001072947	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1	germline;not applicable	germline	GRCh38	NC_000017.11	17	43067686	43067686	17q21.31	no classification provided	2	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003144	3	55351	43067686	A	G	-	-	-	-	-	-	SCV000679566|SCV001238417	-	-	4996T>C 	Tyr1666His	NM_007294.4		5_Others	BRCA1	ENSG00000012048	14613	218423	CCSBVarC003302	ALE00003302	1684T>C	Tyr562His	CEGS2	CegsMutGDEh1011	E12	GDEhDisVCh_40059	H03	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	BRCA1_Tyr562His	17	17	43067686	A	G
4006	G6PD	1192G>A	Glu398Lys	ENSG00000160211	X	154532662	NC_000023.11:154532662:C:T	ALE00004025	CCSBVarC004025	NULL	214971	NULL	GDEhDisVCh_40035	E04	CEGS2	ATGGCAGAGCAGGTGGCCCTGAGCCGGACCCAGGTGTGCGGGATCCTGCGGGAAGAGCTTTTCCAGGGCGATGCCTTCCATCAGTCGGATACACACATATTCATCATCATGGGTGCATCGGGTGACCTGGCCAAGAAGAAGATCTACCCCACCATCTGGTGGCTGTTCCGGGATGGCCTTCTGCCCGAAAACACCTTCATCGTGGGCTATGCCCGTTCCCGCCTCACAGTGGCTGACATCCGCAAACAGAGTGAGCCCTTCTTCAAGGCCACCCCAGAGGAGAAGCTCAAGCTGGAGGACTTCTTTGCCCGCAACTCCTATGTGGCTGGCCAGTACGATGATGCAGCCTCCTACCAGCGCCTCAACAGCCACATGAATGCCCTCCACCTGGGGTCACAGGCCAACCGCCTCTTCTACCTGGCCTTGCCCCCGACCGTCTACGAGGCCGTCACCAAGAACATTCACGAGTCCTGCATGAGCCAGATAGGCTGGAACCGCATCATCGTGGAGAAGCCCTTCGGGAGGGACCTGCAGAGCTCTGACCGGCTGTCCAACCACATCTCCTCCCTGTTCCGTGAGGACCAGATCTACCGCATCGACCACTACCTGGGCAAGGAGATGGTGCAGAACCTCATGGTGCTGAGATTTGCCAACAGGATCTTCGGCCCCATCTGGAACCGGGACAACATCGCCTGCGTTATCCTCACCTTCAAGGAGCCCTTTGGCACTGAGGGTCGCGGGGGCTATTTCGATGAATTTGGGATCATCCGGGACGTGATGCAGAACCACCTACTGCAGATGCTGTGTCTGGTGGCCATGGAGAAGCCCGCCTCCACCAACTCAGATGACGTCCGTGATGAGAAGGTCAAGGTGTTGAAATGCATCTCAGAGGTGCAGGCCAACAATGTGGTCCTGGGCCAGTACGTGGGGAACCCCGATGGAGAGGGCGAGGCCACCAAAGGGTACCTGGACGACCCCACGGTGCCCCGCGGGTCCACCACCGCCACTTTTGCAGCCGTCGTCCTCTATGTGGAGAATGAGAGGTGGGATGGGGTGCCCTTCATCCTGCGCTGCGGCAAGGCCCTGAACGAGCGCAAGGCCGAGGTGAGGCTGCAGTTCCATGATGTGGCCGGCGACATCTTCCACCAGCAGTGCAAGCGCAACGAGCTGGTGATCCGCGTGCAGCCCAACAAGGCCGTGTACACCAAGATGATGACCAAGAAGCCGGGCATGTTCTTCAACCCCGAGGAGTCGGAGCTGGACCTGACCTACGGCAACAGATACAAGAACGTGAAGCTCCCTGACGCCTATGAGCGCCTCATCCTGGACGTCTTCTGCGGGAGCCAGATGCACTTCGTGCGCAGCGACGAGCTCCGTGAGGCCTGGCGTATTTTCACCCCACTGCTGCACCAGATTGAGCTGGAGAAGCCCAAGCCCATCCCCTATATTTATGGCAGCCGAGGCCCCACGGAGGCAGACGAGCTGATGAAGAGAGTGGGTTTCCAGTATGAGGGCACCTACAAGTGGGTGAACCCCCACAAGCTC	792173.0	single nucleotide variant	NM_001360016.2(G6PD):c.1192G>A (p.Glu398Lys)	2539.0	G6PD	HGNC:4057	Pathogenic	1.0	May 20, 2023	137852325.0	-	RCV000991012	MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026	Anemia, nonspherocytic hemolytic, due to G6PD deficiency	germline;maternal;unknown	germline	GRCh38	NC_000023.11	X	154532662.0	154532662.0	Xq28	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA337316269	2.0	804134.0	154532662.0	C	T	-	-	-	-	-	-	SCV001142103|SCV002599372|SCV005373641	-	-	1192G>A 	Glu398Lys	NM_001360016.2	2.0	1_Pathogenic	chrX	G	A	X-154532662-G-A		804134	X	154532662	C	T	E	K	rs137852325	X	153760877	X	153414071	398	G6PD	ENSG00000160211	ENST00000696430	ENSP00000512625	P11413	G6PD_HUMAN	.	.	c.1192G>A	p.Glu398Lys	principal4	Y	.	.	.	-	GAG	1	0	C	C/C	C/C	C/C	C/C	.	0.78662	.	.	0.83643	.	1.0	0.90580	D	1.0	0.97365	D	.	0.94956	.	.	.	.	4.61	0.99266	H	.	0.69872	.	.	0.73617	0.9214	0.95965	D	0.9960	0.99908	D	10	.	0.98957	.	0.848963	0.98832	D	.	0.97849	0.949	0.99385	P11413	E398K	Gain of MoRF binding (P = 0.0029)| Gain of methylation at E398 (P = 0.0073)| Loss of stability (P = 0.1334)| Gain of phosphorylation at T402 (P = 0.1773)| Loss of loop (P = 0.2237)	.	0.99692	.	.	.	0.95480	0.819497585297	0.84925	D	0.972763	0.99714	D	0.667932	0.99900	D	0.721661	0.99899	D	0.999545991420746	0.97827	D	0.99725	0.98926	D	0.95874125	0.97108	0.9285496	0.96951	0.9683203	0.98071	0.90745586	0.95445	-11.128	0.80418	D	.	0.90566	.	0.999990459212003	0.99831	0.99881110	0.98976	0.989	0.99628	.	.	.	.	.	.	4.526718	0.71085	25.6	0.99914936147112188	0.98310	.	.	.	.	.	.	.	.	.	5.82	4.96	0.65108	3.01	0.55043	5.668	0.67818	5.880000	0.50706	0.585	0.3052	1.0	0.71675	1.000000	0.68239	0.977	0.56847	80	0.96675	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Anemia,_nonspherocytic_hemolytic,_due_to_G6PD_deficiency	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.154532662C>T	.	C2720289	300908	466026	Glucose-6-phosphate dehydrogenase, C-terminal	Glu	Lys	792173	single nucleotide variant	NM_001360016.2(G6PD):c.1192G>A (p.Glu398Lys)	2539	G6PD	HGNC:4057	Pathogenic	1	May 20, 2023	137852325	-	RCV000991012	MONDO:MONDO:0010480,MedGen:C2720289,OMIM:300908,Orphanet:466026	Anemia, nonspherocytic hemolytic, due to G6PD deficiency	germline;maternal;unknown	germline	GRCh38	NC_000023.11	X	154532662	154532662	Xq28	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA337316269	2	804134	154532662	C	T	-	-	-	-	-	-	SCV001142103|SCV002599372|SCV005373641	-	-	1192G>A 	Glu398Lys	NM_001360016.2	2	1_Pathogenic	G6PD	ENSG00000160211	4006	214971	CCSBVarC004025	ALE00004025	1192G>A	Glu398Lys	CEGS2	CegsMutGDEh1002	A11	GDEhDisVCh_40035	E04	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	7	0	NULL	0	NULL	0	NULL	0	NULL	G6PD_Glu398Lys	23	X	154532662	C	T
359	CBS	1135C>T	Arg379Trp	ENSG00000160200	21	43060451	NC_000021.9:43060451:G:A	ALE00007303	CCSBVarC007307	NULL	NULL	251	GDEhDisVCh_40013	H04	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGTGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210409.0	single nucleotide variant	NM_000071.3(CBS):c.1135C>T (p.Arg379Trp)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Aug 02, 2024	769080151.0	-	RCV000196320|RCV000763061|RCV001853130|RCV003987440	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria	germline;unknown	germline	GRCh38	NC_000021.9	21	43060451.0	43060451.0	21q22.3	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA320740,UniProtKB:P35520#VAR_046936	2.0	212881.0	43060451.0	G	A	-	-	-	-	-	-	SCV000249731|SCV000893552|SCV001251931|SCV002025088|SCV002159200|SCV004213852|SCV004803657	-	-	1135C>T 	Arg379Trp	NM_000071.3	2.0	1_Pathogenic	chr21	C	T	21-43060451-C-T		212881	21	43060451	G	A	R	W	rs769080151	21	44480561	21	43353630	379	CBS	ENSG00000160200	ENST00000352178	ENSP00000344460	P35520	CBS_HUMAN	c.1135C>T	p.Arg379Trp	c.1135C>T	p.Arg379Trp	principal1	Y	1	.	.	-	CGG	1	2	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.991	0.79680	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.455	0.92175	M	-7.6	0.95353	D	0.945	0.95269	1.1001	0.99665	D	0.9797	0.99373	D	10	0.99076027	0.99583	D	0.772011	0.98194	D	0.885	0.96643	.	.	.	.	.	0.922823597267	0.92145	.	0.89872	.	0.78839	0.752827048302	0.74819	T	0.944429	0.99141	D	0.364889	0.87533	D	0.468508	0.93926	D	0.996967613697052	0.90385	D	0.9951	0.98353	D	0.939988	0.95172	0.7583045	0.85542	0.9072681	0.91927	0.74317837	0.84636	-16.098	0.97908	D	0.6899	0.74530	P	0.998887887511103	0.95246	0.99959427	0.99514	0.982	0.99374	.	.	.	.	.	.	4.033942	0.59743	24.1	0.99862785830335576	0.94097	0.834498	0.75163	D	0.385722946665301	0.60445	4.256017	0.200382346751671	0.49610	3.185045	4.9	1.56	0.22364	1.22	0.31247	0.935	0.28618	2.728000	0.34448	0.526	0.24477	1.0	0.71675	0.999000	0.35501	0.677	0.33494	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	108600	0.000000e+00	0	2	206250	9.696970e-06	0	1	235888	4.239300e-06	0	0	7160	0.000000e+00	0	0	17104	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	12626	0.000000e+00	0	0	42756	0.000000e+00	0	0	15688	0.000000e+00	0	.	.	.	.	1	16116	6.205010e-05	0	0	30488	0.000000e+00	0	0	6178	0.000000e+00	0	0	13340	0.000000e+00	0	0	15962	0.000000e+00	0	1	88732	1.126990e-05	0	0	30604	0.000000e+00	0	1	16116	6.205010e-05	0	0	14880	0.000000e+00	0	0	34250	0.000000e+00	0	0	9564	0.000000e+00	0	0	17692	0.000000e+00	0	0	20860	0.000000e+00	0	1	102516	9.754570e-06	0	0	30522	0.000000e+00	0	1	102516	9.754570e-06	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	9956	1.004419445560466E-4	0	184	0	0	0	0	1	4638	2.1561017680034498E-4	0	0	0	0	0	0	0	0	0	0	0	0	0	1424	0	1	4822	2.0738282870178348E-4	0	0	0	2	16202	1.2344155042587335E-4	Pathogenic/Likely_pathogenic	not_provided|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Homocystinuria|Classic_homocystinuria	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43060451G>A	ClinGen:CA320740|UniProtKB:P35520#VAR_046936	C3661900|C3150344|C0019880|C0751202	236200	394	.	Arg	Trp	210409	single nucleotide variant	NM_000071.3(CBS):c.1135C>T (p.Arg379Trp)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Aug 02, 2024	769080151	-	RCV000196320|RCV000763061|RCV001853130|RCV003987440	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria	germline;unknown	germline	GRCh38	NC_000021.9	21	43060451	43060451	21q22.3	criteria provided, multiple submitters, no conflicts	7	-	N	ClinGen:CA320740,UniProtKB:P35520#VAR_046936	2	212881	43060451	G	A	-	-	-	-	-	-	SCV000249731|SCV000893552|SCV001251931|SCV002025088|SCV002159200|SCV004213852|SCV004803657	-	-	1135C>T 	Arg379Trp	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	251	CCSBVarC007307	ALE00007303	1135C>T	Arg379Trp	Edgotyping3	VUSMutGDEh010	C11	GDEhDisVCh_40013	H04	1	VUSMutGDDh010	C11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	5	0	NULL	0	NULL	0	NULL	CBS_Arg379Trp	21	21	43060451	G	A
3774	TP53	799C>T	Arg267Trp	ENSG00000141510	17	7673821	NC_000017.11:7673821:G:A	ALE00004870	CCSBVarC004870	NULL	214904	NULL	GDEhDisVCh_40053	G06	CEGS2	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGATGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACCGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	151478.0	single nucleotide variant	NM_000546.6(TP53):c.799C>T (p.Arg267Trp)	7157.0	TP53	HGNC:11998	Pathogenic/Likely pathogenic	1.0	Jan 10, 2025	55832599.0	-	RCV000130398|RCV000413074|RCV000538977|RCV000763416|RCV002247507|RCV003460927|RCV001255676|RCV002288637|RCV003149899|RCV004797597	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|11 conditions|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501|MONDO:MONDO:0023644,MedGen:C0220641|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MedGen:CN221562|	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome|11 conditions|Familial cancer of breast|Adrenocortical carcinoma, hereditary|Lip and oral cavity carcinoma|Li-Fraumeni syndrome 1|Breast and/or ovarian cancer|TP53-related disorder	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7673821.0	7673821.0	17p13.1	criteria provided, multiple submitters, no conflicts	20.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000423,UniProtKB:P04637#VAR_036507	2.0	141764.0	7673821.0	G	A	-	-	-	-	-	-	SCV000185257|SCV000491277|SCV000629873|SCV000686775|SCV000894153|SCV001429670|SCV002020264|SCV002519887|SCV002582354|SCV002583015|SCV002598661|SCV003838589|SCV004206250|SCV004221374|SCV004809628|SCV004823766|SCV004931961|SCV005433559|SCV005685076	-	-	799C>T 	Arg267Trp	NM_000546.6	2.0	1_Pathogenic	chr17	C	T	17-7673821-C-T		141764	17	7673821	G	A	R	W	rs55832599	17	7577139	17	7517864	267	TP53	ENSG00000141510	ENST00000445888	ENSP00000391478	P04637	P53_HUMAN	c.799C>T	p.Arg267Trp	c.799C>T	p.Arg267Trp	principal1	Y	1	.	.	-	CGG	1	2	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	0.979	0.90580	D	0.868	0.92348	P	1.0	0.99291	A	simple_aae	0.0	100.0	3.22	0.89268	M	-7.66	0.95529	D	0.988	0.99676	0.9436	0.96288	D	0.9935	0.99849	D	10	0.98784745	0.99164	D	0.677295	0.97315	D	0.917	0.97849	0.911	0.98220	P04637	R267W	Loss of disorder (P = 0.0012)| Loss of phosphorylation at S269 (P = 0.0722)| Gain of sheet (P = 0.1208)| Gain of catalytic residue at L265 (P = 0.1267)| Loss of loop (P = 0.2237)	0.992675829684	0.99250	.	0.86439	.	0.29944	0.674147903919	0.63370	T	0.996567	0.99995	D	0.543131	0.95471	D	0.542393	0.95404	D	0.999541878700256	0.97827	D	.	0.66597	.	0.96828765	0.98067	0.9164042	0.96089	0.9458082	0.95775	0.899782	0.94891	-11.237	0.81002	D	0.9682	0.89127	P	0.983437015685119	0.86201	0.99997652	0.99989	0.995	0.99826	.	.	.	.	.	.	5.385256	0.90253	31.0	0.99894234868618392	0.96745	0.847784	0.76376	D	0.525970682651307	0.68466	5.243778	0.437096400275841	0.63696	4.632341	5.13	4.15	0.47919	5.51	0.94414	2.307	0.43444	5.943000	0.51586	0.672	0.70176	0.996	0.3946	1.000000	0.68239	0.984	0.60417	432	0.80699	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1613230	1.859620e-06	0	2	1179654	1.695410e-06	0	0	74988	0.000000e+00	0	0	912	0.000000e+00	0	0	59796	0.000000e+00	0	0	29578	0.000000e+00	0	0	44846	0.000000e+00	0	0	63974	0.000000e+00	0	0	6060	0.000000e+00	0	2	1179654	1.695410e-06	0	0	90954	0.000000e+00	0	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Pathogenic/Likely_pathogenic	Familial_cancer_of_breast|not_provided|Adrenocortical_carcinoma,_hereditary|Li-Fraumeni_syndrome_1|Lip_and_oral_cavity_carcinoma|Breast_and/or_ovarian_cancer|Bone_osteosarcoma|Glioma_susceptibility_1|Nasopharyngeal_carcinoma|Carcinoma_of_pancreas|Choroid_plexus_papilloma|Carcinoma_of_colon|Basal_cell_carcinoma,_susceptibility_to,_7|Hepatocellular_carcinoma|Li-Fraumeni_syndrome|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.7673821G>A	ClinGen:CA000423|UniProtKB:P04637#VAR_036507	C0346153|C3661900|C1859972|C1835398|C0220641|CN221562|C0585442|C2750850|C2931822|C0235974|C0205770|C0699790|C3553606|C2239176|C0085390|C0027672	114480|202300|151623|259500|137800|607107|260500|614740|114550|PS151623	227535|1501|524|668|150|1333|217074|251899|2807|88673|524|140162	p53, DNA-binding domain|p53, DNA-binding domain	Arg	Trp	151478	single nucleotide variant	NM_000546.6(TP53):c.799C>T (p.Arg267Trp)	7157	TP53	HGNC:11998	Pathogenic/Likely pathogenic	1	Jan 10, 2025	55832599	-	RCV000130398|RCV000413074|RCV000538977|RCV000763416|RCV002247507|RCV003460927|RCV001255676|RCV002288637|RCV003149899|RCV004797597	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|11 conditions|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501|MONDO:MONDO:0023644,MedGen:C0220641|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MedGen:CN221562|	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome|11 conditions|Familial cancer of breast|Adrenocortical carcinoma, hereditary|Lip and oral cavity carcinoma|Li-Fraumeni syndrome 1|Breast and/or ovarian cancer|TP53-related disorder	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7673821	7673821	17p13.1	criteria provided, multiple submitters, no conflicts	20	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000423,UniProtKB:P04637#VAR_036507	2	141764	7673821	G	A	-	-	-	-	-	-	SCV000185257|SCV000491277|SCV000629873|SCV000686775|SCV000894153|SCV001429670|SCV002020264|SCV002519887|SCV002582354|SCV002583015|SCV002598661|SCV003838589|SCV004206250|SCV004221374|SCV004809628|SCV004823766|SCV004931961|SCV005433559|SCV005685076	-	-	799C>T 	Arg267Trp	NM_000546.6	2	1_Pathogenic	TP53	ENSG00000141510	3774	214904	CCSBVarC004870	ALE00004870	799C>T	Arg267Trp	CEGS2	CegsMutGDEh1020	E06	GDEhDisVCh_40053	G06	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	TP53_Arg267Trp	17	17	7673821	G	A
3689	GCK	1160C>A	Ala387Glu	ENSG00000106633	7	44145590	NC_000007.14:44145590:G:T	ALE00006697	CCSBVarC006699	NULL	214861	NULL	GDEhDisVCh_40037	F01	CEGS2	ATGCTGGACGACAGAGCCAGGATGGAGGCCGCCAAGAAGGAGAAGGTAGAGCAGATCCTGGCAGAGTTCCAGCTGCAGGAGGAGGACCTGAAGAAGGTGATGAGACGGATGCAGAAGGAGATGGACCGCGGCCTGAGGCTGGAGACCCATGAAGAGGCCAGTGTGAAGATGCTGCCCACCTACGTGCGCTCCACCCCAGAAGGCTCAGAAGTCGGGGACTTCCTCTCCCTGGACCTGGGTGGCACTAACTTCAGGGTGATGCTGGTGAAGGTGGGAGAAGGTGAGGAGGGGCAGTGGAGCGTGAAGACCAAACACCAGATGTACTCCATCCCCGAGGACGCCATGACCGGCACTGCTGAGATGCTCTTCGACTACATCTCTGAGTGCATCTCCGACTTCCTGGACAAGCATCAGATGAAACACAAGAAGCTGCCCCTGGGCTTCACCTTCTCCTTTCCTGTGAGGCACGAAGACATCGATAAGGGCATCCTTCTCAACTGGACCAAGGGCTTCAAGGCCTCAGGAGCAGAAGGGAACAATGTCGTGGGGCTTCTGCGAGACGCTATCAAACGGAGAGGGGACTTTGAAATGGATGTGGTGGCAATGGTGAATGACACGGTGGCCACGATGATCTCCTGCTACTACGAAGACCATCAGTGCGAGGTCGGCATGATCGTGGGCACGGGCTGCAATGCCTGCTACATGGAGGAGATGCAGAATGTGGAGCTGGTGGAGGGGGACGAGGGCCGCATGTGCGTCAATACCGAGTGGGGCGCCTTCGGGGACTCCGGCGAGCTGGACGAGTTCCTGCTGGAGTATGACCGCCTGGTGGACGAGAGCTCTGCAAACCCCGGTCAGCAGCTGTATGAGAAGCTCATAGGTGGCAAGTACATGGGCGAGCTGGTGCGGCTTGTGCTGCTCAGGCTCGTGGACGAAAACCTGCTCTTCCACGGGGAGGCCTCCGAGCAGCTGCGCACACGCGGAGCCTTCGAGACGCGCTTCGTGTCGCAGGTGGAGAGCGACACGGGCGACCGCAAGCAGATCTACAACATCCTGAGCACGCTGGGGCTGCGACCCTCGACCACCGACTGCGACATCGTGCGCCGCGCCTGCGAGAGCGTGTCTACGCGCGCTGCGCACATGTGCTCGGCGGGGCTGGAGGGCGTCATCAACCGCATGCGCGAGAGCCGCAGCGAGGACGTAATGCGCATCACTGTGGGCGTGGATGGCTCCGTGTACAAGCTGCACCCCAGCTTCAAGGAGCGGTTCCATGCCAGCGTGCGCAGGCTGACGCCCAGCTGCGAGATCACCTTCATCGAGTCGGAGGAGGGCAGTGGCCGGGGCGCGGCCCTGGTCTCGGCGGTGGCCTGTAAGAAGGCCTGTATGCTGGGCCAG	44845.0	single nucleotide variant	NM_000162.5(GCK):c.1160C>A (p.Ala387Glu)	2645.0	GCK	HGNC:4195	Likely pathogenic	1.0	Feb 28, 2024	193921338.0	-	RCV000029844|RCV003883122	MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625	Maturity-onset diabetes of the young type 2|Monogenic diabetes	germline	germline	GRCh38	NC_000007.14	7	44145590.0	44145590.0	7p13	reviewed by expert panel	2.0	-	N	ClinGen:CA213725	2.0	36181.0	44145590.0	G	T	-	-	-	-	-	-	SCV004697906	-	-	1160C>A 	Ala387Glu	NM_000162.5	3.0	1_Pathogenic	chr7	C	A	7-44145590-C-A		36181	7	44145590	G	T	A	E	rs193921338	7	44185189	7	44151714	387	GCK	ENSG00000106633	ENST00000403799	ENSP00000384247	P35557	HXK4_HUMAN	c.1160C>A	p.Ala387Glu	c.1160C>A	p.Ala387Glu	principal1	Y	1	YES	Select	-	GCG	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.002	0.79703	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.375	0.91274	M	-4.12	0.76771	D	0.844	0.83943	1.0862	0.99092	D	0.9717	0.99109	D	10	0.99201083	0.99734	D	0.870064	0.99003	D	0.958	0.99315	0.935	0.99041	P35557	A387E	Gain of disorder (P = 0.0374)| Loss of MoRF binding (P = 0.059)| Loss of catalytic residue at A387 (P = 0.1806)| Gain of helix (P = 0.2294)| Loss of methylation at R392 (P = 0.4738)	0.987331409019	0.98705	.	0.99984	.	0.96565	0.811778783798	0.83736	D	0.947901	0.99219	D	0.560597	0.96212	D	0.567482	0.96152	D	0.997854888439178	0.92528	D	0.964304	0.88661	D	0.98488784	0.99450	0.9533024	0.98573	0.9799398	0.99090	0.97126704	0.99511	-13.645	0.91965	D	0.9824	0.93458	P	0.999603109944392	0.97154	0.99983466	0.99778	0.978	0.99209	.	.	.	.	.	.	5.614955	0.9257	32.0	0.99531726386056985	0.69939	0.974355	0.99552	D	1.03310609236388	0.96655	14.9943	0.958102556661233	0.97626	16.48479	5.46	5.46	0.79994	3.81	0.70705	9.901	0.98627	11.604000	0.93507	0.672	0.70176	1.0	0.71675	1.000000	0.68239	0.969	0.5403	716	0.55914	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	99980	0.000000e+00	0	1	191874	5.211750e-06	0	1	218022	4.586690e-06	0	0	6062	0.000000e+00	0	0	16398	0.000000e+00	0	0	2158	0.000000e+00	0	0	8222	0.000000e+00	0	0	10776	0.000000e+00	0	0	39570	0.000000e+00	0	0	15040	0.000000e+00	0	.	.	.	.	0	14210	0.000000e+00	0	1	29300	3.412970e-05	0	0	5846	0.000000e+00	0	0	12418	0.000000e+00	0	0	13834	0.000000e+00	0	0	82322	0.000000e+00	0	0	29408	0.000000e+00	0	1	29300	3.412970e-05	0	0	13174	0.000000e+00	0	1	33064	3.024440e-05	0	0	9234	0.000000e+00	0	0	16688	0.000000e+00	0	0	17606	0.000000e+00	0	0	93648	0.000000e+00	0	0	29338	0.000000e+00	0	1	33064	3.024440e-05	0	.	1	1604628	6.231970e-07	0	1	59324	1.685660e-05	0	0	74932	0.000000e+00	0	0	912	0.000000e+00	0	1	59324	1.685660e-05	0	0	29448	0.000000e+00	0	0	44558	0.000000e+00	0	0	59780	0.000000e+00	0	0	6032	0.000000e+00	0	0	1177334	0.000000e+00	0	0	90186	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Monogenic_diabetes|Maturity-onset_diabetes_of_the_young_type_2	reviewed_by_expert_panel	NC_000007.14:g.44145590G>T	ClinGen:CA213725	C3888631|C0342277	125851	183625|552	Hexokinase, C-terminal	Ala	Glu	44845	single nucleotide variant	NM_000162.5(GCK):c.1160C>A (p.Ala387Glu)	2645	GCK	HGNC:4195	Likely pathogenic	1	Feb 28, 2024	193921338	-	RCV000029844|RCV003883122	MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625	Maturity-onset diabetes of the young type 2|Monogenic diabetes	germline	germline	GRCh38	NC_000007.14	7	44145590	44145590	7p13	reviewed by expert panel	2	-	N	ClinGen:CA213725	2	36181	44145590	G	T	-	-	-	-	-	-	SCV004697906	-	-	1160C>A 	Ala387Glu	NM_000162.5	3	1_Pathogenic	GCK	ENSG00000106633	3689	214861	CCSBVarC006699	ALE00006697	1160C>A	Ala387Glu	CEGS2	CegsMutGDEh1043	B11	GDEhDisVCh_40037	F01	1	CegsMutGDDh1043	B11	VUSN2Hmut_GDN2h_09	H03	VUSMutpDEST2_03	B10	VUSmut_GDEh09	H03	1	1	1	1	1	5	1	1	1	1	GCK_Ala387Glu	7	7	44145590	G	T
2803	HMBS	739T>C	Cys247Arg	ENSG00000256269	11	119092491	NC_000011.10:119092491:T:C	ALE00005173	CCSBVarC005173	NULL	200941	NULL	GDEhDisVCh_40054	A04	CEGS2	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAGCTTGCTCGCATACAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGGACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCTTGAACATGCCCTGGAGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCGAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTCGGGGAAACCTCAACACCCGGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACCGGGTGGGGCAGATCCTGCACCCTGAGGAATGCATGTATGCTGTGGGCCAGGGGGCCTTGGGCGTGGAAGTGCGAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCCGCATCGCTGAAAGGGCCTTCCTGAGGCACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATGGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCGTAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACGATGCCCAT	16508.0	single nucleotide variant	NM_000190.4(HMBS):c.739T>C (p.Cys247Arg)	3145.0	HMBS	HGNC:4982	Likely pathogenic	1.0	Apr 27, 2022	118204111.0	-	RCV000001534|RCV002298429	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900	Acute intermittent porphyria|not provided	germline	germline	GRCh38	NC_000011.10	11	119092491.0	119092491.0	11q23.3	criteria provided, single submitter	2.0	-	N	OMIM:609806.0029,ClinGen:CA251828,UniProtKB:P08397#VAR_003664	3.0	1469.0	119092491.0	T	C	-	-	-	-	-	-	SCV002588423	-	-	739T>C 	Cys247Arg	NM_000190.4	1.0	1_Pathogenic	chr11	T	C	11-119092491-T-C		1469	11	119092491	T	C	C	R	rs118204111	11	118963201	11	118468411	247	HMBS	ENSG00000256269	ENST00000652429	ENSP00000498786	P08397	HEM3_HUMAN	c.739T>C	p.Cys247Arg	c.739T>C	p.Cys247Arg	principal2	Y	.	YES	Select	+	TGC	1	0	T	T/T	T/T	T/T	T/T	.	0.78662	.	.	0.79703	.	0.998	0.73231	D	0.971	0.72446	D	.	0.99291	.	.	.	.	3.925	0.96220	H	.	0.98155	.	.	0.99676	1.0903	0.99249	D	0.9702	0.99058	D	9	.	0.99822	.	0.647307	0.97002	D	.	0.99874	0.963	0.99626	P08397	C247R	Gain of MoRF binding (P = 0.0818)| Loss of stability (P = 0.1649)| Gain of phosphorylation at T243 (P = 0.1874)| Gain of loop (P = 0.2045)| Gain of disorder (P = 0.2752)	.	0.97282	0.9822774360526177	0.98211	.	.	0.795790910721	0.81289	T	0.987516	0.99931	D	0.5811	0.96983	D	0.596934	0.96933	D	0.999698281288147	0.98518	D	0.981319	0.93978	D	0.9981772	0.99999	0.99488765	0.99998	0.9974032	0.99996	0.9917317	0.99988	-10.862	0.79915	D	0.9946	0.95323	P	0.99971834985505	0.97610	0.41990957	0.80070	0.992	0.99727	.	.	.	.	.	.	5.30356	0.89052	29.8	0.99728061688826253	0.82565	0.980876	0.99856	D	0.910860435130785	0.92239	11.33446	0.838709940678899	0.92296	11.37002	5.24	5.24	0.72825	.	.	7.802	0.84573	7.871000	0.72005	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.997	0.79771	228	0.91137	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Likely_pathogenic	Acute_intermittent_porphyria|not_provided	criteria_provided,_single_submitter	NC_000011.10:g.119092491T>C	ClinGen:CA251828|OMIM:609806.0029|UniProtKB:P08397#VAR_003664	C0162565|C3661900	176000	79276	Porphobilinogen deaminase, C-terminal	Cys	Arg	16508	single nucleotide variant	NM_000190.4(HMBS):c.739T>C (p.Cys247Arg)	3145	HMBS	HGNC:4982	Likely pathogenic	1	Apr 27, 2022	118204111	-	RCV000001534|RCV002298429	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900	Acute intermittent porphyria|not provided	germline	germline	GRCh38	NC_000011.10	11	119092491	119092491	11q23.3	criteria provided, single submitter	2	-	N	OMIM:609806.0029,ClinGen:CA251828,UniProtKB:P08397#VAR_003664	3	1469	119092491	T	C	-	-	-	-	-	-	SCV002588423	-	-	739T>C 	Cys247Arg	NM_000190.4	1	1_Pathogenic	HMBS	ENSG00000256269	2803	200941	CCSBVarC005173	ALE00005173	739T>C	Cys247Arg	CEGS2	CegsMutGDEh1038	E07	GDEhDisVCh_40054	A04	2	CegsMutGDDh1038	E07	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	HMBS_Cys247Arg	11	11	119092491	T	C
52861	F9	1120G>T	Val374Phe	ENSG00000101981	X	139561805	NC_000023.11:139561805:G:T	ALE00004387	CCSBVarC004387	NULL	204381	NULL	GDEhDisVCh_40052	D06	CEGS2	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGATTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT	25678.0	single nucleotide variant	NM_000133.4(F9):c.1120G>T (p.Val374Phe)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Dec 18, 2018	137852271.0	-	RCV000011385|RCV001001418	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	Hereditary factor IX deficiency disease|not specified	germline	germline	GRCh38	NC_000023.11	X	139561805.0	139561805.0	Xq27.1	criteria provided, single submitter	2.0	-	N	ClinGen:CA255427,OMIM:300746.0083	3.0	10639.0	139561805.0	G	T	-	-	-	-	-	-	SCV001158653	-	-	1120G>T 	Val374Phe	NM_000133.4	1.0	1_Pathogenic	chrX	G	T	X-139561805-G-T		10639	X	139561805	G	T	V	F	rs137852271	X	138643964	X	138471630	374	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1120G>T	p.Val374Phe	c.1120G>T	p.Val374Phe	principal1	Y	1	YES	Select	+	GTT	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.002	0.79703	D	0.999	0.77914	D	0.979	0.74458	D	0.95	0.94956	A	simple_aae	5.0	95.0	3.12	0.87775	M	-4.54	0.78505	D	0.782	0.93850	0.8819	0.95415	D	0.8565	0.95211	D	10	0.99082434	0.99592	D	0.857905	0.98905	D	0.850	0.95347	0.953	0.99464	P00740	V374F	Loss of stability (P = 0.0938)| Loss of sheet (P = 0.1158)| Gain of MoRF binding (P = 0.1778)| Loss of catalytic residue at V374 (P = 0.1982)| Loss of phosphorylation at Y371 (P = 0.427)	0.999932037799	0.99993	0.9979477165049676	0.99793	1.87575306562	0.92526	0.448793083429	0.31739	T	0.917974	0.98491	D	0.54769	0.95627	D	0.548942	0.95562	D	0.996272087097168	0.88921	D	0.940906	0.77818	D	0.945814	0.95774	0.8643849	0.92378	0.9583567	0.97069	0.8545136	0.91699	-9.205	0.69263	D	0.5066	0.73177	A	0.999660067107543	0.97392	0.99998975	0.99996	0.986	0.99524	.	.	.	.	.	.	3.888037	0.56637	23.7	0.99288949315307296	0.58247	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	.	.	3.673	0.54417	9.997000	0.83047	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.868	0.4131	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Pathogenic	not_specified|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139561805G>T	ClinGen:CA255427|OMIM:300746.0083	CN169374|C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Val	Phe	25678	single nucleotide variant	NM_000133.4(F9):c.1120G>T (p.Val374Phe)	2158	F9	HGNC:3551	Pathogenic	1	Dec 18, 2018	137852271	-	RCV000011385|RCV001001418	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:CN169374	Hereditary factor IX deficiency disease|not specified	germline	germline	GRCh38	NC_000023.11	X	139561805	139561805	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255427,OMIM:300746.0083	3	10639	139561805	G	T	-	-	-	-	-	-	SCV001158653	-	-	1120G>T 	Val374Phe	NM_000133.4	1	1_Pathogenic	F9	ENSG00000101981	52861	204381	CCSBVarC004387	ALE00004387	1120G>T	Val374Phe	CEGS2	CegsMutGDEh1026	E04	GDEhDisVCh_40052	D06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	F9_Val374Phe	23	X	139561805	G	T
71569	OTC	613A>G	Met205Val	ENSG00000036473	X	38403690	NC_000023.11:38403690:A:G	ALE00005254	CCSBVarC005254	NULL	205894	NULL	GDEhDisVCh_40048	C06	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCGTGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103162.0	single nucleotide variant	NM_000531.6(OTC):c.613A>G (p.Met205Val)	5009.0	OTC	HGNC:8512	Likely pathogenic	1.0	Sep 25, 2017	72558411.0	-	RCV000083512|RCV000634843	MedGen:C3661900|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664	not provided|Ornithine carbamoyltransferase deficiency	germline;unknown	germline	GRCh38	NC_000023.11	X	38403690.0	38403690.0	Xp11.4	criteria provided, single submitter	2.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224709	2.0	97270.0	38403690.0	A	G	-	-	-	-	-	-	SCV000756191	-	-	613A>G 	Met205Val	NM_000531.6	1.0	1_Pathogenic	chrX	A	G	X-38403690-A-G		97270	X	38403690	A	G	M	V	rs72558411	X	38262943	X	38147887	205	OTC	ENSG00000036473	ENST00000039007	ENSP00000039007	P00480	OTC_HUMAN	c.613A>G	p.Met205Val	c.613A>G	p.Met205Val	principal1	Y	1	YES	Select	+	ATG	1	0	A	A/A	A/A	A/A	A/A	0.515	0.07423	T	0.135	0.34455	T	0.904	0.49860	P	0.65	0.52459	P	0.96	0.95575	A	simple_aae	4.0	96.0	2.43	0.70264	M	-2.53	0.54888	D	0.878	0.87569	1.0661	0.98485	D	0.9425	0.98112	D	10	0.9852419	0.98752	D	0.466784	0.94600	D	0.877	0.96345	0.909	0.98139	P00480	M205V	Loss of ubiquitination at K210 (P = 0.1016)| Loss of stability (P = 0.1621)| Loss of MoRF binding (P = 0.2611)| Gain of catalytic residue at M205 (P = 0.2698)| Loss of disorder (P = 0.2864)	0.98834900338	0.98809	0.9377702238451355	0.93719	0.552654234204	0.51775	0.61953997612	0.55598	T	0.857891	0.96796	D	0.617637	0.98001	D	0.649417	0.97968	D	0.938784241676331	0.60735	D	0.935006	0.75543	D	0.9088481	0.92074	0.87043947	0.92800	0.9088481	0.92075	0.87043947	0.92801	-8.543	0.64789	D	0.3895	0.58940	A	0.997883670757906	0.93673	0.99734527	0.98348	0.824	0.90289	.	.	.	.	.	.	4.115728	0.6155	24.3	0.99406864015659269	0.63126	.	.	.	.	.	.	.	.	.	5.91	5.91	0.95233	.	.	7.06	0.76449	9.231000	0.79390	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.997	0.79771	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	not_provided|Ornithine_carbamoyltransferase_deficiency	criteria_provided,_single_submitter	NC_000023.11:g.38403690A>G	ClinGen:CA224709	C3661900|C0268542	311250	664	Aspartate/ornithine carbamoyltransferase, Asp/Orn-binding domain	Met	Val	103162	single nucleotide variant	NM_000531.6(OTC):c.613A>G (p.Met205Val)	5009	OTC	HGNC:8512	Likely pathogenic	1	Sep 25, 2017	72558411	-	RCV000083512|RCV000634843	MedGen:C3661900|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664	not provided|Ornithine carbamoyltransferase deficiency	germline;unknown	germline	GRCh38	NC_000023.11	X	38403690	38403690	Xp11.4	criteria provided, single submitter	2	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224709	2	97270	38403690	A	G	-	-	-	-	-	-	SCV000756191	-	-	613A>G 	Met205Val	NM_000531.6	1	1_Pathogenic	OTC	ENSG00000036473	71569	205894	CCSBVarC005254	ALE00005254	613A>G	Met205Val	CEGS2	CegsMutGDEh1026	H01	GDEhDisVCh_40048	C06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Met205Val	23	X	38403690	A	G
359	CBS	394C>A	Arg132Ser	ENSG00000160200	21	43066300	NC_000021.9:43066300:G:T	ALE00007334	CCSBVarC007345	NULL	NULL	302	GDEhDisVCh_40013	F09	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGAGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	259108.0	single nucleotide variant	NM_000071.3(CBS):c.394C>A (p.Arg132Ser)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Feb 24, 2024	140002610.0	-	RCV001859452|RCV002310885|RCV001833290	MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection|Classic homocystinuria	germline	germline	GRCh38	NC_000021.9	21	43066300.0	43066300.0	21q22.3	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA10587954	2.0	263891.0	43066300.0	G	T	-	-	-	-	-	-	SCV000319382|SCV002185007	-	-	394C>A 	Arg132Ser	NM_000071.3	2.0	4_VUS	chr21	C	A	21-43066300-C-A		263891	21	43066300	G	T	R	S	rs140002610	21	44486410	21	43359479	132	CBS	ENSG00000160200	ENST00000352178	ENSP00000344460	P35520	CBS_HUMAN	c.394C>A	p.Arg132Ser	c.394C>A	p.Arg132Ser	principal1	Y	1	.	.	-	CGC	1	0	G	G/G	G/G	G/G	G/G	0.036	0.55689	D	0.047	0.60067	D	0.777	0.44182	P	0.695	0.53979	P	.	.	.	.	.	.	2.155	0.60044	M	-3.11	0.64505	D	0.589	0.60716	1.0472	0.98054	D	0.8807	0.96031	D	10	0.58288413	0.65655	D	0.357071	0.92401	D	0.585	0.83277	0.498	0.58705	P35520	R132S	Loss of solvent accessibility (P = 0.0238)| Gain of phosphorylation at R132 (P = 0.0412)| Gain of helix (P = 0.0425)| Loss of loop (P = 0.0512)| Gain of ubiquitination at K137 (P = 0.0843)	0.751625969435	0.74740	.	0.77870	.	0.58771	0.425719350576	0.28588	T	0.954194	0.99354	D	-0.0346048	0.46409	T	-0.00804879	0.69592	D	0.495254397392273	0.32144	T	0.964704	0.93270	D	0.8484019	0.87047	0.43626308	0.66829	0.857654	0.87745	0.55154276	0.73815	-9.394	0.70277	D	0.2747	0.56217	B	0.850149246685246	0.73115	0.99910380	0.99146	0.868	0.92825	.	.	.	.	.	.	2.980848	0.3984	21.0	0.99422293521598226	0.63888	0.487523	0.52458	N	-0.0419753248690911	0.39693	2.365203	-0.120847522054401	0.34242	1.988708	5.26	3.21	0.35856	1.76	0.36958	0.676	0.25017	2.814000	0.35006	0.59	0.31918	0.508	0.27108	0.999000	0.35501	0.063	0.16222	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109008	9.173640e-06	0	3	207470	1.445990e-05	0	3	236478	1.268620e-05	0	1	7156	1.397430e-04	0	0	17104	0.000000e+00	0	0	2320	0.000000e+00	0	0	9038	0.000000e+00	0	0	13028	0.000000e+00	0	0	42758	0.000000e+00	0	0	15690	0.000000e+00	0	1	7156	1.397430e-04	0	3	16192	1.852770e-04	0	0	30514	0.000000e+00	0	0	6206	0.000000e+00	0	0	13392	0.000000e+00	0	0	16368	0.000000e+00	0	0	89328	0.000000e+00	0	0	30608	0.000000e+00	0	3	16192	1.852770e-04	0	3	14890	2.014780e-04	0	0	34244	0.000000e+00	0	0	9564	0.000000e+00	0	0	17684	0.000000e+00	0	0	21266	0.000000e+00	0	0	102684	0.000000e+00	0	0	30526	0.000000e+00	0	3	14890	2.014780e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	38834	0	0	122	0	0	112	0	0	3436	0	0	496	0	0	626	0	0	56	0	0	98	0	0	7280	0	0	3558	0	0	168	0	0	51060	0	Uncertain_significance	Classic_homocystinuria|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43066300G>T	ClinGen:CA10587954	C0751202|C4707243|C3150344	236200|PS607086	394|91387	Tryptophan synthase beta chain-like, PALP domain	Arg	Ser	259108	single nucleotide variant	NM_000071.3(CBS):c.394C>A (p.Arg132Ser)	875	CBS	HGNC:1550	Uncertain significance	0	Feb 24, 2024	140002610	-	RCV001859452|RCV002310885|RCV001833290	MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection|Classic homocystinuria	germline	germline	GRCh38	NC_000021.9	21	43066300	43066300	21q22.3	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA10587954	2	263891	43066300	G	T	-	-	-	-	-	-	SCV000319382|SCV002185007	-	-	394C>A 	Arg132Ser	NM_000071.3	2	4_VUS	CBS	ENSG00000160200	359	302	CCSBVarC007345	ALE00007334	394C>A	Arg132Ser	Edgotyping3	VUSMutGDEh011	D04	GDEhDisVCh_40013	F09	1	VUSMutGDDh011	D04	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	5	0	NULL	0	NULL	0	NULL	CBS_Arg132Ser	21	21	43066300	G	T
359	CBS	750G>A	Met250Ile	ENSG00000160200	21	43063978	NC_000021.9:43063978:C:T	ALE00007319	CCSBVarC007327	NULL	NULL	279	GDEhDisVCh_40013	D07	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATACTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210427.0	single nucleotide variant	NM_000071.3(CBS):c.750G>A (p.Met250Ile)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Mar 26, 2024	863223431.0	-	RCV000198250|RCV000800742|RCV002517998	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43063978.0	43063978.0	21q22.3	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA322755	2.0	212854.0	43063978.0	C	T	-	-	-	-	-	-	SCV000249692|SCV000940473	-	-	750G>A 	Met250Ile	NM_000071.3	2.0	4_VUS	chr21	G	A	21-43063978-G-A		212854	21	43063978	C	T	M	I	rs863223431	21	44484088	21	43357157	250	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.750G>A	p.Met250Ile	c.750G>A	p.Met250Ile	principal1	Y	1	.	.	-	ATG	3	0	C	C/C	C/C	C/C	C/C	0.044	0.41252	D	0.04	0.51160	D	0.649	0.40625	P	0.579	0.50149	P	0.74	0.84487	D	simple_aae	26.0	74.0	0.32	0.10268	N	-3.25	0.65311	D	0.933	0.94087	1.0748	0.98722	D	0.9284	0.97630	D	10	0.9334869	0.92600	D	0.58911	0.96338	D	0.839	0.94938	0.546	0.65897	P35520	M250I	Loss of sheet (P = 0.1501)| Gain of loop (P = 0.2045)| Loss of ubiquitination at K247 (P = 0.2243)| Gain of catalytic residue at L251 (P = 0.4714)| Loss of helix (P = 0.4763)	0.912293621321	0.91074	.	0.86681	.	0.73769	0.669504344463	0.62707	T	0.953098	0.99331	D	0.486758	0.93866	D	0.461418	0.93788	D	0.982619404792786	0.74418	D	.	0.73151	.	0.931006	0.94251	0.87306285	0.92985	0.9309188	0.94243	0.8517647	0.91511	-7.509	0.57746	D	.	0.68424	.	0.996146013481463	0.91889	0.99981755	0.99765	0.911	0.95385	.	.	.	.	.	.	4.136764	0.62018	24.4	0.99752349835253662	0.84396	0.903615	0.85238	D	0.337776625927284	0.57882	3.980142	0.419462887965262	0.62577	4.499105	4.95	4.95	0.64849	.	.	6.848	0.75268	7.471000	0.59217	0.469	0.21904	1.0	0.71675	1.000000	0.68239	0.925	0.46138	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	17046	5.8664789393406076E-5	0	268	0	0	84	0	0	6864	0	0	146	0	0	610	0	0	24	0	0	94	0	0	1900	0	0	7132	0	0	108	0	1	27036	3.698772007693446E-5	Uncertain_significance	HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|not_provided|Classic_homocystinuria	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43063978C>T	ClinGen:CA322755	C3150344|CN517202|C0751202	236200	394	Tryptophan synthase beta chain-like, PALP domain	Met	Ile	210427	single nucleotide variant	NM_000071.3(CBS):c.750G>A (p.Met250Ile)	875	CBS	HGNC:1550	Uncertain significance	0	Mar 26, 2024	863223431	-	RCV000198250|RCV000800742|RCV002517998	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43063978	43063978	21q22.3	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA322755	2	212854	43063978	C	T	-	-	-	-	-	-	SCV000249692|SCV000940473	-	-	750G>A 	Met250Ile	NM_000071.3	2	4_VUS	CBS	ENSG00000160200	359	279	CCSBVarC007327	ALE00007319	750G>A	Met250Ile	Edgotyping3	VUSMutGDEh011	B02	GDEhDisVCh_40013	D07	1	VUSMutGDDh011	B02	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	CBS_Met250Ile	21	21	43063978	C	T
7918	MSH2	2500G>A	Ala834Thr	ENSG00000095002	2	47480737	NC_000002.12:47480737:G:A	ALE00001281	CCSBVarC001281	14377	NULL	NULL	GDEhDisVCh_40060	F12	RC4	ATGGCGGTGCAGCCGAAGGAGACGCTGCAGTTGGAGAGCGCGGCCGAGGTCGGCTTCGTGCGCTTCTTTCAGGGCATGCCGGAGAAGCCGACCACCACAGTGCGCCTTTTCGACCGGGGCGACTTCTATACGGCGCACGGCGAGGACGCGCTGCTGGCCGCCCGGGAGGTGTTCAAGACCCAGGGGGTGATCAAGTACATGGGGCCGGCAGGAGCAAAGAATCTGCAGAGTGTTGTGCTTAGTAAAATGAATTTTGAATCTTTTGTAAAAGATCTTCTTCTGGTTCGTCAGTATAGAGTTGAAGTTTATAAGAATAGAGCTGGAAATAAGGCATCCAAGGAGAATGATTGGTATTTGGCATATAAGGCTTCTCCTGGCAATCTCTCTCAGTTTGAAGACATTCTCTTTGGTAACAATGATATGTCAGCTTCCATTGGTGTTGTGGGTGTTAAAATGTCCGCAGTTGATGGCCAGAGACAGGTTGGAGTTGGGTATGTGGATTCCATACAGAGGAAACTAGGACTGTGTGAATTCCCTGATAATGATCAGTTCTCCAATCTTGAGGCTCTCCTCATCCAGATTGGACCAAAGGAATGTGTTTTACCCGGAGGAGAGACTGCTGGAGACATGGGGAAACTGAGACAGATAATTCAAAGAGGAGGAATTCTGATCACAGAAAGAAAAAAAGCTGACTTTTCCACAAAAGACATTTATCAGGACCTCAACCGGTTGTTGAAAGGCAAAAAGGGAGAGCAGATGAATAGTGCTGTATTGCCAGAAATGGAGAATCAGGTTGCAGTTTCATCACTGTCTGCGGTAATCAAGTTTTTAGAACTCTTATCAGATGATTCCAACTTTGGACAGTTTGAACTGACTACTTTTGACTTCAGCCAGTATATGAAATTGGATATTGCAGCAGTCAGAGCCCTTAACCTTTTTCAGGGTTCTGTTGAAGATACCACTGGCTCTCAGTCTCTGGCTGCCTTGCTGAATAAGTGTAAAACCCCTCAAGGACAAAGACTTGTTAACCAGTGGATTAAGCAGCCTCTCATGGATAAGAACAGAATAGAGGAGAGATTGAATTTAGTGGAAGCTTTTGTAGAAGATGCAGAATTGAGGCAGACTTTACAAGAAGATTTACTTCGTCGATTCCCAGATCTTAACCGACTTGCCAAGAAGTTTCAAAGACAAGCAGCAAACTTACAAGATTGTTACCGACTCTATCAGGGTATAAATCAACTACCTAATGTTATACAGGCTCTGGAAAAACATGAAGGAAAACACCAGAAATTATTGTTGGCAGTTTTTGTGACTCCTCTTACTGATCTTCGTTCTGACTTCTCCAAGTTTCAGGAAATGATAGAAACAACTTTAGATATGGATCAGGTGGAAAACCATGAATTCCTTGTAAAACCTTCATTTGATCCTAATCTCAGTGAATTAAGAGAAATAATGAATGACTTGGAAAAGAAGATGCAGTCAACATTAATAAGTGCAGCCAGAGATCTTGGCTTGGACCCTGGCAAACAGATTAAACTGGATTCCAGTGCACAGTTTGGATATTACTTTCGTGTAACCTGTAAGGAAGAAAAAGTCCTTCGTAACAATAAAAACTTTAGTACTGTAGATATCCAGAAGAATGGTGTTAAATTTACCAACAGCAAATTGACTTCTTTAAATGAAGAGTATACCAAAAATAAAACAGAATATGAAGAAGCCCAGGATGCCATTGTTAAAGAAATTGTCAATATTTCTTCAGGCTATGTAGAACCAATGCAGACACTCAATGATGTGTTAGCTCAGCTAGATGCTGTTGTCAGCTTTGCTCACGTGTCAAATGGAGCACCTGTTCCATATGTACGACCAGCCATTTTGGAGAAAGGACAAGGAAGAATTATATTAAAAGCATCCAGGCATGCTTGTGTTGAAGTTCAAGATGAAATTGCATTTATTCCTAATGACGTATACTTTGAAAAAGATAAACAGATGTTCCACATCATTACTGGCCCCAATATGGGAGGTAAATCAACATATATTCGACAAACTGGGGTGATAGTACTCATGGCCCAAATTGGGTGTTTTGTGCCATGTGAGTCAGCAGAAGTGTCCATTGTGGACTGCATCTTAGCCCGAGTAGGGGCTGGTGACAGTCAATTGAAAGGAGTCTCCACGTTCATGGCTGAAATGTTGGAAACTGCTTCTATCCTCAGGTCTGCAACCAAAGATTCATTAATAATCATAGATGAATTGGGAAGAGGAACTTCTACCTACGATGGATTTGGGTTAGCATGGGCTATATCAGAATACATTGCAACAAAGATTGGTGCTTTTTGCATGTTTGCAACCCATTTTCATGAACTTACTGCCTTGGCCAATCAGATACCAACTGTTAATAATCTACATGTCACAGCACTCACCACTGAAGAGACCTTAACTATGCTTTATCAGGTGAAGAAAGGTGTCTGTGATCAAAGTTTTGGGATTCATGTTGCAGAGCTTACTAATTTCCCTAAGCATGTAATAGAGTGTGCTAAACAGAAAGCCCTGGAACTTGAGGAGTTTCAGTATATTGGAGAATCGCAAGGATATGATATCATGGAACCAGCAGCAAAGAAGTGCTATCTGGAAAGAGAGCAAGGTGAAAAAATTATTCAGGAGTTCCTGTCCAAGGTGAAACAAATGCCCTTTACTGAAATGTCAGAAGAAAACATCACAATAAAGTTAAAACAGCTAAAAGCTGAAGTAATAGCAAAGAATAATAGCTTTGTAAATGAAATCATTTCACGAATAAAAGTTACTACG	96461.0	single nucleotide variant	NM_000251.3(MSH2):c.2500G>A (p.Ala834Thr)	4436.0	MSH2	HGNC:7325	Likely benign	0.0	Sep 05, 2013	63750757.0	-	RCV000076488|RCV000131725|RCV000679306|RCV000659884|RCV001084815|RCV005229882	MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0007356,MedGen:C2936783,OMIM:120435,Orphanet:144|MeSH:D003123,MedGen:C0009405|MedGen:CN169374	Lynch syndrome|Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome 1|Hereditary nonpolyposis colorectal neoplasms|not specified	germline;unknown	germline	GRCh38	NC_000002.12	2	47480737.0	47480737.0	2p21	reviewed by expert panel	14.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA020643,UniProtKB:P43246#VAR_004488	2.0	90986.0	47480737.0	G	A	-	-	-	-	-	-	SCV000107517	-	-	2500G>A 	Ala834Thr	NM_000251.3	3.0	2_Benign	chr2	G	A	2-47480737-G-A	0.000147077	90986	2	47480737	G	A	A	T	rs63750757	2	47707876	2	47561380	834	MSH2	ENSG00000095002	ENST00000233146	ENSP00000233146	P43246	MSH2_HUMAN	c.2500G>A	p.Ala834Thr	c.2500G>A	p.Ala834Thr	principal1	Y	1	YES	Select	+	GCT	1	0	G	G/G	G/G	G/G	G/G	0.018	0.54841	D	0.016	0.62681	D	0.999	0.77914	D	0.992	0.80453	D	0.66	0.88920	D	simple_aae	34.0	66.0	3.825	0.95519	H	-2.83	0.59742	D	0.897	0.89680	0.9536	0.96438	D	0.8824	0.96088	D	10	0.85765916	0.84808	D	0.291509	0.90558	D	0.855	0.95533	.	.	.	.	.	0.945582055749	0.94457	0.7716937378121181	0.76991	0.0338531720708	0.03438	0.702017068863	0.67381	T	0.908717	0.98245	D	0.251908	0.78622	D	0.408785	0.92338	D	0.575891852378845	0.35149	D	0.925008	0.94551	D	0.62488204	0.73747	0.62900686	0.78129	0.82975316	0.85701	0.7198016	0.83262	-11.96	0.85585	D	0.6115	0.75491	P	0.977084907216178	0.84650	0.99873120	0.98932	0.585	0.76722	.	.	.	.	.	.	5.377409	0.90144	31.0	0.99916437609412445	0.98450	0.883164	0.81116	D	1.04983139118545	0.97070	15.56844	0.994568475652894	0.98511	18.51274	5.86	5.86	0.93927	.	.	9.236	0.94487	11.759000	0.95591	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	933	0.16020	.	.	.	.	.	.	.	.	.	.	.	.	13	264690	4.9114056E-5	.	9	109402	8.226540e-05	0	22	208100	1.057180e-04	0	21	236914	8.863980e-05	0	0	7164	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	1	9046	1.105460e-04	0	1	13394	7.466030e-05	0	7	42766	1.636810e-04	0	0	15688	0.000000e+00	0	7	42766	1.636810e-04	0	0	16218	0.000000e+00	0	0	30522	0.000000e+00	0	0	6212	0.000000e+00	0	1	13414	7.454900e-05	0	1	16734	5.975860e-05	0	20	89532	2.233840e-04	0	0	30606	0.000000e+00	0	20	89532	2.233840e-04	0	0	14902	0.000000e+00	0	0	34258	0.000000e+00	0	0	9570	0.000000e+00	0	1	17690	5.652910e-05	0	1	21632	4.622780e-05	0	19	102722	1.849650e-04	0	0	30524	0.000000e+00	0	19	102722	1.849650e-04	0	.	227	1614120	1.406340e-04	0	211	1180012	1.788120e-04	0	1	75042	1.332590e-05	0	0	912	0.000000e+00	0	0	60008	0.000000e+00	0	0	29602	0.000000e+00	0	1	44860	2.229160e-05	0	4	64040	6.246100e-05	0	1	6058	1.650710e-04	0	211	1180012	1.788120e-04	0	0	91086	0.000000e+00	0	7	42740	1.6378100140383717E-4	0	306	0	0	112	0	0	8044	0	0	500	0	0	628	0	0	56	0	0	98	0	1	8298	1.2051096649795132E-4	0	8350	0	0	168	0	8	60782	1.3161791319798625E-4	Likely_benign	Lynch_syndrome_1|Hereditary_nonpolyposis_colorectal_neoplasms|Hereditary_cancer-predisposing_syndrome|Lynch_syndrome|not_provided	reviewed_by_expert_panel	NC_000002.12:g.47480737G>A	ClinGen:CA020643|UniProtKB:P43246#VAR_004488	C2936783|C0009405|C0027672|C4552100|C3661900	120435	144|140162|144	DNA mismatch repair protein MutS, C-terminal|DNA mismatch repair protein MutS, C-terminal|DNA mismatch repair protein Msh2, ATP-binding cassette domain	Ala	Thr	96461	single nucleotide variant	NM_000251.3(MSH2):c.2500G>A (p.Ala834Thr)	4436	MSH2	HGNC:7325	Likely benign	0	Sep 05, 2013	63750757	-	RCV000076488|RCV000131725|RCV000679306|RCV000659884|RCV001084815|RCV005229882	MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0007356,MedGen:C2936783,OMIM:120435,Orphanet:144|MeSH:D003123,MedGen:C0009405|MedGen:CN169374	Lynch syndrome|Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome 1|Hereditary nonpolyposis colorectal neoplasms|not specified	germline;unknown	germline	GRCh38	NC_000002.12	2	47480737	47480737	2p21	reviewed by expert panel	14	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA020643,UniProtKB:P43246#VAR_004488	2	90986	47480737	G	A	-	-	-	-	-	-	SCV000107517	-	-	2500G>A 	Ala834Thr	NM_000251.3	3	2_Benign	MSH2	ENSG00000095002	7918	14377	CCSBVarC001281	ALE00001281	2500G>A	Ala834Thr	RC4	RC4_Mut_GDEh1031	C01	GDEhDisVCh_40060	F12	2	RC4_Mut_GDDh1031	C01	NULL	NULL	NULL	NULL	NULL	NULL	1	99	1	99	0	NULL	0	NULL	0	NULL	MSH2_Ala834Thr	2	2	47480737	G	A
7918	MSH2	1262T>C	Leu421Pro	ENSG00000095002	2	47429927	NC_000002.12:47429927:T:C	ALE00003009	CCSBVarC003009	NULL	202666	NULL	GDEhDisVCh_40060	A09	CEGS2	ATGGCGGTGCAGCCGAAGGAGACGCTGCAGTTGGAGAGCGCGGCCGAGGTCGGCTTCGTGCGCTTCTTTCAGGGCATGCCGGAGAAGCCGACCACCACAGTGCGCCTTTTCGACCGGGGCGACTTCTATACGGCGCACGGCGAGGACGCGCTGCTGGCCGCCCGGGAGGTGTTCAAGACCCAGGGGGTGATCAAGTACATGGGGCCGGCAGGAGCAAAGAATCTGCAGAGTGTTGTGCTTAGTAAAATGAATTTTGAATCTTTTGTAAAAGATCTTCTTCTGGTTCGTCAGTATAGAGTTGAAGTTTATAAGAATAGAGCTGGAAATAAGGCATCCAAGGAGAATGATTGGTATTTGGCATATAAGGCTTCTCCTGGCAATCTCTCTCAGTTTGAAGACATTCTCTTTGGTAACAATGATATGTCAGCTTCCATTGGTGTTGTGGGTGTTAAAATGTCCGCAGTTGATGGCCAGAGACAGGTTGGAGTTGGGTATGTGGATTCCATACAGAGGAAACTAGGACTGTGTGAATTCCCTGATAATGATCAGTTCTCCAATCTTGAGGCTCTCCTCATCCAGATTGGACCAAAGGAATGTGTTTTACCCGGAGGAGAGACTGCTGGAGACATGGGGAAACTGAGACAGATAATTCAAAGAGGAGGAATTCTGATCACAGAAAGAAAAAAAGCTGACTTTTCCACAAAAGACATTTATCAGGACCTCAACCGGTTGTTGAAAGGCAAAAAGGGAGAGCAGATGAATAGTGCTGTATTGCCAGAAATGGAGAATCAGGTTGCAGTTTCATCACTGTCTGCGGTAATCAAGTTTTTAGAACTCTTATCAGATGATTCCAACTTTGGACAGTTTGAACTGACTACTTTTGACTTCAGCCAGTATATGAAATTGGATATTGCAGCAGTCAGAGCCCTTAACCTTTTTCAGGGTTCTGTTGAAGATACCACTGGCTCTCAGTCTCTGGCTGCCTTGCTGAATAAGTGTAAAACCCCTCAAGGACAAAGACTTGTTAACCAGTGGATTAAGCAGCCTCTCATGGATAAGAACAGAATAGAGGAGAGATTGAATTTAGTGGAAGCTTTTGTAGAAGATGCAGAATTGAGGCAGACTTTACAAGAAGATTTACTTCGTCGATTCCCAGATCTTAACCGACTTGCCAAGAAGTTTCAAAGACAAGCAGCAAACTTACAAGATTGTTACCGACTCTATCAGGGTATAAATCAACTACCTAATGTTATACAGGCTCCGGAAAAACATGAAGGAAAACACCAGAAATTATTGTTGGCAGTTTTTGTGACTCCTCTTACTGATCTTCGTTCTGACTTCTCCAAGTTTCAGGAAATGATAGAAACAACTTTAGATATGGATCAGGTGGAAAACCATGAATTCCTTGTAAAACCTTCATTTGATCCTAATCTCAGTGAATTAAGAGAAATAATGAATGACTTGGAAAAGAAGATGCAGTCAACATTAATAAGTGCAGCCAGAGATCTTGGCTTGGACCCTGGCAAACAGATTAAACTGGATTCCAGTGCACAGTTTGGATATTACTTTCGTGTAACCTGTAAGGAAGAAAAAGTCCTTCGTAACAATAAAAACTTTAGTACTGTAGATATCCAGAAGAATGGTGTTAAATTTACCAACAGCAAATTGACTTCTTTAAATGAAGAGTATACCAAAAATAAAACAGAATATGAAGAAGCCCAGGATGCCATTGTTAAAGAAATTGTCAATATTTCTTCAGGCTATGTAGAACCAATGCAGACACTCAATGATGTGTTAGCTCAGCTAGATGCTGTTGTCAGCTTTGCTCACGTGTCAAATGGAGCACCTGTTCCATATGTACGACCAGCCATTTTGGAGAAAGGACAAGGAAGAATTATATTAAAAGCATCCAGGCATGCTTGTGTTGAAGTTCAAGATGAAATTGCATTTATTCCTAATGACGTATACTTTGAAAAAGATAAACAGATGTTCCACATCATTACTGGCCCCAATATGGGAGGTAAATCAACATATATTCGACAAACTGGGGTGATAGTACTCATGGCCCAAATTGGGTGTTTTGTGCCATGTGAGTCAGCAGAAGTGTCCATTGTGGACTGCATCTTAGCCCGAGTAGGGGCTGGTGACAGTCAATTGAAAGGAGTCTCCACGTTCATGGCTGAAATGTTGGAAACTGCTTCTATCCTCAGGTCTGCAACCAAAGATTCATTAATAATCATAGATGAATTGGGAAGAGGAACTTCTACCTACGATGGATTTGGGTTAGCATGGGCTATATCAGAATACATTGCAACAAAGATTGGTGCTTTTTGCATGTTTGCAACCCATTTTCATGAACTTACTGCCTTGGCCAATCAGATACCAACTGTTAATAATCTACATGTCACAGCACTCACCACTGAAGAGACCTTAACTATGCTTTATCAGGTGAAGAAAGGTGTCTGTGATCAAAGTTTTGGGATTCATGTTGCAGAGCTTGCTAATTTCCCTAAGCATGTAATAGAGTGTGCTAAACAGAAAGCCCTGGAACTTGAGGAGTTTCAGTATATTGGAGAATCGCAAGGATATGATATCATGGAACCAGCAGCAAAGAAGTGCTATCTGGAAAGAGAGCAAGGTGAAAAAATTATTCAGGAGTTCCTGTCCAAGGTGAAACAAATGCCCTTTACTGAAATGTCAGAAGAAAACATCACAATAAAGTTAAAACAGCTAAAAGCTGAAGTAATAGCAAAGAATAATAGCTTTGTAAATGAAATCATTTCACGAATAAAAGTTACTACG	96061.0	single nucleotide variant	NM_000251.3(MSH2):c.1262T>C (p.Leu421Pro)	4436.0	MSH2	HGNC:7325	Uncertain significance	0.0	Feb 15, 2019	587779080.0	-	RCV001044154	MeSH:D003123,MedGen:C0009405	Hereditary nonpolyposis colorectal neoplasms	germline	germline	GRCh38	NC_000002.12	2	47429927.0	47429927.0	2p21	criteria provided, single submitter	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA017690	2.0	90586.0	47429927.0	T	C	-	-	-	-	-	-	SCV001207935	-	-	1262T>C 	Leu421Pro	NM_000251.3	1.0	4_VUS	chr2	T	C	2-47429927-T-C		90586	2	47429927	T	C	L	P	rs587779080	2	47657066	2	47510570	421	MSH2	ENSG00000095002	ENST00000233146	ENSP00000233146	P43246	MSH2_HUMAN	c.1262T>C	p.Leu421Pro	c.1262T>C	p.Leu421Pro	principal1	Y	1	YES	Select	+	CTG	2	0	T	T/T	T/T	T/T	T/T	0.001	0.91343	D	0.001	0.83643	D	0.998	0.73231	D	0.988	0.77983	D	0.99	0.97926	D	simple_aae	1.0	99.0	3.345	0.90905	M	-6.18	0.90748	D	0.913	0.91505	1.0837	0.99002	D	0.9306	0.97705	D	10	0.9820812	0.98249	D	0.619157	0.96692	D	0.966	0.99545	0.875	0.96561	P43246	L421P	Loss of stability (P = 0.0082)| Gain of disorder (P = 0.0157)| Gain of ubiquitination at K423 (P = 0.1063)| Gain of methylation at K423 (P = 0.1915)| Loss of glycosylation at K423 (P = 0.3432)	0.993665764686	0.99351	0.9048087020158289	0.90393	0.0286589876568	0.02857	0.623760819435	0.56194	T	0.917385	0.98475	D	0.534216	0.95254	D	0.529588	0.95183	D	0.99839586019516	0.93976	D	0.848915	0.53158	T	0.9931416	0.99903	0.9704918	0.99478	0.99195355	0.99855	0.9712706	0.99511	-19.373	0.99869	D	0.9904	0.94113	P	0.999630619042598	0.97271	0.99997030	0.99978	0.987	0.99559	.	.	.	.	.	.	4.946308	0.817	27.6	0.99920491706435099	0.98722	0.919850	0.89058	D	0.881392003713884	0.90768	10.58064	0.809928907696548	0.90422	10.42439	5.35	5.35	0.76261	.	.	7.245	0.77734	7.761000	0.68349	0.582	0.30226	1.0	0.71675	1.000000	0.68239	0.998	0.85369	887	0.27927	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	Hereditary_nonpolyposis_colorectal_neoplasms	criteria_provided,_single_submitter	NC_000002.12:g.47429927T>C	ClinGen:CA017690	C0009405	.	.	DNA mismatch repair protein MutS, core|DNA mismatch repair protein MutS, core	Leu	Pro	96061	single nucleotide variant	NM_000251.3(MSH2):c.1262T>C (p.Leu421Pro)	4436	MSH2	HGNC:7325	Uncertain significance	0	Feb 15, 2019	587779080	-	RCV001044154	MeSH:D003123,MedGen:C0009405	Hereditary nonpolyposis colorectal neoplasms	germline	germline	GRCh38	NC_000002.12	2	47429927	47429927	2p21	criteria provided, single submitter	1	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA017690	2	90586	47429927	T	C	-	-	-	-	-	-	SCV001207935	-	-	1262T>C 	Leu421Pro	NM_000251.3	1	4_VUS	MSH2	ENSG00000095002	7918	202666	CCSBVarC003009	ALE00003009	1262T>C	Leu421Pro	CEGS2	CegsMutGDEh1040	E12	GDEhDisVCh_40060	A09	2	CegsMutGDDh1040	E12	NULL	NULL	VUSMutpDEST2_07	G03	NULL	NULL	1	1	1	1	0	NULL	1	1	0	NULL	MSH2_Leu421Pro	2	2	47429927	T	C
3689	GCK	1153G>A	Gly385Arg	ENSG00000106633	7	44145597	NC_000007.14:44145597:C:T	ALE00006695	CCSBVarC006697	NULL	214859	NULL	GDEhDisVCh_40037	B03	CEGS2	ATGCTGGACGACAGAGCCAGGATGGAGGCCGCCAAGAAGGAGAAGGTAGAGCAGATCCTGGCAGAGTTCCAGCTGCAGGAGGAGGACCTGAAGAAGGTGATGAGACGGATGCAGAAGGAGATGGACCGCGGCCTGAGGCTGGAGACCCATGAAGAGGCCAGTGTGAAGATGCTGCCCACCTACGTGCGCTCCACCCCAGAAGGCTCAGAAGTCGGGGACTTCCTCTCCCTGGACCTGGGTGGCACTAACTTCAGGGTGATGCTGGTGAAGGTGGGAGAAGGTGAGGAGGGGCAGTGGAGCGTGAAGACCAAACACCAGATGTACTCCATCCCCGAGGACGCCATGACCGGCACTGCTGAGATGCTCTTCGACTACATCTCTGAGTGCATCTCCGACTTCCTGGACAAGCATCAGATGAAACACAAGAAGCTGCCCCTGGGCTTCACCTTCTCCTTTCCTGTGAGGCACGAAGACATCGATAAGGGCATCCTTCTCAACTGGACCAAGGGCTTCAAGGCCTCAGGAGCAGAAGGGAACAATGTCGTGGGGCTTCTGCGAGACGCTATCAAACGGAGAGGGGACTTTGAAATGGATGTGGTGGCAATGGTGAATGACACGGTGGCCACGATGATCTCCTGCTACTACGAAGACCATCAGTGCGAGGTCGGCATGATCGTGGGCACGGGCTGCAATGCCTGCTACATGGAGGAGATGCAGAATGTGGAGCTGGTGGAGGGGGACGAGGGCCGCATGTGCGTCAATACCGAGTGGGGCGCCTTCGGGGACTCCGGCGAGCTGGACGAGTTCCTGCTGGAGTATGACCGCCTGGTGGACGAGAGCTCTGCAAACCCCGGTCAGCAGCTGTATGAGAAGCTCATAGGTGGCAAGTACATGGGCGAGCTGGTGCGGCTTGTGCTGCTCAGGCTCGTGGACGAAAACCTGCTCTTCCACGGGGAGGCCTCCGAGCAGCTGCGCACACGCGGAGCCTTCGAGACGCGCTTCGTGTCGCAGGTGGAGAGCGACACGGGCGACCGCAAGCAGATCTACAACATCCTGAGCACGCTGGGGCTGCGACCCTCGACCACCGACTGCGACATCGTGCGCCGCGCCTGCGAGAGCGTGTCTACGCGCGCTGCGCACATGTGCTCGGCGAGGCTGGCGGGCGTCATCAACCGCATGCGCGAGAGCCGCAGCGAGGACGTAATGCGCATCACTGTGGGCGTGGATGGCTCCGTGTACAAGCTGCACCCCAGCTTCAAGGAGCGGTTCCATGCCAGCGTGCGCAGGCTGACGCCCAGCTGCGAGATCACCTTCATCGAGTCGGAGGAGGGCAGTGGCCGGGGCGCGGCCCTGGTCTCGGCGGTGGCCTGTAAGAAGGCCTGTATGCTGGGCCAG	44843.0	single nucleotide variant	NM_000162.5(GCK):c.1153G>A (p.Gly385Arg)	2645.0	GCK	HGNC:4195	Likely pathogenic/Likely risk allele	1.0	Aug 18, 2011	193922267.0	-	RCV000029842|RCV002463594	MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|Human Phenotype Ontology:HP:0004904,MONDO:MONDO:0018911,MedGen:C0342276,OMIM:606391,Orphanet:552	Maturity-onset diabetes of the young type 2|Maturity onset diabetes mellitus in young	germline;unknown	germline	GRCh38	NC_000007.14	7	44145597.0	44145597.0	7p13	criteria provided, multiple submitters, no conflicts	2.0	-	N	ClinGen:CA213721	2.0	36179.0	44145597.0	C	T	-	-	-	-	-	-	SCV000052497|SCV002605086	-	-	1153G>A 	Gly385Arg	NM_000162.5	2.0	1_Pathogenic	chr7	G	A	7-44145597-G-A		36179	7	44145597	C	T	G	R	rs193922267	7	44185196	7	44151721	385	GCK	ENSG00000106633	ENST00000403799	ENSP00000384247	P35557	HXK4_HUMAN	c.1153G>A	p.Gly385Arg	c.1153G>A	p.Gly385Arg	principal1	Y	1	YES	Select	-	GGG	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.8	0.95330	H	-5.13	0.87940	D	0.966	0.97658	1.0885	0.99178	D	0.9687	0.99007	D	10	0.99321365	0.99853	D	0.81417	0.98549	D	0.962	0.99434	0.976	0.99775	P35557	G385R	Gain of methylation at G385 (P = 0.0071)| Gain of MoRF binding (P = 0.0093)| Loss of catalytic residue at A384 (P = 0.0427)| Gain of disorder (P = 0.0551)| Loss of stability (P = 0.4192)	0.976041132959	0.97555	.	0.99910	.	0.97218	0.899795651436	0.96414	D	0.939492	0.99028	D	0.540798	0.95432	D	0.539042	0.95364	D	0.998842716217041	0.95303	D	0.963704	0.86505	D	0.9927741	0.99889	0.9464729	0.98155	0.9899593	0.99758	0.96298075	0.99116	-13.091	0.90510	D	0.9931	0.95140	P	0.99887997863384	0.95226	0.99983823	0.99792	0.984	0.99450	.	.	.	.	.	.	5.272541	0.88551	29.6	0.99894492961875325	0.96745	0.866045	0.78455	D	0.878649383831347	0.90623	10.51293	0.786564022153535	0.88782	9.73724	5.46	5.46	0.79994	3.81	0.70705	4.064	0.57311	7.531000	0.59982	0.596	0.33565	0.997	0.40243	1.000000	0.68239	0.958	0.51242	716	0.55914	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic/Likely_risk_allele	Maturity-onset_diabetes_of_the_young_type_2|Maturity_onset_diabetes_mellitus_in_young	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.44145597C>T	ClinGen:CA213721	C0342277|C0342276	125851|606391	552|552	Hexokinase, C-terminal	Gly	Arg	44843	single nucleotide variant	NM_000162.5(GCK):c.1153G>A (p.Gly385Arg)	2645	GCK	HGNC:4195	Likely pathogenic/Likely risk allele	1	Aug 18, 2011	193922267	-	RCV000029842|RCV002463594	MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|Human Phenotype Ontology:HP:0004904,MONDO:MONDO:0018911,MedGen:C0342276,OMIM:606391,Orphanet:552	Maturity-onset diabetes of the young type 2|Maturity onset diabetes mellitus in young	germline;unknown	germline	GRCh38	NC_000007.14	7	44145597	44145597	7p13	criteria provided, multiple submitters, no conflicts	2	-	N	ClinGen:CA213721	2	36179	44145597	C	T	-	-	-	-	-	-	SCV000052497|SCV002605086	-	-	1153G>A 	Gly385Arg	NM_000162.5	2	1_Pathogenic	GCK	ENSG00000106633	3689	214859	CCSBVarC006697	ALE00006695	1153G>A	Gly385Arg	CEGS2	CegsMutGDEh1044	F08	GDEhDisVCh_40037	B03	1	CegsMutGDDh1044	F08	VUSN2Hmut_GDN2h_09	G06	VUSMutpDEST2_03	H09	VUSmut_GDEh09	G06	1	4	1	1	1	1	1	1	1	1	GCK_Gly385Arg	7	7	44145597	C	T
7918	MSH2	1225C>A	Gln409Lys	ENSG00000095002	2	47429890	NC_000002.12:47429890:C:A	ALE00003008	CCSBVarC003008	NULL	202665	NULL	GDEhDisVCh_40060	B07	CEGS2	ATGGCGGTGCAGCCGAAGGAGACGCTGCAGTTGGAGAGCGCGGCCGAGGTCGGCTTCGTGCGCTTCTTTCAGGGCATGCCGGAGAAGCCGACCACCACAGTGCGCCTTTTCGACCGGGGCGACTTCTATACGGCGCACGGCGAGGACGCGCTGCTGGCCGCCCGGGAGGTGTTCAAGACCCAGGGGGTGATCAAGTACATGGGGCCGGCAGGAGCAAAGAATCTGCAGAGTGTTGTGCTTAGTAAAATGAATTTTGAATCTTTTGTAAAAGATCTTCTTCTGGTTCGTCAGTATAGAGTTGAAGTTTATAAGAATAGAGCTGGAAATAAGGCATCCAAGGAGAATGATTGGTATTTGGCATATAAGGCTTCTCCTGGCAATCTCTCTCAGTTTGAAGACATTCTCTTTGGTAACAATGATATGTCAGCTTCCATTGGTGTTGTGGGTGTTAAAATGTCCGCAGTTGATGGCCAGAGACAGGTTGGAGTTGGGTATGTGGATTCCATACAGAGGAAACTAGGACTGTGTGAATTCCCTGATAATGATCAGTTCTCCAATCTTGAGGCTCTCCTCATCCAGATTGGACCAAAGGAATGTGTTTTACCCGGAGGAGAGACTGCTGGAGACATGGGGAAACTGAGACAGATAATTCAAAGAGGAGGAATTCTGATCACAGAAAGAAAAAAAGCTGACTTTTCCACAAAAGACATTTATCAGGACCTCAACCGGTTGTTGAAAGGCAAAAAGGGAGAGCAGATGAATAGTGCTGTATTGCCAGAAATGGAGAATCAGGTTGCAGTTTCATCACTGTCTGCGGTAATCAAGTTTTTAGAACTCTTATCAGATGATTCCAACTTTGGACAGTTTGAACTGACTACTTTTGACTTCAGCCAGTATATGAAATTGGATATTGCAGCAGTCAGAGCCCTTAACCTTTTTCAGGGTTCTGTTGAAGATACCACTGGCTCTCAGTCTCTGGCTGCCTTGCTGAATAAGTGTAAAACCCCTCAAGGACAAAGACTTGTTAACCAGTGGATTAAGCAGCCTCTCATGGATAAGAACAGAATAGAGGAGAGATTGAATTTAGTGGAAGCTTTTGTAGAAGATGCAGAATTGAGGCAGACTTTACAAGAAGATTTACTTCGTCGATTCCCAGATCTTAACCGACTTGCCAAGAAGTTTCAAAGACAAGCAGCAAACTTACAAGATTGTTACCGACTCTATAAGGGTATAAATCAACTACCTAATGTTATACAGGCTCTGGAAAAACATGAAGGAAAACACCAGAAATTATTGTTGGCAGTTTTTGTGACTCCTCTTACTGATCTTCGTTCTGACTTCTCCAAGTTTCAGGAAATGATAGAAACAACTTTAGATATGGATCAGGTGGAAAACCATGAATTCCTTGTAAAACCTTCATTTGATCCTAATCTCAGTGAATTAAGAGAAATAATGAATGACTTGGAAAAGAAGATGCAGTCAACATTAATAAGTGCAGCCAGAGATCTTGGCTTGGACCCTGGCAAACAGATTAAACTGGATTCCAGTGCACAGTTTGGATATTACTTTCGTGTAACCTGTAAGGAAGAAAAAGTCCTTCGTAACAATAAAAACTTTAGTACTGTAGATATCCAGAAGAATGGTGTTAAATTTACCAACAGCAAATTGACTTCTTTAAATGAAGAGTATACCAAAAATAAAACAGAATATGAAGAAGCCCAGGATGCCATTGTTAAAGAAATTGTCAATATTTCTTCAGGCTATGTAGAACCAATGCAGACACTCAATGATGTGTTAGCTCAGCTAGATGCTGTTGTCAGCTTTGCTCACGTGTCAAATGGAGCACCTGTTCCATATGTACGACCAGCCATTTTGGAGAAAGGACAAGGAAGAATTATATTAAAAGCATCCAGGCATGCTTGTGTTGAAGTTCAAGATGAAATTGCATTTATTCCTAATGACGTATACTTTGAAAAAGATAAACAGATGTTCCACATCATTACTGGCCCCAATATGGGAGGTAAATCAACATATATTCGACAAACTGGGGTGATAGTACTCATGGCCCAAATTGGGTGTTTTGTGCCATGTGAGTCAGCAGAAGTGTCCATTGTGGACTGCATCTTAGCCCGAGTAGGGGCTGGTGACAGTCAATTGAAAGGAGTCTCCACGTTCATGGCTGAAATGTTGGAAACTGCTTCTATCCTCAGGTCTGCAACCAAAGATTCATTAATAATCATAGATGAATTGGGAAGAGGAACTTCTACCTACGATGGATTTGGGTTAGCATGGGCTATATCAGAATACATTGCAACAAAGATTGGTGCTTTTTGCATGTTTGCAACCCATTTTCATGAACTTACTGCCTTGGCCAATCAGATACCAACTGTTAATAATCTACATGTCACAGCACTCACCACTGAAGAGACCTTAACTATGCTTTATCAGGTGAAGAAAGGTGTCTGTGATCAAAGTTTTGGGATTCATGTTGCAGAGCTTGCTAATTTCCCTAAGCATGTAATAGAGTGTGCTAAACAGAAAGCCCTGGAACTTGAGGAGTTTCAGTATATTGGAGAATCGCAAGGATATGATATCATGGAACCAGCAGCAAAGAAGTGCTATCTGGAAAGAGAGCAAGGTGAAAAAATTATTCAGGAGTTCCTGTCCAAGGTGAAACAAATGCCCTTTACTGAAATGTCAGAAGAAAACATCACAATAAAGTTAAAACAGCTAAAAGCTGAAGTAATAGCAAAGAATAATAGCTTTGTAAATGAAATCATTTCACGAATAAAAGTTACTACG	96051.0	single nucleotide variant	NM_000251.3(MSH2):c.1225C>A (p.Gln409Lys)	4436.0	MSH2	HGNC:7325	Uncertain significance	0.0	May 06, 2022	151244108.0	-	RCV000587210|RCV002513805	MedGen:C3661900|MeSH:D003123,MedGen:C0009405	not provided|Hereditary nonpolyposis colorectal neoplasms	germline	germline	GRCh38	NC_000002.12	2	47429890.0	47429890.0	2p21	criteria provided, multiple submitters, no conflicts	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA017589	2.0	90576.0	47429890.0	C	A	-	-	-	-	-	-	SCV000696202|SCV003524762	-	-	1225C>A 	Gln409Lys	NM_000251.3	2.0	4_VUS	chr2	C	A	2-47429890-C-A		90576	2	47429890	C	A	Q	K	rs151244108	2	47657029	2	47510533	409	MSH2	ENSG00000095002	ENST00000233146	ENSP00000233146	P43246	MSH2_HUMAN	c.1225C>A	p.Gln409Lys	c.1225C>A	p.Gln409Lys	principal1	Y	1	YES	Select	+	CAG	1	0	C	C/C	C/C	C/C	C/C	0.006	0.68399	D	0.057	0.46983	T	0.007	0.22346	B	0.072	0.28044	B	0.84	0.90354	D	simple_aae	16.0	84.0	2.72	0.79369	M	-3.36	0.66580	D	0.815	0.81197	0.5204	0.90795	D	0.7840	0.92647	D	10	0.92154294	0.91413	D	0.155525	0.83601	D	0.790	0.93044	0.815	0.92954	P43246	Q409K	Gain of ubiquitination at Q409 (P = 0.0311)| Gain of MoRF binding (P = 0.0445)| Gain of methylation at Q409 (P = 0.0539)| Gain of catalytic residue at Q409 (P = 0.2071)| Gain of glycosylation at Q409 (P = 0.5054)	0.987975851719	0.98771	0.6794396499975914	0.67723	0.00645224362168	0.00544	0.591549634933	0.51646	T	0.77682	0.94021	D	0.447355	0.92307	D	0.404818	0.92213	D	0.893276512622833	0.54193	D	0.933007	0.74843	D	0.8763776	0.89224	0.7840003	0.87114	0.9145652	0.92618	0.7890646	0.87431	-13.571	0.91596	D	0.4798	0.63594	A	0.941220344116595	0.79482	0.99984443	0.99792	0.658	0.80981	.	.	.	.	.	.	3.930067	0.57519	23.9	0.99245494431192427	0.56762	0.807034	0.73019	D	0.370363135461547	0.59614	4.164973	0.479956419210518	0.66482	4.981482	5.45	5.45	0.79660	.	.	7.145	0.77005	7.548000	0.60279	0.576	0.29264	1.0	0.71675	1.000000	0.68239	1.0	0.97202	887	0.27927	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	not_provided|Hereditary_nonpolyposis_colorectal_neoplasms	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.47429890C>A	ClinGen:CA017589	C3661900|C0009405	.	.	DNA mismatch repair protein MutS, core|DNA mismatch repair protein MutS, core	Gln	Lys	96051	single nucleotide variant	NM_000251.3(MSH2):c.1225C>A (p.Gln409Lys)	4436	MSH2	HGNC:7325	Uncertain significance	0	May 06, 2022	151244108	-	RCV000587210|RCV002513805	MedGen:C3661900|MeSH:D003123,MedGen:C0009405	not provided|Hereditary nonpolyposis colorectal neoplasms	germline	germline	GRCh38	NC_000002.12	2	47429890	47429890	2p21	criteria provided, multiple submitters, no conflicts	2	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA017589	2	90576	47429890	C	A	-	-	-	-	-	-	SCV000696202|SCV003524762	-	-	1225C>A 	Gln409Lys	NM_000251.3	2	4_VUS	MSH2	ENSG00000095002	7918	202665	CCSBVarC003008	ALE00003008	1225C>A	Gln409Lys	CEGS2	CegsMutGDEh1037	A11	GDEhDisVCh_40060	B07	2	CegsMutGDDh1037	A11	NULL	NULL	VUSMutpDEST2_07	F03	NULL	NULL	1	1	1	1	0	NULL	1	1	0	NULL	MSH2_Gln409Lys	2	2	47429890	C	A
52861	F9	1217C>T	Ser406Leu	ENSG00000101981	X	139561902	NC_000023.11:139561902:C:T	ALE00004393	CCSBVarC004393	NULL	204386	NULL	GDEhDisVCh_40052	E04	CEGS2	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTTATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT	25656.0	single nucleotide variant	NM_000133.4(F9):c.1217C>T (p.Ser406Leu)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Oct 09, 2017	137852263.0	-	RCV000011363	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561902.0	139561902.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255405,OMIM:300746.0061	1.0	10617.0	139561902.0	C	T	-	-	-	-	-	-	SCV000031595	-	-	1217C>T 	Ser406Leu	NM_000133.4		1_Pathogenic	chrX	C	T	X-139561902-C-T		10617	X	139561902	C	T	S	L	rs137852263	X	138644061	X	138471727	406	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1217C>T	p.Ser406Leu	c.1217C>T	p.Ser406Leu	principal1	Y	1	YES	Select	+	TCA	2	0	C	C/C	C/C	C/C	C/C	0.002	0.72322	D	0.004	0.76775	D	0.924	0.51298	P	0.833	0.59778	P	0.72	0.83457	A	simple_aae	28.0	72.0	2.22	0.62721	M	-3.36	0.68090	D	0.497	0.81297	0.9280	0.96061	D	0.8695	0.95652	D	10	0.98063314	0.98025	D	0.914868	0.99366	D	0.860	0.95717	0.926	0.98766	P00740	S406L	Loss of disorder (P = 0.0238)| Loss of phosphorylation at S406 (P = 0.0427)| Loss of glycosylation at S406 (P = 0.0693)| Loss of sheet (P = 0.437)| Loss of loop (P = 0.4412)	0.990085995164	0.98986	0.9949048274168517	0.99487	1.42151595831	0.85555	0.414036989212	0.26982	T	0.864181	0.96986	D	0.38613	0.89021	D	0.316873	0.88883	D	0.971914410591125	0.69295	D	0.835916	0.50543	T	0.9734807	0.98551	0.96699363	0.99317	0.9693402	0.98169	0.94676954	0.98174	-13.568	0.91585	D	0.52	0.71593	A	0.999310278667129	0.96235	0.99998593	0.99996	0.971	0.98885	.	.	.	.	.	.	4.877112	0.79991	27.2	0.99900846572837232	0.97276	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	7.879	0.8573	7.708000	0.66701	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561902C>T	ClinGen:CA255405|OMIM:300746.0061	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ser	Leu	25656	single nucleotide variant	NM_000133.4(F9):c.1217C>T (p.Ser406Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852263	-	RCV000011363	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561902	139561902	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255405,OMIM:300746.0061	1	10617	139561902	C	T	-	-	-	-	-	-	SCV000031595	-	-	1217C>T 	Ser406Leu	NM_000133.4		1_Pathogenic	F9	ENSG00000101981	52861	204386	CCSBVarC004393	ALE00004393	1217C>T	Ser406Leu	CEGS2	CegsMutGDEh1020	E01	GDEhDisVCh_40052	E04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	F9_Ser406Leu	23	X	139561902	C	T
3172	CBS	1616T>C	Leu539Ser	ENSG00000160200	21	43053920	NC_000021.9:43053920:A:G	ALE00003759	CCSBVarC003759	NULL	214537	NULL	GDEhDisVCh_40055	F04	CEGS2	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTCCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCCGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTCGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	15163.0	single nucleotide variant	NM_000071.3(CBS):c.1616T>C (p.Leu539Ser)	875.0	CBS	HGNC:1550	Likely pathogenic	1.0	Jul 24, 2024	121964968.0	-	RCV000000146|RCV003597960|RCV000675072|RCV002468955	MedGen:C3502110|MedGen:C3150344|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880	Homocystinuria, pyridoxine-responsive|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Classic homocystinuria|Homocystinuria	germline;unknown	germline	GRCh38	NC_000021.9	21	43053920.0	43053920.0	21q22.3	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA113889,UniProtKB:P35520#VAR_002194,OMIM:613381.0008	3.0	124.0	43053920.0	A	G	-	-	-	-	-	-	SCV002766585|SCV004534434	-	-	1616T>C 	Leu539Ser	NM_000071.3	2.0	1_Pathogenic	chr21	T	C	21-43053920-T-C		124	21	43053920	A	G	L	S	rs121964968	21	44474030	21	43347099	539	CBS	ENSG00000160200	ENST00000352178	ENSP00000344460	P35520	CBS_HUMAN	c.1616T>C	p.Leu539Ser	c.1616T>C	p.Leu539Ser	principal1	Y	1	.	.	-	TTG	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	0.996	0.68795	D	0.917	0.65301	D	0.98	0.97016	D	simple_aae	2.0	98.0	3.52	0.92870	H	-4.98	0.82171	D	0.956	0.97441	1.0996	0.99644	D	0.9555	0.98555	D	9	0.978781	0.97745	D	0.885031	0.99124	D	0.976	0.99783	.	.	.	.	.	0.93536889037	0.93419	.	0.98075	.	0.81007	0.503501653671	0.39261	T	0.957121	0.99416	D	0.365029	0.87544	D	0.45569	0.93670	D	0.995635807514191	0.87683	D	0.90121	0.65586	D	0.87060434	0.88756	0.75901157	0.85585	0.9072676	0.91927	0.7118859	0.82803	-13.982	0.93011	D	0.9601	0.88040	P	0.995352809769028	0.91272	0.99955541	0.99487	0.996	0.99859	.	.	.	.	.	.	5.138607	0.86044	28.8	0.99842908372951877	0.92321	0.957606	0.97680	D	0.793629548042286	0.85627	8.656599	0.691993435582126	0.81667	7.605119	5.02	5.02	0.66699	2.97	0.54324	8.668	0.90921	10.776000	0.83756	0.658	0.54518	1.0	0.71675	1.000000	0.68239	0.575	0.30817	988	0.02004	1	1.9968051118210862E-4	0	0.0	0	0.0	0	0.0	1	9.92063492063492E-4	0	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	6140	1.6286644951140066E-4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	250	0	0	0	0	0	0	0	1	6390	1.5649452269170578E-4	Likely_pathogenic	Classic_homocystinuria|Homocystinuria|Homocystinuria,_pyridoxine-responsive|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43053920A>G	ClinGen:CA113889|OMIM:613381.0008|UniProtKB:P35520#VAR_002194	C0751202|C0019880|C3502110|C3150344	236200	394	Cystathionine beta-synthase, C-terminal domain	Leu	Ser	15163	single nucleotide variant	NM_000071.3(CBS):c.1616T>C (p.Leu539Ser)	875	CBS	HGNC:1550	Likely pathogenic	1	Jul 24, 2024	121964968	-	RCV000000146|RCV003597960|RCV000675072|RCV002468955	MedGen:C3502110|MedGen:C3150344|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880	Homocystinuria, pyridoxine-responsive|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Classic homocystinuria|Homocystinuria	germline;unknown	germline	GRCh38	NC_000021.9	21	43053920	43053920	21q22.3	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA113889,UniProtKB:P35520#VAR_002194,OMIM:613381.0008	3	124	43053920	A	G	-	-	-	-	-	-	SCV002766585|SCV004534434	-	-	1616T>C 	Leu539Ser	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	3172	214537	CCSBVarC003759	ALE00003759	1616T>C	Leu539Ser	CEGS2	CegsMutGDEh1033	D04	GDEhDisVCh_40055	F04	1	CegsMutGDDh1033	D04	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	CBS_Leu539Ser	21	21	43053920	A	G
2013	KCNE1	221C>T	Ser74Leu	ENSG00000180509	21	34449414	NC_000021.9:34449414:G:A	ALE00006340	CCSBVarC006340	NULL	214146	NULL	GDEhDisVCh_40065	F01	CEGS2	ATGATCCTGTCTAACACCACAGCGGTGACGCCCTTTCTGACCAAGCTGTGGCAGGAGACAGTTCAGCAGGGTGGCAACATGTCGGGCCTGGCCCACAGGTCCCCCCGCAGCGGTGACGGCAAGCTGGAGGCCCTCTACGTCCTCATGGTACTGGGATTCTTCGGCTTCTTCACCCTGGGCATCATGCTGAGCTACATCCGCTCCAAGAAGCTGGAGCACTTGAACGACCCATTCAACGTCTACATCGAGTCCGATGCCTGGCAAGAGAAGGACAAGGCCTATGTCCAGGCCCGGGTCCTGGAGAGCTACAGGTCG	28517.0	single nucleotide variant	NM_000219.6(KCNE1):c.221C>T (p.Ser74Leu)	3753.0	KCNE1	HGNC:6240	Conflicting classifications of pathogenicity	1.0	Dec 26, 2024	74315446.0	-	RCV000014421|RCV000119079|RCV000603252|RCV000471661|RCV003318541|RCV002482866|RCV004017244	MONDO:MONDO:0013372,MedGen:C1867904,OMIM:613695,Orphanet:101016,Orphanet:768|MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:101016,Orphanet:768|MedGen:CN169374|MONDO:MONDO:0002442,MeSH:D008133,MedGen:C0023976|MedGen:C3661900|MONDO:MONDO:0013372,MedGen:C1867904,OMIM:613695,Orphanet:101016,Orphanet:768;MONDO:MONDO:0012871,MedGen:C2676723,OMIM:612347,Orphanet:768,Orphanet:90647|MedGen:CN230736	Long QT syndrome 5|Congenital long QT syndrome|not specified|Long QT syndrome|not provided|Long QT syndrome 5;Jervell and Lange-Nielsen syndrome 2|Cardiovascular phenotype	germline;not applicable;unknown	germline	GRCh38	NC_000021.9	21	34449414.0	34449414.0	21q22.12	criteria provided, conflicting classifications	8.0	-	N	ClinGen:CA256871,UniProtKB:P15382#VAR_008900,OMIM:176261.0004	3.0	13478.0	34449414.0	G	A	-	-	-	-	-	-	SCV000549145|SCV000711387|SCV002782964|SCV004022801|SCV004849027	-	-	221C>T 	Ser74Leu	NM_000219.6	1.0	3_Conflicting	chr21	C	T	21-34449414-C-T		13478	21	34449414	G	A	S	L	rs74315446	21	35821712	21	34743582	74	KCNE1	ENSG00000180509	ENST00000432085	ENSP00000412498	P15382	KCNE1_HUMAN	c.221C>T	p.Ser74Leu	c.221C>T	p.Ser74Leu	principal1	Y	1	.	.	-	TCG	2	0	G	G/G	G/G	G/G	G/G	0.003	0.68399	D	0.008	0.68204	D	1.0	0.90580	D	0.992	0.80453	D	1.0	0.99291	D	simple_aae	0.0	100.0	2.78	0.80945	M	-4.14	0.75248	D	0.599	0.84151	1.0497	0.98107	D	0.9175	0.97262	D	10	0.8604144	0.85100	D	0.267962	0.89743	D	0.905	0.97394	.	.	.	.	.	0.976686183779	0.97620	.	0.62409	.	0.41270	0.663121879101	0.61793	T	0.939297	0.99023	D	0.311062	0.83706	D	0.378171	0.91302	D	0.973078608512878	0.69748	D	.	0.61383	.	0.5081588	0.67266	0.5400546	0.73164	0.5706729	0.70806	0.49932238	0.70794	-2.94	0.09559	T	.	0.68544	.	0.873296375531174	0.74376	0.99967861	0.99601	0.727	0.84873	.	.	.	.	.	.	4.442422	0.69042	25.3	0.99907933846712671	0.97802	0.895639	0.83526	D	0.750944786548977	0.82872	7.895299	0.657005618986356	0.79016	7.01849	5.16	5.16	0.70523	.	.	8.493	0.90334	11.646000	0.93845	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.345	0.25595	899	0.25042	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	3	264690	1.1334013E-5	.	3	109406	2.742080e-05	0	4	208038	1.922730e-05	0	4	236884	1.688590e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	1	9046	1.105460e-04	0	0	13392	0.000000e+00	0	2	42768	4.676390e-05	0	0	15690	0.000000e+00	0	1	9046	1.105460e-04	0	0	16212	0.000000e+00	0	0	30524	0.000000e+00	0	0	6210	0.000000e+00	0	1	13414	7.454900e-05	0	0	16732	0.000000e+00	0	2	89474	2.235290e-05	0	1	30608	3.267120e-05	0	1	13414	7.454900e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9570	0.000000e+00	0	1	17692	5.652270e-05	0	0	21630	0.000000e+00	0	2	102684	1.947720e-05	0	1	30526	3.275900e-05	0	1	17692	5.652270e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Conflicting_classifications_of_pathogenicity	not_specified|Long_QT_syndrome_5|not_provided|Long_QT_syndrome|Congenital_long_QT_syndrome|Cardiovascular_phenotype|Jervell_and_Lange-Nielsen_syndrome_2	criteria_provided,_conflicting_classifications	NC_000021.9:g.34449414G>A	ClinGen:CA256871|OMIM:176261.0004|UniProtKB:P15382#VAR_008900	CN169374|C1867904|C3661900|C0023976|C1141890|CN230736|C2676723	613695|PS192500|612347	101016|768|101016|768|768|90647	.	Ser	Leu	28517	single nucleotide variant	NM_000219.6(KCNE1):c.221C>T (p.Ser74Leu)	3753	KCNE1	HGNC:6240	Conflicting classifications of pathogenicity	1	Dec 26, 2024	74315446	-	RCV000014421|RCV000119079|RCV000603252|RCV000471661|RCV003318541|RCV002482866|RCV004017244	MONDO:MONDO:0013372,MedGen:C1867904,OMIM:613695,Orphanet:101016,Orphanet:768|MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:101016,Orphanet:768|MedGen:CN169374|MONDO:MONDO:0002442,MeSH:D008133,MedGen:C0023976|MedGen:C3661900|MONDO:MONDO:0013372,MedGen:C1867904,OMIM:613695,Orphanet:101016,Orphanet:768;MONDO:MONDO:0012871,MedGen:C2676723,OMIM:612347,Orphanet:768,Orphanet:90647|MedGen:CN230736	Long QT syndrome 5|Congenital long QT syndrome|not specified|Long QT syndrome|not provided|Long QT syndrome 5;Jervell and Lange-Nielsen syndrome 2|Cardiovascular phenotype	germline;not applicable;unknown	germline	GRCh38	NC_000021.9	21	34449414	34449414	21q22.12	criteria provided, conflicting classifications	8	-	N	ClinGen:CA256871,UniProtKB:P15382#VAR_008900,OMIM:176261.0004	3	13478	34449414	G	A	-	-	-	-	-	-	SCV000549145|SCV000711387|SCV002782964|SCV004022801|SCV004849027	-	-	221C>T 	Ser74Leu	NM_000219.6	1	3_Conflicting	KCNE1	ENSG00000180509	2013	214146	CCSBVarC006340	ALE00006340	221C>T	Ser74Leu	CEGS2	CegsMutGDEh1004	F09	GDEhDisVCh_40065	F01	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	KCNE1_Ser74Leu	21	21	34449414	G	A
14613	BRCA1	1172G>T	Arg391Met	ENSG00000012048	17	43076488	NC_000017.11:43076488:C:A	ALE00002123	CCSBVarC002123	23651	NULL	NULL	GDEhDisVCh_40059	B12	RC4	ATGGATTTATCTGCTCTTCGCGTTGAAGAAGTACAAAATGTCATTAATGCTATGCAGAAAATCTTAGAGTGTCCCATCTGTCTGGAGTTGATCAAGGAACCTGTCTCCACAAAGTGTGACCACATATTTTGCAAATTTTGCATGCTGAAACTTCTCAACCAGAAGAAAGGGCCTTCACAGTGTCCTTTATGTAAGAATGATATAACCAAAAGGAGCCTACAAGAAAGTACGAGATTTAGTCAACTTGTTGAAGAGCTATTGAAAATCATTTGTGCTTTTCAGCTTGACACAGGTTTGGAGTATGCAAACAGCTATAATTTTGCAAAAAAGGAAAATAACTCTCCTGAACATCTAAAAGATGAAGTTTCTATCATCCAAAGTATGGGCTACAGAAACCGTGCCAAAAGACTTCTACAGAGTGAACCCGAAAATCCTTCCTTGCAGGAAACCAGTCTCAGTGTCCAACTCTCTAACCTTGGAACTGTGAGAACTCTGAGGACAAAGCAGCGGATACAACCTCAAAAGACGTCTGTCTACATTGAATTGGGATCTGATTCTTCTGAAGATACCGTTAATAAGGCAACTTATTGCAGTGTGGGAGATCAAGAATTGTTACAAATCACCCCTCAAGGAACCAGGGATGAAATCAGTTTGGATTCTGCAAAAAAGGCTGCTTGTGAATTTTCTGAGACGGATGTAACAAATACTGAACATCATCAACCCAGTAATAATGATTTGAACACCACTGAGAAGCGTGCAGCTGAGAGGCATCCAGAAAAGTATCAGGGTGAAGCAGCATCTGGGTGTGAGAGTGAAACAAGCGTCTCTGAAGACTGCTCAGGGCTATCCTCTCAGAGTGACATTTTAACCACTCAGCAGAGGGATACCATGCAACATAACCTGATAAAGCTCCAGCAGGAAATGGCTGAACTAGAAGCTGTGTTAGAACAGCATGGGAGCCAGCCTTCTAACAGCTACCCTTCCATCATAAGTGACTCTTCTGCCCTTGAGGACCTGCGAAATCCAGAACAAAGCACATCAGAAAAAGTATTAACTTCACAGAAAAGTAGTGAATACCCTATAAGCCAGAATCCAGAAGGCCTTTCTGCTGACAAGTTTGAGGTGTCTGCAGATAGTTCTACCAGTAAAAATAAAGAACCAGGAGTGGAAATGTCATCCCCTTCTAAATGCCCATCATTAGATGATAGGTGGTACATGCACAGTTGCTCTGGGAGTCTTCAGAATAGAAACTACCCATCTCAAGAGGAGCTCATTAAGGTTGTTGATGTGGAGGAGCAACAGCTGGAAGAGTCTGGGCCACACGATTTGACGGAAACATCTTACTTGCCAAGGCAAGATCTAGAGGGAACCCCTTACCTGGAATCTGGAATCAGCCTCTTCTCTGATGACCCTGAATCTGATCCTTCTGAAGACAGAGCCCCAGAGTCAGCTCGTGTTGGCAACATACCATCTTCAACCTCTGCATTGAAAGTTCCCCAATTGAAAGTTGCAGAATCTGCCCAGAGTCCAGCTGCTGCTCATACTACTGATACTGCTGGGTATAATGCAATGGAAGAAAGTGTGAGCAGGGAGAAGCCAGAATTGACAGCTTCAACAGAAAGGGTCAACAAAAGAATGTCCATGGTGGTGTCTGGCCTGACCCCAGAAGAATTTATGCTCGTGTACAAGTTTGCCAGAAAACACCACATCACTTTAACTAATCTAATTACTGAAGAGACTACTCATGTTGTTATGAAAACAGATGCTGAGTTTGTGTGTGAACGGACACTGAAATATTTTCTAGGAATTGCGGGAGGAAAATGGGTAGTTAGCTATTTCTGGGTGACCCAGTCTATTAAAGAAAGAAAAATGCTGAATGAGCATGATTTTGAAGTCAGAGGAGATGTGGTCAATGGAAGAAACCACCAAGGTCCAAAGCGAGCAAGAGAATCCCAGGACAGAAAGATCTTCAGGGGGCTAGAAATCTGTTGCTATGGGCCCTTCACCAACATGCCCACAGGGTGTCCACCCAATTGTGGTTGTGCAGCCAGATGCCTGGACAGAGGACAATGGCTTCCATGCAATTGGGCAGATGTG	46154.0	single nucleotide variant	NM_007294.4(BRCA1):c.4484G>T (p.Arg1495Met)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Jan 23, 2025	80357389.0	-	RCV000131886|RCV000159992|RCV000770739|RCV005016310|RCV000031179|RCV000048576|RCV000462940|RCV001171414|RCV000238601	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MedGen:CN221562|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374	Hereditary cancer-predisposing syndrome|not provided|Breast and/or ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4;Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1;Hereditary breast ovarian cancer syndrome|not specified	germline;unknown	germline	GRCh38	NC_000017.11	17	43076488.0	43076488.0	17q21.31	criteria provided, multiple submitters, no conflicts	24.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	Breast Cancer Information Core (BIC) (BRCA1):4603&base_change=G to T,ClinGen:CA002876,UniProtKB:P38398#VAR_063900	2.0	37598.0	43076488.0	C	A	-	-	-	-	-	-	SCV000076589|SCV000186941|SCV000210177|SCV000223754|SCV000296380|SCV000296803|SCV000325979|SCV000537652|SCV000540946|SCV000605750|SCV000699152|SCV000902222|SCV001140523|SCV002512513|SCV002515213|SCV002537753|SCV004215024|SCV004817666|SCV005647134	-	-	4484G>T 	Arg1495Met	NM_007294.4	2.0	1_Pathogenic	chr17	G	T	17-43076488-G-T		37598	17	43076488	C	A	R	M	rs80357389	17	41228505	17	38482031	1495	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.4484G>T	p.Arg1495Met	principal2	Y	1	.	.	-	AGG	2	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.69466	.	0.468	0.63438	P	0.215	0.73159	B	.	0.99291	.	.	.	.	1.895	0.50187	L	.	0.58927	.	.	0.80306	0.5123	0.90684	D	0.7437	0.91227	D	9	.	0.65625	.	0.825771	0.98644	D	.	0.89238	.	.	.	.	.	.	0.88343	.	0.29073	.	0.18057	0.296483755112	0.09873	T	0.157106	0.49694	T	0.355325	0.86796	D	0.272623	0.86624	D	0.845764636993408	0.49533	D	.	0.55938	.	0.11150219	0.26113	0.10292555	0.24633	0.13314977	0.30712	0.09751014	0.23171	-3.944	0.23826	T	.	0.37685	.	0.925453315994447	0.78001	0.99961948	0.99542	0.915	0.95626	.	.	.	.	.	.	5.032274	0.83736	28.1	0.95831755947551867	0.28156	0.813047	0.73465	D	0.417212491786565	0.62173	4.451626	0.412864384325496	0.62163	4.450753	4.97	4.97	0.65374	5.07	0.90660	3.879	0.55941	5.667000	0.49316	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.977	0.56847	527	0.73883	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	1	109282	9.150640e-06	0	1	207956	4.808710e-06	0	1	236646	4.225720e-06	0	0	7160	0.000000e+00	0	0	17108	0.000000e+00	0	0	2320	0.000000e+00	0	0	9040	0.000000e+00	0	0	13292	0.000000e+00	0	1	42760	2.338630e-05	0	0	15688	0.000000e+00	0	1	42760	2.338630e-05	0	0	16212	0.000000e+00	0	0	30518	0.000000e+00	0	0	6210	0.000000e+00	0	0	13408	0.000000e+00	0	0	16632	0.000000e+00	0	1	89510	1.117190e-05	0	0	30604	0.000000e+00	0	1	89510	1.117190e-05	0	0	14896	0.000000e+00	0	0	34254	0.000000e+00	0	0	9564	0.000000e+00	0	0	17684	0.000000e+00	0	0	21528	0.000000e+00	0	1	102588	9.747730e-06	0	0	30522	0.000000e+00	0	1	102588	9.747730e-06	0	.	4	1613516	2.479060e-06	0	4	1179796	3.390420e-06	0	0	74976	0.000000e+00	0	0	912	0.000000e+00	0	0	59986	0.000000e+00	0	0	29594	0.000000e+00	0	0	44826	0.000000e+00	0	0	63812	0.000000e+00	0	0	6058	0.000000e+00	0	4	1179796	3.390420e-06	0	0	91068	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Pathogenic	Familial_cancer_of_breast|not_specified|Breast_and/or_ovarian_cancer|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.43076488C>A	Breast_Cancer_Information_Core_(BIC)_(BRCA1):4603&base_change%3DG_to_T|ClinGen:CA002876|UniProtKB:P38398#VAR_063900	C0346153|CN169374|CN221562|C3661900|C2676676|C0677776|C0027672	114480|604370	227535|145|145|140162	.	Arg	Met	46154	single nucleotide variant	NM_007294.4(BRCA1):c.4484G>T (p.Arg1495Met)	672	BRCA1	HGNC:1100	Pathogenic	1	Jan 23, 2025	80357389	-	RCV000131886|RCV000159992|RCV000770739|RCV005016310|RCV000031179|RCV000048576|RCV000462940|RCV001171414|RCV000238601	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MedGen:CN221562|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374	Hereditary cancer-predisposing syndrome|not provided|Breast and/or ovarian cancer|Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4;Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1;Hereditary breast ovarian cancer syndrome|not specified	germline;unknown	germline	GRCh38	NC_000017.11	17	43076488	43076488	17q21.31	criteria provided, multiple submitters, no conflicts	24	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	Breast Cancer Information Core (BIC) (BRCA1):4603&base_change=G to T,ClinGen:CA002876,UniProtKB:P38398#VAR_063900	2	37598	43076488	C	A	-	-	-	-	-	-	SCV000076589|SCV000186941|SCV000210177|SCV000223754|SCV000296380|SCV000296803|SCV000325979|SCV000537652|SCV000540946|SCV000605750|SCV000699152|SCV000902222|SCV001140523|SCV002512513|SCV002515213|SCV002537753|SCV004215024|SCV004817666|SCV005647134	-	-	4484G>T 	Arg1495Met	NM_007294.4	2	1_Pathogenic	BRCA1	ENSG00000012048	14613	23651	CCSBVarC002123	ALE00002123	1172G>T	Arg391Met	RC4	RC4_Mut_GDEh1029	E02	GDEhDisVCh_40059	B12	1	RC4_Mut_GDDh1029	E02	NULL	NULL	NULL	NULL	NULL	NULL	1	6	1	4	0	NULL	0	NULL	0	NULL	BRCA1_Arg391Met	17	17	43076488	C	A
3774	TP53	1010G>A	Arg337His	ENSG00000141510	17	7670699	NC_000017.11:7670699:C:T	ALE00000548	CCSBVarC000548	7040	NULL	NULL	GDEhDisVCh_40053	F11	RC4	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACCGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCACTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	27418.0	single nucleotide variant	NM_000546.6(TP53):c.1010G>A (p.Arg337His)	7157.0	TP53	HGNC:11998	Pathogenic/Likely pathogenic	1.0	Dec 05, 2024	121912664.0	-	RCV000013178|RCV000128923|RCV000197240|RCV000576817|RCV000413754|RCV000481814|RCV000989700|RCV001375632|RCV002307364|RCV002496338|RCV004797591|RCV003162248	MedGen:C1859973|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|Human Phenotype Ontology:HP:0010623,Human Phenotype Ontology:HP:0100013,MONDO:MONDO:0021100,MeSH:D001943,MedGen:C1458155|MedGen:C3661900|MONDO:MONDO:0010150,MeSH:D000077195,MedGen:C1168401,OMIM:275355,Orphanet:67037|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|12 conditions||Human Phenotype Ontology:HP:0012126,MONDO:MONDO:0001056,MeSH:D013274,MedGen:C0024623,OMIM:613659	ADRENOCORTICAL CARCINOMA, PEDIATRIC|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Breast neoplasm|not provided|Squamous cell carcinoma of the head and neck|Adrenocortical carcinoma, hereditary|Hereditary breast ovarian cancer syndrome|12 conditions|TP53-related disorder|Gastric cancer	germline;maternal;unknown	germline	GRCh38	NC_000017.11	17	7670699.0	7670699.0	17p13.1	criteria provided, multiple submitters, no conflicts	24.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000013,UniProtKB:P04637#VAR_035016,OMIM:191170.0035	3.0	12379.0	7670699.0	C	T	-	-	-	-	-	-	SCV000172792|SCV000253848|SCV000492466|SCV000537678|SCV000568754|SCV000677744|SCV001140239|SCV001547487|SCV001762195|SCV002030174|SCV002097308|SCV002515183|SCV002582334|SCV002582996|SCV002811422|SCV004183390|SCV004206232|SCV004221343|SCV004823731|SCV004847779|SCV005382098|SCV005407752	-	-	1010G>A 	Arg337His	NM_000546.6	2.0	1_Pathogenic	chr17	G	A	17-7670699-G-A		12379	17	7670699	C	T	R	H	rs121912664	17	7574017	17	7514742	337	TP53	ENSG00000141510	ENST00000503591	ENSP00000426252	P04637	P53_HUMAN	c.*4530G>A	.	c.1010G>A	p.Arg337His	principal1	.	5	.	.	-	CGC	2	0	C	C/C	C/C	C/C	C/C	.	0.42941	.	.	0.47448	.	0.96	0.55293	D	0.719	0.54817	P	.	0.97016	.	.	.	.	2.4	0.69265	M	.	0.47863	.	.	0.80503	0.7348	0.93585	D	0.8401	0.94644	D	10	.	0.95631	.	0.247084	0.88928	D	.	0.88818	0.934	0.99013	P04637	R337H	Loss of MoRF binding (P = 0.0485)| Gain of methylation at R335 (P = 0.0936)| Loss of solvent accessibility (P = 0.239)| Loss of disorder (P = 0.2726)| Gain of catalytic residue at R335 (P = 0.2915)	.	0.95591	.	0.56666	.	0.41720	0.443906903267	0.31071	T	0.877603	0.97386	D	0.166855	0.70619	D	0.177746	0.81733	D	0.790275990962982	0.45420	D	.	0.40911	.	0.7353936	0.79791	0.3291861	0.58571	0.49358842	0.66408	0.31266817	0.57044	-5.447	0.45899	T	.	0.67239	.	0.768085458818429	0.69488	0.99936503	0.99325	0.725	0.84761	.	.	.	.	.	.	3.445163	0.48032	22.5	0.99876254603481207	0.95331	0.202631	0.32709	N	0.00262436853355222	0.41711	2.520475	-0.148351003044252	0.33161	1.915003	5.43	3.45	0.38530	3.44	0.62291	0.244	0.1796	2.735000	0.34500	0.599	0.40292	0.0	0.06393	1.000000	0.68239	0.667	0.33207	450	0.79381	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	1	109272	9.151480e-06	0	3	207780	1.443830e-05	0	1	236428	4.229620e-06	0	0	7120	0.000000e+00	0	1	17092	5.850690e-05	0	0	2316	0.000000e+00	0	0	9044	0.000000e+00	0	0	13390	0.000000e+00	0	0	42736	0.000000e+00	0	0	15662	0.000000e+00	0	1	17092	5.850690e-05	0	0	16134	0.000000e+00	0	2	30480	6.561680e-05	0	0	6200	0.000000e+00	0	0	13406	0.000000e+00	0	0	16728	0.000000e+00	0	0	89436	0.000000e+00	0	0	30538	0.000000e+00	0	2	30480	6.561680e-05	0	0	14852	0.000000e+00	0	1	34216	2.922610e-05	0	0	9538	0.000000e+00	0	0	17688	0.000000e+00	0	0	21626	0.000000e+00	0	0	102440	0.000000e+00	0	0	30456	0.000000e+00	0	1	34216	2.922610e-05	0	.	5	1613858	3.098170e-06	0	3	59966	5.002830e-05	0	0	74912	0.000000e+00	0	0	908	0.000000e+00	0	3	59966	5.002830e-05	0	0	29596	0.000000e+00	0	0	44880	0.000000e+00	0	0	64004	0.000000e+00	0	0	6084	0.000000e+00	0	1	1179976	8.474750e-07	0	0	91046	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Pathogenic/Likely_pathogenic	Adrenocortical_carcinoma,_pediatric|Li-Fraumeni_syndrome_1|Gastric_cancer|Hereditary_cancer-predisposing_syndrome|Li-Fraumeni_syndrome|Colorectal_cancer|Basal_cell_carcinoma,_susceptibility_to,_7|Adrenocortical_carcinoma,_hereditary|Bone_marrow_failure_syndrome_5|Hepatocellular_carcinoma|Nasopharyngeal_carcinoma|Carcinoma_of_pancreas|Choroid_plexus_papilloma|Glioma_susceptibility_1|Bone_osteosarcoma|Familial_cancer_of_breast|Breast_neoplasm|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Squamous_cell_carcinoma_of_the_head_and_neck	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.7670699C>T	ClinGen:CA000013|OMIM:191170.0035|UniProtKB:P04637#VAR_035016	C1859973|C1835398|C0024623|C0027672|C0085390|C0346629|C3553606|C1859972|C4748488|C2239176|C2931822|C0235974|C0205770|C2750850|C0585442|C0346153|C1458155|C0677776|C3661900|C1168401	151623|613659|PS151623|114500|614740|202300|618165|114550|607107|260500|137800|259500|114480|275355	524|140162|524|1501|88673|150|1333|217074|251899|2807|668|227535|145|67037	p53, tetramerisation domain	Arg	His	27418	single nucleotide variant	NM_000546.6(TP53):c.1010G>A (p.Arg337His)	7157	TP53	HGNC:11998	Pathogenic/Likely pathogenic	1	Dec 05, 2024	121912664	-	RCV000013178|RCV000128923|RCV000197240|RCV000576817|RCV000413754|RCV000481814|RCV000989700|RCV001375632|RCV002307364|RCV002496338|RCV004797591|RCV003162248	MedGen:C1859973|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|Human Phenotype Ontology:HP:0010623,Human Phenotype Ontology:HP:0100013,MONDO:MONDO:0021100,MeSH:D001943,MedGen:C1458155|MedGen:C3661900|MONDO:MONDO:0010150,MeSH:D000077195,MedGen:C1168401,OMIM:275355,Orphanet:67037|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|12 conditions||Human Phenotype Ontology:HP:0012126,MONDO:MONDO:0001056,MeSH:D013274,MedGen:C0024623,OMIM:613659	ADRENOCORTICAL CARCINOMA, PEDIATRIC|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Breast neoplasm|not provided|Squamous cell carcinoma of the head and neck|Adrenocortical carcinoma, hereditary|Hereditary breast ovarian cancer syndrome|12 conditions|TP53-related disorder|Gastric cancer	germline;maternal;unknown	germline	GRCh38	NC_000017.11	17	7670699	7670699	17p13.1	criteria provided, multiple submitters, no conflicts	24	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000013,UniProtKB:P04637#VAR_035016,OMIM:191170.0035	3	12379	7670699	C	T	-	-	-	-	-	-	SCV000172792|SCV000253848|SCV000492466|SCV000537678|SCV000568754|SCV000677744|SCV001140239|SCV001547487|SCV001762195|SCV002030174|SCV002097308|SCV002515183|SCV002582334|SCV002582996|SCV002811422|SCV004183390|SCV004206232|SCV004221343|SCV004823731|SCV004847779|SCV005382098|SCV005407752	-	-	1010G>A 	Arg337His	NM_000546.6	2	1_Pathogenic	TP53	ENSG00000141510	3774	7040	CCSBVarC000548	ALE00000548	1010G>A	Arg337His	RC4	RC4_Mut_GDEh1019	E11	GDEhDisVCh_40053	F11	1	RC4_Mut_GDDh1019	E11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	TP53_Arg337His	17	17	7670699	C	T
14613	BRCA1	1159C>G	Pro387Ala	ENSG00000012048	17	43076501	NC_000017.11:43076501:G:C	ALE00003299	CCSBVarC003299	NULL	218408	NULL	GDEhDisVCh_40059	H09	CEGS2	ATGGATTTATCTGCTCTTCGCGTTGAAGAAGTACAAAATGTCATTAATGCTATGCAGAAAATCTTAGAGTGTCCCATCTGTCTGGAGTTGATCAAGGAACCTGTCTCCACAAAGTGTGACCACATATTTTGCAAATTTTGCATGCTGAAACTTCTCAACCAGAAGAAAGGGCCTTCACAGTGTCCTTTATGTAAGAATGATATAACCAAAAGGAGCCTACAAGAAAGTACGAGATTTAGTCAACTTGTTGAAGAGCTATTGAAAATCATTTGTGCTTTTCAGCTTGACACAGGTTTGGAGTATGCAAACAGCTATAATTTTGCAAAAAAGGAAAATAACTCTCCTGAACATCTAAAAGATGAAGTTTCTATCATCCAAAGTATGGGCTACAGAAACCGTGCCAAAAGACTTCTACAGAGTGAACCCGAAAATCCTTCCTTGCAGGAAACCAGTCTCAGTGTCCAACTCTCTAACCTTGGAACTGTGAGAACTCTGAGGACAAAGCAGCGGATACAACCTCAAAAGACGTCTGTCTACATTGAATTGGGATCTGATTCTTCTGAAGATACCGTTAATAAGGCAACTTATTGCAGTGTGGGAGATCAAGAATTGTTACAAATCACCCCTCAAGGAACCAGGGATGAAATCAGTTTGGATTCTGCAAAAAAGGCTGCTTGTGAATTTTCTGAGACGGATGTAACAAATACTGAACATCATCAACCCAGTAATAATGATTTGAACACCACTGAGAAGCGTGCAGCTGAGAGGCATCCAGAAAAGTATCAGGGTGAAGCAGCATCTGGGTGTGAGAGTGAAACAAGCGTCTCTGAAGACTGCTCAGGGCTATCCTCTCAGAGTGACATTTTAACCACTCAGCAGAGGGATACCATGCAACATAACCTGATAAAGCTCCAGCAGGAAATGGCTGAACTAGAAGCTGTGTTAGAACAGCATGGGAGCCAGCCTTCTAACAGCTACCCTTCCATCATAAGTGACTCTTCTGCCCTTGAGGACCTGCGAAATCCAGAACAAAGCACATCAGAAAAAGTATTAACTTCACAGAAAAGTAGTGAATACCCTATAAGCCAGAATCCAGAAGGCCTTTCTGCTGACAAGTTTGAGGTGTCTGCAGATAGTTCTACCAGTAAAAATAAAGAAGCAGGAGTGGAAAGGTCATCCCCTTCTAAATGCCCATCATTAGATGATAGGTGGTACATGCACAGTTGCTCTGGGAGTCTTCAGAATAGAAACTACCCATCTCAAGAGGAGCTCATTAAGGTTGTTGATGTGGAGGAGCAACAGCTGGAAGAGTCTGGGCCACACGATTTGACGGAAACATCTTACTTGCCAAGGCAAGATCTAGAGGGAACCCCTTACCTGGAATCTGGAATCAGCCTCTTCTCTGATGACCCTGAATCTGATCCTTCTGAAGACAGAGCCCCAGAGTCAGCTCGTGTTGGCAACATACCATCTTCAACCTCTGCATTGAAAGTTCCCCAATTGAAAGTTGCAGAATCTGCCCAGAGTCCAGCTGCTGCTCATACTACTGATACTGCTGGGTATAATGCAATGGAAGAAAGTGTGAGCAGGGAGAAGCCAGAATTGACAGCTTCAACAGAAAGGGTCAACAAAAGAATGTCCATGGTGGTGTCTGGCCTGACCCCAGAAGAATTTATGCTCGTGTACAAGTTTGCCAGAAAACACCACATCACTTTAACTAATCTAATTACTGAAGAGACTACTCATGTTGTTATGAAAACAGATGCTGAGTTTGTGTGTGAACGGACACTGAAATATTTTCTAGGAATTGCGGGAGGAAAATGGGTAGTTAGCTATTTCTGGGTGACCCAGTCTATTAAAGAAAGAAAAATGCTGAATGAGCATGATTTTGAAGTCAGAGGAGATGTGGTCAATGGAAGAAACCACCAAGGTCCAAAGCGAGCAAGAGAATCCCAGGACAGAAAGATCTTCAGGGGGCTAGAAATCTGTTGCTATGGGCCCTTCACCAACATGCCCACAGGGTGTCCACCCAATTGTGGTTGTGCAGCCAGATGCCTGGACAGAGGACAATGGCTTCCATGCAATTGGGCAGATGTG	69874.0	single nucleotide variant	NM_007294.4(BRCA1):c.4471C>G (p.Pro1491Ala)	672.0	BRCA1	HGNC:1100	Uncertain significance	0.0	Mar 21, 2024	111034213.0	-	RCV000576950|RCV001360639|RCV004601102	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Familial cancer of breast|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000017.11	17	43076501.0	43076501.0	17q21.31	criteria provided, multiple submitters, no conflicts	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002866	3.0	55207.0	43076501.0	G	C	-	-	-	-	-	-	SCV001556566|SCV005100953	-	-	4471C>G 	Pro1491Ala	NM_007294.4	2.0	4_VUS	chr17	C	G	17-43076501-C-G		55207	17	43076501	G	C	P	A	rs111034213	17	41228518	17	38482044	1491	BRCA1	ENSG00000012048	ENST00000494123	ENSP00000419103	P38398	BRCA1_HUMAN	.	.	c.4471C>G	p.Pro1491Ala	principal2	Y	1	.	.	-	CCA	1	0	G	G/G	G/G	G/G	G/G	.	0.60085	.	.	0.28427	.	0.022	0.35238	B	0.016	0.23122	B	.	.	.	.	.	.	1.78	0.46014	L	.	0.67392	.	.	0.50358	-1.0635	0.10914	T	0.0881	0.33827	T	10	.	0.07942	.	0.04164	0.59881	D	.	0.34465	.	.	.	.	.	.	0.28612	.	0.09755	.	0.12948	0.238522678614	0.02661	T	0.15061	0.48744	T	-0.0152646	0.49199	T	-0.259703	0.48523	T	0.077760711312294	0.09579	T	.	0.74594	.	0.016811376	0.00224	0.021325782	0.00190	0.01885761	0.00408	0.023838464	0.00402	-3.385	0.15123	T	.	0.08118	.	0.0679301513115672	0.39861	0.99158670	0.96990	0.267	0.53761	.	.	.	.	.	.	1.12823	0.15164	11.62	0.69621395145674481	0.09173	0.152145	0.27462	N	-0.705114867284738	0.15682	0.8041004	-0.735481971326327	0.15811	0.8489346	4.97	1.72	0.23435	3.12	0.56789	0.854	0.27538	0.534000	0.19350	0.676	0.76753	0.032	0.2062	0.000000	0.08389	0.98	0.58201	527	0.73883	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	Hereditary_breast_ovarian_cancer_syndrome|Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.43076501G>C	ClinGen:CA002866	C0677776|C0346153|C0027672	114480	145|227535|140162	.	Pro	Ala	69874	single nucleotide variant	NM_007294.4(BRCA1):c.4471C>G (p.Pro1491Ala)	672	BRCA1	HGNC:1100	Uncertain significance	0	Mar 21, 2024	111034213	-	RCV000576950|RCV001360639|RCV004601102	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Familial cancer of breast|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000017.11	17	43076501	43076501	17q21.31	criteria provided, multiple submitters, no conflicts	3	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002866	3	55207	43076501	G	C	-	-	-	-	-	-	SCV001556566|SCV005100953	-	-	4471C>G 	Pro1491Ala	NM_007294.4	2	4_VUS	BRCA1	ENSG00000012048	14613	218408	CCSBVarC003299	ALE00003299	1159C>G	Pro387Ala	CEGS2	CegsMutGDEh1028	F11	GDEhDisVCh_40059	H09	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	BRCA1_Pro387Ala	17	17	43076501	G	C
52861	F9	998C>T	Pro333Leu	ENSG00000101981	X	139561683	NC_000023.11:139561683:C:T	ALE00004385	CCSBVarC004385	NULL	204374	NULL	GDEhDisVCh_40052	A06	CEGS2	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACTTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT	25644.0	single nucleotide variant	NM_000133.4(F9):c.998C>T (p.Pro333Leu)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Oct 09, 2017	137852252.0	-	RCV000011351	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561683.0	139561683.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255375,OMIM:300746.0048	1.0	10605.0	139561683.0	C	T	-	-	-	-	-	-	SCV000031583	-	-	998C>T 	Pro333Leu	NM_000133.4		1_Pathogenic	chrX	C	T	X-139561683-C-T		10605	X	139561683	C	T	P	L	rs137852252	X	138643842	X	138471508	333	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.998C>T	p.Pro333Leu	c.998C>T	p.Pro333Leu	principal1	Y	1	YES	Select	+	CCT	2	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.75	0.90832	A	simple_aae	25.0	75.0	2.73	0.79671	M	-9.94	0.98771	D	0.859	0.92671	1.0159	0.97454	D	0.9163	0.97222	D	10	0.99203384	0.99736	D	0.583299	0.96267	D	0.920	0.97963	0.971	0.99725	P00740	P333L	Gain of sheet (P = 0.0827)| Loss of loop (P = 0.2897)| Gain of catalytic residue at D338 (P = 0.4148)| Loss of glycosylation at S329 (P = 0.7194)| Loss of phosphorylation at T332 (P = 0.7353)	0.995518902514	0.99540	0.9992527010438141	0.99925	1.66441580669	0.89687	0.644322156906	0.59115	T	0.94424	0.99137	D	0.648334	0.99884	D	0.69351	0.99883	D	0.998754501342773	0.95025	D	0.950305	0.80941	D	0.97182083	0.98401	0.9523348	0.98516	0.9780011	0.98935	0.9592478	0.98914	-10.768	0.78441	D	0.6712	0.76851	P	0.999792545073085	0.98009	0.99999225	0.99996	0.99	0.99661	.	.	.	.	.	.	4.736439	0.76387	26.5	0.99714179622655752	0.81581	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	4.99	0.89858	7.542	0.81082	7.707000	0.66650	-0.202	0.08747	1.0	0.71675	1.000000	0.68239	0.989	0.64309	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561683C>T	ClinGen:CA255375|OMIM:300746.0048	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Pro	Leu	25644	single nucleotide variant	NM_000133.4(F9):c.998C>T (p.Pro333Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852252	-	RCV000011351	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561683	139561683	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255375,OMIM:300746.0048	1	10605	139561683	C	T	-	-	-	-	-	-	SCV000031583	-	-	998C>T 	Pro333Leu	NM_000133.4		1_Pathogenic	F9	ENSG00000101981	52861	204374	CCSBVarC004385	ALE00004385	998C>T	Pro333Leu	CEGS2	CegsMutGDEh1025	C09	GDEhDisVCh_40052	A06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	F9_Pro333Leu	23	X	139561683	C	T
2803	HMBS	625G>A	Glu209Lys	ENSG00000256269	11	119092137	NC_000011.10:119092137:G:A	ALE00000331	CCSBVarC000331	4868	NULL	NULL	GDEhDisVCh_40054	E11	RC4	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAGCTTGCTCGCATACAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGGACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCTTGAACATGCCCTGGAGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCGAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTCGGGGAAACCTCAACACCCGGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACCGGGTGGGGCAGATCCTGCACCCTAAGGAATGCATGTATGCTGTGGGCCAGGGGGCCTTGGGCGTGGAAGTGCGAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCTGCATCGCTGAAAGGGCCTTCCTGAGGCACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATGGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCGTAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACGATGCCCAT	1874391.0	single nucleotide variant	NM_000190.4(HMBS):c.625G>A (p.Glu209Lys)	3145.0	HMBS	HGNC:4982	Uncertain significance	0.0	Jun 20, 2024	-1.0	-	RCV003062464	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000011.10	11	119092137.0	119092137.0	11q23.3	criteria provided, multiple submitters, no conflicts	2.0	-	N	ClinGen:CA229596005	2.0	2137264.0	119092137.0	G	A	-	-	-	-	-	-	SCV003440956|SCV005439245	-	-	625G>A 	Glu209Lys	NM_000190.4	2.0	4_VUS	chr11	G	A	11-119092137-G-A	4.78876e-6	2137264	11	119092137	G	A	E	K	rs1007859875	11	118962847	11	118468057	209	HMBS	ENSG00000256269	ENST00000652429	ENSP00000498786	P08397	HEM3_HUMAN	c.625G>A	p.Glu209Lys	c.625G>A	p.Glu209Lys	principal2	Y	.	YES	Select	+	GAG	1	0	G	G/G	G/G	G/G	G/G	.	0.39251	.	.	0.44261	.	0.739	0.42947	P	0.489	0.47307	P	.	0.94956	.	.	.	.	1.57	0.39465	L	.	0.56814	.	.	0.63016	1.1075	0.99844	D	0.9729	0.99149	D	10	.	0.94856	.	0.601227	0.96484	D	.	0.95570	0.846	0.94938	P08397	E209K	Gain of ubiquitination at E209 (P = 0.0337)| Gain of methylation at E209 (P = 0.0447)| Gain of glycosylation at E209 (P = 0.0495)| Gain of MoRF binding (P = 0.0635)| Gain of helix (P = 0.132)	.	0.95680	0.8358615116470038	0.83446	.	.	0.63794708252	0.58207	T	0.940792	0.99059	D	0.51408	0.94666	D	0.500664	0.94588	D	0.895531058311462	0.54457	D	0.945205	0.80399	D	0.6071126	0.72789	0.45779136	0.68235	0.5897087	0.71848	0.5545327	0.73984	-5.812	0.44735	T	0.1014	0.23603	B	0.831223965266546	0.72183	0.18132675	0.72179	0.895	0.94425	.	.	.	.	.	.	5.29528	0.88923	29.8	0.99887727282720495	0.96284	0.933529	0.92529	D	0.479722293173385	0.65728	4.881942	0.578965850205277	0.73289	5.969789	5.3	5.3	0.74708	.	.	8.766	0.91399	11.820000	0.97211	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.981	0.58703	228	0.91137	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	1	109398	9.140930e-06	0	1	208118	4.804970e-06	0	1	236934	4.220580e-06	0	0	7164	0.000000e+00	0	0	17108	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13390	0.000000e+00	0	1	42766	2.338310e-05	0	0	15690	0.000000e+00	0	1	42766	2.338310e-05	0	0	16218	0.000000e+00	0	0	30520	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16730	0.000000e+00	0	1	89550	1.116690e-05	0	0	30608	0.000000e+00	0	1	89550	1.116690e-05	0	0	14902	0.000000e+00	0	0	34256	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21628	0.000000e+00	0	1	102738	9.733500e-06	0	0	30526	0.000000e+00	0	1	102738	9.733500e-06	0	.	9	1613976	5.576290e-06	0	9	1180018	7.627000e-06	0	0	74930	0.000000e+00	0	0	912	0.000000e+00	0	0	60002	0.000000e+00	0	0	29608	0.000000e+00	0	0	44902	0.000000e+00	0	0	64022	0.000000e+00	0	0	6028	0.000000e+00	0	9	1180018	7.627000e-06	0	0	91084	0.000000e+00	0	0	26546	0	0	114	0	0	86	0	0	2804	0	0	496	0	0	628	0	0	26	0	0	98	0	1	4572	2.1872265966754156E-4	0	2918	0	0	112	0	1	35370	2.827254735651682E-5	Uncertain_significance	not_provided	criteria_provided,_single_submitter	NC_000011.10:g.119092137G>A	.	C3661900	.	.	Porphobilinogen deaminase, N-terminal	Glu	Lys	1874391	single nucleotide variant	NM_000190.4(HMBS):c.625G>A (p.Glu209Lys)	3145	HMBS	HGNC:4982	Uncertain significance	0	Jun 20, 2024	-1	-	RCV003062464	MedGen:C3661900	not provided	germline	germline	GRCh38	NC_000011.10	11	119092137	119092137	11q23.3	criteria provided, multiple submitters, no conflicts	2	-	N	ClinGen:CA229596005	2	2137264	119092137	G	A	-	-	-	-	-	-	SCV003440956|SCV005439245	-	-	625G>A 	Glu209Lys	NM_000190.4	2	4_VUS	HMBS	ENSG00000256269	2803	4868	CCSBVarC000331	ALE00000331	625G>A	Glu209Lys	RC4	RC4_Mut_GDEh1018	E04	GDEhDisVCh_40054	E11	2	RC4_Mut_GDDh1018	E04	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	HMBS_Glu209Lys	11	11	119092137	G	A
359	CBS	953C>T	Thr318Met	ENSG00000160200	21	43062954	NC_000021.9:43062954:G:A	ALE00007314	CCSBVarC007320	NULL	NULL	269	GDEhDisVCh_40013	E06	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGATGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	403798.0	single nucleotide variant	NM_000071.3(CBS):c.953C>T (p.Thr318Met)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Jul 03, 2022	769541394.0	-	RCV000468076|RCV000755893|RCV002523289	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3661900|MedGen:C3150344	Classic homocystinuria|not provided|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;unknown	germline	GRCh38	NC_000021.9	21	43062954.0	43062954.0	21q22.3	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA16616303	2.0	405378.0	43062954.0	G	A	-	-	-	-	-	-	SCV000543520|SCV000799106|SCV000883540	-	-	953C>T 	Thr318Met	NM_000071.3	2.0	4_VUS	chr21	C	T	21-43062954-C-T		405378	21	43062954	G	A	T	M	rs769541394	21	44483064	21	43356133	318	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.953C>T	p.Thr318Met	c.953C>T	p.Thr318Met	principal1	Y	1	.	.	-	ACG	2	0	G	G/G	G/G	G/G	G/G	0.007	0.60085	D	0.011	0.65108	D	0.996	0.68795	D	0.82	0.59066	P	.	.	.	.	.	.	2.61	0.76153	M	-2.31	0.51338	N	0.308	0.34747	0.5719	0.91496	D	0.8715	0.95720	D	10	0.6519398	0.69383	D	0.391564	0.93186	D	0.423	0.73008	0.463	0.53105	P35520	T318M	Loss of phosphorylation at T318 (P = 0.0217)| Gain of ubiquitination at K322 (P = 0.0817)| Gain of catalytic residue at V314 (P = 0.1124)| Loss of sheet (P = 0.1158)| Gain of helix (P = 0.132)	0.896227544577	0.89440	.	0.46930	.	0.41206	0.383333712816	0.22704	T	0.962401	0.99523	D	-0.087702	0.38102	T	-0.0944545	0.63566	T	0.331722736358643	0.25998	T	.	0.90043	.	0.15018585	0.33917	0.18996479	0.42226	0.24704894	0.47350	0.24631673	0.49947	-9.018	0.67891	D	.	0.06095	.	0.369651421961533	0.56680	0.99534660	0.97762	0.841	0.91258	.	.	.	.	.	.	4.027536	0.59602	24.1	0.99809085511047246	0.89361	0.778714	0.71007	D	0.128060276385067	0.47524	2.998571	-0.0191453996817501	0.38555	2.294908	4.67	-0.184	0.12594	0.188	0.22855	3.809	0.55401	1.439000	0.26596	0.526	0.24477	0.999	0.42732	0.902000	0.28068	0.574	0.30792	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5	109194	4.579010e-05	0	9	207796	4.331170e-05	0	13	236708	5.492000e-05	0	0	7162	0.000000e+00	0	2	17108	1.169040e-04	0	0	2320	0.000000e+00	0	1	9046	1.105460e-04	0	0	13186	0.000000e+00	0	1	42768	2.338200e-05	0	1	15690	6.373490e-05	0	2	17108	1.169040e-04	0	1	16200	6.172840e-05	0	5	30520	1.638270e-04	0	0	6210	0.000000e+00	0	0	13412	0.000000e+00	0	0	16526	0.000000e+00	0	2	89458	2.235690e-05	0	1	30608	3.267120e-05	0	5	30520	1.638270e-04	0	1	14894	6.714110e-05	0	7	34256	2.043440e-04	0	0	9570	0.000000e+00	0	1	17692	5.652270e-05	0	0	21422	0.000000e+00	0	3	102728	2.920330e-05	0	1	30526	3.275900e-05	0	7	34256	2.043440e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6140	0	0	8	0	0	60	0	0	594	0	0	0	0	0	0	0	0	30	0	0	6	0	1	2332	4.288164665523156E-4	0	602	0	0	90	0	1	9170	1.0905125408942203E-4	Uncertain_significance	HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|not_provided|Classic_homocystinuria	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43062954G>A	ClinGen:CA16616303	C3150344|CN517202|C0751202	236200	394	Tryptophan synthase beta chain-like, PALP domain	Thr	Met	403798	single nucleotide variant	NM_000071.3(CBS):c.953C>T (p.Thr318Met)	875	CBS	HGNC:1550	Uncertain significance	0	Jul 03, 2022	769541394	-	RCV000468076|RCV000755893|RCV002523289	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3661900|MedGen:C3150344	Classic homocystinuria|not provided|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;unknown	germline	GRCh38	NC_000021.9	21	43062954	43062954	21q22.3	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA16616303	2	405378	43062954	G	A	-	-	-	-	-	-	SCV000543520|SCV000799106|SCV000883540	-	-	953C>T 	Thr318Met	NM_000071.3	2	4_VUS	CBS	ENSG00000160200	359	269	CCSBVarC007320	ALE00007314	953C>T	Thr318Met	Edgotyping3	VUSMutGDEh011	B01	GDEhDisVCh_40013	E06	1	VUSMutGDDh011	B01	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	CBS_Thr318Met	21	21	43062954	G	A
52861	F9	1187G>C	Cys396Ser	ENSG00000101981	X	139561872	NC_000023.11:139561872:G:C	ALE00004391	CCSBVarC004391	NULL	204397	NULL	GDEhDisVCh_40052	D04	CEGS2	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTCTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT	25681.0	single nucleotide variant	NM_000133.4(F9):c.1187G>C (p.Cys396Ser)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Jan 01, 1991	137852273.0	-	RCV000011388	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	unknown	unknown	GRCh38	NC_000023.11	X	139561872.0	139561872.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255433,UniProtKB:P00740#VAR_006602,OMIM:300746.0086	1.0	10642.0	139561872.0	G	C	-	-	-	-	-	-	SCV000031620	-	-	1187G>C 	Cys396Ser	NM_000133.4		1_Pathogenic	chrX	G	C	X-139561872-G-C		10642	X	139561872	G	C	C	S	rs137852273	X	138644031	X	138471697	396	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1187G>C	p.Cys396Ser	c.1187G>C	p.Cys396Ser	principal1	Y	1	YES	Select	+	TGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.565	0.99150	H	-9.94	0.98771	D	0.942	0.99987	1.0945	0.99425	D	0.9645	0.98863	D	10	0.99544215	0.99985	D	0.911344	0.99337	D	0.971	0.99671	0.99	0.99894	P00740	C396S	Loss of catalytic residue at M394 (P = 3e-04)| Gain of disorder (P = 0.0059)| Gain of glycosylation at C396 (P = 0.0436)| Loss of sheet (P = 0.1398)| Gain of phosphorylation at Y391 (P = 0.1651)	0.999332245009	0.99931	0.9999735596138305	0.99997	1.81973249962	0.91881	0.692160367966	0.65960	T	0.973421	0.99725	D	0.731828	0.99958	D	0.813444	0.99958	D	0.999975085258484	0.99958	D	0.885211	0.60899	D	0.9936732	0.99922	0.99235654	0.99991	0.9952637	0.99967	0.9873635	0.99955	-14.65	0.95156	D	0.9968	0.97843	P	0.999926344739902	0.98892	0.99999356	0.99996	1	0.99985	.	.	.	.	.	.	4.961018	0.82065	27.7	0.99520179590475488	0.69200	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.968	0.99105	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561872G>C	ClinGen:CA255433|OMIM:300746.0086|UniProtKB:P00740#VAR_006602	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Cys	Ser	25681	single nucleotide variant	NM_000133.4(F9):c.1187G>C (p.Cys396Ser)	2158	F9	HGNC:3551	Pathogenic	1	Jan 01, 1991	137852273	-	RCV000011388	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	unknown	unknown	GRCh38	NC_000023.11	X	139561872	139561872	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255433,UniProtKB:P00740#VAR_006602,OMIM:300746.0086	1	10642	139561872	G	C	-	-	-	-	-	-	SCV000031620	-	-	1187G>C 	Cys396Ser	NM_000133.4		1_Pathogenic	F9	ENSG00000101981	52861	204397	CCSBVarC004391	ALE00004391	1187G>C	Cys396Ser	CEGS2	CegsMutGDEh1019	B07	GDEhDisVCh_40052	D04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	F9_Cys396Ser	23	X	139561872	G	C
359	CBS	400G>A	Gly134Arg	ENSG00000160200	21	43066294	NC_000021.9:43066294:C:T	ALE00007331	CCSBVarC007342	NULL	NULL	298	GDEhDisVCh_40013	C09	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACAGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210440.0	single nucleotide variant	NM_000071.3(CBS):c.400G>A (p.Gly134Arg)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Aug 11, 2022	147474549.0	-	RCV000196511|RCV000469139|RCV002517171	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43066294.0	43066294.0	21q22.3	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA320927	2.0	212879.0	43066294.0	C	T	-	-	-	-	-	-	SCV000249728|SCV000543500	-	-	400G>A 	Gly134Arg	NM_000071.3	2.0	4_VUS	chr21	G	A	21-43066294-G-A		212879	21	43066294	C	T	G	R	rs147474549	21	44486404	21	43359473	134	CBS	ENSG00000160200	ENST00000352178	ENSP00000344460	P35520	CBS_HUMAN	c.400G>A	p.Gly134Arg	c.400G>A	p.Gly134Arg	principal1	Y	1	.	.	-	GGG	1	0	C	C/C	C/C	C/C	C/C	0.013	0.61594	D	0.023	0.65108	D	1.0	0.90580	D	1.0	0.97365	D	0.72	0.83457	D	simple_aae	28.0	72.0	3.96	0.96448	H	-7.96	0.96358	D	0.894	0.89342	0.9972	0.97134	D	0.9892	0.99696	D	10	0.95681256	0.94994	D	0.919928	0.99408	D	0.859	0.95680	0.845	0.94877	P35520	G134R	Gain of helix (P = 0.0425)| Loss of loop (P = 0.0512)| Gain of solvent accessibility (P = 0.08)| Gain of ubiquitination at K137 (P = 0.1235)| Gain of disorder (P = 0.1516)	0.924521707903	0.92317	.	0.93123	.	0.81268	0.650026082993	0.59926	T	0.991486	0.99967	D	0.227788	0.76337	D	0.445803	0.93421	D	0.969353199005127	0.68354	D	0.988968	0.98193	D	0.7442685	0.80303	0.51070327	0.71467	0.73398095	0.79711	0.51771474	0.71878	-13.508	0.91365	D	0.2403	0.50705	B	0.999537699939285	0.96903	0.99974100	0.99666	0.908	0.95204	.	.	.	.	.	.	4.024494	0.59543	24.1	0.99845247922200986	0.92495	0.906843	0.85960	D	0.626431764093497	0.74717	6.203527	0.445254960090777	0.64219	4.695887	5.23	5.23	0.72532	2.86	0.52289	6.845	0.75251	5.719000	0.49537	0.524	0.24207	1.0	0.71675	1.000000	0.68239	0.03	0.13148	988	0.02004	1	1.9968051118210862E-4	0	0.0	0	0.0	0	0.0	1	9.92063492063492E-4	0	0.0	.	.	.	.	8	108968	7.341600e-05	0	20	207442	9.641250e-05	0	21	236436	8.881900e-05	0	0	7152	0.000000e+00	0	1	17100	5.847950e-05	0	0	2320	0.000000e+00	0	4	9040	4.424780e-04	0	0	12998	0.000000e+00	0	3	42760	7.015900e-05	0	0	15688	0.000000e+00	0	4	9040	4.424780e-04	0	0	16184	0.000000e+00	0	2	30510	6.555230e-05	0	0	6208	0.000000e+00	0	13	13392	9.707290e-04	0	0	16338	0.000000e+00	0	5	89346	5.596220e-05	0	0	30606	0.000000e+00	0	13	13392	9.707290e-04	0	0	14888	0.000000e+00	0	2	34240	5.841120e-05	0	0	9566	0.000000e+00	0	11	17686	6.219610e-04	0	0	21236	0.000000e+00	0	8	102680	7.791200e-05	0	0	30524	0.000000e+00	0	11	17686	6.219610e-04	0	.	101	1085548	9.304060e-05	15	34	42500	8.000000e-04	4	5	33534	1.491020e-04	2	0	688	0.000000e+00	0	6	53440	1.122750e-04	1	0	23280	0.000000e+00	0	34	42500	8.000000e-04	4	0	45234	0.000000e+00	0	0	3988	0.000000e+00	0	53	762668	6.949290e-05	7	0	75214	0.000000e+00	0	12	163726	7.329318495535224E-5	0	168	0	4	4472	8.944543828264759E-4	0	3732	0	1	794	0.0012594458438287153	0	968	0	0	1818	0	0	280	0	1	13452	7.43383883437407E-5	0	3900	0	4	6290	6.359300476947536E-4	18	189410	9.503194129137849E-5	Uncertain_significance	not_provided|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Classic_homocystinuria	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43066294C>T	ClinGen:CA320927	C3661900|C3150344|C0751202	236200	394	Tryptophan synthase beta chain-like, PALP domain	Gly	Arg	210440	single nucleotide variant	NM_000071.3(CBS):c.400G>A (p.Gly134Arg)	875	CBS	HGNC:1550	Uncertain significance	0	Aug 11, 2022	147474549	-	RCV000196511|RCV000469139|RCV002517171	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43066294	43066294	21q22.3	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA320927	2	212879	43066294	C	T	-	-	-	-	-	-	SCV000249728|SCV000543500	-	-	400G>A 	Gly134Arg	NM_000071.3	2	4_VUS	CBS	ENSG00000160200	359	298	CCSBVarC007342	ALE00007331	400G>A	Gly134Arg	Edgotyping3	VUSMutGDEh011	A04	GDEhDisVCh_40013	C09	1	VUSMutGDDh011	A04	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	CBS_Gly134Arg	21	21	43066294	C	T
3015	CRX	196G>A	Val66Ile	ENSG00000105392	19	47836338	NC_000019.10:47836338:G:A	ALE00000382	CCSBVarC000382	5253	NULL	NULL	GDEhDisVCh_40040	E12	RC4	ATGATGGCGTATATGAACCCGGGGCCCCACTATTCTGTCAACGCCTTGGCCCTAAGTGGCCCCAGTGTGGATCTGATGCACCAGGCTGTGCCCTACCCAAGCGCCCCCAGGAAGCAGCGGCGGGAGCGCACCACCTTCACCCGGAGCCAACTGGAGGAGCTGGAGGCACTGTTTGCCAAGACCCAGTACCCAGACATCTATGCCCGTGAGGAGGTGGCTCTGAAGATCAATCTGCCTGAGTCCAGGGTTCAGGTTTGGTTCAAGAACCGGAGGGCTAAATGCAGGCAGCAGCGACAGCAGCAGAAACAGCAGCAGCAGCCCCCAGGGGGCCAGGCCAAGGCCCGGCCTGCCAAGAGGAAGGCGGGCACGTCCCCAAGACCCTCCACAGATGTGTGTCCAGACCCTCTGGGCATCTCAGATTCCTACAGTCCCCCTCTGCCCGGCCCCTCAGGCTCCCCAACCACGGCAGTGGCCACTGTGTCCATCTGGAGCCCAGCCTCAGAGTCCCCTTTGCCTGAGGCGCAGCGGGCTGGGCTGGTGGCCTCAGGGCCGTCTCTGACCTCCGCCCCCTATGCCATGACCTACGCCCCGGCCTCCGCTTTCTGCTCTTCCCCCTCCGCCTATGGGTCTCCGAGCTCCTATTTCAGCGGCCTAGACCCCTACCTTTCTCCCATGGTGCCCCAGCTAGGGGGCCCGGCTCTTAGCCCCCTCTCTGGCCCCTCCGTGGGACCTTCCCTGGCCCAGTCCCCCACCTCCCTATCAGGCCAGAGCTATGGCGCCTACAGCCCCGTGGATAGCTTGGAATTCAAGGACCCCACGGGCACCTGGAAATTCACCTACAATCCCATGGACCCTCTGGACTACAAGGATCAGAGTGCCTGGAAGTTTCAGATCTTG	105486.0	single nucleotide variant	NM_000554.6(CRX):c.196G>A (p.Val66Ile)	1406.0	CRX	HGNC:2383	Benign/Likely benign	0.0	Dec 23, 2024	61748438.0	-	RCV000085992|RCV000297047|RCV000331407|RCV001087305|RCV001135902|RCV000990234|RCV001128897|RCV003888486	MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0013449,MedGen:C3151192,OMIM:613829,Orphanet:65|MONDO:MONDO:0013449,MedGen:C3151192,OMIM:613829,Orphanet:65;MONDO:MONDO:0007362,MedGen:C3489532,OMIM:120970,Orphanet:1872|MONDO:MONDO:0007362,MedGen:C3489532,OMIM:120970,Orphanet:1872|MONDO:MONDO:0008764,MedGen:C2931258,OMIM:204000,Orphanet:65|Human Phenotype Ontology:HP:0000547,MONDO:MONDO:0019200,MeSH:D012174,MedGen:C0035334,OMIM:268000,OMIM:PS268000,Orphanet:791|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862	not provided|not specified|Leber congenital amaurosis 7|Leber congenital amaurosis 7;Cone-rod dystrophy 2|Cone-rod dystrophy 2|Leber congenital amaurosis 1|Retinitis pigmentosa|Retinal dystrophy	germline;unknown	germline	GRCh38	NC_000019.10	19	47836338.0	47836338.0	19q13.33	criteria provided, multiple submitters, no conflicts	13.0	-	N	ClinGen:CA227614,UniProtKB:O43186#VAR_076957	2.0	99597.0	47836338.0	G	A	-	-	-	-	-	-	SCV000343554|SCV000413930|SCV000603228|SCV000780642|SCV001021432|SCV001141111|SCV001288390|SCV001295708|SCV001752982|SCV004706293|SCV005072076|SCV005209738	-	-	196G>A 	Val66Ile	NM_000554.6	2.0	2_Benign	chr19	G	A	19-47836338-G-A	0.00357483	99597	19	47836338	G	A	V	I	rs61748438	19	48339595	19	53031407	66	CRX	ENSG00000105392	ENST00000221996	ENSP00000221996	O43186	CRX_HUMAN	c.196G>A	p.Val66Ile	c.196G>A	p.Val66Ile	principal1	Y	2	YES	Select	+	GTC	1	0	G	G/G	G/G	G/G	G/G	1.0	0.00968	T	1.0	0.01173	T	0.033	0.20364	B	0.014	0.16860	B	0.01	0.05039	N	simple_aae	99.0	1.0	-0.045	0.04986	N	0.81	0.01825	N	0.282	0.31706	-0.3046	0.74744	T	0.5748	0.84596	D	10	0.014583826	0.00303	T	0.087085	0.74783	D	0.564	0.82085	.	.	.	.	.	0.971208213089	0.97063	0.5766833030861742	0.57413	0.148135201496	0.16442	0.663567841053	0.61858	T	0.527137	0.83421	D	-0.0871101	0.38200	T	0.108069	0.77276	D	0.0171249165952726	0.00456	T	0.932607	0.74729	D	0.0601943	0.12211	0.06528354	0.13209	0.08464335	0.19423	0.07109007	0.15174	-3.078	0.11056	T	0.1821	0.39588	B	0.0166187155371808	0.27940	0.97831590	0.95357	0.233	0.50175	.	.	.	.	.	.	2.503887	0.32386	19.01	0.2818290788283902	0.01431	0.221131	0.34371	N	-0.50178427963241	0.21764	1.173001	-0.345009838233202	0.26344	1.474249	3.35	2.22	0.27044	-0.768	0.16898	4.921	0.63179	7.908000	0.73922	0.581	0.30088	1.0	0.71675	1.000000	0.68239	0.695	0.34027	912	0.21478	5	9.98402555910543E-4	0	0.0	0	0.0	0	0.0	0	0.0	5	0.005112474437627812	407	264690	0.0015376478	.	377	109406	3.445880e-03	4	703	208114	3.377960e-03	6	783	236942	3.304610e-03	6	4	7164	5.583470e-04	0	10	17112	5.843850e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	117	13392	8.736560e-03	2	116	42768	2.712310e-03	0	128	15690	8.158060e-03	2	128	15690	8.158060e-03	2	11	16218	6.782590e-04	0	20	30524	6.552220e-04	0	0	6210	0.000000e+00	0	1	13416	7.453790e-05	0	144	16732	8.606260e-03	2	254	89546	2.836530e-03	1	269	30608	8.788550e-03	3	269	30608	8.788550e-03	3	10	14902	6.710510e-04	0	23	34260	6.713370e-04	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	188	21630	8.691630e-03	2	286	102746	2.783560e-03	1	269	30526	8.812160e-03	3	269	30526	8.812160e-03	3	.	5577	1614198	3.454970e-03	24	563	64042	8.791110e-03	5	40	75044	5.330210e-04	0	0	912	0.000000e+00	0	36	60020	5.998000e-04	0	1	29608	3.377470e-05	0	2	44888	4.455530e-05	0	563	64042	8.791110e-03	5	6	6062	9.897720e-04	0	4066	1180028	3.445680e-03	5	695	91088	7.629980e-03	14	134	53560	0.002501867064973861	0	306	0	0	146	0	6	8526	7.037297677691766E-4	0	500	0	1	628	0.0015923566878980893	0	56	0	3	104	0.028846153846153848	10	8852	0.0011296882060551287	6	8832	6.793478260869565E-4	0	202	0	154	72678	0.002118935578854674	Benign/Likely_benign	Retinal_dystrophy|not_specified|Leber_congenital_amaurosis_7|Cone-rod_dystrophy_2|Leber_congenital_amaurosis_1|not_provided|Retinitis_pigmentosa	criteria_provided,_multiple_submitters,_no_conflicts	NC_000019.10:g.47836338G>A	ClinGen:CA227614|UniProtKB:O43186#VAR_076957	C0854723|CN169374|C3151192|C3489532|C2931258|C3661900|C0035334	613829|120970|204000|268000|PS268000	71862|65|1872|65|791	Homeodomain|Homeodomain|Homeodomain|Homeodomain	Val	Ile	105486	single nucleotide variant	NM_000554.6(CRX):c.196G>A (p.Val66Ile)	1406	CRX	HGNC:2383	Benign/Likely benign	0	Dec 23, 2024	61748438	-	RCV000085992|RCV000297047|RCV000331407|RCV001087305|RCV001135902|RCV000990234|RCV001128897|RCV003888486	MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0013449,MedGen:C3151192,OMIM:613829,Orphanet:65|MONDO:MONDO:0013449,MedGen:C3151192,OMIM:613829,Orphanet:65;MONDO:MONDO:0007362,MedGen:C3489532,OMIM:120970,Orphanet:1872|MONDO:MONDO:0007362,MedGen:C3489532,OMIM:120970,Orphanet:1872|MONDO:MONDO:0008764,MedGen:C2931258,OMIM:204000,Orphanet:65|Human Phenotype Ontology:HP:0000547,MONDO:MONDO:0019200,MeSH:D012174,MedGen:C0035334,OMIM:268000,OMIM:PS268000,Orphanet:791|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862	not provided|not specified|Leber congenital amaurosis 7|Leber congenital amaurosis 7;Cone-rod dystrophy 2|Cone-rod dystrophy 2|Leber congenital amaurosis 1|Retinitis pigmentosa|Retinal dystrophy	germline;unknown	germline	GRCh38	NC_000019.10	19	47836338	47836338	19q13.33	criteria provided, multiple submitters, no conflicts	13	-	N	ClinGen:CA227614,UniProtKB:O43186#VAR_076957	2	99597	47836338	G	A	-	-	-	-	-	-	SCV000343554|SCV000413930|SCV000603228|SCV000780642|SCV001021432|SCV001141111|SCV001288390|SCV001295708|SCV001752982|SCV004706293|SCV005072076|SCV005209738	-	-	196G>A 	Val66Ile	NM_000554.6	2	2_Benign	CRX	ENSG00000105392	3015	5253	CCSBVarC000382	ALE00000382	196G>A	Val66Ile	RC4	RC4_Mut_GDEh1031	A09	GDEhDisVCh_40040	E12	2	RC4_Mut_GDDh1031	A09	NULL	NULL	NULL	NULL	NULL	NULL	1	5	1	99	0	NULL	0	NULL	0	NULL	CRX_Val66Ile	19	19	47836338	G	A
359	CBS	1353G>C	Glu451Asp	ENSG00000160200	21	43058839	NC_000021.9:43058839:C:G	ALE00007298	CCSBVarC007301	NULL	NULL	241	GDEhDisVCh_40013	A04	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGACGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210402.0	single nucleotide variant	NM_000071.3(CBS):c.1353G>C (p.Glu451Asp)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Sep 24, 2021	367962613.0	-	RCV000198168|RCV000764259|RCV001853129	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;unknown	germline	GRCh38	NC_000021.9	21	43058839.0	43058839.0	21q22.3	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA322659	2.0	212868.0	43058839.0	C	G	-	-	-	-	-	-	SCV000249715|SCV000895267|SCV002250181	-	-	1353G>C 	Glu451Asp	NM_000071.3	2.0	4_VUS	chr21	G	C	21-43058839-G-C		212868	21	43058839	C	G	E	D	rs367962613	21	44478949	21	43352018	451	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.1353G>C	p.Glu451Asp	c.1353G>C	p.Glu451Asp	principal1	Y	1	.	.	-	GAG	3	2	C	C/C	C/C	C/C	C/C	0.224	0.18792	T	0.268	0.22770	T	0.006	0.13655	B	0.033	0.22330	B	.	.	.	.	.	.	1.41	0.35381	L	-1.57	0.37944	N	0.306	0.34427	-0.9101	0.46644	T	0.1317	0.44118	T	10	0.18509325	0.33541	T	0.064226	0.69100	D	0.311	0.63079	0.56	0.67844	P35520	E451D	Loss of sheet (P = 0.1398)| Gain of catalytic residue at G453 (P = 0.1848)| Gain of disorder (P = 0.469)| Loss of stability (P = 0.6425)| Gain of loop (P = 0.6993)	0.400033932507	0.39216	.	0.36538	.	0.34400	0.530908942223	0.43100	T	0.81553	0.95398	D	0.0125743	0.53061	T	-0.213451	0.53048	T	0.0809647608724511	0.09985	T	.	0.57645	.	0.3540869	0.57053	0.21397674	0.45762	0.3320045	0.55304	0.20534661	0.44538	-5.279	0.39782	T	0.0964	0.15673	LB	0.179027165929205	0.48815	0.94926730	0.93335	0.49	0.70797	.	.	.	.	.	.	0.130054	0.05275	1.759	0.93113340516813792	0.22995	0.519023	0.54288	D	-1.02403366837358	0.08010	0.3789748	-1.23405449421087	0.05286	0.2557589	4.71	-5.52	0.02362	-5.0	0.04489	-1.004	0.03792	-1.512000	0.05299	-0.291	0.06302	0.0	0.06393	0.000000	0.08389	0.1	0.18324	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	68184	0.000000e+00	0	1	139168	7.185560e-06	0	1	158998	6.289390e-06	0	0	3238	0.000000e+00	0	0	12926	0.000000e+00	0	0	1510	0.000000e+00	0	0	5158	0.000000e+00	0	0	10198	0.000000e+00	0	0	22018	0.000000e+00	0	0	11728	0.000000e+00	0	.	.	.	.	0	9428	0.000000e+00	0	0	21800	0.000000e+00	0	0	4860	0.000000e+00	0	0	9416	0.000000e+00	0	0	12312	0.000000e+00	0	1	54310	1.841280e-05	0	0	23348	0.000000e+00	0	1	54310	1.841280e-05	0	0	8800	0.000000e+00	0	0	25736	0.000000e+00	0	0	8406	0.000000e+00	0	0	11904	0.000000e+00	0	0	14360	0.000000e+00	0	1	62060	1.611340e-05	0	0	23324	0.000000e+00	0	1	62060	1.611340e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	not_provided|Classic_homocystinuria|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43058839C>G	ClinGen:CA322659	CN517202|C0751202|C3150344	236200	394	CBS domain|CBS domain|CBS domain|Cystathionine beta-synthase, C-terminal domain	Glu	Asp	210402	single nucleotide variant	NM_000071.3(CBS):c.1353G>C (p.Glu451Asp)	875	CBS	HGNC:1550	Uncertain significance	0	Sep 24, 2021	367962613	-	RCV000198168|RCV000764259|RCV001853129	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;unknown	germline	GRCh38	NC_000021.9	21	43058839	43058839	21q22.3	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA322659	2	212868	43058839	C	G	-	-	-	-	-	-	SCV000249715|SCV000895267|SCV002250181	-	-	1353G>C 	Glu451Asp	NM_000071.3	2	4_VUS	CBS	ENSG00000160200	359	241	CCSBVarC007301	ALE00007298	1353G>C	Glu451Asp	Edgotyping3	VUSMutGDEh010	E10	GDEhDisVCh_40013	A04	1	VUSMutGDDh010	E10	NULL	NULL	NULL	NULL	NULL	NULL	1	6	1	6	0	NULL	0	NULL	0	NULL	CBS_Glu451Asp	21	21	43058839	C	G
3172	CBS	341C>T	Ala114Val	ENSG00000160200	21	43066353	NC_000021.9:43066353:G:A	ALE00003747	CCSBVarC003747	NULL	214521	NULL	GDEhDisVCh_40055	E04	CEGS2	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTCCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGTGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCCGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	15158.0	single nucleotide variant	NM_000071.3(CBS):c.341C>T (p.Ala114Val)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Jan 08, 2025	121964964.0	-	RCV000000140|RCV000200823|RCV000590659|RCV002227956|RCV002453244|RCV000490533|RCV003952330	MedGen:C3502110|MedGen:C3661900|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|	Homocystinuria, pyridoxine-responsive|not provided|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection|Classic homocystinuria|CBS-related disorder	biparental;germline;inherited;unknown	germline	GRCh38	NC_000021.9	21	43066353.0	43066353.0	21q22.3	criteria provided, multiple submitters, no conflicts	19.0	-	N	UniProtKB:P35520#VAR_002174,OMIM:613381.0003,ClinGen:CA113878	3.0	119.0	43066353.0	G	A	-	-	-	-	-	-	SCV000249676|SCV000267240|SCV000678069|SCV000695305|SCV000746328|SCV000893556|SCV000956328|SCV001369940|SCV001443030|SCV001448148|SCV001524388|SCV001713878|SCV002617910|SCV002769356|SCV004026264|SCV005052057|SCV005876539	-	-	341C>T 	Ala114Val	NM_000071.3	2.0	1_Pathogenic	chr21	C	T	21-43066353-C-T		119	21	43066353	G	A	A	V	rs121964964	21	44486463	21	43359532	114	CBS	ENSG00000160200	ENST00000398165	ENSP00000381231	P35520	CBS_HUMAN	c.341C>T	p.Ala114Val	c.341C>T	p.Ala114Val	principal1	Y	1	YES	Select	-	GCG	2	0	G	G/G	G/G	G/G	G/G	0.017	0.51407	D	0.02	0.58950	D	0.969	0.56783	D	0.428	0.45338	B	1.0	0.99291	A	simple_aae	0.0	100.0	0.77	0.19267	N	-3.15	0.64159	D	0.967	0.97765	0.9585	0.96513	D	0.8641	0.95470	D	9	0.6711614	0.70456	D	0.412866	0.93622	D	0.880	0.96457	.	.	.	.	.	0.906569392409	0.90493	0.9190000697640606	0.91825	0.753685659022	0.63668	0.754058122635	0.75002	T	0.977705	0.99797	D	0.258179	0.79208	D	0.465144	0.93852	D	0.220334708518176	0.21219	T	.	0.95649	.	0.6627077	0.75777	0.5155119	0.71749	0.7242967	0.79160	0.56278324	0.74449	-8.41	0.63906	D	.	0.56744	.	0.992378843414304	0.89480	0.99965155	0.99571	0.863	0.92532	.	.	.	.	.	.	4.665344	0.74557	26.2	0.99939874256191163	0.99767	0.954410	0.97139	D	0.652690307964407	0.76416	6.505968	0.691079149592257	0.81601	7.588644	5.36	5.36	0.76590	.	.	8.693	0.91034	7.230000	0.57937	0.59	0.31918	1.0	0.71675	1.000000	0.68239	0.971	0.54653	988	0.02004	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	.	.	.	.	24	109226	2.197280e-04	0	48	207722	2.310780e-04	0	51	236616	2.155390e-04	0	1	7162	1.396260e-04	0	9	17104	5.261930e-04	0	0	2320	0.000000e+00	0	1	9044	1.105710e-04	0	0	13230	0.000000e+00	0	13	42764	3.039940e-04	0	0	15688	0.000000e+00	0	9	17104	5.261930e-04	0	2	16198	1.234720e-04	0	10	30514	3.277180e-04	0	0	6206	0.000000e+00	0	2	13402	1.492310e-04	0	0	16570	0.000000e+00	0	33	89366	3.692680e-04	0	1	30606	3.267330e-05	0	33	89366	3.692680e-04	0	2	14896	1.342640e-04	0	10	34242	2.920390e-04	0	0	9562	0.000000e+00	0	2	17690	1.130580e-04	0	0	21468	0.000000e+00	0	36	102614	3.508290e-04	0	1	30524	3.276110e-05	0	36	102614	3.508290e-04	0	.	87	813628	1.069280e-04	6	6	38706	1.550150e-04	1	0	22108	0.000000e+00	0	0	450	0.000000e+00	0	7	45644	1.533610e-04	0	0	20454	0.000000e+00	0	6	38706	1.550150e-04	1	0	37350	0.000000e+00	0	0	2840	0.000000e+00	0	71	541738	1.310600e-04	5	0	67904	0.000000e+00	0	59	184184	3.203318420709725E-4	0	360	0	0	4502	0	0	8950	0	0	790	0	0	968	0	0	1848	0	0	280	0	3	17166	1.7476406850751484E-4	0	9310	0	0	6350	0	62	219048	2.830429860121982E-4	Pathogenic/Likely_pathogenic	Familial_thoracic_aortic_aneurysm_and_aortic_dissection|CBS-related_disorder|Classic_homocystinuria|not_provided|Homocystinuria,_pyridoxine-responsive|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Homocystinuria	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43066353G>A	ClinGen:CA113878|OMIM:613381.0003|UniProtKB:P35520#VAR_002174	C4707243|C0751202|C3661900|C3502110|C3150344|C0019880	PS607086|236200	91387|394	Tryptophan synthase beta chain-like, PALP domain|Cysteine synthase/cystathionine beta-synthase, pyridoxal-phosphate attachment site	Ala	Val	15158	single nucleotide variant	NM_000071.3(CBS):c.341C>T (p.Ala114Val)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Jan 08, 2025	121964964	-	RCV000000140|RCV000200823|RCV000590659|RCV002227956|RCV002453244|RCV000490533|RCV003952330	MedGen:C3502110|MedGen:C3661900|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|	Homocystinuria, pyridoxine-responsive|not provided|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection|Classic homocystinuria|CBS-related disorder	biparental;germline;inherited;unknown	germline	GRCh38	NC_000021.9	21	43066353	43066353	21q22.3	criteria provided, multiple submitters, no conflicts	19	-	N	UniProtKB:P35520#VAR_002174,OMIM:613381.0003,ClinGen:CA113878	3	119	43066353	G	A	-	-	-	-	-	-	SCV000249676|SCV000267240|SCV000678069|SCV000695305|SCV000746328|SCV000893556|SCV000956328|SCV001369940|SCV001443030|SCV001448148|SCV001524388|SCV001713878|SCV002617910|SCV002769356|SCV004026264|SCV005052057|SCV005876539	-	-	341C>T 	Ala114Val	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	309	CCSBVarC007350	ALE00003747	341C>T	Ala114Val	Edgotyping3	VUSMutGDEh011	A05	GDEhDisVCh_40013	C10	1	VUSMutGDDh011	A05	NULL	NULL	NULL	NULL	NULL	NULL	1	3	1	5	0	NULL	0	NULL	0	NULL	CBS_Ala114Val	21	21	43066353	G	A
3172	CBS	341C>T	Ala114Val	ENSG00000160200	21	43066353	NC_000021.9:43066353:G:A	ALE00003747	CCSBVarC003747	NULL	214521	NULL	GDEhDisVCh_40055	E04	CEGS2	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTCCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGTGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCCGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	15158.0	single nucleotide variant	NM_000071.3(CBS):c.341C>T (p.Ala114Val)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Jan 08, 2025	121964964.0	-	RCV000000140|RCV000200823|RCV000590659|RCV002227956|RCV002453244|RCV000490533|RCV003952330	MedGen:C3502110|MedGen:C3661900|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|	Homocystinuria, pyridoxine-responsive|not provided|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection|Classic homocystinuria|CBS-related disorder	biparental;germline;inherited;unknown	germline	GRCh38	NC_000021.9	21	43066353.0	43066353.0	21q22.3	criteria provided, multiple submitters, no conflicts	19.0	-	N	UniProtKB:P35520#VAR_002174,OMIM:613381.0003,ClinGen:CA113878	3.0	119.0	43066353.0	G	A	-	-	-	-	-	-	SCV000249676|SCV000267240|SCV000678069|SCV000695305|SCV000746328|SCV000893556|SCV000956328|SCV001369940|SCV001443030|SCV001448148|SCV001524388|SCV001713878|SCV002617910|SCV002769356|SCV004026264|SCV005052057|SCV005876539	-	-	341C>T 	Ala114Val	NM_000071.3	2.0	1_Pathogenic	chr21	C	T	21-43066353-C-T		119	21	43066353	G	A	A	V	rs121964964	21	44486463	21	43359532	114	CBS	ENSG00000160200	ENST00000398165	ENSP00000381231	P35520	CBS_HUMAN	c.341C>T	p.Ala114Val	c.341C>T	p.Ala114Val	principal1	Y	1	YES	Select	-	GCG	2	0	G	G/G	G/G	G/G	G/G	0.017	0.51407	D	0.02	0.58950	D	0.969	0.56783	D	0.428	0.45338	B	1.0	0.99291	A	simple_aae	0.0	100.0	0.77	0.19267	N	-3.15	0.64159	D	0.967	0.97765	0.9585	0.96513	D	0.8641	0.95470	D	9	0.6711614	0.70456	D	0.412866	0.93622	D	0.880	0.96457	.	.	.	.	.	0.906569392409	0.90493	0.9190000697640606	0.91825	0.753685659022	0.63668	0.754058122635	0.75002	T	0.977705	0.99797	D	0.258179	0.79208	D	0.465144	0.93852	D	0.220334708518176	0.21219	T	.	0.95649	.	0.6627077	0.75777	0.5155119	0.71749	0.7242967	0.79160	0.56278324	0.74449	-8.41	0.63906	D	.	0.56744	.	0.992378843414304	0.89480	0.99965155	0.99571	0.863	0.92532	.	.	.	.	.	.	4.665344	0.74557	26.2	0.99939874256191163	0.99767	0.954410	0.97139	D	0.652690307964407	0.76416	6.505968	0.691079149592257	0.81601	7.588644	5.36	5.36	0.76590	.	.	8.693	0.91034	7.230000	0.57937	0.59	0.31918	1.0	0.71675	1.000000	0.68239	0.971	0.54653	988	0.02004	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	.	.	.	.	24	109226	2.197280e-04	0	48	207722	2.310780e-04	0	51	236616	2.155390e-04	0	1	7162	1.396260e-04	0	9	17104	5.261930e-04	0	0	2320	0.000000e+00	0	1	9044	1.105710e-04	0	0	13230	0.000000e+00	0	13	42764	3.039940e-04	0	0	15688	0.000000e+00	0	9	17104	5.261930e-04	0	2	16198	1.234720e-04	0	10	30514	3.277180e-04	0	0	6206	0.000000e+00	0	2	13402	1.492310e-04	0	0	16570	0.000000e+00	0	33	89366	3.692680e-04	0	1	30606	3.267330e-05	0	33	89366	3.692680e-04	0	2	14896	1.342640e-04	0	10	34242	2.920390e-04	0	0	9562	0.000000e+00	0	2	17690	1.130580e-04	0	0	21468	0.000000e+00	0	36	102614	3.508290e-04	0	1	30524	3.276110e-05	0	36	102614	3.508290e-04	0	.	87	813628	1.069280e-04	6	6	38706	1.550150e-04	1	0	22108	0.000000e+00	0	0	450	0.000000e+00	0	7	45644	1.533610e-04	0	0	20454	0.000000e+00	0	6	38706	1.550150e-04	1	0	37350	0.000000e+00	0	0	2840	0.000000e+00	0	71	541738	1.310600e-04	5	0	67904	0.000000e+00	0	59	184184	3.203318420709725E-4	0	360	0	0	4502	0	0	8950	0	0	790	0	0	968	0	0	1848	0	0	280	0	3	17166	1.7476406850751484E-4	0	9310	0	0	6350	0	62	219048	2.830429860121982E-4	Pathogenic/Likely_pathogenic	Familial_thoracic_aortic_aneurysm_and_aortic_dissection|CBS-related_disorder|Classic_homocystinuria|not_provided|Homocystinuria,_pyridoxine-responsive|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Homocystinuria	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43066353G>A	ClinGen:CA113878|OMIM:613381.0003|UniProtKB:P35520#VAR_002174	C4707243|C0751202|C3661900|C3502110|C3150344|C0019880	PS607086|236200	91387|394	Tryptophan synthase beta chain-like, PALP domain|Cysteine synthase/cystathionine beta-synthase, pyridoxal-phosphate attachment site	Ala	Val	15158	single nucleotide variant	NM_000071.3(CBS):c.341C>T (p.Ala114Val)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Jan 08, 2025	121964964	-	RCV000000140|RCV000200823|RCV000590659|RCV002227956|RCV002453244|RCV000490533|RCV003952330	MedGen:C3502110|MedGen:C3661900|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|	Homocystinuria, pyridoxine-responsive|not provided|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection|Classic homocystinuria|CBS-related disorder	biparental;germline;inherited;unknown	germline	GRCh38	NC_000021.9	21	43066353	43066353	21q22.3	criteria provided, multiple submitters, no conflicts	19	-	N	UniProtKB:P35520#VAR_002174,OMIM:613381.0003,ClinGen:CA113878	3	119	43066353	G	A	-	-	-	-	-	-	SCV000249676|SCV000267240|SCV000678069|SCV000695305|SCV000746328|SCV000893556|SCV000956328|SCV001369940|SCV001443030|SCV001448148|SCV001524388|SCV001713878|SCV002617910|SCV002769356|SCV004026264|SCV005052057|SCV005876539	-	-	341C>T 	Ala114Val	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	3172	214521	CCSBVarC003747	ALE00003747	341C>T	Ala114Val	CEGS2	CegsMutGDEh1032	C12	GDEhDisVCh_40055	E04	1	CegsMutGDDh1032	C12	NULL	NULL	NULL	NULL	NULL	NULL	1	3	1	1	0	NULL	0	NULL	0	NULL	CBS_Ala114Val	21	21	43066353	G	A
52861	F9	217G>A	Glu73Lys	ENSG00000101981	X	139537138	NC_000023.11:139537138:G:A	ALE00002180	CCSBVarC002180	24496	NULL	NULL	GDEhDisVCh_40052	F12	RC4	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAAAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT																																															chrX	G	A	X-139537138-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																														F9	ENSG00000101981	52861	24496	CCSBVarC002180	ALE00002180	217G>A	Glu73Lys	RC4	RC4_Mut_GDEh1022	G11	GDEhDisVCh_40052	F12	2	RC4_Mut_GDDh1022	G11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	F9_Glu73Lys	23	X	139537138	G	A
100011574	PTEN	386G>A	Gly129Glu	ENSG00000171862	10	87933145	NC_000010.11:87933145:G:A	ALE00007031	CCSBVarC007033	NULL	210310	NULL	GDEhDisVCh_40031	C08	CEGS2	ATGACAGCCATCATCAAAGAGATCGTTAGCAGAAACAAAAGGAGATATCAAGAGGATGGATTCGACTTAGACTTGACCTATATTTATCCAAACATTATTGCTATGGGATTTCCTGCAGAAAGACTTGAAGGCGTATACAGGAACAATATTGATGATGTAGTAAGGTTTTTGGATTCAAAGCATAAAAACCATTACAAGATATACAATCTTTGTGCTGAAAGACATTATGACACCGCCAAATTTAATTGCAGAGTTGCACAATATCCTTTTGAAGACCATAACCCACCACAGCTAGAACTTATCAAACCCTTTTGTGAAGATCTTGACCAATGGCTAAGTGAAGATGACAATCATGTTGCAGCAATTCACTGTAAAGCTGGAAAGGAACGAACTGGTGTAATGATATGTGCATATTTATTACATCGGGGCAAATTTTTAAAGGCACAAGAGGCCCTAGATTTCTATGGGGAAGTAAGGACCAGAGACAAAAAGGGAGTAACTATTCCCAGTCAGAGGCGCTATGTGTATTATTATAGCTACCTGTTAAAGAATCATCTGGATTATAGACCAGTGGCACTGTTGTTTCACAAGATGATGTTTGAAACTATTCCAATGTTCAGTGGCGGAACTTGCAATCCTCAGTTTGTGGTCTGCCAGCTAAAGGTGAAGATATATTCCTCCAATTCAGGACCCACACGACGGGAAGACAAGTTCATGTACTTTGAGTTCCCTCAGCCGTTACCTGTGTGTGGTGATATCAAAGTAGAGTTCTTCCACAAACAGAACAAGATGCTAAAAAAGGACAAAATGTTTCACTTTTGGGTAAATACATTCTTCATACCAGGACCAGAGGAAACCTCAGAAAAAGTAGAAAATGGAAGTCTATGTGATCAAGAAATCGATAGCATTTGCAGTATAGAGCGTGCAGATAATGACAAGGAATATCTAGTACTTACTTTAACAAAAAATGATCTTGACAAAGCAAATAAAGACAAAGCCAACCGATACTTTTCTCCAAATTTTAAGGTGAAGCTGTACTTCACAAAAACAGTAGAGGAGCCGTCAAATCCAGAGGCTAGCAGTTCAACTTCTGTAACACCAGATGTTAGTGACAATGAACCTGATCATTATAGATATTCTGACACCACTGACTCTGATCCAGAGAATGAACCTTTTGATGAAGATCAGCATACACAAATTACAAAAGTC	22851.0	single nucleotide variant	NM_000314.8(PTEN):c.386G>A (p.Gly129Glu)	5728.0	PTEN	HGNC:9588	Pathogenic/Likely pathogenic	1.0	Sep 28, 2023	121909218.0	-	RCV000008255|RCV000490577|RCV001021326|RCV000413815|RCV004668707|RCV003332076	MONDO:MONDO:0008021,MedGen:CN072330,OMIM:158350|MONDO:MONDO:0017623,MeSH:D006223,MedGen:C1959582,Orphanet:306498|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651|MONDO:MONDO:0001187,MedGen:C0005684,OMIM:109800,Orphanet:157980	Cowden syndrome 1|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided|Neoplasm|Malignant tumor of urinary bladder	de novo;germline;maternal;somatic;unknown	germline/somatic	GRCh38	NC_000010.11	10	87933145.0	87933145.0	10q23.31	criteria provided, multiple submitters, no conflicts	8.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000431,UniProtKB:P60484#VAR_007465,OMIM:601728.0001	3.0	7812.0	87933145.0	G	A	-	-	-	Likely oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV000490751|SCV000579270|SCV001182928|SCV003439625|SCV004188776	-	SCV005094203	386G>A 	Gly129Glu	NM_000314.8	2.0	1_Pathogenic	chr10	G	A	10-87933145-G-A		7812	10	87933145	G	A	G	E	rs121909218	10	89692902	10	89682882	129	PTEN	ENSG00000171862	ENST00000371953	ENSP00000361021	P60484	PTEN_HUMAN	c.386G>A	p.Gly129Glu	c.386G>A	p.Gly129Glu	principal1	Y	1	YES	Select	+	GGA	2	0	G	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.81	0.95406	H	-7.77	0.95858	D	0.976	0.98669	0.9698	0.96688	D	0.8493	0.94963	D	8	0.992352	0.99770	D	0.779045	0.98255	D	0.940	0.98707	0.923	0.98665	P60484	G129E	Gain of ubiquitination at K128 (P = 0.0416)| Loss of methylation at R130 (P = 0.0577)| Loss of MoRF binding (P = 0.0655)| Loss of catalytic residue at R130 (P = 0.1403)| Gain of disorder (P = 0.1874)	0.977591272689	0.97712	0.9981102697957726	0.99810	2.62646606766	0.98303	0.955161809921	0.99847	D	0.959313	0.99461	D	0.481762	0.93709	D	0.454242	0.93630	D	0.99973326921463	0.98718	D	0.995778	0.98529	D	0.9922173	0.99866	0.9901273	0.99979	0.992623	0.99884	0.9881754	0.99963	-16.43	0.98340	D	0.9999	0.99795	P	0.999952888209737	0.99183	0.99990165	0.99879	1	0.99985	.	.	.	.	.	.	5.81543	0.93682	33.0	0.9982680200994386	0.90946	0.945599	0.95392	D	1.00898495341066	0.95992	14.20707	0.924024154675304	0.96516	14.819	5.22	5.22	0.72246	.	.	9.525	0.97099	11.875000	0.98680	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	940	0.13655	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic/Likely_pathogenic	Malignant_tumor_of_urinary_bladder|Hereditary_cancer-predisposing_syndrome|not_provided|PTEN_hamartoma_tumor_syndrome|Cowden_syndrome_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000010.11:g.87933145G>A	ClinGen:CA000431|OMIM:601728.0001|UniProtKB:P60484#VAR_007465	C0005684|C0027672|C3661900|C1959582|CN072330	109800|158350	157980|140162|306498	Tyrosine-specific protein phosphatases domain|Tensin-type phosphatase domain|Protein-tyrosine phosphatase, catalytic|PTEN, phosphatase domain	Gly	Glu	22851	single nucleotide variant	NM_000314.8(PTEN):c.386G>A (p.Gly129Glu)	5728	PTEN	HGNC:9588	Pathogenic/Likely pathogenic	1	Sep 28, 2023	121909218	-	RCV000008255|RCV000490577|RCV001021326|RCV000413815|RCV004668707|RCV003332076	MONDO:MONDO:0008021,MedGen:CN072330,OMIM:158350|MONDO:MONDO:0017623,MeSH:D006223,MedGen:C1959582,Orphanet:306498|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651|MONDO:MONDO:0001187,MedGen:C0005684,OMIM:109800,Orphanet:157980	Cowden syndrome 1|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided|Neoplasm|Malignant tumor of urinary bladder	de novo;germline;maternal;somatic;unknown	germline/somatic	GRCh38	NC_000010.11	10	87933145	87933145	10q23.31	criteria provided, multiple submitters, no conflicts	8	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000431,UniProtKB:P60484#VAR_007465,OMIM:601728.0001	3	7812	87933145	G	A	-	-	-	Likely oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV000490751|SCV000579270|SCV001182928|SCV003439625|SCV004188776	-	SCV005094203	386G>A 	Gly129Glu	NM_000314.8	2	1_Pathogenic	PTEN	ENSG00000171862	100011574	210310	CCSBVarC007033	ALE00007031	386G>A	Gly129Glu	CEGS2	CegsMutGDEh1023	A08	GDEhDisVCh_40031	C08	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	PTEN_Gly129Glu	10	10	87933145	G	A
3774	TP53	734G>A	Gly245Asp	ENSG00000141510	17	7674229	NC_000017.11:7674229:C:T	ALE00004867	CCSBVarC004867	NULL	214895	NULL	GDEhDisVCh_40053	D06	CEGS2	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGACATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACCGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	27394.0	single nucleotide variant	NM_000546.6(TP53):c.734G>A (p.Gly245Asp)	7157.0	TP53	HGNC:11998	Pathogenic/Likely pathogenic	1.0	Nov 04, 2024	121912656.0	-	RCV000013149|RCV000164465|RCV000206683|RCV000785472|RCV000986053|RCV003473082	Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MedGen:C3661900|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Ovarian neoplasm|not provided|Adrenocortical carcinoma, hereditary	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7674229.0	7674229.0	17p13.1	criteria provided, multiple submitters, no conflicts	9.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	UniProtKB:P04637#VAR_005973,OMIM:191170.0009,ClinGen:CA000371	3.0	12355.0	7674229.0	C	T	-	-	-	-	-	-	SCV000215109|SCV000261202|SCV001134876|SCV001777843|SCV002053062|SCV002582362|SCV002583023|SCV004204266	-	-	734G>A 	Gly245Asp	NM_000546.6	2.0	1_Pathogenic	chr17	G	A	17-7674229-G-A		12355	17	7674229	C	T	G	D	rs121912656	17	7577547	17	7518272	245	TP53	ENSG00000141510	ENST00000503591	ENSP00000426252	P04637	P53_HUMAN	c.*1000G>A	.	c.734G>A	p.Gly245Asp	principal1	.	5	.	.	-	GGC	2	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	0.999	0.97365	D	.	0.99291	.	.	.	.	3.31	0.90471	M	.	0.93155	.	.	0.97221	0.9027	0.95698	D	0.9951	0.99889	D	9	.	0.99789	.	0.704722	0.97584	D	.	0.99740	0.988	0.99876	P04637	G245D	Loss of catalytic residue at G245 (P = 0.2576)| Gain of disorder (P = 0.2728)| Gain of glycosylation at S241 (P = 0.3471)| Loss of sheet (P = 0.3635)| Loss of MoRF binding (P = 0.4874)	.	0.99513	.	0.89967	.	0.43386	0.781971752644	0.79188	T	0.996458	0.99995	D	0.514803	0.94679	D	0.598556	0.96950	D	0.996368050575256	0.89105	D	.	0.94657	.	0.99328375	0.99908	0.9762463	0.99701	0.9925965	0.99882	0.9797306	0.99809	-11.173	0.80671	D	.	0.98262	.	0.998098836246549	0.93953	0.99997842	0.99989	0.997	0.99892	.	.	.	.	.	.	4.753996	0.76831	26.6	0.99864418299205227	0.94280	0.961761	0.98306	D	0.881767961352506	0.90788	10.58978	0.795990677920414	0.89455	10.00593	4.62	4.62	0.56895	4.26	0.80793	7.905	0.86513	5.993000	0.52435	0.596	0.33565	1.0	0.71675	1.000000	0.68239	0.977	0.56847	433	0.80635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109404	0.000000e+00	0	1	208130	4.804690e-06	0	1	236926	4.220730e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42764	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	0	89552	0.000000e+00	0	1	30608	3.267120e-05	0	1	30608	3.267120e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	0	102726	0.000000e+00	0	1	30526	3.275900e-05	0	1	30526	3.275900e-05	0	.	5	1613724	3.098420e-06	0	1	44868	2.228760e-05	0	0	74860	0.000000e+00	0	0	912	0.000000e+00	0	0	59970	0.000000e+00	0	0	29602	0.000000e+00	0	1	44868	2.228760e-05	0	0	64002	0.000000e+00	0	0	6084	0.000000e+00	0	3	1179888	2.542610e-06	0	1	91070	1.098060e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Breast_neoplasm|Ovarian_serous_cystadenocarcinoma|Gastric_adenocarcinoma|Glioblastoma|Carcinoma_of_esophagus|Pancreatic_adenocarcinoma|Uterine_carcinosarcoma|Adrenocortical_carcinoma,_hereditary|Hereditary_cancer-predisposing_syndrome|Ovarian_neoplasm|Lung_adenocarcinoma|Neoplasm_of_brain|Hepatocellular_carcinoma|Squamous_cell_lung_carcinoma|Brainstem_glioma|Transitional_cell_carcinoma_of_the_bladder|Li-Fraumeni_syndrome_1|not_provided|Li-Fraumeni_syndrome|Prostate_adenocarcinoma|Squamous_cell_carcinoma_of_the_head_and_neck|Neoplasm_of_the_large_intestine	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.7674229C>T	ClinGen:CA000371|OMIM:191170.0009|UniProtKB:P04637#VAR_005973	C1458155|C0279663|C0278701|C0017636|C0152018|C0281361|C0280630|C1859972|C0027672|C0919267|C0152013|C0006118|C2239176|C0149782|C0677865|C0279680|C1835398|C3661900|C0085390|C0007112|C1168401|C0009404	202300|114550|151623|PS151623|275355	360|70482|1501|140162|88673|524|524|67037	p53, DNA-binding domain|p53, DNA-binding domain	Gly	Asp	27394	single nucleotide variant	NM_000546.6(TP53):c.734G>A (p.Gly245Asp)	7157	TP53	HGNC:11998	Pathogenic/Likely pathogenic	1	Nov 04, 2024	121912656	-	RCV000013149|RCV000164465|RCV000206683|RCV000785472|RCV000986053|RCV003473082	Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MedGen:C3661900|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Ovarian neoplasm|not provided|Adrenocortical carcinoma, hereditary	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7674229	7674229	17p13.1	criteria provided, multiple submitters, no conflicts	9	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	UniProtKB:P04637#VAR_005973,OMIM:191170.0009,ClinGen:CA000371	3	12355	7674229	C	T	-	-	-	-	-	-	SCV000215109|SCV000261202|SCV001134876|SCV001777843|SCV002053062|SCV002582362|SCV002583023|SCV004204266	-	-	734G>A 	Gly245Asp	NM_000546.6	2	1_Pathogenic	TP53	ENSG00000141510	3774	214895	CCSBVarC004867	ALE00004867	734G>A	Gly245Asp	CEGS2	CegsMutGDEh1019	D12	GDEhDisVCh_40053	D06	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	2	0	NULL	0	NULL	0	NULL	0	NULL	TP53_Gly245Asp	17	17	7674229	C	T
359	CBS	1009A>G	Met337Val	ENSG00000160200	21	43062341	NC_000021.9:43062341:T:C	ALE00007309	CCSBVarC007314	NULL	NULL	261	GDEhDisVCh_40013	G05	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCGTGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210418.0	single nucleotide variant	NM_000071.3(CBS):c.1009A>G (p.Met337Val)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Apr 10, 2022	372822486.0	-	RCV000196067|RCV000243887|RCV001828020|RCV002517166	MedGen:C3661900|MedGen:CN230736|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344	not provided|Cardiovascular phenotype|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;unknown	germline	GRCh38	NC_000021.9	21	43062341.0	43062341.0	21q22.3	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA320468	2.0	212859.0	43062341.0	T	C	-	-	-	-	-	-	SCV000249702|SCV000319264|SCV002787593|SCV003266998	-	-	1009A>G 	Met337Val	NM_000071.3	2.0	4_VUS	chr21	A	G	21-43062341-A-G		212859	21	43062341	T	C	M	V	rs372822486	21	44482451	21	43355520	337	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.1009A>G	p.Met337Val	c.1009A>G	p.Met337Val	principal1	Y	1	.	.	-	ATG	1	0	T	T/T	T/T	T/T	T/T	0.011	0.55689	D	0.011	0.65108	D	0.102	0.25843	B	0.163	0.34894	B	.	.	.	.	.	.	-0.125	0.04560	N	-1.78	0.42002	N	0.646	0.65585	0.4315	0.89523	D	0.7532	0.91564	D	10	0.77504444	0.77167	D	0.255651	0.89273	D	0.628	0.85598	.	.	.	.	.	0.756873525501	0.75274	.	0.83592	.	0.48370	0.55171328783	0.46034	T	0.886626	0.97642	D	0.406877	0.90237	D	0.346674	0.90116	D	0.398324658052332	0.28572	T	.	0.91613	.	0.62584096	0.73798	0.27257445	0.52965	0.6019505	0.72513	0.28439167	0.54226	-5.885	0.45364	T	0.1245	0.26547	LB	0.916061305298617	0.77231	0.99772924	0.98485	0.864	0.92591	.	.	.	.	.	.	3.527636	0.49564	22.8	0.97929139172328039	0.37096	0.770567	0.70440	D	-0.227786246228812	0.31718	1.799911	-0.0832853702458404	0.35776	2.095253	5.28	5.28	0.74083	2.92	0.53394	2.503	0.45168	3.967000	0.40874	0.58	0.29757	1.0	0.71675	1.000000	0.68239	0.137	0.19879	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109326	0.000000e+00	0	1	207618	4.816540e-06	0	1	236630	4.226010e-06	0	0	7156	0.000000e+00	0	0	17094	0.000000e+00	0	0	2314	0.000000e+00	0	0	9046	0.000000e+00	0	0	13388	0.000000e+00	0	0	42730	0.000000e+00	0	0	15684	0.000000e+00	0	.	.	.	.	0	16170	0.000000e+00	0	0	30496	0.000000e+00	0	0	6188	0.000000e+00	0	0	13412	0.000000e+00	0	0	16726	0.000000e+00	0	1	89180	1.121330e-05	0	0	30590	0.000000e+00	0	1	89180	1.121330e-05	0	0	14876	0.000000e+00	0	0	34234	0.000000e+00	0	0	9562	0.000000e+00	0	0	17692	0.000000e+00	0	0	21558	0.000000e+00	0	1	102580	9.748490e-06	0	0	30510	0.000000e+00	0	1	102580	9.748490e-06	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	6062	1.649620587264929E-4	0	8	0	0	26	0	0	586	0	0	0	0	0	0	0	0	30	0	0	0	0	0	2276	0	0	594	0	0	56	0	1	8988	1.1125945705384957E-4	Uncertain_significance	not_provided|Classic_homocystinuria|Cardiovascular_phenotype|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43062341T>C	ClinGen:CA320468	CN517202|C0751202|CN230736|C3150344	236200	394	Tryptophan synthase beta chain-like, PALP domain	Met	Val	210418	single nucleotide variant	NM_000071.3(CBS):c.1009A>G (p.Met337Val)	875	CBS	HGNC:1550	Uncertain significance	0	Apr 10, 2022	372822486	-	RCV000196067|RCV000243887|RCV001828020|RCV002517166	MedGen:C3661900|MedGen:CN230736|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344	not provided|Cardiovascular phenotype|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;unknown	germline	GRCh38	NC_000021.9	21	43062341	43062341	21q22.3	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA320468	2	212859	43062341	T	C	-	-	-	-	-	-	SCV000249702|SCV000319264|SCV002787593|SCV003266998	-	-	1009A>G 	Met337Val	NM_000071.3	2	4_VUS	CBS	ENSG00000160200	359	261	CCSBVarC007314	ALE00007309	1009A>G	Met337Val	Edgotyping3	VUSMutGDEh010	B12	GDEhDisVCh_40013	G05	1	VUSMutGDDh010	B12	NULL	NULL	NULL	NULL	NULL	NULL	1	6	1	6	0	NULL	0	NULL	0	NULL	CBS_Met337Val	21	21	43062341	T	C
359	CBS	302T>C	Leu101Pro	ENSG00000160200	21	43068523	NC_000021.9:43068523:A:G	ALE00007342	CCSBVarC007354	NULL	NULL	314	GDEhDisVCh_40013	G10	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCCGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	187062.0	single nucleotide variant	NM_000071.3(CBS):c.302T>C (p.Leu101Pro)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Jan 06, 2025	786204757.0	-	RCV004754328|RCV001251397|RCV000169617|RCV002228615	|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344	CBS-related disorder|Homocystinuria|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;unknown	germline	GRCh38	NC_000021.9	21	43068523.0	43068523.0	21q22.3	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA274473,UniProtKB:P35520#VAR_021791	2.0	189185.0	43068523.0	A	G	-	-	-	-	-	-	SCV000221143|SCV000826966|SCV001426983|SCV004215542	-	-	302T>C 	Leu101Pro	NM_000071.3	2.0	1_Pathogenic	chr21	T	C	21-43068523-T-C		189185	21	43068523	A	G	L	P	rs786204757	21	44488633	21	43361702	101	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.302T>C	p.Leu101Pro	c.302T>C	p.Leu101Pro	principal1	Y	1	.	.	-	CTG	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	2.26	0.64163	M	-6.2	0.90390	D	0.973	0.98575	1.0084	0.97322	D	0.9031	0.96780	D	10	0.9859358	0.98864	D	0.702718	0.97565	D	0.969	0.99622	0.883	0.96965	P35520	L101P	Loss of catalytic residue at L101 (P = 0.0081)| Loss of stability (P = 0.0226)| Gain of disorder (P = 0.0345)| Gain of glycosylation at L101 (P = 0.043)| Gain of methylation at K97 (P = 0.0477)	0.933825529308	0.93263	.	0.96914	.	0.86003	0.734682798386	0.72143	T	0.964528	0.99564	D	0.5463	0.95603	D	0.546945	0.95539	D	0.998328268527985	0.93780	D	.	0.99753	.	0.9232724	0.93471	0.775445	0.86586	0.86735374	0.88498	0.75307363	0.85227	-14.152	0.93553	D	0.823	0.79816	LP	0.999793785792019	0.98009	0.99983156	0.99778	0.984	0.99450	.	.	.	.	.	.	4.404402	0.68147	25.2	0.99889654730018529	0.96438	0.979094	0.99793	D	0.620892341988886	0.74362	6.14286	0.574774956891262	0.72990	5.921462	4.81	4.81	0.61353	.	.	7.918	0.86946	8.901000	0.78401	0.658	0.54518	1.0	0.71675	1.000000	0.68239	0.305	0.24666	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Classic_homocystinuria|Homocystinuria	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43068523A>G	ClinGen:CA274473|UniProtKB:P35520#VAR_021791	C3150344|C0751202|C0019880	236200	394	Tryptophan synthase beta chain-like, PALP domain	Leu	Pro	187062	single nucleotide variant	NM_000071.3(CBS):c.302T>C (p.Leu101Pro)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Jan 06, 2025	786204757	-	RCV004754328|RCV001251397|RCV000169617|RCV002228615	|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344	CBS-related disorder|Homocystinuria|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;unknown	germline	GRCh38	NC_000021.9	21	43068523	43068523	21q22.3	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA274473,UniProtKB:P35520#VAR_021791	2	189185	43068523	A	G	-	-	-	-	-	-	SCV000221143|SCV000826966|SCV001426983|SCV004215542	-	-	302T>C 	Leu101Pro	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	314	CCSBVarC007354	ALE00007342	302T>C	Leu101Pro	Edgotyping3	VUSMutGDEh011	E05	GDEhDisVCh_40013	G10	1	VUSMutGDDh011	E05	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	CBS_Leu101Pro	21	21	43068523	A	G
359	CBS	1072G>A	Val358Met	ENSG00000160200	21	43060514	NC_000021.9:43060514:C:T	ALE00007306	CCSBVarC007310	NULL	NULL	256	GDEhDisVCh_40013	C05	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCATGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	191134.0	single nucleotide variant	NM_000071.3(CBS):c.1072G>A (p.Val358Met)	875.0	CBS	HGNC:1550	Conflicting classifications of pathogenicity	0.0	Oct 15, 2024	148589243.0	-	RCV000420634|RCV000474043|RCV002415740|RCV002517673|RCV004800313	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:C3150344|MedGen:CN169374	not provided|Classic homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not specified	germline	germline	GRCh38	NC_000021.9	21	43060514.0	43060514.0	21q22.3	criteria provided, conflicting classifications	9.0	-	N	ClinGen:CA239721	2.0	193971.0	43060514.0	C	T	-	-	-	-	-	-	SCV000225480|SCV000249707|SCV000510675|SCV000543512|SCV001300404|SCV002048346|SCV002717559|SCV005423303	-	-	1072G>A 	Val358Met	NM_000071.3	1.0	3_Conflicting	chr21	G	A	21-43060514-G-A		193971	21	43060514	C	T	V	M	rs148589243	21	44480624	21	43353693	358	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.1072G>A	p.Val358Met	c.1072G>A	p.Val358Met	principal1	Y	1	.	.	-	GTG	1	0	C	C/C	C/C	C/C	C/C	0.032	0.44852	D	0.083	0.41751	T	0.765	0.43747	P	0.351	0.42849	B	.	.	.	.	.	.	1.405	0.35314	L	-1.14	0.29284	N	0.389	0.42780	0.5700	0.91472	D	0.7616	0.91860	D	10	0.5307706	0.62861	D	0.336208	0.91871	D	0.565	0.82142	.	.	.	.	.	0.808581580453	0.80526	.	0.76788	.	0.53231	0.480688750744	0.36104	T	0.817821	0.95477	D	-0.00311984	0.50902	T	0.0320418	0.72206	D	0.107241220772266	0.12968	T	.	0.85611	.	0.36529824	0.57907	0.16267394	0.37656	0.33454958	0.55510	0.13983497	0.33256	-6.216	0.48112	T	.	0.24259	.	0.499818839120897	0.60779	0.99663250	0.98114	0.472	0.69612	.	.	.	.	.	.	2.329098	0.29891	18.25	0.99767334577377786	0.85596	0.765136	0.70062	D	-0.0797694225934274	0.38008	2.239616	-0.0664406539977571	0.36486	2.14538	5.05	4.17	0.48244	2.42	0.44885	2.392	0.44189	2.012000	0.30253	0.469	0.21904	0.972	0.3454	0.964000	0.29515	0.017	0.10969	988	0.02004	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	.	.	.	.	10	102520	9.754190e-05	0	21	197560	1.062970e-04	0	19	227898	8.337060e-05	0	1	6862	1.457300e-04	0	0	16992	0.000000e+00	0	0	2294	0.000000e+00	0	0	8880	0.000000e+00	0	0	7680	0.000000e+00	0	9	42336	2.125850e-04	0	0	15620	0.000000e+00	0	9	42336	2.125850e-04	0	2	15248	1.311650e-04	0	0	30330	0.000000e+00	0	0	6070	0.000000e+00	0	0	13104	0.000000e+00	0	0	11010	0.000000e+00	0	19	86528	2.195820e-04	0	0	30528	0.000000e+00	0	19	86528	2.195820e-04	0	2	14208	1.407660e-04	0	0	34104	0.000000e+00	0	0	9490	0.000000e+00	0	0	17526	0.000000e+00	0	0	15856	0.000000e+00	0	17	100728	1.687710e-04	0	0	30450	0.000000e+00	0	17	100728	1.687710e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	7	61886	1.131112044727402E-4	0	86	0	0	84	0	0	2398	0	0	146	0	0	630	0	0	50	0	0	94	0	1	6684	1.4961101137043686E-4	0	2484	0	0	134	0	8	72058	1.1102167698243081E-4	Conflicting_classifications_of_pathogenicity	HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Classic_homocystinuria|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_provided	criteria_provided,_conflicting_classifications	NC_000021.9:g.43060514C>T	ClinGen:CA239721	C3150344|C0751202|C4707243|C3661900	236200|PS607086	394|91387	Tryptophan synthase beta chain-like, PALP domain	Val	Met	191134	single nucleotide variant	NM_000071.3(CBS):c.1072G>A (p.Val358Met)	875	CBS	HGNC:1550	Conflicting classifications of pathogenicity	0	Oct 15, 2024	148589243	-	RCV000420634|RCV000474043|RCV002415740|RCV002517673|RCV004800313	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:C3150344|MedGen:CN169374	not provided|Classic homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not specified	germline	germline	GRCh38	NC_000021.9	21	43060514	43060514	21q22.3	criteria provided, conflicting classifications	9	-	N	ClinGen:CA239721	2	193971	43060514	C	T	-	-	-	-	-	-	SCV000225480|SCV000249707|SCV000510675|SCV000543512|SCV001300404|SCV002048346|SCV002717559|SCV005423303	-	-	1072G>A 	Val358Met	NM_000071.3	1	3_Conflicting	CBS	ENSG00000160200	359	256	CCSBVarC007310	ALE00007306	1072G>A	Val358Met	Edgotyping3	VUSMutGDEh010	F11	GDEhDisVCh_40013	C05	1	VUSMutGDDh010	F11	NULL	NULL	NULL	NULL	NULL	NULL	1	6	1	6	0	NULL	0	NULL	0	NULL	CBS_Val358Met	21	21	43060514	C	T
2803	HMBS	766C>A	His256Asn	ENSG00000256269	11	119092518	NC_000011.10:119092518:C:A	ALE00005177	CCSBVarC005177	NULL	200940	NULL	GDEhDisVCh_40054	F07	CEGS2	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAGCTTGCTCGCATACAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGGACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCTTGAACATGCCCTGGAGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCGAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTCGGGGAAACCTCAACACCCGGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACCGGGTGGGGCAGATCCTGCACCCTGAGGAATGCATGTATGCTGTGGGCCAGGGGGCCTTGGGCGTGGAAGTGCGAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCTGCATCGCTGAAAGGGCCTTCCTGAGGAACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATGGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCGTAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACGATGCCCAT	16513.0	single nucleotide variant	NM_000190.4(HMBS):c.766C>A (p.His256Asn)	3145.0	HMBS	HGNC:4982	Pathogenic	1.0	Dec 01, 1993	118204115.0	-	RCV000001539	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276	Acute intermittent porphyria	germline	germline	GRCh38	NC_000011.10	11	119092518.0	119092518.0	11q23.3	no assertion criteria provided	1.0	-	N	ClinGen:CA251836,UniProtKB:P08397#VAR_003669,OMIM:609806.0034	1.0	1474.0	119092518.0	C	A	-	-	-	-	-	-	SCV000021694	-	-	766C>A 	His256Asn	NM_000190.4		1_Pathogenic	chr11	C	A	11-119092518-C-A		1474	11	119092518	C	A	H	N	rs118204115	11	118963228	11	118468438	256	HMBS	ENSG00000256269	ENST00000652429	ENSP00000498786	P08397	HEM3_HUMAN	c.766C>A	p.His256Asn	c.766C>A	p.His256Asn	principal2	Y	.	YES	Select	+	CAC	1	0	C	C/C	C/C	C/C	C/C	.	0.08361	.	.	0.17823	.	0.546	0.38046	P	0.288	0.40614	B	.	0.97926	.	.	.	.	2.42	0.69809	M	.	0.11479	.	.	0.60035	1.0870	0.99121	D	0.8810	0.96041	D	9	.	0.72944	.	0.154635	0.83526	D	.	0.82257	0.821	0.93359	P08397	H256N	Gain of methylation at R255 (P = 0.2814)| Loss of catalytic residue at E258 (P = 0.3196)| Loss of helix (P = 0.4763)| Loss of disorder (P = 0.5616)| Gain of MoRF binding (P = 0.6045)	.	0.77777	0.6382043804944534	0.63584	.	.	0.583521664143	0.50516	T	0.661814	0.89758	D	0.201684	0.73856	D	0.0519292	0.73515	D	0.723255395889282	0.41564	D	0.974203	0.90838	D	0.39711455	0.60207	0.17150109	0.39208	0.42338273	0.61995	0.2002319	0.43788	-3.527	0.19541	T	0.1596	0.35351	B	0.900888859472124	0.76114	0.03303835	0.55011	0.482	0.70274	.	.	.	.	.	.	3.216449	0.43884	21.8	0.97546153328312879	0.34708	0.617763	0.60241	D	0.310771753279657	0.56479	3.835273	0.400097499637153	0.61364	4.359105	5.24	5.24	0.72825	.	.	2.897	0.4846	5.956000	0.51809	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.994	0.71086	228	0.91137	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	Acute_intermittent_porphyria	no_assertion_criteria_provided	NC_000011.10:g.119092518C>A	ClinGen:CA251836|OMIM:609806.0034|UniProtKB:P08397#VAR_003669	C0162565	176000	79276	Porphobilinogen deaminase, C-terminal|Porphobilinogen deaminase, dipyrromethane cofactor binding site	His	Asn	16513	single nucleotide variant	NM_000190.4(HMBS):c.766C>A (p.His256Asn)	3145	HMBS	HGNC:4982	Pathogenic	1	Dec 01, 1993	118204115	-	RCV000001539	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276	Acute intermittent porphyria	germline	germline	GRCh38	NC_000011.10	11	119092518	119092518	11q23.3	no assertion criteria provided	1	-	N	ClinGen:CA251836,UniProtKB:P08397#VAR_003669,OMIM:609806.0034	1	1474	119092518	C	A	-	-	-	-	-	-	SCV000021694	-	-	766C>A 	His256Asn	NM_000190.4		1_Pathogenic	HMBS	ENSG00000256269	2803	200940	CCSBVarC005177	ALE00005177	766C>A	His256Asn	CEGS2	CegsMutGDEh1042	G06	GDEhDisVCh_40054	F07	2	CegsMutGDDh1042	G06	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	HMBS_His256Asn	11	11	119092518	C	A
359	CBS	833T>C	Ile278Thr	ENSG00000160200	21	43063074	NC_000021.9:43063074:A:G	ALE00000044	CCSBVarC000044	1052	NULL	275	GDEhDisVCh_40013	H02	RC4	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCACTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	15159.0	single nucleotide variant	NM_000071.3(CBS):c.833T>C (p.Ile278Thr)	875.0	CBS	HGNC:1550	Pathogenic	1.0	Jan 29, 2025	5742905.0	-	RCV000000142|RCV000000141|RCV000173640|RCV000078111|RCV001252178|RCV002276525|RCV003128384|RCV000781197|RCV002310621|RCV004584135	MedGen:C3150344|MedGen:C3502110|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3661900|Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,MONDO:MONDO:0001071,MeSH:D008607,MedGen:C3714756|MONDO:MONDO:0003900,MedGen:C0009782||Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria, pyridoxine-responsive|Classic homocystinuria|not provided|Intellectual disability|Connective tissue disorder|See cases|Homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|Thoracic aortic aneurysm or dissection	germline;paternal;unknown	germline	GRCh38	NC_000021.9	21	43063074.0	43063074.0	21q22.3	criteria provided, multiple submitters, no conflicts	37.0	-	N	ClinGen:CA113880,UniProtKB:P35520#VAR_002184,OMIM:613381.0004	3.0	120.0	43063074.0	A	G	-	-	-	-	-	-	SCV000224772|SCV000245588|SCV000249694|SCV000283389|SCV000319225|SCV000436218|SCV000602918|SCV000893555|SCV000919082|SCV000927527|SCV001163820|SCV001194139|SCV001246793|SCV001367822|SCV001437665|SCV001715596|SCV001977085|SCV002016938|SCV002566538|SCV002573187|SCV003804940|SCV004026267|SCV005052059|SCV005068242|SCV005197393|SCV005441947	-	-	833T>C 	Ile278Thr	NM_000071.3	2.0	1_Pathogenic	chr21	T	C	21-43063074-T-C		120	21	43063074	A	G	I	T	rs5742905	21	44483184	21	43356253	278	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.833T>C	p.Ile278Thr	c.833T>C	p.Ile278Thr	principal1	Y	1	.	.	-	ATT	2	0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.049	0.48688	D	0.967	0.56423	D	0.901	0.63988	P	1.0	0.99291	A	simple_aae	0.0	100.0	2.895	0.83647	M	-3.82	0.72035	D	0.838	0.83323	1.1077	0.99846	D	0.9384	0.97971	D	9	0.86817104	0.85919	D	0.71448	0.97678	D	0.740	0.90947	.	.	.	.	.	0.816843541818	0.81366	.	0.94022	.	0.79726	0.513501942158	0.40655	T	0.98401	0.99891	D	0.213268	0.74954	D	0.542963	0.95410	D	0.992955148220062	0.83449	D	.	0.91613	.	0.84802866	0.87018	0.70974994	0.82680	0.8786762	0.89413	0.68491524	0.81263	-11.415	0.81941	D	.	0.35119	.	0.991491577284522	0.89054	0.99972862	0.99655	0.953	0.97907	.	.	.	.	.	.	4.177204	0.62924	24.5	0.98710646225667786	0.45165	0.943504	0.94926	D	0.183559540908805	0.50164	3.231225	0.0314312772757425	0.40895	2.469953	4.67	3.52	0.39345	.	.	8.103	0.89415	10.875000	0.84053	0.587	0.31004	1.0	0.71675	1.000000	0.68239	0.281	0.24089	988	0.02004	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	981	178852	0.0054849819962874335	11	352	0.03125	0	4736	0	165	9033	0.018266356692128862	1	482	0.002074688796680498	4	1126	0.003552397868561279	0	1880	0	0	294	0	36	13422	0.002682163611980331	176	9385	0.018753329781566328	0	6616	0	1198	210177	0.005699957654738625	Pathogenic	Intellectual_disability|Connective_tissue_disorder|Homocystinuria|See_cases|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_provided|Thoracic_aortic_aneurysm_or_dissection|Classic_homocystinuria|Homocystinuria,_pyridoxine-responsive|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43063074A>G	ClinGen:CA113880|OMIM:613381.0004|UniProtKB:P35520#VAR_002184	C3714756|C0009782|C0019880|C4707243|C3661900|C0751202|C3502110|C3150344	PS607086|236200	91387|394	Tryptophan synthase beta chain-like, PALP domain	Ile	Thr	15159	single nucleotide variant	NM_000071.3(CBS):c.833T>C (p.Ile278Thr)	875	CBS	HGNC:1550	Pathogenic	1	Jan 29, 2025	5742905	-	RCV000000142|RCV000000141|RCV000173640|RCV000078111|RCV001252178|RCV002276525|RCV003128384|RCV000781197|RCV002310621|RCV004584135	MedGen:C3150344|MedGen:C3502110|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3661900|Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,MONDO:MONDO:0001071,MeSH:D008607,MedGen:C3714756|MONDO:MONDO:0003900,MedGen:C0009782||Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria, pyridoxine-responsive|Classic homocystinuria|not provided|Intellectual disability|Connective tissue disorder|See cases|Homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|Thoracic aortic aneurysm or dissection	germline;paternal;unknown	germline	GRCh38	NC_000021.9	21	43063074	43063074	21q22.3	criteria provided, multiple submitters, no conflicts	37	-	N	ClinGen:CA113880,UniProtKB:P35520#VAR_002184,OMIM:613381.0004	3	120	43063074	A	G	-	-	-	-	-	-	SCV000224772|SCV000245588|SCV000249694|SCV000283389|SCV000319225|SCV000436218|SCV000602918|SCV000893555|SCV000919082|SCV000927527|SCV001163820|SCV001194139|SCV001246793|SCV001367822|SCV001437665|SCV001715596|SCV001977085|SCV002016938|SCV002566538|SCV002573187|SCV003804940|SCV004026267|SCV005052059|SCV005068242|SCV005197393|SCV005441947	-	-	833T>C 	Ile278Thr	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	275	CCSBVarC000044	ALE00000044	833T>C	Ile278Thr	Edgotyping3	VUSMutGDEh011	F01	NULL	NULL	NULL	VUSMutGDDh011	F01	NULL	NULL	NULL	NULL	NULL	NULL	0	NULL	1	6	0	NULL	0	NULL	0	NULL	CBS_Ile278Thr	21	21	43063074	A	G
359	CBS	833T>C	Ile278Thr	ENSG00000160200	21	43063074	NC_000021.9:43063074:A:G	ALE00000044	CCSBVarC000044	1052	NULL	275	GDEhDisVCh_40013	H02	RC4	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCACTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	15159.0	single nucleotide variant	NM_000071.3(CBS):c.833T>C (p.Ile278Thr)	875.0	CBS	HGNC:1550	Pathogenic	1.0	Jan 29, 2025	5742905.0	-	RCV000000142|RCV000000141|RCV000173640|RCV000078111|RCV001252178|RCV002276525|RCV003128384|RCV000781197|RCV002310621|RCV004584135	MedGen:C3150344|MedGen:C3502110|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3661900|Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,MONDO:MONDO:0001071,MeSH:D008607,MedGen:C3714756|MONDO:MONDO:0003900,MedGen:C0009782||Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria, pyridoxine-responsive|Classic homocystinuria|not provided|Intellectual disability|Connective tissue disorder|See cases|Homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|Thoracic aortic aneurysm or dissection	germline;paternal;unknown	germline	GRCh38	NC_000021.9	21	43063074.0	43063074.0	21q22.3	criteria provided, multiple submitters, no conflicts	37.0	-	N	ClinGen:CA113880,UniProtKB:P35520#VAR_002184,OMIM:613381.0004	3.0	120.0	43063074.0	A	G	-	-	-	-	-	-	SCV000224772|SCV000245588|SCV000249694|SCV000283389|SCV000319225|SCV000436218|SCV000602918|SCV000893555|SCV000919082|SCV000927527|SCV001163820|SCV001194139|SCV001246793|SCV001367822|SCV001437665|SCV001715596|SCV001977085|SCV002016938|SCV002566538|SCV002573187|SCV003804940|SCV004026267|SCV005052059|SCV005068242|SCV005197393|SCV005441947	-	-	833T>C 	Ile278Thr	NM_000071.3	2.0	1_Pathogenic	chr21	T	C	21-43063074-T-C		120	21	43063074	A	G	I	T	rs5742905	21	44483184	21	43356253	278	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.833T>C	p.Ile278Thr	c.833T>C	p.Ile278Thr	principal1	Y	1	.	.	-	ATT	2	0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.049	0.48688	D	0.967	0.56423	D	0.901	0.63988	P	1.0	0.99291	A	simple_aae	0.0	100.0	2.895	0.83647	M	-3.82	0.72035	D	0.838	0.83323	1.1077	0.99846	D	0.9384	0.97971	D	9	0.86817104	0.85919	D	0.71448	0.97678	D	0.740	0.90947	.	.	.	.	.	0.816843541818	0.81366	.	0.94022	.	0.79726	0.513501942158	0.40655	T	0.98401	0.99891	D	0.213268	0.74954	D	0.542963	0.95410	D	0.992955148220062	0.83449	D	.	0.91613	.	0.84802866	0.87018	0.70974994	0.82680	0.8786762	0.89413	0.68491524	0.81263	-11.415	0.81941	D	.	0.35119	.	0.991491577284522	0.89054	0.99972862	0.99655	0.953	0.97907	.	.	.	.	.	.	4.177204	0.62924	24.5	0.98710646225667786	0.45165	0.943504	0.94926	D	0.183559540908805	0.50164	3.231225	0.0314312772757425	0.40895	2.469953	4.67	3.52	0.39345	.	.	8.103	0.89415	10.875000	0.84053	0.587	0.31004	1.0	0.71675	1.000000	0.68239	0.281	0.24089	988	0.02004	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	981	178852	0.0054849819962874335	11	352	0.03125	0	4736	0	165	9033	0.018266356692128862	1	482	0.002074688796680498	4	1126	0.003552397868561279	0	1880	0	0	294	0	36	13422	0.002682163611980331	176	9385	0.018753329781566328	0	6616	0	1198	210177	0.005699957654738625	Pathogenic	Intellectual_disability|Connective_tissue_disorder|Homocystinuria|See_cases|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_provided|Thoracic_aortic_aneurysm_or_dissection|Classic_homocystinuria|Homocystinuria,_pyridoxine-responsive|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43063074A>G	ClinGen:CA113880|OMIM:613381.0004|UniProtKB:P35520#VAR_002184	C3714756|C0009782|C0019880|C4707243|C3661900|C0751202|C3502110|C3150344	PS607086|236200	91387|394	Tryptophan synthase beta chain-like, PALP domain	Ile	Thr	15159	single nucleotide variant	NM_000071.3(CBS):c.833T>C (p.Ile278Thr)	875	CBS	HGNC:1550	Pathogenic	1	Jan 29, 2025	5742905	-	RCV000000142|RCV000000141|RCV000173640|RCV000078111|RCV001252178|RCV002276525|RCV003128384|RCV000781197|RCV002310621|RCV004584135	MedGen:C3150344|MedGen:C3502110|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3661900|Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,MONDO:MONDO:0001071,MeSH:D008607,MedGen:C3714756|MONDO:MONDO:0003900,MedGen:C0009782||Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria, pyridoxine-responsive|Classic homocystinuria|not provided|Intellectual disability|Connective tissue disorder|See cases|Homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|Thoracic aortic aneurysm or dissection	germline;paternal;unknown	germline	GRCh38	NC_000021.9	21	43063074	43063074	21q22.3	criteria provided, multiple submitters, no conflicts	37	-	N	ClinGen:CA113880,UniProtKB:P35520#VAR_002184,OMIM:613381.0004	3	120	43063074	A	G	-	-	-	-	-	-	SCV000224772|SCV000245588|SCV000249694|SCV000283389|SCV000319225|SCV000436218|SCV000602918|SCV000893555|SCV000919082|SCV000927527|SCV001163820|SCV001194139|SCV001246793|SCV001367822|SCV001437665|SCV001715596|SCV001977085|SCV002016938|SCV002566538|SCV002573187|SCV003804940|SCV004026267|SCV005052059|SCV005068242|SCV005197393|SCV005441947	-	-	833T>C 	Ile278Thr	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	1052	CCSBVarC000044	ALE00000044	833T>C	Ile278Thr	RC4	RC4_Mut_GDEh1026	G05	GDEhDisVCh_40013	H02	1	RC4_Mut_GDDh1026	G05	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	CBS_Ile278Thr	21	21	43063074	A	G
3774	TP53	848G>A	Arg283His	ENSG00000141510	17	7673772	NC_000017.11:7673772:C:T	ALE00004875	CCSBVarC004875	NULL	214901	NULL	GDEhDisVCh_40053	C03	CEGS2	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACCGGCACACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	152038.0	single nucleotide variant	NM_000546.6(TP53):c.848G>A (p.Arg283His)	7157.0	TP53	HGNC:11998	Uncertain significance	0.0	Jan 28, 2025	371409680.0	-	RCV000131388|RCV000213060|RCV000507738|RCV000148904|RCV000457935|RCV003415959|RCV003467172|RCV001815237	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|Human Phenotype Ontology:HP:0009592,MONDO:MONDO:0019781,MeSH:D001254,MedGen:C0004114|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524||MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501|MedGen:CN169374	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Astrocytoma|Li-Fraumeni syndrome|TP53-related disorder|Adrenocortical carcinoma, hereditary|not specified	germline;unknown	germline	GRCh38	NC_000017.11	17	7673772.0	7673772.0	17p13.1	criteria provided, multiple submitters, no conflicts	12.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000459,UniProtKB:P04637#VAR_006019	2.0	142324.0	7673772.0	C	T	-	-	-	-	-	-	SCV000186364|SCV000190650|SCV000211762|SCV000545319|SCV000597520|SCV000602281|SCV000605420|SCV000903096|SCV001950095|SCV004107241|SCV004206220|SCV004823759	-	-	848G>A 	Arg283His	NM_000546.6	2.0	4_VUS	chr17	G	A	17-7673772-G-A		142324	17	7673772	C	T	R	H	rs371409680	17	7577090	17	7517815	283	TP53	ENSG00000141510	ENST00000508793	ENSP00000424104	P04637	P53_HUMAN	c.*1344G>A	.	c.848G>A	p.Arg283His	principal1	.	4	.	.	-	CGC	2	0	C	C/C	C/C	C/C	C/C	.	0.78662	.	.	0.74454	.	0.952	0.77914	P	0.838	0.67346	P	.	0.97926	.	.	.	.	2.38	0.68363	M	.	0.65311	.	.	0.82912	1.0598	0.98331	D	0.9862	0.99587	D	10	.	0.75039	.	0.701008	0.97549	D	.	0.94825	.	.	.	.	.	.	0.97079	.	0.28517	.	0.41022	0.438737183809	0.30367	T	0.990026	0.99955	D	0.234006	0.76926	D	0.301011	0.88162	D	0.682959318161011	0.39619	D	.	0.93161	.	0.8047547	0.84010	0.649632	0.79277	0.8139947	0.84623	0.73254085	0.84006	-11.152	0.80547	D	.	0.67856	.	0.843107598223009	0.72760	0.99994957	0.99953	0.745	0.85875	.	.	.	.	.	.	5.075815	0.84714	28.4	0.99908777712917007	0.97876	0.272127	0.38582	N	0.33074546419983	0.57516	3.941805	0.220115237229582	0.50711	3.283206	4.99	4.02	0.45905	3.43	0.62101	3.176	0.50659	5.996000	0.52481	0.596	0.33565	0.997	0.40243	1.000000	0.68239	0.997	0.79771	432	0.80699	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	.	6	109396	5.484660e-05	0	10	208114	4.805060e-05	0	9	236916	3.798810e-05	0	0	7164	0.000000e+00	0	2	17106	1.169180e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13390	0.000000e+00	0	1	42768	2.338200e-05	0	3	15688	1.912290e-04	0	3	15688	1.912290e-04	0	0	16216	0.000000e+00	0	2	30514	6.554370e-05	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16730	0.000000e+00	0	4	89554	4.466580e-05	0	4	30606	1.306930e-04	0	4	30606	1.306930e-04	0	0	14900	0.000000e+00	0	2	34250	5.839420e-05	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21624	0.000000e+00	0	3	102734	2.920160e-05	0	4	30524	1.310440e-04	0	4	30524	1.310440e-04	0	.	34	1613966	2.106610e-05	0	9	91090	9.880340e-05	0	0	74920	0.000000e+00	0	0	910	0.000000e+00	0	3	59972	5.002330e-05	0	0	29608	0.000000e+00	0	1	44860	2.229160e-05	0	1	64016	1.562110e-05	0	0	6084	0.000000e+00	0	19	1180026	1.610130e-05	0	9	91090	9.880340e-05	0	0	15830	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	796	0	0	3324	0	0	112	0	0	20916	0	Uncertain_significance	Astrocytoma|not_provided|Li-Fraumeni_syndrome_1|Adrenocortical_carcinoma,_hereditary|Li-Fraumeni_syndrome|TP53-related_disorder|Hereditary_cancer-predisposing_syndrome|not_specified	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.7673772C>T	ClinGen:CA000459|UniProtKB:P04637#VAR_006019	C0004114|C3661900|C1835398|C1859972|C0085390|C0027672|CN169374	151623|202300|PS151623	524|1501|524|140162	p53, DNA-binding domain|p53, DNA-binding domain	Arg	His	152038	single nucleotide variant	NM_000546.6(TP53):c.848G>A (p.Arg283His)	7157	TP53	HGNC:11998	Uncertain significance	0	Jan 28, 2025	371409680	-	RCV000131388|RCV000213060|RCV000507738|RCV000148904|RCV000457935|RCV003415959|RCV003467172|RCV001815237	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|Human Phenotype Ontology:HP:0009592,MONDO:MONDO:0019781,MeSH:D001254,MedGen:C0004114|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524||MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501|MedGen:CN169374	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome 1|Astrocytoma|Li-Fraumeni syndrome|TP53-related disorder|Adrenocortical carcinoma, hereditary|not specified	germline;unknown	germline	GRCh38	NC_000017.11	17	7673772	7673772	17p13.1	criteria provided, multiple submitters, no conflicts	12	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000459,UniProtKB:P04637#VAR_006019	2	142324	7673772	C	T	-	-	-	-	-	-	SCV000186364|SCV000190650|SCV000211762|SCV000545319|SCV000597520|SCV000602281|SCV000605420|SCV000903096|SCV001950095|SCV004107241|SCV004206220|SCV004823759	-	-	848G>A 	Arg283His	NM_000546.6	2	4_VUS	TP53	ENSG00000141510	3774	214901	CCSBVarC004875	ALE00004875	848G>A	Arg283His	CEGS2	CegsMutGDEh1012	B04	GDEhDisVCh_40053	C03	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	TP53_Arg283His	17	17	7673772	C	T
3774	TP53	659A>G	Tyr220Cys	ENSG00000141510	17	7674872	NC_000017.11:7674872:T:C	ALE00004864	CCSBVarC004864	NULL	214893	NULL	GDEhDisVCh_40053	C05	CEGS2	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTGTGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACCGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	133276.0	single nucleotide variant	NM_000546.6(TP53):c.659A>G (p.Tyr220Cys)	7157.0	TP53	HGNC:11998	Pathogenic	1.0	Aug 05, 2024	121912666.0	-	RCV000115731|RCV000213055|RCV000232050|RCV001310212|RCV001527468|RCV001579295|RCV002490776|RCV000433936|RCV003162539|RCV003460829|RCV003407499|RCV003997298|RCV000785544|RCV004668782	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|Human Phenotype Ontology:HP:0005550,Human Phenotype Ontology:HP:0006734,Human Phenotype Ontology:HP:0006760,MONDO:MONDO:0004948,MeSH:D015451,MedGen:C0023434,OMIM:151400,Orphanet:67038|Human Phenotype Ontology:HP:0003002,MONDO:MONDO:0004989,MedGen:C0678222|12 conditions|MONDO:MONDO:0010150,MeSH:D000077195,MedGen:C1168401,OMIM:275355,Orphanet:67037|Human Phenotype Ontology:HP:0012126,MONDO:MONDO:0001056,MeSH:D013274,MedGen:C0024623,OMIM:613659|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501||Human Phenotype Ontology:HP:0002889,Human Phenotype Ontology:HP:0006744,Human Phenotype Ontology:HP:0006759,MONDO:MONDO:0006639,MeSH:D018268,MedGen:C0206686,Orphanet:1501|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|B-cell chronic lymphocytic leukemia|Breast carcinoma|12 conditions|Squamous cell carcinoma of the head and neck|Gastric cancer|Adrenocortical carcinoma, hereditary|TP53-related disorder|Adrenal cortex carcinoma|Ovarian neoplasm|Neoplasm	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7674872.0	7674872.0	17p13.1	reviewed by expert panel	28.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000315,UniProtKB:P04637#VAR_005957	2.0	127819.0	7674872.0	T	C	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV001142546	-	SCV005094428	659A>G 	Tyr220Cys	NM_000546.6	3.0	1_Pathogenic	chr17	A	G	17-7674872-A-G		127819	17	7674872	T	C	Y	C	rs121912666	17	7578190	17	7518915	220	TP53	ENSG00000141510	ENST00000503591	ENSP00000426252	P04637	P53_HUMAN	c.*357A>G	.	c.659A>G	p.Tyr220Cys	principal1	.	5	.	.	-	TAT	2	0	T	T/T	T/T	T/T	T/T	.	0.72322	.	.	0.92967	.	1.0	0.90580	D	0.999	0.97365	D	.	0.99291	.	.	.	.	3.165	0.88471	M	.	0.97459	.	.	0.91621	0.9542	0.96447	D	0.9921	0.99806	D	10	.	0.99531	.	0.748599	0.97989	D	.	0.98562	0.938	0.99125	P04637	Y220C	Gain of catalytic residue at P219 (P = 0.0188)| Loss of phosphorylation at Y220 (P = 0.0641)| Loss of sheet (P = 0.1501)| Loss of disorder (P = 0.1712)| Loss of glycosylation at P222 (P = 0.2467)	.	0.98199	.	0.79871	.	0.92306	0.65837687254	0.61115	T	0.995389	0.99991	D	0.546373	0.95605	D	0.562537	0.95942	D	0.997192919254303	0.90910	D	.	0.55548	.	0.91062677	0.92241	0.9287594	0.96966	0.94778126	0.95978	0.8928712	0.94395	-10.054	0.75330	D	.	0.81817	.	0.999282920044118	0.96155	0.99997306	0.99978	0.994	0.99793	.	.	.	.	.	.	5.127489	0.85822	28.7	0.99803056665645673	0.88737	0.839540	0.75604	D	0.750362639718156	0.82836	7.885704	0.664333451297186	0.79570	7.134308	5.28	5.28	0.74083	.	.	6.252	0.72468	7.888000	0.72926	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.998	0.85369	433	0.80635	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	1	109388	9.141770e-06	0	1	208090	4.805610e-06	0	2	236878	8.443160e-06	0	0	7162	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	1	42758	2.338740e-05	0	0	15684	0.000000e+00	0	1	42758	2.338740e-05	0	0	16212	0.000000e+00	0	0	30518	0.000000e+00	0	0	6212	0.000000e+00	0	0	13414	0.000000e+00	0	0	16734	0.000000e+00	0	1	89538	1.116840e-05	0	0	30596	0.000000e+00	0	1	89538	1.116840e-05	0	0	14898	0.000000e+00	0	0	34254	0.000000e+00	0	0	9572	0.000000e+00	0	0	17690	0.000000e+00	0	0	21626	0.000000e+00	0	2	102706	1.947310e-05	0	0	30514	0.000000e+00	0	2	102706	1.947310e-05	0	.	8	1613958	4.956760e-06	0	1	64036	1.561620e-05	0	0	74914	0.000000e+00	0	0	912	0.000000e+00	0	0	59992	0.000000e+00	0	0	29604	0.000000e+00	0	0	44898	0.000000e+00	0	1	64036	1.561620e-05	0	0	6084	0.000000e+00	0	7	1179948	5.932460e-06	0	0	91086	0.000000e+00	0	1	26576	3.7627934978928356E-5	0	114	0	0	86	0	0	3230	0	0	500	0	0	628	0	0	26	0	0	98	0	0	4634	0	0	3344	0	0	112	0	1	35892	2.786136186336788E-5	Pathogenic	Ovarian_neoplasm|Pancreatic_adenocarcinoma|Breast_neoplasm|Lung_adenocarcinoma|Glioblastoma|B-cell_chronic_lymphocytic_leukemia|Breast_carcinoma|Li-Fraumeni_syndrome|Transitional_cell_carcinoma_of_the_bladder|Hereditary_cancer-predisposing_syndrome|Adrenocortical_carcinoma,_hereditary|Malignant_melanoma_of_skin|Uterine_carcinosarcoma|Small_cell_lung_carcinoma|Adrenal_cortex_carcinoma|Gastric_adenocarcinoma|Ovarian_serous_cystadenocarcinoma|Malignant_neoplasm_of_body_of_uterus|Prostate_adenocarcinoma|Papillary_renal_cell_carcinoma,_sporadic|Neoplasm_of_brain|Neoplasm_of_the_large_intestine|Hepatocellular_carcinoma|Acute_myeloid_leukemia|Papillary_renal_cell_carcinoma_type_1|Squamous_cell_lung_carcinoma|not_provided|Gastric_cancer|Li-Fraumeni_syndrome_1|Bone_osteosarcoma|Colorectal_cancer|Familial_cancer_of_breast|Basal_cell_carcinoma,_susceptibility_to,_7|Bone_marrow_failure_syndrome_5|Glioma_susceptibility_1|Nasopharyngeal_carcinoma|Carcinoma_of_pancreas|Choroid_plexus_papilloma|Squamous_cell_carcinoma_of_the_head_and_neck|TP53-related_disorder	reviewed_by_expert_panel	NC_000017.11:g.7674872T>C	ClinGen:CA000315|UniProtKB:P04637#VAR_005957	C0919267|C0281361|C1458155|C0152013|C0017636|C0023434|C0678222|C0085390|C0279680|C0027672|C1859972|C0151779|C0280630|C0149925|C0206686|C0278701|C0279663|C0153574|C0007112|C1336078|C0006118|C0009404|C2239176|C0023467|C1336839|C0149782|C3661900|C0024623|C1835398|C0585442|C0346629|C0346153|C3553606|C4748488|C2750850|C2931822|C0235974|C0205770|C1168401	151400|PS151623|202300|182280|114550|601626|605074|613659|151623|259500|114500|114480|614740|618165|137800|607107|260500|275355	360|67038|524|140162|1501|70573|1501|88673|519|47044|524|668|227535|150|1333|217074|251899|2807|67037	p53, DNA-binding domain|p53, DNA-binding domain	Tyr	Cys	133276	single nucleotide variant	NM_000546.6(TP53):c.659A>G (p.Tyr220Cys)	7157	TP53	HGNC:11998	Pathogenic	1	Aug 05, 2024	121912666	-	RCV000115731|RCV000213055|RCV000232050|RCV001310212|RCV001527468|RCV001579295|RCV002490776|RCV000433936|RCV003162539|RCV003460829|RCV003407499|RCV003997298|RCV000785544|RCV004668782	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|Human Phenotype Ontology:HP:0005550,Human Phenotype Ontology:HP:0006734,Human Phenotype Ontology:HP:0006760,MONDO:MONDO:0004948,MeSH:D015451,MedGen:C0023434,OMIM:151400,Orphanet:67038|Human Phenotype Ontology:HP:0003002,MONDO:MONDO:0004989,MedGen:C0678222|12 conditions|MONDO:MONDO:0010150,MeSH:D000077195,MedGen:C1168401,OMIM:275355,Orphanet:67037|Human Phenotype Ontology:HP:0012126,MONDO:MONDO:0001056,MeSH:D013274,MedGen:C0024623,OMIM:613659|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501||Human Phenotype Ontology:HP:0002889,Human Phenotype Ontology:HP:0006744,Human Phenotype Ontology:HP:0006759,MONDO:MONDO:0006639,MeSH:D018268,MedGen:C0206686,Orphanet:1501|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651	Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|B-cell chronic lymphocytic leukemia|Breast carcinoma|12 conditions|Squamous cell carcinoma of the head and neck|Gastric cancer|Adrenocortical carcinoma, hereditary|TP53-related disorder|Adrenal cortex carcinoma|Ovarian neoplasm|Neoplasm	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7674872	7674872	17p13.1	reviewed by expert panel	28	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000315,UniProtKB:P04637#VAR_005957	2	127819	7674872	T	C	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV001142546	-	SCV005094428	659A>G 	Tyr220Cys	NM_000546.6	3	1_Pathogenic	TP53	ENSG00000141510	3774	214893	CCSBVarC004864	ALE00004864	659A>G	Tyr220Cys	CEGS2	CegsMutGDEh1018	B05	GDEhDisVCh_40053	C05	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	TP53_Tyr220Cys	17	17	7674872	T	C
52861	F9	496A>T	Asn166Tyr	ENSG00000101981	X	139548467	NC_000023.11:139548467:A:T	ALE00004378	CCSBVarC004378	NULL	204359	NULL	GDEhDisVCh_40052	F01	CEGS2	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAATACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT	25621.0	single nucleotide variant	NM_000133.4(F9):c.496A>T (p.Asn166Tyr)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Apr 01, 1989	137852236.0	-	RCV000011328	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548467.0	139548467.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255337,OMIM:300746.0025	1.0	10582.0	139548467.0	A	T	-	-	-	-	-	-	SCV000031559	-	-	496A>T 	Asn166Tyr	NM_000133.4		1_Pathogenic	chrX	A	T	X-139548467-A-T		10582	X	139548467	A	T	N	Y	rs137852236	X	138630626	X	138458292	166	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.496A>T	p.Asn166Tyr	c.496A>T	p.Asn166Tyr	principal1	Y	1	YES	Select	+	AAC	1	0	A	A/A	A/A	A/A	A/A	0.003	0.68399	D	0.002	0.79703	D	0.895	0.49259	P	0.615	0.51228	P	0.81	0.87956	A	simple_aae	19.0	81.0	3.02	0.86089	M	-3.77	0.73413	D	0.275	0.71543	0.5779	0.91577	D	0.8513	0.95032	D	9	0.94212544	0.93464	D	0.513166	0.95325	D	0.555	0.81565	0.883	0.96965	P00740	N166Y	Loss of disorder (P = 0.0391)| Gain of phosphorylation at N166 (P = 0.0516)| Loss of methylation at K168 (P = 0.0966)| Gain of ubiquitination at K168 (P = 0.1115)| Loss of glycosylation at S169 (P = 0.2228)	0.970123982418	0.96952	0.9832254753781753	0.98307	1.40884785401	0.85328	0.308290779591	0.11640	T	0.959002	0.99454	D	0.133446	0.67463	D	-0.0460908	0.67052	D	0.983754932880402	0.75128	D	0.882612	0.60210	D	0.8240546	0.85305	0.6250371	0.77910	0.8234179	0.85263	0.63639706	0.78539	-11.067	0.80089	D	0.1682	0.59540	B	0.99871094433747	0.94924	0.99996221	0.99965	0.945	0.97437	.	.	.	.	.	.	2.840319	0.37541	20.5	0.9908196188715952	0.52061	.	.	.	.	.	.	.	.	.	4.94	2.02	0.25572	-2.27	0.10681	1.74	0.37957	3.148000	0.36593	-0.122	0.13835	1.0	0.71675	1.000000	0.68239	0.959	0.5146	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139548467A>T	ClinGen:CA255337|OMIM:300746.0025	C0008533	306900	98879	.	Asn	Tyr	25621	single nucleotide variant	NM_000133.4(F9):c.496A>T (p.Asn166Tyr)	2158	F9	HGNC:3551	Pathogenic	1	Apr 01, 1989	137852236	-	RCV000011328	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139548467	139548467	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255337,OMIM:300746.0025	1	10582	139548467	A	T	-	-	-	-	-	-	SCV000031559	-	-	496A>T 	Asn166Tyr	NM_000133.4		1_Pathogenic	F9	ENSG00000101981	52861	204359	CCSBVarC004378	ALE00004378	496A>T	Asn166Tyr	CEGS2	CegsMutGDEh1010	A03	GDEhDisVCh_40052	F01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	F9_Asn166Tyr	23	X	139548467	A	T
7918	MSH2	1168C>T	Leu390Phe	ENSG00000095002	2	47429833	NC_000002.12:47429833:C:T	ALE00001279	CCSBVarC001279	14276	NULL	NULL	GDEhDisVCh_40060	D12	RC4	ATGGCGGTGCAGCCGAAGGAGACGCTGCAGTTGGAGAGCGCGGCCGAGGTCGGCTTCGTGCGCTTCTTTCAGGGCATGCCGGAGAAGCCGACCACCACAGTGCGCCTTTTCGACCGGGGCGACTTCTATACGGCGCACGGCGAGGACGCGCTGCTGGCCGCCCGGGAGGTGTTCAAGACCCAGGGGGTGATCAAGTACATGGGGCCGGCAGGAGCAAAGAATCTGCAGAGTGTTGTGCTTAGTAAAATGAATTTTGAATCTTTTGTAAAAGATCTTCTTCTGGTTCGTCAGTATAGAGTTGAAGTTTATAAGAATAGAGCTGGAAATAAGGCATCCAAGGAGAATGATTGGTATTTGGCATATAAGGCTTCTCCTGGCAATCTCTCTCAGTTTGAAGACATTCTCTTTGGTAACAATGATATGTCAGCTTCCATTGGTGTTGTGGGTGTTAAAATGTCCGCAGTTGATGGCCAGAGACAGGTTGGAGTTGGGTATGTGGATTCCATACAGAGGAAACTAGGACTGTGTGAATTCCCTGATAATGATCAGTTCTCCAATCTTGAGGCTCTCCTCATCCAGATTGGACCAAAGGAATGTGTTTTACCCGGAGGAGAGACTGCTGGAGACATGGGGAAACTGAGACAGATAATTCAAAGAGGAGGAATTCTGATCACAGAAAGAAAAAAAGCTGACTTTTCCACAAAAGACATTTATCAGGACCTCAACCGGTTGTTGAAAGGCAAAAAGGGAGAGCAGATGAATAGTGCTGTATTGCCAGAAATGGAGAATCAGGTTGCAGTTTCATCACTGTCTGCGGTAATCAAGTTTTTAGAACTCTTATCAGATGATTCCAACTTTGGACAGTTTGAACTGACTACTTTTGACTTCAGCCAGTATATGAAATTGGATATTGCAGCAGTCAGAGCCCTTAACCTTTTTCAGGGTTCTGTTGAAGATACCACTGGCTCTCAGTCTCTGGCTGCCTTGCTGAATAAGTGTAAAACCCCTCAAGGACAAAGACTTGTTAACCAGTGGATTAAGCAGCCTCTCATGGATAAGAACAGAATAGAGGAGAGATTGAATTTAGTGGAAGCTTTTGTAGAAGATGCAGAATTGAGGCAGACTTTACAAGAAGATTTACTTCGTCGATTCCCAGATCTTAACCGATTTGCCAAGAAGTTTCAAAGACAAGCAGCAAACTTACAAGATTGTTACCGACTCTATCAGGGTATAAATCAACTACCTAATGTTATACAGGCTCTGGAAAAACATGAAGGAAAACACCAGAAATTATTGTTGGCAGTTTTTGTGACTCCTCTTACTGATCTTCGTTCTGACTTCTCCAAGTTTCAGGAAATGATAGAAACAACTTTAGATATGGATCAGGTGGAAAACCATGAATTCCTTGTAAAACCTTCATTTGATCCTAATCTCAGTGAATTAAGAGAAATAATGAATGACTTGGAAAAGAAGATGCAGTCAACATTAATAAGTGCAGCCAGAGATCTTGGCTTGGACCCTGGCAAACAGATTAAACTGGATTCCAGTGCACAGTTTGGATATTACTTTCGTGTAACCTGTAAGGAAGAAAAAGTCCTTCGTAACAATAAAAACTTTAGTACTGTAGATATCCAGAAGAATGGTGTTAAATTTACCAACAGCAAATTGACTTCTTTAAATGAAGAGTATACCAAAAATAAAACAGAATATGAAGAAGCCCAGGATGCCATTGTTAAAGAAATTGTCAATATTTCTTCAGGCTATGTAGAACCAATGCAGACACTCAATGATGTGTTAGCTCAGCTAGATGCTGTTGTCAGCTTTGCTCACGTGTCAAATGGAGCACCTGTTCCATATGTACGACCAGCCATTTTGGAGAAAGGACAAGGAAGAATTATATTAAAAGCATCCAGGCATGCTTGTGTTGAAGTTCAAGATGAAATTGCATTTATTCCTAATGACGTATACTTTGAAAAAGATAAACAGATGTTCCACATCATTACTGGCCCCAATATGGGAGGTAAATCAACATATATTCGACAAACTGGGGTGATAGTACTCATGGCCCAAATTGGGTGTTTTGTGCCATGTGAGTCAGCAGAAGTGTCCATTGTGGACTGCATCTTAGCCCGAGTAGGGGCTGGTGACAGTCAATTGAAAGGAGTCTCCACGTTCATGGCTGAAATGTTGGAAACTGCTTCTATCCTCAGGTCTGCAACCAAAGATTCATTAATAATCATAGATGAATTGGGAAGAGGAACTTCTACCTACGATGGATTTGGGTTAGCATGGGCTATATCAGAATACATTGCAACAAAGATTGGTGCTTTTTGCATGTTTGCAACCCATTTTCATGAACTTACTGCCTTGGCCAATCAGATACCAACTGTTAATAATCTACATGTCACAGCACTCACCACTGAAGAGACCTTAACTATGCTTTATCAGGTGAAGAAAGGTGTCTGTGATCAAAGTTTTGGGATTCATGTTGCAGAGCTTGCTAATTTCCCTAAGCATGTAATAGAGTGTGCTAAACAGAAAGCCCTGGAACTTGAGGAGTTTCAGTATATTGGAGAATCGCAAGGATATGATATCATGGAACCAGCAGCAAAGAAGTGCTATCTGGAAAGAGAGCAAGGTGAAAAAATTATTCAGGAGTTCCTGTCCAAGGTGAAACAAATGCCCTTTACTGAAATGTCAGAAGAAAACATCACAATAAAGTTAAAACAGCTAAAAGCTGAAGTAATAGCAAAGAATAATAGCTTTGTAAATGAAATCATTTCACGAATAAAAGTTACTACG	50080.0	single nucleotide variant	NM_000251.3(MSH2):c.1168C>T (p.Leu390Phe)	4436.0	MSH2	HGNC:7325	Benign	0.0	Sep 05, 2013	17224367.0	-	RCV000034549|RCV000078420|RCV000076053|RCV001081498|RCV000115495|RCV001355669|RCV003149606|RCV001094729	MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MeSH:D003123,MedGen:C0009405|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0002032,MedGen:C0699790|MedGen:CN221562|MONDO:MONDO:0007356,MedGen:C2936783,OMIM:120435,Orphanet:144	not provided|not specified|Lynch syndrome|Hereditary nonpolyposis colorectal neoplasms|Hereditary cancer-predisposing syndrome|Carcinoma of colon|Breast and/or ovarian cancer|Lynch syndrome 1	germline;unknown	germline	GRCh38	NC_000002.12	2	47429833.0	47429833.0	2p21	reviewed by expert panel	17.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA017403,UniProtKB:P43246#VAR_004478	2.0	41641.0	47429833.0	C	T	-	-	-	-	-	-	SCV000107066	-	-	1168C>T 	Leu390Phe	NM_000251.3	3.0	2_Benign	chr2	C	T	2-47429833-C-T	0.000759315	41641	2	47429833	C	T	L	F	rs17224367	2	47656972	2	47510476	390	MSH2	ENSG00000095002	ENST00000233146	ENSP00000233146	P43246	MSH2_HUMAN	c.1168C>T	p.Leu390Phe	c.1168C>T	p.Leu390Phe	principal1	Y	1	YES	Select	+	CTT	1	0	C	C/C	C/C	C/C	C/C	0.011	0.56615	D	0.037	0.52410	D	0.148	0.34152	B	0.405	0.44648	B	0.07	0.60618	N	simple_aae	93.0	7.0	2.58	0.75182	M	-3.58	0.69987	D	0.503	0.53564	0.2975	0.87468	D	0.6085	0.86074	D	10	0.011555076	0.00248	T	.	.	.	0.683	0.88344	.	.	.	.	.	0.911487597256	0.90993	0.5789064713478618	0.57635	0.00940685693056	0.00821	0.689419746399	0.65566	T	0.848693	0.96508	D	-0.116395	0.33357	T	0.0762873	0.75146	D	0.113155298902112	0.13573	T	0.925407	0.95313	D	0.65998703	0.75631	0.6932612	0.81736	0.78929925	0.83020	0.6325286	0.78326	-12.131	0.85523	D	0.4712	0.71715	A	0.717481212535375	0.67629	0.99963940	0.99561	0.344	0.60468	.	.	.	.	.	.	3.862753	0.56112	23.7	0.99798797423549146	0.88381	0.214931	0.33825	N	0.234234948736202	0.52629	3.458083	0.332905195737336	0.57257	3.914227	5.69	4.62	0.56895	3.64	0.66725	1.611	0.36596	4.690000	0.44438	0.576	0.29264	0.994	0.38383	1.000000	0.68239	0.999	0.91597	887	0.27927	14	0.0027955271565495207	0	0.0	0	0.0	0	0.0	14	0.013888888888888888	0	0.0	218	264690	8.23605E-4	.	205	109402	1.873820e-03	4	291	208112	1.398290e-03	3	381	236926	1.608100e-03	4	0	7162	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	196	9046	2.166700e-02	4	0	13394	0.000000e+00	0	1	42768	2.338200e-05	0	7	15688	4.462010e-04	0	196	9046	2.166700e-02	4	0	16216	0.000000e+00	0	0	30522	0.000000e+00	0	0	6212	0.000000e+00	0	273	13416	2.034880e-02	3	0	16734	0.000000e+00	0	1	89546	1.116740e-05	0	15	30604	4.901320e-04	0	273	13416	2.034880e-02	3	0	14900	0.000000e+00	0	0	34258	0.000000e+00	0	0	9572	0.000000e+00	0	359	17692	2.029170e-02	4	0	21632	0.000000e+00	0	5	102732	4.867030e-05	0	15	30522	4.914490e-04	0	359	17692	2.029170e-02	4	.	1194	1614116	7.397240e-04	16	1111	44862	2.476480e-02	16	0	75030	0.000000e+00	0	0	912	0.000000e+00	0	0	60018	0.000000e+00	0	0	29604	0.000000e+00	0	1111	44862	2.476480e-02	16	0	64012	0.000000e+00	0	0	6062	0.000000e+00	0	20	1180024	1.694880e-05	0	30	91082	3.293740e-04	0	3	196468	1.526966223507136E-5	0	216	0	81	2766	0.02928416485900217	0	6034	0	0	806	0	0	1036	0	1	682	0.001466275659824047	0	296	0	7	14668	4.772293427870194E-4	0	6250	0	82	3448	0.023781902552204175	92	222972	4.126078610767271E-4	Benign	Breast_and/or_ovarian_cancer|Lynch_syndrome_1|Hereditary_cancer-predisposing_syndrome|not_specified|Lynch_syndrome|Carcinoma_of_colon|Hereditary_nonpolyposis_colorectal_neoplasms|not_provided	reviewed_by_expert_panel	NC_000002.12:g.47429833C>T	ClinGen:CA017403|UniProtKB:P43246#VAR_004478	CN221562|C2936783|C0027672|CN169374|C4552100|C0699790|C0009405|C3661900	120435	144|140162|144	DNA mismatch repair protein MutS, core|DNA mismatch repair protein MutS, core	Leu	Phe	50080	single nucleotide variant	NM_000251.3(MSH2):c.1168C>T (p.Leu390Phe)	4436	MSH2	HGNC:7325	Benign	0	Sep 05, 2013	17224367	-	RCV000034549|RCV000078420|RCV000076053|RCV001081498|RCV000115495|RCV001355669|RCV003149606|RCV001094729	MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MeSH:D003123,MedGen:C0009405|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0002032,MedGen:C0699790|MedGen:CN221562|MONDO:MONDO:0007356,MedGen:C2936783,OMIM:120435,Orphanet:144	not provided|not specified|Lynch syndrome|Hereditary nonpolyposis colorectal neoplasms|Hereditary cancer-predisposing syndrome|Carcinoma of colon|Breast and/or ovarian cancer|Lynch syndrome 1	germline;unknown	germline	GRCh38	NC_000002.12	2	47429833	47429833	2p21	reviewed by expert panel	17	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA017403,UniProtKB:P43246#VAR_004478	2	41641	47429833	C	T	-	-	-	-	-	-	SCV000107066	-	-	1168C>T 	Leu390Phe	NM_000251.3	3	2_Benign	MSH2	ENSG00000095002	7918	14276	CCSBVarC001279	ALE00001279	1168C>T	Leu390Phe	RC4	RC4_Mut_GDEh1031	A01	GDEhDisVCh_40060	D12	2	RC4_Mut_GDDh1031	A01	NULL	NULL	NULL	NULL	NULL	NULL	1	99	1	7	0	NULL	0	NULL	0	NULL	MSH2_Leu390Phe	2	2	47429833	C	T
2013	KCNE1	176T>C	Leu59Pro	ENSG00000180509	21	34449459	NC_000021.9:34449459:A:G	ALE00006337	CCSBVarC006337	NULL	214141	NULL	GDEhDisVCh_40065	E05	CEGS2	ATGATCCTGTCTAACACCACAGCGGTGACGCCCTTTCTGACCAAGCTGTGGCAGGAGACAGTTCAGCAGGGTGGCAACATGTCGGGCCTGGCCCACAGGTCCCCCCGCAGCGGTGACGGCAAGCTGGAGGCCCTCTACGTCCTCATGGTACTGGGATTCTTCGGCTTCTTCACCCCGGGCATCATGCTGAGCTACATCCGCTCCAAGAAGCTGGAGCACTCGAACGACCCATTCAACGTCTACATCGAGTCCGATGCCTGGCAAGAGAAGGACAAGGCCTATGTCCAGGCCCGGGTCCTGGAGAGCTACAGGTCG	136407.0	single nucleotide variant	NM_000219.6(KCNE1):c.176T>C (p.Leu59Pro)	3753.0	KCNE1	HGNC:6240	Uncertain significance	0.0	Oct 20, 2016	141813529.0	-	RCV000119071|RCV000455708|RCV004777584	MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:101016,Orphanet:768|MedGen:CN169374|MONDO:MONDO:0013372,MedGen:C1867904,OMIM:613695,Orphanet:101016,Orphanet:768	Congenital long QT syndrome|not specified|Long QT syndrome 5	germline;not applicable	germline	GRCh38	NC_000021.9	21	34449459.0	34449459.0	21q22.12	criteria provided, single submitter	3.0	-	N	ClinGen:CA331935,UniProtKB:P15382#VAR_074915	2.0	132659.0	34449459.0	A	G	-	-	-	-	-	-	SCV000539420	-	-	176T>C 	Leu59Pro	NM_000219.6	1.0	4_VUS	chr21	T	C	21-34449459-T-C		132659	21	34449459	A	G	L	P	rs141813529	21	35821757	21	34743627	59	KCNE1	ENSG00000180509	ENST00000399286	ENSP00000382226	P15382	KCNE1_HUMAN	c.176T>C	p.Leu59Pro	c.176T>C	p.Leu59Pro	principal1	Y	1	YES	Select	-	CTG	2	0	A	A/A	A/A	A/A	A/A	0.015	0.52650	D	0.008	0.68204	D	0.998	0.73231	D	0.98	0.74847	D	0.99	0.97926	D	simple_aae	1.0	99.0	2.665	0.77788	M	-3.75	0.71195	D	0.896	0.90585	1.0370	0.97846	D	0.9146	0.97165	D	10	0.90428615	0.89678	D	0.729146	0.97814	D	0.870	0.96086	0.496	0.58390	P15382	L59P	Loss of stability (P = 0.0565)| Loss of helix (P = 0.1299)| Gain of sheet (P = 0.1451)| Loss of MoRF binding (P = 0.359)| Gain of phosphorylation at S64 (P = 0.3872)	0.963618073955	0.96290	0.8727435919038766	0.87162	.	0.50709	0.579115748405	0.49894	T	0.916036	0.98440	D	0.397236	0.89681	D	0.348311	0.90183	D	0.978098392486572	0.71967	D	.	0.38641	.	0.8486244	0.87063	0.854909	0.91726	0.8270462	0.85512	0.8349045	0.90380	-13.659	0.91912	D	.	0.85998	.	0.93861873077674	0.79216	0.99977260	0.99701	0.61	0.78201	.	.	.	.	.	.	4.835013	0.78925	27.0	0.99894737975025449	0.96821	0.904632	0.85464	D	0.724016732421817	0.81105	7.468363	0.682770544976722	0.80967	7.441807	5.16	5.16	0.70523	3.96	0.75470	6.159	0.71733	11.029000	0.85064	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.994	0.71086	899	0.25042	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109408	9.140100e-06	0	3	208070	1.441820e-05	0	2	236928	8.441380e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16212	0.000000e+00	0	0	30524	0.000000e+00	0	0	6210	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	2	89506	2.234490e-05	0	0	30608	0.000000e+00	0	2	89506	2.234490e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	1	102726	9.734630e-06	0	0	30526	0.000000e+00	0	1	102726	9.734630e-06	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	13110	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	716	0	0	2294	0	0	108	0	0	17078	0	Uncertain_significance	Congenital_long_QT_syndrome|not_specified	criteria_provided,_single_submitter	NC_000021.9:g.34449459A>G	ClinGen:CA331935|UniProtKB:P15382#VAR_074915	C1141890|CN169374	PS192500	101016|768	.	Leu	Pro	136407	single nucleotide variant	NM_000219.6(KCNE1):c.176T>C (p.Leu59Pro)	3753	KCNE1	HGNC:6240	Uncertain significance	0	Oct 20, 2016	141813529	-	RCV000119071|RCV000455708|RCV004777584	MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:101016,Orphanet:768|MedGen:CN169374|MONDO:MONDO:0013372,MedGen:C1867904,OMIM:613695,Orphanet:101016,Orphanet:768	Congenital long QT syndrome|not specified|Long QT syndrome 5	germline;not applicable	germline	GRCh38	NC_000021.9	21	34449459	34449459	21q22.12	criteria provided, single submitter	3	-	N	ClinGen:CA331935,UniProtKB:P15382#VAR_074915	2	132659	34449459	A	G	-	-	-	-	-	-	SCV000539420	-	-	176T>C 	Leu59Pro	NM_000219.6	1	4_VUS	KCNE1	ENSG00000180509	2013	214141	CCSBVarC006337	ALE00006337	176T>C	Leu59Pro	CEGS2	CegsMutGDEh1014	E03	GDEhDisVCh_40065	E05	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	4	0	NULL	0	NULL	0	NULL	0	NULL	KCNE1_Leu59Pro	21	21	34449459	A	G
2803	HMBS	583C>T	Arg195Cys	ENSG00000256269	11	119091497	NC_000011.10:119091497:C:T	ALE00005168	CCSBVarC005168	NULL	200936	NULL	GDEhDisVCh_40054	E08	CEGS2	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAGCTTGCTCGCATACAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGGACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCTTGAACATGCCCTGGAGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCGAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTCGGGGAAACCTCAACACCCGGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGTGCATGGGCTGGCACAACCGGGTGGGGCAGATCCTGCACCCTGAGGAATGCATGTATGCTGTGGGCCAGGGGGCCTTGGGCGTGGAAGTGCGAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCTGCATCGCTGAAAGGGCCTTCCTGAGGCACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATGGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCGTAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACGATGCCCAT	171129.0	single nucleotide variant	NM_000190.4(HMBS):c.583C>T (p.Arg195Cys)	3145.0	HMBS	HGNC:4982	Pathogenic	1.0	Oct 30, 2024	34413634.0	-	RCV000148509|RCV001041963	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900	Acute intermittent porphyria|not provided	germline	germline	GRCh38	NC_000011.10	11	119091497.0	119091497.0	11q23.3	criteria provided, single submitter	2.0	-	N	ClinGen:CA272877,UniProtKB:P08397#VAR_003656	2.0	161251.0	119091497.0	C	T	-	-	-	-	-	-	SCV001205617	-	-	583C>T 	Arg195Cys	NM_000190.4	1.0	1_Pathogenic	chr11	C	T	11-119091497-C-T	4.2883e-6	161251	11	119091497	C	T	R	C	rs34413634	11	118962207	11	118467417	195	HMBS	ENSG00000256269	ENST00000652429	ENSP00000498786	P08397	HEM3_HUMAN	c.583C>T	p.Arg195Cys	c.583C>T	p.Arg195Cys	principal2	Y	.	YES	Select	+	CGC	1	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	1.0	0.97365	D	.	0.97926	.	.	.	.	4.465	0.98846	H	.	0.96074	.	.	0.96886	0.9224	0.95980	D	0.9971	0.99930	D	10	.	0.95335	.	0.611225	0.96601	D	.	0.97318	.	.	.	.	.	.	0.98045	0.9703382934487912	0.97005	.	.	0.672052979469	0.63070	T	0.99727	0.99997	D	0.550346	0.95766	D	0.552757	0.95703	D	0.9998539686203	0.99358	D	0.999706	0.99911	D	0.98425967	0.99407	0.93367016	0.97307	0.9818209	0.99233	0.9470098	0.98190	-11.377	0.81998	D	0.9561	0.92535	P	0.999529425028906	0.96869	0.47329053	0.81303	0.992	0.99727	.	.	.	.	.	.	5.776933	0.93514	33.0	0.99929786013626687	0.99279	0.821829	0.74135	D	1.00511884949098	0.95876	14.08343	0.900425950493327	0.95567	13.76994	5.96	5.96	0.96689	.	.	2.357	0.43881	7.650000	0.63706	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.997	0.79771	228	0.91137	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	0	65032	0.000000e+00	0	1	132486	7.547970e-06	0	0	151810	0.000000e+00	0	0	2852	0.000000e+00	0	0	12384	0.000000e+00	0	0	1454	0.000000e+00	0	0	4604	0.000000e+00	0	0	11468	0.000000e+00	0	0	19462	0.000000e+00	0	0	11444	0.000000e+00	0	.	.	.	.	0	8682	0.000000e+00	0	0	20684	0.000000e+00	0	0	4754	0.000000e+00	0	0	8792	0.000000e+00	0	0	13480	0.000000e+00	0	1	49728	2.010940e-05	0	0	22782	0.000000e+00	0	1	49728	2.010940e-05	0	0	8152	0.000000e+00	0	0	24654	0.000000e+00	0	0	8328	0.000000e+00	0	0	11040	0.000000e+00	0	0	15350	0.000000e+00	0	0	57216	0.000000e+00	0	0	22772	0.000000e+00	0	.	.	.	.	.	7	1551406	4.512040e-06	0	7	1146816	6.103860e-06	0	0	73056	0.000000e+00	0	0	912	0.000000e+00	0	0	50992	0.000000e+00	0	0	28652	0.000000e+00	0	0	40940	0.000000e+00	0	0	59870	0.000000e+00	0	0	6014	0.000000e+00	0	7	1146816	6.103860e-06	0	0	84070	0.000000e+00	0	1	37010	2.7019724398811132E-5	0	150	0	0	352	0	1	3854	2.594706798131811E-4	0	852	0	0	820	0	0	60	0	0	142	0	0	4746	0	1	4004	2.4975024975024975E-4	0	412	0	2	47986	4.167882299003876E-5	Pathogenic	not_provided|Acute_intermittent_porphyria	criteria_provided,_single_submitter	NC_000011.10:g.119091497C>T	ClinGen:CA272877|UniProtKB:P08397#VAR_003656	C3661900|C0162565	176000	79276	Porphobilinogen deaminase, N-terminal	Arg	Cys	171129	single nucleotide variant	NM_000190.4(HMBS):c.583C>T (p.Arg195Cys)	3145	HMBS	HGNC:4982	Pathogenic	1	Oct 30, 2024	34413634	-	RCV000148509|RCV001041963	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900	Acute intermittent porphyria|not provided	germline	germline	GRCh38	NC_000011.10	11	119091497	119091497	11q23.3	criteria provided, single submitter	2	-	N	ClinGen:CA272877,UniProtKB:P08397#VAR_003656	2	161251	119091497	C	T	-	-	-	-	-	-	SCV001205617	-	-	583C>T 	Arg195Cys	NM_000190.4	1	1_Pathogenic	HMBS	ENSG00000256269	2803	200936	CCSBVarC005168	ALE00005168	583C>T	Arg195Cys	CEGS2	CegsMutGDEh1045	E06	GDEhDisVCh_40054	E08	2	CegsMutGDDh1045	E06	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	HMBS_Arg195Cys	11	11	119091497	C	T
3172	CBS	1330G>A	Asp444Asn	ENSG00000160200	21	43058862	NC_000021.9:43058862:C:T	ALE00003757	CCSBVarC003757	NULL	214535	NULL	GDEhDisVCh_40055	D09	CEGS2	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTCCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCCGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCAACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	15165.0	single nucleotide variant	NM_000071.3(CBS):c.1330G>A (p.Asp444Asn)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Jan 23, 2025	28934891.0	-	RCV000000149|RCV000000148|RCV000174656|RCV004754226|RCV002381232|RCV000078108|RCV000781196	MedGen:C3150344|MedGen:C3502110|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394||MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:C3661900|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria, pyridoxine-responsive|Classic homocystinuria|CBS-related disorder|Familial thoracic aortic aneurysm and aortic dissection|not provided|Homocystinuria	germline;unknown	germline	GRCh38	NC_000021.9	21	43058862.0	43058862.0	21q22.3	criteria provided, multiple submitters, no conflicts	13.0	-	N	ClinGen:CA113893,UniProtKB:P35520#VAR_002192,OMIM:613381.0010	3.0	126.0	43058862.0	C	T	-	-	-	-	-	-	SCV000225994|SCV000249732|SCV000543508|SCV000803554|SCV000893550|SCV000914970|SCV000919081|SCV001194106|SCV002692917|SCV004213855	-	-	1330G>A 	Asp444Asn	NM_000071.3	2.0	1_Pathogenic	chr21	G	A	21-43058862-G-A		126	21	43058862	C	T	D	N	rs28934891	21	44478972	21	43352041	444	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.1330G>A	p.Asp444Asn	c.1330G>A	p.Asp444Asn	principal1	Y	1	.	.	-	GAC	1	0	C	C/C	C/C	C/C	C/C	0.1	0.30652	T	0.141	0.33771	T	0.122	0.26763	B	0.047	0.24833	B	1.0	0.99291	A	simple_aae	0.0	100.0	2.29	0.65064	M	-3.1	0.63579	D	0.933	0.93850	-0.2868	0.75243	T	0.3741	0.73145	T	9	0.5941371	0.66256	D	0.214094	0.87408	D	0.604	0.84322	.	.	.	.	.	0.900766965787	0.89902	.	0.78474	.	0.41908	0.617369413376	0.55291	T	0.925105	0.98673	D	-0.198664	0.20681	T	-0.0935218	0.63639	T	0.140423461794853	0.16107	T	.	0.85963	.	0.75088805	0.80688	0.47985598	0.69615	0.7914962	0.83159	0.39601335	0.64004	-5.121	0.38173	T	.	0.65875	.	0.953656552102547	0.80886	0.99454176	0.97570	0.922	0.96050	.	.	.	.	.	.	4.595734	0.72795	25.9	0.99910380338299121	0.98024	0.874158	0.79613	D	0.383627194399772	0.60329	4.243423	0.415106417693596	0.62303	4.467023	4.71	4.71	0.58959	2.6	0.47613	7.501	0.80483	4.641000	0.44233	0.52	0.23855	1.0	0.71675	1.000000	0.68239	0.977	0.56847	988	0.02004	2	3.9936102236421724E-4	0	0.0	2	0.0019880715705765406	0	0.0	0	0.0	0	0.0	.	.	.	.	20	70008	2.856820e-04	0	32	141918	2.254820e-04	0	56	161956	3.457730e-04	0	1	3414	2.929120e-04	0	9	13004	6.920950e-04	0	0	1524	0.000000e+00	0	0	5276	0.000000e+00	0	0	10712	0.000000e+00	0	9	22828	3.942530e-04	0	0	11818	0.000000e+00	0	9	13004	6.920950e-04	0	2	9694	2.063130e-04	0	15	21948	6.834340e-04	0	0	4880	0.000000e+00	0	0	9710	0.000000e+00	0	0	12852	0.000000e+00	0	14	55600	2.517990e-04	0	0	23506	0.000000e+00	0	15	21948	6.834340e-04	0	2	9056	2.208480e-04	0	34	25884	1.313550e-03	0	0	8420	0.000000e+00	0	0	12154	0.000000e+00	0	0	14948	0.000000e+00	0	17	63558	2.674720e-04	0	0	23482	0.000000e+00	0	34	25884	1.313550e-03	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	32	110230	2.903020956182527E-4	0	194	0	0	64	0	0	5460	0	0	342	0	0	40	0	0	56	0	0	6	0	2	13994	1.4291839359725596E-4	0	5654	0	0	120	0	34	130386	2.607641924746522E-4	Pathogenic/Likely_pathogenic	Homocystinuria|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|Classic_homocystinuria|not_provided|Homocystinuria,_pyridoxine-responsive|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43058862C>T	ClinGen:CA113893|OMIM:613381.0010|UniProtKB:P35520#VAR_002192	C0019880|C4707243|C0751202|C3661900|C3502110|C3150344	PS607086|236200	91387|394	CBS domain|CBS domain|CBS domain|Cystathionine beta-synthase, C-terminal domain	Asp	Asn	15165	single nucleotide variant	NM_000071.3(CBS):c.1330G>A (p.Asp444Asn)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Jan 23, 2025	28934891	-	RCV000000149|RCV000000148|RCV000174656|RCV004754226|RCV002381232|RCV000078108|RCV000781196	MedGen:C3150344|MedGen:C3502110|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394||MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:C3661900|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria, pyridoxine-responsive|Classic homocystinuria|CBS-related disorder|Familial thoracic aortic aneurysm and aortic dissection|not provided|Homocystinuria	germline;unknown	germline	GRCh38	NC_000021.9	21	43058862	43058862	21q22.3	criteria provided, multiple submitters, no conflicts	13	-	N	ClinGen:CA113893,UniProtKB:P35520#VAR_002192,OMIM:613381.0010	3	126	43058862	C	T	-	-	-	-	-	-	SCV000225994|SCV000249732|SCV000543508|SCV000803554|SCV000893550|SCV000914970|SCV000919081|SCV001194106|SCV002692917|SCV004213855	-	-	1330G>A 	Asp444Asn	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	243	CCSBVarC007302	ALE00003757	1330G>A	Asp444Asn	Edgotyping3	VUSMutGDEh010	F10	GDEhDisVCh_40013	B04	1	VUSMutGDDh010	F10	NULL	NULL	NULL	NULL	NULL	NULL	1	6	1	7	0	NULL	0	NULL	0	NULL	CBS_Asp444Asn	21	21	43058862	C	T
3172	CBS	1330G>A	Asp444Asn	ENSG00000160200	21	43058862	NC_000021.9:43058862:C:T	ALE00003757	CCSBVarC003757	NULL	214535	NULL	GDEhDisVCh_40055	D09	CEGS2	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTCCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCCGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCAACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	15165.0	single nucleotide variant	NM_000071.3(CBS):c.1330G>A (p.Asp444Asn)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Jan 23, 2025	28934891.0	-	RCV000000149|RCV000000148|RCV000174656|RCV004754226|RCV002381232|RCV000078108|RCV000781196	MedGen:C3150344|MedGen:C3502110|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394||MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:C3661900|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria, pyridoxine-responsive|Classic homocystinuria|CBS-related disorder|Familial thoracic aortic aneurysm and aortic dissection|not provided|Homocystinuria	germline;unknown	germline	GRCh38	NC_000021.9	21	43058862.0	43058862.0	21q22.3	criteria provided, multiple submitters, no conflicts	13.0	-	N	ClinGen:CA113893,UniProtKB:P35520#VAR_002192,OMIM:613381.0010	3.0	126.0	43058862.0	C	T	-	-	-	-	-	-	SCV000225994|SCV000249732|SCV000543508|SCV000803554|SCV000893550|SCV000914970|SCV000919081|SCV001194106|SCV002692917|SCV004213855	-	-	1330G>A 	Asp444Asn	NM_000071.3	2.0	1_Pathogenic	chr21	G	A	21-43058862-G-A		126	21	43058862	C	T	D	N	rs28934891	21	44478972	21	43352041	444	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.1330G>A	p.Asp444Asn	c.1330G>A	p.Asp444Asn	principal1	Y	1	.	.	-	GAC	1	0	C	C/C	C/C	C/C	C/C	0.1	0.30652	T	0.141	0.33771	T	0.122	0.26763	B	0.047	0.24833	B	1.0	0.99291	A	simple_aae	0.0	100.0	2.29	0.65064	M	-3.1	0.63579	D	0.933	0.93850	-0.2868	0.75243	T	0.3741	0.73145	T	9	0.5941371	0.66256	D	0.214094	0.87408	D	0.604	0.84322	.	.	.	.	.	0.900766965787	0.89902	.	0.78474	.	0.41908	0.617369413376	0.55291	T	0.925105	0.98673	D	-0.198664	0.20681	T	-0.0935218	0.63639	T	0.140423461794853	0.16107	T	.	0.85963	.	0.75088805	0.80688	0.47985598	0.69615	0.7914962	0.83159	0.39601335	0.64004	-5.121	0.38173	T	.	0.65875	.	0.953656552102547	0.80886	0.99454176	0.97570	0.922	0.96050	.	.	.	.	.	.	4.595734	0.72795	25.9	0.99910380338299121	0.98024	0.874158	0.79613	D	0.383627194399772	0.60329	4.243423	0.415106417693596	0.62303	4.467023	4.71	4.71	0.58959	2.6	0.47613	7.501	0.80483	4.641000	0.44233	0.52	0.23855	1.0	0.71675	1.000000	0.68239	0.977	0.56847	988	0.02004	2	3.9936102236421724E-4	0	0.0	2	0.0019880715705765406	0	0.0	0	0.0	0	0.0	.	.	.	.	20	70008	2.856820e-04	0	32	141918	2.254820e-04	0	56	161956	3.457730e-04	0	1	3414	2.929120e-04	0	9	13004	6.920950e-04	0	0	1524	0.000000e+00	0	0	5276	0.000000e+00	0	0	10712	0.000000e+00	0	9	22828	3.942530e-04	0	0	11818	0.000000e+00	0	9	13004	6.920950e-04	0	2	9694	2.063130e-04	0	15	21948	6.834340e-04	0	0	4880	0.000000e+00	0	0	9710	0.000000e+00	0	0	12852	0.000000e+00	0	14	55600	2.517990e-04	0	0	23506	0.000000e+00	0	15	21948	6.834340e-04	0	2	9056	2.208480e-04	0	34	25884	1.313550e-03	0	0	8420	0.000000e+00	0	0	12154	0.000000e+00	0	0	14948	0.000000e+00	0	17	63558	2.674720e-04	0	0	23482	0.000000e+00	0	34	25884	1.313550e-03	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	32	110230	2.903020956182527E-4	0	194	0	0	64	0	0	5460	0	0	342	0	0	40	0	0	56	0	0	6	0	2	13994	1.4291839359725596E-4	0	5654	0	0	120	0	34	130386	2.607641924746522E-4	Pathogenic/Likely_pathogenic	Homocystinuria|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|Classic_homocystinuria|not_provided|Homocystinuria,_pyridoxine-responsive|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43058862C>T	ClinGen:CA113893|OMIM:613381.0010|UniProtKB:P35520#VAR_002192	C0019880|C4707243|C0751202|C3661900|C3502110|C3150344	PS607086|236200	91387|394	CBS domain|CBS domain|CBS domain|Cystathionine beta-synthase, C-terminal domain	Asp	Asn	15165	single nucleotide variant	NM_000071.3(CBS):c.1330G>A (p.Asp444Asn)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Jan 23, 2025	28934891	-	RCV000000149|RCV000000148|RCV000174656|RCV004754226|RCV002381232|RCV000078108|RCV000781196	MedGen:C3150344|MedGen:C3502110|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394||MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:C3661900|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria, pyridoxine-responsive|Classic homocystinuria|CBS-related disorder|Familial thoracic aortic aneurysm and aortic dissection|not provided|Homocystinuria	germline;unknown	germline	GRCh38	NC_000021.9	21	43058862	43058862	21q22.3	criteria provided, multiple submitters, no conflicts	13	-	N	ClinGen:CA113893,UniProtKB:P35520#VAR_002192,OMIM:613381.0010	3	126	43058862	C	T	-	-	-	-	-	-	SCV000225994|SCV000249732|SCV000543508|SCV000803554|SCV000893550|SCV000914970|SCV000919081|SCV001194106|SCV002692917|SCV004213855	-	-	1330G>A 	Asp444Asn	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	3172	214535	CCSBVarC003757	ALE00003757	1330G>A	Asp444Asn	CEGS2	CegsMutGDEh1042	H05	GDEhDisVCh_40055	D09	1	CegsMutGDDh1042	H05	NULL	NULL	NULL	NULL	NULL	NULL	1	6	1	1	0	NULL	0	NULL	0	NULL	CBS_Asp444Asn	21	21	43058862	C	T
7918	MSH2	1022T>C	Leu341Pro	ENSG00000095002	2	47416375	NC_000002.12:47416375:T:C	ALE00003007	CCSBVarC003007	NULL	202659	NULL	GDEhDisVCh_40060	G08	CEGS2	ATGGCGGTGCAGCCGAAGGAGACGCTGCAGTTGGAGAGCGCGGCCGAGGTCGGCTTCGTGCGCTTCTTTCAGGGCATGCCGGAGAAGCCGACCACCACAGTGCGCCTTTTCGACCGGGGCGACTTCTATACGGCGCACGGCGAGGACGCGCTGCTGGCCGCCCGGGAGGTGTTCAAGACCCAGGGGGTGATCAAGTACATGGGGCCGGCAGGAGCAAAGAATCTGCAGAGTGTTGTGCTTAGTAAAATGAATTTTGAATCTTTTGTAAAAGATCTTCTTCTGGTTCGTCAGTATAGAGTTGAAGTTTATAAGAATAGAGCTGGAAATAAGGCATCCAAGGAGAATGATTGGTATTTGGCATATAAGGCTTCTCCTGGCAATCTCTCTCAGTTTGAAGACATTCTCTTTGGTAACAATGATATGTCAGCTTCCATTGGTGTTGTGGGTGTTAAAATGTCCGCAGTTGATGGCCAGAGACAGGTTGGAGTTGGGTATGTGGATTCCATACAGAGGAAACTAGGACTGTGTGAATTCCCTGATAATGATCAGTTCTCCAATCTTGAGGCTCTCCTCATCCAGATTGGACCAAAGGAATGTGTTTTACCCGGAGGAGAGACTGCTGGAGACATGGGGAAACTGAGACAGATAATTCAAAGAGGAGGAATTCTGATCACAGAAAGAAAAAAAGCTGACTTTTCCACAAAAGACATTTATCAGGACCTCAACCGGTTGTTGAAAGGCAAAAAGGGAGAGCAGATGAATAGTGCTGTATTGCCAGAAATGGAGAATCAGGTTGCAGTTTCATCACTGTCTGCGGTAATCAAGTTTTTAGAACTCTTATCAGATGATTCCAACTTTGGACAGTTTGAACTGACTACTTTTGACTTCAGCCAGTATATGAAATTGGATATTGCAGCAGTCAGAGCCCTTAACCTTTTTCAGGGTTCTGTTGAAGATACCACTGGCTCTCAGTCTCTGGCTGCCTTGCTGAATAAGTGTAAAACCCCTCAAGGACAAAGACCTGTTAACCAGTGGATTAAGCAGCCTCTCATGGATAAGAACAGAATAGAGGAGAGATTGAATTTAGTGGAAGCTTTTGTAGAAGATGCAGAATTGAGGCAGACTTTACAAGAAGATTTACTTCGTCGATTCCCAGATCTTAACCGACTTGCCAAGAAGTTTCAAAGACAAGCAGCAAACTTACAAGATTGTTACCGACTCTATCAGGGTATAAATCAACTACCTAATGTTATACAGGCTCTGGAAAAACATGAAGGAAAACACCAGAAATTATTGTTGGCAGTTTTTGTGACTCCTCTTACTGATCTTCGTTCTGACTTCTCCAAGTTTCAGGAAATGATAGAAACAACTTTAGATATGGATCAGGTGGAAAACCATGAATTCCTTGTAAAACCTTCATTTGATCCTAATCTCAGTGAATTAAGAGAAATAATGAATGACTTGGAAAAGAAGATGCAGTCAACATTAATAAGTGCAGCCAGAGATCTTGGCTTGGACCCTGGCAAACAGATTAAACTGGATTCCAGTGCACAGTTTGGATATTACTTTCGTGTAACCTGTAAGGAAGAAAAAGTCCTTCGTAACAATAAAAACTTTAGTACTGTAGATATCCAGAAGAATGGTGTTAAATTTACCAACAGCAAATTGACTTCTTTAAATGAAGAGTATACCAAAAATAAAACAGAATATGAAGAAGCCCAGGATGCCATTGTTAAAGAAATTGTCAATATTTCTTCAGGCTATGTAGAACCAATGCAGACACTCAATGATGTGTTAGCTCAGCTAGATGCTGTTGTCAGCTTTGCTCACGTGTCAAATGGAGCACCTGTTCCATATGTACGACCAGCCATTTTGGAGAAAGGACAAGGAAGAATTATATTAAAAGCATCCAGGCATGCTTGTGTTGAAGTTCAAGATGAAATTGCATTTATTCCTAATGACGTATACTTTGAAAAAGATAAACAGATGTTCCACATCATTACTGGCCCCAATATGGGAGGTAAATCAACATATATTCGACAAACTGGGGTGATAGTACTCATGGCCCAAATTGGGTGTTTTGTGCCATGTGAGTCAGCAGAAGTGTCCATTGTGGACTGCATCTTAGCCCGAGTAGGGGCTGGTGACAGTCAATTGAAAGGAGTCTCCACGTTCATGGCTGAAATGTTGGAAACTGCTTCTATCCTCAGGTCTGCAACCAAAGATTCATTAATAATCATAGATGAATTGGGAAGAGGAACTTCTACCTACGATGGATTTGGGTTAGCATGGGCTATATCAGAATACATTGCAACAAAGATTGGTGCTTTTTGCATGTTTGCAACCCATTTTCATGAACTTACTGCCTTGGCCAATCAGATACCAACTGTTAATAATCTACATGTCACAGCACTCACCACTGAAGAGACCTTAACTATGCTTTATCAGGTGAAGAAAGGTGTCTGTGATCAAAGTTTTGGGATTCATGTTGCAGAGCTTGCTAATTTCCCTAAGCATGTAATAGAGTGTGCTAAACAGAAAGCCCTGGAACTTGAGGAGTTTCAGTATATTGGAGAATCGCAAGGATATGATATCATGGAACCAGCAGCAAAGAAGTGCTATCTGGAAAGAGAGCAAGGTGAAAAAATTATTCAGGAGTTCCTGTCCAAGGTGAAACAAATGCCCTTTACTGAAATGTCAGAAGAAAACATCACAATAAAGTTAAAACAGCTAAAAGCTGAAGTAATAGCAAAGAATAATAGCTTTGTAAATGAAATCATTTCACGAATAAAAGTTACTACG	95982.0	single nucleotide variant	NM_000251.3(MSH2):c.1022T>C (p.Leu341Pro)	4436.0	MSH2	HGNC:7325	Likely pathogenic	1.0	Jun 21, 2019	63751147.0	-	RCV000076002|RCV001213427	MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MeSH:D003123,MedGen:C0009405	Lynch syndrome|Hereditary nonpolyposis colorectal neoplasms	germline	germline	GRCh38	NC_000002.12	2	47416375.0	47416375.0	2p21	reviewed by expert panel	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016875	2.0	90507.0	47416375.0	T	C	-	-	-	-	-	-	SCV000107012	-	-	1022T>C 	Leu341Pro	NM_000251.3	3.0	1_Pathogenic	chr2	T	C	2-47416375-T-C		90507	2	47416375	T	C	L	P	rs63751147	2	47643514	2	47497018	341	MSH2	ENSG00000095002	ENST00000233146	ENSP00000233146	P43246	MSH2_HUMAN	c.1022T>C	p.Leu341Pro	c.1022T>C	p.Leu341Pro	principal1	Y	1	YES	Select	+	CTT	2	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.97	0.96253	A	simple_aae	3.0	97.0	3.52	0.92870	H	-6.84	0.93080	D	0.978	0.99026	1.0942	0.99411	D	0.9378	0.97950	D	10	0.9863108	0.98922	D	0.416497	0.93693	D	0.970	0.99647	0.89	0.97304	P43246	L341P	Gain of disorder (P = 0.0124)| Gain of glycosylation at L341 (P = 0.0405)| Loss of stability (P = 0.043)| Loss of MoRF binding (P = 0.0543)| Loss of catalytic residue at L341 (P = 0.0939)	0.976544263001	0.97606	0.8912934507466421	0.89030	0.0292131453974	0.02910	0.851528048515	0.89828	D	0.918923	0.98515	D	0.554356	0.95836	D	0.558517	0.95772	D	0.999508142471313	0.97654	D	0.955704	0.88094	D	0.99427384	0.99941	0.9692355	0.99422	0.99154145	0.99836	0.9719972	0.99542	-15.944	0.97681	D	0.9948	0.97843	P	0.999952477274656	0.99183	0.99990058	0.99879	1	0.99985	.	.	.	.	.	.	5.031014	0.83699	28.1	0.99925898483493958	0.99043	0.959811	0.98024	D	0.924861721418433	0.92885	11.71154	0.847646760094844	0.92840	11.68692	5.62	5.62	0.85695	3.82	0.71118	7.869	0.85551	7.755000	0.68253	0.609	0.47831	1.0	0.71675	1.000000	0.68239	0.993	0.69292	824	0.40289	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Lynch_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms	reviewed_by_expert_panel	NC_000002.12:g.47416375T>C	ClinGen:CA016875	C4552100|C0009405	.	144	DNA mismatch repair protein MutS, core|DNA mismatch repair protein MutS, core	Leu	Pro	95982	single nucleotide variant	NM_000251.3(MSH2):c.1022T>C (p.Leu341Pro)	4436	MSH2	HGNC:7325	Likely pathogenic	1	Jun 21, 2019	63751147	-	RCV000076002|RCV001213427	MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MeSH:D003123,MedGen:C0009405	Lynch syndrome|Hereditary nonpolyposis colorectal neoplasms	germline	germline	GRCh38	NC_000002.12	2	47416375	47416375	2p21	reviewed by expert panel	2	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016875	2	90507	47416375	T	C	-	-	-	-	-	-	SCV000107012	-	-	1022T>C 	Leu341Pro	NM_000251.3	3	1_Pathogenic	MSH2	ENSG00000095002	7918	202659	CCSBVarC003007	ALE00003007	1022T>C	Leu341Pro	CEGS2	CegsMutGDEh1040	C09	GDEhDisVCh_40060	G08	2	CegsMutGDDh1040	C09	NULL	NULL	VUSMutpDEST2_07	E03	NULL	NULL	1	1	1	5	0	NULL	1	1	0	NULL	MSH2_Leu341Pro	2	2	47416375	T	C
71569	OTC	1005G>A	Met335Ile	ENSG00000036473	X	38411999	NC_000023.11:38411999:G:A	ALE00005263	CCSBVarC005263	NULL	205973	NULL	GDEhDisVCh_40048	G05	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATAGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	102983.0	single nucleotide variant	NM_000531.6(OTC):c.1005G>A (p.Met335Ile)	5009.0	OTC	HGNC:8512	Uncertain significance	1.0	Mar 29, 2022	281865553.0	-	RCV000083315|RCV002514457	MedGen:C3661900|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664	not provided|Ornithine carbamoyltransferase deficiency	germline;unknown	germline	GRCh38	NC_000023.11	X	38411999.0	38411999.0	Xp11.4	criteria provided, single submitter	2.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224432	2.0	97091.0	38411999.0	G	A	-	-	-	-	-	-	SCV003444648	-	-	1005G>A 	Met335Ile	NM_000531.6	1.0	4_VUS	chrX	G	A	X-38411999-G-A		97091	X	38411999	G	A	M	I	rs281865553	X	38271252	X	38156196	335	OTC	ENSG00000036473	ENST00000713758	ENSP00000519059	P00480	OTC_HUMAN	.	.	c.1005G>A	p.Met335Ile	principal1	Y	.	.	.	+	ATG	3	0	G	G/G	G/G	G/G	G/G	.	0.08337	.	.	0.03636	.	0.98	0.59367	D	0.849	0.60609	P	.	0.97926	.	.	.	.	1.905	0.50677	L	.	0.55206	.	.	0.91275	1.1129	0.99881	D	0.9613	0.98753	D	10	.	0.99171	.	0.933305	0.99518	D	.	0.98562	0.904	0.97931	P00480	M335I	Loss of catalytic residue at M335 (P = 6e-04)| Loss of helix (P = 0.1706)| Gain of ubiquitination at K331 (P = 0.2261)| Gain of methylation at K331 (P = 0.2912)| Loss of MoRF binding (P = 0.2916)	.	0.99447	.	0.96219	.	0.78777	0.75031453371	0.74448	T	0.892907	0.97818	D	0.609741	0.97990	D	0.638074	0.97959	D	0.979593873023987	0.72724	D	.	0.86253	.	0.84426045	0.86740	0.8651436	0.92431	0.8347565	0.86055	0.81402767	0.89018	-6.165	0.47699	T	.	0.81636	.	0.994802816227331	0.90888	0.99746630	0.98390	0.92	0.95929	.	.	.	.	.	.	5.70099	0.93125	33.0	0.99337233040867312	0.60070	.	.	.	.	.	.	.	.	.	5.16	5.16	0.70523	.	.	9.49	0.96938	11.723000	0.94857	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	Ornithine_carbamoyltransferase_deficiency|not_provided	criteria_provided,_single_submitter	NC_000023.11:g.38411999G>A	ClinGen:CA224432	C0268542|CN517202	311250	664	Aspartate/ornithine carbamoyltransferase, Asp/Orn-binding domain	Met	Ile	102983	single nucleotide variant	NM_000531.6(OTC):c.1005G>A (p.Met335Ile)	5009	OTC	HGNC:8512	Uncertain significance	1	Mar 29, 2022	281865553	-	RCV000083315|RCV002514457	MedGen:C3661900|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664	not provided|Ornithine carbamoyltransferase deficiency	germline;unknown	germline	GRCh38	NC_000023.11	X	38411999	38411999	Xp11.4	criteria provided, single submitter	2	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224432	2	97091	38411999	G	A	-	-	-	-	-	-	SCV003444648	-	-	1005G>A 	Met335Ile	NM_000531.6	1	4_VUS	OTC	ENSG00000036473	71569	205973	CCSBVarC005263	ALE00005263	1005G>A	Met335Ile	CEGS2	CegsMutGDEh1021	E09	GDEhDisVCh_40048	G05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Met335Ile	23	X	38411999	G	A
2803	HMBS	962G>A	Arg321His	ENSG00000256269	11	119093159	NC_000011.10:119093159:G:A	ALE00005178	CCSBVarC005178	NULL	200946	NULL	GDEhDisVCh_40054	B09	CEGS2	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAGCTTGCTCGCATACAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGGACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCTTGAACATGCCCTGGAGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCGAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTCGGGGAAACCTCAACACCCGGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACCGGGTGGGGCAGATCCTGCACCCTGAGGAATGCATGTATGCTGTGGGCCAGGGGGCCTTGGGCGTGGAAGTGCGAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCTGCATCGCTGAAAGGGCCTTCCTGAGGCACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATGGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCATAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACGATGCCCAT	171131.0	single nucleotide variant	NM_000190.4(HMBS):c.962G>A (p.Arg321His)	3145.0	HMBS	HGNC:4982	Conflicting classifications of pathogenicity	0.0	Feb 02, 2025	150428209.0	-	RCV000148508|RCV000730694	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900	Acute intermittent porphyria|not provided	germline;not applicable	germline	GRCh38	NC_000011.10	11	119093159.0	119093159.0	11q23.3	criteria provided, conflicting classifications	8.0	-	N	ClinGen:CA272874	2.0	161250.0	119093159.0	G	A	-	-	-	-	-	-	SCV000367707|SCV000858452|SCV001051958|SCV001132051|SCV001764085	-	-	962G>A 	Arg321His	NM_000190.4	1.0	3_Conflicting	chr11	G	A	11-119093159-G-A	0.00128533	161250	11	119093159	G	A	R	H	rs150428209	11	118963869	11	118469079	321	HMBS	ENSG00000256269	ENST00000652429	ENSP00000498786	P08397	HEM3_HUMAN	c.962G>A	p.Arg321His	c.962G>A	p.Arg321His	principal2	Y	.	YES	Select	+	CGT	2	0	G	G/G	G/G	G/G	G/G	.	0.17221	.	.	0.31545	.	0.01	0.15546	B	0.007	0.12988	B	.	0.16373	.	.	.	.	1.01	0.25176	L	.	0.23101	.	.	0.72440	1.3840	0.99989	D	0.9535	0.98487	D	10	.	0.01961	.	0.746019	0.97967	D	.	0.82027	.	.	.	.	.	.	0.99428	0.32063829405747085	0.31776	.	.	0.245244860649	0.03286	T	0.377637	0.73904	T	-0.0929411	0.37234	T	0.0878623	0.75924	D	0.00434302333184015	0.00046	T	0.927007	0.74353	D	0.13126433	0.30337	0.045844223	0.06275	0.114731535	0.26841	0.044000093	0.05617	-4.069	0.29791	T	0.0852	0.23287	B	0.0862180440551417	0.41983	0.04845008	0.59156	0.053	0.14148	.	.	.	.	.	.	1.431216	0.18518	13.77	0.85070210413198144	0.15906	0.191087	0.31617	N	-0.909542547684793	0.10491	0.508263	-0.858022797407406	0.12868	0.6774282	5.35	-0.632	0.10914	-1.14	0.15097	-0.597	0.05819	0.128000	0.15073	0.674	0.70877	0.001	0.13799	0.000000	0.08389	0.988	0.63383	228	0.91137	2	3.9936102236421724E-4	0	0.0	0	0.0	0	0.0	0	0.0	2	0.002044989775051125	269	264690	0.0010162832	.	141	109408	1.288750e-03	1	230	208128	1.105090e-03	1	281	236952	1.185890e-03	1	2	7164	2.791740e-04	0	12	17112	7.012620e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	14	13394	1.045240e-03	0	108	42768	2.525250e-03	1	5	15690	3.186740e-04	0	108	42768	2.525250e-03	1	3	16218	1.849800e-04	0	14	30522	4.586860e-04	0	0	6212	0.000000e+00	0	1	13416	7.453790e-05	0	16	16734	9.561370e-04	0	185	89552	2.065840e-03	1	9	30608	2.940410e-04	0	185	89552	2.065840e-03	1	3	14902	2.013150e-04	0	17	34258	4.962340e-04	0	0	9570	0.000000e+00	0	1	17692	5.652270e-05	0	22	21632	1.017010e-03	0	227	102752	2.209200e-03	1	9	30526	2.948310e-04	0	227	102752	2.209200e-03	1	.	2034	1614178	1.260080e-03	4	1813	1180004	1.536440e-03	2	7	75054	9.326620e-05	0	0	910	0.000000e+00	0	29	60028	4.831080e-04	0	0	29600	0.000000e+00	0	2	44886	4.455730e-05	0	73	64040	1.139910e-03	0	6	6062	9.897720e-04	0	1813	1180004	1.536440e-03	2	27	91088	2.964170e-04	0	284	174478	0.001627712376345442	0	176	0	0	4502	0	0	4798	0	0	796	0	1	964	0.001037344398340249	0	1848	0	0	280	0	19	16012	0.0011866100424681488	0	4974	0	0	6350	0	304	203854	0.0014912633551463301	Conflicting_classifications_of_pathogenicity	Acute_intermittent_porphyria|not_provided	criteria_provided,_conflicting_classifications	NC_000011.10:g.119093159G>A	ClinGen:CA272874	C0162565|C3661900	176000	79276	.	Arg	His	171131	single nucleotide variant	NM_000190.4(HMBS):c.962G>A (p.Arg321His)	3145	HMBS	HGNC:4982	Conflicting classifications of pathogenicity	0	Feb 02, 2025	150428209	-	RCV000148508|RCV000730694	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900	Acute intermittent porphyria|not provided	germline;not applicable	germline	GRCh38	NC_000011.10	11	119093159	119093159	11q23.3	criteria provided, conflicting classifications	8	-	N	ClinGen:CA272874	2	161250	119093159	G	A	-	-	-	-	-	-	SCV000367707|SCV000858452|SCV001051958|SCV001132051|SCV001764085	-	-	962G>A 	Arg321His	NM_000190.4	1	3_Conflicting	HMBS	ENSG00000256269	2803	200946	CCSBVarC005178	ALE00005178	962G>A	Arg321His	CEGS2	CegsMutGDEh1045	A10	GDEhDisVCh_40054	B09	2	CegsMutGDDh1045	A10	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	HMBS_Arg321His	11	11	119093159	G	A
71569	OTC	785C>T	Thr262Ile	ENSG00000036473	X	38408943	NC_000023.11:38408943:C:T	ALE00005258	CCSBVarC005258	NULL	205946	NULL	GDEhDisVCh_40048	B05	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTATAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103215.0	single nucleotide variant	NM_000531.6(OTC):c.785C>T (p.Thr262Ile)	5009.0	OTC	HGNC:8512	Pathogenic	1.0	-	67333670.0	-	RCV000083570	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38408943.0	38408943.0	Xp11.4	no assertion criteria provided	1.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224785	2.0	97323.0	38408943.0	C	T	-	-	-	-	-	-	SCV000115656	-	-	785C>T 	Thr262Ile	NM_000531.6		1_Pathogenic	chrX	C	T	X-38408943-C-T		97323	X	38408943	C	T	T	I	rs67333670	X	38268196	X	38153140	262	OTC	ENSG00000036473	ENST00000039007	ENSP00000039007	P00480	OTC_HUMAN	c.785C>T	p.Thr262Ile	c.785C>T	p.Thr262Ile	principal1	Y	1	YES	Select	+	ACA	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	0.96	0.95575	A	simple_aae	4.0	96.0	4.53	0.99048	H	-5.92	0.88991	D	0.993	0.99866	1.0043	0.97253	D	0.9868	0.99608	D	10	0.9944295	0.99943	D	0.976449	0.99867	D	0.986	0.99942	0.939	0.99152	P00480	T262I	Gain of catalytic residue at T262 (P = 0.1244)| Loss of helix (P = 0.1299)| Gain of sheet (P = 0.1945)| Gain of loop (P = 0.2754)| Loss of disorder (P = 0.4135)	0.998126104315	0.99807	0.9765402165296867	0.97632	1.22131841582	0.80998	0.699750840664	0.67053	T	0.971764	0.99697	D	0.728733	0.99954	D	0.808998	0.99953	D	0.999757587909698	0.98821	D	0.930407	0.74172	D	0.97731584	0.98879	0.9847453	0.99918	0.9867756	0.99573	0.98609155	0.99939	-14.461	0.94469	D	0.9924	0.94404	P	0.999868593961729	0.98431	0.99880075	0.98970	1	0.99985	.	.	.	.	.	.	4.802715	0.78095	26.8	0.99911633520771503	0.98096	.	.	.	.	.	.	.	.	.	5.58	5.58	0.84339	4.91	0.89049	7.458	0.79867	7.514000	0.59726	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.998	0.85369	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided	no_assertion_criteria_provided	NC_000023.11:g.38408943C>T	ClinGen:CA224785	CN517202	.	.	Aspartate/ornithine carbamoyltransferase, Asp/Orn-binding domain	Thr	Ile	103215	single nucleotide variant	NM_000531.6(OTC):c.785C>T (p.Thr262Ile)	5009	OTC	HGNC:8512	Pathogenic	1	-	67333670	-	RCV000083570	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38408943	38408943	Xp11.4	no assertion criteria provided	1	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224785	2	97323	38408943	C	T	-	-	-	-	-	-	SCV000115656	-	-	785C>T 	Thr262Ile	NM_000531.6		1_Pathogenic	OTC	ENSG00000036473	71569	205946	CCSBVarC005258	ALE00005258	785C>T	Thr262Ile	CEGS2	CegsMutGDEh1020	G05	GDEhDisVCh_40048	B05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Thr262Ile	23	X	38408943	C	T
3774	TP53	451C>T	Pro151Ser	ENSG00000141510	17	7675161	NC_000017.11:7675161:G:A	ALE00004858	CCSBVarC004858	NULL	214888	NULL	GDEhDisVCh_40053	H01	CEGS2	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACATCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACCGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	27409.0	single nucleotide variant	NM_000546.6(TP53):c.451C>T (p.Pro151Ser)	7157.0	TP53	HGNC:11998	Pathogenic/Likely pathogenic	1.0	Jan 10, 2025	28934874.0	-	RCV000013169|RCV000079203|RCV002288487|RCV001257523|RCV000219702|RCV000633355|RCV000785532	MONDO:MONDO:0004988,MedGen:C0858252|MedGen:C3661900|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|Human Phenotype Ontology:HP:0002859,MONDO:MONDO:0005212,MeSH:D012208,MedGen:C0035412,Orphanet:780|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267	Breast adenocarcinoma|not provided|Li-Fraumeni syndrome 1|Rhabdomyosarcoma|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Ovarian neoplasm	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7675161.0	7675161.0	17p13.1	criteria provided, multiple submitters, no conflicts	9.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000200,UniProtKB:P04637#VAR_005895,OMIM:191170.0026	3.0	12370.0	7675161.0	G	A	-	-	-	-	-	-	SCV000111072|SCV000272964|SCV000754577|SCV000839120|SCV002582395|SCV002583057|SCV005685078	-	-	451C>T 	Pro151Ser	NM_000546.6	2.0	1_Pathogenic	chr17	C	T	17-7675161-C-T		12370	17	7675161	G	A	P	S	rs28934874	17	7578479	17	7519204	151	TP53	ENSG00000141510	ENST00000714357	ENSP00000519624	P04637	P53_HUMAN	.	.	c.451C>T	p.Pro151Ser	principal1	Y	.	.	.	-	CCC	1	0	G	G/G	G/G	G/G	G/G	.	0.72322	.	.	0.79703	.	0.98	0.90580	D	0.837	0.97365	P	.	0.99291	.	.	.	.	2.295	0.65211	M	.	0.94367	.	.	0.68798	0.9310	0.96104	D	0.9949	0.99884	D	10	.	0.99554	.	0.572593	0.96134	D	.	0.97130	0.967	0.99678	P04637	P151S	Loss of glycosylation at S149 (P = 0.0648)| Loss of catalytic residue at P151 (P = 0.0855)| Gain of MoRF binding (P = 0.0859)| Loss of phosphorylation at T150 (P = 0.0952)| Gain of methylation at R156 (P = 0.1367)	.	0.96823	.	0.65835	.	0.87620	0.48640191555	0.36890	T	0.997133	0.99997	D	0.506784	0.94430	D	0.490184	0.94351	D	0.987674295902252	0.77962	D	.	0.43496	.	0.95697474	0.96925	0.89510816	0.94555	0.9586572	0.97099	0.8826087	0.93661	-11.507	0.83780	D	.	0.89929	.	0.961811913227224	0.81979	0.99992776	0.99924	0.967	0.98682	.	.	.	.	.	.	3.845674	0.55757	23.6	0.99893465332376985	0.96668	0.948814	0.96070	D	0.737531090941784	0.81992	7.6777	0.66888054329157	0.79914	7.2078	5.59	5.59	0.84656	5.22	0.92103	8.002	0.8806	11.896000	0.99223	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.692	0.33937	434	0.80544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Lung_adenocarcinoma|Li-Fraumeni_syndrome_1|Transitional_cell_carcinoma_of_the_bladder|Neoplasm_of_the_large_intestine|Adenoid_cystic_carcinoma|Malignant_neoplasm_of_body_of_uterus|Ovarian_serous_cystadenocarcinoma|Gastric_adenocarcinoma|Squamous_cell_lung_carcinoma|Carcinoma_of_esophagus|Pancreatic_adenocarcinoma|Rhabdomyosarcoma|Hereditary_cancer-predisposing_syndrome|Li-Fraumeni_syndrome|Breast_adenocarcinoma|Breast_neoplasm|Neoplasm_of_brain|Ovarian_neoplasm|Malignant_melanoma_of_skin|not_provided|Multiple_myeloma|Uterine_carcinosarcoma|Hepatocellular_carcinoma|Squamous_cell_carcinoma_of_the_head_and_neck	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.7675161G>A	ClinGen:CA000200|OMIM:191170.0026|UniProtKB:P04637#VAR_005895	C0152013|C1835398|C0279680|C0009404|C0010606|C0153574|C0279663|C0278701|C0149782|C0152018|C0281361|C0035412|C0027672|C0085390|C0858252|C1458155|C0006118|C0919267|C0151779|C3661900|C0026764|C0280630|C2239176|C1168401	151623|PS151623|254500|114550|275355	524|70482|780|140162|524|29073|85443|88673|67037	p53, DNA-binding domain|p53, DNA-binding domain	Pro	Ser	27409	single nucleotide variant	NM_000546.6(TP53):c.451C>T (p.Pro151Ser)	7157	TP53	HGNC:11998	Pathogenic/Likely pathogenic	1	Jan 10, 2025	28934874	-	RCV000013169|RCV000079203|RCV002288487|RCV001257523|RCV000219702|RCV000633355|RCV000785532	MONDO:MONDO:0004988,MedGen:C0858252|MedGen:C3661900|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|Human Phenotype Ontology:HP:0002859,MONDO:MONDO:0005212,MeSH:D012208,MedGen:C0035412,Orphanet:780|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267	Breast adenocarcinoma|not provided|Li-Fraumeni syndrome 1|Rhabdomyosarcoma|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Ovarian neoplasm	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7675161	7675161	17p13.1	criteria provided, multiple submitters, no conflicts	9	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000200,UniProtKB:P04637#VAR_005895,OMIM:191170.0026	3	12370	7675161	G	A	-	-	-	-	-	-	SCV000111072|SCV000272964|SCV000754577|SCV000839120|SCV002582395|SCV002583057|SCV005685078	-	-	451C>T 	Pro151Ser	NM_000546.6	2	1_Pathogenic	TP53	ENSG00000141510	3774	214888	CCSBVarC004858	ALE00004858	451C>T	Pro151Ser	CEGS2	CegsMutGDEh1010	E02	GDEhDisVCh_40053	H01	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	TP53_Pro151Ser	17	17	7675161	G	A
7201	RAD51D	698A>G	Glu233Gly	ENSG00000185379	17	35103294	NC_000017.11:35103294:T:C	ALE00001140	CCSBVarC001140	12776	NULL	NULL	GDEhDisVCh_40046	H04	RC4	ATGGGCGTGCTCAGGGTCGGACTGTGCCCTGGCCTTACCGAGGAGATGATCCAGCTTCTCAGGAGCCACAGGATCAAGACAGTGGTGGACCTGGTTTCTGCAGACCTGGAAGAGGTAGCTCAGAAATGTGGCTTGTCTTACAAGGCCCTGGTTGCCCTGAGGCGGGTGCTGCTGGCTCAGTTCTCGGCTTTCCCCGTGAATGGCGCTGATCTCTACGAGGAACTGAAGACCTCCACTGCCATCCTGTCCACTGGCATTGGCAGTCTTGATAAACTGCTTGATGCTGGTCTCTATACTGGAGAAGTGACTGAAATTGTAGGAGGCCCAGGTAGCGGCAAAACTCAGGTATGTCTCTGTATGGCAGCAAATGTGGCCCATGGCCTGCAGCAAAACGTCCTATATGTAGATTCCAATGGAGGGCTGACAGCTTCCCGCCTCCTCCAGCTGCTTCAGGCTAAAACCCAGGATGAGGAGGAACAGGCAGAAGCTCTCCGGAGGATCCAGGTGGTGCATGCATTTGACATCTTCCAGATGCTGGATGTGCTGCAGGAGCTCCGAGGCACTGTGGCCCAGCAGGTGACTGGTTCTTCAGGAACTGTGAAGGTGGTGGTTGTGGACTCGGTCACTGCGGTGGTTTCCCCACTTCTGGGAGGTCAGCAGAGGGAAGGCTTGGCCTTGATGATGCAGCTGGCCCGAGGGCTGAAGACCCTGGCCCGGGACCTTGGCATGGCAGTGGTGGTGACCAACCACATAACTCGAGACAGGGACAGCGGGAGGCTCAAACCTGCCCTCGGACGCTCCTGGAGCTTTGTGCCCAGCACTCGGATTCTCCTGGACACCATCGAGGGAGCAGGAGCATCAGGCGGCCGGCGCATGGCGTGTCTGGCCAAATCTTCCCGACAGCCAACAGGTTTCCAGGAGATGGTAGACATTGGGACCTGGGGGACCTCAGAGCAGAGTGCCACATTACAGGGTGATCAGACA	142576.0	single nucleotide variant	NM_002878.4(RAD51D):c.698A>G (p.Glu233Gly)	5892.0	RAD51D	HGNC:9823	Benign/Likely benign	0.0	Mar 04, 2025	28363284.0	-	RCV000128967|RCV000203773|RCV000212967|RCV001354814|RCV000588832|RCV001723701	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not specified|Malignant tumor of breast|not provided|Hereditary breast ovarian cancer syndrome	germline;unknown	germline	GRCh38	NC_000017.11	17	35103294.0	35103294.0	17q12	criteria provided, multiple submitters, no conflicts	20.0	-	N	ClinGen:CA293923,UniProtKB:O75771#VAR_020564	2.0	138873.0	35103294.0	T	C	-	-	-	-	-	-	SCV000171275|SCV000172849|SCV000262197|SCV000292107|SCV000488546|SCV000604996|SCV000698112|SCV000806585|SCV000859932|SCV000889832|SCV002550915|SCV004044167|SCV005214637	-	-	698A>G 	Glu233Gly	NM_002878.4	2.0	2_Benign	chr17	A	G	17-35103294-A-G		138873	17	35103294	T	C	E	G	rs28363284	17	33430313	17	30454426	233	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.698A>G	p.Glu233Gly	c.698A>G	p.Glu233Gly	principal1	Y	5	.	.	-	GAG	2	0	T	T/T	T/T	T/T	T/T	.	0.36459	.	0.451	0.68204	T	0.973	0.90580	D	0.785	0.86259	P	0.01	0.13669	N	simple_aae	99.0	1.0	1.85	0.48914	L	.	0.66695	.	0.562	0.63954	-0.5609	0.66221	T	0.2448	0.61193	T	10	0.012577295	0.00266	T	.	.	.	0.189	0.46391	.	.	.	.	.	0.911308683432	0.90975	.	0.64516	.	0.41897	.	.	.	0.290868	0.66175	T	-0.22489	0.17038	T	-0.07823	0.64785	T	0.021744398197262	0.00877	T	0.918208	0.70530	D	0.46690348	0.64786	0.5062009	0.71202	0.46690348	0.64786	0.5062009	0.71203	-7.244	0.74324	T	0.4981	0.71170	A	0.0150280587944397	0.27128	0.89164200	0.90920	0.292	0.56112	.	.	.	.	.	.	4.817542	0.78468	26.9	0.97842595494901574	0.36495	0.450689	0.50327	N	0.408714271726761	0.61704	4.397588	0.40833569100615	0.61877	4.417963	4.92	4.92	0.64102	.	.	2.999	0.49258	7.756000	0.68269	0.609	0.47831	1.0	0.71675	1.000000	0.68239	0.998	0.85369	908	0.22602	22	0.00439297124600639	0	0.0	11	0.010934393638170975	9	0.012968299711815562	0	0.0	2	0.002044989775051125	2903	264690	0.010967547	.	877	106826	8.209610e-03	7	1989	203334	9.781940e-03	19	2153	232226	9.271140e-03	19	17	6852	2.481030e-03	0	139	16760	8.293560e-03	0	2	2226	8.984730e-04	0	0	8848	0.000000e+00	0	19	13238	1.435260e-03	0	642	41754	1.537580e-02	7	46	15266	3.013230e-03	0	642	41754	1.537580e-02	7	54	15672	3.445640e-03	0	220	29852	7.369690e-03	0	11	6048	1.818780e-03	0	0	13294	0.000000e+00	0	21	16462	1.275670e-03	0	1541	87382	1.763520e-02	18	94	29872	3.146760e-03	0	1541	87382	1.763520e-02	18	44	14468	3.041190e-03	0	242	33624	7.197240e-03	0	16	9428	1.697070e-03	0	0	17460	0.000000e+00	0	25	21078	1.186070e-03	0	1672	100816	1.658470e-02	18	94	29798	3.154570e-03	0	1672	100816	1.658470e-02	18	.	27113	1611638	1.682330e-02	297	24903	1179112	2.112010e-02	286	234	74922	3.123250e-03	0	10	912	1.096490e-02	0	477	59646	7.997180e-03	0	54	29510	1.829890e-03	0	1	44820	2.231150e-05	0	106	63816	1.661030e-03	0	43	6018	7.145230e-03	1	24903	1179112	2.112010e-02	286	335	90476	3.702640e-03	3	3387	201918	0.016774136035420318	0	358	0	0	4530	0	38	9444	0.004023718763235917	6	800	0.0075	12	974	0.012320328542094456	1	1850	5.405405405405405E-4	0	282	0	223	18644	0.011960952585282129	38	9802	0.0038767598449296063	1	6380	1.5673981191222572E-4	3667	238800	0.015355946398659967	Benign/Likely_benign	not_provided|Hereditary_cancer-predisposing_syndrome|not_specified|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Malignant_tumor_of_breast	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.35103294T>C	ClinGen:CA293923|UniProtKB:O75771#VAR_020564	C3661900|C0027672|CN169374|C0677776|C3280345|C0006142	614291	140162|145|145	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	Glu	Gly	142576	single nucleotide variant	NM_002878.4(RAD51D):c.698A>G (p.Glu233Gly)	5892	RAD51D	HGNC:9823	Benign/Likely benign	0	Mar 04, 2025	28363284	-	RCV000128967|RCV000203773|RCV000212967|RCV001354814|RCV000588832|RCV001723701	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:CN169374|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial, susceptibility to, 4|not specified|Malignant tumor of breast|not provided|Hereditary breast ovarian cancer syndrome	germline;unknown	germline	GRCh38	NC_000017.11	17	35103294	35103294	17q12	criteria provided, multiple submitters, no conflicts	20	-	N	ClinGen:CA293923,UniProtKB:O75771#VAR_020564	2	138873	35103294	T	C	-	-	-	-	-	-	SCV000171275|SCV000172849|SCV000262197|SCV000292107|SCV000488546|SCV000604996|SCV000698112|SCV000806585|SCV000859932|SCV000889832|SCV002550915|SCV004044167|SCV005214637	-	-	698A>G 	Glu233Gly	NM_002878.4	2	2_Benign	RAD51D	ENSG00000185379	7201	12776	CCSBVarC001140	ALE00001140	698A>G	Glu233Gly	RC4	RC4_Mut_GDEh1002	C07	GDEhDisVCh_40046	H04	2	RC4_Mut_GDDh1002	C07	NULL	NULL	VUSMutpDEST2_06	F01	VUSmut_GDEh12	G05	1	2	1	1	0	NULL	1	1	1	1	RAD51D_Glu233Gly	17	17	35103294	T	C
2803	HMBS	499C>T	Arg167Trp	ENSG00000256269	11	119091413	NC_000011.10:119091413:C:T	ALE00005164	CCSBVarC005164	NULL	200933	NULL	GDEhDisVCh_40054	E05	CEGS2	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAGCTTGCTCGCATACAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGGACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCTTGAACATGCCCTGGAGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCGAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTTGGGGAAACCTCAACACCCGGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACCGGGTGGGGCAGATCCTGCACCCTGAGGAATGCATGTATGCTGTGGGCCAGGGGGCCTTGGGCGTGGAAGTGCGAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCTGCATCGCTGAAAGGGCCTTCCTGAGGCACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATGGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCGTAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACGATGCCCAT	16495.0	single nucleotide variant	NM_000190.4(HMBS):c.499C>T (p.Arg167Trp)	3145.0	HMBS	HGNC:4982	Pathogenic	1.0	Dec 23, 2024	118204101.0	-	RCV000001521|RCV000489906|RCV003764512	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704	Acute intermittent porphyria|not provided|Encephalopathy, porphyria-related	germline	germline	GRCh38	NC_000011.10	11	119091413.0	119091413.0	11q23.3	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA251813,UniProtKB:P08397#VAR_003652,OMIM:609806.0013	3.0	1456.0	119091413.0	C	T	-	-	-	-	-	-	SCV000577609|SCV000944323|SCV003822772	-	-	499C>T 	Arg167Trp	NM_000190.4	2.0	1_Pathogenic	chr11	C	T	11-119091413-C-T	0.0000178827	1456	11	119091413	C	T	R	W	rs118204101	11	118962123	11	118467333	167	HMBS	ENSG00000256269	ENST00000652429	ENSP00000498786	P08397	HEM3_HUMAN	c.499C>T	p.Arg167Trp	c.499C>T	p.Arg167Trp	principal2	Y	.	YES	Select	+	CGG	1	2	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	1.0	0.97365	D	.	0.99291	.	.	.	.	4.47	0.98862	H	.	0.95993	.	.	0.99781	0.9220	0.95974	D	0.9969	0.99925	D	8	.	0.99183	.	0.63732	0.96895	D	.	0.98815	0.935	0.99041	P08397	R167W	Loss of disorder (P = 0.005)| Loss of phosphorylation at S165 (P = 0.0626)| Loss of catalytic residue at R167 (P = 0.0698)| Loss of methylation at R167 (P = 0.0968)| Loss of MoRF binding (P = 0.1082)	.	0.98805	0.9452538033324966	0.94473	.	.	0.799257516861	0.81818	T	0.996766	0.99996	D	0.466542	0.93148	D	0.554924	0.95729	D	0.9987753033638	0.95085	D	0.968103	0.88633	D	0.95707107	0.96936	0.9364312	0.97495	0.9548803	0.96710	0.9486082	0.98289	-14.152	0.93771	D	0.9678	0.89069	P	0.999562839962743	0.97008	0.36574966	0.78714	0.997	0.99892	.	.	.	.	.	.	5.272347	0.88542	29.6	0.99915589236646773	0.98380	0.850988	0.76698	D	0.730269790374957	0.81518	7.564326	0.566952235508211	0.72434	5.833057	5.59	2.46	0.28956	3.52	0.63825	2.499	0.45133	0.815000	0.21873	0.599	0.40292	1.0	0.71675	0.999000	0.35501	0.991	0.66489	228	0.91137	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	.	3	65048	4.611980e-05	0	6	132592	4.525160e-05	0	6	151818	3.952100e-05	0	0	2858	0.000000e+00	0	1	12384	8.074940e-05	0	0	1454	0.000000e+00	0	0	4604	0.000000e+00	0	2	11472	1.743380e-04	0	0	19468	0.000000e+00	0	0	11444	0.000000e+00	0	1	12384	8.074940e-05	0	0	8702	0.000000e+00	0	1	20684	4.834650e-05	0	0	4758	0.000000e+00	0	0	8792	0.000000e+00	0	3	13484	2.224860e-04	0	2	49808	4.015420e-05	0	0	22782	0.000000e+00	0	1	20684	4.834650e-05	0	0	8160	0.000000e+00	0	1	24652	4.056470e-05	0	0	8322	0.000000e+00	0	0	11040	0.000000e+00	0	3	15358	1.953380e-04	0	2	57218	3.495400e-05	0	0	22770	0.000000e+00	0	1	24652	4.056470e-05	0	.	25	1550366	1.612520e-05	0	6	59884	1.001940e-04	0	0	73154	0.000000e+00	0	0	912	0.000000e+00	0	1	51008	1.960480e-05	0	0	28650	0.000000e+00	0	0	40920	0.000000e+00	0	6	59884	1.001940e-04	0	0	5990	0.000000e+00	0	14	1145742	1.221920e-05	0	0	84046	0.000000e+00	0	1	15830	6.317119393556538E-5	0	122	0	0	146	0	0	3804	0	0	146	0	0	610	0	0	56	0	0	104	0	1	2880	3.4722222222222224E-4	0	3926	0	0	202	0	2	23698	8.439530762089628E-5	Pathogenic	Encephalopathy,_porphyria-related|Acute_intermittent_porphyria|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.119091413C>T	ClinGen:CA251813|OMIM:609806.0013|UniProtKB:P08397#VAR_003652	CN376852|C0162565|C3661900	620704|176000	79276	Porphobilinogen deaminase, N-terminal	Arg	Trp	16495	single nucleotide variant	NM_000190.4(HMBS):c.499C>T (p.Arg167Trp)	3145	HMBS	HGNC:4982	Pathogenic	1	Dec 23, 2024	118204101	-	RCV000001521|RCV000489906|RCV003764512	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704	Acute intermittent porphyria|not provided|Encephalopathy, porphyria-related	germline	germline	GRCh38	NC_000011.10	11	119091413	119091413	11q23.3	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA251813,UniProtKB:P08397#VAR_003652,OMIM:609806.0013	3	1456	119091413	C	T	-	-	-	-	-	-	SCV000577609|SCV000944323|SCV003822772	-	-	499C>T 	Arg167Trp	NM_000190.4	2	1_Pathogenic	HMBS	ENSG00000256269	2803	200933	CCSBVarC005164	ALE00005164	499C>T	Arg167Trp	CEGS2	CegsMutGDEh1040	B05	GDEhDisVCh_40054	E05	2	CegsMutGDDh1040	B05	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	HMBS_Arg167Trp	11	11	119091413	C	T
3172	CBS	919G>A	Gly307Ser	ENSG00000160200	21	43062988	NC_000021.9:43062988:C:T	ALE00003753	CCSBVarC003753	NULL	214529	NULL	GDEhDisVCh_40055	B08	CEGS2	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTCCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCAGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCCGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	15156.0	single nucleotide variant	NM_000071.3(CBS):c.919G>A (p.Gly307Ser)	875.0	CBS	HGNC:1550	Pathogenic	1.0	Dec 23, 2024	121964962.0	-	RCV000000137|RCV000000138|RCV000078112|RCV000173641|RCV000366433|RCV002313701|RCV003914786	MedGen:C4017308|MedGen:C3150344|MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|	Homocystinuria, pyridoxine-nonresponsive|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not provided|Classic homocystinuria|Homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|CBS-related disorder	germline;unknown	germline	GRCh38	NC_000021.9	21	43062988.0	43062988.0	21q22.3	criteria provided, multiple submitters, no conflicts	17.0	-	N	ClinGen:CA113874,UniProtKB:P35520#VAR_002186,OMIM:613381.0001	3.0	117.0	43062988.0	C	T	-	-	-	-	-	-	SCV000224773|SCV000249696|SCV000436215|SCV000543511|SCV000695310|SCV000711669|SCV000738476|SCV000893554|SCV001163819|SCV001193980|SCV002821086|SCV004175579	-	-	919G>A 	Gly307Ser	NM_000071.3	2.0	1_Pathogenic	chr21	G	A	21-43062988-G-A		117	21	43062988	C	T	G	S	rs121964962	21	44483098	21	43356167	307	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.919G>A	p.Gly307Ser	c.919G>A	p.Gly307Ser	principal1	Y	1	.	.	-	GGC	1	0	C	C/C	C/C	C/C	C/C	0.002	0.72322	D	0.002	0.79703	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.095	0.87372	M	-5.62	0.86790	D	0.966	0.97870	1.0716	0.98630	D	0.9781	0.99320	D	9	0.9709107	0.96652	D	0.87819	0.99068	D	0.946	0.98921	.	.	.	.	.	0.948013315529	0.94704	.	0.96479	.	0.78143	0.707827687263	0.68224	T	0.986355	0.99919	D	0.308079	0.83479	D	0.536822	0.95338	D	0.731001853942871	0.41964	D	.	0.98841	.	0.95271325	0.96487	0.88872755	0.94098	0.9481711	0.96019	0.8795776	0.93445	-12.897	0.88958	D	0.8411	0.79251	LP	0.999707299544991	0.97565	0.99971312	0.99632	0.989	0.99628	.	.	.	.	.	.	4.988591	0.82721	27.9	0.99851036837532237	0.93018	0.933366	0.92490	D	0.68425202105595	0.78486	6.904548	0.584901590414184	0.73714	6.039562	4.67	4.67	0.58039	2.39	0.44462	6.848	0.75268	5.760000	0.49753	0.469	0.21904	1.0	0.71675	1.000000	0.68239	0.548	0.30173	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	16	109350	1.463190e-04	0	36	208040	1.730440e-04	0	34	236898	1.435220e-04	0	2	7162	2.792520e-04	0	0	17108	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	1	13342	7.495130e-05	0	12	42768	2.805840e-04	0	0	15690	0.000000e+00	0	12	42768	2.805840e-04	0	2	16214	1.233500e-04	0	0	30520	0.000000e+00	0	0	6212	0.000000e+00	0	0	13414	0.000000e+00	0	1	16682	5.994490e-05	0	32	89526	3.574380e-04	0	0	30608	0.000000e+00	0	32	89526	3.574380e-04	0	2	14900	1.342280e-04	0	0	34256	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	1	21580	4.633920e-05	0	29	102752	2.822330e-04	0	0	30526	0.000000e+00	0	29	102752	2.822330e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	55	174796	3.1465250921073706E-4	0	246	0	0	4406	0	1	6222	1.607200257152041E-4	0	646	0	0	358	0	0	1820	0	0	182	0	3	16870	1.7783046828689981E-4	1	6468	1.5460729746444033E-4	0	6226	0	59	205546	2.8704037052533255E-4	Pathogenic	Homocystinuria|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_provided|Classic_homocystinuria|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Homocystinuria,_pyridoxine-nonresponsive|CBS-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43062988C>T	ClinGen:CA113874|OMIM:613381.0001|UniProtKB:P35520#VAR_002186	C0019880|C4707243|C3661900|C0751202|C3150344|C4017308	PS607086|236200	91387|394	Tryptophan synthase beta chain-like, PALP domain	Gly	Ser	15156	single nucleotide variant	NM_000071.3(CBS):c.919G>A (p.Gly307Ser)	875	CBS	HGNC:1550	Pathogenic	1	Dec 23, 2024	121964962	-	RCV000000137|RCV000000138|RCV000078112|RCV000173641|RCV000366433|RCV002313701|RCV003914786	MedGen:C4017308|MedGen:C3150344|MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|	Homocystinuria, pyridoxine-nonresponsive|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not provided|Classic homocystinuria|Homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|CBS-related disorder	germline;unknown	germline	GRCh38	NC_000021.9	21	43062988	43062988	21q22.3	criteria provided, multiple submitters, no conflicts	17	-	N	ClinGen:CA113874,UniProtKB:P35520#VAR_002186,OMIM:613381.0001	3	117	43062988	C	T	-	-	-	-	-	-	SCV000224773|SCV000249696|SCV000436215|SCV000543511|SCV000695310|SCV000711669|SCV000738476|SCV000893554|SCV001163819|SCV001193980|SCV002821086|SCV004175579	-	-	919G>A 	Gly307Ser	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	270	CCSBVarC007321	ALE00003753	919G>A	Gly307Ser	Edgotyping3	VUSMutGDEh011	C01	GDEhDisVCh_40013	F06	1	VUSMutGDDh011	C01	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	CBS_Gly307Ser	21	21	43062988	C	T
3172	CBS	919G>A	Gly307Ser	ENSG00000160200	21	43062988	NC_000021.9:43062988:C:T	ALE00003753	CCSBVarC003753	NULL	214529	NULL	GDEhDisVCh_40055	B08	CEGS2	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTCCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCAGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCCGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	15156.0	single nucleotide variant	NM_000071.3(CBS):c.919G>A (p.Gly307Ser)	875.0	CBS	HGNC:1550	Pathogenic	1.0	Dec 23, 2024	121964962.0	-	RCV000000137|RCV000000138|RCV000078112|RCV000173641|RCV000366433|RCV002313701|RCV003914786	MedGen:C4017308|MedGen:C3150344|MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|	Homocystinuria, pyridoxine-nonresponsive|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not provided|Classic homocystinuria|Homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|CBS-related disorder	germline;unknown	germline	GRCh38	NC_000021.9	21	43062988.0	43062988.0	21q22.3	criteria provided, multiple submitters, no conflicts	17.0	-	N	ClinGen:CA113874,UniProtKB:P35520#VAR_002186,OMIM:613381.0001	3.0	117.0	43062988.0	C	T	-	-	-	-	-	-	SCV000224773|SCV000249696|SCV000436215|SCV000543511|SCV000695310|SCV000711669|SCV000738476|SCV000893554|SCV001163819|SCV001193980|SCV002821086|SCV004175579	-	-	919G>A 	Gly307Ser	NM_000071.3	2.0	1_Pathogenic	chr21	G	A	21-43062988-G-A		117	21	43062988	C	T	G	S	rs121964962	21	44483098	21	43356167	307	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.919G>A	p.Gly307Ser	c.919G>A	p.Gly307Ser	principal1	Y	1	.	.	-	GGC	1	0	C	C/C	C/C	C/C	C/C	0.002	0.72322	D	0.002	0.79703	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.095	0.87372	M	-5.62	0.86790	D	0.966	0.97870	1.0716	0.98630	D	0.9781	0.99320	D	9	0.9709107	0.96652	D	0.87819	0.99068	D	0.946	0.98921	.	.	.	.	.	0.948013315529	0.94704	.	0.96479	.	0.78143	0.707827687263	0.68224	T	0.986355	0.99919	D	0.308079	0.83479	D	0.536822	0.95338	D	0.731001853942871	0.41964	D	.	0.98841	.	0.95271325	0.96487	0.88872755	0.94098	0.9481711	0.96019	0.8795776	0.93445	-12.897	0.88958	D	0.8411	0.79251	LP	0.999707299544991	0.97565	0.99971312	0.99632	0.989	0.99628	.	.	.	.	.	.	4.988591	0.82721	27.9	0.99851036837532237	0.93018	0.933366	0.92490	D	0.68425202105595	0.78486	6.904548	0.584901590414184	0.73714	6.039562	4.67	4.67	0.58039	2.39	0.44462	6.848	0.75268	5.760000	0.49753	0.469	0.21904	1.0	0.71675	1.000000	0.68239	0.548	0.30173	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	16	109350	1.463190e-04	0	36	208040	1.730440e-04	0	34	236898	1.435220e-04	0	2	7162	2.792520e-04	0	0	17108	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	1	13342	7.495130e-05	0	12	42768	2.805840e-04	0	0	15690	0.000000e+00	0	12	42768	2.805840e-04	0	2	16214	1.233500e-04	0	0	30520	0.000000e+00	0	0	6212	0.000000e+00	0	0	13414	0.000000e+00	0	1	16682	5.994490e-05	0	32	89526	3.574380e-04	0	0	30608	0.000000e+00	0	32	89526	3.574380e-04	0	2	14900	1.342280e-04	0	0	34256	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	1	21580	4.633920e-05	0	29	102752	2.822330e-04	0	0	30526	0.000000e+00	0	29	102752	2.822330e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	55	174796	3.1465250921073706E-4	0	246	0	0	4406	0	1	6222	1.607200257152041E-4	0	646	0	0	358	0	0	1820	0	0	182	0	3	16870	1.7783046828689981E-4	1	6468	1.5460729746444033E-4	0	6226	0	59	205546	2.8704037052533255E-4	Pathogenic	Homocystinuria|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_provided|Classic_homocystinuria|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Homocystinuria,_pyridoxine-nonresponsive|CBS-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43062988C>T	ClinGen:CA113874|OMIM:613381.0001|UniProtKB:P35520#VAR_002186	C0019880|C4707243|C3661900|C0751202|C3150344|C4017308	PS607086|236200	91387|394	Tryptophan synthase beta chain-like, PALP domain	Gly	Ser	15156	single nucleotide variant	NM_000071.3(CBS):c.919G>A (p.Gly307Ser)	875	CBS	HGNC:1550	Pathogenic	1	Dec 23, 2024	121964962	-	RCV000000137|RCV000000138|RCV000078112|RCV000173641|RCV000366433|RCV002313701|RCV003914786	MedGen:C4017308|MedGen:C3150344|MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|	Homocystinuria, pyridoxine-nonresponsive|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not provided|Classic homocystinuria|Homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|CBS-related disorder	germline;unknown	germline	GRCh38	NC_000021.9	21	43062988	43062988	21q22.3	criteria provided, multiple submitters, no conflicts	17	-	N	ClinGen:CA113874,UniProtKB:P35520#VAR_002186,OMIM:613381.0001	3	117	43062988	C	T	-	-	-	-	-	-	SCV000224773|SCV000249696|SCV000436215|SCV000543511|SCV000695310|SCV000711669|SCV000738476|SCV000893554|SCV001163819|SCV001193980|SCV002821086|SCV004175579	-	-	919G>A 	Gly307Ser	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	3172	214529	CCSBVarC003753	ALE00003753	919G>A	Gly307Ser	CEGS2	CegsMutGDEh1040	G11	GDEhDisVCh_40055	B08	1	CegsMutGDDh1040	G11	NULL	NULL	NULL	NULL	NULL	NULL	1	6	1	2	0	NULL	0	NULL	0	NULL	CBS_Gly307Ser	21	21	43062988	C	T
3774	TP53	91G>A	Val31Ile	ENSG00000141510	17	7676387	NC_000017.11:7676387:C:T	ALE00000545	CCSBVarC000545	6902	NULL	NULL	GDEhDisVCh_40053	C11	RC4	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACATTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACCGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	133284.0	single nucleotide variant	NM_000546.6(TP53):c.91G>A (p.Val31Ile)	7157.0	TP53	HGNC:11998	Conflicting classifications of pathogenicity	1.0	Feb 04, 2025	201753350.0	-	RCV000115742|RCV000123100|RCV000122173|RCV000409871|RCV000586196|RCV001030741|RCV003492490|RCV003945046	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MedGen:CN169374|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN221562|	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not specified|Li-Fraumeni syndrome 1|not provided|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|TP53-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	7676387.0	7676387.0	17p13.1	criteria provided, conflicting classifications	16.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA357868,UniProtKB:P04637#VAR_044554	2.0	127827.0	7676387.0	C	T	-	-	-	-	-	-	SCV000149651|SCV000166401|SCV000187523|SCV000407074|SCV000487895|SCV000697455|SCV000910670|SCV001140270|SCV001193757|SCV002046225|SCV002532723|SCV004017840|SCV004239793	-	-	91G>A 	Val31Ile	NM_000546.6	1.0	3_Conflicting	chr17	G	A	17-7676387-G-A		127827	17	7676387	C	T	V	I	rs201753350	17	7579705	17	7520430	31	TP53	ENSG00000141510	ENST00000445888	ENSP00000391478	P04637	P53_HUMAN	c.91G>A	p.Val31Ile	c.91G>A	p.Val31Ile	principal1	Y	1	.	.	-	GTT	1	0	C	C/C	C/C	C/C	C/C	0.635	0.26866	T	0.474	0.14578	T	0.001	0.13006	B	0.002	0.10086	B	0.02	0.08015	A	simple_aae	98.0	2.0	0.935	0.23470	L	-0.14	0.09239	N	0.081	0.07106	1.4552	0.99992	D	0.8903	0.96352	D	10	0.00851649	0.00190	T	0.407238	0.93510	D	0.569	0.82371	.	.	.	.	.	0.959186965634	0.95840	.	0.18280	.	0.49594	.	.	.	0.387689	0.74682	T	-0.167766	0.25231	T	-0.016812	0.69014	D	0.00906884427412508	0.00113	T	.	0.30191	.	0.109469086	0.25650	0.05052391	0.07961	0.070131674	0.15280	0.04615128	0.06385	-3.794	0.21873	T	0.0694	0.19706	B	0.0303630851786765	0.32921	0.99915480	0.99178	0.014	0.01428	.	.	.	.	.	.	1.094301	0.148	11.32	0.70781234506302726	0.09559	0.066351	0.12812	N	-1.43959223617898	0.02277	0.1013981	-1.45851346034345	0.02657	0.1243784	3.37	-4.85	0.02914	-5.0	0.04489	-0.909	0.04172	-0.979000	0.06749	-0.197	0.09064	0.0	0.06393	0.000000	0.08389	0.969	0.5403	434	0.80544	9	0.0017971246006389776	0	0.0	0	0.0	0	0.0	9	0.008928571428571428	0	0.0	22	264690	8.31161E-5	.	33	109092	3.024970e-04	0	55	206258	2.666560e-04	1	61	236026	2.584460e-04	1	0	7090	0.000000e+00	0	0	17050	0.000000e+00	0	0	2320	0.000000e+00	0	32	9014	3.550030e-03	0	0	13384	0.000000e+00	0	1	42724	2.340600e-05	0	0	15604	0.000000e+00	0	32	9014	3.550030e-03	0	0	15806	0.000000e+00	0	0	30428	0.000000e+00	0	0	6142	0.000000e+00	0	55	13330	4.126030e-03	1	0	16724	0.000000e+00	0	0	88514	0.000000e+00	0	0	30516	0.000000e+00	0	55	13330	4.126030e-03	1	0	14672	0.000000e+00	0	0	34196	0.000000e+00	0	0	9548	0.000000e+00	0	60	17660	3.397510e-03	1	0	21622	0.000000e+00	0	1	102296	9.775550e-06	0	0	30440	0.000000e+00	0	60	17660	3.397510e-03	1	.	252	1613564	1.561760e-04	4	237	44856	5.283570e-03	4	0	74912	0.000000e+00	0	0	910	0.000000e+00	0	0	59956	0.000000e+00	0	0	29606	0.000000e+00	0	237	44856	5.283570e-03	4	0	63796	0.000000e+00	0	0	6062	0.000000e+00	0	7	1179894	5.932740e-06	0	0	91070	0.000000e+00	0	1	146986	6.8033690283428356E-6	0	168	0	21	4438	0.00473186119873817	0	3752	0	0	442	0	0	950	0	2	1818	0.0011001100110011	0	274	0	6	9522	6.30119722747322E-4	0	3920	0	23	6256	0.003676470588235294	30	168350	1.782001782001782E-4	Conflicting_classifications_of_pathogenicity	Li-Fraumeni_syndrome_1|not_specified|not_provided|Li-Fraumeni_syndrome|Breast_and/or_ovarian_cancer|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|TP53-related_disorder	criteria_provided,_conflicting_classifications	NC_000017.11:g.7676387C>T	ClinGen:CA357868|UniProtKB:P04637#VAR_044554	C1835398|CN169374|C3661900|C0085390|CN221562|C0677776|C0027672	151623|PS151623	524|524|145|140162	.	Val	Ile	133284	single nucleotide variant	NM_000546.6(TP53):c.91G>A (p.Val31Ile)	7157	TP53	HGNC:11998	Conflicting classifications of pathogenicity	1	Feb 04, 2025	201753350	-	RCV000115742|RCV000123100|RCV000122173|RCV000409871|RCV000586196|RCV001030741|RCV003492490|RCV003945046	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MedGen:CN169374|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MedGen:C3661900|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN221562|	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not specified|Li-Fraumeni syndrome 1|not provided|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|TP53-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	7676387	7676387	17p13.1	criteria provided, conflicting classifications	16	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA357868,UniProtKB:P04637#VAR_044554	2	127827	7676387	C	T	-	-	-	-	-	-	SCV000149651|SCV000166401|SCV000187523|SCV000407074|SCV000487895|SCV000697455|SCV000910670|SCV001140270|SCV001193757|SCV002046225|SCV002532723|SCV004017840|SCV004239793	-	-	91G>A 	Val31Ile	NM_000546.6	1	3_Conflicting	TP53	ENSG00000141510	3774	6902	CCSBVarC000545	ALE00000545	91G>A	Val31Ile	RC4	RC4_Mut_GDEh1019	B11	GDEhDisVCh_40053	C11	1	RC4_Mut_GDDh1019	B11	NULL	NULL	NULL	NULL	NULL	NULL	1	3	1	1	0	NULL	0	NULL	0	NULL	TP53_Val31Ile	17	17	7676387	C	T
359	CBS	1280C>T	Pro427Leu	ENSG00000160200	21	43058912	NC_000021.9:43058912:G:A	ALE00007299	CCSBVarC007303	NULL	NULL	245	GDEhDisVCh_40013	C04	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCTGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210403.0	single nucleotide variant	NM_000071.3(CBS):c.1280C>T (p.Pro427Leu)	875.0	CBS	HGNC:1550	Conflicting classifications of pathogenicity	1.0	Feb 20, 2024	863223434.0	-	RCV000197292|RCV000584030|RCV003462306|RCV002517170	MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344	not provided|not specified|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;unknown	germline	GRCh38	NC_000021.9	21	43058912.0	43058912.0	21q22.3	criteria provided, conflicting classifications	5.0	-	N	ClinGen:CA321746,UniProtKB:P35520#VAR_074592	2.0	212867.0	43058912.0	G	A	-	-	-	-	-	-	SCV000249714|SCV002766586|SCV003471323|SCV004213879	-	-	1280C>T 	Pro427Leu	NM_000071.3	1.0	3_Conflicting	chr21	C	T	21-43058912-C-T		212867	21	43058912	G	A	P	L	rs863223434	21	44479022	21	43352091	427	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.1280C>T	p.Pro427Leu	c.1280C>T	p.Pro427Leu	principal1	Y	1	.	.	-	CCG	2	0	G	G/G	G/G	G/G	G/G	0.031	0.45197	D	0.12	0.36305	T	0.211	0.30005	B	0.117	0.32017	B	0.94	0.94378	A	simple_aae	6.0	94.0	2.83	0.82191	M	-6.2	0.90390	D	0.933	0.94087	0.2006	0.85858	D	0.5242	0.82200	D	10	0.9838824	0.98536	D	0.625344	0.96762	D	0.783	0.92762	0.794	0.91466	P35520	P427L	Loss of glycosylation at T424 (P = 0.1057)| Gain of sheet (P = 0.1208)| Loss of phosphorylation at T424 (P = 0.1222)| Loss of catalytic residue at P427 (P = 0.2207)| Loss of loop (P = 0.4412)	0.915302788015	0.91381	.	0.85266	.	0.42416	0.742067098618	0.73230	T	0.954137	0.99353	D	0.486928	0.93870	D	0.461662	0.93792	D	0.590892107147432	0.35730	D	.	0.90715	.	0.46808785	0.64859	0.31318378	0.57095	0.50597554	0.67139	0.24640906	0.49959	-13.554	0.91534	D	.	0.52820	.	0.973817159057508	0.83980	0.99747840	0.98394	0.904	0.94963	.	.	.	.	.	.	3.735205	0.53535	23.4	0.98561024656946694	0.43094	0.946187	0.95519	D	0.426142673207301	0.62671	4.509557	0.382941644233395	0.60302	4.239744	4.71	4.71	0.58959	.	.	9.476	0.96867	11.371000	0.92617	0.586	0.30628	1.0	0.71675	1.000000	0.68239	0.037	0.13987	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	79470	0.000000e+00	0	2	157640	1.268710e-05	0	2	180216	1.109780e-05	0	0	4134	0.000000e+00	0	0	13832	0.000000e+00	0	0	1632	0.000000e+00	0	0	6248	0.000000e+00	0	0	11072	0.000000e+00	0	0	28536	0.000000e+00	0	0	12502	0.000000e+00	0	.	.	.	.	0	11078	0.000000e+00	0	0	23642	0.000000e+00	0	0	5074	0.000000e+00	0	0	10998	0.000000e+00	0	0	13368	0.000000e+00	0	0	64590	0.000000e+00	0	2	24946	8.017320e-05	0	2	24946	8.017320e-05	0	0	10334	0.000000e+00	0	0	27538	0.000000e+00	0	0	8590	0.000000e+00	0	0	13790	0.000000e+00	0	0	15858	0.000000e+00	0	0	74452	0.000000e+00	0	2	24918	8.026330e-05	0	2	24918	8.026330e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	21190	9.438414346389807E-5	0	0	0	0	0	0	0	20	0	0	336	0	0	18	0	0	0	0	0	0	0	0	4052	0	0	20	0	0	0	0	2	25616	7.807620237351655E-5	Conflicting_classifications_of_pathogenicity	not_provided|Classic_homocystinuria|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|not_specified	criteria_provided,_conflicting_classifications	NC_000021.9:g.43058912G>A	ClinGen:CA321746|UniProtKB:P35520#VAR_074592	C3661900|C0751202|C3150344|CN169374	236200	394	CBS domain|CBS domain|CBS domain|Cystathionine beta-synthase, C-terminal domain	Pro	Leu	210403	single nucleotide variant	NM_000071.3(CBS):c.1280C>T (p.Pro427Leu)	875	CBS	HGNC:1550	Conflicting classifications of pathogenicity	1	Feb 20, 2024	863223434	-	RCV000197292|RCV000584030|RCV003462306|RCV002517170	MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344	not provided|not specified|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;unknown	germline	GRCh38	NC_000021.9	21	43058912	43058912	21q22.3	criteria provided, conflicting classifications	5	-	N	ClinGen:CA321746,UniProtKB:P35520#VAR_074592	2	212867	43058912	G	A	-	-	-	-	-	-	SCV000249714|SCV002766586|SCV003471323|SCV004213879	-	-	1280C>T 	Pro427Leu	NM_000071.3	1	3_Conflicting	CBS	ENSG00000160200	359	245	CCSBVarC007303	ALE00007299	1280C>T	Pro427Leu	Edgotyping3	VUSMutGDEh010	G10	GDEhDisVCh_40013	C04	1	VUSMutGDDh010	G10	NULL	NULL	NULL	NULL	NULL	NULL	1	3	1	6	0	NULL	0	NULL	0	NULL	CBS_Pro427Leu	21	21	43058912	G	A
71569	OTC	790A>G	Thr264Ala	ENSG00000036473	X	38408948	NC_000023.11:38408948:A:G	ALE00005260	CCSBVarC005260	NULL	205953	NULL	GDEhDisVCh_40048	G06	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACGCTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103218.0	single nucleotide variant	NM_000531.6(OTC):c.790A>G (p.Thr264Ala)	5009.0	OTC	HGNC:8512	Pathogenic	1.0	Aug 20, 2022	72558444.0	-	RCV000083573|RCV002514461	MedGen:C3661900|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664	not provided|Ornithine carbamoyltransferase deficiency	germline;unknown	germline	GRCh38	NC_000023.11	X	38408948.0	38408948.0	Xp11.4	criteria provided, single submitter	2.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224789,UniProtKB:P00480#VAR_004922	2.0	97326.0	38408948.0	A	G	-	-	-	-	-	-	SCV003445133	-	-	790A>G 	Thr264Ala	NM_000531.6	1.0	1_Pathogenic	chrX	A	G	X-38408948-A-G		97326	X	38408948	A	G	T	A	rs72558444	X	38268201	X	38153145	264	OTC	ENSG00000036473	ENST00000039007	ENSP00000039007	P00480	OTC_HUMAN	c.790A>G	p.Thr264Ala	c.790A>G	p.Thr264Ala	principal1	Y	1	YES	Select	+	ACT	1	0	A	A/A	A/A	A/A	A/A	0.002	0.72322	D	0.017	0.60671	D	0.998	0.73231	D	0.96	0.70309	D	0.91	0.92786	A	simple_aae	9.0	91.0	2.83	0.82191	M	-3.92	0.73186	D	0.874	0.87133	1.0802	0.98885	D	0.9744	0.99198	D	10	0.99310017	0.99843	D	0.934849	0.99530	D	0.981	0.99874	0.938	0.99125	P00480	T264A	Gain of catalytic residue at T264 (P = 0.042)| Gain of helix (P = 0.0854)| Loss of loop (P = 0.0986)| Loss of sheet (P = 0.1158)| Loss of disorder (P = 0.206)	0.999672884819	0.99966	0.9297133975061703	0.92905	0.885781201236	0.69801	0.604941487312	0.53535	T	0.960374	0.99483	D	0.692423	0.99923	D	0.756841	0.99923	D	0.983857274055481	0.75193	D	0.996437	0.98730	D	0.9690251	0.98138	0.9601294	0.98963	0.95179856	0.96393	0.9485299	0.98285	-9.755	0.72511	D	0.8331	0.78841	P	0.999709605533959	0.97565	0.99855990	0.98844	0.952	0.97849	.	.	.	.	.	.	4.40017	0.68045	25.2	0.99798746469689581	0.88381	.	.	.	.	.	.	.	.	.	5.58	5.58	0.84339	.	.	8.813	0.91606	10.979000	0.84613	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.998	0.85369	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided|Ornithine_carbamoyltransferase_deficiency	criteria_provided,_single_submitter	NC_000023.11:g.38408948A>G	ClinGen:CA224789|UniProtKB:P00480#VAR_004922	C3661900|C0268542	311250	664	Aspartate/ornithine carbamoyltransferase, Asp/Orn-binding domain	Thr	Ala	103218	single nucleotide variant	NM_000531.6(OTC):c.790A>G (p.Thr264Ala)	5009	OTC	HGNC:8512	Pathogenic	1	Aug 20, 2022	72558444	-	RCV000083573|RCV002514461	MedGen:C3661900|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664	not provided|Ornithine carbamoyltransferase deficiency	germline;unknown	germline	GRCh38	NC_000023.11	X	38408948	38408948	Xp11.4	criteria provided, single submitter	2	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224789,UniProtKB:P00480#VAR_004922	2	97326	38408948	A	G	-	-	-	-	-	-	SCV003445133	-	-	790A>G 	Thr264Ala	NM_000531.6	1	1_Pathogenic	OTC	ENSG00000036473	71569	205953	CCSBVarC005260	ALE00005260	790A>G	Thr264Ala	CEGS2	CegsMutGDEh1026	G06	GDEhDisVCh_40048	G06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Thr264Ala	23	X	38408948	A	G
71569	OTC	481A>G	Asn161Asp	ENSG00000036473	X	38401369	NC_000023.11:38401369:A:G	ALE00005247	CCSBVarC005247	NULL	205849	NULL	GDEhDisVCh_40048	F03	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCGATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103107.0	single nucleotide variant	NM_000531.6(OTC):c.481A>G (p.Asn161Asp)	5009.0	OTC	HGNC:8512	Pathogenic	1.0	-	72556270.0	-	RCV000083454	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38401369.0	38401369.0	Xp11.4	no assertion criteria provided	1.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224633	2.0	97215.0	38401369.0	A	G	-	-	-	-	-	-	SCV000115540	-	-	481A>G 	Asn161Asp	NM_000531.6		1_Pathogenic	chrX	A	G	X-38401369-A-G		97215	X	38401369	A	G	N	D	rs72556270	X	38260622	X	38145566	161	OTC	ENSG00000036473	ENST00000039007	ENSP00000039007	P00480	OTC_HUMAN	c.481A>G	p.Asn161Asp	c.481A>G	p.Asn161Asp	principal1	Y	1	YES	Select	+	AAT	1	0	A	A/A	A/A	A/A	A/A	0.003	0.68399	D	0.005	0.72530	D	1.0	0.90580	D	0.994	0.82066	D	0.78	0.86494	A	simple_aae	22.0	78.0	3.895	0.96020	H	-4.83	0.80975	D	0.979	0.98940	0.9140	0.95860	D	0.9940	0.99862	D	10	0.99631965	0.99998	D	0.967326	0.99795	D	0.940	0.98707	0.997	0.99969	P00480	N161D	Gain of phosphorylation at S156 (P = 0.1081)| Loss of catalytic residue at S164 (P = 0.1618)| Loss of sheet (P = 0.302)| Gain of loop (P = 0.4248)| Gain of disorder (P = 0.4715)	0.982595724326	0.98223	0.9930026757395383	0.99295	1.15822426379	0.79290	0.599163889885	0.52720	T	0.991898	0.99971	D	0.424019	0.91165	D	0.371297	0.91056	D	0.997797727584839	0.92374	D	0.950105	0.80860	D	0.9852889	0.99476	0.9771887	0.99733	0.9852889	0.99476	0.9771887	0.99733	-13.608	0.91730	D	0.9253	0.84588	P	0.999856460289074	0.98365	0.99707040	0.98253	0.985	0.99487	.	.	.	.	.	.	4.598909	0.72876	25.9	0.99816575733487811	0.89981	.	.	.	.	.	.	.	.	.	5.97	5.97	0.96929	.	.	8.892	0.92159	11.083000	0.85806	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.997	0.79771	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided	no_assertion_criteria_provided	NC_000023.11:g.38401369A>G	ClinGen:CA224633	CN517202	.	.	Aspartate/ornithine carbamoyltransferase, carbamoyl-P binding	Asn	Asp	103107	single nucleotide variant	NM_000531.6(OTC):c.481A>G (p.Asn161Asp)	5009	OTC	HGNC:8512	Pathogenic	1	-	72556270	-	RCV000083454	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38401369	38401369	Xp11.4	no assertion criteria provided	1	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224633	2	97215	38401369	A	G	-	-	-	-	-	-	SCV000115540	-	-	481A>G 	Asn161Asp	NM_000531.6		1_Pathogenic	OTC	ENSG00000036473	71569	205849	CCSBVarC005247	ALE00005247	481A>G	Asn161Asp	CEGS2	CegsMutGDEh1017	H03	GDEhDisVCh_40048	F03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	3	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Asn161Asp	23	X	38401369	A	G
359	CBS	785C>T	Thr262Met	ENSG00000160200	21	43063943	NC_000021.9:43063943:G:A	ALE00007317	CCSBVarC007325	NULL	NULL	277	GDEhDisVCh_40013	B07	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCATGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	196148.0	single nucleotide variant	NM_000071.3(CBS):c.785C>T (p.Thr262Met)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Jan 15, 2025	149119723.0	-	RCV000180461|RCV000200469|RCV002228800|RCV001251422|RCV004821994	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3661900|MedGen:C3150344|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Classic homocystinuria|not provided|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria|Familial thoracic aortic aneurysm and aortic dissection	germline;unknown	germline	GRCh38	NC_000021.9	21	43063943.0	43063943.0	21q22.3	criteria provided, multiple submitters, no conflicts	10.0	-	N	ClinGen:CA275440,UniProtKB:P35520#VAR_008072	2.0	198988.0	43063943.0	G	A	-	-	-	-	-	-	SCV000232906|SCV000249693|SCV000486524|SCV000649850|SCV001427013|SCV004213861|SCV004227691|SCV005051105|SCV005545927	-	-	785C>T 	Thr262Met	NM_000071.3	2.0	1_Pathogenic	chr21	C	T	21-43063943-C-T		198988	21	43063943	G	A	T	M	rs149119723	21	44484053	21	43357122	262	CBS	ENSG00000160200	ENST00000398165	ENSP00000381231	P35520	CBS_HUMAN	c.785C>T	p.Thr262Met	c.785C>T	p.Thr262Met	principal1	Y	1	YES	Select	-	ACG	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	2.52	0.73336	M	-4.94	0.81865	D	0.918	0.92086	1.0568	0.98262	D	0.9197	0.97336	D	10	0.96996534	0.96530	D	0.740834	0.97920	D	0.945	0.98886	.	.	.	.	.	0.939793142571	0.93869	0.9338835008492459	0.93326	1.14100540041	0.78805	0.725155472755	0.70749	T	0.985569	0.99910	D	0.519748	0.94851	D	0.524292	0.95059	D	0.962376296520233	0.66134	D	.	0.97669	.	0.9495166	0.96157	0.8597857	0.92060	0.95824206	0.97057	0.8390819	0.90657	-13.111	0.89836	D	.	0.51874	.	0.999661560113819	0.97392	0.99988484	0.99849	0.987	0.99559	.	.	.	.	.	.	5.430287	0.90819	31.0	0.99932771280325194	0.99439	0.958478	0.97821	D	0.753490679455275	0.83041	7.937886	0.715029510149715	0.83429	8.043119	4.95	4.95	0.64849	.	.	8.698	0.91064	6.454000	0.55748	0.526	0.24477	1.0	0.71675	1.000000	0.68239	0.893	0.4309	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	108830	2.756590e-05	0	7	206702	3.386520e-05	0	7	235666	2.970310e-05	0	0	7018	0.000000e+00	0	0	17068	0.000000e+00	0	0	2312	0.000000e+00	0	0	9032	0.000000e+00	0	3	13300	2.255640e-04	0	0	42598	0.000000e+00	0	0	15600	0.000000e+00	0	.	.	.	.	1	15982	6.257040e-05	0	0	30426	0.000000e+00	0	0	6176	0.000000e+00	0	0	13388	0.000000e+00	0	3	16634	1.803530e-04	0	2	88858	2.250780e-05	0	0	30406	0.000000e+00	0	1	15982	6.257040e-05	0	1	14702	6.801800e-05	0	0	34172	0.000000e+00	0	0	9556	0.000000e+00	0	0	17676	0.000000e+00	0	3	21322	1.407000e-04	0	2	102310	1.954840e-05	0	0	30330	0.000000e+00	0	1	14702	6.801800e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	25910	7.719027402547279E-5	0	298	0	0	86	0	0	7438	0	0	146	0	0	610	0	0	26	0	0	98	0	0	2178	0	0	7736	0	0	112	0	2	36790	5.436259853220984E-5	Pathogenic/Likely_pathogenic	HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|not_provided|Classic_homocystinuria|Homocystinuria	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43063943G>A	ClinGen:CA275440|UniProtKB:P35520#VAR_008072	C3150344|C3661900|C0751202|C0019880	236200	394	Tryptophan synthase beta chain-like, PALP domain	Thr	Met	196148	single nucleotide variant	NM_000071.3(CBS):c.785C>T (p.Thr262Met)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Jan 15, 2025	149119723	-	RCV000180461|RCV000200469|RCV002228800|RCV001251422|RCV004821994	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3661900|MedGen:C3150344|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Classic homocystinuria|not provided|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria|Familial thoracic aortic aneurysm and aortic dissection	germline;unknown	germline	GRCh38	NC_000021.9	21	43063943	43063943	21q22.3	criteria provided, multiple submitters, no conflicts	10	-	N	ClinGen:CA275440,UniProtKB:P35520#VAR_008072	2	198988	43063943	G	A	-	-	-	-	-	-	SCV000232906|SCV000249693|SCV000486524|SCV000649850|SCV001427013|SCV004213861|SCV004227691|SCV005051105|SCV005545927	-	-	785C>T 	Thr262Met	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	277	CCSBVarC007325	ALE00007317	785C>T	Thr262Met	Edgotyping3	VUSMutGDEh011	H01	GDEhDisVCh_40013	B07	1	VUSMutGDDh011	H01	NULL	NULL	NULL	NULL	NULL	NULL	1	5	1	5	0	NULL	0	NULL	0	NULL	CBS_Thr262Met	21	21	43063943	G	A
359	CBS	770C>T	Thr257Met	ENSG00000160200	21	43063958	NC_000021.9:43063958:G:A	ALE00007318	CCSBVarC007326	NULL	NULL	278	GDEhDisVCh_40013	C07	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCATGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	187056.0	single nucleotide variant	NM_000071.3(CBS):c.770C>T (p.Thr257Met)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Apr 13, 2024	758236584.0	-	RCV000169294|RCV000197988|RCV000790997|RCV002228778|RCV003128393|RCV000780084	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3661900|MONDO:MONDO:0004743,MedGen:C0598608,OMIM:603174|MedGen:C3150344||Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880	Classic homocystinuria|not provided|Hyperhomocysteinemia|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|See cases|Homocystinuria	germline;unknown	germline	GRCh38	NC_000021.9	21	43063958.0	43063958.0	21q22.3	criteria provided, multiple submitters, no conflicts	9.0	-	N	ClinGen:CA274140,UniProtKB:P35520#VAR_002183	2.0	188927.0	43063958.0	G	A	-	-	-	-	-	-	SCV000220612|SCV000249729|SCV000649849|SCV000917110|SCV000930258|SCV000930259|SCV003804941|SCV004213856|SCV004847670	-	-	770C>T 	Thr257Met	NM_000071.3	2.0	1_Pathogenic	chr21	C	T	21-43063958-C-T		188927	21	43063958	G	A	T	M	rs758236584	21	44484068	21	43357137	257	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.770C>T	p.Thr257Met	c.770C>T	p.Thr257Met	principal1	Y	1	.	.	-	ACG	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.78	0.99608	H	-6.0	0.89554	D	0.983	0.99270	0.9719	0.96722	D	0.9907	0.99754	D	10	0.9965373	0.99999	D	0.950473	0.99659	D	0.958	0.99315	0.966	0.99665	P35520	T257M	Gain of MoRF binding (P = 0.0819)| Gain of sheet (P = 0.0827)| Gain of phosphorylation at T262 (P = 0.133)| Loss of helix (P = 0.2022)| Gain of loop (P = 0.2754)	0.943217082282	0.94217	.	0.96353	.	0.78887	0.690693080425	0.65750	T	0.994732	0.99988	D	0.421291	0.91024	D	0.604047	0.97260	D	0.991239845752716	0.81361	D	.	0.99178	.	0.9877935	0.99635	0.94569737	0.98106	0.9837511	0.99371	0.933253	0.97279	-15.752	0.97372	D	0.8767	0.81229	LP	0.99991044886231	0.98806	0.99981147	0.99752	0.968	0.98734	.	.	.	.	.	.	5.033114	0.83748	28.1	0.99900940467896038	0.97276	0.945550	0.95381	D	0.835803609458826	0.88222	9.521494	0.640136339909568	0.77755	6.764935	4.95	4.06	0.46510	.	.	8.698	0.91064	6.452000	0.55743	0.526	0.24477	1.0	0.71675	1.000000	0.68239	0.425	0.27389	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4	108420	3.689360e-05	0	8	206016	3.883190e-05	0	9	234768	3.833570e-05	0	1	6920	1.445090e-04	0	2	17028	1.174540e-04	0	0	2298	0.000000e+00	0	0	9024	0.000000e+00	0	0	13290	0.000000e+00	0	0	42458	0.000000e+00	0	1	15504	6.449950e-05	0	1	6920	1.445090e-04	0	1	15866	6.302790e-05	0	2	30356	6.588480e-05	0	0	6152	0.000000e+00	0	0	13370	0.000000e+00	0	0	16622	0.000000e+00	0	0	88612	0.000000e+00	0	4	30224	1.323450e-04	0	4	30224	1.323450e-04	0	1	14588	6.854950e-05	0	3	34110	8.795070e-05	0	0	9530	0.000000e+00	0	0	17664	0.000000e+00	0	0	21126	0.000000e+00	0	0	102016	0.000000e+00	0	4	30148	1.326790e-04	0	4	30148	1.326790e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	15752	0	0	122	0	0	112	0	0	3370	0	0	146	0	0	610	0	0	56	0	0	98	0	2	2772	7.215007215007215E-4	0	3492	0	0	168	0	2	23038	8.681309141418526E-5	Pathogenic/Likely_pathogenic	not_provided|Homocystinuria|See_cases|Hyperhomocysteinemia|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Classic_homocystinuria	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43063958G>A	ClinGen:CA274140|UniProtKB:P35520#VAR_002183	C3661900|C0019880|C0598608|C3150344|C0751202	603174|236200	394	Tryptophan synthase beta chain-like, PALP domain	Thr	Met	187056	single nucleotide variant	NM_000071.3(CBS):c.770C>T (p.Thr257Met)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Apr 13, 2024	758236584	-	RCV000169294|RCV000197988|RCV000790997|RCV002228778|RCV003128393|RCV000780084	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3661900|MONDO:MONDO:0004743,MedGen:C0598608,OMIM:603174|MedGen:C3150344||Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880	Classic homocystinuria|not provided|Hyperhomocysteinemia|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|See cases|Homocystinuria	germline;unknown	germline	GRCh38	NC_000021.9	21	43063958	43063958	21q22.3	criteria provided, multiple submitters, no conflicts	9	-	N	ClinGen:CA274140,UniProtKB:P35520#VAR_002183	2	188927	43063958	G	A	-	-	-	-	-	-	SCV000220612|SCV000249729|SCV000649849|SCV000917110|SCV000930258|SCV000930259|SCV003804941|SCV004213856|SCV004847670	-	-	770C>T 	Thr257Met	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	278	CCSBVarC007326	ALE00007318	770C>T	Thr257Met	Edgotyping3	VUSMutGDEh011	A02	GDEhDisVCh_40013	C07	1	VUSMutGDDh011	A02	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	5	0	NULL	0	NULL	0	NULL	CBS_Thr257Met	21	21	43063958	G	A
3774	TP53	742C>T	Arg248Trp	ENSG00000141510	17	7674221	NC_000017.11:7674221:G:A	ALE00004868	CCSBVarC004868	NULL	214897	NULL	GDEhDisVCh_40053	F02	CEGS2	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACTGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACCGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	27386.0	single nucleotide variant	NM_000546.6(TP53):c.742C>T (p.Arg248Trp)	7157.0	TP53	HGNC:11998	Pathogenic	1.0	Aug 05, 2024	121912651.0	-	RCV000115735|RCV000438698|RCV000785485|RCV001255674|RCV000013140|RCV003149569|RCV000213057|RCV004745154|RCV003318332|RCV003460463|RCV000168242|RCV000735293|RCV001271100|RCV001374442|RCV003105772|RCV003162243	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0023644,MedGen:C0220641|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MedGen:CN221562|MedGen:C3661900||MONDO:MONDO:0018905,MeSH:D016403,MedGen:C0079744,Orphanet:544|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|7 conditions|Human Phenotype Ontology:HP:0030392,MONDO:MONDO:0016718,MedGen:C0431109,Orphanet:251899|MONDO:MONDO:0005411,MedGen:C0153452|MONDO:MONDO:0004557,MedGen:C0334459|Human Phenotype Ontology:HP:0012126,MONDO:MONDO:0001056,MeSH:D013274,MedGen:C0024623,OMIM:613659	Hereditary cancer-predisposing syndrome|Neoplasm|Ovarian neoplasm|Lip and oral cavity carcinoma|Li-Fraumeni syndrome 1|Breast and/or ovarian cancer|not provided|TP53-related disorder|Malignant lymphoma, large B-cell, diffuse|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome|7 conditions|Choroid plexus carcinoma|Gallbladder cancer|Congenital fibrosarcoma|Gastric cancer	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7674221.0	7674221.0	17p13.1	reviewed by expert panel	34.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000382,UniProtKB:P04637#VAR_005984,OMIM:191170.0001	3.0	12347.0	7674221.0	G	A	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV001142555	-	SCV005094410	742C>T 	Arg248Trp	NM_000546.6	3.0	1_Pathogenic	chr17	C	T	17-7674221-C-T		12347	17	7674221	G	A	R	W	rs121912651	17	7577539	17	7518264	248	TP53	ENSG00000141510	ENST00000714359	ENSP00000519626	P04637	P53_HUMAN	.	.	c.742C>T	p.Arg248Trp	principal1	Y	.	.	.	-	CGG	1	2	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	1.0	0.97365	D	.	0.99291	.	.	.	.	3.28	0.90083	M	.	0.96021	.	.	0.99781	0.9869	0.96963	D	0.9928	0.99829	D	9	.	0.99767	.	0.818748	0.98587	D	.	0.98227	0.986	0.99859	P04637	R248W	Loss of disorder (P = 0.0612)| Loss of stability (P = 0.1453)| Loss of catalytic residue at R248 (P = 0.1486)| Loss of sheet (P = 0.3635)| Loss of loop (P = 0.4412)	.	0.98381	.	0.91347	.	0.40225	0.757502555847	0.75515	T	0.996404	0.99995	D	0.537007	0.95300	D	0.533597	0.95230	D	0.998216211795807	0.93479	D	0.89861	0.67473	D	0.9681523	0.98055	0.9585236	0.98874	0.9542256	0.96643	0.9738809	0.99616	-12.669	0.87981	D	.	0.96519	.	0.998526870833081	0.94596	0.99997866	0.99989	0.984	0.99450	.	.	.	.	.	.	5.203168	0.87314	29.2	0.99905232378863651	0.97578	0.851721	0.76775	D	0.50614229999783	0.67279	5.08357	0.371297220558985	0.59587	4.16117	4.62	2.56	0.29762	3.1	0.56488	0.835	0.27277	7.575000	0.60872	0.672	0.70176	1.0	0.71675	1.000000	0.68239	0.874	0.41704	433	0.80635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109406	9.140270e-06	0	1	208130	4.804690e-06	0	1	236940	4.220480e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13394	0.000000e+00	0	1	42768	2.338200e-05	0	0	15690	0.000000e+00	0	1	42768	2.338200e-05	0	0	16218	0.000000e+00	0	0	30522	0.000000e+00	0	0	6212	0.000000e+00	0	0	13414	0.000000e+00	0	0	16734	0.000000e+00	0	1	89556	1.116620e-05	0	0	30608	0.000000e+00	0	1	89556	1.116620e-05	0	0	14902	0.000000e+00	0	0	34258	0.000000e+00	0	0	9572	0.000000e+00	0	0	17690	0.000000e+00	0	0	21632	0.000000e+00	0	1	102740	9.733310e-06	0	0	30526	0.000000e+00	0	1	102740	9.733310e-06	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	23858	8.382932349735938E-5	0	84	0	0	84	0	0	2656	0	0	500	0	0	628	0	0	24	0	0	94	0	0	4610	0	0	2740	0	0	108	0	2	32538	6.146659290675518E-5	Pathogenic	Hereditary_cancer-predisposing_syndrome|Ovarian_neoplasm|Malignant_melanoma_of_skin|Brainstem_glioma|Squamous_cell_carcinoma_of_the_skin|Transitional_cell_carcinoma_of_the_bladder|Adrenocortical_carcinoma,_hereditary|Neoplasm_of_the_large_intestine|B-cell_chronic_lymphocytic_leukemia|Gastric_cancer|Lung_adenocarcinoma|Carcinoma_of_esophagus|Breast_and/or_ovarian_cancer|Myelodysplastic_syndrome|Li-Fraumeni_syndrome|Multiple_myeloma|not_provided|Neoplasm_of_brain|Medulloblastoma|Small_cell_lung_carcinoma|Hepatocellular_carcinoma|Squamous_cell_lung_carcinoma|Li-Fraumeni_syndrome_1|Squamous_cell_carcinoma_of_the_head_and_neck|Congenital_fibrosarcoma|Webbed_neck|Short_stature|Abnormality_of_the_tongue|Pancytopenia|Cognitive_impairment|Acute_myeloid_leukemia|Pectus_excavatum|Gallbladder_cancer|Choroid_plexus_carcinoma|Uterine_carcinosarcoma|Prostate_adenocarcinoma|Malignant_neoplasm_of_body_of_uterus|Ovarian_serous_cystadenocarcinoma|Gastric_adenocarcinoma|Glioblastoma|Breast_neoplasm|Lip_and_oral_cavity_carcinoma|Neoplasm|Malignant_lymphoma,_large_B-cell,_diffuse|Pancreatic_adenocarcinoma	reviewed_by_expert_panel	NC_000017.11:g.7674221G>A	ClinGen:CA000382|OMIM:191170.0001|UniProtKB:P04637#VAR_005984	C0027672|C0919267|C0151779|C0677865|C0553723|C0279680|C1859972|C0009404|C0023434|C0024623|C0152013|C0152018|CN221562|C3463824|C0085390|C0026764|C3661900|C0006118|C0025149|C0149925|C2239176|C0149782|C1835398|C1168401|C0334459|C0221217|C0349588|C0878638|C0030312|C0338656|C0023467|C2051831|C0153452|C0431109|C0280630|C0007112|C0153574|C0279663|C0278701|C0017636|C1458155|C0220641|C0027651|C0079744|C0281361	202300|151400|613659|614286|PS151623|254500|155255|182280|114550|151623|275355|601626|169300	140162|1501|67038|70482|52688|524|29073|85443|616|70573|88673|524|67037|519|251899|360|544	p53, DNA-binding domain|p53, DNA-binding domain	Arg	Trp	27386	single nucleotide variant	NM_000546.6(TP53):c.742C>T (p.Arg248Trp)	7157	TP53	HGNC:11998	Pathogenic	1	Aug 05, 2024	121912651	-	RCV000115735|RCV000438698|RCV000785485|RCV001255674|RCV000013140|RCV003149569|RCV000213057|RCV004745154|RCV003318332|RCV003460463|RCV000168242|RCV000735293|RCV001271100|RCV001374442|RCV003105772|RCV003162243	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0023644,MedGen:C0220641|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MedGen:CN221562|MedGen:C3661900||MONDO:MONDO:0018905,MeSH:D016403,MedGen:C0079744,Orphanet:544|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|7 conditions|Human Phenotype Ontology:HP:0030392,MONDO:MONDO:0016718,MedGen:C0431109,Orphanet:251899|MONDO:MONDO:0005411,MedGen:C0153452|MONDO:MONDO:0004557,MedGen:C0334459|Human Phenotype Ontology:HP:0012126,MONDO:MONDO:0001056,MeSH:D013274,MedGen:C0024623,OMIM:613659	Hereditary cancer-predisposing syndrome|Neoplasm|Ovarian neoplasm|Lip and oral cavity carcinoma|Li-Fraumeni syndrome 1|Breast and/or ovarian cancer|not provided|TP53-related disorder|Malignant lymphoma, large B-cell, diffuse|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome|7 conditions|Choroid plexus carcinoma|Gallbladder cancer|Congenital fibrosarcoma|Gastric cancer	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7674221	7674221	17p13.1	reviewed by expert panel	34	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000382,UniProtKB:P04637#VAR_005984,OMIM:191170.0001	3	12347	7674221	G	A	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV001142555	-	SCV005094410	742C>T 	Arg248Trp	NM_000546.6	3	1_Pathogenic	TP53	ENSG00000141510	3774	214897	CCSBVarC004868	ALE00004868	742C>T	Arg248Trp	CEGS2	CegsMutGDEh1011	G03	GDEhDisVCh_40053	F02	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	TP53_Arg248Trp	17	17	7674221	G	A
2013	KCNE1	247G>A	Glu83Lys	ENSG00000180509	21	34449388	NC_000021.9:34449388:C:T	ALE00006342	CCSBVarC006342	NULL	214144	NULL	GDEhDisVCh_40065	F06	CEGS2	ATGATCCTGTCTAACACCACAGCGGTGACGCCCTTTCTGACCAAGCTGTGGCAGGAGACAGTTCAGCAGGGTGGCAACATGTCGGGCCTGGCCCACAGGTCCCCCCGCAGCGGTGACGGCAAGCTGGAGGCCCTCTACGTCCTCATGGTACTGGGATTCTTCGGCTTCTTCACCCTGGGCATCATGCTGAGCTACATCCGCTCCAAGAAGCTGGAGCACTCGAACGACCCATTCAACGTCTACATCAAGTCCGATGCCTGGCAAGAGAAGGACAAGGCCTATGTCCAGGCCCGGGTCCTGGAGAGCTACAGGTCG	136421.0	single nucleotide variant	NM_000219.6(KCNE1):c.247G>A (p.Glu83Lys)	3753.0	KCNE1	HGNC:6240	Uncertain significance	0.0	Jan 29, 2024	199473360.0	-	RCV000119085|RCV000250531|RCV000454805|RCV000765503|RCV001340194|RCV001531539|RCV004777593	MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:101016,Orphanet:768|MedGen:CN230736|MedGen:CN169374|MONDO:MONDO:0012871,MedGen:C2676723,OMIM:612347,Orphanet:768,Orphanet:90647;MONDO:MONDO:0013372,MedGen:C1867904,OMIM:613695,Orphanet:101016,Orphanet:768|MONDO:MONDO:0002442,MeSH:D008133,MedGen:C0023976|MedGen:C3661900|MONDO:MONDO:0013372,MedGen:C1867904,OMIM:613695,Orphanet:101016,Orphanet:768	Congenital long QT syndrome|Cardiovascular phenotype|not specified|Jervell and Lange-Nielsen syndrome 2;Long QT syndrome 5|Long QT syndrome|not provided|Long QT syndrome 5	germline;not applicable;unknown	germline	GRCh38	NC_000021.9	21	34449388.0	34449388.0	21q22.12	criteria provided, multiple submitters, no conflicts	8.0	-	N	ClinGen:CA331955,UniProtKB:P15382#VAR_074919	2.0	132673.0	34449388.0	C	T	-	-	-	-	-	-	SCV000318985|SCV000539418|SCV000896806|SCV001533993|SCV001746730|SCV005078962	-	-	247G>A 	Glu83Lys	NM_000219.6	2.0	4_VUS	chr21	G	A	21-34449388-G-A		132673	21	34449388	C	T	E	K	rs199473360	21	35821686	21	34743556	83	KCNE1	ENSG00000180509	ENST00000621601	ENSP00000483895	P15382	KCNE1_HUMAN	c.247G>A	p.Glu83Lys	c.247G>A	p.Glu83Lys	principal1	Y	4	.	.	-	GAG	1	0	C	C/C	C/C	C/C	C/C	.	0.25377	.	0.191	0.28698	T	0.805	0.45224	P	0.397	0.44398	B	.	0.95575	.	.	.	.	2.595	0.75684	M	.	0.40464	.	0.525	0.78081	0.1343	0.84718	D	0.7666	0.92036	D	10	0.42679998	0.56885	D	0.196694	0.86460	D	.	0.86674	.	.	.	.	.	0.892177180194	0.89028	.	0.68808	.	0.33896	0.534445762634	0.43597	T	0.699233	0.91241	D	0.0190359	0.53941	T	0.0539957	0.73652	D	0.152616438678281	0.17094	T	.	0.49657	.	0.14008401	0.32057	0.14663069	0.34629	0.14096677	0.32225	0.13949113	0.33184	-2.524	0.05953	T	.	0.38420	.	0.776366661898476	0.69814	0.99898076	0.99072	0.231	0.49947	.	.	.	.	.	.	1.872567	0.23825	16.15	0.99739044264743704	0.83352	0.512592	0.53913	D	-0.0729956677445373	0.38310	2.261767	-0.104637071536673	0.34896	2.033877	5.16	2.13	0.26374	2.11	0.40938	1.339	0.33595	1.337000	0.25795	0.549	0.27038	0.999	0.42732	0.784000	0.26885	0.153	0.20454	899	0.25042	1	1.9968051118210862E-4	0	0.0	0	0.0	0	0.0	0	0.0	1	0.0010224948875255625	11	264690	4.155805E-5	.	6	109406	5.484160e-05	0	11	208072	5.286630e-05	0	10	236930	4.220660e-05	0	0	7164	0.000000e+00	0	1	17112	5.843850e-05	0	0	2320	0.000000e+00	0	2	9046	2.210920e-04	0	0	13392	0.000000e+00	0	1	42768	2.338200e-05	0	2	15690	1.274700e-04	0	2	9046	2.210920e-04	0	0	16210	0.000000e+00	0	3	30522	9.828980e-05	0	0	6212	0.000000e+00	0	3	13412	2.236800e-04	0	0	16732	0.000000e+00	0	3	89510	3.351580e-05	0	2	30608	6.534240e-05	0	3	13412	2.236800e-04	0	0	14902	0.000000e+00	0	3	34260	8.756570e-05	0	0	9572	0.000000e+00	0	3	17692	1.695680e-04	0	0	21630	0.000000e+00	0	2	102730	1.946850e-05	0	2	30526	6.551790e-05	0	3	17692	1.695680e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4	26588	1.5044380923724988E-4	0	114	0	0	86	0	0	2804	0	0	500	0	0	628	0	0	26	0	0	98	0	0	4588	0	0	2918	0	0	112	0	4	35432	1.1289230074508918E-4	Uncertain_significance	Jervell_and_Lange-Nielsen_syndrome_2|Long_QT_syndrome_5|Long_QT_syndrome|not_specified|Cardiovascular_phenotype|not_provided|Congenital_long_QT_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.34449388C>T	ClinGen:CA331955|UniProtKB:P15382#VAR_074919	C2676723|C1867904|C0023976|CN169374|CN230736|C3661900|C1141890	612347|613695|PS192500	768|90647|101016|768|101016|768	.	Glu	Lys	136421	single nucleotide variant	NM_000219.6(KCNE1):c.247G>A (p.Glu83Lys)	3753	KCNE1	HGNC:6240	Uncertain significance	0	Jan 29, 2024	199473360	-	RCV000119085|RCV000250531|RCV000454805|RCV000765503|RCV001340194|RCV001531539|RCV004777593	MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:101016,Orphanet:768|MedGen:CN230736|MedGen:CN169374|MONDO:MONDO:0012871,MedGen:C2676723,OMIM:612347,Orphanet:768,Orphanet:90647;MONDO:MONDO:0013372,MedGen:C1867904,OMIM:613695,Orphanet:101016,Orphanet:768|MONDO:MONDO:0002442,MeSH:D008133,MedGen:C0023976|MedGen:C3661900|MONDO:MONDO:0013372,MedGen:C1867904,OMIM:613695,Orphanet:101016,Orphanet:768	Congenital long QT syndrome|Cardiovascular phenotype|not specified|Jervell and Lange-Nielsen syndrome 2;Long QT syndrome 5|Long QT syndrome|not provided|Long QT syndrome 5	germline;not applicable;unknown	germline	GRCh38	NC_000021.9	21	34449388	34449388	21q22.12	criteria provided, multiple submitters, no conflicts	8	-	N	ClinGen:CA331955,UniProtKB:P15382#VAR_074919	2	132673	34449388	C	T	-	-	-	-	-	-	SCV000318985|SCV000539418|SCV000896806|SCV001533993|SCV001746730|SCV005078962	-	-	247G>A 	Glu83Lys	NM_000219.6	2	4_VUS	KCNE1	ENSG00000180509	2013	214144	CCSBVarC006342	ALE00006342	247G>A	Glu83Lys	CEGS2	CegsMutGDEh1015	F07	GDEhDisVCh_40065	F06	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	KCNE1_Glu83Lys	21	21	34449388	C	T
14613	BRCA1	212G>A	Arg71Lys	ENSG00000012048	17	43106456	NC_000017.11:43106456:C:T	ALE00003297	CCSBVarC003297	NULL	218389	NULL	GDEhDisVCh_40059	E03	CEGS2	ATGGATTTATCTGCTCTTCGCGTTGAAGAAGTACAAAATGTCATTAATGCTATGCAGAAAATCTTAGAGTGTCCCATCTGTCTGGAGTTGATCAAGGAACCTGTCTCCACAAAGTGTGACCACATATTTTGCAAATTTTGCATGCTGAAACTTCTCAACCAGAAGAAAGGGCCTTCACAGTGTCCTTTATGTAAGAATGATATAACCAAAAAGAGCCTACAAGAAAGTACGAGATTTAGTCAACTTGTTGAAGAGCTATTGAAAATCATTTGTGCTTTTCAGCTTGACACAGGTTTGGAGTATGCAAACAGCTATAATTTTGCAAAAAAGGAAAATAACTCTCCTGAACATCTAAAAGATGAAGTTTCTATCATCCAAAGTATGGGCTACAGAAACCGTGCCAAAAGACTTCTACAGAGTGAACCCGAAAATCCTTCCTTGCAGGAAACCAGTCTCAGTGTCCAACTCTCTAACCTTGGAACTGTGAGAACTCTGAGGACAAAGCAGCGGATACAACCTCAAAAGACGTCTGTCTACATTGAATTGGGATCTGATTCTTCTGAAGATACCGTTAATAAGGCAACTTATTGCAGTGTGGGAGATCAAGAATTGTTACAAATCACCCCTCAAGGAACCAGGGATGAAATCAGTTTGGATTCTGCAAAAAAGGCTGCTTGTGAATTTTCTGAGACGGATGTAACAAATACTGAACATCATCAACCCAGTAATAATGATTTGAACACCACTGAGAAGCGTGCAGCTGAGAGGCATCCAGAAAAGTATCAGGGTGAAGCAGCATCTGGGTGTGAGAGTGAAACAAGCGTCTCTGAAGACTGCTCAGGGCTATCCTCTCAGAGTGACATTTTAACCACTCAGCAGAGGGATACCATGCAACATAACCTGATAAAGCTCCAGCAGGAAATGGCTGAACTAGAAGCTGTGTTAGAACAGCATGGGAGCCAGCCTTCTAACAGCTACCCTTCCATCATAAGTGACTCTTCTGCCCTTGAGGACCTGCGAAATCCAGAACAAAGCACATCAGAAAAAGTATTAACTTCACAGAAAAGTAGTGAATACCCTATAAGCCAGAATCCAGAAGGCCTTTCTGCTGACAAGTTTGAGGTGTCTGCAGATAGTTCTACCAGTAAAAATAAAGAACCAGGAGTGGAAAGGTCATCCCCTTCTAAATGCCCATCATTAGATGATAGGTGGTACATGCACAGTTGCTCTGGGAGTCTTCAGAATAGAAACTACCCATCTCAAGAGGAGCTCATTAAGGTTGTTGATGTGGAGGAGCAACAGCTGGAAGAGTCTGGGCCACACGATTTGACGGAAACATCTTACTTGCCAAGGCAAGATCTAGAGGGAACCCCTTACCTGGAATCTGGAATCAGCCTCTTCTCTGATGACCCTGAATCTGATCCTTCTGAAGACAGAGCCCCAGAGTCAGCTCGTGTTGGCAACATACCATCTTCAACCTCTGCATTGAAAGTTCCCCAATTGAAAGTTGCAGAATCTGCCCAGAGTCCAGCTGCTGCTCATACTACTGATACTGCTGGGTATAATGCAATGGAAGAAAGTGTGAGCAGGGAGAAGCCAGAATTGACAGCTTCAACAGAAAGGGTCAACAAAAGAATGTCCATGGTGGTGTCTGGCCTGACCCCAGAAGAATTTATGCTCGTGTACAAGTTTGCCAGAAAACACCACATCACTTTAACTAATCTAATTACTGAAGAGACTACTCATGTTGTTATGAAAACAGATGCTGAGTTTGTGTGTGAACGGACACTGAAATATTTTCTAGGAATTGCGGGAGGAAAATGGGTAGTTAGCTATTTCTGGGTGACCCAGTCTATTAAAGAAAGAAAAATGCTGAATGAGCATGATTTTGAAGTCAGAGGAGATGTGGTCAATGGAAGAAACCACCAAGGTCCAAAGCGAGCAAGAGAATCCCAGGACAGAAAGATCTTCAGGGGGCTAGAAATCTGTTGCTATGGGCCCTTCACCAACATGCCCACAGGGTGTCCACCCAATTGTGGTTGTGCAGCCAGATGCCTGGACAGAGGACAATGGCTTCCATGCAATTGGGCAGATGTG	69138.0	single nucleotide variant	NM_007294.4(BRCA1):c.212G>A (p.Arg71Lys)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Jul 30, 2024	80356913.0	-	RCV000112023|RCV000503702|RCV001180531|RCV001384425|RCV004795985	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43106456.0	43106456.0	17q21.31	criteria provided, multiple submitters, no conflicts	11.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA001420,UniProtKB:P38398#VAR_020681	2.0	54471.0	43106456.0	C	T	-	-	-	-	-	-	SCV000325249|SCV001345474|SCV001583916|SCV002046151|SCV002600545|SCV002726126|SCV003809169|SCV005416672	-	-	212G>A 	Arg71Lys	NM_007294.4	2.0	1_Pathogenic	chr17	G	A	17-43106456-G-A		54471	17	43106456	C	T	R	K	rs80356913	17	41258473	17	38511999	71	BRCA1	ENSG00000012048	ENST00000494123	ENSP00000419103	P38398	BRCA1_HUMAN	c.212G>A	p.Arg71Lys	c.212G>A	p.Arg71Lys	principal2	Y	1	.	.	-	AGG	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.016	0.68204	D	0.9	0.59057	P	0.275	0.68273	B	.	0.99291	.	.	.	.	2.455	0.71058	M	-0.66	0.59576	N	.	0.78462	0.7801	0.94146	D	0.8430	0.94745	D	9	0.82008123	0.81025	D	0.514985	0.95351	D	0.737	0.90816	0.727	0.86044	E9PFC7	R71K	Gain of methylation at R71 (P = 0.0062)| Gain of relative solvent accessibility (P = 0.0522)| Gain of ubiquitination at R71 (P = 0.068)| Gain of disorder (P = 0.0771)| Gain of solvent accessibility (P = 0.1456)	0.968767862813	0.96814	.	0.47432	.	0.17790	0.610298812389	0.54292	T	0.29865	0.66937	T	0.411382	0.90492	D	0.353145	0.90373	D	0.960748553276062	0.65672	D	.	0.27626	.	0.80958927	0.84328	0.4717919	0.69118	0.759881	0.81221	0.3838624	0.63093	-8.907	0.67174	D	0.7791	0.80812	LP	0.996372846491178	0.92086	0.99942493	0.99371	0.917	0.95747	.	.	.	.	.	.	5.467383	0.91245	32.0	0.99505402231752338	0.68305	0.849361	0.76532	D	0.589132871463434	0.72350	5.814887	0.56907193894025	0.72585	5.856808	4.64	4.64	0.57348	.	.	4.108	0.57643	7.641000	0.63257	0.531	0.24877	1.0	0.71675	1.000000	0.68239	0.995	0.73271	459	0.78836	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	424	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	424	0	0	0	0	0	476	0	Pathogenic	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.43106456C>T	ClinGen:CA001420|UniProtKB:P38398#VAR_020681	C0677776|C0027672|C3661900|C2676676	604370	145|140162|145	.	Arg	Lys	69138	single nucleotide variant	NM_007294.4(BRCA1):c.212G>A (p.Arg71Lys)	672	BRCA1	HGNC:1100	Pathogenic	1	Jul 30, 2024	80356913	-	RCV000112023|RCV000503702|RCV001180531|RCV001384425|RCV004795985	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43106456	43106456	17q21.31	criteria provided, multiple submitters, no conflicts	11	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA001420,UniProtKB:P38398#VAR_020681	2	54471	43106456	C	T	-	-	-	-	-	-	SCV000325249|SCV001345474|SCV001583916|SCV002046151|SCV002600545|SCV002726126|SCV003809169|SCV005416672	-	-	212G>A 	Arg71Lys	NM_007294.4	2	1_Pathogenic	BRCA1	ENSG00000012048	14613	218389	CCSBVarC003297	ALE00003297	212G>A	Arg71Lys	CEGS2	CegsMutGDEh1010	A12	GDEhDisVCh_40059	E03	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	7	0	NULL	0	NULL	0	NULL	0	NULL	BRCA1_Arg71Lys	17	17	43106456	C	T
8459	ASPA	854A>C	Glu285Ala	ENSG00000108381	17	3499000	NC_000017.11:3499000:A:C	ALE00001386	CCSBVarC001386	15721	NULL	NULL	GDEhDisVCh_40040	F04	RC4	ATGACTTCTTGTCACATTGCTGAAGAACATATACAAAAGGTTGCTATCTTTGGAGGAACCCATGGGAATGAGCTAACCGGAGTATTTCTGGTTAAGCATTGGCTAGAGAATGGCGCTGAGATTCAGAGAACAGGGCTGGAGGTAAAACCATTTATTACTAACCCCAGAGCAGTGAAGAAGTGTACCAGATATATTGACTGTGACCTGAATCGCATTTTTGACCTTGAAAATCTTGGCAAAAAAATGTCAGAAGATTTGCCATATGAAGTGAGAAGGGCTCAAGAAATAAATCATTTATTTGGTCCAAAAGACAGTGAAGATTCCTATGACATTATTTTTGACCTTCACAACACCACCTCTAACATGGGGTGCACTCTTATTCTTGAGGATTCCAGGAATAACTTTTTAATTCAGATGTTTCATTACATTAAGACTTCTCTGGCTCCACTACCCTGCTACGTTTATCTGATTGAGCATCCTTCCCTCAAATATGCGACCACTCGTTCCATAGCCAAGTATCCTGTGGGTATAGAAGTTGGTCCTCAGCCTCAAGGGGTTCTGAGAGCTGATATCTTGGATCAAATGAGAAAAATGATTAAACATGCTCTTGATTTTATACATCATTTCAATGAAGGAAAAGAATTTCCTCCCTGCGCCATTGAGGTCTATAAAATTATAGAGAAAGTTGATTACCCCCGGGATGAAAATGGAGAAATTGCTGCTATCATCCATCCTAATCTGCAGGATCAAGACTGGAAACCACTGCATCCTGGGGATCCCATGTTTTTAACTCTTGATGGGAAGACGATCCCACTGGGCGGAGACTGTACCGTGTACCCCGTGTTTGTGAATGCGGCCGCATATTACGAAAAGAAAGAAGCTTTTGCAAAGACAACTAAACTAACGCTCAATGCAAAAAGTATTCGCTGCTGTTTACAT	17644.0	single nucleotide variant	NM_000049.4(ASPA):c.854A>C (p.Glu285Ala)	443.0	ASPA	HGNC:756	Pathogenic	1.0	Jan 08, 2025	28940279.0	-	RCV000002723|RCV000590467|RCV000420704|RCV002444416	MONDO:MONDO:0010079,MedGen:C0206307,OMIM:271900,Orphanet:141|MedGen:C0751663|MedGen:C3661900|MeSH:D030342,MedGen:C0950123	Spongy degeneration of central nervous system|Canavan Disease, Familial Form|not provided|Inborn genetic diseases	germline;paternal;unknown	germline	GRCh38	NC_000017.11	17	3499000.0	3499000.0	17p13.2	criteria provided, multiple submitters, no conflicts	19.0	-	Y	ClinGen:CA325511,UniProtKB:P45381#VAR_004999,OMIM:608034.0001	3.0	2605.0	3499000.0	A	C	-	-	-	-	-	-	SCV000218961|SCV000231463|SCV000245578|SCV000512105|SCV000694157|SCV000894113|SCV000914761|SCV001163419|SCV001193950|SCV001245018|SCV002019551|SCV002033195|SCV002678906	-	-	854A>C 	Glu285Ala	NM_000049.4	2.0	1_Pathogenic	chr17	A	C	17-3499000-A-C	0.00021616	2605	17	3499000	A	C	E	A	rs28940279	17	3402294	17	3349044	285	ASPA	ENSG00000108381	ENST00000456349	ENSP00000409976	P45381	ACY2_HUMAN	c.854A>C	p.Glu285Ala	c.854A>C	p.Glu285Ala	principal1	Y	1	.	.	+	GAG	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.445	0.92067	M	-5.64	0.86945	D	0.821	0.81598	1.1430	0.99940	D	0.9594	0.98687	D	9	0.1546188	0.28817	T	0.38468	0.93037	D	0.946	0.98921	.	.	.	.	.	0.985706297631	0.98539	.	0.95403	.	0.42621	0.627549469471	0.56732	T	0.918401	0.98502	D	0.401749	0.89945	D	0.575977	0.96268	D	0.271785620191202	0.23545	T	.	0.73799	.	0.90353787	0.91581	0.80343163	0.88339	0.92926353	0.94076	0.764455	0.85914	-12.277	0.86210	D	0.9883	0.93074	LP	0.999231841340603	0.96026	0.99460960	0.97586	0.971	0.98885	.	.	.	.	.	.	4.359283	0.67086	25.0	0.99548204871533663	0.70997	0.942557	0.94709	D	0.698009439276086	0.79390	7.091101	0.579952107781817	0.73358	5.981255	5.76	4.68	0.58268	3.87	0.72853	8.939	0.92492	11.181000	0.88328	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.023	0.12113	734	0.53826	.	.	.	.	.	.	.	.	.	.	.	.	68	264690	2.569043E-4	.	27	109392	2.468190e-04	0	68	208092	3.267790e-04	0	105	236900	4.432250e-04	0	2	7160	2.793300e-04	0	0	17108	0.000000e+00	0	23	2320	9.913790e-03	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	1	42762	2.338520e-05	0	0	15688	0.000000e+00	0	2	7160	2.793300e-04	0	2	16214	1.233500e-04	0	0	30516	0.000000e+00	0	58	6212	9.336770e-03	0	0	13414	0.000000e+00	0	0	16734	0.000000e+00	0	3	89532	3.350760e-05	0	0	30604	0.000000e+00	0	2	16214	1.233500e-04	0	2	14898	1.342460e-04	0	0	34252	0.000000e+00	0	90	9572	9.402420e-03	0	0	17690	0.000000e+00	0	0	21632	0.000000e+00	0	6	102714	5.841460e-05	0	0	30522	0.000000e+00	0	2	14898	1.342460e-04	0	.	356	1614100	2.205560e-04	0	274	29602	9.256130e-03	0	1	74932	1.334540e-05	0	0	912	0.000000e+00	0	1	60012	1.666330e-05	0	274	29602	9.256130e-03	0	0	44904	0.000000e+00	0	0	64038	0.000000e+00	0	0	6084	0.000000e+00	0	41	1180040	3.474460e-05	0	0	91090	0.000000e+00	0	99	180062	5.498106207861736E-4	0	360	0	0	2712	0	3	9432	3.180661577608143E-4	0	796	0	0	968	0	0	682	0	0	280	0	12	15588	7.698229407236335E-4	3	9792	3.0637254901960784E-4	0	3394	0	114	210880	5.405918057663126E-4	Pathogenic	Canavan_Disease,_Familial_Form|Inborn_genetic_diseases|not_provided|Spongy_degeneration_of_central_nervous_system	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.3499000A>C	ClinGen:CA325511|Genetic_Testing_Registry_(GTR):GTR000321625|Genetic_Testing_Registry_(GTR):GTR000508973|Genetic_Testing_Registry_(GTR):GTR000597669|OMIM:608034.0001|UniProtKB:P45381#VAR_004999	C0751663|C0950123|C3661900|C0206307	271900	141	.	Glu	Ala	17644	single nucleotide variant	NM_000049.4(ASPA):c.854A>C (p.Glu285Ala)	443	ASPA	HGNC:756	Pathogenic	1	Jan 08, 2025	28940279	-	RCV000002723|RCV000590467|RCV000420704|RCV002444416	MONDO:MONDO:0010079,MedGen:C0206307,OMIM:271900,Orphanet:141|MedGen:C0751663|MedGen:C3661900|MeSH:D030342,MedGen:C0950123	Spongy degeneration of central nervous system|Canavan Disease, Familial Form|not provided|Inborn genetic diseases	germline;paternal;unknown	germline	GRCh38	NC_000017.11	17	3499000	3499000	17p13.2	criteria provided, multiple submitters, no conflicts	19	-	Y	ClinGen:CA325511,UniProtKB:P45381#VAR_004999,OMIM:608034.0001	3	2605	3499000	A	C	-	-	-	-	-	-	SCV000218961|SCV000231463|SCV000245578|SCV000512105|SCV000694157|SCV000894113|SCV000914761|SCV001163419|SCV001193950|SCV001245018|SCV002019551|SCV002033195|SCV002678906	-	-	854A>C 	Glu285Ala	NM_000049.4	2	1_Pathogenic	ASPA	ENSG00000108381	8459	15721	CCSBVarC001386	ALE00001386	854A>C	Glu285Ala	RC4	RC4_Mut_GDEh1016	G01	GDEhDisVCh_40040	F04	2	RC4_Mut_GDDh1016	G01	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	ASPA_Glu285Ala	17	17	3499000	A	C
2803	HMBS	755C>T	Ala252Val	ENSG00000256269	11	119092507	NC_000011.10:119092507:C:T	ALE00005176	CCSBVarC005176	NULL	200942	NULL	GDEhDisVCh_40054	D07	CEGS2	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAGCTTGCTCGCATACAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGGACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCTTGAACATGCCCTGGAGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCGAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTCGGGGAAACCTCAACACCCGGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACCGGGTGGGGCAGATCCTGCACCCTGAGGAATGCATGTATGCTGTGGGCCAGGGGGCCTTGGGCGTGGAAGTGCGAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCTGCATCGCTGAAAGGGTCTTCCTGAGGCACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATGGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCGTAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACGATGCCCAT	16512.0	single nucleotide variant	NM_000190.4(HMBS):c.755C>T (p.Ala252Val)	3145.0	HMBS	HGNC:4982	Pathogenic	1.0	Dec 01, 1993	118204114.0	-	RCV000001538	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276	Acute intermittent porphyria	germline	germline	GRCh38	NC_000011.10	11	119092507.0	119092507.0	11q23.3	no assertion criteria provided	1.0	-	N	ClinGen:CA251834,UniProtKB:P08397#VAR_003668,OMIM:609806.0033	1.0	1473.0	119092507.0	C	T	-	-	-	-	-	-	SCV000021693	-	-	755C>T 	Ala252Val	NM_000190.4		1_Pathogenic	chr11	C	T	11-119092507-C-T		1473	11	119092507	C	T	A	V	rs118204114	11	118963217	11	118468427	252	HMBS	ENSG00000256269	ENST00000652429	ENSP00000498786	P08397	HEM3_HUMAN	c.755C>T	p.Ala252Val	c.755C>T	p.Ala252Val	principal2	Y	.	YES	Select	+	GCC	2	0	C	C/C	C/C	C/C	C/C	.	0.72322	.	.	0.55281	.	0.107	0.26097	B	0.097	0.30392	B	.	0.97926	.	.	.	.	2.76	0.80456	M	.	0.62039	.	.	0.82201	0.9737	0.96750	D	0.9316	0.97739	D	9	.	0.96984	.	0.3086	0.91093	D	.	0.94374	0.935	0.99041	P08397	A252V	Loss of catalytic residue at A252 (P = 0.0344)| Loss of methylation at R255 (P = 0.4078)| Gain of MoRF binding (P = 0.564)| Loss of helix (P = 0.6555)| Loss of disorder (P = 0.6714)	.	0.97885	0.8369897311874793	0.83559	.	.	0.632630169392	0.57453	T	0.971703	0.99696	D	0.545865	0.95596	D	0.546321	0.95531	D	0.962264060974121	0.66102	D	0.987901	0.95926	D	0.88892263	0.90279	0.81493074	0.89076	0.91241264	0.92412	0.8381258	0.90593	-8.484	0.64399	D	0.7104	0.74340	P	0.996622567730506	0.92311	0.23534976	0.74589	0.955	0.98022	.	.	.	.	.	.	4.679191	0.74916	26.2	0.9983030953696117	0.91205	0.964820	0.98698	D	0.315479336033447	0.56722	3.859968	0.448529610016467	0.64429	4.721709	5.24	5.24	0.72825	5.83	0.96354	7.693	0.83514	7.655000	0.63966	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.999	0.91597	228	0.91137	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	.	.	.	.	1	109394	9.141270e-06	0	1	208108	4.805200e-06	0	1	236842	4.222220e-06	0	0	7162	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13384	0.000000e+00	0	1	42768	2.338200e-05	0	0	15688	0.000000e+00	0	1	42768	2.338200e-05	0	0	16214	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16724	0.000000e+00	0	1	89548	1.116720e-05	0	0	30606	0.000000e+00	0	1	89548	1.116720e-05	0	0	14900	0.000000e+00	0	0	34258	0.000000e+00	0	0	9568	0.000000e+00	0	0	17692	0.000000e+00	0	0	21620	0.000000e+00	0	1	102660	9.740890e-06	0	0	30524	0.000000e+00	0	1	102660	9.740890e-06	0	.	1	1614164	6.195160e-07	0	1	1180028	8.474380e-07	0	0	75030	0.000000e+00	0	0	912	0.000000e+00	0	0	60028	0.000000e+00	0	0	29606	0.000000e+00	0	0	44888	0.000000e+00	0	0	64018	0.000000e+00	0	0	6062	0.000000e+00	0	1	1180028	8.474380e-07	0	0	91082	0.000000e+00	0	0	76	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	106	0	0	434	0	0	34	0	0	656	0	Pathogenic	Acute_intermittent_porphyria	no_assertion_criteria_provided	NC_000011.10:g.119092507C>T	ClinGen:CA251834|OMIM:609806.0033|UniProtKB:P08397#VAR_003668	C0162565	176000	79276	Porphobilinogen deaminase, C-terminal|Porphobilinogen deaminase, dipyrromethane cofactor binding site	Ala	Val	16512	single nucleotide variant	NM_000190.4(HMBS):c.755C>T (p.Ala252Val)	3145	HMBS	HGNC:4982	Pathogenic	1	Dec 01, 1993	118204114	-	RCV000001538	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276	Acute intermittent porphyria	germline	germline	GRCh38	NC_000011.10	11	119092507	119092507	11q23.3	no assertion criteria provided	1	-	N	ClinGen:CA251834,UniProtKB:P08397#VAR_003668,OMIM:609806.0033	1	1473	119092507	C	T	-	-	-	-	-	-	SCV000021693	-	-	755C>T 	Ala252Val	NM_000190.4		1_Pathogenic	HMBS	ENSG00000256269	2803	200942	CCSBVarC005176	ALE00005176	755C>T	Ala252Val	CEGS2	CegsMutGDEh1042	E04	GDEhDisVCh_40054	D07	2	CegsMutGDDh1042	E04	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	HMBS_Ala252Val	11	11	119092507	C	T
3774	TP53	842A>G	Asp281Gly	ENSG00000141510	17	7673778	NC_000017.11:7673778:T:C	ALE00004873	CCSBVarC004873	NULL	214902	NULL	GDEhDisVCh_40053	A07	CEGS2	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGGCCGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	150855.0	single nucleotide variant	NM_000546.6(TP53):c.842A>G (p.Asp281Gly)	7157.0	TP53	HGNC:11998	Pathogenic	1.0	Jul 21, 2024	587781525.0	-	RCV000129516|RCV000633367|RCV002288626|RCV003237737	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MedGen:C3661900	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	7673778.0	7673778.0	17p13.1	criteria provided, multiple submitters, no conflicts	6.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000450,UniProtKB:P04637#VAR_006012	2.0	141141.0	7673778.0	T	C	-	-	-	-	-	-	SCV000184291|SCV000754589|SCV002011126|SCV002581506|SCV002582450|SCV002583112|SCV005045783	-	-	842A>G 	Asp281Gly	NM_000546.6	2.0	1_Pathogenic	chr17	A	G	17-7673778-A-G		141141	17	7673778	T	C	D	G	rs587781525	17	7577096	17	7517821	281	TP53	ENSG00000141510	ENST00000714357	ENSP00000519624	P04637	P53_HUMAN	.	.	c.842A>G	p.Asp281Gly	principal1	Y	.	.	.	-	GAC	2	0	T	T/T	T/T	T/T	T/T	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	0.996	0.97365	D	.	0.99291	.	.	.	.	3.23	0.89408	M	.	0.92496	.	.	0.98479	0.9284	0.96067	D	0.9941	0.99864	D	10	.	0.99803	.	0.741521	0.97926	D	.	0.99740	0.975	0.99765	P04637	D281G	Gain of MoRF binding (P = 0.0296)| Loss of stability (P = 0.0382)| Gain of methylation at R280 (P = 0.0399)| Loss of solvent accessibility (P = 0.1177)| Gain of catalytic residue at G279 (P = 0.2166)	.	0.99634	.	0.91911	.	0.43398	0.591819405556	0.51684	T	0.993724	0.99982	D	0.583801	0.97041	D	0.600813	0.96992	D	0.997705161571503	0.92146	D	.	0.95766	.	0.9726211	0.98474	0.93756837	0.97572	0.96431077	0.97674	0.9460315	0.98128	-13.423	0.91049	D	.	0.99054	.	0.997536422134682	0.93247	0.99998164	0.99989	0.997	0.99892	.	.	.	.	.	.	4.912055	0.80867	27.4	0.99848660467946071	0.92843	0.947901	0.95882	D	0.871257527487729	0.90229	10.33383	0.794963487777002	0.89381	9.976146	5.13	5.13	0.69688	.	.	8.017	0.8876	6.226000	0.55244	0.661	0.55789	1.0	0.71675	1.000000	0.68239	0.998	0.85369	432	0.80699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Transitional_cell_carcinoma_of_the_bladder|Squamous_cell_carcinoma_of_the_skin|Hepatocellular_carcinoma|not_provided|Pancreatic_adenocarcinoma|Malignant_neoplasm_of_body_of_uterus|Uterine_carcinosarcoma|Gastric_adenocarcinoma|Ovarian_serous_cystadenocarcinoma|Neuroblastoma|Multiple_myeloma|Papillary_renal_cell_carcinoma_type_1|Hereditary_cancer-predisposing_syndrome|Li-Fraumeni_syndrome|Malignant_melanoma_of_skin|B-cell_chronic_lymphocytic_leukemia|Breast_neoplasm|Glioblastoma|Li-Fraumeni_syndrome_1|Lung_adenocarcinoma|Squamous_cell_lung_carcinoma|Squamous_cell_carcinoma_of_the_head_and_neck	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.7673778T>C	ClinGen:CA000450|UniProtKB:P04637#VAR_006012	C0279680|C0553723|C2239176|C3661900|C0281361|C0153574|C0280630|C0278701|C0279663|C0027819|C0026764|C1336839|C0027672|C0085390|C0151779|C0023434|C1458155|C0017636|C1835398|C0152013|C0149782|C1168401	114550|254500|605074|PS151623|151400|151623|275355	88673|635|29073|85443|47044|140162|524|67038|360|524|67037	p53, DNA-binding domain|p53, DNA-binding domain	Asp	Gly	150855	single nucleotide variant	NM_000546.6(TP53):c.842A>G (p.Asp281Gly)	7157	TP53	HGNC:11998	Pathogenic	1	Jul 21, 2024	587781525	-	RCV000129516|RCV000633367|RCV002288626|RCV003237737	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MedGen:C3661900	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	7673778	7673778	17p13.1	criteria provided, multiple submitters, no conflicts	6	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000450,UniProtKB:P04637#VAR_006012	2	141141	7673778	T	C	-	-	-	-	-	-	SCV000184291|SCV000754589|SCV002011126|SCV002581506|SCV002582450|SCV002583112|SCV005045783	-	-	842A>G 	Asp281Gly	NM_000546.6	2	1_Pathogenic	TP53	ENSG00000141510	3774	214902	CCSBVarC004873	ALE00004873	842A>G	Asp281Gly	CEGS2	CegsMutGDEh1020	D10	GDEhDisVCh_40053	A07	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	TP53_Asp281Gly	17	17	7673778	T	C
3774	TP53	566C>T	Ala189Val	ENSG00000141510	17	7674965	NC_000017.11:7674965:G:A	ALE00004862	CCSBVarC004862	NULL	214891	NULL	GDEhDisVCh_40053	A01	CEGS2	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGTCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACCGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	27421.0	single nucleotide variant	NM_000546.6(TP53):c.566C>T (p.Ala189Val)	7157.0	TP53	HGNC:11998	Conflicting classifications of pathogenicity	1.0	Jan 12, 2025	121912665.0	-	RCV000013182|RCV000132058|RCV000144671|RCV001192620|RCV000536677|RCV001030736|RCV003476892	MONDO:MONDO:0023113,MedGen:CN280943|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MedGen:CN169374|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	Familial colorectal cancer|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|not specified|Li-Fraumeni syndrome|Hereditary breast ovarian cancer syndrome|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	7674965.0	7674965.0	17p13.1	criteria provided, conflicting classifications	12.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000270,UniProtKB:P04637#VAR_044978,OMIM:191170.0038	3.0	12382.0	7674965.0	G	A	-	-	-	-	-	-	SCV000187120|SCV000488324|SCV000629841|SCV001193752|SCV001354218|SCV001360870|SCV002530467|SCV004017926|SCV004221363|SCV005078064	-	-	566C>T 	Ala189Val	NM_000546.6	1.0	3_Conflicting	chr17	C	T	17-7674965-C-T		12382	17	7674965	G	A	A	V	rs121912665	17	7578283	17	7519008	189	TP53	ENSG00000141510	ENST00000445888	ENSP00000391478	P04637	P53_HUMAN	c.566C>T	p.Ala189Val	c.566C>T	p.Ala189Val	principal1	Y	1	.	.	-	GCC	2	0	G	G/G	G/G	G/G	G/G	0.059	0.50835	T	0.087	0.45051	T	0.874	0.68795	P	0.771	0.61636	P	1.0	0.99291	D	simple_aae	0.0	100.0	2.06	0.56495	M	-2.31	0.55364	N	0.887	0.88561	1.0205	0.97537	D	0.9875	0.99632	D	9	0.93864036	0.93115	D	0.673903	0.97280	D	0.790	0.93044	0.865	0.96028	P04637	A189V	Loss of disorder (P = 0.1065)| Gain of catalytic residue at A189 (P = 0.2289)| Loss of sheet (P = 0.302)| Loss of glycosylation at P190 (P = 0.3407)| Loss of phosphorylation at S185 (P = 0.4128)	0.957862757569	0.95704	.	0.37037	.	0.89624	0.506407022476	0.39665	T	0.918993	0.98517	D	0.246169	0.78078	D	0.416152	0.92569	D	0.549996287891267	0.34165	D	.	0.78984	.	0.6540995	0.75314	0.5627952	0.74449	0.55837077	0.70125	0.6060981	0.76860	-8.58	0.68914	D	0.5887	0.71154	P	0.842065321927251	0.72708	0.99995184	0.99953	0.711	0.83978	.	.	.	.	.	.	4.797977	0.77971	26.8	0.99865689397808366	0.94371	0.945926	0.95463	D	0.624804646752451	0.74610	6.185497	0.573797217583111	0.72920	5.910257	5.41	5.41	0.78283	.	.	8.062	0.89291	11.864000	0.98400	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.957	0.51031	433	0.80635	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	3	109398	2.742280e-05	0	6	208100	2.883230e-05	0	6	236918	2.532520e-05	0	0	7162	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	2	9046	2.210920e-04	0	0	13394	0.000000e+00	0	1	42762	2.338520e-05	0	0	15690	0.000000e+00	0	2	9046	2.210920e-04	0	0	16216	0.000000e+00	0	0	30516	0.000000e+00	0	0	6210	0.000000e+00	0	5	13416	3.726890e-04	0	0	16734	0.000000e+00	0	1	89536	1.116870e-05	0	0	30606	0.000000e+00	0	5	13416	3.726890e-04	0	0	14900	0.000000e+00	0	0	34252	0.000000e+00	0	0	9570	0.000000e+00	0	5	17692	2.826140e-04	0	0	21632	0.000000e+00	0	1	102728	9.734440e-06	0	0	30524	0.000000e+00	0	5	17692	2.826140e-04	0	.	43	1614044	2.664120e-05	0	41	44894	9.132620e-04	0	0	74918	0.000000e+00	0	0	910	0.000000e+00	0	0	59996	0.000000e+00	0	0	29602	0.000000e+00	0	41	44894	9.132620e-04	0	0	64044	0.000000e+00	0	0	6084	0.000000e+00	0	1	1180018	8.474450e-07	0	0	91090	0.000000e+00	0	0	92838	0	0	168	0	3	2682	0.0011185682326621924	0	3594	0	0	436	0	0	928	0	0	626	0	0	280	0	0	2010	0	0	3762	0	3	3308	9.068923821039903E-4	3	103562	2.8968154342326335E-5	Conflicting_classifications_of_pathogenicity	Li-Fraumeni_syndrome_1|Hereditary_breast_ovarian_cancer_syndrome|not_specified|not_provided|Hereditary_cancer-predisposing_syndrome|Familial_colorectal_cancer|Li-Fraumeni_syndrome	criteria_provided,_conflicting_classifications	NC_000017.11:g.7674965G>A	ClinGen:CA000270|OMIM:191170.0038|UniProtKB:P04637#VAR_044978	C1835398|C0677776|CN169374|C3661900|C0027672|CN280943|C0085390	151623|PS151623	524|145|140162|524	p53, DNA-binding domain|p53, DNA-binding domain	Ala	Val	27421	single nucleotide variant	NM_000546.6(TP53):c.566C>T (p.Ala189Val)	7157	TP53	HGNC:11998	Conflicting classifications of pathogenicity	1	Jan 12, 2025	121912665	-	RCV000013182|RCV000132058|RCV000144671|RCV001192620|RCV000536677|RCV001030736|RCV003476892	MONDO:MONDO:0023113,MedGen:CN280943|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MedGen:CN169374|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	Familial colorectal cancer|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|not specified|Li-Fraumeni syndrome|Hereditary breast ovarian cancer syndrome|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	7674965	7674965	17p13.1	criteria provided, conflicting classifications	12	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000270,UniProtKB:P04637#VAR_044978,OMIM:191170.0038	3	12382	7674965	G	A	-	-	-	-	-	-	SCV000187120|SCV000488324|SCV000629841|SCV001193752|SCV001354218|SCV001360870|SCV002530467|SCV004017926|SCV004221363|SCV005078064	-	-	566C>T 	Ala189Val	NM_000546.6	1	3_Conflicting	TP53	ENSG00000141510	3774	214891	CCSBVarC004862	ALE00004862	566C>T	Ala189Val	CEGS2	CegsMutGDEh1002	G03	GDEhDisVCh_40053	A01	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	4	0	NULL	0	NULL	0	NULL	0	NULL	TP53_Ala189Val	17	17	7674965	G	A
71569	OTC	658C>G	Pro220Ala	ENSG00000036473	X	38403735	NC_000023.11:38403735:C:G	ALE00005255	CCSBVarC005255	NULL	205921	NULL	GDEhDisVCh_40048	F04	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTGCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103173.0	single nucleotide variant	NM_000531.6(OTC):c.658C>G (p.Pro220Ala)	5009.0	OTC	HGNC:8512	Pathogenic	1.0	-	72558425.0	-	RCV000083525	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38403735.0	38403735.0	Xp11.4	no assertion criteria provided	1.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224727,UniProtKB:P00480#VAR_004912	2.0	97281.0	38403735.0	C	G	-	-	-	-	-	-	SCV000115611	-	-	658C>G 	Pro220Ala	NM_000531.6		1_Pathogenic	chrX	C	G	X-38403735-C-G		97281	X	38403735	C	G	P	A	rs72558425	X	38262988	X	38147932	220	OTC	ENSG00000036473	ENST00000039007	ENSP00000039007	P00480	OTC_HUMAN	c.658C>G	p.Pro220Ala	c.658C>G	p.Pro220Ala	principal1	Y	1	YES	Select	+	CCA	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.92	0.93300	A	simple_aae	8.0	92.0	4.04	0.96934	H	-8.0	0.96508	D	0.968	0.97870	0.9202	0.95948	D	0.9959	0.99906	D	10	0.9962404	0.99997	D	0.97131	0.99827	D	0.987	0.99952	0.985	0.99851	P00480	P220A	Loss of methylation at K221 (P = 0.067)| Loss of phosphorylation at T219 (P = 0.0782)| Loss of disorder (P = 0.0978)| Gain of ubiquitination at K221 (P = 0.1115)| Loss of glycosylation at T219 (P = 0.12)	0.998492474825	0.99845	0.984294107652528	0.98415	1.14122281943	0.78812	0.576980829239	0.49593	T	0.993102	0.99979	D	0.729944	0.99956	D	0.810738	0.99956	D	0.999907612800598	0.99626	D	0.932007	0.74594	D	0.9802594	0.99114	0.9827392	0.99881	0.9802594	0.99115	0.9827392	0.99881	-12.231	0.85995	D	0.7973	0.77108	P	0.998349667832603	0.94314	0.99889920	0.99026	0.966	0.98629	.	.	.	.	.	.	4.592362	0.72714	25.9	0.99588852584352494	0.73486	.	.	.	.	.	.	.	.	.	5.92	5.92	0.95551	.	.	7.523	0.80833	7.595000	0.61432	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.994	0.71086	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided	no_assertion_criteria_provided	NC_000023.11:g.38403735C>G	ClinGen:CA224727|UniProtKB:P00480#VAR_004912	CN517202	.	.	Aspartate/ornithine carbamoyltransferase, Asp/Orn-binding domain	Pro	Ala	103173	single nucleotide variant	NM_000531.6(OTC):c.658C>G (p.Pro220Ala)	5009	OTC	HGNC:8512	Pathogenic	1	-	72558425	-	RCV000083525	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38403735	38403735	Xp11.4	no assertion criteria provided	1	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224727,UniProtKB:P00480#VAR_004912	2	97281	38403735	C	G	-	-	-	-	-	-	SCV000115611	-	-	658C>G 	Pro220Ala	NM_000531.6		1_Pathogenic	OTC	ENSG00000036473	71569	205921	CCSBVarC005255	ALE00005255	658C>G	Pro220Ala	CEGS2	CegsMutGDEh1019	E05	GDEhDisVCh_40048	F04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Pro220Ala	23	X	38403735	C	G
3689	GCK	1130G>A	Arg377His	ENSG00000106633	7	44145620	NC_000007.14:44145620:C:T	ALE00006694	CCSBVarC006696	NULL	214856	NULL	GDEhDisVCh_40037	G02	CEGS2	ATGCTGGACGACAGAGCCAGGATGGAGGCCGCCAAGAAGGAGAAGGTAGAGCAGATCCTGGCAGAGTTCCAGCTGCAGGAGGAGGACCTGAAGAAGGTGATGAGACGGATGCAGAAGGAGATGGACCGCGGCCTGAGGCTGGAGACCCATGAAGAGGCCAGTGTGAAGATGCTGCCCACCTACGTGCGCTCCACCCCAGAAGGCTCAGAAGTCGGGGACTTCCTCTCCCTGGACCTGGGTGGCACTAACTTCAGGGTGATGCTGGTGAAGGTGGGAGAAGGTGAGGAGGGGCAGTGGAGCGTGAAGACCAAACACCAGATGTACTCCATCCCCGAGGACGCCATGACCGGCACTGCTGAGATGCTCTTCGACTACATCTCTGAGTGCATCTCCGACTTCCTGGACAAGCATCAGATGAAACACAAGAAGCTGCCCCTGGGCTTCACCTTCTCCTTTCCTGTGAGGCACGAAGACATCGATAAGGGCATCCTTCTCAACTGGACCAAGGGCTTCAAGGCCTCAGGAGCAGAAGGGAACAATGTCGTGGGGCTTCTGCGAGACGCTATCAAACGGAGAGGGGACTTTGAAATGGATGTGGTGGCAATGGTGAATGACACGGTGGCCACGATGATCTCCTGCTACTACGAAGACCATCAGTGCGAGGTCGGCATGATCGTGGGCACGGGCTGCAATGCCTGCTACATGGAGGAGATGCAGAATGTGGAGCTGGTGGAGGGGGACGAGGGCCGCATGTGCGTCAATACCGAGTGGGGCGCCTTCGGGGACTCCGGCGAGCTGGACGAGTTCCTGCTGGAGTATGACCGCCTGGTGGACGAGAGCTCTGCAAACCCCGGTCAGCAGCTGTATGAGAAGCTCATAGGTGGCAAGTACATGGGCGAGCTGGTGCGGCTTGTGCTGCTCAGGCTCGTGGACGAAAACCTGCTCTTCCACGGGGAGGCCTCCGAGCAGCTGCGCACACGCGGAGCCTTCGAGACGCGCTTCGTGTCGCAGGTGGAGAGCGACACGGGCGACCGCAAGCAGATCTACAACATCCTGAGCACGCTGGGGCTGCGACCCTCGACCACCGACTGCGACATCGTGCGCCGCGCCTGCGAGAGCGTGTCTACGCACGCTGCGCACATGTGCTCGGCGGGGCTGGCGGGCGTCATCAACCGCATGCGCGAGAGCCGCAGCGAGGACGTAATGCGCATCACTGTGGGCGTGGATGGCTCCGTGTACAAGCTGCACCCCAGCTTCAAGGAGCGGTTCCATGCCAGCGTGCGCAGGCTGACGCCCAGCTGCGAGATCACCTTCATCGAGTCGGAGGAGGGCAGTGGCCGGGGCGCGGCCCTGGTCTCGGCGGTGGCCTGTAAGAAGGCCTGTATGCTGGGCCAG	44840.0	single nucleotide variant	NM_000162.5(GCK):c.1130G>A (p.Arg377His)	2645.0	GCK	HGNC:4195	Likely pathogenic	1.0	Aug 08, 2023	193922264.0	-	RCV000029839|RCV003325945|RCV000518143|RCV001818186|RCV002321490	MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625|MedGen:CN169374|MedGen:C3661900|Human Phenotype Ontology:HP:0004904,MONDO:MONDO:0018911,MedGen:C0342276,OMIM:606391,Orphanet:552	Maturity-onset diabetes of the young type 2|Monogenic diabetes|not specified|not provided|Maturity onset diabetes mellitus in young	germline	germline	GRCh38	NC_000007.14	7	44145620.0	44145620.0	7p13	reviewed by expert panel	6.0	-	N	ClinGen:CA213715	2.0	36176.0	44145620.0	C	T	-	-	-	-	-	-	SCV004032103	-	-	1130G>A 	Arg377His	NM_000162.5	3.0	1_Pathogenic	chr7	G	A	7-44145620-G-A		36176	7	44145620	C	T	R	H	rs193922264	7	44185219	7	44151744	377	GCK	ENSG00000106633	ENST00000403799	ENSP00000384247	P35557	HXK4_HUMAN	c.1130G>A	p.Arg377His	c.1130G>A	p.Arg377His	principal1	Y	1	YES	Select	-	CGC	2	0	C	C/C	C/C	C/C	C/C	0.012	0.91343	D	0.016	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.665	0.94230	H	-4.58	0.80373	D	0.987	0.99555	0.9513	0.96403	D	0.9919	0.99799	D	10	0.9927044	0.99805	D	0.92279	0.99432	D	0.981	0.99874	0.998	0.99980	P35557	R377H	Loss of MoRF binding (P = 0.0301)| Loss of methylation at R377 (P = 0.1359)| Loss of disorder (P = 0.1407)| Loss of phosphorylation at S375 (P = 0.166)| Gain of glycosylation at T376 (P = 0.2133)	0.991665179887	0.99147	.	0.99511	.	0.97457	0.870703577995	0.92657	D	0.968607	0.99641	D	0.563151	0.96263	D	0.571151	0.96204	D	0.999769032001495	0.98872	D	0.861414	0.55397	D	0.96201694	0.97442	0.6692838	0.80380	0.94607353	0.95801	0.783297	0.87071	-14.066	0.93311	D	0.9367	0.85569	P	0.993254127371425	0.89946	0.99981445	0.99752	0.981	0.99334	.	.	.	.	.	.	5.982029	0.94261	34.0	0.9994390743564775	0.99869	0.938367	0.93723	D	0.933056278161452	0.93244	11.93765	0.826275423044149	0.91512	10.94791	5.2	5.2	0.71681	.	.	6.104	0.71225	7.529000	0.59950	0.596	0.33565	1.0	0.71675	1.000000	0.68239	0.957	0.51031	716	0.55914	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	424	0	0	0	0	0	0	0	0	0	0	0	0	0	0	50	0	0	424	0	0	0	0	0	474	0	Likely_pathogenic	not_provided|Maturity-onset_diabetes_of_the_young_type_2|Maturity_onset_diabetes_mellitus_in_young|Monogenic_diabetes|not_specified	reviewed_by_expert_panel	NC_000007.14:g.44145620C>T	ClinGen:CA213715	C3661900|C0342277|C0342276|C3888631|CN169374	125851|606391	552|552|183625	Hexokinase, C-terminal	Arg	His	44840	single nucleotide variant	NM_000162.5(GCK):c.1130G>A (p.Arg377His)	2645	GCK	HGNC:4195	Likely pathogenic	1	Aug 08, 2023	193922264	-	RCV000029839|RCV003325945|RCV000518143|RCV001818186|RCV002321490	MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625|MedGen:CN169374|MedGen:C3661900|Human Phenotype Ontology:HP:0004904,MONDO:MONDO:0018911,MedGen:C0342276,OMIM:606391,Orphanet:552	Maturity-onset diabetes of the young type 2|Monogenic diabetes|not specified|not provided|Maturity onset diabetes mellitus in young	germline	germline	GRCh38	NC_000007.14	7	44145620	44145620	7p13	reviewed by expert panel	6	-	N	ClinGen:CA213715	2	36176	44145620	C	T	-	-	-	-	-	-	SCV004032103	-	-	1130G>A 	Arg377His	NM_000162.5	3	1_Pathogenic	GCK	ENSG00000106633	3689	214856	CCSBVarC006696	ALE00006694	1130G>A	Arg377His	CEGS2	CegsMutGDEh1044	C05	GDEhDisVCh_40037	G02	1	CegsMutGDDh1044	C05	VUSN2Hmut_GDN2h_09	G05	VUSMutpDEST2_03	G09	VUSmut_GDEh09	G05	1	1	1	1	1	1	1	1	1	1	GCK_Arg377His	7	7	44145620	C	T
14468	TPK1	148A>C	Asn50His	ENSG00000196511	7	144682946	NC_000007.14:144682946:T:G	ALE00005853	CCSBVarC005853	NULL	218332	NULL	GDEhDisVCh_40090	D06	CEGS2	ATGGAGCATGCCTTTACCCCGTTGGAGCCCCTGCTTTCCACTGGGAATTTGAAGTACTGCCTTGTAATTCTTAATCAGCCTTTGGACAACTATTTTCGTCATCTTTGGAACAAAGCTCTTTTAAGAGCCTGTGCCGATGGAGGTGCCCACCGCTTATATGATATCACCGAAGGAGAGAGAGAAAGCTTTTTGCCTGAATTCATCAATGGAGACTTTGATTCTATTAGGCCTGAAGTCAGAGAATACTATGCTACTAAGGGATGTGAGCTCATTTCAACTCCTGATCAAGACCACACTGACTTTACTAAGTGCCTTAAAATGCTCCAAAAGAAGATAGAAGAAAAAGACTTAAAGGTTGATGTGATCGTGACACTGGGAGGCCTTGCTGGGCGTTTTGACCAGATTATGGCATCTGTGAATACCTTGTTCCAAGCGACTCACATCACTCCTTTTCCAATTATAATAATCCAAGAGGAATCGCTGATCTACCTGCTCCAACCAGGAAAGCACAGGTTGCATGTAGACACTGGAATGGAGGGTGATTGGTGTGGCCTTATTCCTGTTGGACAGCCTTGTAGTCAGGTTACAACCACAGGCCTCAAGTGGAACCTCACAAATGATGTGCTTGCTTTTGGAACATTGGTCAGTACTTCCAATACCTACGACGGGTCTGGTGTTGTGACTGTGGAAACTGACCACCCACTCCTCTGGACCATGGCCATCAAAAGC	39525.0	single nucleotide variant	NM_022445.4(TPK1):c.148A>C (p.Asn50His)	27010.0	TPK1	HGNC:17358	Pathogenic	1.0	Dec 09, 2011	387906935.0	-	RCV000023531	MONDO:MONDO:0013761,MedGen:C3280866,OMIM:614458,Orphanet:293955	Childhood encephalopathy due to thiamine pyrophosphokinase deficiency	germline	germline	GRCh38	NC_000007.14	7	144682946.0	144682946.0	7q35	no assertion criteria provided	1.0	-	N	ClinGen:CA129339,UniProtKB:Q9H3S4#VAR_067392,OMIM:606370.0001	1.0	30568.0	144682946.0	T	G	-	-	-	-	-	-	SCV000044822	-	-	148A>C 	Asn50His	NM_022445.4		1_Pathogenic	chr7	A	C	7-144682946-A-C		30568	7	144682946	T	G	N	H	rs387906935	7	144380039	7	144010972	50	TPK1	ENSG00000196511	ENST00000360057	ENSP00000353165	Q9H3S4	TPK1_HUMAN	c.148A>C	p.Asn50His	c.148A>C	p.Asn50His	principal1	Y	1	YES	Select	-	AAC	1	0	T	T/T	T/T	T/T	T/T	0.002	0.72322	D	0.028	0.55281	D	1.0	0.90580	D	0.998	0.88579	D	0.82	0.89397	A	simple_aae	18.0	82.0	3.165	0.88471	M	-3.15	0.72390	D	0.803	0.87459	0.6356	0.92333	D	0.7563	0.91673	D	10	0.9722638	0.96830	D	0.129243	0.81072	D	0.706	0.89423	0.927	0.98799	Q9H3S4	N50H	Gain of disorder (P = 0.0849)| Gain of loop (P = 0.1069)| Loss of helix (P = 0.2022)| Gain of catalytic residue at L52 (P = 0.2669)| Gain of phosphorylation at Y53 (P = 0.2887)	0.844119709855	0.84140	0.8469067075486448	0.84558	0.670258421466	0.59130	0.471933841705	0.34900	T	0.832489	0.95983	D	0.121089	0.66240	D	-0.063841	0.65820	T	0.985888185988907	0.76580	D	0.963804	0.86602	D	0.92997354	0.94147	0.8282496	0.89942	0.9366974	0.94834	0.8183861	0.89299	-12.885	0.88908	D	0.8159	0.77989	P	0.983044329435162	0.86093	0.67232020	0.85496	0.473	0.69678	.	.	.	.	.	.	4.68795	0.75138	26.3	0.99675581558913762	0.78934	0.469733	0.51431	N	0.776684384396305	0.84543	8.341359	0.75073761053793	0.86135	8.817646	6.02	6.02	0.97555	.	.	4.036	0.57104	7.831000	0.70162	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.999	0.91597	936	0.14735	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	Childhood_encephalopathy_due_to_thiamine_pyrophosphokinase_deficiency	no_assertion_criteria_provided	NC_000007.14:g.144682946T>G	ClinGen:CA129339|OMIM:606370.0001|UniProtKB:Q9H3S4#VAR_067392	C3280866	614458	293955	Thiamin pyrophosphokinase, catalytic domain	Asn	His	39525	single nucleotide variant	NM_022445.4(TPK1):c.148A>C (p.Asn50His)	27010	TPK1	HGNC:17358	Pathogenic	1	Dec 09, 2011	387906935	-	RCV000023531	MONDO:MONDO:0013761,MedGen:C3280866,OMIM:614458,Orphanet:293955	Childhood encephalopathy due to thiamine pyrophosphokinase deficiency	germline	germline	GRCh38	NC_000007.14	7	144682946	144682946	7q35	no assertion criteria provided	1	-	N	ClinGen:CA129339,UniProtKB:Q9H3S4#VAR_067392,OMIM:606370.0001	1	30568	144682946	T	G	-	-	-	-	-	-	SCV000044822	-	-	148A>C 	Asn50His	NM_022445.4		1_Pathogenic	TPK1	ENSG00000196511	14468	218332	CCSBVarC005853	ALE00005853	148A>C	Asn50His	CEGS2	CegsMutGDEh1033	C08	GDEhDisVCh_40090	D06	2	CegsMutGDDh1033	C08	VUSN2Hmut_GDN2h_06	B05	VUSMutpDEST2_11	A09	VUSmut_GDEh06	B05	1	1	1	1	1	1	1	1	1	1	TPK1_Asn50His	7	7	144682946	T	G
2803	HMBS	181G>A	Asp61Asn	ENSG00000256269	11	119089102	NC_000011.10:119089102:G:A	ALE00000329	CCSBVarC000329	4825	NULL	NULL	GDEhDisVCh_40054	C11	RC4	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAGCTTGCTCGCATACAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGAACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCTTGAACATGCCCTGGAGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCGAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTCGGGGAAACCTCAACACCCGGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACCGGGTGGGGCAGATCCTGCACCCTGAGGAATGCATGTATGCTGTGGGCCAGGGGGCCTTGGGCGTGGAAGTGCGAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCTGCATCGCTGAAAGGGCCTTCCTGAGGCACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATGGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCGTAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACGATGCCCAT																																															chr11	G	A	11-119089102-G-A	6.84122e-7																																																																																																																																																																																																																																																																																																																																																																																																																																													HMBS	ENSG00000256269	2803	4825	CCSBVarC000329	ALE00000329	181G>A	Asp61Asn	RC4	RC4_Mut_GDEh1018	C04	GDEhDisVCh_40054	C11	2	RC4_Mut_GDDh1018	C04	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	HMBS_Asp61Asn	11	11	119089102	G	A
100011574	PTEN	500C>A	Thr167Asn	ENSG00000171862	10	87952125	NC_000010.11:87952125:C:A	ALE00007029	CCSBVarC007031	NULL	210312	NULL	GDEhDisVCh_40031	G08	CEGS2	ATGACAGCCATCATCAAAGAGATCGTTAGCAGAAACAAAAGGAGATATCAAGAGGATGGATTCGACTTAGACTTGACCTATATTTATCCAAACATTATTGCTATGGGATTTCCTGCAGAAAGACTTGAAGGCGTATACAGGAACAATATTGATGATGTAGTAAGGTTTTTGGATTCAAAGCATAAAAACCATTACAAGATATACAATCTTTGTGCTGAAAGACATTATGACACCGCCAAATTTAATTGCAGAGTTGCACAATATCCTTTTGAAGACCATAACCCACCACAGCTAGAACTTATCAAACCCTTTTGTGAAGATCTTGACCAATGGCTAAGTGAAGATGACAATCATGTTGCAGCAATTCACTGTAAAGCTGGAAAGGGACGAACTGGTGTAATGATATGTGCATATTTATTACATCGGGGCAAATTTTTAAAGGCACAAGAGGCCCTAGATTTCTATGGGGAAGTAAGGACCAGAGACAAAAAGGGAGTAAATATTCCCAGTCAGAGGCGCTATGTGTATTATTATAGCTACCTGTTAAAGAATCATCTGGATTATAGACCAGTGGCACTGTTGTTTCACAAGATGATGTTTGAAACTATTCCAATGTTCAGTGGCGGAACTTGCAATCCTCAGTTTGTGGTCTGCCAGCTAAAGGTGAAGATATATTCCTCCAATTCAGGACCCACACGACGGGAAGACAAGTTCATGTACTTTGAGTTCCCTCAGCCGTTACCTGTGTGTGGTGATATCAAAGTAGAGTTCTTCCACAAACAGAACAAGATGCTAAAAAAGGACAAAATGTTTCACTTTTGGGTAAATACATTCTTCATACCAGGACCAGAGGAAACCTCAGAAAAAGTAGAAAATGGAAGTCTATGTGATCAAGAAATCGATAGCATTTGCAGTATAGAGCGTGCAGATAATGACAAGGAATATCTAGTACTTACTTTAACAAAAAATGATCTTGACAAAGCAAATAAAGACAAAGCCAACCGATACTTTTCTCCAAATTTTAAGGTGAAGCTGTACTTCACAAAAACAGTAGAGGAGCCGTCAAATCCAGAGGCTAGCAGTTCAACTTCTGTAACACCAGATGTTAGTGACAATGAACCTGATCATTATAGATATTCTGACACCACTGACTCTGATCCAGAGAATGAACCTTTTGATGAAGATCAGCATACACAAATTACAAAAGTC	48267.0	single nucleotide variant	NM_000314.8(PTEN):c.500C>A (p.Thr167Asn)	5728.0	PTEN	HGNC:9588	Likely pathogenic	1.0	Jun 14, 2023	397514559.0	-	RCV000032872|RCV000758223	MONDO:MONDO:0011537,MedGen:C1854416,OMIM:605309,Orphanet:210548|MONDO:MONDO:0017623,MeSH:D006223,MedGen:C1959582,Orphanet:306498	Macrocephaly-autism syndrome|PTEN hamartoma tumor syndrome	germline	germline	GRCh38	NC_000010.11	10	87952125.0	87952125.0	10q23.31	reviewed by expert panel	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000487,UniProtKB:P60484#VAR_076763,OMIM:601728.0042	3.0	39668.0	87952125.0	C	A	-	-	-	-	-	-	SCV000886858	-	-	500C>A 	Thr167Asn	NM_000314.8	3.0	1_Pathogenic	chr10	C	A	10-87952125-C-A	0.0	39668	10	87952125	C	A	T	N	rs397514559	10	89711882	10	89701862	167	PTEN	ENSG00000171862	ENST00000371953	ENSP00000361021	P60484	PTEN_HUMAN	c.500C>A	p.Thr167Asn	c.500C>A	p.Thr167Asn	principal1	Y	1	YES	Select	+	ACT	2	0	C	./.	./.	./.	./.	0.0	0.91343	D	0.002	0.79703	D	0.999	0.77914	D	0.955	0.69584	D	0.92	0.93300	A	simple_aae	8.0	92.0	2.83	0.82191	M	-4.58	0.78839	D	0.924	0.92789	1.0948	0.99438	D	0.9715	0.99102	D	9	0.9283338	0.92089	D	0.84234	0.98779	D	0.751	0.91423	0.378	0.39175	P60484	T167N	Gain of catalytic residue at T167 (P = 0.003)| Loss of glycosylation at T167 (P = 0.0273)| Loss of methylation at K163 (P = 0.0875)| Gain of MoRF binding (P = 0.1138)| Gain of relative solvent accessibility (P = 0.1259)	0.953837466438	0.95295	0.8701185848565498	0.86896	2.49547626508	0.97587	0.832960128784	0.86994	D	0.921512	0.98582	D	0.284762	0.81587	D	0.171265	0.81350	D	0.996563613414764	0.89521	D	0.974503	0.90939	D	0.877069	0.89281	0.75074387	0.85087	0.89267546	0.90607	0.7882876	0.87383	-13.911	0.92778	D	0.9962	0.96154	P	0.999870147860613	0.98499	0.99979872	0.99739	0.967	0.98682	.	.	.	.	.	.	5.43375	0.90864	32.0	0.99360553328316203	0.61043	0.917913	0.88580	D	0.861309835791529	0.89684	10.09857	0.838160181109092	0.92263	11.35105	5.74	5.74	0.90056	6.35	0.99115	7.464	0.7996	7.687000	0.65653	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.999	0.91597	926	0.17784	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Likely_pathogenic	Macrocephaly-autism_syndrome|PTEN_hamartoma_tumor_syndrome	reviewed_by_expert_panel	NC_000010.11:g.87952125C>A	ClinGen:CA000487|OMIM:601728.0042|UniProtKB:P60484#VAR_076763	C1854416|C1959582	605309	210548|306498	Tyrosine-specific protein phosphatases domain|Tensin-type phosphatase domain|Protein-tyrosine phosphatase, catalytic|PTEN, phosphatase domain	Thr	Asn	48267	single nucleotide variant	NM_000314.8(PTEN):c.500C>A (p.Thr167Asn)	5728	PTEN	HGNC:9588	Likely pathogenic	1	Jun 14, 2023	397514559	-	RCV000032872|RCV000758223	MONDO:MONDO:0011537,MedGen:C1854416,OMIM:605309,Orphanet:210548|MONDO:MONDO:0017623,MeSH:D006223,MedGen:C1959582,Orphanet:306498	Macrocephaly-autism syndrome|PTEN hamartoma tumor syndrome	germline	germline	GRCh38	NC_000010.11	10	87952125	87952125	10q23.31	reviewed by expert panel	2	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000487,UniProtKB:P60484#VAR_076763,OMIM:601728.0042	3	39668	87952125	C	A	-	-	-	-	-	-	SCV000886858	-	-	500C>A 	Thr167Asn	NM_000314.8	3	1_Pathogenic	PTEN	ENSG00000171862	100011574	210312	CCSBVarC007031	ALE00007029	500C>A	Thr167Asn	CEGS2	CegsMutGDEh1023	G09	GDEhDisVCh_40031	G08	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	PTEN_Thr167Asn	10	10	87952125	C	A
71569	OTC	490T>C	Ser164Pro	ENSG00000036473	X	38401378	NC_000023.11:38401378:T:C	ALE00005248	CCSBVarC005248	NULL	205870	NULL	GDEhDisVCh_40048	H03	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGCCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103111.0	single nucleotide variant	NM_000531.6(OTC):c.490T>C (p.Ser164Pro)	5009.0	OTC	HGNC:8512	Pathogenic	1.0	-	72556273.0	-	RCV000083459	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38401378.0	38401378.0	Xp11.4	no assertion criteria provided	1.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224640	2.0	97219.0	38401378.0	T	C	-	-	-	-	-	-	SCV000115545	-	-	490T>C 	Ser164Pro	NM_000531.6		1_Pathogenic	chrX	T	C	X-38401378-T-C	0.0	97219	X	38401378	T	C	S	P	rs72556273	X	38260631	X	38145575	164	OTC	ENSG00000036473	ENST00000039007	ENSP00000039007	P00480	OTC_HUMAN	c.490T>C	p.Ser164Pro	c.490T>C	p.Ser164Pro	principal1	Y	1	YES	Select	+	TCA	1	0	T	T/T	T/T	T/T	T/T	0.058	0.37901	T	0.013	0.63436	D	1.0	0.90580	D	1.0	0.97365	D	0.95	0.94956	A	simple_aae	5.0	95.0	3.655	0.94139	H	-4.33	0.76771	D	0.987	0.99555	1.0279	0.97671	D	0.9840	0.99512	D	10	0.99511206	0.99975	D	0.958813	0.99727	D	0.966	0.99545	0.941	0.99203	P00480	S164P	Loss of catalytic residue at S164 (P = 0.0641)| Loss of stability (P = 0.2165)| Loss of loop (P = 0.2897)| Loss of sheet (P = 0.302)| Gain of phosphorylation at Y167 (P = 0.3791)	0.99667102004	0.99659	0.9896779762021651	0.98959	1.33045043217	0.83554	0.635188698769	0.57816	T	0.972398	0.99708	D	0.693085	0.99924	D	0.757792	0.99923	D	0.998160541057587	0.93345	D	0.993751	0.97964	D	0.99350244	0.99916	0.9808492	0.99838	0.99350244	0.99916	0.9808492	0.99838	-15.812	0.97471	D	0.988	0.92990	P	0.999978954517533	0.99427	0.99864346	0.98885	0.974	0.99029	.	.	.	.	.	.	4.809679	0.78275	26.9	0.99897030958742061	0.96973	.	.	.	.	.	.	.	.	.	5.97	5.97	0.96929	.	.	7.628	0.82424	7.798000	0.69116	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.999	0.91597	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided	no_assertion_criteria_provided	NC_000023.11:g.38401378T>C	ClinGen:CA224640	CN517202	.	.	Aspartate/ornithine carbamoyltransferase, carbamoyl-P binding	Ser	Pro	103111	single nucleotide variant	NM_000531.6(OTC):c.490T>C (p.Ser164Pro)	5009	OTC	HGNC:8512	Pathogenic	1	-	72556273	-	RCV000083459	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38401378	38401378	Xp11.4	no assertion criteria provided	1	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224640	2	97219	38401378	T	C	-	-	-	-	-	-	SCV000115545	-	-	490T>C 	Ser164Pro	NM_000531.6		1_Pathogenic	OTC	ENSG00000036473	71569	205870	CCSBVarC005248	ALE00005248	490T>C	Ser164Pro	CEGS2	CegsMutGDEh1017	A10	GDEhDisVCh_40048	H03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Ser164Pro	23	X	38401378	T	C
2803	HMBS	530T>G	Leu177Arg	ENSG00000256269	11	119091444	NC_000011.10:119091444:T:G	ALE00005167	CCSBVarC005167	NULL	200934	NULL	GDEhDisVCh_40054	A06	CEGS2	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAGCTTGCTCGCATACAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGGACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCTTGAACATGCCCTGGAGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCGAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTCGGGGAAACCTCAACACCCGGCTTCGGAAGCGGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACCGGGTGGGGCAGATCCTGCACCCTGAGGAATGCATGTATGCTGTGGGCCAGGGGGCCTTGGGCGTGGAAGTGCGAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCTGCATCGCTGAAAGGGCCTTCCTGAGGCACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATGGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCGTAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACGATGCCCAT	16505.0	single nucleotide variant	NM_000190.4(HMBS):c.530T>G (p.Leu177Arg)	3145.0	HMBS	HGNC:4982	Pathogenic	1.0	May 12, 2024	118204108.0	-	RCV000001531|RCV000795368	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900	Acute intermittent porphyria|not provided	germline	germline	GRCh38	NC_000011.10	11	119091444.0	119091444.0	11q23.3	criteria provided, single submitter	2.0	-	N	ClinGen:CA251824,UniProtKB:P08397#VAR_003655,OMIM:609806.0025	3.0	1466.0	119091444.0	T	G	-	-	-	-	-	-	SCV000934830	-	-	530T>G 	Leu177Arg	NM_000190.4	1.0	1_Pathogenic	chr11	T	G	11-119091444-T-G		1466	11	119091444	T	G	L	R	rs118204108	11	118962154	11	118467364	177	HMBS	ENSG00000256269	ENST00000652429	ENSP00000498786	P08397	HEM3_HUMAN	c.530T>G	p.Leu177Arg	c.530T>G	p.Leu177Arg	principal2	Y	.	YES	Select	+	CTG	2	0	T	T/T	T/T	T/T	T/T	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	1.0	0.97365	D	.	0.97926	.	.	.	.	4.36	0.98474	H	.	0.88658	.	.	0.99488	0.8976	0.95626	D	0.9965	0.99918	D	9	.	0.99905	.	0.778706	0.98252	D	.	0.99762	0.962	0.99611	P08397	L177R	Gain of disorder (P = 0.0269)| Loss of stability (P = 0.0272)| Gain of MoRF binding (P = 0.0286)| Loss of ubiquitination at K176 (P = 0.04)| Gain of methylation at K176 (P = 0.1086)	.	0.97744	0.983534111802567	0.98338	.	.	0.66516071558	0.62086	T	0.996548	0.99995	D	0.581728	0.96992	D	0.597836	0.96943	D	0.999697804450989	0.98518	D	0.9966	0.98792	D	0.99231756	0.99871	0.9704963	0.99478	0.9869665	0.99584	0.97443515	0.99637	-14.057	0.93253	D	0.9787	0.91138	P	0.999862870021976	0.98431	0.42257014	0.80134	1	0.99985	.	.	.	.	.	.	5.479796	0.91377	32.0	0.9977249345090573	0.86015	0.948240	0.95951	D	1.08391501024531	0.97813	16.84069	0.987955024229163	0.98372	18.12268	5.95	5.95	0.96408	5.91	0.96850	7.965	0.87528	7.881000	0.72550	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.987	0.62545	228	0.91137	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Acute_intermittent_porphyria|not_provided	criteria_provided,_single_submitter	NC_000011.10:g.119091444T>G	ClinGen:CA251824|OMIM:609806.0025|UniProtKB:P08397#VAR_003655	C0162565|C3661900	176000	79276	Porphobilinogen deaminase, N-terminal	Leu	Arg	16505	single nucleotide variant	NM_000190.4(HMBS):c.530T>G (p.Leu177Arg)	3145	HMBS	HGNC:4982	Pathogenic	1	May 12, 2024	118204108	-	RCV000001531|RCV000795368	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900	Acute intermittent porphyria|not provided	germline	germline	GRCh38	NC_000011.10	11	119091444	119091444	11q23.3	criteria provided, single submitter	2	-	N	ClinGen:CA251824,UniProtKB:P08397#VAR_003655,OMIM:609806.0025	3	1466	119091444	T	G	-	-	-	-	-	-	SCV000934830	-	-	530T>G 	Leu177Arg	NM_000190.4	1	1_Pathogenic	HMBS	ENSG00000256269	2803	200934	CCSBVarC005167	ALE00005167	530T>G	Leu177Arg	CEGS2	CegsMutGDEh1040	E10	GDEhDisVCh_40054	A06	2	CegsMutGDDh1040	E10	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	HMBS_Leu177Arg	11	11	119091444	T	G
3689	GCK	1367C>T	Ala456Val	ENSG00000106633	7	44145167	NC_000007.14:44145167:G:A	ALE00006698	CCSBVarC006700	NULL	214863	NULL	GDEhDisVCh_40037	A02	CEGS2	ATGCTGGACGACAGAGCCAGGATGGAGGCCGCCAAGAAGGAGAAGGTAGAGCAGATCCTGGCAGAGTTCCAGCTGCAGGAGGAGGACCTGAAGAAGGTGATGAGACGGATGCAGAAGGAGATGGACCGCGGCCTGAGGCTGGAGACCCATGAAGAGGCCAGTGTGAAGATGCTGCCCACCTACGTGCGCTCCACCCCAGAAGGCTCAGAAGTCGGGGACTTCCTCTCCCTGGACCTGGGTGGCACTAACTTCAGGGTGATGCTGGTGAAGGTGGGAGAAGGTGAGGAGGGGCAGTGGAGCGTGAAGACCAAACACCAGATGTACTCCATCCCCGAGGACGCCATGACCGGCACTGCTGAGATGCTCTTCGACTACATCTCTGAGTGCATCTCCGACTTCCTGGACAAGCATCAGATGAAACACAAGAAGCTGCCCCTGGGCTTCACCTTCTCCTTTCCTGTGAGGCACGAAGACATCGATAAGGGCATCCTTCTCAACTGGACCAAGGGCTTCAAGGCCTCAGGAGCAGAAGGGAACAATGTCGTGGGGCTTCTGCGAGACGCTATCAAACGGAGAGGGGACTTTGAAATGGATGTGGTGGCAATGGTGAATGACACGGTGGCCACGATGATCTCCTGCTACTACGAAGACCATCAGTGCGAGGTCGGCATGATCGTGGGCACGGGCTGCAATGCCTGCTACATGGAGGAGATGCAGAATGTGGAGCTGGTGGAGGGGGACGAGGGCCGCATGTGCGTCAATACCGAGTGGGGCGCCTTCGGGGACTCCGGCGAGCTGGACGAGTTCCTGCTGGAGTATGACCGCCTGGTGGACGAGAGCTCTGCAAACCCCGGTCAGCAGCTGTATGAGAAGCTCATAGGTGGCAAGTACATGGGCGAGCTGGTGCGGCTTGTGCTGCTCAGGCTCGTGGACGAAAACCTGCTCTTCCACGGGGAGGCCTCCGAGCAGCTGCGCACACGCGGAGCCTTCGAGACGCGCTTCGTGTCGCAGGTGGAGAGCGACACGGGCGACCGCAAGCAGATCTACAACATCCTGAGCACGCTGGGGCTGCGACCCTCGACCACCGACTGCGACATCGTGCGCCGCGCCTGCGAGAGCGTGTCTACGCGCGCTGCGCACATGTGCTCGGCGGGGCTGGCGGGCGTCATCAACCGCATGCGCGAGAGCCGCAGCGAGGACGTAATGCGCATCACTGTGGGCGTGGATGGCTCCGTGTACAAGCTGCACCCCAGCTTCAAGGAGCGGTTCCATGCCAGCGTGCGCAGGCTGACGCCCAGCTGCGAGATCACCTTCATCGAGTCGGAGGAGGGCAGTGGCCGGGGCGCGGCCCTGGTCTCGGCGGTGGTCTGTAAGAAGGCCTGTATGCTGGGCCAG	31182.0	single nucleotide variant	NM_000162.5(GCK):c.1367C>T (p.Ala456Val)	2645.0	GCK	HGNC:4195	Pathogenic	1.0	Jan 28, 2023	104894014.0	-	RCV000017525|RCV001818166	MONDO:MONDO:0011236,MedGen:C1865290,OMIM:602485,Orphanet:79299|MedGen:C3661900	Hyperinsulinism due to glucokinase deficiency|not provided	germline	germline	GRCh38	NC_000007.14	7	44145167.0	44145167.0	7p13	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA257433,OMIM:138079.0012	3.0	16143.0	44145167.0	G	A	-	-	-	-	-	-	SCV002069051|SCV004295117	-	-	1367C>T 	Ala456Val	NM_000162.5	2.0	1_Pathogenic	chr7	C	T	7-44145167-C-T		16143	7	44145167	G	A	A	V	rs104894014	7	44184766	7	44151291	456	GCK	ENSG00000106633	ENST00000403799	ENSP00000384247	P35557	HXK4_HUMAN	c.1367C>T	p.Ala456Val	c.1367C>T	p.Ala456Val	principal1	Y	1	YES	Select	-	GCC	2	0	G	G/G	G/G	G/G	G/G	0.001	0.91343	D	0.031	0.79703	D	0.741	0.43007	P	0.285	0.40507	B	0.94	0.97926	A	simple_aae	6.0	94.0	2.59	0.75533	M	-2.98	0.72746	D	0.748	0.80898	1.0449	0.98005	D	0.9341	0.97825	D	9	0.9824671	0.98310	D	0.669219	0.97232	D	0.883	0.96569	0.917	0.98450	P35557	A456V	Loss of ubiquitination at K459 (P = 0.0573)| Loss of disorder (P = 0.0694)| Gain of MoRF binding (P = 0.1055)| Gain of methylation at K458 (P = 0.3134)| Loss of glycosylation at K459 (P = 0.3226)	0.983964010106	0.98362	.	0.97998	.	0.85765	0.658395051956	0.61117	T	0.871267	0.97198	D	0.541934	0.95451	D	0.540674	0.95384	D	0.993778884410858	0.84594	D	0.928207	0.73431	D	0.9264582	0.93791	0.7326991	0.84014	0.9079935	0.91994	0.6160257	0.77410	-10.765	0.78424	D	0.3825	0.78963	A	0.982473258176508	0.85939	0.99973851	0.99666	1	0.99985	.	.	.	.	.	.	4.859673	0.79556	27.1	0.99911769611563572	0.98096	0.964248	0.98628	D	0.735291984358795	0.81845	7.642499	0.778162557345056	0.88171	9.507479	5.75	5.75	0.90377	.	.	9.382	0.96604	11.769000	0.95819	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.963	0.52396	721	0.55304	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	Hyperinsulinism_due_to_glucokinase_deficiency|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.44145167G>A	ClinGen:CA257433|OMIM:138079.0012	C1865290|C3661900	602485	79299	.	Ala	Val	31182	single nucleotide variant	NM_000162.5(GCK):c.1367C>T (p.Ala456Val)	2645	GCK	HGNC:4195	Pathogenic	1	Jan 28, 2023	104894014	-	RCV000017525|RCV001818166	MONDO:MONDO:0011236,MedGen:C1865290,OMIM:602485,Orphanet:79299|MedGen:C3661900	Hyperinsulinism due to glucokinase deficiency|not provided	germline	germline	GRCh38	NC_000007.14	7	44145167	44145167	7p13	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA257433,OMIM:138079.0012	3	16143	44145167	G	A	-	-	-	-	-	-	SCV002069051|SCV004295117	-	-	1367C>T 	Ala456Val	NM_000162.5	2	1_Pathogenic	GCK	ENSG00000106633	3689	214863	CCSBVarC006700	ALE00006698	1367C>T	Ala456Val	CEGS2	CegsMutGDEh1043	F12	GDEhDisVCh_40037	A02	1	CegsMutGDDh1043	F12	VUSN2Hmut_GDN2h_09	E04	VUSMutpDEST2_03	C10	VUSmut_GDEh09	E04	1	7	1	7	1	6	1	6	1	6	GCK_Ala456Val	7	7	44145167	G	A
7918	MSH2	1004C>T	Thr335Ile	ENSG00000095002	2	47416357	NC_000002.12:47416357:C:T	ALE00003006	CCSBVarC003006	NULL	202658	NULL	GDEhDisVCh_40060	H06	CEGS2	ATGGCGGTGCAGCCGAAGGAGACGCTGCAGTTGGAGAGCGCGGCCGAGGTCGGCTTCGTGCGCTTCTTTCAGGGCATGCCGGAGAAGCCGACCACCACAGTGCGCCTTTTCGACCGGGGCGACTTCTATACGGCGCACGGCGAGGACGCGCTGCTGGCCGCCCGGGAGGTGTTCAAGACCCAGGGGGTGATCAAGTACATGGGGCCGGCAGGAGCAAAGAATCTGCAGAGTGTTGTGCTTAGTAAAATGAATTTTGAATCTTTTGTAAAAGATCTTCTTCTGGTTCGTCAGTATAGAGTTGAAGTTTATAAGAATAGAGCTGGAAATAAGGCATCCAAGGAGAATGATTGGTATTTGGCATATAAGGCTTCTCCTGGCAATCTCTCTCAGTTTGAAGACATTCTCTTTGGTAACAATGATATGTCAGCTTCCATTGGTGTTGTGGGTGTTAAAATGTCCGCAGTTGATGGCCAGAGACAGGTTGGAGTTGGGTATGTGGATTCCATACAGAGGAAACTAGGACTGTGTGAATTCCCTGATAATGATCAGTTCTCCAATCTTGAGGCTCTCCTCATCCAGATTGGACCAAAGGAATGTGTTTTACCCGGAGGAGAGACTGCTGGAGACATGGGGAAACTGAGACAGATAATTCAAAGAGGAGGAATTCTGATCACAGAAAGAAAAAAAGCTGACTTTTCCACAAAAGACATTTATCAGGACCTCAACCGGTTGTTGAAAGGCAAAAAGGGAGAGCAGATGAATAGTGCTGTATTGCCAGAAATGGAGAATCAGGTTGCAGTTTCATCACTGTCTGCGGTAATCAAGTTTTTAGAACTCTTATCAGATGATTCCAACTTTGGACAGTTTGAACTGACTACTTTTGACTTCAGCCAGTATATGAAATTGGATATTGCAGCAGTCAGAGCCCTTAACCTTTTTCAGGGTTCTGTTGAAGATACCACTGGCTCTCAGTCTCTGGCTGCCTTGCTGAATAAGTGTAAAATCCCTCAAGGACAAAGACTTGTTAACCAGTGGATTAAGCAGCCTCTCATGGATAAGAACAGAATAGAGGAGAGATTGAATTTAGTGGAAGCTTTTGTAGAAGATGCAGAATTGAGGCAGACTTTACAAGAAGATTTACTTCGTCGATTCCCAGATCTTAACCGACTTGCCAAGAAGTTTCAAAGACAAGCAGCAAACTTACAAGATTGTTACCGACTCTATCAGGGTATAAATCAACTACCTAATGTTATACAGGCTCTGGAAAAACATGAAGGAAAACACCAGAAATTATTGTTGGCAGTTTTTGTGACTCCTCTTACTGATCTTCGTTCTGACTTCTCCAAGTTTCAGGAAATGATAGAAACAACTTTAGATATGGATCAGGTGGAAAACCATGAATTCCTTGTAAAACCTTCATTTGATCCTAATCTCAGTGAATTAAGAGAAATAATGAATGACTTGGAAAAGAAGATGCAGTCAACATTAATAAGTGCAGCCAGAGATCTTGGCTTGGACCCTGGCAAACAGATTAAACTGGATTCCAGTGCACAGTTTGGATATTACTTTCGTGTAACCTGTAAGGAAGAAAAAGTCCTTCGTAACAATAAAAACTTTAGTACTGTAGATATCCAGAAGAATGGTGTTAAATTTACCAACAGCAAATTGACTTCTTTAAATGAAGAGTATACCAAAAATAAAACAGAATATGAAGAAGCCCAGGATGCCATTGTTAAAGAAATTGTCAATATTTCTTCAGGCTATGTAGAACCAATGCAGACACTCAATGATGTGTTAGCTCAGCTAGATGCTGTTGTCAGCTTTGCTCACGTGTCAAATGGAGCACCTGTTCCATATGTACGACCAGCCATTTTGGAGAAAGGACAAGGAAGAATTATATTAAAAGCATCCAGGCATGCTTGTGTTGAAGTTCAAGATGAAATTGCATTTATTCCTAATGACGTATACTTTGAAAAAGATAAACAGATGTTCCACATCATTACTGGCCCCAATATGGGAGGTAAATCAACATATATTCGACAAACTGGGGTGATAGTACTCATGGCCCAAATTGGGTGTTTTGTGCCATGTGAGTCAGCAGAAGTGTCCATTGTGGACTGCATCTTAGCCCGAGTAGGGGCTGGTGACAGTCAATTGAAAGGAGTCTCCACGTTCATGGCTGAAATGTTGGAAACTGCTTCTATCCTCAGGTCTGCAACCAAAGATTCATTAATAATCATAGATGAATTGGGAAGAGGAACTTCTACCTACGATGGATTTGGGTTAGCATGGGCTATATCAGAATACATTGCAACAAAGATTGGTGCTTTTTGCATGTTTGCAACCCATTTTCATGAACTTACTGCCTTGGCCAATCAGATACCAACTGTTAATAATCTACATGTCACAGCACTCACCACTGAAGAGACCTTAACTATGCTTTATCAGGTGAAGAAAGGTGTCTGTGATCAAAGTTTTGGGATTCATGTTGCAGAGCTTGCTAATTTCCCTAAGCATGTAATAGAGTGTGCTAAACAGAAAGCCCTGGAACTTGAGGAGTTTCAGTATATTGGAGAATCGCAAGGATATGATATCATGGAACCAGCAGCAAAGAAGTGCTATCTGGAAAGAGAGCAAGGTGAAAAAATTATTCAGGAGTTCCTGTCCAAGGTGAAACAAATGCCCTTTACTGAAATGTCAGAAGAAAACATCACAATAAAGTTAAAACAGCTAAAAGCTGAAGTAATAGCAAAGAATAATAGCTTTGTAAATGAAATCATTTCACGAATAAAAGTTACTACG	95974.0	single nucleotide variant	NM_000251.3(MSH2):c.1004C>T (p.Thr335Ile)	4436.0	MSH2	HGNC:7325	Uncertain significance	0.0	May 08, 2024	63750602.0	-	RCV000236871|RCV001344528	MedGen:C3661900|MeSH:D003123,MedGen:C0009405	not provided|Hereditary nonpolyposis colorectal neoplasms	germline	germline	GRCh38	NC_000002.12	2	47416357.0	47416357.0	2p21	criteria provided, multiple submitters, no conflicts	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016806,UniProtKB:P43246#VAR_043760	2.0	90499.0	47416357.0	C	T	-	-	-	-	-	-	SCV000293507|SCV001538588	-	-	1004C>T 	Thr335Ile	NM_000251.3	2.0	4_VUS	chr2	C	T	2-47416357-C-T	2.05612e-6	90499	2	47416357	C	T	T	I	rs63750602	2	47643496	2	47497000	335	MSH2	ENSG00000095002	ENST00000233146	ENSP00000233146	P43246	MSH2_HUMAN	c.1004C>T	p.Thr335Ile	c.1004C>T	p.Thr335Ile	principal1	Y	1	YES	Select	+	ACC	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.002	0.83643	D	0.999	0.90580	D	0.995	0.83178	D	0.81	0.93300	D	simple_aae	19.0	81.0	3.525	0.92921	H	-5.77	0.87940	D	0.98	0.99026	1.0878	0.99151	D	0.9708	0.99078	D	10	0.98929	0.99381	D	0.568177	0.96078	D	0.975	0.99762	0.926	0.98766	P43246	T335I	Loss of disorder (P = 0.0749)| Gain of MoRF binding (P = 0.1046)| Loss of phosphorylation at T335 (P = 0.1459)| Loss of methylation at K332 (P = 0.1775)| Gain of helix (P = 0.2059)	0.98554447009	0.98523	0.8360262820743574	0.83463	0.0340003905406	0.03455	0.797455430031	0.81543	T	0.929503	0.98783	D	0.584342	0.97050	D	0.601591	0.97001	D	0.992751598358154	0.83186	D	0.999575	0.99830	D	0.9581188	0.97044	0.92695224	0.96839	0.9708321	0.98309	0.9362093	0.97480	-12.377	0.86705	D	0.9633	0.90112	P	0.997023447629364	0.92697	0.99984264	0.99792	0.986	0.99524	.	.	.	.	.	.	4.726554	0.76136	26.4	0.99911006789451806	0.98024	0.901174	0.84701	D	0.976549554600036	0.94950	13.20148	0.909179137188649	0.95939	14.15029	5.62	5.62	0.85695	3.82	0.71118	7.759	0.84127	7.512000	0.59699	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.998	0.85369	824	0.40289	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109408	0.000000e+00	0	0	208130	0.000000e+00	0	1	236928	4.220690e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	0	89554	0.000000e+00	0	0	30608	0.000000e+00	0	.	.	.	.	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	1	102734	9.733880e-06	0	0	30526	0.000000e+00	0	1	102734	9.733880e-06	0	.	3	1611324	1.861820e-06	0	1	91016	1.098710e-05	0	0	74952	0.000000e+00	0	0	912	0.000000e+00	0	0	60010	0.000000e+00	0	0	29580	0.000000e+00	0	0	44852	0.000000e+00	0	0	64026	0.000000e+00	0	0	6058	0.000000e+00	0	2	1177500	1.698510e-06	0	1	91016	1.098710e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	Hereditary_nonpolyposis_colorectal_neoplasms|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000002.12:g.47416357C>T	ClinGen:CA016806|UniProtKB:P43246#VAR_043760	C0009405|C3661900	.	.	DNA mismatch repair protein MutS, core|DNA mismatch repair protein MutS, core	Thr	Ile	95974	single nucleotide variant	NM_000251.3(MSH2):c.1004C>T (p.Thr335Ile)	4436	MSH2	HGNC:7325	Uncertain significance	0	May 08, 2024	63750602	-	RCV000236871|RCV001344528	MedGen:C3661900|MeSH:D003123,MedGen:C0009405	not provided|Hereditary nonpolyposis colorectal neoplasms	germline	germline	GRCh38	NC_000002.12	2	47416357	47416357	2p21	criteria provided, multiple submitters, no conflicts	2	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA016806,UniProtKB:P43246#VAR_043760	2	90499	47416357	C	T	-	-	-	-	-	-	SCV000293507|SCV001538588	-	-	1004C>T 	Thr335Ile	NM_000251.3	2	4_VUS	MSH2	ENSG00000095002	7918	202658	CCSBVarC003006	ALE00003006	1004C>T	Thr335Ile	CEGS2	CegsMutGDEh1037	E06	GDEhDisVCh_40060	H06	2	CegsMutGDDh1037	E06	NULL	NULL	VUSMutpDEST2_07	D03	NULL	NULL	1	1	1	1	0	NULL	1	1	0	NULL	MSH2_Thr335Ile	2	2	47416357	C	T
3172	CBS	434C>T	Pro145Leu	ENSG00000160200	21	43066260	NC_000021.9:43066260:G:A	ALE00003750	CCSBVarC003750	NULL	214522	NULL	GDEhDisVCh_40055	A07	CEGS2	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTCCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCTGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCCGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	15157.0	single nucleotide variant	NM_000071.3(CBS):c.434C>T (p.Pro145Leu)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Aug 01, 2024	121964963.0	-	RCV000000139|RCV000625555|RCV001250193|RCV002227955	MedGen:C3502110|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344	Homocystinuria, pyridoxine-responsive|Classic homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;inherited;unknown	germline	GRCh38	NC_000021.9	21	43066260.0	43066260.0	21q22.3	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA113876,UniProtKB:P35520#VAR_002178,OMIM:613381.0002	3.0	118.0	43066260.0	G	A	-	-	-	-	-	-	SCV000930439|SCV001393783|SCV001424384|SCV004215561|SCV005381641	-	-	434C>T 	Pro145Leu	NM_000071.3	2.0	1_Pathogenic	chr21	C	T	21-43066260-C-T		118	21	43066260	G	A	P	L	rs121964963	21	44486370	21	43359439	145	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.434C>T	p.Pro145Leu	c.434C>T	p.Pro145Leu	principal1	Y	1	.	.	-	CCG	2	0	G	G/G	G/G	G/G	G/G	0.001	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	0.998	0.88579	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.48	0.92449	M	-9.62	0.98586	D	0.912	0.91390	1.1016	0.99724	D	0.9530	0.98470	D	9	0.99409586	0.99922	D	0.659401	0.97130	D	0.925	0.98152	0.935	0.99041	P35520	P145L	Loss of disorder (P = 0.0377)| Loss of glycosylation at T146 (P = 0.0564)| Gain of sheet (P = 0.0827)| Loss of phosphorylation at T146 (P = 0.0921)| Loss of catalytic residue at P145 (P = 0.1277)	0.941240362198	0.94016	.	0.96284	.	0.78518	0.800106883049	0.81947	T	0.98551	0.99909	D	0.438656	0.91901	D	0.561451	0.95928	D	0.99949586391449	0.97611	D	.	0.98816	.	0.9602329	0.97260	0.8466256	0.91163	0.96367216	0.97609	0.8289921	0.89992	-14.906	0.95637	D	0.9094	0.83364	LP	0.999763683576372	0.97851	0.99987042	0.99835	0.997	0.99892	.	.	.	.	.	.	5.239538	0.87974	29.4	0.99886131467000761	0.96129	0.947669	0.95833	D	0.827814626038984	0.87745	9.349182	0.702467476960658	0.82469	7.798867	5.23	5.23	0.72532	.	.	8.693	0.91034	11.382000	0.92639	0.59	0.31918	1.0	0.71675	1.000000	0.68239	0.102	0.18419	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	108278	0.000000e+00	0	0	206624	0.000000e+00	0	1	235678	4.243080e-06	0	0	7140	0.000000e+00	0	0	17100	0.000000e+00	0	0	2314	0.000000e+00	0	0	9032	0.000000e+00	0	0	12378	0.000000e+00	0	0	42724	0.000000e+00	0	0	15688	0.000000e+00	0	.	.	.	.	0	16168	0.000000e+00	0	0	30506	0.000000e+00	0	0	6200	0.000000e+00	0	0	13380	0.000000e+00	0	0	15718	0.000000e+00	0	0	89200	0.000000e+00	0	0	30606	0.000000e+00	0	.	.	.	.	0	14870	0.000000e+00	0	0	34236	0.000000e+00	0	0	9560	0.000000e+00	0	1	17678	5.656750e-05	0	0	20614	0.000000e+00	0	0	102590	0.000000e+00	0	0	30524	0.000000e+00	0	1	17678	5.656750e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic/Likely_pathogenic	Homocystinuria|Homocystinuria,_pyridoxine-responsive|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Classic_homocystinuria	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43066260G>A	ClinGen:CA113876|OMIM:613381.0002|UniProtKB:P35520#VAR_002178	C0019880|C3502110|C3150344|C0751202	236200	394	Tryptophan synthase beta chain-like, PALP domain	Pro	Leu	15157	single nucleotide variant	NM_000071.3(CBS):c.434C>T (p.Pro145Leu)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Aug 01, 2024	121964963	-	RCV000000139|RCV000625555|RCV001250193|RCV002227955	MedGen:C3502110|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344	Homocystinuria, pyridoxine-responsive|Classic homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;inherited;unknown	germline	GRCh38	NC_000021.9	21	43066260	43066260	21q22.3	criteria provided, multiple submitters, no conflicts	7	-	N	ClinGen:CA113876,UniProtKB:P35520#VAR_002178,OMIM:613381.0002	3	118	43066260	G	A	-	-	-	-	-	-	SCV000930439|SCV001393783|SCV001424384|SCV004215561|SCV005381641	-	-	434C>T 	Pro145Leu	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	294	CCSBVarC007339	ALE00003750	434C>T	Pro145Leu	Edgotyping3	VUSMutGDEh011	F03	GDEhDisVCh_40013	H08	1	VUSMutGDDh011	F03	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	5	0	NULL	0	NULL	0	NULL	CBS_Pro145Leu	21	21	43066260	G	A
3172	CBS	434C>T	Pro145Leu	ENSG00000160200	21	43066260	NC_000021.9:43066260:G:A	ALE00003750	CCSBVarC003750	NULL	214522	NULL	GDEhDisVCh_40055	A07	CEGS2	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTCCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCTGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCCGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	15157.0	single nucleotide variant	NM_000071.3(CBS):c.434C>T (p.Pro145Leu)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Aug 01, 2024	121964963.0	-	RCV000000139|RCV000625555|RCV001250193|RCV002227955	MedGen:C3502110|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344	Homocystinuria, pyridoxine-responsive|Classic homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;inherited;unknown	germline	GRCh38	NC_000021.9	21	43066260.0	43066260.0	21q22.3	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA113876,UniProtKB:P35520#VAR_002178,OMIM:613381.0002	3.0	118.0	43066260.0	G	A	-	-	-	-	-	-	SCV000930439|SCV001393783|SCV001424384|SCV004215561|SCV005381641	-	-	434C>T 	Pro145Leu	NM_000071.3	2.0	1_Pathogenic	chr21	C	T	21-43066260-C-T		118	21	43066260	G	A	P	L	rs121964963	21	44486370	21	43359439	145	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.434C>T	p.Pro145Leu	c.434C>T	p.Pro145Leu	principal1	Y	1	.	.	-	CCG	2	0	G	G/G	G/G	G/G	G/G	0.001	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	0.998	0.88579	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.48	0.92449	M	-9.62	0.98586	D	0.912	0.91390	1.1016	0.99724	D	0.9530	0.98470	D	9	0.99409586	0.99922	D	0.659401	0.97130	D	0.925	0.98152	0.935	0.99041	P35520	P145L	Loss of disorder (P = 0.0377)| Loss of glycosylation at T146 (P = 0.0564)| Gain of sheet (P = 0.0827)| Loss of phosphorylation at T146 (P = 0.0921)| Loss of catalytic residue at P145 (P = 0.1277)	0.941240362198	0.94016	.	0.96284	.	0.78518	0.800106883049	0.81947	T	0.98551	0.99909	D	0.438656	0.91901	D	0.561451	0.95928	D	0.99949586391449	0.97611	D	.	0.98816	.	0.9602329	0.97260	0.8466256	0.91163	0.96367216	0.97609	0.8289921	0.89992	-14.906	0.95637	D	0.9094	0.83364	LP	0.999763683576372	0.97851	0.99987042	0.99835	0.997	0.99892	.	.	.	.	.	.	5.239538	0.87974	29.4	0.99886131467000761	0.96129	0.947669	0.95833	D	0.827814626038984	0.87745	9.349182	0.702467476960658	0.82469	7.798867	5.23	5.23	0.72532	.	.	8.693	0.91034	11.382000	0.92639	0.59	0.31918	1.0	0.71675	1.000000	0.68239	0.102	0.18419	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	108278	0.000000e+00	0	0	206624	0.000000e+00	0	1	235678	4.243080e-06	0	0	7140	0.000000e+00	0	0	17100	0.000000e+00	0	0	2314	0.000000e+00	0	0	9032	0.000000e+00	0	0	12378	0.000000e+00	0	0	42724	0.000000e+00	0	0	15688	0.000000e+00	0	.	.	.	.	0	16168	0.000000e+00	0	0	30506	0.000000e+00	0	0	6200	0.000000e+00	0	0	13380	0.000000e+00	0	0	15718	0.000000e+00	0	0	89200	0.000000e+00	0	0	30606	0.000000e+00	0	.	.	.	.	0	14870	0.000000e+00	0	0	34236	0.000000e+00	0	0	9560	0.000000e+00	0	1	17678	5.656750e-05	0	0	20614	0.000000e+00	0	0	102590	0.000000e+00	0	0	30524	0.000000e+00	0	1	17678	5.656750e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic/Likely_pathogenic	Homocystinuria|Homocystinuria,_pyridoxine-responsive|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Classic_homocystinuria	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43066260G>A	ClinGen:CA113876|OMIM:613381.0002|UniProtKB:P35520#VAR_002178	C0019880|C3502110|C3150344|C0751202	236200	394	Tryptophan synthase beta chain-like, PALP domain	Pro	Leu	15157	single nucleotide variant	NM_000071.3(CBS):c.434C>T (p.Pro145Leu)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Aug 01, 2024	121964963	-	RCV000000139|RCV000625555|RCV001250193|RCV002227955	MedGen:C3502110|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344	Homocystinuria, pyridoxine-responsive|Classic homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;inherited;unknown	germline	GRCh38	NC_000021.9	21	43066260	43066260	21q22.3	criteria provided, multiple submitters, no conflicts	7	-	N	ClinGen:CA113876,UniProtKB:P35520#VAR_002178,OMIM:613381.0002	3	118	43066260	G	A	-	-	-	-	-	-	SCV000930439|SCV001393783|SCV001424384|SCV004215561|SCV005381641	-	-	434C>T 	Pro145Leu	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	3172	214522	CCSBVarC003750	ALE00003750	434C>T	Pro145Leu	CEGS2	CegsMutGDEh1039	A08	GDEhDisVCh_40055	A07	1	CegsMutGDDh1039	A08	NULL	NULL	NULL	NULL	NULL	NULL	1	6	1	1	0	NULL	0	NULL	0	NULL	CBS_Pro145Leu	21	21	43066260	G	A
3774	TP53	467G>A	Arg156His	ENSG00000141510	17	7675145	NC_000017.11:7675145:C:T	ALE00004859	CCSBVarC004859	NULL	214890	NULL	GDEhDisVCh_40053	C04	CEGS2	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCACGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACCGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	133268.0	single nucleotide variant	NM_000546.6(TP53):c.467G>A (p.Arg156His)	7157.0	TP53	HGNC:11998	Uncertain significance	1.0	Feb 22, 2021	371524413.0	-	RCV000115722|RCV000148908|RCV000213052|RCV000656987|RCV000989720|RCV003467059|RCV005016393|RCV001030737|RCV001293017|RCV002272128	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0010150,MeSH:D000077195,MedGen:C1168401,OMIM:275355,Orphanet:67037|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501|12 conditions|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not specified|not provided|Squamous cell carcinoma of the head and neck|Adrenocortical carcinoma, hereditary|12 conditions|Hereditary breast ovarian cancer syndrome|Li-Fraumeni syndrome 1|Familial cancer of breast	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7675145.0	7675145.0	17p13.1	reviewed by expert panel	19.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000216,UniProtKB:P04637#VAR_044841	2.0	127811.0	7675145.0	C	T	-	-	-	-	-	-	SCV001481787	-	-	467G>A 	Arg156His	NM_000546.6	3.0	4_VUS	chr17	G	A	17-7675145-G-A		127811	17	7675145	C	T	R	H	rs371524413	17	7578463	17	7519188	156	TP53	ENSG00000141510	ENST00000445888	ENSP00000391478	P04637	P53_HUMAN	c.467G>A	p.Arg156His	c.467G>A	p.Arg156His	principal1	Y	1	.	.	-	CGC	2	0	C	C/C	C/C	C/C	C/C	0.023	0.63383	D	0.253	0.48688	T	0.981	0.90580	D	0.826	0.65544	P	0.99	0.97926	D	simple_aae	1.0	99.0	2.3	0.65510	M	-0.68	0.32155	N	0.745	0.74349	1.0790	0.98848	D	0.9827	0.99470	D	10	0.7863584	0.78065	D	0.580224	0.96229	D	0.627	0.85546	.	.	.	.	.	0.96212896792	0.96138	.	0.36392	.	0.91925	0.321985304356	0.13710	T	0.796892	0.94734	D	0.171905	0.71087	D	0.190681	0.82481	D	0.695308089256287	0.40193	D	.	0.50637	.	0.39438	0.60016	0.11918635	0.28699	0.33014143	0.55151	0.11775264	0.28357	-8.451	0.64690	D	0.1586	0.41620	B	0.31580158718421	0.54804	0.99974567	0.99678	0.292	0.56112	.	.	.	.	.	.	2.182287	0.27866	17.59	0.99793923151291997	0.87938	0.604550	0.59416	D	0.00383049912895711	0.41766	2.52475	-0.144334035034761	0.33317	1.925519	5.47	3.45	0.38530	2.13	0.41176	4.688	0.61487	1.370000	0.26034	0.599	0.40292	0.394	0.26209	0.764000	0.26727	0.06	0.1601	434	0.80544	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	.	2	109386	1.828390e-05	0	4	207988	1.923190e-05	0	3	236748	1.267170e-05	0	0	7160	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13390	0.000000e+00	0	1	42760	2.338630e-05	0	1	15686	6.375110e-05	0	1	15686	6.375110e-05	0	0	16198	0.000000e+00	0	0	30518	0.000000e+00	0	0	6208	0.000000e+00	0	0	13416	0.000000e+00	0	0	16728	0.000000e+00	0	2	89454	2.235790e-05	0	2	30604	6.535090e-05	0	2	30604	6.535090e-05	0	0	14884	0.000000e+00	0	0	34258	0.000000e+00	0	0	9566	0.000000e+00	0	0	17692	0.000000e+00	0	0	21624	0.000000e+00	0	1	102586	9.747920e-06	0	2	30522	6.552650e-05	0	2	30522	6.552650e-05	0	.	55	1614024	3.407630e-05	0	3	44892	6.682710e-05	0	1	74906	1.335010e-05	0	0	910	0.000000e+00	0	1	59992	1.666890e-05	0	0	29608	0.000000e+00	0	3	44892	6.682710e-05	0	1	64020	1.562010e-05	0	0	6084	0.000000e+00	0	47	1180040	3.982920e-05	0	2	91088	2.195680e-05	0	0	15828	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	1	744	0.0013440860215053765	0	2898	0	0	112	0	1	20436	4.893325504012527E-5	Uncertain_significance	Hereditary_cancer-predisposing_syndrome|Li-Fraumeni_syndrome|not_provided|Hereditary_breast_ovarian_cancer_syndrome|Squamous_cell_carcinoma_of_the_head_and_neck|Familial_cancer_of_breast|Adrenocortical_carcinoma,_hereditary|not_specified|Li-Fraumeni_syndrome_1	reviewed_by_expert_panel	NC_000017.11:g.7675145C>T	ClinGen:CA000216|UniProtKB:P04637#VAR_044841	C0027672|C0085390|C3661900|C0677776|C1168401|C0346153|C1859972|CN169374|C1835398	PS151623|275355|114480|202300|151623	140162|524|145|67037|227535|1501|524	p53, DNA-binding domain|p53, DNA-binding domain	Arg	His	133268	single nucleotide variant	NM_000546.6(TP53):c.467G>A (p.Arg156His)	7157	TP53	HGNC:11998	Uncertain significance	1	Feb 22, 2021	371524413	-	RCV000115722|RCV000148908|RCV000213052|RCV000656987|RCV000989720|RCV003467059|RCV005016393|RCV001030737|RCV001293017|RCV002272128	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0010150,MeSH:D000077195,MedGen:C1168401,OMIM:275355,Orphanet:67037|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501|12 conditions|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not specified|not provided|Squamous cell carcinoma of the head and neck|Adrenocortical carcinoma, hereditary|12 conditions|Hereditary breast ovarian cancer syndrome|Li-Fraumeni syndrome 1|Familial cancer of breast	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7675145	7675145	17p13.1	reviewed by expert panel	19	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000216,UniProtKB:P04637#VAR_044841	2	127811	7675145	C	T	-	-	-	-	-	-	SCV001481787	-	-	467G>A 	Arg156His	NM_000546.6	3	4_VUS	TP53	ENSG00000141510	3774	214890	CCSBVarC004859	ALE00004859	467G>A	Arg156His	CEGS2	CegsMutGDEh1016	B10	GDEhDisVCh_40053	C04	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	2	0	NULL	0	NULL	0	NULL	0	NULL	TP53_Arg156His	17	17	7675145	C	T
71569	OTC	418G>C	Ala140Pro	ENSG00000036473	X	38401306	NC_000023.11:38401306:G:C	ALE00005241	CCSBVarC005241	NULL	205878	NULL	GDEhDisVCh_40048	D03	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGCCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103088.0	single nucleotide variant	NM_000531.6(OTC):c.418G>C (p.Ala140Pro)	5009.0	OTC	HGNC:8512	Likely pathogenic	1.0	Dec 15, 2016	72556260.0	-	RCV000083431|RCV000587672	MedGen:C3661900|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664	not provided|Ornithine carbamoyltransferase deficiency	germline;unknown	germline	GRCh38	NC_000023.11	X	38401306.0	38401306.0	Xp11.4	criteria provided, single submitter	2.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224595,UniProtKB:P00480#VAR_010605	2.0	97196.0	38401306.0	G	C	-	-	-	-	-	-	SCV000697261	-	-	418G>C 	Ala140Pro	NM_000531.6	1.0	1_Pathogenic	chrX	G	C	X-38401306-G-C		97196	X	38401306	G	C	A	P	rs72556260	X	38260559	X	38145503	140	OTC	ENSG00000036473	ENST00000039007	ENSP00000039007	P00480	OTC_HUMAN	c.418G>C	p.Ala140Pro	c.418G>C	p.Ala140Pro	principal1	Y	1	YES	Select	+	GCT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.087	0.41092	T	1.0	0.90580	D	1.0	0.97365	D	0.95	0.94956	A	simple_aae	5.0	95.0	3.55	0.93172	H	-4.3	0.76526	D	0.986	0.99488	1.0450	0.98008	D	0.9825	0.99464	D	10	0.99556077	0.99988	D	0.937889	0.99556	D	0.969	0.99622	0.948	0.99364	P00480	A140P	Loss of stability (P = 0.0812)| Gain of sheet (P = 0.1208)| Gain of phosphorylation at Y143 (P = 0.2111)| Loss of loop (P = 0.2237)| Loss of ubiquitination at K144 (P = 0.2248)	0.997079320666	0.99700	0.9940512023035746	0.99401	1.34388094395	0.83842	0.719474077225	0.69918	T	0.962671	0.99528	D	0.736406	0.99966	D	0.82002	0.99966	D	0.999411940574646	0.97286	D	0.923008	0.71928	D	0.9958619	0.99979	0.98981816	0.99977	0.9958619	0.99979	0.98981816	0.99977	-12.504	0.87250	D	0.9767	0.90494	P	0.999988920088332	0.99579	0.99884087	0.98992	0.981	0.99334	.	.	.	.	.	.	4.980465	0.8253	27.8	0.9981083966472194	0.89450	.	.	.	.	.	.	.	.	.	5.97	5.97	0.96929	.	.	9.543	0.97194	11.692000	0.94378	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.992	0.67791	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	not_provided|Ornithine_carbamoyltransferase_deficiency	criteria_provided,_single_submitter	NC_000023.11:g.38401306G>C	ClinGen:CA224595|UniProtKB:P00480#VAR_010605	CN517202|C0268542	311250	664	Aspartate/ornithine carbamoyltransferase, carbamoyl-P binding	Ala	Pro	103088	single nucleotide variant	NM_000531.6(OTC):c.418G>C (p.Ala140Pro)	5009	OTC	HGNC:8512	Likely pathogenic	1	Dec 15, 2016	72556260	-	RCV000083431|RCV000587672	MedGen:C3661900|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664	not provided|Ornithine carbamoyltransferase deficiency	germline;unknown	germline	GRCh38	NC_000023.11	X	38401306	38401306	Xp11.4	criteria provided, single submitter	2	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224595,UniProtKB:P00480#VAR_010605	2	97196	38401306	G	C	-	-	-	-	-	-	SCV000697261	-	-	418G>C 	Ala140Pro	NM_000531.6	1	1_Pathogenic	OTC	ENSG00000036473	71569	205878	CCSBVarC005241	ALE00005241	418G>C	Ala140Pro	CEGS2	CegsMutGDEh1017	C01	GDEhDisVCh_40048	D03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Ala140Pro	23	X	38401306	G	C
7918	MSH2	118G>A	Gly40Ser	ENSG00000095002	2	47403309	NC_000002.12:47403309:G:A	ALE00003002	CCSBVarC003002	NULL	202632	NULL	GDEhDisVCh_40060	G07	CEGS2	ATGGCGGTGCAGCCGAAGGAGACGCTGCAGTTGGAGAGCGCGGCCGAGGTCGGCTTCGTGCGCTTCTTTCAGGGCATGCCGGAGAAGCCGACCACCACAGTGCGCCTTTTCGACCGGAGCGACTTCTATACGGCGCACGGCGAGGACGCGCTGCTGGCCGCCCGGGAGGTGTTCAAGACCCAGGGGGTGATCAAGTACATGGGGCCGGCAGGAGCAAAGAATCTGCAGAGTGTTGTGCTTAGTAAAATGAATTTTGAATCTTTTGTAAAAGATCTTCTTCTGGTTCGTCAGTATAGAGTTGAAGTTTATAAGAATAGAGCTGGAAATAAGGCATCCAAGGAGAATGATTGGTATTTGGCATATAAGGCTTCTCCTGGCAATCTCTCTCAGTTTGAAGACATTCTCTTTGGTAACAATGATATGTCAGCTTCCATTGGTGTTGTGGGTGTTAAAATGTCCGCAGTTGATGGCCAGAGACAGGTTGGAGTTGGGTATGTGGATTCCATACAGAGGAAACTAGGACTGTGTGAATTCCCTGATAATGATCAGTTCTCCAATCTTGAGGCTCTCCTCATCCAGATTGGACCAAAGGAATGTGTTTTACCCGGAGGAGAGACTGCTGGAGACATGGGGAAACTGAGACAGATAATTCAAAGAGGAGGAATTCTGATCACAGAAAGAAAAAAAGCTGACTTTTCCACAAAAGACATTTATCAGGACCTCAACCGGTTGTTGAAAGGCAAAAAGGGAGAGCAGATGAATAGTGCTGTATTGCCAGAAATGGAGAATCAGGTTGCAGTTTCATCACTGTCTGCGGTAATCAAGTTTTTAGAACTCTTATCAGATGATTCCAACTTTGGACAGTTTGAACTGACTACTTTTGACTTCAGCCAGTATATGAAATTGGATATTGCAGCAGTCAGAGCCCTTAACCTTTTTCAGGGTTCTGTTGAAGATACCACTGGCTCTCAGTCTCTGGCTGCCTTGCTGAATAAGTGTAAAACCCCTCAAGGACAAAGACTTGTTAACCAGTGGATTAAGCAGCCTCTCATGGATAAGAACAGAATAGAGGAGAGATTGAATTTAGTGGAAGCTTTTGTAGAAGATGCAGAATTGAGGCAGACTTTACAAGAAGATTTACTTCGTCGATTCCCAGATCTTAACCGACTTGCCAAGAAGTTTCAAAGACAAGCAGCAAACTTACAAGATTGTTACCGACTCTATCAGGGTATAAATCAACTACCTAATGTTATACAGGCTCTGGAAAAACATGAAGGAAAACACCAGAAATTATTGTTGGCAGTTTTTGTGACTCCTCTTACTGATCTTCGTTCTGACTTCTCCAAGTTTCAGGAAATGATAGAAACAACTTTAGATATGGATCAGGTGGAAAACCATGAATTCCTTGTAAAACCTTCATTTGATCCTAATCTCAGTGAATTAAGAGAAATAATGAATGACTTGGAAAAGAAGATGCAGTCAACATTAATAAGTGCAGCCAGAGATCTTGGCTTGGACCCTGGCAAACAGATTAAACTGGATTCCAGTGCACAGTTTGGATATTACTTTCGTGTAACCTGTAAGGAAGAAAAAGTCCTTCGTAACAATAAAAACTTTAGTACTGTAGATATCCAGAAGAATGGTGTTAAATTTACCAACAGCAAATTGACTTCTTTAAATGAAGAGTATACCAAAAATAAAACAGAATATGAAGAAGCCCAGGATGCCATTGTTAAAGAAATTGTCAATATTTCTTCAGGCTATGTAGAACCAATGCAGACACTCAATGATGTGTTAGCTCAGCTAGATGCTGTTGTCAGCTTTGCTCACGTGTCAAATGGAGCACCTGTTCCATATGTACGACCAGCCATTTTGGAGAAAGGACAAGGAAGAATTATATTAAAAGCATCCAGGCATGCTTGTGTTGAAGTTCAAGATGAAATTGCATTTATTCCTAATGACGTATACTTTGAAAAAGATAAACAGATGTTCCACATCATTACTGGCCCCAATATGGGAGGTAAATCAACATATATTCGACAAACTGGGGTGATAGTACTCATGGCCCAAATTGGGTGTTTTGTGCCATGTGAGTCAGCAGAAGTGTCCATTGTGGACTGCATCTTAGCCCGAGTAGGGGCTGGTGACAGTCAATTGAAAGGAGTCTCCACGTTCATGGCTGAAATGTTGGAAACTGCTTCTATCCTCAGGTCTGCAACCAAAGATTCATTAATAATCATAGATGAATTGGGAAGAGGAACTTCTACCTACGATGGATTTGGGTTAGCATGGGCTATATCAGAATACATTGCAACAAAGATTGGTGCTTTTTGCATGTTTGCAACCCATTTTCATGAACTTACTGCCTTGGCCAATCAGATACCAACTGTTAATAATCTACATGTCACAGCACTCACCACTGAAGAGACCTTAACTATGCTTTATCAGGTGAAGAAAGGTGTCTGTGATCAAAGTTTTGGGATTCATGTTGCAGAGCTTGCTAATTTCCCTAAGCATGTAATAGAGTGTGCTAAACAGAAAGCCCTGGAACTTGAGGAGTTTCAGTATATTGGAGAATCGCAAGGATATGATATCATGGAACCAGCAGCAAAGAAGTGCTATCTGGAAAGAGAGCAAGGTGAAAAAATTATTCAGGAGTTCCTGTCCAAGGTGAAACAAATGCCCTTTACTGAAATGTCAGAAGAAAACATCACAATAAAGTTAAAACAGCTAAAAGCTGAAGTAATAGCAAAGAATAATAGCTTTGTAAATGAAATCATTTCACGAATAAAAGTTACTACG	96035.0	single nucleotide variant	NM_000251.3(MSH2):c.118G>A (p.Gly40Ser)	4436.0	MSH2	HGNC:7325	Conflicting classifications of pathogenicity	0.0	Jan 27, 2025	63751260.0	-	RCV000236371|RCV000491838|RCV000627704|RCV000781559|RCV001030704|RCV003997143|RCV004528275|RCV003466962	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MeSH:D003123,MedGen:C0009405|MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144||MONDO:MONDO:0007356,MedGen:C2936783,OMIM:120435,Orphanet:144	not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|not specified|Hereditary breast ovarian cancer syndrome|Lynch syndrome|MSH2-related disorder|Lynch syndrome 1	germline;unknown	germline	GRCh38	NC_000002.12	2	47403309.0	47403309.0	2p21	criteria provided, conflicting classifications	9.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA017443,UniProtKB:P43246#VAR_043739	2.0	90560.0	47403309.0	G	A	-	-	-	-	-	-	SCV000284097|SCV000293503|SCV000580530|SCV000684914|SCV000919699|SCV001193626|SCV004106621|SCV004196335|SCV004828914	-	-	118G>A 	Gly40Ser	NM_000251.3	1.0	3_Conflicting	chr2	G	A	2-47403309-G-A	0.0000495774	90560	2	47403309	G	A	G	S	rs63751260	2	47630448	2	47483952	40	MSH2	ENSG00000095002	ENST00000233146	ENSP00000233146	P43246	MSH2_HUMAN	c.118G>A	p.Gly40Ser	c.118G>A	p.Gly40Ser	principal1	Y	1	YES	Select	+	GGC	1	0	G	G/G	G/G	G/G	G/G	0.294	0.18727	T	0.493	0.11621	T	0.034	0.31229	B	0.101	0.31291	B	0.91	0.92786	D	simple_aae	9.0	91.0	0.855	0.21196	L	-1.43	0.35175	N	0.446	0.76851	0.0539	0.83242	D	0.6165	0.86412	D	10	0.85102975	0.84115	D	0.360936	0.92494	D	0.554	0.81507	0.981	0.99819	P43246	G40S	Loss of stability (P = 0.0863)| Gain of phosphorylation at G40 (P = 0.1265)| Loss of catalytic residue at D38 (P = 0.2349)| Loss of methylation at R35 (P = 0.2901)| Loss of sheet (P = 0.302)	0.985884469458	0.98557	0.49466912239097766	0.49192	0.00962096649644	0.00843	0.746061563492	0.73818	T	0.700201	0.91277	D	0.332423	0.85223	D	0.239726	0.85029	D	0.342879265546799	0.26440	T	0.935706	0.90468	D	0.32369438	0.54618	0.26060125	0.51627	0.25956824	0.48679	0.18618259	0.41632	-2.792	0.08118	T	0.1029	0.25819	B	0.27295739187413	0.53172	0.99924672	0.99245	0.106	0.29384	.	.	.	.	.	.	3.709802	0.53038	23.3	0.99604743942332441	0.74486	0.343143	0.43717	N	-0.055343360483035	0.39094	2.320139	0.113132810397336	0.44943	2.789023	5.49	5.49	0.80997	.	.	5.585	0.67267	11.719000	0.94790	0.67	0.6921	1.0	0.71675	1.000000	0.68239	0.963	0.52396	786	0.46777	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	0	100886	0.000000e+00	0	2	188552	1.060720e-05	0	2	218432	9.156170e-06	0	0	6082	0.000000e+00	0	0	15886	0.000000e+00	0	0	2008	0.000000e+00	0	0	8110	0.000000e+00	0	0	12802	0.000000e+00	0	0	39896	0.000000e+00	0	0	14314	0.000000e+00	0	.	.	.	.	0	13898	0.000000e+00	0	0	27934	0.000000e+00	0	0	5542	0.000000e+00	0	2	12674	1.578030e-04	0	0	15632	0.000000e+00	0	0	80280	0.000000e+00	0	0	28200	0.000000e+00	0	2	12674	1.578030e-04	0	0	13044	0.000000e+00	0	0	31806	0.000000e+00	0	0	9054	0.000000e+00	0	2	16544	1.208900e-04	0	0	19298	0.000000e+00	0	0	95232	0.000000e+00	0	0	28152	0.000000e+00	0	2	16544	1.208900e-04	0	.	73	1604508	4.549680e-05	0	70	44564	1.570770e-03	0	0	74876	0.000000e+00	0	0	910	0.000000e+00	0	0	58160	0.000000e+00	0	0	29218	0.000000e+00	0	70	44564	1.570770e-03	0	0	62324	0.000000e+00	0	0	5936	0.000000e+00	0	1	1177374	8.493480e-07	0	0	89034	0.000000e+00	0	0	13102	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	768	0	0	2720	0	0	108	0	0	17548	0	Conflicting_classifications_of_pathogenicity	Hereditary_nonpolyposis_colorectal_neoplasms|Lynch_syndrome|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Lynch_syndrome_1|not_specified|MSH2-related_disorder|not_provided	criteria_provided,_conflicting_classifications	NC_000002.12:g.47403309G>A	ClinGen:CA017443|UniProtKB:P43246#VAR_043739	C0009405|C4552100|C0677776|C0027672|C2936783|CN169374|C3661900	120435	144|145|140162|144	DNA mismatch repair protein MutS-like, N-terminal	Gly	Ser	96035	single nucleotide variant	NM_000251.3(MSH2):c.118G>A (p.Gly40Ser)	4436	MSH2	HGNC:7325	Conflicting classifications of pathogenicity	0	Jan 27, 2025	63751260	-	RCV000236371|RCV000491838|RCV000627704|RCV000781559|RCV001030704|RCV003997143|RCV004528275|RCV003466962	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MeSH:D003123,MedGen:C0009405|MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144||MONDO:MONDO:0007356,MedGen:C2936783,OMIM:120435,Orphanet:144	not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|not specified|Hereditary breast ovarian cancer syndrome|Lynch syndrome|MSH2-related disorder|Lynch syndrome 1	germline;unknown	germline	GRCh38	NC_000002.12	2	47403309	47403309	2p21	criteria provided, conflicting classifications	9	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA017443,UniProtKB:P43246#VAR_043739	2	90560	47403309	G	A	-	-	-	-	-	-	SCV000284097|SCV000293503|SCV000580530|SCV000684914|SCV000919699|SCV001193626|SCV004106621|SCV004196335|SCV004828914	-	-	118G>A 	Gly40Ser	NM_000251.3	1	3_Conflicting	MSH2	ENSG00000095002	7918	202632	CCSBVarC003002	ALE00003002	118G>A	Gly40Ser	CEGS2	CegsMutGDEh1039	A02	GDEhDisVCh_40060	G07	2	CegsMutGDDh1039	A02	NULL	NULL	VUSMutpDEST2_07	H02	NULL	NULL	1	1	1	1	0	NULL	1	1	0	NULL	MSH2_Gly40Ser	2	2	47403309	G	A
14613	BRCA1	1760C>G	Thr587Arg	ENSG00000012048	17	43067610	NC_000017.11:43067610:G:C	ALE00003304	CCSBVarC003304	NULL	218425	NULL	GDEhDisVCh_40059	C01	CEGS2	ATGGATTTATCTGCTCTTCGCGTTGAAGAAGTACAAAATGTCATTAATGCTATGCAGAAAATCTTAGAGTGTCCCATCTGTCTGGAGTTGATCAAGGAACCTGTCTCCACAAAGTGTGACCACATATTTTGCAAATTTTGCATGCTGAAACTTCTCAACCAGAAGAAAGGGCCTTCACAGTGTCCTTTATGTAAGAATGATATAACCAAAAGGAGCCTACAAGAAAGTACGAGATTTAGTCAACTTGTTGAAGAGCTATTGAAAATCATTTGTGCTTTTCAGCTTGACACAGGTTTGGAGTATGCAAACAGCTATAATTTTGCAAAAAAGGAAAATAACTCTCCTGAACATCTAAAAGATGAAGTTTCTATCATCCAAAGTATGGGCTACAGAAACCGTGCCAAAAGACTTCTACAGAGTGAACCCGAAAATCCTTCCTTGCAGGAAACCAGTCTCAGTGTCCAACTCTCTAACCTTGGAACTGTGAGAACTCTGAGGACAAAGCAGCGGATACAACCTCAAAAGACGTCTGTCTACATTGAATTGGGATCTGATTCTTCTGAAGATACCGTTAATAAGGCAACTTATTGCAGTGTGGGAGATCAAGAATTGTTACAAATCACCCCTCAAGGAACCAGGGATGAAATCAGTTTGGATTCTGCAAAAAAGGCTGCTTGTGAATTTTCTGAGACGGATGTAACAAATACTGAACATCATCAACCCAGTAATAATGATTTGAACACCACTGAGAAGCGTGCAGCTGAGAGGCATCCAGAAAAGTATCAGGGTGAAGCAGCATCTGGGTGTGAGAGTGAAACAAGCGTCTCTGAAGACTGCTCAGGGCTATCCTCTCAGAGTGACATTTTAACCACTCAGCAGAGGGATACCATGCAACATAACCTGATAAAGCTCCAGCAGGAAATGGCTGAACTAGAAGCTGTGTTAGAACAGCATGGGAGCCAGCCTTCTAACAGCTACCCTTCCATCATAAGTGACTCTTCTGCCCTTGAGGACCTGCGAAATCCAGAACAAAGCACATCAGAAAAAGTATTAACTTCACAGAAAAGTAGTGAATACCCTATAAGCCAGAATCCAGAAGGCCTTTCTGCTGACAAGTTTGAGGTGTCTGCAGATAGTTCTACCAGTAAAAATAAAGAACCAGGAGTGGAAAGGTCATCCCCTTCTAAATGCCCATCATTAGATGATAGGTGGTACATGCACAGTTGCTCTGGGAGTCTTCAGAATAGAAACTACCCATCTCAAGAGGAGCTCATTAAGGTTGTTGATGTGGAGGAGCAACAGCTGGAAGAGTCTGGGCCACACGATTTGACGGAAACATCTTACTTGCCAAGGCAAGATCTAGAGGGAACCCCTTACCTGGAATCTGGAATCAGCCTCTTCTCTGATGACCCTGAATCTGATCCTTCTGAAGACAGAGCCCCAGAGTCAGCTCGTGTTGGCAACATACCATCTTCAACCTCTGCATTGAAAGTTCCCCAATTGAAAGTTGCAGAATCTGCCCAGAGTCCAGCTGCTGCTCATACTACTGATACTGCTGGGTATAATGCAATGGAAGAAAGTGTGAGCAGGGAGAAGCCAGAATTGACAGCTTCAACAGAAAGGGTCAACAAAAGAATGTCCATGGTGGTGTCTGGCCTGACCCCAGAAGAATTTATGCTCGTGTACAAGTTTGCCAGAAAACACCACATCACTTTAACTAATCTAATTACTGAAGAGACTACTCATGTTGTTATGAAAAGAGATGCTGAGTTTGTGTGTGAACGGACACTGAAATATTTTCTAGGAATTGCGGGAGGAAAATGGGTAGTTAGCTATTTCTGGGTGACCCAGTCTATTAAAGAAAGAAAAATGCTGAATGAGCATGATTTTGAAGTCAGAGGAGATGTGGTCAATGGAAGAAACCACCAAGGTCCAAAGCGAGCAAGAGAATCCCAGGACAGAAAGATCTTCAGGGGGCTAGAAATCTGTTGCTATGGGCCCTTCACCAACATGCCCACAGGGTGTCCACCCAATTGTGGTTGTGCAGCCAGATGCCTGGACAGAGGACAATGGCTTCCATGCAATTGGGCAGATGTG	70040.0	single nucleotide variant	NM_007294.4(BRCA1):c.5072C>G (p.Thr1691Arg)	672.0	BRCA1	HGNC:1100	Likely pathogenic	1.0	Oct 04, 2021	80357034.0	-	RCV000577017|RCV001077998|RCV002257395	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	germline;not applicable	germline	GRCh38	NC_000017.11	17	43067610.0	43067610.0	17q21.31	criteria provided, multiple submitters, no conflicts	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003189	3.0	55373.0	43067610.0	G	C	-	-	-	-	-	-	SCV002537807|SCV002644099	-	-	5072C>G 	Thr1691Arg	NM_007294.4	2.0	1_Pathogenic	chr17	C	G	17-43067610-C-G		55373	17	43067610	G	C	T	R	rs80357034	17	41219627	17	38473153	1691	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.5072C>G	p.Thr1691Arg	principal2	Y	1	.	.	-	ACA	2	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	0.585	0.90580	P	0.218	0.92348	B	.	.	.	.	.	.	3.175	0.88626	M	.	0.81626	.	.	0.90585	0.5201	0.90791	D	0.6944	0.89429	D	10	.	0.86953	.	0.786117	0.98314	D	.	0.94900	.	.	.	.	.	.	0.94962	.	0.79901	.	0.15475	0.765162229538	0.76658	T	0.292953	0.76109	T	0.409641	0.90394	D	0.350645	0.90276	D	0.983474791049957	0.74950	D	0.952305	0.85727	D	0.955418	0.96765	0.8308187	0.90111	0.950228	0.96231	0.7571084	0.85471	-6.573	0.63425	T	.	0.88256	.	0.991494696303718	0.89054	0.99986839	0.99835	0.994	0.99793	.	.	.	.	.	.	4.249871	0.64569	24.7	0.99500239805060597	0.68015	0.838290	0.75493	D	0.775208299271413	0.84447	8.314456	0.736429675756228	0.85057	8.492664	5.24	5.24	0.72825	.	.	6.008	0.70468	11.808000	0.96854	0.569	0.28905	1.0	0.71675	1.000000	0.68239	0.985	0.61072	545	0.72635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.43067610G>C	ClinGen:CA003189	C0346153|C0027672|C2676676	114480|604370	227535|140162|145	BRCT domain|BRCT domain|BRCT domain	Thr	Arg	70040	single nucleotide variant	NM_007294.4(BRCA1):c.5072C>G (p.Thr1691Arg)	672	BRCA1	HGNC:1100	Likely pathogenic	1	Oct 04, 2021	80357034	-	RCV000577017|RCV001077998|RCV002257395	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	germline;not applicable	germline	GRCh38	NC_000017.11	17	43067610	43067610	17q21.31	criteria provided, multiple submitters, no conflicts	4	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003189	3	55373	43067610	G	C	-	-	-	-	-	-	SCV002537807|SCV002644099	-	-	5072C>G 	Thr1691Arg	NM_007294.4	2	1_Pathogenic	BRCA1	ENSG00000012048	14613	218425	CCSBVarC003304	ALE00003304	1760C>G	Thr587Arg	CEGS2	CegsMutGDEh1003	H05	GDEhDisVCh_40059	C01	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	BRCA1_Thr587Arg	17	17	43067610	G	C
7918	MSH2	2141C>T	Ala714Val	ENSG00000095002	2	47476502	NC_000002.12:47476502:C:T	ALE00003016	CCSBVarC003016	NULL	202689	NULL	GDEhDisVCh_40060	H09	CEGS2	ATGGCGGTGCAGCCGAAGGAGACGCTGCAGTTGGAGAGCGCGGCCGAGGTCGGCTTCGTGCGCTTCTTTCAGGGCATGCCGGAGAAGCCGACCACCACAGTGCGCCTTTTCGACCGGGGCGACTTCTATACGGCGCACGGCGAGGACGCGCTGCTGGCCGCCCGGGAGGTGTTCAAGACCCAGGGGGTGATCAAGTACATGGGGCCGGCAGGAGCAAAGAATCTGCAGAGTGTTGTGCTTAGTAAAATGAATTTTGAATCTTTTGTAAAAGATCTTCTTCTGGTTCGTCAGTATAGAGTTGAAGTTTATAAGAATAGAGCTGGAAATAAGGCATCCAAGGAGAATGATTGGTATTTGGCATATAAGGCTTCTCCTGGCAATCTCTCTCAGTTTGAAGACATTCTCTTTGGTAACAATGATATGTCAGCTTCCATTGGTGTTGTGGGTGTTAAAATGTCCGCAGTTGATGGCCAGAGACAGGTTGGAGTTGGGTATGTGGATTCCATACAGAGGAAACTAGGACTGTGTGAATTCCCTGATAATGATCAGTTCTCCAATCTTGAGGCTCTCCTCATCCAGATTGGACCAAAGGAATGTGTTTTACCCGGAGGAGAGACTGCTGGAGACATGGGGAAACTGAGACAGATAATTCAAAGAGGAGGAATTCTGATCACAGAAAGAAAAAAAGCTGACTTTTCCACAAAAGACATTTATCAGGACCTCAACCGGTTGTTGAAAGGCAAAAAGGGAGAGCAGATGAATAGTGCTGTATTGCCAGAAATGGAGAATCAGGTTGCAGTTTCATCACTGTCTGCGGTAATCAAGTTTTTAGAACTCTTATCAGATGATTCCAACTTTGGACAGTTTGAACTGACTACTTTTGACTTCAGCCAGTATATGAAATTGGATATTGCAGCAGTCAGAGCCCTTAACCTTTTTCAGGGTTCTGTTGAAGATACCACTGGCTCTCAGTCTCTGGCTGCCTTGCTGAATAAGTGTAAAACCCCTCAAGGACAAAGACTTGTTAACCAGTGGATTAAGCAGCCTCTCATGGATAAGAACAGAATAGAGGAGAGATTGAATTTAGTGGAAGCTTTTGTAGAAGATGCAGAATTGAGGCAGACTTTACAAGAAGATTTACTTCGTCGATTCCCAGATCTTAACCGACTTGCCAAGAAGTTTCAAAGACAAGCAGCAAACTTACAAGATTGTTACCGACTCTATCAGGGTATAAATCAACTACCTAATGTTATACAGGCTCTGGAAAAACATGAAGGAAAACACCAGAAATTATTGTTGGCAGTTTTTGTGACTCCTCTTACTGATCTTCGTTCTGACTTCTCCAAGTTTCAGGAAATGATAGAAACAACTTTAGATATGGATCAGGTGGAAAACCATGAATTCCTTGTAAAACCTTCATTTGATCCTAATCTCAGTGAATTAAGAGAAATAATGAATGACTTGGAAAAGAAGATGCAGTCAACATTAATAAGTGCAGCCAGAGATCTTGGCTTGGACCCTGGCAAACAGATTAAACTGGATTCCAGTGCACAGTTTGGATATTACTTTCGTGTAACCTGTAAGGAAGAAAAAGTCCTTCGTAACAATAAAAACTTTAGTACTGTAGATATCCAGAAGAATGGTGTTAAATTTACCAACAGCAAATTGACTTCTTTAAATGAAGAGTATACCAAAAATAAAACAGAATATGAAGAAGCCCAGGATGCCATTGTTAAAGAAATTGTCAATATTTCTTCAGGCTATGTAGAACCAATGCAGACACTCAATGATGTGTTAGCTCAGCTAGATGCTGTTGTCAGCTTTGCTCACGTGTCAAATGGAGCACCTGTTCCATATGTACGACCAGCCATTTTGGAGAAAGGACAAGGAAGAATTATATTAAAAGCATCCAGGCATGCTTGTGTTGAAGTTCAAGATGAAATTGCATTTATTCCTAATGACGTATACTTTGAAAAAGATAAACAGATGTTCCACATCATTACTGGCCCCAATATGGGAGGTAAATCAACATATATTCGACAAACTGGGGTGATAGTACTCATGGCCCAAATTGGGTGTTTTGTGCCATGTGAGTCAGCAGAAGTGTCCATTGTGGACTGCATCTTAGCCCGAGTAGGGGTTGGTGACAGTCAATTGAAAGGAGTCTCCACGTTCATGGCTGAAATGTTGGAAACTGCTTCTATCCTCAGGTCTGCAACCAAAGATTCATTAATAATCATAGATGAATTGGGAAGAGGAACTTCTACCTACGATGGATTTGGGTTAGCATGGGCTATATCAGAATACATTGCAACAAAGATTGGTGCTTTTTGCATGTTTGCAACCCATTTTCATGAACTTACTGCCTTGGCCAATCAGATACCAACTGTTAATAATCTACATGTCACAGCACTCACCACTGAAGAGACCTTAACTATGCTTTATCAGGTGAAGAAAGGTGTCTGTGATCAAAGTTTTGGGATTCATGTTGCAGAGCTTGCTAATTTCCCTAAGCATGTAATAGAGTGTGCTAAACAGAAAGCCCTGGAACTTGAGGAGTTTCAGTATATTGGAGAATCGCAAGGATATGATATCATGGAACCAGCAGCAAAGAAGTGCTATCTGGAAAGAGAGCAAGGTGAAAAAATTATTCAGGAGTTCCTGTCCAAGGTGAAACAAATGCCCTTTACTGAAATGTCAGAAGAAAACATCACAATAAAGTTAAAACAGCTAAAAGCTGAAGTAATAGCAAAGAATAATAGCTTTGTAAATGAAATCATTTCACGAATAAAAGTTACTACG	96382.0	single nucleotide variant	NM_000251.3(MSH2):c.2141C>T (p.Ala714Val)	4436.0	MSH2	HGNC:7325	Conflicting classifications of pathogenicity	0.0	Oct 23, 2024	63751224.0	-	RCV000535935|RCV000574384|RCV003997159|RCV004537294	MeSH:D003123,MedGen:C0009405|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|	Hereditary nonpolyposis colorectal neoplasms|Hereditary cancer-predisposing syndrome|Lynch syndrome|MSH2-related disorder	germline	germline	GRCh38	NC_000002.12	2	47476502.0	47476502.0	2p21	criteria provided, conflicting classifications	5.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA020132,UniProtKB:P43246#VAR_043780	2.0	90907.0	47476502.0	C	T	-	-	-	-	-	-	SCV000625355|SCV000662221|SCV001344425|SCV004825681	-	-	2141C>T 	Ala714Val	NM_000251.3	1.0	3_Conflicting	chr2	C	T	2-47476502-C-T		90907	2	47476502	C	T	A	V	rs63751224	2	47703641	2	47557145	714	MSH2	ENSG00000095002	ENST00000233146	ENSP00000233146	P43246	MSH2_HUMAN	c.2141C>T	p.Ala714Val	c.2141C>T	p.Ala714Val	principal1	Y	1	YES	Select	+	GCT	2	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.002	0.79703	D	1.0	0.90580	D	0.999	0.92348	D	0.95	0.94956	D	simple_aae	5.0	95.0	4.11	0.97321	H	-3.7	0.70591	D	0.975	0.98575	0.9762	0.96789	D	0.8941	0.96479	D	10	0.985591	0.98808	D	0.373931	0.92798	D	0.862	0.95791	0.958	0.99550	P43246	A714V	Loss of disorder (P = 0.1194)| Loss of helix (P = 0.1706)| Gain of loop (P = 0.2045)| Gain of catalytic residue at S717 (P = 0.3528)| Loss of sheet (P = 0.5184)	0.972278768439	0.97171	0.9552373488742578	0.95481	0.0352651258399	0.03600	0.783959150314	0.79490	T	0.862445	0.96934	D	0.476231	0.93511	D	0.446297	0.93431	D	0.998841464519501	0.95303	D	0.994076	0.98052	D	0.89886045	0.91156	0.86874735	0.92682	0.9116881	0.92343	0.8556145	0.91774	-12.425	0.86893	D	0.9578	0.90864	P	0.9972422098868	0.92926	0.99913245	0.99166	0.786	0.88157	.	.	.	.	.	.	5.330777	0.89477	30.0	0.99914369011209281	0.98310	0.859423	0.77628	D	1.06757304365497	0.97471	16.21001	1.00474973421896	0.98709	19.13527	6.08	6.08	0.98980	4.03	0.76886	7.568	0.81592	7.669000	0.64727	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.998	0.85369	929	0.16852	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614032	6.195660e-07	0	1	1180032	8.474350e-07	0	0	74914	0.000000e+00	0	0	912	0.000000e+00	0	0	59994	0.000000e+00	0	0	29608	0.000000e+00	0	0	44894	0.000000e+00	0	0	64020	0.000000e+00	0	0	6084	0.000000e+00	0	1	1180032	8.474350e-07	0	0	91088	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Lynch_syndrome|Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|MSH2-related_disorder	criteria_provided,_conflicting_classifications	NC_000002.12:g.47476502C>T	ClinGen:CA020132|UniProtKB:P43246#VAR_043780	C4552100|C0027672|C0009405	.	144|140162	DNA mismatch repair protein MutS, C-terminal|DNA mismatch repair protein MutS, C-terminal|DNA mismatch repair protein Msh2, ATP-binding cassette domain	Ala	Val	96382	single nucleotide variant	NM_000251.3(MSH2):c.2141C>T (p.Ala714Val)	4436	MSH2	HGNC:7325	Conflicting classifications of pathogenicity	0	Oct 23, 2024	63751224	-	RCV000535935|RCV000574384|RCV003997159|RCV004537294	MeSH:D003123,MedGen:C0009405|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|	Hereditary nonpolyposis colorectal neoplasms|Hereditary cancer-predisposing syndrome|Lynch syndrome|MSH2-related disorder	germline	germline	GRCh38	NC_000002.12	2	47476502	47476502	2p21	criteria provided, conflicting classifications	5	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA020132,UniProtKB:P43246#VAR_043780	2	90907	47476502	C	T	-	-	-	-	-	-	SCV000625355|SCV000662221|SCV001344425|SCV004825681	-	-	2141C>T 	Ala714Val	NM_000251.3	1	3_Conflicting	MSH2	ENSG00000095002	7918	202689	CCSBVarC003016	ALE00003016	2141C>T	Ala714Val	CEGS2	CegsMutGDEh1044	B06	GDEhDisVCh_40060	H09	2	CegsMutGDDh1044	B06	NULL	NULL	VUSMutpDEST2_07	E04	NULL	NULL	1	1	1	1	0	NULL	1	1	0	NULL	MSH2_Ala714Val	2	2	47476502	C	T
52861	F9	767T>C	Ile256Thr	ENSG00000101981	X	139560784	NC_000023.11:139560784:T:C	ALE00002182	CCSBVarC002182	24741	NULL	NULL	GDEhDisVCh_40052	D12	RC4	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTACCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT																																															chrX	T	C	X-139560784-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																														F9	ENSG00000101981	52861	24741	CCSBVarC002182	ALE00002182	767T>C	Ile256Thr	RC4	RC4_Mut_GDEh1022	E11	GDEhDisVCh_40052	D12	2	RC4_Mut_GDDh1022	E11	NULL	NULL	NULL	NULL	NULL	NULL	1	2	1	2	0	NULL	0	NULL	0	NULL	F9_Ile256Thr	23	X	139560784	T	C
3172	CBS	797G>A	Arg266Lys	ENSG00000160200	21	43063931	NC_000021.9:43063931:C:T	ALE00003752	CCSBVarC003752	NULL	214527	NULL	GDEhDisVCh_40055	A08	CEGS2	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTCCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAAGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCCGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	15164.0	single nucleotide variant	NM_000071.3(CBS):c.797G>A (p.Arg266Lys)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Aug 07, 2024	121964969.0	-	RCV000000147|RCV000469164|RCV001192721|RCV002227958|RCV001546787|RCV002313702	MedGen:C3502110|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344|MedGen:C3661900|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Homocystinuria, pyridoxine-responsive|Classic homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not provided|Familial thoracic aortic aneurysm and aortic dissection	germline;unknown	germline	GRCh38	NC_000021.9	21	43063931.0	43063931.0	21q22.3	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA113891,UniProtKB:P35520#VAR_008074,OMIM:613381.0009	3.0	125.0	43063931.0	C	T	-	-	-	-	-	-	SCV000543517|SCV000738475|SCV000790684|SCV001361016|SCV001766369|SCV004215539	-	-	797G>A 	Arg266Lys	NM_000071.3	2.0	1_Pathogenic	chr21	G	A	21-43063931-G-A		125	21	43063931	C	T	R	K	rs121964969	21	44484041	21	43357110	266	CBS	ENSG00000160200	ENST00000398165	ENSP00000381231	P35520	CBS_HUMAN	c.797G>A	p.Arg266Lys	c.797G>A	p.Arg266Lys	principal1	Y	1	YES	Select	-	AGG	2	0	C	C/C	C/C	C/C	C/C	0.109	0.29423	T	0.14	0.33883	T	0.767	0.43799	P	0.797	0.58056	P	1.0	0.99291	A	simple_aae	0.0	100.0	0.995	0.24948	L	-2.6	0.56009	D	0.92	0.92320	0.8905	0.95528	D	0.8712	0.95710	D	9	0.9115095	0.90410	D	0.25653	0.89308	D	0.843	0.95087	.	.	.	.	.	0.897765064896	0.89597	0.9369886763262394	0.93639	0.94605654675	0.72246	0.687344670296	0.65267	T	0.971423	0.99691	D	0.448863	0.92373	D	0.42247	0.92770	D	0.958910882472992	0.65177	D	.	0.90939	.	0.84843266	0.87049	0.60303986	0.76689	0.82101625	0.85098	0.668818	0.80355	-6.776	0.52447	T	.	0.60250	.	0.992849778848106	0.89724	0.99964726	0.99571	0.859	0.92299	.	.	.	.	.	.	4.779258	0.77485	26.7	0.99760996624967146	0.85104	0.936084	0.93164	D	0.434844075701216	0.63159	4.566911	0.490057147956861	0.67152	5.069537	4.95	4.95	0.64849	2.4	0.44600	6.848	0.75268	7.471000	0.59217	0.469	0.21904	1.0	0.71675	1.000000	0.68239	0.977	0.56847	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	108926	9.180540e-06	0	1	206786	4.835920e-06	0	2	235746	8.483710e-06	0	0	7048	0.000000e+00	0	0	17078	0.000000e+00	0	0	2308	0.000000e+00	0	0	9032	0.000000e+00	0	0	13292	0.000000e+00	0	1	42644	2.345000e-05	0	0	15620	0.000000e+00	0	1	42644	2.345000e-05	0	0	16004	0.000000e+00	0	0	30432	0.000000e+00	0	0	6174	0.000000e+00	0	0	13384	0.000000e+00	0	0	16626	0.000000e+00	0	1	88914	1.124680e-05	0	0	30418	0.000000e+00	0	1	88914	1.124680e-05	0	0	14730	0.000000e+00	0	0	34176	0.000000e+00	0	0	9550	0.000000e+00	0	0	17678	0.000000e+00	0	0	21318	0.000000e+00	0	2	102352	1.954040e-05	0	0	30340	0.000000e+00	0	2	102352	1.954040e-05	0	.	3	216584	1.385140e-05	0	3	110860	2.706120e-05	0	0	9582	0.000000e+00	0	0	66	0.000000e+00	0	0	13438	0.000000e+00	0	0	5476	0.000000e+00	0	0	22620	0.000000e+00	0	0	13034	0.000000e+00	0	0	844	0.000000e+00	0	3	110860	2.706120e-05	0	0	29158	0.000000e+00	0	2	33928	5.894836123555765E-5	0	268	0	0	84	0	0	6884	0	0	500	0	0	628	0	0	24	0	0	94	0	0	5984	0	0	7152	0	0	108	0	2	48394	4.132743728561392E-5	Pathogenic/Likely_pathogenic	Homocystinuria|not_provided|Classic_homocystinuria|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|Homocystinuria,_pyridoxine-responsive|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43063931C>T	ClinGen:CA113891|OMIM:613381.0009|UniProtKB:P35520#VAR_008074	C0019880|C3661900|C0751202|C4707243|C3502110|C3150344	236200|PS607086	394|91387	Tryptophan synthase beta chain-like, PALP domain	Arg	Lys	15164	single nucleotide variant	NM_000071.3(CBS):c.797G>A (p.Arg266Lys)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Aug 07, 2024	121964969	-	RCV000000147|RCV000469164|RCV001192721|RCV002227958|RCV001546787|RCV002313702	MedGen:C3502110|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344|MedGen:C3661900|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Homocystinuria, pyridoxine-responsive|Classic homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not provided|Familial thoracic aortic aneurysm and aortic dissection	germline;unknown	germline	GRCh38	NC_000021.9	21	43063931	43063931	21q22.3	criteria provided, multiple submitters, no conflicts	7	-	N	ClinGen:CA113891,UniProtKB:P35520#VAR_008074,OMIM:613381.0009	3	125	43063931	C	T	-	-	-	-	-	-	SCV000543517|SCV000738475|SCV000790684|SCV001361016|SCV001766369|SCV004215539	-	-	797G>A 	Arg266Lys	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	276	CCSBVarC007324	ALE00003752	797G>A	Arg266Lys	Edgotyping3	VUSMutGDEh011	G01	GDEhDisVCh_40013	A07	1	VUSMutGDDh011	G01	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	CBS_Arg266Lys	21	21	43063931	C	T
3172	CBS	797G>A	Arg266Lys	ENSG00000160200	21	43063931	NC_000021.9:43063931:C:T	ALE00003752	CCSBVarC003752	NULL	214527	NULL	GDEhDisVCh_40055	A08	CEGS2	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTCCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAAGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCCGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	15164.0	single nucleotide variant	NM_000071.3(CBS):c.797G>A (p.Arg266Lys)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Aug 07, 2024	121964969.0	-	RCV000000147|RCV000469164|RCV001192721|RCV002227958|RCV001546787|RCV002313702	MedGen:C3502110|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344|MedGen:C3661900|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Homocystinuria, pyridoxine-responsive|Classic homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not provided|Familial thoracic aortic aneurysm and aortic dissection	germline;unknown	germline	GRCh38	NC_000021.9	21	43063931.0	43063931.0	21q22.3	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA113891,UniProtKB:P35520#VAR_008074,OMIM:613381.0009	3.0	125.0	43063931.0	C	T	-	-	-	-	-	-	SCV000543517|SCV000738475|SCV000790684|SCV001361016|SCV001766369|SCV004215539	-	-	797G>A 	Arg266Lys	NM_000071.3	2.0	1_Pathogenic	chr21	G	A	21-43063931-G-A		125	21	43063931	C	T	R	K	rs121964969	21	44484041	21	43357110	266	CBS	ENSG00000160200	ENST00000398165	ENSP00000381231	P35520	CBS_HUMAN	c.797G>A	p.Arg266Lys	c.797G>A	p.Arg266Lys	principal1	Y	1	YES	Select	-	AGG	2	0	C	C/C	C/C	C/C	C/C	0.109	0.29423	T	0.14	0.33883	T	0.767	0.43799	P	0.797	0.58056	P	1.0	0.99291	A	simple_aae	0.0	100.0	0.995	0.24948	L	-2.6	0.56009	D	0.92	0.92320	0.8905	0.95528	D	0.8712	0.95710	D	9	0.9115095	0.90410	D	0.25653	0.89308	D	0.843	0.95087	.	.	.	.	.	0.897765064896	0.89597	0.9369886763262394	0.93639	0.94605654675	0.72246	0.687344670296	0.65267	T	0.971423	0.99691	D	0.448863	0.92373	D	0.42247	0.92770	D	0.958910882472992	0.65177	D	.	0.90939	.	0.84843266	0.87049	0.60303986	0.76689	0.82101625	0.85098	0.668818	0.80355	-6.776	0.52447	T	.	0.60250	.	0.992849778848106	0.89724	0.99964726	0.99571	0.859	0.92299	.	.	.	.	.	.	4.779258	0.77485	26.7	0.99760996624967146	0.85104	0.936084	0.93164	D	0.434844075701216	0.63159	4.566911	0.490057147956861	0.67152	5.069537	4.95	4.95	0.64849	2.4	0.44600	6.848	0.75268	7.471000	0.59217	0.469	0.21904	1.0	0.71675	1.000000	0.68239	0.977	0.56847	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	108926	9.180540e-06	0	1	206786	4.835920e-06	0	2	235746	8.483710e-06	0	0	7048	0.000000e+00	0	0	17078	0.000000e+00	0	0	2308	0.000000e+00	0	0	9032	0.000000e+00	0	0	13292	0.000000e+00	0	1	42644	2.345000e-05	0	0	15620	0.000000e+00	0	1	42644	2.345000e-05	0	0	16004	0.000000e+00	0	0	30432	0.000000e+00	0	0	6174	0.000000e+00	0	0	13384	0.000000e+00	0	0	16626	0.000000e+00	0	1	88914	1.124680e-05	0	0	30418	0.000000e+00	0	1	88914	1.124680e-05	0	0	14730	0.000000e+00	0	0	34176	0.000000e+00	0	0	9550	0.000000e+00	0	0	17678	0.000000e+00	0	0	21318	0.000000e+00	0	2	102352	1.954040e-05	0	0	30340	0.000000e+00	0	2	102352	1.954040e-05	0	.	3	216584	1.385140e-05	0	3	110860	2.706120e-05	0	0	9582	0.000000e+00	0	0	66	0.000000e+00	0	0	13438	0.000000e+00	0	0	5476	0.000000e+00	0	0	22620	0.000000e+00	0	0	13034	0.000000e+00	0	0	844	0.000000e+00	0	3	110860	2.706120e-05	0	0	29158	0.000000e+00	0	2	33928	5.894836123555765E-5	0	268	0	0	84	0	0	6884	0	0	500	0	0	628	0	0	24	0	0	94	0	0	5984	0	0	7152	0	0	108	0	2	48394	4.132743728561392E-5	Pathogenic/Likely_pathogenic	Homocystinuria|not_provided|Classic_homocystinuria|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|Homocystinuria,_pyridoxine-responsive|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43063931C>T	ClinGen:CA113891|OMIM:613381.0009|UniProtKB:P35520#VAR_008074	C0019880|C3661900|C0751202|C4707243|C3502110|C3150344	236200|PS607086	394|91387	Tryptophan synthase beta chain-like, PALP domain	Arg	Lys	15164	single nucleotide variant	NM_000071.3(CBS):c.797G>A (p.Arg266Lys)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Aug 07, 2024	121964969	-	RCV000000147|RCV000469164|RCV001192721|RCV002227958|RCV001546787|RCV002313702	MedGen:C3502110|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344|MedGen:C3661900|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Homocystinuria, pyridoxine-responsive|Classic homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not provided|Familial thoracic aortic aneurysm and aortic dissection	germline;unknown	germline	GRCh38	NC_000021.9	21	43063931	43063931	21q22.3	criteria provided, multiple submitters, no conflicts	7	-	N	ClinGen:CA113891,UniProtKB:P35520#VAR_008074,OMIM:613381.0009	3	125	43063931	C	T	-	-	-	-	-	-	SCV000543517|SCV000738475|SCV000790684|SCV001361016|SCV001766369|SCV004215539	-	-	797G>A 	Arg266Lys	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	3172	214527	CCSBVarC003752	ALE00003752	797G>A	Arg266Lys	CEGS2	CegsMutGDEh1040	B08	GDEhDisVCh_40055	A08	1	CegsMutGDDh1040	B08	NULL	NULL	NULL	NULL	NULL	NULL	1	6	1	2	0	NULL	0	NULL	0	NULL	CBS_Arg266Lys	21	21	43063931	C	T
7918	MSH2	1319T>C	Leu440Pro	ENSG00000095002	2	47445590	NC_000002.12:47445590:T:C	ALE00003010	CCSBVarC003010	NULL	202667	NULL	GDEhDisVCh_40060	C07	CEGS2	ATGGCGGTGCAGCCGAAGGAGACGCTGCAGTTGGAGAGCGCGGCCGAGGTCGGCTTCGTGCGCTTCTTTCAGGGCATGCCGGAGAAGCCGACCACCACAGTGCGCCTTTTCGACCGGGGCGACTTCTATACGGCGCACGGCGAGGACGCGCTGCTGGCCGCCCGGGAGGTGTTCAAGACCCAGGGGGTGATCAAGTACATGGGGCCGGCAGGAGCAAAGAATCTGCAGAGTGTTGTGCTTAGTAAAATGAATTTTGAATCTTTTGTAAAAGATCTTCTTCTGGTTCGTCAGTATAGAGTTGAAGTTTATAAGAATAGAGCTGGAAATAAGGCATCCAAGGAGAATGATTGGTATTTGGCATATAAGGCTTCTCCTGGCAATCTCTCTCAGTTTGAAGACATTCTCTTTGGTAACAATGATATGTCAGCTTCCATTGGTGTTGTGGGTGTTAAAATGTCCGCAGTTGATGGCCAGAGACAGGTTGGAGTTGGGTATGTGGATTCCATACAGAGGAAACTAGGACTGTGTGAATTCCCTGATAATGATCAGTTCTCCAATCTTGAGGCTCTCCTCATCCAGATTGGACCAAAGGAATGTGTTTTACCCGGAGGAGAGACTGCTGGAGACATGGGGAAACTGAGACAGATAATTCAAAGAGGAGGAATTCTGATCACAGAAAGAAAAAAAGCTGACTTTTCCACAAAAGACATTTATCAGGACCTCAACCGGTTGTTGAAAGGCAAAAAGGGAGAGCAGATGAATAGTGCTGTATTGCCAGAAATGGAGAATCAGGTTGCAGTTTCATCACTGTCTGCGGTAATCAAGTTTTTAGAACTCTTATCAGATGATTCCAACTTTGGACAGTTTGAACTGACTACTTTTGACTTCAGCCAGTATATGAAATTGGATATTGCAGCAGTCAGAGCCCTTAACCTTTTTCAGGGTTCTGTTGAAGATACCACTGGCTCTCAGTCTCTGGCTGCCTTGCTGAATAAGTGTAAAACCCCTCAAGGACAAAGACTTGTTAACCAGTGGATTAAGCAGCCTCTCATGGATAAGAACAGAATAGAGGAGAGATTGAATTTAGTGGAAGCTTTTGTAGAAGATGCAGAATTGAGGCAGACTTTACAAGAAGATTTACTTCGTCGATTCCCAGATCTTAACCGACTTGCCAAGAAGTTTCAAAGACAAGCAGCAAACTTACAAGATTGTTACCGACTCTATCAGGGTATAAATCAACTACCTAATGTTATACAGGCTCTGGAAAAACATGAAGGAAAACACCAGAAATTATTGTTGGCAGTTTTTGTGACTCCTCCTACTGATCTTCGTTCTGACTTCTCCAAGTTTCAGGAAATGATAGAAACAACTTTAGATATGGATCAGGTGGAAAACCATGAATTCCTTGTAAAACCTTCATTTGATCCTAATCTCAGTGAATTAAGAGAAATAATGAATGACTTGGAAAAGAAGATGCAGTCAACATTAATAAGTGCAGCCAGAGATCTTGGCTTGGACCCTGGCAAACAGATTAAACTGGATTCCAGTGCACAGTTTGGATATTACTTTCGTGTAACCTGTAAGGAAGAAAAAGTCCTTCGTAACAATAAAAACTTTAGTACTGTAGATATCCAGAAGAATGGTGTTAAATTTACCAACAGCAAATTGACTTCTTTAAATGAAGAGTATACCAAAAATAAAACAGAATATGAAGAAGCCCAGGATGCCATTGTTAAAGAAATTGTCAATATTTCTTCAGGCTATGTAGAACCAATGCAGACACTCAATGATGTGTTAGCTCAGCTAGATGCTGTTGTCAGCTTTGCTCACGTGTCAAATGGAGCACCTGTTCCATATGTACGACCAGCCATTTTGGAGAAAGGACAAGGAAGAATTATATTAAAAGCATCCAGGCATGCTTGTGTTGAAGTTCAAGATGAAATTGCATTTATTCCTAATGACGTATACTTTGAAAAAGATAAACAGATGTTCCACATCATTACTGGCCCCAATATGGGAGGTAAATCAACATATATTCGACAAACTGGGGTGATAGTACTCATGGCCCAAATTGGGTGTTTTGTGCCATGTGAGTCAGCAGAAGTGTCCATTGTGGACTGCATCTTAGCCCGAGTAGGGGCTGGTGACAGTCAATTGAAAGGAGTCTCCACGTTCATGGCTGAAATGTTGGAAACTGCTTCTATCCTCAGGTCTGCAACCAAAGATTCATTAATAATCATAGATGAATTGGGAAGAGGAACTTCTACCTACGATGGATTTGGGTTAGCATGGGCTATATCAGAATACATTGCAACAAAGATTGGTGCTTTTTGCATGTTTGCAACCCATTTTCATGAACTTACTGCCTTGGCCAATCAGATACCAACTGTTAATAATCTACATGTCACAGCACTCACCACTGAAGAGACCTTAACTATGCTTTATCAGGTGAAGAAAGGTGTCTGTGATCAAAGTTTTGGGATTCATGTTGCAGAGCTTGCTAATTTCCCTAAGCATGTAATAGAGTGTGCTAAACAGAAAGCCCTGGAACTTGAGGAGTTTCAGTATATTGGAGAATCGCAAGGATATGATATCATGGAACCAGCAGCAAAGAAGTGCTATCTGGAAAGAGAGCAAGGTGAAAAAATTATTCAGGAGTTCCTGTCCAAGGTGAAACAAATGCCCTTTACTGAAATGTCAGAAGAAAACATCACAATAAAGTTAAAACAGCTAAAAGCTGAAGTAATAGCAAAGAATAATAGCTTTGTAAATGAAATCATTTCACGAATAAAAGTTACTACG	96100.0	single nucleotide variant	NM_000251.3(MSH2):c.1319T>C (p.Leu440Pro)	4436.0	MSH2	HGNC:7325	Pathogenic	1.0	Sep 05, 2013	587779084.0	-	RCV000076121|RCV000491100|RCV002514349	MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MeSH:D003123,MedGen:C0009405	Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms	germline	germline	GRCh38	NC_000002.12	2	47445590.0	47445590.0	2p21	reviewed by expert panel	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA017968	2.0	90625.0	47445590.0	T	C	-	-	-	-	-	-	SCV000107137	-	-	1319T>C 	Leu440Pro	NM_000251.3	3.0	1_Pathogenic	chr2	T	C	2-47445590-T-C		90625	2	47445590	T	C	L	P	rs587779084	2	47672729	2	47526233	440	MSH2	ENSG00000095002	ENST00000233146	ENSP00000233146	P43246	MSH2_HUMAN	c.1319T>C	p.Leu440Pro	c.1319T>C	p.Leu440Pro	principal1	Y	1	YES	Select	+	CTT	2	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	0.995	0.83178	D	0.97	0.96253	A	simple_aae	3.0	97.0	3.43	0.91906	M	-5.92	0.89426	D	0.796	0.79136	1.0804	0.98891	D	0.9303	0.97695	D	10	0.9857696	0.98837	D	0.352849	0.92298	D	0.949	0.99024	0.909	0.98139	P43246	L440P	Gain of catalytic residue at P439 (P = 0.0133)| Loss of helix (P = 0.0167)| Gain of loop (P = 0.0195)| Gain of disorder (P = 0.0319)| Gain of phosphorylation at T441 (P = 0.0952)	0.968864496671	0.96823	0.8866284164249552	0.88560	0.025698694687	0.02545	0.465708136559	0.34048	T	0.856641	0.96757	D	0.530146	0.95125	D	0.523741	0.95053	D	0.996698439121246	0.89798	D	0.90251	0.65876	D	0.99525034	0.99967	0.97811323	0.99762	0.9951887	0.99965	0.9730935	0.99586	-15.768	0.97399	D	0.9808	0.91771	P	0.998997177503882	0.95471	0.99997747	0.99989	0.995	0.99826	.	.	.	.	.	.	4.695162	0.75318	26.3	0.99927931197318876	0.99222	0.719129	0.66891	D	0.864955149948797	0.89887	10.18412	0.792484068950195	0.89208	9.905044	5.56	5.56	0.83655	3.35	0.60746	5.795	0.68801	7.631000	0.62792	0.587	0.31004	1.0	0.71675	1.000000	0.68239	0.971	0.54653	916	0.20739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Lynch_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000002.12:g.47445590T>C	ClinGen:CA017968	C4552100|C0009405|C0027672	.	144|140162	DNA mismatch repair protein MutS, core|DNA mismatch repair protein MutS, core	Leu	Pro	96100	single nucleotide variant	NM_000251.3(MSH2):c.1319T>C (p.Leu440Pro)	4436	MSH2	HGNC:7325	Pathogenic	1	Sep 05, 2013	587779084	-	RCV000076121|RCV000491100|RCV002514349	MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MeSH:D003123,MedGen:C0009405	Lynch syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms	germline	germline	GRCh38	NC_000002.12	2	47445590	47445590	2p21	reviewed by expert panel	4	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA017968	2	90625	47445590	T	C	-	-	-	-	-	-	SCV000107137	-	-	1319T>C 	Leu440Pro	NM_000251.3	3	1_Pathogenic	MSH2	ENSG00000095002	7918	202667	CCSBVarC003010	ALE00003010	1319T>C	Leu440Pro	CEGS2	CegsMutGDEh1038	H01	GDEhDisVCh_40060	C07	2	CegsMutGDDh1038	H01	NULL	NULL	VUSMutpDEST2_07	H03	NULL	NULL	1	1	1	1	0	NULL	1	1	0	NULL	MSH2_Leu440Pro	2	2	47445590	T	C
7918	MSH2	1688A>C	Tyr563Ser	ENSG00000095002	2	47470991	NC_000002.12:47470991:A:C	ALE00003013	CCSBVarC003013	NULL	202674	NULL	GDEhDisVCh_40060	E09	CEGS2	ATGGCGGTGCAGCCGAAGGAGACGCTGCAGTTGGAGAGCGCGGCCGAGGTCGGCTTCGTGCGCTTCTTTCAGGGCATGCCGGAGAAGCCGACCACCACAGTGCGCCTTTTCGACCGGGGCGACTTCTATACGGCGCACGGCGAGGACGCGCTGCTGGCCGCCCGGGAGGTGTTCAAGACCCAGGGGGTGATCAAGTACATGGGGCCGGCAGGAGCAAAGAATCTGCAGAGTGTTGTGCTTAGTAAAATGAATTTTGAATCTTTTGTAAAAGATCTTCTTCTGGTTCGTCAGTATAGAGTTGAAGTTTATAAGAATAGAGCTGGAAATAAGGCATCCAAGGAGAATGATTGGTATTTGGCATATAAGGCTTCTCCTGGCAATCTCTCTCAGTTTGAAGACATTCTCTTTGGTAACAATGATATGTCAGCTTCCATTGGTGTTGTGGGTGTTAAAATGTCCGCAGTTGATGGCCAGAGACAGGTTGGAGTTGGGTATGTGGATTCCATACAGAGGAAACTAGGACTGTGTGAATTCCCTGATAATGATCAGTTCTCCAATCTTGAGGCTCTCCTCATCCAGATTGGACCAAAGGAATGTGTTTTACCCGGAGGAGAGACTGCTGGAGACATGGGGAAACTGAGACAGATAATTCAAAGAGGAGGAATTCTGATCACAGAAAGAAAAAAAGCTGACTTTTCCACAAAAGACATTTATCAGGACCTCAACCGGTTGTTGAAAGGCAAAAAGGGAGAGCAGATGAATAGTGCTGTATTGCCAGAAATGGAGAATCAGGTTGCAGTTTCATCACTGTCTGCGGTAATCAAGTTTTTAGAACTCTTATCAGATGATTCCAACTTTGGACAGTTTGAACTGACTACTTTTGACTTCAGCCAGTATATGAAATTGGATATTGCAGCAGTCAGAGCCCTTAACCTTTTTCAGGGTTCTGTTGAAGATACCACTGGCTCTCAGTCTCTGGCTGCCTTGCTGAATAAGTGTAAAACCCCTCAAGGACAAAGACTTGTTAACCAGTGGATTAAGCAGCCTCTCATGGATAAGAACAGAATAGAGGAGAGATTGAATTTAGTGGAAGCTTTTGTAGAAGATGCAGAATTGAGGCAGACTTTACAAGAAGATTTACTTCGTCGATTCCCAGATCTTAACCGACTTGCCAAGAAGTTTCAAAGACAAGCAGCAAACTTACAAGATTGTTACCGACTCTATCAGGGTATAAATCAACTACCTAATGTTATACAGGCTCTGGAAAAACATGAAGGAAAACACCAGAAATTATTGTTGGCAGTTTTTGTGACTCCTCTTACTGATCTTCGTTCTGACTTCTCCAAGTTTCAGGAAATGATAGAAACAACTTTAGATATGGATCAGGTGGAAAACCATGAATTCCTTGTAAAACCTTCATTTGATCCTAATCTCAGTGAATTAAGAGAAATAATGAATGACTTGGAAAAGAAGATGCAGTCAACATTAATAAGTGCAGCCAGAGATCTTGGCTTGGACCCTGGCAAACAGATTAAACTGGATTCCAGTGCACAGTTTGGATATTACTTTCGTGTAACCTGTAAGGAAGAAAAAGTCCTTCGTAACAATAAAAACTTTAGTACTGTAGATATCCAGAAGAATGGTGTTAAATTTACCAACAGCAAATTGACTTCTTTAAATGAAGAGTCTACCAAAAATAAAACAGAATATGAAGAAGCCCAGGATGCCATTGTTAAAGAAATTGTCAATATTTCTTCAGGCTATGTAGAACCAATGCAGACACTCAATGATGTGTTAGCTCAGCTAGATGCTGTTGTCAGCTTTGCTCACGTGTCAAATGGAGCACCTGTTCCATATGTACGACCAGCCATTTTGGAGAAAGGACAAGGAAGAATTATATTAAAAGCATCCAGGCATGCTTGTGTTGAAGTTCAAGATGAAATTGCATTTATTCCTAATGACGTATACTTTGAAAAAGATAAACAGATGTTCCACATCATTACTGGCCCCAATATGGGAGGTAAATCAACATATATTCGACAAACTGGGGTGATAGTACTCATGGCCCAAATTGGGTGTTTTGTGCCATGTGAGTCAGCAGAAGTGTCCATTGTGGACTGCATCTTAGCCCGAGTAGGGGCTGGTGACAGTCAATTGAAAGGAGTCTCCACGTTCATGGCTGAAATGTTGGAAACTGCTTCTATCCTCAGGTCTGCAACCAAAGATTCATTAATAATCATAGATGAATTGGGAAGAGGAACTTCTACCTACGATGGATTTGGGTTAGCATGGGCTATATCAGAATACATTGCAACAAAGATTGGTGCTTTTTGCATGTTTGCAACCCATTTTCATGAACTTACTGCCTTGGCCAATCAGATACCAACTGTTAATAATCTACATGTCACAGCACTCACCACTGAAGAGACCTTAACTATGCTTTATCAGGTGAAGAAAGGTGTCTGTGATCAAAGTTTTGGGATTCATGTTGCAGAGCTTGCTAATTTCCCTAAGCATGTAATAGAGTGTGCTAAACAGAAAGCCCTGGAACTTGAGGAGTTTCAGTATATTGGAGAATCGCAAGGATATGATATCATGGAACCAGCAGCAAAGAAGTGCTATCTGGAAAGAGAGCAAGGTGAAAAAATTATTCAGGAGTTCCTGTCCAAGGTGAAACAAATGCCCTTTACTGAAATGTCAGAAGAAAACATCACAATAAAGTTAAAACAGCTAAAAGCTGAAGTAATAGCAAAGAATAATAGCTTTGTAAATGAAATCATTTCACGAATAAAAGTTACTACG																																															chr2	A	C	2-47470991-A-C																																																																																																																																																																																																																																																																																																																																																																																																																																														MSH2	ENSG00000095002	7918	202674	CCSBVarC003013	ALE00003013	1688A>C	Tyr563Ser	CEGS2	CegsMutGDEh1041	E08	GDEhDisVCh_40060	E09	2	CegsMutGDDh1041	E08	NULL	NULL	VUSMutpDEST2_07	B04	NULL	NULL	1	1	1	1	0	NULL	1	1	0	NULL	MSH2_Tyr563Ser	2	2	47470991	A	C
52861	F9	881G>A	Arg294Gln	ENSG00000101981	X	139561566	NC_000023.11:139561566:G:A	ALE00004382	CCSBVarC004382	NULL	204371	NULL	GDEhDisVCh_40052	F07	CEGS2	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCAAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT	25641.0	single nucleotide variant	NM_000133.4(F9):c.881G>A (p.Arg294Gln)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Nov 01, 2024	137852249.0	-	RCV000011348|RCV000814168|RCV000851909|RCV004724733	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139561566.0	139561566.0	Xq27.1	reviewed by expert panel	11.0	-	N	ClinGen:CA255368,UniProtKB:P00740#VAR_006583,OMIM:300746.0045	3.0	10602.0	139561566.0	G	A	-	-	-	-	-	-	SCV005437142	-	-	881G>A 	Arg294Gln	NM_000133.4	3.0	1_Pathogenic	chrX	G	A	X-139561566-G-A	1.82809e-6	10602	X	139561566	G	A	R	Q	rs137852249	X	138643725	X	138471391	294	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.881G>A	p.Arg294Gln	c.881G>A	p.Arg294Gln	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.08	0.36067	T	0.177	0.30054	T	0.992	0.64752	D	0.541	0.48867	P	0.76	0.86984	A	simple_aae	24.0	76.0	1.665	0.42444	L	-1.54	0.37362	N	0.334	0.49268	0.3200	0.87825	D	0.8304	0.94300	D	10	0.97296536	0.96923	D	0.272407	0.89905	D	0.576	0.82769	0.899	0.97715	P00740	R294Q	Loss of methylation at K293 (P = 0.0676)| Gain of sheet (P = 0.0827)| Loss of MoRF binding (P = 0.1006)| Gain of ubiquitination at K293 (P = 0.1204)| Gain of disorder (P = 0.1703)	0.992843060398	0.99267	0.9585912016915898	0.95820	1.76066134508	0.91089	0.260667711496	0.04971	T	0.696638	0.91142	D	0.313999	0.83923	D	0.213262	0.83714	D	0.932065665721893	0.59548	D	0.787321	0.42431	T	0.8708545	0.88776	0.8305342	0.90092	0.8341477	0.86012	0.74242586	0.84591	-10.286	0.77265	D	0.1903	0.47870	B	0.988798436711402	0.87928	0.99998462	0.99989	0.691	0.82854	.	.	.	.	.	.	4.434207	0.6885	25.3	0.99937078441635274	0.99661	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	4.79	0.87757	2.44	0.44615	9.966000	0.82858	0.618	0.50684	0.068	0.2209	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	58	264690	2.1912425E-4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1207641	1.656120e-06	0	2	892887	2.239930e-06	0	0	57732	0.000000e+00	0	0	685	0.000000e+00	0	0	45799	0.000000e+00	0	0	21907	0.000000e+00	0	0	33771	0.000000e+00	0	0	46785	0.000000e+00	0	0	4338	0.000000e+00	0	2	892887	2.239930e-06	0	0	56270	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561566G>A	ClinGen:CA255368|OMIM:300746.0045|UniProtKB:P00740#VAR_006583	C0008533|C0019069|C2749016	306900|134500|306700|300807	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Gln	25641	single nucleotide variant	NM_000133.4(F9):c.881G>A (p.Arg294Gln)	2158	F9	HGNC:3551	Pathogenic	1	Nov 01, 2024	137852249	-	RCV000011348|RCV000814168|RCV000851909|RCV004724733	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MedGen:C3661900	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139561566	139561566	Xq27.1	reviewed by expert panel	11	-	N	ClinGen:CA255368,UniProtKB:P00740#VAR_006583,OMIM:300746.0045	3	10602	139561566	G	A	-	-	-	-	-	-	SCV005437142	-	-	881G>A 	Arg294Gln	NM_000133.4	3	1_Pathogenic	F9	ENSG00000101981	52861	204371	CCSBVarC004382	ALE00004382	881G>A	Arg294Gln	CEGS2	CegsMutGDEh1029	D02	GDEhDisVCh_40052	F07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	F9_Arg294Gln	23	X	139561566	G	A
3689	GCK	532G>C	Gly178Arg	ENSG00000106633	7	44150016	NC_000007.14:44150016:C:G	ALE00006685	CCSBVarC006687	NULL	214822	NULL	GDEhDisVCh_40037	E06	CEGS2	ATGCTGGACGACAGAGCCAGGATGGAGGCCGCCAAGAAGGAGAAGGTAGAGCAGATCCTGGCAGAGTTCCAGCTGCAGGAGGAGGACCTGAAGAAGGTGATGAGACGGATGCAGAAGGAGATGGACCGCGGCCTGAGGCTGGAGACCCATGAAGAGGCCAGTGTGAAGATGCTGCCCACCTACGTGCGCTCCACCCCAGAAGGCTCAGAAGTCGGGGACTTCCTCTCCCTGGACCTGGGTGGCACTAACTTCAGGGTGATGCTGGTGAAGGTGGGAGAAGGTGAGGAGGGGCAGTGGAGCGTGAAGACCAAACACCAGATGTACTCCATCCCCGAGGACGCCATGACCGGCACTGCTGAGATGCTCTTCGACTACATCTCTGAGTGCATCTCCGACTTCCTGGACAAGCATCAGATGAAACACAAGAAGCTGCCCCTGGGCTTCACCTTCTCCTTTCCTGTGAGGCACGAAGACATCGATAAGGGCATCCTTCTCAACTGGACCAAGGGCTTCAAGGCCTCAGGAGCAGAACGGAACAATGTCGTGGGGCTTCTGCGAGACGCTATCAAACGGAGAGGGGACTTTGAAATGGATGTGGTGGCAATGGTGAATGACACGGTGGCCACGATGATCTCCTGCTACTACGAAGACCATCAGTGCGAGGTCGGCATGATCGTGGGCACGGGCTGCAATGCCTGCTACATGGAGGAGATGCAGAATGTGGAGCTGGTGGAGGGGGACGAGGGCCGCATGTGCGTCAATACCGAGTGGGGCGCCTTCGGGGACTCCGGCGAGCTGGACGAGTTCCTGCTGGAGTATGACCGCCTGGTGGACGAGAGCTCTGCAAACCCCGGTCAGCAGCTGTATGAGAAGCTCATAGGTGGCAAGTACATGGGCGAGCTGGTGCGGCTTGTGCTGCTCAGGCTCGTGGACGAAAACCTGCTCTTCCACGGGGAGGCCTCCGAGCAGCTGCGCACACGCGGAGCCTTCGAGACGCGCTTCGTGTCGCAGGTGGAGAGCGACACGGGCGACCGCAAGCAGATCTACAACATCCTGAGCACGCTGGGGCTGCGACCCTCGACCACCGACTGCGACATCGTGCGCCGCGCCTGCGAGAGCGTGTCTACGCGCGCTGCGCACATGTGCTCGGCGGGGCTGGCGGGCGTCATCAACCGCATGCGCGAGAGCCGCAGCGAGGACGTAATGCGCATCACTGTGGGCGTGGATGGCTCCGTGTACAAGCTGCACCCCAGCTTCAAGGAGCGGTTCCATGCCAGCGTGCGCAGGCTGACGCCCAGCTGCGAGATCACCTTCATCGAGTCGGAGGAGGGCAGTGGCCGGGGCGCGGCCCTGGTCTCGGCGGTGGCCTGTAAGAAGGCCTGTATGCTGGGCCAG																																															chr7	G	C	7-44150016-G-C																																																																																																																																																																																																																																																																																																																																																																																																																																														GCK	ENSG00000106633	3689	214822	CCSBVarC006687	ALE00006685	532G>C	Gly178Arg	CEGS2	CegsMutGDEh1046	E03	GDEhDisVCh_40037	E06	1	CegsMutGDDh1046	E03	VUSN2Hmut_GDN2h_10	B01	VUSMutpDEST2_03	F08	VUSmut_GDEh10	B01	1	1	1	1	1	1	1	1	1	6	GCK_Gly178Arg	7	7	44150016	C	G
3689	GCK	661G>A	Glu221Lys	ENSG00000106633	7	44149778	NC_000007.14:44149778:C:T	ALE00006687	CCSBVarC006689	NULL	214835	NULL	GDEhDisVCh_40037	B08	CEGS2	ATGCTGGACGACAGAGCCAGGATGGAGGCCGCCAAGAAGGAGAAGGTAGAGCAGATCCTGGCAGAGTTCCAGCTGCAGGAGGAGGACCTGAAGAAGGTGATGAGACGGATGCAGAAGGAGATGGACCGCGGCCTGAGGCTGGAGACCCATGAAGAGGCCAGTGTGAAGATGCTGCCCACCTACGTGCGCTCCACCCCAGAAGGCTCAGAAGTCGGGGACTTCCTCTCCCTGGACCTGGGTGGCACTAACTTCAGGGTGATGCTGGTGAAGGTGGGAGAAGGTGAGGAGGGGCAGTGGAGCGTGAAGACCAAACACCAGATGTACTCCATCCCCGAGGACGCCATGACCGGCACTGCTGAGATGCTCTTCGACTACATCTCTGAGTGCATCTCCGACTTCCTGGACAAGCATCAGATGAAACACAAGAAGCTGCCCCTGGGCTTCACCTTCTCCTTTCCTGTGAGGCACGAAGACATCGATAAGGGCATCCTTCTCAACTGGACCAAGGGCTTCAAGGCCTCAGGAGCAGAAGGGAACAATGTCGTGGGGCTTCTGCGAGACGCTATCAAACGGAGAGGGGACTTTGAAATGGATGTGGTGGCAATGGTGAATGACACGGTGGCCACGATGATCTCCTGCTACTACGAAGACCATCAGTGCAAGGTCGGCATGATCGTGGGCACGGGCTGCAATGCCTGCTACATGGAGGAGATGCAGAATGTGGAGCTGGTGGAGGGGGACGAGGGCCGCATGTGCGTCAATACCGAGTGGGGCGCCTTCGGGGACTCCGGCGAGCTGGACGAGTTCCTGCTGGAGTATGACCGCCTGGTGGACGAGAGCTCTGCAAACCCCGGTCAGCAGCTGTATGAGAAGCTCATAGGTGGCAAGTACATGGGCGAGCTGGTGCGGCTTGTGCTGCTCAGGCTCGTGGACGAAAACCTGCTCTTCCACGGGGAGGCCTCCGAGCAGCTGCGCACACGCGGAGCCTTCGAGACGCGCTTCGTGTCGCAGGTGGAGAGCGACACGGGCGACCGCAAGCAGATCTACAACATCCTGAGCACGCTGGGGCTGCGACCCTCGACCACCGACTGCGACATCGTGCGCCGCGCCTGCGAGAGCGTGTCTACGCGCGCTGCGCACATGTGCTCGGCGGGGCTGGCGGGCGTCATCAACCGCATGCGCGAGAGCCGCAGCGAGGACGTAATGCGCATCACTGTGGGCGTGGATGGCTCCGTGTACAAGCTGCACCCCAGCTTCAAGGAGCGGTTCCATGCCAGCGTGCGCAGGCTGACGCCCAGCTGCGAGATCACCTTCATCGAGTCGGAGGAGGGCAGTGGCCGGGGCGCGGCCCTGGTCTCGGCGGTGGCCTGTAAGAAGGCCTGTATGCTGGGCCAG	44905.0	single nucleotide variant	NM_000162.5(GCK):c.661G>A (p.Glu221Lys)	2645.0	GCK	HGNC:4195	Pathogenic	1.0	Feb 28, 2024	193922317.0	-	RCV000029904|RCV000711781|RCV002371787|RCV003155041	MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:C3661900|Human Phenotype Ontology:HP:0004904,MONDO:MONDO:0018911,MedGen:C0342276,OMIM:606391,Orphanet:552|MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625	Maturity-onset diabetes of the young type 2|not provided|Maturity onset diabetes mellitus in young|Monogenic diabetes	germline	germline	GRCh38	NC_000007.14	7	44149778.0	44149778.0	7p13	reviewed by expert panel	6.0	-	N	ClinGen:CA213824,UniProtKB:P35557#VAR_003702	2.0	36241.0	44149778.0	C	T	-	-	-	-	-	-	SCV004697921	-	-	661G>A 	Glu221Lys	NM_000162.5	3.0	1_Pathogenic	chr7	G	A	7-44149778-G-A		36241	7	44149778	C	T	E	K	rs193922317	7	44189377	7	44155902	221	GCK	ENSG00000106633	ENST00000403799	ENSP00000384247	P35557	HXK4_HUMAN	c.661G>A	p.Glu221Lys	c.661G>A	p.Glu221Lys	principal1	Y	1	YES	Select	-	GAG	1	0	C	C/C	C/C	C/C	C/C	0.113	0.28905	T	0.204	0.27537	T	1.0	0.90580	D	0.998	0.88579	D	0.98	0.97016	A	simple_aae	2.0	98.0	1.21	0.30316	L	-3.61	0.69513	D	0.933	0.94561	0.8006	0.94399	D	0.8954	0.96523	D	10	0.9329977	0.92552	D	0.108562	0.78449	D	0.789	0.93005	0.834	0.94200	P35557	E221K	Gain of methylation at E221 (P = 0.0028)| Gain of ubiquitination at E221 (P = 0.0267)| Gain of relative solvent accessibility (P = 0.2629)| Gain of solvent accessibility (P = 0.2987)| Loss of sheet (P = 0.302)	0.983011969047	0.98265	.	0.99768	.	0.96833	0.733988523483	0.72041	T	0.750067	0.93081	D	0.47959	0.93637	D	0.451121	0.93558	D	0.995560765266418	0.87555	D	0.987968	0.95957	D	0.8720905	0.88876	0.77897	0.86803	0.8974364	0.91030	0.6910655	0.81612	-10.642	0.77732	D	0.7102	0.81122	P	0.99866779060353	0.94835	0.99977785	0.99714	0.832	0.90743	.	.	.	.	.	.	6.105187	0.94579	34.0	0.99921364031156767	0.98788	0.959188	0.97930	D	0.666727412039614	0.77334	6.67797	0.740520883425636	0.85365	8.583408	6.17	6.17	0.99707	3.81	0.70705	7.905	0.86513	7.614000	0.62087	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.982	0.59239	671	0.60828	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4	1614066	2.478210e-06	0	3	1179996	2.542380e-06	0	0	75030	0.000000e+00	0	0	912	0.000000e+00	0	0	60020	0.000000e+00	0	0	29604	0.000000e+00	0	0	44870	0.000000e+00	0	0	63988	0.000000e+00	0	0	6062	0.000000e+00	0	3	1179996	2.542380e-06	0	0	91078	0.000000e+00	0	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Maturity-onset_diabetes_of_the_young_type_2|Maturity_onset_diabetes_mellitus_in_young|Monogenic_diabetes|not_provided	reviewed_by_expert_panel	NC_000007.14:g.44149778C>T	ClinGen:CA213824|UniProtKB:P35557#VAR_003702	C0342277|C0342276|C3888631|C3661900	125851|606391	552|552|183625	.	Glu	Lys	44905	single nucleotide variant	NM_000162.5(GCK):c.661G>A (p.Glu221Lys)	2645	GCK	HGNC:4195	Pathogenic	1	Feb 28, 2024	193922317	-	RCV000029904|RCV000711781|RCV002371787|RCV003155041	MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:C3661900|Human Phenotype Ontology:HP:0004904,MONDO:MONDO:0018911,MedGen:C0342276,OMIM:606391,Orphanet:552|MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625	Maturity-onset diabetes of the young type 2|not provided|Maturity onset diabetes mellitus in young|Monogenic diabetes	germline	germline	GRCh38	NC_000007.14	7	44149778	44149778	7p13	reviewed by expert panel	6	-	N	ClinGen:CA213824,UniProtKB:P35557#VAR_003702	2	36241	44149778	C	T	-	-	-	-	-	-	SCV004697921	-	-	661G>A 	Glu221Lys	NM_000162.5	3	1_Pathogenic	GCK	ENSG00000106633	3689	214835	CCSBVarC006689	ALE00006687	661G>A	Glu221Lys	CEGS2	CegsMutGDEh1046	B11	GDEhDisVCh_40037	B08	1	CegsMutGDDh1046	B11	VUSN2Hmut_GDN2h_10	E03	VUSMutpDEST2_03	H08	VUSmut_GDEh10	E03	1	1	1	1	1	1	1	1	1	1	GCK_Glu221Lys	7	7	44149778	C	T
2803	HMBS	667G>A	Glu223Lys	ENSG00000256269	11	119092419	NC_000011.10:119092419:G:A	ALE00005171	CCSBVarC005171	NULL	200944	NULL	GDEhDisVCh_40054	H03	CEGS2	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAGCTTGCTCGCATACAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGGACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCTTGAACATGCCCTGGAGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCGAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTCGGGGAAACCTCAACACCCGGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACCGGGTGGGGCAGATCCTGCACCCTGAGGAATGCATGTATGCTGTGGGCCAGGGGGCCTTGGGCGTGAAAGTGCGAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCTGCATCGCTGAAAGGGCCTTCCTGAGGCACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATGGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCGTAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACGATGCCCAT	16506.0	single nucleotide variant	NM_000190.4(HMBS):c.667G>A (p.Glu223Lys)	3145.0	HMBS	HGNC:4982	Conflicting classifications of pathogenicity	1.0	Aug 08, 2019	118204110.0	-	RCV000001532|RCV001209137	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900	Acute intermittent porphyria|not provided	germline;unknown	germline	GRCh38	NC_000011.10	11	119092419.0	119092419.0	11q23.3	criteria provided, conflicting classifications	3.0	-	N	ClinGen:CA251826,UniProtKB:P08397#VAR_003659,OMIM:609806.0027	3.0	1467.0	119092419.0	G	A	-	-	-	-	-	-	SCV000923439|SCV001380560	-	-	667G>A 	Glu223Lys	NM_000190.4	1.0	3_Conflicting	chr11	G	A	11-119092419-G-A	1.36818e-6	1467	11	119092419	G	A	E	K	rs118204110	11	118963129	11	118468339	223	HMBS	ENSG00000256269	ENST00000652429	ENSP00000498786	P08397	HEM3_HUMAN	c.667G>A	p.Glu223Lys	c.667G>A	p.Glu223Lys	principal2	Y	.	YES	Select	+	GAA	1	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.83643	.	0.984	0.60748	D	0.844	0.60367	P	.	0.97016	.	.	.	.	4.39	0.98587	H	.	0.70105	.	.	0.98575	0.9422	0.96268	D	0.9940	0.99862	D	9	.	0.99405	.	0.620418	0.96706	D	.	0.99491	0.958	0.99550	P08397	E223K	Gain of ubiquitination at E223 (P = 0.0247)| Gain of methylation at E223 (P = 0.2525)| Gain of catalytic residue at G218 (P = 0.2916)| Loss of sheet (P = 0.302)| Gain of MoRF binding (P = 0.3431)	.	0.96597	0.9828188442725427	0.98266	.	.	0.804392039776	0.82601	D	0.993857	0.99983	D	0.578822	0.96948	D	0.593661	0.96898	D	0.999448597431183	0.97407	D	0.998339	0.99218	D	0.99575716	0.99977	0.9741762	0.99627	0.99394846	0.99931	0.9588173	0.98891	-12.917	0.89042	D	0.9885	0.93132	P	0.999885612956612	0.98571	0.39407990	0.79441	0.997	0.99892	.	.	.	.	.	.	5.893047	0.93979	33.0	0.99921160894565186	0.98788	0.960290	0.98095	D	1.07768468966601	0.97685	16.59439	0.984470716393643	0.98295	17.92141	5.24	5.24	0.72825	.	.	9.732	0.98033	11.804000	0.96740	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.989	0.64309	228	0.91137	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1614098	1.239080e-06	0	2	1180018	1.694890e-06	0	0	75058	0.000000e+00	0	0	912	0.000000e+00	0	0	60020	0.000000e+00	0	0	29606	0.000000e+00	0	0	44878	0.000000e+00	0	0	63952	0.000000e+00	0	0	6060	0.000000e+00	0	2	1180018	1.694890e-06	0	0	91086	0.000000e+00	0	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Conflicting_classifications_of_pathogenicity	Acute_intermittent_porphyria|not_provided	criteria_provided,_conflicting_classifications	NC_000011.10:g.119092419G>A	ClinGen:CA251826|OMIM:609806.0027|UniProtKB:P08397#VAR_003659	C0162565|C3661900	176000	79276	Porphobilinogen deaminase, N-terminal	Glu	Lys	16506	single nucleotide variant	NM_000190.4(HMBS):c.667G>A (p.Glu223Lys)	3145	HMBS	HGNC:4982	Conflicting classifications of pathogenicity	1	Aug 08, 2019	118204110	-	RCV000001532|RCV001209137	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900	Acute intermittent porphyria|not provided	germline;unknown	germline	GRCh38	NC_000011.10	11	119092419	119092419	11q23.3	criteria provided, conflicting classifications	3	-	N	ClinGen:CA251826,UniProtKB:P08397#VAR_003659,OMIM:609806.0027	3	1467	119092419	G	A	-	-	-	-	-	-	SCV000923439|SCV001380560	-	-	667G>A 	Glu223Lys	NM_000190.4	1	3_Conflicting	HMBS	ENSG00000256269	2803	200944	CCSBVarC005171	ALE00005171	667G>A	Glu223Lys	CEGS2	CegsMutGDEh1037	G11	GDEhDisVCh_40054	H03	2	CegsMutGDDh1037	G11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	HMBS_Glu223Lys	11	11	119092419	G	A
100011574	PTEN	1066A>G	Asn356Asp	ENSG00000171862	10	87965326	NC_000010.11:87965326:A:G	ALE00007030	CCSBVarC007032	NULL	210313	NULL	GDEhDisVCh_40031	B09	CEGS2	ATGACAGCCATCATCAAAGAGATCGTTAGCAGAAACAAAAGGAGATATCAAGAGGATGGATTCGACTTAGACTTGACCTATATTTATCCAAACATTATTGCTATGGGATTTCCTGCAGAAAGACTTGAAGGCGTATACAGGAACAATATTGATGATGTAGTAAGGTTTTTGGATTCAAAGCATAAAAACCATTACAAGATATACAATCTTTGTGCTGAAAGACATTATGACACCGCCAAATTTAATTGCAGAGTTGCACAATATCCTTTTGAAGACCATAACCCACCACAGCTAGAACTTATCAAACCCTTTTGTGAAGATCTTGACCAATGGCTAAGTGAAGATGACAATCATGTTGCAGCAATTCACTGTAAAGCTGGAAAGGGACGAACTGGTGTAATGATATGTGCATATTTATTACATCGGGGCAAATTTTTAAAGGCACAAGAGGCCCTAGATTTCTATGGGGAAGTAAGGACCAGAGACAAAAAGGGAGTAACTATTCCCAGTCAGAGGCGCTATGTGTATTATTATAGCTACCTGTTAAAGAATCATCTGGATTATAGACCAGTGGCACTGTTGTTTCACAAGATGATGTTTGAAACTATTCCAATGTTCAGTGGCGGAACTTGCAATCCTCAGTTTGTGGTCTGCCAGCTAAAGGTGAAGATATATTCCTCCAATTCAGGACCCACACGACGGGAAGACAAGTTCATGTACTTTGAGTTCCCTCAGCCGTTACCTGTGTGTGGTGATATCAAAGTAGAGTTCTTCCACAAACAGAACAAGATGCTAAAAAAGGACAAAATGTTTCACTTTTGGGTAAATACATTCTTCATACCAGGACCAGAGGAAACCTCAGAAAAAGTAGAAAATGGAAGTCTATGTGATCAAGAAATCGATAGCATTTGCAGTATAGAGCGTGCAGATAATGACAAGGAATATCTAGTACTTACTTTAACAAAAAATGATCTTGACAAAGCAAATAAAGACAAAGCCAACCGATACTTTTCTCCAAATTTTAAGGTGAAGCTGTACTTCACAAAAACAGTAGAGGAGCCGTCAGATCCAGAGGCTAGCAGTTCAACTTCTGTAACACCAGATGTTAGTGACAATGAACCTGATCATTATAGATATTCTGACACCACTGACTCTGATCCAGAGAATGAACCTTTTGATGAAGATCAGCATACACAAATTACAAAAGTC	151977.0	single nucleotide variant	NM_000314.8(PTEN):c.1066A>G (p.Asn356Asp)	5728.0	PTEN	HGNC:9588	Conflicting classifications of pathogenicity	0.0	Jan 17, 2025	587782345.0	-	RCV000131284|RCV000463640|RCV001818323|RCV003477549|RCV004567128	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0017623,MeSH:D006223,MedGen:C1959582,Orphanet:306498|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0013092,MedGen:C2751642,OMIM:613028,Orphanet:182067	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|not specified|not provided|Glioma susceptibility 2	germline;unknown	germline	GRCh38	NC_000010.11	10	87965326.0	87965326.0	10q23.31	criteria provided, conflicting classifications	9.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000279	2.0	142263.0	87965326.0	A	G	-	-	-	-	-	-	SCV000186253|SCV000541613|SCV000691140|SCV002070087|SCV002600820|SCV004219123|SCV004838602|SCV005052562|SCV005402558	-	-	1066A>G 	Asn356Asp	NM_000314.8	1.0	3_Conflicting	chr10	A	G	10-87965326-A-G	2.05781e-6	142263	10	87965326	A	G	N	D	rs587782345	10	89725083	10	89715063	356	PTEN	ENSG00000171862	ENST00000371953	ENSP00000361021	P60484	PTEN_HUMAN	c.1066A>G	p.Asn356Asp	c.1066A>G	p.Asn356Asp	principal1	Y	1	YES	Select	+	AAT	1	0	A	./.	./.	./.	./.	0.118	0.28279	T	0.515	0.10810	T	0.435	0.35735	B	0.073	0.28124	B	0.83	0.88920	D	simple_aae	17.0	83.0	0.695	0.17891	N	-1.49	0.36370	N	0.787	0.78271	0.1063	0.84221	D	0.5811	0.84877	D	9	0.6980783	0.72015	D	0.135448	0.81739	D	0.383	0.69869	0.113	0.02225	P60484	N356D	Gain of glycosylation at S361 (P = 0.1645)| Gain of loop (P = 0.2045)| Loss of sheet (P = 0.302)| Gain of phosphorylation at S361 (P = 0.3458)| Loss of catalytic residue at P357 (P = 0.5409)	0.893004252121	0.89112	0.2446137421758835	0.24184	1.54415707829	0.87738	0.803328573704	0.82441	D	0.597704	0.86941	D	0.10606	0.64691	D	-0.0854285	0.64251	T	0.41515702009201	0.29202	T	0.968403	0.88541	D	0.28598306	0.51284	0.2365524	0.48746	0.27961746	0.50679	0.25065598	0.50468	-3.497	0.16402	T	0.1558	0.34536	B	0.970775901919185	0.83416	0.99674386	0.98148	0.626	0.79135	.	.	.	.	.	.	3.595408	0.50844	23.0	0.99030189689473536	0.50873	0.932071	0.92159	D	0.093688802494968	0.45915	2.861428	0.291433297334189	0.54802	3.667338	5.35	5.35	0.76261	.	.	8.904	0.92222	11.225000	0.89915	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.999	0.91597	896	0.25495	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	segdup	0	106426	0.000000e+00	0	1	203282	4.919270e-06	0	0	231262	0.000000e+00	0	0	6790	0.000000e+00	0	0	16866	0.000000e+00	0	0	2168	0.000000e+00	0	0	8906	0.000000e+00	0	0	13326	0.000000e+00	0	0	41122	0.000000e+00	0	0	15390	0.000000e+00	0	.	.	.	.	0	15630	0.000000e+00	0	0	29982	0.000000e+00	0	0	6000	0.000000e+00	0	0	13314	0.000000e+00	0	0	16578	0.000000e+00	0	1	87042	1.148870e-05	0	0	29988	0.000000e+00	0	1	87042	1.148870e-05	0	0	14348	0.000000e+00	0	0	33732	0.000000e+00	0	0	9350	0.000000e+00	0	0	17464	0.000000e+00	0	0	21358	0.000000e+00	0	0	99618	0.000000e+00	0	0	29910	0.000000e+00	0	.	.	.	.	.	3	1610172	1.863150e-06	0	1	44800	2.232140e-05	0	0	74970	0.000000e+00	0	0	912	0.000000e+00	0	0	59650	0.000000e+00	0	0	29446	0.000000e+00	0	1	44800	2.232140e-05	0	0	63808	0.000000e+00	0	0	6058	0.000000e+00	0	2	1177664	1.698280e-06	0	0	90570	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Glioma_susceptibility_2|PTEN_hamartoma_tumor_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000010.11:g.87965326A>G	ClinGen:CA000279	C0027672|CN169374|C3661900|C2751642|C1959582	613028	140162|182067|306498	.	Asn	Asp	151977	single nucleotide variant	NM_000314.8(PTEN):c.1066A>G (p.Asn356Asp)	5728	PTEN	HGNC:9588	Conflicting classifications of pathogenicity	0	Jan 17, 2025	587782345	-	RCV000131284|RCV000463640|RCV001818323|RCV003477549|RCV004567128	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0017623,MeSH:D006223,MedGen:C1959582,Orphanet:306498|MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0013092,MedGen:C2751642,OMIM:613028,Orphanet:182067	Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|not specified|not provided|Glioma susceptibility 2	germline;unknown	germline	GRCh38	NC_000010.11	10	87965326	87965326	10q23.31	criteria provided, conflicting classifications	9	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000279	2	142263	87965326	A	G	-	-	-	-	-	-	SCV000186253|SCV000541613|SCV000691140|SCV002070087|SCV002600820|SCV004219123|SCV004838602|SCV005052562|SCV005402558	-	-	1066A>G 	Asn356Asp	NM_000314.8	1	3_Conflicting	PTEN	ENSG00000171862	100011574	210313	CCSBVarC007032	ALE00007030	1066A>G	Asn356Asp	CEGS2	CegsMutGDEh1023	C11	GDEhDisVCh_40031	B09	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	PTEN_Asn356Asp	10	10	87965326	A	G
2803	HMBS	77G>A	Arg26His	ENSG00000256269	11	119088298	NC_000011.10:119088298:G:A	ALE00005157	CCSBVarC005157	NULL	200922	NULL	GDEhDisVCh_40054	C04	CEGS2	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCACAAGAGCCAGCTTGCTCGCATACAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGGACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCTTGAACATGCCCTGGAGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCGAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTCGGGGAAACCTCAACACCCGGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACCGGGTGGGGCAGATCCTGCACCCTGAGGAATGCATGTATGCTGTGGGCCAGGGGGCCTTGGGCGTGGAAGTGCGAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCTGCATCGCTGAAAGGGCCTTCCTGAGGCACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATGGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCGTAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACGATGCCCAT	16482.0	single nucleotide variant	NM_000190.4(HMBS):c.77G>A (p.Arg26His)	3145.0	HMBS	HGNC:4982	Pathogenic	1.0	Nov 02, 2024	118204103.0	-	RCV000001508|RCV000798844	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900	Acute intermittent porphyria|not provided	germline	germline	GRCh38	NC_000011.10	11	119088298.0	119088298.0	11q23.3	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA251791,UniProtKB:P08397#VAR_003639,OMIM:609806.0015	3.0	1443.0	119088298.0	G	A	-	-	-	-	-	-	SCV000938479|SCV005414015	-	-	77G>A 	Arg26His	NM_000190.4	2.0	1_Pathogenic	chr11	G	A	11-119088298-G-A	6.84103e-7	1443	11	119088298	G	A	R	H	rs118204103	11	118959008	11	118464218	26	HMBS	ENSG00000256269	ENST00000652429	ENSP00000498786	P08397	HEM3_HUMAN	c.77G>A	p.Arg26His	c.77G>A	p.Arg26His	principal2	Y	.	YES	Select	+	CGC	2	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	0.984	0.76117	D	.	0.97016	.	.	.	.	4.47	0.98862	H	.	0.79262	.	.	0.89342	0.9246	0.96012	D	0.9977	0.99943	D	9	.	0.99726	.	0.668687	0.97227	D	.	0.99647	0.991	0.99904	P08397	R26H	Loss of phosphorylation at T25 (P = 0.0975)| Loss of methylation at K27 (P = 0.1033)| Gain of catalytic residue at K27 (P = 0.1145)| Loss of disorder (P = 0.1319)| Loss of MoRF binding (P = 0.2161)	.	0.98196	0.94187620925175	0.94133	.	.	0.715661764145	0.69362	T	0.997606	0.99998	D	0.590797	0.97339	D	0.610862	0.97297	D	0.999914169311523	0.99678	D	0.9954	0.98433	D	0.96320134	0.97562	0.8812829	0.93566	0.9360872	0.94771	0.8641442	0.92362	-14.194	0.93682	D	0.9974	0.96927	P	0.99739938518121	0.93089	0.40135920	0.79621	0.992	0.99727	.	.	.	.	.	.	6.147239	0.94675	34.0	0.99955459766990529	0.99975	0.913011	0.87396	D	1.14604209760668	0.98893	19.80175	1.03741763637192	0.99224	21.34227	5.52	5.52	0.82128	6.13	0.98113	7.968	0.87561	11.821000	0.97243	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	228	0.91137	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614074	6.195500e-07	0	1	1179960	8.474860e-07	0	0	75044	0.000000e+00	0	0	910	0.000000e+00	0	0	60012	0.000000e+00	0	0	29608	0.000000e+00	0	0	44890	0.000000e+00	0	0	64034	0.000000e+00	0	0	6038	0.000000e+00	0	1	1179960	8.474860e-07	0	0	91080	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided|Acute_intermittent_porphyria	criteria_provided,_single_submitter	NC_000011.10:g.119088298G>A	ClinGen:CA251791|OMIM:609806.0015|UniProtKB:P08397#VAR_003639	C3661900|C0162565	176000	79276	Porphobilinogen deaminase, N-terminal	Arg	His	16482	single nucleotide variant	NM_000190.4(HMBS):c.77G>A (p.Arg26His)	3145	HMBS	HGNC:4982	Pathogenic	1	Nov 02, 2024	118204103	-	RCV000001508|RCV000798844	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900	Acute intermittent porphyria|not provided	germline	germline	GRCh38	NC_000011.10	11	119088298	119088298	11q23.3	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA251791,UniProtKB:P08397#VAR_003639,OMIM:609806.0015	3	1443	119088298	G	A	-	-	-	-	-	-	SCV000938479|SCV005414015	-	-	77G>A 	Arg26His	NM_000190.4	2	1_Pathogenic	HMBS	ENSG00000256269	2803	200922	CCSBVarC005157	ALE00005157	77G>A	Arg26His	CEGS2	CegsMutGDEh1038	H11	GDEhDisVCh_40054	C04	2	CegsMutGDDh1038	H11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	HMBS_Arg26His	11	11	119088298	G	A
71569	OTC	988A>G	Arg330Gly	ENSG00000036473	X	38411982	NC_000023.11:38411982:A:G	ALE00005262	CCSBVarC005262	NULL	205985	NULL	GDEhDisVCh_40048	F05	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACGGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103268.0	single nucleotide variant	NM_000531.6(OTC):c.988A>G (p.Arg330Gly)	5009.0	OTC	HGNC:8512	Pathogenic/Likely pathogenic	1.0	May 09, 2021	72558478.0	-	RCV000083625|RCV001857406	MedGen:C3661900|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664	not provided|Ornithine carbamoyltransferase deficiency	germline;unknown	germline	GRCh38	NC_000023.11	X	38411982.0	38411982.0	Xp11.4	criteria provided, multiple submitters, no conflicts	3.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224864,UniProtKB:P00480#VAR_004939	2.0	97376.0	38411982.0	A	G	-	-	-	-	-	-	SCV000582814|SCV002240986	-	-	988A>G 	Arg330Gly	NM_000531.6	2.0	1_Pathogenic	chrX	A	G	X-38411982-A-G		97376	X	38411982	A	G	R	G	rs72558478	X	38271235	X	38156179	330	OTC	ENSG00000036473	ENST00000713758	ENSP00000519059	P00480	OTC_HUMAN	.	.	c.988A>G	p.Arg330Gly	principal1	Y	.	.	.	+	AGA	1	2	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	0.996	0.84488	D	.	0.86984	.	.	.	.	4.55	0.99107	H	.	0.91674	.	.	0.99555	1.0064	0.97289	D	0.9857	0.99569	D	10	.	0.99990	.	0.878453	0.99071	D	.	0.99993	0.983	0.99835	P00480	R330G	Loss of stability (P = 0.051)| Loss of helix (P = 0.1706)| Loss of solvent accessibility (P = 0.239)| Loss of MoRF binding (P = 0.2457)| Loss of catalytic residue at R330 (P = 0.2469)	.	0.99963	.	0.99638	.	0.83797	0.80196338892	0.82231	T	0.944309	0.99139	D	0.715609	0.99943	D	0.790147	0.99943	D	0.998867630958557	0.95367	D	.	0.82046	.	0.99270296	0.99887	0.9886225	0.99967	0.9948744	0.99958	0.9846236	0.99917	-13.675	0.91969	D	.	0.93806	.	0.999911455277147	0.98806	0.99867560	0.98905	0.997	0.99892	.	.	.	.	.	.	4.92238	0.8112	27.5	0.99792629539781053	0.87849	.	.	.	.	.	.	.	.	.	5.16	5.16	0.70523	.	.	6.717	0.74586	9.208000	0.79253	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.995	0.73271	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Ornithine_carbamoyltransferase_deficiency|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.38411982A>G	ClinGen:CA224864|UniProtKB:P00480#VAR_004939	C0268542|C3661900	311250	664	Aspartate/ornithine carbamoyltransferase, Asp/Orn-binding domain	Arg	Gly	103268	single nucleotide variant	NM_000531.6(OTC):c.988A>G (p.Arg330Gly)	5009	OTC	HGNC:8512	Pathogenic/Likely pathogenic	1	May 09, 2021	72558478	-	RCV000083625|RCV001857406	MedGen:C3661900|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664	not provided|Ornithine carbamoyltransferase deficiency	germline;unknown	germline	GRCh38	NC_000023.11	X	38411982	38411982	Xp11.4	criteria provided, multiple submitters, no conflicts	3	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224864,UniProtKB:P00480#VAR_004939	2	97376	38411982	A	G	-	-	-	-	-	-	SCV000582814|SCV002240986	-	-	988A>G 	Arg330Gly	NM_000531.6	2	1_Pathogenic	OTC	ENSG00000036473	71569	205985	CCSBVarC005262	ALE00005262	988A>G	Arg330Gly	CEGS2	CegsMutGDEh1021	B04	GDEhDisVCh_40048	F05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Arg330Gly	23	X	38411982	A	G
3015	CRX	121C>T	Arg41Trp	ENSG00000105392	19	47836263	NC_000019.10:47836263:C:T	ALE00000380	CCSBVarC000380	5249	NULL	NULL	GDEhDisVCh_40040	C12	RC4	ATGATGGCGTATATGAACCCGGGGCCCCACTATTCTGTCAACGCCTTGGCCCTAAGTGGCCCCAGTGTGGATCTGATGCACCAGGCTGTGCCCTACCCAAGCGCCCCCAGGAAGCAGCGGTGGGAGCGCACCACCTTCACCCGGAGCCAACTGGAGGAGCTGGAGGCACTGTTTGCCAAGACCCAGTACCCAGACGTCTATGCCCGTGAGGAGGTGGCTCTGAAGATCAATCTGCCTGAGTCCAGGGTTCAGGTTTGGTTCAAGAACCGGAGGGCTAAATGCAGGCAGCAGCGACAGCAGCAGAAACAGCAGCAGCAGCCCCCAGGGGGCCAGGCCAAGGCCCGGCCTGCCAAGAGGAAGGCGGGCACGTCCCCAAGACCCTCCACAGATGTGTGTCCAGACCCTCTGGGCATCTCAGATTCCTACAGTCCCCCTCTGCCCGGCCCCTCAGGCTCCCCAACCACGGCAGTGGCCACTGTGTCCATCTGGAGCCCAGCCTCAGAGTCCCCTTTGCCTGAGGCGCAGCGGGCTGGGCTGGTGGCCTCAGGGCCGTCTCTGACCTCCGCCCCCTATGCCATGACCTACGCCCCGGCCTCCGCTTTCTGCTCTTCCCCCTCCGCCTATGGGTCTCCGAGCTCCTATTTCAGCGGCCTAGACCCCTACCTTTCTCCCATGGTGCCCCAGCTAGGGGGCCCGGCTCTTAGCCCCCTCTCTGGCCCCTCCGTGGGACCTTCCCTGGCCCAGTCCCCCACCTCCCTATCAGGCCAGAGCTATGGCGCCTACAGCCCCGTGGATAGCTTGGAATTCAAGGACCCCACGGGCACCTGGAAATTCACCTACAATCCCATGGACCCTCTGGACTACAAGGATCAGAGTGCCTGGAAGTTTCAGATCTTG	22457.0	single nucleotide variant	NM_000554.6(CRX):c.121C>T (p.Arg41Trp)	1406.0	CRX	HGNC:2383	Pathogenic/Likely pathogenic	1.0	Jan 17, 2025	104894672.0	-	RCV000085989|RCV000007843|RCV001073396|RCV003324484|RCV003324485|RCV001386169	MedGen:C3661900|MONDO:MONDO:0007362,MedGen:C3489532,OMIM:120970,Orphanet:1872|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862|Human Phenotype Ontology:HP:0000548,MONDO:MONDO:0015993,MedGen:C4085590,OMIM:PS120970,Orphanet:1872|Human Phenotype Ontology:HP:0000547,MONDO:MONDO:0019200,MeSH:D012174,MedGen:C0035334,OMIM:268000,OMIM:PS268000,Orphanet:791|MONDO:MONDO:0007362,MedGen:C3489532,OMIM:120970,Orphanet:1872;MONDO:MONDO:0013449,MedGen:C3151192,OMIM:613829,Orphanet:65	not provided|Cone-rod dystrophy 2|Retinal dystrophy|Cone-rod dystrophy|Retinitis pigmentosa|Cone-rod dystrophy 2;Leber congenital amaurosis 7	germline	germline	GRCh38	NC_000019.10	19	47836263.0	47836263.0	19q13.33	criteria provided, multiple submitters, no conflicts	12.0	-	N	OMIM:602225.0005,ClinGen:CA118790,UniProtKB:O43186#VAR_003750	3.0	7418.0	47836263.0	C	T	-	-	-	-	-	-	SCV001238937|SCV001586307|SCV002520975|SCV004030395|SCV004030396|SCV004706290|SCV005070688	-	-	121C>T 	Arg41Trp	NM_000554.6	2.0	1_Pathogenic	chr19	C	T	19-47836263-C-T	4.10432e-6	7418	19	47836263	C	T	R	W	rs104894672	19	48339520	19	53031332	41	CRX	ENSG00000105392	ENST00000221996	ENSP00000221996	O43186	CRX_HUMAN	c.121C>T	p.Arg41Trp	c.121C>T	p.Arg41Trp	principal1	Y	2	YES	Select	+	CGG	1	2	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.996	0.84488	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.505	0.98972	H	-6.83	0.95993	D	0.942	0.94916	1.1254	0.99917	D	0.9589	0.98670	D	9	0.9886997	0.99294	D	0.678054	0.97322	D	0.954	0.99189	0.94	0.99178	O43186	R41W	Loss of disorder (P = 0.0088)| Loss of glycosylation at T45 (P = 0.0718)| Loss of phosphorylation at T44 (P = 0.0773)| Loss of MoRF binding (P = 0.0807)| Gain of catalytic residue at E42 (P = 0.2294)	0.982273958719	0.98190	0.8566661157334813	0.85541	0.739256525941	0.62911	0.962255001068	0.99931	D	0.966019	0.99592	D	0.402331	0.89980	D	0.509273	0.94780	D	0.997130811214447	0.90772	D	0.927007	0.83981	D	0.870852	0.88776	0.81118655	0.88834	0.8245371	0.85340	0.82757753	0.89899	-13.076	0.89696	D	0.9969	0.96584	P	0.996944092949051	0.92617	0.99920613	0.99218	0.949	0.97673	.	.	.	.	.	.	4.756562	0.76901	26.6	0.99894847957579325	0.96821	0.673716	0.63838	D	0.578969039670544	0.71712	5.716039	0.404247170001402	0.61622	4.388637	3.67	3.67	0.41167	1.66	0.35877	2.136	0.41848	1.446000	0.26652	-0.316	0.05935	1.0	0.71675	1.000000	0.68239	0.95	0.49685	912	0.21478	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	109364	1.828760e-05	0	2	207888	9.620560e-06	0	2	236744	8.447940e-06	0	0	7158	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	1	9044	1.105710e-04	0	0	13392	0.000000e+00	0	1	42734	2.340060e-05	0	0	15690	0.000000e+00	0	1	9044	1.105710e-04	0	0	16154	0.000000e+00	0	0	30522	0.000000e+00	0	0	6204	0.000000e+00	0	1	13412	7.456010e-05	0	0	16732	0.000000e+00	0	1	89402	1.118540e-05	0	0	30608	0.000000e+00	0	1	13412	7.456010e-05	0	0	14840	0.000000e+00	0	0	34258	0.000000e+00	0	0	9568	0.000000e+00	0	1	17690	5.652910e-05	0	0	21626	0.000000e+00	0	1	102622	9.744500e-06	0	0	30526	0.000000e+00	0	1	17690	5.652910e-05	0	.	6	1614132	3.717170e-06	0	1	44874	2.228460e-05	0	0	75032	0.000000e+00	0	0	912	0.000000e+00	0	0	60012	0.000000e+00	0	0	29608	0.000000e+00	0	1	44874	2.228460e-05	0	0	64028	0.000000e+00	0	0	6058	0.000000e+00	0	4	1180022	3.389770e-06	0	0	91080	0.000000e+00	0	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Cone-rod_dystrophy|Cone-rod_dystrophy_2|Leber_congenital_amaurosis_7|Retinal_dystrophy|Retinitis_pigmentosa|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000019.10:g.47836263C>T	ClinGen:CA118790|OMIM:602225.0005|UniProtKB:O43186#VAR_003750	C4085590|C3489532|C3151192|C0854723|C0035334|C3661900	PS120970|120970|613829|268000|PS268000	1872|1872|65|71862|791	Homeodomain|Homeodomain|Homeodomain|Homeodomain	Arg	Trp	22457	single nucleotide variant	NM_000554.6(CRX):c.121C>T (p.Arg41Trp)	1406	CRX	HGNC:2383	Pathogenic/Likely pathogenic	1	Jan 17, 2025	104894672	-	RCV000085989|RCV000007843|RCV001073396|RCV003324484|RCV003324485|RCV001386169	MedGen:C3661900|MONDO:MONDO:0007362,MedGen:C3489532,OMIM:120970,Orphanet:1872|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862|Human Phenotype Ontology:HP:0000548,MONDO:MONDO:0015993,MedGen:C4085590,OMIM:PS120970,Orphanet:1872|Human Phenotype Ontology:HP:0000547,MONDO:MONDO:0019200,MeSH:D012174,MedGen:C0035334,OMIM:268000,OMIM:PS268000,Orphanet:791|MONDO:MONDO:0007362,MedGen:C3489532,OMIM:120970,Orphanet:1872;MONDO:MONDO:0013449,MedGen:C3151192,OMIM:613829,Orphanet:65	not provided|Cone-rod dystrophy 2|Retinal dystrophy|Cone-rod dystrophy|Retinitis pigmentosa|Cone-rod dystrophy 2;Leber congenital amaurosis 7	germline	germline	GRCh38	NC_000019.10	19	47836263	47836263	19q13.33	criteria provided, multiple submitters, no conflicts	12	-	N	OMIM:602225.0005,ClinGen:CA118790,UniProtKB:O43186#VAR_003750	3	7418	47836263	C	T	-	-	-	-	-	-	SCV001238937|SCV001586307|SCV002520975|SCV004030395|SCV004030396|SCV004706290|SCV005070688	-	-	121C>T 	Arg41Trp	NM_000554.6	2	1_Pathogenic	CRX	ENSG00000105392	3015	5249	CCSBVarC000380	ALE00000380	121C>T	Arg41Trp	RC4	RC4_Mut_GDEh1031	G08	GDEhDisVCh_40040	C12	2	RC4_Mut_GDDh1031	G08	NULL	NULL	NULL	NULL	NULL	NULL	1	5	1	99	0	NULL	0	NULL	0	NULL	CRX_Arg41Trp	19	19	47836263	C	T
71569	OTC	444G>T	Leu148Phe	ENSG00000036473	X	38401332	NC_000023.11:38401332:G:T	ALE00005244	CCSBVarC005244	NULL	205890	NULL	GDEhDisVCh_40048	A06	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTTGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103096.0	single nucleotide variant	NM_000531.6(OTC):c.444G>T (p.Leu148Phe)	5009.0	OTC	HGNC:8512	Pathogenic	1.0	-	66741318.0	-	RCV000083442	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38401332.0	38401332.0	Xp11.4	no assertion criteria provided	1.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224613,UniProtKB:P00480#VAR_004880	2.0	97204.0	38401332.0	G	T	-	-	-	-	-	-	SCV000115528	-	-	444G>T 	Leu148Phe	NM_000531.6		1_Pathogenic	chrX	G	T	X-38401332-G-T		97204	X	38401332	G	T	L	F	rs66741318	X	38260585	X	38145529	148	OTC	ENSG00000036473	ENST00000713758	ENSP00000519059	P00480	OTC_HUMAN	.	.	c.444G>T	p.Leu148Phe	principal1	Y	.	.	.	+	TTG	3	2	G	G/G	G/G	G/G	G/G	.	0.68399	.	.	0.76775	.	1.0	0.90580	D	0.99	0.78943	D	.	0.94956	.	.	.	.	2.96	0.84955	M	.	0.57138	.	.	0.90017	1.0880	0.99159	D	0.9663	0.98924	D	10	.	0.99690	.	0.820584	0.98602	D	.	0.97130	0.915	0.98375	P00480	L148F	Loss of ubiquitination at K153 (P = 0.0816)| Loss of stability (P = 0.154)| Loss of disorder (P = 0.1568)| Gain of methylation at K144 (P = 0.2076)| Gain of helix (P = 0.2294)	.	0.99227	.	0.94598	.	0.81070	0.517794311047	0.41257	T	0.939721	0.99033	D	0.625009	0.99862	D	0.660006	0.99395	D	0.985450863838196	0.76272	D	.	0.55301	.	0.9509156	0.96301	0.90234804	0.95076	0.9509156	0.96302	0.90234804	0.95076	-7.176	0.55378	T	.	0.84719	.	0.997801625381415	0.93571	0.99856335	0.98844	0.979	0.99252	.	.	.	.	.	.	3.910372	0.57099	23.8	0.99918930762911995	0.98587	.	.	.	.	.	.	.	.	.	5.97	5.08	0.68332	.	.	3.826	0.55528	5.742000	0.49654	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.995	0.73271	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided	no_assertion_criteria_provided	NC_000023.11:g.38401332G>T	ClinGen:CA224613|UniProtKB:P00480#VAR_004880	CN517202	.	.	Aspartate/ornithine carbamoyltransferase, carbamoyl-P binding	Leu	Phe	103096	single nucleotide variant	NM_000531.6(OTC):c.444G>T (p.Leu148Phe)	5009	OTC	HGNC:8512	Pathogenic	1	-	66741318	-	RCV000083442	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38401332	38401332	Xp11.4	no assertion criteria provided	1	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224613,UniProtKB:P00480#VAR_004880	2	97204	38401332	G	T	-	-	-	-	-	-	SCV000115528	-	-	444G>T 	Leu148Phe	NM_000531.6		1_Pathogenic	OTC	ENSG00000036473	71569	205890	CCSBVarC005244	ALE00005244	444G>T	Leu148Phe	CEGS2	CegsMutGDEh1025	A10	GDEhDisVCh_40048	A06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Leu148Phe	23	X	38401332	G	T
359	CBS	1150A>G	Lys384Glu	ENSG00000160200	21	43059299	NC_000021.9:43059299:T:C	ALE00007302	CCSBVarC007306	NULL	NULL	249	GDEhDisVCh_40013	G04	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCGAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	15162.0	single nucleotide variant	NM_000071.3(CBS):c.1150A>G (p.Lys384Glu)	875.0	CBS	HGNC:1550	Likely pathogenic	1.0	Nov 13, 2024	121964967.0	-	RCV000000145|RCV003495103	MedGen:C3502110|MedGen:C3150344	Homocystinuria, pyridoxine-responsive|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43059299.0	43059299.0	21q22.3	criteria provided, single submitter	2.0	-	N	ClinGen:CA113887,UniProtKB:P35520#VAR_002191,OMIM:613381.0007	3.0	123.0	43059299.0	T	C	-	-	-	-	-	-	SCV004283189	-	-	1150A>G 	Lys384Glu	NM_000071.3	1.0	1_Pathogenic	chr21	A	G	21-43059299-A-G		123	21	43059299	T	C	K	E	rs121964967	21	44479409	21	43352478	384	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.1150A>G	p.Lys384Glu	c.1150A>G	p.Lys384Glu	principal1	Y	1	.	.	-	AAG	1	0	T	T/T	T/T	T/T	T/T	0.001	0.78662	D	0.011	0.65108	D	0.999	0.77914	D	0.983	0.75798	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.515	0.92818	H	-3.73	0.70957	D	0.962	0.97221	1.0997	0.99648	D	0.9758	0.99245	D	9	0.9922403	0.99758	D	0.931237	0.99501	D	0.962	0.99434	0.88	0.96816	P35520	K384E	Loss of MoRF binding (P = 0.0022)| Loss of methylation at K384 (P = 0.0171)| Gain of helix (P = 0.0325)| Loss of catalytic residue at K384 (P = 0.0424)| Gain of phosphorylation at Y381 (P = 0.0911)	0.920581314067	0.91917	.	0.92997	.	0.82729	0.585263907909	0.50760	T	0.904713	0.98138	D	0.555577	0.95976	D	0.560271	0.95914	D	0.993034353915624	0.83554	D	.	0.78810	.	0.97970265	0.99071	0.93023497	0.97069	0.986692	0.99567	0.9189	0.96269	-14.929	0.95693	D	0.9639	0.88531	LP	0.999261483423878	0.96103	0.99958950	0.99514	0.984	0.99450	.	.	.	.	.	.	4.777585	0.77444	26.7	0.99834904030057559	0.91634	0.860081	0.77707	D	0.650064384320805	0.76244	6.47442	0.529381921740265	0.69810	5.437799	4.74	4.74	0.59667	.	.	7.596	0.82022	5.874000	0.50641	0.58	0.29757	1.0	0.71675	1.000000	0.68239	0.585	0.31061	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Homocystinuria,_pyridoxine-responsive|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_single_submitter	NC_000021.9:g.43059299T>C	ClinGen:CA113887|OMIM:613381.0007|UniProtKB:P35520#VAR_002191	C3502110|C3150344	.	.	.	Lys	Glu	15162	single nucleotide variant	NM_000071.3(CBS):c.1150A>G (p.Lys384Glu)	875	CBS	HGNC:1550	Likely pathogenic	1	Nov 13, 2024	121964967	-	RCV000000145|RCV003495103	MedGen:C3502110|MedGen:C3150344	Homocystinuria, pyridoxine-responsive|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43059299	43059299	21q22.3	criteria provided, single submitter	2	-	N	ClinGen:CA113887,UniProtKB:P35520#VAR_002191,OMIM:613381.0007	3	123	43059299	T	C	-	-	-	-	-	-	SCV004283189	-	-	1150A>G 	Lys384Glu	NM_000071.3	1	1_Pathogenic	CBS	ENSG00000160200	359	249	CCSBVarC007306	ALE00007302	1150A>G	Lys384Glu	Edgotyping3	VUSMutGDEh010	B11	GDEhDisVCh_40013	G04	1	VUSMutGDDh010	B11	NULL	NULL	NULL	NULL	NULL	NULL	1	6	1	6	0	NULL	0	NULL	0	NULL	CBS_Lys384Glu	21	21	43059299	T	C
3689	GCK	752T>C	Met251Thr	ENSG00000106633	7	44147761	NC_000007.14:44147761:A:G	ALE00006689	CCSBVarC006691	NULL	214842	NULL	GDEhDisVCh_40037	H03	CEGS2	ATGCTGGACGACAGAGCCAGGATGGAGGCCGCCAAGAAGGAGAAGGTAGAGCAGATCCTGGCAGAGTTCCAGCTGCAGGAGGAGGACCTGAAGAAGGTGATGAGACGGATGCAGAAGGAGATGGACCGCGGCCTGAGGCTGGAGACCCATGAAGAGGCCAGTGTGAAGATGCTGCCCACCTACGTGCGCTCCACCCCAGAAGGCTCAGAAGTCGGGGACTTCCTCTCCCTGGACCTGGGTGGCACTAACTTCAGGGTGATGCTGGTGAAGGTGGGAGAAGGTGAGGAGGGGCAGTGGAGCGTGAAGACCAAACACCAGATGTACTCCATCCCCGAGGACGCCATGACCGGCACTGCTGAGATGCTCTTCGACTACATCTCTGAGTGCATCTCCGACTTCCTGGACAAGCATCAGATGAAACACAAGAAGCTGCCCCTGGGCTTCACCTTCTCCTTTCCTGTGAGGCACGAAGACATCGATAAGGGCATCCTTCTCAACTGGACCAAGGGCTTCAAGGCCTCAGGAGCAGAAGGGAACAATGTCGTGGGGCTTCTGCGAGACGCTATCAAACGGAGAGGGGACTTTGAAATGGATGTGGTGGCAATGGTGAATGACACGGTGGCCACGATGATCTCCTGCTACTACGAAGACCATCAGTGCGAGGTCGGCATGATCGTGGGCACGGGCTGCAATGCCTGCTACATGGAGGAGATGCAGAATGTGGAGCTGGTGGAGGGGGACGAGGGCCGCACGTGCGTCAATACCGAGTGGGGCGCCTTCGGGGACTCCGGCGAGCTGGACGAGTTCCTGCTGGAGTATGACCGCCTGGTGGACGAGAGCTCTGCAAACCCCGGTCAGCAGCTGTATGAGAAGCTCATAGGTGGCAAGTACATGGGCGAGCTGGTGCGGCTTGTGCTGCTCAGGCTCGTGGACGAAAACCTGCTCTTCCACGGGGAGGCCTCCGAGCAGCTGCGCACACGCGGAGCCTTCGAGACGCGCTTCGTGTCGCAGGTGGAGAGCGACACGGGCGACCGCAAGCAGATCTACAACATCCTGAGCACGCTGGGGCTGCGACCCTCGACCACCGACTGCGACATCGTGCGCCGCGCCTGCGAGAGCGTGTCTACGCGCGCTGCGCACATGTGCTCGGCGGGGCTGGCGGGCGTCATCAACCGCATGCGCGAGAGCCGCAGCGAGGACGTAATGCGCATCACTGTGGGCGTGGATGGCTCCGTGTACAAGCTGCACCCCAGCTTCAAGGAGCGGTTCCATGCCAGCGTGCGCAGGCTGACGCCCAGCTGCGAGATCACCTTCATCGAGTCGGAGGAGGGCAGTGGCCGGGGCGCGGCCCTGGTCTCGGCGGTGGCCTGTAAGAAGGCCTGTATGCTGGGCCAG	44915.0	single nucleotide variant	NM_000162.5(GCK):c.752T>C (p.Met251Thr)	2645.0	GCK	HGNC:4195	Likely pathogenic	1.0	Aug 18, 2011	193922326.0	-	RCV000029914	MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552	Maturity-onset diabetes of the young type 2	germline	germline	GRCh38	NC_000007.14	7	44147761.0	44147761.0	7p13	criteria provided, single submitter	1.0	-	N	ClinGen:CA213840	2.0	36251.0	44147761.0	A	G	-	-	-	-	-	-	SCV000052569	-	-	752T>C 	Met251Thr	NM_000162.5	1.0	1_Pathogenic	chr7	T	C	7-44147761-T-C		36251	7	44147761	A	G	M	T	rs193922326	7	44187360	7	44153885	251	GCK	ENSG00000106633	ENST00000403799	ENSP00000384247	P35557	HXK4_HUMAN	c.752T>C	p.Met251Thr	c.752T>C	p.Met251Thr	principal1	Y	1	YES	Select	-	ATG	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.017	0.60671	D	0.995	0.67505	D	0.986	0.76920	D	1.0	0.99291	A	simple_aae	0.0	100.0	2.875	0.83215	M	-5.42	0.85499	D	0.984	0.99346	1.0939	0.99398	D	0.9434	0.98142	D	10	0.9929316	0.99827	D	0.810136	0.98516	D	0.958	0.99315	0.964	0.99639	P35557	M251T	Gain of phosphorylation at M251 (P = 0.0354)| Loss of stability (P = 0.0855)| Gain of glycosylation at M251 (P = 0.1029)| Gain of disorder (P = 0.1361)| Gain of catalytic residue at M251 (P = 0.2063)	0.968788596446	0.96816	.	0.99555	.	0.95313	0.82486641407	0.85751	D	0.914621	0.98402	D	0.549203	0.95653	D	0.551115	0.95589	D	0.997693359851837	0.92120	D	0.929807	0.73982	D	0.9549938	0.96722	0.9617509	0.99050	0.96466744	0.97710	0.96202224	0.99065	-11.075	0.80132	D	0.97	0.90769	P	0.999031307169696	0.95557	0.99983132	0.99778	0.985	0.99487	.	.	.	.	.	.	5.062186	0.84404	28.3	0.99328249489691056	0.59720	0.946730	0.95635	D	0.810235373814387	0.86670	8.984149	0.778746685223209	0.88214	9.523028	5.33	5.33	0.75646	.	.	9.269	0.94905	11.133000	0.86872	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.99	0.65338	698	0.58020	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1613630	6.197210e-07	0	0	75068	0.000000e+00	0	0	75068	0.000000e+00	0	0	910	0.000000e+00	0	0	60034	0.000000e+00	0	0	29608	0.000000e+00	0	0	44888	0.000000e+00	0	0	63438	0.000000e+00	0	0	6062	0.000000e+00	0	0	1180030	0.000000e+00	0	0	91086	0.000000e+00	0	0	74	0	0	0	0	0	30	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	30	0	0	652	0	Likely_pathogenic	Maturity-onset_diabetes_of_the_young_type_2	criteria_provided,_single_submitter	NC_000007.14:g.44147761A>G	ClinGen:CA213840	C0342277	125851	552	Hexokinase, C-terminal	Met	Thr	44915	single nucleotide variant	NM_000162.5(GCK):c.752T>C (p.Met251Thr)	2645	GCK	HGNC:4195	Likely pathogenic	1	Aug 18, 2011	193922326	-	RCV000029914	MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552	Maturity-onset diabetes of the young type 2	germline	germline	GRCh38	NC_000007.14	7	44147761	44147761	7p13	criteria provided, single submitter	1	-	N	ClinGen:CA213840	2	36251	44147761	A	G	-	-	-	-	-	-	SCV000052569	-	-	752T>C 	Met251Thr	NM_000162.5	1	1_Pathogenic	GCK	ENSG00000106633	3689	214842	CCSBVarC006691	ALE00006689	752T>C	Met251Thr	CEGS2	CegsMutGDEh1044	E12	GDEhDisVCh_40037	H03	1	CegsMutGDDh1044	E12	VUSN2Hmut_GDN2h_09	A08	VUSMutpDEST2_03	B09	VUSmut_GDEh09	A08	1	1	1	1	1	1	1	1	1	1	GCK_Met251Thr	7	7	44147761	A	G
3774	TP53	398T>C	Met133Thr	ENSG00000141510	17	7675214	NC_000017.11:7675214:A:G	ALE00004856	CCSBVarC004856	NULL	214885	NULL	GDEhDisVCh_40053	H03	CEGS2	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGACGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACCGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	27396.0	single nucleotide variant	NM_000546.6(TP53):c.398T>C (p.Met133Thr)	7157.0	TP53	HGNC:11998	Pathogenic	1.0	Oct 26, 2023	28934873.0	-	RCV000013151|RCV000492130|RCV001383051|RCV004786255	Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MedGen:C3661900	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided	germline	germline	GRCh38	NC_000017.11	17	7675214.0	7675214.0	17p13.1	criteria provided, multiple submitters, no conflicts	5.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000158,UniProtKB:P04637#VAR_005875,OMIM:191170.0011	3.0	12357.0	7675214.0	A	G	-	-	-	-	-	-	SCV000581145|SCV001582069|SCV002582605|SCV002583167|SCV005401389	-	-	398T>C 	Met133Thr	NM_000546.6	2.0	1_Pathogenic	chr17	T	C	17-7675214-T-C		12357	17	7675214	A	G	M	T	rs28934873	17	7578532	17	7519257	133	TP53	ENSG00000141510	ENST00000445888	ENSP00000391478	P04637	P53_HUMAN	c.398T>C	p.Met133Thr	c.398T>C	p.Met133Thr	principal1	Y	1	.	.	-	ATG	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	0.001	0.41256	B	0.113	0.61121	B	1.0	0.99291	A	simple_aae	0.0	100.0	0	0.06502	N	-3.01	0.62541	D	0.858	0.85414	1.0972	0.99541	D	0.9720	0.99119	D	9	0.9776781	0.98462	D	0.716004	0.97692	D	0.780	0.92639	0.916	0.98413	P04637	M133T	Loss of catalytic residue at M133 (P = 0.0062)| Loss of stability (P = 0.0192)| Gain of methylation at K132 (P = 0.0296)| Loss of helix (P = 0.2271)| Loss of ubiquitination at K132 (P = 0.2335)	0.992438338713	0.99226	.	0.61714	.	0.73124	0.589907288551	0.51414	T	0.979229	0.99821	D	0.428613	0.91400	D	0.377897	0.91294	D	0.976832866668701	0.71367	D	.	0.81706	.	0.9219513	0.93339	0.8752803	0.93141	0.9179911	0.92951	0.8754695	0.93155	-6.997	0.55162	T	0.9114	0.87930	P	0.982543080127452	0.85958	0.99992170	0.99909	0.973	0.98982	.	.	.	.	.	.	3.952499	0.57988	23.9	0.98652093278531261	0.44320	0.966728	0.98915	D	0.169324514316386	0.49484	3.170123	0.346740604155534	0.58089	4.000965	5.48	5.48	0.80649	5.37	0.93424	9.321	0.95539	9.408000	0.80715	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.999	0.91597	434	0.80544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	Li-Fraumeni_syndrome|Hereditary_cancer-predisposing_syndrome|Li-Fraumeni_syndrome_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.7675214A>G	ClinGen:CA000158|OMIM:191170.0011|UniProtKB:P04637#VAR_005875	C0085390|C0027672|C1835398	PS151623|151623	524|140162|524	p53, DNA-binding domain|p53, DNA-binding domain	Met	Thr	27396	single nucleotide variant	NM_000546.6(TP53):c.398T>C (p.Met133Thr)	7157	TP53	HGNC:11998	Pathogenic	1	Oct 26, 2023	28934873	-	RCV000013151|RCV000492130|RCV001383051|RCV004786255	Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MedGen:C3661900	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided	germline	germline	GRCh38	NC_000017.11	17	7675214	7675214	17p13.1	criteria provided, multiple submitters, no conflicts	5	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000158,UniProtKB:P04637#VAR_005875,OMIM:191170.0011	3	12357	7675214	A	G	-	-	-	-	-	-	SCV000581145|SCV001582069|SCV002582605|SCV002583167|SCV005401389	-	-	398T>C 	Met133Thr	NM_000546.6	2	1_Pathogenic	TP53	ENSG00000141510	3774	214885	CCSBVarC004856	ALE00004856	398T>C	Met133Thr	CEGS2	CegsMutGDEh1016	G01	GDEhDisVCh_40053	H03	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	TP53_Met133Thr	17	17	7675214	A	G
359	CBS	502G>A	Val168Met	ENSG00000160200	21	43065645	NC_000021.9:43065645:C:T	ALE00007327	CCSBVarC007336	NULL	NULL	291	GDEhDisVCh_40013	E08	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCATGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	15166.0	single nucleotide variant	NM_000071.3(CBS):c.502G>A (p.Val168Met)	875.0	CBS	HGNC:1550	Conflicting classifications of pathogenicity	1.0	Aug 01, 2024	121964970.0	-	RCV000000150|RCV000179250|RCV000458159|RCV002227959|RCV002310622|RCV002265542	MedGen:C3502110|MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880	Homocystinuria, pyridoxine-responsive|not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection|Homocystinuria	germline;unknown	germline	GRCh38	NC_000021.9	21	43065645.0	43065645.0	21q22.3	criteria provided, conflicting classifications	10.0	-	N	ClinGen:CA113895,UniProtKB:P35520#VAR_002180,OMIM:613381.0011	3.0	127.0	43065645.0	C	T	-	-	-	-	-	-	SCV000231470|SCV000249683|SCV000317362|SCV000543513|SCV001298058|SCV002547805|SCV004171931|SCV004213878	-	-	502G>A 	Val168Met	NM_000071.3	1.0	3_Conflicting	chr21	G	A	21-43065645-G-A		127	21	43065645	C	T	V	M	rs121964970	21	44485755	21	43358824	168	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.502G>A	p.Val168Met	c.502G>A	p.Val168Met	principal1	Y	1	.	.	-	GTG	1	0	C	C/C	C/C	C/C	C/C	0.012	0.60085	D	0.005	0.79703	D	0.997	0.70687	D	0.9	0.63907	P	0.99	0.97926	A	simple_aae	1.0	99.0	4.165	0.97608	H	-2.55	0.59257	D	0.893	0.89230	1.0877	0.99148	D	0.9652	0.98887	D	9	0.984113	0.98572	D	0.66049	0.97141	D	0.904	0.97356	0.928	0.98831	P35520	V168M	Loss of sheet (P = 0.0817)| Gain of MoRF binding (P = 0.0887)| Gain of glycosylation at P170 (P = 0.1168)| Loss of ubiquitination at K172 (P = 0.1381)| Gain of disorder (P = 0.1509)	0.953266672194	0.95237	.	0.87295	.	0.76485	0.769056499004	0.77243	T	0.988433	0.99940	D	0.528095	0.95036	D	0.520796	0.94962	D	0.980381965637207	0.73145	D	.	0.94986	.	0.8931835	0.90650	0.7888421	0.87417	0.92525524	0.93671	0.7712763	0.86330	-10.712	0.78126	D	.	0.82153	.	0.995808855843389	0.91612	0.99984181	0.99792	0.919	0.95868	.	.	.	.	.	.	5.021681	0.83489	28.0	0.99904322911254917	0.97503	0.897426	0.83900	D	0.886999415521491	0.91058	10.71962	0.75052170700091	0.86118	8.812544	4.56	4.56	0.55591	2.56	0.46987	6.783	0.74914	4.517000	0.43750	0.52	0.23855	1.0	0.71675	1.000000	0.68239	0.656	0.32898	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	79238	1.262020e-05	0	2	156982	1.274030e-05	0	2	179012	1.117240e-05	0	0	3984	0.000000e+00	0	0	14138	0.000000e+00	0	0	1604	0.000000e+00	0	0	6336	0.000000e+00	0	0	11836	0.000000e+00	0	0	27132	0.000000e+00	0	1	12688	7.881460e-05	0	1	12688	7.881460e-05	0	0	10756	0.000000e+00	0	0	24378	0.000000e+00	0	0	5042	0.000000e+00	0	0	10502	0.000000e+00	0	0	14188	0.000000e+00	0	1	63184	1.582680e-05	0	1	24972	4.004490e-05	0	1	24972	4.004490e-05	0	0	9958	0.000000e+00	0	0	28250	0.000000e+00	0	0	8554	0.000000e+00	0	0	13570	0.000000e+00	0	0	16688	0.000000e+00	0	1	72360	1.381980e-05	0	1	24930	4.011230e-05	0	1	24930	4.011230e-05	0	.	12	299628	4.004970e-05	3	8	40610	1.969960e-04	2	0	9368	0.000000e+00	0	0	0	.	0	0	14810	0.000000e+00	0	0	8526	0.000000e+00	0	0	25720	0.000000e+00	0	0	17598	0.000000e+00	0	0	1242	0.000000e+00	0	2	164720	1.214180e-05	0	8	40610	1.969960e-04	2	0	17026	0	0	268	0	0	84	0	0	6856	0	0	146	0	0	610	0	0	24	0	0	94	0	0	1894	0	0	7124	0	0	108	0	0	27002	0	Conflicting_classifications_of_pathogenicity	Homocystinuria|Familial_hypercholesterolemia|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_provided|Classic_homocystinuria|Homocystinuria,_pyridoxine-responsive|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_conflicting_classifications	NC_000021.9:g.43065645C>T	ClinGen:CA113895|OMIM:613381.0011|UniProtKB:P35520#VAR_002180	C0019880|C0020445|C4707243|C3661900|C0751202|C3502110|C3150344	PS143890|PS607086|236200	91387|394	Tryptophan synthase beta chain-like, PALP domain	Val	Met	15166	single nucleotide variant	NM_000071.3(CBS):c.502G>A (p.Val168Met)	875	CBS	HGNC:1550	Conflicting classifications of pathogenicity	1	Aug 01, 2024	121964970	-	RCV000000150|RCV000179250|RCV000458159|RCV002227959|RCV002310622|RCV002265542	MedGen:C3502110|MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880	Homocystinuria, pyridoxine-responsive|not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection|Homocystinuria	germline;unknown	germline	GRCh38	NC_000021.9	21	43065645	43065645	21q22.3	criteria provided, conflicting classifications	10	-	N	ClinGen:CA113895,UniProtKB:P35520#VAR_002180,OMIM:613381.0011	3	127	43065645	C	T	-	-	-	-	-	-	SCV000231470|SCV000249683|SCV000317362|SCV000543513|SCV001298058|SCV002547805|SCV004171931|SCV004213878	-	-	502G>A 	Val168Met	NM_000071.3	1	3_Conflicting	CBS	ENSG00000160200	359	291	CCSBVarC007336	ALE00007327	502G>A	Val168Met	Edgotyping3	VUSMutGDEh011	C03	GDEhDisVCh_40013	E08	1	VUSMutGDDh011	C03	NULL	NULL	NULL	NULL	NULL	NULL	1	3	1	5	0	NULL	0	NULL	0	NULL	CBS_Val168Met	21	21	43065645	C	T
359	CBS	1039G>A	Gly347Ser	ENSG00000160200	21	43062311	NC_000021.9:43062311:C:T	ALE00007308	CCSBVarC007313	NULL	NULL	260	GDEhDisVCh_40013	F05	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCAGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	187055.0	single nucleotide variant	NM_000071.3(CBS):c.1039G>A (p.Gly347Ser)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Jan 30, 2025	771298943.0	-	RCV000169132|RCV002390401|RCV002228607|RCV000197584|RCV000780082	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:C3150344|MedGen:C3661900|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880	Classic homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not provided|Homocystinuria	germline;unknown	germline	GRCh38	NC_000021.9	21	43062311.0	43062311.0	21q22.3	criteria provided, multiple submitters, no conflicts	11.0	-	N	ClinGen:CA273978	2.0	188801.0	43062311.0	C	T	-	-	-	-	-	-	SCV000220343|SCV000249703|SCV000917108|SCV000937630|SCV001163818|SCV001748028|SCV002701152|SCV002778332|SCV004227690	-	-	1039G>A 	Gly347Ser	NM_000071.3	2.0	1_Pathogenic	chr21	G	A	21-43062311-G-A		188801	21	43062311	C	T	G	S	rs771298943	21	44482421	21	43355490	347	CBS	ENSG00000160200	ENST00000352178	ENSP00000344460	P35520	CBS_HUMAN	c.1039G>A	p.Gly347Ser	c.1039G>A	p.Gly347Ser	principal1	Y	1	.	.	-	GGT	1	0	C	C/C	C/C	C/C	C/C	0.002	0.72322	D	0.003	0.76775	D	0.999	0.77914	D	0.996	0.84488	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.85	0.99713	H	-5.82	0.88318	D	0.86	0.85626	1.0749	0.98725	D	0.9718	0.99112	D	10	0.9945397	0.99949	D	0.747687	0.97981	D	0.987	0.99952	0.959	0.99566	P35520	G347S	Gain of sheet (P = 0.0827)| Gain of glycosylation at G347 (P = 0.0991)| Gain of disorder (P = 0.1407)| Loss of loop (P = 0.2897)| Loss of helix (P = 0.3949)	0.940820109721	0.93973	.	0.97692	.	0.78143	0.639955461025	0.58493	T	0.987833	0.99934	D	0.542702	0.95464	D	0.541778	0.95397	D	0.998648583889008	0.94691	D	0.99836	0.99218	D	0.9759375	0.98765	0.88082397	0.93533	0.9624422	0.97485	0.89567363	0.94596	-10.287	0.75688	D	0.8411	0.79963	P	0.999643436837848	0.97310	0.99964905	0.99571	0.974	0.99029	.	.	.	.	.	.	6.26257	0.94909	34.0	0.99802816965386676	0.88737	0.957535	0.97669	D	0.948025298776316	0.93872	12.36071	0.802724492270221	0.89927	10.20478	5.28	5.28	0.74083	2.92	0.53394	6.848	0.75268	5.716000	0.49523	0.524	0.24207	1.0	0.71675	1.000000	0.68239	0.143	0.20099	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Homocystinuria|not_provided|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Classic_homocystinuria|Familial_thoracic_aortic_aneurysm_and_aortic_dissection	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43062311C>T	ClinGen:CA273978	C0019880|C3661900|C3150344|C0751202|C4707243	236200|PS607086	394|91387	Tryptophan synthase beta chain-like, PALP domain	Gly	Ser	187055	single nucleotide variant	NM_000071.3(CBS):c.1039G>A (p.Gly347Ser)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Jan 30, 2025	771298943	-	RCV000169132|RCV002390401|RCV002228607|RCV000197584|RCV000780082	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:C3150344|MedGen:C3661900|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880	Classic homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not provided|Homocystinuria	germline;unknown	germline	GRCh38	NC_000021.9	21	43062311	43062311	21q22.3	criteria provided, multiple submitters, no conflicts	11	-	N	ClinGen:CA273978	2	188801	43062311	C	T	-	-	-	-	-	-	SCV000220343|SCV000249703|SCV000917108|SCV000937630|SCV001163818|SCV001748028|SCV002701152|SCV002778332|SCV004227690	-	-	1039G>A 	Gly347Ser	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	260	CCSBVarC007313	ALE00007308	1039G>A	Gly347Ser	Edgotyping3	VUSMutGDEh010	A12	GDEhDisVCh_40013	F05	1	VUSMutGDDh010	A12	NULL	NULL	NULL	NULL	NULL	NULL	1	3	1	6	0	NULL	0	NULL	0	NULL	CBS_Gly347Ser	21	21	43062311	C	T
359	CBS	209C>T	Pro70Leu	ENSG00000160200	21	43071985	NC_000021.9:43071985:G:A	ALE00007349	CCSBVarC007361	NULL	NULL	321	GDEhDisVCh_40013	F11	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCTGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210448.0	single nucleotide variant	NM_000071.3(CBS):c.209C>T (p.Pro70Leu)	875.0	CBS	HGNC:1550	Conflicting classifications of pathogenicity	0.0	Jul 17, 2024	2229413.0	-	RCV000199276|RCV002517161|RCV002415830	MedGen:CN169374|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	not specified|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection	germline	germline	GRCh38	NC_000021.9	21	43071985.0	43071985.0	21q22.3	criteria provided, conflicting classifications	3.0	-	N	ClinGen:CA323808	2.0	212841.0	43071985.0	G	A	-	-	-	-	-	-	SCV000249675|SCV000819704|SCV002724523	-	-	209C>T 	Pro70Leu	NM_000071.3	1.0	3_Conflicting	chr21	C	T	21-43071985-C-T		212841	21	43071985	G	A	P	L	rs2229413	21	44492095	21	43365164	70	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.209C>T	p.Pro70Leu	c.209C>T	p.Pro70Leu	principal1	Y	1	.	.	-	CCG	2	0	G	G/G	G/G	G/G	G/G	0.661	0.04713	T	0.703	0.05756	T	0.0	0.02950	B	0.0	0.01384	B	.	.	.	.	.	.	-1.245	0.00778	N	-0.22	0.10415	N	0.093	0.07242	-0.3092	0.74614	T	0.7345	0.90896	D	9	0.02443254	0.00670	T	0.079892	0.73246	D	0.317	0.63716	.	.	.	.	.	0.191931220699	0.18455	.	0.21212	.	0.36886	0.257500439882	0.04599	T	0.354587	0.72000	T	-0.233059	0.15963	T	-0.256393	0.48853	T	0.00363158867276514	0.00038	T	.	0.25525	.	0.20985572	0.42943	0.050034907	0.07786	0.14063913	0.32163	0.038669765	0.03799	-6.705	0.51914	T	0.0552	0.00512	LB	0.00242849074998268	0.14171	0.98118067	0.95639	0.042	0.10339	.	.	.	.	.	.	-0.43885	0.02077	0.191	0.38646133002316962	0.02633	0.124659	0.23867	N	-1.8817734451479	0.00372	0.01607962	-1.9471163358104	0.00391	0.01741368	5.32	-10.6	0.00212	-4.94	0.04584	-0.529	0.06286	-1.530000	0.05259	-1.13	0.01462	0.0	0.06393	0.000000	0.08389	0.043	0.14597	988	0.02004	2	3.9936102236421724E-4	1	7.564296520423601E-4	0	0.0	0	0.0	0	0.0	1	0.0010224948875255625	.	.	.	.	7	109394	6.398890e-05	0	10	206712	4.837650e-05	0	10	235514	4.246030e-05	0	4	7164	5.583470e-04	0	0	17108	0.000000e+00	0	0	2320	0.000000e+00	0	1	9046	1.105460e-04	0	0	13392	0.000000e+00	0	1	42766	2.338310e-05	0	1	15686	6.375110e-05	0	4	7164	5.583470e-04	0	6	16212	3.700960e-04	0	0	30514	0.000000e+00	0	0	6202	0.000000e+00	0	2	13416	1.490760e-04	0	0	16732	0.000000e+00	0	1	88178	1.134070e-05	0	1	30604	3.267550e-05	0	6	16212	3.700960e-04	0	5	14902	3.355250e-04	0	0	34252	0.000000e+00	0	0	9560	0.000000e+00	0	3	17692	1.695680e-04	0	0	21626	0.000000e+00	0	1	101348	9.866990e-06	0	1	30522	3.276330e-05	0	5	14902	3.355250e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4	103978	3.846967627767412E-5	0	238	0	0	2594	0	2	5484	3.6469730123997083E-4	0	644	0	0	336	0	0	600	0	0	182	0	0	6788	0	2	5722	3.495281370150297E-4	0	3194	0	6	120844	4.965078944755222E-5	Conflicting_classifications_of_pathogenicity	Familial_thoracic_aortic_aneurysm_and_aortic_dissection|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|not_specified	criteria_provided,_conflicting_classifications	NC_000021.9:g.43071985G>A	ClinGen:CA323808	C4707243|C3150344|CN169374	PS607086	91387	.	Pro	Leu	210448	single nucleotide variant	NM_000071.3(CBS):c.209C>T (p.Pro70Leu)	875	CBS	HGNC:1550	Conflicting classifications of pathogenicity	0	Jul 17, 2024	2229413	-	RCV000199276|RCV002517161|RCV002415830	MedGen:CN169374|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	not specified|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection	germline	germline	GRCh38	NC_000021.9	21	43071985	43071985	21q22.3	criteria provided, conflicting classifications	3	-	N	ClinGen:CA323808	2	212841	43071985	G	A	-	-	-	-	-	-	SCV000249675|SCV000819704|SCV002724523	-	-	209C>T 	Pro70Leu	NM_000071.3	1	3_Conflicting	CBS	ENSG00000160200	359	321	CCSBVarC007361	ALE00007349	209C>T	Pro70Leu	Edgotyping3	VUSMutGDEh011	D06	GDEhDisVCh_40013	F11	1	VUSMutGDDh011	D06	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	CBS_Pro70Leu	21	21	43071985	G	A
14613	BRCA1	1504A>G	Lys502Glu	ENSG00000012048	17	43071098	NC_000017.11:43071098:T:C	ALE00003301	CCSBVarC003301	NULL	218418	NULL	GDEhDisVCh_40059	H08	CEGS2	ATGGATTTATCTGCTCTTCGCGTTGAAGAAGTACAAAATGTCATTAATGCTATGCAGAAAATCTTAGAGTGTCCCATCTGTCTGGAGTTGATCAAGGAACCTGTCTCCACAAAGTGTGACCACATATTTTGCAAATTTTGCATGCTGAAACTTCTCAACCAGAAGAAAGGGCCTTCACAGTGTCCTTTATGTAAGAATGATATAACCAAAAGGAGCCTACAAGAAAGTACGAGATTTAGTCAACTTGTTGAAGAGCTATTGAAAATCATTTGTGCTTTTCAGCTTGACACAGGTTTGGAGTATGCAAACAGCTATAATTTTGCAAAAAAGGAAAATAACTCTCCTGAACATCTAAAAGATGAAGTTTCTATCATCCAAAGTATGGGCTACAGAAACCGTGCCAAAAGACTTCTACAGAGTGAACCCGAAAATCCTTCCTTGCAGGAAACCAGTCTCAGTGTCCAACTCTCTAACCTTGGAACTGTGAGAACTCTGAGGACAAAGCAGCGGATACAACCTCAAAAGACGTCTGTCTACATTGAATTGGGATCTGATTCTTCTGAAGATACCGTTAATAAGGCAACTTATTGCAGTGTGGGAGATCAAGAATTGTTACAAATCACCCCTCAAGGAACCAGGGATGAAATCAGTTTGGATTCTGCAAAAAAGGCTGCTTGTGAATTTTCTGAGACGGATGTAACAAATACTGAACATCATCAACCCAGTAATAATGATTTGAACACCACTGAGAAGCGTGCAGCTGAGAGGCATCCAGAAAAGTATCAGGGTGAAGCAGCATCTGGGTGTGAGAGTGAAACAAGCGTCTCTGAAGACTGCTCAGGGCTATCCTCTCAGAGTGACATTTTAACCACTCAGCAGAGGGATACCATGCAACATAACCTGATAAAGCTCCAGCAGGAAATGGCTGAACTAGAAGCTGTGTTAGAACAGCATGGGAGCCAGCCTTCTAACAGCTACCCTTCCATCATAAGTGACTCTTCTGCCCTTGAGGACCTGCGAAATCCAGAACAAAGCACATCAGAAAAAGTATTAACTTCACAGAAAAGTAGTGAATACCCTATAAGCCAGAATCCAGAAGGCCTTTCTGCTGACAAGTTTGAGGTGTCTGCAGATAGTTCTACCAGTAAAAATAAAGAACCAGGAGTGGAAAGGTCATCCCCTTCTAAATGCCCATCATTAGATGATAGGTGGTACATGCACAGTTGCTCTGGGAGTCTTCAGAATAGAAACTACCCATCTCAAGAGGAGCTCATTAAGGTTGTTGATGTGGAGGAGCAACAGCTGGAAGAGTCTGGGCCACACGATTTGACGGAAACATCTTACTTGCCAAGGCAAGATCTAGAGGGAACCCCTTACCTGGAATCTGGAATCAGCCTCTTCTCTGATGACCCTGAATCTGATCCTTCTGAAGACAGAGCCCCAGAGTCAGCTCGTGTTGGCAACATACCATCTTCAACCTCTGCATTGAAAGTTCCCCAATTGGAAGTTGCAGAATCTGCCCAGAGTCCAGCTGCTGCTCATACTACTGATACTGCTGGGTATAATGCAATGGAAGAAAGTGTGAGCAGGGAGAAGCCAGAATTGACAGCTTCAACAGAAAGGGTCAACAAAAGAATGTCCATGGTGGTGTCTGGCCTGACCCCAGAAGAATTTATGCTCGTGTACAAGTTTGCCAGAAAACACCACATCACTTTAACTAATCTAATTACTGAAGAGACTACTCATGTTGTTATGAAAACAGATGCTGAGTTTGTGTGTGAACGGACACTGAAATATTTTCTAGGAATTGCGGGAGGAAAATGGGTAGTTAGCTATTTCTGGGTGACCCAGTCTATTAAAGAAAGAAAAATGCTGAATGAGCATGATTTTGAAGTCAGAGGAGATGTGGTCAATGGAAGAAACCACCAAGGTCCAAAGCGAGCAAGAGAATCCCAGGACAGAAAGATCTTCAGGGGGCTAGAAATCTGTTGCTATGGGCCCTTCACCAACATGCCCACAGGGTGTCCACCCAATTGTGGTTGTGCAGCCAGATGCCTGGACAGAGGACAATGGCTTCCATGCAATTGGGCAGATGTG	46168.0	single nucleotide variant	NM_007294.4(BRCA1):c.4816A>G (p.Lys1606Glu)	672.0	BRCA1	HGNC:1100	Benign	0.0	Jun 18, 2019	80356943.0	-	RCV000048668|RCV000436368|RCV000735492|RCV000130005|RCV004554630|RCV000031193|RCV001281714	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374|MedGen:CN221562|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162||MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900	Hereditary breast ovarian cancer syndrome|not specified|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|BRCA1-related disorder|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	43071098.0	43071098.0	17q21.31	reviewed by expert panel	16.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003037,UniProtKB:P38398#VAR_007790	2.0	37612.0	43071098.0	T	C	-	-	-	-	-	-	SCV001161595	-	-	4816A>G 	Lys1606Glu	NM_007294.4	3.0	2_Benign	chr17	A	G	17-43071098-A-G		37612	17	43071098	T	C	K	E	rs80356943	17	41223115	17	38476641	1606	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.4816A>G	p.Lys1606Glu	principal2	Y	1	.	.	-	AAA	1	0	T	T/T	T/T	T/T	T/T	.	0.72322	.	.	0.49207	.	0.0	0.02950	B	0.0	0.01384	B	.	0.99291	.	.	.	.	0	0.06502	N	.	0.10767	.	.	0.28302	-0.5432	0.66897	T	0.4017	0.75178	T	10	.	0.37017	.	0.227152	0.88048	D	.	0.75894	.	.	.	.	.	.	0.58443	.	0.16602	.	0.12617	0.260015904903	0.04893	T	0.098826	0.40015	T	0.0938011	0.63355	D	0.0772584	0.75211	D	0.106747360008648	0.12918	T	0.852615	0.53662	D	0.096304744	0.22477	0.09333296	0.22003	0.09800102	0.22901	0.07730816	0.17192	-3.059	0.10842	T	.	0.04993	.	0.00105470856972761	0.09785	0.99718000	0.98290	0.042	0.10339	.	.	.	.	.	.	1.918289	0.24404	16.37	0.91817812478712357	0.21378	0.169829	0.29455	N	-0.929974890242364	0.10024	0.4834715	-0.879878298600479	0.12355	0.6474283	4.92	2.88	0.32534	3.03	0.55386	2.465	0.44835	6.225000	0.55234	-0.114	0.14662	0.492	0.26984	1.000000	0.68239	0.007	0.07843	543	0.72771	.	.	.	.	.	.	.	.	.	.	.	.	6	264690	2.2668026E-5	.	3	109406	2.742080e-05	0	5	208130	2.402340e-05	0	7	236868	2.955230e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	3	42768	7.014590e-05	0	0	15690	0.000000e+00	0	3	42768	7.014590e-05	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16732	0.000000e+00	0	5	89554	5.583220e-05	0	0	30608	0.000000e+00	0	5	89554	5.583220e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	7	102672	6.817830e-05	0	0	30526	0.000000e+00	0	7	102672	6.817830e-05	0	.	50	1613986	3.097920e-05	0	45	1180018	3.813500e-05	0	1	74914	1.334860e-05	0	0	912	0.000000e+00	0	0	59958	0.000000e+00	0	0	29606	0.000000e+00	0	0	44898	0.000000e+00	0	0	64032	0.000000e+00	0	0	6084	0.000000e+00	0	45	1180018	3.813500e-05	0	0	91082	0.000000e+00	0	1	19780	5.0556117290192114E-5	0	298	0	0	86	0	1	7864	1.271617497456765E-4	0	146	0	0	610	0	0	26	0	0	98	0	0	1982	0	1	8162	1.2251899044351874E-4	0	112	0	2	30890	6.474587245063128E-5	Benign	BRCA1-related_disorder|not_specified|Hereditary_breast_ovarian_cancer_syndrome|Breast_and/or_ovarian_cancer|Hereditary_cancer-predisposing_syndrome|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43071098T>C	ClinGen:CA003037|UniProtKB:P38398#VAR_007790	CN169374|C0677776|CN221562|C0027672|C3661900|C2676676	604370	145|140162|145	.	Lys	Glu	46168	single nucleotide variant	NM_007294.4(BRCA1):c.4816A>G (p.Lys1606Glu)	672	BRCA1	HGNC:1100	Benign	0	Jun 18, 2019	80356943	-	RCV000048668|RCV000436368|RCV000735492|RCV000130005|RCV004554630|RCV000031193|RCV001281714	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374|MedGen:CN221562|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162||MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900	Hereditary breast ovarian cancer syndrome|not specified|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|BRCA1-related disorder|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	43071098	43071098	17q21.31	reviewed by expert panel	16	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003037,UniProtKB:P38398#VAR_007790	2	37612	43071098	T	C	-	-	-	-	-	-	SCV001161595	-	-	4816A>G 	Lys1606Glu	NM_007294.4	3	2_Benign	BRCA1	ENSG00000012048	14613	218418	CCSBVarC003301	ALE00003301	1504A>G	Lys502Glu	CEGS2	CegsMutGDEh1026	D01	GDEhDisVCh_40059	H08	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	BRCA1_Lys502Glu	17	17	43071098	T	C
7918	MSH2	319G>C	Ala107Pro	ENSG00000095002	2	47408508	NC_000002.12:47408508:G:C	ALE00003004	CCSBVarC003004	NULL	202639	NULL	GDEhDisVCh_40060	B10	CEGS2	ATGGCGGTGCAGCCGAAGGAGACGCTGCAGTTGGAGAGCGCGGCCGAGGTCGGCTTCGTGCGCTTCTTTCAGGGCATGCCGGAGAAGCCGACCACCACAGTGCGCCTTTTCGACCGGGGCGACTTCTATACGGCGCACGGCGAGGACGCGCTGCTGGCCGCCCGGGAGGTGTTCAAGACCCAGGGGGTGATCAAGTACATGGGGCCGGCAGGAGCAAAGAATCTGCAGAGTGTTGTGCTTAGTAAAATGAATTTTGAATCTTTTGTAAAAGATCTTCTTCTGGTTCGTCAGTATAGAGTTGAAGTTTATAAGAATAGACCTGGAAATAAGGCATCCAAGGAGAATGATTGGTATTTGGCATATAAGGCTTCTCCTGGCAATCTCTCTCAGTTTGAAGACATTCTCTTTGGTAACAATGATATGTCAGCTTCCATTGGTGTTGTGGGTGTTAAAATGTCCGCAGTTGATGGCCAGAGACAGGTTGGAGTTGGGTATGTGGATTCCATACAGAGGAAACTAGGACTGTGTGAATTCCCTGATAATGATCAGTTCTCCAATCTTGAGGCTCTCCTCATCCAGATTGGACCAAAGGAATGTGTTTTACCCGGAGGAGAGACTGCTGGAGACATGGGGAAACTGAGACAGATAATTCAAAGAGGAGGAATTCTGATCACAGAAAGAAAAAAAGCTGACTTTTCCACAAAAGACATTTATCAGGACCTCAACCGGTTGTTGAAAGGCAAAAAGGGAGAGCAGATGAATAGTGCTGTATTGCCAGAAATGGAGAATCAGGTTGCAGTTTCATCACTGTCTGCGGTAATCAAGTTTTTAGAACTCTTATCAGATGATTCCAACTTTGGACAGTTTGAACTGACTACTTTTGACTTCAGCCAGTATATGAAATTGGATATTGCAGCAGTCAGAGCCCTTAACCTTTTTCAGGGTTCTGTTGAAGATACCACTGGCTCTCAGTCTCTGGCTGCCTTGCTGAATAAGTGTAAAACCCCTCAAGGACAAAGACTTGTTAACCAGTGGATTAAGCAGCCTCTCATGGATAAGAACAGAATAGAGGAGAGATTGAATTTAGTGGAAGCTTTTGTAGAAGATGCAGAATTGAGGCAGACTTTACAAGAAGATTTACTTCGTCGATTCCCAGATCTTAACCGACTTGCCAAGAAGTTTCAAAGACAAGCAGCAAACTTACAAGATTGTTACCGACTCTATCAGGGTATAAATCAACTACCTAATGTTATACAGGCTCTGGAAAAACATGAAGGAAAACACCAGAAATTATTGTTGGCAGTTTTTGTGACTCCTCTTACTGATCTTCGTTCTGACTTCTCCAAGTTTCAGGAAATGATAGAAACAACTTTAGATATGGATCAGGTGGAAAACCATGAATTCCTTGTAAAACCTTCATTTGATCCTAATCTCAGTGAATTAAGAGAAATAATGAATGACTTGGAAAAGAAGATGCAGTCAACATTAATAAGTGCAGCCAGAGATCTTGGCTTGGACCCTGGCAAACAGATTAAACTGGATTCCAGTGCACAGTTTGGATATTACTTTCGTGTAACCTGTAAGGAAGAAAAAGTCCTTCGTAACAATAAAAACTTTAGTACTGTAGATATCCAGAAGAATGGTGTTAAATTTACCAACAGCAAATTGACTTCTTTAAATGAAGAGTATACCAAAAATAAAACAGAATATGAAGAAGCCCAGGATGCCATTGTTAAAGAAATTGTCAATATTTCTTCAGGCTATGTAGAACCAATGCAGACACTCAATGATGTGTTAGCTCAGCTAGATGCTGTTGTCAGCTTTGCTCACGTGTCAAATGGAGCACCTGTTCCATATGTACGACCAGCCATTTTGGAGAAAGGACAAGGAAGAATTATATTAAAAGCATCCAGGCATGCTTGTGTTGAAGTTCAAGATGAAATTGCATTTATTCCTAATGACGTATACTTTGAAAAAGATAAACAGATGTTCCACATCATTACTGGCCCCAATATGGGAGGTAAATCAACATATATTCGACAAACTGGGGTGATAGTACTCATGGCCCAAATTGGGTGTTTTGTGCCATGTGAGTCAGCAGAAGTGTCCATTGTGGACTGCATCTTAGCCCGAGTAGGGGCTGGTGACAGTCAATTGAAAGGAGTCTCCACGTTCATGGCTGAAATGTTGGAAACTGCTTCTATCCTCAGGTCTGCAACCAAAGATTCATTAATAATCATAGATGAATTGGGAAGAGGAACTTCTACCTACGATGGATTTGGGTTAGCATGGGCTATATCAGAATACATTGCAACAAAGATTGGTGCTTTTTGCATGTTTGCAACCCATTTTCATGAACTTACTGCCTTGGCCAATCAGATACCAACTGTTAATAATCTACATGTCACAGCACTCACCACTGAAGAGACCTTAACTATGCTTTATCAGGTGAAGAAAGGTGTCTGTGATCAAAGTTTTGGGATTCATGTTGCAGAGCTTGCTAATTTCCCTAAGCATGTAATAGAGTGTGCTAAACAGAAAGCCCTGGAACTTGAGGAGTTTCAGTATATTGGAGAATCGCAAGGATATGATATCATGGAACCAGCAGCAAAGAAGTGCTATCTGGAAAGAGAGCAAGGTGAAAAAATTATTCAGGAGTTCCTGTCCAAGGTGAAACAAATGCCCTTTACTGAAATGTCAGAAGAAAACATCACAATAAAGTTAAAACAGCTAAAAGCTGAAGTAATAGCAAAGAATAATAGCTTTGTAAATGAAATCATTTCACGAATAAAAGTTACTACG	96538.0	single nucleotide variant	NM_000251.3(MSH2):c.319G>C (p.Ala107Pro)	4436.0	MSH2	HGNC:7325	Conflicting classifications of pathogenicity	0.0	Jun 04, 2024	587779158.0	-	RCV000131126|RCV000811372|RCV003317079|RCV003466967|RCV003997172	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MeSH:D003123,MedGen:C0009405|MedGen:C3661900|MONDO:MONDO:0007356,MedGen:C2936783,OMIM:120435,Orphanet:144|MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|not provided|Lynch syndrome 1|Lynch syndrome	germline;unknown	germline	GRCh38	NC_000002.12	2	47408508.0	47408508.0	2p21	criteria provided, conflicting classifications	6.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA021012	2.0	91063.0	47408508.0	G	C	-	-	-	-	-	-	SCV000186057|SCV000951634|SCV001350529|SCV004021570|SCV004196891|SCV004827747	-	-	319G>C 	Ala107Pro	NM_000251.3	1.0	3_Conflicting	chr2	G	C	2-47408508-G-C	9.59066e-6	91063	2	47408508	G	C	A	P	rs587779158	2	47635647	2	47489151	107	MSH2	ENSG00000095002	ENST00000233146	ENSP00000233146	P43246	MSH2_HUMAN	c.319G>C	p.Ala107Pro	c.319G>C	p.Ala107Pro	principal1	Y	1	YES	Select	+	GCT	1	0	G	G/G	G/G	G/G	G/G	0.085	0.32912	T	0.133	0.35663	T	0.015	0.56216	B	0.015	0.53776	B	0.27	0.69764	N	simple_aae	73.0	27.0	1.15	0.29146	L	-1.62	0.38917	N	0.744	0.90245	0.2335	0.86414	D	0.5883	0.85196	D	10	0.8629122	0.85364	D	0.053003	0.65168	D	0.643	0.86371	0.813	0.92818	P43246	A107P	Gain of glycosylation at A107 (P = 0.0252)| Loss of MoRF binding (P = 0.0444)| Gain of methylation at K110 (P = 0.0582)| Gain of disorder (P = 0.083)| Loss of ubiquitination at K110 (P = 0.1151)	0.985634772415	0.98532	0.45602835709383027	0.45321	0.0204193935576	0.01944	0.654562473297	0.60571	T	0.482336	0.80907	T	0.360275	0.87184	D	0.279734	0.87018	D	0.541451687982182	0.33846	D	0.916508	0.70078	D	0.64212453	0.74671	0.50301856	0.71014	0.5541404	0.69891	0.44018832	0.67090	-2.277	0.04435	T	0.2078	0.43486	B	0.119026124868615	0.44926	0.99969375	0.99611	0.429	0.66697	.	.	.	.	.	.	3.322063	0.45774	22.2	0.99495031518111288	0.67728	0.691286	0.65007	D	0.0733747952784561	0.44967	2.782505	0.143646738403513	0.46536	2.92066	5.31	5.31	0.75027	.	.	4.501	0.60201	11.628000	0.93687	0.597	0.3436	1.0	0.71675	1.000000	0.68239	0.998	0.85369	807	0.43408	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	.	1	109362	9.143940e-06	0	1	208010	4.807460e-06	0	1	236800	4.222970e-06	0	0	7164	0.000000e+00	0	0	17088	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	1	42764	2.338420e-05	0	0	15672	0.000000e+00	0	1	42764	2.338420e-05	0	0	16212	0.000000e+00	0	0	30492	0.000000e+00	0	0	6210	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	1	89506	1.117240e-05	0	0	30578	0.000000e+00	0	1	89506	1.117240e-05	0	0	14896	0.000000e+00	0	0	34228	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	1	102672	9.739750e-06	0	0	30496	0.000000e+00	0	1	102672	9.739750e-06	0	.	15	1611652	9.307220e-06	0	2	74760	2.675230e-05	0	2	74760	2.675230e-05	0	0	912	0.000000e+00	0	0	59956	0.000000e+00	0	0	29578	0.000000e+00	0	0	44832	0.000000e+00	0	0	63968	0.000000e+00	0	0	6066	0.000000e+00	0	12	1178188	1.018510e-05	0	0	90982	0.000000e+00	0	1	24516	4.078968836678088E-5	0	108	0	0	84	0	0	2728	0	0	500	0	0	628	0	0	24	0	0	94	0	0	4562	0	0	2836	0	0	108	0	1	33244	3.0080616051016725E-5	Conflicting_classifications_of_pathogenicity	Hereditary_nonpolyposis_colorectal_neoplasms|Lynch_syndrome_1|not_provided|Hereditary_cancer-predisposing_syndrome|Lynch_syndrome	criteria_provided,_conflicting_classifications	NC_000002.12:g.47408508G>C	ClinGen:CA021012	C0009405|C2936783|C3661900|C0027672|C4552100	120435	144|140162|144	DNA mismatch repair protein MutS-like, N-terminal	Ala	Pro	96538	single nucleotide variant	NM_000251.3(MSH2):c.319G>C (p.Ala107Pro)	4436	MSH2	HGNC:7325	Conflicting classifications of pathogenicity	0	Jun 04, 2024	587779158	-	RCV000131126|RCV000811372|RCV003317079|RCV003466967|RCV003997172	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MeSH:D003123,MedGen:C0009405|MedGen:C3661900|MONDO:MONDO:0007356,MedGen:C2936783,OMIM:120435,Orphanet:144|MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144	Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|not provided|Lynch syndrome 1|Lynch syndrome	germline;unknown	germline	GRCh38	NC_000002.12	2	47408508	47408508	2p21	criteria provided, conflicting classifications	6	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA021012	2	91063	47408508	G	C	-	-	-	-	-	-	SCV000186057|SCV000951634|SCV001350529|SCV004021570|SCV004196891|SCV004827747	-	-	319G>C 	Ala107Pro	NM_000251.3	1	3_Conflicting	MSH2	ENSG00000095002	7918	202639	CCSBVarC003004	ALE00003004	319G>C	Ala107Pro	CEGS2	CegsMutGDEh1046	A02	GDEhDisVCh_40060	B10	2	CegsMutGDDh1046	A02	NULL	NULL	VUSMutpDEST2_07	A03	NULL	NULL	1	1	1	1	0	NULL	1	1	0	NULL	MSH2_Ala107Pro	2	2	47408508	G	C
14613	BRCA1	1253A>G	Tyr418Cys	ENSG00000012048	17	43074441	NC_000017.11:43074441:T:C	ALE00003300	CCSBVarC003300	NULL	218410	NULL	GDEhDisVCh_40059	G03	CEGS2	ATGGATTTATCTGCTCTTCGCGTTGAAGAAGTACAAAATGTCATTAATGCTATGCAGAAAATCTTAGAGTGTCCCATCTGTCTGGAGTTGATCAAGGAACCTGTCTCCACAAAGTGTGACCACATATTTTGCAAATTTTGCATGCTGAAACTTCTCAACCAGAAGAAAGGGCCTTCACAGTGTCCTTTATGTAAGAATGATATAACCAAAAGGAGCCTACAAGAAAGTACGAGATTTAGTCAACTTGTTGAAGAGCTATTGAAAATCATTTGTGCTTTTCAGCTTGACACAGGTTTGGAGTATGCAAACAGCTATAATTTTGCAAAAAAGGAAAATAACTCTCCTGAACATCTAAAAGATGAAGTTTCTATCATCCAAAGTATGGGCTACAGAAACCGTGCCAAAAGACTTCTACAGAGTGAACCCGAAAATCCTTCCTTGCAGGAAACCAGTCTCAGTGTCCAACTCTCTAACCTTGGAACTGTGAGAACTCTGAGGACAAAGCAGCGGATACAACCTCAAAAGACGTCTGTCTACATTGAATTGGGATCTGATTCTTCTGAAGATACCGTTAATAAGGCAACTTATTGCAGTGTGGGAGATCAAGAATTGTTACAAATCACCCCTCAAGGAACCAGGGATGAAATCAGTTTGGATTCTGCAAAAAAGGCTGCTTGTGAATTTTCTGAGACGGATGTAACAAATACTGAACATCATCAACCCAGTAATAATGATTTGAACACCACTGAGAAGCGTGCAGCTGAGAGGCATCCAGAAAAGTATCAGGGTGAAGCAGCATCTGGGTGTGAGAGTGAAACAAGCGTCTCTGAAGACTGCTCAGGGCTATCCTCTCAGAGTGACATTTTAACCACTCAGCAGAGGGATACCATGCAACATAACCTGATAAAGCTCCAGCAGGAAATGGCTGAACTAGAAGCTGTGTTAGAACAGCATGGGAGCCAGCCTTCTAACAGCTACCCTTCCATCATAAGTGACTCTTCTGCCCTTGAGGACCTGCGAAATCCAGAACAAAGCACATCAGAAAAAGTATTAACTTCACAGAAAAGTAGTGAATACCCTATAAGCCAGAATCCAGAAGGCCTTTCTGCTGACAAGTTTGAGGTGTCTGCAGATAGTTCTACCAGTAAAAATAAAGAACCAGGAGTGGAAAGGTCATCCCCTTCTAAATGCCCATCATTAGATGATAGGTGGTACATGCACAGTTGCTCTGGGAGTCTTCAGAATAGAAACTGCCCATCTCAAGAGGAGCTCATTAAGGTTGTTGATGTGGAGGAGCAACAGCTGGAAGAGTCTGGGCCACACGATTTGACGGAAACATCTTACTTGCCAAGGCAAGATCTAGAGGGAACCCCTTACCTGGAATCTGGAATCAGCCTCTTCTCTGATGACCCTGAATCTGATCCTTCTGAAGACAGAGCCCCAGAGTCAGCTCGTGTTGGCAACATACCATCTTCAACCTCTGCATTGAAAGTTCCCCAATTGAAAGTTGCAGAATCTGCCCAGAGTCCAGCTGCTGCTCATACTACTGATACTGCTGGGTATAATGCAATGGAAGAAAGTGTGAGCAGGGAGAAGCCAGAATTGACAGCTTCAACAGAAAGGGTCAACAAAAGAATGTCCATGGTGGTGTCTGGCCTGACCCCAGAAGAATTTATGCTCGTGTACAAGTTTGCCAGAAAACACCACATCACTTTAACTAATCTAATTACTGAAGAGACTACTCATGTTGTTATGAAAACAGATGCTGAGTTTGTGTGTGAACGGACACTGAAATATTTTCTAGGAATTGCGGGAGGAAAATGGGTAGTTAGCTATTTCTGGGTGACCCAGTCTATTAAAGAAAGAAAAATGCTGAATGAGCATGATTTTGAAGTCAGAGGAGATGTGGTCAATGGAAGAAACCACCAAGGTCCAAAGCGAGCAAGAGAATCCCAGGACAGAAAGATCTTCAGGGGGCTAGAAATCTGTTGCTATGGGCCCTTCACCAACATGCCCACAGGGTGTCCACCCAATTGTGGTTGTGCAGCCAGATGCCTGGACAGAGGACAATGGCTTCCATGCAATTGGGCAGATGTG	69895.0	single nucleotide variant	NM_007294.4(BRCA1):c.4565A>G (p.Tyr1522Cys)	672.0	BRCA1	HGNC:1100	Conflicting classifications of pathogenicity	0.0	Sep 30, 2024	80357379.0	-	RCV000112358|RCV000165983|RCV001342447|RCV001818228	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	germline	germline	GRCh38	NC_000017.11	17	43074441.0	43074441.0	17q21.31	criteria provided, conflicting classifications	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002906	2.0	55228.0	43074441.0	T	C	-	-	-	-	-	-	SCV000216741|SCV001536380|SCV002070133	-	-	4565A>G 	Tyr1522Cys	NM_007294.4	1.0	3_Conflicting	chr17	A	G	17-43074441-A-G		55228	17	43074441	T	C	Y	C	rs80357379	17	41226458	17	38479984	1522	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.4565A>G	p.Tyr1522Cys	principal2	Y	1	.	.	-	TAC	2	0	t	T/T	T/T	T/T	T/T	.	0.26103	.	.	0.30459	.	0.0	0.02950	B	0.001	0.04348	B	.	0.99291	.	.	.	.	-0.695	0.01869	N	.	0.10415	.	.	0.16216	-0.7790	0.56179	T	0.2631	0.63272	T	10	.	0.09603	.	0.089331	0.75225	D	.	0.77473	.	.	.	.	.	.	0.36112	.	0.09728	.	0.11208	0.228942677379	0.01893	T	0.075351	0.34897	T	0.118369	0.65967	D	-0.0677481	0.65542	T	0.0496161624987665	0.05379	T	.	0.51365	.	0.03482149	0.03946	0.032172415	0.01924	0.031494617	0.02973	0.04741417	0.06837	-2.72	0.08072	T	.	0.11803	.	0.000230105805935889	0.04607	0.99557954	0.97821	0.044	0.11041	.	.	.	.	.	.	0.069371	0.04794	1.397	0.51302518306206013	0.04592	0.069064	0.13472	N	-1.42888280195571	0.02364	0.1053954	-1.37159892614542	0.03506	0.1661958	5.37	-2.01	0.06989	-1.05	0.15513	0.167	0.16474	-0.887000	0.07074	-0.946	0.02063	0.455	0.26694	0.000000	0.08389	0.011	0.09394	534	0.73376	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|not_specified|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_conflicting_classifications	NC_000017.11:g.43074441T>C	ClinGen:CA002906	C0677776|C0027672|CN169374|C2676676	604370	145|140162|145	.	Tyr	Cys	69895	single nucleotide variant	NM_007294.4(BRCA1):c.4565A>G (p.Tyr1522Cys)	672	BRCA1	HGNC:1100	Conflicting classifications of pathogenicity	0	Sep 30, 2024	80357379	-	RCV000112358|RCV000165983|RCV001342447|RCV001818228	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN169374	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not specified	germline	germline	GRCh38	NC_000017.11	17	43074441	43074441	17q21.31	criteria provided, conflicting classifications	4	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002906	2	55228	43074441	T	C	-	-	-	-	-	-	SCV000216741|SCV001536380|SCV002070133	-	-	4565A>G 	Tyr1522Cys	NM_007294.4	1	3_Conflicting	BRCA1	ENSG00000012048	14613	218410	CCSBVarC003300	ALE00003300	1253A>G	Tyr418Cys	CEGS2	CegsMutGDEh1011	G06	GDEhDisVCh_40059	G03	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	BRCA1_Tyr418Cys	17	17	43074441	T	C
7918	MSH2	1685A>T	Glu562Val	ENSG00000095002	2	47470988	NC_000002.12:47470988:A:T	ALE00003012	CCSBVarC003012	NULL	202677	NULL	GDEhDisVCh_40060	C09	CEGS2	ATGGCGGTGCAGCCGAAGGAGACGCTGCAGTTGGAGAGCGCGGCCGAGGTCGGCTTCGTGCGCTTCTTTCAGGGCATGCCGGAGAAGCCGACCACCACAGTGCGCCTTTTCGACCGGGGCGACTTCTATACGGCGCACGGCGAGGACGCGCTGCTGGCCGCCCGGGAGGTGTTCAAGACCCAGGGGGTGATCAAGTACATGGGGCCGGCAGGAGCAAAGAATCTGCAGAGTGTTGTGCTTAGTAAAATGAATTTTGAATCTTTTGTAAAAGATCTTCTTCTGGTTCGTCAGTATAGAGTTGAAGTTTATAAGAATAGAGCTGGAAATAAGGCATCCAAGGAGAATGATTGGTATTTGGCATATAAGGCTTCTCCTGGCAATCTCTCTCAGTTTGAAGACATTCTCTTTGGTAACAATGATATGTCAGCTTCCATTGGTGTTGTGGGTGTTAAAATGTCCGCAGTTGATGGCCAGAGACAGGTTGGAGTTGGGTATGTGGATTCCATACAGAGGAAACTAGGACTGTGTGAATTCCCTGATAATGATCAGTTCTCCAATCTTGAGGCTCTCCTCATCCAGATTGGACCAAAGGAATGTGTTTTACCCGGAGGAGAGACTGCTGGAGACATGGGGAAACTGAGACAGATAATTCAAAGAGGAGGAATTCTGATCACAGAAAGAAAAAAAGCTGACTTTTCCACAAAAGACATTTATCAGGACCTCAACCGGTTGTTGAAAGGCAAAAAGGGAGAGCAGATGAATAGTGCTGTATTGCCAGAAATGGAGAATCAGGTTGCAGTTTCATCACTGTCTGCGGTAATCAAGTTTTTAGAACTCTTATCAGATGATTCCAACTTTGGACAGTTTGAACTGACTACTTTTGACTTCAGCCAGTATATGAAATTGGATATTGCAGCAGTCAGAGCCCTTAACCTTTTTCAGGGTTCTGTTGAAGATACCACTGGCTCTCAGTCTCTGGCTGCCTTGCTGAATAAGTGTAAAACCCCTCAAGGACAAAGACTTGTTAACCAGTGGATTAAGCAGCCTCTCATGGATAAGAACAGAATAGAGGAGAGATTGAATTTAGTGGAAGCTTTTGTAGAAGATGCAGAATTGAGGCAGACTTTACAAGAAGATTTACTTCGTCGATTCCCAGATCTTAACCGACTTGCCAAGAAGTTTCAAAGACAAGCAGCAAACTTACAAGATTGTTACCGACTCTATCAGGGTATAAATCAACTACCTAATGTTATACAGGCTCTGGAAAAACATGAAGGAAAACACCAGAAATTATTGTTGGCAGTTTTTGTGACTCCTCTTACTGATCTTCGTTCTGACTTCTCCAAGTTTCAGGAAATGATAGAAACAACTTTAGATATGGATCAGGTGGAAAACCATGAATTCCTTGTAAAACCTTCATTTGATCCTAATCTCAGTGAATTAAGAGAAATAATGAATGACTTGGAAAAGAAGATGCAGTCAACATTAATAAGTGCAGCCAGAGATCTTGGCTTGGACCCTGGCAAACAGATTAAACTGGATTCCAGTGCACAGTTTGGATATTACTTTCGTGTAACCTGTAAGGAAGAAAAAGTCCTTCGTAACAATAAAAACTTTAGTACTGTAGATATCCAGAAGAATGGTGTTAAATTTACCAACAGCAAATTGACTTCTTTAAATGAAGTGTATACCAAAAATAAAACAGAATATGAAGAAGCCCAGGATGCCATTGTTAAAGAAATTGTCAATATTTCTTCAGGCTATGTAGAACCAATGCAGACACTCAATGATGTGTTAGCTCAGCTAGATGCTGTTGTCAGCTTTGCTCACGTGTCAAATGGAGCACCTGTTCCATATGTACGACCAGCCATTTTGGAGAAAGGACAAGGAAGAATTATATTAAAAGCATCCAGGCATGCTTGTGTTGAAGTTCAAGATGAAATTGCATTTATTCCTAATGACGTATACTTTGAAAAAGATAAACAGATGTTCCACATCATTACTGGCCCCAATATGGGAGGTAAATCAACATATATTCGACAAACTGGGGTGATAGTACTCATGGCCCAAATTGGGTGTTTTGTGCCATGTGAGTCAGCAGAAGTGTCCATTGTGGACTGCATCTTAGCCCGAGTAGGGGCTGGTGACAGTCAATTGAAAGGAGTCTCCACGTTCATGGCTGAAATGTTGGAAACTGCTTCTATCCTCAGGTCTGCAACCAAAGATTCATTAATAATCATAGATGAATTGGGAAGAGGAACTTCTACCTACGATGGATTTGGGTTAGCATGGGCTATATCAGAATACATTGCAACAAAGATTGGTGCTTTTTGCATGTTTGCAACCCATTTTCATGAACTTACTGCCTTGGCCAATCAGATACCAACTGTTAATAATCTACATGTCACAGCACTCACCACTGAAGAGACCTTAACTATGCTTTATCAGGTGAAGAAAGGTGTCTGTGATCAAAGTTTTGGGATTCATGTTGCAGAGCTTGCTAATTTCCCTAAGCATGTAATAGAGTGTGCTAAACAGAAAGCCCTGGAACTTGAGGAGTTTCAGTATATTGGAGAATCGCAAGGATATGATATCATGGAACCAGCAGCAAAGAAGTGCTATCTGGAAAGAGAGCAAGGTGAAAAAATTATTCAGGAGTTCCTGTCCAAGGTGAAACAAATGCCCTTTACTGAAATGTCAGAAGAAAACATCACAATAAAGTTAAAACAGCTAAAAGCTGAAGTAATAGCAAAGAATAATAGCTTTGTAAATGAAATCATTTCACGAATAAAAGTTACTACG	96222.0	single nucleotide variant	NM_000251.3(MSH2):c.1685A>T (p.Glu562Val)	4436.0	MSH2	HGNC:7325	Conflicting classifications of pathogenicity	0.0	Dec 06, 2022	63750997.0	-	RCV000686405|RCV000774573	MeSH:D003123,MedGen:C0009405|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Hereditary nonpolyposis colorectal neoplasms|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000002.12	2	47470988.0	47470988.0	2p21	criteria provided, conflicting classifications	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA018999,UniProtKB:P43246#VAR_004480	2.0	90747.0	47470988.0	A	T	-	-	-	-	-	-	SCV000813923|SCV000908313|SCV002715861	-	-	1685A>T 	Glu562Val	NM_000251.3	1.0	3_Conflicting	chr2	A	T	2-47470988-A-T	2.14298e-6	90747	2	47470988	A	T	E	V	rs63750997	2	47698127	2	47551631	562	MSH2	ENSG00000095002	ENST00000233146	ENSP00000233146	P43246	MSH2_HUMAN	c.1685A>T	p.Glu562Val	c.1685A>T	p.Glu562Val	principal1	Y	1	YES	Select	+	GAG	2	0	A	A/A	A/A	A/A	A/A	0.033	0.47480	D	0.053	0.47932	T	0.416	0.62341	B	0.457	0.61798	P	0.98	0.97016	D	simple_aae	2.0	98.0	2.465	0.71362	M	-5.18	0.87094	D	0.668	0.71275	0.8531	0.95050	D	0.8404	0.94654	D	10	0.9562175	0.94929	D	0.213398	0.87373	D	0.921	0.98001	0.85	0.95175	P43246	E562V	Loss of disorder (P = 0.0186)| Gain of MoRF binding (P = 0.1055)| Loss of phosphorylation at T564 (P = 0.1533)| Loss of ubiquitination at K565 (P = 0.2143)| Gain of catalytic residue at N560 (P = 0.248)	0.978113232937	0.97766	0.614829812185399	0.61238	0.0239354764077	0.02353	0.584791898727	0.50694	T	0.846818	0.96449	D	0.326361	0.84807	D	0.413166	0.92475	D	0.777452199698029	0.44602	D	0.914809	0.69558	D	0.72369987	0.79124	0.69167614	0.81646	0.7012943	0.77876	0.62586063	0.77956	-8.848	0.69975	D	0.1711	0.37629	B	0.737254711314804	0.68333	0.99983311	0.99778	0.883	0.93708	.	.	.	.	.	.	4.675532	0.7482	26.2	0.99463320182860859	0.65989	0.868144	0.78738	D	0.748491489929866	0.82710	7.854704	0.760316347824103	0.86853	9.048627	5.86	5.86	0.93927	4.03	0.76886	8.596	0.90651	11.153000	0.87425	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.985	0.61072	938	0.14418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	109160	1.832170e-05	0	2	207376	9.644320e-06	0	2	235860	8.479610e-06	0	0	7160	0.000000e+00	0	0	17018	0.000000e+00	0	0	2316	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	0	42740	0.000000e+00	0	2	15576	1.284030e-04	0	2	15576	1.284030e-04	0	0	16060	0.000000e+00	0	0	30414	0.000000e+00	0	0	6204	0.000000e+00	0	0	13412	0.000000e+00	0	0	16732	0.000000e+00	0	0	89338	0.000000e+00	0	2	30372	6.585010e-05	0	2	30372	6.585010e-05	0	0	14746	0.000000e+00	0	0	34140	0.000000e+00	0	0	9560	0.000000e+00	0	0	17692	0.000000e+00	0	0	21626	0.000000e+00	0	0	102222	0.000000e+00	0	2	30290	6.602840e-05	0	2	30290	6.602840e-05	0	.	3	1552276	1.932650e-06	0	2	89540	2.233640e-05	0	1	73874	1.353660e-05	0	0	912	0.000000e+00	0	0	59892	0.000000e+00	0	0	29206	0.000000e+00	0	0	44482	0.000000e+00	0	0	63960	0.000000e+00	0	0	5746	0.000000e+00	0	0	1124372	0.000000e+00	0	2	89540	2.233640e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms	criteria_provided,_conflicting_classifications	NC_000002.12:g.47470988A>T	ClinGen:CA018999|UniProtKB:P43246#VAR_004480	C0027672|C0009405	.	140162	DNA mismatch repair protein MutS, clamp|DNA mismatch repair protein MutS, core|DNA mismatch repair protein MutS, core	Glu	Val	96222	single nucleotide variant	NM_000251.3(MSH2):c.1685A>T (p.Glu562Val)	4436	MSH2	HGNC:7325	Conflicting classifications of pathogenicity	0	Dec 06, 2022	63750997	-	RCV000686405|RCV000774573	MeSH:D003123,MedGen:C0009405|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Hereditary nonpolyposis colorectal neoplasms|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000002.12	2	47470988	47470988	2p21	criteria provided, conflicting classifications	3	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA018999,UniProtKB:P43246#VAR_004480	2	90747	47470988	A	T	-	-	-	-	-	-	SCV000813923|SCV000908313|SCV002715861	-	-	1685A>T 	Glu562Val	NM_000251.3	1	3_Conflicting	MSH2	ENSG00000095002	7918	202677	CCSBVarC003012	ALE00003012	1685A>T	Glu562Val	CEGS2	CegsMutGDEh1041	A05	GDEhDisVCh_40060	C09	2	CegsMutGDDh1041	A05	NULL	NULL	VUSMutpDEST2_07	C04	NULL	NULL	1	1	1	1	0	NULL	1	1	0	NULL	MSH2_Glu562Val	2	2	47470988	A	T
52861	F9	328G>A	Asp110Asn	ENSG00000101981	X	139541126	NC_000023.11:139541126:G:A	ALE00004376	CCSBVarC004376	NULL	204357	NULL	GDEhDisVCh_40052	C07	CEGS2	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGAATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT	25682.0	single nucleotide variant	NM_000133.4(F9):c.328G>A (p.Asp110Asn)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Oct 09, 2017	137852274.0	-	RCV000011389	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541126.0	139541126.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255435,UniProtKB:P00740#VAR_006551,OMIM:300746.0087	1.0	10643.0	139541126.0	G	A	-	-	-	-	-	-	SCV000031621	-	-	328G>A 	Asp110Asn	NM_000133.4		1_Pathogenic	chrX	G	A	X-139541126-G-A		10643	X	139541126	G	A	D	N	rs137852274	X	138623285	X	138450951	110	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.328G>A	p.Asp110Asn	c.328G>A	p.Asp110Asn	principal1	Y	1	YES	Select	+	GAT	1	0	G	G/G	G/G	G/G	G/G	0.006	0.61594	D	0.008	0.68204	D	0.997	0.70687	D	0.957	0.69900	D	0.97	0.96253	A	simple_aae	3.0	97.0	1.095	0.27258	L	-4.21	0.75805	D	0.647	0.65671	1.0226	0.97576	D	0.9866	0.99601	D	10	0.99035263	0.99530	D	0.962922	0.99760	D	0.819	0.94182	0.925	0.98733	P00740	D110N	Gain of methylation at K109 (P = 0.0752)| Loss of stability (P = 0.1722)| Gain of sheet (P = 0.1945)| Loss of disorder (P = 0.2408)| Loss of ubiquitination at K109 (P = 0.2547)	0.994855140868	0.99473	0.9787809428603149	0.97859	2.87732945386	0.99059	0.632549464703	0.57442	T	0.878352	0.97407	D	0.177508	0.71606	D	0.0172016	0.71239	D	0.991527616977692	0.81689	D	0.962504	0.85963	D	0.8451415	0.86805	0.8911182	0.94269	0.8674805	0.88509	0.8738812	0.93043	-7.125	0.55010	T	0.4071	0.59925	A	0.991977909549927	0.89283	0.99997795	0.99989	0.979	0.99252	.	.	.	.	.	.	4.524378	0.71019	25.6	0.99927164946011271	0.99164	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	.	.	5.823	0.6903	11.714000	0.94708	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.981	0.58703	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139541126G>A	ClinGen:CA255435|OMIM:300746.0087|UniProtKB:P00740#VAR_006551	C0008533	306900	98879	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	Asp	Asn	25682	single nucleotide variant	NM_000133.4(F9):c.328G>A (p.Asp110Asn)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852274	-	RCV000011389	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541126	139541126	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255435,UniProtKB:P00740#VAR_006551,OMIM:300746.0087	1	10643	139541126	G	A	-	-	-	-	-	-	SCV000031621	-	-	328G>A 	Asp110Asn	NM_000133.4		1_Pathogenic	F9	ENSG00000101981	52861	204357	CCSBVarC004376	ALE00004376	328G>A	Asp110Asn	CEGS2	CegsMutGDEh1028	F01	GDEhDisVCh_40052	C07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	F9_Asp110Asn	23	X	139541126	G	A
71569	OTC	425T>A	Val142Glu	ENSG00000036473	X	38401313	NC_000023.11:38401313:T:A	ALE00005243	CCSBVarC005243	NULL	205854	NULL	GDEhDisVCh_40048	D07	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGAGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103091.0	single nucleotide variant	NM_000531.6(OTC):c.425T>A (p.Val142Glu)	5009.0	OTC	HGNC:8512	Pathogenic	1.0	-	72556261.0	-	RCV000083436	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38401313.0	38401313.0	Xp11.4	no assertion criteria provided	1.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224602	2.0	97199.0	38401313.0	T	A	-	-	-	-	-	-	SCV000115522	-	-	425T>A 	Val142Glu	NM_000531.6		1_Pathogenic	chrX	T	A	X-38401313-T-A		97199	X	38401313	T	A	V	E	rs72556261	X	38260566	X	38145510	142	OTC	ENSG00000036473	ENST00000039007	ENSP00000039007	P00480	OTC_HUMAN	c.425T>A	p.Val142Glu	c.425T>A	p.Val142Glu	principal1	Y	1	YES	Select	+	GTG	2	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.005	0.72530	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.065	0.86866	M	-4.83	0.80975	D	0.993	0.99866	1.0345	0.97797	D	0.9833	0.99490	D	10	0.9944657	0.99945	D	0.969024	0.99809	D	0.961	0.99405	0.899	0.97715	P00480	V142E	Gain of disorder (P = 0.0118)| Loss of stability (P = 0.0655)| Gain of phosphorylation at S146 (P = 0.1311)| Gain of sheet (P = 0.1539)| Gain of ubiquitination at K144 (P = 0.2244)	0.989107889504	0.98886	0.9902666328413338	0.99018	1.51818414962	0.87322	0.708636641502	0.68342	T	0.95912	0.99457	D	0.714363	0.99940	D	0.788357	0.99939	D	0.998965263366699	0.95690	D	0.868913	0.57104	D	0.99191743	0.99854	0.9898275	0.99977	0.99191743	0.99854	0.9898275	0.99977	-15.062	0.96004	D	0.9442	0.86281	P	0.999961842378135	0.99297	0.99847000	0.98800	0.989	0.99628	.	.	.	.	.	.	4.759644	0.76984	26.6	0.98938228947424489	0.48977	.	.	.	.	.	.	.	.	.	5.97	5.97	0.96929	5.17	0.91630	7.628	0.82424	7.798000	0.69116	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.996	0.76032	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided	no_assertion_criteria_provided	NC_000023.11:g.38401313T>A	ClinGen:CA224602	CN517202	.	.	Aspartate/ornithine carbamoyltransferase, carbamoyl-P binding	Val	Glu	103091	single nucleotide variant	NM_000531.6(OTC):c.425T>A (p.Val142Glu)	5009	OTC	HGNC:8512	Pathogenic	1	-	72556261	-	RCV000083436	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38401313	38401313	Xp11.4	no assertion criteria provided	1	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224602	2	97199	38401313	T	A	-	-	-	-	-	-	SCV000115522	-	-	425T>A 	Val142Glu	NM_000531.6		1_Pathogenic	OTC	ENSG00000036473	71569	205854	CCSBVarC005243	ALE00005243	425T>A	Val142Glu	CEGS2	CegsMutGDEh1028	F02	GDEhDisVCh_40048	D07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Val142Glu	23	X	38401313	T	A
52861	F9	917A>G	Asn306Ser	ENSG00000101981	X	139561602	NC_000023.11:139561602:A:G	ALE00004384	CCSBVarC004384	NULL	204373	NULL	GDEhDisVCh_40052	D03	CEGS2	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAGTGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT	25643.0	single nucleotide variant	NM_000133.4(F9):c.917A>G (p.Asn306Ser)	2158.0	F9	HGNC:3551	Likely pathogenic	1.0	Jul 22, 2024	137852251.0	-	RCV000011350	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561602.0	139561602.0	Xq27.1	criteria provided, single submitter	2.0	-	N	ClinGen:CA255373,UniProtKB:P00740#VAR_017315,OMIM:300746.0047	3.0	10604.0	139561602.0	A	G	-	-	-	-	-	-	SCV005627711	-	-	917A>G 	Asn306Ser	NM_000133.4	1.0	1_Pathogenic	chrX	A	G	X-139561602-A-G		10604	X	139561602	A	G	N	S	rs137852251	X	138643761	X	138471427	306	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.917A>G	p.Asn306Ser	c.917A>G	p.Asn306Ser	principal1	Y	1	YES	Select	+	AAT	2	0	A	A/A	A/A	A/A	A/A	0.128	0.33072	T	0.333	0.28160	T	0.25	0.31206	B	0.039	0.23609	B	0.72	0.88440	A	simple_aae	28.0	72.0	0.51	0.13403	N	-2.34	0.54569	N	0.417	0.81098	0.6325	0.92292	D	0.7974	0.93121	D	10	0.91224134	0.90484	D	0.846921	0.98816	D	0.578	0.82883	0.844	0.94817	P00740	N306S	Gain of glycosylation at N306 (P = 0.0217)| Loss of ubiquitination at K311 (P = 0.0896)| Gain of disorder (P = 0.1577)| Gain of methylation at K311 (P = 0.1802)| Gain of MoRF binding (P = 0.2369)	0.970814190553	0.97022	0.9591642282066425	0.95878	1.46342036736	0.86334	0.460176557302	0.33292	T	0.7397	0.92714	D	0.0619128	0.59570	T	-0.148843	0.59060	T	0.923391759395599	0.58161	D	0.945705	0.79299	D	0.68832976	0.77164	0.7750274	0.86560	0.57284623	0.70926	0.7595891	0.85621	-6.325	0.48981	T	0.0936	0.19222	B	0.983465118204216	0.86210	0.99995030	0.99953	0.725	0.84761	.	.	.	.	.	.	3.389643	0.4701	22.4	0.99862385950794386	0.94097	.	.	.	.	.	.	.	.	.	5.42	5.42	0.78637	3.79	0.69847	7.108	0.76751	11.260000	0.91057	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.992	0.67791	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2636	0	0	146	0	0	610	0	0	24	0	0	94	0	0	518	0	0	2720	0	0	108	0	0	11158	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561602A>G	ClinGen:CA255373|OMIM:300746.0047|UniProtKB:P00740#VAR_017315	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Asn	Ser	25643	single nucleotide variant	NM_000133.4(F9):c.917A>G (p.Asn306Ser)	2158	F9	HGNC:3551	Likely pathogenic	1	Jul 22, 2024	137852251	-	RCV000011350	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561602	139561602	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255373,UniProtKB:P00740#VAR_017315,OMIM:300746.0047	3	10604	139561602	A	G	-	-	-	-	-	-	SCV005627711	-	-	917A>G 	Asn306Ser	NM_000133.4	1	1_Pathogenic	F9	ENSG00000101981	52861	204373	CCSBVarC004384	ALE00004384	917A>G	Asn306Ser	CEGS2	CegsMutGDEh1017	F07	GDEhDisVCh_40052	D03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	F9_Asn306Ser	23	X	139561602	A	G
359	CBS	361C>T	Arg121Cys	ENSG00000160200	21	43066333	NC_000021.9:43066333:G:A	ALE00007336	CCSBVarC007347	NULL	NULL	306	GDEhDisVCh_40013	H09	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACTGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210443.0	single nucleotide variant	NM_000071.3(CBS):c.361C>T (p.Arg121Cys)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Jun 17, 2024	775992753.0	-	RCV000196859|RCV000475484|RCV001192722|RCV002229025	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344	not provided|Classic homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;unknown	germline	GRCh38	NC_000021.9	21	43066333.0	43066333.0	21q22.3	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA321269,UniProtKB:P35520#VAR_008054	2.0	212842.0	43066333.0	G	A	-	-	-	-	-	-	SCV000249677|SCV000436228|SCV000543501|SCV001361017|SCV004213853	-	-	361C>T 	Arg121Cys	NM_000071.3	2.0	1_Pathogenic	chr21	C	T	21-43066333-C-T		212842	21	43066333	G	A	R	C	rs775992753	21	44486443	21	43359512	121	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.361C>T	p.Arg121Cys	c.361C>T	p.Arg121Cys	principal1	Y	1	.	.	-	CGC	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.85	0.99713	H	-7.95	0.96441	D	0.98	0.99026	1.0098	0.97347	D	0.9841	0.99516	D	10	0.99336433	0.99866	D	0.788429	0.98334	D	0.938	0.98634	0.99	0.99894	P35520	R121C	Gain of catalytic residue at S123 (P = 0.0362)| Loss of disorder (P = 0.0514)| Loss of phosphorylation at S123 (P = 0.0554)| Gain of ubiquitination at K119 (P = 0.0728)| Loss of MoRF binding (P = 0.1082)	0.943716897315	0.94268	.	0.97674	.	0.83375	0.869600832462	0.92500	D	0.996614	0.99995	D	0.472114	0.93366	D	0.548039	0.95552	D	0.999462783336639	0.97487	D	.	0.99265	.	0.9741018	0.98606	0.8518024	0.91514	0.9734125	0.98544	0.84967136	0.91370	-13.604	0.91715	D	.	0.77332	.	0.999740562374676	0.97751	0.99986959	0.99835	0.995	0.99826	.	.	.	.	.	.	5.688705	0.93053	33.0	0.99916741198239767	0.98450	0.762608	0.69887	D	0.858689971820992	0.89541	10.03755	0.706469739468737	0.82778	7.875491	5.26	4.37	0.51773	1.79	0.37285	3.429	0.5266	9.495000	0.80930	0.59	0.31918	1.0	0.71675	1.000000	0.68239	0.984	0.60417	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	109218	2.746800e-05	0	4	207768	1.925220e-05	0	3	236688	1.267490e-05	0	0	7164	0.000000e+00	0	0	17104	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13216	0.000000e+00	0	3	42766	7.014920e-05	0	0	15690	0.000000e+00	0	3	42766	7.014920e-05	0	0	16200	0.000000e+00	0	0	30514	0.000000e+00	0	0	6208	0.000000e+00	0	0	13404	0.000000e+00	0	0	16556	0.000000e+00	0	4	89416	4.473470e-05	0	0	30608	0.000000e+00	0	4	89416	4.473470e-05	0	0	14900	0.000000e+00	0	0	34244	0.000000e+00	0	0	9564	0.000000e+00	0	0	17690	0.000000e+00	0	0	21454	0.000000e+00	0	3	102690	2.921410e-05	0	0	30526	0.000000e+00	0	3	102690	2.921410e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Homocystinuria|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Classic_homocystinuria|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43066333G>A	ClinGen:CA321269|UniProtKB:P35520#VAR_008054	C0019880|C3150344|C0751202|C3661900	236200	394	Tryptophan synthase beta chain-like, PALP domain|Cysteine synthase/cystathionine beta-synthase, pyridoxal-phosphate attachment site	Arg	Cys	210443	single nucleotide variant	NM_000071.3(CBS):c.361C>T (p.Arg121Cys)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Jun 17, 2024	775992753	-	RCV000196859|RCV000475484|RCV001192722|RCV002229025	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344	not provided|Classic homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;unknown	germline	GRCh38	NC_000021.9	21	43066333	43066333	21q22.3	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA321269,UniProtKB:P35520#VAR_008054	2	212842	43066333	G	A	-	-	-	-	-	-	SCV000249677|SCV000436228|SCV000543501|SCV001361017|SCV004213853	-	-	361C>T 	Arg121Cys	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	306	CCSBVarC007347	ALE00007336	361C>T	Arg121Cys	Edgotyping3	VUSMutGDEh011	F04	GDEhDisVCh_40013	H09	1	VUSMutGDDh011	F04	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	6	0	NULL	0	NULL	0	NULL	CBS_Arg121Cys	21	21	43066333	G	A
3689	GCK	706G>A	Glu236Lys	ENSG00000106633	7	44147807	NC_000007.14:44147807:C:T	ALE00006688	CCSBVarC006690	NULL	214841	NULL	GDEhDisVCh_40037	B09	CEGS2	ATGCTGGACGACAGAGCCAGGATGGAGGCCGCCAAGAAGGAGAAGGTAGAGCAGATCCTGGCAGAGTTCCAGCTGCAGGAGGAGGACCTGAAGAAGGTGATGAGACGGATGCAGAAGGAGATGGACCGCGGCCTGAGGCTGGAGACCCATGAAGAGGCCAGTGTGAAGATGCTGCCCACCTACGTGCGCTCCACCCCAGAAGGCTCAGAAGTCGGGGACTTCCTCTCCCTGGACCTGGGTGGCACTAACTTCAGGGTGATGCTGGTGAAGGTGGGAGAAGGTGAGGAGGGGCAGTGGAGCGTGAAGACCAAACACCAGATGTACTCCATCCCCGAGGACGCCATGACCGGCACTGCTGAGATGCTCTTCGACTACATCTCTGAGTGCATCTCCGACTTCCTGGACAAGCATCAGATGAAACACAAGAAGCTGCCCCTGGGCTTCACCTTCTCCTTTCCTGTGAGGCACGAAGACATCGATAAGGGCATCCTTCTCAACTGGACCAAGGGCTTCAAGGCCTCAGGAGCAGAAGGGAACAATGTCGTGGGGCTTCTGCGAGACGCTATCAAACGGAGAGGGGACTTTGAAATGGATGTGGTGGCAATGGTGAATGACACGGTGGCCACGATGATCTCCTGCTACTACGAAGACCATCAGTGCGAGGTCGGCATGATCGTGGGCACGGGCTGCAATGCCTGCTACATGAAGGAGATGCAGAATGTGGAGCTGGTGGAGGGGGACGAGGGCCGCATGTGCGTCAATACCGAGTGGGGCGCCTTCGGGGACTCCGGCGAGCTGGACGAGTTCCTGCTGGAGTATGACCGCCTGGTGGACGAGAGCTCTGCAAACCCCGGTCAGCAGCTGTATGAGAAGCTCATAGGTGGCAAGTACATGGGCGAGCTGGTGCGGCTTGTGCTGCTCAGGCTCGTGGACGAAAACCTGCTCTTCCACGGGGAGGCCTCCGAGCAGCTGCGCACACGCGGAGCCTTCGAGACGCGCTTCGTGTCGCAGGTGGAGAGCGACACGGGCGACCGCAAGCAGATCTACAACATCCTGAGCACGCTGGGGCTGCGACCCTCGACCACCGACTGCGACATCGTGCGCCGCGCCTGCGAGAGCGTGTCTACGCGCGCTGCGCACATGTGCTCGGCGGGGCTGGCGGGCGTCATCAACCGCATGCGCGAGAGCCGCAGCGAGGACGTAATGCGCATCACTGTGGGCGTGGATGGCTCCGTGTACAAGCTGCACCCCAGCTTCAAGGAGCGGTTCCATGCCAGCGTGCGCAGGCTGACGCCCAGCTGCGAGATCACCTTCATCGAGTCGGAGGAGGGCAGTGGCCGGGGCGCGGCCCTGGTCTCGGCGGTGGCCTGTAAGAAGGCCTGTATGCTGGGCCAG	134592.0	single nucleotide variant	NM_000162.5(GCK):c.706G>A (p.Glu236Lys)	2645.0	GCK	HGNC:4195	Pathogenic	1.0	Jul 23, 2013	587780347.0	-	RCV000117134	Human Phenotype Ontology:HP:0009800,MONDO:MONDO:0005406,MedGen:C0085207	Gestational diabetes	germline	germline	GRCh38	NC_000007.14	7	44147807.0	44147807.0	7p13	criteria provided, single submitter	1.0	-	N	ClinGen:CA152959	2.0	129146.0	44147807.0	C	T	-	-	-	-	-	-	SCV000151295	-	-	706G>A 	Glu236Lys	NM_000162.5	1.0	1_Pathogenic	chr7	G	A	7-44147807-G-A		129146	7	44147807	C	T	E	K	rs587780347	7	44187406	7	44153931	236	GCK	ENSG00000106633	ENST00000403799	ENSP00000384247	P35557	HXK4_HUMAN	c.706G>A	p.Glu236Lys	c.706G>A	p.Glu236Lys	principal1	Y	1	YES	Select	-	GAG	1	0	C	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	0.919	0.90580	P	0.516	0.81117	P	0.98	0.97016	A	simple_aae	2.0	98.0	3.21	0.89132	M	-3.87	0.73927	D	0.978	0.98852	1.0743	0.98707	D	0.9742	0.99192	D	10	0.9937334	0.99895	D	0.894246	0.99198	D	0.974	0.99740	0.973	0.99746	P35557	E236K	Gain of ubiquitination at E236 (P = 0.0211)| Gain of solvent accessibility (P = 0.0354)| Gain of relative solvent accessibility (P = 0.0479)| Gain of helix (P = 0.132)| Loss of disorder (P = 0.1517)	0.992240804147	0.99206	.	0.99989	.	0.93887	0.781423449516	0.79105	T	0.960711	0.99489	D	0.55768	0.96014	D	0.563292	0.95951	D	0.997166931629181	0.90840	D	0.996975	0.98847	D	0.9809106	0.99164	0.9369222	0.97528	0.978466	0.98972	0.9503648	0.98397	-11.484	0.82550	D	0.9799	0.93806	P	0.999540949425348	0.96938	0.99984169	0.99792	0.997	0.99892	.	.	.	.	.	.	4.854396	0.79419	27.1	0.9993479115210343	0.99535	0.957177	0.97611	D	0.884927365843838	0.90953	10.66793	0.822983792051016	0.91295	10.83932	5.23	5.23	0.72532	.	.	7.826	0.84902	7.618000	0.62247	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.997	0.79771	698	0.58020	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Gestational_diabetes	criteria_provided,_single_submitter	NC_000007.14:g.44147807C>T	ClinGen:CA152959	C0085207	.	.	Hexokinase, C-terminal	Glu	Lys	134592	single nucleotide variant	NM_000162.5(GCK):c.706G>A (p.Glu236Lys)	2645	GCK	HGNC:4195	Pathogenic	1	Jul 23, 2013	587780347	-	RCV000117134	Human Phenotype Ontology:HP:0009800,MONDO:MONDO:0005406,MedGen:C0085207	Gestational diabetes	germline	germline	GRCh38	NC_000007.14	7	44147807	44147807	7p13	criteria provided, single submitter	1	-	N	ClinGen:CA152959	2	129146	44147807	C	T	-	-	-	-	-	-	SCV000151295	-	-	706G>A 	Glu236Lys	NM_000162.5	1	1_Pathogenic	GCK	ENSG00000106633	3689	214841	CCSBVarC006690	ALE00006688	706G>A	Glu236Lys	CEGS2	CegsMutGDEh1047	F05	GDEhDisVCh_40037	B09	1	CegsMutGDDh1047	F05	VUSN2Hmut_GDN2h_10	B05	VUSMutpDEST2_03	A09	VUSmut_GDEh10	B05	1	1	1	4	1	1	1	1	1	1	GCK_Glu236Lys	7	7	44147807	C	T
3689	GCK	523G>C	Gly175Arg	ENSG00000106633	7	44150025	NC_000007.14:44150025:C:G	ALE00006686	CCSBVarC006688	NULL	214825	NULL	GDEhDisVCh_40037	A07	CEGS2	ATGCTGGACGACAGAGCCAGGATGGAGGCCGCCAAGAAGGAGAAGGTAGAGCAGATCCTGGCAGAGTTCCAGCTGCAGGAGGAGGACCTGAAGAAGGTGATGAGACGGATGCAGAAGGAGATGGACCGCGGCCTGAGGCTGGAGACCCATGAAGAGGCCAGTGTGAAGATGCTGCCCACCTACGTGCGCTCCACCCCAGAAGGCTCAGAAGTCGGGGACTTCCTCTCCCTGGACCTGGGTGGCACTAACTTCAGGGTGATGCTGGTGAAGGTGGGAGAAGGTGAGGAGGGGCAGTGGAGCGTGAAGACCAAACACCAGATGTACTCCATCCCCGAGGACGCCATGACCGGCACTGCTGAGATGCTCTTCGACTACATCTCTGAGTGCATCTCCGACTTCCTGGACAAGCATCAGATGAAACACAAGAAGCTGCCCCTGGGCTTCACCTTCTCCTTTCCTGTGAGGCACGAAGACATCGATAAGGGCATCCTTCTCAACTGGACCAAGGGCTTCAAGGCCTCACGAGCAGAAGGGAACAATGTCGTGGGGCTTCTGCGAGACGCTATCAAACGGAGAGGGGACTTTGAAATGGATGTGGTGGCAATGGTGAATGACACGGTGGCCACGATGATCTCCTGCTACTACGAAGACCATCAGTGCGAGGTCGGCATGATCGTGGGCACGGGCTGCAATGCCTGCTACATGGAGGAGATGCAGAATGTGGAGCTGGTGGAGGGGGACGAGGGCCGCATGTGCGTCAATACCGAGTGGGGCGCCTTCGGGGACTCCGGCGAGCTGGACGAGTTCCTGCTGGAGTATGACCGCCTGGTGGACGAGAGCTCTGCAAACCCCGGTCAGCAGCTGTATGAGAAGCTCATAGGTGGCAAGTACATGGGCGAGCTGGTGCGGCTTGTGCTGCTCAGGCTCGTGGACGAAAACCTGCTCTTCCACGGGGAGGCCTCCGAGCAGCTGCGCACACGCGGAGCCTTCGAGACGCGCTTCGTGTCGCAGGTGGAGAGCGACACGGGCGACCGCAAGCAGATCTACAACATCCTGAGCACGCTGGGGCTGCGACCCTCGACCACCGACTGCGACATCGTGCGCCGCGCCTGCGAGAGCGTGTCTACGCGCGCTGCGCACATGTGCTCGGCGGGGCTGGCGGGCGTCATCAACCGCATGCGCGAGAGCCGCAGCGAGGACGTAATGCGCATCACTGTGGGCGTGGATGGCTCCGTGTACAAGCTGCACCCCAGCTTCAAGGAGCGGTTCCATGCCAGCGTGCGCAGGCTGACGCCCAGCTGCGAGATCACCTTCATCGAGTCGGAGGAGGGCAGTGGCCGGGGCGCGGCCCTGGTCTCGGCGGTGGCCTGTAAGAAGGCCTGTATGCTGGGCCAG	3184695.0	single nucleotide variant	NM_000162.5(GCK):c.523G>C (p.Gly175Arg)	2645.0	GCK	HGNC:4195	Pathogenic	1.0	Feb 23, 2024	-1.0	-	RCV003883459	MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625	Monogenic diabetes	germline	germline	GRCh38	NC_000007.14	7	44150025.0	44150025.0	7p13	reviewed by expert panel	1.0	-	N	ClinGen:CA367401686	2.0	3024423.0	44150025.0	C	G	-	-	-	-	-	-	SCV004697926	-	-	523G>C 	Gly175Arg	NM_000162.5	3.0	1_Pathogenic	chr7	G	C	7-44150025-G-C		3024423	7	44150025	C	G	G	R	.	7	44189624	7	44156149	175	GCK	ENSG00000106633	ENST00000403799	ENSP00000384247	P35557	HXK4_HUMAN	c.523G>C	p.Gly175Arg	c.523G>C	p.Gly175Arg	principal1	Y	1	YES	Select	-	GGA	1	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.002	0.79703	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	D	simple_aae	0.0	100.0	3.12	0.87775	M	-4.9	0.82724	D	0.986	0.99555	1.0855	0.99065	D	0.9786	0.99336	D	10	0.9885726	0.99275	D	0.644074	0.96968	D	0.965	0.99518	0.931	0.98924	P35557	G175R	Gain of solvent accessibility (P = 0.0042)| Gain of MoRF binding (P = 0.0243)| Loss of ubiquitination at K172 (P = 0.0303)| Loss of catalytic residue at G175 (P = 0.0658)| Gain of relative solvent accessibility (P = 0.09)	0.980989907939	0.98059	.	0.97734	.	0.97218	0.894961953163	0.95857	D	0.965681	0.99586	D	0.537165	0.95302	D	0.533824	0.95233	D	0.998664021492004	0.94753	D	0.976102	0.91686	D	0.8858796	0.90018	0.8613234	0.92165	0.89920586	0.91188	0.87691617	0.93257	-11.47	0.82228	D	0.8182	0.84062	P	0.996650295463753	0.92339	0.99983668	0.99792	0.977	0.99166	.	.	.	.	.	.	5.143258	0.86143	28.8	0.99941511458053944	0.99797	0.960488	0.98125	D	0.923742279552392	0.92833	11.68111	0.882600563202776	0.94739	13.02673	5.69	5.69	0.88329	3.87	0.72853	6.164	0.71785	7.609000	0.61899	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.994	0.71086	667	0.61202	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Monogenic_diabetes	reviewed_by_expert_panel	NC_000007.14:g.44150025C>G	.	C3888631	.	183625	Hexokinase, N-terminal	Gly	Arg	3184695	single nucleotide variant	NM_000162.5(GCK):c.523G>C (p.Gly175Arg)	2645	GCK	HGNC:4195	Pathogenic	1	Feb 23, 2024	-1	-	RCV003883459	MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625	Monogenic diabetes	germline	germline	GRCh38	NC_000007.14	7	44150025	44150025	7p13	reviewed by expert panel	1	-	N	ClinGen:CA367401686	2	3024423	44150025	C	G	-	-	-	-	-	-	SCV004697926	-	-	523G>C 	Gly175Arg	NM_000162.5	3	1_Pathogenic	GCK	ENSG00000106633	3689	214825	CCSBVarC006688	ALE00006686	523G>C	Gly175Arg	CEGS2	CegsMutGDEh1046	E05	GDEhDisVCh_40037	A07	1	CegsMutGDDh1046	E05	VUSN2Hmut_GDN2h_10	G01	VUSMutpDEST2_03	G08	VUSmut_GDEh10	G01	1	1	1	1	1	1	1	5	1	1	GCK_Gly175Arg	7	7	44150025	C	G
52861	F9	1357T>C	Trp453Arg	ENSG00000101981	X	139562042	NC_000023.11:139562042:T:C	ALE00004398	CCSBVarC004398	NULL	204396	NULL	GDEhDisVCh_40052	E05	CEGS2	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACCGGATTAAGGAAAAAACAAAGCTCACT	25667.0	single nucleotide variant	NM_000133.4(F9):c.1357T>C (p.Trp453Arg)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Sep 01, 1989	137852269.0	-	RCV000011372	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562042.0	139562042.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255422,UniProtKB:P00740#VAR_017324,OMIM:300746.0070	1.0	10628.0	139562042.0	T	C	-	-	-	-	-	-	SCV000031604	-	-	1357T>C 	Trp453Arg	NM_000133.4		1_Pathogenic	chrX	T	C	X-139562042-T-C		10628	X	139562042	T	C	W	R	rs137852269	X	138644201	X	138471867	453	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1357T>C	p.Trp453Arg	c.1357T>C	p.Trp453Arg	principal1	Y	1	YES	Select	+	TGG	1	0	T	./.	./.	./.	./.	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.98	0.99291	A	simple_aae	2.0	98.0	4.5	0.98957	H	-12.84	0.99834	D	0.926	0.98940	1.0083	0.97321	D	0.9857	0.99569	D	10	0.99427634	0.99934	D	0.987685	0.99948	D	0.984	0.99918	0.983	0.99835	P00740	W453R	Gain of disorder (P = 0.005)| Gain of phosphorylation at T458 (P = 0.1069)| Loss of methylation at K457 (P = 0.119)| Loss of stability (P = 0.1289)| Gain of catalytic residue at W453 (P = 0.1548)	0.999744162249	0.99974	0.9998368683257477	0.99983	2.17286694384	0.95501	0.792695641518	0.80818	T	0.971015	0.99684	D	0.73814	0.99967	D	0.82251	0.99967	D	0.999932289123535	0.99780	D	0.827517	0.48982	T	0.9940456	0.99934	0.9917848	0.99989	0.994228	0.99940	0.99098927	0.99985	-16.213	0.98135	D	0.9806	0.94923	P	0.999834134473653	0.98239	0.99999380	0.99996	1	0.99985	.	.	.	.	.	.	4.886611	0.80235	27.3	0.99613210292578003	0.74962	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	.	.	7.991	0.87929	7.901000	0.73593	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.994	0.71086	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0	0	0	0	0	0	0	0	0	426	0	0	0	0	0	0	0	0	0	0	0	0	0	0	52	0	0	426	0	0	0	0	0	478	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139562042T>C	ClinGen:CA255422|OMIM:300746.0070|UniProtKB:P00740#VAR_017324	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Trp	Arg	25667	single nucleotide variant	NM_000133.4(F9):c.1357T>C (p.Trp453Arg)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852269	-	RCV000011372	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562042	139562042	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255422,UniProtKB:P00740#VAR_017324,OMIM:300746.0070	1	10628	139562042	T	C	-	-	-	-	-	-	SCV000031604	-	-	1357T>C 	Trp453Arg	NM_000133.4		1_Pathogenic	F9	ENSG00000101981	52861	204396	CCSBVarC004398	ALE00004398	1357T>C	Trp453Arg	CEGS2	CegsMutGDEh1021	H10	GDEhDisVCh_40052	E05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	F9_Trp453Arg	23	X	139562042	T	C
3689	GCK	131G>A	Gly44Asp	ENSG00000106633	7	44153378	NC_000007.14:44153378:C:T	ALE00006684	CCSBVarC006686	NULL	214816	NULL	GDEhDisVCh_40037	C06	CEGS2	ATGCTGGACGACAGAGCCAGGATGGAGGCCGCCAAGAAGGAGAAGGTAGAGCAGATCCTGGCAGAGTTCCAGCTGCAGGAGGAGGACCTGAAGAAGGTGATGAGACGGATGCAGAAGGAGATGGACCGCGACCTGAGGCTGGAGACCCATGAAGAGGCCAGTGTGAAGATGCTGCCCACCTACGTGCGCTCCACCCCAGAAGGCTCAGAAGTCGGGGACTTCCTCTCCCTGGACCTGGGTGGCACTAACTTCAGGGTGATGCTGGTGAAGGTGGGAGAAGGTGAGGAGGGGCAGTGGAGCGTGAAGACCAAACACCAGATGTACTCCATCCCCGAGGACGCCATGACCGGCACTGCTGAGATGCTCTTCGACTACATCTCTGAGTGCATCTCCGACTTCCTGGACAAGCATCAGATGAAACACAAGAAGCTGCCCCTGGGCTTCACCTTCTCCTTTCCTGTGAGGCACGAAGACATCGATAAGGGCATCCTTCTCAACTGGACCAAGGGCTTCAAGGCCTCAGGAGCAGAAGGGAACAATGTCGTGGGGCTTCTGCGAGACGCTATCAAACGGAGAGGGGACTTTGAAATGGATGTGGTGGCAATGGTGAATGACACGGTGGCCACGATGATCTCCTGCTACTACGAAGACCATCAGTGCGAGGTCGGCATGATCGTGGGCACGGGCTGCAATGCCTGCTACATGGAGGAGATGCAGAATGTGGAGCTGGTGGAGGGGGACGAGGGCCGCATGTGCGTCAATACCGAGTGGGGCGCCTTCGGGGACTCCGGCGAGCTGGACGAGTTCCTGCTGGAGTATGACCGCCTGGTGGACGAGAGCTCTGCAAACCCCGGTCAGCAGCTGTATGAGAAGCTCATAGGTGGCAAGTACATGGGCGAGCTGGTGCGGCTTGTGCTGCTCAGGCTCGTGGACGAAAACCTGCTCTTCCACGGGGAGGCCTCCGAGCAGCTGCGCACACGCGGAGCCTTCGAGACGCGCTTCGTGTCGCAGGTGGAGAGCGACACGGGCGACCGCAAGCAGATCTACAACATCCTGAGCACGCTGGGGCTGCGACCCTCGACCACCGACTGCGACATCGTGCGCCGCGCCTGCGAGAGCGTGTCTACGCGCGCTGCGCACATGTGCTCGGCGGGGCTGGCGGGCGTCATCAACCGCATGCGCGAGAGCCGCAGCGAGGACGTAATGCGCATCACTGTGGGCGTGGATGGCTCCGTGTACAAGCTGCACCCCAGCTTCAAGGAGCGGTTCCATGCCAGCGTGCGCAGGCTGACGCCCAGCTGCGAGATCACCTTCATCGAGTCGGAGGAGGGCAGTGGCCGGGGCGCGGCCCTGGTCTCGGCGGTGGCCTGTAAGAAGGCCTGTATGCTGGGCCAG	44860.0	single nucleotide variant	NM_000162.5(GCK):c.131G>A (p.Gly44Asp)	2645.0	GCK	HGNC:4195	Likely pathogenic	1.0	Dec 22, 2020	193922279.0	-	RCV000029859|RCV001659731	MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:C3661900	Maturity-onset diabetes of the young type 2|not provided	germline;unknown	germline	GRCh38	NC_000007.14	7	44153378.0	44153378.0	7p13	criteria provided, multiple submitters, no conflicts	2.0	-	N	ClinGen:CA213753	2.0	36196.0	44153378.0	C	T	-	-	-	-	-	-	SCV000052514|SCV001880693	-	-	131G>A 	Gly44Asp	NM_000162.5	2.0	1_Pathogenic	chr7	G	A	7-44153378-G-A		36196	7	44153378	C	T	G	D	rs193922279	7	44192977	7	44159502	44	GCK	ENSG00000106633	ENST00000403799	ENSP00000384247	P35557	HXK4_HUMAN	c.131G>A	p.Gly44Asp	c.131G>A	p.Gly44Asp	principal1	Y	1	YES	Select	-	GGC	2	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.43	0.91906	M	-6.61	0.92107	D	0.987	0.99555	1.0420	0.97946	D	0.9843	0.99522	D	10	0.9938576	0.99905	D	0.730092	0.97823	D	0.995	0.99995	0.975	0.99765	P35557	G44D	Gain of ubiquitination at K39 (P = 0.0338)| Gain of relative solvent accessibility (P = 0.0479)| Loss of MoRF binding (P = 0.0547)| Gain of solvent accessibility (P = 0.0704)| Gain of methylation at K39 (P = 0.1946)	0.994501673353	0.99437	.	0.99561	.	0.97725	0.765996813774	0.76783	T	0.983493	0.99884	D	0.558376	0.96027	D	0.564292	0.95963	D	0.99753725528717	0.91722	D	0.852415	0.53609	D	0.98802197	0.99649	0.96305007	0.99119	0.9821352	0.99256	0.96254826	0.99093	-13.79	0.92369	D	0.9952	0.96856	P	0.999849354954065	0.98301	0.99985075	0.99806	0.989	0.99628	.	.	.	.	.	.	5.049595	0.84127	28.2	0.99871518253421354	0.94906	0.960824	0.98174	D	0.938107438145651	0.93462	12.07909	0.85351650784371	0.93181	11.90075	5.08	5.08	0.68332	.	.	7.879	0.8573	7.617000	0.62206	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.96	0.51684	649	0.63066	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1614180	6.195100e-07	0	1	1180034	8.474330e-07	0	0	75044	0.000000e+00	0	0	912	0.000000e+00	0	0	60026	0.000000e+00	0	0	29608	0.000000e+00	0	0	44888	0.000000e+00	0	0	64014	0.000000e+00	0	0	6062	0.000000e+00	0	1	1180034	8.474330e-07	0	0	91086	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	not_provided|Maturity-onset_diabetes_of_the_young_type_2	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.44153378C>T	ClinGen:CA213753	C3661900|C0342277	125851	552	Hexokinase, N-terminal	Gly	Asp	44860	single nucleotide variant	NM_000162.5(GCK):c.131G>A (p.Gly44Asp)	2645	GCK	HGNC:4195	Likely pathogenic	1	Dec 22, 2020	193922279	-	RCV000029859|RCV001659731	MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:C3661900	Maturity-onset diabetes of the young type 2|not provided	germline;unknown	germline	GRCh38	NC_000007.14	7	44153378	44153378	7p13	criteria provided, multiple submitters, no conflicts	2	-	N	ClinGen:CA213753	2	36196	44153378	C	T	-	-	-	-	-	-	SCV000052514|SCV001880693	-	-	131G>A 	Gly44Asp	NM_000162.5	2	1_Pathogenic	GCK	ENSG00000106633	3689	214816	CCSBVarC006686	ALE00006684	131G>A	Gly44Asp	CEGS2	CegsMutGDEh1046	C02	GDEhDisVCh_40037	C06	1	CegsMutGDDh1046	C02	VUSN2Hmut_GDN2h_09	D12	VUSMutpDEST2_03	E08	VUSmut_GDEh09	D12	1	1	1	1	1	1	1	1	1	1	GCK_Gly44Asp	7	7	44153378	C	T
359	CBS	112G>A	Ala38Thr	ENSG00000160200	21	43072082	NC_000021.9:43072082:C:T	ALE00007353	CCSBVarC007365	NULL	NULL	326	GDEhDisVCh_40013	B12	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAACCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	410882.0	single nucleotide variant	NM_000071.3(CBS):c.112G>A (p.Ala38Thr)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Jul 11, 2016	1064795253.0	-	RCV000483422	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000021.9	21	43072082.0	43072082.0	21q22.3	criteria provided, single submitter	1.0	-	N	ClinGen:CA16621018	2.0	421617.0	43072082.0	C	T	-	-	-	-	-	-	SCV000570881	-	-	112G>A 	Ala38Thr	NM_000071.3	1.0	4_VUS	chr21	G	A	21-43072082-G-A		421617	21	43072082	C	T	A	T	rs1064795253	21	44492192	21	43365261	38	CBS	ENSG00000160200	ENST00000352178	ENSP00000344460	P35520	CBS_HUMAN	c.112G>A	p.Ala38Thr	c.112G>A	p.Ala38Thr	principal1	Y	1	.	.	-	GCC	1	0	C	C/C	C/C	C/C	C/C	0.572	0.06911	T	0.633	0.08982	T	0.025	0.19257	B	0.028	0.21332	B	.	.	.	.	.	.	1.825	0.47724	L	0.22	0.04670	N	0.093	0.07242	0.5288	0.90913	D	0.8977	0.96599	D	10	0.06396493	0.08386	T	0.234239	0.88373	D	0.251	0.55812	0.124	0.02998	P35520	A38T	Gain of phosphorylation at A38 (P = 0.0069)| Gain of glycosylation at A38 (P = 0.0684)| Gain of methylation at K36 (P = 0.0883)| Gain of sheet (P = 0.1208)| Loss of loop (P = 0.2237)	0.421799068777	0.41407	.	0.35853	.	0.35387	0.334938466549	0.15664	T	0.336382	0.70415	T	-0.00512488	0.50624	T	-0.245138	0.49968	T	0.0438176551663492	0.04347	T	0.622038	0.23664	T	0.05856657	0.11690	0.04411686	0.05660	0.07228779	0.15920	0.045348905	0.06095	-4.268	0.27754	T	0.0665	0.02553	B	0.0923903385783486	0.42608	0.98358810	0.95898	0.073	0.20544	.	.	.	.	.	.	1.104462	0.1491	11.41	0.9487197748978996	0.25929	0.101298	0.20141	N	-0.882567317713232	0.11122	0.5422799	-0.907529141867123	0.11711	0.6099843	4.81	-0.298	0.12150	-1.72	0.12625	0.476	0.21969	-1.983000	0.04415	0.524	0.24207	0.275	0.25179	0.000000	0.08389	0.46	0.28168	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	not_provided	criteria_provided,_single_submitter	NC_000021.9:g.43072082C>T	ClinGen:CA16621018	CN517202	.	.	.	Ala	Thr	410882	single nucleotide variant	NM_000071.3(CBS):c.112G>A (p.Ala38Thr)	875	CBS	HGNC:1550	Uncertain significance	0	Jul 11, 2016	1064795253	-	RCV000483422	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000021.9	21	43072082	43072082	21q22.3	criteria provided, single submitter	1	-	N	ClinGen:CA16621018	2	421617	43072082	C	T	-	-	-	-	-	-	SCV000570881	-	-	112G>A 	Ala38Thr	NM_000071.3	1	4_VUS	CBS	ENSG00000160200	359	326	CCSBVarC007365	ALE00007353	112G>A	Ala38Thr	Edgotyping3	VUSMutGDEh011	A07	GDEhDisVCh_40013	B12	1	VUSMutGDDh011	A07	NULL	NULL	NULL	NULL	NULL	NULL	1	4	1	6	0	NULL	0	NULL	0	NULL	CBS_Ala38Thr	21	21	43072082	C	T
359	CBS	700G>A	Asp234Asn	ENSG00000160200	21	43065239	NC_000021.9:43065239:C:T	ALE00007320	CCSBVarC007328	NULL	NULL	280	GDEhDisVCh_40013	E07	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACAACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210429.0	single nucleotide variant	NM_000071.3(CBS):c.700G>A (p.Asp234Asn)	875.0	CBS	HGNC:1550	Pathogenic	1.0	Sep 16, 2024	773734233.0	-	RCV000199941|RCV000586183|RCV002228832|RCV003462304	MedGen:C3661900|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394	not provided|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Classic homocystinuria	germline;unknown	germline	GRCh38	NC_000021.9	21	43065239.0	43065239.0	21q22.3	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA324489,UniProtKB:P35520#VAR_008071	2.0	212852.0	43065239.0	C	T	-	-	-	-	-	-	SCV000249690|SCV000695308|SCV001385812|SCV004213897	-	-	700G>A 	Asp234Asn	NM_000071.3	2.0	1_Pathogenic	chr21	G	A	21-43065239-G-A		212852	21	43065239	C	T	D	N	rs773734233	21	44485349	21	43358418	234	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.700G>A	p.Asp234Asn	c.700G>A	p.Asp234Asn	principal1	Y	1	.	.	-	GAC	1	0	C	C/C	C/C	C/C	C/C	0.022	0.48802	D	0.031	0.54136	D	0.994	0.66535	D	0.901	0.63988	P	1.0	0.99291	A	simple_aae	0.0	100.0	1.725	0.44368	L	-4.91	0.81626	D	0.893	0.89342	0.9978	0.97144	D	0.9105	0.97027	D	10	0.97029006	0.96572	D	0.493113	0.95023	D	0.731	0.90551	0.789	0.91095	P35520	D234N	Loss of helix (P = 0.0558)| Loss of phosphorylation at Y233 (P = 0.2063)| Gain of disorder (P = 0.2545)| Gain of loop (P = 0.2754)| Loss of catalytic residue at D234 (P = 0.3508)	0.935752010977	0.93458	.	0.85343	.	0.77668	0.692867875099	0.66061	T	0.974671	0.99746	D	-0.00274609	0.50954	T	-0.0601931	0.66078	T	0.883164405822754	0.53074	D	.	0.88512	.	0.9111224	0.92288	0.6625813	0.80003	0.92327124	0.93472	0.6568453	0.79682	-9.25	0.69371	D	0.3142	0.54052	LB	0.983733853558096	0.86285	0.99937767	0.99340	0.987	0.99559	.	.	.	.	.	.	4.803759	0.78123	26.8	0.9990753107457736	0.97802	0.907929	0.86207	D	0.606476218376182	0.73440	5.989999	0.574792736390597	0.72990	5.921672	4.84	4.84	0.62077	2.66	0.48641	6.648	0.74275	7.408000	0.58688	0.513	0.23433	1.0	0.71675	1.000000	0.68239	0.671	0.33321	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	21	264690	7.93381E-5	.	0	109390	0.000000e+00	0	3	208078	1.441770e-05	0	3	236922	1.266240e-05	0	0	7162	0.000000e+00	0	0	17104	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13390	0.000000e+00	0	0	42764	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16214	0.000000e+00	0	0	30514	0.000000e+00	0	0	6212	0.000000e+00	0	0	13414	0.000000e+00	0	0	16730	0.000000e+00	0	0	89526	0.000000e+00	0	3	30608	9.801360e-05	0	3	30608	9.801360e-05	0	0	14900	0.000000e+00	0	0	34248	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21628	0.000000e+00	0	0	102738	0.000000e+00	0	3	30526	9.827690e-05	0	3	30526	9.827690e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic	not_provided|Classic_homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43065239C>T	ClinGen:CA324489|UniProtKB:P35520#VAR_008071	C3661900|C0751202|C0019880|C3150344	236200	394	Tryptophan synthase beta chain-like, PALP domain	Asp	Asn	210429	single nucleotide variant	NM_000071.3(CBS):c.700G>A (p.Asp234Asn)	875	CBS	HGNC:1550	Pathogenic	1	Sep 16, 2024	773734233	-	RCV000199941|RCV000586183|RCV002228832|RCV003462304	MedGen:C3661900|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394	not provided|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Classic homocystinuria	germline;unknown	germline	GRCh38	NC_000021.9	21	43065239	43065239	21q22.3	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA324489,UniProtKB:P35520#VAR_008071	2	212852	43065239	C	T	-	-	-	-	-	-	SCV000249690|SCV000695308|SCV001385812|SCV004213897	-	-	700G>A 	Asp234Asn	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	280	CCSBVarC007328	ALE00007320	700G>A	Asp234Asn	Edgotyping3	VUSMutGDEh011	C02	GDEhDisVCh_40013	E07	1	VUSMutGDDh011	C02	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	CBS_Asp234Asn	21	21	43065239	C	T
359	CBS	959T>C	Val320Ala	ENSG00000160200	21	43062391	NC_000021.9:43062391:A:G	ALE00007313	CCSBVarC007319	NULL	NULL	268	GDEhDisVCh_40013	D06	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGCGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	358636.0	single nucleotide variant	NM_000071.3(CBS):c.959T>C (p.Val320Ala)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Dec 23, 2024	781567152.0	-	RCV000410016|RCV000780081|RCV001000797|RCV001861384	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:CN169374|MedGen:C3150344	Classic homocystinuria|Homocystinuria|not specified|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;unknown	germline	GRCh38	NC_000021.9	21	43062391.0	43062391.0	21q22.3	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA16041998	2.0	371028.0	43062391.0	A	G	-	-	-	-	-	-	SCV000486482|SCV000917107|SCV001157857|SCV002156643|SCV004213867	-	-	959T>C 	Val320Ala	NM_000071.3	2.0	1_Pathogenic	chr21	T	C	21-43062391-T-C		371028	21	43062391	A	G	V	A	rs781567152	21	44482501	21	43355570	320	CBS	ENSG00000160200	ENST00000352178	ENSP00000344460	P35520	CBS_HUMAN	c.959T>C	p.Val320Ala	c.959T>C	p.Val320Ala	principal1	Y	1	.	.	-	GTG	2	0	A	A/A	A/A	A/A	A/A	0.028	0.46288	D	0.024	0.56982	D	0.985	0.61134	D	0.951	0.68937	D	0.96	0.95575	A	simple_aae	4.0	96.0	2.025	0.55249	M	-3.92	0.73186	D	0.829	0.82403	1.0120	0.97386	D	0.9157	0.97202	D	10	0.9799534	0.97921	D	0.613116	0.96623	D	0.912	0.97659	0.858	0.95637	P35520	V320A	Gain of disorder (P = 0.1046)| Loss of methylation at K322 (P = 0.1131)| Loss of sheet (P = 0.1158)| Gain of ubiquitination at K322 (P = 0.1245)| Loss of stability (P = 0.2072)	0.899979810299	0.89823	.	0.93660	.	0.79365	0.661450743675	0.61556	T	0.978187	0.99804	D	0.395944	0.89607	D	0.438627	0.93234	D	0.839098334312439	0.48980	D	0.967203	0.88094	D	0.842892	0.86640	0.69730407	0.81967	0.8269995	0.85509	0.685151	0.81276	-8.823	0.66628	D	0.3382	0.56164	B	0.968419970487751	0.83006	0.99942696	0.99379	0.929	0.96474	.	.	.	.	.	.	4.417668	0.68454	25.2	0.99659595207277951	0.77844	0.951187	0.96540	D	0.580612452324752	0.71815	5.731941	0.514017783439047	0.68762	5.288836	5.04	5.04	0.67250	.	.	8.103	0.89415	10.801000	0.83816	0.658	0.54518	1.0	0.71675	1.000000	0.68239	0.169	0.20991	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	109212	2.746950e-05	0	4	207282	1.929740e-05	0	4	236404	1.692020e-05	0	0	7136	0.000000e+00	0	0	17072	0.000000e+00	0	0	2318	0.000000e+00	0	0	9036	0.000000e+00	0	0	13382	0.000000e+00	0	3	42688	7.027740e-05	0	0	15668	0.000000e+00	0	3	42688	7.027740e-05	0	0	16124	0.000000e+00	0	0	30470	0.000000e+00	0	0	6182	0.000000e+00	0	0	13390	0.000000e+00	0	0	16722	0.000000e+00	0	4	88976	4.495590e-05	0	0	30564	0.000000e+00	0	4	88976	4.495590e-05	0	0	14846	0.000000e+00	0	0	34210	0.000000e+00	0	0	9560	0.000000e+00	0	0	17680	0.000000e+00	0	0	21508	0.000000e+00	0	4	102506	3.902210e-05	0	0	30484	0.000000e+00	0	4	102506	3.902210e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Homocystinuria|not_specified|Classic_homocystinuria|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43062391A>G	ClinGen:CA16041998	C0019880|CN169374|C0751202|C3150344	236200	394	Tryptophan synthase beta chain-like, PALP domain	Val	Ala	358636	single nucleotide variant	NM_000071.3(CBS):c.959T>C (p.Val320Ala)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Dec 23, 2024	781567152	-	RCV000410016|RCV000780081|RCV001000797|RCV001861384	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:CN169374|MedGen:C3150344	Classic homocystinuria|Homocystinuria|not specified|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;unknown	germline	GRCh38	NC_000021.9	21	43062391	43062391	21q22.3	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA16041998	2	371028	43062391	A	G	-	-	-	-	-	-	SCV000486482|SCV000917107|SCV001157857|SCV002156643|SCV004213867	-	-	959T>C 	Val320Ala	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	268	CCSBVarC007319	ALE00007313	959T>C	Val320Ala	Edgotyping3	VUSMutGDEh011	A01	GDEhDisVCh_40013	D06	1	VUSMutGDDh011	A01	NULL	NULL	NULL	NULL	NULL	NULL	1	6	1	6	0	NULL	0	NULL	0	NULL	CBS_Val320Ala	21	21	43062391	A	G
359	CBS	1070C>G	Ala357Gly	ENSG00000160200	21	43060516	NC_000021.9:43060516:G:C	ALE00007307	CCSBVarC007311	NULL	NULL	257	GDEhDisVCh_40013	D05	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGGCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210413.0	single nucleotide variant	NM_000071.3(CBS):c.1070C>G (p.Ala357Gly)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Nov 01, 2022	863223437.0	-	RCV000199512|RCV000473415|RCV002229030	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43060516.0	43060516.0	21q22.3	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA324052	2.0	212880.0	43060516.0	G	C	-	-	-	-	-	-	SCV000249730|SCV000543515|SCV003829289	-	-	1070C>G 	Ala357Gly	NM_000071.3	2.0	4_VUS	chr21	C	G	21-43060516-C-G		212880	21	43060516	G	C	A	G	rs863223437	21	44480626	21	43353695	357	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.1070C>G	p.Ala357Gly	c.1070C>G	p.Ala357Gly	principal1	Y	1	.	.	-	GCC	2	0	G	G/G	G/G	G/G	G/G	0.039	0.42645	D	0.024	0.56982	D	0.631	0.40232	P	0.896	0.63549	P	.	.	.	.	.	.	3.12	0.87775	M	-3.91	0.73078	D	0.625	0.63869	0.1427	0.84865	D	0.5198	0.81988	D	10	0.9603481	0.95385	D	0.523002	0.95467	D	0.834	0.94750	0.759	0.88753	P35520	A357G	Loss of ubiquitination at K359 (P = 0.1343)| Gain of disorder (P = 0.1469)| Gain of catalytic residue at V358 (P = 0.1715)| Gain of helix (P = 0.1736)| Loss of stability (P = 0.234)	0.89676527426	0.89496	.	0.88199	.	0.73866	0.579359054565	0.49929	T	0.984052	0.99891	D	0.32678	0.84836	D	0.314486	0.88776	D	0.964560031890869	0.66780	D	.	0.79913	.	0.8264615	0.85471	0.52191067	0.72122	0.75632465	0.81010	0.53816986	0.73056	-10.312	0.75834	D	.	0.44900	.	0.985885407731369	0.86926	0.99841535	0.98775	0.866	0.92708	.	.	.	.	.	.	4.426357	0.68657	25.3	0.9952062865626623	0.69261	0.965227	0.98745	D	0.356185793507232	0.58855	4.083187	0.293000588611773	0.54892	3.676368	5.05	5.05	0.67523	.	.	9.476	0.96867	9.507000	0.80945	0.526	0.24477	1.0	0.71675	1.000000	0.68239	0.003	0.0525	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	101870	9.816430e-06	0	1	196572	5.087190e-06	0	2	226916	8.813830e-06	0	0	6846	0.000000e+00	0	1	16982	5.888590e-05	0	0	2290	0.000000e+00	0	0	8872	0.000000e+00	0	0	7130	0.000000e+00	0	0	42290	0.000000e+00	0	0	15616	0.000000e+00	0	1	16982	5.888590e-05	0	0	15172	0.000000e+00	0	1	30316	3.298590e-05	0	0	6046	0.000000e+00	0	0	13088	0.000000e+00	0	0	10456	0.000000e+00	0	0	86248	0.000000e+00	0	0	30524	0.000000e+00	0	1	30316	3.298590e-05	0	0	14162	0.000000e+00	0	1	34094	2.933070e-05	0	0	9478	0.000000e+00	0	0	17516	0.000000e+00	0	0	15266	0.000000e+00	0	1	100438	9.956390e-06	0	0	30446	0.000000e+00	0	1	34094	2.933070e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Uncertain_significance	not_provided|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Classic_homocystinuria	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43060516G>C	ClinGen:CA324052	C3661900|C3150344|C0751202	236200	394	Tryptophan synthase beta chain-like, PALP domain	Ala	Gly	210413	single nucleotide variant	NM_000071.3(CBS):c.1070C>G (p.Ala357Gly)	875	CBS	HGNC:1550	Uncertain significance	0	Nov 01, 2022	863223437	-	RCV000199512|RCV000473415|RCV002229030	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43060516	43060516	21q22.3	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA324052	2	212880	43060516	G	C	-	-	-	-	-	-	SCV000249730|SCV000543515|SCV003829289	-	-	1070C>G 	Ala357Gly	NM_000071.3	2	4_VUS	CBS	ENSG00000160200	359	257	CCSBVarC007311	ALE00007307	1070C>G	Ala357Gly	Edgotyping3	VUSMutGDEh010	G11	GDEhDisVCh_40013	D05	1	VUSMutGDDh010	G11	NULL	NULL	NULL	NULL	NULL	NULL	1	6	1	6	0	NULL	0	NULL	0	NULL	CBS_Ala357Gly	21	21	43060516	G	C
71569	OTC	374C>T	Thr125Met	ENSG00000036473	X	38381417	NC_000023.11:38381417:C:T	ALE00005238	CCSBVarC005238	NULL	205845	NULL	GDEhDisVCh_40048	H01	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCATGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103067.0	single nucleotide variant	NM_000531.6(OTC):c.374C>T (p.Thr125Met)	5009.0	OTC	HGNC:8512	Uncertain significance	1.0	Jul 28, 2023	72554356.0	-	RCV000083408|RCV000148721|RCV000702655|RCV003323392	MedGen:C3661900|Human Phenotype Ontology:HP:0001987,Human Phenotype Ontology:HP:0008308,Human Phenotype Ontology:HP:0008334,MedGen:C5574662|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664|MedGen:CN169374	not provided|Hyperammonemia|Ornithine carbamoyltransferase deficiency|not specified	germline;unknown	germline	GRCh38	NC_000023.11	X	38381417.0	38381417.0	Xp11.4	criteria provided, multiple submitters, no conflicts	9.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA211702,UniProtKB:P00480#VAR_004874	2.0	97175.0	38381417.0	C	T	-	-	-	-	-	-	SCV000190453|SCV000780968|SCV000831517|SCV001829538|SCV002033207|SCV004028789|SCV004047963	-	-	374C>T 	Thr125Met	NM_000531.6	2.0	4_VUS	chrX	C	T	X-38381417-C-T	0.000015982	97175	X	38381417	C	T	T	M	rs72554356	X	38240670	X	38125614	125	OTC	ENSG00000036473	ENST00000713758	ENSP00000519059	P00480	OTC_HUMAN	.	.	c.374C>T	p.Thr125Met	principal1	Y	.	.	.	+	ACG	2	0	C	C/C	C/C	C/C	C/C	.	0.28402	.	.	0.26042	.	0.688	0.41600	P	0.056	0.26150	B	.	0.40172	.	.	.	.	1.295	0.32304	L	.	0.19232	.	.	0.75916	0.2478	0.86652	D	0.7854	0.92696	D	10	.	0.69855	.	0.114179	0.79231	D	.	0.83722	.	.	.	.	.	.	0.99096	.	0.67957	.	0.40971	0.360228955746	0.19399	T	0.6757	0.90326	D	0.132642	0.67386	D	0.14509	0.79723	D	0.0271027761987938	0.01551	T	.	0.52390	.	0.12709038	0.29490	0.2466839	0.49994	0.12709038	0.29490	0.2466839	0.49993	-5.525	0.42152	T	.	0.16953	.	0.156601468173851	0.47515	0.98665430	0.96264	0.231	0.49947	.	.	.	.	.	.	-0.140876	0.03415	0.616	0.9200916097844164	0.21597	.	.	.	.	.	.	.	.	.	5.91	-2.96	0.05208	-3.63	0.07047	-0.465	0.06772	-3.612000	0.02673	-0.838	0.02819	0.0	0.06393	0.000000	0.08389	0.849	0.40168	758	0.50788	1	2.6490066225165563E-4	1	9.970089730807576E-4	0	0.0	0	0.0	0	0.0	0	0.0	3	264690	1.1334013E-5	.	1	79924	1.251190e-05	0	2	151130	1.323360e-05	0	2	171484	1.166290e-05	0	1	5680	1.760560e-04	0	0	13611	0.000000e+00	0	0	1758	0.000000e+00	0	0	6903	0.000000e+00	0	0	9921	0.000000e+00	0	0	30744	0.000000e+00	0	0	9864	0.000000e+00	0	1	5680	1.760560e-04	0	1	13091	7.638840e-05	0	0	24321	0.000000e+00	0	0	4641	0.000000e+00	0	1	10106	9.895110e-05	0	0	12144	0.000000e+00	0	0	64323	0.000000e+00	0	0	18906	0.000000e+00	0	1	10106	9.895110e-05	0	1	12025	8.316010e-05	0	0	27101	0.000000e+00	0	0	7073	0.000000e+00	0	1	13292	7.523320e-05	0	0	15935	0.000000e+00	0	0	73092	0.000000e+00	0	0	18843	0.000000e+00	0	1	12025	8.316010e-05	0	.	18	1175056	1.531840e-05	0	2	55925	3.576220e-05	0	1	56405	1.772890e-05	0	0	688	0.000000e+00	0	1	45596	2.193170e-05	0	0	21804	0.000000e+00	0	1	33647	2.972030e-05	0	1	46379	2.156150e-05	0	0	4257	0.000000e+00	0	9	863860	1.041840e-05	0	2	55925	3.576220e-05	0	0	92790	0	0	168	0	0	2682	0	0	3594	0	0	436	0	0	928	0	0	626	0	0	280	0	0	2010	0	0	3762	0	0	3308	0	0	103514	0	Uncertain_significance	not_provided|not_specified|Hyperammonemia|Ornithine_carbamoyltransferase_deficiency	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.38381417C>T	ClinGen:CA211702|UniProtKB:P00480#VAR_004874	C3661900|CN169374|C5574662|C0268542	311250	664	Aspartate/ornithine carbamoyltransferase, carbamoyl-P binding	Thr	Met	103067	single nucleotide variant	NM_000531.6(OTC):c.374C>T (p.Thr125Met)	5009	OTC	HGNC:8512	Uncertain significance	1	Jul 28, 2023	72554356	-	RCV000083408|RCV000148721|RCV000702655|RCV003323392	MedGen:C3661900|Human Phenotype Ontology:HP:0001987,Human Phenotype Ontology:HP:0008308,Human Phenotype Ontology:HP:0008334,MedGen:C5574662|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664|MedGen:CN169374	not provided|Hyperammonemia|Ornithine carbamoyltransferase deficiency|not specified	germline;unknown	germline	GRCh38	NC_000023.11	X	38381417	38381417	Xp11.4	criteria provided, multiple submitters, no conflicts	9	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA211702,UniProtKB:P00480#VAR_004874	2	97175	38381417	C	T	-	-	-	-	-	-	SCV000190453|SCV000780968|SCV000831517|SCV001829538|SCV002033207|SCV004028789|SCV004047963	-	-	374C>T 	Thr125Met	NM_000531.6	2	4_VUS	OTC	ENSG00000036473	71569	205845	CCSBVarC005238	ALE00005238	374C>T	Thr125Met	CEGS2	CegsMutGDEh1010	G08	GDEhDisVCh_40048	H01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Thr125Met	23	X	38381417	C	T
14613	BRCA1	1773T>A	Phe591Leu	ENSG00000012048	17	43063941	NC_000017.11:43063941:A:T	ALE00003305	CCSBVarC003305	NULL	218428	NULL	GDEhDisVCh_40059	F06	CEGS2	ATGGATTTATCTGCTCTTCGCGTTGAAGAAGTACAAAATGTCATTAATGCTATGCAGAAAATCTTAGAGTGTCCCATCTGTCTGGAGTTGATCAAGGAACCTGTCTCCACAAAGTGTGACCACATATTTTGCAAATTTTGCATGCTGAAACTTCTCAACCAGAAGAAAGGGCCTTCACAGTGTCCTTTATGTAAGAATGATATAACCAAAAGGAGCCTACAAGAAAGTACGAGATTTAGTCAACTTGTTGAAGAGCTATTGAAAATCATTTGTGCTTTTCAGCTTGACACAGGTTTGGAGTATGCAAACAGCTATAATTTTGCAAAAAAGGAAAATAACTCTCCTGAACATCTAAAAGATGAAGTTTCTATCATCCAAAGTATGGGCTACAGAAACCGTGCCAAAAGACTTCTACAGAGTGAACCCGAAAATCCTTCCTTGCAGGAAACCAGTCTCAGTGTCCAACTCTCTAACCTTGGAACTGTGAGAACTCTGAGGACAAAGCAGCGGATACAACCTCAAAAGACGTCTGTCTACATTGAATTGGGATCTGATTCTTCTGAAGATACCGTTAATAAGGCAACTTATTGCAGTGTGGGAGATCAAGAATTGTTACAAATCACCCCTCAAGGAACCAGGGATGAAATCAGTTTGGATTCTGCAAAAAAGGCTGCTTGTGAATTTTCTGAGACGGATGTAACAAATACTGAACATCATCAACCCAGTAATAATGATTTGAACACCACTGAGAAGCGTGCAGCTGAGAGGCATCCAGAAAAGTATCAGGGTGAAGCAGCATCTGGGTGTGAGAGTGAAACAAGCGTCTCTGAAGACTGCTCAGGGCTATCCTCTCAGAGTGACATTTTAACCACTCAGCAGAGGGATACCATGCAACATAACCTGATAAAGCTCCAGCAGGAAATGGCTGAACTAGAAGCTGTGTTAGAACAGCATGGGAGCCAGCCTTCTAACAGCTACCCTTCCATCATAAGTGACTCTTCTGCCCTTGAGGACCTGCGAAATCCAGAACAAAGCACATCAGAAAAAGTATTAACTTCACAGAAAAGTAGTGAATACCCTATAAGCCAGAATCCAGAAGGCCTTTCTGCTGACAAGTTTGAGGTGTCTGCAGATAGTTCTACCAGTAAAAATAAAGAACCAGGAGTGGAAAGGTCATCCCCTTCTAAATGCCCATCATTAGATGATAGGTGGTACATGCACAGTTGCTCTGGGAGTCTTCAGAATAGAAACTACCCATCTCAAGAGGAGCTCATTAAGGTTGTTGATGTGGAGGAGCAACAGCTGGAAGAGTCTGGGCCACACGATTTGACGGAAACATCTTACTTGCCAAGGCAAGATCTAGAGGGAACCCCTTACCTGGAATCTGGAATCAGCCTCTTCTCTGATGACCCTGAATCTGATCCTTCTGAAGACAGAGCCCCAGAGTCAGCTCGTGTTGGCAACATACCATCTTCAACCTCTGCATTGAAAGTTCCCCAATTGAAAGTTGCAGAATCTGCCCAGAGTCCAGCTGCTGCTCATACTACTGATACTGCTGGGTATAATGCAATGGAAGAAAGTGTGAGCAGGGAGAAGCCAGAATTGACAGCTTCAACAGAAAGGGTCAACAAAAGAATGTCCATGGTGGTGTCTGGCCTGACCCCAGAAGAATTTATGCTCGTGTACAAGTTTGCCAGAAAACACCACATCACTTTAACTAATCTAATTACTGAAGAGACTACTCATGTTGTTATGAAAACAGATGCTGAGTTAGTGTGTGAACGGACACTGAAATATTTTCTAGGAATTGCGGGAGGAAAATGGGTAGTTAGCTATTTCTGGGTGACCCAGTCTATTAAAGAAAGAAAAATGCTGAATGAGCATGATTTTGAAGTCAGAGGAGATGTGGTCAATGGAAGAAACCACCAAGGTCCAAAGCGAGCAAGAGAATCCCAGGACAGAAAGATCTTCAGGGGGCTAGAAATCTGTTGCTATGGGCCCTTCACCAACATGCCCACAGGGTGTCCACCCAATTGTGGTTGTGCAGCCAGATGCCTGGACAGAGGACAATGGCTTCCATGCAATTGGGCAGATGTG	70056.0	single nucleotide variant	NM_007294.4(BRCA1):c.5085T>A (p.Phe1695Leu)	672.0	BRCA1	HGNC:1100	Conflicting classifications of pathogenicity	0.0	Apr 26, 2023	80357387.0	-	RCV000112493|RCV000562837|RCV001853018	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	germline;not applicable	germline	GRCh38	NC_000017.11	17	43063941.0	43063941.0	17q21.31	criteria provided, conflicting classifications	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003223	2.0	55389.0	43063941.0	A	T	-	-	-	-	-	-	SCV000660974|SCV002187048	-	-	5085T>A 	Phe1695Leu	NM_007294.4	1.0	3_Conflicting	chr17	T	A	17-43063941-T-A		55389	17	43063941	A	T	F	L	rs80357387	17	41215958	17	38469484	1695	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.5085T>A	p.Phe1695Leu	principal2	Y	1	.	.	-	TTT	3	2	A	A/A	A/A	A/A	A/A	.	0.25997	.	.	0.09167	.	0.237	0.30812	B	0.107	0.31213	B	.	.	.	.	.	.	0.135	0.08601	N	.	0.42578	.	.	0.55139	0.4353	0.89578	D	0.6291	0.86934	D	10	.	0.54565	.	0.768432	0.98164	D	.	0.77150	.	.	.	.	.	.	0.82922	.	0.46484	.	0.27990	0.637575030327	0.58154	T	0.133578	0.46135	T	0.169896	0.70900	D	0.00626705	0.70525	D	0.324614346916885	0.25715	T	.	0.56037	.	0.2819536	0.50902	0.15177552	0.35630	0.2757978	0.50311	0.17792259	0.40291	-3.59	0.38578	T	.	0.80507	.	0.151693788840998	0.47210	0.99911267	0.99153	0.531	0.73422	.	.	.	.	.	.	1.972208	0.25095	16.62	0.91899320551777408	0.21471	0.371736	0.45580	N	-0.338194724745546	0.27430	1.522421	-0.156317829821601	0.32854	1.89438	5.83	4.74	0.59667	1.84	0.37836	1.51	0.35504	2.150000	0.30988	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.996	0.76032	549	0.72286	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109358	0.000000e+00	0	0	207972	0.000000e+00	0	1	236754	4.223790e-06	0	0	7154	0.000000e+00	0	0	17104	0.000000e+00	0	0	2314	0.000000e+00	0	0	9038	0.000000e+00	0	0	13394	0.000000e+00	0	0	42754	0.000000e+00	0	0	15686	0.000000e+00	0	.	.	.	.	0	16194	0.000000e+00	0	0	30508	0.000000e+00	0	0	6206	0.000000e+00	0	0	13402	0.000000e+00	0	0	16734	0.000000e+00	0	0	89470	0.000000e+00	0	0	30600	0.000000e+00	0	.	.	.	.	0	14886	0.000000e+00	0	0	34246	0.000000e+00	0	0	9556	0.000000e+00	0	0	17682	0.000000e+00	0	0	21628	0.000000e+00	0	1	102632	9.743550e-06	0	0	30518	0.000000e+00	0	1	102632	9.743550e-06	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_conflicting_classifications	NC_000017.11:g.43063941A>T	ClinGen:CA003223	C0677776|C0027672|C2676676	604370	145|140162|145	BRCT domain|BRCT domain|BRCT domain	Phe	Leu	70056	single nucleotide variant	NM_007294.4(BRCA1):c.5085T>A (p.Phe1695Leu)	672	BRCA1	HGNC:1100	Conflicting classifications of pathogenicity	0	Apr 26, 2023	80357387	-	RCV000112493|RCV000562837|RCV001853018	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	germline;not applicable	germline	GRCh38	NC_000017.11	17	43063941	43063941	17q21.31	criteria provided, conflicting classifications	4	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003223	2	55389	43063941	A	T	-	-	-	-	-	-	SCV000660974|SCV002187048	-	-	5085T>A 	Phe1695Leu	NM_007294.4	1	3_Conflicting	BRCA1	ENSG00000012048	14613	218428	CCSBVarC003305	ALE00003305	1773T>A	Phe591Leu	CEGS2	CegsMutGDEh1019	H03	GDEhDisVCh_40059	F06	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	BRCA1_Phe591Leu	17	17	43063941	A	T
359	CBS	857T>C	Ile286Thr	ENSG00000160200	21	43063050	NC_000021.9:43063050:A:G	ALE00007315	CCSBVarC007322	NULL	NULL	272	GDEhDisVCh_40013	G06	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCACCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	404257.0	single nucleotide variant	NM_000071.3(CBS):c.857T>C (p.Ile286Thr)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Feb 23, 2021	1060500681.0	-	RCV002230313	MedGen:C3150344	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43063050.0	43063050.0	21q22.3	criteria provided, single submitter	1.0	-	N	ClinGen:CA16616516	2.0	405372.0	43063050.0	A	G	-	-	-	-	-	-	SCV000543504	-	-	857T>C 	Ile286Thr	NM_000071.3	1.0	4_VUS	chr21	T	C	21-43063050-T-C		405372	21	43063050	A	G	I	T	rs1060500681	21	44483160	21	43356229	286	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.857T>C	p.Ile286Thr	c.857T>C	p.Ile286Thr	principal1	Y	1	.	.	-	ATC	2	0	A	A/A	A/A	A/A	A/A	0.012	0.54841	D	0.023	0.57446	D	0.64	0.40411	P	0.677	0.53360	P	.	.	.	.	.	.	2.075	0.56867	M	-3.7	0.70591	D	0.572	0.59268	0.7828	0.94180	D	0.8683	0.95612	D	10	0.8337259	0.82349	D	0.416551	0.93694	D	0.749	0.91337	0.583	0.70883	P35520	I286T	Gain of disorder (P = 0.0234)| Gain of glycosylation at I286 (P = 0.0676)| Loss of stability (P = 0.0736)| Gain of phosphorylation at I286 (P = 0.0762)| Gain of relative solvent accessibility (P = 0.1571)	0.815188845362	0.81198	.	0.91592	.	0.71418	0.731743454933	0.71711	T	0.97387	0.99733	D	0.308503	0.83515	D	0.205367	0.83301	D	0.961571872234344	0.65904	D	.	0.80795	.	0.42984414	0.62421	0.30684322	0.56488	0.44295472	0.63274	0.27449173	0.53171	-11.244	0.81039	D	.	0.50777	.	0.93689111196239	0.79046	0.99902749	0.99103	0.935	0.96837	.	.	.	.	.	.	3.659381	0.52057	23.2	0.99480678114674126	0.66893	0.898585	0.84144	D	0.208273794346811	0.51360	3.339908	0.15621318741405	0.47204	2.976921	4.67	3.48	0.38875	1.28	0.31841	6.306	0.72845	10.875000	0.84053	0.587	0.31004	1.0	0.71675	1.000000	0.68239	0.165	0.2086	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_single_submitter	NC_000021.9:g.43063050A>G	ClinGen:CA16616516	C3150344	.	.	Tryptophan synthase beta chain-like, PALP domain	Ile	Thr	404257	single nucleotide variant	NM_000071.3(CBS):c.857T>C (p.Ile286Thr)	875	CBS	HGNC:1550	Uncertain significance	0	Feb 23, 2021	1060500681	-	RCV002230313	MedGen:C3150344	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43063050	43063050	21q22.3	criteria provided, single submitter	1	-	N	ClinGen:CA16616516	2	405372	43063050	A	G	-	-	-	-	-	-	SCV000543504	-	-	857T>C 	Ile286Thr	NM_000071.3	1	4_VUS	CBS	ENSG00000160200	359	272	CCSBVarC007322	ALE00007315	857T>C	Ile286Thr	Edgotyping3	VUSMutGDEh011	D01	GDEhDisVCh_40013	G06	1	VUSMutGDDh011	D01	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	CBS_Ile286Thr	21	21	43063050	A	G
9564	NDUFAF6	296A>G	Gln99Arg	ENSG00000156170	8	95032093	NC_000008.11:95032093:A:G	ALE00006326	CCSBVarC006326	NULL	203118	NULL	GDEhDisVCh_40035	D01	CEGS2	ATGGCGGCCTCCGCGCACGGCTCTGTCTGGGGGCCGTTGCGGCTTGGCATCCCCGGCCTGTGCTGCCGCCGGCCGCCTCTGGGTCTGTACGCGCGCATGCGGCGGCTGCCCGGGCCGGAGGTGTCTGGGCGGAGCGTGGCTGCGGCCAGCGGACCGGGCGCCTGGGGCACTGACCACTACTGCCTGGAGCTGCTGCGGAAACGGGATTATGAAGGTTATTTATGCTCCCTGCTGCTCCCTGCAGAATCCCGAAGCTCTGTTTTTGCACTGAGGGCCTTTAATGTGGAACTGGCTCGGGCTGGATTACTCTTGCTGCTGTCTTGCTGTACTGTATGCCACTGGGATCTGAACACTAAACATTGC	15586.0	single nucleotide variant	NM_152416.4(NDUFAF6):c.296A>G (p.Gln99Arg)	137682.0	NDUFAF6	HGNC:28625	Pathogenic	1.0	Jul 11, 2008	137853184.0	-	RCV000000577	MONDO:MONDO:0032622,MedGen:C4748786,OMIM:618239	Mitochondrial complex 1 deficiency, nuclear type 17	germline	germline	GRCh38	NC_000008.11	8	95032093.0	95032093.0	8q22.1	no assertion criteria provided	1.0	-	N	ClinGen:CA114348,UniProtKB:Q330K2#VAR_047770,OMIM:612392.0001	1.0	547.0	95032093.0	A	G	-	-	-	-	-	-	SCV000020726	-	-	296A>G 	Gln99Arg	NM_152416.4		1_Pathogenic	chr8	A	G	8-95032093-A-G		547	8	95032093	A	G	Q	R	rs137853184	8	96044321	8	96113497	99	NDUFAF6	ENSG00000156170	ENST00000396124	ENSP00000379430	Q330K2	NDUF6_HUMAN	c.296A>G	p.Gln99Arg	c.296A>G	p.Gln99Arg	principal1	Y	2	YES	Select	+	CAG	2	0	A	A/A	A/A	A/A	A/A	0.365	0.11802	T	0.992	0.02388	T	0.004	0.12194	B	0.03	0.21742	B	0.9	0.92286	A	simple_aae	10.0	90.0	0.085	0.08269	N	-0.77	0.21370	N	0.86	0.85626	-0.3609	0.73117	T	0.3465	0.71010	T	9	0.87774056	0.86931	D	0.071212	0.71109	D	0.388	0.70282	0.551	0.66599	Q330K2	Q99R	Gain of MoRF binding (P = 0.0468)| Loss of ubiquitination at K101 (P = 0.0877)| Loss of solvent accessibility (P = 0.1952)| Loss of disorder (P = 0.2235)| Gain of phosphorylation at S103 (P = 0.3007)	0.792757683783	0.78919	0.5123060442750326	0.50959	0.199888420713	0.22117	0.557974696159	0.46915	T	0.194165	0.54764	T	0.312906	0.83846	D	0.211691	0.83636	D	0.685116589069366	0.39719	D	0.70353	0.31123	T	0.14543341	0.33057	0.13785385	0.32847	0.12435532	0.28924	0.11888552	0.28627	-10.114	0.74669	D	0.1824	0.39639	B	0.811319954097454	0.71274	0.93395180	0.92569	0.133	0.35254	.	.	.	.	.	.	4.217163	0.63824	24.6	0.80621294866690685	0.13503	0.950800	0.96466	D	0.438295488005878	0.63353	4.589974	0.481726706392708	0.66601	4.996804	5.61	4.45	0.53308	2.75	0.50313	8.775	0.91431	11.119000	0.86523	0.756	0.943	1.0	0.71675	1.000000	0.68239	1.0	0.97202	871	0.31342	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Mitochondrial_complex_1_deficiency,_nuclear_type_17	no_assertion_criteria_provided	NC_000008.11:g.95032093A>G	ClinGen:CA114348|OMIM:612392.0001|UniProtKB:Q330K2#VAR_047770	C4748786	618239	.	.	Gln	Arg	15586	single nucleotide variant	NM_152416.4(NDUFAF6):c.296A>G (p.Gln99Arg)	137682	NDUFAF6	HGNC:28625	Pathogenic	1	Jul 11, 2008	137853184	-	RCV000000577	MONDO:MONDO:0032622,MedGen:C4748786,OMIM:618239	Mitochondrial complex 1 deficiency, nuclear type 17	germline	germline	GRCh38	NC_000008.11	8	95032093	95032093	8q22.1	no assertion criteria provided	1	-	N	ClinGen:CA114348,UniProtKB:Q330K2#VAR_047770,OMIM:612392.0001	1	547	95032093	A	G	-	-	-	-	-	-	SCV000020726	-	-	296A>G 	Gln99Arg	NM_152416.4		1_Pathogenic	NDUFAF6	ENSG00000156170	9564	203118	CCSBVarC006326	ALE00006326	296A>G	Gln99Arg	CEGS2	CegsMutGDEh1001	B02	GDEhDisVCh_40035	D01	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	NDUFAF6_Gln99Arg	8	8	95032093	A	G
71569	OTC	803T>C	Met268Thr	ENSG00000036473	X	38408961	NC_000023.11:38408961:T:C	ALE00005261	CCSBVarC005261	NULL	205954	NULL	GDEhDisVCh_40048	D05	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCACGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103225.0	single nucleotide variant	NM_000531.6(OTC):c.803T>C (p.Met268Thr)	5009.0	OTC	HGNC:8512	Pathogenic/Likely pathogenic	1.0	Nov 08, 2022	72558449.0	-	RCV000083580|RCV000702113	MedGen:C3661900|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664	not provided|Ornithine carbamoyltransferase deficiency	germline;unknown	germline	GRCh38	NC_000023.11	X	38408961.0	38408961.0	Xp11.4	criteria provided, multiple submitters, no conflicts	3.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224799,UniProtKB:P00480#VAR_004925	2.0	97333.0	38408961.0	T	C	-	-	-	-	-	-	SCV000830948|SCV002020194	-	-	803T>C 	Met268Thr	NM_000531.6	2.0	1_Pathogenic	chrX	T	C	X-38408961-T-C		97333	X	38408961	T	C	M	T	rs72558449	X	38268214	X	38153158	268	OTC	ENSG00000036473	ENST00000039007	ENSP00000039007	P00480	OTC_HUMAN	c.803T>C	p.Met268Thr	c.803T>C	p.Met268Thr	principal1	Y	1	YES	Select	+	ATG	2	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	0.994	0.82066	D	0.95	0.94956	A	simple_aae	5.0	95.0	3.845	0.95664	H	-5.92	0.88991	D	0.929	0.93377	1.0517	0.98150	D	0.9812	0.99422	D	10	0.995661	0.99990	D	0.981762	0.99906	D	0.977	0.99803	0.942	0.99227	P00480	M268T	Loss of catalytic residue at M268 (P = 0.0055)| Loss of helix (P = 0.0558)| Gain of sheet (P = 0.0827)| Gain of loop (P = 0.0851)| Loss of stability (P = 0.0897)	0.99771128625	0.99765	0.9852180063546714	0.98508	1.20936736318	0.80681	0.661142468452	0.61511	T	0.980667	0.99843	D	0.727989	0.99953	D	0.807929	0.99953	D	0.996587514877319	0.89564	D	0.995723	0.98506	D	0.98500663	0.99458	0.98994875	0.99978	0.9883747	0.99670	0.9891565	0.99972	-13.381	0.90891	D	0.9765	0.90459	P	0.999457527271671	0.96641	0.99869260	0.98911	0.995	0.99826	.	.	.	.	.	.	4.515731	0.70809	25.6	0.99363322069993376	0.61169	.	.	.	.	.	.	.	.	.	5.58	5.58	0.84339	.	.	7.562	0.81321	7.727000	0.67649	0.665	0.62996	1.0	0.71675	1.000000	0.68239	1.0	0.97202	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	not_provided|Ornithine_carbamoyltransferase_deficiency	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.38408961T>C	ClinGen:CA224799|UniProtKB:P00480#VAR_004925	C3661900|C0268542	311250	664	Aspartate/ornithine carbamoyltransferase, Asp/Orn-binding domain	Met	Thr	103225	single nucleotide variant	NM_000531.6(OTC):c.803T>C (p.Met268Thr)	5009	OTC	HGNC:8512	Pathogenic/Likely pathogenic	1	Nov 08, 2022	72558449	-	RCV000083580|RCV000702113	MedGen:C3661900|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664	not provided|Ornithine carbamoyltransferase deficiency	germline;unknown	germline	GRCh38	NC_000023.11	X	38408961	38408961	Xp11.4	criteria provided, multiple submitters, no conflicts	3	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224799,UniProtKB:P00480#VAR_004925	2	97333	38408961	T	C	-	-	-	-	-	-	SCV000830948|SCV002020194	-	-	803T>C 	Met268Thr	NM_000531.6	2	1_Pathogenic	OTC	ENSG00000036473	71569	205954	CCSBVarC005261	ALE00005261	803T>C	Met268Thr	CEGS2	CegsMutGDEh1020	E09	GDEhDisVCh_40048	D05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Met268Thr	23	X	38408961	T	C
14613	BRCA1	1891G>A	Glu631Lys	ENSG00000012048	17	43057126	NC_000017.11:43057126:C:T	ALE00003307	CCSBVarC003307	NULL	218448	NULL	GDEhDisVCh_40059	A09	CEGS2	ATGGATTTATCTGCTCTTCGCGTTGAAGAAGTACAAAATGTCATTAATGCTATGCAGAAAATCTTAGAGTGTCCCATCTGTCTGGAGTTGATCAAGGAACCTGTCTCCACAAAGTGTGACCACATATTTTGCAAATTTTGCATGCTGAAACTTCTCAACCAGAAGAAAGGGCCTTCACAGTGTCCTTTATGTAAGAATGATATAACCAAAAGGAGCCTACAAGAAAGTACGAGATTTAGTCAACTTGTTGAAGAGCTATTGAAAATCATTTGTGCTTTTCAGCTTGACACAGGTTTGGAGTATGCAAACAGCTATAATTTTGCAAAAAAGGAAAATAACTCTCCTGAACATCTAAAAGATGAAGTTTCTATCATCCAAAGTATGGGCTACAGAAACCGTGCCAAAAGACTTCTACAGAGTGAACCCGAAAATCCTTCCTTGCAGGAAACCAGTCTCAGTGTCCAACTCTCTAACCTTGGAACTGTGAGAACTCTGAGGACAAAGCAGCGGATACAACCTCAAAAGACGTCTGTCTACATTGAATTGGGATCTGATTCTTCTGAAGATACCGTTAATAAGGCAACTTATTGCAGTGTGGGAGATCAAGAATTGTTACAAATCACCCCTCAAGGAACCAGGGATGAAATCAGTTTGGATTCTGCAAAAAAGGCTGCTTGTGAATTTTCTGAGACGGATGTAACAAATACTGAACATCATCAACCCAGTAATAATGATTTGAACACCACTGAGAAGCGTGCAGCTGAGAGGCATCCAGAAAAGTATCAGGGTGAAGCAGCATCTGGGTGTGAGAGTGAAACAAGCGTCTCTGAAGACTGCTCAGGGCTATCCTCTCAGAGTGACATTTTAACCACTCAGCAGAGGGATACCATGCAACATAACCTGATAAAGCTCCAGCAGGAAATGGCTGAACTAGAAGCTGTGTTAGAACAGCATGGGAGCCAGCCTTCTAACAGCTACCCTTCCATCATAAGTGACTCTTCTGCCCTTGAGGACCTGCGAAATCCAGAACAAAGCACATCAGAAAAAGTATTAACTTCACAGAAAAGTAGTGAATACCCTATAAGCCAGAATCCAGAAGGCCTTTCTGCTGACAAGTTTGAGGTGTCTGCAGATAGTTCTACCAGTAAAAATAAAGAACCAGGAGTGGAAAGGTCATCCCCTTCTAAATGCCCATCATTAGATGATAGGTGGTACATGCACAGTTGCTCTGGGAGTCTTCAGAATAGAAACTACCCATCTCAAGAGGAGCTCATTAAGGTTGTTGATGTGGAGGAGCAACAGCTGGAAGAGTCTGGGCCACACGATTTGACGGAAACATCTTACTTGCCAAGGCAAGATCTAGAGGGAACCCCTTACCTGGAATCTGGAATCAGCCTCTTCTCTGATGACCCTGAATCTGATCCTTCTGAAGACAGAGCCCCAGAGTCAGCTCGTGTTGGCAACATACCATCTTCAACCTCTGCATTGAAAGTTCCCCAATTGAAAGTTGCAGAATCTGCCCAGAGTCCAGCTGCTGCTCATACTACTGATACTGCTGGGTATAATGCAATGGAAGAAAGTGTGAGCAGGGAGAAGCCAGAATTGACAGCTTCAACAGAAAGGGTCAACAAAAGAATGTCCATGGTGGTGTCTGGCCTGACCCCAGAAGAATTTATGCTCGTGTACAAGTTTGCCAGAAAACACCACATCACTTTAACTAATCTAATTACTGAAGAGACTACTCATGTTGTTATGAAAACAGATGCTGAGTTTGTGTGTGAACGGACACTGAAATATTTTCTAGGAATTGCGGGAGGAAAATGGGTAGTTAGCTATTTCTGGGTGACCCAGTCTATTAAAGAAAGAAAAATGCTGAATGAGCATGATTTTAAAGTCAGAGGAGATGTGGTCAATGGAAGAAACCACCAAGGTCCAAAGCGAGCAAGAGAATCCCAGGACAGAAAGATCTTCAGGGGGCTAGAAATCTGTTGCTATGGGCCCTTCACCAACATGCCCACAGGGTGTCCACCCAATTGTGGTTGTGCAGCCAGATGCCTGGACAGAGGACAATGGCTTCCATGCAATTGGGCAGATGTG	70122.0	single nucleotide variant	NM_007294.4(BRCA1):c.5203G>A (p.Glu1735Lys)	672.0	BRCA1	HGNC:1100	not provided	0.0	-	397509238.0	-	RCV000577367|RCV001072517	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1	germline;not applicable	germline	GRCh38	NC_000017.11	17	43057126.0	43057126.0	17q21.31	no classification provided	2.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003353,UniProtKB:P38398#VAR_070505	3.0	55455.0	43057126.0	C	T	-	-	-	-	-	-	SCV000679293|SCV001237915	-	-	5203G>A 	Glu1735Lys	NM_007294.4		5_Others	chr17	G	A	17-43057126-G-A		55455	17	43057126	C	T	E	K	rs397509238	17	41209143	17	38462669	1735	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.5203G>A	p.Glu1735Lys	principal2	Y	1	.	.	-	GAA	1	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	0.904	0.90580	P	0.17	0.88579	B	.	.	.	.	.	.	3.64	0.94011	H	.	0.66115	.	.	0.97441	1.0854	0.99062	D	0.9540	0.98504	D	10	.	0.91685	.	0.776902	0.98236	D	.	0.94374	.	.	.	.	.	.	0.94343	.	0.86555	.	0.10057	0.611799120903	0.54504	T	0.384042	0.81335	T	0.454957	0.92647	D	0.415738	0.92557	D	0.99232280254364	0.82639	D	.	0.97033	.	0.87069577	0.88763	0.49804372	0.70717	0.8283224	0.85601	0.4636008	0.68604	-14.271	0.93916	D	.	0.86411	.	0.997865992856704	0.93647	0.99988377	0.99849	0.931	0.96596	.	.	.	.	.	.	4.661471	0.74461	26.2	0.99903481763990787	0.97503	0.684509	0.64555	D	0.813291850711605	0.86860	9.046169	0.751252984158328	0.86175	8.829661	5.07	5.07	0.68064	3.31	0.60027	4.681	0.61438	7.412000	0.58717	0.593	0.32293	1.0	0.71675	1.000000	0.68239	1.0	0.97202	518	0.74567	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	Familial_cancer_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	no_classification_provided	NC_000017.11:g.43057126C>T	ClinGen:CA003353|UniProtKB:P38398#VAR_070505	C0346153|C2676676	114480|604370	227535|145	BRCT domain	Glu	Lys	70122	single nucleotide variant	NM_007294.4(BRCA1):c.5203G>A (p.Glu1735Lys)	672	BRCA1	HGNC:1100	not provided	0	-	397509238	-	RCV000577367|RCV001072517	MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145	Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1	germline;not applicable	germline	GRCh38	NC_000017.11	17	43057126	43057126	17q21.31	no classification provided	2	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003353,UniProtKB:P38398#VAR_070505	3	55455	43057126	C	T	-	-	-	-	-	-	SCV000679293|SCV001237915	-	-	5203G>A 	Glu1735Lys	NM_007294.4		5_Others	BRCA1	ENSG00000012048	14613	218448	CCSBVarC003307	ALE00003307	1891G>A	Glu631Lys	CEGS2	CegsMutGDEh1026	D09	GDEhDisVCh_40059	A09	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	BRCA1_Glu631Lys	17	17	43057126	C	T
52861	F9	1219T>C	Cys407Arg	ENSG00000101981	X	139561904	NC_000023.11:139561904:T:C	ALE00002183	CCSBVarC002183	24983	NULL	NULL	GDEhDisVCh_40052	E12	RC4	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCACGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT																																															chrX	T	C	X-139561904-T-C																																																																																																																																																																																																																																																																																																																																																																																																																																														F9	ENSG00000101981	52861	24983	CCSBVarC002183	ALE00002183	1219T>C	Cys407Arg	RC4	RC4_Mut_GDEh1022	F11	GDEhDisVCh_40052	E12	2	RC4_Mut_GDDh1022	F11	NULL	NULL	NULL	NULL	NULL	NULL	1	4	1	1	0	NULL	0	NULL	0	NULL	F9_Cys407Arg	23	X	139561904	T	C
14613	BRCA1	1784G>A	Arg595Gln	ENSG00000012048	17	43063930	NC_000017.11:43063930:C:T	ALE00003306	CCSBVarC003306	NULL	218429	NULL	GDEhDisVCh_40059	B04	CEGS2	ATGGATTTATCTGCTCTTCGCGTTGAAGAAGTACAAAATGTCATTAATGCTATGCAGAAAATCTTAGAGTGTCCCATCTGTCTGGAGTTGATCAAGGAACCTGTCTCCACAAAGTGTGACCACATATTTTGCAAATTTTGCATGCTGAAACTTCTCAACCAGAAGAAAGGGCCTTCACAGTGTCCTTTATGTAAGAATGATATAACCAAAAGGAGCCTACAAGAAAGTACGAGATTTAGTCAACTTGTTGAAGAGCTATTGAAAATCATTTGTGCTTTTCAGCTTGACACAGGTTTGGAGTATGCAAACAGCTATAATTTTGCAAAAAAGGAAAATAACTCTCCTGAACATCTAAAAGATGAAGTTTCTATCATCCAAAGTATGGGCTACAGAAACCGTGCCAAAAGACTTCTACAGAGTGAACCCGAAAATCCTTCCTTGCAGGAAACCAGTCTCAGTGTCCAACTCTCTAACCTTGGAACTGTGAGAACTCTGAGGACAAAGCAGCGGATACAACCTCAAAAGACGTCTGTCTACATTGAATTGGGATCTGATTCTTCTGAAGATACCGTTAATAAGGCAACTTATTGCAGTGTGGGAGATCAAGAATTGTTACAAATCACCCCTCAAGGAACCAGGGATGAAATCAGTTTGGATTCTGCAAAAAAGGCTGCTTGTGAATTTTCTGAGACGGATGTAACAAATACTGAACATCATCAACCCAGTAATAATGATTTGAACACCACTGAGAAGCGTGCAGCTGAGAGGCATCCAGAAAAGTATCAGGGTGAAGCAGCATCTGGGTGTGAGAGTGAAACAAGCGTCTCTGAAGACTGCTCAGGGCTATCCTCTCAGAGTGACATTTTAACCACTCAGCAGAGGGATACCATGCAACATAACCTGATAAAGCTCCAGCAGGAAATGGCTGAACTAGAAGCTGTGTTAGAACAGCATGGGAGCCAGCCTTCTAACAGCTACCCTTCCATCATAAGTGACTCTTCTGCCCTTGAGGACCTGCGAAATCCAGAACAAAGCACATCAGAAAAAGTATTAACTTCACAGAAAAGTAGTGAATACCCTATAAGCCAGAATCCAGAAGGCCTTTCTGCTGACAAGTTTGAGGTGTCTGCAGATAGTTCTACCAGTAAAAATAAAGAACCAGGAGTGGAAAGGTCATCCCCTTCTAAATGCCCATCATTAGATGATAGGTGGTACATGCACAGTTGCTCTGGGAGTCTTCAGAATAGAAACTACCCATCTCAAGAGGAGCTCATTAAGGTTGTTGATGTGGAGGAGCAACAGCTGGAAGAGTCTGGGCCACACGATTTGACGGAAACATCTTACTTGCCAAGGCAAGATCTAGAGGGAACCCCTTACCTGGAATCTGGAATCAGCCTCTTCTCTGATGACCCTGAATCTGATCCTTCTGAAGACAGAGCCCCAGAGTCAGCTCGTGTTGGCAACATACCATCTTCAACCTCTGCATTGAAAGTTCCCCAATTGAAAGTTGCAGAATCTGCCCAGAGTCCAGCTGCTGCTCATACTACTGATACTGCTGGGTATAATGCAATGGAAGAAAGTGTGAGCAGGGAGAAGCCAGAATTGACAGCTTCAACAGAAAGGGTCAACAAAAGAATGTCCATGGTGGTGTCTGGCCTGACCCCAGAAGAATTTATGCTCGTGTACAAGTTTGCCAGAAAACACCACATCACTTTAACTAATCTAATTACTGAAGAGACTACTCATGTTGTTATGAAAACAGATGCTGAGTTTGTGTGTGAACAGACACTGAAATATTTTCTAGGAATTGCGGGAGGAAAATGGGTAGTTAGCTATTTCTGGGTGACCCAGTCTATTAAAGAAAGAAAAATGCTGAATGAGCATGATTTTGAAGTCAGAGGAGATGTGGTCAATGGAAGAAACCACCAAGGTCCAAAGCGAGCAAGAGAATCCCAGGACAGAAAGATCTTCAGGGGGCTAGAAATCTGTTGCTATGGGCCCTTCACCAACATGCCCACAGGGTGTCCACCCAATTGTGGTTGTGCAGCCAGATGCCTGGACAGAGGACAATGGCTTCCATGCAATTGGGCAGATGTG	46192.0	single nucleotide variant	NM_007294.4(BRCA1):c.5096G>A (p.Arg1699Gln)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	May 10, 2017	41293459.0	-	RCV000031217|RCV000048790|RCV000131564|RCV000195350|RCV000735446|RCV000785422|RCV002250479|RCV002496477|RCV003162265|RCV004802991|RCV004554634	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN221562|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|Human Phenotype Ontology:HP:0012126,MONDO:MONDO:0001056,MeSH:D013274,MedGen:C0024623,OMIM:613659|MONDO:MONDO:0700268,MedGen:CN377757|	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|Ovarian neoplasm|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1;Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Familial cancer of breast|Gastric cancer|BRCA1-related cancer predisposition|BRCA1-related disorder	germline;maternal;unknown	germline	GRCh38	NC_000017.11	17	43063930.0	43063930.0	17q21.31	reviewed by expert panel	49.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003235,UniProtKB:P38398#VAR_070501,OMIM:113705.0037	3.0	37636.0	43063930.0	C	T	-	-	-	-	-	-	SCV001156534	-	-	5096G>A 	Arg1699Gln	NM_007294.4	3.0	1_Pathogenic	chr17	G	A	17-43063930-G-A		37636	17	43063930	C	T	R	Q	rs41293459	17	41215947	17	38469473	1699	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	.	.	c.5096G>A	p.Arg1699Gln	principal2	Y	1	.	.	-	CGG	2	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	0.995	0.90580	D	0.454	0.97365	P	.	0.97926	.	.	.	.	3.23	0.89408	M	.	0.63232	.	.	0.96659	0.9361	0.96178	D	0.8732	0.95778	D	10	.	0.83114	.	0.74691	0.97975	D	.	0.92843	.	.	.	.	.	.	0.96647	.	0.87449	.	0.39535	0.661911010742	0.61621	T	0.392783	0.80349	T	0.34877	0.86324	D	0.419574	0.92678	D	0.950455367565155	0.63113	D	.	0.97283	.	0.96523166	0.97765	0.7972393	0.87946	0.9692461	0.98160	0.77520096	0.86571	-11.318	0.81678	D	.	0.82063	.	0.987067707466189	0.87311	0.99990070	0.99879	0.902	0.94843	.	.	.	.	.	.	5.19884	0.87233	29.2	0.99957871779371688	0.99986	0.805899	0.72937	D	0.871042515796463	0.90217	10.32869	0.832238134394619	0.91891	11.14783	5.83	5.83	0.93049	.	.	4.855	0.62708	7.634000	0.62929	0.53	0.24764	1.0	0.71675	1.000000	0.68239	0.998	0.85369	549	0.72286	.	.	.	.	.	.	.	.	.	.	.	.	6	264690	2.2668026E-5	.	2	109352	1.828960e-05	0	4	207994	1.923130e-05	0	6	236774	2.534060e-05	0	0	7152	0.000000e+00	0	0	17106	0.000000e+00	0	0	2310	0.000000e+00	0	0	9042	0.000000e+00	0	0	13394	0.000000e+00	0	2	42748	4.678580e-05	0	0	15686	0.000000e+00	0	2	42748	4.678580e-05	0	0	16198	0.000000e+00	0	0	30512	0.000000e+00	0	0	6206	0.000000e+00	0	0	13408	0.000000e+00	0	0	16734	0.000000e+00	0	4	89478	4.470370e-05	0	0	30598	0.000000e+00	0	4	89478	4.470370e-05	0	0	14886	0.000000e+00	0	0	34248	0.000000e+00	0	0	9556	0.000000e+00	0	0	17686	0.000000e+00	0	0	21630	0.000000e+00	0	6	102642	5.845560e-05	0	0	30516	0.000000e+00	0	6	102642	5.845560e-05	0	.	30	1613816	1.858950e-05	0	3	44856	6.688070e-05	0	0	74854	0.000000e+00	0	0	912	0.000000e+00	0	0	59980	0.000000e+00	0	0	29598	0.000000e+00	0	3	44856	6.688070e-05	0	0	64006	0.000000e+00	0	0	6084	0.000000e+00	0	25	1179960	2.118720e-05	0	1	91080	1.097940e-05	0	0	49660	0	0	364	0	0	398	0	0	9488	0	0	498	0	0	802	0	0	62	0	0	146	0	0	2420	0	0	9852	0	0	460	0	0	63838	0	Pathogenic	BRCA1-related_disorder|Familial_cancer_of_breast|Pancreatic_cancer,_susceptibility_to,_4|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Fanconi_anemia,_complementation_group_S|Hereditary_breast_ovarian_cancer_syndrome|Breast_and/or_ovarian_cancer|Ovarian_neoplasm|Gastric_cancer|Hereditary_cancer-predisposing_syndrome|not_provided	reviewed_by_expert_panel	NC_000017.11:g.43063930C>T	ClinGen:CA003235|OMIM:113705.0037|UniProtKB:P38398#VAR_070501	C0346153|C3280442|C2676676|C4554406|C0677776|CN221562|C0919267|C0024623|C0027672|C3661900	114480|614320|604370|617883|613659	227535|1333|145|145|140162	BRCT domain|BRCT domain|BRCT domain	Arg	Gln	46192	single nucleotide variant	NM_007294.4(BRCA1):c.5096G>A (p.Arg1699Gln)	672	BRCA1	HGNC:1100	Pathogenic	1	May 10, 2017	41293459	-	RCV000031217|RCV000048790|RCV000131564|RCV000195350|RCV000735446|RCV000785422|RCV002250479|RCV002496477|RCV003162265|RCV004802991|RCV004554634	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN221562|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333;MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|Human Phenotype Ontology:HP:0012126,MONDO:MONDO:0001056,MeSH:D013274,MedGen:C0024623,OMIM:613659|MONDO:MONDO:0700268,MedGen:CN377757|	Breast-ovarian cancer, familial, susceptibility to, 1|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|Ovarian neoplasm|Familial cancer of breast|Breast-ovarian cancer, familial, susceptibility to, 1;Fanconi anemia, complementation group S;Pancreatic cancer, susceptibility to, 4;Familial cancer of breast|Gastric cancer|BRCA1-related cancer predisposition|BRCA1-related disorder	germline;maternal;unknown	germline	GRCh38	NC_000017.11	17	43063930	43063930	17q21.31	reviewed by expert panel	49	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003235,UniProtKB:P38398#VAR_070501,OMIM:113705.0037	3	37636	43063930	C	T	-	-	-	-	-	-	SCV001156534	-	-	5096G>A 	Arg1699Gln	NM_007294.4	3	1_Pathogenic	BRCA1	ENSG00000012048	14613	218429	CCSBVarC003306	ALE00003306	1784G>A	Arg595Gln	CEGS2	CegsMutGDEh1012	D06	GDEhDisVCh_40059	B04	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	BRCA1_Arg595Gln	17	17	43063930	C	T
3172	CBS	430G>A	Glu144Lys	ENSG00000160200	21	43066264	NC_000021.9:43066264:C:T	ALE00003749	CCSBVarC003749	NULL	214524	NULL	GDEhDisVCh_40055	C04	CEGS2	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTCCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCAAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCCGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	15161.0	single nucleotide variant	NM_000071.3(CBS):c.430G>A (p.Glu144Lys)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Apr 25, 2024	121964966.0	-	RCV000000144|RCV000169074|RCV000723427|RCV001251284|RCV002227957|RCV003415595	MedGen:C3502110|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3661900|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344|	Homocystinuria, pyridoxine-responsive|Classic homocystinuria|not provided|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|CBS-related disorder	germline;inherited;unknown	germline	GRCh38	NC_000021.9	21	43066264.0	43066264.0	21q22.3	criteria provided, multiple submitters, no conflicts	12.0	-	N	ClinGen:CA113885,UniProtKB:P35520#VAR_002177,OMIM:613381.0006	3.0	122.0	43066264.0	C	T	-	-	-	-	-	-	SCV000331006|SCV000649837|SCV001246795|SCV001426817|SCV001480070|SCV001757529|SCV002060159|SCV002543828|SCV004213898|SCV004848730	-	-	430G>A 	Glu144Lys	NM_000071.3	2.0	1_Pathogenic	chr21	G	A	21-43066264-G-A		122	21	43066264	C	T	E	K	rs121964966	21	44486374	21	43359443	144	CBS	ENSG00000160200	ENST00000398165	ENSP00000381231	P35520	CBS_HUMAN	c.430G>A	p.Glu144Lys	c.430G>A	p.Glu144Lys	principal1	Y	1	YES	Select	-	GAG	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.002	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.835	0.99692	H	-3.98	0.74082	D	0.986	0.99555	1.0509	0.98133	D	0.9729	0.99149	D	9	0.99125385	0.99645	D	0.720097	0.97730	D	0.844	0.95124	0.946	0.99321	P35520	E144K	Gain of methylation at E144 (P = 0.0066)| Gain of ubiquitination at E144 (P = 0.0138)| Gain of glycosylation at E144 (P = 0.1129)| Loss of stability (P = 0.1853)| Gain of phosphorylation at T146 (P = 0.1933)	0.898461317554	0.89668	0.9910311731326676	0.99096	1.19150631811	0.80185	0.764729678631	0.76593	T	0.995962	0.99993	D	0.402103	0.89963	D	0.542471	0.95405	D	0.997495710849762	0.91622	D	.	0.98523	.	0.99341935	0.99913	0.94474405	0.98045	0.98920643	0.99717	0.934537	0.97367	-10.054	0.74313	D	.	0.92510	.	0.999887319851922	0.98571	0.99985123	0.99806	0.986	0.99524	.	.	.	.	.	.	4.946184	0.817	27.6	0.99893171153021076	0.96668	0.864864	0.78298	D	0.616063543852058	0.74053	6.090749	0.419453020785335	0.62577	4.499043	5.23	4.33	0.51026	2.86	0.52289	6.845	0.75251	7.389000	0.58567	0.524	0.24207	1.0	0.71675	1.000000	0.68239	0.067	0.16491	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	108416	2.767120e-05	0	7	206804	3.384850e-05	0	6	235826	2.544250e-05	0	1	7138	1.400950e-04	0	0	17100	0.000000e+00	0	0	2316	0.000000e+00	0	0	9032	0.000000e+00	0	0	12512	0.000000e+00	0	1	42728	2.340390e-05	0	1	15688	6.374300e-05	0	1	7138	1.400950e-04	0	1	16166	6.185820e-05	0	0	30506	0.000000e+00	0	0	6204	0.000000e+00	0	0	13388	0.000000e+00	0	0	15852	0.000000e+00	0	3	89236	3.361870e-05	0	3	30606	9.802000e-05	0	3	30606	9.802000e-05	0	1	14870	6.724950e-05	0	0	34236	0.000000e+00	0	0	9562	0.000000e+00	0	0	17678	0.000000e+00	0	0	20748	0.000000e+00	0	2	102602	1.949280e-05	0	3	30524	9.828330e-05	0	3	30524	9.828330e-05	0	.	10	1312710	7.617830e-06	1	6	79922	7.507320e-05	1	0	39230	0.000000e+00	0	0	772	0.000000e+00	0	0	55106	0.000000e+00	0	0	24714	0.000000e+00	0	1	43596	2.293790e-05	0	0	48442	0.000000e+00	0	0	4574	0.000000e+00	0	3	964216	3.111340e-06	0	6	79922	7.507320e-05	1	0	24370	0	0	108	0	0	84	0	0	2728	0	0	494	0	0	628	0	0	24	0	0	94	0	0	4536	0	0	2836	0	0	108	0	0	33066	0	Pathogenic/Likely_pathogenic	Homocystinuria|not_provided|Classic_homocystinuria|CBS-related_disorder|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Homocystinuria,_pyridoxine-responsive	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43066264C>T	ClinGen:CA113885|OMIM:613381.0006|UniProtKB:P35520#VAR_002177	C0019880|C3661900|C0751202|C3150344|C3502110	236200	394	Tryptophan synthase beta chain-like, PALP domain	Glu	Lys	15161	single nucleotide variant	NM_000071.3(CBS):c.430G>A (p.Glu144Lys)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Apr 25, 2024	121964966	-	RCV000000144|RCV000169074|RCV000723427|RCV001251284|RCV002227957|RCV003415595	MedGen:C3502110|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3661900|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344|	Homocystinuria, pyridoxine-responsive|Classic homocystinuria|not provided|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|CBS-related disorder	germline;inherited;unknown	germline	GRCh38	NC_000021.9	21	43066264	43066264	21q22.3	criteria provided, multiple submitters, no conflicts	12	-	N	ClinGen:CA113885,UniProtKB:P35520#VAR_002177,OMIM:613381.0006	3	122	43066264	C	T	-	-	-	-	-	-	SCV000331006|SCV000649837|SCV001246795|SCV001426817|SCV001480070|SCV001757529|SCV002060159|SCV002543828|SCV004213898|SCV004848730	-	-	430G>A 	Glu144Lys	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	295	CCSBVarC007340	ALE00003749	430G>A	Glu144Lys	Edgotyping3	VUSMutGDEh011	G03	GDEhDisVCh_40013	A09	1	VUSMutGDDh011	G03	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	5	0	NULL	0	NULL	0	NULL	CBS_Glu144Lys	21	21	43066264	C	T
3172	CBS	430G>A	Glu144Lys	ENSG00000160200	21	43066264	NC_000021.9:43066264:C:T	ALE00003749	CCSBVarC003749	NULL	214524	NULL	GDEhDisVCh_40055	C04	CEGS2	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTCCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCAAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCCGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	15161.0	single nucleotide variant	NM_000071.3(CBS):c.430G>A (p.Glu144Lys)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Apr 25, 2024	121964966.0	-	RCV000000144|RCV000169074|RCV000723427|RCV001251284|RCV002227957|RCV003415595	MedGen:C3502110|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3661900|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344|	Homocystinuria, pyridoxine-responsive|Classic homocystinuria|not provided|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|CBS-related disorder	germline;inherited;unknown	germline	GRCh38	NC_000021.9	21	43066264.0	43066264.0	21q22.3	criteria provided, multiple submitters, no conflicts	12.0	-	N	ClinGen:CA113885,UniProtKB:P35520#VAR_002177,OMIM:613381.0006	3.0	122.0	43066264.0	C	T	-	-	-	-	-	-	SCV000331006|SCV000649837|SCV001246795|SCV001426817|SCV001480070|SCV001757529|SCV002060159|SCV002543828|SCV004213898|SCV004848730	-	-	430G>A 	Glu144Lys	NM_000071.3	2.0	1_Pathogenic	chr21	G	A	21-43066264-G-A		122	21	43066264	C	T	E	K	rs121964966	21	44486374	21	43359443	144	CBS	ENSG00000160200	ENST00000398165	ENSP00000381231	P35520	CBS_HUMAN	c.430G>A	p.Glu144Lys	c.430G>A	p.Glu144Lys	principal1	Y	1	YES	Select	-	GAG	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.002	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.835	0.99692	H	-3.98	0.74082	D	0.986	0.99555	1.0509	0.98133	D	0.9729	0.99149	D	9	0.99125385	0.99645	D	0.720097	0.97730	D	0.844	0.95124	0.946	0.99321	P35520	E144K	Gain of methylation at E144 (P = 0.0066)| Gain of ubiquitination at E144 (P = 0.0138)| Gain of glycosylation at E144 (P = 0.1129)| Loss of stability (P = 0.1853)| Gain of phosphorylation at T146 (P = 0.1933)	0.898461317554	0.89668	0.9910311731326676	0.99096	1.19150631811	0.80185	0.764729678631	0.76593	T	0.995962	0.99993	D	0.402103	0.89963	D	0.542471	0.95405	D	0.997495710849762	0.91622	D	.	0.98523	.	0.99341935	0.99913	0.94474405	0.98045	0.98920643	0.99717	0.934537	0.97367	-10.054	0.74313	D	.	0.92510	.	0.999887319851922	0.98571	0.99985123	0.99806	0.986	0.99524	.	.	.	.	.	.	4.946184	0.817	27.6	0.99893171153021076	0.96668	0.864864	0.78298	D	0.616063543852058	0.74053	6.090749	0.419453020785335	0.62577	4.499043	5.23	4.33	0.51026	2.86	0.52289	6.845	0.75251	7.389000	0.58567	0.524	0.24207	1.0	0.71675	1.000000	0.68239	0.067	0.16491	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	108416	2.767120e-05	0	7	206804	3.384850e-05	0	6	235826	2.544250e-05	0	1	7138	1.400950e-04	0	0	17100	0.000000e+00	0	0	2316	0.000000e+00	0	0	9032	0.000000e+00	0	0	12512	0.000000e+00	0	1	42728	2.340390e-05	0	1	15688	6.374300e-05	0	1	7138	1.400950e-04	0	1	16166	6.185820e-05	0	0	30506	0.000000e+00	0	0	6204	0.000000e+00	0	0	13388	0.000000e+00	0	0	15852	0.000000e+00	0	3	89236	3.361870e-05	0	3	30606	9.802000e-05	0	3	30606	9.802000e-05	0	1	14870	6.724950e-05	0	0	34236	0.000000e+00	0	0	9562	0.000000e+00	0	0	17678	0.000000e+00	0	0	20748	0.000000e+00	0	2	102602	1.949280e-05	0	3	30524	9.828330e-05	0	3	30524	9.828330e-05	0	.	10	1312710	7.617830e-06	1	6	79922	7.507320e-05	1	0	39230	0.000000e+00	0	0	772	0.000000e+00	0	0	55106	0.000000e+00	0	0	24714	0.000000e+00	0	1	43596	2.293790e-05	0	0	48442	0.000000e+00	0	0	4574	0.000000e+00	0	3	964216	3.111340e-06	0	6	79922	7.507320e-05	1	0	24370	0	0	108	0	0	84	0	0	2728	0	0	494	0	0	628	0	0	24	0	0	94	0	0	4536	0	0	2836	0	0	108	0	0	33066	0	Pathogenic/Likely_pathogenic	Homocystinuria|not_provided|Classic_homocystinuria|CBS-related_disorder|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Homocystinuria,_pyridoxine-responsive	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43066264C>T	ClinGen:CA113885|OMIM:613381.0006|UniProtKB:P35520#VAR_002177	C0019880|C3661900|C0751202|C3150344|C3502110	236200	394	Tryptophan synthase beta chain-like, PALP domain	Glu	Lys	15161	single nucleotide variant	NM_000071.3(CBS):c.430G>A (p.Glu144Lys)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Apr 25, 2024	121964966	-	RCV000000144|RCV000169074|RCV000723427|RCV001251284|RCV002227957|RCV003415595	MedGen:C3502110|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3661900|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344|	Homocystinuria, pyridoxine-responsive|Classic homocystinuria|not provided|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|CBS-related disorder	germline;inherited;unknown	germline	GRCh38	NC_000021.9	21	43066264	43066264	21q22.3	criteria provided, multiple submitters, no conflicts	12	-	N	ClinGen:CA113885,UniProtKB:P35520#VAR_002177,OMIM:613381.0006	3	122	43066264	C	T	-	-	-	-	-	-	SCV000331006|SCV000649837|SCV001246795|SCV001426817|SCV001480070|SCV001757529|SCV002060159|SCV002543828|SCV004213898|SCV004848730	-	-	430G>A 	Glu144Lys	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	3172	214524	CCSBVarC003749	ALE00003749	430G>A	Glu144Lys	CEGS2	CegsMutGDEh1032	G03	GDEhDisVCh_40055	C04	1	CegsMutGDDh1032	G03	NULL	NULL	NULL	NULL	NULL	NULL	1	3	1	1	0	NULL	0	NULL	0	NULL	CBS_Glu144Lys	21	21	43066264	C	T
2803	HMBS	820G>A	Gly274Arg	ENSG00000256269	11	119092806	NC_000011.10:119092806:G:A	ALE00000332	CCSBVarC000332	4909	NULL	NULL	GDEhDisVCh_40054	F11	RC4	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAGCTTGCTCGCATACAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGGACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCTTGAACATGCCCTGGAGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCGAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTCGGGGAAACCTCAACACCCGGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACCGGGTGGGGCAGATCCTGCACCCTGAGGAATGCATGTATGCTGTGGGCCAGGGGGCCTTGGGCGTGGAAGTGCGAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCTGCATCGCTGAAAGGGCCTTCCTGAGGCACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATAGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCGTAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACGATGCCCAT																																															chr11	G	A	11-119092806-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																														HMBS	ENSG00000256269	2803	4909	CCSBVarC000332	ALE00000332	820G>A	Gly274Arg	RC4	RC4_Mut_GDEh1018	F04	GDEhDisVCh_40054	F11	2	RC4_Mut_GDDh1018	F04	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	HMBS_Gly274Arg	11	11	119092806	G	A
14613	BRCA1	1979T>C	Leu660Pro	ENSG00000012048	17	43051104	NC_000017.11:43051104:A:G	ALE00003309	CCSBVarC003309	NULL	218449	NULL	GDEhDisVCh_40059	B09	CEGS2	ATGGATTTATCTGCTCTTCGCGTTGAAGAAGTACAAAATGTCATTAATGCTATGCAGAAAATCTTAGAGTGTCCCATCTGTCTGGAGTTGATCAAGGAACCTGTCTCCACAAAGTGTGACCACATATTTTGCAAATTTTGCATGCTGAAACTTCTCAACCAGAAGAAAGGGCCTTCACAGTGTCCTTTATGTAAGAATGATATAACCAAAAGGAGCCTACAAGAAAGTACGAGATTTAGTCAACTTGTTGAAGAGCTATTGAAAATCATTTGTGCTTTTCAGCTTGACACAGGTTTGGAGTATGCAAACAGCTATAATTTTGCAAAAAAGGAAAATAACTCTCCTGAACATCTAAAAGATGAAGTTTCTATCATCCAAAGTATGGGCTACAGAAACCGTGCCAAAAGACTTCTACAGAGTGAACCCGAAAATCCTTCCTTGCAGGAAACCAGTCTCAGTGTCCAACTCTCTAACCTTGGAACTGTGAGAACTCTGAGGACAAAGCAGCGGATACAACCTCAAAAGACGTCTGTCTACATTGAATTGGGATCTGATTCTTCTGAAGATACCGTTAATAAGGCAACTTATTGCAGTGTGGGAGATCAAGAATTGTTACAAATCACCCCTCAAGGAACCAGGGATGAAATCAGTTTGGATTCTGCAAAAAAGGCTGCTTGTGAATTTTCTGAGACGGATGTAACAAATACTGAACATCATCAACCCAGTAATAATGATTTGAACACCACTGAGAAGCGTGCAGCTGAGAGGCATCCAGAAAAGTATCAGGGTGAAGCAGCATCTGGGTGTGAGAGTGAAACAAGCGTCTCTGAAGACTGCTCAGGGCTATCCTCTCAGAGTGACATTTTAACCACTCAGCAGAGGGATACCATGCAACATAACCTGATAAAGCTCCAGCAGGAAATGGCTGAACTAGAAGCTGTGTTAGAACAGCATGGGAGCCAGCCTTCTAACAGCTACCCTTCCATCATAAGTGACTCTTCTGCCCTTGAGGACCTGCGAAATCCAGAACAAAGCACATCAGAAAAAGTATTAACTTCACAGAAAAGTAGTGAATACCCTATAAGCCAGAATCCAGAAGGCCTTTCTGCTGACAAGTTTGAGGTGTCTGCAGATAGTTCTACCAGTAAAAATAAAGAACCAGGAGTGGAAAGGTCATCCCCTTCTAAATGCCCATCATTAGATGATAGGTGGTACATGCACAGTTGCTCTGGGAGTCTTCAGAATAGAAACTACCCATCTCAAGAGGAGCTCATTAAGGTTGTTGATGTGGAGGAGCAACAGCTGGAAGAGTCTGGGCCACACGATTTGACGGAAACATCTTACTTGCCAAGGCAAGATCTAGAGGGAACCCCTTACCTGGAATCTGGAATCAGCCTCTTCTCTGATGACCCTGAATCTGATCCTTCTGAAGACAGAGCCCCAGAGTCAGCTCGTGTTGGCAACATACCATCTTCAACCTCTGCATTGAAAGTTCCCCAATTGAAAGTTGCAGAATCTGCCCAGAGTCCAGCTGCTGCTCATACTACTGATACTGCTGGGTATAATGCAATGGAAGAAAGTGTGAGCAGGGAGAAGCCAGAATTGACAGCTTCAACAGAAAGGGTCAACAAAAGAATGTCCATGGTGGTGTCTGGCCTGACCCCAGAAGAATTTATGCTCGTGTACAAGTTTGCCAGAAAACACCACATCACTTTAACTAATCTAATTACTGAAGAGACTACTCATGTTGTTATGAAAACAGATGCTGAGTTTGTGTGTGAACGGACACTGAAATATTTTCTAGGAATTGCGGGAGGAAAATGGGTAGTTAGCTATTTCTGGGTGACCCAGTCTATTAAAGAAAGAAAAATGCTGAATGAGCATGATTTTGAAGTCAGAGGAGATGTGGTCAATGGAAGAAACCACCAAGGTCCAAAGCGAGCAAGAGAATCCCAGGACAGAAAGATCTTCAGGGGGCCAGAAATCTGTTGCTATGGGCCCTTCACCAACATGCCCACAGGGTGTCCACCCAATTGTGGTTGTGCAGCCAGATGCCTGGACAGAGGACAATGGCTTCCATGCAATTGGGCAGATGTG	70177.0	single nucleotide variant	NM_007294.4(BRCA1):c.5291T>C (p.Leu1764Pro)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	80357281.0	-	RCV000112604|RCV000509995|RCV000588744|RCV001528204	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43051104.0	43051104.0	17q21.31	reviewed by expert panel	12.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00049,ClinGen:CA003449,UniProtKB:P38398#VAR_063908	2.0	55510.0	43051104.0	A	G	-	-	-	-	-	-	SCV000244395	-	-	5291T>C 	Leu1764Pro	NM_007294.4	3.0	1_Pathogenic	chr17	T	C	17-43051104-T-C		55510	17	43051104	A	G	L	P	rs80357281	17	41203121	17	38456647	1764	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.5291T>C	p.Leu1764Pro	principal2	Y	1	.	.	-	CTA	2	0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.79703	.	0.999	0.90580	D	0.937	0.77493	D	.	0.99291	.	.	.	.	2.255	0.63995	M	.	0.80457	.	.	0.93732	0.6256	0.92204	D	0.7595	0.91786	D	10	.	0.90949	.	0.852334	0.98860	D	.	0.88008	.	.	.	.	.	.	0.98778	.	0.82492	.	0.52805	0.554721057415	0.46456	T	0.394982	0.75228	T	0.436743	0.91807	D	0.389575	0.91707	D	0.994264304637909	0.85335	D	0.89611	0.63951	D	0.8910151	0.90460	0.6202942	0.77645	0.89131314	0.90488	0.55023813	0.73742	-11.462	0.82186	D	.	0.84401	.	0.997750985165462	0.93509	0.99987125	0.99835	0.96	0.98304	.	.	.	.	.	.	4.871541	0.79856	27.2	0.99898762507631778	0.97125	0.796452	0.72256	D	0.591172089691292	0.72477	5.834971	0.566318150584601	0.72388	5.826055	5.06	5.06	0.67796	5.33	0.93090	5.026	0.63961	11.097000	0.86063	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.96	0.51684	449	0.79449	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided|Hereditary_breast_ovarian_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	reviewed_by_expert_panel	NC_000017.11:g.43051104A>G	BRCA1-HCI:BRCA1_00049|ClinGen:CA003449|UniProtKB:P38398#VAR_063908	C3661900|C0677776|C0027672|C2676676	604370	145|140162|145	.	Leu	Pro	70177	single nucleotide variant	NM_007294.4(BRCA1):c.5291T>C (p.Leu1764Pro)	672	BRCA1	HGNC:1100	Pathogenic	1	Aug 10, 2015	80357281	-	RCV000112604|RCV000509995|RCV000588744|RCV001528204	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43051104	43051104	17q21.31	reviewed by expert panel	12	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00049,ClinGen:CA003449,UniProtKB:P38398#VAR_063908	2	55510	43051104	A	G	-	-	-	-	-	-	SCV000244395	-	-	5291T>C 	Leu1764Pro	NM_007294.4	3	1_Pathogenic	BRCA1	ENSG00000012048	14613	218449	CCSBVarC003309	ALE00003309	1979T>C	Leu660Pro	CEGS2	CegsMutGDEh1027	B03	GDEhDisVCh_40059	B09	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	BRCA1_Leu660Pro	17	17	43051104	A	G
359	CBS	362G>A	Arg121His	ENSG00000160200	21	43066332	NC_000021.9:43066332:C:T	ALE00007335	CCSBVarC007346	NULL	NULL	305	GDEhDisVCh_40013	G09	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCACATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	187059.0	single nucleotide variant	NM_000071.3(CBS):c.362G>A (p.Arg121His)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Jun 03, 2024	770095972.0	-	RCV001192720|RCV000169322|RCV002228611|RCV002453568	Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Homocystinuria|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection	germline;unknown	germline	GRCh38	NC_000021.9	21	43066332.0	43066332.0	21q22.3	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA274172,UniProtKB:P35520#VAR_008055	2.0	188948.0	43066332.0	C	T	-	-	-	-	-	-	SCV001224398|SCV001361015|SCV002060177|SCV002615953|SCV004213844	-	-	362G>A 	Arg121His	NM_000071.3	2.0	1_Pathogenic	chr21	G	A	21-43066332-G-A		188948	21	43066332	C	T	R	H	rs770095972	21	44486442	21	43359511	121	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.362G>A	p.Arg121His	c.362G>A	p.Arg121His	principal1	Y	1	.	.	-	CGC	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.85	0.99713	H	-4.97	0.82250	D	0.958	0.96886	1.0157	0.97450	D	0.9836	0.99499	D	10	0.9497962	0.94248	D	0.765448	0.98138	D	0.964	0.99491	.	.	.	.	.	0.953283652498	0.95239	.	0.97153	.	0.81896	0.839653491974	0.88021	D	0.996218	0.99994	D	0.356096	0.86859	D	0.553166	0.95708	D	0.998535871505737	0.94372	D	.	0.99230	.	0.9641831	0.97661	0.87056124	0.92809	0.9678619	0.98026	0.83406717	0.90326	-15.003	0.95868	D	.	0.77290	.	0.999810496523691	0.98120	0.99988317	0.99849	0.995	0.99826	.	.	.	.	.	.	5.818496	0.93696	33.0	0.99934523108213613	0.99535	0.908621	0.86367	D	0.807460088935056	0.86496	8.928179	0.669990670323754	0.79996	7.225861	5.26	4.38	0.51962	2.86	0.52289	6.845	0.75251	5.695000	0.49429	0.524	0.24207	1.0	0.71675	1.000000	0.68239	0.977	0.56847	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	109176	1.831900e-05	0	5	207732	2.406950e-05	0	5	236654	2.112790e-05	0	2	7162	2.792520e-04	0	0	17104	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13174	0.000000e+00	0	0	42766	0.000000e+00	0	0	15690	0.000000e+00	0	2	7162	2.792520e-04	0	3	16200	1.851850e-04	0	0	30514	0.000000e+00	0	0	6208	0.000000e+00	0	0	13406	0.000000e+00	0	0	16514	0.000000e+00	0	2	89420	2.236640e-05	0	0	30608	0.000000e+00	0	3	16200	1.851850e-04	0	3	14900	2.013420e-04	0	0	34244	0.000000e+00	0	0	9566	0.000000e+00	0	0	17692	0.000000e+00	0	0	21412	0.000000e+00	0	2	102694	1.947530e-05	0	0	30526	0.000000e+00	0	3	14900	2.013420e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	42618	4.692852785208128E-5	0	306	0	0	112	0	1	8040	1.243781094527363E-4	0	496	0	0	628	0	0	56	0	0	98	0	0	8268	0	1	8346	1.1981787682722263E-4	0	168	0	3	60622	4.948698492296526E-5	Pathogenic/Likely_pathogenic	Classic_homocystinuria|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Homocystinuria	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43066332C>T	ClinGen:CA274172|UniProtKB:P35520#VAR_008055	C0751202|C4707243|C3150344|C0019880	236200|PS607086	394|91387	Tryptophan synthase beta chain-like, PALP domain|Cysteine synthase/cystathionine beta-synthase, pyridoxal-phosphate attachment site	Arg	His	187059	single nucleotide variant	NM_000071.3(CBS):c.362G>A (p.Arg121His)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Jun 03, 2024	770095972	-	RCV001192720|RCV000169322|RCV002228611|RCV002453568	Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Homocystinuria|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection	germline;unknown	germline	GRCh38	NC_000021.9	21	43066332	43066332	21q22.3	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA274172,UniProtKB:P35520#VAR_008055	2	188948	43066332	C	T	-	-	-	-	-	-	SCV001224398|SCV001361015|SCV002060177|SCV002615953|SCV004213844	-	-	362G>A 	Arg121His	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	305	CCSBVarC007346	ALE00007335	362G>A	Arg121His	Edgotyping3	VUSMutGDEh011	E04	GDEhDisVCh_40013	G09	1	VUSMutGDDh011	E04	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	CBS_Arg121His	21	21	43066332	C	T
2013	KCNE1	200G>A	Arg67His	ENSG00000180509	21	34449435	NC_000021.9:34449435:C:T	ALE00006338	CCSBVarC006338	NULL	214142	NULL	GDEhDisVCh_40065	H01	CEGS2	ATGATCCTGTCTAACACCACAGCGGTGACGCCCTTTCTGACCAAGCTGTGGCAGGAGACAGTTCAGCAGGGTGGCAACATGTCGGGCCTGGCCCACAGGTCCCCCCGCAGCGGTGACGGCAAGCTGGAGGCCCTCTACGTCCTCATGGTACTGGGATTCTTCGGCTTCTTCACCCTGGGCATCATGCTGAGCTACATCCACTCCAAGAAGCTGGAGCACTCGAACGACCCATTCAACGTCTACATCGAGTCCGATGCCTGGCAAGAGAAGGACAAGGCCTATGTCCAGGCCCGGGTCCTGGAGAGCTACAGGTCG	136409.0	single nucleotide variant	NM_000219.6(KCNE1):c.200G>A (p.Arg67His)	3753.0	KCNE1	HGNC:6240	Uncertain significance	0.0	Jan 30, 2025	79654911.0	-	RCV000119073|RCV000148517|RCV000223718|RCV000413332|RCV000621667|RCV001335180|RCV004777585|RCV002492404	MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:101016,Orphanet:768|MONDO:MONDO:0002442,MeSH:D008133,MedGen:C0023976|MedGen:CN169374|MedGen:C3661900|MedGen:CN230736|MONDO:MONDO:0012871,MedGen:C2676723,OMIM:612347,Orphanet:768,Orphanet:90647|MONDO:MONDO:0013372,MedGen:C1867904,OMIM:613695,Orphanet:101016,Orphanet:768|MONDO:MONDO:0012871,MedGen:C2676723,OMIM:612347,Orphanet:768,Orphanet:90647;MONDO:MONDO:0013372,MedGen:C1867904,OMIM:613695,Orphanet:101016,Orphanet:768	Congenital long QT syndrome|Long QT syndrome|not specified|not provided|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome 2|Long QT syndrome 5|Jervell and Lange-Nielsen syndrome 2;Long QT syndrome 5	germline;maternal;not applicable	germline	GRCh38	NC_000021.9	21	34449435.0	34449435.0	21q22.12	criteria provided, multiple submitters, no conflicts	10.0	-	N	ClinGen:CA211451,UniProtKB:P15382#VAR_074917	2.0	132661.0	34449435.0	C	T	-	-	-	-	-	-	SCV000490577|SCV000738236|SCV000813827|SCV001528268|SCV001715594|SCV002802106	-	-	200G>A 	Arg67His	NM_000219.6	2.0	4_VUS	chr21	G	A	21-34449435-G-A		132661	21	34449435	C	T	R	H	rs79654911	21	35821733	21	34743603	67	KCNE1	ENSG00000180509	ENST00000432085	ENSP00000412498	P15382	KCNE1_HUMAN	c.200G>A	p.Arg67His	c.200G>A	p.Arg67His	principal1	Y	1	.	.	-	CGC	2	0	C	C/C	C/C	C/C	C/C	0.002	0.72322	D	0.004	0.74454	D	1.0	0.90580	D	0.987	0.77493	D	0.98	0.97016	D	simple_aae	2.0	98.0	2.78	0.80945	M	-3.89	0.72856	D	0.884	0.91970	1.0571	0.98270	D	0.9206	0.97367	D	10	0.93507683	0.92759	D	0.223186	0.87860	D	0.909	0.97545	.	.	.	.	.	0.98122436057	0.98083	.	0.83037	.	0.46476	0.654693245888	0.60590	T	0.954931	0.99369	D	0.163362	0.70295	D	0.350916	0.90284	D	0.873182117938995	0.52043	D	.	0.63832	.	0.56250644	0.70354	0.4864167	0.70017	0.5416714	0.69192	0.4714587	0.69097	-5.242	0.39413	T	.	0.59523	.	0.767436042044439	0.69462	0.99952948	0.99461	0.829	0.90573	.	.	.	.	.	.	5.111145	0.8547	28.6	0.99957863083044796	0.99986	0.765908	0.70115	D	0.797338426278428	0.85860	8.728404	0.740319827976832	0.85353	8.578887	5.16	5.16	0.70523	6.15	0.98224	5.006	0.63812	5.845000	0.50358	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.998	0.85369	899	0.25042	.	.	.	.	.	.	.	.	.	.	.	.	39	264690	1.4734217E-4	.	4	109406	3.656110e-05	0	7	208038	3.364770e-05	0	9	236886	3.799300e-05	0	0	7164	0.000000e+00	0	0	17110	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	2	42768	4.676390e-05	0	0	15690	0.000000e+00	0	2	42768	4.676390e-05	0	2	16214	1.233500e-04	0	0	30522	0.000000e+00	0	0	6210	0.000000e+00	0	1	13416	7.453790e-05	0	0	16734	0.000000e+00	0	3	89472	3.353000e-05	0	0	30608	0.000000e+00	0	2	16214	1.233500e-04	0	2	14902	1.342100e-04	0	0	34258	0.000000e+00	0	0	9570	0.000000e+00	0	1	17692	5.652270e-05	0	0	21632	0.000000e+00	0	4	102688	3.895290e-05	0	0	30526	0.000000e+00	0	2	14902	1.342100e-04	0	.	139	1538590	9.034250e-05	0	15	68502	2.189720e-04	0	15	68502	2.189720e-04	0	0	776	0.000000e+00	0	1	57554	1.737500e-05	0	0	28678	0.000000e+00	0	2	43652	4.581690e-05	0	0	62450	0.000000e+00	0	0	5948	0.000000e+00	0	116	1122012	1.033860e-04	0	1	88696	1.127450e-05	0	0	9690	0	0	114	0	0	86	0	3	2784	0.0010775862068965517	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	3	2898	0.0010351966873706005	0	112	0	3	14050	2.1352313167259787E-4	Uncertain_significance	Jervell_and_Lange-Nielsen_syndrome_2|Congenital_long_QT_syndrome|Cardiovascular_phenotype|not_provided|Long_QT_syndrome_5|Long_QT_syndrome|not_specified	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.34449435C>T	ClinGen:CA211451|UniProtKB:P15382#VAR_074917	C2676723|C1141890|CN230736|C3661900|C1867904|C0023976|CN169374	612347|PS192500|613695	768|90647|101016|768|101016|768	.	Arg	His	136409	single nucleotide variant	NM_000219.6(KCNE1):c.200G>A (p.Arg67His)	3753	KCNE1	HGNC:6240	Uncertain significance	0	Jan 30, 2025	79654911	-	RCV000119073|RCV000148517|RCV000223718|RCV000413332|RCV000621667|RCV001335180|RCV004777585|RCV002492404	MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:101016,Orphanet:768|MONDO:MONDO:0002442,MeSH:D008133,MedGen:C0023976|MedGen:CN169374|MedGen:C3661900|MedGen:CN230736|MONDO:MONDO:0012871,MedGen:C2676723,OMIM:612347,Orphanet:768,Orphanet:90647|MONDO:MONDO:0013372,MedGen:C1867904,OMIM:613695,Orphanet:101016,Orphanet:768|MONDO:MONDO:0012871,MedGen:C2676723,OMIM:612347,Orphanet:768,Orphanet:90647;MONDO:MONDO:0013372,MedGen:C1867904,OMIM:613695,Orphanet:101016,Orphanet:768	Congenital long QT syndrome|Long QT syndrome|not specified|not provided|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome 2|Long QT syndrome 5|Jervell and Lange-Nielsen syndrome 2;Long QT syndrome 5	germline;maternal;not applicable	germline	GRCh38	NC_000021.9	21	34449435	34449435	21q22.12	criteria provided, multiple submitters, no conflicts	10	-	N	ClinGen:CA211451,UniProtKB:P15382#VAR_074917	2	132661	34449435	C	T	-	-	-	-	-	-	SCV000490577|SCV000738236|SCV000813827|SCV001528268|SCV001715594|SCV002802106	-	-	200G>A 	Arg67His	NM_000219.6	2	4_VUS	KCNE1	ENSG00000180509	2013	214142	CCSBVarC006338	ALE00006338	200G>A	Arg67His	CEGS2	CegsMutGDEh1005	B03	GDEhDisVCh_40065	H01	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	KCNE1_Arg67His	21	21	34449435	C	T
71569	OTC	562G>C	Gly188Arg	ENSG00000036473	X	38403639	NC_000023.11:38403639:G:C	ALE00005252	CCSBVarC005252	NULL	205918	NULL	GDEhDisVCh_40048	D04	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAACGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103140.0	single nucleotide variant	NM_000531.6(OTC):c.562G>C (p.Gly188Arg)	5009.0	OTC	HGNC:8512	Pathogenic	1.0	-	72556294.0	-	RCV000083489	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38403639.0	38403639.0	Xp11.4	no assertion criteria provided	1.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224680,UniProtKB:P00480#VAR_004897	2.0	97248.0	38403639.0	G	C	-	-	-	-	-	-	SCV000115575	-	-	562G>C 	Gly188Arg	NM_000531.6		1_Pathogenic	chrX	G	C	X-38403639-G-C		97248	X	38403639	G	C	G	R	rs72556294	X	38262892	X	38147836	188	OTC	ENSG00000036473	ENST00000039007	ENSP00000039007	P00480	OTC_HUMAN	c.562G>C	p.Gly188Arg	c.562G>C	p.Gly188Arg	principal1	Y	1	YES	Select	+	GGT	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	0.999	0.92348	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.385	0.91389	M	-7.73	0.95749	D	0.804	0.79913	1.0302	0.97716	D	0.9862	0.99587	D	10	0.99052393	0.99553	D	0.962097	0.99753	D	0.957	0.99285	0.916	0.98413	P00480	G188R	Gain of solvent accessibility (P = 0.0306)| Loss of ubiquitination at K187 (P = 0.0666)| Gain of MoRF binding (P = 0.0936)| Loss of catalytic residue at L189 (P = 0.1168)| Gain of methylation at K187 (P = 0.118)	0.972065501246	0.97150	0.9410699978101301	0.94052	1.288090895	0.82632	0.852364897728	0.89954	D	0.972186	0.99704	D	0.683255	0.99918	D	0.743672	0.99917	D	0.999283611774445	0.96791	D	0.934307	0.75359	D	0.97373104	0.98572	0.9733935	0.99597	0.97373104	0.98572	0.9733935	0.99598	-10.739	0.78278	D	0.6626	0.71376	P	0.999052569431465	0.95600	0.99861500	0.98869	1	0.99985	.	.	.	.	.	.	5.196773	0.87192	29.1	0.99934319962193163	0.99535	.	.	.	.	.	.	.	.	.	5.91	5.91	0.95233	.	.	9.273	0.94946	11.708000	0.94615	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided	no_assertion_criteria_provided	NC_000023.11:g.38403639G>C	ClinGen:CA224680|UniProtKB:P00480#VAR_004897	CN517202	.	.	Aspartate/ornithine carbamoyltransferase, Asp/Orn-binding domain	Gly	Arg	103140	single nucleotide variant	NM_000531.6(OTC):c.562G>C (p.Gly188Arg)	5009	OTC	HGNC:8512	Pathogenic	1	-	72556294	-	RCV000083489	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38403639	38403639	Xp11.4	no assertion criteria provided	1	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224680,UniProtKB:P00480#VAR_004897	2	97248	38403639	G	C	-	-	-	-	-	-	SCV000115575	-	-	562G>C 	Gly188Arg	NM_000531.6		1_Pathogenic	OTC	ENSG00000036473	71569	205918	CCSBVarC005252	ALE00005252	562G>C	Gly188Arg	CEGS2	CegsMutGDEh1018	G10	GDEhDisVCh_40048	D04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Gly188Arg	23	X	38403639	G	C
71569	OTC	731T>A	Leu244Gln	ENSG00000036473	X	38408889	NC_000023.11:38408889:T:A	ALE00005257	CCSBVarC005257	NULL	205960	NULL	GDEhDisVCh_40048	C02	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCAGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103198.0	single nucleotide variant	NM_000531.6(OTC):c.731T>A (p.Leu244Gln)	5009.0	OTC	HGNC:8512	Pathogenic	1.0	-	72558436.0	-	RCV000083552	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38408889.0	38408889.0	Xp11.4	no assertion criteria provided	1.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224764,UniProtKB:P00480#VAR_004917	2.0	97306.0	38408889.0	T	A	-	-	-	-	-	-	SCV000115638	-	-	731T>A 	Leu244Gln	NM_000531.6		1_Pathogenic	chrX	T	A	X-38408889-T-A		97306	X	38408889	T	A	L	Q	rs72558436	X	38268142	X	38153086	244	OTC	ENSG00000036473	ENST00000039007	ENSP00000039007	P00480	OTC_HUMAN	c.731T>A	p.Leu244Gln	c.731T>A	p.Leu244Gln	principal1	Y	1	YES	Select	+	CTG	2	0	T	T/T	T/T	T/T	T/T	0.002	0.72322	D	0.003	0.76775	D	0.854	0.47092	P	0.247	0.38902	B	0.76	0.85499	A	simple_aae	24.0	76.0	3.105	0.87531	M	-3.85	0.72390	D	0.868	0.86483	1.0744	0.98710	D	0.9485	0.98318	D	10	0.99191844	0.99724	D	0.967562	0.99797	D	0.903	0.97318	0.933	0.98984	P00480	L244Q	Gain of disorder (P = 0.0287)| Gain of ubiquitination at K243 (P = 0.0568)| Loss of stability (P = 0.0568)| Gain of methylation at K243 (P = 0.0619)| Loss of sheet (P = 0.1158)	0.995199962387	0.99508	0.9903411479088147	0.99027	0.784768294499	0.65239	0.391564518213	0.23863	T	0.955425	0.99380	D	0.582815	0.97008	D	0.599397	0.96959	D	0.986073136329651	0.76720	D	0.89651	0.63781	D	0.9707802	0.98304	0.95765144	0.98826	0.9782891	0.98958	0.9202052	0.96362	-12.434	0.86934	D	0.8535	0.79909	P	0.998550624984996	0.94646	0.99784780	0.98531	0.976	0.99121	.	.	.	.	.	.	4.768908	0.77221	26.7	0.98621292936931715	0.43901	.	.	.	.	.	.	.	.	.	5.58	5.58	0.84339	.	.	7.559	0.81272	7.761000	0.68349	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.999	0.91597	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided	no_assertion_criteria_provided	NC_000023.11:g.38408889T>A	ClinGen:CA224764|UniProtKB:P00480#VAR_004917	CN517202	.	.	Aspartate/ornithine carbamoyltransferase, Asp/Orn-binding domain	Leu	Gln	103198	single nucleotide variant	NM_000531.6(OTC):c.731T>A (p.Leu244Gln)	5009	OTC	HGNC:8512	Pathogenic	1	-	72558436	-	RCV000083552	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38408889	38408889	Xp11.4	no assertion criteria provided	1	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224764,UniProtKB:P00480#VAR_004917	2	97306	38408889	T	A	-	-	-	-	-	-	SCV000115638	-	-	731T>A 	Leu244Gln	NM_000531.6		1_Pathogenic	OTC	ENSG00000036473	71569	205960	CCSBVarC005257	ALE00005257	731T>A	Leu244Gln	CEGS2	CegsMutGDEh1011	C09	GDEhDisVCh_40048	C02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Leu244Gln	23	X	38408889	T	A
2013	KCNE1	226G>A	Asp76Asn	ENSG00000180509	21	34449409	NC_000021.9:34449409:C:T	ALE00000219	CCSBVarC000219	3299	NULL	NULL	GDEhDisVCh_40065	F09	RC4	ATGATCCTGTCTAACACCACAGCGGTGACGCCCTTTCTGACCAAGCTGTGGCAGGAGACAGTTCAGCAGGGTGGCAACATGTCGGGCCTGGCCCACAGGTCCCCCCGCAGCGGTGACGGCAAGCTGGAGGCCCTCTACGTCCTCATGGTACTGGGATTCTTCGGCTTCTTCACCCTGGGCATCATGCTGAGCTACATCCGCTCCAAGAAGCTGGAGCACTCGAACAACCCATTCAACGTCTACATCGAGTCCGATGCCTGGCAAGAGAAGGACAAGGCCTATGTCCAGGCCCGGGTCCTGGAGAGCTACAGGTCG	28516.0	single nucleotide variant	NM_000219.6(KCNE1):c.226G>A (p.Asp76Asn)	3753.0	KCNE1	HGNC:6240	Conflicting classifications of pathogenicity	1.0	Feb 07, 2025	74315445.0	-	RCV000014420|RCV000014419|RCV000119080|RCV000148512|RCV000222568|RCV000243273|RCV000471399|RCV000606753|RCV000678806|RCV005054138	MONDO:MONDO:0013372,MedGen:C1867904,OMIM:613695,Orphanet:101016,Orphanet:768|MONDO:MONDO:0012871,MedGen:C2676723,OMIM:612347,Orphanet:768,Orphanet:90647|MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:101016,Orphanet:768|MONDO:MONDO:0024540,MedGen:C4551509,OMIM:220400,Orphanet:768,Orphanet:90647|MedGen:C3661900|MedGen:CN230736|MONDO:MONDO:0002442,MeSH:D008133,MedGen:C0023976|MONDO:MONDO:0002441,MedGen:C0022387,OMIM:PS220400,Orphanet:90647|MedGen:CN169374|MONDO:MONDO:0016587,MeSH:D019571,MedGen:C0349788,Orphanet:247	Long QT syndrome 5|Jervell and Lange-Nielsen syndrome 2|Congenital long QT syndrome|Jervell and Lange-Nielsen syndrome 1|not provided|Cardiovascular phenotype|Long QT syndrome|Jervell and Lange-Nielsen syndrome|not specified|Arrhythmogenic right ventricular cardiomyopathy	germline;not applicable;paternal;unknown	germline	GRCh38	NC_000021.9	21	34449409.0	34449409.0	21q22.12	criteria provided, conflicting classifications	22.0	-	N	ClinGen:CA256867,UniProtKB:P15382#VAR_008901,OMIM:176261.0003	3.0	13477.0	34449409.0	C	T	-	-	-	-	-	-	SCV000278993|SCV000319991|SCV000549148|SCV000692512|SCV000711385|SCV000711386|SCV000839962|SCV000987324|SCV001246782|SCV001474376|SCV002320700|SCV002503420|SCV004021977|SCV005045721|SCV005398184|SCV005688989	-	-	226G>A 	Asp76Asn	NM_000219.6	1.0	3_Conflicting	chr21	G	A	21-34449409-G-A		13477	21	34449409	C	T	D	N	rs74315445	21	35821707	21	34743577	76	KCNE1	ENSG00000180509	ENST00000432085	ENSP00000412498	P15382	KCNE1_HUMAN	c.226G>A	p.Asp76Asn	c.226G>A	p.Asp76Asn	principal1	Y	1	.	.	-	GAC	1	0	C	C/C	C/C	C/C	C/C	0.086	0.32753	T	0.0	0.92967	D	0.983	0.60394	D	0.793	0.57824	P	0.96	0.95575	A	simple_aae	4.0	96.0	2.43	0.70264	M	-2.73	0.58114	D	0.592	0.77985	0.8761	0.95340	D	0.8575	0.95245	D	10	0.78488266	0.77945	D	0.11448	0.79271	D	0.617	0.85019	.	.	.	.	.	0.959337311341	0.95855	.	0.84817	.	0.38659	0.630446374416	0.57143	T	0.903899	0.98116	D	-0.168853	0.25068	T	-0.25462	0.49030	T	0.488749325275421	0.31906	T	.	0.44467	.	0.20403557	0.42181	0.17988478	0.40614	0.17810585	0.38505	0.2204978	0.46654	-6.227	0.48201	T	.	0.67739	.	0.345845698440958	0.55870	0.99725720	0.98317	0.594	0.77258	.	.	.	.	.	.	3.942996	0.57793	23.9	0.9977085211426856	0.85930	0.573704	0.57528	D	0.480509518227283	0.65772	4.887785	0.415687807459517	0.62340	4.471294	5.16	5.16	0.70523	7.77	0.99973	5.044	0.64101	7.556000	0.60437	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.019	0.11385	899	0.25042	.	.	.	.	.	.	.	.	.	.	.	.	16	264690	6.044807E-5	.	7	109402	6.398420e-05	0	13	208036	6.248920e-05	0	17	236882	7.176570e-05	0	0	7164	0.000000e+00	0	1	17110	5.844540e-05	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	5	42766	1.169150e-04	0	1	15690	6.373490e-05	0	5	42766	1.169150e-04	0	0	16212	0.000000e+00	0	1	30522	3.276330e-05	0	0	6210	0.000000e+00	0	0	13414	0.000000e+00	0	0	16732	0.000000e+00	0	10	89474	1.117640e-04	0	2	30608	6.534240e-05	0	10	89474	1.117640e-04	0	0	14902	0.000000e+00	0	1	34258	2.919030e-05	0	0	9570	0.000000e+00	0	1	17692	5.652270e-05	0	0	21630	0.000000e+00	0	13	102684	1.266020e-04	0	2	30526	6.551790e-05	0	13	102684	1.266020e-04	0	.	195	1598798	1.219670e-04	3	183	1171850	1.561630e-04	3	2	71910	2.781250e-05	0	0	850	0.000000e+00	0	1	58696	1.703690e-05	0	0	29348	0.000000e+00	0	2	44302	4.514470e-05	0	0	63112	0.000000e+00	0	0	6080	0.000000e+00	0	183	1171850	1.561630e-04	3	4	90486	4.420570e-05	0	6	43032	1.3943112102621306E-4	0	298	0	0	120	0	1	7940	1.2594458438287153E-4	0	500	0	0	628	0	0	26	0	0	104	0	1	6566	1.5229972586049346E-4	1	8238	1.2138868657441127E-4	0	146	0	8	59214	1.3510318505758774E-4	Conflicting_classifications_of_pathogenicity	Jervell_and_Lange-Nielsen_syndrome|Sudden_unexplained_death|Arrhythmogenic_right_ventricular_cardiomyopathy|Brugada_syndrome|not_provided|not_specified|Cardiovascular_phenotype|Jervell_and_Lange-Nielsen_syndrome_1|Jervell_and_Lange-Nielsen_syndrome_2|Long_QT_syndrome_5|Congenital_long_QT_syndrome|Long_QT_syndrome	criteria_provided,_conflicting_classifications	NC_000021.9:g.34449409C>T	ClinGen:CA256867|OMIM:176261.0003|UniProtKB:P15382#VAR_008901	C0022387|C0520806|C0349788|C1142166|C3661900|CN169374|CN230736|C4551509|C2676723|C1867904|C1141890|C0023976	PS220400|PS601144|220400|612347|613695|PS192500	90647|247|130|768|90647|768|90647|101016|768|101016|768	.	Asp	Asn	28516	single nucleotide variant	NM_000219.6(KCNE1):c.226G>A (p.Asp76Asn)	3753	KCNE1	HGNC:6240	Conflicting classifications of pathogenicity	1	Feb 07, 2025	74315445	-	RCV000014420|RCV000014419|RCV000119080|RCV000148512|RCV000222568|RCV000243273|RCV000471399|RCV000606753|RCV000678806|RCV005054138	MONDO:MONDO:0013372,MedGen:C1867904,OMIM:613695,Orphanet:101016,Orphanet:768|MONDO:MONDO:0012871,MedGen:C2676723,OMIM:612347,Orphanet:768,Orphanet:90647|MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:101016,Orphanet:768|MONDO:MONDO:0024540,MedGen:C4551509,OMIM:220400,Orphanet:768,Orphanet:90647|MedGen:C3661900|MedGen:CN230736|MONDO:MONDO:0002442,MeSH:D008133,MedGen:C0023976|MONDO:MONDO:0002441,MedGen:C0022387,OMIM:PS220400,Orphanet:90647|MedGen:CN169374|MONDO:MONDO:0016587,MeSH:D019571,MedGen:C0349788,Orphanet:247	Long QT syndrome 5|Jervell and Lange-Nielsen syndrome 2|Congenital long QT syndrome|Jervell and Lange-Nielsen syndrome 1|not provided|Cardiovascular phenotype|Long QT syndrome|Jervell and Lange-Nielsen syndrome|not specified|Arrhythmogenic right ventricular cardiomyopathy	germline;not applicable;paternal;unknown	germline	GRCh38	NC_000021.9	21	34449409	34449409	21q22.12	criteria provided, conflicting classifications	22	-	N	ClinGen:CA256867,UniProtKB:P15382#VAR_008901,OMIM:176261.0003	3	13477	34449409	C	T	-	-	-	-	-	-	SCV000278993|SCV000319991|SCV000549148|SCV000692512|SCV000711385|SCV000711386|SCV000839962|SCV000987324|SCV001246782|SCV001474376|SCV002320700|SCV002503420|SCV004021977|SCV005045721|SCV005398184|SCV005688989	-	-	226G>A 	Asp76Asn	NM_000219.6	1	3_Conflicting	KCNE1	ENSG00000180509	2013	3299	CCSBVarC000219	ALE00000219	226G>A	Asp76Asn	RC4	RC4_Mut_GDEh1010	G07	GDEhDisVCh_40065	F09	1	RC4_Mut_GDDh1010	G07	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	6	0	NULL	0	NULL	0	NULL	KCNE1_Asp76Asn	21	21	34449409	C	T
359	CBS	297C>G	Phe99Leu	ENSG00000160200	21	43068528	NC_000021.9:43068528:G:C	ALE00007344	CCSBVarC007356	NULL	NULL	316	GDEhDisVCh_40013	A11	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTGGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	243635.0	single nucleotide variant	NM_000071.3(CBS):c.297C>G (p.Phe99Leu)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Apr 12, 2022	749697783.0	-	RCV001854831	MedGen:C3150344	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43068528.0	43068528.0	21q22.3	criteria provided, single submitter	1.0	-	N	ClinGen:CA10583890	2.0	236937.0	43068528.0	G	C	-	-	-	-	-	-	SCV002187744	-	-	297C>G 	Phe99Leu	NM_000071.3	1.0	4_VUS	chr21	C	G	21-43068528-C-G		236937	21	43068528	G	C	F	L	rs749697783	21	44488638	21	43361707	99	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.297C>G	p.Phe99Leu	c.297C>G	p.Phe99Leu	principal1	Y	1	.	.	-	TTC	3	2	G	G/G	G/G	G/G	G/G	0.749	0.05061	T	0.72	0.11906	T	0.003	0.11208	B	0.008	0.13705	B	.	.	.	.	.	.	0.415	0.12397	N	-2.3	0.58763	N	0.464	0.49905	0.2913	0.87367	D	0.7170	0.90260	D	10	0.0851098	0.14220	T	0.080929	0.73480	D	0.289	0.60609	0.302	0.26877	P35520	F99L	Loss of methylation at K98 (P = 0.0284)| Loss of MoRF binding (P = 0.108)| Loss of sheet (P = 0.1158)| Gain of helix (P = 0.2059)| Gain of disorder (P = 0.2435)	0.24896430686	0.24088	.	0.80220	.	0.41206	0.526581287384	0.42492	T	0.853951	0.96674	D	0.0655816	0.60027	T	-0.143573	0.59523	T	0.0437401171211615	0.04334	T	.	0.69743	.	0.23121893	0.45563	0.06500612	0.13113	0.16034997	0.35674	0.06515593	0.13164	-6.07	0.46919	T	.	0.73310	.	0.757299711721055	0.69075	0.98960620	0.96672	0.269	0.53957	.	.	.	.	.	.	-0.481534	0.01932	0.163	0.67914648154877733	0.08630	0.193789	0.31878	N	-1.45870563564793	0.02128	0.09457983	-1.48994240575851	0.02393	0.1115634	4.81	-8.93	0.00664	-4.18	0.05913	0.557	0.23241	-7.905000	0.01071	-0.206	0.0855	0.974	0.34718	0.000000	0.08389	0.325	0.25136	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_single_submitter	NC_000021.9:g.43068528G>C	ClinGen:CA10583890	C3150344	.	.	Tryptophan synthase beta chain-like, PALP domain	Phe	Leu	243635	single nucleotide variant	NM_000071.3(CBS):c.297C>G (p.Phe99Leu)	875	CBS	HGNC:1550	Uncertain significance	0	Apr 12, 2022	749697783	-	RCV001854831	MedGen:C3150344	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43068528	43068528	21q22.3	criteria provided, single submitter	1	-	N	ClinGen:CA10583890	2	236937	43068528	G	C	-	-	-	-	-	-	SCV002187744	-	-	297C>G 	Phe99Leu	NM_000071.3	1	4_VUS	CBS	ENSG00000160200	359	316	CCSBVarC007356	ALE00007344	297C>G	Phe99Leu	Edgotyping3	VUSMutGDEh011	G05	GDEhDisVCh_40013	A11	1	VUSMutGDDh011	G05	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	7	0	NULL	0	NULL	0	NULL	CBS_Phe99Leu	21	21	43068528	G	C
359	CBS	152G>A	Arg51Lys	ENSG00000160200	21	43072042	NC_000021.9:43072042:C:T	ALE00007350	CCSBVarC007362	NULL	NULL	322	GDEhDisVCh_40013	G11	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAAGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	410881.0	single nucleotide variant	NM_000071.3(CBS):c.152G>A (p.Arg51Lys)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Jan 22, 2024	370983323.0	-	RCV000486724|RCV001301346|RCV002231109|RCV002402397	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection	germline	germline	GRCh38	NC_000021.9	21	43072042.0	43072042.0	21q22.3	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA16621017	2.0	420469.0	43072042.0	C	T	-	-	-	-	-	-	SCV000569322|SCV001490512|SCV002708256	-	-	152G>A 	Arg51Lys	NM_000071.3	2.0	4_VUS	chr21	G	A	21-43072042-G-A		420469	21	43072042	C	T	R	K	rs370983323	21	44492152	21	43365221	51	CBS	ENSG00000160200	ENST00000352178	ENSP00000344460	P35520	CBS_HUMAN	c.152G>A	p.Arg51Lys	c.152G>A	p.Arg51Lys	principal1	Y	1	.	.	-	AGG	2	0	C	C/C	C/C	C/C	C/C	1.0	0.02839	T	0.941	0.05306	T	0.0	0.02950	B	0.001	0.04348	B	.	.	.	.	.	.	1.45	0.36554	L	0.13	0.10415	N	0.168	0.19070	0.4574	0.89902	D	0.8696	0.95655	D	10	0.16363475	0.30281	T	0.363413	0.92552	D	0.439	0.74168	.	.	.	.	.	0.635742182071	0.62992	.	0.62020	.	0.36667	0.443847805262	0.31064	T	0.330938	0.69931	T	-0.0915067	0.37472	T	-0.132551	0.60480	T	0.0548586006465259	0.06268	T	0.761924	0.39699	T	0.5942376	0.72093	0.14003626	0.33299	0.65070057	0.75133	0.21021551	0.45233	-3.977	0.23479	T	0.0749	0.12187	B	0.640323422892779	0.65075	0.99515283	0.97713	0.206	0.46915	.	.	.	.	.	.	2.271654	0.29089	17.99	0.92001999086264408	0.21588	0.382329	0.46244	N	-0.345414555647983	0.27162	1.505572	-0.149370924595094	0.33122	1.912362	5.64	3.59	0.40184	3.16	0.57388	1.708	0.37623	0.975000	0.23168	0.524	0.24207	0.97	0.34375	0.748000	0.26611	0.915	0.45059	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109388	0.000000e+00	0	2	207242	9.650550e-06	0	1	236380	4.230480e-06	0	0	7160	0.000000e+00	0	0	17108	0.000000e+00	0	0	2318	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	0	42764	0.000000e+00	0	0	15686	0.000000e+00	0	.	.	.	.	2	16190	1.235330e-04	0	0	30510	0.000000e+00	0	0	6188	0.000000e+00	0	0	13412	0.000000e+00	0	0	16732	0.000000e+00	0	0	88754	0.000000e+00	0	0	30602	0.000000e+00	0	2	16190	1.235330e-04	0	1	14892	6.715010e-05	0	0	34250	0.000000e+00	0	0	9558	0.000000e+00	0	0	17692	0.000000e+00	0	0	21630	0.000000e+00	0	0	102222	0.000000e+00	0	0	30520	0.000000e+00	0	1	14892	6.715010e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	10090	0	0	184	0	0	0	0	1	4654	2.1486892995272884E-4	0	0	0	0	0	0	0	0	0	0	0	0	0	1434	0	1	4838	2.0669698222405952E-4	0	0	0	1	16362	6.111722283339445E-5	Uncertain_significance	not_provided|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Classic_homocystinuria|Familial_thoracic_aortic_aneurysm_and_aortic_dissection	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43072042C>T	ClinGen:CA16621017	C3661900|C3150344|C0751202|C4707243	236200|PS607086	394|91387	.	Arg	Lys	410881	single nucleotide variant	NM_000071.3(CBS):c.152G>A (p.Arg51Lys)	875	CBS	HGNC:1550	Uncertain significance	0	Jan 22, 2024	370983323	-	RCV000486724|RCV001301346|RCV002231109|RCV002402397	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection	germline	germline	GRCh38	NC_000021.9	21	43072042	43072042	21q22.3	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA16621017	2	420469	43072042	C	T	-	-	-	-	-	-	SCV000569322|SCV001490512|SCV002708256	-	-	152G>A 	Arg51Lys	NM_000071.3	2	4_VUS	CBS	ENSG00000160200	359	322	CCSBVarC007362	ALE00007350	152G>A	Arg51Lys	Edgotyping3	VUSMutGDEh011	E06	GDEhDisVCh_40013	G11	1	VUSMutGDDh011	E06	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	CBS_Arg51Lys	21	21	43072042	C	T
71569	OTC	527A>G	Tyr176Cys	ENSG00000036473	X	38401415	NC_000023.11:38401415:A:G	ALE00005250	CCSBVarC005250	NULL	205885	NULL	GDEhDisVCh_40048	B04	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTGCCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103127.0	single nucleotide variant	NM_000531.6(OTC):c.527A>G (p.Tyr176Cys)	5009.0	OTC	HGNC:8512	Pathogenic	1.0	-	72556283.0	-	RCV000083475	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38401415.0	38401415.0	Xp11.4	no assertion criteria provided	1.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224665,UniProtKB:P00480#VAR_004889	2.0	97235.0	38401415.0	A	G	-	-	-	-	-	-	SCV000115561	-	-	527A>G 	Tyr176Cys	NM_000531.6		1_Pathogenic	chrX	A	G	X-38401415-A-G		97235	X	38401415	A	G	Y	C	rs72556283	X	38260668	X	38145612	176	OTC	ENSG00000036473	ENST00000039007	ENSP00000039007	P00480	OTC_HUMAN	c.527A>G	p.Tyr176Cys	c.527A>G	p.Tyr176Cys	principal1	Y	1	YES	Select	+	TAC	2	0	A	A/A	A/A	A/A	A/A	0.002	0.72322	D	0.007	0.69466	D	1.0	0.90580	D	0.99	0.78943	D	0.91	0.92786	A	simple_aae	9.0	91.0	1.115	0.28553	L	-2.94	0.61467	D	0.907	0.90815	1.0872	0.99129	D	0.9493	0.98345	D	10	0.98749304	0.99110	D	0.802006	0.98448	D	0.888	0.96755	0.866	0.96082	P00480	Y176C	Gain of catalytic residue at T178 (P = 0.1089)| Loss of stability (P = 0.1324)| Loss of disorder (P = 0.2445)| Loss of phosphorylation at T178 (P = 0.5661)| Loss of helix (P = 0.7926)	0.999777502907	0.99977	0.9279169522893973	0.92724	1.30902103664	0.83090	0.797196507454	0.81504	T	0.923622	0.98636	D	0.623011	0.98947	D	0.657136	0.98928	D	0.979928433895111	0.72898	D	0.994201	0.98093	D	0.93461376	0.94620	0.8531266	0.91604	0.93461376	0.94620	0.8531266	0.91604	-7.665	0.58836	D	0.3592	0.57124	A	0.999120672544137	0.95759	0.99840040	0.98766	0.944	0.97378	.	.	.	.	.	.	4.617707	0.73351	26.0	0.99816498079774008	0.89981	.	.	.	.	.	.	.	.	.	5.97	5.97	0.96929	5.17	0.91630	5.311	0.65651	7.948000	0.75811	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.995	0.73271	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided	no_assertion_criteria_provided	NC_000023.11:g.38401415A>G	ClinGen:CA224665|UniProtKB:P00480#VAR_004889	CN517202	.	.	Aspartate/ornithine carbamoyltransferase, carbamoyl-P binding	Tyr	Cys	103127	single nucleotide variant	NM_000531.6(OTC):c.527A>G (p.Tyr176Cys)	5009	OTC	HGNC:8512	Pathogenic	1	-	72556283	-	RCV000083475	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38401415	38401415	Xp11.4	no assertion criteria provided	1	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224665,UniProtKB:P00480#VAR_004889	2	97235	38401415	A	G	-	-	-	-	-	-	SCV000115561	-	-	527A>G 	Tyr176Cys	NM_000531.6		1_Pathogenic	OTC	ENSG00000036473	71569	205885	CCSBVarC005250	ALE00005250	527A>G	Tyr176Cys	CEGS2	CegsMutGDEh1018	C04	GDEhDisVCh_40048	B04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Tyr176Cys	23	X	38401415	A	G
52861	F9	1189G>C	Ala397Pro	ENSG00000101981	X	139561874	NC_000023.11:139561874:G:C	ALE00004392	CCSBVarC004392	NULL	204368	NULL	GDEhDisVCh_40052	E07	CEGS2	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTCCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT	25701.0	single nucleotide variant	NM_000133.4(F9):c.1189G>C (p.Ala397Pro)	2158.0	F9	HGNC:3551	Pathogenic	1.0	May 01, 1998	137852281.0	-	RCV000011407	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561874.0	139561874.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255454,UniProtKB:P00740#VAR_017317,OMIM:300746.0104	1.0	10662.0	139561874.0	G	C	-	-	-	-	-	-	SCV000031639	-	-	1189G>C 	Ala397Pro	NM_000133.4		1_Pathogenic	chrX	G	C	X-139561874-G-C		10662	X	139561874	G	C	A	P	rs137852281	X	138644033	X	138471699	397	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1189G>C	p.Ala397Pro	c.1189G>C	p.Ala397Pro	principal1	Y	1	YES	Select	+	GCT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.115	0.97347	H	-4.97	0.82092	D	0.878	0.96202	1.1025	0.99756	D	0.9557	0.98562	D	10	0.99310195	0.99843	D	0.941142	0.99582	D	0.974	0.99740	0.957	0.99533	P00740	A397P	Gain of disorder (P = 0.0911)| Loss of sheet (P = 0.1398)| Loss of stability (P = 0.1608)| Loss of catalytic residue at N393 (P = 0.4493)| Loss of MoRF binding (P = 0.452)	0.999646589023	0.99963	0.9999893549903599	0.99998	1.86989205249	0.92474	0.694044589996	0.66230	T	0.972943	0.99717	D	0.702117	0.99930	D	0.770766	0.99930	D	0.999667882919312	0.98376	D	0.941906	0.78261	D	0.9954094	0.99970	0.992814	0.99993	0.9955629	0.99973	0.9920948	0.99990	-16.845	0.98777	D	0.9929	0.94596	P	0.999994138420688	0.99831	0.99999404	0.99996	1	0.99985	.	.	.	.	.	.	5.096493	0.85159	28.5	0.99810165860495959	0.89450	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	7.987	0.87843	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.998	0.85369	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561874G>C	ClinGen:CA255454|OMIM:300746.0104|UniProtKB:P00740#VAR_017317	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ala	Pro	25701	single nucleotide variant	NM_000133.4(F9):c.1189G>C (p.Ala397Pro)	2158	F9	HGNC:3551	Pathogenic	1	May 01, 1998	137852281	-	RCV000011407	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561874	139561874	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255454,UniProtKB:P00740#VAR_017317,OMIM:300746.0104	1	10662	139561874	G	C	-	-	-	-	-	-	SCV000031639	-	-	1189G>C 	Ala397Pro	NM_000133.4		1_Pathogenic	F9	ENSG00000101981	52861	204368	CCSBVarC004392	ALE00004392	1189G>C	Ala397Pro	CEGS2	CegsMutGDEh1028	E12	GDEhDisVCh_40052	E07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	F9_Ala397Pro	23	X	139561874	G	C
359	CBS	1411G>A	Gly471Arg	ENSG00000160200	21	43058201	NC_000021.9:43058201:C:T	ALE00007295	CCSBVarC007297	NULL	NULL	237	GDEhDisVCh_40013	E03	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCAGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210398.0	single nucleotide variant	NM_000071.3(CBS):c.1411G>A (p.Gly471Arg)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Jan 30, 2024	201098477.0	-	RCV000200328|RCV000764258|RCV002229031|RCV003987441	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|MedGen:CN169374	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not specified	germline;unknown	germline	GRCh38	NC_000021.9	21	43058201.0	43058201.0	21q22.3	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA324881	2.0	212882.0	43058201.0	C	T	-	-	-	-	-	-	SCV000249733|SCV000895266|SCV001509202|SCV004803978	-	-	1411G>A 	Gly471Arg	NM_000071.3	2.0	4_VUS	chr21	G	A	21-43058201-G-A		212882	21	43058201	C	T	G	R	rs201098477	21	44478311	21	43351380	471	CBS	ENSG00000160200	ENST00000352178	ENSP00000344460	P35520	CBS_HUMAN	c.1411G>A	p.Gly471Arg	c.1411G>A	p.Gly471Arg	principal1	Y	1	.	.	-	GGG	1	0	C	C/C	C/C	C/C	C/C	0.104	0.30095	T	0.118	0.36569	T	0.752	0.43324	P	0.288	0.40614	B	.	.	.	.	.	.	2.455	0.71058	M	-3.95	0.73512	D	0.823	0.81898	-0.0404	0.81325	T	0.4436	0.77985	T	10	0.75996065	0.76040	D	0.287194	0.90415	D	0.782	0.92721	0.453	0.51473	P35520	G471R	Gain of solvent accessibility (P = 0.0097)| Loss of ubiquitination at K472 (P = 0.0298)| Gain of MoRF binding (P = 0.0318)| Loss of catalytic residue at A470 (P = 0.0593)| Gain of methylation at K472 (P = 0.0823)	0.908031585211	0.90641	.	0.81407	.	0.48207	0.659110307693	0.61219	T	0.896849	0.97926	D	0.254496	0.78864	D	0.449756	0.93520	D	0.322335690259933	0.25624	T	0.951905	0.81519	D	0.60360354	0.72600	0.34103167	0.59614	0.5952178	0.72148	0.32057285	0.57785	-8.296	0.63143	D	0.1675	0.36944	B	0.96949923454721	0.83191	0.99804110	0.98607	0.921	0.95990	.	.	.	.	.	.	4.782691	0.77583	26.7	0.99898160539472747	0.97050	0.959670	0.98003	D	0.456793497802858	0.64403	4.716945	0.469187283012348	0.65773	4.890054	4.62	4.62	0.56895	2.62	0.47948	7.501	0.80483	7.352000	0.58366	0.465	0.21751	1.0	0.71675	1.000000	0.68239	0.762	0.36254	988	0.02004	2	3.9936102236421724E-4	1	7.564296520423601E-4	0	0.0	1	0.001440922190201729	0	0.0	0	0.0	.	.	.	.	8	109402	7.312480e-05	0	22	208054	1.057420e-04	0	22	236914	9.286070e-05	0	1	7162	1.396260e-04	0	6	17112	3.506310e-04	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13394	0.000000e+00	0	1	42766	2.338310e-05	0	0	15690	0.000000e+00	0	6	17112	3.506310e-04	0	6	16202	3.703250e-04	0	14	30524	4.586550e-04	0	0	6208	0.000000e+00	0	0	13412	0.000000e+00	0	0	16732	0.000000e+00	0	1	89506	1.117240e-05	0	1	30608	3.267120e-05	0	14	30524	4.586550e-04	0	6	14892	4.029010e-04	0	14	34260	4.086400e-04	0	0	9570	0.000000e+00	0	0	17690	0.000000e+00	0	0	21628	0.000000e+00	0	1	102728	9.734440e-06	0	1	30526	3.275900e-05	0	14	34260	4.086400e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	77478	3.872066909316193E-5	0	2	0	0	1824	0	0	180	0	0	6	0	0	22	0	0	1192	0	0	6	0	1	7904	1.2651821862348178E-4	0	182	0	0	3016	0	4	88614	4.513959419504819E-5	Uncertain_significance	not_provided|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|not_specified|Classic_homocystinuria	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43058201C>T	ClinGen:CA324881	C3661900|C3150344|CN169374|C0751202	236200	394	CBS domain|Cystathionine beta-synthase, C-terminal domain	Gly	Arg	210398	single nucleotide variant	NM_000071.3(CBS):c.1411G>A (p.Gly471Arg)	875	CBS	HGNC:1550	Uncertain significance	0	Jan 30, 2024	201098477	-	RCV000200328|RCV000764258|RCV002229031|RCV003987441	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|MedGen:CN169374	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not specified	germline;unknown	germline	GRCh38	NC_000021.9	21	43058201	43058201	21q22.3	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA324881	2	212882	43058201	C	T	-	-	-	-	-	-	SCV000249733|SCV000895266|SCV001509202|SCV004803978	-	-	1411G>A 	Gly471Arg	NM_000071.3	2	4_VUS	CBS	ENSG00000160200	359	237	CCSBVarC007297	ALE00007295	1411G>A	Gly471Arg	Edgotyping3	VUSMutGDEh010	A10	GDEhDisVCh_40013	E03	1	VUSMutGDDh010	A10	NULL	NULL	NULL	NULL	NULL	NULL	1	3	1	6	0	NULL	0	NULL	0	NULL	CBS_Gly471Arg	21	21	43058201	C	T
7201	RAD51D	494G>A	Arg165Gln	ENSG00000185379	17	35106468	NC_000017.11:35106468:C:T	ALE00002917	CCSBVarC002917	900197	NULL	NULL	GDEhDisVCh_40046	E03	RC4	ATGGGCGTGCTCAGGGTCGGACTGTGCCCTGGCCTTACCGAGGAGATGATCCAGCTTCTCAGGAGCCACAGGATCAAGACAGTGGTGGACCTGGTTTCTGCAGACCTGGAAGAGGTAGCTCAGAAATGTGGCTTGTCTTACAAGGCCCTGGTTGCCCTGAGGCGGGTGCTGCTGGCTCAGTTCTCGGCTTTCCCCGTGAATGGCGCTGATCTCTACGAGGAACTGAAGACCTCCACTGCCATCCTGTCCACTGGCATTGGCAGTCTTGATAAACTGCTTGATGCTGGTCTCTATACTGGAGAAGTGACTGAAATTGTAGGAGGCCCAGGTAGCGGCAAAACTCAGGTATGTCTCTGTATGGCAGCAAATGTGGCCCATGGCCTGCAGCAAAACGTCCTATATGTAGATTCCAATGGAGGGCTGACAGCTTCCCGCCTCCTCCAGCTGCTTCAGGCTAAAACCCAGGATGAGGAGGAACAGGCAGAAGCTCTCCAGAGGATCCAGGTGGTGCATGCATTTGACATCTTCCAGATGCTGGATGTGCTGCAGGAGCTCCGAGGCACTGTGGCCCAGCAGGTGACTGGTTCTTCAGGAACTGTGAAGGTGGTGGTTGTGGACTCGGTCACTGCGGTGGTTTCCCCACTTCTGGGAGGTCAGCAGAGGGAAGGCTTGGCCTTGATGATGCAGCTGGCCCGAGAGCTGAAGACCCTGGCCCGGGACCTTGGCATGGCAGTGGTGGTGACCAACCACATAACTCGAGACAGGGACAGCGGGAGGCTCAAACCTGCCCTCGGACGCTCCTGGAGCTTTGTGCCCAGCACTCGGATTCTCCTGGACACCATCGAGGGAGCAGGAGCATCAGGCGGCCGGCGCATGGCGTGTCTGGCCAAATCTTCCCGACAGCCAACAGGTTTCCAGGAGATGGTAGACATTGGGACCTGGGGGACCTCAGAGCAGAGTGCCACATTACAGGGTGATCAGACA	151873.0	single nucleotide variant	NM_002878.4(RAD51D):c.494G>A (p.Arg165Gln)	5892.0	RAD51D	HGNC:9823	Benign	0.0	Feb 04, 2025	4796033.0	-	RCV000131069|RCV000245575|RCV000409134|RCV001705932	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	35106468.0	35106468.0	17q12	criteria provided, multiple submitters, no conflicts	12.0	-	N	ClinGen:CA167606,UniProtKB:O75771#VAR_020561	2.0	142159.0	35106468.0	C	T	-	-	-	-	-	-	SCV000185999|SCV000292088|SCV000309255|SCV000488799|SCV000884439|SCV001440195|SCV001717669|SCV001841070|SCV004044159|SCV005253873	-	-	494G>A 	Arg165Gln	NM_002878.4	2.0	2_Benign	chr17	G	A	17-35106468-G-A		142159	17	35106468	C	T	R	Q	rs4796033	17	33433487	17	30457600	165	RAD51D	ENSG00000185379	ENST00000394589	ENSP00000378090	O75771	RA51D_HUMAN	c.494G>A	p.Arg165Gln	c.494G>A	p.Arg165Gln	principal1	Y	5	.	.	-	CGG	2	0	C	C/C	C/C	C/C	C/C	0.003	0.68399	D	1.0	0.01173	T	0.0	0.14667	B	0.001	0.04348	B	0.01	0.13669	P	simple_aae	99.0	1.0	-1.43	0.00575	N	-3.12	0.63808	D	0.019	0.15800	-1.0318	0.19845	T	0.0001	0.00038	T	9	0.0022848845	0.00033	T	.	.	.	0.127	0.34681	.	.	.	.	.	.	.	.	0.04975	.	0.41278	.	.	.	0.074496	0.34695	T	-0.647874	0.00072	T	-0.559582	0.16122	T	0.00742585393685776	0.00085	T	0.740726	0.35767	T	0.029415702	0.02411	0.048267353	0.07149	0.029415702	0.02411	0.048267353	0.07148	3.206	0.12431	T	0.057	0.00818	B	2.61638337411342e-05	0.01340	0.02316738	0.51051	0.078	0.22017	.	.	.	.	.	.	1.452401	0.18765	13.9	0.91470505594779028	0.20995	0.077101	0.15335	N	-1.06674822980265	0.07176	0.3368571	-0.830017416971714	0.13532	0.7160679	4.96	0.253	0.14768	1.12	0.30289	1.179	0.31705	0.032000	0.13801	-0.169	0.1135	1.0	0.71675	0.963000	0.29478	0.96	0.51684	917	0.20141	476	0.0950479233226837	18	0.01361573373676248	130	0.12922465208747516	153	0.22046109510086456	41	0.040674603174603176	134	0.13701431492842536	31713	264690	0.119811855	.	17045	107270	1.588980e-01	1699	31945	204674	1.560770e-01	3152	36543	232850	1.569380e-01	3557	180	6652	2.705950e-02	1	5012	16850	2.974480e-01	784	395	2196	1.798720e-01	42	413	9024	4.576680e-02	8	2281	13332	1.710920e-01	204	6003	41956	1.430780e-01	432	2481	15384	1.612710e-01	210	5012	16850	2.974480e-01	784	458	15532	2.948750e-02	12	9035	30024	3.009260e-01	1451	1134	6024	1.882470e-01	111	564	13384	4.213990e-02	6	2827	16654	1.697490e-01	255	12341	88222	1.398860e-01	860	4896	30022	1.630800e-01	411	9035	30024	3.009260e-01	1451	409	14258	2.868570e-02	9	9971	33746	2.954720e-01	1567	1778	9368	1.897950e-01	174	815	17666	4.613380e-02	15	3630	21494	1.688840e-01	330	14237	100834	1.411920e-01	990	4879	29942	1.629480e-01	407	9971	33746	2.954720e-01	1567	.	223574	1611192	1.387630e-01	17336	15964	59646	2.676460e-01	2333	2280	74974	3.041050e-02	55	100	912	1.096490e-01	6	15964	59646	2.676460e-01	2333	5762	29446	1.956800e-01	582	1940	44876	4.323020e-02	36	10732	63890	1.679760e-01	897	779	6052	1.287180e-01	57	162928	1178350	1.382680e-01	11455	14721	90614	1.624580e-01	1305	47230	333254	0.14172373024779897	6	594	0.010101010101010102	215	5014	0.04287993617869964	636	15964	0.03983963918817339	182	1488	0.12231182795698925	1955	7246	0.2698040298095501	99	1968	0.05030487804878049	864	5226	0.1653272101033295	3257	24004	0.13568571904682553	642	16558	0.03877279864717961	314	6982	0.04497278716700086	54444	394758	0.1379174076269512	Benign	not_specified|not_provided|Breast-ovarian_cancer,_familial,_susceptibility_to,_4|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.35106468C>T	ClinGen:CA167606|UniProtKB:O75771#VAR_020561	CN169374|C3661900|C3280345|C0027672	614291	145|140162	DNA recombination and repair protein Rad51-like, C-terminal|DNA recombination and repair protein RecA-like, ATP-binding domain|AAA+ ATPase domain|DNA repair protein RAD51 homolog 4, C-terminal	Arg	Gln	151873	single nucleotide variant	NM_002878.4(RAD51D):c.494G>A (p.Arg165Gln)	5892	RAD51D	HGNC:9823	Benign	0	Feb 04, 2025	4796033	-	RCV000131069|RCV000245575|RCV000409134|RCV001705932	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0013669,MedGen:C3280345,OMIM:614291,Orphanet:145|MedGen:C3661900	Hereditary cancer-predisposing syndrome|not specified|Breast-ovarian cancer, familial, susceptibility to, 4|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	35106468	35106468	17q12	criteria provided, multiple submitters, no conflicts	12	-	N	ClinGen:CA167606,UniProtKB:O75771#VAR_020561	2	142159	35106468	C	T	-	-	-	-	-	-	SCV000185999|SCV000292088|SCV000309255|SCV000488799|SCV000884439|SCV001440195|SCV001717669|SCV001841070|SCV004044159|SCV005253873	-	-	494G>A 	Arg165Gln	NM_002878.4	2	2_Benign	RAD51D	ENSG00000185379	7201	900197	CCSBVarC002917	ALE00002917	494G>A	Arg165Gln	RC4	NatVar_GDE_001	F05	GDEhDisVCh_40046	E03	2	NULL	NULL	NULL	NULL	VUSMutpDEST2_06	G01	VUSmut_GDEh12	E02	1	1	0	NULL	0	NULL	1	1	1	1	RAD51D_Arg165Gln	17	17	35106468	C	T
3774	TP53	580C>T	Leu194Phe	ENSG00000141510	17	7674951	NC_000017.11:7674951:G:A	ALE00004863	CCSBVarC004863	NULL	214892	NULL	GDEhDisVCh_40053	H04	CEGS2	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATTTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACCGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	133274.0	single nucleotide variant	NM_000546.6(TP53):c.580C>T (p.Leu194Phe)	7157.0	TP53	HGNC:11998	Pathogenic/Likely pathogenic	1.0	Jun 10, 2024	587780071.0	-	RCV000115728|RCV001377420|RCV005229909|RCV002288599|RCV002288598|RCV003997297	MedGen:C3661900|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|Human Phenotype Ontology:HP:0002889,Human Phenotype Ontology:HP:0006744,Human Phenotype Ontology:HP:0006759,MONDO:MONDO:0006639,MeSH:D018268,MedGen:C0206686,Orphanet:1501	not provided|Li-Fraumeni syndrome|Neoplasm|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Adrenal cortex carcinoma	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7674951.0	7674951.0	17p13.1	criteria provided, multiple submitters, no conflicts	7.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000278,UniProtKB:P04637#VAR_044997	2.0	127817.0	7674951.0	G	A	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV000149637|SCV001574751|SCV002582374|SCV002583035|SCV002648064|SCV004933219	-	SCV005871951	580C>T 	Leu194Phe	NM_000546.6	2.0	1_Pathogenic	chr17	C	T	17-7674951-C-T		127817	17	7674951	G	A	L	F	rs587780071	17	7578269	17	7518994	194	TP53	ENSG00000141510	ENST00000445888	ENSP00000391478	P04637	P53_HUMAN	c.580C>T	p.Leu194Phe	c.580C>T	p.Leu194Phe	principal1	Y	1	.	.	-	CTT	1	0	G	G/G	G/G	G/G	G/G	0.026	0.78662	D	0.062	0.92967	T	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	2.29	0.65064	M	-3.83	0.72277	D	0.737	0.78366	0.9677	0.96655	D	0.9905	0.99746	D	10	0.9803592	0.97984	D	0.69384	0.97479	D	0.851	0.95384	0.907	0.98057	P04637	L194F	Loss of disorder (P = 0.1456)| Gain of catalytic residue at L194 (P = 0.1534)| Loss of sheet (P = 0.302)| Gain of methylation at R196 (P = 0.3661)| Gain of loop (P = 0.4248)	0.995132339244	0.99501	.	0.54980	.	0.90672	0.692809700966	0.66053	T	0.979528	0.99826	D	0.554285	0.95835	D	0.558416	0.95771	D	0.992747008800507	0.83173	D	.	0.99559	.	0.85721934	0.87710	0.70703596	0.82524	0.8658772	0.88382	0.71490955	0.82977	-11.047	0.79980	D	0.9428	0.88913	P	0.999484378102776	0.96737	0.99997140	0.99978	0.968	0.98734	.	.	.	.	.	.	4.671192	0.7471	26.2	0.99810758939654542	0.89450	0.942440	0.94685	D	0.411006102035688	0.61828	4.412079	0.301591630174668	0.55397	3.726212	5.41	4.44	0.53107	3.98	0.75857	8.135	0.8953	9.924000	0.82556	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.99	0.65338	433	0.80635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Pancreatic_adenocarcinoma|Neoplasm_of_the_large_intestine|Glioblastoma|Li-Fraumeni_syndrome|Lung_adenocarcinoma|Hereditary_cancer-predisposing_syndrome|Hepatocellular_carcinoma|Transitional_cell_carcinoma_of_the_bladder|Li-Fraumeni_syndrome_1|Breast_neoplasm|Neoplasm_of_brain|Squamous_cell_carcinoma_of_the_head_and_neck|Neoplasm_of_uterine_cervix|Ovarian_serous_cystadenocarcinoma|Adrenal_cortex_carcinoma|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.7674951G>A	ClinGen:CA000278|UniProtKB:P04637#VAR_044997	C0281361|C0009404|C0017636|C0085390|C0152013|C0027672|C2239176|C0279680|C1835398|C1458155|C0006118|C1168401|C0007873|C0279663|C0206686|C3661900	PS151623|114550|151623|275355	360|524|140162|88673|524|67037|1501	p53, DNA-binding domain|p53, DNA-binding domain	Leu	Phe	133274	single nucleotide variant	NM_000546.6(TP53):c.580C>T (p.Leu194Phe)	7157	TP53	HGNC:11998	Pathogenic/Likely pathogenic	1	Jun 10, 2024	587780071	-	RCV000115728|RCV001377420|RCV005229909|RCV002288599|RCV002288598|RCV003997297	MedGen:C3661900|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|Human Phenotype Ontology:HP:0002889,Human Phenotype Ontology:HP:0006744,Human Phenotype Ontology:HP:0006759,MONDO:MONDO:0006639,MeSH:D018268,MedGen:C0206686,Orphanet:1501	not provided|Li-Fraumeni syndrome|Neoplasm|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Adrenal cortex carcinoma	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7674951	7674951	17p13.1	criteria provided, multiple submitters, no conflicts	7	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000278,UniProtKB:P04637#VAR_044997	2	127817	7674951	G	A	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV000149637|SCV001574751|SCV002582374|SCV002583035|SCV002648064|SCV004933219	-	SCV005871951	580C>T 	Leu194Phe	NM_000546.6	2	1_Pathogenic	TP53	ENSG00000141510	3774	214892	CCSBVarC004863	ALE00004863	580C>T	Leu194Phe	CEGS2	CegsMutGDEh1017	F10	GDEhDisVCh_40053	H04	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	2	0	NULL	0	NULL	0	NULL	0	NULL	TP53_Leu194Phe	17	17	7674951	G	A
359	CBS	1357G>T	Gly453Trp	ENSG00000160200	21	43058835	NC_000021.9:43058835:C:A	ALE00007297	CCSBVarC007300	NULL	NULL	240	GDEhDisVCh_40013	H03	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGTGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	350756.0	single nucleotide variant	NM_000071.3(CBS):c.1357G>T (p.Gly453Trp)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Jan 13, 2018	886057099.0	-	RCV000339973	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394	Classic homocystinuria	germline	germline	GRCh38	NC_000021.9	21	43058835.0	43058835.0	21q22.3	criteria provided, single submitter	1.0	-	N	ClinGen:CA10653005	2.0	340081.0	43058835.0	C	A	-	-	-	-	-	-	SCV000436206	-	-	1357G>T 	Gly453Trp	NM_000071.3	1.0	4_VUS	chr21	G	T	21-43058835-G-T		340081	21	43058835	C	A	G	W	rs886057099	21	44478945	21	43352014	453	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.1357G>T	p.Gly453Trp	c.1357G>T	p.Gly453Trp	principal1	Y	1	.	.	-	GGG	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	.	.	.	.	.	.	4.195	0.97755	H	-7.02	0.93800	D	0.91	0.91737	1.1053	0.99818	D	0.9561	0.98576	D	10	0.99315095	0.99848	D	0.869361	0.98998	D	0.879	0.96419	0.807	0.92401	P35520	G453W	Gain of catalytic residue at G453 (P = 0.0449)| Loss of relative solvent accessibility (P = 0.1807)| Loss of sheet (P = 0.302)| Loss of solvent accessibility (P = 0.3744)| Loss of disorder (P = 0.465)	0.905880144628	0.90422	.	0.86006	.	0.80944	0.657553434372	0.60998	T	0.972912	0.99716	D	0.498443	0.94200	D	0.478202	0.94123	D	0.996704638004303	0.89820	D	.	0.88469	.	0.9497255	0.96179	0.8616703	0.92190	0.952253	0.96440	0.85249203	0.91562	-13.242	0.90355	D	0.7775	0.76208	LP	0.998962305675079	0.95408	0.99959440	0.99514	0.995	0.99826	.	.	.	.	.	.	5.760369	0.93435	33.0	0.99279429271973985	0.57898	0.984125	0.99938	D	0.676149714239039	0.77952	6.798032	0.538801369403346	0.70463	5.532339	4.71	4.71	0.58959	2.6	0.47613	7.501	0.80483	7.354000	0.58376	0.52	0.23855	1.0	0.71675	1.000000	0.68239	0.048	0.15055	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	Classic_homocystinuria	criteria_provided,_single_submitter	NC_000021.9:g.43058835C>A	ClinGen:CA10653005	C0751202	236200	394	CBS domain|CBS domain|CBS domain|Cystathionine beta-synthase, C-terminal domain	Gly	Trp	350756	single nucleotide variant	NM_000071.3(CBS):c.1357G>T (p.Gly453Trp)	875	CBS	HGNC:1550	Uncertain significance	0	Jan 13, 2018	886057099	-	RCV000339973	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394	Classic homocystinuria	germline	germline	GRCh38	NC_000021.9	21	43058835	43058835	21q22.3	criteria provided, single submitter	1	-	N	ClinGen:CA10653005	2	340081	43058835	C	A	-	-	-	-	-	-	SCV000436206	-	-	1357G>T 	Gly453Trp	NM_000071.3	1	4_VUS	CBS	ENSG00000160200	359	240	CCSBVarC007300	ALE00007297	1357G>T	Gly453Trp	Edgotyping3	VUSMutGDEh010	D10	GDEhDisVCh_40013	H03	1	VUSMutGDDh010	D10	NULL	NULL	NULL	NULL	NULL	NULL	1	6	1	6	0	NULL	0	NULL	0	NULL	CBS_Gly453Trp	21	21	43058835	C	A
3774	TP53	31G>C	Glu11Gln	ENSG00000141510	17	7676564	NC_000017.11:7676564:C:G	ALE00004855	CCSBVarC004855	NULL	214881	NULL	GDEhDisVCh_40053	G01	CEGS2	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCCAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACCGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	50162.0	single nucleotide variant	NM_000546.6(TP53):c.31G>C (p.Glu11Gln)	7157.0	TP53	HGNC:11998	Conflicting classifications of pathogenicity	0.0	Mar 04, 2025	201382018.0	-	RCV000034640|RCV000161016|RCV000226569|RCV000213044|RCV001030742|RCV001124310|RCV003924896	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not specified|Hereditary breast ovarian cancer syndrome|Li-Fraumeni syndrome 1|TP53-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	7676564.0	7676564.0	17p13.1	criteria provided, conflicting classifications	15.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000106,UniProtKB:P04637#VAR_044548	2.0	41723.0	7676564.0	C	G	-	-	-	-	-	-	SCV000211732|SCV000214035|SCV000285187|SCV000731481|SCV000839129|SCV000910740|SCV000918326|SCV001134866|SCV001193758|SCV001283247|SCV002530447|SCV002760893	-	-	31G>C 	Glu11Gln	NM_000546.6	1.0	3_Conflicting	chr17	G	C	17-7676564-G-C		41723	17	7676564	C	G	E	Q	rs201382018	17	7579882	17	7520607	11	TP53	ENSG00000141510	ENST00000714359	ENSP00000519626	P04637	P53_HUMAN	.	.	c.31G>C	p.Glu11Gln	principal1	Y	.	.	.	-	GAG	1	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.57446	.	0.996	0.70687	D	0.945	0.68158	D	.	0.97016	.	.	.	.	1.935	0.51654	L	.	0.26154	.	.	0.34534	1.0976	0.99560	D	0.9844	0.99526	D	10	.	0.33862	.	0.287028	0.90410	D	.	0.74871	.	.	.	.	.	.	0.90156	.	0.18759	.	0.88832	.	.	.	0.60812	0.87424	D	-0.0299991	0.47084	T	0.0890459	0.76004	D	0.217615061703596	0.21083	T	0.938806	0.78557	D	0.11914139	0.27812	0.058817867	0.10943	0.19036691	0.40305	0.06425448	0.12852	-3.809	0.20957	T	.	0.57067	.	0.0734175826341819	0.40546	0.99949825	0.99436	0.115	0.31465	.	.	.	.	.	.	3.013873	0.4039	21.1	0.99632737617969958	0.76169	0.373386	0.45684	N	0.367782113020294	0.59476	4.149939	0.244016136794018	0.52061	3.406673	5.36	5.36	0.76590	5.0	0.89963	2.056	0.41085	4.780000	0.44907	0.596	0.33565	0.26	0.25034	1.000000	0.68239	0.32	0.25019	434	0.80544	1	1.9968051118210862E-4	0	0.0	0	0.0	0	0.0	1	9.92063492063492E-4	0	0.0	12	264690	4.533605E-5	.	4	109278	3.660390e-05	0	13	207490	6.265360e-05	0	13	236698	5.492230e-05	0	0	7134	0.000000e+00	0	0	17088	0.000000e+00	0	0	2320	0.000000e+00	0	4	9042	4.423800e-04	0	0	13394	0.000000e+00	0	0	42756	0.000000e+00	0	0	15640	0.000000e+00	0	4	9042	4.423800e-04	0	0	16076	0.000000e+00	0	0	30468	0.000000e+00	0	0	6182	0.000000e+00	0	13	13380	9.715990e-04	0	0	16734	0.000000e+00	0	0	89274	0.000000e+00	0	0	30550	0.000000e+00	0	13	13380	9.715990e-04	0	0	14868	0.000000e+00	0	0	34228	0.000000e+00	0	0	9568	0.000000e+00	0	13	17688	7.349620e-04	0	0	21624	0.000000e+00	0	0	102648	0.000000e+00	0	0	30470	0.000000e+00	0	13	17688	7.349620e-04	0	.	189	1613940	1.171050e-04	1	187	44872	4.167410e-03	1	0	74974	0.000000e+00	0	0	912	0.000000e+00	0	0	59974	0.000000e+00	0	0	29608	0.000000e+00	0	187	44872	4.167410e-03	1	0	63962	0.000000e+00	0	0	6060	0.000000e+00	0	1	1180002	8.474560e-07	0	0	91072	0.000000e+00	0	0	19780	0	0	298	0	0	84	0	0	7438	0	0	146	0	0	610	0	0	26	0	0	98	0	0	1930	0	0	7736	0	0	110	0	0	30410	0	Conflicting_classifications_of_pathogenicity	Hereditary_breast_ovarian_cancer_syndrome|not_provided|TP53-related_disorder|Li-Fraumeni_syndrome_1|Li-Fraumeni_syndrome|Hereditary_cancer-predisposing_syndrome|not_specified	criteria_provided,_conflicting_classifications	NC_000017.11:g.7676564C>G	ClinGen:CA000106|UniProtKB:P04637#VAR_044548	C0677776|C3661900|C1835398|C0085390|C0027672|CN169374	151623|PS151623	145|524|524|140162	p53 transactivation domain	Glu	Gln	50162	single nucleotide variant	NM_000546.6(TP53):c.31G>C (p.Glu11Gln)	7157	TP53	HGNC:11998	Conflicting classifications of pathogenicity	0	Mar 04, 2025	201382018	-	RCV000034640|RCV000161016|RCV000226569|RCV000213044|RCV001030742|RCV001124310|RCV003924896	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|	not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not specified|Hereditary breast ovarian cancer syndrome|Li-Fraumeni syndrome 1|TP53-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	7676564	7676564	17p13.1	criteria provided, conflicting classifications	15	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000106,UniProtKB:P04637#VAR_044548	2	41723	7676564	C	G	-	-	-	-	-	-	SCV000211732|SCV000214035|SCV000285187|SCV000731481|SCV000839129|SCV000910740|SCV000918326|SCV001134866|SCV001193758|SCV001283247|SCV002530447|SCV002760893	-	-	31G>C 	Glu11Gln	NM_000546.6	1	3_Conflicting	TP53	ENSG00000141510	3774	214881	CCSBVarC004855	ALE00004855	31G>C	Glu11Gln	CEGS2	CegsMutGDEh1009	B11	GDEhDisVCh_40053	G01	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	TP53_Glu11Gln	17	17	7676564	C	G
359	CBS	636C>G	Asn212Lys	ENSG00000160200	21	43065417	NC_000021.9:43065417:G:C	ALE00007322	CCSBVarC007330	NULL	NULL	283	GDEhDisVCh_40013	G07	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAAGGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210433.0	single nucleotide variant	NM_000071.3(CBS):c.636C>G (p.Asn212Lys)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Mar 15, 2014	2298758.0	-	RCV000196277|RCV001276190	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394	not provided|Classic homocystinuria	germline	germline	GRCh38	NC_000021.9	21	43065417.0	43065417.0	21q22.3	criteria provided, single submitter	2.0	-	N	ClinGen:CA320697	2.0	212850.0	43065417.0	G	C	-	-	-	-	-	-	SCV000249688	-	-	636C>G 	Asn212Lys	NM_000071.3	1.0	4_VUS	chr21	C	G	21-43065417-C-G		212850	21	43065417	G	C	N	K	rs2298758	21	44485527	21	43358596	212	CBS	ENSG00000160200	ENST00000398165	ENSP00000381231	P35520	CBS_HUMAN	c.636C>G	p.Asn212Lys	c.636C>G	p.Asn212Lys	principal1	Y	1	YES	Select	-	AAC	3	2	G	G/G	G/G	G/G	G/G	1.0	0.00968	T	1.0	0.01173	T	0.001	0.07480	B	0.008	0.13705	B	0.67	0.80805	D	simple_aae	33.0	67.0	-1.715	0.00344	N	0.78	0.01906	N	0.606	0.62248	-0.5137	0.68009	T	0.4252	0.76801	T	10	0.051193625	0.04962	T	0.230769	0.88216	D	0.355	0.67429	0.376	0.38849	P35520	N212K	Gain of ubiquitination at N212 (P = 0.0289)| Gain of MoRF binding (P = 0.0629)| Gain of sheet (P = 0.1945)| Gain of solvent accessibility (P = 0.2097)| Gain of disorder (P = 0.2505)	0.208816687407	0.20106	0.7589659280645777	0.75711	0.402848295305	0.40947	0.660536170006	0.61424	T	0.649695	0.89248	D	-0.285185	0.09895	T	-0.24718	0.49768	T	0.00972983116328769	0.00126	T	.	0.67978	.	0.18100852	0.38941	0.12582956	0.30236	0.16249669	0.36033	0.12973598	0.31105	-8.893	0.67083	D	.	0.24464	.	0.830015270146103	0.72125	0.96999060	0.94655	0.222	0.48897	.	.	.	.	.	.	-1.097379	0.00644	0.017	0.74004852470105631	0.10706	0.447976	0.50169	N	-1.57092649840618	0.01403	0.06174852	-1.47241814863597	0.02538	0.118565	4.65	-6.61	0.01655	-5.33	0.03991	-0.783	0.04751	-5.403000	0.01742	-0.172	0.11105	0.024	0.20069	0.000000	0.08389	0.929	0.46613	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	16	109326	1.463510e-04	0	29	207654	1.396550e-04	0	29	235952	1.229060e-04	0	0	7146	0.000000e+00	0	0	17088	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13388	0.000000e+00	0	0	42766	0.000000e+00	0	16	15662	1.021580e-03	0	16	15662	1.021580e-03	0	0	16110	0.000000e+00	0	0	30482	0.000000e+00	0	0	6194	0.000000e+00	0	0	13394	0.000000e+00	0	0	16728	0.000000e+00	0	0	89314	0.000000e+00	0	29	30580	9.483320e-04	0	29	30580	9.483320e-04	0	0	14884	0.000000e+00	0	0	34214	0.000000e+00	0	0	9534	0.000000e+00	0	0	17686	0.000000e+00	0	0	21626	0.000000e+00	0	0	101906	0.000000e+00	0	29	30496	9.509440e-04	0	29	30496	9.509440e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	not_provided|Classic_homocystinuria	criteria_provided,_single_submitter	NC_000021.9:g.43065417G>C	ClinGen:CA320697	CN517202|C0751202	236200	394	Tryptophan synthase beta chain-like, PALP domain	Asn	Lys	210433	single nucleotide variant	NM_000071.3(CBS):c.636C>G (p.Asn212Lys)	875	CBS	HGNC:1550	Uncertain significance	0	Mar 15, 2014	2298758	-	RCV000196277|RCV001276190	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394	not provided|Classic homocystinuria	germline	germline	GRCh38	NC_000021.9	21	43065417	43065417	21q22.3	criteria provided, single submitter	2	-	N	ClinGen:CA320697	2	212850	43065417	G	C	-	-	-	-	-	-	SCV000249688	-	-	636C>G 	Asn212Lys	NM_000071.3	1	4_VUS	CBS	ENSG00000160200	359	283	CCSBVarC007330	ALE00007322	636C>G	Asn212Lys	Edgotyping3	VUSMutGDEh011	E02	GDEhDisVCh_40013	G07	1	VUSMutGDDh011	E02	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	CBS_Asn212Lys	21	21	43065417	G	C
3015	CRX	472G>A	Ala158Thr	ENSG00000105392	19	47839539	NC_000019.10:47839539:G:A	ALE00000383	CCSBVarC000383	5262	NULL	NULL	GDEhDisVCh_40040	F12	RC4	ATGATGGCGTATATGAACCCGGGGCCCCACTATTCTGTCAACGCCTTGGCCCTAAGTGGCCCCAGTGTGGATCTGATGCACCAGGCTGTGCCCTACCCAAGCGCCCCCAGGAAGCAGCGGCGGGAGCGCACCACCTTCACCCGGAGCCAACTGGAGGAGCTGGAGGCACTGTTTGCCAAGACCCAGTACCCAGACGTCTATGCCCGTGAGGAGGTGGCTCTGAAGATCAATCTGCCTGAGTCCAGGGTTCAGGTTTGGTTCAAGAACCGGAGGGCTAAATGCAGGCAGCAGCGACAGCAGCAGAAACAGCAGCAGCAGCCCCCAGGGGGCCAGGCCAAGGCCCGGCCTGCCAAGAGGAAGGCGGGCACGTCCCCAAGACCCTCCACAGATGTGTGTCCAGACCCTCTGGGCATCTCAGATTCCTACAGTCCCCCTCTGCCCGGCCCCTCAGGCTCCCCAACCACGGCAGTGACCACTGTGTCCATCTGGAGCCCAGCCTCAGAGTCCCCTTTGCCTGAGGCGCAGCGGGCTGGGCTGGTGGCCTCAGGGCCGTCTCTGACCTCCGCCCCCTATGCCATGACCTACGCCCCGGCCTCCGCTTTCTGCTCTTCCCCCTCCGCCTATGGGTCTCCGAGCTCCTATTTCAGCGGCCTAGACCCCTACCTTTCTCCCATGGTGCCCCAGCTAGGGGGCCCGGCTCTTAGCCCCCTCTCTGGCCCCTCCGTGGGACCTTCCCTGGCCCAGTCCCCCACCTCCCTATCAGGCCAGAGCTATGGCGCCTACAGCCCCGTGGATAGCTTGGAATTCAAGGACCCCACGGGCACCTGGAAATTCACCTACAATCCCATGGACCCTCTGGACTACAAGGATCAGAGTGCCTGGAAGTTTCAGATCTTG	105497.0	single nucleotide variant	NM_000554.6(CRX):c.472G>A (p.Ala158Thr)	1406.0	CRX	HGNC:2383	Benign/Likely benign	0.0	Feb 03, 2025	61748445.0	-	RCV000086004|RCV000347317|RCV000178122|RCV001081848|RCV000308806|RCV000390414|RCV002498461|RCV004815141	MedGen:C3661900|MONDO:MONDO:0007362,MedGen:C3489532,OMIM:120970,Orphanet:1872|MedGen:CN169374|MONDO:MONDO:0013449,MedGen:C3151192,OMIM:613829,Orphanet:65;MONDO:MONDO:0007362,MedGen:C3489532,OMIM:120970,Orphanet:1872|Human Phenotype Ontology:HP:0000547,MONDO:MONDO:0019200,MeSH:D012174,MedGen:C0035334,OMIM:268000,OMIM:PS268000,Orphanet:791|MONDO:MONDO:0013449,MedGen:C3151192,OMIM:613829,Orphanet:65|Human Phenotype Ontology:HP:0000547,MONDO:MONDO:0019200,MeSH:D012174,MedGen:C0035334,OMIM:268000,OMIM:PS268000,Orphanet:791;MONDO:MONDO:0013449,MedGen:C3151192,OMIM:613829,Orphanet:65;MONDO:MONDO:0007362,MedGen:C3489532,OMIM:120970,Orphanet:1872|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862	not provided|Cone-rod dystrophy 2|not specified|Leber congenital amaurosis 7;Cone-rod dystrophy 2|Retinitis pigmentosa|Leber congenital amaurosis 7|Retinitis pigmentosa;Leber congenital amaurosis 7;Cone-rod dystrophy 2|Retinal dystrophy	germline;unknown	germline	GRCh38	NC_000019.10	19	47839539.0	47839539.0	19q13.33	criteria provided, multiple submitters, no conflicts	10.0	-	N	ClinGen:CA202718,UniProtKB:O43186#VAR_007948	2.0	99608.0	47839539.0	G	A	-	-	-	-	-	-	SCV000230126|SCV000305361|SCV000413937|SCV000413938|SCV000413939|SCV000658612|SCV001157153|SCV001864790|SCV002811245|SCV005072105|SCV005209741	-	-	472G>A 	Ala158Thr	NM_000554.6	2.0	2_Benign	chr19	G	A	19-47839539-G-A	0.00275998	99608	19	47839539	G	A	A	T	rs61748445	19	48342796	19	53034608	158	CRX	ENSG00000105392	ENST00000221996	ENSP00000221996	O43186	CRX_HUMAN	c.472G>A	p.Ala158Thr	c.472G>A	p.Ala158Thr	principal1	Y	2	YES	Select	+	GCC	1	0	G	G/G	G/G	G/G	G/G	0.176	0.22427	T	0.212	0.26847	T	0.012	0.16277	B	0.006	0.12129	B	0.12	0.31989	P	simple_aae	88.0	12.0	2.19	0.61389	M	-0.69	0.19656	N	0.398	0.43650	-0.8983	0.47965	T	0.0596	0.24776	T	10	0.0023398101	0.00034	T	.	.	.	0.271	0.58427	.	.	.	.	.	0.715798992675	0.71104	0.5489886510977043	0.54635	0.267385964474	0.28986	0.852294623852	0.89943	D	0.173048	0.51935	T	-0.454527	0.00992	T	-0.356255	0.38131	T	0.0111390766440302	0.00162	T	0.880112	0.59606	D	0.057536457	0.11358	0.09141216	0.21458	0.06834481	0.14744	0.091776036	0.21562	-2.227	0.04177	T	0.0997	0.17126	B	0.0779564569562759	0.41081	0.83723915	0.89290	0.054	0.14486	.	.	.	.	.	.	3.37603	0.46753	22.3	0.99757427715145808	0.84785	0.154223	0.27706	N	-0.496108153650052	0.21949	1.184184	-0.479849161891275	0.22396	1.234823	3.07	2.01	0.25499	2.38	0.44324	4.24	0.58583	9.425000	0.80803	0.604	0.46135	1.0	0.71675	1.000000	0.68239	0.936	0.47515	912	0.21478	125	0.02496006389776358	118	0.08925869894099848	1	9.940357852882703E-4	6	0.008645533141210375	0	0.0	0	0.0	7417	264690	0.028021459	.	757	109084	6.939610e-03	28	1668	206700	8.069670e-03	68	1581	235212	6.721600e-03	60	641	7158	8.955020e-02	28	95	17062	5.567930e-03	0	5	2292	2.181500e-03	0	0	9042	0.000000e+00	0	1	13318	7.508630e-05	0	7	42650	1.641270e-04	0	2	15660	1.277140e-04	0	641	7158	8.955020e-02	28	1435	15952	8.995740e-02	68	166	30444	5.452630e-03	0	11	6138	1.792110e-03	0	0	13406	0.000000e+00	0	1	16650	6.006010e-05	0	29	88742	3.267900e-04	0	5	30546	1.636880e-04	0	1435	15952	8.995740e-02	68	1317	14652	8.988530e-02	60	183	34150	5.358710e-03	0	23	9436	2.437470e-03	0	0	17684	0.000000e+00	0	1	21522	4.646410e-05	0	28	101728	2.752440e-04	0	5	30464	1.641280e-04	0	1317	14652	8.988530e-02	60	.	7669	1613370	4.753400e-03	295	6412	74962	8.553670e-02	284	6412	74962	8.553670e-02	284	0	912	0.000000e+00	0	445	59958	7.421860e-03	2	82	29538	2.776090e-03	0	0	44864	0.000000e+00	0	3	63932	4.692490e-05	0	32	6054	5.285760e-03	0	293	1179654	2.483780e-04	0	15	91034	1.647740e-04	0	28	48940	5.721291377196567E-4	30	306	0.09803921568627451	0	112	0	629	8080	0.07784653465346535	11	500	0.022	4	628	0.006369426751592357	0	56	0	0	98	0	57	8726	0.006532202612881045	659	8386	0.07858335320772716	0	168	0	759	67446	0.01125344720220621	Benign/Likely_benign	Leber_congenital_amaurosis_7|Retinitis_pigmentosa|Cone-rod_dystrophy_2|not_specified|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000019.10:g.47839539G>A	ClinGen:CA202718|UniProtKB:O43186#VAR_007948	C3151192|C0035334|C3489532|CN169374|C3661900	613829|268000|PS268000|120970	65|791|1872	.	Ala	Thr	105497	single nucleotide variant	NM_000554.6(CRX):c.472G>A (p.Ala158Thr)	1406	CRX	HGNC:2383	Benign/Likely benign	0	Feb 03, 2025	61748445	-	RCV000086004|RCV000347317|RCV000178122|RCV001081848|RCV000308806|RCV000390414|RCV002498461|RCV004815141	MedGen:C3661900|MONDO:MONDO:0007362,MedGen:C3489532,OMIM:120970,Orphanet:1872|MedGen:CN169374|MONDO:MONDO:0013449,MedGen:C3151192,OMIM:613829,Orphanet:65;MONDO:MONDO:0007362,MedGen:C3489532,OMIM:120970,Orphanet:1872|Human Phenotype Ontology:HP:0000547,MONDO:MONDO:0019200,MeSH:D012174,MedGen:C0035334,OMIM:268000,OMIM:PS268000,Orphanet:791|MONDO:MONDO:0013449,MedGen:C3151192,OMIM:613829,Orphanet:65|Human Phenotype Ontology:HP:0000547,MONDO:MONDO:0019200,MeSH:D012174,MedGen:C0035334,OMIM:268000,OMIM:PS268000,Orphanet:791;MONDO:MONDO:0013449,MedGen:C3151192,OMIM:613829,Orphanet:65;MONDO:MONDO:0007362,MedGen:C3489532,OMIM:120970,Orphanet:1872|Human Phenotype Ontology:HP:0000556,Human Phenotype Ontology:HP:0007736,Human Phenotype Ontology:HP:0007910,Human Phenotype Ontology:HP:0007974,Human Phenotype Ontology:HP:0007982,MONDO:MONDO:0019118,MeSH:D058499,MedGen:C0854723,Orphanet:71862	not provided|Cone-rod dystrophy 2|not specified|Leber congenital amaurosis 7;Cone-rod dystrophy 2|Retinitis pigmentosa|Leber congenital amaurosis 7|Retinitis pigmentosa;Leber congenital amaurosis 7;Cone-rod dystrophy 2|Retinal dystrophy	germline;unknown	germline	GRCh38	NC_000019.10	19	47839539	47839539	19q13.33	criteria provided, multiple submitters, no conflicts	10	-	N	ClinGen:CA202718,UniProtKB:O43186#VAR_007948	2	99608	47839539	G	A	-	-	-	-	-	-	SCV000230126|SCV000305361|SCV000413937|SCV000413938|SCV000413939|SCV000658612|SCV001157153|SCV001864790|SCV002811245|SCV005072105|SCV005209741	-	-	472G>A 	Ala158Thr	NM_000554.6	2	2_Benign	CRX	ENSG00000105392	3015	5262	CCSBVarC000383	ALE00000383	472G>A	Ala158Thr	RC4	RC4_Mut_GDEh1031	B09	GDEhDisVCh_40040	F12	2	RC4_Mut_GDDh1031	B09	NULL	NULL	NULL	NULL	NULL	NULL	1	5	1	99	0	NULL	0	NULL	0	NULL	CRX_Ala158Thr	19	19	47839539	G	A
359	CBS	531G>C	Lys177Asn	ENSG00000160200	21	43065616	NC_000021.9:43065616:C:G	ALE00007326	CCSBVarC007335	NULL	NULL	290	GDEhDisVCh_40013	D08	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAACGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	410880.0	single nucleotide variant	NM_000071.3(CBS):c.531G>C (p.Lys177Asn)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	May 20, 2016	1064795022.0	-	RCV000478922	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000021.9	21	43065616.0	43065616.0	21q22.3	criteria provided, single submitter	1.0	-	N	ClinGen:CA16621016	2.0	421268.0	43065616.0	C	G	-	-	-	-	-	-	SCV000570413	-	-	531G>C 	Lys177Asn	NM_000071.3	1.0	4_VUS	chr21	G	C	21-43065616-G-C		421268	21	43065616	C	G	K	N	rs1064795022	21	44485726	21	43358795	177	CBS	ENSG00000160200	ENST00000352178	ENSP00000344460	P35520	CBS_HUMAN	c.531G>C	p.Lys177Asn	c.531G>C	p.Lys177Asn	principal1	Y	1	.	.	-	AAG	3	2	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.026	0.83643	D	1.0	0.90580	D	1.0	0.97365	D	.	.	.	.	.	.	2.285	0.64989	M	-4.99	0.82250	D	0.706	0.70917	0.9668	0.96641	D	0.9434	0.98142	D	9	0.9638083	0.96106	D	0.744172	0.97950	D	0.732	0.90595	0.841	0.94634	P35520	K177N	Loss of ubiquitination at K177 (P = 0.0255)| Loss of disorder (P = 0.1074)| Loss of phosphorylation at S174 (P = 0.1317)| Loss of methylation at K172 (P = 0.1769)| Loss of MoRF binding (P = 0.2151)	0.890807817065	0.88889	.	0.92891	.	0.80944	0.720446705818	0.70060	T	0.986427	0.99919	D	0.209317	0.74576	D	0.0628927	0.74246	D	0.994522452354431	0.85750	D	0.989401	0.99091	D	0.9860204	0.99524	0.90555406	0.95308	0.98897153	0.99704	0.9062855	0.95362	-12.697	0.88104	D	0.9935	0.95230	P	0.99964039288364	0.97310	0.99965322	0.99571	0.91	0.95324	.	.	.	.	.	.	7.388834	0.96472	36.0	0.99505461484046676	0.68363	0.832187	0.74969	D	0.214005375103768	0.51638	3.365733	0.0566482896241267	0.42108	2.563452	4.8	2.01	0.25499	.	.	3.225	0.51043	5.620000	0.49157	-0.265	0.06842	1.0	0.71675	1.000000	0.68239	0.028	0.12877	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	not_provided	criteria_provided,_single_submitter	NC_000021.9:g.43065616C>G	ClinGen:CA16621016	CN517202	.	.	Tryptophan synthase beta chain-like, PALP domain	Lys	Asn	410880	single nucleotide variant	NM_000071.3(CBS):c.531G>C (p.Lys177Asn)	875	CBS	HGNC:1550	Uncertain significance	0	May 20, 2016	1064795022	-	RCV000478922	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000021.9	21	43065616	43065616	21q22.3	criteria provided, single submitter	1	-	N	ClinGen:CA16621016	2	421268	43065616	C	G	-	-	-	-	-	-	SCV000570413	-	-	531G>C 	Lys177Asn	NM_000071.3	1	4_VUS	CBS	ENSG00000160200	359	290	CCSBVarC007335	ALE00007326	531G>C	Lys177Asn	Edgotyping3	VUSMutGDEh011	B03	GDEhDisVCh_40013	D08	1	VUSMutGDDh011	B03	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	5	0	NULL	0	NULL	0	NULL	CBS_Lys177Asn	21	21	43065616	C	G
2803	HMBS	748G>A	Glu250Lys	ENSG00000256269	11	119092500	NC_000011.10:119092500:G:A	ALE00005174	CCSBVarC005174	NULL	200945	NULL	GDEhDisVCh_40054	H06	CEGS2	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAGCTTGCTCGCATACAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGGACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCTTGAACATGCCCTGGAGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCGAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTCGGGGAAACCTCAACACCCGGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACCGGGTGGGGCAGATCCTGCACCCTGAGGAATGCATGTATGCTGTGGGCCAGGGGGCCTTGGGCGTGGAAGTGCGAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCTGCATCGCTAAAAGGGCCTTCCTGAGGCACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATGGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCGTAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACGATGCCCAT	16510.0	single nucleotide variant	NM_000190.4(HMBS):c.748G>A (p.Glu250Lys)	3145.0	HMBS	HGNC:4982	Pathogenic	1.0	Jan 01, 1994	118204112.0	-	RCV000001536	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276	Acute intermittent porphyria	germline	germline	GRCh38	NC_000011.10	11	119092500.0	119092500.0	11q23.3	no assertion criteria provided	1.0	-	N	ClinGen:CA251830,UniProtKB:P08397#VAR_003666,OMIM:609806.0031	1.0	1471.0	119092500.0	G	A	-	-	-	-	-	-	SCV000021691	-	-	748G>A 	Glu250Lys	NM_000190.4		1_Pathogenic	chr11	G	A	11-119092500-G-A		1471	11	119092500	G	A	E	K	rs118204112	11	118963210	11	118468420	250	HMBS	ENSG00000256269	ENST00000652429	ENSP00000498786	P08397	HEM3_HUMAN	c.748G>A	p.Glu250Lys	c.748G>A	p.Glu250Lys	principal2	Y	.	YES	Select	+	GAA	1	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.83643	.	0.992	0.64752	D	0.914	0.64978	D	.	0.97926	.	.	.	.	4.825	0.99678	H	.	0.69751	.	.	0.99617	0.9146	0.95868	D	0.9975	0.99938	D	9	.	0.99558	.	0.738524	0.97899	D	.	0.99491	0.987	0.99867	P08397	E250K	Gain of ubiquitination at E250 (P = 0.0428)| Gain of MoRF binding (P = 0.0511)| Loss of stability (P = 0.133)| Gain of catalytic residue at E250 (P = 0.1966)| Gain of methylation at R255 (P = 0.391)	.	0.98017	0.989704692009024	0.98962	.	.	0.765738248825	0.76745	T	0.992676	0.99976	D	0.587906	0.97317	D	0.60671	0.97274	D	0.998330771923065	0.93808	D	0.999644	0.99872	D	0.9871062	0.99593	0.9669672	0.99316	0.98515564	0.99468	0.9623646	0.99083	-12.947	0.90370	D	0.9963	0.96212	P	0.999883168686179	0.98571	0.39991770	0.79586	0.997	0.99892	.	.	.	.	.	.	6.168285	0.9472	34.0	0.99931779663292331	0.99388	0.964492	0.98659	D	1.08555498492097	0.97845	16.9058	0.995398746587554	0.98528	18.56252	5.24	5.24	0.72825	.	.	9.732	0.98033	11.804000	0.96740	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.992	0.67791	228	0.91137	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Acute_intermittent_porphyria	no_assertion_criteria_provided	NC_000011.10:g.119092500G>A	ClinGen:CA251830|OMIM:609806.0031|UniProtKB:P08397#VAR_003666	C0162565	176000	79276	Porphobilinogen deaminase, C-terminal|Porphobilinogen deaminase, dipyrromethane cofactor binding site	Glu	Lys	16510	single nucleotide variant	NM_000190.4(HMBS):c.748G>A (p.Glu250Lys)	3145	HMBS	HGNC:4982	Pathogenic	1	Jan 01, 1994	118204112	-	RCV000001536	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276	Acute intermittent porphyria	germline	germline	GRCh38	NC_000011.10	11	119092500	119092500	11q23.3	no assertion criteria provided	1	-	N	ClinGen:CA251830,UniProtKB:P08397#VAR_003666,OMIM:609806.0031	1	1471	119092500	G	A	-	-	-	-	-	-	SCV000021691	-	-	748G>A 	Glu250Lys	NM_000190.4		1_Pathogenic	HMBS	ENSG00000256269	2803	200945	CCSBVarC005174	ALE00005174	748G>A	Glu250Lys	CEGS2	CegsMutGDEh1041	D10	GDEhDisVCh_40054	H06	2	CegsMutGDDh1041	D10	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	HMBS_Glu250Lys	11	11	119092500	G	A
359	CBS	1436T>C	Val479Ala	ENSG00000160200	21	43058176	NC_000021.9:43058176:A:G	ALE00007294	CCSBVarC007296	NULL	NULL	236	GDEhDisVCh_40013	D03	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGCTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	259084.0	single nucleotide variant	NM_000071.3(CBS):c.1436T>C (p.Val479Ala)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Jan 22, 2014	886038933.0	-	RCV000253951|RCV001273207	MedGen:CN230736|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394	Cardiovascular phenotype|Classic homocystinuria	germline	germline	GRCh38	NC_000021.9	21	43058176.0	43058176.0	21q22.3	criteria provided, single submitter	2.0	-	N	ClinGen:CA10587935	2.0	263813.0	43058176.0	A	G	-	-	-	-	-	-	SCV000319229	-	-	1436T>C 	Val479Ala	NM_000071.3	1.0	4_VUS	chr21	T	C	21-43058176-T-C		263813	21	43058176	A	G	V	A	rs886038933	21	44478286	21	43351355	479	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.1436T>C	p.Val479Ala	c.1436T>C	p.Val479Ala	principal1	Y	1	.	.	-	GTT	2	0	A	A/A	A/A	A/A	A/A	0.178	0.22252	T	0.165	0.31245	T	0.132	0.27225	B	0.088	0.29689	B	.	.	.	.	.	.	2.555	0.74371	M	-3.15	0.64159	D	0.867	0.86916	0.9572	0.96492	D	0.9070	0.96910	D	10	0.97253376	0.96865	D	0.596999	0.96433	D	0.762	0.91891	0.768	0.89476	P35520	V479A	Loss of stability (P = 0.0025)| Gain of disorder (P = 0.0512)| Gain of catalytic residue at V479 (P = 0.0632)| Loss of helix (P = 0.1299)| Loss of MoRF binding (P = 0.1334)	0.811776346281	0.80851	.	0.88189	.	0.52109	0.581616938114	0.50246	T	0.821643	0.95611	D	0.244599	0.77931	D	0.295101	0.87883	D	0.751558244228363	0.43077	D	.	0.67186	.	0.42494887	0.62098	0.18078725	0.40762	0.3451656	0.56358	0.18407674	0.41295	-8.316	0.63278	D	.	0.47099	.	0.973621495597351	0.83943	0.99770230	0.98474	0.79	0.88380	.	.	.	.	.	.	3.714606	0.53133	23.3	0.99310042039055468	0.59041	0.945516	0.95375	D	0.0600087987662144	0.44347	2.731413	0.0712756008415878	0.42829	2.619744	4.62	4.62	0.56895	.	.	8.838	0.91764	8.895000	0.78393	0.582	0.30226	1.0	0.71675	1.000000	0.68239	0.348	0.25663	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109404	9.140430e-06	0	1	208054	4.806440e-06	0	1	236926	4.220730e-06	0	1	7162	1.396260e-04	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	1	7162	1.396260e-04	0	1	16202	6.172080e-05	0	0	30524	0.000000e+00	0	0	6208	0.000000e+00	0	0	13414	0.000000e+00	0	0	16732	0.000000e+00	0	0	89506	0.000000e+00	0	0	30606	0.000000e+00	0	1	16202	6.172080e-05	0	1	14892	6.715010e-05	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21628	0.000000e+00	0	0	102738	0.000000e+00	0	0	30524	0.000000e+00	0	1	14892	6.715010e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	Cardiovascular_phenotype|Classic_homocystinuria	criteria_provided,_single_submitter	NC_000021.9:g.43058176A>G	ClinGen:CA10587935	CN230736|C0751202	236200	394	Cystathionine beta-synthase, C-terminal domain	Val	Ala	259084	single nucleotide variant	NM_000071.3(CBS):c.1436T>C (p.Val479Ala)	875	CBS	HGNC:1550	Uncertain significance	0	Jan 22, 2014	886038933	-	RCV000253951|RCV001273207	MedGen:CN230736|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394	Cardiovascular phenotype|Classic homocystinuria	germline	germline	GRCh38	NC_000021.9	21	43058176	43058176	21q22.3	criteria provided, single submitter	2	-	N	ClinGen:CA10587935	2	263813	43058176	A	G	-	-	-	-	-	-	SCV000319229	-	-	1436T>C 	Val479Ala	NM_000071.3	1	4_VUS	CBS	ENSG00000160200	359	236	CCSBVarC007296	ALE00007294	1436T>C	Val479Ala	Edgotyping3	VUSMutGDEh010	H09	GDEhDisVCh_40013	D03	1	VUSMutGDDh010	H09	NULL	NULL	NULL	NULL	NULL	NULL	1	3	1	5	0	NULL	0	NULL	0	NULL	CBS_Val479Ala	21	21	43058176	A	G
14613	BRCA1	32T>C	Val11Ala	ENSG00000012048	17	43124065	NC_000017.11:43124065:A:G	ALE00002121	CCSBVarC002121	23562	NULL	NULL	GDEhDisVCh_40059	H11	RC4	ATGGATTTATCTGCTCTTCGCGTTGAAGAAGCACAAAATGTCATTAATGCTATGCAGAAAATCTTAGAGTGTCCCATCTGTCTGGAGTTGATCAAGGAACCTGTCTCCACAAAGTGTGACCACATATTTTGCAAATTTTGCATGCTGAAACTTCTCAACCAGAAGAAAGGGCCTTCACAGTGTCCTTTATGTAAGAATGATATAACCAAAAGGAGCCTACAAGAAAGTACGAGATTTAGTCAACTTGTTGAAGAGCTATTGAAAATCATTTGTGCTTTTCAGCTTGACACAGGTTTGGAGTATGCAAACAGCTATAATTTTGCAAAAAAGGAAAATAACTCTCCTGAACATCTAAAAGATGAAGTTTCTATCATCCAAAGTATGGGCTACAGAAACCGTGCCAAAAGACTTCTACAGAGTGAACCCGAAAATCCTTCCTTGCAGGAAACCAGTCTCAGTGTCCAACTCTCTAACCTTGGAACTGTGAGAACTCTGAGGACAAAGCAGCGGATACAACCTCAAAAGACGTCTGTCTACATTGAATTGGGATCTGATTCTTCTGAAGATACCGTTAATAAGGCAACTTATTGCAGTGTGGGAGATCAAGAATTGTTACAAATCACCCCTCAAGGAACCAGGGATGAAATCAGTTTGGATTCTGCAAAAAAGGCTGCTTGTGAATTTTCTGAGACGGATGTAACAAATACTGAACATCATCAACCCAGTAATAATGATTTGAACACCACTGAGAAGCGTGCAGCTGAGAGGCATCCAGAAAAGTATCAGGGTGAAGCAGCATCTGGGTGTGAGAGTGAAACAAGCGTCTCTGAAGACTGCTCAGGGCTATCCTCTCAGAGTGACATTTTAACCACTCAGCAGAGGGATACCATGCAACATAACCTGATAAAGCTCCAGCAGGAAATGGCTGAACTAGAAGCTGTGTTAGAACAGCATGGGAGCCAGCCTTCTAACAGCTACCCTTCCATCATAAGTGACTCTTCTGCCCTTGAGGACCTGCGAAATCCAGAACAAAGCACATCAGAAAAAGTATTAACTTCACAGAAAAGTAGTGAATACCCTATAAGCCAGAATCCAGAAGGCCTTTCTGCTGACAAGTTTGAGGTGTCTGCAGATAGTTCTACCAGTAAAAATAAAGAACCAGGAGTGGAAAGGTCATCCCCTTCTAAATGCCCATCATTAGATGATAGGTGGTACATGCACAGTTGCTCTGGGAGTCTTCAGAATAGAAACTACCCATCTCAAGAGGAGCTCATTAAGGTTGTTGATGTGGAGGAGCAACAGCTGGAAGAGTCTGGGCCACACGATTTGACGGAAACATCTTACTTGCCAAGGCAAGATCTAGAGGGAACCCCTTACCTGGAATCTGGAATCAGCCTCTTCTCTGATGACCCTGAATCTGATCCTTCTGAAGACAGAGCCCCAGAGTCAGCTCGTGTTGGCAACATACCATCTTCAACCTCTGCATTGAAAGTTCCCCAATTGAAAGTTGCAGAATCTGCCCAGAGTCCAGCTGCTGCTCATACTACTGATACTGCTGGGTATAATGCAATGGAAGAAAGTGTGAGCAGGGAGAAGCCAGAATTGACAGCTTCAACAGAAAGGGTCAACAAAAGAATGTCCATGGTGGTGTCTGGCCTGACCCCAGAAGAATTTATGCTCGTGTACAAGTTTGCCAGAAAACACCACATCACTTTAACTAATCTAATTACTGAAGAGACTACTCATGTTGTTATGAAAACAGATGCTGAGTTTGTGTGTGAACGGACACTGAAATATTTTCTAGGAATTGCGGGAGGAAAATGGGTAGTTAGCTATTTCTGGGTGACCCAGTCTATTAAAGAAAGAAAAATGCTGAATGAGCATGATTTTGAAGTCAGAGGAGATGTGGTCAATGGAAGAAACCACCAAGGTCCAAAGCGAGCAAGAGAATCCCAGGACAGAAAGATCTTCAGGGGGCTAGAAATCTGTTGCTATGGGCCCTTCACCAACATGCCCACAGGGTGTCCACCCAATTGTGGTTGTGCAGCCAGATGCCTGGACAGAGGACAATGGCTTCCATGCAATTGGGCAGATGTG	69495.0	single nucleotide variant	NM_007294.4(BRCA1):c.32T>C (p.Val11Ala)	672.0	BRCA1	HGNC:1100	Uncertain significance	0.0	Jan 09, 2019	80357017.0	-	RCV000111609|RCV001019782	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	germline;not applicable	germline	GRCh38	NC_000017.11	17	43124065.0	43124065.0	17q21.31	criteria provided, single submitter	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002131,UniProtKB:P38398#VAR_007754	2.0	54828.0	43124065.0	A	G	-	-	-	-	-	-	SCV001181186	-	-	32T>C 	Val11Ala	NM_007294.4	1.0	4_VUS	chr17	T	C	17-43124065-T-C		54828	17	43124065	A	G	V	A	rs80357017	17	41276082	17	38529608	11	BRCA1	ENSG00000012048	ENST00000494123	ENSP00000419103	P38398	BRCA1_HUMAN	c.32T>C	p.Val11Ala	c.32T>C	p.Val11Ala	principal2	Y	1	.	.	-	GTA	2	0	A	./.	./.	./.	./.	0.0	0.91343	D	0.15	0.44850	T	0.979	0.59057	D	0.525	0.68273	P	.	.	.	.	.	.	-0.05	0.04960	N	-0.93	0.68915	N	.	0.78176	0.1104	0.84297	D	0.5505	0.83470	D	10	0.8004947	0.79251	D	0.533751	0.95619	D	0.727	0.90374	0.73	0.86307	E9PFC7	V11A	Loss of helix (P = 0.0626)| Loss of stability (P = 0.0682)| Gain of disorder (P = 0.1013)| Gain of loop (P = 0.2045)| Gain of methylation at R7 (P = 0.6378)	0.968011597025	0.96737	.	0.67205	.	0.40672	0.681263923645	0.64391	T	0.312303	0.68234	T	0.333327	0.85282	D	0.241024	0.85090	D	0.841864228248596	0.49207	D	.	0.64313	.	0.52061254	0.67990	0.29239133	0.55052	0.66638017	0.75976	0.28592685	0.54387	-8.793	0.66432	D	0.8681	0.81829	LP	0.988701711537603	0.87895	0.99891650	0.99037	0.862	0.92474	.	.	.	.	.	.	4.312986	0.66011	24.9	0.99839403693669271	0.91978	0.759203	0.69650	D	0.312753915383058	0.56581	3.845653	0.309496174958636	0.55866	3.772667	3.83	3.83	0.43219	.	.	4.168	0.58094	11.085000	0.85842	0.634	0.51995	1.0	0.71675	1.000000	0.68239	0.941	0.48226	469	0.78193	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1	criteria_provided,_single_submitter	NC_000017.11:g.43124065A>G	ClinGen:CA002131|UniProtKB:P38398#VAR_007754	C0027672|C2676676	604370	140162|145	.	Val	Ala	69495	single nucleotide variant	NM_007294.4(BRCA1):c.32T>C (p.Val11Ala)	672	BRCA1	HGNC:1100	Uncertain significance	0	Jan 09, 2019	80357017	-	RCV000111609|RCV001019782	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome	germline;not applicable	germline	GRCh38	NC_000017.11	17	43124065	43124065	17q21.31	criteria provided, single submitter	3	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002131,UniProtKB:P38398#VAR_007754	2	54828	43124065	A	G	-	-	-	-	-	-	SCV001181186	-	-	32T>C 	Val11Ala	NM_007294.4	1	4_VUS	BRCA1	ENSG00000012048	14613	23562	CCSBVarC002121	ALE00002121	32T>C	Val11Ala	RC4	RC4_Mut_GDEh1029	C02	GDEhDisVCh_40059	H11	1	RC4_Mut_GDDh1029	C02	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	7	0	NULL	0	NULL	0	NULL	BRCA1_Val11Ala	17	17	43124065	A	G
3774	TP53	844C>T	Arg282Trp	ENSG00000141510	17	7673776	NC_000017.11:7673776:G:A	ALE00004874	CCSBVarC004874	NULL	214906	NULL	GDEhDisVCh_40053	H02	CEGS2	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACTGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	27403.0	single nucleotide variant	NM_000546.6(TP53):c.844C>T (p.Arg282Trp)	7157.0	TP53	HGNC:11998	Pathogenic/Likely pathogenic	1.0	Feb 03, 2025	28934574.0	-	RCV000210145|RCV000144670|RCV000236400|RCV000441472|RCV000785546|RCV000013161|RCV001270278|RCV003315223|RCV004566738|RCV000148905|RCV004668718|RCV004797589|RCV000722016	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MedGen:C3661900|MONDO:MONDO:0010150,MeSH:D000077195,MedGen:C1168401,OMIM:275355,Orphanet:67037|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0800290,MedGen:C2675080|MONDO:MONDO:0005575,MedGen:C0346629,OMIM:114500|MONDO:MONDO:0858939,MedGen:C5669918|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651||MONDO:MONDO:0016684,MedGen:C0334579,Orphanet:251589;Human Phenotype Ontology:HP:0033682,MONDO:MONDO:0016690,MedGen:C0334586,Orphanet:251607	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|not provided|Squamous cell carcinoma of the head and neck|Ovarian neoplasm|Li-fraumeni-like syndrome|Colorectal cancer|Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome|Neoplasm|TP53-related disorder|Astrocytoma, anaplastic;Pleomorphic xanthoastrocytoma	germline;maternal;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7673776.0	7673776.0	17p13.1	criteria provided, multiple submitters, no conflicts	34.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000454,UniProtKB:P04637#VAR_006016,OMIM:191170.0018	3.0	12364.0	7673776.0	G	A	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV000253852|SCV000266136|SCV000292698|SCV000407070|SCV000581079|SCV000680092|SCV000691656|SCV000785099|SCV000821787|SCV000839109|SCV000853189|SCV001450496|SCV001450497|SCV002030224|SCV002069228|SCV002073337|SCV002532713|SCV002581144|SCV002582345|SCV002583007|SCV002757862|SCV004012928|SCV004015238|SCV004017907|SCV004241252|SCV004848861|SCV005054335|SCV005407751|SCV005425720	-	SCV005094389	844C>T 	Arg282Trp	NM_000546.6	2.0	1_Pathogenic	chr17	C	T	17-7673776-C-T		12364	17	7673776	G	A	R	W	rs28934574	17	7577094	17	7517819	282	TP53	ENSG00000141510	ENST00000508793	ENSP00000424104	P04637	P53_HUMAN	c.*1340C>T	.	c.844C>T	p.Arg282Trp	principal1	.	4	.	.	-	CGG	1	2	G	G/G	G/G	G/G	G/G	.	0.72322	.	.	0.92967	.	1.0	0.90580	D	1.0	0.97365	D	.	0.99291	.	.	.	.	3.145	0.88167	M	.	0.95500	.	.	0.93732	1.0192	0.97513	D	0.9922	0.99809	D	9	.	0.95183	.	0.675578	0.97297	D	.	0.97054	.	.	.	.	.	.	0.97983	.	0.83775	.	0.40111	0.640371799469	0.58553	T	0.995057	0.99989	D	0.542691	0.95464	D	0.541762	0.95397	D	0.997483193874359	0.91597	D	.	0.69696	.	0.90636075	0.91841	0.7978396	0.87984	0.89165527	0.90517	0.85779256	0.91923	-11.739	0.85755	D	.	0.86554	.	0.998284442799187	0.94224	0.99997365	0.99978	0.981	0.99334	.	.	.	.	.	.	5.014453	0.83327	28.0	0.99891854592684859	0.96592	0.831851	0.74940	D	0.395382723831395	0.60970	4.31469	0.221923140594956	0.50812	3.292387	4.75	1.49	0.21909	1.76	0.36958	4.023	0.57011	6.503000	0.55856	0.672	0.70176	1.0	0.71675	1.000000	0.68239	0.997	0.79771	432	0.80699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109384	0.000000e+00	0	1	208072	4.806030e-06	0	0	236888	0.000000e+00	0	0	7162	0.000000e+00	0	0	17110	0.000000e+00	0	0	2318	0.000000e+00	0	0	9046	0.000000e+00	0	0	13388	0.000000e+00	0	0	42762	0.000000e+00	0	0	15686	0.000000e+00	0	.	.	.	.	0	16214	0.000000e+00	0	0	30512	0.000000e+00	0	0	6210	0.000000e+00	0	0	13416	0.000000e+00	0	0	16726	0.000000e+00	0	1	89538	1.116840e-05	0	0	30598	0.000000e+00	0	1	89538	1.116840e-05	0	0	14898	0.000000e+00	0	0	34248	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21624	0.000000e+00	0	0	102722	0.000000e+00	0	0	30516	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	22944	4.3584379358437934E-5	0	8	0	0	26	0	0	606	0	0	354	0	0	18	0	0	30	0	0	0	0	1	6360	1.5723270440251572E-4	0	614	0	0	56	0	2	30346	6.590654451987082E-5	Pathogenic/Likely_pathogenic	Hereditary_cancer-predisposing_syndrome|Glioblastoma|Breast_neoplasm|Colorectal_cancer|Carcinoma_of_esophagus|Pancreatic_adenocarcinoma|Neoplasm_of_brain|Diffuse_pediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|not_provided|Li-fraumeni-like_syndrome|Papillary_renal_cell_carcinoma_type_1|Squamous_cell_carcinoma_of_the_skin|Li-Fraumeni_syndrome_1|Squamous_cell_lung_carcinoma|Hepatocellular_carcinoma|Pleomorphic_xanthoastrocytoma|Astrocytoma,_anaplastic|Li-Fraumeni_syndrome|Transitional_cell_carcinoma_of_the_bladder|Adrenocortical_carcinoma,_hereditary|Prostate_adenocarcinoma|Malignant_neoplasm_of_body_of_uterus|Ovarian_serous_cystadenocarcinoma|Gastric_adenocarcinoma|Ovarian_neoplasm|Neoplasm_of_the_large_intestine|Squamous_cell_carcinoma_of_the_head_and_neck|Non-Hodgkin_lymphoma|Malignant_melanoma_of_skin|Lung_adenocarcinoma	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.7673776G>A	ClinGen:CA000454|OMIM:191170.0018|UniProtKB:P04637#VAR_006016	C0027672|C0017636|C1458155|C0346629|C0152018|C0281361|C0006118|C5669918|C3661900|C2675080|C1336839|C0553723|C1835398|C0149782|C2239176|C0334586|C0334579|C0085390|C0279680|C1859972|C0007112|C0153574|C0279663|C0278701|C0919267|C0009404|C1168401|C0024305|C0151779|C0152013	114500|605074|151623|114550|PS151623|202300|275355	140162|360|70482|47044|524|88673|251607|251589|524|1501|67037|547	p53, DNA-binding domain|p53, DNA-binding domain	Arg	Trp	27403	single nucleotide variant	NM_000546.6(TP53):c.844C>T (p.Arg282Trp)	7157	TP53	HGNC:11998	Pathogenic/Likely pathogenic	1	Feb 03, 2025	28934574	-	RCV000210145|RCV000144670|RCV000236400|RCV000441472|RCV000785546|RCV000013161|RCV001270278|RCV003315223|RCV004566738|RCV000148905|RCV004668718|RCV004797589|RCV000722016	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MedGen:C3661900|MONDO:MONDO:0010150,MeSH:D000077195,MedGen:C1168401,OMIM:275355,Orphanet:67037|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0800290,MedGen:C2675080|MONDO:MONDO:0005575,MedGen:C0346629,OMIM:114500|MONDO:MONDO:0858939,MedGen:C5669918|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651||MONDO:MONDO:0016684,MedGen:C0334579,Orphanet:251589;Human Phenotype Ontology:HP:0033682,MONDO:MONDO:0016690,MedGen:C0334586,Orphanet:251607	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|not provided|Squamous cell carcinoma of the head and neck|Ovarian neoplasm|Li-fraumeni-like syndrome|Colorectal cancer|Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome|Neoplasm|TP53-related disorder|Astrocytoma, anaplastic;Pleomorphic xanthoastrocytoma	germline;maternal;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7673776	7673776	17p13.1	criteria provided, multiple submitters, no conflicts	34	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000454,UniProtKB:P04637#VAR_006016,OMIM:191170.0018	3	12364	7673776	G	A	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV000253852|SCV000266136|SCV000292698|SCV000407070|SCV000581079|SCV000680092|SCV000691656|SCV000785099|SCV000821787|SCV000839109|SCV000853189|SCV001450496|SCV001450497|SCV002030224|SCV002069228|SCV002073337|SCV002532713|SCV002581144|SCV002582345|SCV002583007|SCV002757862|SCV004012928|SCV004015238|SCV004017907|SCV004241252|SCV004848861|SCV005054335|SCV005407751|SCV005425720	-	SCV005094389	844C>T 	Arg282Trp	NM_000546.6	2	1_Pathogenic	TP53	ENSG00000141510	3774	214906	CCSBVarC004874	ALE00004874	844C>T	Arg282Trp	CEGS2	CegsMutGDEh1011	F09	GDEhDisVCh_40053	H02	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	TP53_Arg282Trp	17	17	7673776	G	A
359	CBS	461T>A	Leu154Gln	ENSG00000160200	21	43065686	NC_000021.9:43065686:A:T	ALE00000043	CCSBVarC000043	1022	NULL	NULL	GDEhDisVCh_40013	B03	RC4	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCAGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG																																															chr21	T	A	21-43065686-T-A																																																																																																																																																																																																																																																																																																																																																																																																																																														CBS	ENSG00000160200	359	1022	CCSBVarC000043	ALE00000043	461T>A	Leu154Gln	RC4	RC4_Mut_GDEh1026	A06	GDEhDisVCh_40013	B03	1	RC4_Mut_GDDh1026	A06	NULL	NULL	NULL	NULL	NULL	NULL	1	3	1	2	0	NULL	0	NULL	0	NULL	CBS_Leu154Gln	21	21	43065686	A	T
71569	OTC	422G>C	Arg141Pro	ENSG00000036473	X	38401310	NC_000023.11:38401310:G:C	ALE00005242	CCSBVarC005242	NULL	205887	NULL	GDEhDisVCh_40048	C08	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCCAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103090.0	single nucleotide variant	NM_000531.6(OTC):c.422G>C (p.Arg141Pro)	5009.0	OTC	HGNC:8512	Likely pathogenic	1.0	May 28, 2019	68026851.0	-	RCV000083435|RCV000990786	MedGen:C3661900|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664	not provided|Ornithine carbamoyltransferase deficiency	unknown	unknown	GRCh38	NC_000023.11	X	38401310.0	38401310.0	Xp11.4	criteria provided, single submitter	2.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224601,UniProtKB:P00480#VAR_004878	2.0	97198.0	38401310.0	G	C	-	-	-	-	-	-	SCV001141823	-	-	422G>C 	Arg141Pro	NM_000531.6	1.0	1_Pathogenic	chrX	G	C	X-38401310-G-C	4.60383e-6	97198	X	38401310	G	C	R	P	rs68026851	X	38260563	X	38145507	141	OTC	ENSG00000036473	ENST00000713758	ENSP00000519059	P00480	OTC_HUMAN	.	.	c.422G>C	p.Arg141Pro	principal1	Y	.	.	.	+	CGA	2	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	1.0	0.97365	D	.	0.97016	.	.	.	.	4.24	0.97965	H	.	0.93155	.	.	0.99931	0.9955	0.97105	D	0.9992	0.99972	D	10	.	0.99975	.	0.978935	0.99885	D	.	0.99822	0.992	0.99914	P00480	R141P	Loss of stability (P = 0.0735)| Gain of sheet (P = 0.1208)| Gain of phosphorylation at Y143 (P = 0.1328)| Gain of ubiquitination at K144 (P = 0.1989)| Loss of loop (P = 0.2237)	.	0.99904	.	0.99915	.	0.85535	0.635047793388	0.57796	T	0.984544	0.99898	D	0.74175	0.99971	D	0.827696	0.99971	D	0.92965179681778	0.59147	D	.	0.73846	.	0.9981609	0.99999	0.99315506	0.99994	0.9981609	0.99999	0.99315506	0.99994	-13.882	0.92681	D	.	0.93337	.	0.999980037173451	0.99579	0.99885297	0.98998	1	0.99985	.	.	.	.	.	.	4.996215	0.82899	27.9	0.99727842331043337	0.82565	.	.	.	.	.	.	.	.	.	5.97	5.11	0.69146	5.17	0.91630	9.543	0.97194	9.811000	0.81777	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.995	0.73271	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	not_provided|Ornithine_carbamoyltransferase_deficiency	criteria_provided,_single_submitter	NC_000023.11:g.38401310G>C	ClinGen:CA224601|UniProtKB:P00480#VAR_004878	CN517202|C0268542	311250	664	Aspartate/ornithine carbamoyltransferase, carbamoyl-P binding	Arg	Pro	103090	single nucleotide variant	NM_000531.6(OTC):c.422G>C (p.Arg141Pro)	5009	OTC	HGNC:8512	Likely pathogenic	1	May 28, 2019	68026851	-	RCV000083435|RCV000990786	MedGen:C3661900|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664	not provided|Ornithine carbamoyltransferase deficiency	unknown	unknown	GRCh38	NC_000023.11	X	38401310	38401310	Xp11.4	criteria provided, single submitter	2	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224601,UniProtKB:P00480#VAR_004878	2	97198	38401310	G	C	-	-	-	-	-	-	SCV001141823	-	-	422G>C 	Arg141Pro	NM_000531.6	1	1_Pathogenic	OTC	ENSG00000036473	71569	205887	CCSBVarC005242	ALE00005242	422G>C	Arg141Pro	CEGS2	CegsMutGDEh1029	B04	GDEhDisVCh_40048	C08	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Arg141Pro	23	X	38401310	G	C
359	CBS	1111G>A	Val371Met	ENSG00000160200	21	43060475	NC_000021.9:43060475:C:T	ALE00007304	CCSBVarC007308	NULL	NULL	253	GDEhDisVCh_40013	A05	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCATGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210411.0	single nucleotide variant	NM_000071.3(CBS):c.1111G>A (p.Val371Met)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Jan 28, 2025	372010465.0	-	RCV000196393|RCV000410135|RCV002229026|RCV002433873|RCV003401061|RCV003895256	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection|Homocystinuria|CBS-related disorder	germline;unknown	germline	GRCh38	NC_000021.9	21	43060475.0	43060475.0	21q22.3	criteria provided, multiple submitters, no conflicts	9.0	-	N	ClinGen:CA320805,UniProtKB:P35520#VAR_002190	2.0	212862.0	43060475.0	C	T	-	-	-	-	-	-	SCV000249708|SCV000486774|SCV000941319|SCV002016937|SCV002741510|SCV002787247|SCV004121979|SCV004213882	-	-	1111G>A 	Val371Met	NM_000071.3	2.0	1_Pathogenic	chr21	G	A	21-43060475-G-A		212862	21	43060475	C	T	V	M	rs372010465	21	44480585	21	43353654	371	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.1111G>A	p.Val371Met	c.1111G>A	p.Val371Met	principal1	Y	1	.	.	-	GTG	1	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.95	0.96383	H	-2.93	0.61315	D	0.898	0.89792	0.9029	0.95701	D	0.9942	0.99867	D	10	0.9618988	0.95561	D	0.951942	0.99671	D	0.956	0.99253	.	.	.	.	.	0.949913644318	0.94897	.	0.91071	.	0.78275	0.650010406971	0.59924	T	0.99	0.99955	D	0.56055	0.96211	D	0.567415	0.96152	D	0.997655272483826	0.92021	D	.	0.98275	.	0.92085814	0.93232	0.7634399	0.85852	0.92312515	0.93457	0.74872935	0.84968	-12.748	0.88324	D	.	0.61170	.	0.998357336224666	0.94329	0.99966764	0.99591	0.976	0.99121	.	.	.	.	.	.	4.864406	0.79665	27.1	0.99891944066376592	0.96592	0.823220	0.74243	D	0.941959527019131	0.93623	12.1877	0.791117139434264	0.89107	9.865853	4.9	4.9	0.63598	2.45	0.45325	7.501	0.80483	5.709000	0.49490	0.469	0.21904	1.0	0.71675	1.000000	0.68239	0.67	0.33292	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	107676	1.857420e-05	0	2	204864	9.762570e-06	0	2	234818	8.517230e-06	0	1	7134	1.401740e-04	0	0	17100	0.000000e+00	0	0	2320	0.000000e+00	0	0	9040	0.000000e+00	0	0	11758	0.000000e+00	0	1	42738	2.339840e-05	0	0	15688	0.000000e+00	0	1	7134	1.401740e-04	0	1	16042	6.233640e-05	0	0	30478	0.000000e+00	0	0	6166	0.000000e+00	0	0	13326	0.000000e+00	0	0	15094	0.000000e+00	0	1	88336	1.132040e-05	0	0	30604	0.000000e+00	0	1	16042	6.233640e-05	0	1	14836	6.740360e-05	0	0	34246	0.000000e+00	0	0	9556	0.000000e+00	0	0	17686	0.000000e+00	0	0	19992	0.000000e+00	0	1	102382	9.767340e-06	0	0	30522	0.000000e+00	0	1	14836	6.740360e-05	0	.	3	41866	7.165720e-05	0	1	2336	4.280820e-04	0	1	2336	4.280820e-04	0	0	0	.	0	0	3650	0.000000e+00	0	0	912	0.000000e+00	0	0	2596	0.000000e+00	0	0	1190	0.000000e+00	0	0	156	0.000000e+00	0	2	21808	9.170950e-05	0	0	7040	0.000000e+00	0	0	6144	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	250	0	0	0	0	0	0	0	0	6394	0	Pathogenic/Likely_pathogenic	Classic_homocystinuria|CBS-related_disorder|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Homocystinuria|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43060475C>T	ClinGen:CA320805|UniProtKB:P35520#VAR_002190	C0751202|C3150344|C0019880|C4707243|C3661900	236200|PS607086	394|91387	Tryptophan synthase beta chain-like, PALP domain	Val	Met	210411	single nucleotide variant	NM_000071.3(CBS):c.1111G>A (p.Val371Met)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Jan 28, 2025	372010465	-	RCV000196393|RCV000410135|RCV002229026|RCV002433873|RCV003401061|RCV003895256	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection|Homocystinuria|CBS-related disorder	germline;unknown	germline	GRCh38	NC_000021.9	21	43060475	43060475	21q22.3	criteria provided, multiple submitters, no conflicts	9	-	N	ClinGen:CA320805,UniProtKB:P35520#VAR_002190	2	212862	43060475	C	T	-	-	-	-	-	-	SCV000249708|SCV000486774|SCV000941319|SCV002016937|SCV002741510|SCV002787247|SCV004121979|SCV004213882	-	-	1111G>A 	Val371Met	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	253	CCSBVarC007308	ALE00007304	1111G>A	Val371Met	Edgotyping3	VUSMutGDEh010	D11	GDEhDisVCh_40013	A05	1	VUSMutGDDh010	D11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	CBS_Val371Met	21	21	43060475	C	T
359	CBS	992C>T	Ala331Val	ENSG00000160200	21	43062358	NC_000021.9:43062358:G:A	ALE00007312	CCSBVarC007318	NULL	NULL	266	GDEhDisVCh_40013	C06	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGTGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	190956.0	single nucleotide variant	NM_000071.3(CBS):c.992C>T (p.Ala331Val)	875.0	CBS	HGNC:1550	Likely pathogenic	1.0	May 31, 2024	777919630.0	-	RCV000173977|RCV001252181|RCV002516607|RCV003462276|RCV004601121	MedGen:C3661900|Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,MONDO:MONDO:0001071,MeSH:D008607,MedGen:C3714756|MedGen:C3150344|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	not provided|Intellectual disability|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Classic homocystinuria|Familial thoracic aortic aneurysm and aortic dissection	germline;unknown	germline	GRCh38	NC_000021.9	21	43062358.0	43062358.0	21q22.3	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA239449,UniProtKB:P35520#VAR_002187	2.0	193793.0	43062358.0	G	A	-	-	-	-	-	-	SCV003256154|SCV004213902|SCV005098231|SCV005849398	-	-	992C>T 	Ala331Val	NM_000071.3	2.0	1_Pathogenic	chr21	C	T	21-43062358-C-T		193793	21	43062358	G	A	A	V	rs777919630	21	44482468	21	43355537	331	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.992C>T	p.Ala331Val	c.992C>T	p.Ala331Val	principal1	Y	1	.	.	-	GCG	2	0	G	G/G	G/G	G/G	G/G	0.004	0.65576	D	0.004	0.74454	D	0.941	0.52895	P	0.504	0.47759	P	1.0	0.99291	D	simple_aae	0.0	100.0	3.095	0.87372	M	-2.9	0.60859	D	0.879	0.88009	1.1454	0.99942	D	0.9211	0.97384	D	10	0.99425566	0.99932	D	0.530257	0.95570	D	0.701	0.89192	0.927	0.98799	P35520	A331V	Gain of helix (P = 0.062)| Loss of disorder (P = 0.08)| Loss of loop (P = 0.0986)| Loss of phosphorylation at T333 (P = 0.2442)| Gain of catalytic residue at E330 (P = 0.2981)	0.881429571351	0.87935	.	0.90499	.	0.49968	0.378096103668	0.21961	T	0.974001	0.99735	D	0.226444	0.76208	D	0.269022	0.86427	D	0.882142603397369	0.52965	D	.	0.81906	.	0.46725446	0.64807	0.25882652	0.51424	0.5604965	0.70244	0.28771538	0.54572	-9.839	0.73021	D	0.3519	0.56660	A	0.970193243349749	0.83313	0.99859640	0.98864	0.947	0.97555	.	.	.	.	.	.	3.789079	0.54608	23.5	0.99849301750751229	0.92843	0.906257	0.85830	D	0.452415187427736	0.64151	4.686297	0.383649462910228	0.60345	4.244511	5.15	5.15	0.70247	2.92	0.53394	6.803	0.75031	11.393000	0.92662	0.59	0.31918	1.0	0.71675	1.000000	0.68239	0.05	0.15227	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	109348	1.829020e-05	0	2	207672	9.630570e-06	0	2	236692	8.449800e-06	0	0	7156	0.000000e+00	0	0	17096	0.000000e+00	0	0	2318	0.000000e+00	0	0	9046	0.000000e+00	0	0	13388	0.000000e+00	0	0	42742	0.000000e+00	0	2	15688	1.274860e-04	0	2	15688	1.274860e-04	0	0	16180	0.000000e+00	0	0	30496	0.000000e+00	0	0	6196	0.000000e+00	0	0	13406	0.000000e+00	0	0	16728	0.000000e+00	0	0	89220	0.000000e+00	0	2	30590	6.538080e-05	0	2	30590	6.538080e-05	0	0	14884	0.000000e+00	0	0	34236	0.000000e+00	0	0	9566	0.000000e+00	0	0	17690	0.000000e+00	0	0	21578	0.000000e+00	0	0	102610	0.000000e+00	0	2	30510	6.555230e-05	0	2	30510	6.555230e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	not_provided|Classic_homocystinuria|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|Intellectual_disability	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43062358G>A	ClinGen:CA239449|UniProtKB:P35520#VAR_002187	C3661900|C0751202|C3150344|C4707243|C3714756	236200|PS607086	394|91387	Tryptophan synthase beta chain-like, PALP domain	Ala	Val	190956	single nucleotide variant	NM_000071.3(CBS):c.992C>T (p.Ala331Val)	875	CBS	HGNC:1550	Likely pathogenic	1	May 31, 2024	777919630	-	RCV000173977|RCV001252181|RCV002516607|RCV003462276|RCV004601121	MedGen:C3661900|Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,MONDO:MONDO:0001071,MeSH:D008607,MedGen:C3714756|MedGen:C3150344|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	not provided|Intellectual disability|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Classic homocystinuria|Familial thoracic aortic aneurysm and aortic dissection	germline;unknown	germline	GRCh38	NC_000021.9	21	43062358	43062358	21q22.3	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA239449,UniProtKB:P35520#VAR_002187	2	193793	43062358	G	A	-	-	-	-	-	-	SCV003256154|SCV004213902|SCV005098231|SCV005849398	-	-	992C>T 	Ala331Val	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	266	CCSBVarC007318	ALE00007312	992C>T	Ala331Val	Edgotyping3	VUSMutGDEh010	F12	GDEhDisVCh_40013	C06	1	VUSMutGDDh010	F12	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	CBS_Ala331Val	21	21	43062358	G	A
8459	ASPA	427A>T	Ile143Phe	ENSG00000108381	17	3481793	NC_000017.11:3481793:A:T	ALE00001384	CCSBVarC001384	15694	NULL	NULL	GDEhDisVCh_40040	D04	RC4	ATGACTTCTTGTCACATTGCTGAAGAACATATACAAAAGGTTGCTATCTTTGGAGGAACCCATGGGAATGAGCTAACCGGAGTATTTCTGGTTAAGCATTGGCTAGAGAATGGCGCTGAGATTCAGAGAACAGGGCTGGAGGTAAAACCATTTATTACTAACCCCAGAGCAGTGAAGAAGTGTACCAGATATATTGACTGTGACCTGAATCGCATTTTTGACCTTGAAAATCTTGGCAAAAAAATGTCAGAAGATTTGCCATATGAAGTGAGAAGGGCTCAAGAAATAAATCATTTATTTGGTCCAAAAGACAGTGAAGATTCCTATGACATTATTTTTGACCTTCACAACACCACCTCTAACATGGGGTGCACTCTTATTCTTGAGGATTCCAGGAATAACTTTTTAATTCAGATGTTTCATTACTTTAAGACTTCTCTGGCTCCACTACCCTGCTACGTTTATCTGATTGAGCATCCTTCCCTCAAATATGCGACCACTCGTTCCATAGCCAAGTATCCTGTGGGTATAGAAGTTGGTCCTCAGCCTCAAGGGGTTCTGAGAGCTGATATCTTGGATCAAATGAGAAAAATGATTAAACATGCTCTTGATTTTATACATCATTTCAATGAAGGAAAAGAATTTCCTCCCTGCGCCATTGAGGTCTATAAAATTATAGAGAAAGTTGATTACCCCCGGGATGAAAATGGAGAAATTGCTGCTATCATCCATCCTAATCTGCAGGATCAAGACTGGAAACCACTGCATCCTGGGGATCCCATGTTTTTAACTCTTGATGGGAAGACGATCCCACTGGGCGGAGACTGTACCGTGTACCCCGTGTTTGTGAATGAGGCCGCATATTACGAAAAGAAAGAAGCTTTTGCAAAGACAACTAAACTAACGCTCAATGCAAAAAGTATTCGCTGCTGTTTACAT	360237.0	single nucleotide variant	NM_000049.4(ASPA):c.427A>T (p.Ile143Phe)	443.0	ASPA	HGNC:756	Pathogenic/Likely pathogenic	1.0	Mar 14, 2024	199565861.0	-	RCV000414045|RCV000675094	MedGen:C3661900|MONDO:MONDO:0010079,MedGen:C0206307,OMIM:271900,Orphanet:141	not provided|Spongy degeneration of central nervous system	germline;unknown	germline	GRCh38	NC_000017.11	17	3481793.0	3481793.0	17p13.2	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA8288916	2.0	372307.0	3481793.0	A	T	-	-	-	-	-	-	SCV000490412|SCV001163411|SCV002033284|SCV002309438	-	-	427A>T 	Ile143Phe	NM_000049.4	2.0	1_Pathogenic	chr17	A	T	17-3481793-A-T	6.92666e-7	372307	17	3481793	A	T	I	F	rs199565861	17	3385087	17	3331837	143	ASPA	ENSG00000108381	ENST00000263080	ENSP00000263080	P45381	ACY2_HUMAN	c.427A>T	p.Ile143Phe	c.427A>T	p.Ile143Phe	principal1	Y	1	YES	Select	+	ATT	1	0	A	A/A	A/A	A/A	A/A	0.013	0.54059	D	0.017	0.60671	D	1.0	0.90580	D	0.982	0.75481	D	0.95	0.94956	A	simple_aae	5.0	95.0	2.765	0.80595	M	-2.95	0.61611	D	0.94	0.94679	1.1005	0.99681	D	0.9545	0.98521	D	10	0.9807823	0.98047	D	0.244536	0.88821	D	0.949	0.99024	0.884	0.97015	P45381	I143F	Loss of catalytic residue at I143 (P = 0.0297)| Gain of methylation at K144 (P = 0.0585)| Loss of stability (P = 0.1392)| Loss of helix (P = 0.1706)| Loss of ubiquitination at K144 (P = 0.1828)	0.94725311577	0.94627	0.8889399671858282	0.88793	0.502564449384	0.48321	0.625375151634	0.56424	T	0.906641	0.98190	D	0.44815	0.92341	D	0.495691	0.94488	D	0.967329740524292	0.67661	D	0.760524	0.38289	T	0.7146083	0.78614	0.4766168	0.69416	0.6856972	0.77020	0.4741847	0.69267	-8.29	0.63103	D	0.4984	0.65234	A	0.881814124418545	0.74880	0.98927270	0.96622	0.96	0.98304	.	.	.	.	.	.	4.147371	0.62258	24.4	0.9883009966740619	0.47038	0.946461	0.95579	D	0.82039787360307	0.87293	9.192481	0.78855925802687	0.88924	9.793581	5.61	5.61	0.85327	2.77	0.50688	7.292	0.78137	6.156000	0.54338	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.995	0.73271	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	0	102202	0.000000e+00	0	1	196760	5.082330e-06	0	1	222848	4.487360e-06	0	0	6760	0.000000e+00	0	0	16466	0.000000e+00	0	0	2080	0.000000e+00	0	0	8598	0.000000e+00	0	0	13258	0.000000e+00	0	0	38346	0.000000e+00	0	0	14886	0.000000e+00	0	.	.	.	.	0	15354	0.000000e+00	0	1	29238	3.420210e-05	0	0	5902	0.000000e+00	0	0	13228	0.000000e+00	0	0	16468	0.000000e+00	0	0	82870	0.000000e+00	0	0	29048	0.000000e+00	0	1	29238	3.420210e-05	0	0	14122	0.000000e+00	0	1	32998	3.030490e-05	0	0	9240	0.000000e+00	0	0	17150	0.000000e+00	0	0	21024	0.000000e+00	0	0	94000	0.000000e+00	0	0	28976	0.000000e+00	0	1	32998	3.030490e-05	0	.	1	1596008	6.265630e-07	0	1	59254	1.687650e-05	0	0	74718	0.000000e+00	0	0	912	0.000000e+00	0	1	59254	1.687650e-05	0	0	29350	0.000000e+00	0	0	44674	0.000000e+00	0	0	63542	0.000000e+00	0	0	5376	0.000000e+00	0	0	1166734	0.000000e+00	0	0	89666	0.000000e+00	0	0	42832	0	0	306	0	0	112	0	0	8516	0	0	500	0	0	628	0	0	56	0	0	98	0	0	8532	0	0	8822	0	0	168	0	0	61580	0	Pathogenic/Likely_pathogenic	not_provided|Spongy_degeneration_of_central_nervous_system	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.3481793A>T	ClinGen:CA8288916	C3661900|C0206307	271900	141	.	Ile	Phe	360237	single nucleotide variant	NM_000049.4(ASPA):c.427A>T (p.Ile143Phe)	443	ASPA	HGNC:756	Pathogenic/Likely pathogenic	1	Mar 14, 2024	199565861	-	RCV000414045|RCV000675094	MedGen:C3661900|MONDO:MONDO:0010079,MedGen:C0206307,OMIM:271900,Orphanet:141	not provided|Spongy degeneration of central nervous system	germline;unknown	germline	GRCh38	NC_000017.11	17	3481793	3481793	17p13.2	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA8288916	2	372307	3481793	A	T	-	-	-	-	-	-	SCV000490412|SCV001163411|SCV002033284|SCV002309438	-	-	427A>T 	Ile143Phe	NM_000049.4	2	1_Pathogenic	ASPA	ENSG00000108381	8459	15694	CCSBVarC001384	ALE00001384	427A>T	Ile143Phe	RC4	RC4_Mut_GDEh1016	E01	GDEhDisVCh_40040	D04	2	RC4_Mut_GDDh1016	E01	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	ASPA_Ile143Phe	17	17	3481793	A	T
3774	TP53	854A>T	Glu285Val	ENSG00000141510	17	7673766	NC_000017.11:7673766:T:A	ALE00004876	CCSBVarC004876	NULL	214903	NULL	GDEhDisVCh_40053	F09	CEGS2	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACCGGCGCACAGTGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	27423.0	single nucleotide variant	NM_000546.6(TP53):c.854A>T (p.Glu285Val)	7157.0	TP53	HGNC:11998	Pathogenic	1.0	Dec 21, 2018	121912667.0	-	RCV000013185|RCV000013184|RCV000813961|RCV005229782	Human Phenotype Ontology:HP:0030392,MONDO:MONDO:0016718,MedGen:C0431109,Orphanet:251899|MedGen:C1859973|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651	Choroid plexus carcinoma|ADRENOCORTICAL CARCINOMA, PEDIATRIC|Li-Fraumeni syndrome|Neoplasm	germline;somatic	germline/somatic	GRCh38	NC_000017.11	17	7673766.0	7673766.0	17p13.1	criteria provided, single submitter	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000463,UniProtKB:P04637#VAR_006025,OMIM:191170.0040	3.0	12384.0	7673766.0	T	A	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV000954348	-	SCV005871919	854A>T 	Glu285Val	NM_000546.6	1.0	1_Pathogenic	chr17	A	T	17-7673766-A-T		12384	17	7673766	T	A	E	V	rs121912667	17	7577084	17	7517809	285	TP53	ENSG00000141510	ENST00000269305	ENSP00000269305	P04637	P53_HUMAN	c.854A>T	p.Glu285Val	c.854A>T	p.Glu285Val	principal1	Y	1	YES	Select	-	GAG	2	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.001	0.83643	D	0.999	0.77914	D	0.994	0.82066	D	1.0	0.99291	A	simple_aae	0.0	100.0	2.7	0.78845	M	-6.0	0.89554	D	0.82	0.81598	0.9645	0.96605	D	0.9912	0.99773	D	10	0.9882528	0.99226	D	0.811462	0.98527	D	0.936	0.98562	0.893	0.97445	P04637	E285V	Gain of MoRF binding (P = 0.0173)| Loss of helix (P = 0.1299)| Loss of solvent accessibility (P = 0.3368)| Loss of disorder (P = 0.3522)| Gain of methylation at R280 (P = 0.3794)	0.971105026577	0.97051	0.8230809726085035	0.82160	0.403298712097	0.40990	0.378945022821	0.22083	T	0.994911	0.99989	D	0.481554	0.93703	D	0.453942	0.93624	D	0.998267889022827	0.93617	D	.	0.74053	.	0.954564	0.96677	0.8808208	0.93533	0.958137	0.97046	0.8804198	0.93504	-11.772	0.85385	D	0.9819	0.91510	LP	0.989964744055539	0.88386	0.99997530	0.99989	0.953	0.97907	.	.	.	.	.	.	4.755627	0.76873	26.6	0.99354933214919994	0.60794	0.929902	0.91606	D	0.733578136730069	0.81734	7.615844	0.65740766961109	0.79049	7.024702	4.99	4.99	0.65898	4.5	0.84251	8.017	0.8876	6.226000	0.55244	0.661	0.55789	1.0	0.71675	1.000000	0.68239	0.992	0.67791	432	0.80699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Choroid_plexus_carcinoma|Adrenocortical_carcinoma,_pediatric|Li-Fraumeni_syndrome	criteria_provided,_single_submitter	NC_000017.11:g.7673766T>A	ClinGen:CA000463|OMIM:191170.0040|UniProtKB:P04637#VAR_006025	C0431109|C1859973|C0085390	PS151623	251899|524	p53, DNA-binding domain|p53, DNA-binding domain	Glu	Val	27423	single nucleotide variant	NM_000546.6(TP53):c.854A>T (p.Glu285Val)	7157	TP53	HGNC:11998	Pathogenic	1	Dec 21, 2018	121912667	-	RCV000013185|RCV000013184|RCV000813961|RCV005229782	Human Phenotype Ontology:HP:0030392,MONDO:MONDO:0016718,MedGen:C0431109,Orphanet:251899|MedGen:C1859973|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651	Choroid plexus carcinoma|ADRENOCORTICAL CARCINOMA, PEDIATRIC|Li-Fraumeni syndrome|Neoplasm	germline;somatic	germline/somatic	GRCh38	NC_000017.11	17	7673766	7673766	17p13.1	criteria provided, single submitter	3	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000463,UniProtKB:P04637#VAR_006025,OMIM:191170.0040	3	12384	7673766	T	A	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV000954348	-	SCV005871919	854A>T 	Glu285Val	NM_000546.6	1	1_Pathogenic	TP53	ENSG00000141510	3774	214903	CCSBVarC004876	ALE00004876	854A>T	Glu285Val	CEGS2	CegsMutGDEh1026	G09	GDEhDisVCh_40053	F09	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	TP53_Glu285Val	17	17	7673766	T	A
52861	F9	218A>T	Glu73Val	ENSG00000101981	X	139537139	NC_000023.11:139537139:A:T	ALE00004374	CCSBVarC004374	NULL	204348	NULL	GDEhDisVCh_40052	A07	CEGS2	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGTAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT	25610.0	single nucleotide variant	NM_000133.4(F9):c.218A>T (p.Glu73Val)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Feb 19, 1990	137852226.0	-	RCV000011317	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537139.0	139537139.0	Xq27.1	no assertion criteria provided	1.0	-	N	UniProtKB:P00740#VAR_006542,OMIM:300746.0014,ClinGen:CA255316	1.0	10571.0	139537139.0	A	T	-	-	-	-	-	-	SCV000031548	-	-	218A>T 	Glu73Val	NM_000133.4		1_Pathogenic	chrX	A	T	X-139537139-A-T		10571	X	139537139	A	T	E	V	rs137852226	X	138619298	X	138446964	73	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.218A>T	p.Glu73Val	c.218A>T	p.Glu73Val	principal1	Y	1	YES	Select	+	GAA	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.997	0.86259	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.8	0.95330	H	-5.93	0.89056	D	0.83	0.91390	0.9304	0.96095	D	0.9947	0.99879	D	10	0.99308085	0.99841	D	0.957945	0.99720	D	0.976	0.99783	0.972	0.99735	P00740	E73V	Loss of sheet (P = 0.0228)| Loss of ubiquitination at K68 (P = 0.0391)| Loss of disorder (P = 0.0402)| Gain of loop (P = 0.0851)| Loss of phosphorylation at S70 (P = 0.1735)	0.999812538853	0.99980	0.9910322472733558	0.99096	0.462158744156	0.45459	0.553981482983	0.46353	T	0.991043	0.99964	D	0.739945	0.99969	D	0.825103	0.99969	D	0.999292135238647	0.96829	D	0.985426	0.95006	D	0.9843717	0.99415	0.96451426	0.99195	0.9655434	0.97797	0.9547829	0.98661	-14.372	0.94215	D	0.8952	0.84530	P	0.999841268525741	0.98301	0.99999270	0.99996	0.987	0.99559	.	.	.	.	.	.	4.901742	0.80612	27.4	0.99303529145021763	0.58784	.	.	.	.	.	.	.	.	.	5.19	5.19	0.71389	5.06	0.90556	8.504	0.90364	11.053000	0.85349	0.756	0.943	1.0	0.71675	1.000000	0.68239	1.0	0.97202	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139537139A>T	ClinGen:CA255316|OMIM:300746.0014|UniProtKB:P00740#VAR_006542	C0008533	306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Val	25610	single nucleotide variant	NM_000133.4(F9):c.218A>T (p.Glu73Val)	2158	F9	HGNC:3551	Pathogenic	1	Feb 19, 1990	137852226	-	RCV000011317	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537139	139537139	Xq27.1	no assertion criteria provided	1	-	N	UniProtKB:P00740#VAR_006542,OMIM:300746.0014,ClinGen:CA255316	1	10571	139537139	A	T	-	-	-	-	-	-	SCV000031548	-	-	218A>T 	Glu73Val	NM_000133.4		1_Pathogenic	F9	ENSG00000101981	52861	204348	CCSBVarC004374	ALE00004374	218A>T	Glu73Val	CEGS2	CegsMutGDEh1027	H04	GDEhDisVCh_40052	A07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	F9_Glu73Val	23	X	139537139	A	T
359	CBS	844C>T	Pro282Ser	ENSG00000160200	21	43063063	NC_000021.9:43063063:G:A	ALE00007316	CCSBVarC007323	NULL	NULL	274	GDEhDisVCh_40013	H06	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATTCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	360445.0	single nucleotide variant	NM_000071.3(CBS):c.844C>T (p.Pro282Ser)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Aug 10, 2023	1057518515.0	-	RCV000413391	MedGen:CN169374	not specified	germline	germline	GRCh38	NC_000021.9	21	43063063.0	43063063.0	21q22.3	criteria provided, multiple submitters, no conflicts	2.0	-	N	ClinGen:CA16043118	2.0	373629.0	43063063.0	G	A	-	-	-	-	-	-	SCV000492242|SCV004038851	-	-	844C>T 	Pro282Ser	NM_000071.3	2.0	4_VUS	chr21	C	T	21-43063063-C-T		373629	21	43063063	G	A	P	S	rs1057518515	21	44483173	21	43356242	282	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.844C>T	p.Pro282Ser	c.844C>T	p.Pro282Ser	principal1	Y	1	.	.	-	CCC	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.997	0.86259	D	.	.	.	.	.	.	3.68	0.94358	H	-7.86	0.96101	D	0.961	0.97221	1.0210	0.97546	D	0.9858	0.99573	D	10	0.99625254	0.99997	D	0.926529	0.99462	D	0.955	0.99221	0.918	0.98488	P35520	P282S	Gain of catalytic residue at P282 (P = 0.0287)| Gain of phosphorylation at P282 (P = 0.0587)| Gain of disorder (P = 0.1514)| Loss of glycosylation at S285 (P = 0.1871)| Loss of sheet (P = 0.1907)	0.935147704856	0.93397	.	0.96858	.	0.78392	0.559001505375	0.47061	T	0.982693	0.99873	D	0.578801	0.96948	D	0.593631	0.96898	D	0.998811841011047	0.95208	D	.	0.95681	.	0.888286	0.90224	0.8003344	0.88141	0.92231816	0.93376	0.77904505	0.86808	-10.886	0.79097	D	0.7782	0.76240	LP	0.999622538101173	0.97231	0.99976319	0.99689	0.972	0.98934	.	.	.	.	.	.	4.69369	0.7529	26.3	0.99815795750785385	0.89893	0.958042	0.97751	D	0.622978582180842	0.74494	6.165455	0.431557807683709	0.63343	4.589918	4.67	4.67	0.58039	2.39	0.44462	8.698	0.91064	11.471000	0.92868	0.526	0.24477	1.0	0.71675	1.000000	0.68239	0.115	0.19	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	not_specified	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43063063G>A	ClinGen:CA16043118	CN169374	.	.	Tryptophan synthase beta chain-like, PALP domain	Pro	Ser	360445	single nucleotide variant	NM_000071.3(CBS):c.844C>T (p.Pro282Ser)	875	CBS	HGNC:1550	Uncertain significance	0	Aug 10, 2023	1057518515	-	RCV000413391	MedGen:CN169374	not specified	germline	germline	GRCh38	NC_000021.9	21	43063063	43063063	21q22.3	criteria provided, multiple submitters, no conflicts	2	-	N	ClinGen:CA16043118	2	373629	43063063	G	A	-	-	-	-	-	-	SCV000492242|SCV004038851	-	-	844C>T 	Pro282Ser	NM_000071.3	2	4_VUS	CBS	ENSG00000160200	359	274	CCSBVarC007323	ALE00007316	844C>T	Pro282Ser	Edgotyping3	VUSMutGDEh011	E01	GDEhDisVCh_40013	H06	1	VUSMutGDDh011	E01	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	CBS_Pro282Ser	21	21	43063063	G	A
52861	F9	82T>C	Cys28Arg	ENSG00000101981	X	139530846	NC_000023.11:139530846:T:C	ALE00004373	CCSBVarC004373	NULL	204347	NULL	GDEhDisVCh_40052	G02	CEGS2	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAACGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT	25696.0	single nucleotide variant	NM_000133.4(F9):c.82T>C (p.Cys28Arg)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Feb 02, 2021	387906481.0	-	RCV000011402|RCV001851793	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139530846.0	139530846.0	Xq27.1	criteria provided, single submitter	2.0	-	N	ClinGen:CA255450,UniProtKB:P00740#VAR_006522,OMIM:300746.0100	3.0	10657.0	139530846.0	T	C	-	-	-	-	-	-	SCV002126918	-	-	82T>C 	Cys28Arg	NM_000133.4	1.0	1_Pathogenic	chrX	T	C	X-139530846-T-C		10657	X	139530846	T	C	C	R	rs387906481	X	138613005	X	138440671	28	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.82T>C	p.Cys28Arg	c.82T>C	p.Cys28Arg	principal1	Y	1	YES	Select	+	TGT	1	0	T	./.	./.	./.	./.	0.527	0.07137	T	0.497	0.13225	T	0.002	0.09864	B	0.005	0.11213	B	0.96	0.95575	A	simple_aae	4.0	96.0	2.05	0.56288	M	-0.6	0.18812	N	0.677	0.76569	-0.1274	0.79369	T	0.5835	0.84984	D	10	0.9344977	0.92701	D	0.110281	0.78694	D	0.621	0.85231	0.889	0.97257	P00740	C28R	Loss of catalytic residue at V30 (P = 0.0571)| Gain of solvent accessibility (P = 0.0971)| Gain of relative solvent accessibility (P = 0.1571)| Loss of stability (P = 0.2248)| Gain of loop (P = 0.3485)	0.999672884819	0.99966	0.8743106529995943	0.87320	0.131800438695	0.14606	0.564161062241	0.47787	T	0.440732	0.78393	T	0.449804	0.92418	D	0.408336	0.92325	D	0.215877322444314	0.20996	T	0.450155	0.16159	T	0.67080367	0.76212	0.4603896	0.68400	0.49801674	0.66671	0.38168523	0.62926	-5.036	0.49978	T	0.2472	0.53440	B	0.991303745387021	0.88967	0.99995670	0.99965	0.611	0.78260	.	.	.	.	.	.	2.378924	0.3059	18.47	0.90666156510274398	0.20170	.	.	.	.	.	.	.	.	.	5.23	4.0	0.45610	.	.	1.529	0.35708	2.835000	0.35126	0.663	0.56753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	937	0.14592	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect	criteria_provided,_single_submitter	NC_000023.11:g.139530846T>C	ClinGen:CA255450|OMIM:300746.0100|UniProtKB:P00740#VAR_006522	C0008533|C2749016	306900|300807	98879	Gamma-carboxyglutamic acid-rich (GLA) domain	Cys	Arg	25696	single nucleotide variant	NM_000133.4(F9):c.82T>C (p.Cys28Arg)	2158	F9	HGNC:3551	Pathogenic	1	Feb 02, 2021	387906481	-	RCV000011402|RCV001851793	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139530846	139530846	Xq27.1	criteria provided, single submitter	2	-	N	ClinGen:CA255450,UniProtKB:P00740#VAR_006522,OMIM:300746.0100	3	10657	139530846	T	C	-	-	-	-	-	-	SCV002126918	-	-	82T>C 	Cys28Arg	NM_000133.4	1	1_Pathogenic	F9	ENSG00000101981	52861	204347	CCSBVarC004373	ALE00004373	82T>C	Cys28Arg	CEGS2	CegsMutGDEh1015	F10	GDEhDisVCh_40052	G02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	F9_Cys28Arg	23	X	139530846	T	C
52861	F9	1232G>T	Ser411Ile	ENSG00000101981	X	139561917	NC_000023.11:139561917:G:T	ALE00004395	CCSBVarC004395	NULL	204388	NULL	GDEhDisVCh_40052	F06	CEGS2	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATATTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT	25688.0	single nucleotide variant	NM_000133.4(F9):c.1232G>T (p.Ser411Ile)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Mar 01, 1992	137852276.0	-	RCV000011395	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561917.0	139561917.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255439,UniProtKB:P00740#VAR_017319,OMIM:300746.0093	1.0	10649.0	139561917.0	G	T	-	-	-	-	-	-	SCV000031627	-	-	1232G>T 	Ser411Ile	NM_000133.4		1_Pathogenic	chrX	G	T	X-139561917-G-T		10649	X	139561917	G	T	S	I	rs137852276	X	138644076	X	138471742	411	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1232G>T	p.Ser411Ile	c.1232G>T	p.Ser411Ile	principal1	Y	1	YES	Select	+	AGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.001	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.97	0.96253	A	simple_aae	3.0	97.0	3.86	0.95772	H	-5.96	0.89237	D	0.931	0.99617	1.0873	0.99132	D	0.9673	0.98959	D	10	0.99438184	0.99940	D	0.916627	0.99381	D	0.975	0.99762	0.966	0.99665	P00740	S411I	Loss of glycosylation at S411 (P = 0.0088)| Loss of disorder (P = 0.0103)| Loss of sheet (P = 0.0817)| Loss of phosphorylation at S406 (P = 0.1048)| Loss of loop (P = 0.4412)	0.999417800528	0.99939	0.999860389252611	0.99986	1.79064612635	0.91462	0.677589416504	0.63863	T	0.941744	0.99081	D	0.729601	0.99956	D	0.810245	0.99956	D	0.999679207801819	0.98421	D	0.975769	0.91526	D	0.9967038	0.99990	0.99245435	0.99991	0.9970585	0.99994	0.9916432	0.99988	-13.265	0.90845	D	0.967	0.90387	P	0.999849576725281	0.98301	0.99999240	0.99996	1	0.99985	.	.	.	.	.	.	5.091302	0.85044	28.5	0.99652915189651026	0.77467	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.99	0.89858	9.93	0.98824	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.991	0.66489	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561917G>T	ClinGen:CA255439|OMIM:300746.0093|UniProtKB:P00740#VAR_017319	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Ser	Ile	25688	single nucleotide variant	NM_000133.4(F9):c.1232G>T (p.Ser411Ile)	2158	F9	HGNC:3551	Pathogenic	1	Mar 01, 1992	137852276	-	RCV000011395	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561917	139561917	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255439,UniProtKB:P00740#VAR_017319,OMIM:300746.0093	1	10649	139561917	G	T	-	-	-	-	-	-	SCV000031627	-	-	1232G>T 	Ser411Ile	NM_000133.4		1_Pathogenic	F9	ENSG00000101981	52861	204388	CCSBVarC004395	ALE00004395	1232G>T	Ser411Ile	CEGS2	CegsMutGDEh1026	A08	GDEhDisVCh_40052	F06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	F9_Ser411Ile	23	X	139561917	G	T
14613	BRCA1	1742C>T	Thr581Ile	ENSG00000012048	17	43067628	NC_000017.11:43067628:G:A	ALE00003303	CCSBVarC003303	NULL	218422	NULL	GDEhDisVCh_40059	C06	CEGS2	ATGGATTTATCTGCTCTTCGCGTTGAAGAAGTACAAAATGTCATTAATGCTATGCAGAAAATCTTAGAGTGTCCCATCTGTCTGGAGTTGATCAAGGAACCTGTCTCCACAAAGTGTGACCACATATTTTGCAAATTTTGCATGCTGAAACTTCTCAACCAGAAGAAAGGGCCTTCACAGTGTCCTTTATGTAAGAATGATATAACCAAAAGGAGCCTACAAGAAAGTACGAGATTTAGTCAACTTGTTGAAGAGCTATTGAAAATCATTTGTGCTTTTCAGCTTGACACAGGTTTGGAGTATGCAAACAGCTATAATTTTGCAAAAAAGGAAAATAACTCTCCTGAACATCTAAAAGATGAAGTTTCTATCATCCAAAGTATGGGCTACAGAAACCGTGCCAAAAGACTTCTACAGAGTGAACCCGAAAATCCTTCCTTGCAGGAAACCAGTCTCAGTGTCCAACTCTCTAACCTTGGAACTGTGAGAACTCTGAGGACAAAGCAGCGGATACAACCTCAAAAGACGTCTGTCTACATTGAATTGGGATCTGATTCTTCTGAAGATACCGTTAATAAGGCAACTTATTGCAGTGTGGGAGATCAAGAATTGTTACAAATCACCCCTCAAGGAACCAGGGATGAAATCAGTTTGGATTCTGCAAAAAAGGCTGCTTGTGAATTTTCTGAGACGGATGTAACAAATACTGAACATCATCAACCCAGTAATAATGATTTGAACACCACTGAGAAGCGTGCAGCTGAGAGGCATCCAGAAAAGTATCAGGGTGAAGCAGCATCTGGGTGTGAGAGTGAAACAAGCGTCTCTGAAGACTGCTCAGGGCTATCCTCTCAGAGTGACATTTTAACCACTCAGCAGAGGGATACCATGCAACATAACCTGATAAAGCTCCAGCAGGAAATGGCTGAACTAGAAGCTGTGTTAGAACAGCATGGGAGCCAGCCTTCTAACAGCTACCCTTCCATCATAAGTGACTCTTCTGCCCTTGAGGACCTGCGAAATCCAGAACAAAGCACATCAGAAAAAGTATTAACTTCACAGAAAAGTAGTGAATACCCTATAAGCCAGAATCCAGAAGGCCTTTCTGCTGACAAGTTTGAGGTGTCTGCAGATAGTTCTACCAGTAAAAATAAAGAACCAGGAGTGGAAAGGTCATCCCCTTCTAAATGCCCATCATTAGATGATAGGTGGTACATGCACAGTTGCTCTGGGAGTCTTCAGAATAGAAACTACCCATCTCAAGAGGAGCTCATTAAGGTTGTTGATGTGGAGGAGCAACAGCTGGAAGAGTCTGGGCCACACGATTTGACGGAAACATCTTACTTGCCAAGGCAAGATCTAGAGGGAACCCCTTACCTGGAATCTGGAATCAGCCTCTTCTCTGATGACCCTGAATCTGATCCTTCTGAAGACAGAGCCCCAGAGTCAGCTCGTGTTGGCAACATACCATCTTCAACCTCTGCATTGAAAGTTCCCCAATTGAAAGTTGCAGAATCTGCCCAGAGTCCAGCTGCTGCTCATACTACTGATACTGCTGGGTATAATGCAATGGAAGAAAGTGTGAGCAGGGAGAAGCCAGAATTGACAGCTTCAACAGAAAGGGTCAACAAAAGAATGTCCATGGTGGTGTCTGGCCTGACCCCAGAAGAATTTATGCTCGTGTACAAGTTTGCCAGAAAACACCACATCACTTTAACTAATCTAATTACTGAAGAGACTATTCATGTTGTTATGAAAACAGATGCTGAGTTTGTGTGTGAACGGACACTGAAATATTTTCTAGGAATTGCGGGAGGAAAATGGGTAGTTAGCTATTTCTGGGTGACCCAGTCTATTAAAGAAAGAAAAATGCTGAATGAGCATGATTTTGAAGTCAGAGGAGATGTGGTCAATGGAAGAAACCACCAAGGTCCAAAGCGAGCAAGAGAATCCCAGGACAGAAAGATCTTCAGGGGGCTAGAAATCTGTTGCTATGGGCCCTTCACCAACATGCCCACAGGGTGTCCACCCAATTGTGGTTGTGCAGCCAGATGCCTGGACAGAGGACAATGGCTTCCATGCAATTGGGCAGATGTG	70032.0	single nucleotide variant	NM_007294.4(BRCA1):c.5054C>T (p.Thr1685Ile)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Aug 10, 2015	80357043.0	-	RCV000112476|RCV001853017|RCV002336188|RCV004998172	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43067628.0	43067628.0	17q21.31	reviewed by expert panel	9.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00050,ClinGen:CA003175,UniProtKB:P38398#VAR_063903	2.0	55365.0	43067628.0	G	A	-	-	-	-	-	-	SCV000244380	-	-	5054C>T 	Thr1685Ile	NM_007294.4	3.0	1_Pathogenic	chr17	C	T	17-43067628-C-T		55365	17	43067628	G	A	T	I	rs80357043	17	41219645	17	38473171	1685	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.5054C>T	p.Thr1685Ile	principal2	Y	1	.	.	-	ACT	2	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	0.89	0.90580	P	0.329	0.92348	B	.	0.99291	.	.	.	.	3.31	0.90471	M	.	0.82367	.	.	0.95034	0.7600	0.93898	D	0.7898	0.92853	D	10	.	0.85827	.	0.72506	0.97777	D	.	0.96457	.	.	.	.	.	.	0.96144	.	0.90972	.	0.19319	0.753464519978	0.74914	T	0.409904	0.82120	T	0.438305	0.91883	D	0.391819	0.91782	D	0.983474791049957	0.74950	D	0.958004	0.85541	D	0.88979423	0.90355	0.6439081	0.78957	0.9066492	0.91869	0.62467957	0.77890	-14.562	0.94802	D	.	0.91617	.	0.991231594940223	0.88934	0.99987290	0.99835	0.987	0.99559	.	.	.	.	.	.	4.1672	0.62705	24.5	0.99904362282002479	0.97578	0.771366	0.70495	D	0.813238141695724	0.86857	9.04512	0.757877512501455	0.86669	8.988454	5.24	5.24	0.72825	.	.	6.008	0.70468	11.804000	0.96740	0.569	0.28905	1.0	0.71675	1.000000	0.68239	0.976	0.56441	545	0.72635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1612146	1.860870e-06	0	1	44884	2.227970e-05	0	0	74826	0.000000e+00	0	0	912	0.000000e+00	0	0	59984	0.000000e+00	0	0	29592	0.000000e+00	0	1	44884	2.227970e-05	0	0	64008	0.000000e+00	0	0	6078	0.000000e+00	0	2	1178384	1.697240e-06	0	0	91058	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_cancer-predisposing_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43067628G>A	BRCA1-HCI:BRCA1_00050|ClinGen:CA003175|UniProtKB:P38398#VAR_063903	C0677776|C2676676|C0027672	604370	145|145|140162	BRCT domain|BRCT domain|BRCT domain	Thr	Ile	70032	single nucleotide variant	NM_007294.4(BRCA1):c.5054C>T (p.Thr1685Ile)	672	BRCA1	HGNC:1100	Pathogenic	1	Aug 10, 2015	80357043	-	RCV000112476|RCV001853017|RCV002336188|RCV004998172	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43067628	43067628	17q21.31	reviewed by expert panel	9	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00050,ClinGen:CA003175,UniProtKB:P38398#VAR_063903	2	55365	43067628	G	A	-	-	-	-	-	-	SCV000244380	-	-	5054C>T 	Thr1685Ile	NM_007294.4	3	1_Pathogenic	BRCA1	ENSG00000012048	14613	218422	CCSBVarC003303	ALE00003303	1742C>T	Thr581Ile	CEGS2	CegsMutGDEh1018	D09	GDEhDisVCh_40059	C06	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	BRCA1_Thr581Ile	17	17	43067628	G	A
71569	OTC	119G>A	Arg40His	ENSG00000036473	X	38367332	NC_000023.11:38367332:G:A	ALE00002759	CCSBVarC002759	35411	NULL	NULL	GDEhDisVCh_40048	A12	RC4	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCATGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	26053.0	single nucleotide variant	NM_000531.6(OTC):c.119G>A (p.Arg40His)	5009.0	OTC	HGNC:8512	Pathogenic/Likely pathogenic	1.0	May 29, 2024	72554308.0	-	RCV000011761|RCV000083333	MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664|MedGen:C3661900	Ornithine carbamoyltransferase deficiency|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	38367332.0	38367332.0	Xp11.4	criteria provided, multiple submitters, no conflicts	15.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224454,UniProtKB:P00480#VAR_004846,OMIM:300461.0029	3.0	11014.0	38367332.0	G	A	-	-	-	-	-	-	SCV000485682|SCV000490962|SCV000840025|SCV000854966|SCV000945273|SCV002033213|SCV004026360|SCV004040714|SCV004226706|SCV005085998|SCV005184458|SCV005682890	-	-	119G>A 	Arg40His	NM_000531.6	2.0	1_Pathogenic	chrX	G	A	X-38367332-G-A	0.0	11014	X	38367332	G	A	R	H	rs72554308	X	38226585	X	38111529	40	OTC	ENSG00000036473	ENST00000713758	ENSP00000519059	P00480	OTC_HUMAN	.	.	c.119G>A	p.Arg40His	principal1	Y	.	.	.	+	CGT	2	0	G	./.	./.	./.	./.	.	0.50835	.	.	0.57928	.	0.54	0.37923	P	0.034	0.22547	B	.	0.42965	.	.	.	.	3.03	0.86272	M	.	0.65199	.	.	0.76475	1.1401	0.99937	D	0.9493	0.98345	D	9	.	0.99234	.	0.39456	0.93249	D	.	0.84806	0.976	0.99775	P00480	R40H	Loss of MoRF binding (P = 0.0407)| Gain of ubiquitination at K38 (P = 0.0444)| Gain of catalytic residue at L42 (P = 0.0609)| Loss of sheet (P = 0.0817)| Loss of stability (P = 0.1143)	.	0.90746	.	0.93631	.	0.55207	0.415773153305	0.27221	T	0.849152	0.96523	D	0.231072	0.76649	D	0.0941429	0.76346	D	0.994004309177399	0.84934	D	.	0.51848	.	0.5407871	0.69141	0.3259423	0.58277	0.5407871	0.69142	0.3259423	0.58276	-6.593	0.51065	T	.	0.36709	.	0.955738197715107	0.81149	0.98716130	0.96331	0.917	0.95747	.	.	.	.	.	.	3.500219	0.49051	22.7	0.98464551756084728	0.41906	.	.	.	.	.	.	.	.	.	5.39	4.54	0.55168	3.96	0.75470	5.092	0.64425	7.490000	0.59422	-0.165	0.11495	1.0	0.71675	1.000000	0.68239	0.948	0.49339	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	not_provided|Ornithine_carbamoyltransferase_deficiency	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.38367332G>A	ClinGen:CA224454|OMIM:300461.0029|UniProtKB:P00480#VAR_004846	C3661900|C0268542	311250	664	Aspartate/ornithine carbamoyltransferase, carbamoyl-P binding	Arg	His	26053	single nucleotide variant	NM_000531.6(OTC):c.119G>A (p.Arg40His)	5009	OTC	HGNC:8512	Pathogenic/Likely pathogenic	1	May 29, 2024	72554308	-	RCV000011761|RCV000083333	MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664|MedGen:C3661900	Ornithine carbamoyltransferase deficiency|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	38367332	38367332	Xp11.4	criteria provided, multiple submitters, no conflicts	15	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224454,UniProtKB:P00480#VAR_004846,OMIM:300461.0029	3	11014	38367332	G	A	-	-	-	-	-	-	SCV000485682|SCV000490962|SCV000840025|SCV000854966|SCV000945273|SCV002033213|SCV004026360|SCV004040714|SCV004226706|SCV005085998|SCV005184458|SCV005682890	-	-	119G>A 	Arg40His	NM_000531.6	2	1_Pathogenic	OTC	ENSG00000036473	71569	35411	CCSBVarC002759	ALE00002759	119G>A	Arg40His	RC4	RC4_Mut_GDEh1017	A12	GDEhDisVCh_40048	A12	2	RC4_Mut_GDDh1017	A12	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	4	0	NULL	0	NULL	0	NULL	OTC_Arg40His	23	X	38367332	G	A
2803	HMBS	242T>C	Leu81Pro	ENSG00000256269	11	119089248	NC_000011.10:119089248:T:C	ALE00005159	CCSBVarC005159	NULL	200927	NULL	GDEhDisVCh_40054	H04	CEGS2	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAGCTTGCTCGCATACAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGGACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCCTGAACATGCCCTGGAGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCGAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTCGGGGAAACCTCAACACCCGGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACCGGGTGGGGCAGATCCTGCACCCTGAGGAATGCATGTATGCTGTGGGCCAGGGGGCCTTGGGCGTGGAAGTGCGAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCTGCATCGCTGAAAGGGCCTTCCTGAGGCACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATGGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCGTAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACGATGCCCAT	16524.0	single nucleotide variant	NM_000190.4(HMBS):c.242T>C (p.Leu81Pro)	3145.0	HMBS	HGNC:4982	Pathogenic	1.0	Jan 01, 2004	118204119.0	-	RCV003764513	MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704	Encephalopathy, porphyria-related	germline	germline	GRCh38	NC_000011.10	11	119089248.0	119089248.0	11q23.3	no assertion criteria provided	1.0	-	N	ClinGen:CA251843,UniProtKB:P08397#VAR_025563,OMIM:609806.0045	1.0	1485.0	119089248.0	T	C	-	-	-	-	-	-	SCV000021705	-	-	242T>C 	Leu81Pro	NM_000190.4		1_Pathogenic	chr11	T	C	11-119089248-T-C		1485	11	119089248	T	C	L	P	rs118204119	11	118959958	11	118465168	81	HMBS	ENSG00000256269	ENST00000652429	ENSP00000498786	P08397	HEM3_HUMAN	c.242T>C	p.Leu81Pro	c.242T>C	p.Leu81Pro	principal2	Y	.	YES	Select	+	CTT	2	0	T	T/T	T/T	T/T	T/T	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	1.0	0.97365	D	.	0.99291	.	.	.	.	4.2	0.97779	H	.	0.93040	.	.	0.99026	0.9330	0.96133	D	0.9951	0.99889	D	9	.	0.99856	.	0.867657	0.98984	D	.	0.99783	0.971	0.99725	P08397	L81P	Gain of disorder (P = 0.0292)| Gain of ubiquitination at K79 (P = 0.0804)| Gain of phosphorylation at T78 (P = 0.0928)| Gain of glycosylation at L81 (P = 0.0945)| Loss of stability (P = 0.1367)	.	0.99345	0.9765642607558596	0.97634	.	.	0.857390701771	0.90709	D	0.99328	0.99980	D	0.58477	0.97173	D	0.602205	0.97008	D	0.99982762336731	0.99193	D	0.99516	0.98370	D	0.9905138	0.99786	0.9536428	0.98593	0.9839415	0.99385	0.9553901	0.98697	-16.615	0.99082	D	0.9973	0.96927	P	0.999991326508259	0.99831	0.41906053	0.80050	1	0.99985	.	.	.	.	.	.	5.395449	0.90388	31.0	0.99916275516384256	0.98450	0.973601	0.99503	D	0.938515060976654	0.93478	12.09053	0.823569374365732	0.91334	10.85838	5.96	4.81	0.61353	5.13	0.91238	7.449	0.79752	7.880000	0.72494	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.997	0.79771	228	0.91137	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Encephalopathy,_porphyria-related	no_assertion_criteria_provided	NC_000011.10:g.119089248T>C	ClinGen:CA251843|OMIM:609806.0045|UniProtKB:P08397#VAR_025563	CN376852	620704	.	Porphobilinogen deaminase, N-terminal	Leu	Pro	16524	single nucleotide variant	NM_000190.4(HMBS):c.242T>C (p.Leu81Pro)	3145	HMBS	HGNC:4982	Pathogenic	1	Jan 01, 2004	118204119	-	RCV003764513	MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704	Encephalopathy, porphyria-related	germline	germline	GRCh38	NC_000011.10	11	119089248	119089248	11q23.3	no assertion criteria provided	1	-	N	ClinGen:CA251843,UniProtKB:P08397#VAR_025563,OMIM:609806.0045	1	1485	119089248	T	C	-	-	-	-	-	-	SCV000021705	-	-	242T>C 	Leu81Pro	NM_000190.4		1_Pathogenic	HMBS	ENSG00000256269	2803	200927	CCSBVarC005159	ALE00005159	242T>C	Leu81Pro	CEGS2	CegsMutGDEh1039	B07	GDEhDisVCh_40054	H04	2	CegsMutGDDh1039	B07	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	HMBS_Leu81Pro	11	11	119089248	T	C
2013	KCNE1	29C>T	Thr10Met	ENSG00000180509	21	34449606	NC_000021.9:34449606:G:A	ALE00006333	CCSBVarC006333	NULL	214139	NULL	GDEhDisVCh_40065	F03	CEGS2	ATGATCCTGTCTAACACCACAGCGGTGATGCCCTTTCTGACCAAGCTGTGGCAGGAGACAGTTCAGCAGGGTGGCAACATGTCGGGCCTGGCCCACAGGTCCCCCCGCAGCGGTGACGGCAAGCTGGAGGCCCTCTACGTCCTCATGGTACTGGGATTCTTCGGCTTCTTCACCCTGGGCATCATGCTGAGCTACATCCGCTCCAAGAAGCTGGAGCACTCGAACGACCCATTCAACGTCTACATCGAGTCCGATGCCTGGCAAGAGAAGGACAAGGCCTATGTCCAGGCCCGGGTCCTGGAGAGCTACAGGTCG	136425.0	single nucleotide variant	NM_000219.6(KCNE1):c.29C>T (p.Thr10Met)	3753.0	KCNE1	HGNC:6240	Conflicting classifications of pathogenicity	0.0	Jan 29, 2025	144917638.0	-	RCV000119089|RCV000148515|RCV000208391|RCV000618890|RCV001139931|RCV001529228|RCV004754301|RCV004777595	MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:101016,Orphanet:768|MONDO:MONDO:0002442,MeSH:D008133,MedGen:C0023976|MedGen:CN169374|MedGen:CN230736|MONDO:MONDO:0012871,MedGen:C2676723,OMIM:612347,Orphanet:768,Orphanet:90647|MedGen:C3661900||MONDO:MONDO:0013372,MedGen:C1867904,OMIM:613695,Orphanet:101016,Orphanet:768	Congenital long QT syndrome|Long QT syndrome|not specified|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome 2|not provided|KCNE1-related disorder|Long QT syndrome 5	germline;not applicable;unknown	germline	GRCh38	NC_000021.9	21	34449606.0	34449606.0	21q22.12	criteria provided, conflicting classifications	13.0	-	N	ClinGen:CA211441,UniProtKB:P15382#VAR_074909	2.0	132677.0	34449606.0	G	A	-	-	-	-	-	-	SCV000050605|SCV000190227|SCV000263970|SCV000728587|SCV000736408|SCV000812446|SCV001300131|SCV003813999|SCV005726838	-	-	29C>T 	Thr10Met	NM_000219.6	1.0	3_Conflicting	chr21	C	T	21-34449606-C-T		132677	21	34449606	G	A	T	M	rs144917638	21	35821904	21	34743774	10	KCNE1	ENSG00000180509	ENST00000621601	ENSP00000483895	P15382	KCNE1_HUMAN	c.29C>T	p.Thr10Met	c.29C>T	p.Thr10Met	principal1	Y	4	.	.	-	ACG	2	0	G	G/G	G/G	G/G	G/G	.	0.12180	.	0.23	0.25427	T	0.001	0.07480	B	0.003	0.08696	B	.	0.97926	.	.	.	.	-0.38	0.03061	N	.	0.12213	.	0.041	0.08619	-0.5777	0.65558	T	0.3956	0.74739	T	10	0.045074433	0.03541	T	0.074962	0.72075	D	.	0.77984	.	.	.	.	.	0.545173277474	0.53835	.	0.39436	.	0.08794	0.249600023031	0.03727	T	0.412061	0.76467	T	-0.289157	0.09495	T	-0.296753	0.44726	T	0.00860703531440309	0.00104	T	.	0.16061	.	0.012878743	0.00044	0.024856415	0.00518	0.012492841	0.00035	0.03023639	0.01464	-4.846	0.35164	T	.	0.01669	.	0.0231307164371046	0.30647	0.99834895	0.98743	0.024	0.04173	.	.	.	.	.	.	0.096461	0.05007	1.548	0.73931888924860811	0.10679	0.055061	0.09912	N	-1.83426464048498	0.00463	0.02007908	-1.91322505167736	0.00457	0.02040418	4.82	-9.65	0.00451	-8.27	0.00722	-1.216	0.03093	-0.695000	0.07856	-0.78	0.03349	0.0	0.06393	0.000000	0.08389	0.002	0.04174	900	0.24584	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	22	109398	2.011010e-04	0	48	207926	2.308510e-04	0	53	236834	2.237850e-04	0	0	7162	0.000000e+00	0	4	17112	2.337540e-04	0	0	2320	0.000000e+00	0	1	9046	1.105460e-04	0	0	13392	0.000000e+00	0	8	42762	1.870820e-04	0	9	15690	5.736140e-04	0	9	15690	5.736140e-04	0	1	16186	6.178180e-05	0	7	30516	2.293880e-04	0	0	6208	0.000000e+00	0	3	13404	2.238140e-04	0	0	16732	0.000000e+00	0	19	89412	2.124990e-04	0	18	30608	5.880820e-04	0	18	30608	5.880820e-04	0	1	14888	6.716820e-05	0	8	34256	2.335360e-04	0	0	9564	0.000000e+00	0	3	17692	1.695680e-04	0	0	21624	0.000000e+00	0	22	102666	2.142870e-04	0	18	30526	5.896610e-04	0	18	30526	5.896610e-04	0	.	192	908414	2.113570e-04	10	5	4100	1.219510e-03	0	2	42424	4.714310e-05	0	0	454	0.000000e+00	0	5	46894	1.066230e-04	0	0	21258	0.000000e+00	0	8	36082	2.217170e-04	0	0	49914	0.000000e+00	0	5	4100	1.219510e-03	0	113	600796	1.880840e-04	5	53	66834	7.930100e-04	5	9	46812	1.9225839528326071E-4	0	300	0	0	110	0	1	7968	1.255020080321285E-4	0	500	0	0	628	0	0	54	0	0	94	0	3	8522	3.5203003989673785E-4	1	8268	1.2094823415578132E-4	0	164	0	13	64988	2.000369298947498E-4	Conflicting_classifications_of_pathogenicity	Jervell_and_Lange-Nielsen_syndrome_2|Congenital_long_QT_syndrome|Cardiovascular_phenotype|Long_QT_syndrome|not_provided|not_specified	criteria_provided,_conflicting_classifications	NC_000021.9:g.34449606G>A	ClinGen:CA211441|UniProtKB:P15382#VAR_074909	C2676723|C1141890|CN230736|C0023976|C3661900|CN169374	612347|PS192500	768|90647|101016|768	.	Thr	Met	136425	single nucleotide variant	NM_000219.6(KCNE1):c.29C>T (p.Thr10Met)	3753	KCNE1	HGNC:6240	Conflicting classifications of pathogenicity	0	Jan 29, 2025	144917638	-	RCV000119089|RCV000148515|RCV000208391|RCV000618890|RCV001139931|RCV001529228|RCV004754301|RCV004777595	MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:101016,Orphanet:768|MONDO:MONDO:0002442,MeSH:D008133,MedGen:C0023976|MedGen:CN169374|MedGen:CN230736|MONDO:MONDO:0012871,MedGen:C2676723,OMIM:612347,Orphanet:768,Orphanet:90647|MedGen:C3661900||MONDO:MONDO:0013372,MedGen:C1867904,OMIM:613695,Orphanet:101016,Orphanet:768	Congenital long QT syndrome|Long QT syndrome|not specified|Cardiovascular phenotype|Jervell and Lange-Nielsen syndrome 2|not provided|KCNE1-related disorder|Long QT syndrome 5	germline;not applicable;unknown	germline	GRCh38	NC_000021.9	21	34449606	34449606	21q22.12	criteria provided, conflicting classifications	13	-	N	ClinGen:CA211441,UniProtKB:P15382#VAR_074909	2	132677	34449606	G	A	-	-	-	-	-	-	SCV000050605|SCV000190227|SCV000263970|SCV000728587|SCV000736408|SCV000812446|SCV001300131|SCV003813999|SCV005726838	-	-	29C>T 	Thr10Met	NM_000219.6	1	3_Conflicting	KCNE1	ENSG00000180509	2013	214139	CCSBVarC006333	ALE00006333	29C>T	Thr10Met	CEGS2	CegsMutGDEh1012	G07	GDEhDisVCh_40065	F03	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	4	0	NULL	0	NULL	0	NULL	0	NULL	KCNE1_Thr10Met	21	21	34449606	G	A
52861	F9	1069G>A	Gly357Arg	ENSG00000101981	X	139561754	NC_000023.11:139561754:G:A	ALE00004386	CCSBVarC004386	NULL	204380	NULL	GDEhDisVCh_40052	H03	CEGS2	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGAGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT	25650.0	single nucleotide variant	NM_000133.4(F9):c.1069G>A (p.Gly357Arg)	2158.0	F9	HGNC:3551	Pathogenic/Likely pathogenic	1.0	Sep 01, 2022	137852257.0	-	RCV000011357|RCV000851648	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561754.0	139561754.0	Xq27.1	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA255389,UniProtKB:P00740#VAR_017316,OMIM:300746.0054	3.0	10611.0	139561754.0	G	A	-	-	-	-	-	-	SCV000899416|SCV002573125	-	-	1069G>A 	Gly357Arg	NM_000133.4	2.0	1_Pathogenic	chrX	G	A	X-139561754-G-A		10611	X	139561754	G	A	G	R	rs137852257	X	138643913	X	138471579	357	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1069G>A	p.Gly357Arg	c.1069G>A	p.Gly357Arg	principal1	Y	1	YES	Select	+	GGA	1	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.18	0.97682	H	-7.95	0.96333	D	0.916	0.99826	1.0795	0.98863	D	0.9544	0.98518	D	10	0.995182	0.99977	D	0.906856	0.99300	D	0.953	0.99157	0.986	0.99859	P00740	G357R	Gain of MoRF binding (P = 0.0302)| Gain of methylation at K362 (P = 0.1005)| Loss of catalytic residue at W356 (P = 0.1106)| Loss of glycosylation at S354 (P = 0.115)| Loss of sheet (P = 0.1398)	0.997918789465	0.99786	0.9982126436659727	0.99820	1.79749068387	0.91559	0.483639627695	0.36509	T	0.974572	0.99744	D	0.726137	0.99952	D	0.805269	0.99952	D	0.999871015548706	0.99466	D	0.921608	0.71470	D	0.9938451	0.99928	0.98331475	0.99892	0.99436826	0.99944	0.9819979	0.99865	-14.024	0.95239	D	0.9808	0.93613	P	0.999911895729495	0.98806	0.99999261	0.99996	1	0.99985	.	.	.	.	.	.	5.190434	0.87068	29.1	0.99916914203747009	0.98450	.	.	.	.	.	.	.	.	.	5.66	4.8	0.61109	.	.	9.568	0.97322	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	1.0	0.97202	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7696	0	0	108	0	0	118	0	0	3142	0	0	146	0	0	610	0	0	24	0	0	100	0	0	578	0	0	3250	0	0	142	0	0	12522	0	Pathogenic/Likely_pathogenic	Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561754G>A	ClinGen:CA255389|OMIM:300746.0054|UniProtKB:P00740#VAR_017316	C0008533|C0019069	306900|134500|306700	98879|98878	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Gly	Arg	25650	single nucleotide variant	NM_000133.4(F9):c.1069G>A (p.Gly357Arg)	2158	F9	HGNC:3551	Pathogenic/Likely pathogenic	1	Sep 01, 2022	137852257	-	RCV000011357|RCV000851648	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease	germline;unknown	germline	GRCh38	NC_000023.11	X	139561754	139561754	Xq27.1	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA255389,UniProtKB:P00740#VAR_017316,OMIM:300746.0054	3	10611	139561754	G	A	-	-	-	-	-	-	SCV000899416|SCV002573125	-	-	1069G>A 	Gly357Arg	NM_000133.4	2	1_Pathogenic	F9	ENSG00000101981	52861	204380	CCSBVarC004386	ALE00004386	1069G>A	Gly357Arg	CEGS2	CegsMutGDEh1018	F05	GDEhDisVCh_40052	H03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	F9_Gly357Arg	23	X	139561754	G	A
359	CBS	65A>G	His22Arg	ENSG00000160200	21	43072129	NC_000021.9:43072129:T:C	ALE00007354	CCSBVarC007366	NULL	NULL	327	GDEhDisVCh_40013	C12	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACGCTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210452.0	single nucleotide variant	NM_000071.3(CBS):c.65A>G (p.His22Arg)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Dec 02, 2024	763151207.0	-	RCV000197426|RCV000648122|RCV002515348|RCV004821999|RCV004700579	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:CN169374	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection|not specified	germline;unknown	germline	GRCh38	NC_000021.9	21	43072129.0	43072129.0	21q22.3	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA321891	2.0	212870.0	43072129.0	T	C	-	-	-	-	-	-	SCV000249717|SCV000769935|SCV002541703|SCV005203101|SCV005545937	-	-	65A>G 	His22Arg	NM_000071.3	2.0	4_VUS	chr21	A	G	21-43072129-A-G		212870	21	43072129	T	C	H	R	rs763151207	21	44492239	21	43365308	22	CBS	ENSG00000160200	ENST00000398165	ENSP00000381231	P35520	CBS_HUMAN	c.65A>G	p.His22Arg	c.65A>G	p.His22Arg	principal1	Y	1	YES	Select	-	CAC	2	0	T	T/T	T/T	T/T	T/T	0.136	0.32753	T	0.252	0.25502	T	0.001	0.07480	B	0.001	0.04348	B	.	.	.	.	.	.	1.725	0.44368	L	-0.36	0.13346	N	0.187	0.20526	0.5108	0.90663	D	0.9008	0.96702	D	10	0.102733195	0.18645	T	0.137114	0.81909	D	0.313	0.63293	0.164	0.06800	P35520	H22R	Gain of solvent accessibility (P = 0.0021)| Gain of MoRF binding (P = 0.0082)| Gain of relative solvent accessibility (P = 0.0166)| Gain of helix (P = 0.062)| Loss of glycosylation at S19 (P = 0.1084)	0.326881540566	0.31892	0.22829685657134346	0.22555	0.423011330703	0.42495	0.422617137432	0.28163	T	0.449637	0.78949	T	-0.104381	0.35342	T	-0.206801	0.53687	T	0.0389017023384248	0.03465	T	.	0.14783	.	0.14245163	0.32504	0.039642923	0.04118	0.10458244	0.24501	0.03666475	0.03170	-2.718	0.07463	T	.	0.00818	.	0.0325593746129361	0.33508	0.99149220	0.96972	0.142	0.36990	.	.	.	.	.	.	-0.580351	0.01631	0.112	0.46803054752934675	0.03815	0.209458	0.33333	N	-1.15506901267492	0.05631	0.2603906	-1.22487958301128	0.05425	0.2628579	4.81	-2.29	0.06407	-5.08	0.04365	-1.012	0.03762	-3.712000	0.02602	-1.105	0.01506	0.0	0.06393	0.000000	0.08389	0.004	0.06081	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4	108698	3.679920e-05	0	9	203906	4.413800e-05	0	7	233648	2.995960e-05	0	0	7052	0.000000e+00	0	0	17026	0.000000e+00	0	1	2298	4.351610e-04	0	0	9004	0.000000e+00	0	0	13358	0.000000e+00	0	3	42374	7.079810e-05	0	0	15688	0.000000e+00	0	3	42374	7.079810e-05	0	0	15388	0.000000e+00	0	0	30384	0.000000e+00	0	1	6060	1.650170e-04	0	0	13364	0.000000e+00	0	0	16676	0.000000e+00	0	8	86682	9.229140e-05	0	0	30594	0.000000e+00	0	8	86682	9.229140e-05	0	0	14168	0.000000e+00	0	0	34136	0.000000e+00	0	1	9494	1.053300e-04	0	0	17646	0.000000e+00	0	0	21382	0.000000e+00	0	6	100752	5.955220e-05	0	0	30518	0.000000e+00	0	6	100752	5.955220e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4	27420	1.4587892049598833E-4	0	8	0	0	26	0	0	606	0	0	354	0	0	18	0	0	30	0	0	0	0	0	6376	0	0	614	0	0	56	0	4	34838	1.148171536827602E-4	Uncertain_significance	not_provided|Classic_homocystinuria|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43072129T>C	ClinGen:CA321891	CN517202|C0751202|C3150344	236200	394	.	His	Arg	210452	single nucleotide variant	NM_000071.3(CBS):c.65A>G (p.His22Arg)	875	CBS	HGNC:1550	Uncertain significance	0	Dec 02, 2024	763151207	-	RCV000197426|RCV000648122|RCV002515348|RCV004821999|RCV004700579	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:CN169374	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection|not specified	germline;unknown	germline	GRCh38	NC_000021.9	21	43072129	43072129	21q22.3	criteria provided, multiple submitters, no conflicts	7	-	N	ClinGen:CA321891	2	212870	43072129	T	C	-	-	-	-	-	-	SCV000249717|SCV000769935|SCV002541703|SCV005203101|SCV005545937	-	-	65A>G 	His22Arg	NM_000071.3	2	4_VUS	CBS	ENSG00000160200	359	327	CCSBVarC007366	ALE00007354	65A>G	His22Arg	Edgotyping3	VUSMutGDEh011	B07	GDEhDisVCh_40013	C12	1	VUSMutGDDh011	B07	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	CBS_His22Arg	21	21	43072129	T	C
2803	HMBS	601C>T	Arg201Trp	ENSG00000256269	11	119091515	NC_000011.10:119091515:C:T	ALE00005169	CCSBVarC005169	NULL	200935	NULL	GDEhDisVCh_40054	C06	CEGS2	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAGCTTGCTCGCATACAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGGACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCTTGAACATGCCCTGGAGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCGAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTCGGGGAAACCTCAACACCCGGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACTGGGTGGGGCAGATCCTGCACCCTGAGGAATGCATGTATGCTGTGGGCCAGGGGGCCTTGGGCGTGGAAGTGCGAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCTGCATCGCTGAAAGGGCCTTCCTGAGGCACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATGGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCGTAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACGATGCCCAT	16501.0	single nucleotide variant	NM_000190.4(HMBS):c.601C>T (p.Arg201Trp)	3145.0	HMBS	HGNC:4982	Pathogenic/Likely pathogenic	1.0	Dec 21, 2024	118204109.0	-	RCV000001527|RCV000432186|RCV004584591	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704	Acute intermittent porphyria|not provided|Encephalopathy, porphyria-related	germline	germline	GRCh38	NC_000011.10	11	119091515.0	119091515.0	11q23.3	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA251820,UniProtKB:P08397#VAR_003657,OMIM:609806.0026	3.0	1462.0	119091515.0	C	T	-	-	-	-	-	-	SCV000516851|SCV000915504|SCV000955273|SCV004226625|SCV005068334|SCV005415831	-	-	601C>T 	Arg201Trp	NM_000190.4	2.0	1_Pathogenic	chr11	C	T	11-119091515-C-T	0.0000143086	1462	11	119091515	C	T	R	W	rs118204109	11	118962225	11	118467435	201	HMBS	ENSG00000256269	ENST00000652429	ENSP00000498786	P08397	HEM3_HUMAN	c.601C>T	p.Arg201Trp	c.601C>T	p.Arg201Trp	principal2	Y	.	YES	Select	+	CGG	1	2	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	1.0	0.97365	D	.	0.99291	.	.	.	.	3.575	0.93413	H	.	0.95782	.	.	0.91045	1.0854	0.99062	D	0.9886	0.99673	D	9	.	0.99847	.	0.531776	0.95592	D	.	0.98152	0.92	0.98560	P08397	R201W	Loss of MoRF binding (P = 0.0825)| Gain of helix (P = 0.132)| Gain of catalytic residue at Q204 (P = 0.1645)| Gain of loop (P = 0.4248)| Loss of sheet (P = 0.437)	.	0.97919	0.9397756445098893	0.93921	.	.	0.642184257507	0.58810	T	0.986404	0.99919	D	0.393788	0.89480	D	0.531473	0.95206	D	0.994390308856964	0.85540	D	0.982235	0.94464	D	0.95610327	0.96835	0.8298145	0.90045	0.96116644	0.97356	0.8561837	0.91813	-14.948	0.95739	D	0.6621	0.78902	P	0.999088984520639	0.95667	0.37251950	0.78891	1	0.99985	.	.	.	.	.	.	4.326851	0.66334	24.9	0.99856672582283434	0.93553	0.790155	0.71810	D	0.341065952017913	0.58054	3.998233	0.206590644942969	0.49956	3.215702	5.62	1.46	0.21714	2.65	0.48461	1.996	0.405	2.181000	0.31213	-0.177	0.10546	1.0	0.71675	1.000000	0.68239	0.648	0.3268	228	0.91137	.	.	.	.	.	.	.	.	.	.	.	.	10	264690	3.7780046E-5	.	2	65024	3.075790e-05	0	3	132228	2.268810e-05	0	4	151632	2.637970e-05	0	0	2852	0.000000e+00	0	0	12384	0.000000e+00	0	0	1454	0.000000e+00	0	1	4604	2.172020e-04	0	0	11468	0.000000e+00	0	1	19454	5.140330e-05	0	0	11444	0.000000e+00	0	1	4604	2.172020e-04	0	0	8602	0.000000e+00	0	1	20682	4.835120e-05	0	0	4744	0.000000e+00	0	1	8782	1.138690e-04	0	0	13478	0.000000e+00	0	1	49578	2.017020e-05	0	0	22782	0.000000e+00	0	1	8782	1.138690e-04	0	0	8080	0.000000e+00	0	1	24654	4.056140e-05	0	0	8318	0.000000e+00	0	1	11040	9.057970e-05	0	0	15348	0.000000e+00	0	2	57126	3.501030e-05	0	0	22770	0.000000e+00	0	1	11040	9.057970e-05	0	.	26	1550004	1.677420e-05	0	2	40940	4.885200e-05	0	1	73032	1.369260e-05	0	0	912	0.000000e+00	0	0	50994	0.000000e+00	0	0	28644	0.000000e+00	0	2	40940	4.885200e-05	0	0	59792	0.000000e+00	0	0	6012	0.000000e+00	0	22	1145592	1.920400e-05	0	1	84050	1.189770e-05	0	1	26666	3.7500937523438084E-5	0	114	0	0	120	0	0	3238	0	0	500	0	1	628	0.0015923566878980893	0	26	0	0	104	0	1	4696	2.1294718909710392E-4	0	3352	0	0	146	0	3	36092	8.31209132217666E-5	Pathogenic/Likely_pathogenic	Encephalopathy,_porphyria-related|Acute_intermittent_porphyria|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.119091515C>T	ClinGen:CA251820|OMIM:609806.0026|UniProtKB:P08397#VAR_003657	CN376852|C0162565|C3661900	620704|176000	79276	Porphobilinogen deaminase, N-terminal	Arg	Trp	16501	single nucleotide variant	NM_000190.4(HMBS):c.601C>T (p.Arg201Trp)	3145	HMBS	HGNC:4982	Pathogenic/Likely pathogenic	1	Dec 21, 2024	118204109	-	RCV000001527|RCV000432186|RCV004584591	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704	Acute intermittent porphyria|not provided|Encephalopathy, porphyria-related	germline	germline	GRCh38	NC_000011.10	11	119091515	119091515	11q23.3	criteria provided, multiple submitters, no conflicts	7	-	N	ClinGen:CA251820,UniProtKB:P08397#VAR_003657,OMIM:609806.0026	3	1462	119091515	C	T	-	-	-	-	-	-	SCV000516851|SCV000915504|SCV000955273|SCV004226625|SCV005068334|SCV005415831	-	-	601C>T 	Arg201Trp	NM_000190.4	2	1_Pathogenic	HMBS	ENSG00000256269	2803	200935	CCSBVarC005169	ALE00005169	601C>T	Arg201Trp	CEGS2	CegsMutGDEh1041	E02	GDEhDisVCh_40054	C06	2	CegsMutGDDh1041	E02	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	HMBS_Arg201Trp	11	11	119091515	C	T
2803	HMBS	257A>T	Glu86Val	ENSG00000256269	11	119089263	NC_000011.10:119089263:A:T	ALE00005160	CCSBVarC005160	NULL	200926	NULL	GDEhDisVCh_40054	D03	CEGS2	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAGCTTGCTCGCATACAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGGACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCTTGAACATGCCCTGGTGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCGAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTCGGGGAAACCTCAACACCCGGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACCGGGTGGGGCAGATCCTGCACCCTGAGGAATGCATGTATGCTGTGGGCCAGGGGGCCTTGGGCGTGGAAGTGCGAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCTGCATCGCTGAAAGGGCCTTCCTGAGGCACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATGGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCGTAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACGATGCCCAT	171128.0	single nucleotide variant	NM_000190.4(HMBS):c.257A>T (p.Glu86Val)	3145.0	HMBS	HGNC:4982	Conflicting classifications of pathogenicity	0.0	Jan 24, 2025	150763621.0	-	RCV000148510|RCV001514054|RCV003927449	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|	Acute intermittent porphyria|not provided|HMBS-related disorder	germline	germline	GRCh38	NC_000011.10	11	119089263.0	119089263.0	11q23.3	criteria provided, conflicting classifications	7.0	-	N	ClinGen:CA272879,UniProtKB:P08397#VAR_025564	2.0	161252.0	119089263.0	A	T	-	-	-	-	-	-	SCV001167212|SCV001261488|SCV001721801|SCV001822907|SCV002541174	-	-	257A>T 	Glu86Val	NM_000190.4	1.0	3_Conflicting	chr11	A	T	11-119089263-A-T	0.000441296	161252	11	119089263	A	T	E	V	rs150763621	11	118959973	11	118465183	86	HMBS	ENSG00000256269	ENST00000652429	ENSP00000498786	P08397	HEM3_HUMAN	c.257A>T	p.Glu86Val	c.257A>T	p.Glu86Val	principal2	Y	.	YES	Select	+	GAG	2	0	A	A/A	A/A	A/A	A/A	.	0.21176	.	.	0.35789	.	0.996	0.77914	D	0.952	0.69100	D	.	0.13669	.	.	.	.	1.09	0.27188	L	.	0.62887	.	.	0.79136	1.0972	0.99541	D	0.9735	0.99169	D	10	.	0.00319	.	0.419506	0.93751	D	.	0.97167	.	.	.	.	.	.	0.93792	0.6347533317158794	0.63238	.	.	0.638639688492	0.58306	T	0.783028	0.94240	D	0.305539	0.83282	D	0.493258	0.94422	D	0.0607448145747185	0.07204	T	0.978852	0.92661	D	0.54433566	0.69341	0.3582298	0.61063	0.45547208	0.64071	0.31428748	0.57197	-6.406	0.51861	T	0.4027	0.59683	A	0.97727566799837	0.84692	0.19951561	0.73062	0.868	0.92825	.	.	.	.	.	.	4.992618	0.8281	27.9	0.99206915280202579	0.55544	0.945445	0.95360	D	0.607929687953653	0.73534	6.005115	0.678876757756973	0.80671	7.37513	5.96	5.96	0.96689	5.21	0.92006	8.683	0.90982	6.865000	0.56840	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.992	0.67791	228	0.91137	.	.	.	.	.	.	.	.	.	.	.	.	125	264690	4.7225057E-4	.	49	109408	4.478650e-04	0	141	208136	6.774420e-04	1	198	236958	8.355910e-04	1	0	7164	0.000000e+00	0	1	17112	5.843850e-05	0	39	2320	1.681030e-02	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	7	42768	1.636740e-04	0	0	15690	0.000000e+00	0	7	42768	1.636740e-04	0	2	16218	1.233200e-04	0	1	30524	3.276110e-05	0	109	6212	1.754670e-02	1	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	22	89558	2.456510e-04	0	0	30608	0.000000e+00	0	22	89558	2.456510e-04	0	2	14902	1.342100e-04	0	1	34260	2.918860e-05	0	164	9572	1.713330e-02	1	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	23	102754	2.238360e-04	0	0	30526	0.000000e+00	0	23	102754	2.238360e-04	0	.	716	1613784	4.436780e-04	4	499	29608	1.685360e-02	4	5	74906	6.675030e-05	0	0	912	0.000000e+00	0	2	60000	3.333330e-05	0	499	29608	1.685360e-02	4	0	44890	0.000000e+00	0	0	64026	0.000000e+00	0	0	5920	0.000000e+00	0	128	1179982	1.084760e-04	0	0	91074	0.000000e+00	0	143	96962	0.0014748045626121573	0	174	0	0	2670	0	4	4198	9.528346831824678E-4	0	790	0	0	946	0	0	656	0	0	274	0	27	8054	0.0033523714924261236	4	4372	9.149130832570906E-4	0	3326	0	174	114724	0.0015166835187057635	Conflicting_classifications_of_pathogenicity	not_provided|Acute_intermittent_porphyria|HMBS-related_disorder	criteria_provided,_conflicting_classifications	NC_000011.10:g.119089263A>T	ClinGen:CA272879|UniProtKB:P08397#VAR_025564	C3661900|C0162565	176000	79276	Porphobilinogen deaminase, N-terminal	Glu	Val	171128	single nucleotide variant	NM_000190.4(HMBS):c.257A>T (p.Glu86Val)	3145	HMBS	HGNC:4982	Conflicting classifications of pathogenicity	0	Jan 24, 2025	150763621	-	RCV000148510|RCV001514054|RCV003927449	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|	Acute intermittent porphyria|not provided|HMBS-related disorder	germline	germline	GRCh38	NC_000011.10	11	119089263	119089263	11q23.3	criteria provided, conflicting classifications	7	-	N	ClinGen:CA272879,UniProtKB:P08397#VAR_025564	2	161252	119089263	A	T	-	-	-	-	-	-	SCV001167212|SCV001261488|SCV001721801|SCV001822907|SCV002541174	-	-	257A>T 	Glu86Val	NM_000190.4	1	3_Conflicting	HMBS	ENSG00000256269	2803	200926	CCSBVarC005160	ALE00005160	257A>T	Glu86Val	CEGS2	CegsMutGDEh1037	D01	GDEhDisVCh_40054	D03	2	CegsMutGDDh1037	D01	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	HMBS_Glu86Val	11	11	119089263	A	T
359	CBS	134G>A	Arg45Gln	ENSG00000160200	21	43072060	NC_000021.9:43072060:C:T	ALE00007351	CCSBVarC007363	NULL	NULL	324	GDEhDisVCh_40013	H11	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCAGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	243637.0	single nucleotide variant	NM_000071.3(CBS):c.134G>A (p.Arg45Gln)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Oct 25, 2024	759502207.0	-	RCV000229516|RCV001658051|RCV002315675|RCV002516304	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3661900|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:C3150344	Classic homocystinuria|not provided|Familial thoracic aortic aneurysm and aortic dissection|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43072060.0	43072060.0	21q22.3	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA10583892	2.0	236935.0	43072060.0	C	T	-	-	-	-	-	-	SCV000283382|SCV000738491|SCV001872633|SCV005878670	-	-	134G>A 	Arg45Gln	NM_000071.3	2.0	4_VUS	chr21	G	A	21-43072060-G-A		236935	21	43072060	C	T	R	Q	rs759502207	21	44492170	21	43365239	45	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.134G>A	p.Arg45Gln	c.134G>A	p.Arg45Gln	principal1	Y	1	.	.	-	CGG	2	0	C	C/C	C/C	C/C	C/C	0.18	0.45197	T	0.058	0.57928	T	0.625	0.40069	P	0.01	0.14938	B	0.13	0.33788	N	simple_aae	87.0	13.0	2.86	0.82861	M	-1.68	0.51497	N	0.498	0.53211	0.8141	0.94567	D	0.9288	0.97644	D	10	0.19464254	0.34905	T	0.193277	0.86259	D	0.547	0.81097	.	.	.	.	.	0.729920866366	0.72537	.	0.74741	.	0.41323	0.400807052851	0.25152	T	0.616159	0.87789	D	0.047725	0.57757	T	0.122926	0.78267	D	0.0578272493752416	0.06747	T	.	0.89836	.	0.25522205	0.48225	0.13731083	0.32733	0.25096	0.47771	0.15751074	0.36711	-3.802	0.20852	T	0.125	0.26484	LB	0.901004520602866	0.76122	0.99794870	0.98571	0.4	0.64657	.	.	.	.	.	.	1.572782	0.20164	14.61	0.99866365371275034	0.94461	0.417051	0.48349	N	-0.301702118683476	0.28804	1.609743	-0.342306615253811	0.26428	1.479442	5.64	2.66	0.30590	0.675	0.26496	0.291	0.18812	-0.324000	0.09983	0.524	0.24207	0.026	0.20224	0.000000	0.08389	0.201	0.2197	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	8	109384	7.313680e-05	0	14	207396	6.750370e-05	0	18	236564	7.608930e-05	0	1	7160	1.396650e-04	0	1	17110	5.844540e-05	0	0	2312	0.000000e+00	0	0	9044	0.000000e+00	0	0	13392	0.000000e+00	0	3	42762	7.015570e-05	0	3	15690	1.912050e-04	0	3	15690	1.912050e-04	0	1	16194	6.175130e-05	0	1	30516	3.276970e-05	0	0	6182	0.000000e+00	0	0	13412	0.000000e+00	0	0	16732	0.000000e+00	0	5	88904	5.624040e-05	0	7	30608	2.286980e-04	0	7	30608	2.286980e-04	0	1	14890	6.715920e-05	0	1	34258	2.919030e-05	0	0	9554	0.000000e+00	0	0	17690	0.000000e+00	0	0	21630	0.000000e+00	0	9	102398	8.789230e-05	0	7	30526	2.293130e-04	0	7	30526	2.293130e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	26986	1.1116875416882828E-4	0	184	0	0	0	0	1	4674	2.139495079161318E-4	0	354	0	0	18	0	0	0	0	0	0	0	1	5526	1.8096272167933406E-4	1	4858	2.058460271716756E-4	0	0	0	5	37742	1.3247840601981876E-4	Uncertain_significance	Classic_homocystinuria|not_provided|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43072060C>T	ClinGen:CA10583892	C0751202|C3661900|C4707243|C3150344	236200|PS607086	394|91387	.	Arg	Gln	243637	single nucleotide variant	NM_000071.3(CBS):c.134G>A (p.Arg45Gln)	875	CBS	HGNC:1550	Uncertain significance	0	Oct 25, 2024	759502207	-	RCV000229516|RCV001658051|RCV002315675|RCV002516304	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3661900|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:C3150344	Classic homocystinuria|not provided|Familial thoracic aortic aneurysm and aortic dissection|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43072060	43072060	21q22.3	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA10583892	2	236935	43072060	C	T	-	-	-	-	-	-	SCV000283382|SCV000738491|SCV001872633|SCV005878670	-	-	134G>A 	Arg45Gln	NM_000071.3	2	4_VUS	CBS	ENSG00000160200	359	324	CCSBVarC007363	ALE00007351	134G>A	Arg45Gln	Edgotyping3	VUSMutGDEh011	G06	GDEhDisVCh_40013	H11	1	VUSMutGDDh011	G06	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	5	0	NULL	0	NULL	0	NULL	CBS_Arg45Gln	21	21	43072060	C	T
100011574	PTEN	235G>A	Ala79Thr	ENSG00000171862	10	87931071	NC_000010.11:87931071:G:A	ALE00007028	CCSBVarC007030	NULL	210305	NULL	GDEhDisVCh_40031	C07	CEGS2	ATGACAGCCATCATCAAAGAGATCGTTAGCAGAAACAAAAGGAGATATCAAGAGGATGGATTCGACTTAGACTTGACCTATATTTATCCAAACATTATTGCTATGGGATTTCCTGCAGAAAGACTTGAAGGCGTATACAGGAACAATATTGATGATGTAGTAAGGTTTTTGGATTCAAAGCATAAAAACCATTACAAGATATACAATCTTTGTGCTGAAAGACATTATGACACCACCAAATTTAATTGCAGAGTTGCACAATATCCTTTTGAAGACCATAACCCACCACAGCTAGAACTTATCAAACCCTTTTGTGAAGATCTTGACCAATGGCTAAGTGAAGATGACAATCATGTTGCAGCAATTCACTGTAAAGCTGGAAAGGGACGAACTGGTGTAATGATATGTGCATATTTATTACATCGGGGCAAATTTTTAAAGGCACAAGAGGCCCTAGATTTCTATGGGGAAGTAAGGACCAGAGACAAAAAGGGAGTAACTATTCCCAGTCAGAGGCGCTATGTGTATTATTATAGCTACCTGTTAAAGAATCATCTGGATTATAGACCAGTGGCACTGTTGTTTCACAAGATGATGTTTGAAACTATTCCAATGTTCAGTGGCGGAACTTGCAATCCTCAGTTTGTGGTCTGCCAGCTAAAGGTGAAGATATATTCCTCCAATTCAGGACCCACACGACGGGAAGACAAGTTCATGTACTTTGAGTTCCCTCAGCCGTTACCTGTGTGTGGTGATATCAAAGTAGAGTTCTTCCACAAACAGAACAAGATGCTAAAAAAGGACAAAATGTTTCACTTTTGGGTAAATACATTCTTCATACCAGGACCAGAGGAAACCTCAGAAAAAGTAGAAAATGGAAGTCTATGTGATCAAGAAATCGATAGCATTTGCAGTATAGAGCGTGCAGATAATGACAAGGAATATCTAGTACTTACTTTAACAAAAAATGATCTTGACAAAGCAAATAAAGACAAAGCCAACCGATACTTTTCTCCAAATTTTAAGGTGAAGCTGTACTTCACAAAAACAGTAGAGGAGCCGTCAAATCCAGAGGCTAGCAGTTCAACTTCTGTAACACCAGATGTTAGTGACAATGAACCTGATCATTATAGATATTCTGACACCACTGACTCTGATCCAGAGAATGAACCTTTTGATGAAGATCAGCATACACAAATTACAAAAGTC	50121.0	single nucleotide variant	NM_000314.8(PTEN):c.235G>A (p.Ala79Thr)	5728.0	PTEN	HGNC:9588	Likely benign	1.0	Apr 06, 2018	202004587.0	-	RCV000409443|RCV000123046|RCV000129085|RCV000034594|RCV001257777|RCV002477056|RCV000626250|RCV001796959|RCV001357785|RCV003492331|RCV004528160	MONDO:MONDO:0008021,MedGen:CN072330,OMIM:158350|MONDO:MONDO:0017623,MeSH:D006223,MedGen:C1959582,Orphanet:306498|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,MONDO:MONDO:0001071,MeSH:D008607,MedGen:C3714756|Human Phenotype Ontology:HP:0012125,MONDO:MONDO:0008315,MedGen:C0376358,Orphanet:1331;MONDO:MONDO:0008021,MedGen:CN072330,OMIM:158350;MONDO:MONDO:0013092,MedGen:C2751642,OMIM:613028,Orphanet:182067;MONDO:MONDO:0011789,MedGen:C3551915,OMIM:607174,Orphanet:263662;MONDO:MONDO:0011537,MedGen:C1854416,OMIM:605309,Orphanet:210548|MONDO:MONDO:0011537,MedGen:C1854416,OMIM:605309,Orphanet:210548|MedGen:CN169374|MONDO:MONDO:0002032,MedGen:C0699790|MedGen:CN221562|	Cowden syndrome 1|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided|Intellectual disability|Malignant tumor of prostate;Cowden syndrome 1;Glioma susceptibility 2;Familial meningioma;Macrocephaly-autism syndrome|Macrocephaly-autism syndrome|not specified|Carcinoma of colon|Breast and/or ovarian cancer|PTEN-related disorder	germline;inherited;unknown	germline	GRCh38	NC_000010.11	10	87931071.0	87931071.0	10q23.31	reviewed by expert panel	23.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000358	2.0	41682.0	87931071.0	G	A	-	-	-	-	-	-	SCV000840467	-	-	235G>A 	Ala79Thr	NM_000314.8	3.0	2_Benign	chr10	G	A	10-87931071-G-A	0.000134051	41682	10	87931071	G	A	A	T	rs202004587	10	89690828	10	89680808	79	PTEN	ENSG00000171862	ENST00000371953	ENSP00000361021	P60484	PTEN_HUMAN	c.235G>A	p.Ala79Thr	c.235G>A	p.Ala79Thr	principal1	Y	1	YES	Select	+	GCC	1	0	G	./.	./.	./.	./.	0.579	0.06047	T	0.594	0.08238	T	0.002	0.09864	B	0.005	0.11213	B	0.89	0.91795	D	simple_aae	11.0	89.0	-0.39	0.03030	N	0.09	0.05888	N	0.59	0.60801	0.3912	0.88920	D	0.7996	0.93199	D	9	0.3464243	0.51228	D	0.096974	0.76620	D	0.485	0.77279	.	.	.	.	.	0.981023137776	0.98062	0.75240060115523	0.75052	1.12027867867	0.78154	0.81595659256	0.84380	D	0.412741	0.76514	T	0.0865203	0.62532	D	0.146183	0.79796	D	0.1317448168993	0.15347	T	0.875312	0.58518	D	0.14961809	0.33814	0.071898535	0.15441	0.21288243	0.43330	0.0713658	0.15266	-3.18	0.12249	T	0.0682	0.02901	B	0.597118578748254	0.63730	0.99714345	0.98276	0.679	0.82175	.	.	.	.	.	.	3.949724	0.57931	23.9	0.97363881357002335	0.33764	0.602101	0.59265	D	-0.098336801114816	0.37192	2.180053	0.129070295824174	0.45769	2.856828	5.62	4.7	0.58726	.	.	4.291	0.58904	8.503000	0.77399	0.618	0.50684	1.0	0.71675	1.000000	0.68239	0.997	0.79771	939	0.14250	.	.	.	.	.	.	.	.	.	.	.	.	22	264690	8.31161E-5	segdup	12	109158	1.099320e-04	0	25	207422	1.205270e-04	0	21	235774	8.906830e-05	0	0	7140	0.000000e+00	0	0	17082	0.000000e+00	0	0	2316	0.000000e+00	0	0	9022	0.000000e+00	0	0	13382	0.000000e+00	0	8	42642	1.876080e-04	0	4	15674	2.552000e-04	0	4	15674	2.552000e-04	0	1	16160	6.188120e-05	0	0	30422	0.000000e+00	0	0	6196	0.000000e+00	0	0	13366	0.000000e+00	0	0	16700	0.000000e+00	0	18	89188	2.018210e-04	0	5	30552	1.636550e-04	0	18	89188	2.018210e-04	0	0	14850	0.000000e+00	0	0	34164	0.000000e+00	0	0	9546	0.000000e+00	0	0	17654	0.000000e+00	0	0	21582	0.000000e+00	0	15	101928	1.471630e-04	0	5	30472	1.640850e-04	0	5	30472	1.640850e-04	0	.	207	1605922	1.288980e-04	0	10	6022	1.660580e-03	0	5	74552	6.706730e-05	0	0	912	0.000000e+00	0	3	59784	5.018070e-05	0	0	29432	0.000000e+00	0	1	44618	2.241250e-05	0	0	63784	0.000000e+00	0	10	6022	1.660580e-03	0	170	1173830	1.448250e-04	0	9	90878	9.903390e-05	0	33	113488	2.9077964190046525E-4	0	304	0	0	150	0	0	8542	0	0	506	0	0	650	0	0	82	0	0	104	0	6	14094	4.257130693912303E-4	0	8846	0	0	232	0	39	137920	2.827726218097448E-4	Likely_benign	Breast_and/or_ovarian_cancer|Macrocephaly-autism_syndrome|Cowden_syndrome_1|Familial_meningioma|Glioma_susceptibility_2|Malignant_tumor_of_prostate|not_specified|Hereditary_cancer-predisposing_syndrome|not_provided|PTEN_hamartoma_tumor_syndrome|PTEN-related_disorder|Intellectual_disability|Carcinoma_of_colon	reviewed_by_expert_panel	NC_000010.11:g.87931071G>A	ClinGen:CA000358	CN221562|C1854416|CN072330|C3551915|C2751642|C0376358|CN169374|C0027672|C3661900|C1959582|C3714756|C0699790	605309|158350|607174|613028	210548|263662|182067|1331|140162|306498	Tensin-type phosphatase domain|Protein-tyrosine phosphatase, catalytic|PTEN, phosphatase domain	Ala	Thr	50121	single nucleotide variant	NM_000314.8(PTEN):c.235G>A (p.Ala79Thr)	5728	PTEN	HGNC:9588	Likely benign	1	Apr 06, 2018	202004587	-	RCV000409443|RCV000123046|RCV000129085|RCV000034594|RCV001257777|RCV002477056|RCV000626250|RCV001796959|RCV001357785|RCV003492331|RCV004528160	MONDO:MONDO:0008021,MedGen:CN072330,OMIM:158350|MONDO:MONDO:0017623,MeSH:D006223,MedGen:C1959582,Orphanet:306498|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|Human Phenotype Ontology:HP:0000730,Human Phenotype Ontology:HP:0001249,Human Phenotype Ontology:HP:0001267,Human Phenotype Ontology:HP:0001286,Human Phenotype Ontology:HP:0002122,Human Phenotype Ontology:HP:0002192,Human Phenotype Ontology:HP:0002316,Human Phenotype Ontology:HP:0002382,Human Phenotype Ontology:HP:0002386,Human Phenotype Ontology:HP:0002402,Human Phenotype Ontology:HP:0002458,Human Phenotype Ontology:HP:0002482,Human Phenotype Ontology:HP:0002499,Human Phenotype Ontology:HP:0002543,Human Phenotype Ontology:HP:0003767,Human Phenotype Ontology:HP:0006833,Human Phenotype Ontology:HP:0007154,Human Phenotype Ontology:HP:0007176,Human Phenotype Ontology:HP:0007180,MONDO:MONDO:0001071,MeSH:D008607,MedGen:C3714756|Human Phenotype Ontology:HP:0012125,MONDO:MONDO:0008315,MedGen:C0376358,Orphanet:1331;MONDO:MONDO:0008021,MedGen:CN072330,OMIM:158350;MONDO:MONDO:0013092,MedGen:C2751642,OMIM:613028,Orphanet:182067;MONDO:MONDO:0011789,MedGen:C3551915,OMIM:607174,Orphanet:263662;MONDO:MONDO:0011537,MedGen:C1854416,OMIM:605309,Orphanet:210548|MONDO:MONDO:0011537,MedGen:C1854416,OMIM:605309,Orphanet:210548|MedGen:CN169374|MONDO:MONDO:0002032,MedGen:C0699790|MedGen:CN221562|	Cowden syndrome 1|PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|not provided|Intellectual disability|Malignant tumor of prostate;Cowden syndrome 1;Glioma susceptibility 2;Familial meningioma;Macrocephaly-autism syndrome|Macrocephaly-autism syndrome|not specified|Carcinoma of colon|Breast and/or ovarian cancer|PTEN-related disorder	germline;inherited;unknown	germline	GRCh38	NC_000010.11	10	87931071	87931071	10q23.31	reviewed by expert panel	23	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000358	2	41682	87931071	G	A	-	-	-	-	-	-	SCV000840467	-	-	235G>A 	Ala79Thr	NM_000314.8	3	2_Benign	PTEN	ENSG00000171862	100011574	210305	CCSBVarC007030	ALE00007028	235G>A	Ala79Thr	CEGS2	CegsMutGDEh1023	H01	GDEhDisVCh_40031	C07	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	PTEN_Ala79Thr	10	10	87931071	G	A
359	CBS	133C>T	Arg45Trp	ENSG00000160200	21	43072061	NC_000021.9:43072061:G:A	ALE00007352	CCSBVarC007364	NULL	NULL	325	GDEhDisVCh_40013	A12	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCTGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210451.0	single nucleotide variant	NM_000071.3(CBS):c.133C>T (p.Arg45Trp)	875.0	CBS	HGNC:1550	Conflicting classifications of pathogenicity	0.0	Jan 18, 2025	201372812.0	-	RCV000198945|RCV001081627|RCV002229027|RCV002381662|RCV004767135	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:CN169374	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection|not specified	germline	germline	GRCh38	NC_000021.9	21	43072061.0	43072061.0	21q22.3	criteria provided, conflicting classifications	6.0	-	N	ClinGen:CA323483	2.0	212871.0	43072061.0	G	A	-	-	-	-	-	-	SCV000249718|SCV000555953|SCV001247531|SCV002692736|SCV005380623	-	-	133C>T 	Arg45Trp	NM_000071.3	1.0	3_Conflicting	chr21	C	T	21-43072061-C-T		212871	21	43072061	G	A	R	W	rs201372812	21	44492171	21	43365240	45	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.133C>T	p.Arg45Trp	c.133C>T	p.Arg45Trp	principal1	Y	1	.	.	-	CGG	1	2	G	G/G	G/G	G/G	G/G	0.01	0.57638	D	0.01	0.83643	D	0.998	0.73231	D	0.535	0.48706	P	0.03	0.10877	N	simple_aae	97.0	3.0	2.86	0.82861	M	-3.91	0.81940	D	0.638	0.65068	1.0097	0.97345	D	0.9603	0.98718	D	10	0.013109982	0.00276	T	0.547729	0.95810	D	0.692	0.88771	.	.	.	.	.	0.899012474923	0.89724	.	0.79129	.	0.62705	0.507719099522	0.39848	T	0.894935	0.97874	D	-0.0106787	0.49845	T	0.211046	0.83601	D	0.0781965552765088	0.09634	T	.	0.95766	.	0.23981139	0.46548	0.19159622	0.42480	0.25195286	0.47877	0.16354132	0.37811	-7.145	0.55155	T	.	0.35559	.	0.886629833821125	0.75176	0.99943110	0.99379	0.794	0.88603	.	.	.	.	.	.	3.212452	0.43817	21.8	0.99871795753177339	0.94906	0.682132	0.64397	D	0.158001544563865	0.48944	3.122299	0.0960793736944226	0.44073	2.718543	5.4	3.58	0.40064	2.12	0.41056	1.953	0.40082	2.705000	0.34273	-0.189	0.09506	0.989	0.36837	0.999000	0.35501	0.19	0.21645	988	0.02004	9	0.0017971246006389776	0	0.0	0	0.0	0	0.0	0	0.0	9	0.009202453987730062	.	.	.	.	73	109376	6.674220e-04	0	162	207338	7.813330e-04	1	161	236530	6.806750e-04	1	3	7160	4.189940e-04	0	0	17110	0.000000e+00	0	0	2312	0.000000e+00	0	1	9042	1.105950e-04	0	0	13392	0.000000e+00	0	3	42758	7.016230e-05	0	65	15688	4.143290e-03	0	65	15688	4.143290e-03	0	6	16182	3.707820e-04	0	0	30514	0.000000e+00	0	0	6182	0.000000e+00	0	1	13410	7.457120e-05	0	0	16732	0.000000e+00	0	20	88864	2.250630e-04	1	124	30606	4.051490e-03	0	124	30606	4.051490e-03	0	6	14882	4.031720e-04	0	0	34256	0.000000e+00	0	1	9552	1.046900e-04	0	1	17688	5.653550e-05	0	0	21628	0.000000e+00	0	18	102380	1.758160e-04	1	124	30524	4.062380e-03	0	124	30524	4.062380e-03	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	39	102064	3.821131838846214E-4	0	194	0	0	1806	0	3	5434	5.520794994479205E-4	0	354	0	0	38	0	0	1202	0	0	0	0	8	15500	5.161290322580645E-4	3	5628	5.330490405117271E-4	0	3008	0	50	126592	3.9496966632962587E-4	Conflicting_classifications_of_pathogenicity	HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|not_provided|Classic_homocystinuria|Familial_thoracic_aortic_aneurysm_and_aortic_dissection	criteria_provided,_conflicting_classifications	NC_000021.9:g.43072061G>A	ClinGen:CA323483	C3150344|C3661900|C0751202|C4707243	236200|PS607086	394|91387	.	Arg	Trp	210451	single nucleotide variant	NM_000071.3(CBS):c.133C>T (p.Arg45Trp)	875	CBS	HGNC:1550	Conflicting classifications of pathogenicity	0	Jan 18, 2025	201372812	-	RCV000198945|RCV001081627|RCV002229027|RCV002381662|RCV004767135	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:CN169374	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection|not specified	germline	germline	GRCh38	NC_000021.9	21	43072061	43072061	21q22.3	criteria provided, conflicting classifications	6	-	N	ClinGen:CA323483	2	212871	43072061	G	A	-	-	-	-	-	-	SCV000249718|SCV000555953|SCV001247531|SCV002692736|SCV005380623	-	-	133C>T 	Arg45Trp	NM_000071.3	1	3_Conflicting	CBS	ENSG00000160200	359	325	CCSBVarC007364	ALE00007352	133C>T	Arg45Trp	Edgotyping3	VUSMutGDEh011	H06	GDEhDisVCh_40013	A12	1	VUSMutGDDh011	H06	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	5	0	NULL	0	NULL	0	NULL	CBS_Arg45Trp	21	21	43072061	G	A
100010885	SGCB	452C>G	Thr151Arg	ENSG00000163069	4	52028899	NC_000004.12:52028899:G:C	ALE00006986	CCSBVarC006988	NULL	225817	NULL	GDEhDisVCh_40045	E01	CEGS2	ATGGCGGCAGCGGCGGCGGCGGCTGCAGAACAGCAAAGTTCCAATGGTCCTGTAAAGAAGTCCATGCGTGAGAAGGCTGTTGAGAGAAGGAGTGTCAATAAAGAGCACAACAGTAACTTTAAAGCTGGATACATTCCGATTGATGAAGATCGTCTCCACAAAACAGGGTTGAGAGGAAGAAAGGGCAATTTAGCCATCTGTGTGATTATCCTCTTGTTTATCCTGGCTGTCATCAATTTAATAATAACACTTGTTATTTGGGCCGTGATTCGCATTGGACCAAATGGCTGTGATAGTATGGAGTTTCATGAAAGTGGCCTGCTTCGATTTAAGCAAGTATCTGACATGGGAGTGATCCACCCTCTTTATAAAAGCACAGTAGGAGGAAGGCGAAATGAAAATTTGGTCATCACTGGCAACAACCAGCCTATTGTTTTTCAGCAAGGGACAAGAAAGCTCAGTGTAGAAAACAACAAAACTTCTATTACAAGTGACATCGGCATGCAGTTTTTTGACCCGAGGACTCAAAATATCTTATTCAGCACAGACTATGAAACTCATGAGTTTCATTTGCCAAGTGGAGTGAAAAGTTTGAATGTTCAAAAGGCATCTACTGAAAGGATTACCAGCAATGCTACCAGTGATTTAAATATAAAAGTTGATGGGCGTGCTATTGTGCGTGGAAATGAAGGTGTATTCATTATGGGCAAAACCATTGAATTTCACATGGGTGGTAATATGGAGTTAAAGGCGGAAAACAGTATCATCCTAAATGGATCTGTGATGGTCAGCACCACCCGCCTACCCAGTTCCTCCAGTGGAGACCAGTTGGGTAGTGGTGACTGGGTACGCTACAAGCTCTGCATGTGTGCTGATGGGACGCTCTTCAAGGTGCAAGTAACCAGCCAGAACATGGGCTGCCAAATCTCAGACAACCCCTGTGGAAACACTCAT	23751.0	single nucleotide variant	NM_000232.5(SGCB):c.452C>G (p.Thr151Arg)	6443.0	SGCB	HGNC:10806	Pathogenic	1.0	Jan 09, 2025	28936383.0	-	RCV000009250|RCV000598498|RCV004998080	MONDO:MONDO:0011423,MedGen:C1858593,OMIM:604286,Orphanet:119|MedGen:C3661900|MONDO:MONDO:0015152,MedGen:C2931907,OMIM:PS253600,Orphanet:102015	Autosomal recessive limb-girdle muscular dystrophy type 2E|not provided|Autosomal recessive limb-girdle muscular dystrophy	germline;unknown	germline	GRCh38	NC_000004.12	4	52028899.0	52028899.0	4q12	reviewed by expert panel	8.0	-	N	ClinGen:CA119849,UniProtKB:Q16585#VAR_010395,OMIM:600900.0001	3.0	8712.0	52028899.0	G	C	-	-	-	-	-	-	SCV005620296	-	-	452C>G 	Thr151Arg	NM_000232.5	3.0	1_Pathogenic	chr4	C	G	4-52028899-C-G		8712	4	52028899	G	C	T	R	rs28936383	4	52895065	4	52589822	151	SGCB	ENSG00000163069	ENST00000381431	ENSP00000370839	Q16585	SGCB_HUMAN	c.452C>G	p.Thr151Arg	c.452C>G	p.Thr151Arg	principal1	Y	1	YES	Select	-	ACA	2	0	G	./.	./.	./.	./.	0.008	0.58783	D	0.012	0.64242	D	0.996	0.68795	D	0.913	0.64880	D	0.93	0.93829	A	simple_aae	7.0	93.0	2.08	0.57221	M	-1.8	0.42386	N	0.948	0.95621	0.7378	0.93621	D	0.8697	0.95659	D	9	0.902816	0.89529	D	0.205093	0.86933	D	0.868	0.96013	0.649	0.78559	Q16585	T151R	Loss of ubiquitination at K152 (P = 0.0503)| Loss of catalytic residue at T150 (P = 0.1589)| Gain of MoRF binding (P = 0.1901)| Gain of disorder (P = 0.2104)| Gain of methylation at K152 (P = 0.2761)	0.995943955444	0.99584	0.7257140302025777	0.72371	0.352980546658	0.36830	0.745668232441	0.73761	T	0.806018	0.95060	D	0.448582	0.92361	D	0.406581	0.92266	D	0.931575775146484	0.59466	D	0.925707	0.72612	D	0.55184233	0.69761	0.5144078	0.71685	0.49544832	0.66519	0.5098161	0.71415	-4.072	0.24900	T	0.7492	0.74968	P	0.98104140349518	0.85570	0.99924517	0.99238	0.463	0.69012	.	.	.	.	.	.	4.930779	0.81319	27.5	0.99574793796193684	0.72654	0.914647	0.87787	D	0.677892266249817	0.78064	6.820687	0.690400006228629	0.81547	7.576469	5.36	5.36	0.76590	.	.	8.002	0.8806	11.884000	0.98912	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.997	0.79771	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1613460	1.859360e-06	0	2	1179684	1.695370e-06	0	0	74846	0.000000e+00	0	0	912	0.000000e+00	0	0	59990	0.000000e+00	0	0	29600	0.000000e+00	0	0	44854	0.000000e+00	0	0	63940	0.000000e+00	0	0	6084	0.000000e+00	0	2	1179684	1.695370e-06	0	0	91080	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic/Likely_pathogenic	Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2E|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000004.12:g.52028899G>C	ClinGen:CA119849|OMIM:600900.0001|UniProtKB:Q16585#VAR_010395	C1858593|C3661900	604286	119	.	Thr	Arg	23751	single nucleotide variant	NM_000232.5(SGCB):c.452C>G (p.Thr151Arg)	6443	SGCB	HGNC:10806	Pathogenic	1	Jan 09, 2025	28936383	-	RCV000009250|RCV000598498|RCV004998080	MONDO:MONDO:0011423,MedGen:C1858593,OMIM:604286,Orphanet:119|MedGen:C3661900|MONDO:MONDO:0015152,MedGen:C2931907,OMIM:PS253600,Orphanet:102015	Autosomal recessive limb-girdle muscular dystrophy type 2E|not provided|Autosomal recessive limb-girdle muscular dystrophy	germline;unknown	germline	GRCh38	NC_000004.12	4	52028899	52028899	4q12	reviewed by expert panel	8	-	N	ClinGen:CA119849,UniProtKB:Q16585#VAR_010395,OMIM:600900.0001	3	8712	52028899	G	C	-	-	-	-	-	-	SCV005620296	-	-	452C>G 	Thr151Arg	NM_000232.5	3	1_Pathogenic	SGCB	ENSG00000163069	100010885	225817	CCSBVarC006988	ALE00006986	452C>G	Thr151Arg	CEGS2	CegsMutGDEh1043	G07	GDEhDisVCh_40045	E01	1	CegsMutGDDh1043	G07	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	SGCB_Thr151Arg	4	4	52028899	G	C
71569	OTC	392T>C	Leu131Ser	ENSG00000036473	X	38401280	NC_000023.11:38401280:T:C	ALE00005239	CCSBVarC005239	NULL	205874	NULL	GDEhDisVCh_40048	G02	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATCGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103078.0	single nucleotide variant	NM_000531.6(OTC):c.392T>C (p.Leu131Ser)	5009.0	OTC	HGNC:8512	Pathogenic	1.0	-	72556252.0	-	RCV000083421	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38401280.0	38401280.0	Xp11.4	no assertion criteria provided	1.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224578	2.0	97186.0	38401280.0	T	C	-	-	-	-	-	-	SCV000115507	-	-	392T>C 	Leu131Ser	NM_000531.6		1_Pathogenic	chrX	T	C	X-38401280-T-C		97186	X	38401280	T	C	L	S	rs72556252	X	38260533	X	38145477	131	OTC	ENSG00000036473	ENST00000713758	ENSP00000519059	P00480	OTC_HUMAN	.	.	c.392T>C	p.Leu131Ser	principal1	Y	.	.	.	+	TTG	2	0	T	T/T	T/T	T/T	T/T	.	0.78662	.	.	0.83643	.	1.0	0.90580	D	1.0	0.97365	D	.	0.84994	.	.	.	.	4.125	0.97400	H	.	0.84554	.	.	0.97870	0.9409	0.96249	D	0.9922	0.99809	D	10	.	0.99966	.	0.990087	0.99963	D	.	0.99783	0.938	0.99125	P00480	L131S	Gain of disorder (P = 0.0017)| Gain of phosphorylation at L131 (P = 0.0283)| Loss of catalytic residue at L131 (P = 0.0744)| Gain of methylation at R129 (P = 0.11)| Gain of glycosylation at T127 (P = 0.1867)	.	0.99177	.	0.99419	.	0.84846	0.781852185726	0.79169	T	0.975921	0.99767	D	0.722519	0.99950	D	0.800072	0.99949	D	0.999176323413849	0.96398	D	.	0.94333	.	0.95360494	0.96580	0.96369994	0.99153	0.95360494	0.96580	0.96369994	0.99153	-12.37	0.86640	D	.	0.86513	.	0.999345726886528	0.96318	0.99864570	0.98890	0.994	0.99793	.	.	.	.	.	.	4.703137	0.75526	26.3	0.99863531262033267	0.94188	.	.	.	.	.	.	.	.	.	5.88	5.88	0.94556	5.17	0.91630	7.628	0.82424	7.797000	0.69090	0.609	0.47831	1.0	0.71675	1.000000	0.68239	0.984	0.60417	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic	not_provided	no_assertion_criteria_provided	NC_000023.11:g.38401280T>C	ClinGen:CA224578	CN517202	.	.	Aspartate/ornithine carbamoyltransferase, carbamoyl-P binding	Leu	Ser	103078	single nucleotide variant	NM_000531.6(OTC):c.392T>C (p.Leu131Ser)	5009	OTC	HGNC:8512	Pathogenic	1	-	72556252	-	RCV000083421	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38401280	38401280	Xp11.4	no assertion criteria provided	1	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224578	2	97186	38401280	T	C	-	-	-	-	-	-	SCV000115507	-	-	392T>C 	Leu131Ser	NM_000531.6		1_Pathogenic	OTC	ENSG00000036473	71569	205874	CCSBVarC005239	ALE00005239	392T>C	Leu131Ser	CEGS2	CegsMutGDEh1015	D09	GDEhDisVCh_40048	G02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Leu131Ser	23	X	38401280	T	C
71569	OTC	533C>T	Thr178Met	ENSG00000036473	X	38401421	NC_000023.11:38401421:C:T	ALE00005251	CCSBVarC005251	NULL	205883	NULL	GDEhDisVCh_40048	B02	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCATGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103129.0	single nucleotide variant	NM_000531.6(OTC):c.533C>T (p.Thr178Met)	5009.0	OTC	HGNC:8512	Pathogenic	1.0	Oct 27, 2024	72556284.0	-	RCV000083477|RCV001262181	MedGen:C3661900|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664	not provided|Ornithine carbamoyltransferase deficiency	germline;unknown	germline	GRCh38	NC_000023.11	X	38401421.0	38401421.0	Xp11.4	criteria provided, multiple submitters, no conflicts	8.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224668,UniProtKB:P00480#VAR_004890	2.0	97237.0	38401421.0	C	T	-	-	-	-	-	-	SCV000490676|SCV001439962|SCV002033221|SCV002185534|SCV002817188|SCV004237391|SCV005416292	-	-	533C>T 	Thr178Met	NM_000531.6	2.0	1_Pathogenic	chrX	C	T	X-38401421-C-T		97237	X	38401421	C	T	T	M	rs72556284	X	38260674	X	38145618	178	OTC	ENSG00000036473	ENST00000039007	ENSP00000039007	P00480	OTC_HUMAN	c.533C>T	p.Thr178Met	c.533C>T	p.Thr178Met	principal1	Y	1	YES	Select	+	ACG	2	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.89	0.91795	A	simple_aae	11.0	89.0	3.96	0.96448	H	-5.7	0.87410	D	0.985	0.99419	0.9834	0.96906	D	0.9904	0.99742	D	10	0.9960351	0.99996	D	0.979551	0.99890	D	0.989	0.99969	0.975	0.99765	P00480	T178M	Loss of disorder (P = 0.1536)| Loss of helix (P = 0.2022)| Gain of catalytic residue at T178 (P = 0.44)| Loss of phosphorylation at T178 (P = 0.5032)| Loss of stability (P = 0.7529)	0.997783995256	0.99773	0.9744967051836074	0.97425	1.19930797931	0.80382	0.799012005329	0.81780	T	0.98588	0.99913	D	0.728449	0.99953	D	0.80859	0.99953	D	0.999807417392731	0.99082	D	0.985401	0.94986	D	0.9435238	0.95539	0.958408	0.98868	0.9435238	0.95539	0.958408	0.98868	-16.098	0.97908	D	0.8191	0.78144	P	0.999207609326413	0.95951	0.99872100	0.98926	0.976	0.99121	.	.	.	.	.	.	4.894302	0.80424	27.3	0.9991072050695623	0.98024	.	.	.	.	.	.	.	.	.	5.97	5.97	0.96929	5.17	0.91630	7.523	0.80833	7.568000	0.60703	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.999	0.91597	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Ornithine_carbamoyltransferase_deficiency|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.38401421C>T	ClinGen:CA224668|UniProtKB:P00480#VAR_004890	C0268542|C3661900	311250	664	Aspartate/ornithine carbamoyltransferase, carbamoyl-P binding	Thr	Met	103129	single nucleotide variant	NM_000531.6(OTC):c.533C>T (p.Thr178Met)	5009	OTC	HGNC:8512	Pathogenic	1	Oct 27, 2024	72556284	-	RCV000083477|RCV001262181	MedGen:C3661900|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664	not provided|Ornithine carbamoyltransferase deficiency	germline;unknown	germline	GRCh38	NC_000023.11	X	38401421	38401421	Xp11.4	criteria provided, multiple submitters, no conflicts	8	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224668,UniProtKB:P00480#VAR_004890	2	97237	38401421	C	T	-	-	-	-	-	-	SCV000490676|SCV001439962|SCV002033221|SCV002185534|SCV002817188|SCV004237391|SCV005416292	-	-	533C>T 	Thr178Met	NM_000531.6	2	1_Pathogenic	OTC	ENSG00000036473	71569	205883	CCSBVarC005251	ALE00005251	533C>T	Thr178Met	CEGS2	CegsMutGDEh1011	D03	GDEhDisVCh_40048	B02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Thr178Met	23	X	38401421	C	T
13571	XRCC2	808T>G	Phe270Val	ENSG00000196584	7	152648677	NC_000007.14:152648677:A:C	ALE00005690	CCSBVarC005690	NULL	218098	NULL	GDEhDisVCh_40090	A05	CEGS2	ATGTGTAGTGCCTTCCATAGGGCTGAGTCTGGGACCGAGCTCCTTGCCCGACTTGAAGGTAGAAGTTCCTTGAAAGAAATAGAACCAAATCTGTTTGCTGATGAAGATTCACCTGTGCATGGTGATATTCTTGAATTTCATGGCCCAGAAGGAACAGGAAAAACAGAAATGCTTTATCACCTAACAGCACGATGTATACTTCCCAAATCAGAAGGTGGCCTGGAAGTAGAAGTCTTATTTATTGATACAGATTACCACTTTGATATGCTCCGGCTAGTTACAATTCTTGAGCACAGACTATCCCAAAGCTCTGAAGAAATAATCAAATACTGCCTGGGAAGATTTTTTTTGGTGTACTGCAGTAGTAGCACCCACTTACTTCTTACACTTTACTCACTAGAAAGTATGTTTTGTAGTCACCCATCTCTCTGCCTTTTGATTTTGGATAGCCTGTCAGCTTTTTACTGGATAGACCGCGTCAATGGAGGAGAAAGTGTGAACTTACAGGAGTCTACTCTGAGGAAATGTTCTCAGTGCTTAGAGAAGCTTGTAAATGACTATCGCCTGGTTCTTTTTGCAACGACACAAACTATAATGCAGAAAGCCTCGAGCTCATCAGAAGAACCTTCTCATGCCTCTCGACGACTGTGTGATGTGGACATAGACTACAGACCTTATCTCTGTAAGGCATGGCAGCAACTGGTGAAGCACAGGATGTTTTTCTCCAAACAAGATGATTCTCAAAGCAGCAACCAATTTTCATTAGTTTCACGTTGTTTAAAAAGTAACAGTTTAAAAAAACATTTTGTTATTATTGGAGAAAGTGGGGTTGAATTTTGT	133422.0	single nucleotide variant	NM_005431.2(XRCC2):c.808T>G (p.Phe270Val)	7516.0	XRCC2	HGNC:12829	Benign/Likely benign	0.0	Jan 01, 2025	145085742.0	-	RCV000115899|RCV000565731|RCV000858406|RCV000988009|RCV003925117	MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0014987,MedGen:C4310651,OMIM:617247|	not specified|Hereditary cancer-predisposing syndrome|not provided|Fanconi anemia complementation group U|XRCC2-related disorder	germline;unknown	germline	GRCh38	NC_000007.14	7	152648677.0	152648677.0	7q36.1	criteria provided, multiple submitters, no conflicts	9.0	-	N	UniProtKB:O43543#VAR_077186,ClinGen:CA288151	2.0	127965.0	152648677.0	A	C	-	-	-	-	-	-	SCV000149808|SCV000288895|SCV000675836|SCV001137555|SCV002066409|SCV002538384|SCV005219894	-	-	808T>G 	Phe270Val	NM_005431.2	2.0	2_Benign	chr7	T	G	7-152648677-T-G		127965	7	152648677	A	C	F	V	rs145085742	7	152345762	7	151976695	270	XRCC2	ENSG00000196584	ENST00000359321	ENSP00000352271	O43543	XRCC2_HUMAN	c.808T>G	p.Phe270Val	c.808T>G	p.Phe270Val	principal1	Y	1	YES	Select	-	TTT	1	0	A	./.	./.	./.	./.	0.005	0.63383	D	0.0	0.92967	D	1.0	0.90580	D	0.976	0.73565	D	0.37	0.61445	N	simple_aae	63.0	37.0	2.72	0.79369	M	-2.95	0.61611	D	0.764	0.76103	-0.0154	0.81854	T	0.4247	0.76767	T	10	0.02209574	0.00541	T	0.0922	0.75769	D	0.690	0.88677	.	.	.	.	.	0.915452881053	0.91396	0.705016151633191	0.70292	0.200461330323	0.22171	0.60987842083	0.54231	T	0.344361	0.71115	T	-0.0749161	0.40188	T	0.124177	0.78351	D	0.0461402483604224	0.04765	T	0.705929	0.31400	T	0.391508	0.59813	0.34508806	0.59962	0.44551316	0.63439	0.3159416	0.57353	-7.666	0.58843	D	0.6843	0.72261	P	0.601770037330194	0.63874	0.21603966	0.73798	0.352	0.61092	.	.	.	.	.	.	4.290926	0.65503	24.8	0.99055021513798003	0.51428	0.721838	0.67077	D	0.681020621152856	0.78273	6.861732	0.636827002194004	0.77508	6.717107	5.49	5.49	0.80997	6.27	0.98789	6.985	0.76023	10.874000	0.84049	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.664	0.33122	988	0.02004	13	0.002595846645367412	13	0.009833585476550681	0	0.0	0	0.0	0	0.0	0	0.0	650	264690	0.002455703	.	61	107108	5.695190e-04	0	129	201832	6.391450e-04	0	120	230266	5.211360e-04	0	58	7132	8.132360e-03	0	1	16158	6.188880e-05	0	0	2248	0.000000e+00	0	0	9018	0.000000e+00	0	0	13234	0.000000e+00	0	1	42354	2.361050e-05	0	0	15092	0.000000e+00	0	58	7132	8.132360e-03	0	121	15600	7.756410e-03	0	4	28710	1.393240e-04	0	0	5890	0.000000e+00	0	0	13378	0.000000e+00	0	0	16476	0.000000e+00	0	1	87828	1.138590e-05	0	0	29302	0.000000e+00	0	121	15600	7.756410e-03	0	114	14288	7.978720e-03	0	4	32420	1.233810e-04	0	0	9198	0.000000e+00	0	0	17386	0.000000e+00	0	0	21338	0.000000e+00	0	1	101024	9.898640e-06	0	0	29220	0.000000e+00	0	114	14288	7.978720e-03	0	.	578	1608224	3.594030e-04	2	517	74588	6.931410e-03	2	517	74588	6.931410e-03	2	0	912	0.000000e+00	0	24	58498	4.102700e-04	0	0	29334	0.000000e+00	0	0	44846	0.000000e+00	0	0	63754	0.000000e+00	0	0	6000	0.000000e+00	0	5	1177964	4.244610e-06	0	1	90120	1.109630e-05	0	0	111404	0	3	124	0.024193548387096774	0	1984	0	19	4044	0.004698318496538081	1	506	0.001976284584980237	0	650	0	0	1246	0	0	104	0	1	14810	6.75219446320054E-5	22	4168	0.00527831094049904	0	3230	0	24	134872	1.7794649741977579E-4	Benign/Likely_benign	not_provided|not_specified|XRCC2-related_disorder|Fanconi_anemia_complementation_group_U|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000007.14:g.152648677A>C	ClinGen:CA288151|UniProtKB:O43543#VAR_077186	C3661900|CN169374|C4310651|C0027672	617247	140162	.	Phe	Val	133422	single nucleotide variant	NM_005431.2(XRCC2):c.808T>G (p.Phe270Val)	7516	XRCC2	HGNC:12829	Benign/Likely benign	0	Jan 01, 2025	145085742	-	RCV000115899|RCV000565731|RCV000858406|RCV000988009|RCV003925117	MedGen:CN169374|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MONDO:MONDO:0014987,MedGen:C4310651,OMIM:617247|	not specified|Hereditary cancer-predisposing syndrome|not provided|Fanconi anemia complementation group U|XRCC2-related disorder	germline;unknown	germline	GRCh38	NC_000007.14	7	152648677	152648677	7q36.1	criteria provided, multiple submitters, no conflicts	9	-	N	UniProtKB:O43543#VAR_077186,ClinGen:CA288151	2	127965	152648677	A	C	-	-	-	-	-	-	SCV000149808|SCV000288895|SCV000675836|SCV001137555|SCV002066409|SCV002538384|SCV005219894	-	-	808T>G 	Phe270Val	NM_005431.2	2	2_Benign	XRCC2	ENSG00000196584	13571	218098	CCSBVarC005690	ALE00005690	808T>G	Phe270Val	CEGS2	CegsMutGDEh1030	D06	GDEhDisVCh_40090	A05	2	CegsMutGDDh1030	D06	VUSN2Hmut_GDN2h_05	D04	VUSMutpDEST2_11	H04	VUSmut_GDEh05	D04	1	1	1	1	1	1	1	1	1	1	XRCC2_Phe270Val	7	7	152648677	A	C
100010885	SGCB	299T>A	Met100Lys	ENSG00000163069	4	52029808	NC_000004.12:52029808:A:T	ALE00006985	CCSBVarC006987	NULL	225816	NULL	GDEhDisVCh_40045	D01	CEGS2	ATGGCGGCAGCGGCGGCGGCGGCTGCAGAACAGCAAAGTTCCAATGGTCCTGTAAAGAAGTCCATGCGTGAGAAGGCTGTTGAGAGAAGGAGTGTCAATAAAGAGCACAACAGTAACTTTAAAGCTGGATACATTCCGATTGATGAAGATCGTCTCCACAAAACAGGGTTGAGAGGAAGAAAGGGCAATTTAGCCATCTGTGTGATTATCCTCTTGTTTATCCTGGCTGTCATCAATTTAATAATAACACTTGTTATTTGGGCCGTGATTCGCATTGGACCAAATGGCTGTGATAGTAAGGAGTTTCATGAAAGTGGCCTGCTTCGATTTAAGCAAGTATCTGACATGGGAGTGATCCACCCTCTTTATAAAAGCACAGTAGGAGGAAGGCGAAATGAAAATTTGGTCATCACTGGCAACAACCAGCCTATTGTTTTTCAGCAAGGGACAACAAAGCTCAGTGTAGAAAACAACAAAACTTCTATTACAAGTGACATCGGCATGCAGTTTTTTGACCCGAGGACTCAAAATATCTTATTCAGCACAGACTATGAAACTCATGAGTTTCATTTGCCAAGTGGAGTGAAAAGTTTGAATGTTCAAAAGGCATCTACTGAAAGGATTACCAGCAATGCTACCAGTGATTTAAATATAAAAGTTGATGGGCGTGCTATTGTGCGTGGAAATGAAGGTGTATTCATTATGGGCAAAACCATTGAATTTCACATGGGTGGTAATATGGAGTTAAAGGCGGAAAACAGTATCATCCTAAATGGATCTGTGATGGTCAGCACCACCCGCCTACCCAGTTCCTCCAGTGGAGACCAGTTGGGTAGTGGTGACTGGGTACGCTACAAGCTCTGCATGTGTGCTGATGGGACGCTCTTCAAGGTGCAAGTAACCAGCCAGAACATGGGCTGCCAAATCTCAGACAACCCCTGTGGAAACACTCAT	23757.0	single nucleotide variant	NM_000232.5(SGCB):c.299T>A (p.Met100Lys)	6443.0	SGCB	HGNC:10806	Pathogenic/Likely pathogenic	1.0	Dec 02, 2024	104893871.0	-	RCV000009256	MONDO:MONDO:0011423,MedGen:C1858593,OMIM:604286,Orphanet:119	Autosomal recessive limb-girdle muscular dystrophy type 2E	germline;unknown	germline	GRCh38	NC_000004.12	4	52029808.0	52029808.0	4q12	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA119858,UniProtKB:Q16585#VAR_010393,OMIM:600900.0007	3.0	8718.0	52029808.0	A	T	-	-	-	-	-	-	SCV000797524|SCV001136738|SCV002261967|SCV004208743|SCV005665317	-	-	299T>A 	Met100Lys	NM_000232.5	2.0	1_Pathogenic	chr4	T	A	4-52029808-T-A		8718	4	52029808	A	T	M	K	rs104893871	4	52895974	4	52590731	100	SGCB	ENSG00000163069	ENST00000381431	ENSP00000370839	Q16585	SGCB_HUMAN	c.299T>A	p.Met100Lys	c.299T>A	p.Met100Lys	principal1	Y	1	YES	Select	-	ATG	2	0	A	A/A	A/A	A/A	A/A	0.001	0.78662	D	0.004	0.74454	D	0.274	0.31873	B	0.212	0.37395	B	0.92	0.93300	A	simple_aae	8.0	92.0	2.51	0.72944	M	-4.72	0.80031	D	0.869	0.86590	0.9217	0.95970	D	0.8085	0.93517	D	9	0.9578867	0.95111	D	0.293571	0.90624	D	0.946	0.98921	0.83	0.93946	Q16585	M100K	Gain of disorder (P = 0.0154)| Gain of ubiquitination at M100 (P = 0.0155)| Loss of stability (P = 0.0247)| Gain of loop (P = 0.1069)| Loss of glycosylation at S105 (P = 0.1143)	0.993865714822	0.99371	0.9675598908485775	0.96725	0.319931632253	0.33896	0.683906912804	0.64771	T	0.942643	0.99101	D	0.517264	0.94763	D	0.505238	0.94686	D	0.992189407348633	0.82466	D	0.889111	0.61972	D	0.89255524	0.90595	0.8477175	0.91236	0.89283806	0.90622	0.84525985	0.91071	-9.683	0.72071	D	0.9696	0.89333	P	0.960811735108473	0.81836	0.99946207	0.99403	0.932	0.96656	.	.	.	.	.	.	4.784859	0.77638	26.7	0.98726969080392457	0.45398	0.928961	0.91367	D	0.386547045540273	0.60489	4.260999	0.47799733645373	0.66352	4.964704	5.25	5.25	0.73133	4.3	0.81401	9.074	0.93422	11.232000	0.90150	0.691	0.84104	1.0	0.71675	1.000000	0.68239	0.991	0.66489	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1613898	6.196180e-07	0	0	75024	0.000000e+00	0	0	75024	0.000000e+00	0	0	912	0.000000e+00	0	0	59998	0.000000e+00	0	0	29596	0.000000e+00	0	0	44868	0.000000e+00	0	0	64012	0.000000e+00	0	0	6058	0.000000e+00	0	0	1179854	0.000000e+00	0	0	91074	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2E	criteria_provided,_conflicting_classifications	NC_000004.12:g.52029808A>T	ClinGen:CA119858|OMIM:600900.0007|UniProtKB:Q16585#VAR_010393	C1858593	604286	119	.	Met	Lys	23757	single nucleotide variant	NM_000232.5(SGCB):c.299T>A (p.Met100Lys)	6443	SGCB	HGNC:10806	Pathogenic/Likely pathogenic	1	Dec 02, 2024	104893871	-	RCV000009256	MONDO:MONDO:0011423,MedGen:C1858593,OMIM:604286,Orphanet:119	Autosomal recessive limb-girdle muscular dystrophy type 2E	germline;unknown	germline	GRCh38	NC_000004.12	4	52029808	52029808	4q12	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA119858,UniProtKB:Q16585#VAR_010393,OMIM:600900.0007	3	8718	52029808	A	T	-	-	-	-	-	-	SCV000797524|SCV001136738|SCV002261967|SCV004208743|SCV005665317	-	-	299T>A 	Met100Lys	NM_000232.5	2	1_Pathogenic	SGCB	ENSG00000163069	100010885	225816	CCSBVarC006987	ALE00006985	299T>A	Met100Lys	CEGS2	CegsMutGDEh1043	E06	GDEhDisVCh_40045	D01	1	CegsMutGDDh1043	E06	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	SGCB_Met100Lys	4	4	52029808	A	T
2803	HMBS	647G>A	Gly216Asp	ENSG00000256269	11	119092159	NC_000011.10:119092159:G:A	ALE00005170	CCSBVarC005170	NULL	200937	NULL	GDEhDisVCh_40054	G08	CEGS2	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAGCTTGCTCGCATACAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGGACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCTTGAACATGCCCTGGAGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCGAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTCGGGGAAACCTCAACACCCGGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACCGGGTGGGGCAGATCCTGCACCCTGAGGAATGCATGTATGCTGTGGACCAGGGGGCCTTGGGCGTGGAAGTGCGAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCTGCATCGCTGAAAGGGCCTTCCTGAGGCACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATGGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCGTAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACGATGCCCAT	16517.0	single nucleotide variant	NM_000190.4(HMBS):c.647G>A (p.Gly216Asp)	3145.0	HMBS	HGNC:4982	Pathogenic	1.0	Sep 01, 2022	118204116.0	-	RCV000001543|RCV001851552	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900	Acute intermittent porphyria|not provided	germline	germline	GRCh38	NC_000011.10	11	119092159.0	119092159.0	11q23.3	criteria provided, single submitter	2.0	-	N	ClinGen:CA251838,UniProtKB:P08397#VAR_011015,OMIM:609806.0038	3.0	1478.0	119092159.0	G	A	-	-	-	-	-	-	SCV002270784	-	-	647G>A 	Gly216Asp	NM_000190.4	1.0	1_Pathogenic	chr11	G	A	11-119092159-G-A	1.36822e-6	1478	11	119092159	G	A	G	D	rs118204116	11	118962869	11	118468079	216	HMBS	ENSG00000256269	ENST00000652429	ENSP00000498786	P08397	HEM3_HUMAN	c.647G>A	p.Gly216Asp	c.647G>A	p.Gly216Asp	principal2	Y	.	YES	Select	+	GGC	2	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	0.98	0.67505	D	0.932	0.66718	D	.	0.97926	.	.	.	.	4.32	0.98311	H	.	0.90003	.	.	0.99555	0.9003	0.95663	D	0.9953	0.99893	D	9	.	0.99798	.	0.701875	0.97557	D	.	0.99695	0.98	0.99810	P08397	G216D	Loss of phosphorylation at Y213 (P = 0.1626)| Gain of catalytic residue at G218 (P = 0.2704)| Loss of sheet (P = 0.302)| Gain of loop (P = 0.4248)| Gain of stability (P = 0.5311)	.	0.97922	0.9771113150999144	0.97690	.	.	0.862901568413	0.91525	D	0.994095	0.99985	D	0.589392	0.97327	D	0.608844	0.97284	D	0.999509811401367	0.97654	D	0.981385	0.93698	D	0.9970425	0.99993	0.98820347	0.99963	0.99231875	0.99871	0.9836354	0.99899	-12.909	0.89976	D	0.998	0.97565	P	0.999474145391979	0.96705	0.34261006	0.78086	0.994	0.99793	.	.	.	.	.	.	5.884996	0.93951	33.0	0.99831407140949091	0.91291	0.950637	0.96432	D	0.806729551703391	0.86452	8.913641	0.697938280092001	0.82124	7.713957	5.3	4.38	0.51962	6.08	0.97853	8.766	0.91399	11.817000	0.97121	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	228	0.91137	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1614046	1.239120e-06	0	2	1179962	1.694970e-06	0	0	75024	0.000000e+00	0	0	912	0.000000e+00	0	0	60018	0.000000e+00	0	0	29606	0.000000e+00	0	0	44888	0.000000e+00	0	0	64026	0.000000e+00	0	0	6028	0.000000e+00	0	2	1179962	1.694970e-06	0	0	91074	0.000000e+00	0	0	9768	0	0	114	0	0	120	0	0	3218	0	0	146	0	0	610	0	0	26	0	0	104	0	0	604	0	0	3332	0	0	146	0	0	14710	0	Pathogenic	Acute_intermittent_porphyria|not_provided	criteria_provided,_single_submitter	NC_000011.10:g.119092159G>A	ClinGen:CA251838|OMIM:609806.0038|UniProtKB:P08397#VAR_011015	C0162565|C3661900	176000	79276	Porphobilinogen deaminase, N-terminal	Gly	Asp	16517	single nucleotide variant	NM_000190.4(HMBS):c.647G>A (p.Gly216Asp)	3145	HMBS	HGNC:4982	Pathogenic	1	Sep 01, 2022	118204116	-	RCV000001543|RCV001851552	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900	Acute intermittent porphyria|not provided	germline	germline	GRCh38	NC_000011.10	11	119092159	119092159	11q23.3	criteria provided, single submitter	2	-	N	ClinGen:CA251838,UniProtKB:P08397#VAR_011015,OMIM:609806.0038	3	1478	119092159	G	A	-	-	-	-	-	-	SCV002270784	-	-	647G>A 	Gly216Asp	NM_000190.4	1	1_Pathogenic	HMBS	ENSG00000256269	2803	200937	CCSBVarC005170	ALE00005170	647G>A	Gly216Asp	CEGS2	CegsMutGDEh1045	F07	GDEhDisVCh_40054	G08	2	CegsMutGDDh1045	F07	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	HMBS_Gly216Asp	11	11	119092159	G	A
5961	TARDBP	506A>G	Asp169Gly	ENSG00000120948	1	11018836	NC_000001.11:11018836:A:G	ALE00005767	CCSBVarC005767	NULL	202028	NULL	GDEhDisVCh_40090	H04	CEGS2	ATGTCTGAATATATTCGGGTAACCGAAGATGAGAACGATGAGCCCATTGAAATACCATCGGAAGACGATGGGACGGTGCTGCTCTCCACGGTTACAGCCCAGTTTCCAGGGGCGTGTGGGCTTCGCTACAGGAATCCAGTGTCTCAGTGTATGAGAGGTGTCCGGCTGGTAGAAGGAATTCTGCATGCCCCAGATGCTGGCTGGGGAAATCTGGTGTATGTTGTCAACTATCCAAAAGATAACAAAAGAAAAATGGATGAGACAGATGCTTCATCAGCAGTGAAAGTGAAAAGAGCAGTCCAGAAAACATCCGATTTAATAGTGTTGGGTCTCCCATGGAAAACAACCGAACAGGACCTGAAAGAGTATTTTAGTACCTTTGGAGAAGTTCTTATGGTGCAGGTCAAGAAAGATCTTAAGACTGGTCATTCAAAGGGGTTTGGCTTTGTTCGTTTTACGGAATATGAAACACAAGTGAAAGTAATGTCACAGCGACATATGATAGGTGGACGATGGTGTGACTGCAAACTTCCTAATTCTAAGCAAAGCCAAGATGAGCCTTTGAGAAGCAGAAAAGTGTTTGTGGGGCGCTGTACAGAGGACATGACTGAGGATGAGCTGCGGGAGTTCTTCTCTCAGTACGGGGATGTGATGGATGTCTTCATCCCCAAGCCATTCAGGGCCTTTGCCTTTGTTACATTTGCAGATGATCAGATTGCGCAGTCTCTTTGTGGAGAGGACTTGATCATTAAAGGAATCAGCGTTCATATATCCAATGCC	20272.0	single nucleotide variant	NM_007375.4(TARDBP):c.506A>G (p.Asp169Gly)	23435.0	TARDBP	HGNC:11571	Pathogenic	1.0	May 01, 2008	80356717.0	-	RCV000005544	MONDO:MONDO:0012790,MedGen:C2677565,OMIM:612069,Orphanet:275872,Orphanet:803	Amyotrophic lateral sclerosis type 10	germline	germline	GRCh38	NC_000001.11	1	11018836.0	11018836.0	1p36.22	no assertion criteria provided	2.0	-	N	ClinGen:CA340377,UniProtKB:Q13148#VAR_045657,OMIM:605078.0006	1.0	5233.0	11018836.0	A	G	-	-	-	-	-	-	SCV000025726	-	-	506A>G 	Asp169Gly	NM_007375.4		1_Pathogenic	chr1	A	G	1-11018836-A-G		5233	1	11018836	A	G	D	G	rs80356717	1	11078893	1	11001480	169	TARDBP	ENSG00000120948	ENST00000639083	ENSP00000491203	Q13148	TADBP_HUMAN	c.506A>G	p.Asp169Gly	c.506A>G	p.Asp169Gly	principal1	Y	5	.	.	+	GAT	2	0	A	./.	./.	./.	./.	.	0.47480	.	.	0.51463	.	0.635	0.40326	P	0.364	0.43305	B	.	0.97016	.	.	.	.	1.045	0.26625	L	.	0.88727	.	.	0.91160	0.6796	0.92894	D	0.7283	0.90673	D	9	0.9036323	0.89613	D	0.146238	0.82790	D	.	0.94975	0.773	0.89871	Q13148	D169G	Gain of MoRF binding (P = 0.033)| Loss of catalytic residue at D169 (P = 0.05)| Loss of sheet (P = 0.1158)| Gain of loop (P = 0.2045)| Gain of helix (P = 0.2059)	.	0.98450	.	0.98327	.	0.98340	0.885120630264	0.94632	D	0.822449	0.95639	D	0.446726	0.92276	D	0.403914	0.92181	D	0.964754939079285	0.66841	D	.	0.89187	.	0.7886938	0.82980	0.7763599	0.86642	0.79025185	0.83080	0.7894129	0.87454	-10.902	0.79186	D	0.9429	0.86153	P	0.989101522203956	0.88046	0.99987018	0.99835	0.769	0.87211	.	.	.	.	.	.	5.000965	0.83013	27.9	0.99667271434127513	0.78353	0.940916	0.94332	D	0.451834047461557	0.64120	4.682286	0.564933620079155	0.72292	5.810565	5.81	5.81	0.92402	3.89	0.73480	9.023	0.93208	11.215000	0.89560	0.75	0.87077	1.0	0.71675	1.000000	0.68239	1.0	0.97202	846	0.36176	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	19570	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	3418	0	0	434	0	0	34	0	0	23462	0	Pathogenic	Amyotrophic_lateral_sclerosis_type_10	no_assertion_criteria_provided	NC_000001.11:g.11018836A>G	ClinGen:CA340377|OMIM:605078.0006|UniProtKB:Q13148#VAR_045657	C2677565	612069	275872|803	RNA recognition motif domain|RNA recognition motif domain	Asp	Gly	20272	single nucleotide variant	NM_007375.4(TARDBP):c.506A>G (p.Asp169Gly)	23435	TARDBP	HGNC:11571	Pathogenic	1	May 01, 2008	80356717	-	RCV000005544	MONDO:MONDO:0012790,MedGen:C2677565,OMIM:612069,Orphanet:275872,Orphanet:803	Amyotrophic lateral sclerosis type 10	germline	germline	GRCh38	NC_000001.11	1	11018836	11018836	1p36.22	no assertion criteria provided	2	-	N	ClinGen:CA340377,UniProtKB:Q13148#VAR_045657,OMIM:605078.0006	1	5233	11018836	A	G	-	-	-	-	-	-	SCV000025726	-	-	506A>G 	Asp169Gly	NM_007375.4		1_Pathogenic	TARDBP	ENSG00000120948	5961	202028	CCSBVarC005767	ALE00005767	506A>G	Asp169Gly	CEGS2	CegsMutGDEh1030	E05	GDEhDisVCh_40090	H04	2	CegsMutGDDh1030	E05	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	TARDBP_Asp169Gly	1	1	11018836	A	G
359	CBS	325T>C	Cys109Arg	ENSG00000160200	21	43066369	NC_000021.9:43066369:A:G	ALE00007340	CCSBVarC007352	NULL	NULL	311	GDEhDisVCh_40013	E10	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGCGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210444.0	single nucleotide variant	NM_000071.3(CBS):c.325T>C (p.Cys109Arg)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Feb 06, 2025	778220779.0	-	RCV000199752|RCV000248928|RCV000535881|RCV000588375|RCV002229441|RCV004754347	MedGen:C3661900|MedGen:CN230736|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344|	not provided|Cardiovascular phenotype|Classic homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|CBS-related disorder	germline;unknown	germline	GRCh38	NC_000021.9	21	43066369.0	43066369.0	21q22.3	criteria provided, multiple submitters, no conflicts	11.0	-	N	ClinGen:CA324303,UniProtKB:P35520#VAR_021792	2.0	212878.0	43066369.0	A	G	-	-	-	-	-	-	SCV000249727|SCV000319354|SCV000649832|SCV000695304|SCV000700264|SCV004213870|SCV004847626|SCV005876998	-	-	325T>C 	Cys109Arg	NM_000071.3	2.0	1_Pathogenic	chr21	T	C	21-43066369-T-C		212878	21	43066369	A	G	C	R	rs778220779	21	44486479	21	43359548	109	CBS	ENSG00000160200	ENST00000398165	ENSP00000381231	P35520	CBS_HUMAN	c.325T>C	p.Cys109Arg	c.325T>C	p.Cys109Arg	principal1	Y	1	YES	Select	-	TGT	1	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.001	0.83643	D	1.0	0.90580	D	0.998	0.88579	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.765	0.95058	H	-11.9	0.99585	D	0.975	0.98575	1.0978	0.99568	D	0.9499	0.98365	D	10	0.99190193	0.99721	D	0.883334	0.99110	D	0.979	0.99840	0.943	0.99252	P35520	C109R	Gain of MoRF binding (P = 0.026)| Loss of methylation at K108 (P = 0.0405)| Gain of disorder (P = 0.0657)| Gain of relative solvent accessibility (P = 0.2363)| Loss of ubiquitination at K108 (P = 0.2413)	0.941625851215	0.94055	0.9893906711101572	0.98931	1.52078213034	0.87371	0.920038700104	0.98326	D	0.968422	0.99637	D	0.499919	0.94235	D	0.543969	0.95423	D	0.999472320079803	0.97528	D	.	0.94657	.	0.9979372	0.99998	0.9928428	0.99993	0.99614656	0.99983	0.9938923	0.99996	-16.734	0.98670	D	.	0.92384	.	0.999773468930688	0.97903	0.99988127	0.99849	1	0.99985	.	.	.	.	.	.	5.364154	0.89965	31.0	0.99768578692814736	0.85678	0.975917	0.99644	D	0.918639876881402	0.92601	11.54251	0.840533049223308	0.92410	11.43375	5.36	5.36	0.76590	.	.	8.099	0.89404	10.806000	0.83829	0.658	0.54518	1.0	0.71675	1.000000	0.68239	0.961	0.51915	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	109228	1.831030e-05	0	3	207562	1.445350e-05	0	4	236484	1.691450e-05	0	0	7160	0.000000e+00	0	0	17102	0.000000e+00	0	0	2320	0.000000e+00	0	0	9042	0.000000e+00	0	0	13244	0.000000e+00	0	2	42758	4.677490e-05	0	0	15688	0.000000e+00	0	2	42758	4.677490e-05	0	0	16196	0.000000e+00	0	0	30512	0.000000e+00	0	0	6208	0.000000e+00	0	0	13398	0.000000e+00	0	0	16584	0.000000e+00	0	3	89198	3.363300e-05	0	0	30606	0.000000e+00	0	3	89198	3.363300e-05	0	0	14896	0.000000e+00	0	0	34242	0.000000e+00	0	0	9564	0.000000e+00	0	0	17688	0.000000e+00	0	0	21482	0.000000e+00	0	3	102470	2.927690e-05	0	0	30524	0.000000e+00	0	3	102470	2.927690e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic/Likely_pathogenic	HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Classic_homocystinuria|not_provided|Cardiovascular_phenotype|Homocystinuria	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43066369A>G	ClinGen:CA324303|UniProtKB:P35520#VAR_021792	C3150344|C0751202|C3661900|CN230736|C0019880	236200	394	Tryptophan synthase beta chain-like, PALP domain|Cysteine synthase/cystathionine beta-synthase, pyridoxal-phosphate attachment site	Cys	Arg	210444	single nucleotide variant	NM_000071.3(CBS):c.325T>C (p.Cys109Arg)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Feb 06, 2025	778220779	-	RCV000199752|RCV000248928|RCV000535881|RCV000588375|RCV002229441|RCV004754347	MedGen:C3661900|MedGen:CN230736|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344|	not provided|Cardiovascular phenotype|Classic homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|CBS-related disorder	germline;unknown	germline	GRCh38	NC_000021.9	21	43066369	43066369	21q22.3	criteria provided, multiple submitters, no conflicts	11	-	N	ClinGen:CA324303,UniProtKB:P35520#VAR_021792	2	212878	43066369	A	G	-	-	-	-	-	-	SCV000249727|SCV000319354|SCV000649832|SCV000695304|SCV000700264|SCV004213870|SCV004847626|SCV005876998	-	-	325T>C 	Cys109Arg	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	311	CCSBVarC007352	ALE00007340	325T>C	Cys109Arg	Edgotyping3	VUSMutGDEh011	C05	GDEhDisVCh_40013	E10	1	VUSMutGDDh011	C05	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	CBS_Cys109Arg	21	21	43066369	A	G
359	CBS	1208C>T	Thr403Met	ENSG00000160200	21	43059241	NC_000021.9:43059241:G:A	ALE00007301	CCSBVarC007305	NULL	NULL	248	GDEhDisVCh_40013	E04	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCATGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	266286.0	single nucleotide variant	NM_000071.3(CBS):c.1208C>T (p.Thr403Met)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Sep 03, 2021	886042297.0	-	RCV000372121|RCV002518836|RCV003144192	MedGen:C3661900|MedGen:C3150344|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394	not provided|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Classic homocystinuria	germline	germline	GRCh38	NC_000021.9	21	43059241.0	43059241.0	21q22.3	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA10604053	2.0	282049.0	43059241.0	G	A	-	-	-	-	-	-	SCV000333222|SCV001987036|SCV002956019|SCV003829293|SCV005195155	-	-	1208C>T 	Thr403Met	NM_000071.3	2.0	4_VUS	chr21	C	T	21-43059241-C-T		282049	21	43059241	G	A	T	M	rs886042297	21	44479351	21	43352420	403	CBS	ENSG00000160200	ENST00000398165	ENSP00000381231	P35520	CBS_HUMAN	c.1208C>T	p.Thr403Met	c.1208C>T	p.Thr403Met	principal1	Y	1	YES	Select	-	ACG	2	0	G	G/G	G/G	G/G	G/G	0.164	0.23477	T	0.159	0.31849	T	0.0	0.02950	B	0.001	0.04348	B	.	.	.	.	.	.	-0.44	0.02839	N	-0.38	0.13346	N	0.212	0.23473	1.0147	0.97432	D	0.9323	0.97763	D	10	0.13545632	0.25464	T	0.342304	0.92030	D	0.379	0.69534	0.356	0.35591	P35520	T403M	Loss of sheet (P = 0.0457)| Loss of ubiquitination at K398 (P = 0.0877)| Loss of disorder (P = 0.11)| Gain of methylation at K405 (P = 0.1425)| Loss of phosphorylation at T403 (P = 0.1666)	0.328752806141	0.32072	0.30600477970572565	0.30314	0.360481707023	0.37433	0.305942445993	0.11287	T	0.426803	0.77485	T	-0.0423109	0.45268	T	-0.201699	0.54173	T	0.0637963530037214	0.07664	T	.	0.03638	.	0.040159237	0.05626	0.07411244	0.16168	0.070973024	0.15533	0.05815143	0.10703	-3.907	0.22427	T	.	0.01041	.	0.000128786950113422	0.03290	0.97768340	0.95298	0.27	0.54055	.	.	.	.	.	.	-0.976565	0.00806	0.027	0.82927074274771995	0.14677	0.243402	0.36263	N	-1.63454119784769	0.01092	0.04782993	-1.66806571168052	0.01271	0.05796617	4.6	-4.6	0.03151	.	.	-0.109	0.10845	-0.465000	0.09054	-1.863	0.00561	0.0	0.06393	0.000000	0.08389	0.0	0.00835	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109194	0.000000e+00	0	1	207762	4.813200e-06	0	1	236712	4.224540e-06	0	0	7156	0.000000e+00	0	0	17104	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13202	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16194	0.000000e+00	0	0	30516	0.000000e+00	0	0	6206	0.000000e+00	0	0	13400	0.000000e+00	0	0	16542	0.000000e+00	0	0	89446	0.000000e+00	0	1	30608	3.267120e-05	0	1	30608	3.267120e-05	0	0	14894	0.000000e+00	0	0	34252	0.000000e+00	0	0	9568	0.000000e+00	0	0	17690	0.000000e+00	0	0	21440	0.000000e+00	0	0	102728	0.000000e+00	0	1	30526	3.275900e-05	0	1	30526	3.275900e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|not_provided|Classic_homocystinuria	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43059241G>A	ClinGen:CA10604053	C3150344|C3661900|C0751202	236200	394	.	Thr	Met	266286	single nucleotide variant	NM_000071.3(CBS):c.1208C>T (p.Thr403Met)	875	CBS	HGNC:1550	Uncertain significance	0	Sep 03, 2021	886042297	-	RCV000372121|RCV002518836|RCV003144192	MedGen:C3661900|MedGen:C3150344|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394	not provided|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Classic homocystinuria	germline	germline	GRCh38	NC_000021.9	21	43059241	43059241	21q22.3	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA10604053	2	282049	43059241	G	A	-	-	-	-	-	-	SCV000333222|SCV001987036|SCV002956019|SCV003829293|SCV005195155	-	-	1208C>T 	Thr403Met	NM_000071.3	2	4_VUS	CBS	ENSG00000160200	359	248	CCSBVarC007305	ALE00007301	1208C>T	Thr403Met	Edgotyping3	VUSMutGDEh010	A11	GDEhDisVCh_40013	E04	1	VUSMutGDDh010	A11	NULL	NULL	NULL	NULL	NULL	NULL	1	4	1	6	0	NULL	0	NULL	0	NULL	CBS_Thr403Met	21	21	43059241	G	A
359	CBS	301C>G	Leu101Val	ENSG00000160200	21	43068524	NC_000021.9:43068524:G:C	ALE00007343	CCSBVarC007355	NULL	NULL	315	GDEhDisVCh_40013	H10	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCGTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	350760.0	single nucleotide variant	NM_000071.3(CBS):c.301C>G (p.Leu101Val)	875.0	CBS	HGNC:1550	Conflicting classifications of pathogenicity	1.0	Jan 01, 2024	369644531.0	-	RCV000310277|RCV003495126|RCV002510881	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|MedGen:C3661900	Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not provided	germline	germline	GRCh38	NC_000021.9	21	43068524.0	43068524.0	21q22.3	criteria provided, conflicting classifications	3.0	-	N	ClinGen:CA10653007	2.0	340091.0	43068524.0	G	C	-	-	-	-	-	-	SCV000436231|SCV002820576|SCV004283758	-	-	301C>G 	Leu101Val	NM_000071.3	1.0	3_Conflicting	chr21	C	G	21-43068524-C-G		340091	21	43068524	G	C	L	V	rs369644531	21	44488634	21	43361703	101	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.301C>G	p.Leu101Val	c.301C>G	p.Leu101Val	principal1	Y	1	.	.	-	CTG	1	2	G	G/G	G/G	G/G	G/G	0.121	0.27913	T	0.147	0.33109	T	0.488	0.36923	P	0.295	0.40843	B	.	.	.	.	.	.	1.48	0.36986	L	-1.89	0.44100	N	0.463	0.50086	0.7244	0.93455	D	0.8149	0.93747	D	10	0.49391818	0.60833	D	0.154991	0.83556	D	0.535	0.80385	.	.	.	.	.	0.858956982649	0.85649	.	0.76657	.	0.47104	0.614768862724	0.54923	T	0.878906	0.97424	D	0.19193	0.72941	D	0.0379175	0.72589	D	0.562369167804718	0.34633	D	.	0.99111	.	0.33335072	0.55412	0.134155	0.32065	0.3412797	0.56051	0.17990167	0.40617	-8.507	0.64551	D	.	0.33344	.	0.536696958972271	0.61895	0.99842300	0.98775	0.54	0.73984	.	.	.	.	.	.	2.252564	0.28829	17.91	0.99615088082936742	0.75081	0.766353	0.70147	D	0.12545082914903	0.47400	2.987965	0.200759282840762	0.49632	3.186922	4.81	4.81	0.61353	2.97	0.54324	3.646	0.54228	7.007000	0.57285	0.59	0.31918	1.0	0.71675	1.000000	0.68239	0.323	0.25089	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109402	9.140600e-06	0	4	208050	1.922610e-05	0	4	236834	1.688950e-05	0	0	7162	0.000000e+00	0	0	17112	0.000000e+00	0	1	2320	4.310340e-04	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42764	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16206	0.000000e+00	0	0	30522	0.000000e+00	0	4	6212	6.439150e-04	0	0	13414	0.000000e+00	0	0	16734	0.000000e+00	0	0	89492	0.000000e+00	0	0	30608	0.000000e+00	0	.	.	.	.	0	14892	0.000000e+00	0	0	34258	0.000000e+00	0	4	9570	4.179730e-04	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	0	102648	0.000000e+00	0	0	30526	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	30576	6.541077969649399E-5	0	116	0	0	110	0	0	3314	0	0	500	0	0	628	0	0	54	0	0	94	0	0	6838	0	0	3430	0	0	164	0	2	42230	4.735969689793985E-5	Conflicting_classifications_of_pathogenicity	HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Classic_homocystinuria|not_provided	criteria_provided,_conflicting_classifications	NC_000021.9:g.43068524G>C	ClinGen:CA10653007	C3150344|C0751202|C3661900	236200	394	Tryptophan synthase beta chain-like, PALP domain	Leu	Val	350760	single nucleotide variant	NM_000071.3(CBS):c.301C>G (p.Leu101Val)	875	CBS	HGNC:1550	Conflicting classifications of pathogenicity	1	Jan 01, 2024	369644531	-	RCV000310277|RCV003495126|RCV002510881	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|MedGen:C3661900	Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|not provided	germline	germline	GRCh38	NC_000021.9	21	43068524	43068524	21q22.3	criteria provided, conflicting classifications	3	-	N	ClinGen:CA10653007	2	340091	43068524	G	C	-	-	-	-	-	-	SCV000436231|SCV002820576|SCV004283758	-	-	301C>G 	Leu101Val	NM_000071.3	1	3_Conflicting	CBS	ENSG00000160200	359	315	CCSBVarC007355	ALE00007343	301C>G	Leu101Val	Edgotyping3	VUSMutGDEh011	F05	GDEhDisVCh_40013	H10	1	VUSMutGDDh011	F05	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	5	0	NULL	0	NULL	0	NULL	CBS_Leu101Val	21	21	43068524	G	C
7918	MSH2	38G>T	Ser13Ile	ENSG00000095002	2	47403229	NC_000002.12:47403229:G:T	ALE00001278	CCSBVarC001278	14183	NULL	NULL	GDEhDisVCh_40060	C12	RC4	ATGGCGGTGCAGCCGAAGGAGACGCTGCAGTTGGAGATCGCGGCCGAGGTCGGCTTCGTGCGCTTCTTTCAGGGCATGCCGGAGAAGCCGACCACCACAGTGCGCCTTTTCGACCGGGGCGACTTCTATACGGCGCACGGCGAGGACGCGCTGCTGGCCGCCCGGGAGGTGTTCAAGACCCAGGGGGTGATCAAGTACATGGGGCCGGCAGGAGCAAAGAATCTGCAGAGTGTTGTGCTTAGTAAAATGAATTTTGAATCTTTTGTAAAAGATCTTCTTCTGGTTCGTCAGTATAGAGTTGAAGTTTATAAGAATAGAGCTGGAAATAAGGCATCCAAGGAGAATGATTGGTATTTGGCATATAAGGCTTCTCCTGGCAATCTCTCTCAGTTTGAAGACATTCTCTTTGGTAACAATGATATGTCAGCTTCCATTGGTGTTGTGGGTGTTAAAATGTCCGCAGTTGATGGCCAGAGACAGGTTGGAGTTGGGTATGTGGATTCCATACAGAGGAAACTAGGACTGTGTGAATTCCCTGATAATGATCAGTTCTCCAATCTTGAGGCTCTCCTCATCCAGATTGGACCAAAGGAATGTGTTTTACCCGGAGGAGAGACTGCTGGAGACATGGGGAAACTGAGACAGATAATTCAAAGAGGAGGAATTCTGATCACAGAAAGAAAAAAAGCTGACTTTTCCACAAAAGACATTTATCAGGACCTCAACCGGTTGTTGAAAGGCAAAAAGGGAGAGCAGATGAATAGTGCTGTATTGCCAGAAATGGAGAATCAGGTTGCAGTTTCATCACTGTCTGCGGTAATCAAGTTTTTAGAACTCTTATCAGATGATTCCAACTTTGGACAGTTTGAACTGACTACTTTTGACTTCAGCCAGTATATGAAATTGGATATTGCAGCAGTCAGAGCCCTTAACCTTTTTCAGGGTTCTGTTGAAGATACCACTGGCTCTCAGTCTCTGGCTGCCTTGCTGAATAAGTGTAAAACCCCTCAAGGACAAAGACTTGTTAACCAGTGGATTAAGCAGCCTCTCATGGATAAGAACAGAATAGAGGAGAGATTGAATTTAGTGGAAGCTTTTGTAGAAGATGCAGAATTGAGGCAGACTTTACAAGAAGATTTACTTCGTCGATTCCCAGATCTTAACCGACTTGCCAAGAAGTTTCAAAGACAAGCAGCAAACTTACAAGATTGTTACCGACTCTATCAGGGTATAAATCAACTACCTAATGTTATACAGGCTCTGGAAAAACATGAAGGAAAACACCAGAAATTATTGTTGGCAGTTTTTGTGACTCCTCTTACTGATCTTCGTTCTGACTTCTCCAAGTTTCAGGAAATGATAGAAACAACTTTAGATATGGATCAGGTGGAAAACCATGAATTCCTTGTAAAACCTTCATTTGATCCTAATCTCAGTGAATTAAGAGAAATAATGAATGACTTGGAAAAGAAGATGCAGTCAACATTAATAAGTGCAGCCAGAGATCTTGGCTTGGACCCTGGCAAACAGATTAAACTGGATTCCAGTGCACAGTTTGGATATTACTTTCGTGTAACCTGTAAGGAAGAAAAAGTCCTTCGTAACAATAAAAACTTTAGTACTGTAGATATCCAGAAGAATGGTGTTAAATTTACCAACAGCAAATTGACTTCTTTAAATGAAGAGTATACCAAAAATAAAACAGAATATGAAGAAGCCCAGGATGCCATTGTTAAAGAAATTGTCAATATTTCTTCAGGCTATGTAGAACCAATGCAGACACTCAATGATGTGTTAGCTCAGCTAGATGCTGTTGTCAGCTTTGCTCACGTGTCAAATGGAGCACCTGTTCCATATGTACGACCAGCCATTTTGGAGAAAGGACAAGGAAGAATTATATTAAAAGCATCCAGGCATGCTTGTGTTGAAGTTCAAGATGAAATTGCATTTATTCCTAATGACGTATACTTTGAAAAAGATAAACAGATGTTCCACATCATTACTGGCCCCAATATGGGAGGTAAATCAACATATATTCGACAAACTGGGGTGATAGTACTCATGGCCCAAATTGGGTGTTTTGTGCCATGTGAGTCAGCAGAAGTGTCCATTGTGGACTGCATCTTAGCCCGAGTAGGGGCTGGTGACAGTCAATTGAAAGGAGTCTCCACGTTCATGGCTGAAATGTTGGAAACTGCTTCTATCCTCAGGTCTGCAACCAAAGATTCATTAATAATCATAGATGAATTGGGAAGAGGAACTTCTACCTACGATGGATTTGGGTTAGCATGGGCTATATCAGAATACATTGCAACAAAGATTGGTGCTTTTTGCATGTTTGCAACCCATTTTCATGAACTTACTGCCTTGGCCAATCAGATACCAACTGTTAATAATCTACATGTCACAGCACTCACCACTGAAGAGACCTTAACTATGCTTTATCAGGTGAAGAAAGGTGTCTGTGATCAAAGTTTTGGGATTCATGTTGCAGAGCTTGCTAATTTCCCTAAGCATGTAATAGAGTGTGCTAAACAGAAAGCCCTGGAACTTGAGGAGTTTCAGTATATTGGAGAATCGCAAGGATATGATATCATGGAACCAGCAGCAAAGAAGTGCTATCTGGAAAGAGAGCAAGGTGAAAAAATTATTCAGGAGTTCCTGTCCAAGGTGAAACAAATGCCCTTTACTGAAATGTCAGAAGAAAACATCACAATAAAGTTAAAACAGCTAAAAGCTGAAGTAATAGCAAAGAATAATAGCTTTGTAAATGAAATCATTTCACGAATAAAAGTTACTACG																																															chr2	G	T	2-47403229-G-T	0.0																																																																																																																																																																																																																																																																																																																																																																																																																																													MSH2	ENSG00000095002	7918	14183	CCSBVarC001278	ALE00001278	38G>T	Ser13Ile	RC4	RC4_Mut_GDEh1030	F12	GDEhDisVCh_40060	C12	2	RC4_Mut_GDDh1030	F12	NULL	NULL	VUSMutpDEST2_07	D02	NULL	NULL	1	7	1	4	0	NULL	1	6	0	NULL	MSH2_Ser13Ile	2	2	47403229	G	T
3689	GCK	895G>C	Gly299Arg	ENSG00000106633	7	44146587	NC_000007.14:44146587:C:G	ALE00006692	CCSBVarC006694	NULL	214851	NULL	GDEhDisVCh_40037	G05	CEGS2	ATGCTGGACGACAGAGCCAGGATGGAGGCCGCCAAGAAGGAGAAGGTAGAGCAGATCCTGGCAGAGTTCCAGCTGCAGGAGGAGGACCTGAAGAAGGTGATGAGACGGATGCAGAAGGAGATGGACCGCGGCCTGAGGCTGGAGACCCATGAAGAGGCCAGTGTGAAGATGCTGCCCACCTACGTGCGCTCCACCCCAGAAGGCTCAGAAGTCGGGGACTTCCTCTCCCTGGACCTGGGTGGCACTAACTTCAGGGTGATGCTGGTGAAGGTGGGAGAAGGTGAGGAGGGGCAGTGGAGCGTGAAGACCAAACACCAGATGTACTCCATCCCCGAGGACGCCATGACCGGCACTGCTGAGATGCTCTTCGACTACATCTCTGAGTGCATCTCCGACTTCCTGGACAAGCATCAGATGAAACACAAGAAGCTGCCCCTGGGCTTCACCTTCTCCTTTCCTGTGAGGCACGAAGACATCGATAAGGGCATCCTTCTCAACTGGACCAAGGGCTTCAAGGCCTCAGGAGCAGAAGGGAACAATGTCGTGGGGCTTCTGCGAGACGCTATCAAACGGAGAGGGGACTTTGAAATGGATGTGGTGGCAATGGTGAATGACACGGTGGCCACGATGATCTCCTGCTACTACGAAGACCATCAGTGCGAGGTCGGCATGATCGTGGGCACGGGCTGCAATGCCTGCTACATGGAGGAGATGCAGAATGTGGAGCTGGTGGAGGGGGACGAGGGCCGCATGTGCGTCAATACCGAGTGGGGCGCCTTCGGGGACTCCGGCGAGCTGGACGAGTTCCTGCTGGAGTATGACCGCCTGGTGGACGAGAGCTCTGCAAACCCCGGTCAGCAGCTGTATGAGAAGCTCATAGGTGGCAAGTACATGCGCGAGCTGGTGCGGCTTGTGCTGCTCAGGCTCGTGGACGAAAACCTGCTCTTCCACGGGGAGGCCTCCGAGCAGCTGCGCACACGCGGAGCCTTCGAGACGCGCTTCGTGTCGCAGGTGGAGAGCGACACGGGCGACCGCAAGCAGATCTACAACATCCTGAGCACGCTGGGGCTGCGACCCTCGACCACCGACTGCGACATCGTGCGCCGCGCCTGCGAGAGCGTGTCTACGCGCGCTGCGCACATGTGCTCGGCGGGGCTGGCGGGCGTCATCAACCGCATGCGCGAGAGCCGCAGCGAGGACGTAATGCGCATCACTGTGGGCGTGGATGGCTCCGTGTACAAGCTGCACCCCAGCTTCAAGGAGCGGTTCCATGCCAGCGTGCGCAGGCTGACGCCCAGCTGCGAGATCACCTTCATCGAGTCGGAGGAGGGCAGTGGCCGGGGCGCGGCCCTGGTCTCGGCGGTGGCCTGTAAGAAGGCCTGTATGCTGGGCCAG	31175.0	single nucleotide variant	NM_000162.5(GCK):c.895G>C (p.Gly299Arg)	2645.0	GCK	HGNC:4195	Pathogenic	1.0	May 18, 2024	104894009.0	-	RCV000017516|RCV001288185	MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:C3661900	Maturity-onset diabetes of the young type 2|not provided	germline;unknown	germline	GRCh38	NC_000007.14	7	44146587.0	44146587.0	7p13	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA126212,UniProtKB:P35557#VAR_003710,OMIM:138079.0005	3.0	16136.0	44146587.0	C	G	-	-	-	-	-	-	SCV001475132|SCV005835277	-	-	895G>C 	Gly299Arg	NM_000162.5	2.0	1_Pathogenic	chr7	G	C	7-44146587-G-C		16136	7	44146587	C	G	G	R	rs104894009	7	44186186	7	44152711	299	GCK	ENSG00000106633	ENST00000403799	ENSP00000384247	P35557	HXK4_HUMAN	c.895G>C	p.Gly299Arg	c.895G>C	p.Gly299Arg	principal1	Y	1	YES	Select	-	GGC	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.001	0.83643	D	0.999	0.77914	D	0.967	0.80453	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.615	0.93786	H	-7.4	0.95559	D	0.991	0.99781	0.9545	0.96452	D	0.9917	0.99792	D	9	0.9954407	0.99985	D	0.958393	0.99723	D	0.985	0.99930	0.997	0.99969	P35557	G299R	Gain of MoRF binding (P = 0.0095)| Gain of methylation at K296 (P = 0.1057)| Loss of ubiquitination at K296 (P = 0.152)| Gain of glycosylation at K296 (P = 0.1608)| Gain of helix (P = 0.1736)	0.992121500454	0.99194	.	0.99891	.	0.97104	0.775753200054	0.78249	T	0.968658	0.99642	D	0.564186	0.96283	D	0.572637	0.96224	D	0.999379277229309	0.97130	D	0.999394	0.99805	D	0.9890143	0.99706	0.96495694	0.99216	0.9860968	0.99530	0.960452	0.98980	-13.277	0.90754	D	0.9967	0.96856	P	0.999827466907589	0.98179	0.99984097	0.99792	0.997	0.99892	.	.	.	.	.	.	5.624991	0.92642	32.0	0.9993193236961907	0.99439	0.967442	0.98988	D	0.926695616404469	0.92965	11.76197	0.826377040188961	0.91519	10.9513	4.77	4.77	0.60376	.	.	7.766	0.84189	7.538000	0.60097	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.995	0.73271	712	0.56407	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided|Maturity-onset_diabetes_of_the_young_type_2	criteria_provided,_single_submitter	NC_000007.14:g.44146587C>G	ClinGen:CA126212|OMIM:138079.0005|UniProtKB:P35557#VAR_003710	C3661900|C0342277	125851	552	Hexokinase, C-terminal	Gly	Arg	31175	single nucleotide variant	NM_000162.5(GCK):c.895G>C (p.Gly299Arg)	2645	GCK	HGNC:4195	Pathogenic	1	May 18, 2024	104894009	-	RCV000017516|RCV001288185	MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:C3661900	Maturity-onset diabetes of the young type 2|not provided	germline;unknown	germline	GRCh38	NC_000007.14	7	44146587	44146587	7p13	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA126212,UniProtKB:P35557#VAR_003710,OMIM:138079.0005	3	16136	44146587	C	G	-	-	-	-	-	-	SCV001475132|SCV005835277	-	-	895G>C 	Gly299Arg	NM_000162.5	2	1_Pathogenic	GCK	ENSG00000106633	3689	214851	CCSBVarC006694	ALE00006692	895G>C	Gly299Arg	CEGS2	CegsMutGDEh1045	E10	GDEhDisVCh_40037	G05	1	CegsMutGDDh1045	E10	VUSN2Hmut_GDN2h_09	B11	VUSMutpDEST2_03	E09	VUSmut_GDEh09	B11	1	1	1	1	1	1	1	1	1	7	GCK_Gly299Arg	7	7	44146587	C	G
2803	HMBS	500G>A	Arg167Gln	ENSG00000256269	11	119091414	NC_000011.10:119091414:G:A	ALE00005165	CCSBVarC005165	NULL	200931	NULL	GDEhDisVCh_40054	F03	CEGS2	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAGCTTGCTCGCATACAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGGACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCTTGAACATGCCCTGGAGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCGAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTCAGGGAAACCTCAACACCCGGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACCGGGTGGGGCAGATCCTGCACCCTGAGGAATGCATGTATGCTGTGGGCCAGGGGGCCTTGGGCGTGGAAGTGCGAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCTGCATCGCTGAAAGGGCCTTCCTGAGGCACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATGGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCGTAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACGATGCCCAT	16485.0	single nucleotide variant	NM_000190.4(HMBS):c.500G>A (p.Arg167Gln)	3145.0	HMBS	HGNC:4982	Pathogenic/Likely pathogenic	1.0	Dec 26, 2024	118204095.0	-	RCV000001511|RCV000520560|RCV003764510|RCV003764509	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958226,MedGen:C5935575,OMIM:620711|MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704	Acute intermittent porphyria|not provided|Leukoencephalopathy, porphyria-related|Encephalopathy, porphyria-related	germline;not applicable;unknown	germline	GRCh38	NC_000011.10	11	119091414.0	119091414.0	11q23.3	criteria provided, multiple submitters, no conflicts	9.0	-	N	ClinGen:CA251795,UniProtKB:P08397#VAR_003651,OMIM:609806.0005	3.0	1446.0	119091414.0	G	A	-	-	-	-	-	-	SCV000616739|SCV001132052|SCV001220631|SCV002059538|SCV004099797|SCV004226624	-	-	500G>A 	Arg167Gln	NM_000190.4	2.0	1_Pathogenic	chr11	G	A	11-119091414-G-A	0.0000714944	1446	11	119091414	G	A	R	Q	rs118204095	11	118962124	11	118467334	167	HMBS	ENSG00000256269	ENST00000652429	ENSP00000498786	P08397	HEM3_HUMAN	c.500G>A	p.Arg167Gln	c.500G>A	p.Arg167Gln	principal2	Y	.	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	0.999	0.92348	D	.	0.97926	.	.	.	.	4.47	0.98862	H	.	0.73719	.	.	0.99270	0.9015	0.95680	D	0.9974	0.99936	D	9	.	0.90053	.	0.570538	0.96108	D	.	0.98488	.	.	.	.	.	.	0.98037	0.9226281451906604	0.92190	.	.	0.690265059471	0.65687	T	0.997348	0.99997	D	0.422159	0.91068	D	0.605294	0.97266	D	0.998139619827271	0.93265	D	0.993042	0.97822	D	0.9738522	0.98584	0.9580932	0.98851	0.9606895	0.97307	0.9386867	0.97647	-13.053	0.89603	D	0.9858	0.92409	P	0.99957541651783	0.97044	0.39117932	0.79368	0.997	0.99892	.	.	.	.	.	.	8.637649	0.97824	38.0	0.99943123104295695	0.99848	0.962367	0.98389	D	1.166860771854	0.99181	21.11462	1.05940119228111	0.99479	23.07704	5.59	5.59	0.84656	5.91	0.96850	9.934	0.98847	11.823000	0.97301	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.992	0.67791	228	0.91137	.	.	.	.	.	.	.	.	.	.	.	.	20	264690	7.556009E-5	.	3	65048	4.611980e-05	0	7	132592	5.279350e-05	0	5	151816	3.293460e-05	0	0	2860	0.000000e+00	0	1	12384	8.074940e-05	0	0	1454	0.000000e+00	0	0	4604	0.000000e+00	0	0	11472	0.000000e+00	0	1	19468	5.136630e-05	0	0	11442	0.000000e+00	0	1	12384	8.074940e-05	0	1	8700	1.149430e-04	0	1	20684	4.834650e-05	0	0	4756	0.000000e+00	0	0	8792	0.000000e+00	0	0	13488	0.000000e+00	0	4	49812	8.030190e-05	0	0	22780	0.000000e+00	0	1	8700	1.149430e-04	0	1	8160	1.225490e-04	0	1	24652	4.056470e-05	0	0	8326	0.000000e+00	0	0	11040	0.000000e+00	0	0	15362	0.000000e+00	0	2	57210	3.495890e-05	0	0	22768	0.000000e+00	0	1	8160	1.225490e-04	0	.	109	1550946	7.027970e-05	0	99	1146426	8.635530e-05	0	6	73048	8.213780e-05	0	0	910	0.000000e+00	0	2	50986	3.922650e-05	0	0	28652	0.000000e+00	0	1	40942	2.442480e-05	0	0	59880	0.000000e+00	0	0	6008	0.000000e+00	0	99	1146426	8.635530e-05	0	0	84054	0.000000e+00	0	9	25918	3.4724901612778763E-4	0	298	0	0	86	0	0	7864	0	0	146	0	0	610	0	0	26	0	0	98	0	0	2232	0	0	8162	0	0	112	0	9	37278	2.4142926122646064E-4	Pathogenic/Likely_pathogenic	Encephalopathy,_porphyria-related|Leukoencephalopathy,_porphyria-related|Acute_intermittent_porphyria|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.119091414G>A	ClinGen:CA251795|OMIM:609806.0005|UniProtKB:P08397#VAR_003651	CN376852|CN376853|C0162565|C3661900	620704|620711|176000	79276	Porphobilinogen deaminase, N-terminal	Arg	Gln	16485	single nucleotide variant	NM_000190.4(HMBS):c.500G>A (p.Arg167Gln)	3145	HMBS	HGNC:4982	Pathogenic/Likely pathogenic	1	Dec 26, 2024	118204095	-	RCV000001511|RCV000520560|RCV003764510|RCV003764509	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958226,MedGen:C5935575,OMIM:620711|MONDO:MONDO:0958224,MedGen:C5935574,OMIM:620704	Acute intermittent porphyria|not provided|Leukoencephalopathy, porphyria-related|Encephalopathy, porphyria-related	germline;not applicable;unknown	germline	GRCh38	NC_000011.10	11	119091414	119091414	11q23.3	criteria provided, multiple submitters, no conflicts	9	-	N	ClinGen:CA251795,UniProtKB:P08397#VAR_003651,OMIM:609806.0005	3	1446	119091414	G	A	-	-	-	-	-	-	SCV000616739|SCV001132052|SCV001220631|SCV002059538|SCV004099797|SCV004226624	-	-	500G>A 	Arg167Gln	NM_000190.4	2	1_Pathogenic	HMBS	ENSG00000256269	2803	200931	CCSBVarC005165	ALE00005165	500G>A	Arg167Gln	CEGS2	CegsMutGDEh1037	B10	GDEhDisVCh_40054	F03	2	CegsMutGDDh1037	B10	NULL	NULL	NULL	NULL	NULL	NULL	1	4	1	1	0	NULL	0	NULL	0	NULL	HMBS_Arg167Gln	11	11	119091414	G	A
7918	MSH2	913G>A	Ala305Thr	ENSG00000095002	2	47414389	NC_000002.12:47414389:G:A	ALE00003005	CCSBVarC003005	NULL	202656	NULL	GDEhDisVCh_40060	E08	CEGS2	ATGGCGGTGCAGCCGAAGGAGACGCTGCAGTTGGAGAGCGCGGCCGAGGTCGGCTTCGTGCGCTTCTTTCAGGGCATGCCGGAGAAGCCGACCACCACAGTGCGCCTTTTCGACCGGGGCGACTTCTATACGGCGCACGGCGAGGACGCGCTGCTGGCCGCCCGGGAGGTGTTCAAGACCCAGGGGGTGATCAAGTACATGGGGCCGGCAGGAGCAAAGAATCTGCAGAGTGTTGTGCTTAGTAAAATGAATTTTGAATCTTTTGTAAAAGATCTTCTTCTGGTTCGTCAGTATAGAGTTGAAGTTTATAAGAATAGAGCTGGAAATAAGGCATCCAAGGAGAATGATTGGTATTTGGCATATAAGGCTTCTCCTGGCAATCTCTCTCAGTTTGAAGACATTCTCTTTGGTAACAATGATATGTCAGCTTCCATTGGTGTTGTGGGTGTTAAAATGTCCGCAGTTGATGGCCAGAGACAGGTTGGAGTTGGGTATGTGGATTCCATACAGAGGAAACTAGGACTGTGTGAATTCCCTGATAATGATCAGTTCTCCAATCTTGAGGCTCTCCTCATCCAGATTGGACCAAAGGAATGTGTTTTACCCGGAGGAGAGACTGCTGGAGACATGGGGAAACTGAGACAGATAATTCAAAGAGGAGGAATTCTGATCACAGAAAGAAAAAAAGCTGACTTTTCCACAAAAGACATTTATCAGGACCTCAACCGGTTGTTGAAAGGCAAAAAGGGAGAGCAGATGAATAGTGCTGTATTGCCAGAAATGGAGAATCAGGTTGCAGTTTCATCACTGTCTGCGGTAATCAAGTTTTTAGAACTCTTATCAGATGATTCCAACTTTGGACAGTTTGAACTGACTACTTTTGACTTCAGCCAGTATATGAAATTGGATATTACAGCAGTCAGAGCCCTTAACCTTTTTCAGGGTTCTGTTGAAGATACCACTGGCTCTCAGTCTCTGGCTGCCTTGCTGAATAAGTGTAAAACCCCTCAAGGACAAAGACTTGTTAACCAGTGGATTAAGCAGCCTCTCATGGATAAGAACAGAATAGAGGAGAGATTGAATTTAGTGGAAGCTTTTGTAGAAGATGCAGAATTGAGGCAGACTTTACAAGAAGATTTACTTCGTCGATTCCCAGATCTTAACCGACTTGCCAAGAAGTTTCAAAGACAAGCAGCAAACTTACAAGATTGTTACCGACTCTATCAGGGTATAAATCAACTACCTAATGTTATACAGGCTCTGGAAAAACATGAAGGAAAACACCAGAAATTATTGTTGGCAGTTTTTGTGACTCCTCTTACTGATCTTCGTTCTGACTTCTCCAAGTTTCAGGAAATGATAGAAACAACTTTAGATATGGATCAGGTGGAAAACCATGAATTCCTTGTAAAACCTTCATTTGATCCTAATCTCAGTGAATTAAGAGAAATAATGAATGACTTGGAAAAGAAGATGCAGTCAACATTAATAAGTGCAGCCAGAGATCTTGGCTTGGACCCTGGCAAACAGATTAAACTGGATTCCAGTGCACAGTTTGGATATTACTTTCGTGTAACCTGTAAGGAAGAAAAAGTCCTTCGTAACAATAAAAACTTTAGTACTGTAGATATCCAGAAGAATGGTGTTAAATTTACCAACAGCAAATTGACTTCTTTAAATGAAGAGTATACCAAAAATAAAACAGAATATGAAGAAGCCCAGGATGCCATTGTTAAAGAAATTGTCAATATTTCTTCAGGCTATGTAGAACCAATGCAGACACTCAATGATGTGTTAGCTCAGCTAGATGCTGTTGTCAGCTTTGCTCACGTGTCAAATGGAGCACCTGTTCCATATGTACGACCAGCCATTTTGGAGAAAGGACAAGGAAGAATTATATTAAAAGCATCCAGGCATGCTTGTGTTGAAGTTCAAGATGAAATTGCATTTATTCCTAATGACGTATACTTTGAAAAAGATAAACAGATGTTCCACATCATTACTGGCCCCAATATGGGAGGTAAATCAACATATATTCGACAAACTGGGGTGATAGTACTCATGGCCCAAATTGGGTGTTTTGTGCCATGTGAGTCAGCAGAAGTGTCCATTGTGGACTGCATCTTAGCCCGAGTAGGGGCTGGTGACAGTCAATTGAAAGGAGTCTCCACGTTCATGGCTGAAATGTTGGAAACTGCTTCTATCCTCAGGTCTGCAACCAAAGATTCATTAATAATCATAGATGAATTGGGAAGAGGAACTTCTACCTACGATGGATTTGGGTTAGCATGGGCTATATCAGAATACATTGCAACAAAGATTGGTGCTTTTTGCATGTTTGCAACCCATTTTCATGAACTTACTGCCTTGGCCAATCAGATACCAACTGTTAATAATCTACATGTCACAGCACTCACCACTGAAGAGACCTTAACTATGCTTTATCAGGTGAAGAAAGGTGTCTGTGATCAAAGTTTTGGGATTCATGTTGCAGAGCTTGCTAATTTCCCTAAGCATGTAATAGAGTGTGCTAAACAGAAAGCCCTGGAACTTGAGGAGTTTCAGTATATTGGAGAATCGCAAGGATATGATATCATGGAACCAGCAGCAAAGAAGTGCTATCTGGAAAGAGAGCAAGGTGAAAAAATTATTCAGGAGTTCCTGTCCAAGGTGAAACAAATGCCCTTTACTGAAATGTCAGAAGAAAACATCACAATAAAGTTAAAACAGCTAAAAGCTGAAGTAATAGCAAAGAATAATAGCTTTGTAAATGAAATCATTTCACGAATAAAAGTTACTACG	96718.0	single nucleotide variant	NM_000251.3(MSH2):c.913G>A (p.Ala305Thr)	4436.0	MSH2	HGNC:7325	Conflicting classifications of pathogenicity	0.0	Feb 04, 2025	63751454.0	-	RCV000076748|RCV000115547|RCV000148633|RCV000656876|RCV001084038|RCV001193245|RCV003492427|RCV004542749	MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN221576|MedGen:C3661900|MeSH:D003123,MedGen:C0009405|MedGen:CN169374|MedGen:CN221562|	Lynch syndrome|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|not provided|Hereditary nonpolyposis colorectal neoplasms|not specified|Breast and/or ovarian cancer|MSH2-related disorder	germline;unknown	germline	GRCh38	NC_000002.12	2	47414389.0	47414389.0	2p21	criteria provided, conflicting classifications	14.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA022539,UniProtKB:P43246#VAR_004476	2.0	91243.0	47414389.0	G	A	-	-	-	-	-	-	SCV000149456|SCV000213040|SCV000254431|SCV000537524|SCV000601493|SCV001361973|SCV002071715|SCV002526756|SCV004239292	-	-	913G>A 	Ala305Thr	NM_000251.3	1.0	3_Conflicting	chr2	G	A	2-47414389-G-A	0.000155877	91243	2	47414389	G	A	A	T	rs63751454	2	47641528	2	47495032	305	MSH2	ENSG00000095002	ENST00000233146	ENSP00000233146	P43246	MSH2_HUMAN	c.913G>A	p.Ala305Thr	c.913G>A	p.Ala305Thr	principal1	Y	1	YES	Select	+	GCA	1	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.004	0.76775	D	1.0	0.90580	D	0.998	0.97365	D	0.94	0.94378	D	simple_aae	6.0	94.0	2.89	0.83536	M	-3.32	0.66115	D	0.849	0.84464	0.9478	0.96351	D	0.8732	0.95778	D	10	0.8921547	0.88434	D	0.299858	0.90825	D	0.929	0.98302	.	.	.	.	.	0.936001043092	0.93484	0.40196623656329183	0.39909	0.0355435215691	0.03634	0.705297231674	0.67857	T	0.766434	0.93658	D	0.322045	0.84506	D	0.45052	0.93535	D	0.839249789714813	0.48992	D	0.991087	0.99872	D	0.76715356	0.81654	0.73939323	0.84410	0.7933799	0.83279	0.639396	0.78707	-6.537	0.50636	T	0.4237	0.75483	A	0.954915691297885	0.81044	0.99990821	0.99894	0.939	0.97079	.	.	.	.	.	.	5.00534	0.83114	28.0	0.99905528428087276	0.97653	0.827654	0.74597	D	0.849816592853045	0.89039	9.833824	0.78827112203654	0.88904	9.785329	5.14	4.23	0.49261	.	.	7.72	0.83765	7.363000	0.58421	0.597	0.3436	1.0	0.71675	1.000000	0.68239	0.997	0.79771	829	0.39487	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5	108554	4.606000e-05	0	12	205894	5.828240e-05	0	12	234344	5.120680e-05	0	1	7140	1.400560e-04	0	0	16946	0.000000e+00	0	0	2290	0.000000e+00	0	0	9026	0.000000e+00	0	0	13368	0.000000e+00	0	4	42506	9.410440e-05	0	0	15386	0.000000e+00	0	1	7140	1.400560e-04	0	1	16090	6.215040e-05	0	0	30294	0.000000e+00	0	0	6112	0.000000e+00	0	0	13376	0.000000e+00	0	0	16714	0.000000e+00	0	11	88434	1.243870e-04	0	0	30092	0.000000e+00	0	11	88434	1.243870e-04	0	1	14774	6.768650e-05	0	0	34024	0.000000e+00	0	0	9466	0.000000e+00	0	0	17628	0.000000e+00	0	0	21498	0.000000e+00	0	11	101420	1.084600e-04	0	0	30010	0.000000e+00	0	11	101420	1.084600e-04	0	.	214	1432352	1.494050e-04	0	200	1063270	1.880990e-04	0	4	60720	6.587620e-05	0	0	858	0.000000e+00	0	0	49974	0.000000e+00	0	0	25334	0.000000e+00	0	0	35614	0.000000e+00	0	0	51534	0.000000e+00	0	0	4540	0.000000e+00	0	200	1063270	1.880990e-04	0	0	86796	0.000000e+00	0	3	23770	1.2620950778291965E-4	0	300	0	0	110	0	0	7948	0	0	146	0	0	610	0	0	54	0	0	94	0	0	4180	0	0	8248	0	0	164	0	3	37212	8.061915511125443E-5	Conflicting_classifications_of_pathogenicity	not_provided|Hereditary_nonpolyposis_colorectal_neoplasms|Lynch_syndrome|not_specified|MSH2-related_disorder|Breast_and/or_ovarian_cancer|Colorectal_cancer,_non-polyposis|Hereditary_cancer-predisposing_syndrome	criteria_provided,_conflicting_classifications	NC_000002.12:g.47414389G>A	ClinGen:CA022539|UniProtKB:P43246#VAR_004476	C3661900|C0009405|C4552100|CN169374|CN221562|CN221576|C0027672	.	144|140162	DNA mismatch repair protein MutS, core	Ala	Thr	96718	single nucleotide variant	NM_000251.3(MSH2):c.913G>A (p.Ala305Thr)	4436	MSH2	HGNC:7325	Conflicting classifications of pathogenicity	0	Feb 04, 2025	63751454	-	RCV000076748|RCV000115547|RCV000148633|RCV000656876|RCV001084038|RCV001193245|RCV003492427|RCV004542749	MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN221576|MedGen:C3661900|MeSH:D003123,MedGen:C0009405|MedGen:CN169374|MedGen:CN221562|	Lynch syndrome|Hereditary cancer-predisposing syndrome|Colorectal cancer, non-polyposis|not provided|Hereditary nonpolyposis colorectal neoplasms|not specified|Breast and/or ovarian cancer|MSH2-related disorder	germline;unknown	germline	GRCh38	NC_000002.12	2	47414389	47414389	2p21	criteria provided, conflicting classifications	14	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA022539,UniProtKB:P43246#VAR_004476	2	91243	47414389	G	A	-	-	-	-	-	-	SCV000149456|SCV000213040|SCV000254431|SCV000537524|SCV000601493|SCV001361973|SCV002071715|SCV002526756|SCV004239292	-	-	913G>A 	Ala305Thr	NM_000251.3	1	3_Conflicting	MSH2	ENSG00000095002	7918	202656	CCSBVarC003005	ALE00003005	913G>A	Ala305Thr	CEGS2	CegsMutGDEh1040	H04	GDEhDisVCh_40060	E08	2	CegsMutGDDh1040	H04	NULL	NULL	VUSMutpDEST2_07	C03	NULL	NULL	1	1	1	1	0	NULL	1	1	0	NULL	MSH2_Ala305Thr	2	2	47414389	G	A
7918	MSH2	274C>G	Leu92Val	ENSG00000095002	2	47408463	NC_000002.12:47408463:C:G	ALE00003003	CCSBVarC003003	NULL	202640	NULL	GDEhDisVCh_40060	B08	CEGS2	ATGGCGGTGCAGCCGAAGGAGACGCTGCAGTTGGAGAGCGCGGCCGAGGTCGGCTTCGTGCGCTTCTTTCAGGGCATGCCGGAGAAGCCGACCACCACAGTGCGCCTTTTCGACCGGGGCGACTTCTATACGGCGCACGGCGAGGACGCGCTGCTGGCCGCCCGGGAGGTGTTCAAGACCCAGGGGGTGATCAAGTACATGGGGCCGGCAGGAGCAAAGAATCTGCAGAGTGTTGTGCTTAGTAAAATGAATTTTGAATCTTTTGTAAAAGATGTTCTTCTGGTTCGTCAGTATAGAGTTGAAGTTTATAAGAATAGAGCTGGAAATAAGGCATCCAAGGAGAATGATTGGTATTTGGCATATAAGGCTTCTCCTGGCAATCTCTCTCAGTTTGAAGACATTCTCTTTGGTAACAATGATATGTCAGCTTCCATTGGTGTTGTGGGTGTTAAAATGTCCGCAGTTGATGGCCAGAGACAGGTTGGAGTTGGGTATGTGGATTCCATACAGAGGAAACTAGGACTGTGTGAATTCCCTGATAATGATCAGTTCTCCAATCTTGAGGCTCTCCTCATCCAGATTGGACCAAAGGAATGTGTTTTACCCGGAGGAGAGACTGCTGGAGACATGGGGAAACTGAGACAGATAATTCAAAGAGGAGGAATTCTGATCACAGAAAGAAAAAAAGCTGACTTTTCCACAAAAGACATTTATCAGGACCTCAACCGGTTGTTGAAAGGCAAAAAGGGAGAGCAGATGAATAGTGCTGTATTGCCAGAAATGGAGAATCAGGTTGCAGTTTCATCACTGTCTGCGGTAATCAAGTTTTTAGAACTCTTATCAGATGATTCCAACTTTGGACAGTTTGAACTGACTACTTTTGACTTCAGCCAGTATATGAAATTGGATATTGCAGCAGTCAGAGCCCTTAACCTTTTTCAGGGTTCTGTTGAAGATACCACTGGCTCTCAGTCTCTGGCTGCCTTGCTGAATAAGTGTAAAACCCCTCAAGGACAAAGACTTGTTAACCAGTGGATTAAGCAGCCTCTCATGGATAAGAACAGAATAGAGGAGAGATTGAATTTAGTGGAAGCTTTTGTAGAAGATGCAGAATTGAGGCAGACTTTACAAGAAGATTTACTTCGTCGATTCCCAGATCTTAACCGACTTGCCAAGAAGTTTCAAAGACAAGCAGCAAACTTACAAGATTGTTACCGACTCTATCAGGGTATAAATCAACTACCTAATGTTATACAGGCTCTGGAAAAACATGAAGGAAAACACCAGAAATTATTGTTGGCAGTTTTTGTGACTCCTCTTACTGATCTTCGTTCTGACTTCTCCAAGTTTCAGGAAATGATAGAAACAACTTTAGATATGGATCAGGTGGAAAACCATGAATTCCTTGTAAAACCTTCATTTGATCCTAATCTCAGTGAATTAAGAGAAATAATGAATGACTTGGAAAAGAAGATGCAGTCAACATTAATAAGTGCAGCCAGAGATCTTGGCTTGGACCCTGGCAAACAGATTAAACTGGATTCCAGTGCACAGTTTGGATATTACTTTCGTGTAACCTGTAAGGAAGAAAAAGTCCTTCGTAACAATAAAAACTTTAGTACTGTAGATATCCAGAAGAATGGTGTTAAATTTACCAACAGCAAATTGACTTCTTTAAATGAAGAGTATACCAAAAATAAAACAGAATATGAAGAAGCCCAGGATGCCATTGTTAAAGAAATTGTCAATATTTCTTCAGGCTATGTAGAACCAATGCAGACACTCAATGATGTGTTAGCTCAGCTAGATGCTGTTGTCAGCTTTGCTCACGTGTCAAATGGAGCACCTGTTCCATATGTACGACCAGCCATTTTGGAGAAAGGACAAGGAAGAATTATATTAAAAGCATCCAGGCATGCTTGTGTTGAAGTTCAAGATGAAATTGCATTTATTCCTAATGACGTATACTTTGAAAAAGATAAACAGATGTTCCACATCATTACTGGCCCCAATATGGGAGGTAAATCAACATATATTCGACAAACTGGGGTGATAGTACTCATGGCCCAAATTGGGTGTTTTGTGCCATGTGAGTCAGCAGAAGTGTCCATTGTGGACTGCATCTTAGCCCGAGTAGGGGCTGGTGACAGTCAATTGAAAGGAGTCTCCACGTTCATGGCTGAAATGTTGGAAACTGCTTCTATCCTCAGGTCTGCAACCAAAGATTCATTAATAATCATAGATGAATTGGGAAGAGGAACTTCTACCTACGATGGATTTGGGTTAGCATGGGCTATATCAGAATACATTGCAACAAAGATTGGTGCTTTTTGCATGTTTGCAACCCATTTTCATGAACTTACTGCCTTGGCCAATCAGATACCAACTGTTAATAATCTACATGTCACAGCACTCACCACTGAAGAGACCTTAACTATGCTTTATCAGGTGAAGAAAGGTGTCTGTGATCAAAGTTTTGGGATTCATGTTGCAGAGCTTGCTAATTTCCCTAAGCATGTAATAGAGTGTGCTAAACAGAAAGCCCTGGAACTTGAGGAGTTTCAGTATATTGGAGAATCGCAAGGATATGATATCATGGAACCAGCAGCAAAGAAGTGCTATCTGGAAAGAGAGCAAGGTGAAAAAATTATTCAGGAGTTCCTGTCCAAGGTGAAACAAATGCCCTTTACTGAAATGTCAGAAGAAAACATCACAATAAAGTTAAAACAGCTAAAAGCTGAAGTAATAGCAAAGAATAATAGCTTTGTAAATGAAATCATTTCACGAATAAAAGTTACTACG	96516.0	single nucleotide variant	NM_000251.3(MSH2):c.274C>G (p.Leu92Val)	4436.0	MSH2	HGNC:7325	Conflicting classifications of pathogenicity	0.0	Dec 30, 2024	587779154.0	-	RCV000221964|RCV000412138|RCV000552261|RCV001196697|RCV001353838|RCV003387753|RCV003997169	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0007356,MedGen:C2936783,OMIM:120435,Orphanet:144|MeSH:D003123,MedGen:C0009405|MONDO:MONDO:0010159,MedGen:C5399763,OMIM:276300,Orphanet:252202|MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144	Hereditary cancer-predisposing syndrome|Lynch syndrome 1|Hereditary nonpolyposis colorectal neoplasms|Mismatch repair cancer syndrome 1|not provided|not specified|Lynch syndrome	germline;unknown	germline	GRCh38	NC_000002.12	2	47408463.0	47408463.0	2p21	criteria provided, conflicting classifications	12.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA020916	2.0	91041.0	47408463.0	C	G	-	-	-	-	-	-	SCV000277387|SCV000489185|SCV000625408|SCV000690095|SCV000729490|SCV001135696|SCV001367328|SCV001370542|SCV004018383|SCV004100074|SCV004824285	-	-	274C>G 	Leu92Val	NM_000251.3	1.0	3_Conflicting	chr2	C	G	2-47408463-C-G	0.0000383616	91041	2	47408463	C	G	L	V	rs587779154	2	47635602	2	47489106	92	MSH2	ENSG00000095002	ENST00000233146	ENSP00000233146	P43246	MSH2_HUMAN	c.274C>G	p.Leu92Val	c.274C>G	p.Leu92Val	principal1	Y	1	YES	Select	+	CTT	1	0	C	C/C	C/C	C/C	C/C	0.296	0.14778	T	0.39	0.18313	T	0.995	0.90580	D	0.973	0.92348	D	0.97	0.96253	A	simple_aae	3.0	97.0	2.28	0.64737	M	-1.76	0.42002	N	0.889	0.90245	0.7272	0.93489	D	0.8611	0.95367	D	10	0.65310025	0.69447	D	0.133022	0.81485	D	0.748	0.91294	0.739	0.87083	P43246	L92V	Gain of MoRF binding (P = 0.082)| Gain of methylation at K90 (P = 0.2517)| Loss of stability (P = 0.277)| Gain of relative solvent accessibility (P = 0.281)| Loss of loop (P = 0.3664)	0.94711587672	0.94613	0.5690204935852731	0.56644	0.0235980657725	0.02324	0.719057261944	0.69858	T	0.691096	0.90930	D	0.245836	0.78047	D	0.411542	0.92426	D	0.346336215734482	0.26576	T	0.956904	0.87314	D	0.711924	0.78465	0.50691473	0.71244	0.7226111	0.79064	0.52958715	0.72564	-9.496	0.70913	D	0.3024	0.57155	B	0.630201878801769	0.64756	0.99981660	0.99765	0.298	0.56646	.	.	.	.	.	.	4.573544	0.72242	25.8	0.74233153948602471	0.10792	0.452161	0.50412	N	0.393334592927035	0.60860	4.302211	0.349573311985691	0.58259	4.018912	5.31	5.31	0.75027	.	.	2.231	0.42757	7.522000	0.59842	0.531	0.24877	1.0	0.71675	1.000000	0.68239	0.996	0.76032	807	0.43408	.	.	.	.	.	.	.	.	.	.	.	.	7	264690	2.644603E-5	.	7	109304	6.404160e-05	0	9	207906	4.328880e-05	0	15	236686	6.337510e-05	0	0	7164	0.000000e+00	0	0	17066	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13386	0.000000e+00	0	3	42756	7.016560e-05	0	4	15658	2.554600e-04	0	4	15658	2.554600e-04	0	0	16210	0.000000e+00	0	0	30464	0.000000e+00	0	0	6212	0.000000e+00	0	0	13414	0.000000e+00	0	0	16728	0.000000e+00	0	1	89472	1.117670e-05	0	8	30550	2.618660e-04	0	8	30550	2.618660e-04	0	0	14896	0.000000e+00	0	0	34200	0.000000e+00	0	0	9572	0.000000e+00	0	0	17690	0.000000e+00	0	0	21620	0.000000e+00	0	7	102636	6.820220e-05	0	8	30468	2.625710e-04	0	8	30468	2.625710e-04	0	.	58	1611226	3.599740e-05	0	2	6064	3.298150e-04	0	0	74464	0.000000e+00	0	0	912	0.000000e+00	0	0	59822	0.000000e+00	0	0	29580	0.000000e+00	0	0	44832	0.000000e+00	0	0	63860	0.000000e+00	0	2	6064	3.298150e-04	0	29	1178358	2.461050e-05	0	22	90930	2.419440e-04	0	0	9688	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14048	0	Conflicting_classifications_of_pathogenicity	not_provided|Hereditary_nonpolyposis_colorectal_neoplasms|Lynch_syndrome|Mismatch_repair_cancer_syndrome_1|Lynch_syndrome_1|not_specified|Hereditary_cancer-predisposing_syndrome	criteria_provided,_conflicting_classifications	NC_000002.12:g.47408463C>G	ClinGen:CA020916	C3661900|C0009405|C4552100|C5399763|C2936783|CN169374|C0027672	276300|120435	144|252202|144|140162	DNA mismatch repair protein MutS-like, N-terminal	Leu	Val	96516	single nucleotide variant	NM_000251.3(MSH2):c.274C>G (p.Leu92Val)	4436	MSH2	HGNC:7325	Conflicting classifications of pathogenicity	0	Dec 30, 2024	587779154	-	RCV000221964|RCV000412138|RCV000552261|RCV001196697|RCV001353838|RCV003387753|RCV003997169	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0007356,MedGen:C2936783,OMIM:120435,Orphanet:144|MeSH:D003123,MedGen:C0009405|MONDO:MONDO:0010159,MedGen:C5399763,OMIM:276300,Orphanet:252202|MedGen:C3661900|MedGen:CN169374|MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144	Hereditary cancer-predisposing syndrome|Lynch syndrome 1|Hereditary nonpolyposis colorectal neoplasms|Mismatch repair cancer syndrome 1|not provided|not specified|Lynch syndrome	germline;unknown	germline	GRCh38	NC_000002.12	2	47408463	47408463	2p21	criteria provided, conflicting classifications	12	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA020916	2	91041	47408463	C	G	-	-	-	-	-	-	SCV000277387|SCV000489185|SCV000625408|SCV000690095|SCV000729490|SCV001135696|SCV001367328|SCV001370542|SCV004018383|SCV004100074|SCV004824285	-	-	274C>G 	Leu92Val	NM_000251.3	1	3_Conflicting	MSH2	ENSG00000095002	7918	202640	CCSBVarC003003	ALE00003003	274C>G	Leu92Val	CEGS2	CegsMutGDEh1039	G08	GDEhDisVCh_40060	B08	2	CegsMutGDDh1039	G08	NULL	NULL	VUSMutpDEST2_07	B03	NULL	NULL	1	1	1	1	0	NULL	1	1	0	NULL	MSH2_Leu92Val	2	2	47408463	C	G
3774	TP53	541C>T	Arg181Cys	ENSG00000141510	17	7675071	NC_000017.11:7675071:G:A	ALE00004861	CCSBVarC004861	NULL	214887	NULL	GDEhDisVCh_40053	C02	CEGS2	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGTGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACCGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	152338.0	single nucleotide variant	NM_000546.6(TP53):c.541C>T (p.Arg181Cys)	7157.0	TP53	HGNC:11998	Conflicting classifications of pathogenicity	1.0	Jan 27, 2025	587782596.0	-	RCV000131943|RCV000168292|RCV000236276|RCV003474780|RCV004544301|RCV005229969	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MedGen:C3661900|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided|Adrenocortical carcinoma, hereditary|Familial cancer of breast|Neoplasm	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7675071.0	7675071.0	17p13.1	criteria provided, conflicting classifications	8.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000257,UniProtKB:P04637#VAR_044946	2.0	142624.0	7675071.0	G	A	-	-	-	Likely oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV000186999|SCV000218970|SCV000293523|SCV000911991|SCV004204247|SCV005043037|SCV005198839	-	SCV005871953	541C>T 	Arg181Cys	NM_000546.6	1.0	3_Conflicting	chr17	C	T	17-7675071-C-T		142624	17	7675071	G	A	R	C	rs587782596	17	7578389	17	7519114	181	TP53	ENSG00000141510	ENST00000445888	ENSP00000391478	P04637	P53_HUMAN	c.541C>T	p.Arg181Cys	c.541C>T	p.Arg181Cys	principal1	Y	1	.	.	-	CGC	1	0	G	G/G	G/G	G/G	G/G	0.005	0.78662	D	0.022	0.69466	D	0.183	0.73231	B	0.192	0.71743	B	1.0	0.99291	A	simple_aae	0.0	100.0	2	0.54176	M	-2.34	0.62771	N	0.902	0.90245	1.0015	0.97205	D	0.9898	0.99719	D	10	0.98500514	0.98714	D	0.671379	0.97254	D	0.891	0.96866	0.93	0.98894	P04637	R181C	Gain of catalytic residue at S183 (P = 0.0137)| Loss of disorder (P = 0.0457)| Loss of phosphorylation at S183 (P = 0.0752)| Loss of MoRF binding (P = 0.3205)| Gain of glycosylation at S185 (P = 0.3455)	0.983310495296	0.98295	.	0.41769	.	0.81946	0.513644933701	0.40675	T	0.896555	0.97918	D	0.492215	0.94015	D	0.469257	0.93938	D	0.95509284734726	0.64201	D	.	0.42897	.	0.75907695	0.81171	0.6560967	0.79639	0.7465721	0.80438	0.5638737	0.74510	-6.807	0.57343	T	0.7821	0.76415	P	0.564996780343059	0.62751	0.99995790	0.99965	0.944	0.97378	.	.	.	.	.	.	4.649383	0.74144	26.1	0.99744769625590657	0.83792	0.959988	0.98051	D	0.473360838931378	0.65359	4.83535	0.540714305661623	0.70594	5.551828	5.47	5.47	0.80318	5.48	0.94220	6.353	0.73043	9.948000	0.82735	0.676	0.76753	0.999	0.42732	1.000000	0.68239	0.552	0.30267	434	0.80544	.	.	.	.	.	.	.	.	.	.	.	.	3	264690	1.1334013E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	1614080	1.858640e-06	0	3	1180042	2.542280e-06	0	0	74930	0.000000e+00	0	0	912	0.000000e+00	0	0	59996	0.000000e+00	0	0	29606	0.000000e+00	0	0	44888	0.000000e+00	0	0	64044	0.000000e+00	0	0	6084	0.000000e+00	0	3	1180042	2.542280e-06	0	0	91092	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Conflicting_classifications_of_pathogenicity	Adrenocortical_carcinoma,_hereditary|Familial_cancer_of_breast|Li-Fraumeni_syndrome|not_provided|Hereditary_cancer-predisposing_syndrome	criteria_provided,_conflicting_classifications	NC_000017.11:g.7675071G>A	ClinGen:CA000257|UniProtKB:P04637#VAR_044946	C1859972|C0346153|C0085390|C3661900|C0027672	202300|114480|PS151623	1501|227535|524|140162	p53, DNA-binding domain|p53, DNA-binding domain	Arg	Cys	152338	single nucleotide variant	NM_000546.6(TP53):c.541C>T (p.Arg181Cys)	7157	TP53	HGNC:11998	Conflicting classifications of pathogenicity	1	Jan 27, 2025	587782596	-	RCV000131943|RCV000168292|RCV000236276|RCV003474780|RCV004544301|RCV005229969	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MedGen:C3661900|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided|Adrenocortical carcinoma, hereditary|Familial cancer of breast|Neoplasm	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7675071	7675071	17p13.1	criteria provided, conflicting classifications	8	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000257,UniProtKB:P04637#VAR_044946	2	142624	7675071	G	A	-	-	-	Likely oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV000186999|SCV000218970|SCV000293523|SCV000911991|SCV004204247|SCV005043037|SCV005198839	-	SCV005871953	541C>T 	Arg181Cys	NM_000546.6	1	3_Conflicting	TP53	ENSG00000141510	3774	214887	CCSBVarC004861	ALE00004861	541C>T	Arg181Cys	CEGS2	CegsMutGDEh1010	B09	GDEhDisVCh_40053	C02	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	5	0	NULL	0	NULL	0	NULL	0	NULL	TP53_Arg181Cys	17	17	7675071	G	A
52861	F9	237A>C	Glu79Asp	ENSG00000101981	X	139537158	NC_000023.11:139537158:A:C	ALE00004375	CCSBVarC004375	NULL	204351	NULL	GDEhDisVCh_40052	C01	CEGS2	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGACAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT	25613.0	single nucleotide variant	NM_000133.4(F9):c.237A>C (p.Glu79Asp)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Sep 01, 1989	137852229.0	-	RCV000011320	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537158.0	139537158.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255320,UniProtKB:P00740#VAR_017309,OMIM:300746.0017	1.0	10574.0	139537158.0	A	C	-	-	-	-	-	-	SCV000031551	-	-	237A>C 	Glu79Asp	NM_000133.4		1_Pathogenic	chrX	A	C	X-139537158-A-C		10574	X	139537158	A	C	E	D	rs137852229	X	138619317	X	138446983	79	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.237A>C	p.Glu79Asp	c.237A>C	p.Glu79Asp	principal1	Y	1	YES	Select	+	GAA	3	2	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.011	0.66047	D	0.994	0.66535	D	0.962	0.70672	D	0.85	0.90832	A	simple_aae	15.0	85.0	3.63	0.93919	H	-2.37	0.53117	N	0.688	0.85520	1.0915	0.99298	D	0.9746	0.99205	D	9	0.9869484	0.99023	D	0.918148	0.99393	D	0.904	0.97356	0.964	0.99639	P00740	E79D	Loss of sheet (P = 0.1158)| Loss of stability (P = 0.1642)| Loss of disorder (P = 0.192)| Gain of phosphorylation at T81 (P = 0.2609)| Loss of glycosylation at T81 (P = 0.2976)	0.999777502907	0.99977	0.9717501412150729	0.97149	0.409842432222	0.41506	0.653217494488	0.60380	T	0.969314	0.99654	D	0.676114	0.99906	D	0.733415	0.99905	D	0.995045900344849	0.86625	D	0.824718	0.48513	T	0.95628124	0.96853	0.9119187	0.95767	0.96466774	0.97710	0.9036028	0.95166	-8.05	0.61484	D	0.6918	0.72962	P	0.99825584643864	0.94179	0.99999140	0.99996	0.912	0.95445	.	.	.	.	.	.	3.810108	0.55032	23.5	0.92958632986930401	0.22783	.	.	.	.	.	.	.	.	.	5.19	4.02	0.45905	.	.	1.126	0.31059	7.954000	0.75935	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.986	0.61779	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139537158A>C	ClinGen:CA255320|OMIM:300746.0017|UniProtKB:P00740#VAR_017309	C0008533	306900	98879	Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain|Gamma-carboxyglutamic acid-rich (GLA) domain	Glu	Asp	25613	single nucleotide variant	NM_000133.4(F9):c.237A>C (p.Glu79Asp)	2158	F9	HGNC:3551	Pathogenic	1	Sep 01, 1989	137852229	-	RCV000011320	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139537158	139537158	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255320,UniProtKB:P00740#VAR_017309,OMIM:300746.0017	1	10574	139537158	A	C	-	-	-	-	-	-	SCV000031551	-	-	237A>C 	Glu79Asp	NM_000133.4		1_Pathogenic	F9	ENSG00000101981	52861	204351	CCSBVarC004375	ALE00004375	237A>C	Glu79Asp	CEGS2	CegsMutGDEh1009	F08	GDEhDisVCh_40052	C01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	F9_Glu79Asp	23	X	139537158	A	C
359	CBS	306G>C	Lys102Asn	ENSG00000160200	21	43068519	NC_000021.9:43068519:C:G	ALE00007341	CCSBVarC007353	NULL	NULL	312	GDEhDisVCh_40013	F10	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAACTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	187061.0	single nucleotide variant	NM_000071.3(CBS):c.306G>C (p.Lys102Asn)	875.0	CBS	HGNC:1550	Conflicting classifications of pathogenicity	1.0	Mar 15, 2023	786204609.0	-	RCV000169368|RCV003226233|RCV002444680|RCV002515197	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:CN169374|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:C3150344	Classic homocystinuria|not specified|Familial thoracic aortic aneurysm and aortic dissection|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;unknown	germline	GRCh38	NC_000021.9	21	43068519.0	43068519.0	21q22.3	criteria provided, conflicting classifications	4.0	-	N	ClinGen:CA274220,UniProtKB:P35520#VAR_002173,ClinVar:2501029	2.0	188989.0	43068519.0	C	G	-	-	-	-	-	-	SCV000220743|SCV002753262|SCV002973349|SCV003922486	-	-	306G>C 	Lys102Asn	NM_000071.3	1.0	3_Conflicting	chr21	G	C	21-43068519-G-C		188989	21	43068519	C	G	K	N	rs786204609	21	44488629	21	43361698	102	CBS	ENSG00000160200	ENST00000352178	ENSP00000344460	P35520	CBS_HUMAN	c.306G>C	p.Lys102Asn	c.306G>C	p.Lys102Asn	principal1	Y	1	.	.	-	AAG	3	2	C	C/C	C/C	C/C	C/C	0.003	0.68399	D	0.003	0.76775	D	0.998	0.73231	D	0.97	0.72228	D	0.99	0.97926	A	simple_aae	1.0	99.0	1.855	0.48991	L	-3.74	0.75085	D	0.756	0.75638	0.8876	0.95489	D	0.8900	0.96342	D	10	0.95609665	0.94916	D	0.502623	0.95168	D	0.658	0.87125	0.86	0.95750	P35520	K102N	Loss of methylation at K102 (P = 0.0079)| Loss of MoRF binding (P = 0.0545)| Loss of sheet (P = 0.1158)| Loss of glycosylation at K102 (P = 0.172)| Loss of catalytic residue at K102 (P = 0.2444)	0.920821527155	0.91941	.	0.85511	.	0.77123	0.708931684494	0.68386	T	0.952491	0.99318	D	0.129002	0.67028	D	-0.0524743	0.66615	D	0.980773985385895	0.73357	D	0.972303	0.89967	D	0.8396494	0.86405	0.5141448	0.71669	0.75294954	0.80811	0.47084063	0.69059	-9.172	0.68876	D	0.3679	0.57663	A	0.994521540030713	0.90703	0.99920696	0.99218	0.955	0.98022	.	.	.	.	.	.	3.643735	0.51757	23.1	0.99865291951310764	0.94371	0.531494	0.55018	D	0.476860943282972	0.65562	4.860825	0.412714619160011	0.62153	4.449659	4.81	3.9	0.44174	1.94	0.38959	1.432	0.34651	1.573000	0.27514	-0.282	0.06414	1.0	0.71675	1.000000	0.68239	0.203	0.22028	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109402	0.000000e+00	0	0	208034	0.000000e+00	0	1	236830	4.222440e-06	0	0	7162	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42764	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16206	0.000000e+00	0	0	30522	0.000000e+00	0	0	6212	0.000000e+00	0	0	13414	0.000000e+00	0	0	16734	0.000000e+00	0	0	89474	0.000000e+00	0	0	30608	0.000000e+00	0	.	.	.	.	0	14892	0.000000e+00	0	0	34258	0.000000e+00	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	0	102644	0.000000e+00	0	0	30526	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	not_specified|Classic_homocystinuria|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Familial_thoracic_aortic_aneurysm_and_aortic_dissection	criteria_provided,_conflicting_classifications	NC_000021.9:g.43068519C>G	ClinGen:CA274220|UniProtKB:P35520#VAR_002173	CN169374|C0751202|C3150344|C4707243	236200|PS607086	394|91387	Tryptophan synthase beta chain-like, PALP domain	Lys	Asn	187061	single nucleotide variant	NM_000071.3(CBS):c.306G>C (p.Lys102Asn)	875	CBS	HGNC:1550	Conflicting classifications of pathogenicity	1	Mar 15, 2023	786204609	-	RCV000169368|RCV003226233|RCV002444680|RCV002515197	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:CN169374|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:C3150344	Classic homocystinuria|not specified|Familial thoracic aortic aneurysm and aortic dissection|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;unknown	germline	GRCh38	NC_000021.9	21	43068519	43068519	21q22.3	criteria provided, conflicting classifications	4	-	N	ClinGen:CA274220,UniProtKB:P35520#VAR_002173,ClinVar:2501029	2	188989	43068519	C	G	-	-	-	-	-	-	SCV000220743|SCV002753262|SCV002973349|SCV003922486	-	-	306G>C 	Lys102Asn	NM_000071.3	1	3_Conflicting	CBS	ENSG00000160200	359	312	CCSBVarC007353	ALE00007341	306G>C	Lys102Asn	Edgotyping3	VUSMutGDEh011	D05	GDEhDisVCh_40013	F10	1	VUSMutGDDh011	D05	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	CBS_Lys102Asn	21	21	43068519	C	G
71569	OTC	1033T>C	Tyr345His	ENSG00000036473	X	38421050	NC_000023.11:38421050:T:C	ALE00005264	CCSBVarC005264	NULL	205991	NULL	GDEhDisVCh_40048	E02	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATCACTCACCTCAGCTCCAGAAGCCTAAATTT	102992.0	single nucleotide variant	NM_000531.6(OTC):c.1033T>C (p.Tyr345His)	5009.0	OTC	HGNC:8512	Conflicting classifications of pathogenicity	1.0	Feb 03, 2023	66469337.0	-	RCV000083324|RCV001063477	MedGen:C3661900|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664	not provided|Ornithine carbamoyltransferase deficiency	germline;unknown	germline	GRCh38	NC_000023.11	X	38421050.0	38421050.0	Xp11.4	criteria provided, conflicting classifications	3.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224442	2.0	97100.0	38421050.0	T	C	-	-	-	-	-	-	SCV001228324|SCV004235695	-	-	1033T>C 	Tyr345His	NM_000531.6	1.0	3_Conflicting	chrX	T	C	X-38421050-T-C		97100	X	38421050	T	C	Y	H	rs66469337	X	38280303	X	38165247	345	OTC	ENSG00000036473	ENST00000039007	ENSP00000039007	P00480	OTC_HUMAN	c.1033T>C	p.Tyr345His	c.1033T>C	p.Tyr345His	principal1	Y	1	YES	Select	+	TAC	1	0	T	T/T	T/T	T/T	T/T	0.238	0.17919	T	0.311	0.19915	T	0.042	0.21486	B	0.03	0.21742	B	0.67	0.80805	D	simple_aae	33.0	67.0	1.305	0.32522	L	-0.84	0.22889	N	0.675	0.68098	0.8166	0.94598	D	0.8922	0.96415	D	10	0.928227	0.92079	D	0.540319	0.95709	D	0.674	0.87911	0.831	0.94010	P00480	Y345H	Gain of disorder (P = 0.0233)| Loss of helix (P = 0.0558)| Gain of loop (P = 0.0851)| Loss of stability (P = 0.1811)| Gain of catalytic residue at D344 (P = 0.2644)	0.983898044342	0.98355	0.8662201427103319	0.86505	0.526693845599	0.50005	0.686007201672	0.65074	T	0.380806	0.74152	T	0.554045	0.95831	D	0.558071	0.95767	D	0.828200221061707	0.48113	D	0.90091	0.65488	D	0.5740317	0.70989	0.3861961	0.63270	0.46853617	0.64887	0.41637868	0.65470	-9.019	0.67897	D	0.375	0.58092	A	0.93201561106006	0.78583	0.99329210	0.97305	0.926	0.96292	.	.	.	.	.	.	3.376439	0.46763	22.3	0.99053186933955273	0.51383	.	.	.	.	.	.	.	.	.	5.33	5.33	0.75646	.	.	6.649	0.74278	7.776000	0.68617	0.665	0.62996	1.0	0.71675	1.000000	0.68239	1.0	0.97202	768	0.49456	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	not_provided|Ornithine_carbamoyltransferase_deficiency	criteria_provided,_conflicting_classifications	NC_000023.11:g.38421050T>C	ClinGen:CA224442	C3661900|C0268542	311250	664	.	Tyr	His	102992	single nucleotide variant	NM_000531.6(OTC):c.1033T>C (p.Tyr345His)	5009	OTC	HGNC:8512	Conflicting classifications of pathogenicity	1	Feb 03, 2023	66469337	-	RCV000083324|RCV001063477	MedGen:C3661900|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664	not provided|Ornithine carbamoyltransferase deficiency	germline;unknown	germline	GRCh38	NC_000023.11	X	38421050	38421050	Xp11.4	criteria provided, conflicting classifications	3	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224442	2	97100	38421050	T	C	-	-	-	-	-	-	SCV001228324|SCV004235695	-	-	1033T>C 	Tyr345His	NM_000531.6	1	3_Conflicting	OTC	ENSG00000036473	71569	205991	CCSBVarC005264	ALE00005264	1033T>C	Tyr345His	CEGS2	CegsMutGDEh1012	G03	GDEhDisVCh_40048	E02	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	2	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Tyr345His	23	X	38421050	T	C
359	CBS	442G>A	Gly148Arg	ENSG00000160200	21	43066252	NC_000021.9:43066252:C:T	ALE00007329	CCSBVarC007338	NULL	NULL	293	GDEhDisVCh_40013	G08	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCAGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	358643.0	single nucleotide variant	NM_000071.3(CBS):c.442G>A (p.Gly148Arg)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Oct 08, 2024	755952006.0	-	RCV000411624|RCV002230731|RCV001193389|RCV002328897|RCV003314591	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:C3661900	Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|not provided	germline;unknown	germline	GRCh38	NC_000021.9	21	43066252.0	43066252.0	21q22.3	criteria provided, multiple submitters, no conflicts	7.0	-	N	ClinGen:CA16042005	2.0	371512.0	43066252.0	C	T	-	-	-	-	-	-	SCV000487113|SCV001229019|SCV001362174|SCV002631193|SCV004014224|SCV004213888	-	-	442G>A 	Gly148Arg	NM_000071.3	2.0	1_Pathogenic	chr21	G	A	21-43066252-G-A		371512	21	43066252	C	T	G	R	rs755952006	21	44486362	21	43359431	148	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.442G>A	p.Gly148Arg	c.442G>A	p.Gly148Arg	principal1	Y	1	.	.	-	GGG	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.85	0.99713	H	-7.96	0.96508	D	0.994	0.99902	0.9324	0.96124	D	0.9986	0.99961	D	10	0.9960003	0.99995	D	0.929059	0.99483	D	0.936	0.98562	0.996	0.99957	P35520	G148R	Gain of MoRF binding (P = 0.078)| Gain of phosphorylation at T146 (P = 0.1184)| Gain of glycosylation at T146 (P = 0.1562)| Gain of loop (P = 0.2045)| Loss of catalytic residue at N149 (P = 0.2264)	0.938795599918	0.93768	.	0.99336	.	0.81268	0.844782710075	0.88805	D	0.991051	0.99964	D	0.423934	0.91158	D	0.553322	0.95710	D	0.99969482421875	0.98518	D	.	0.98487	.	0.9618206	0.97422	0.86142087	0.92172	0.9684344	0.98082	0.87238175	0.92937	-11.284	0.81252	D	.	0.95768	.	0.99994433417024	0.99079	0.99985814	0.99820	1	0.99985	.	.	.	.	.	.	4.978954	0.82491	27.8	0.99865729348682641	0.94371	0.891177	0.82627	D	0.875330471988597	0.90446	10.43207	0.705401714364688	0.82694	7.854872	5.23	5.23	0.72532	2.86	0.52289	6.845	0.75251	5.693000	0.49420	0.524	0.24207	1.0	0.71675	1.000000	0.68239	0.073	0.16871	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	107938	1.852920e-05	0	3	206222	1.454740e-05	0	3	235278	1.275090e-05	0	0	7134	0.000000e+00	0	1	17098	5.848640e-05	0	0	2314	0.000000e+00	0	0	9026	0.000000e+00	0	0	12074	0.000000e+00	0	1	42710	2.341370e-05	0	0	15686	0.000000e+00	0	1	17098	5.848640e-05	0	1	16154	6.190420e-05	0	1	30502	3.278470e-05	0	0	6198	0.000000e+00	0	0	13370	0.000000e+00	0	0	15414	0.000000e+00	0	1	89140	1.121830e-05	0	0	30604	0.000000e+00	0	1	16154	6.190420e-05	0	1	14860	6.729480e-05	0	1	34236	2.920900e-05	0	0	9560	0.000000e+00	0	0	17670	0.000000e+00	0	0	20306	0.000000e+00	0	1	102526	9.753620e-06	0	0	30522	0.000000e+00	0	1	14860	6.729480e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	24304	4.114549045424621E-5	0	108	0	0	84	0	0	2728	0	0	494	0	0	628	0	0	24	0	0	94	0	0	4514	0	0	2836	0	0	108	0	1	32978	3.0323245800230458E-5	Pathogenic/Likely_pathogenic	Homocystinuria|Classic_homocystinuria|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43066252C>T	ClinGen:CA16042005	C0019880|C0751202|C3150344|C4707243|C3661900	236200|PS607086	394|91387	Tryptophan synthase beta chain-like, PALP domain	Gly	Arg	358643	single nucleotide variant	NM_000071.3(CBS):c.442G>A (p.Gly148Arg)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Oct 08, 2024	755952006	-	RCV000411624|RCV002230731|RCV001193389|RCV002328897|RCV003314591	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:C3661900	Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|not provided	germline;unknown	germline	GRCh38	NC_000021.9	21	43066252	43066252	21q22.3	criteria provided, multiple submitters, no conflicts	7	-	N	ClinGen:CA16042005	2	371512	43066252	C	T	-	-	-	-	-	-	SCV000487113|SCV001229019|SCV001362174|SCV002631193|SCV004014224|SCV004213888	-	-	442G>A 	Gly148Arg	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	293	CCSBVarC007338	ALE00007329	442G>A	Gly148Arg	Edgotyping3	VUSMutGDEh011	E03	GDEhDisVCh_40013	G08	1	VUSMutGDDh011	E03	NULL	NULL	NULL	NULL	NULL	NULL	1	5	1	5	0	NULL	0	NULL	0	NULL	CBS_Gly148Arg	21	21	43066252	C	T
14613	BRCA1	2005A>T	Thr669Ser	ENSG00000012048	17	43051078	NC_000017.11:43051078:T:A	ALE00002124	CCSBVarC002124	23739	NULL	NULL	GDEhDisVCh_40059	G11	RC4	ATGGATTTATCTGCTCTTCGCGTTGAAGAAGTACAAAATGTCATTAATGCTATGCAGAAAATCTTAGAGTGTCCCATCTGTCTGGAGTTGATCAAGGAACCTGTCTCCACAAAGTGTGACCACATATTTTGCAAATTTTGCATGCTGAAACTTCTCAACCAGAAGAAAGGGCCTTCACAGTGTCCTTTATGTAAGAATGATATAACCAAAAGGAGCCTACAAGAAAGTACGAGATTTAGTCAACTTGTTGAAGAGCTATTGAAAATCATTTGTGCTTTTCAGCTTGACACAGGTTTGGAGTATGCAAACAGCTATAATTTTGCAAAAAAGGAAAATAACTCTCCTGAACATCTAAAAGATGAAGTTTCTATCATCCAAAGTATGGGCTACAGAAACCGTGCCAAAAGACTTCTACAGAGTGAACCCGAAAATCCTTCCTTGCAGGAAACCAGTCTCAGTGTCCAACTCTCTAACCTTGGAACTGTGAGAACTCTGAGGACAAAGCAGCGGATACAACCTCAAAAGACGTCTGTCTACATTGAATTGGGATCTGATTCTTCTGAAGATACCGTTAATAAGGCAACTTATTGCAGTGTGGGAGATCAAGAATTGTTACAAATCACCCCTCAAGGAACCAGGGATGAAATCAGTTTGGATTCTGCAAAAAAGGCTGCTTGTGAATTTTCTGAGACGGATGTAACAAATACTGAACATCATCAACCCAGTAATAATGATTTGAACACCACTGAGAAGCGTGCAGCTGAGAGGCATCCAGAAAAGTATCAGGGTGAAGCAGCATCTGGGTGTGAGAGTGAAACAAGCGTCTCTGAAGACTGCTCAGGGCTATCCTCTCAGAGTGACATTTTAACCACTCAGCAGAGGGATACCATGCAACATAACCTGATAAAGCTCCAGCAGGAAATGGCTGAACTAGAAGCTGTGTTAGAACAGCATGGGAGCCAGCCTTCTAACAGCTACCCTTCCATCATAAGTGACTCTTCTGCCCTTGAGGACCTGCGAAATCCAGAACAAAGCACATCAGAAAAAGTATTAACTTCACAGAAAAGTAGTGAATACCCTATAAGCCAGAATCCAGAAGGCCTTTCTGCTGACAAGTTTGAGGTGTCTGCAGATAGTTCTACCAGTAAAAATAAAGAACCAGGAGTGGAAAGGTCATCCCCTTCTAAATGCCCATCATTAGATGATAGGTGGTACATGCACAGTTGCTCTGGGAGTCTTCAGAATAGAAACTACCCATCTCAAGAGGAGCTCATTAAGGTTGTTGATGTGGAGGAGCAACAGCTGGAAGAGTCTGGGCCACACGATTTGACGGAAACATCTTACTTGCCAAGGCAAGATCTAGAGGGAACCCCTTACCTGGAATCTGGAATCAGCCTCTTCTCTGATGACCCTGAATCTGATCCTTCTGAAGACAGAGCCCCAGAGTCAGCTCGTGTTGGCAACATACCATCTTCAACCTCTGCATTGAAAGTTCCCCAATTGAAAGTTGCAGAATCTGCCCAGAGTCCAGCTGCTGCTCATACTACTGATACTGCTGGGTATAATGCAATGGAAGAAAGTGTGAGCAGGGAGAAGCCAGAATTGACAGCTTCAACAGAAAGGGTCAACAAAAGAATGTCCATGGTGGTGTCTGGCCTGACCCCAGAAGAATTTATGCTCGTGTACAAGTTTGCCAGAAAACACCACATCACTTTAACTAATCTAATTACTGAAGAGACTACTCATGTTGTTATGAAAACAGATGCTGAGTTTGTGTGTGAACGGACACTGAAATATTTTCTAGGAATTGCGGGAGGAAAATGGGTAGTTAGCTATTTCTGGGTGACCCAGTCTATTAAAGAAAGAAAAATGCTGAATGAGCATGATTTTGAAGTCAGAGGAGATGTGGTCAATGGAAGAAACCACCAAGGTCCAAAGCGAGCAAGAGAATCCCAGGACAGAAAGATCTTCAGGGGGCTAGAAATCTGTTGCTATGGGCCCTTCTCCAACATGCCCACAGGGTGTCCACCCAATTGTGGTTGTGCAGCCAGATGCCTGGACAGAGGACAATGGCTTCCATGCAATTGGGCAGATGTG	70188.0	single nucleotide variant	NM_007294.4(BRCA1):c.5317A>T (p.Thr1773Ser)	672.0	BRCA1	HGNC:1100	Conflicting classifications of pathogenicity	0.0	Jan 14, 2025	80357324.0	-	RCV000077613|RCV000164158|RCV001498333|RCV001545333|RCV003235023	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900|MedGen:CN169374	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|not specified	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43051078.0	43051078.0	17q21.31	criteria provided, conflicting classifications	9.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003470	2.0	55521.0	43051078.0	T	A	-	-	-	-	-	-	SCV000214774|SCV000488253|SCV000908985|SCV001703083|SCV001764649|SCV003933883	-	-	5317A>T 	Thr1773Ser	NM_007294.4	1.0	3_Conflicting	chr17	A	T	17-43051078-A-T		55521	17	43051078	T	A	T	S	rs80357324	17	41203095	17	38456621	1773	BRCA1	ENSG00000012048	ENST00000618469	ENSP00000478114	P38398	BRCA1_HUMAN	.	.	c.5317A>T	p.Thr1773Ser	principal2	Y	1	.	.	-	ACC	1	0	T	T/T	T/T	T/T	T/T	.	0.91343	.	.	0.92967	.	0.619	0.77914	P	0.133	0.83178	B	.	0.68318	.	.	.	.	1.95	0.52299	M	.	0.63463	.	.	0.63442	0.6827	0.92933	D	0.7555	0.91645	D	10	.	0.81792	.	0.646988	0.96999	D	.	0.88296	.	.	.	.	.	.	0.91836	.	0.27361	.	0.25914	0.482681810856	0.36378	T	0.130915	0.45709	T	0.200734	0.73767	D	0.0505642	0.73424	D	0.896451056003571	0.54565	D	0.812719	0.52439	T	0.6611269	0.75692	0.2858274	0.54377	0.5551733	0.69948	0.28640422	0.54436	-5.584	0.43146	T	.	0.50258	.	0.570100781881928	0.62906	0.99965191	0.99571	0.725	0.84761	.	.	.	.	.	.	3.818427	0.55196	23.6	0.99625763606741358	0.75743	0.728294	0.67518	D	0.616239995146814	0.74063	6.092648	0.601529860608617	0.74915	6.242596	5.21	5.21	0.71966	5.33	0.93090	4.286	0.58874	2.859000	0.35272	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.994	0.71086	449	0.79449	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	0	109376	0.000000e+00	0	3	208046	1.441990e-05	0	2	236892	8.442670e-06	0	0	7156	0.000000e+00	0	0	17100	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13392	0.000000e+00	0	0	42766	0.000000e+00	0	0	15684	0.000000e+00	0	.	.	.	.	1	16198	6.173600e-05	0	0	30504	0.000000e+00	0	0	6212	0.000000e+00	0	0	13412	0.000000e+00	0	0	16732	0.000000e+00	0	2	89520	2.234140e-05	0	0	30602	0.000000e+00	0	1	16198	6.173600e-05	0	1	14894	6.714110e-05	0	0	34248	0.000000e+00	0	0	9570	0.000000e+00	0	0	17690	0.000000e+00	0	0	21630	0.000000e+00	0	1	102720	9.735200e-06	0	0	30520	0.000000e+00	0	1	14894	6.714110e-05	0	.	19	1613864	1.177300e-05	0	19	1179958	1.610230e-05	0	0	74872	0.000000e+00	0	0	912	0.000000e+00	0	0	59982	0.000000e+00	0	0	29606	0.000000e+00	0	0	44878	0.000000e+00	0	0	64010	0.000000e+00	0	0	6082	0.000000e+00	0	19	1179958	1.610230e-05	0	0	91082	0.000000e+00	0	1	9690	1.0319917440660474E-4	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	1	14050	7.117437722419929E-5	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|not_provided|Hereditary_breast_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|not_specified	criteria_provided,_conflicting_classifications	NC_000017.11:g.43051078T>A	ClinGen:CA003470	C0027672|C3661900|C0677776|C2676676|CN169374	604370	140162|145|145	.	Thr	Ser	70188	single nucleotide variant	NM_007294.4(BRCA1):c.5317A>T (p.Thr1773Ser)	672	BRCA1	HGNC:1100	Conflicting classifications of pathogenicity	0	Jan 14, 2025	80357324	-	RCV000077613|RCV000164158|RCV001498333|RCV001545333|RCV003235023	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:C3661900|MedGen:CN169374	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided|not specified	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43051078	43051078	17q21.31	criteria provided, conflicting classifications	9	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA003470	2	55521	43051078	T	A	-	-	-	-	-	-	SCV000214774|SCV000488253|SCV000908985|SCV001703083|SCV001764649|SCV003933883	-	-	5317A>T 	Thr1773Ser	NM_007294.4	1	3_Conflicting	BRCA1	ENSG00000012048	14613	23739	CCSBVarC002124	ALE00002124	2005A>T	Thr669Ser	RC4	RC4_Mut_GDEh1029	B02	GDEhDisVCh_40059	G11	1	RC4_Mut_GDDh1029	B02	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	7	0	NULL	0	NULL	0	NULL	BRCA1_Thr669Ser	17	17	43051078	T	A
52861	F9	329A>G	Asp110Gly	ENSG00000101981	X	139541127	NC_000023.11:139541127:A:G	ALE00004377	CCSBVarC004377	NULL	204356	NULL	GDEhDisVCh_40052	B07	CEGS2	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGGTGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT	25619.0	single nucleotide variant	NM_000133.4(F9):c.329A>G (p.Asp110Gly)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Apr 01, 1989	137852234.0	-	RCV000011326	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541127.0	139541127.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255331,OMIM:300746.0023	1.0	10580.0	139541127.0	A	G	-	-	-	-	-	-	SCV000031557	-	-	329A>G 	Asp110Gly	NM_000133.4		1_Pathogenic	chrX	A	G	X-139541127-A-G		10580	X	139541127	A	G	D	G	rs137852234	X	138623286	X	138450952	110	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.329A>G	p.Asp110Gly	c.329A>G	p.Asp110Gly	principal1	Y	1	YES	Select	+	GAT	2	0	A	A/A	A/A	A/A	A/A	0.034	0.44188	D	0.028	0.55281	D	0.929	0.51703	P	0.905	0.64254	P	0.94	0.94378	A	simple_aae	6.0	94.0	2.635	0.76933	M	-5.91	0.88932	D	0.75	0.74808	0.9907	0.97025	D	0.9883	0.99662	D	10	0.99250877	0.99786	D	0.945041	0.99615	D	0.922	0.98039	0.929	0.98863	P00740	D110G	Loss of stability (P = 0.0418)| Gain of glycosylation at S107 (P = 0.0829)| Loss of ubiquitination at K109 (P = 0.1139)| Gain of sheet (P = 0.1208)| Gain of methylation at K109 (P = 0.1483)	0.999829378711	0.99982	0.9935189380505333	0.99346	3.4416008843	0.99720	0.602996945381	0.53261	T	0.959561	0.99466	D	0.665778	0.99899	D	0.718567	0.99898	D	0.993830382823944	0.84682	D	0.946205	0.79408	D	0.96431756	0.97674	0.9610434	0.99012	0.9560345	0.96828	0.9480847	0.98257	-10.347	0.76039	D	0.703	0.73028	P	0.997306026786761	0.92990	0.99999225	0.99996	0.951	0.97790	.	.	.	.	.	.	4.697825	0.75387	26.3	0.99816010581735481	0.89981	.	.	.	.	.	.	.	.	.	5.81	5.81	0.92402	5.16	0.91535	8.369	0.90039	11.105000	0.86221	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.979	0.57726	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	1	2644	3.7821482602118004E-4	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	1	2728	3.6656891495601173E-4	0	142	0	1	11340	8.818342151675486E-5	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139541127A>G	ClinGen:CA255331|OMIM:300746.0023	C0008533	306900	98879	EGF-like domain|EGF-like calcium-binding, conserved site|EGF-like domain|EGF-like calcium-binding domain|EGF-like domain	Asp	Gly	25619	single nucleotide variant	NM_000133.4(F9):c.329A>G (p.Asp110Gly)	2158	F9	HGNC:3551	Pathogenic	1	Apr 01, 1989	137852234	-	RCV000011326	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139541127	139541127	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255331,OMIM:300746.0023	1	10580	139541127	A	G	-	-	-	-	-	-	SCV000031557	-	-	329A>G 	Asp110Gly	NM_000133.4		1_Pathogenic	F9	ENSG00000101981	52861	204356	CCSBVarC004377	ALE00004377	329A>G	Asp110Gly	CEGS2	CegsMutGDEh1027	D10	GDEhDisVCh_40052	B07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	F9_Asp110Gly	23	X	139541127	A	G
359	CBS	1539C>G	His513Gln	ENSG00000160200	21	43056816	NC_000021.9:43056816:G:C	ALE00007293	CCSBVarC007295	NULL	NULL	230	GDEhDisVCh_40013	C03	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCAGGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	378555.0	single nucleotide variant	NM_000071.3(CBS):c.1539C>G (p.His513Gln)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Jan 25, 2017	187828882.0	-	RCV000424660	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000021.9	21	43056816.0	43056816.0	21q22.3	criteria provided, single submitter	1.0	-	N	ClinGen:CA16608554	2.0	393133.0	43056816.0	G	C	-	-	-	-	-	-	SCV000536498	-	-	1539C>G 	His513Gln	NM_000071.3	1.0	4_VUS	chr21	C	G	21-43056816-C-G		393133	21	43056816	G	C	H	Q	rs187828882	21	44476926	21	43349995	513	CBS	ENSG00000160200	ENST00000398165	ENSP00000381231	P35520	CBS_HUMAN	c.1539C>G	p.His513Gln	c.1539C>G	p.His513Gln	principal1	Y	1	YES	Select	-	CAC	3	2	G	G/G	G/G	G/G	G/G	0.407	0.10306	T	0.658	0.06661	T	0.18	0.29064	B	0.032	0.22132	B	.	.	.	.	.	.	2.05	0.56288	M	-2.19	0.49367	N	0.769	0.76757	-0.5930	0.64948	T	0.2809	0.65133	T	10	0.66848534	0.70304	D	0.091591	0.75655	D	0.667	0.87569	0.418	0.45729	P35520	H513Q	Loss of sheet (P = 0.1398)| Loss of disorder (P = 0.1825)| Loss of loop (P = 0.2237)| Gain of phosphorylation at Y518 (P = 0.3024)| Loss of catalytic residue at Q515 (P = 0.3324)	0.593630346942	0.58730	0.7782857805283246	0.77654	0.351907675512	0.36742	0.54155600071	0.44601	T	0.641596	0.88906	D	0.2812	0.81282	D	0.166148	0.81042	D	0.462005615234375	0.30927	T	.	0.40724	.	0.47241616	0.65126	0.3067768	0.56481	0.41844338	0.61666	0.31292146	0.57068	-4.742	0.33946	T	.	0.51908	.	0.626351217961157	0.64635	0.99213400	0.97085	0.519	0.72665	.	.	.	.	.	.	0.612668	0.09839	6.576	0.89321970407095208	0.18950	0.637270	0.61473	D	-0.571045983046401	0.19588	1.040825	-0.678468853541295	0.17216	0.9307849	4.72	-3.28	0.04719	-4.82	0.04777	-1.115	0.03403	-2.927000	0.03239	-0.896	0.02364	0.008	0.17977	0.000000	0.08389	0.679	0.33553	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	not_provided	criteria_provided,_single_submitter	NC_000021.9:g.43056816G>C	ClinGen:CA16608554	CN517202	.	.	Cystathionine beta-synthase, C-terminal domain	His	Gln	378555	single nucleotide variant	NM_000071.3(CBS):c.1539C>G (p.His513Gln)	875	CBS	HGNC:1550	Uncertain significance	0	Jan 25, 2017	187828882	-	RCV000424660	MedGen:CN517202	not provided	germline	germline	GRCh38	NC_000021.9	21	43056816	43056816	21q22.3	criteria provided, single submitter	1	-	N	ClinGen:CA16608554	2	393133	43056816	G	C	-	-	-	-	-	-	SCV000536498	-	-	1539C>G 	His513Gln	NM_000071.3	1	4_VUS	CBS	ENSG00000160200	359	230	CCSBVarC007295	ALE00007293	1539C>G	His513Gln	Edgotyping3	VUSMutGDEh010	G09	GDEhDisVCh_40013	C03	1	VUSMutGDDh010	G09	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	5	0	NULL	0	NULL	0	NULL	CBS_His513Gln	21	21	43056816	G	C
3689	GCK	758T>C	Val253Ala	ENSG00000106633	7	44147755	NC_000007.14:44147755:A:G	ALE00006690	CCSBVarC006692	NULL	214843	NULL	GDEhDisVCh_40037	C04	CEGS2	ATGCTGGACGACAGAGCCAGGATGGAGGCCGCCAAGAAGGAGAAGGTAGAGCAGATCCTGGCAGAGTTCCAGCTGCAGGAGGAGGACCTGAAGAAGGTGATGAGACGGATGCAGAAGGAGATGGACCGCGGCCTGAGGCTGGAGACCCATGAAGAGGCCAGTGTGAAGATGCTGCCCACCTACGTGCGCTCCACCCCAGAAGGCTCAGAAGTCGGGGACTTCCTCTCCCTGGACCTGGGTGGCACTAACTTCAGGGTGATGCTGGTGAAGGTGGGAGAAGGTGAGGAGGGGCAGTGGAGCGTGAAGACCAAACACCAGATGTACTCCATCCCCGAGGACGCCATGACCGGCACTGCTGAGATGCTCTTCGACTACATCTCTGAGTGCATCTCCGACTTCCTGGACAAGCATCAGATGAAACACAAGAAGCTGCCCCTGGGCTTCACCTTCTCCTTTCCTGTGAGGCACGAAGACATCGATAAGGGCATCCTTCTCAACTGGACCAAGGGCTTCAAGGCCTCAGGAGCAGAAGGGAACAATGTCGTGGGGCTTCTGCGAGACGCTATCAAACGGAGAGGGGACTTTGAAATGGATGTGGTGGCAATGGTGAATGACACGGTGGCCACGATGATCTCCTGCTACTACGAAGACCATCAGTGCGAGGTCGGCATGATCGTGGGCACGGGCTGCAATGCCTGCTACATGGAGGAGATGCAGAATGTGGAGCTGGTGGAGGGGGACGAGGGCCGCATGTGCGCCAATACCGAGTGGGGCGCCTTCGGGGACTCCGGCGAGCTGGACGAGTTCCTGCTGGAGTATGACCGCCTGGTGGACGAGAGCTCTGCAAACCCCGGTCAGCAGCTGTATGAGAAGCTCATAGGTGGCAAGTACATGGGCGAGCTGGTGCGGCTTGTGCTGCTCAGGCTCGTGGACGAAAACCTGCTCTTCCACGGGGAGGCCTCCGAGCAGCTGCGCACACGCGGAGCCTTCGAGACGCGCTTCGTGTCGCAGGTGGAGAGCGACACGGGCGACCGCAAGCAGATCTACAACATCCTGAGCACGCTGGGGCTGCGACCCTCGACCACCGACTGCGACATCGTGCGCCGCGCCTGCGAGAGCGTGTCTACGCGCGCTGCGCACATGTGCTCGGCGGGGCTGGCGGGCGTCATCAACCGCATGCGCGAGAGCCGCAGCGAGGACGTAATGCGCATCACTGTGGGCGTGGATGGCTCCGTGTACAAGCTGCACCCCAGCTTCAAGGAGCGGTTCCATGCCAGCGTGCGCAGGCTGACGCCCAGCTGCGAGATCACCTTCATCGAGTCGGAGGAGGGCAGTGGCCGGGGCGCGGCCCTGGTCTCGGCGGTGGCCTGTAAGAAGGCCTGTATGCTGGGCCAG	44916.0	single nucleotide variant	NM_000162.5(GCK):c.758T>C (p.Val253Ala)	2645.0	GCK	HGNC:4195	Conflicting classifications of pathogenicity	1.0	Jan 06, 2025	193921400.0	-	RCV000029915|RCV002472937	MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:C3661900	Maturity-onset diabetes of the young type 2|not provided	germline;unknown	germline	GRCh38	NC_000007.14	7	44147755.0	44147755.0	7p13	criteria provided, conflicting classifications	3.0	-	N	ClinGen:CA213842	2.0	36252.0	44147755.0	A	G	-	-	-	-	-	-	SCV000052570|SCV002771537|SCV004295161	-	-	758T>C 	Val253Ala	NM_000162.5	1.0	3_Conflicting	chr7	T	C	7-44147755-T-C		36252	7	44147755	A	G	V	A	rs193921400	7	44187354	7	44153879	253	GCK	ENSG00000106633	ENST00000403799	ENSP00000384247	P35557	HXK4_HUMAN	c.758T>C	p.Val253Ala	c.758T>C	p.Val253Ala	principal1	Y	1	YES	Select	-	GTC	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.001	0.83643	D	0.046	0.32504	B	0.091	0.39681	B	1.0	0.99291	A	simple_aae	0.0	100.0	2.52	0.73336	M	-3.74	0.72508	D	0.946	0.95387	1.1157	0.99893	D	0.9563	0.98582	D	10	0.98990583	0.99469	D	0.866135	0.98971	D	0.944	0.98850	0.941	0.99203	P35557	V253A	Loss of stability (P = 0.1098)| Gain of disorder (P = 0.1266)| Loss of sheet (P = 0.1907)| Loss of loop (P = 0.2237)| Gain of phosphorylation at T255 (P = 0.3168)	0.956797812616	0.95596	.	0.99913	.	0.83247	0.752755045891	0.74809	T	0.952674	0.99322	D	0.537995	0.95317	D	0.535016	0.95247	D	0.994682133197784	0.86012	D	0.915608	0.69816	D	0.97441125	0.98633	0.9509784	0.98434	0.96781456	0.98022	0.94139534	0.97827	-11.973	0.85024	D	0.9629	0.91552	P	0.99694917489775	0.92617	0.99967897	0.99601	0.992	0.99727	.	.	.	.	.	.	5.084575	0.84903	28.4	0.99161198946824824	0.54174	0.949176	0.96141	D	0.39616959401749	0.61014	4.319522	0.468540282191959	0.65730	4.884625	5.23	5.23	0.72532	3.81	0.70705	9.228	0.94416	11.133000	0.86872	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.967	0.53449	698	0.58020	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Conflicting_classifications_of_pathogenicity	not_provided|Maturity-onset_diabetes_of_the_young_type_2	criteria_provided,_conflicting_classifications	NC_000007.14:g.44147755A>G	ClinGen:CA213842	C3661900|C0342277	125851	552	Hexokinase, C-terminal	Val	Ala	44916	single nucleotide variant	NM_000162.5(GCK):c.758T>C (p.Val253Ala)	2645	GCK	HGNC:4195	Conflicting classifications of pathogenicity	1	Jan 06, 2025	193921400	-	RCV000029915|RCV002472937	MONDO:MONDO:0007453,MedGen:C0342277,OMIM:125851,Orphanet:552|MedGen:C3661900	Maturity-onset diabetes of the young type 2|not provided	germline;unknown	germline	GRCh38	NC_000007.14	7	44147755	44147755	7p13	criteria provided, conflicting classifications	3	-	N	ClinGen:CA213842	2	36252	44147755	A	G	-	-	-	-	-	-	SCV000052570|SCV002771537|SCV004295161	-	-	758T>C 	Val253Ala	NM_000162.5	1	3_Conflicting	GCK	ENSG00000106633	3689	214843	CCSBVarC006692	ALE00006690	758T>C	Val253Ala	CEGS2	CegsMutGDEh1045	G02	GDEhDisVCh_40037	C04	1	CegsMutGDDh1045	G02	VUSN2Hmut_GDN2h_09	H08	VUSMutpDEST2_03	C09	VUSmut_GDEh09	H08	1	4	1	1	1	1	1	1	1	1	GCK_Val253Ala	7	7	44147755	A	G
3774	TP53	800G>A	Arg267Gln	ENSG00000141510	17	7673820	NC_000017.11:7673820:C:T	ALE00004871	CCSBVarC004871	NULL	214907	NULL	GDEhDisVCh_40053	B08	CEGS2	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACAGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACCGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	133280.0	single nucleotide variant	NM_000546.6(TP53):c.800G>A (p.Arg267Gln)	7157.0	TP53	HGNC:11998	Uncertain significance	0.0	Aug 11, 2020	587780075.0	-	RCV000115737|RCV000205433|RCV000213058|RCV000662441|RCV001358329|RCV001358724|RCV004567016	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MedGen:C3661900|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:CN169374|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided|Li-Fraumeni syndrome 1|Malignant tumor of breast|not specified|Adrenocortical carcinoma, hereditary	germline;unknown	germline	GRCh38	NC_000017.11	17	7673820.0	7673820.0	17p13.1	reviewed by expert panel	13.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000424,UniProtKB:P04637#VAR_045330	2.0	127823.0	7673820.0	C	T	-	-	-	-	-	-	SCV001429619	-	-	800G>A 	Arg267Gln	NM_000546.6	3.0	4_VUS	chr17	G	A	17-7673820-G-A		127823	17	7673820	C	T	R	Q	rs587780075	17	7577138	17	7517863	267	TP53	ENSG00000141510	ENST00000714357	ENSP00000519624	P04637	P53_HUMAN	.	.	c.800G>A	p.Arg267Gln	principal1	Y	.	.	.	-	CGG	2	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.76775	.	1.0	0.90580	D	0.99	0.78943	D	.	0.97926	.	.	.	.	3.22	0.89268	M	.	0.72277	.	.	0.98575	1.0344	0.97795	D	0.9911	0.99769	D	10	.	0.99425	.	0.74989	0.98001	D	.	0.97281	0.962	0.99611	P04637	R267Q	Loss of catalytic residue at R267 (P = 0.0441)| Loss of phosphorylation at S269 (P = 0.0796)| Loss of disorder (P = 0.1109)| Loss of sheet (P = 0.1158)| Loss of MoRF binding (P = 0.1345)	.	0.99779	.	0.80629	.	0.41214	0.544253587723	0.44982	T	0.98962	0.99951	D	0.534336	0.95256	D	0.593406	0.96896	D	0.990935742855072	0.81029	D	.	0.59150	.	0.9401422	0.95189	0.88856435	0.94086	0.95100576	0.96311	0.8649341	0.92417	-10.066	0.75477	D	.	0.83591	.	0.986241870642578	0.87041	0.99996698	0.99978	0.96	0.98304	.	.	.	.	.	.	5.24498	0.8808	29.5	0.99929575850033314	0.99279	0.924879	0.90323	D	0.534071730767398	0.68954	5.311911	0.420774789962361	0.62660	4.508891	5.13	3.12	0.34908	4.48	0.83983	7.905	0.86513	4.944000	0.46309	0.596	0.33565	1.0	0.71675	1.000000	0.68239	0.99	0.65338	432	0.80699	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	1	108608	9.207420e-06	0	2	206710	9.675390e-06	0	2	235140	8.505570e-06	0	0	7076	0.000000e+00	0	0	16970	0.000000e+00	0	0	2296	0.000000e+00	0	0	8988	0.000000e+00	0	0	13372	0.000000e+00	0	0	42424	0.000000e+00	0	0	15584	0.000000e+00	0	.	.	.	.	0	16082	0.000000e+00	0	0	30262	0.000000e+00	0	0	6176	0.000000e+00	0	0	13378	0.000000e+00	0	0	16702	0.000000e+00	0	1	88848	1.125520e-05	0	0	30430	0.000000e+00	0	1	88848	1.125520e-05	0	0	14788	0.000000e+00	0	0	34006	0.000000e+00	0	0	9532	0.000000e+00	0	0	17606	0.000000e+00	0	0	21492	0.000000e+00	0	1	101790	9.824150e-06	0	0	30350	0.000000e+00	0	1	101790	9.824150e-06	0	.	8	1613260	4.958900e-06	0	8	1179724	6.781250e-06	0	0	74860	0.000000e+00	0	0	912	0.000000e+00	0	0	59818	0.000000e+00	0	0	29580	0.000000e+00	0	0	44838	0.000000e+00	0	0	64002	0.000000e+00	0	0	6084	0.000000e+00	0	8	1179724	6.781250e-06	0	0	90990	0.000000e+00	0	5	90090	5.55000555000555E-5	0	138	0	0	2680	0	0	3446	0	0	436	0	0	928	0	0	624	0	0	276	0	0	2032	0	0	3584	0	0	3304	0	5	100650	4.9677098857426726E-5	Uncertain_significance	Li-Fraumeni_syndrome_1|Malignant_tumor_of_breast|not_provided|not_specified|Adrenocortical_carcinoma,_hereditary|Hereditary_cancer-predisposing_syndrome|Li-Fraumeni_syndrome	reviewed_by_expert_panel	NC_000017.11:g.7673820C>T	ClinGen:CA000424|UniProtKB:P04637#VAR_045330	C1835398|C0006142|C3661900|CN169374|C1859972|C0027672|C0085390	151623|202300|PS151623	524|1501|140162|524	p53, DNA-binding domain|p53, DNA-binding domain	Arg	Gln	133280	single nucleotide variant	NM_000546.6(TP53):c.800G>A (p.Arg267Gln)	7157	TP53	HGNC:11998	Uncertain significance	0	Aug 11, 2020	587780075	-	RCV000115737|RCV000205433|RCV000213058|RCV000662441|RCV001358329|RCV001358724|RCV004567016	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MedGen:C3661900|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MONDO:MONDO:0007254,MedGen:C0006142|MedGen:CN169374|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided|Li-Fraumeni syndrome 1|Malignant tumor of breast|not specified|Adrenocortical carcinoma, hereditary	germline;unknown	germline	GRCh38	NC_000017.11	17	7673820	7673820	17p13.1	reviewed by expert panel	13	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000424,UniProtKB:P04637#VAR_045330	2	127823	7673820	C	T	-	-	-	-	-	-	SCV001429619	-	-	800G>A 	Arg267Gln	NM_000546.6	3	4_VUS	TP53	ENSG00000141510	3774	214907	CCSBVarC004871	ALE00004871	800G>A	Arg267Gln	CEGS2	CegsMutGDEh1023	F12	GDEhDisVCh_40053	B08	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	TP53_Arg267Gln	17	17	7673820	C	T
3689	GCK	1133C>T	Ala378Val	ENSG00000106633	7	44145617	NC_000007.14:44145617:G:A	ALE00006693	CCSBVarC006695	NULL	214853	NULL	GDEhDisVCh_40037	E02	CEGS2	ATGCTGGACGACAGAGCCAGGATGGAGGCCGCCAAGAAGGAGAAGGTAGAGCAGATCCTGGCAGAGTTCCAGCTGCAGGAGGAGGACCTGAAGAAGGTGATGAGACGGATGCAGAAGGAGATGGACCGCGGCCTGAGGCTGGAGACCCATGAAGAGGCCAGTGTGAAGATGCTGCCCACCTACGTGCGCTCCACCCCAGAAGGCTCAGAAGTCGGGGACTTCCTCTCCCTGGACCTGGGTGGCACTAACTTCAGGGTGATGCTGGTGAAGGTGGGAGAAGGTGAGGAGGGGCAGTGGAGCGTGAAGACCAAACACCAGATGTACTCCATCCCCGAGGACGCCATGACCGGCACTGCTGAGATGCTCTTCGACTACATCTCTGAGTGCATCTCCGACTTCCTGGACAAGCATCAGATGAAACACAAGAAGCTGCCCCTGGGCTTCACCTTCTCCTTTCCTGTGAGGCACGAAGACATCGATAAGGGCATCCTTCTCAACTGGACCAAGGGCTTCAAGGCCTCAGGAGCAGAAGGGAACAATGTCGTGGGGCTTCTGCGAGACGCTATCAAACGGAGAGGGGACTTTGAAATGGATGTGGTGGCAATGGTGAATGACACGGTGGCCACGATGATCTCCTGCTACTACGAAGACCATCAGTGCGAGGTCGGCATGATCGTGGGCACGGGCTGCAATGCCTGCTACATGGAGGAGATGCAGAATGTGGAGCTGGTGGAGGGGGACGAGGGCCGCATGTGCGTCAATACCGAGTGGGGCGCCTTCGGGGACTCCGGCGAGCTGGACGAGTTCCTGCTGGAGTATGACCGCCTGGTGGACGAGAGCTCTGCAAACCCCGGTCAGCAGCTGTATGAGAAGCTCATAGGTGGCAAGTACATGGGCGAGCTGGTGCGGCTTGTGCTGCTCAGGCTCGTGGACGAAAACCTGCTCTTCCACGGGGAGGCCTCCGAGCAGCTGCGCACACGCGGAGCCTTCGAGACGCGCTTCGTGTCGCAGGTGGAGAGCGACACGGGCGACCGCAAGCAGATCTACAACATCCTGAGCACGCTGGGGCTGCGACCCTCGACCACCGACTGCGACATCGTGCGCCGCGCCTGCGAGAGCGTGTCTACGCGCGTTGCGCACATGTGCTCGGCGGGGCTGGCGGGCGTCATCAACCGCATGCGCGAGAGCCGCAGCGAGGACGTAATGCGCATCACTGTGGGCGTGGATGGCTCCGTGTACAAGCTGCACCCCAGCTTCAAGGAGCGGTTCCATGCCAGCGTGCGCAGGCTGACGCCCAGCTGCGAGATCACCTTCATCGAGTCGGAGGAGGGCAGTGGCCGGGGCGCGGCCCTGGTCTCGGCGGTGGCCTGTAAGAAGGCCTGTATGCTGGGCCAG	33928.0	single nucleotide variant	NM_000162.5(GCK):c.1133C>T (p.Ala378Val)	2645.0	GCK	HGNC:4195	Pathogenic	1.0	Aug 08, 2023	193929374.0	-	RCV000020165|RCV003325943|RCV003556055	MONDO:MONDO:0100164,MedGen:C1833104,OMIM:PS606176,Orphanet:99885|MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625|MedGen:C3661900	Permanent neonatal diabetes mellitus|Monogenic diabetes|not provided	germline;unknown	germline	GRCh38	NC_000007.14	7	44145617.0	44145617.0	7p13	reviewed by expert panel	3.0	-	N	ClinGen:CA341585	3.0	21076.0	44145617.0	G	A	-	-	-	-	-	-	SCV004032113	-	-	1133C>T 	Ala378Val	NM_000162.5	3.0	1_Pathogenic	chr7	C	T	7-44145617-C-T		21076	7	44145617	G	A	A	V	rs193929374	7	44185216	7	44151741	378	GCK	ENSG00000106633	ENST00000403799	ENSP00000384247	P35557	HXK4_HUMAN	c.1133C>T	p.Ala378Val	c.1133C>T	p.Ala378Val	principal1	Y	1	YES	Select	-	GCT	2	0	G	G/G	G/G	G/G	G/G	0.001	0.78662	D	0.002	0.83643	D	0.99	0.90580	D	0.665	0.72228	P	1.0	0.99291	A	simple_aae	0.0	100.0	3.695	0.94487	H	-3.4	0.69154	D	0.939	0.94561	1.0450	0.98008	D	0.9837	0.99503	D	9	0.99024475	0.99515	D	0.840994	0.98768	D	0.967	0.99571	0.965	0.99652	P35557	A378V	Loss of disorder (P = 0.07)| Gain of MoRF binding (P = 0.0918)| Gain of catalytic residue at A378 (P = 0.1448)| Loss of phosphorylation at S375 (P = 0.2736)| Loss of glycosylation at S375 (P = 0.2819)	0.979336656616	0.97890	.	0.99421	.	0.92746	0.819278240204	0.84891	D	0.949354	0.99250	D	0.574071	0.96649	D	0.586837	0.96593	D	0.997845649719238	0.92501	D	0.981602	0.98014	D	0.9497514	0.96182	0.87423605	0.93068	0.93814224	0.94983	0.8982886	0.94783	-12.991	0.89350	D	0.9213	0.86543	P	0.952500608346312	0.80744	0.99983370	0.99778	0.995	0.99826	.	.	.	.	.	.	5.607563	0.92514	32.0	0.99916898543066002	0.98450	0.970281	0.99255	D	0.831745765888475	0.87981	9.433492	0.775992041354949	0.88012	9.449598	5.2	5.2	0.71681	3.45	0.62472	8.056	0.89273	11.601000	0.93486	0.672	0.70176	1.0	0.71675	1.000000	0.68239	0.939	0.47934	716	0.55914	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Monogenic_diabetes|Permanent_neonatal_diabetes_mellitus|not_provided	reviewed_by_expert_panel	NC_000007.14:g.44145617G>A	ClinGen:CA341585	C3888631|C1833104|C3661900	PS606176	183625|99885	Hexokinase, C-terminal	Ala	Val	33928	single nucleotide variant	NM_000162.5(GCK):c.1133C>T (p.Ala378Val)	2645	GCK	HGNC:4195	Pathogenic	1	Aug 08, 2023	193929374	-	RCV000020165|RCV003325943|RCV003556055	MONDO:MONDO:0100164,MedGen:C1833104,OMIM:PS606176,Orphanet:99885|MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625|MedGen:C3661900	Permanent neonatal diabetes mellitus|Monogenic diabetes|not provided	germline;unknown	germline	GRCh38	NC_000007.14	7	44145617	44145617	7p13	reviewed by expert panel	3	-	N	ClinGen:CA341585	3	21076	44145617	G	A	-	-	-	-	-	-	SCV004032113	-	-	1133C>T 	Ala378Val	NM_000162.5	3	1_Pathogenic	GCK	ENSG00000106633	3689	214853	CCSBVarC006695	ALE00006693	1133C>T	Ala378Val	CEGS2	CegsMutGDEh1044	E02	GDEhDisVCh_40037	E02	1	CegsMutGDDh1044	E02	VUSN2Hmut_GDN2h_09	H04	VUSMutpDEST2_03	F09	VUSmut_GDEh09	H04	1	1	1	5	1	5	1	5	1	5	GCK_Ala378Val	7	7	44145617	G	A
3172	CBS	1006C>T	Arg336Cys	ENSG00000160200	21	43062344	NC_000021.9:43062344:G:A	ALE00003754	CCSBVarC003754	NULL	214530	NULL	GDEhDisVCh_40055	E08	CEGS2	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTCCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCTGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCCGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	98334.0	single nucleotide variant	NM_000071.3(CBS):c.1006C>T (p.Arg336Cys)	875.0	CBS	HGNC:1550	Pathogenic	1.0	Jan 27, 2025	398123151.0	-	RCV000078105|RCV000169310|RCV002228199|RCV001280568|RCV003905038	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria|CBS-related disorder	germline;unknown	germline	GRCh38	NC_000021.9	21	43062344.0	43062344.0	21q22.3	criteria provided, multiple submitters, no conflicts	14.0	-	N	UniProtKB:P35520#VAR_002188,ClinGen:CA274154	3.0	92423.0	43062344.0	G	A	-	-	-	-	-	-	SCV000220632|SCV000225195|SCV000249700|SCV000893553|SCV000945559|SCV001467771|SCV002016941|SCV002585903|SCV004213869|SCV004804690	-	-	1006C>T 	Arg336Cys	NM_000071.3	2.0	1_Pathogenic	chr21	C	T	21-43062344-C-T		92423	21	43062344	G	A	R	C	rs398123151	21	44482454	21	43355523	336	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.1006C>T	p.Arg336Cys	c.1006C>T	p.Arg336Cys	principal1	Y	1	.	.	-	CGC	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.605	0.99254	H	-7.85	0.96074	D	0.981	0.99110	1.0925	0.99339	D	0.9668	0.98942	D	10	0.99244225	0.99779	D	0.698903	0.97528	D	0.966	0.99545	.	.	.	.	.	0.939073747726	0.93796	.	0.96028	.	0.83375	0.63569521904	0.57889	T	0.992343	0.99974	D	0.503887	0.94344	D	0.59368	0.96899	D	0.999291062355042	0.96829	D	.	0.81706	.	0.9615011	0.97390	0.84274644	0.90902	0.95348656	0.96568	0.8332194	0.90270	-10.169	0.74995	D	0.4293	0.61107	A	0.999299564550619	0.96182	0.99968469	0.99601	0.994	0.99793	.	.	.	.	.	.	5.226296	0.87742	29.3	0.99933314391090389	0.99488	0.965020	0.98722	D	0.903567740283401	0.91889	11.14257	0.765187955997437	0.87218	9.170349	5.28	5.28	0.74083	2.92	0.53394	8.698	0.91064	9.523000	0.80966	0.59	0.31918	1.0	0.71675	1.000000	0.68239	0.14	0.1999	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109302	9.148960e-06	0	3	207546	1.445460e-05	0	4	236558	1.690920e-05	0	0	7152	0.000000e+00	0	0	17092	0.000000e+00	0	0	2316	0.000000e+00	0	0	9042	0.000000e+00	0	0	13386	0.000000e+00	0	1	42716	2.341040e-05	0	0	15686	0.000000e+00	0	1	42716	2.341040e-05	0	0	16162	0.000000e+00	0	0	30486	0.000000e+00	0	0	6192	0.000000e+00	0	0	13400	0.000000e+00	0	0	16724	0.000000e+00	0	3	89142	3.365420e-05	0	0	30586	0.000000e+00	0	3	89142	3.365420e-05	0	0	14870	0.000000e+00	0	0	34226	0.000000e+00	0	0	9562	0.000000e+00	0	0	17684	0.000000e+00	0	0	21562	0.000000e+00	0	4	102532	3.901220e-05	0	0	30508	0.000000e+00	0	4	102532	3.901220e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	33050	9.07715582450832E-5	0	192	0	0	26	0	0	5260	0	0	354	0	0	18	0	0	30	0	0	0	0	0	7802	0	0	5452	0	0	56	0	3	46732	6.41958401095609E-5	Pathogenic	Homocystinuria|not_provided|Classic_homocystinuria|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|CBS-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43062344G>A	ClinGen:CA274154|UniProtKB:P35520#VAR_002188	C0019880|C3661900|C0751202|C3150344	236200	394	Tryptophan synthase beta chain-like, PALP domain	Arg	Cys	98334	single nucleotide variant	NM_000071.3(CBS):c.1006C>T (p.Arg336Cys)	875	CBS	HGNC:1550	Pathogenic	1	Jan 27, 2025	398123151	-	RCV000078105|RCV000169310|RCV002228199|RCV001280568|RCV003905038	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria|CBS-related disorder	germline;unknown	germline	GRCh38	NC_000021.9	21	43062344	43062344	21q22.3	criteria provided, multiple submitters, no conflicts	14	-	N	UniProtKB:P35520#VAR_002188,ClinGen:CA274154	3	92423	43062344	G	A	-	-	-	-	-	-	SCV000220632|SCV000225195|SCV000249700|SCV000893553|SCV000945559|SCV001467771|SCV002016941|SCV002585903|SCV004213869|SCV004804690	-	-	1006C>T 	Arg336Cys	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	264	CCSBVarC007317	ALE00003754	1006C>T	Arg336Cys	Edgotyping3	VUSMutGDEh010	E12	GDEhDisVCh_40013	B06	1	VUSMutGDDh010	E12	NULL	NULL	NULL	NULL	NULL	NULL	1	6	1	6	0	NULL	0	NULL	0	NULL	CBS_Arg336Cys	21	21	43062344	G	A
3172	CBS	1006C>T	Arg336Cys	ENSG00000160200	21	43062344	NC_000021.9:43062344:G:A	ALE00003754	CCSBVarC003754	NULL	214530	NULL	GDEhDisVCh_40055	E08	CEGS2	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTCCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCTGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCCGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	98334.0	single nucleotide variant	NM_000071.3(CBS):c.1006C>T (p.Arg336Cys)	875.0	CBS	HGNC:1550	Pathogenic	1.0	Jan 27, 2025	398123151.0	-	RCV000078105|RCV000169310|RCV002228199|RCV001280568|RCV003905038	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria|CBS-related disorder	germline;unknown	germline	GRCh38	NC_000021.9	21	43062344.0	43062344.0	21q22.3	criteria provided, multiple submitters, no conflicts	14.0	-	N	UniProtKB:P35520#VAR_002188,ClinGen:CA274154	3.0	92423.0	43062344.0	G	A	-	-	-	-	-	-	SCV000220632|SCV000225195|SCV000249700|SCV000893553|SCV000945559|SCV001467771|SCV002016941|SCV002585903|SCV004213869|SCV004804690	-	-	1006C>T 	Arg336Cys	NM_000071.3	2.0	1_Pathogenic	chr21	C	T	21-43062344-C-T		92423	21	43062344	G	A	R	C	rs398123151	21	44482454	21	43355523	336	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.1006C>T	p.Arg336Cys	c.1006C>T	p.Arg336Cys	principal1	Y	1	.	.	-	CGC	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	4.605	0.99254	H	-7.85	0.96074	D	0.981	0.99110	1.0925	0.99339	D	0.9668	0.98942	D	10	0.99244225	0.99779	D	0.698903	0.97528	D	0.966	0.99545	.	.	.	.	.	0.939073747726	0.93796	.	0.96028	.	0.83375	0.63569521904	0.57889	T	0.992343	0.99974	D	0.503887	0.94344	D	0.59368	0.96899	D	0.999291062355042	0.96829	D	.	0.81706	.	0.9615011	0.97390	0.84274644	0.90902	0.95348656	0.96568	0.8332194	0.90270	-10.169	0.74995	D	0.4293	0.61107	A	0.999299564550619	0.96182	0.99968469	0.99601	0.994	0.99793	.	.	.	.	.	.	5.226296	0.87742	29.3	0.99933314391090389	0.99488	0.965020	0.98722	D	0.903567740283401	0.91889	11.14257	0.765187955997437	0.87218	9.170349	5.28	5.28	0.74083	2.92	0.53394	8.698	0.91064	9.523000	0.80966	0.59	0.31918	1.0	0.71675	1.000000	0.68239	0.14	0.1999	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109302	9.148960e-06	0	3	207546	1.445460e-05	0	4	236558	1.690920e-05	0	0	7152	0.000000e+00	0	0	17092	0.000000e+00	0	0	2316	0.000000e+00	0	0	9042	0.000000e+00	0	0	13386	0.000000e+00	0	1	42716	2.341040e-05	0	0	15686	0.000000e+00	0	1	42716	2.341040e-05	0	0	16162	0.000000e+00	0	0	30486	0.000000e+00	0	0	6192	0.000000e+00	0	0	13400	0.000000e+00	0	0	16724	0.000000e+00	0	3	89142	3.365420e-05	0	0	30586	0.000000e+00	0	3	89142	3.365420e-05	0	0	14870	0.000000e+00	0	0	34226	0.000000e+00	0	0	9562	0.000000e+00	0	0	17684	0.000000e+00	0	0	21562	0.000000e+00	0	4	102532	3.901220e-05	0	0	30508	0.000000e+00	0	4	102532	3.901220e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	33050	9.07715582450832E-5	0	192	0	0	26	0	0	5260	0	0	354	0	0	18	0	0	30	0	0	0	0	0	7802	0	0	5452	0	0	56	0	3	46732	6.41958401095609E-5	Pathogenic	Homocystinuria|not_provided|Classic_homocystinuria|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|CBS-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43062344G>A	ClinGen:CA274154|UniProtKB:P35520#VAR_002188	C0019880|C3661900|C0751202|C3150344	236200	394	Tryptophan synthase beta chain-like, PALP domain	Arg	Cys	98334	single nucleotide variant	NM_000071.3(CBS):c.1006C>T (p.Arg336Cys)	875	CBS	HGNC:1550	Pathogenic	1	Jan 27, 2025	398123151	-	RCV000078105|RCV000169310|RCV002228199|RCV001280568|RCV003905038	MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|	not provided|Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria|CBS-related disorder	germline;unknown	germline	GRCh38	NC_000021.9	21	43062344	43062344	21q22.3	criteria provided, multiple submitters, no conflicts	14	-	N	UniProtKB:P35520#VAR_002188,ClinGen:CA274154	3	92423	43062344	G	A	-	-	-	-	-	-	SCV000220632|SCV000225195|SCV000249700|SCV000893553|SCV000945559|SCV001467771|SCV002016941|SCV002585903|SCV004213869|SCV004804690	-	-	1006C>T 	Arg336Cys	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	3172	214530	CCSBVarC003754	ALE00003754	1006C>T	Arg336Cys	CEGS2	CegsMutGDEh1041	G03	GDEhDisVCh_40055	E08	1	CegsMutGDDh1041	G03	NULL	NULL	NULL	NULL	NULL	NULL	1	3	1	1	0	NULL	0	NULL	0	NULL	CBS_Arg336Cys	21	21	43062344	G	A
3172	CBS	1060G>A	Val354Met	ENSG00000160200	21	43060526	NC_000021.9:43060526:C:T	ALE00003756	CCSBVarC003756	NULL	214532	NULL	GDEhDisVCh_40055	H08	CEGS2	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTCCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGATGGCGGTGGCCGTGAAGGCCGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG																																															chr21	G	A	21-43060526-G-A																																																																																																																																																																																																																																																																																																																																																																																																																																														CBS	ENSG00000160200	3172	214532	CCSBVarC003756	ALE00003756	1060G>A	Val354Met	CEGS2	CegsMutGDEh1041	D09	GDEhDisVCh_40055	H08	1	CegsMutGDDh1041	D09	NULL	NULL	NULL	NULL	NULL	NULL	1	5	1	1	0	NULL	0	NULL	0	NULL	CBS_Val354Met	21	21	43060526	C	T
7918	MSH2	1881A>C	Lys627Asn	ENSG00000095002	2	47475146	NC_000002.12:47475146:A:C	ALE00003014	CCSBVarC003014	NULL	202680	NULL	GDEhDisVCh_40060	F10	CEGS2	ATGGCGGTGCAGCCGAAGGAGACGCTGCAGTTGGAGAGCGCGGCCGAGGTCGGCTTCGTGCGCTTCTTTCAGGGCATGCCGGAGAAGCCGACCACCACAGTGCGCCTTTTCGACCGGGGCGACTTCTATACGGCGCACGGCGAGGACGCGCTGCTGGCCGCCCGGGAGGTGTTCAAGACCCAGGGGGTGATCAAGTACATGGGGCCGGCAGGAGCAAAGAATCTGCAGAGTGTTGTGCTTAGTAAAATGAATTTTGAATCTTTTGTAAAAGATCTTCTTCTGGTTCGTCAGTATAGAGTTGAAGTTTATAAGAATAGAGCTGGAAATAAGGCATCCAAGGAGAATGATTGGTATTTGGCATATAAGGCTTCTCCTGGCAATCTCTCTCAGTTTGAAGACATTCTCTTTGGTAACAATGATATGTCAGCTTCCATTGGTGTTGTGGGTGTTAAAATGTCCGCAGTTGATGGCCAGAGACAGGTTGGAGTTGGGTATGTGGATTCCATACAGAGGAAACTAGGACTGTGTGAATTCCCTGATAATGATCAGTTCTCCAATCTTGAGGCTCTCCTCATCCAGATTGGACCAAAGGAATGTGTTTTACCCGGAGGAGAGACTGCTGGAGACATGGGGAAACTGAGACAGATAATTCAAAGAGGAGGAATTCTGATCACAGAAAGAAAAAAAGCTGACTTTTCCACAAAAGACATTTATCAGGACCTCAACCGGTTGTTGAAAGGCAAAAAGGGAGAGCAGATGAATAGTGCTGTATTGCCAGAAATGGAGAATCAGGTTGCAGTTTCATCACTGTCTGCGGTAATCAAGTTTTTAGAACTCTTATCAGATGATTCCAACTTTGGACAGTTTGAACTGACTACTTTTGACTTCAGCCAGTATATGAAATTGGATATTGCAGCAGTCAGAGCCCTTAACCTTTTTCAGGGTTCTGTTGAAGATACCACTGGCTCTCAGTCTCTGGCTGCCTTGCTGAATAAGTGTAAAACCCCTCAAGGACAAAGACTTGTTAACCAGTGGATTAAGCAGCCTCTCATGGATAAGAACAGAATAGAGGAGAGATTGAATTTAGTGGAAGCTTTTGTAGAAGATGCAGAATTGAGGCAGACTTTACAAGAAGATTTACTTCGTCGATTCCCAGATCTTAACCGACTTGCCAAGAAGTTTCAAAGACAAGCAGCAAACTTACAAGATTGTTACCGACTCTATCAGGGTATAAATCAACTACCTAATGTTATACAGGCTCTGGAAAAACATGAAGGAAAACACCAGAAATTATTGTTGGCAGTTTTTGTGACTCCTCTTACTGATCTTCGTTCTGACTTCTCCAAGTTTCAGGAAATGATAGAAACAACTTTAGATATGGATCAGGTGGAAAACCATGAATTCCTTGTAAAACCTTCATTTGATCCTAATCTCAGTGAATTAAGAGAAATAATGAATGACTTGGAAAAGAAGATGCAGTCAACATTAATAAGTGCAGCCAGAGATCTTGGCTTGGACCCTGGCAAACAGATTAAACTGGATTCCAGTGCACAGTTTGGATATTACTTTCGTGTAACCTGTAAGGAAGAAAAAGTCCTTCGTAACAATAAAAACTTTAGTACTGTAGATATCCAGAAGAATGGTGTTAAATTTACCAACAGCAAATTGACTTCTTTAAATGAAGAGTATACCAAAAATAAAACAGAATATGAAGAAGCCCAGGATGCCATTGTTAAAGAAATTGTCAATATTTCTTCAGGCTATGTAGAACCAATGCAGACACTCAATGATGTGTTAGCTCAGCTAGATGCTGTTGTCAGCTTTGCTCACGTGTCAAATGGAGCACCTGTTCCATATGTACGACCAGCCATTTTGGAGAACGGACAAGGAAGAATTATATTAAAAGCATCCAGGCATGCTTGTGTTGAAGTTCAAGATGAAATTGCATTTATTCCTAATGACGTATACTTTGAAAAAGATAAACAGATGTTCCACATCATTACTGGCCCCAATATGGGAGGTAAATCAACATATATTCGACAAACTGGGGTGATAGTACTCATGGCCCAAATTGGGTGTTTTGTGCCATGTGAGTCAGCAGAAGTGTCCATTGTGGACTGCATCTTAGCCCGAGTAGGGGCTGGTGACAGTCAATTGAAAGGAGTCTCCACGTTCATGGCTGAAATGTTGGAAACTGCTTCTATCCTCAGGTCTGCAACCAAAGATTCATTAATAATCATAGATGAATTGGGAAGAGGAACTTCTACCTACGATGGATTTGGGTTAGCATGGGCTATATCAGAATACATTGCAACAAAGATTGGTGCTTTTTGCATGTTTGCAACCCATTTTCATGAACTTACTGCCTTGGCCAATCAGATACCAACTGTTAATAATCTACATGTCACAGCACTCACCACTGAAGAGACCTTAACTATGCTTTATCAGGTGAAGAAAGGTGTCTGTGATCAAAGTTTTGGGATTCATGTTGCAGAGCTTGCTAATTTCCCTAAGCATGTAATAGAGTGTGCTAAACAGAAAGCCCTGGAACTTGAGGAGTTTCAGTATATTGGAGAATCGCAAGGATATGATATCATGGAACCAGCAGCAAAGAAGTGCTATCTGGAAAGAGAGCAAGGTGAAAAAATTATTCAGGAGTTCCTGTCCAAGGTGAAACAAATGCCCTTTACTGAAATGTCAGAAGAAAACATCACAATAAAGTTAAAACAGCTAAAAGCTGAAGTAATAGCAAAGAATAATAGCTTTGTAAATGAAATCATTTCACGAATAAAAGTTACTACG	96285.0	single nucleotide variant	NM_000251.3(MSH2):c.1881A>C (p.Lys627Asn)	4436.0	MSH2	HGNC:7325	Uncertain significance	0.0	Dec 04, 2024	63750626.0	-	RCV005198145	MeSH:D003123,MedGen:C0009405	Hereditary nonpolyposis colorectal neoplasms	germline	germline	GRCh38	NC_000002.12	2	47475146.0	47475146.0	2p21	criteria provided, single submitter	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	-	2.0	3720338.0	47475146.0	A	C	-	-	-	-	-	-	SCV005834814	-	-	1881A>C 	Lys627Asn	NM_000251.3	1.0	4_VUS	chr2	A	C	2-47475146-A-C	6.84052e-7																																																																																																																																																																																																																																																																																																																																																																																																																																													MSH2	ENSG00000095002	7918	202680	CCSBVarC003014	ALE00003014	1881A>C	Lys627Asn	CEGS2	CegsMutGDEh1047	G03	GDEhDisVCh_40060	F10	2	CegsMutGDDh1047	G03	NULL	NULL	VUSMutpDEST2_07	D04	NULL	NULL	1	1	1	1	0	NULL	1	1	0	NULL	MSH2_Lys627Asn	2	2	47475146	A	C
14613	BRCA1	536A>G	Tyr179Cys	ENSG00000012048	17	43099786	NC_000017.11:43099786:T:C	ALE00002122	CCSBVarC002122	23622	NULL	NULL	GDEhDisVCh_40059	A12	RC4	ATGGATTTATCTGCTCTTCGCGTTGAAGAAGTACAAAATGTCATTAATGCTATGCAGAAAATCTTAGAGTGTCCCATCTGTCTGGAGTTGATCAAGGAACCTGTCTCCACAAAGTGTGACCACATATTTTGCAAATTTTGCATGCTGAAACTTCTCAACCAGAAGAAAGGGCCTTCACAGTGTCCTTTATGTAAGAATGATATAACCAAAAGGAGCCTACAAGAAAGTACGAGATTTAGTCAACTTGTTGAAGAGCTATTGAAAATCATTTGTGCTTTTCAGCTTGACACAGGTTTGGAGTATGCAAACAGCTATAATTTTGCAAAAAAGGAAAATAACTCTCCTGAACATCTAAAAGATGAAGTTTCTATCATCCAAAGTATGGGCTACAGAAACCGTGCCAAAAGACTTCTACAGAGTGAACCCGAAAATCCTTCCTTGCAGGAAACCAGTCTCAGTGTCCAACTCTCTAACCTTGGAACTGTGAGAACTCTGAGGACAAAGCAGCGGATACAACCTCAAAAGACGTCTGTCTGCATTGAATTGGGATCTGATTCTTCTGAAGATACCGTTAATAAGGCAACTTATTGCAGTGTGGGAGATCAAGAATTGTTACAAATCACCCCTCAAGGAACCAGGGATGAAATCAGTTTGGATTCTGCAAAAAAGGCTGCTTGTGAATTTTCTGAGACGGATGTAACAAATACTGAACATCATCAACCCAGTAATAATGATTTGAACACCACTGAGAAGCGTGCAGCTGAGAGGCATCCAGAAAAGTATCAGGGTGAAGCAGCATCTGGGTGTGAGAGTGAAACAAGCGTCTCTGAAGACTGCTCAGGGCTATCCTCTCAGAGTGACATTTTAACCACTCAGCAGAGGGATACCATGCAACATAACCTGATAAAGCTCCAGCAGGAAATGGCTGAACTAGAAGCTGTGTTAGAACAGCATGGGAGCCAGCCTTCTAACAGCTACCCTTCCATCATAAGTGACTCTTCTGCCCTTGAGGACCTGCGAAATCCAGAACAAAGCACATCAGAAAAAGTATTAACTTCACAGAAAAGTAGTGAATACCCTATAAGCCAGAATCCAGAAGGCCTTTCTGCTGACAAGTTTGAGGTGTCTGCAGATAGTTCTACCAGTAAAAATAAAGAACCAGGAGTGGAAAGGTCATCCCCTTCTAAATGCCCATCATTAGATGATAGGTGGTACATGCACAGTTGCTCTGGGAGTCTTCAGAATAGAAACTACCCATCTCAAGAGGAGCTCATTAAGGTTGTTGATGTGGAGGAGCAACAGCTGGAAGAGTCTGGGCCACACGATTTGACGGAAACATCTTACTTGCCAAGGCAAGATCTAGAGGGAACCCCTTACCTGGAATCTGGAATCAGCCTCTTCTCTGATGACCCTGAATCTGATCCTTCTGAAGACAGAGCCCCAGAGTCAGCTCGTGTTGGCAACATACCATCTTCAACCTCTGCATTGAAAGTTCCCCAATTGAAAGTTGCAGAATCTGCCCAGAGTCCAGCTGCTGCTCATACTACTGATACTGCTGGGTATAATGCAATGGAAGAAAGTGTGAGCAGGGAGAAGCCAGAATTGACAGCTTCAACAGAAAGGGTCAACAAAAGAATGTCCATGGTGGTGTCTGGCCTGACCCCAGAAGAATTTATGCTCGTGTACAAGTTTGCCAGAAAACACCACATCACTTTAACTAATCTAATTACTGAAGAGACTACTCATGTTGTTATGAAAACAGATGCTGAGTTTGTGTGTGAACGGACACTGAAATATTTTCTAGGAATTGCGGGAGGAAAATGGGTAGTTAGCTATTTCTGGGTGACCCAGTCTATTAAAGAAAGAAAAATGCTGAATGAGCATGATTTTGAAGTCAGAGGAGATGTGGTCAATGGAAGAAACCACCAAGGTCCAAAGCGAGCAAGAGAATCCCAGGACAGAAAGATCTTCAGGGGGCTAGAAATCTGTTGCTATGGGCCCTTCACCAACATGCCCACAGGGTGTCCACCCAATTGTGGTTGTGCAGCCAGATGCCTGGACAGAGGACAATGGCTTCCATGCAATTGGGCAGATGTG	46217.0	single nucleotide variant	NM_007294.4(BRCA1):c.536A>G (p.Tyr179Cys)	672.0	BRCA1	HGNC:1100	Benign	0.0	Aug 10, 2015	56187033.0	-	RCV000031242|RCV000162619|RCV000168482|RCV000167816|RCV001798034|RCV000656646|RCV001353554|RCV004802993	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN221562|MedGen:C3661900|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0700268,MedGen:CN377757	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|not provided|Malignant tumor of breast|BRCA1-related cancer predisposition	germline;unknown	germline	GRCh38	NC_000017.11	17	43099786.0	43099786.0	17q21.31	reviewed by expert panel	38.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00031,ClinGen:CA003536	2.0	37661.0	43099786.0	T	C	-	-	-	-	-	-	SCV000244401	-	-	536A>G 	Tyr179Cys	NM_007294.4	3.0	2_Benign	chr17	A	G	17-43099786-A-G		37661	17	43099786	T	C	Y	C	rs56187033	17	41251803	17	38505329	179	BRCA1	ENSG00000012048	ENST00000494123	ENSP00000419103	P38398	BRCA1_HUMAN	c.536A>G	p.Tyr179Cys	c.536A>G	p.Tyr179Cys	principal2	Y	1	.	.	-	TAC	2	0	T	T/T	T/T	T/T	T/T	0.0	0.91343	D	0.0	0.92967	D	0.999	0.90580	D	0.846	0.86259	P	.	0.59775	.	.	.	.	2.535	0.73728	M	-2.09	0.85723	N	.	0.90815	1.0614	0.98370	D	0.9373	0.97933	D	10	0.62496126	0.67910	D	0.878662	0.99072	D	0.754	0.91551	.	.	.	.	.	0.96293862096	0.96221	.	0.32379	.	0.45988	0.652622818947	0.60295	T	0.323428	0.69256	T	0.306192	0.83336	D	0.516305	0.94911	D	0.121282078325748	0.14370	T	.	0.62021	.	0.29764855	0.52360	0.21324788	0.45661	0.24526212	0.47154	0.22946356	0.47839	-3.004	0.14668	T	0.2119	0.46775	LB	0.883583179899125	0.74987	0.99932075	0.99296	0.259	0.52962	.	.	.	.	.	.	3.785718	0.54542	23.5	0.99814136649599927	0.89805	0.719490	0.66916	D	0.546903432674803	0.69735	5.422258	0.491088279802083	0.67221	5.078707	5.16	5.16	0.70523	.	.	3.356	0.52081	3.355000	0.37896	0.609	0.47831	1.0	0.71675	1.000000	0.68239	0.872	0.41571	470	0.78130	1	1.9968051118210862E-4	0	0.0	0	0.0	0	0.0	0	0.0	1	0.0010224948875255625	106	264690	4.0046847E-4	.	25	109408	2.285020e-04	0	52	208128	2.498460e-04	0	59	236926	2.490230e-04	0	1	7164	1.395870e-04	0	4	17112	2.337540e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	14	42768	3.273480e-04	0	5	15690	3.186740e-04	0	14	42768	3.273480e-04	0	1	16218	6.165990e-05	0	7	30524	2.293280e-04	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	33	89552	3.685010e-04	0	8	30608	2.613700e-04	0	33	89552	3.685010e-04	0	1	14902	6.710510e-05	0	10	34260	2.918860e-04	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	37	102726	3.601810e-04	0	8	30526	2.620720e-04	0	37	102726	3.601810e-04	0	.	542	1608112	3.370410e-04	8	112	6048	1.851850e-02	6	5	74878	6.677530e-05	0	0	912	0.000000e+00	0	25	60000	4.166670e-04	0	0	29562	0.000000e+00	0	1	44858	2.229260e-05	0	1	64030	1.561770e-05	0	112	6048	1.851850e-02	6	322	1174564	2.741440e-04	0	29	90962	3.188140e-04	2	84	184382	4.555759238971266E-4	0	360	0	0	4498	0	2	9428	2.1213406873143826E-4	1	794	0.0012594458438287153	1	966	0.0010351966873706005	0	1848	0	0	280	0	27	18114	0.0014905597880092746	2	9788	2.043318348998774E-4	0	6346	0	115	220670	5.211401640458604E-4	Benign	Breast_and/or_ovarian_cancer|not_specified|not_provided|Malignant_tumor_of_breast|Hereditary_cancer-predisposing_syndrome|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Hereditary_breast_ovarian_cancer_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43099786T>C	BRCA1-HCI:BRCA1_00031|ClinGen:CA003536	CN221562|CN169374|C3661900|C0006142|C0027672|C2676676|C0677776	604370	140162|145|145	.	Tyr	Cys	46217	single nucleotide variant	NM_007294.4(BRCA1):c.536A>G (p.Tyr179Cys)	672	BRCA1	HGNC:1100	Benign	0	Aug 10, 2015	56187033	-	RCV000031242|RCV000162619|RCV000168482|RCV000167816|RCV001798034|RCV000656646|RCV001353554|RCV004802993	MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MedGen:CN221562|MedGen:C3661900|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0700268,MedGen:CN377757	Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|Breast and/or ovarian cancer|not provided|Malignant tumor of breast|BRCA1-related cancer predisposition	germline;unknown	germline	GRCh38	NC_000017.11	17	43099786	43099786	17q21.31	reviewed by expert panel	38	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	BRCA1-HCI:BRCA1_00031,ClinGen:CA003536	2	37661	43099786	T	C	-	-	-	-	-	-	SCV000244401	-	-	536A>G 	Tyr179Cys	NM_007294.4	3	2_Benign	BRCA1	ENSG00000012048	14613	23622	CCSBVarC002122	ALE00002122	536A>G	Tyr179Cys	RC4	RC4_Mut_GDEh1029	D02	GDEhDisVCh_40059	A12	1	RC4_Mut_GDDh1029	D02	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	BRCA1_Tyr179Cys	17	17	43099786	T	C
359	CBS	1367T>C	Leu456Pro	ENSG00000160200	21	43058245	NC_000021.9:43058245:A:G	ALE00000045	CCSBVarC000045	1092	NULL	NULL	GDEhDisVCh_40013	A03	RC4	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCCGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	848811.0	single nucleotide variant	NM_000071.3(CBS):c.1367T>C (p.Leu456Pro)	875.0	CBS	HGNC:1550	Likely pathogenic	1.0	Feb 12, 2024	1981524462.0	-	RCV002240613|RCV004570272	MedGen:C3150344|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Classic homocystinuria	germline;unknown	germline	GRCh38	NC_000021.9	21	43058245.0	43058245.0	21q22.3	criteria provided, multiple submitters, no conflicts	2.0	-	N	ClinGen:CA410396812	2.0	858640.0	43058245.0	A	G	-	-	-	-	-	-	SCV001229460|SCV005060022	-	-	1367T>C 	Leu456Pro	NM_000071.3	2.0	1_Pathogenic	chr21	T	C	21-43058245-T-C		858640	21	43058245	A	G	L	P	rs1981524462	21	44478355	21	43351424	456	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.1367T>C	p.Leu456Pro	c.1367T>C	p.Leu456Pro	principal1	Y	1	.	.	-	CTG	2	0	A	A/A	A/A	A/A	A/A	0.033	0.44516	D	0.036	0.52410	D	0.999	0.77914	D	0.99	0.78943	D	1.0	0.99291	D	simple_aae	0.0	100.0	3.63	0.93919	H	-3.56	0.68915	D	0.984	0.99488	0.3390	0.88120	D	0.5563	0.83742	D	10	0.98772943	0.99147	D	0.557614	0.95941	D	0.933	0.98451	0.894	0.97491	P35520	L456P	Loss of stability (P = 0.0536)| Loss of sheet (P = 0.1398)| Gain of disorder (P = 0.4372)| Gain of loop (P = 0.4661)| Loss of helix (P = 0.4763)	0.921065995355	0.91966	.	0.95125	.	0.85737	0.721268773079	0.70181	T	0.905578	0.98161	D	0.513396	0.94655	D	0.499681	0.94576	D	0.984481182808392	0.75603	D	.	0.67517	.	0.9785669	0.98980	0.89779174	0.94747	0.97074586	0.98302	0.89544535	0.94579	-13.162	0.90040	D	0.6708	0.71711	LP	0.999475883998006	0.96705	0.99939823	0.99356	0.93	0.96535	.	.	.	.	.	.	5.323674	0.89371	30.0	0.99891271382117086	0.96515	0.981361	0.99871	D	0.521281743767708	0.68182	5.205022	0.500750533643951	0.67866	5.165637	4.62	4.62	0.56895	2.62	0.47948	8.838	0.91764	10.738000	0.83679	0.582	0.30226	1.0	0.71675	1.000000	0.68239	0.774	0.36708	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Classic_homocystinuria	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43058245A>G	.	C3150344|C0751202	236200	394	CBS domain|CBS domain|CBS domain|Cystathionine beta-synthase, C-terminal domain	Leu	Pro	848811	single nucleotide variant	NM_000071.3(CBS):c.1367T>C (p.Leu456Pro)	875	CBS	HGNC:1550	Likely pathogenic	1	Feb 12, 2024	1981524462	-	RCV002240613|RCV004570272	MedGen:C3150344|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394	HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Classic homocystinuria	germline;unknown	germline	GRCh38	NC_000021.9	21	43058245	43058245	21q22.3	criteria provided, multiple submitters, no conflicts	2	-	N	ClinGen:CA410396812	2	858640	43058245	A	G	-	-	-	-	-	-	SCV001229460|SCV005060022	-	-	1367T>C 	Leu456Pro	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	1092	CCSBVarC000045	ALE00000045	1367T>C	Leu456Pro	RC4	RC4_Mut_GDEh1026	H05	GDEhDisVCh_40013	A03	1	RC4_Mut_GDDh1026	H05	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	CBS_Leu456Pro	21	21	43058245	A	G
7918	MSH2	1571G>C	Arg524Pro	ENSG00000095002	2	47466718	NC_000002.12:47466718:G:C	ALE00003011	CCSBVarC003011	NULL	202671	NULL	GDEhDisVCh_40060	E10	CEGS2	ATGGCGGTGCAGCCGAAGGAGACGCTGCAGTTGGAGAGCGCGGCCGAGGTCGGCTTCGTGCGCTTCTTTCAGGGCATGCCGGAGAAGCCGACCACCACAGTGCGCCTTTTCGACCGGGGCGACTTCTATACGGCGCACGGCGAGGACGCGCTGCTGGCCGCCCGGGAGGTGTTCAAGACCCAGGGGGTGATCAAGTACATGGGGCCGGCAGGAGCAAAGAATCTGCAGAGTGTTGTGCTTAGTAAAATGAATTTTGAATCTTTTGTAAAAGATCTTCTTCTGGTTCGTCAGTATAGAGTTGAAGTTTATAAGAATAGAGCTGGAAATAAGGCATCCAAGGAGAATGATTGGTATTTGGCATATAAGGCTTCTCCTGGCAATCTCTCTCAGTTTGAAGACATTCTCTTTGGTAACAATGATATGTCAGCTTCCATTGGTGTTGTGGGTGTTAAAATGTCCGCAGTTGATGGCCAGAGACAGGTTGGAGTTGGGTATGTGGATTCCATACAGAGGAAACTAGGACTGTGTGAATTCCCTGATAATGATCAGTTCTCCAATCTTGAGGCTCTCCTCATCCAGATTGGACCAAAGGAATGTGTTTTACCCGGAGGAGAGACTGCTGGAGACATGGGGAAACTGAGACAGATAATTCAAAGAGGAGGAATTCTGATCACAGAAAGAAAAAAAGCTGACTTTTCCACAAAAGACATTTATCAGGACCTCAACCGGTTGTTGAAAGGCAAAAAGGGAGAGCAGATGAATAGTGCTGTATTGCCAGAAATGGAGAATCAGGTTGCAGTTTCATCACTGTCTGCGGTAATCAAGTTTTTAGAACTCTTATCAGATGATTCCAACTTTGGACAGTTTGAACTGACTACTTTTGACTTCAGCCAGTATATGAAATTGGATATTGCAGCAGTCAGAGCCCTTAACCTTTTTCAGGGTTCTGTTGAAGATACCACTGGCTCTCAGTCTCTGGCTGCCTTGCTGAATAAGTGTAAAACCCCTCAAGGACAAAGACTTGTTAACCAGTGGATTAAGCAGCCTCTCATGGATAAGAACAGAATAGAGGAGAGATTGAATTTAGTGGAAGCTTTTGTAGAAGATGCAGAATTGAGGCAGACTTTACAAGAAGATTTACTTCGTCGATTCCCAGATCTTAACCGACTTGCCAAGAAGTTTCAAAGACAAGCAGCAAACTTACAAGATTGTTACCGACTCTATCAGGGTATAAATCAACTACCTAATGTTATACAGGCTCTGGAAAAACATGAAGGAAAACACCAGAAATTATTGTTGGCAGTTTTTGTGACTCCTCTTACTGATCTTCGTTCTGACTTCTCCAAGTTTCAGGAAATGATAGAAACAACTTTAGATATGGATCAGGTGGAAAACCATGAATTCCTTGTAAAACCTTCATTTGATCCTAATCTCAGTGAATTAAGAGAAATAATGAATGACTTGGAAAAGAAGATGCAGTCAACATTAATAAGTGCAGCCAGAGATCTTGGCTTGGACCCTGGCAAACAGATTAAACTGGATTCCAGTGCACAGTTTGGATATTACTTTCCTGTAACCTGTAAGGAAGAAAAAGTCCTTCGTAACAATAAAAACTTTAGTACTGTAGATATCCAGAAGAATGGTGTTAAATTTACCAACAGCAAATTGACTTCTTTAAATGAAGAGTATACCAAAAATAAAACAGAATATGAAGAAGCCCAGGATGCCATTGTTAAAGAAATTGTCAATATTTCTTCAGGCTATGTAGAACCAATGCAGACACTCAATGATGTGTTAGCTCAGCTAGATGCTGTTGTCAGCTTTGCTCACGTGTCAAATGGAGCACCTGTTCCATATGTACGACCAGCCATTTTGGAGAAAGGACAAGGAAGAATTATATTAAAAGCATCCAGGCATGCTTGTGTTGAAGTTCAAGATGAAATTGCATTTATTCCTAATGACGTATACTTTGAAAAAGATAAACAGATGTTCCACATCATTACTGGCCCCAATATGGGAGGTAAATCAACATATATTCGACAAACTGGGGTGATAGTACTCATGGCCCAAATTGGGTGTTTTGTGCCATGTGAGTCAGCAGAAGTGTCCATTGTGGACTGCATCTTAGCCCGAGTAGGGGCTGGTGACAGTCAATTGAAAGGAGTCTCCACGTTCATGGCTGAAATGTTGGAAACTGCTTCTATCCTCAGGTCTGCAACCAAAGATTCATTAATAATCATAGATGAATTGGGAAGAGGAACTTCTACCTACGATGGATTTGGGTTAGCATGGGCTATATCAGAATACATTGCAACAAAGATTGGTGCTTTTTGCATGTTTGCAACCCATTTTCATGAACTTACTGCCTTGGCCAATCAGATACCAACTGTTAATAATCTACATGTCACAGCACTCACCACTGAAGAGACCTTAACTATGCTTTATCAGGTGAAGAAAGGTGTCTGTGATCAAAGTTTTGGGATTCATGTTGCAGAGCTTGCTAATTTCCCTAAGCATGTAATAGAGTGTGCTAAACAGAAAGCCCTGGAACTTGAGGAGTTTCAGTATATTGGAGAATCGCAAGGATATGATATCATGGAACCAGCAGCAAAGAAGTGCTATCTGGAAAGAGAGCAAGGTGAAAAAATTATTCAGGAGTTCCTGTCCAAGGTGAAACAAATGCCCTTTACTGAAATGTCAGAAGAAAACATCACAATAAAGTTAAAACAGCTAAAAGCTGAAGTAATAGCAAAGAATAATAGCTTTGTAAATGAAATCATTTCACGAATAAAAGTTACTACG	16798.0	single nucleotide variant	NM_000251.3(MSH2):c.1571G>C (p.Arg524Pro)	4436.0	MSH2	HGNC:7325	Likely pathogenic	1.0	Jun 21, 2019	63751207.0	-	RCV000001829|RCV000076197|RCV000165648|RCV000256140|RCV000531855|RCV001251063	MONDO:MONDO:0007356,MedGen:C2936783,OMIM:120435,Orphanet:144|MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MeSH:D003123,MedGen:C0009405|MONDO:MONDO:0018630,MedGen:C1333990,OMIM:PS120435,Orphanet:443909	Lynch syndrome 1|Lynch syndrome|Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colorectal neoplasms|Hereditary nonpolyposis colon cancer	germline;unknown	germline	GRCh38	NC_000002.12	2	47466718.0	47466718.0	2p21	reviewed by expert panel	11.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA018643,UniProtKB:P43246#VAR_004479,OMIM:609309.0007	3.0	1759.0	47466718.0	G	C	-	-	-	-	-	-	SCV000107214	-	-	1571G>C 	Arg524Pro	NM_000251.3	3.0	1_Pathogenic	chr2	G	C	2-47466718-G-C		1759	2	47466718	G	C	R	P	rs63751207	2	47693857	2	47547361	524	MSH2	ENSG00000095002	ENST00000233146	ENSP00000233146	P43246	MSH2_HUMAN	c.1571G>C	p.Arg524Pro	c.1571G>C	p.Arg524Pro	principal1	Y	1	YES	Select	+	CGT	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.002	0.79703	D	1.0	0.90580	D	0.999	0.92348	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.295	0.90281	M	-6.86	0.93155	D	0.987	0.99730	0.9878	0.96978	D	0.8806	0.96028	D	10	0.97912604	0.97797	D	0.388943	0.93130	D	0.943	0.98815	0.864	0.95972	P43246	R524P	Loss of catalytic residue at R524 (P = 0.0336)| Loss of MoRF binding (P = 0.0622)| Gain of ubiquitination at K528 (P = 0.0645)| Gain of phosphorylation at Y522 (P = 0.1676)| Loss of stability (P = 0.171)	0.985113603301	0.98479	0.9100355394594808	0.90920	0.030626927755	0.03064	0.655993163586	0.60774	T	0.846712	0.96445	D	0.495147	0.94103	D	0.473468	0.94026	D	0.994119167327881	0.85104	D	0.970603	0.90586	D	0.9934161	0.99913	0.9759951	0.99693	0.99292386	0.99895	0.97606224	0.99695	-19.988	0.99930	D	0.9996	0.99217	P	0.999820610910913	0.98179	0.99997234	0.99978	0.966	0.98629	.	.	.	.	.	.	5.690283	0.93063	33.0	0.99732422381883812	0.82920	0.948632	0.96031	D	0.925852733645019	0.92929	11.73861	0.860308242076328	0.93568	12.15379	6.04	5.17	0.70808	3.05	0.55714	9.061	0.9336	11.703000	0.94538	0.672	0.70176	1.0	0.71675	1.000000	0.68239	1.0	0.97202	934	0.15398	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Lynch_syndrome_1|Hereditary_cancer-predisposing_syndrome|Lynch_syndrome|Hereditary_nonpolyposis_colon_cancer|Hereditary_nonpolyposis_colorectal_neoplasms|not_provided	reviewed_by_expert_panel	NC_000002.12:g.47466718G>C	ClinGen:CA018643|OMIM:609309.0007|UniProtKB:P43246#VAR_004479	C2936783|C0027672|C4552100|C1333990|C0009405|C3661900	120435|PS120435	144|140162|144|443909	DNA mismatch repair protein MutS, clamp|DNA mismatch repair protein MutS, core|DNA mismatch repair protein MutS, core	Arg	Pro	16798	single nucleotide variant	NM_000251.3(MSH2):c.1571G>C (p.Arg524Pro)	4436	MSH2	HGNC:7325	Likely pathogenic	1	Jun 21, 2019	63751207	-	RCV000001829|RCV000076197|RCV000165648|RCV000256140|RCV000531855|RCV001251063	MONDO:MONDO:0007356,MedGen:C2936783,OMIM:120435,Orphanet:144|MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:C3661900|MeSH:D003123,MedGen:C0009405|MONDO:MONDO:0018630,MedGen:C1333990,OMIM:PS120435,Orphanet:443909	Lynch syndrome 1|Lynch syndrome|Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colorectal neoplasms|Hereditary nonpolyposis colon cancer	germline;unknown	germline	GRCh38	NC_000002.12	2	47466718	47466718	2p21	reviewed by expert panel	11	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA018643,UniProtKB:P43246#VAR_004479,OMIM:609309.0007	3	1759	47466718	G	C	-	-	-	-	-	-	SCV000107214	-	-	1571G>C 	Arg524Pro	NM_000251.3	3	1_Pathogenic	MSH2	ENSG00000095002	7918	202671	CCSBVarC003011	ALE00003011	1571G>C	Arg524Pro	CEGS2	CegsMutGDEh1047	C02	GDEhDisVCh_40060	E10	2	CegsMutGDDh1047	C02	NULL	NULL	VUSMutpDEST2_07	A04	NULL	NULL	1	1	1	1	0	NULL	1	1	0	NULL	MSH2_Arg524Pro	2	2	47466718	G	C
2803	HMBS	296A>G	Asp99Gly	ENSG00000256269	11	119089712	NC_000011.10:119089712:A:G	ALE00000330	CCSBVarC000330	4838	NULL	NULL	GDEhDisVCh_40054	D11	RC4	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAGCTTGCTCGCATACAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGGACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCTTGAACATGCCCTGGAGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGGCCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCGAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTCGGGGAAACCTCAACACCCGGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACCGGGTGGGGCAGATCCTGCACCCTGAGGAATGCATGTATGCTGTGGGCCAGGGGGCCTTGGGCGTGGAAGTGCGAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCTGCATCGCTGAAAGGGCCTTCCTGAGGCACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATGGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCGTAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACGATGCCCAT																																															chr11	A	G	11-119089712-A-G																																																																																																																																																																																																																																																																																																																																																																																																																																														HMBS	ENSG00000256269	2803	4838	CCSBVarC000330	ALE00000330	296A>G	Asp99Gly	RC4	RC4_Mut_GDEh1018	D04	GDEhDisVCh_40054	D11	2	RC4_Mut_GDDh1018	D04	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	HMBS_Asp99Gly	11	11	119089712	A	G
71569	OTC	416T>C	Leu139Ser	ENSG00000036473	X	38401304	NC_000023.11:38401304:T:C	ALE00005240	CCSBVarC005240	NULL	205886	NULL	GDEhDisVCh_40048	B03	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATCGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103087.0	single nucleotide variant	NM_000531.6(OTC):c.416T>C (p.Leu139Ser)	5009.0	OTC	HGNC:8512	Pathogenic	1.0	Aug 30, 2024	72556259.0	-	RCV000083430|RCV003509490	MedGen:C3661900|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664	not provided|Ornithine carbamoyltransferase deficiency	germline;unknown	germline	GRCh38	NC_000023.11	X	38401304.0	38401304.0	Xp11.4	criteria provided, multiple submitters, no conflicts	3.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224594,UniProtKB:P00480#VAR_004877	2.0	97195.0	38401304.0	T	C	-	-	-	-	-	-	SCV004299809|SCV005874589	-	-	416T>C 	Leu139Ser	NM_000531.6	2.0	1_Pathogenic	chrX	T	C	X-38401304-T-C		97195	X	38401304	T	C	L	S	rs72556259	X	38260557	X	38145501	139	OTC	ENSG00000036473	ENST00000713758	ENSP00000519059	P00480	OTC_HUMAN	.	.	c.416T>C	p.Leu139Ser	principal1	Y	.	.	.	+	TTG	2	0	T	T/T	T/T	T/T	T/T	.	0.78662	.	.	0.83643	.	1.0	0.90580	D	1.0	0.97365	D	.	0.94956	.	.	.	.	1.49	0.37143	L	.	0.80288	.	.	0.94916	1.1069	0.99838	D	0.9590	0.98674	D	10	.	0.99886	.	0.922517	0.99430	D	.	0.98743	0.934	0.99013	P00480	L139S	Gain of disorder (P = 0.0134)| Gain of phosphorylation at L139 (P = 0.0635)| Gain of catalytic residue at R141 (P = 0.1132)| Gain of sheet (P = 0.1539)| Loss of stability (P = 0.2368)	.	0.99514	.	0.98582	.	0.80981	0.695479333401	0.66436	T	0.948058	0.99222	D	0.662117	0.99897	D	0.713309	0.99896	D	0.997256696224213	0.91050	D	.	0.59150	.	0.96937907	0.98172	0.9524505	0.98523	0.96937907	0.98172	0.9524505	0.98523	-9.316	0.69786	D	.	0.86647	.	0.999510780359312	0.96835	0.99860280	0.98864	0.995	0.99826	.	.	.	.	.	.	4.54037	0.71417	25.7	0.99885873711108686	0.96129	.	.	.	.	.	.	.	.	.	5.97	5.97	0.96929	5.17	0.91630	7.628	0.82424	7.798000	0.69116	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.989	0.64309	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Ornithine_carbamoyltransferase_deficiency|not_provided	criteria_provided,_single_submitter	NC_000023.11:g.38401304T>C	ClinGen:CA224594|UniProtKB:P00480#VAR_004877	C0268542|C3661900	311250	664	Aspartate/ornithine carbamoyltransferase, carbamoyl-P binding	Leu	Ser	103087	single nucleotide variant	NM_000531.6(OTC):c.416T>C (p.Leu139Ser)	5009	OTC	HGNC:8512	Pathogenic	1	Aug 30, 2024	72556259	-	RCV000083430|RCV003509490	MedGen:C3661900|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664	not provided|Ornithine carbamoyltransferase deficiency	germline;unknown	germline	GRCh38	NC_000023.11	X	38401304	38401304	Xp11.4	criteria provided, multiple submitters, no conflicts	3	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224594,UniProtKB:P00480#VAR_004877	2	97195	38401304	T	C	-	-	-	-	-	-	SCV004299809|SCV005874589	-	-	416T>C 	Leu139Ser	NM_000531.6	2	1_Pathogenic	OTC	ENSG00000036473	71569	205886	CCSBVarC005240	ALE00005240	416T>C	Leu139Ser	CEGS2	CegsMutGDEh1016	F07	GDEhDisVCh_40048	B03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Leu139Ser	23	X	38401304	T	C
2013	KCNE1	163G>A	Gly55Ser	ENSG00000180509	21	34449472	NC_000021.9:34449472:C:T	ALE00006336	CCSBVarC006336	NULL	214140	NULL	GDEhDisVCh_40065	A05	CEGS2	ATGATCCTGTCTAACACCACAGCGGTGACGCCCTTTCTGACCAAGCTGTGGCAGGAGACAGTTCAGCAGGGTGGCAACATGTCGGGCCTGGCCCACAGGTCCCCCCGCAGCGGTGACGGCAAGCTGGAGGCCCTCTACGTCCTCATGGTACTGGGATTCTTCAGCTTCTTCACCCTGGGCATCATGCTGAGCTACATCCGCTCCAAGAAGCTGGAGCACTCGAACGACCCATTCAACGTCTACATCGAGTCCGATGCCTGGCAAGAGAAGGACAAGGCCTATGTCCAGGCCCGGGTCCTGGAGAGCTACAGGTCG	136405.0	single nucleotide variant	NM_000219.6(KCNE1):c.163G>A (p.Gly55Ser)	3753.0	KCNE1	HGNC:6240	Conflicting classifications of pathogenicity	0.0	Oct 31, 2024	199473644.0	-	RCV000119069|RCV000150858|RCV000463748|RCV000786139|RCV002399485|RCV004777582|RCV002477299	MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:101016,Orphanet:768|MedGen:CN169374|MONDO:MONDO:0002442,MeSH:D008133,MedGen:C0023976|MedGen:C3661900|MedGen:CN230736|MONDO:MONDO:0013372,MedGen:C1867904,OMIM:613695,Orphanet:101016,Orphanet:768|MONDO:MONDO:0012871,MedGen:C2676723,OMIM:612347,Orphanet:768,Orphanet:90647;MONDO:MONDO:0013372,MedGen:C1867904,OMIM:613695,Orphanet:101016,Orphanet:768	Congenital long QT syndrome|not specified|Long QT syndrome|not provided|Cardiovascular phenotype|Long QT syndrome 5|Jervell and Lange-Nielsen syndrome 2;Long QT syndrome 5	germline;not applicable;unknown	germline	GRCh38	NC_000021.9	21	34449472.0	34449472.0	21q22.12	criteria provided, conflicting classifications	8.0	-	N	ClinGen:CA176429,UniProtKB:P15382#VAR_074913	2.0	132657.0	34449472.0	C	T	-	-	-	-	-	-	SCV000198416|SCV000549147|SCV001769652|SCV002704558|SCV002785867	-	-	163G>A 	Gly55Ser	NM_000219.6	1.0	3_Conflicting	chr21	G	A	21-34449472-G-A		132657	21	34449472	C	T	G	S	rs199473644	21	35821770	21	34743640	55	KCNE1	ENSG00000180509	ENST00000621601	ENSP00000483895	P15382	KCNE1_HUMAN	c.163G>A	p.Gly55Ser	c.163G>A	p.Gly55Ser	principal1	Y	4	.	.	-	GGC	1	0	C	C/C	C/C	C/C	C/C	.	0.15441	.	0.27	0.22634	T	0.979	0.59057	D	0.784	0.57451	P	.	0.99291	.	.	.	.	2.75	0.80203	M	.	0.51010	.	0.431	0.72350	0.7217	0.93421	D	0.8601	0.95333	D	10	0.30607948	0.47740	D	0.157289	0.83746	D	.	0.88629	0.342	0.33324	P15382	G55S	Gain of catalytic residue at G55 (P = 0.1848)| Gain of MoRF binding (P = 0.3431)| Loss of helix (P = 0.3949)| Loss of sheet (P = 0.5184)| Loss of stability (P = 0.5657)	0.929391321752	0.92812	.	0.63791	.	0.30751	0.469049274921	0.34504	T	0.808996	0.95167	D	0.126494	0.66781	D	0.286655	0.87390	D	0.413275688886642	0.29132	T	.	0.38823	.	0.1235934	0.28764	0.18165056	0.40903	0.16956283	0.37179	0.16433854	0.37953	-2.935	0.09508	T	.	0.37308	.	0.310496437982564	0.54611	0.99823110	0.98689	0.216	0.48172	.	.	.	.	.	.	3.181006	0.43265	21.7	0.99838209855543592	0.91892	0.682322	0.64410	D	0.343176938918012	0.58166	4.009876	0.335387827711348	0.57407	3.929649	5.16	5.16	0.70523	1.86	0.38060	3.103	0.50086	4.783000	0.44925	0.549	0.27038	0.995	0.38864	1.000000	0.68239	0.498	0.2902	899	0.25042	2	3.9936102236421724E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	1	0.0010224948875255625	.	.	.	.	20	109406	1.828050e-04	0	31	208074	1.489850e-04	0	28	236934	1.181760e-04	0	2	7164	2.791740e-04	0	1	17112	5.843850e-05	0	0	2320	0.000000e+00	0	3	9046	3.316380e-04	0	0	13392	0.000000e+00	0	2	42768	4.676390e-05	0	11	15690	7.010830e-04	0	11	15690	7.010830e-04	0	3	16218	1.849800e-04	0	2	30524	6.552220e-05	0	1	6210	1.610310e-04	0	3	13416	2.236140e-04	0	0	16732	0.000000e+00	0	5	89504	5.586340e-05	0	16	30608	5.227390e-04	0	16	30608	5.227390e-04	0	3	14902	2.013150e-04	0	2	34260	5.837710e-05	0	1	9570	1.044930e-04	0	3	17692	1.695680e-04	0	0	21630	0.000000e+00	0	3	102734	2.920160e-05	0	15	30526	4.913840e-04	0	15	30526	4.913840e-04	0	.	74	1202928	6.151660e-05	4	34	79370	4.283730e-04	2	6	51692	1.160720e-04	0	0	562	0.000000e+00	0	2	52130	3.836560e-05	0	1	25646	3.899240e-05	0	3	39180	7.656970e-05	0	0	58914	0.000000e+00	0	0	5340	0.000000e+00	0	27	840560	3.212140e-05	2	34	79370	4.283730e-04	2	2	36802	5.4344872561273845E-5	0	116	0	1	144	0.006944444444444444	0	3322	0	0	500	0	0	628	0	0	54	0	0	100	0	1	7144	1.3997760358342665E-4	0	3438	0	1	198	0.005050505050505051	4	48810	8.195041999590248E-5	Conflicting_classifications_of_pathogenicity	Congenital_long_QT_syndrome|Jervell_and_Lange-Nielsen_syndrome_2|Long_QT_syndrome_5|Cardiovascular_phenotype|not_specified|not_provided|Long_QT_syndrome	criteria_provided,_conflicting_classifications	NC_000021.9:g.34449472C>T	ClinGen:CA176429|UniProtKB:P15382#VAR_074913	C1141890|C2676723|C1867904|CN230736|CN169374|C3661900|C0023976	PS192500|612347|613695	101016|768|768|90647|101016|768	.	Gly	Ser	136405	single nucleotide variant	NM_000219.6(KCNE1):c.163G>A (p.Gly55Ser)	3753	KCNE1	HGNC:6240	Conflicting classifications of pathogenicity	0	Oct 31, 2024	199473644	-	RCV000119069|RCV000150858|RCV000463748|RCV000786139|RCV002399485|RCV004777582|RCV002477299	MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:101016,Orphanet:768|MedGen:CN169374|MONDO:MONDO:0002442,MeSH:D008133,MedGen:C0023976|MedGen:C3661900|MedGen:CN230736|MONDO:MONDO:0013372,MedGen:C1867904,OMIM:613695,Orphanet:101016,Orphanet:768|MONDO:MONDO:0012871,MedGen:C2676723,OMIM:612347,Orphanet:768,Orphanet:90647;MONDO:MONDO:0013372,MedGen:C1867904,OMIM:613695,Orphanet:101016,Orphanet:768	Congenital long QT syndrome|not specified|Long QT syndrome|not provided|Cardiovascular phenotype|Long QT syndrome 5|Jervell and Lange-Nielsen syndrome 2;Long QT syndrome 5	germline;not applicable;unknown	germline	GRCh38	NC_000021.9	21	34449472	34449472	21q22.12	criteria provided, conflicting classifications	8	-	N	ClinGen:CA176429,UniProtKB:P15382#VAR_074913	2	132657	34449472	C	T	-	-	-	-	-	-	SCV000198416|SCV000549147|SCV001769652|SCV002704558|SCV002785867	-	-	163G>A 	Gly55Ser	NM_000219.6	1	3_Conflicting	KCNE1	ENSG00000180509	2013	214140	CCSBVarC006336	ALE00006336	163G>A	Gly55Ser	CEGS2	CegsMutGDEh1013	D09	GDEhDisVCh_40065	A05	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	KCNE1_Gly55Ser	21	21	34449472	C	T
2803	HMBS	446G>A	Arg149Gln	ENSG00000256269	11	119090213	NC_000011.10:119090213:G:A	ALE00005163	CCSBVarC005163	NULL	200930	NULL	GDEhDisVCh_40054	E03	CEGS2	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAGCTTGCTCGCATACAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGGACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCTTGAACATGCCCTGGAGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCAAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTCGGGGAAACCTCAACACCCGGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACCGGGTGGGGCAGATCCTGCACCCTGAGGAATGCATGTATGCTGTGGGCCAGGGGGCCTTGGGCGTGGAAGTGCGAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCTGCATCGCTGAAAGGGCCTTCCTGAGGCACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATGGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCGTAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACGATGCCCAT	16488.0	single nucleotide variant	NM_000190.4(HMBS):c.446G>A (p.Arg149Gln)	3145.0	HMBS	HGNC:4982	Pathogenic	1.0	Oct 08, 1999	118204098.0	-	RCV000001514	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276	Acute intermittent porphyria	germline	germline	GRCh38	NC_000011.10	11	119090213.0	119090213.0	11q23.3	no assertion criteria provided	1.0	-	N	ClinGen:CA251802,UniProtKB:P08397#VAR_003650,OMIM:609806.0008	1.0	1449.0	119090213.0	G	A	-	-	-	-	-	-	SCV000021669	-	-	446G>A 	Arg149Gln	NM_000190.4		1_Pathogenic	chr11	G	A	11-119090213-G-A		1449	11	119090213	G	A	R	Q	rs118204098	11	118960923	11	118466133	149	HMBS	ENSG00000256269	ENST00000652429	ENSP00000498786	P08397	HEM3_HUMAN	c.446G>A	p.Arg149Gln	c.446G>A	p.Arg149Gln	principal2	Y	.	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	0.999	0.92348	D	.	0.97926	.	.	.	.	4.125	0.97400	H	.	0.71557	.	.	0.99617	0.9258	0.96030	D	0.9979	0.99947	D	9	.	0.99875	.	0.665105	0.97189	D	.	0.99285	0.987	0.99867	P08397	R149Q	Loss of MoRF binding (P = 0.0216)| Loss of methylation at R149 (P = 0.0499)| Loss of phosphorylation at S147 (P = 0.0769)| Loss of catalytic residue at R149 (P = 0.0953)| Loss of helix (P = 0.1299)	.	0.98849	0.9004548517599092	0.89954	.	.	0.620476007462	0.55731	T	0.996618	0.99995	D	0.592801	0.97349	D	0.613741	0.97307	D	0.999856233596802	0.99358	D	0.999654	0.99880	D	0.9785351	0.98978	0.9302809	0.97072	0.98125356	0.99190	0.94504	0.98064	-15.339	0.96604	D	0.9908	0.93839	P	0.999550081799675	0.96973	0.39844300	0.79549	0.995	0.99826	.	.	.	.	.	.	5.851943	0.93829	33.0	0.99954113174828796	0.99963	0.953544	0.96982	D	1.19462742128387	0.99497	23.23098	1.09238016298993	0.99747	26.2228	6.11	6.11	0.99131	6.13	0.98113	9.647	0.97855	11.799000	0.96601	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.84	0.39676	228	0.91137	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	78	0	0	0	0	0	34	0	0	434	0	0	0	0	0	0	0	0	0	0	0	6	0	0	108	0	0	434	0	0	34	0	0	660	0	Pathogenic	Acute_intermittent_porphyria	no_assertion_criteria_provided	NC_000011.10:g.119090213G>A	ClinGen:CA251802|OMIM:609806.0008|UniProtKB:P08397#VAR_003650	C0162565	176000	79276	Porphobilinogen deaminase, N-terminal	Arg	Gln	16488	single nucleotide variant	NM_000190.4(HMBS):c.446G>A (p.Arg149Gln)	3145	HMBS	HGNC:4982	Pathogenic	1	Oct 08, 1999	118204098	-	RCV000001514	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276	Acute intermittent porphyria	germline	germline	GRCh38	NC_000011.10	11	119090213	119090213	11q23.3	no assertion criteria provided	1	-	N	ClinGen:CA251802,UniProtKB:P08397#VAR_003650,OMIM:609806.0008	1	1449	119090213	G	A	-	-	-	-	-	-	SCV000021669	-	-	446G>A 	Arg149Gln	NM_000190.4		1_Pathogenic	HMBS	ENSG00000256269	2803	200930	CCSBVarC005163	ALE00005163	446G>A	Arg149Gln	CEGS2	CegsMutGDEh1037	B04	GDEhDisVCh_40054	E03	2	CegsMutGDDh1037	B04	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	2	0	NULL	0	NULL	0	NULL	HMBS_Arg149Gln	11	11	119090213	G	A
359	CBS	346G>A	Gly116Arg	ENSG00000160200	21	43066348	NC_000021.9:43066348:C:T	ALE00007338	CCSBVarC007349	NULL	NULL	308	GDEhDisVCh_40013	B10	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCAGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	187060.0	single nucleotide variant	NM_000071.3(CBS):c.346G>A (p.Gly116Arg)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Oct 31, 2024	760214620.0	-	RCV000169116|RCV001844063|RCV002228606	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344	Classic homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;unknown	germline	GRCh38	NC_000021.9	21	43066348.0	43066348.0	21q22.3	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA273957,UniProtKB:P35520#VAR_008053	2.0	188787.0	43066348.0	C	T	-	-	-	-	-	-	SCV000220318|SCV001580706|SCV002104117|SCV004215530	-	-	346G>A 	Gly116Arg	NM_000071.3	2.0	1_Pathogenic	chr21	G	A	21-43066348-G-A		188787	21	43066348	C	T	G	R	rs760214620	21	44486458	21	43359527	116	CBS	ENSG00000160200	ENST00000352178	ENSP00000344460	P35520	CBS_HUMAN	c.346G>A	p.Gly116Arg	c.346G>A	p.Gly116Arg	principal1	Y	1	.	.	-	GGG	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.885	0.95950	H	-7.95	0.96333	D	0.998	0.99987	1.0827	0.98968	D	0.9741	0.99188	D	10	0.99000096	0.99481	D	0.819931	0.98596	D	0.985	0.99930	0.96	0.99581	P35520	G116R	Gain of MoRF binding (P = 0.0239)| Gain of methylation at G116 (P = 0.0383)| Loss of catalytic residue at S117 (P = 0.0974)| Loss of ubiquitination at K119 (P = 0.1327)| Gain of disorder (P = 0.1584)	0.942902866382	0.94185	.	0.97150	.	0.81268	0.767123699188	0.76953	T	0.988878	0.99945	D	0.563512	0.96271	D	0.571669	0.96211	D	0.999860286712646	0.99413	D	0.993326	0.97839	D	0.9465351	0.95849	0.88035583	0.93499	0.95022994	0.96231	0.8861821	0.93915	-10.182	0.75071	D	0.9567	0.87630	P	0.999978075997301	0.99427	0.99987140	0.99835	0.997	0.99892	.	.	.	.	.	.	6.161688	0.94706	34.0	0.99934706336345425	0.99535	0.909921	0.86669	D	0.960523549935893	0.94363	12.72409	0.879145703914122	0.94569	12.88757	5.36	5.36	0.76590	3.11	0.56638	6.845	0.75251	7.399000	0.58628	0.524	0.24207	1.0	0.71675	1.000000	0.68239	0.972	0.54981	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109242	0.000000e+00	0	1	207764	4.813150e-06	0	1	236650	4.225650e-06	0	0	7164	0.000000e+00	0	0	17104	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13240	0.000000e+00	0	0	42766	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16202	0.000000e+00	0	1	30514	3.277180e-05	0	0	6210	0.000000e+00	0	0	13402	0.000000e+00	0	0	16580	0.000000e+00	0	0	89388	0.000000e+00	0	0	30608	0.000000e+00	0	1	30514	3.277180e-05	0	0	14900	0.000000e+00	0	1	34244	2.920220e-05	0	0	9564	0.000000e+00	0	0	17690	0.000000e+00	0	0	21478	0.000000e+00	0	0	102628	0.000000e+00	0	0	30526	0.000000e+00	0	1	34244	2.920220e-05	0	.	6	832052	7.211090e-06	1	3	46350	6.472490e-05	1	0	22788	0.000000e+00	0	0	464	0.000000e+00	0	3	46350	6.472490e-05	1	0	20748	0.000000e+00	0	1	39016	2.563050e-05	0	0	37886	0.000000e+00	0	0	2916	0.000000e+00	0	2	556292	3.595230e-06	0	0	68494	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Classic_homocystinuria|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Homocystinuria	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43066348C>T	ClinGen:CA273957|UniProtKB:P35520#VAR_008053	C0751202|C3150344|C0019880	236200	394	Tryptophan synthase beta chain-like, PALP domain|Cysteine synthase/cystathionine beta-synthase, pyridoxal-phosphate attachment site	Gly	Arg	187060	single nucleotide variant	NM_000071.3(CBS):c.346G>A (p.Gly116Arg)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Oct 31, 2024	760214620	-	RCV000169116|RCV001844063|RCV002228606	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880|MedGen:C3150344	Classic homocystinuria|Homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;unknown	germline	GRCh38	NC_000021.9	21	43066348	43066348	21q22.3	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA273957,UniProtKB:P35520#VAR_008053	2	188787	43066348	C	T	-	-	-	-	-	-	SCV000220318|SCV001580706|SCV002104117|SCV004215530	-	-	346G>A 	Gly116Arg	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	308	CCSBVarC007349	ALE00007338	346G>A	Gly116Arg	Edgotyping3	VUSMutGDEh011	H04	GDEhDisVCh_40013	B10	1	VUSMutGDDh011	H04	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	5	0	NULL	0	NULL	0	NULL	CBS_Gly116Arg	21	21	43066348	C	T
359	CBS	52C>T	Arg18Cys	ENSG00000160200	21	43072142	NC_000021.9:43072142:G:A	ALE00007355	CCSBVarC007367	NULL	NULL	328	GDEhDisVCh_40013	D12	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACTGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	259103.0	single nucleotide variant	NM_000071.3(CBS):c.52C>T (p.Arg18Cys)	875.0	CBS	HGNC:1550	Benign/Likely benign	0.0	Jan 23, 2025	201827340.0	-	RCV000359251|RCV000466468|RCV001722372|RCV002310871|RCV002229712	MedGen:CN169374|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3661900|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:C3150344	not specified|Classic homocystinuria|not provided|Familial thoracic aortic aneurysm and aortic dissection|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;unknown	germline	GRCh38	NC_000021.9	21	43072142.0	43072142.0	21q22.3	criteria provided, multiple submitters, no conflicts	9.0	-	N	ClinGen:CA10587951,UniProtKB:P35520#VAR_046921	2.0	263858.0	43072142.0	G	A	-	-	-	-	-	-	SCV000319320|SCV000340481|SCV000512491|SCV000555946|SCV000803571|SCV001298526	-	-	52C>T 	Arg18Cys	NM_000071.3	2.0	2_Benign	chr21	C	T	21-43072142-C-T		263858	21	43072142	G	A	R	C	rs201827340	21	44492252	21	43365321	18	CBS	ENSG00000160200	ENST00000352178	ENSP00000344460	P35520	CBS_HUMAN	c.52C>T	p.Arg18Cys	c.52C>T	p.Arg18Cys	principal1	Y	1	.	.	-	CGC	1	0	G	G/G	G/G	G/G	G/G	0.069	0.37063	T	0.074	0.43323	T	0.453	0.36148	P	0.115	0.31846	B	0.0	0.01751	N	simple_aae	100.0	0.0	0.695	0.17891	N	-0.31	0.13928	N	0.155	0.16216	0.7043	0.93205	D	0.8718	0.95730	D	10	0.0056720674	0.00124	T	.	.	.	0.231	0.52992	.	.	.	.	.	0.578198000816	0.57171	.	0.28978	.	0.56053	0.305001705885	0.11144	T	0.376337	0.73801	T	-0.273226	0.11157	T	-0.155851	0.58434	T	0.00999543690811698	0.00132	T	0.69743	0.32212	T	0.12776664	0.29629	0.043931026	0.05593	0.21342921	0.43398	0.04293284	0.05242	-2.865	0.08808	T	0.0829	0.09720	B	0.0764962308523673	0.40913	0.99340683	0.97329	0.284	0.55381	.	.	.	.	.	.	1.633767	0.20888	14.94	0.98339881671989082	0.40561	0.351463	0.44269	N	-0.704571476039576	0.15697	0.8050021	-0.728860576183646	0.15972	0.8583862	4.85	2.98	0.33493	-1.88	0.12021	1.028	0.29832	2.935000	0.35718	-0.193	0.0929	0.001	0.13799	0.999000	0.35501	0.011	0.09394	988	0.02004	13	0.002595846645367412	0	0.0	0	0.0	0	0.0	13	0.012896825396825396	0	0.0	.	.	.	.	108	108386	9.964390e-04	0	151	202432	7.459290e-04	0	204	232114	8.788780e-04	0	1	6964	1.435960e-04	0	0	16996	0.000000e+00	0	0	2284	0.000000e+00	0	106	9002	1.177520e-02	0	0	13344	0.000000e+00	0	0	42242	0.000000e+00	0	0	15668	0.000000e+00	0	106	9002	1.177520e-02	0	3	14886	2.015320e-04	0	0	30322	0.000000e+00	0	1	6004	1.665560e-04	0	143	13356	1.070680e-02	0	0	16640	0.000000e+00	0	0	85960	0.000000e+00	0	1	30554	3.272890e-05	0	143	13356	1.070680e-02	0	2	13690	1.460920e-04	0	0	34076	0.000000e+00	0	1	9424	1.061120e-04	0	197	17636	1.117030e-02	0	0	21232	0.000000e+00	0	0	100074	0.000000e+00	0	1	30476	3.281270e-05	0	197	17636	1.117030e-02	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	38910	0	0	10	0	1	26	0.038461538461538464	0	760	0	0	0	0	0	20	0	0	56	0	0	0	0	3	4632	6.476683937823834E-4	0	770	0	1	82	0.012195121951219513	4	44414	9.006169225919755E-5	Benign/Likely_benign	Classic_homocystinuria|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|not_provided|not_specified	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43072142G>A	ClinGen:CA10587951|UniProtKB:P35520#VAR_046921	C0751202|C4707243|C3150344|C3661900|CN169374	236200|PS607086	394|91387	.	Arg	Cys	259103	single nucleotide variant	NM_000071.3(CBS):c.52C>T (p.Arg18Cys)	875	CBS	HGNC:1550	Benign/Likely benign	0	Jan 23, 2025	201827340	-	RCV000359251|RCV000466468|RCV001722372|RCV002310871|RCV002229712	MedGen:CN169374|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3661900|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:C3150344	not specified|Classic homocystinuria|not provided|Familial thoracic aortic aneurysm and aortic dissection|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline;unknown	germline	GRCh38	NC_000021.9	21	43072142	43072142	21q22.3	criteria provided, multiple submitters, no conflicts	9	-	N	ClinGen:CA10587951,UniProtKB:P35520#VAR_046921	2	263858	43072142	G	A	-	-	-	-	-	-	SCV000319320|SCV000340481|SCV000512491|SCV000555946|SCV000803571|SCV001298526	-	-	52C>T 	Arg18Cys	NM_000071.3	2	2_Benign	CBS	ENSG00000160200	359	328	CCSBVarC007367	ALE00007355	52C>T	Arg18Cys	Edgotyping3	VUSMutGDEh011	C07	GDEhDisVCh_40013	D12	1	VUSMutGDDh011	C07	NULL	NULL	NULL	NULL	NULL	NULL	1	3	1	5	0	NULL	0	NULL	0	NULL	CBS_Arg18Cys	21	21	43072142	G	A
71569	OTC	947T>C	Phe316Ser	ENSG00000036473	X	38411941	NC_000023.11:38411941:T:C	ALE00002762	CCSBVarC002762	35642	NULL	NULL	GDEhDisVCh_40048	H11	RC4	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTCTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103260.0	single nucleotide variant	NM_000531.6(OTC):c.947T>C (p.Phe316Ser)	5009.0	OTC	HGNC:8512	Pathogenic	1.0	-	72558471.0	-	RCV000083617	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38411941.0	38411941.0	Xp11.4	no assertion criteria provided	1.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224852	2.0	97368.0	38411941.0	T	C	-	-	-	-	-	-	SCV000115703	-	-	947T>C 	Phe316Ser	NM_000531.6		1_Pathogenic	chrX	T	C	X-38411941-T-C		97368	X	38411941	T	C	F	S	rs72558471	X	38271194	X	38156138	316	OTC	ENSG00000036473	ENST00000713758	ENSP00000519059	P00480	OTC_HUMAN	.	.	c.947T>C	p.Phe316Ser	principal1	Y	.	.	.	+	TTT	2	0	T	T/T	T/T	T/T	T/T	.	0.91343	.	.	0.79703	.	0.999	0.77914	D	0.988	0.77983	D	.	0.71892	.	.	.	.	4.15	0.97531	H	.	0.90468	.	.	0.99730	1.0432	0.97971	D	0.9822	0.99454	D	10	.	0.99878	.	0.870388	0.99006	D	.	0.99930	0.877	0.96664	P00480	F316S	Gain of disorder (P = 0.0022)| Gain of phosphorylation at F316 (P = 0.0322)| Gain of glycosylation at F316 (P = 0.0514)| Loss of catalytic residue at F316 (P = 0.1209)| Gain of helix (P = 0.132)	.	0.99911	.	0.98346	.	0.88508	0.735570311546	0.72273	T	0.978208	0.99805	D	0.724827	0.99951	D	0.803388	0.99951	D	0.997690677642822	0.92120	D	.	0.97679	.	0.9958325	0.99978	0.98938495	0.99974	0.9950717	0.99963	0.98527247	0.99927	-13.702	0.92064	D	.	0.91617	.	0.999861249749778	0.98431	0.99865720	0.98895	1	0.99985	.	.	.	.	.	.	4.747896	0.76678	26.5	0.99850585802870573	0.93018	.	.	.	.	.	.	.	.	.	5.16	5.16	0.70523	4.73	0.87084	7.543	0.81102	7.782000	0.68741	0.665	0.62996	1.0	0.71675	1.000000	0.68239	0.706	0.34365	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided	no_assertion_criteria_provided	NC_000023.11:g.38411941T>C	ClinGen:CA224852	CN517202	.	.	Aspartate/ornithine carbamoyltransferase, Asp/Orn-binding domain	Phe	Ser	103260	single nucleotide variant	NM_000531.6(OTC):c.947T>C (p.Phe316Ser)	5009	OTC	HGNC:8512	Pathogenic	1	-	72558471	-	RCV000083617	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38411941	38411941	Xp11.4	no assertion criteria provided	1	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224852	2	97368	38411941	T	C	-	-	-	-	-	-	SCV000115703	-	-	947T>C 	Phe316Ser	NM_000531.6		1_Pathogenic	OTC	ENSG00000036473	71569	35642	CCSBVarC002762	ALE00002762	947T>C	Phe316Ser	RC4	RC4_Mut_GDEh1017	H11	GDEhDisVCh_40048	H11	2	RC4_Mut_GDDh1017	H11	NULL	NULL	NULL	NULL	NULL	NULL	1	6	1	1	0	NULL	0	NULL	0	NULL	OTC_Phe316Ser	23	X	38411941	T	C
3172	CBS	415G>A	Gly139Arg	ENSG00000160200	21	43066279	NC_000021.9:43066279:C:T	ALE00003748	CCSBVarC003748	NULL	214523	NULL	GDEhDisVCh_40055	G06	CEGS2	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTCCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCAGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCCGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	15160.0	single nucleotide variant	NM_000071.3(CBS):c.415G>A (p.Gly139Arg)	875.0	CBS	HGNC:1550	Conflicting classifications of pathogenicity	1.0	Nov 21, 2024	121964965.0	-	RCV000000143|RCV002468954|RCV003764500	MedGen:C3502110|MedGen:CN169374|MedGen:C3150344	Homocystinuria, pyridoxine-responsive|not specified|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43066279.0	43066279.0	21q22.3	criteria provided, conflicting classifications	3.0	-	N	ClinGen:CA113883,UniProtKB:P35520#VAR_008060,OMIM:613381.0005	3.0	121.0	43066279.0	C	T	-	-	-	-	-	-	SCV002766587|SCV004649013	-	-	415G>A 	Gly139Arg	NM_000071.3	1.0	3_Conflicting	chr21	G	A	21-43066279-G-A		121	21	43066279	C	T	G	R	rs121964965	21	44486389	21	43359458	139	CBS	ENSG00000160200	ENST00000398165	ENSP00000381231	P35520	CBS_HUMAN	c.415G>A	p.Gly139Arg	c.415G>A	p.Gly139Arg	principal1	Y	1	YES	Select	-	GGG	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.001	0.92967	D	1.0	0.90580	D	0.998	0.88579	D	1.0	0.99291	A	simple_aae	0.0	100.0	3.905	0.96088	H	-7.96	0.96508	D	0.937	0.94324	1.0121	0.97387	D	0.9867	0.99604	D	9	0.98298	0.98391	D	0.935602	0.99537	D	0.926	0.98190	0.858	0.95637	P35520	G139R	Gain of phosphorylation at T141 (P = 0.0948)| Loss of methylation at K137 (P = 0.123)| Loss of ubiquitination at K137 (P = 0.1388)| Gain of sheet (P = 0.1539)| Gain of catalytic residue at G139 (P = 0.1544)	0.9366353079	0.93548	0.9332380524639506	0.93260	1.23181786945	0.81268	0.792135357857	0.80733	T	0.986225	0.99917	D	0.378721	0.88546	D	0.542899	0.95410	D	0.998734891414642	0.94964	D	.	0.97448	.	0.8951779	0.90827	0.7759714	0.86618	0.8723523	0.88898	0.8281501	0.89936	-10.578	0.77368	D	.	0.67188	.	0.999561313081832	0.97008	0.99982601	0.99778	1	0.99985	.	.	.	.	.	.	4.849499	0.79296	27.1	0.99918053777179294	0.98519	0.911060	0.86934	D	0.837085743982379	0.88296	9.549446	0.689470055682665	0.81477	7.559846	5.23	5.23	0.72532	2.86	0.52289	6.845	0.75251	4.654000	0.44286	0.524	0.24207	1.0	0.71675	1.000000	0.68239	0.214	0.22342	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4	108656	3.681340e-05	0	7	207112	3.379810e-05	0	7	236114	2.964670e-05	0	2	7148	2.797990e-04	0	1	17100	5.847950e-05	0	0	2320	0.000000e+00	0	0	9038	0.000000e+00	0	0	12702	0.000000e+00	0	1	42750	2.339180e-05	0	0	15688	0.000000e+00	0	2	7148	2.797990e-04	0	2	16174	1.236550e-04	0	2	30508	6.555660e-05	0	0	6210	0.000000e+00	0	0	13392	0.000000e+00	0	0	16042	0.000000e+00	0	2	89324	2.239040e-05	0	1	30606	3.267330e-05	0	2	16174	1.236550e-04	0	2	14880	1.344090e-04	0	2	34240	5.841120e-05	0	0	9566	0.000000e+00	0	0	17684	0.000000e+00	0	0	20940	0.000000e+00	0	2	102664	1.948100e-05	0	1	30524	3.276110e-05	0	2	14880	1.344090e-04	0	.	11	1159678	9.485390e-06	2	3	43004	6.976100e-05	1	2	36172	5.529140e-05	0	0	734	0.000000e+00	0	2	54372	3.678360e-05	0	0	23846	0.000000e+00	0	3	43004	6.976100e-05	1	0	46884	0.000000e+00	0	0	4176	0.000000e+00	0	4	826120	4.841910e-06	1	0	77064	0.000000e+00	0	2	15902	1.2577034335303736E-4	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	762	0	0	2898	0	0	112	0	2	20528	9.742790335151988E-5	Conflicting_classifications_of_pathogenicity	not_specified|Homocystinuria,_pyridoxine-responsive|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_conflicting_classifications	NC_000021.9:g.43066279C>T	ClinGen:CA113883|OMIM:613381.0005|UniProtKB:P35520#VAR_008060	CN169374|C3502110|C3150344	.	.	Tryptophan synthase beta chain-like, PALP domain	Gly	Arg	15160	single nucleotide variant	NM_000071.3(CBS):c.415G>A (p.Gly139Arg)	875	CBS	HGNC:1550	Conflicting classifications of pathogenicity	1	Nov 21, 2024	121964965	-	RCV000000143|RCV002468954|RCV003764500	MedGen:C3502110|MedGen:CN169374|MedGen:C3150344	Homocystinuria, pyridoxine-responsive|not specified|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43066279	43066279	21q22.3	criteria provided, conflicting classifications	3	-	N	ClinGen:CA113883,UniProtKB:P35520#VAR_008060,OMIM:613381.0005	3	121	43066279	C	T	-	-	-	-	-	-	SCV002766587|SCV004649013	-	-	415G>A 	Gly139Arg	NM_000071.3	1	3_Conflicting	CBS	ENSG00000160200	3172	214523	CCSBVarC003748	ALE00003748	415G>A	Gly139Arg	CEGS2	CegsMutGDEh1039	G04	GDEhDisVCh_40055	G06	1	CegsMutGDDh1039	G04	NULL	NULL	NULL	NULL	NULL	NULL	1	6	1	7	0	NULL	0	NULL	0	NULL	CBS_Gly139Arg	21	21	43066279	C	T
71569	OTC	788A>G	Asp263Gly	ENSG00000036473	X	38408946	NC_000023.11:38408946:A:G	ALE00005259	CCSBVarC005259	NULL	205943	NULL	GDEhDisVCh_40048	E06	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGGCACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103217.0	single nucleotide variant	NM_000531.6(OTC):c.788A>G (p.Asp263Gly)	5009.0	OTC	HGNC:8512	Likely pathogenic	1.0	Apr 11, 2023	72558443.0	-	RCV000083572|RCV003398689	MedGen:C3661900|	not provided|OTC-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	38408946.0	38408946.0	Xp11.4	criteria provided, single submitter	2.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224788,UniProtKB:P00480#VAR_004920	2.0	97325.0	38408946.0	A	G	-	-	-	-	-	-	SCV004120419	-	-	788A>G 	Asp263Gly	NM_000531.6	1.0	1_Pathogenic	chrX	A	G	X-38408946-A-G		97325	X	38408946	A	G	D	G	rs72558443	X	38268199	X	38153143	263	OTC	ENSG00000036473	ENST00000713758	ENSP00000519059	P00480	OTC_HUMAN	.	.	c.788A>G	p.Asp263Gly	principal1	Y	.	.	.	+	GAC	2	0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	1.0	0.97365	D	.	0.96253	.	.	.	.	4.045	0.96963	H	.	0.93713	.	.	0.99026	1.0249	0.97617	D	0.9843	0.99522	D	10	.	0.99997	.	0.987962	0.99950	D	.	0.99986	0.986	0.99859	P00480	D263G	Loss of catalytic residue at D263 (P = 0.0086)| Loss of stability (P = 0.0668)| Loss of helix (P = 0.1299)| Gain of sheet (P = 0.1945)| Gain of disorder (P = 0.2403)	.	0.99977	.	0.99373	.	0.84180	0.71132349968	0.68732	T	0.989003	0.99946	D	0.740831	0.99970	D	0.826376	0.99970	D	0.999868035316467	0.99413	D	.	0.99119	.	0.9940409	0.99934	0.99179196	0.99989	0.99379796	0.99926	0.99128824	0.99986	-13.741	0.92200	D	.	0.95614	.	0.999932387026423	0.98982	0.99882260	0.98981	1	0.99985	.	.	.	.	.	.	5.226427	0.87742	29.3	0.99874032848562966	0.95164	.	.	.	.	.	.	.	.	.	5.58	5.58	0.84339	4.91	0.89049	8.813	0.91606	10.979000	0.84613	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.998	0.85369	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	OTC-related_disorder|not_provided	criteria_provided,_single_submitter	NC_000023.11:g.38408946A>G	ClinGen:CA224788|UniProtKB:P00480#VAR_004920	C3661900	.	.	Aspartate/ornithine carbamoyltransferase, Asp/Orn-binding domain	Asp	Gly	103217	single nucleotide variant	NM_000531.6(OTC):c.788A>G (p.Asp263Gly)	5009	OTC	HGNC:8512	Likely pathogenic	1	Apr 11, 2023	72558443	-	RCV000083572|RCV003398689	MedGen:C3661900|	not provided|OTC-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	38408946	38408946	Xp11.4	criteria provided, single submitter	2	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224788,UniProtKB:P00480#VAR_004920	2	97325	38408946	A	G	-	-	-	-	-	-	SCV004120419	-	-	788A>G 	Asp263Gly	NM_000531.6	1	1_Pathogenic	OTC	ENSG00000036473	71569	205943	CCSBVarC005259	ALE00005259	788A>G	Asp263Gly	CEGS2	CegsMutGDEh1026	H02	GDEhDisVCh_40048	E06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	3	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Asp263Gly	23	X	38408946	A	G
71569	OTC	605A>C	His202Pro	ENSG00000036473	X	38403682	NC_000023.11:38403682:A:C	ALE00005253	CCSBVarC005253	NULL	205927	NULL	GDEhDisVCh_40048	B01	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCCCTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103160.0	single nucleotide variant	NM_000531.6(OTC):c.605A>C (p.His202Pro)	5009.0	OTC	HGNC:8512	Pathogenic	1.0	-	72558409.0	-	RCV000083510	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38403682.0	38403682.0	Xp11.4	no assertion criteria provided	1.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224706	2.0	97268.0	38403682.0	A	C	-	-	-	-	-	-	SCV000115596	-	-	605A>C 	His202Pro	NM_000531.6		1_Pathogenic	chrX	A	C	X-38403682-A-C		97268	X	38403682	A	C	H	P	rs72558409	X	38262935	X	38147879	202	OTC	ENSG00000036473	ENST00000713758	ENSP00000519059	P00480	OTC_HUMAN	.	.	c.605A>C	p.His202Pro	principal1	Y	.	.	.	+	CAC	2	0	A	A/A	A/A	A/A	A/A	.	0.46288	.	.	0.70891	.	0.998	0.73231	D	0.989	0.78402	D	.	0.87470	.	.	.	.	3.57	0.93366	H	.	0.96690	.	.	0.96999	1.0483	0.98077	D	0.9815	0.99431	D	10	.	0.99955	.	0.868523	0.98991	D	.	0.99803	0.936	0.99070	P00480	H202P	Loss of catalytic residue at S207 (P = 0.1121)| Loss of MoRF binding (P = 0.2149)| Gain of glycosylation at S203 (P = 0.3647)| Loss of helix (P = 0.3949)| Loss of stability (P = 0.4162)	.	0.99397	.	0.99401	.	0.86583	0.71638584137	0.69468	T	0.980089	0.99834	D	0.698003	0.99927	D	0.764857	0.99927	D	0.9984410405159	0.94118	D	.	0.65157	.	0.9950677	0.99963	0.98701906	0.99950	0.9950677	0.99963	0.98701906	0.99951	-13.431	0.91079	D	.	0.80133	.	0.999122797728776	0.95759	0.99870310	0.98916	0.978	0.99209	.	.	.	.	.	.	4.848167	0.79255	27.1	0.98859965119192372	0.47559	.	.	.	.	.	.	.	.	.	5.91	5.91	0.95233	4.91	0.89049	8.892	0.92159	11.096000	0.86043	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.997	0.79771	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided	no_assertion_criteria_provided	NC_000023.11:g.38403682A>C	ClinGen:CA224706	CN517202	.	.	Aspartate/ornithine carbamoyltransferase, Asp/Orn-binding domain	His	Pro	103160	single nucleotide variant	NM_000531.6(OTC):c.605A>C (p.His202Pro)	5009	OTC	HGNC:8512	Pathogenic	1	-	72558409	-	RCV000083510	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38403682	38403682	Xp11.4	no assertion criteria provided	1	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224706	2	97268	38403682	A	C	-	-	-	-	-	-	SCV000115596	-	-	605A>C 	His202Pro	NM_000531.6		1_Pathogenic	OTC	ENSG00000036473	71569	205927	CCSBVarC005253	ALE00005253	605A>C	His202Pro	CEGS2	CegsMutGDEh1002	D01	GDEhDisVCh_40048	B01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	OTC_His202Pro	23	X	38403682	A	C
52861	F9	1240C>A	Pro414Thr	ENSG00000101981	X	139561925	NC_000023.11:139561925:C:A	ALE00004396	CCSBVarC004396	NULL	204390	NULL	GDEhDisVCh_40052	H06	CEGS2	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGAACCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT	25659.0	single nucleotide variant	NM_000133.4(F9):c.1240C>A (p.Pro414Thr)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Oct 09, 2017	137852265.0	-	RCV000011366	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561925.0	139561925.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255411,UniProtKB:P00740#VAR_017321,OMIM:300746.0064	1.0	10620.0	139561925.0	C	A	-	-	-	-	-	-	SCV000031598	-	-	1240C>A 	Pro414Thr	NM_000133.4		1_Pathogenic	chrX	C	A	X-139561925-C-A		10620	X	139561925	C	A	P	T	rs137852265	X	138644084	X	138471750	414	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1240C>A	p.Pro414Thr	c.1240C>A	p.Pro414Thr	principal1	Y	1	YES	Select	+	CCC	1	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.999	0.92348	D	0.95	0.95575	A	simple_aae	5.0	95.0	4.135	0.97453	H	-7.95	0.96333	D	0.904	0.97441	1.0542	0.98204	D	0.9807	0.99405	D	10	0.995023	0.99972	D	0.93761	0.99553	D	0.993	0.99990	0.977	0.99784	P00740	P414T	Gain of glycosylation at P414 (P = 0.0313)| Gain of catalytic residue at P414 (P = 0.1349)| Loss of stability (P = 0.1869)| Loss of phosphorylation at T417 (P = 0.2062)| Loss of disorder (P = 0.2097)	0.999276639572	0.99925	0.9997634824830927	0.99976	1.73687855107	0.90779	0.588735103607	0.51248	T	0.971606	0.99695	D	0.735212	0.99960	D	0.818304	0.99960	D	0.999857425689697	0.99358	D	0.982202	0.94194	D	0.987573	0.99622	0.98076874	0.99835	0.9917446	0.99846	0.9748375	0.99652	-13.076	0.89696	D	0.8299	0.82559	P	0.999697756973981	0.97521	0.99999330	0.99996	1	0.99985	.	.	.	.	.	.	4.356568	0.67023	25.0	0.99745405639585871	0.83867	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	4.11	0.78390	7.879	0.8573	4.925000	0.46154	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.964	0.52647	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	4	264690	1.51120175E-5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561925C>A	ClinGen:CA255411|OMIM:300746.0064|UniProtKB:P00740#VAR_017321	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Pro	Thr	25659	single nucleotide variant	NM_000133.4(F9):c.1240C>A (p.Pro414Thr)	2158	F9	HGNC:3551	Pathogenic	1	Oct 09, 2017	137852265	-	RCV000011366	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561925	139561925	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255411,UniProtKB:P00740#VAR_017321,OMIM:300746.0064	1	10620	139561925	C	A	-	-	-	-	-	-	SCV000031598	-	-	1240C>A 	Pro414Thr	NM_000133.4		1_Pathogenic	F9	ENSG00000101981	52861	204390	CCSBVarC004396	ALE00004396	1240C>A	Pro414Thr	CEGS2	CegsMutGDEh1026	E12	GDEhDisVCh_40052	H06	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	F9_Pro414Thr	23	X	139561925	C	A
3774	TP53	455C>T	Pro152Leu	ENSG00000141510	17	7675157	NC_000017.11:7675157:G:A	ALE00000546	CCSBVarC000546	6929	NULL	NULL	GDEhDisVCh_40053	D11	RC4	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCTGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACCGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	152480.0	single nucleotide variant	NM_000546.6(TP53):c.455C>T (p.Pro152Leu)	7157.0	TP53	HGNC:11998	Pathogenic	1.0	Aug 05, 2024	587782705.0	-	RCV000132156|RCV000168122|RCV000677669|RCV000755703|RCV001270267|RCV000583667|RCV003462034|RCV001255632|RCV004668801|RCV004797600	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0010150,MeSH:D000077195,MedGen:C1168401,OMIM:275355,Orphanet:67037|MedGen:C3661900|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501|MONDO:MONDO:0023644,MedGen:C0220641|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651|	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Familial cancer of breast|Squamous cell carcinoma of the head and neck|not provided|Adrenocortical carcinoma, hereditary|Lip and oral cavity carcinoma|Neoplasm|TP53-related disorder	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7675157.0	7675157.0	17p13.1	reviewed by expert panel	19.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000204,UniProtKB:P04637#VAR_005897	2.0	142766.0	7675157.0	G	A	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV001142563	-	SCV005094450	455C>T 	Pro152Leu	NM_000546.6	3.0	1_Pathogenic	chr17	C	T	17-7675157-C-T		142766	17	7675157	G	A	P	L	rs587782705	17	7578475	17	7519200	152	TP53	ENSG00000141510	ENST00000508793	ENSP00000424104	P04637	P53_HUMAN	c.455C>T	p.Pro152Leu	c.455C>T	p.Pro152Leu	principal1	.	4	.	.	-	CCG	2	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	.	0.92967	.	0.99	0.90580	D	0.91	0.80453	D	.	0.99291	.	.	.	.	2.315	0.66058	M	-9.29	0.98487	D	.	0.86916	0.9309	0.96103	D	0.9954	0.99896	D	10	0.99406177	0.99919	D	0.734616	0.97864	D	0.878	0.96382	0.932	0.98955	P04637	P152L	Loss of catalytic residue at P151 (P = 0.0116)| Loss of glycosylation at P152 (P = 0.0119)| Loss of disorder (P = 0.0384)| Loss of phosphorylation at T155 (P = 0.0736)| Gain of methylation at R156 (P = 0.1049)	0.987773132982	0.98750	.	0.71366	.	0.88397	0.482567846775	0.36362	T	0.984183	0.99893	D	0.55405	0.95831	D	0.558078	0.95767	D	0.999319195747375	0.96902	D	.	0.74447	.	0.9495784	0.96163	0.89266187	0.94379	0.9413383	0.95312	0.8767477	0.93245	-9.279	0.70546	D	0.4915	0.64139	A	0.989391971689619	0.88158	0.99993932	0.99939	0.986	0.99524	.	.	.	.	.	.	4.453007	0.69299	25.3	0.99737795385909966	0.83280	0.951527	0.96606	D	0.745211895631738	0.82498	7.800914	0.664608643677434	0.79590	7.138674	5.59	5.59	0.84656	.	.	10.003	0.9969	11.893000	0.99147	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.431	0.27521	434	0.80544	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	1	109378	9.142610e-06	0	2	208000	9.615380e-06	0	1	236752	4.223830e-06	0	0	7160	0.000000e+00	0	0	17110	0.000000e+00	0	1	2320	4.310340e-04	0	0	9046	0.000000e+00	0	0	13382	0.000000e+00	0	0	42758	0.000000e+00	0	0	15688	0.000000e+00	0	.	.	.	.	0	16204	0.000000e+00	0	0	30520	0.000000e+00	0	1	6208	1.610820e-04	0	0	13416	0.000000e+00	0	0	16720	0.000000e+00	0	1	89464	1.117770e-05	0	0	30606	0.000000e+00	0	1	89464	1.117770e-05	0	0	14888	0.000000e+00	0	0	34258	0.000000e+00	0	1	9564	1.045590e-04	0	0	17692	0.000000e+00	0	0	21616	0.000000e+00	0	0	102596	0.000000e+00	0	0	30524	0.000000e+00	0	.	.	.	.	.	3	1614046	1.858680e-06	0	1	29604	3.377920e-05	0	0	74926	0.000000e+00	0	0	912	0.000000e+00	0	0	59992	0.000000e+00	0	1	29604	3.377920e-05	0	0	44890	0.000000e+00	0	0	64026	0.000000e+00	0	0	6084	0.000000e+00	0	2	1180036	1.694860e-06	0	0	91092	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Pathogenic	not_provided|Li-Fraumeni_syndrome_1|Adrenocortical_carcinoma,_hereditary|Li-Fraumeni_syndrome|Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Squamous_cell_carcinoma_of_the_head_and_neck|Lip_and_oral_cavity_carcinoma	reviewed_by_expert_panel	NC_000017.11:g.7675157G>A	ClinGen:CA000204|UniProtKB:P04637#VAR_005897	C3661900|C1835398|C1859972|C0085390|C0346153|C0027672|C1168401|C0220641	151623|202300|PS151623|114480|275355	524|1501|524|227535|140162|67037	p53, DNA-binding domain|p53, DNA-binding domain	Pro	Leu	152480	single nucleotide variant	NM_000546.6(TP53):c.455C>T (p.Pro152Leu)	7157	TP53	HGNC:11998	Pathogenic	1	Aug 05, 2024	587782705	-	RCV000132156|RCV000168122|RCV000677669|RCV000755703|RCV001270267|RCV000583667|RCV003462034|RCV001255632|RCV004668801|RCV004797600	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535|MONDO:MONDO:0010150,MeSH:D000077195,MedGen:C1168401,OMIM:275355,Orphanet:67037|MedGen:C3661900|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501|MONDO:MONDO:0023644,MedGen:C0220641|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651|	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Familial cancer of breast|Squamous cell carcinoma of the head and neck|not provided|Adrenocortical carcinoma, hereditary|Lip and oral cavity carcinoma|Neoplasm|TP53-related disorder	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7675157	7675157	17p13.1	reviewed by expert panel	19	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000204,UniProtKB:P04637#VAR_005897	2	142766	7675157	G	A	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV001142563	-	SCV005094450	455C>T 	Pro152Leu	NM_000546.6	3	1_Pathogenic	TP53	ENSG00000141510	3774	6929	CCSBVarC000546	ALE00000546	455C>T	Pro152Leu	RC4	RC4_Mut_GDEh1019	C11	GDEhDisVCh_40053	D11	1	RC4_Mut_GDDh1019	C11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	TP53_Pro152Leu	17	17	7675157	G	A
2013	KCNE1	242A>G	Tyr81Cys	ENSG00000180509	21	34449393	NC_000021.9:34449393:T:C	ALE00006341	CCSBVarC006341	NULL	214137	NULL	GDEhDisVCh_40065	C02	CEGS2	ATGATCCTGTCTAACACCACAGCGGTGACGCCCTTTCTGACCAAGCTGTGGCAGGAGACAGTTCAGCAGGGTGGCAACATGTCGGGCCTGGCCCACAGGTCCCCCCGCAGCGGTGACGGCAAGCTGGAGGCCCTCTACGTCCTCATGGTACTGGGATTCTTCGGCTTCTTCACCCTGGGCATCATGCTGAGCTACATCCGCTCCAAGAAGCTGGAGCACTCGAACGACCCATTCAACGTCTGCATCGAGTCCGATGCCTGGCAAGAGAAGGACAAGGCCTATGTCCAGGCCCGGGTCCTGGAGAGCTACAGGTCG	136419.0	single nucleotide variant	NM_000219.6(KCNE1):c.242A>G (p.Tyr81Cys)	3753.0	KCNE1	HGNC:6240	Uncertain significance	0.0	Sep 01, 2021	199473359.0	-	RCV000119083|RCV000795910|RCV001753500|RCV003162553|RCV004777591	MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:101016,Orphanet:768|MONDO:MONDO:0002442,MeSH:D008133,MedGen:C0023976|MedGen:C3661900|MedGen:CN230736|MONDO:MONDO:0013372,MedGen:C1867904,OMIM:613695,Orphanet:101016,Orphanet:768	Congenital long QT syndrome|Long QT syndrome|not provided|Cardiovascular phenotype|Long QT syndrome 5	germline;not applicable	germline	GRCh38	NC_000021.9	21	34449393.0	34449393.0	21q22.12	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA331950	2.0	132671.0	34449393.0	T	C	-	-	-	-	-	-	SCV000935391|SCV001985330|SCV003910007	-	-	242A>G 	Tyr81Cys	NM_000219.6	2.0	4_VUS	chr21	A	G	21-34449393-A-G		132671	21	34449393	T	C	Y	C	rs199473359	21	35821691	21	34743561	81	KCNE1	ENSG00000180509	ENST00000611936	ENSP00000478215	P15382	KCNE1_HUMAN	c.242A>G	p.Tyr81Cys	c.242A>G	p.Tyr81Cys	principal1	Y	4	.	.	-	TAC	2	0	T	T/T	T/T	T/T	T/T	.	0.91343	.	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	.	0.99291	.	.	.	.	2.8	0.81458	M	.	0.97132	.	0.932	0.99781	1.0483	0.98077	D	0.9150	0.97178	D	10	0.9326924	0.92521	D	0.224842	0.87939	D	.	0.97811	0.681	0.81804	P15382	Y81C	Loss of phosphorylation at Y81 (P = 0.0215)| Loss of disorder (P = 0.1123)| Loss of catalytic residue at Y81 (P = 0.146)| Loss of helix (P = 0.2662)| Loss of sheet (P = 0.302)	0.92614053698	0.92482	.	0.96130	.	0.46738	0.767442941666	0.77001	T	0.948778	0.99238	D	0.267217	0.80045	D	0.371764	0.91075	D	0.998468220233917	0.94174	D	.	0.53310	.	0.803067	0.83900	0.76695436	0.86065	0.8287846	0.85633	0.74170417	0.84548	-5.548	0.42366	T	.	0.80864	.	0.997630474103689	0.93365	0.99959689	0.99523	0.779	0.87767	.	.	.	.	.	.	3.85784	0.56001	23.7	0.99774260695339501	0.86185	0.892277	0.82842	D	0.685840880149942	0.78590	6.925655	0.582775254176039	0.73561	6.014453	5.16	5.16	0.70523	.	.	6.807	0.7505	7.770000	0.68503	0.609	0.47831	1.0	0.71675	1.000000	0.68239	0.162	0.2076	899	0.25042	.	.	.	.	.	.	.	.	.	.	.	.	5	264690	1.8890023E-5	.	0	109408	0.000000e+00	0	0	208078	0.000000e+00	0	2	236930	8.441310e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42768	0.000000e+00	0	0	15690	0.000000e+00	0	.	.	.	.	0	16212	0.000000e+00	0	0	30522	0.000000e+00	0	0	6210	0.000000e+00	0	0	13410	0.000000e+00	0	0	16734	0.000000e+00	0	0	89516	0.000000e+00	0	0	30608	0.000000e+00	0	.	.	.	.	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9570	0.000000e+00	0	2	17692	1.130450e-04	0	0	21632	0.000000e+00	0	0	102728	0.000000e+00	0	0	30526	0.000000e+00	0	2	17692	1.130450e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Uncertain_significance	Congenital_long_QT_syndrome|Cardiovascular_phenotype|not_provided|Long_QT_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.34449393T>C	ClinGen:CA331950	C1141890|CN230736|C3661900|C0023976	PS192500	101016|768	.	Tyr	Cys	136419	single nucleotide variant	NM_000219.6(KCNE1):c.242A>G (p.Tyr81Cys)	3753	KCNE1	HGNC:6240	Uncertain significance	0	Sep 01, 2021	199473359	-	RCV000119083|RCV000795910|RCV001753500|RCV003162553|RCV004777591	MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:101016,Orphanet:768|MONDO:MONDO:0002442,MeSH:D008133,MedGen:C0023976|MedGen:C3661900|MedGen:CN230736|MONDO:MONDO:0013372,MedGen:C1867904,OMIM:613695,Orphanet:101016,Orphanet:768	Congenital long QT syndrome|Long QT syndrome|not provided|Cardiovascular phenotype|Long QT syndrome 5	germline;not applicable	germline	GRCh38	NC_000021.9	21	34449393	34449393	21q22.12	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA331950	2	132671	34449393	T	C	-	-	-	-	-	-	SCV000935391|SCV001985330|SCV003910007	-	-	242A>G 	Tyr81Cys	NM_000219.6	2	4_VUS	KCNE1	ENSG00000180509	2013	214137	CCSBVarC006341	ALE00006341	242A>G	Tyr81Cys	CEGS2	CegsMutGDEh1005	A09	GDEhDisVCh_40065	C02	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	KCNE1_Tyr81Cys	21	21	34449393	T	C
2803	HMBS	346C>T	Arg116Trp	ENSG00000256269	11	119089991	NC_000011.10:119089991:C:T	ALE00005162	CCSBVarC005162	NULL	200929	NULL	GDEhDisVCh_40054	C05	CEGS2	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAGCTTGCTCGCATACAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGGACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCTTGAACATGCCCTGGAGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAGTGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCGAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTCGGGGAAACCTCAACACCCGGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACCGGGTGGGGCAGATCCTGCACCCTGAGGAATGCATGTATGCTGTGGGCCAGGGGGCCTTGGGCGTGGAAGTGCGAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCTGCATCGCTGAAAGGGCCTTCCTGAGGCACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATGGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCGTAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACGATGCCCAT	16484.0	single nucleotide variant	NM_000190.4(HMBS):c.346C>T (p.Arg116Trp)	3145.0	HMBS	HGNC:4982	Pathogenic	1.0	Aug 27, 2024	118204094.0	-	RCV000001510|RCV001212053	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900	Acute intermittent porphyria|not provided	germline;maternal	germline	GRCh38	NC_000011.10	11	119089991.0	119089991.0	11q23.3	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA251793,UniProtKB:P08397#VAR_003647,OMIM:609806.0004	3.0	1445.0	119089991.0	C	T	-	-	-	-	-	-	SCV001383626|SCV002569876|SCV002575020|SCV004047777|SCV004226622	-	-	346C>T 	Arg116Trp	NM_000190.4	2.0	1_Pathogenic	chr11	C	T	11-119089991-C-T	2.73869e-6	1445	11	119089991	C	T	R	W	rs118204094	11	118960701	11	118465911	116	HMBS	ENSG00000256269	ENST00000652429	ENSP00000498786	P08397	HEM3_HUMAN	c.346C>T	p.Arg116Trp	c.346C>T	p.Arg116Trp	principal2	Y	.	YES	Select	+	CGG	1	2	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	1.0	0.97365	D	.	0.92786	.	.	.	.	4.46	0.98830	H	.	0.96158	.	.	0.97110	0.9093	0.95792	D	0.9970	0.99927	D	9	.	0.99681	.	0.76463	0.98131	D	.	0.99057	0.972	0.99735	P08397	R116W	Loss of catalytic residue at R116 (P = 0.0058)| Loss of ubiquitination at K115 (P = 0.043)| Gain of sheet (P = 0.1208)| Loss of disorder (P = 0.1696)| Loss of solvent accessibility (P = 0.2668)	.	0.98326	0.9377956176326859	0.93721	.	.	0.656994223595	0.60917	T	0.997415	0.99997	D	0.550618	0.95771	D	0.553148	0.95708	D	0.999319672584534	0.96902	D	0.998048	0.99128	D	0.9612548	0.97365	0.9243987	0.96659	0.9700023	0.98231	0.91569835	0.96039	-15.921	0.97645	D	0.9591	0.87917	P	0.999683494710372	0.97477	0.36994347	0.78824	0.995	0.99826	.	.	.	.	.	.	5.005916	0.83126	28.0	0.99915795244622707	0.98380	0.845239	0.76129	D	0.796206214024259	0.85791	8.706541	0.645985145502364	0.78194	6.85102	6.17	4.25	0.49600	5.16	0.91535	3.28	0.51476	2.149000	0.30982	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.747	0.35717	228	0.91137	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	109402	9.140600e-06	0	1	208110	4.805150e-06	0	1	236930	4.220660e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	1	42764	2.338420e-05	0	0	15690	0.000000e+00	0	1	42764	2.338420e-05	0	0	16212	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	1	89540	1.116820e-05	0	0	30608	0.000000e+00	0	1	89540	1.116820e-05	0	0	14896	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	1	102734	9.733880e-06	0	0	30526	0.000000e+00	0	1	102734	9.733880e-06	0	.	5	1612738	3.100320e-06	0	1	74906	1.335010e-05	0	1	74906	1.335010e-05	0	0	912	0.000000e+00	0	0	60006	0.000000e+00	0	0	29604	0.000000e+00	0	0	44892	0.000000e+00	0	0	64036	0.000000e+00	0	0	6078	0.000000e+00	0	4	1178814	3.393240e-06	0	0	91056	0.000000e+00	0	0	7040	0	0	84	0	0	118	0	0	2642	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2726	0	0	142	0	0	11338	0	Pathogenic	Acute_intermittent_porphyria|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.119089991C>T	ClinGen:CA251793|OMIM:609806.0004|UniProtKB:P08397#VAR_003647	C0162565|C3661900	176000	79276	Porphobilinogen deaminase, N-terminal	Arg	Trp	16484	single nucleotide variant	NM_000190.4(HMBS):c.346C>T (p.Arg116Trp)	3145	HMBS	HGNC:4982	Pathogenic	1	Aug 27, 2024	118204094	-	RCV000001510|RCV001212053	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900	Acute intermittent porphyria|not provided	germline;maternal	germline	GRCh38	NC_000011.10	11	119089991	119089991	11q23.3	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA251793,UniProtKB:P08397#VAR_003647,OMIM:609806.0004	3	1445	119089991	C	T	-	-	-	-	-	-	SCV001383626|SCV002569876|SCV002575020|SCV004047777|SCV004226622	-	-	346C>T 	Arg116Trp	NM_000190.4	2	1_Pathogenic	HMBS	ENSG00000256269	2803	200929	CCSBVarC005162	ALE00005162	346C>T	Arg116Trp	CEGS2	CegsMutGDEh1039	B11	GDEhDisVCh_40054	C05	2	CegsMutGDDh1039	B11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	HMBS_Arg116Trp	11	11	119089991	C	T
3774	TP53	711G>A	Met237Ile	ENSG00000141510	17	7674252	NC_000017.11:7674252:C:T	ALE00004866	CCSBVarC004866	NULL	214894	NULL	GDEhDisVCh_40053	A06	CEGS2	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATATGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACCGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	152428.0	single nucleotide variant	NM_000546.6(TP53):c.711G>A (p.Met237Ile)	7157.0	TP53	HGNC:11998	Pathogenic	1.0	Apr 20, 2021	587782664.0	-	RCV000132084|RCV000785336|RCV000464261|RCV001271055|RCV000581940|RCV001527088|RCV001567943|RCV004668799|RCV003462031	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MedGen:CN221562|MedGen:CN169374|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MedGen:C3661900|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501	Hereditary cancer-predisposing syndrome|Ovarian neoplasm|Li-Fraumeni syndrome|Breast and/or ovarian cancer|not specified|Li-Fraumeni syndrome 1|not provided|Neoplasm|Adrenocortical carcinoma, hereditary	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7674252.0	7674252.0	17p13.1	reviewed by expert panel	11.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000349,UniProtKB:P04637#VAR_005965	2.0	142714.0	7674252.0	C	T	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV001737927	-	SCV005094421	711G>A 	Met237Ile	NM_000546.6	3.0	1_Pathogenic	chr17	G	A	17-7674252-G-A		142714	17	7674252	C	T	M	I	rs587782664	17	7577570	17	7518295	237	TP53	ENSG00000141510	ENST00000508793	ENSP00000424104	P04637	P53_HUMAN	c.*864G>A	.	c.711G>A	p.Met237Ile	principal1	.	4	.	.	-	ATG	3	0	C	C/C	C/C	C/C	C/C	.	0.61594	.	.	0.92967	.	1.0	0.90580	D	0.999	0.92348	D	.	0.99291	.	.	.	.	3.27	0.89959	M	.	0.72856	.	.	0.94324	1.0315	0.97740	D	0.9885	0.99669	D	10	.	0.99673	.	0.831185	0.98688	D	.	0.98076	0.954	0.99482	P04637	M237I	Gain of sheet (P = 0.0827)| Loss of disorder (P = 0.1633)| Loss of loop (P = 0.2237)| Loss of phosphorylation at Y234 (P = 0.2999)| Gain of catalytic residue at S241 (P = 0.3274)	.	0.96350	.	0.67544	.	0.40962	0.723813772202	0.70553	T	0.995428	0.99991	D	0.355437	0.86804	D	0.441912	0.93319	D	0.990088403224945	0.80149	D	.	0.52963	.	0.947784	0.95978	0.8971333	0.94700	0.9417198	0.95352	0.8712897	0.92860	-8.383	0.68389	D	.	0.96455	.	0.999941047624081	0.99079	0.99995923	0.99965	0.989	0.99628	.	.	.	.	.	.	4.360223	0.67111	25.0	0.99626673019539747	0.75804	0.910708	0.86850	D	0.682841807552304	0.78393	6.885876	0.580936228130046	0.73428	5.992762	4.09	3.12	0.34908	.	.	7.829	0.84931	7.650000	0.63706	0.596	0.33565	1.0	0.71675	1.000000	0.68239	1.0	0.97202	433	0.80635	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	0	109404	0.000000e+00	0	0	208132	0.000000e+00	0	1	236946	4.220370e-06	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	0	42766	0.000000e+00	0	0	15688	0.000000e+00	0	.	.	.	.	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	0	16734	0.000000e+00	0	0	89556	0.000000e+00	0	0	30606	0.000000e+00	0	.	.	.	.	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	1	17692	5.652270e-05	0	0	21632	0.000000e+00	0	0	102744	0.000000e+00	0	0	30524	0.000000e+00	0	1	17692	5.652270e-05	0	.	2	1613582	1.239480e-06	0	2	1179804	1.695200e-06	0	0	74910	0.000000e+00	0	0	912	0.000000e+00	0	0	59954	0.000000e+00	0	0	29604	0.000000e+00	0	0	44850	0.000000e+00	0	0	63922	0.000000e+00	0	0	6062	0.000000e+00	0	2	1179804	1.695200e-06	0	0	91076	0.000000e+00	0	0	9690	0	0	114	0	0	86	0	0	3210	0	0	146	0	0	610	0	0	26	0	0	98	0	0	548	0	0	3324	0	0	112	0	0	14528	0	Pathogenic	Pancreatic_adenocarcinoma|Adrenocortical_carcinoma,_hereditary|not_provided|Ovarian_neoplasm|not_specified|Hereditary_cancer-predisposing_syndrome|Squamous_cell_carcinoma_of_the_head_and_neck|Brainstem_glioma|Li-Fraumeni_syndrome_1|Carcinoma_of_esophagus|Breast_and/or_ovarian_cancer|Lung_adenocarcinoma|Li-Fraumeni_syndrome|Ovarian_serous_cystadenocarcinoma|Malignant_neoplasm_of_body_of_uterus|Gastric_adenocarcinoma|Neoplasm_of_the_large_intestine|Squamous_cell_lung_carcinoma|Breast_neoplasm|Neoplasm_of_brain	reviewed_by_expert_panel	NC_000017.11:g.7674252C>T	ClinGen:CA000349|UniProtKB:P04637#VAR_005965	C0281361|C1859972|C3661900|C0919267|CN169374|C0027672|C1168401|C0677865|C1835398|C0152018|CN221562|C0152013|C0085390|C0279663|C0153574|C0278701|C0009404|C0149782|C1458155|C0006118	202300|275355|151623|PS151623	1501|140162|67037|524|70482|524	p53, DNA-binding domain|p53, DNA-binding domain	Met	Ile	152428	single nucleotide variant	NM_000546.6(TP53):c.711G>A (p.Met237Ile)	7157	TP53	HGNC:11998	Pathogenic	1	Apr 20, 2021	587782664	-	RCV000132084|RCV000785336|RCV000464261|RCV001271055|RCV000581940|RCV001527088|RCV001567943|RCV004668799|RCV003462031	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MedGen:CN221562|MedGen:CN169374|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MedGen:C3661900|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501	Hereditary cancer-predisposing syndrome|Ovarian neoplasm|Li-Fraumeni syndrome|Breast and/or ovarian cancer|not specified|Li-Fraumeni syndrome 1|not provided|Neoplasm|Adrenocortical carcinoma, hereditary	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7674252	7674252	17p13.1	reviewed by expert panel	11	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000349,UniProtKB:P04637#VAR_005965	2	142714	7674252	C	T	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV001737927	-	SCV005094421	711G>A 	Met237Ile	NM_000546.6	3	1_Pathogenic	TP53	ENSG00000141510	3774	214894	CCSBVarC004866	ALE00004866	711G>A	Met237Ile	CEGS2	CegsMutGDEh1019	D06	GDEhDisVCh_40053	A06	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	TP53_Met237Ile	17	17	7674252	C	T
359	CBS	1358G>A	Gly453Glu	ENSG00000160200	21	43058834	NC_000021.9:43058834:C:T	ALE00007296	CCSBVarC007299	NULL	NULL	239	GDEhDisVCh_40013	G03	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGAGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	259091.0	single nucleotide variant	NM_000071.3(CBS):c.1358G>A (p.Gly453Glu)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Apr 11, 2023	886039146.0	-	RCV000990350|RCV002518722|RCV002311162	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection	germline;unknown	germline	GRCh38	NC_000021.9	21	43058834.0	43058834.0	21q22.3	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA10587940	2.0	264408.0	43058834.0	C	T	-	-	-	-	-	-	SCV000320330|SCV001141296|SCV003011997|SCV003829290	-	-	1358G>A 	Gly453Glu	NM_000071.3	2.0	4_VUS	chr21	G	A	21-43058834-G-A		264408	21	43058834	C	T	G	E	rs886039146	21	44478944	21	43352013	453	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.1358G>A	p.Gly453Glu	c.1358G>A	p.Gly453Glu	principal1	Y	1	.	.	-	GGG	2	0	C	C/C	C/C	C/C	C/C	0.041	0.42072	D	0.071	0.43880	T	0.992	0.64752	D	0.881	0.62572	P	.	.	.	.	.	.	2.95	0.84763	M	-6.58	0.91977	D	0.91	0.91390	1.1021	0.99743	D	0.9428	0.98122	D	9	0.98999923	0.99481	D	0.799161	0.98424	D	0.808	0.93758	0.758	0.88672	P35520	G453E	Loss of catalytic residue at A452 (P = 0.0367)| Gain of solvent accessibility (P = 0.0596)| Gain of relative solvent accessibility (P = 0.1894)| Loss of sheet (P = 0.302)| Gain of disorder (P = 0.5199)	0.907281360879	0.90565	.	0.87796	.	0.81731	0.660366415977	0.61400	T	0.951918	0.99306	D	0.425041	0.91217	D	0.372765	0.91108	D	0.994127988815308	0.85120	D	.	0.81627	.	0.8620552	0.88082	0.68558115	0.81300	0.8664144	0.88425	0.6728986	0.80584	-12.389	0.86728	D	.	0.69981	.	0.993787051991263	0.90248	0.99949110	0.99428	0.935	0.96837	.	.	.	.	.	.	5.517583	0.91755	32.0	0.99644064863498849	0.76907	0.916613	0.88264	D	0.68851941355544	0.78763	6.961499	0.543608097858921	0.70795	5.581778	4.71	4.71	0.58959	.	.	7.501	0.80483	7.354000	0.58376	0.52	0.23855	1.0	0.71675	1.000000	0.68239	0.058	0.15862	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Classic_homocystinuria|Familial_thoracic_aortic_aneurysm_and_aortic_dissection	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43058834C>T	ClinGen:CA10587940	C3150344|C0751202|C4707243	236200|PS607086	394|91387	CBS domain|CBS domain|CBS domain|Cystathionine beta-synthase, C-terminal domain	Gly	Glu	259091	single nucleotide variant	NM_000071.3(CBS):c.1358G>A (p.Gly453Glu)	875	CBS	HGNC:1550	Uncertain significance	0	Apr 11, 2023	886039146	-	RCV000990350|RCV002518722|RCV002311162	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection	germline;unknown	germline	GRCh38	NC_000021.9	21	43058834	43058834	21q22.3	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA10587940	2	264408	43058834	C	T	-	-	-	-	-	-	SCV000320330|SCV001141296|SCV003011997|SCV003829290	-	-	1358G>A 	Gly453Glu	NM_000071.3	2	4_VUS	CBS	ENSG00000160200	359	239	CCSBVarC007299	ALE00007296	1358G>A	Gly453Glu	Edgotyping3	VUSMutGDEh010	C10	GDEhDisVCh_40013	G03	1	VUSMutGDDh010	C10	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	5	0	NULL	0	NULL	0	NULL	CBS_Gly453Glu	21	21	43058834	C	T
52861	F9	1151G>T	Arg384Leu	ENSG00000101981	X	139561836	NC_000023.11:139561836:G:T	ALE00004390	CCSBVarC004390	NULL	204369	NULL	GDEhDisVCh_40052	B04	CEGS2	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCTATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT	25707.0	single nucleotide variant	NM_000133.4(F9):c.1151G>T (p.Arg384Leu)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Oct 22, 2009	137852283.0	-	RCV000119810|RCV000011414	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561836.0	139561836.0	Xq27.1	no assertion criteria provided	2.0	-	N	ClinGen:CA121138,UniProtKB:P00740#VAR_062999,OMIM:300746.0112	1.0	10668.0	139561836.0	G	T	-	-	-	-	-	-	SCV000031646	-	-	1151G>T 	Arg384Leu	NM_000133.4		1_Pathogenic	chrX	G	T	X-139561836-G-T		10668	X	139561836	G	T	R	L	rs137852283	X	138643995	X	138471661	384	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1151G>T	p.Arg384Leu	c.1151G>T	p.Arg384Leu	principal1	Y	1	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	0.163	0.23568	T	0.396	0.15423	T	0.002	0.09864	B	0.005	0.11213	B	0.88	0.93300	A	simple_aae	12.0	88.0	0.955	0.23747	L	-2.31	0.51338	N	0.51	0.85948	-0.5473	0.66743	T	0.4357	0.77488	T	10	0.9098561	0.90243	D	0.729767	0.97820	D	0.566	0.82199	0.843	0.94756	P00740	R384L	Loss of catalytic residue at R384 (P = 0.0424)| Gain of ubiquitination at K387 (P = 0.0495)| Gain of helix (P = 0.132)| Loss of solvent accessibility (P = 0.1922)| Loss of MoRF binding (P = 0.2268)	0.999777502907	0.99977	0.960364883388395	0.95999	1.39186615189	0.84950	0.338467955589	0.16193	T	0.838065	0.96168	D	0.262672	0.79628	D	0.139533	0.79364	D	0.43669804930687	0.29998	T	0.756624	0.39747	T	0.62263954	0.73626	0.44579682	0.67459	0.633839	0.74229	0.30190954	0.56005	-4.722	0.33708	T	0.1582	0.53858	B	0.974507408459896	0.84116	0.99994540	0.99953	0.676	0.82005	.	.	.	.	.	.	2.257674	0.28896	17.93	0.99630479295637608	0.76047	.	.	.	.	.	.	.	.	.	5.66	2.91	0.32820	3.27	0.59264	1.5	0.35396	4.414000	0.43370	0.676	0.76753	0.035	0.20792	1.000000	0.68239	0.988	0.63383	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561836G>T	ClinGen:CA121138|OMIM:300746.0112|UniProtKB:P00740#VAR_062999	C2749016|C0008533	300807|306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Arg	Leu	25707	single nucleotide variant	NM_000133.4(F9):c.1151G>T (p.Arg384Leu)	2158	F9	HGNC:3551	Pathogenic	1	Oct 22, 2009	137852283	-	RCV000119810|RCV000011414	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807	Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect	germline	germline	GRCh38	NC_000023.11	X	139561836	139561836	Xq27.1	no assertion criteria provided	2	-	N	ClinGen:CA121138,UniProtKB:P00740#VAR_062999,OMIM:300746.0112	1	10668	139561836	G	T	-	-	-	-	-	-	SCV000031646	-	-	1151G>T 	Arg384Leu	NM_000133.4		1_Pathogenic	F9	ENSG00000101981	52861	204369	CCSBVarC004390	ALE00004390	1151G>T	Arg384Leu	CEGS2	CegsMutGDEh1018	C12	GDEhDisVCh_40052	B04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	F9_Arg384Leu	23	X	139561836	G	T
359	CBS	340G>A	Ala114Thr	ENSG00000160200	21	43066354	NC_000021.9:43066354:C:T	ALE00007339	CCSBVarC007351	NULL	NULL	310	GDEhDisVCh_40013	D10	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACACGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	422364.0	single nucleotide variant	NM_000071.3(CBS):c.340G>A (p.Ala114Thr)	875.0	CBS	HGNC:1550	Likely pathogenic	1.0	Dec 06, 2023	377708532.0	-	RCV000493781|RCV002231627	MedGen:C3661900|MedGen:C3150344	not provided|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43066354.0	43066354.0	21q22.3	criteria provided, multiple submitters, no conflicts	2.0	-	N	ClinGen:CA321097898	2.0	429655.0	43066354.0	C	T	-	-	-	-	-	-	SCV000582275|SCV001544434	-	-	340G>A 	Ala114Thr	NM_000071.3	2.0	1_Pathogenic	chr21	G	A	21-43066354-G-A		429655	21	43066354	C	T	A	T	rs377708532	21	44486464	21	43359533	114	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.340G>A	p.Ala114Thr	c.340G>A	p.Ala114Thr	principal1	Y	1	.	.	-	GCG	1	0	C	C/C	C/C	C/C	C/C	0.035	0.43867	D	0.021	0.58429	D	0.992	0.64752	D	0.845	0.60425	P	0.83	0.88920	A	simple_aae	17.0	83.0	1.12	0.28626	L	-2.82	0.59576	D	0.94	0.94798	1.0674	0.98519	D	0.9363	0.97899	D	10	0.91378725	0.90638	D	0.316287	0.91319	D	0.848	0.95273	0.801	0.91975	P35520	A114T	Gain of ubiquitination at K119 (P = 0.0822)| Gain of methylation at K119 (P = 0.1265)| Loss of catalytic residue at A114 (P = 0.1687)| Gain of helix (P = 0.1736)| Gain of disorder (P = 0.1858)	0.949107120044	0.94815	.	0.91934	.	0.75056	0.734948992729	0.72182	T	0.978087	0.99803	D	0.219631	0.75559	D	0.246836	0.85367	D	0.983553409576416	0.75000	D	.	0.93755	.	0.8581151	0.87779	0.58730257	0.75816	0.8066974	0.84138	0.65940493	0.79825	-9.057	0.68141	D	0.298	0.54668	LB	0.991024400970907	0.88839	0.99976128	0.99689	0.934	0.96777	.	.	.	.	.	.	4.831609	0.78828	27.0	0.99925320765731851	0.99043	0.779331	0.71050	D	0.78245710337454	0.84916	8.446717	0.740996755670925	0.85402	8.594123	5.36	5.36	0.76590	3.11	0.56638	5.174	0.64928	5.718000	0.49532	0.524	0.24207	1.0	0.71675	1.000000	0.68239	0.967	0.53449	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	109238	1.830860e-05	0	2	207730	9.627880e-06	0	3	236614	1.267890e-05	0	0	7164	0.000000e+00	0	0	17104	0.000000e+00	0	0	2320	0.000000e+00	0	1	9044	1.105710e-04	0	0	13244	0.000000e+00	0	1	42760	2.338630e-05	0	0	15688	0.000000e+00	0	1	9044	1.105710e-04	0	0	16204	0.000000e+00	0	0	30514	0.000000e+00	0	0	6210	0.000000e+00	0	1	13402	7.461570e-05	0	0	16584	0.000000e+00	0	1	89350	1.119190e-05	0	0	30606	0.000000e+00	0	1	13402	7.461570e-05	0	0	14900	0.000000e+00	0	0	34244	0.000000e+00	0	0	9566	0.000000e+00	0	1	17690	5.652910e-05	0	0	21482	0.000000e+00	0	2	102588	1.949550e-05	0	0	30524	0.000000e+00	0	1	17690	5.652910e-05	0	.	4	803184	4.980180e-06	1	1	38570	2.592690e-05	0	0	21830	0.000000e+00	0	0	448	0.000000e+00	0	0	45424	0.000000e+00	0	0	20312	0.000000e+00	0	1	38570	2.592690e-05	0	0	37178	0.000000e+00	0	0	2790	0.000000e+00	0	1	532964	1.876300e-06	0	0	67626	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	not_provided|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43066354C>T	ClinGen:CA321097898	C3661900|C3150344	.	.	Tryptophan synthase beta chain-like, PALP domain|Cysteine synthase/cystathionine beta-synthase, pyridoxal-phosphate attachment site	Ala	Thr	422364	single nucleotide variant	NM_000071.3(CBS):c.340G>A (p.Ala114Thr)	875	CBS	HGNC:1550	Likely pathogenic	1	Dec 06, 2023	377708532	-	RCV000493781|RCV002231627	MedGen:C3661900|MedGen:C3150344	not provided|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43066354	43066354	21q22.3	criteria provided, multiple submitters, no conflicts	2	-	N	ClinGen:CA321097898	2	429655	43066354	C	T	-	-	-	-	-	-	SCV000582275|SCV001544434	-	-	340G>A 	Ala114Thr	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	310	CCSBVarC007351	ALE00007339	340G>A	Ala114Thr	Edgotyping3	VUSMutGDEh011	B05	GDEhDisVCh_40013	D10	1	VUSMutGDDh011	B05	NULL	NULL	NULL	NULL	NULL	NULL	1	3	1	5	0	NULL	0	NULL	0	NULL	CBS_Ala114Thr	21	21	43066354	C	T
359	CBS	469G>A	Ala157Thr	ENSG00000160200	21	43065678	NC_000021.9:43065678:C:T	ALE00007328	CCSBVarC007337	NULL	NULL	292	GDEhDisVCh_40013	F08	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGACTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	259104.0	single nucleotide variant	NM_000071.3(CBS):c.469G>A (p.Ala157Thr)	875.0	CBS	HGNC:1550	Conflicting classifications of pathogenicity	0.0	Oct 13, 2024	199817801.0	-	RCV000527354|RCV001589301|RCV002518703|RCV002310909	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3661900|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Classic homocystinuria|not provided|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection	germline	germline	GRCh38	NC_000021.9	21	43065678.0	43065678.0	21q22.3	criteria provided, conflicting classifications	4.0	-	N	ClinGen:CA10587952	2.0	263924.0	43065678.0	C	T	-	-	-	-	-	-	SCV000319464|SCV000649840|SCV001815025	-	-	469G>A 	Ala157Thr	NM_000071.3	1.0	3_Conflicting	chr21	G	A	21-43065678-G-A		263924	21	43065678	C	T	A	T	rs199817801	21	44485788	21	43358857	157	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.469G>A	p.Ala157Thr	c.469G>A	p.Ala157Thr	principal1	Y	1	.	.	-	GCT	1	0	C	C/C	C/C	C/C	C/C	0.117	0.34068	T	0.125	0.36569	T	0.106	0.26054	B	0.17	0.35300	B	0.77	0.85999	D	simple_aae	23.0	77.0	1.825	0.47724	L	-2.39	0.52633	N	0.486	0.51792	0.7042	0.93203	D	0.9003	0.96686	D	10	0.45538643	0.58623	D	0.374105	0.92802	D	0.546	0.81038	.	.	.	.	.	0.613797026484	0.60771	.	0.82735	.	0.42779	0.537581384182	0.44041	T	0.970735	0.99680	D	0.14974	0.69020	D	-0.0226856	0.68625	D	0.61748594045639	0.36793	D	.	0.61727	.	0.16217905	0.35980	0.20800634	0.44922	0.17512906	0.38048	0.21868387	0.46408	-9.034	0.67994	D	0.0846	0.20771	LB	0.1100786347182	0.44203	0.99693966	0.98211	0.586	0.76781	.	.	.	.	.	.	2.080518	0.26506	17.13	0.97118562752782178	0.32627	0.678160	0.64132	D	-0.508993712022181	0.21531	1.158886	-0.48976801804542	0.22121	1.218507	4.7	2.86	0.32346	0.506	0.25187	4.073	0.57379	1.578000	0.27543	-0.996	0.01835	1.0	0.71675	0.997000	0.33331	0.177	0.21247	988	0.02004	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	6962	1.4363688595231256E-4	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	1	10680	9.363295880149813E-5	Conflicting_classifications_of_pathogenicity	not_provided|Classic_homocystinuria|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_conflicting_classifications	NC_000021.9:g.43065678C>T	ClinGen:CA10587952	C3661900|C0751202|C4707243|C3150344	236200|PS607086	394|91387	Tryptophan synthase beta chain-like, PALP domain	Ala	Thr	259104	single nucleotide variant	NM_000071.3(CBS):c.469G>A (p.Ala157Thr)	875	CBS	HGNC:1550	Conflicting classifications of pathogenicity	0	Oct 13, 2024	199817801	-	RCV000527354|RCV001589301|RCV002518703|RCV002310909	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3661900|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Classic homocystinuria|not provided|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection	germline	germline	GRCh38	NC_000021.9	21	43065678	43065678	21q22.3	criteria provided, conflicting classifications	4	-	N	ClinGen:CA10587952	2	263924	43065678	C	T	-	-	-	-	-	-	SCV000319464|SCV000649840|SCV001815025	-	-	469G>A 	Ala157Thr	NM_000071.3	1	3_Conflicting	CBS	ENSG00000160200	359	292	CCSBVarC007337	ALE00007328	469G>A	Ala157Thr	Edgotyping3	VUSMutGDEh011	D03	GDEhDisVCh_40013	F08	1	VUSMutGDDh011	D03	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	CBS_Ala157Thr	21	21	43065678	C	T
100010885	SGCB	272G>C	Arg91Pro	ENSG00000163069	4	52029835	NC_000004.12:52029835:C:G	ALE00006984	CCSBVarC006986	NULL	225815	NULL	GDEhDisVCh_40045	B01	CEGS2	ATGGCGGCAGCGGCGGCGGCGGCTGCAGAACAGCAAAGTTCCAATGGTCCTGTAAAGAAGTCCATGCGTGAGAAGGCTGTTGAGAGAAGGAGTGTCAATAAAGAGCACAACAGTAACTTTAAAGCTGGATACATTCCGATTGATGAAGATCGTCTCCACAAAACAGGGTTGAGAGGAAGAAAGGGCAATTTAGCCATCTGTGTGATTATCCTCTTGTTTATCCTGGCTGTCATCAATTTAATAATAACACTTGTTATTTGGGCCGTGATTCCCATTGGACCAAATGGCTGTGATAGTATGGAGTTTCATGAAAGTGGCCTGCTTCGATTTAAGCAAGTATCTGACATGGGAGTGATCCACCCTCTTTATAAAAGCACAGTAGGAGGAAGGCGAAATGAAAATTTGGTCATCACTGGCAACAACCAGCCTATTGTTTTTCAGCAAGGGACAACAAAGCTCAGTGTAGAAAACAACAAAACTTCTATTACAAGTGACATCGGCATGCAGTTTTTTGACCCGAGGACTCAAAATATCTTATTCAGCACAGACTATGAAACTCATGAGTTTCATTTGCCAAGTGGAGTGAAAAGTTTGAATGTTCAAAAGGCATCTACTGAAAGGATTACCAGCAATGCTACCAGTGATTTAAATATAAAAGTTGATGGGCGTGCTATTGTGCGTGGAAATGAAGGTGTATTCATTATGGGCAAAACCATTGAATTTCACATGGGTGGTAATATGGAGTTAAAGGCGGAAAACAGTATCATCCTAAATGGATCTGTGATGGTCAGCACCACCCGCCTACCCAGTTCCTCCAGTGGAGACCAGTTGGGTAGTGGTGACTGGGTACGCTACAAGCTCTGCATGTGTGCTGATGGGACGCTCTTCAAGGTGCAAGTAACCAGCCAGAACATGGGCTGCCAAATCTCAGACAACCCCTGTGGAAACACTCAT	23755.0	single nucleotide variant	NM_000232.5(SGCB):c.272G>C (p.Arg91Pro)	6443.0	SGCB	HGNC:10806	Pathogenic	1.0	Dec 01, 1996	104893869.0	-	RCV000009254	MONDO:MONDO:0011423,MedGen:C1858593,OMIM:604286,Orphanet:119	Autosomal recessive limb-girdle muscular dystrophy type 2E	germline	germline	GRCh38	NC_000004.12	4	52029835.0	52029835.0	4q12	no assertion criteria provided	1.0	-	N	ClinGen:CA119854,UniProtKB:Q16585#VAR_010392,OMIM:600900.0005	1.0	8716.0	52029835.0	C	G	-	-	-	-	-	-	SCV000029472	-	-	272G>C 	Arg91Pro	NM_000232.5		1_Pathogenic	chr4	G	C	4-52029835-G-C		8716	4	52029835	C	G	R	P	rs104893869	4	52896001	4	52590758	91	SGCB	ENSG00000163069	ENST00000381431	ENSP00000370839	Q16585	SGCB_HUMAN	c.272G>C	p.Arg91Pro	c.272G>C	p.Arg91Pro	principal1	Y	1	YES	Select	-	CGC	2	0	C	C/C	C/C	C/C	C/C	0.006	0.61594	D	0.027	0.55686	D	0.999	0.77914	D	0.998	0.88579	D	0.98	0.97016	A	simple_aae	2.0	98.0	2.61	0.76153	M	-5.3	0.84415	D	0.996	0.99956	0.9022	0.95690	D	0.8955	0.96526	D	10	0.97065616	0.96620	D	0.223431	0.87871	D	0.919	0.97925	0.839	0.94511	Q16585	R91P	Gain of loop (P = 0.1069)| Loss of MoRF binding (P = 0.1089)| Gain of catalytic residue at V89 (P = 0.1409)| Loss of helix (P = 0.2022)| Loss of stability (P = 0.2641)	0.986005058645	0.98570	0.9441369448954535	0.94360	0.461703636023	0.45423	0.792022943497	0.80717	T	0.973536	0.99727	D	0.511552	0.94584	D	0.497033	0.94505	D	0.997767925262451	0.92299	D	0.926607	0.72881	D	0.8654814	0.88349	0.8358798	0.90444	0.87931824	0.89467	0.86071044	0.92124	-9.291	0.69629	D	0.9878	0.92934	P	0.997364844045001	0.93055	0.99966276	0.99581	0.816	0.89837	.	.	.	.	.	.	5.17912	0.86851	29.0	0.99763735110294904	0.85266	0.959569	0.97988	D	0.769737358587086	0.84095	8.217289	0.748260649373976	0.85951	8.759762	5.25	5.25	0.73133	.	.	7.695	0.83532	7.684000	0.65502	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.98	0.58201	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1613542	6.197550e-07	0	1	1179684	8.476850e-07	0	0	74960	0.000000e+00	0	0	912	0.000000e+00	0	0	59990	0.000000e+00	0	0	29590	0.000000e+00	0	0	44858	0.000000e+00	0	0	63964	0.000000e+00	0	0	6060	0.000000e+00	0	1	1179684	8.476850e-07	0	0	91042	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2E	no_assertion_criteria_provided	NC_000004.12:g.52029835C>G	ClinGen:CA119854|OMIM:600900.0005|UniProtKB:Q16585#VAR_010392	C1858593	604286	119	.	Arg	Pro	23755	single nucleotide variant	NM_000232.5(SGCB):c.272G>C (p.Arg91Pro)	6443	SGCB	HGNC:10806	Pathogenic	1	Dec 01, 1996	104893869	-	RCV000009254	MONDO:MONDO:0011423,MedGen:C1858593,OMIM:604286,Orphanet:119	Autosomal recessive limb-girdle muscular dystrophy type 2E	germline	germline	GRCh38	NC_000004.12	4	52029835	52029835	4q12	no assertion criteria provided	1	-	N	ClinGen:CA119854,UniProtKB:Q16585#VAR_010392,OMIM:600900.0005	1	8716	52029835	C	G	-	-	-	-	-	-	SCV000029472	-	-	272G>C 	Arg91Pro	NM_000232.5		1_Pathogenic	SGCB	ENSG00000163069	100010885	225815	CCSBVarC006986	ALE00006984	272G>C	Arg91Pro	CEGS2	CegsMutGDEh1043	F05	GDEhDisVCh_40045	B01	1	CegsMutGDDh1043	F05	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	99	0	NULL	0	NULL	0	NULL	SGCB_Arg91Pro	4	4	52029835	C	G
72199	TSC2	2666C>T	Ala889Val	ENSG00000103197	16	2076094	NC_000016.10:2076094:C:T	ALE00002950	CCSBVarC002950	NULL	206229	NULL	GDEhDisVCh_40090	A03	CEGS2	ATGGCCAAACCAACAAGCAAAGATTCAGGCTTGAAGGAGAAGTTTAAGATTCTGTTGGGACTGGGAACACCGAGGCCAAATCCCAGGTCTGCAGAGGGTAAACAGACGGAGTTTATCATCACCGCGGAAATACTGAGAGAACTGAGCATGGAATGTGGCCTCAACAATCGCATCCGGATGATAGGGCAGATTTGTGAAGTCGCAAAAACCAAGAAATTTGAAGAGCACGCAGTGGAAGCACTCTGGAAGGCGGTCGCGGATCTGTTGCAGCCGGAGCGGCCGCTGGAGGCCCGGCACGCGGTGCTGGCTCTGCTGAAGGCCATCGTGCAGGGGCAGGGCGAGCGTTTGGGGGTCCTCAGAGCCCTCTTCTTTAAGGTCATCAAGGATTACCCTTCCAACGAAGACCTTCACGAAAGGCTGGAGGTTTTCAAGGCCCTCACAGACAATGGGAGACACATCACCTACTTGGAGGAAGAGCTGGCTGACTTTGTCCTGCAGTGGATGGATGTTGGCTTGTCCTCGGAATTCCTTCTGGTGCTGGTGAACTTGGTCAAATTCAATAGCTGTTACCTCGACGAGTACATCGCAAGGATGGTTCAGATGATCTGTCTGCTGTGCGTCCGGACCGTGTCCTCTGTGGACATAGAGGTCTCCCTGCAGGTGCTGGACGCCGTGGTCTGCTACAACTGCCTGCCGGCTGAGAGCCTCCCGCTGTTCATCGTTACCCTCTGTCGCACCATCAACGTCAAGGAGCTCTGCGAGCCTTGCTGGAAGCTGATGCGGAACCTCCTTGGCACCCACCTGGGCCACAGCGCCATCTACAACATGTGCCACCTCATGGAGGACAGAGCCTACATGGAGGACGCGCCCCTGCTGAGAGGAGCCGTGTTTTTTGTGGGCATGGCTCTCTGGGGAGCCCACCGGCTCTATTCTCTCAGGAACTCGCCGACATCTGTGTTGCCATCATTTTACCAGGCCATGGCATGTCCGAACGAGGTGGTGTCCTATGAGATCGTCCTGTCCATCACCAGGCTCATCAAGAAGTATAGGAAGGAGCTCCAGGTGGTGGCGTGGGACATTCTGCTGAACATCATCGAACGGCTCCTTCAGCAGCTCCAGACCTTGGACAGCCCGGAGCTCAGGACCATCGTCCATGACCTGTTGACCACGGTGGAGGAGCTGTGTGACCAGAACGAGTTCCACGGGTCTCAGGAGAGATACTTTGAACTGGTGGAGAGATGTGCGGACCAGAGGCCTGAGTCCTCCCTCCTGAACCTGATCTCCTATAGAGCGCAGTCCATCCACCCGGCCAAGGACGGCTGGATTCAGAACCTGCAGGCGCTGATGGAGAGATTCTTCAGGAGCGAGTCCCGAGGCGCCGTGCGCATCAAGGTGCTGGACGTGCTGTCCTTTGTGCTGCTCATCAACAGGCAGTTCTATGAGGAGGAGCTGATTAACTCAGTGGTCATCTCGCAGCTCTCCCACATCCCCGAGGATAAAGACCACCAGGTCCGAAAGCTGGCCACCCAGTTGCTGGTGGACCTGGCAGAGGGCTGCCACACACACCACTTCAACAGCCTGCTGGACATCATCGAGAAGGTGATGGCCCGCTCCCTCTCCCCACCCCCGGAGCTGGAAGAAAGGGATGTGGCCGCATACTCGGCCTCCTTGGAGGATGTGAAGACAGCCGTCCTGGGGCTTCTGGTCATCCTTCAGACCAAGCTGTACACCCTGCCTGCAAGCCACGCCACGCGTGTGTATGAGATGCTGGTCAGCCACATTCAGCTCCACTACAAGCACAGCTACACCCTGCCAATCGCGAGCAGCATCCGGCTGCAGGCCTTTGACTTCCTGTTGCTGCTGCGGGCCGACTCACTGCACCGCCTGGGCCTGCCCAACAAGGATGGAGTCGTGCGGTTCAGCCCCTACTGCGTCTGCGACTACATGGAGCCAGAGAGAGGCTCTGAGAAGAAGACCAGCGGCCCCCTTTCTCCTCCCACAGGGCCTCCTGGCCCGGCGCCTGCAGGCCCCGCCGTGCGGCTGGGGTCCGTGCCCTACTCCCTGCTCTTCCGCGTCCTGCTGCAGTGCTTGAAGCAGGAGTCTGACTGGGAGGTGCTGAAGCTGGTTCTGGGCAGGCTGCCTGAGTCCCTGCGCTATAAAGTGCTCATCTTTACTTCCCCTTGCAGTGTGGACCAGCTGTGCTCTGCTCTCTGCTCCATGCTTTCAGGCCCAAAGACACTGGAGCGGCTCCGAGGCGCCCCAGAAGGCTTCTCCAGAACTGACTTGCACCTGGCCGTGGTTCCAGTGCTGACAGCATTAATCTCTTACCATAACTACCTGGACAAAACCAAACAGCGCGAGATGGTCTACTGCCTGGAGCAGGGCCTCATCCACCGCTGTGCCAGCCAGTGCGTCGTGGCCTTGTCCATCTGCAGCGTGGAGATGCCTGACATCATCATCAAGGCGCTGCCTGTTCTGGTGGTGAAGCTCACGCACATCTCAGCCACAGCCAGCATGGCCGTCCCACTGCTGGAGTTCCTGTCCACTCTGGCCAGGCTGCCGCACCTCTACAGGAACTTTGCCGCGGAGCAGTATGCCAGTGTGTTCGCCATCTCCCTGCCGTACACCAACCCCTCCAAGTTTAATCAGTACATCGTGTGTCTGGTCCATCACGTCATAGCCATGTGGTTCATCAGGTGCCGCCTGCCCTTCCGGAAGGATTTTGTCCCTTTCATCACTAAGGGCCTGCGGTCCAATGTCCTCTTGTCTTTTGATGACACCCCCGAGAAGGACAGCTTCAGGGCCCGGAGTACTAGTCTCAACGAGAGACCCAAGAGTCTGAGGATAGCCAGACCCCCCAAACAAGGCTTGAATAACTCTCCACCCGTGAAAGAATTCAAGGAGAGCTCTGCAGCCGAGGCCTTCCGGTGCCGCAGCATCAGTGTGTCTGAACATGTGGTCCGCAGCAGGATACAGACGTCCCTCACCAGTGCCAGCTTGGGGTCTGCAGATGAGAACTCCGTGGCCCAGGCTGACGATAGCATGAAAAACCTCCACCTGGAGCTCACGGAAACCTGTCTGGACATGATGGCTCGATACGTCTTCTCCAACTTCACGGCTGTCCCGAAGAGGTCTCCTGTGGGCGAGTTCCTCCTAGCGGGTGGCAGGACCAAAACCTGGCTGGTTGGGAACAAGCTTGTCACTGTGACGACAAGCGTGGGAACCGGGACCCGGTCGTTACTAGGCCTGGACTCGGGGGAGCTGCAGTCCGGCCCGGAGTCGAGCTCCAGCCCCGGGGTGCATGTGAGACAGACCAAGGAGGCGCCGGCCAAGCTGGAGTCCCAGGCTGGGCAGCAGGTGTCCCGTGGGGCCCGGGATCGGGTCCGTTCCATGTCGGGGGGCCATGGTCTTCGAGTTGGCGCCCTGGACGTGCCGGCCTCCCAGTTCCTGGGCAGTGCCACTTCTCCAGGACCACGGACTGCACCAGCCGCGAAACCTGAGAAGGCCTCAGCTGGCACCCGGGTTCCTGTGCAGGAGAAGACGAACCTGGCGGCCTATGTGCCCCTGCTGACCCAGGGCTGGGCGGAGATCCTGGTCCGGAGGCCCACAGGGAACACCAGCTGGCTGATGAGCCTGGAGAACCCGCTCAGCCCTTTCTCCTCGGACATCAACAACATGCCCCTGCAGGAGCTGTCTAACGCCCTCATGGCGGCTGAGCGCTTCAAGGAGCACCGGGACACAGCCCTGTACAAGTCACTGTCGGTGCCGGCAGCCAGCACGGCCAAACCCCCTCCTCTGCCTCGCTCCAACACAGACTCCGCCGTGGTCATGGAGGAGGGAAGTCCGGGCGAGGTTCCTGTGCTGGTGGAGCCCCCAGGGTTGGAGGACGTTGAGGCAGCGCTAGGCATGGACAGGCGCACGGATGCCTACAGCAGGTCGTCCTCAGTCTCCAGCCAGGAGGAGAAGTCGCTCCACGCGGAGGAGCTGGTTGGCAGGGGCATCCCCATCGAGCGAGTCGTCTCCTCGGAGGGTGGCCGGCCCTCTGTGGACCTCTCCTTCCAGCCCTCGCAGCCCCTGAGCAAGTCCAGCTCCTCTCCCGAGCTGCAGACTCTGCAGGACATCCTCGGGGACCCTGGGGACAAGGCCGACGTGGGCCGGCTGAGCCCTGAGGTTAAGGCCCGGTCACAGTCAGGGACCCTGGACGGGGAAAGTGCTGCCTGGTCGGCCTCGGGCGAAGACAGTCGGGGCCAGCCCGAGGGTCCCTTGCCTTCCAGCTCCCCCCGCTCGCCCAGTGGCCTCCGGCCCCGAGGTTACACCATCTCCGACTCGGCCCCATCACGCAGGGGCAAGAGAGTAGAGAGGGACGCCTTAAAGAGCAGAGCCACAGCCTCCAATGCAGAGAAAGTGCCAGGCATCAACCCCAGTTTCGTGTTCCTGCAGCTCTACCATTCCCCCTTCTTTGGCGACGAGTCAAACAAGCCAATCCTGCTGCCCAATGAGTCACAGTCCTTTGAGCGGTCGGTGCAGCTCCTCGACCAGATCCCATCATACGACACCCACAAGATCGCCGTCCTGTATGTTGGAGAAGGCCAGAGCAACAGCGAGCTCGCCATCCTGTCCAATGAGCATGGCTCCTACAGGTACACGGAGTTCCTGACGGGCCTGGGCCGGCTCATCGAGCTGAAGGACTGCCAGCCGGACAAGGTGTACCTGGGAGGCCTGGACGTGTGTGGTGAGGACGGCCAGTTCACCTACTGCTGGCACGATGACATCATGCAAGCCGTCTTCCACATCGCCACCCTGATGCCCACCAAGGACGTGGACAAGCACCGCTGCGACAAGAAGCGCCACCTGGGCAACGACTTTGTGTCCATTGTCTACAATGACTCCGGTGAGGACTTCAAGCTTGGCACCATCAAGGGCCAGTTCAACTTTGTCCACGTGATGGTCACCCCGCTGGACTACGAGTGCAACCTGGTGTCCCTGCAGTGCAGGAAAGACATGGAGGGCCTTGTGGACACCAGCGTGGCCAAGATCGTGTCTGACCGCAACCTGCCCTTCGTGGCCCGCCAGATGGCCCTGCACGCAAATATGGCCTCACAGGTGCATCATAGCCGCTCCAACCCCACCGATATCTACCCCTCCAAGTGGATTGCCCGGCTCCGCCACATCAAGCGGCTCCGCCAGCGGATCTGCGAGGAAGCCGCCTACTCCAACCCCAGCCTACCTCTGGTGCACCCTCCGTCCCATAGCAAAGCCCCTGCACAGACTCCAGCCGAGCCCACACCTGGCTATGAGGTGGGCCAGCGGAAGCGCCTCATCTCCTCGGTGGAGGACTTCACCGAGTTTGTG	58748.0	single nucleotide variant	NM_000548.5(TSC2):c.2666C>T (p.Ala889Val)	7249.0	TSC2	HGNC:12363	Pathogenic/Likely pathogenic	1.0	Sep 06, 2024	137854155.0	-	RCV000042847|RCV000201152|RCV002433527	MONDO:MONDO:0001734,MedGen:C0041341,OMIM:PS191100,Orphanet:805|MONDO:MONDO:0013199,MedGen:C1860707,OMIM:613254,Orphanet:805|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000016.10	16	2076094.0	2076094.0	16p13.3	criteria provided, multiple submitters, no conflicts	5.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA017841,Tuberous sclerosis database (TSC2):TSC2_01111	2.0	49586.0	2076094.0	C	T	-	-	-	-	-	-	SCV000255887|SCV000765936|SCV002039675|SCV002744844	-	-	2666C>T 	Ala889Val	NM_000548.5	2.0	1_Pathogenic	chr16	C	T	16-2076094-C-T		49586	16	2076094	C	T	A	V	rs137854155	16	2126095	16	2066096	889	TSC2	ENSG00000103197	ENST00000219476	ENSP00000219476	P49815	TSC2_HUMAN	c.2666C>T	p.Ala889Val	c.2666C>T	p.Ala889Val	.	Y	5	YES	Select	+	GCC	2	0	C	C/C	C/C	C/C	C/C	0.002	0.91343	D	0.006	0.72530	D	0.999	0.77914	D	0.992	0.86259	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.065	0.86866	M	-3.44	0.69154	D	0.858	0.98852	0.9119	0.95829	D	0.8752	0.95846	D	10	0.9474385	0.94005	D	0.669747	0.97238	D	0.933	0.98451	0.803	0.92118	P49815	A889V	Gain of sheet (P = 0.0477)| Loss of helix (P = 0.0626)| Gain of MoRF binding (P = 0.1511)| Loss of catalytic residue at Y884 (P = 0.5774)| Loss of phosphorylation at Y884 (P = 0.761)	0.985348005081	0.98503	0.842078376300292	0.84072	.	.	0.914422988892	0.97868	D	0.916955	0.98464	D	0.48912	0.93923	D	0.464811	0.93846	D	0.992605480692072	0.82993	D	0.961904	0.85643	D	0.8487137	0.87069	0.6960782	0.81897	0.79152215	0.83160	0.6667845	0.80240	-11.051	0.81039	D	0.9948	0.95515	P	0.998353915045384	0.94329	0.99981409	0.99752	0.788	0.88269	.	.	.	.	.	.	4.953615	0.81882	27.6	0.99928228867372737	0.99222	0.937533	0.93522	D	0.796800970271298	0.85830	8.718031	0.761078624028193	0.86910	9.067436	5.09	5.09	0.68605	4.21	0.80015	7.842	0.85154	7.577000	0.60922	0.596	0.33565	1.0	0.71675	1.000000	0.68239	0.995	0.73271	774	0.48524	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Tuberous_sclerosis_2|Tuberous_sclerosis_syndrome|Hereditary_cancer-predisposing_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000016.10:g.2076094C>T	ClinGen:CA017841|Tuberous_sclerosis_database_(TSC2):TSC2_01111	C1860707|C0041341|C0027672	613254|PS191100	805|805|140162	Tuberin-type domain	Ala	Val	58748	single nucleotide variant	NM_000548.5(TSC2):c.2666C>T (p.Ala889Val)	7249	TSC2	HGNC:12363	Pathogenic/Likely pathogenic	1	Sep 06, 2024	137854155	-	RCV000042847|RCV000201152|RCV002433527	MONDO:MONDO:0001734,MedGen:C0041341,OMIM:PS191100,Orphanet:805|MONDO:MONDO:0013199,MedGen:C1860707,OMIM:613254,Orphanet:805|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Tuberous sclerosis syndrome|Tuberous sclerosis 2|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000016.10	16	2076094	2076094	16p13.3	criteria provided, multiple submitters, no conflicts	5	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA017841,Tuberous sclerosis database (TSC2):TSC2_01111	2	49586	2076094	C	T	-	-	-	-	-	-	SCV000255887|SCV000765936|SCV002039675|SCV002744844	-	-	2666C>T 	Ala889Val	NM_000548.5	2	1_Pathogenic	TSC2	ENSG00000103197	72199	206229	CCSBVarC002950	ALE00002950	2666C>T	Ala889Val	CEGS2	CegsMutGDEh1018	D08	GDEhDisVCh_40090	A03	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	TSC2_Ala889Val	16	16	2076094	C	T
52861	F9	572G>A	Arg191His	ENSG00000101981	X	139551113	NC_000023.11:139551113:G:A	ALE00004379	CCSBVarC004379	NULL	204360	NULL	GDEhDisVCh_40052	D07	CEGS2	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCATGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT	25624.0	single nucleotide variant	NM_000133.4(F9):c.572G>A (p.Arg191His)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Feb 09, 2024	137852238.0	-	RCV000011331|RCV000851602|RCV001390296|RCV002247326|RCV002284168	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139551113.0	139551113.0	Xq27.1	reviewed by expert panel	8.0	-	N	ClinGen:CA255342,UniProtKB:P00740#VAR_006568,OMIM:300746.0027	3.0	10585.0	139551113.0	G	A	-	-	-	-	-	-	SCV004363686	-	-	572G>A 	Arg191His	NM_000133.4	3.0	1_Pathogenic	chrX	G	A	X-139551113-G-A	2.73283e-6	10585	X	139551113	G	A	R	H	rs137852238	X	138633272	X	138460938	191	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.572G>A	p.Arg191His	c.572G>A	p.Arg191His	principal1	Y	1	YES	Select	+	CGT	2	0	G	G/G	G/G	G/G	G/G	0.038	0.43243	D	0.059	0.48432	T	0.461	0.36381	P	0.03	0.21742	B	0.29	0.82936	A	simple_aae	71.0	29.0	2.175	0.60790	M	-2.18	0.49201	N	0.464	0.68361	0.9910	0.97030	D	0.8837	0.96132	D	10	0.94853324	0.94118	D	0.304049	0.90955	D	0.730	0.90507	0.858	0.95637	P00740	R191H	Gain of methylation at K188 (P = 0.0471)| Gain of catalytic residue at E193 (P = 0.064)| Loss of phosphorylation at T194 (P = 0.0802)| Gain of ubiquitination at K188 (P = 0.0961)| Gain of glycosylation at T194 (P = 0.1036)	0.998451674901	0.99840	0.97817949293013	0.97797	1.82565083264	0.91968	0.427083998919	0.28775	T	0.584288	0.86309	D	0.484746	0.93800	D	0.458528	0.93722	D	0.752935725469828	0.43154	D	0.872513	0.60210	D	0.42576137	0.62152	0.29486942	0.55303	0.37745458	0.58804	0.20733581	0.44825	-4.38	0.29315	T	0.1576	0.40318	B	0.981076557386951	0.85578	0.99997842	0.99989	0.724	0.84705	.	.	.	.	.	.	2.919779	0.38835	20.8	0.99887204579505651	0.96206	.	.	.	.	.	.	.	.	.	4.94	4.94	0.64600	4.5	0.84251	4.306	0.58997	11.735000	0.95080	0.676	0.76753	0.997	0.40243	1.000000	0.68239	0.055	0.15632	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	80340	1.244710e-05	0	1	151847	6.585580e-06	0	1	172250	5.805520e-06	0	0	5702	0.000000e+00	0	0	13667	0.000000e+00	0	0	1767	0.000000e+00	0	0	6917	0.000000e+00	0	0	9933	0.000000e+00	0	1	30953	3.230700e-05	0	0	9951	0.000000e+00	0	1	30953	3.230700e-05	0	0	13134	0.000000e+00	0	0	24390	0.000000e+00	0	0	4647	0.000000e+00	0	0	10128	0.000000e+00	0	0	12191	0.000000e+00	0	1	64663	1.546480e-05	0	0	19069	0.000000e+00	0	1	64663	1.546480e-05	0	0	12064	0.000000e+00	0	0	27168	0.000000e+00	0	0	7081	0.000000e+00	0	0	13319	0.000000e+00	0	0	15996	0.000000e+00	0	1	73473	1.361040e-05	0	0	19004	0.000000e+00	0	1	73473	1.361040e-05	0	.	4	1209580	3.306930e-06	0	4	894893	4.469810e-06	0	0	57163	0.000000e+00	0	0	688	0.000000e+00	0	0	45737	0.000000e+00	0	0	22034	0.000000e+00	0	0	33770	0.000000e+00	0	0	46533	0.000000e+00	0	0	4373	0.000000e+00	0	4	894893	4.469810e-06	0	0	56787	0.000000e+00	0	0	92674	0	0	176	0	0	2674	0	1	4172	2.3969319271332693E-4	0	436	0	0	928	0	0	656	0	0	274	0	0	3978	0	1	4348	2.2999080036798528E-4	0	3330	0	1	105968	9.436811112788767E-6	Pathogenic	Thrombophilia,_X-linked,_due_to_factor_9_defect|Hereditary_factor_IX_deficiency_disease|Hereditary_factor_VIII_deficiency_disease|not_provided	reviewed_by_expert_panel	NC_000023.11:g.139551113G>A	ClinGen:CA255342|OMIM:300746.0027|UniProtKB:P00740#VAR_006568	C2749016|C0008533|C0019069|C3661900	300807|306900|134500|306700	98879|98878	.	Arg	His	25624	single nucleotide variant	NM_000133.4(F9):c.572G>A (p.Arg191His)	2158	F9	HGNC:3551	Pathogenic	1	Feb 09, 2024	137852238	-	RCV000011331|RCV000851602|RCV001390296|RCV002247326|RCV002284168	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010602,MedGen:C0019069,OMIM:306700,Orphanet:98878|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807|MedGen:C3661900	Hereditary factor IX deficiency disease|Hereditary factor VIII deficiency disease|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Thrombophilia, X-linked, due to factor 9 defect|not provided	germline;unknown	germline	GRCh38	NC_000023.11	X	139551113	139551113	Xq27.1	reviewed by expert panel	8	-	N	ClinGen:CA255342,UniProtKB:P00740#VAR_006568,OMIM:300746.0027	3	10585	139551113	G	A	-	-	-	-	-	-	SCV004363686	-	-	572G>A 	Arg191His	NM_000133.4	3	1_Pathogenic	F9	ENSG00000101981	52861	204360	CCSBVarC004379	ALE00004379	572G>A	Arg191His	CEGS2	CegsMutGDEh1028	C04	GDEhDisVCh_40052	D07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	F9_Arg191His	23	X	139551113	G	A
7918	MSH2	287G>A	Arg96His	ENSG00000095002	2	47408476	NC_000002.12:47408476:G:A	ALE00008457	CCSBVarC008476	NULL	NULL	209	NULL	NULL	Edgotyping3	ATGGCGGTGCAGCCGAAGGAGACGCTGCAGTTGGAGAGCGCGGCCGAGGTCGGCTTCGTGCGCTTCTTTCAGGGCATGCCGGAGAAGCCGACCACCACAGTGCGCCTTTTCGACCGGGGCGACTTCTATACGGCGCACGGCGAGGACGCGCTGCTGGCCGCCCGGGAGGTGTTCAAGACCCAGGGGGTGATCAAGTACATGGGGCCGGCAGGAGCAAAGAATCTGCAGAGTGTTGTGCTTAGTAAAATGAATTTTGAATCTTTTGTAAAAGATCTTCTTCTGGTTCATCAGTATAGAGTTGAAGTTTATAAGAATAGAGCTGGAAATAAGGCATCCAAGGAGAATGATTGGTATTTGGCATATAAGGCTTCTCCTGGCAATCTCTCTCAGTTTGAAGACATTCTCTTTGGTAACAATGATATGTCAGCTTCCATTGGTGTTGTGGGTGTTAAAATGTCCGCAGTTGATGGCCAGAGACAGGTTGGAGTTGGGTATGTGGATTCCATACAGAGGAAACTAGGACTGTGTGAATTCCCTGATAATGATCAGTTCTCCAATCTTGAGGCTCTCCTCATCCAGATTGGACCAAAGGAATGTGTTTTACCCGGAGGAGAGACTGCTGGAGACATGGGGAAACTGAGACAGATAATTCAAAGAGGAGGAATTCTGATCACAGAAAGAAAAAAAGCTGACTTTTCCACAAAAGACATTTATCAGGACCTCAACCGGTTGTTGAAAGGCAAAAAGGGAGAGCAGATGAATAGTGCTGTATTGCCAGAAATGGAGAATCAGGTTGCAGTTTCATCACTGTCTGCGGTAATCAAGTTTTTAGAACTCTTATCAGATGATTCCAACTTTGGACAGTTTGAACTGACTACTTTTGACTTCAGCCAGTATATGAAATTGGATATTGCAGCAGTCAGAGCCCTTAACCTTTTTCAGGGTTCTGTTGAAGATACCACTGGCTCTCAGTCTCTGGCTGCCTTGCTGAATAAGTGTAAAACCCCTCAAGGACAAAGACTTGTTAACCAGTGGATTAAGCAGCCTCTCATGGATAAGAACAGAATAGAGGAGAGATTGAATTTAGTGGAAGCTTTTGTAGAAGATGCAGAATTGAGGCAGACTTTACAAGAAGATTTACTTCGTCGATTCCCAGATCTTAACCGACTTGCCAAGAAGTTTCAAAGACAAGCAGCAAACTTACAAGATTGTTACCGACTCTATCAGGGTATAAATCAACTACCTAATGTTATACAGGCTCTGGAAAAACATGAAGGAAAACACCAGAAATTATTGTTGGCAGTTTTTGTGACTCCTCTTACTGATCTTCGTTCTGACTTCTCCAAGTTTCAGGAAATGATAGAAACAACTTTAGATATGGATCAGGTGGAAAACCATGAATTCCTTGTAAAACCTTCATTTGATCCTAATCTCAGTGAATTAAGAGAAATAATGAATGACTTGGAAAAGAAGATGCAGTCAACATTAATAAGTGCAGCCAGAGATCTTGGCTTGGACCCTGGCAAACAGATTAAACTGGATTCCAGTGCACAGTTTGGATATTACTTTCGTGTAACCTGTAAGGAAGAAAAAGTCCTTCGTAACAATAAAAACTTTAGTACTGTAGATATCCAGAAGAATGGTGTTAAATTTACCAACAGCAAATTGACTTCTTTAAATGAAGAGTATACCAAAAATAAAACAGAATATGAAGAAGCCCAGGATGCCATTGTTAAAGAAATTGTCAATATTTCTTCAGGCTATGTAGAACCAATGCAGACACTCAATGATGTGTTAGCTCAGCTAGATGCTGTTGTCAGCTTTGCTCACGTGTCAAATGGAGCACCTGTTCCATATGTACGACCAGCCATTTTGGAGAAAGGACAAGGAAGAATTATATTAAAAGCATCCAGGCATGCTTGTGTTGAAGTTCAAGATGAAATTGCATTTATTCCTAATGACGTATACTTTGAAAAAGATAAACAGATGTTCCACATCATTACTGGCCCCAATATGGGAGGTAAATCAACATATATTCGACAAACTGGGGTGATAGTACTCATGGCCCAAATTGGGTGTTTTGTGCCATGTGAGTCAGCAGAAGTGTCCATTGTGGACTGCATCTTAGCCCGAGTAGGGGCTGGTGACAGTCAATTGAAAGGAGTCTCCACGTTCATGGCTGAAATGTTGGAAACTGCTTCTATCCTCAGGTCTGCAACCAAAGATTCATTAATAATCATAGATGAATTGGGAAGAGGAACTTCTACCTACGATGGATTTGGGTTAGCATGGGCTATATCAGAATACATTGCAACAAAGATTGGTGCTTTTTGCATGTTTGCAACCCATTTTCATGAACTTACTGCCTTGGCCAATCAGATACCAACTGTTAATAATCTACATGTCACAGCACTCACCACTGAAGAGACCTTAACTATGCTTTATCAGGTGAAGAAAGGTGTCTGTGATCAAAGTTTTGGGATTCATGTTGCAGAGCTTGCTAATTTCCCTAAGCATGTAATAGAGTGTGCTAAACAGAAAGCCCTGGAACTTGAGGAGTTTCAGTATATTGGAGAATCGCAAGGATATGATATCATGGAACCAGCAGCAAAGAAGTGCTATCTGGAAAGAGAGCAAGGTGAAAAAATTATTCAGGAGTTCCTGTCCAAGGTGAAACAAATGCCCTTTACTGAAATGTCAGAAGAAAACATCACAATAAAGTTAAAACAGCTAAAAGCTGAAGTAATAGCAAAGAATAATAGCTTTGTAAATGAAATCATTTCACGAATAAAAGTTACTACG	96528.0	single nucleotide variant	NM_000251.3(MSH2):c.287G>A (p.Arg96His)	4436.0	MSH2	HGNC:7325	Likely benign	0.0	Sep 05, 2013	63750002.0	-	RCV000076555|RCV000164188|RCV000442211|RCV000524401|RCV000662472|RCV001719812	MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MeSH:D003123,MedGen:C0009405|MONDO:MONDO:0007356,MedGen:C2936783,OMIM:120435,Orphanet:144|MedGen:C3661900	Lynch syndrome|Hereditary cancer-predisposing syndrome|not specified|Hereditary nonpolyposis colorectal neoplasms|Lynch syndrome 1|not provided	germline;unknown	germline	GRCh38	NC_000002.12	2	47408476.0	47408476.0	2p21	reviewed by expert panel	9.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA020967,UniProtKB:P43246#VAR_004471	2.0	91053.0	47408476.0	G	A	-	-	-	-	-	-	SCV000107584	-	-	287G>A 	Arg96His	NM_000251.3	3.0	2_Benign	chr2	G	A	2-47408476-G-A	0.0000280777	91053	2	47408476	G	A	R	H	rs63750002	2	47635615	2	47489119	96	MSH2	ENSG00000095002	ENST00000233146	ENSP00000233146	P43246	MSH2_HUMAN	c.287G>A	p.Arg96His	c.287G>A	p.Arg96His	principal1	Y	1	YES	Select	+	CGT	2	0	G	G/G	G/G	G/G	G/G	0.09	0.33562	T	0.117	0.36701	T	0.987	0.90580	D	0.864	0.80453	P	0.42	0.65374	N	simple_aae	58.0	42.0	2.15	0.59964	M	-3.35	0.66466	D	0.677	0.76945	0.8266	0.94723	D	0.8458	0.94842	D	10	0.58637846	0.65842	D	0.105764	0.78036	D	0.727	0.90374	0.356	0.35591	P43246	R96H	Loss of MoRF binding (P = 0.013)| Gain of catalytic residue at E101 (P = 0.1963)| Loss of sheet (P = 0.302)| Gain of methylation at R99 (P = 0.3892)| Loss of helix (P = 0.4763)	0.887574509307	0.88560	0.5866815285506732	0.58415	0.0321411802095	0.03232	0.829075574875	0.86397	D	0.716038	0.91861	D	0.212881	0.74916	D	0.175669	0.81611	D	0.462182227267249	0.30933	T	0.917608	0.70316	D	0.3206727	0.54364	0.2878715	0.54589	0.5055657	0.67115	0.31920123	0.57657	-11.59	0.82848	D	0.2026	0.48343	B	0.56422066802293	0.62728	0.99965942	0.99581	0.774	0.87488	.	.	.	.	.	.	4.954976	0.81908	27.7	0.99869115274159315	0.94730	0.848393	0.76436	D	0.59042560580744	0.72429	5.827613	0.558315073998965	0.71823	5.737877	5.31	5.31	0.75027	2.29	0.43147	8.662	0.90898	4.864000	0.45576	0.597	0.3436	1.0	0.71675	1.000000	0.68239	0.989	0.64309	807	0.43408	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	109348	1.829020e-05	0	5	207978	2.404100e-05	0	4	236760	1.689470e-05	0	0	7164	0.000000e+00	0	0	17082	0.000000e+00	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13392	0.000000e+00	0	2	42762	4.677050e-05	0	0	15668	0.000000e+00	0	2	42762	4.677050e-05	0	0	16210	0.000000e+00	0	0	30484	0.000000e+00	0	0	6210	0.000000e+00	0	0	13414	0.000000e+00	0	0	16732	0.000000e+00	0	4	89496	4.469470e-05	0	1	30572	3.270970e-05	0	4	89496	4.469470e-05	0	0	14894	0.000000e+00	0	0	34218	0.000000e+00	0	0	9570	0.000000e+00	0	0	17688	0.000000e+00	0	0	21628	0.000000e+00	0	3	102664	2.922150e-05	0	1	30490	3.279760e-05	0	1	30490	3.279760e-05	0	.	46	1611882	2.853810e-05	0	42	1178610	3.563520e-05	0	0	74696	0.000000e+00	0	0	912	0.000000e+00	0	0	59882	0.000000e+00	0	0	29592	0.000000e+00	0	0	44858	0.000000e+00	0	1	63878	1.565480e-05	0	0	6072	0.000000e+00	0	42	1178610	3.563520e-05	0	2	90964	2.198670e-05	0	2	24516	8.157937673356176E-5	0	108	0	0	84	0	0	2728	0	0	500	0	0	628	0	0	24	0	0	94	0	0	4562	0	0	2836	0	0	108	0	2	33244	6.016123210203345E-5	Likely_benign	Hereditary_nonpolyposis_colorectal_neoplasms|Lynch_syndrome_1|not_provided|Hereditary_cancer-predisposing_syndrome|Lynch_syndrome|not_specified	reviewed_by_expert_panel	NC_000002.12:g.47408476G>A	ClinGen:CA020967|UniProtKB:P43246#VAR_004471	C0009405|C2936783|C3661900|C0027672|C4552100|CN169374	120435	144|140162|144	DNA mismatch repair protein MutS-like, N-terminal	Arg	His	96528	single nucleotide variant	NM_000251.3(MSH2):c.287G>A (p.Arg96His)	4436	MSH2	HGNC:7325	Likely benign	0	Sep 05, 2013	63750002	-	RCV000076555|RCV000164188|RCV000442211|RCV000524401|RCV000662472|RCV001719812	MONDO:MONDO:0005835,MedGen:C4552100,Orphanet:144|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|MeSH:D003123,MedGen:C0009405|MONDO:MONDO:0007356,MedGen:C2936783,OMIM:120435,Orphanet:144|MedGen:C3661900	Lynch syndrome|Hereditary cancer-predisposing syndrome|not specified|Hereditary nonpolyposis colorectal neoplasms|Lynch syndrome 1|not provided	germline;unknown	germline	GRCh38	NC_000002.12	2	47408476	47408476	2p21	reviewed by expert panel	9	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA020967,UniProtKB:P43246#VAR_004471	2	91053	47408476	G	A	-	-	-	-	-	-	SCV000107584	-	-	287G>A 	Arg96His	NM_000251.3	3	2_Benign	MSH2	ENSG00000095002	7918	209	CCSBVarC008476	ALE00008457	287G>A	Arg96His	Edgotyping3	VUSmut_GDEh11	A08	NULL	NULL	NULL	NULL	NULL	NULL	NULL	VUSMutpDEST2_07	C02	VUSmut_GDEh11	A08	0	NULL	0	NULL	0	NULL	1	1	1	7	MSH2_Arg96His	2	2	47408476	G	A
3172	CBS	304A>C	Lys102Gln	ENSG00000160200	21	43068521	NC_000021.9:43068521:T:G	ALE00003746	CCSBVarC003746	NULL	214520	NULL	GDEhDisVCh_40055	D06	CEGS2	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTCCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGCAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCCGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	140380.0	single nucleotide variant	NM_000071.3(CBS):c.304A>C (p.Lys102Gln)	875.0	CBS	HGNC:1550	Benign/Likely benign	0.0	Jan 29, 2025	34040148.0	-	RCV000178036|RCV000224394|RCV000233317|RCV002312820|RCV002228454|RCV002277188	MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:C3150344|MONDO:MONDO:0003900,MedGen:C0009782	not specified|not provided|Classic homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Connective tissue disorder	germline;unknown	germline	GRCh38	NC_000021.9	21	43068521.0	43068521.0	21q22.3	criteria provided, multiple submitters, no conflicts	16.0	-	N	ClinGen:CA302971,UniProtKB:P35520#VAR_008052	2.0	136677.0	43068521.0	T	G	-	-	-	-	-	-	SCV000167573|SCV000230022|SCV000268833|SCV000281546|SCV000283386|SCV000436230|SCV000738386|SCV000803598|SCV000883541|SCV002547804|SCV002566483|SCV005206372	-	-	304A>C 	Lys102Gln	NM_000071.3	2.0	2_Benign	chr21	A	C	21-43068521-A-C		136677	21	43068521	T	G	K	Q	rs34040148	21	44488631	21	43361700	102	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.304A>C	p.Lys102Gln	c.304A>C	p.Lys102Gln	principal1	Y	1	.	.	-	AAG	1	0	T	T/T	T/T	T/T	T/T	0.101	0.32282	T	0.091	0.40454	T	0.556	0.38262	P	0.232	0.38315	B	0.01	0.05039	N	simple_aae	99.0	1.0	1.855	0.48991	L	-2.28	0.61611	N	0.494	0.52504	0.0632	0.83418	D	0.4669	0.79344	T	10	0.012555659	0.00266	T	.	.	.	0.578	0.82883	.	.	.	.	.	0.852628768757	0.85005	.	0.79870	.	0.39928	0.661741733551	0.61597	T	0.927347	0.98729	D	-0.202917	0.20070	T	-0.0349757	0.67806	D	0.0236101967360085	0.01092	T	.	0.68829	.	0.63689244	0.74391	0.15798584	0.36801	0.6334487	0.74207	0.25271472	0.50711	-8.185	0.62397	D	0.1055	0.19546	LB	0.778692397335854	0.69907	0.99573650	0.97863	0.758	0.86598	.	.	.	.	.	.	2.712895	0.35534	19.91	0.98161707593664205	0.38923	0.798152	0.72377	D	0.158451003923779	0.48965	3.124212	0.204310399058024	0.49828	3.204402	4.81	4.81	0.61353	2.97	0.54324	4.079	0.57424	3.969000	0.40889	0.58	0.29757	1.0	0.71675	1.000000	0.68239	0.26	0.23565	988	0.02004	59	0.01178115015974441	59	0.04462934947049924	0	0.0	0	0.0	0	0.0	0	0.0	.	.	.	.	332	109402	3.034680e-03	7	724	208042	3.480070e-03	15	680	236832	2.871230e-03	12	293	7162	4.091040e-02	7	33	17112	1.928470e-03	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	0	13394	0.000000e+00	0	3	42764	7.015250e-05	0	0	15690	0.000000e+00	0	293	7162	4.091040e-02	7	645	16208	3.979520e-02	15	60	30522	1.965800e-03	0	0	6212	0.000000e+00	0	0	13414	0.000000e+00	0	0	16734	0.000000e+00	0	12	89482	1.341050e-04	0	0	30608	0.000000e+00	0	645	16208	3.979520e-02	15	588	14894	3.947900e-02	12	69	34258	2.014130e-03	0	0	9570	0.000000e+00	0	0	17692	0.000000e+00	0	0	21632	0.000000e+00	0	17	102644	1.656210e-04	0	0	30526	0.000000e+00	0	588	14894	3.947900e-02	12	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	20	190478	1.0499900250947616E-4	13	370	0.03513513513513514	0	4474	0	336	9218	0.036450423085267955	1	818	0.0012224938875305623	1	1056	9.46969696969697E-4	0	1846	0	0	296	0	38	17888	0.00212432915921288	349	9588	0.03639966624947851	0	6320	0	409	226444	0.0018061860769108477	Benign/Likely_benign	not_provided|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|Classic_homocystinuria|Connective_tissue_disorder|not_specified	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43068521T>G	ClinGen:CA302971|UniProtKB:P35520#VAR_008052	C3661900|C3150344|C4707243|C0751202|C0009782|CN169374	PS607086|236200	91387|394	Tryptophan synthase beta chain-like, PALP domain	Lys	Gln	140380	single nucleotide variant	NM_000071.3(CBS):c.304A>C (p.Lys102Gln)	875	CBS	HGNC:1550	Benign/Likely benign	0	Jan 29, 2025	34040148	-	RCV000178036|RCV000224394|RCV000233317|RCV002312820|RCV002228454|RCV002277188	MedGen:CN169374|MedGen:C3661900|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:C3150344|MONDO:MONDO:0003900,MedGen:C0009782	not specified|not provided|Classic homocystinuria|Familial thoracic aortic aneurysm and aortic dissection|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Connective tissue disorder	germline;unknown	germline	GRCh38	NC_000021.9	21	43068521	43068521	21q22.3	criteria provided, multiple submitters, no conflicts	16	-	N	ClinGen:CA302971,UniProtKB:P35520#VAR_008052	2	136677	43068521	T	G	-	-	-	-	-	-	SCV000167573|SCV000230022|SCV000268833|SCV000281546|SCV000283386|SCV000436230|SCV000738386|SCV000803598|SCV000883541|SCV002547804|SCV002566483|SCV005206372	-	-	304A>C 	Lys102Gln	NM_000071.3	2	2_Benign	CBS	ENSG00000160200	3172	214520	CCSBVarC003746	ALE00003746	304A>C	Lys102Gln	CEGS2	CegsMutGDEh1039	B01	GDEhDisVCh_40055	D06	1	CegsMutGDDh1039	B01	NULL	NULL	NULL	NULL	NULL	NULL	1	3	1	1	0	NULL	0	NULL	0	NULL	CBS_Lys102Gln	21	21	43068521	T	G
71569	OTC	503A>G	His168Arg	ENSG00000036473	X	38401391	NC_000023.11:38401391:A:G	ALE00005249	CCSBVarC005249	NULL	205884	NULL	GDEhDisVCh_40048	B08	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGCATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCGTCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103117.0	single nucleotide variant	NM_000531.6(OTC):c.503A>G (p.His168Arg)	5009.0	OTC	HGNC:8512	Pathogenic	1.0	Apr 30, 2021	66867430.0	-	RCV000083465|RCV001854459	MedGen:C3661900|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664	not provided|Ornithine carbamoyltransferase deficiency	germline;unknown	germline	GRCh38	NC_000023.11	X	38401391.0	38401391.0	Xp11.4	criteria provided, single submitter	2.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224651,UniProtKB:P00480#VAR_004885	2.0	97225.0	38401391.0	A	G	-	-	-	-	-	-	SCV002141784	-	-	503A>G 	His168Arg	NM_000531.6	1.0	1_Pathogenic	chrX	A	G	X-38401391-A-G		97225	X	38401391	A	G	H	R	rs66867430	X	38260644	X	38145588	168	OTC	ENSG00000036473	ENST00000039007	ENSP00000039007	P00480	OTC_HUMAN	c.503A>G	p.His168Arg	c.503A>G	p.His168Arg	principal1	Y	1	YES	Select	+	CAT	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.91	0.92786	A	simple_aae	9.0	91.0	3.63	0.93919	H	-7.94	0.96309	D	0.995	0.99931	0.9807	0.96862	D	0.9991	0.99970	D	10	0.99664426	0.99999	D	0.982903	0.99915	D	0.970	0.99647	0.995	0.99946	P00480	H168R	Loss of catalytic residue at Q171 (P = 0.2251)| Gain of relative solvent accessibility (P = 0.2816)| Loss of phosphorylation at Y167 (P = 0.3882)| Gain of solvent accessibility (P = 0.4304)| Loss of loop (P = 0.4412)	0.999517709484	0.99950	0.9976614442405444	0.99765	1.17788593196	0.79821	0.686989367008	0.65215	T	0.988258	0.99938	D	0.740065	0.99969	D	0.825275	0.99969	D	0.999543070793152	0.97827	D	0.985426	0.95006	D	0.99510276	0.99963	0.99542964	0.99998	0.99510276	0.99963	0.99542964	0.99999	-14.152	0.93553	D	0.9936	0.94881	P	0.999989496064368	0.99579	0.99882940	0.98987	0.994	0.99793	.	.	.	.	.	.	4.621317	0.73433	26.0	0.99760560505890872	0.85024	.	.	.	.	.	.	.	.	.	5.97	5.97	0.96929	5.17	0.91630	8.892	0.92159	11.081000	0.85771	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.998	0.85369	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Ornithine_carbamoyltransferase_deficiency|not_provided	criteria_provided,_single_submitter	NC_000023.11:g.38401391A>G	ClinGen:CA224651|UniProtKB:P00480#VAR_004885	C0268542|C3661900	311250	664	Aspartate/ornithine carbamoyltransferase, carbamoyl-P binding	His	Arg	103117	single nucleotide variant	NM_000531.6(OTC):c.503A>G (p.His168Arg)	5009	OTC	HGNC:8512	Pathogenic	1	Apr 30, 2021	66867430	-	RCV000083465|RCV001854459	MedGen:C3661900|MONDO:MONDO:0010703,MedGen:C0268542,OMIM:311250,Orphanet:664	not provided|Ornithine carbamoyltransferase deficiency	germline;unknown	germline	GRCh38	NC_000023.11	X	38401391	38401391	Xp11.4	criteria provided, single submitter	2	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224651,UniProtKB:P00480#VAR_004885	2	97225	38401391	A	G	-	-	-	-	-	-	SCV002141784	-	-	503A>G 	His168Arg	NM_000531.6	1	1_Pathogenic	OTC	ENSG00000036473	71569	205884	CCSBVarC005249	ALE00005249	503A>G	His168Arg	CEGS2	CegsMutGDEh1029	F01	GDEhDisVCh_40048	B08	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	OTC_His168Arg	23	X	38401391	A	G
52861	F9	677G>A	Arg226Gln	ENSG00000101981	X	139551218	NC_000023.11:139551218:G:A	ALE00004380	CCSBVarC004380	NULL	204362	NULL	GDEhDisVCh_40052	H01	CEGS2	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCAGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT	25630.0	single nucleotide variant	NM_000133.4(F9):c.677G>A (p.Arg226Gln)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Jun 21, 2024	137852241.0	-	RCV000011337|RCV001727513|RCV004752695|RCV004814880	MedGen:CN043453|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879||MedGen:C3661900	Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided	germline	germline	GRCh38	NC_000023.11	X	139551218.0	139551218.0	Xq27.1	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA121128,UniProtKB:P00740#VAR_006572,OMIM:300746.0031	3.0	10591.0	139551218.0	G	A	-	-	-	-	-	-	SCV001976456|SCV005439229	-	-	677G>A 	Arg226Gln	NM_000133.4	2.0	1_Pathogenic	chrX	G	A	X-139551218-G-A		10591	X	139551218	G	A	R	Q	rs137852241	X	138633377	X	138461043	226	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.677G>A	p.Arg226Gln	c.677G>A	p.Arg226Gln	principal1	Y	1	YES	Select	+	CGG	2	0	G	G/G	G/G	G/G	G/G	0.002	0.72322	D	0.005	0.72530	D	0.998	0.73231	D	0.852	0.60752	P	0.77	0.87956	A	simple_aae	23.0	77.0	2.175	0.60790	M	-3.36	0.66580	D	0.864	0.90815	0.9333	0.96137	D	0.8506	0.95008	D	10	0.9918215	0.99712	D	0.848427	0.98828	D	0.793	0.93165	0.952	0.99445	P00740	R226Q	Loss of catalytic residue at R226 (P = 0.0625)| Gain of disorder (P = 0.1443)| Loss of phosphorylation at T225 (P = 0.1492)| Loss of sheet (P = 0.1907)| Gain of loop (P = 0.3485)	0.999946805639	0.99994	0.9984916172821304	0.99848	1.74758098799	0.90920	0.388901472092	0.23489	T	0.836803	0.96127	D	0.587764	0.97316	D	0.606506	0.97273	D	0.987725436687469	0.78004	D	0.737626	0.35241	T	0.75372374	0.80855	0.8180072	0.89275	0.782613	0.82601	0.7921764	0.87626	-10.798	0.78608	D	0.2674	0.59270	B	0.999623815643521	0.97231	0.99998748	0.99996	0.983	0.99413	.	.	.	.	.	.	4.412827	0.68339	25.2	0.99948969239605312	0.99931	.	.	.	.	.	.	.	.	.	5.31	5.31	0.75027	4.78	0.87641	5.361	0.65922	11.788000	0.96297	0.676	0.76753	0.988	0.36621	1.000000	0.68239	0.94	0.48078	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7618	0	0	108	0	0	84	0	0	2708	0	0	146	0	0	610	0	0	24	0	0	94	0	0	470	0	0	2816	0	0	108	0	0	11862	0	Pathogenic	Hemophilia_b(m)|Hereditary_factor_IX_deficiency_disease	criteria_provided,_single_submitter	NC_000023.11:g.139551218G>A	ClinGen:CA121128|OMIM:300746.0031|UniProtKB:P00740#VAR_006572	CN043453|C0008533	306900	98879	Serine proteases, trypsin domain	Arg	Gln	25630	single nucleotide variant	NM_000133.4(F9):c.677G>A (p.Arg226Gln)	2158	F9	HGNC:3551	Pathogenic	1	Jun 21, 2024	137852241	-	RCV000011337|RCV001727513|RCV004752695|RCV004814880	MedGen:CN043453|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879||MedGen:C3661900	Hemophilia b(m)|Hereditary factor IX deficiency disease|F9-related disorder|not provided	germline	germline	GRCh38	NC_000023.11	X	139551218	139551218	Xq27.1	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA121128,UniProtKB:P00740#VAR_006572,OMIM:300746.0031	3	10591	139551218	G	A	-	-	-	-	-	-	SCV001976456|SCV005439229	-	-	677G>A 	Arg226Gln	NM_000133.4	2	1_Pathogenic	F9	ENSG00000101981	52861	204362	CCSBVarC004380	ALE00004380	677G>A	Arg226Gln	CEGS2	CegsMutGDEh1010	H09	GDEhDisVCh_40052	H01	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	F9_Arg226Gln	23	X	139551218	G	A
3774	TP53	875A>T	Lys292Ile	ENSG00000141510	17	7673745	NC_000017.11:7673745:T:A	ALE00004878	CCSBVarC004878	NULL	214909	NULL	GDEhDisVCh_40053	D08	CEGS2	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACCGGCGCACAGAGGAAGAGAATCTCCGCAAGATAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	27417.0	single nucleotide variant	NM_000546.6(TP53):c.875A>T (p.Lys292Ile)	7157.0	TP53	HGNC:11998	Uncertain significance	1.0	Jan 05, 2021	121912663.0	-	RCV000013177|RCV001525191	Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000017.11	17	7673745.0	7673745.0	17p13.1	criteria provided, multiple submitters, no conflicts	3.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000469,UniProtKB:P04637#VAR_015819,OMIM:191170.0034	3.0	12378.0	7673745.0	T	A	-	-	-	-	-	-	SCV001735235|SCV002686234	-	-	875A>T 	Lys292Ile	NM_000546.6	2.0	4_VUS	chr17	A	T	17-7673745-A-T		12378	17	7673745	T	A	K	I	rs121912663	17	7577063	17	7517788	292	TP53	ENSG00000141510	ENST00000714357	ENSP00000519624	P04637	P53_HUMAN	.	.	c.875A>T	p.Lys292Ile	principal1	Y	.	.	.	-	AAA	2	0	T	T/T	T/T	T/T	T/T	.	0.78662	.	.	0.69466	.	0.017	0.19879	B	0.164	0.50996	B	.	0.97926	.	.	.	.	3.015	0.85979	M	.	0.68211	.	.	0.47797	1.1215	0.99909	D	0.9876	0.99636	D	9	.	0.89338	.	0.74453	0.97953	D	.	0.94675	0.718	0.85249	P04637	K292I	Loss of ubiquitination at K292 (P = 4e-04)| Loss of glycosylation at K292 (P = 0.0259)| Gain of methylation at K291 (P = 0.044)| Gain of helix (P = 0.132)| Loss of solvent accessibility (P = 0.1434)	.	0.99148	.	0.52949	.	0.32887	0.396621346474	0.24571	T	0.903158	0.98096	D	0.384261	0.88905	D	0.314188	0.88765	D	0.978122889995575	0.71981	D	.	0.73289	.	0.78328	0.82641	0.36814708	0.61868	0.768551	0.81740	0.4408064	0.67131	-9.259	0.69428	D	.	0.57742	.	0.885299752899093	0.75094	0.99993730	0.99939	0.357	0.61479	.	.	.	.	.	.	3.389818	0.4701	22.4	0.99361362446224943	0.61085	0.625906	0.60753	D	0.0440680667977269	0.43611	2.671596	0.0528993193681723	0.41926	2.549339	5.12	4.02	0.45905	4.24	0.80495	4.201	0.58323	4.197000	0.42521	0.661	0.55789	1.0	0.71675	1.000000	0.68239	0.816	0.38482	432	0.80699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	Hereditary_cancer-predisposing_syndrome|Li-Fraumeni_syndrome_1	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.7673745T>A	ClinGen:CA000469|OMIM:191170.0034|UniProtKB:P04637#VAR_015819	C0027672|C1835398	151623	140162|524	.	Lys	Ile	27417	single nucleotide variant	NM_000546.6(TP53):c.875A>T (p.Lys292Ile)	7157	TP53	HGNC:11998	Uncertain significance	1	Jan 05, 2021	121912663	-	RCV000013177|RCV001525191	Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	germline	germline	GRCh38	NC_000017.11	17	7673745	7673745	17p13.1	criteria provided, multiple submitters, no conflicts	3	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000469,UniProtKB:P04637#VAR_015819,OMIM:191170.0034	3	12378	7673745	T	A	-	-	-	-	-	-	SCV001735235|SCV002686234	-	-	875A>T 	Lys292Ile	NM_000546.6	2	4_VUS	TP53	ENSG00000141510	3774	214909	CCSBVarC004878	ALE00004878	875A>T	Lys292Ile	CEGS2	CegsMutGDEh1024	F04	GDEhDisVCh_40053	D08	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	6	0	NULL	0	NULL	0	NULL	0	NULL	TP53_Lys292Ile	17	17	7673745	T	A
3774	TP53	770T>A	Leu257Gln	ENSG00000141510	17	7674193	NC_000017.11:7674193:A:T	ALE00004869	CCSBVarC004869	NULL	214899	NULL	GDEhDisVCh_40053	C09	CEGS2	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACAGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACCGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	27411.0	single nucleotide variant	NM_000546.6(TP53):c.770T>A (p.Leu257Gln)	7157.0	TP53	HGNC:11998	Conflicting classifications of pathogenicity	1.0	Jun 15, 2023	28934577.0	-	RCV000013171|RCV000469142|RCV000785553|RCV002399320	MONDO:MONDO:0800290,MedGen:C2675080|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Li-fraumeni-like syndrome|Li-Fraumeni syndrome|Ovarian neoplasm|Hereditary cancer-predisposing syndrome	germline;somatic	germline/somatic	GRCh38	NC_000017.11	17	7674193.0	7674193.0	17p13.1	criteria provided, conflicting classifications	4.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000402,UniProtKB:P04637#VAR_045284,OMIM:191170.0028	3.0	12372.0	7674193.0	A	T	-	-	-	-	-	-	SCV000545266|SCV002674840	-	-	770T>A 	Leu257Gln	NM_000546.6	1.0	3_Conflicting	chr17	T	A	17-7674193-T-A		12372	17	7674193	A	T	L	Q	rs28934577	17	7577511	17	7518236	257	TP53	ENSG00000141510	ENST00000714357	ENSP00000519624	P04637	P53_HUMAN	.	.	c.770T>A	p.Leu257Gln	principal1	Y	.	.	.	-	CTG	2	0	A	A/A	A/A	A/A	A/A	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	0.999	0.97365	D	.	0.99291	.	.	.	.	3.295	0.90281	M	.	0.87253	.	.	0.99488	0.9221	0.95976	D	0.9948	0.99882	D	9	.	0.99668	.	0.783088	0.98289	D	.	0.97811	0.966	0.99665	P04637	L257Q	Loss of catalytic residue at L257 (P = 0.0431)| Gain of disorder (P = 0.0502)| Loss of stability (P = 0.0502)| Loss of sheet (P = 0.1398)| Gain of phosphorylation at T256 (P = 0.1985)	.	0.99854	.	0.95017	.	0.40264	0.704273700714	0.67708	T	0.995135	0.99990	D	0.584126	0.97046	D	0.60128	0.96997	D	0.996989606335633	0.90432	D	.	0.93728	.	0.9925288	0.99879	0.97110087	0.99504	0.99098575	0.99810	0.9734171	0.99599	-14.929	0.95693	D	.	0.95665	.	0.998411078595952	0.94420	0.99997520	0.99978	0.979	0.99252	.	.	.	.	.	.	4.442791	0.69055	25.3	0.99002531627237111	0.50278	0.917645	0.88513	D	0.633214901197439	0.75154	6.279274	0.506268561201229	0.68240	5.216329	4.62	3.53	0.39462	4.25	0.80650	9.325	0.96016	9.386000	0.80578	0.756	0.943	1.0	0.71675	1.000000	0.68239	0.737	0.35372	432	0.80699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Conflicting_classifications_of_pathogenicity	Hereditary_cancer-predisposing_syndrome|Ovarian_neoplasm|Li-fraumeni-like_syndrome|Li-Fraumeni_syndrome	criteria_provided,_conflicting_classifications	NC_000017.11:g.7674193A>T	ClinGen:CA000402|OMIM:191170.0028|UniProtKB:P04637#VAR_045284	C0027672|C0919267|C2675080|C0085390	PS151623	140162|524	p53, DNA-binding domain|p53, DNA-binding domain	Leu	Gln	27411	single nucleotide variant	NM_000546.6(TP53):c.770T>A (p.Leu257Gln)	7157	TP53	HGNC:11998	Conflicting classifications of pathogenicity	1	Jun 15, 2023	28934577	-	RCV000013171|RCV000469142|RCV000785553|RCV002399320	MONDO:MONDO:0800290,MedGen:C2675080|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162	Li-fraumeni-like syndrome|Li-Fraumeni syndrome|Ovarian neoplasm|Hereditary cancer-predisposing syndrome	germline;somatic	germline/somatic	GRCh38	NC_000017.11	17	7674193	7674193	17p13.1	criteria provided, conflicting classifications	4	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000402,UniProtKB:P04637#VAR_045284,OMIM:191170.0028	3	12372	7674193	A	T	-	-	-	-	-	-	SCV000545266|SCV002674840	-	-	770T>A 	Leu257Gln	NM_000546.6	1	3_Conflicting	TP53	ENSG00000141510	3774	214899	CCSBVarC004869	ALE00004869	770T>A	Leu257Gln	CEGS2	CegsMutGDEh1026	B03	GDEhDisVCh_40053	C09	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	TP53_Leu257Gln	17	17	7674193	A	T
52861	F9	907C>T	His303Tyr	ENSG00000101981	X	139561592	NC_000023.11:139561592:C:T	ALE00004383	CCSBVarC004383	NULL	204372	NULL	GDEhDisVCh_40052	G07	CEGS2	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACTACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT	25680.0	single nucleotide variant	NM_000133.4(F9):c.907C>T (p.His303Tyr)	2158.0	F9	HGNC:3551	Benign/Likely benign	0.0	Jan 19, 2025	1801202.0	-	RCV000011387|RCV001081157|RCV002496326|RCV001167683|RCV003944813	|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	FACTOR IX POLYMORPHISM|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139561592.0	139561592.0	Xq27.1	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA121135,OMIM:300746.0085	3.0	10641.0	139561592.0	C	T	-	-	-	-	-	-	SCV001001225|SCV001330208|SCV002804939	-	-	907C>T 	His303Tyr	NM_000133.4	2.0	2_Benign	chrX	C	T	X-139561592-C-T	0.000794178	10641	X	139561592	C	T	H	Y	rs1801202	X	138643751	X	138471417	303	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.907C>T	p.His303Tyr	c.907C>T	p.His303Tyr	principal1	Y	1	YES	Select	+	CAC	1	0	C	C/C	C/C	C/C	C/C	1.0	0.00968	T	0.089	0.40770	T	0.0	0.02950	B	0.002	0.06938	B	0.03	0.13669	N	simple_aae	97.0	3.0	0.65	0.16042	N	-2.11	0.48032	N	0.134	0.12993	-0.5347	0.67220	T	0.5304	0.82502	D	10	0.058540702	0.06886	T	0.074688	0.72008	D	0.549	0.81214	.	.	.	.	.	0.999367092589	0.99934	0.9381481836570156	0.93756	0.738624950036	0.62872	0.438427627087	0.30325	T	0.723082	0.92116	D	-0.0624261	0.42182	T	0.075559	0.75097	D	0.0133548470984691	0.00239	T	0.640436	0.25033	T	0.22414766	0.44724	0.17656629	0.40065	0.32649112	0.54850	0.2341255	0.48437	-3.72	0.19630	T	0.0722	0.19100	B	0.69627509395232	0.66900	0.99989235	0.99864	0.254	0.52448	.	.	.	.	.	.	1.514762	0.19488	14.27	0.32830897832429229	0.01925	.	.	.	.	.	.	.	.	.	5.42	1.68	0.23158	0.182	0.22814	2.06	0.41124	-0.323000	0.09991	-0.916	0.02232	0.989	0.36837	0.000000	0.08389	0.866	0.41182	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	95	264690	3.5891042E-4	.	30	79075	3.793870e-04	0	77	149245	5.159300e-04	0	80	169267	4.726260e-04	0	1	5695	1.755930e-04	0	0	13550	0.000000e+00	0	0	1702	0.000000e+00	0	0	6914	0.000000e+00	0	1	9845	1.015740e-04	0	26	30478	8.530740e-04	0	0	9460	0.000000e+00	0	26	30478	8.530740e-04	0	2	13110	1.525550e-04	0	2	24192	8.267200e-05	0	2	4471	4.473270e-04	0	0	10122	0.000000e+00	0	1	12089	8.271980e-05	0	65	63767	1.019340e-03	0	0	17929	0.000000e+00	0	65	63767	1.019340e-03	0	2	12041	1.660990e-04	0	2	26917	7.430250e-05	0	1	6829	1.464340e-04	0	0	13305	0.000000e+00	0	3	15789	1.900060e-04	0	67	72442	9.248780e-04	0	0	17864	0.000000e+00	0	67	72442	9.248780e-04	0	.	916	1206317	7.593360e-04	2	856	892587	9.590100e-04	1	9	57230	1.572600e-04	0	0	687	0.000000e+00	0	4	45609	8.770200e-05	0	5	21910	2.282060e-04	0	0	33722	0.000000e+00	0	18	46566	3.865480e-04	0	0	4367	0.000000e+00	0	856	892587	9.590100e-04	1	2	56193	3.559160e-05	1	115	152922	7.520173683315677E-4	0	176	0	0	2712	0	1	4708	2.1240441801189465E-4	0	442	0	0	950	0	0	682	0	0	280	0	8	9886	8.092251669026907E-4	1	4884	2.0475020475020476E-4	0	3394	0	124	172758	7.177670498616562E-4	Benign/Likely_benign	Hereditary_factor_IX_deficiency_disease|Thrombophilia,_X-linked,_due_to_factor_9_defect|FACTOR_IX_POLYMORPHISM|Warfarin_sensitivity,_X-linked|F9-related_disorder	criteria_provided,_multiple_submitters,_no_conflicts	NC_000023.11:g.139561592C>T	ClinGen:CA121135|OMIM:300746.0085	C0008533|C2749016|C5393318	306900|300807|301052	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	His	Tyr	25680	single nucleotide variant	NM_000133.4(F9):c.907C>T (p.His303Tyr)	2158	F9	HGNC:3551	Benign/Likely benign	0	Jan 19, 2025	1801202	-	RCV000011387|RCV001081157|RCV002496326|RCV001167683|RCV003944813	|MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MedGen:C5393318,OMIM:301052;MONDO:MONDO:0010432,MedGen:C2749016,OMIM:300807;MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879|	FACTOR IX POLYMORPHISM|Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Warfarin sensitivity, X-linked;Thrombophilia, X-linked, due to factor 9 defect;Hereditary factor IX deficiency disease|Hereditary factor IX deficiency disease|F9-related disorder	germline;unknown	germline	GRCh38	NC_000023.11	X	139561592	139561592	Xq27.1	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA121135,OMIM:300746.0085	3	10641	139561592	C	T	-	-	-	-	-	-	SCV001001225|SCV001330208|SCV002804939	-	-	907C>T 	His303Tyr	NM_000133.4	2	2_Benign	F9	ENSG00000101981	52861	204372	CCSBVarC004383	ALE00004383	907C>T	His303Tyr	CEGS2	CegsMutGDEh1029	E06	GDEhDisVCh_40052	G07	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	F9_His303Tyr	23	X	139561592	C	T
2803	HMBS	331G>A	Gly111Arg	ENSG00000256269	11	119089747	NC_000011.10:119089747:G:A	ALE00005161	CCSBVarC005161	NULL	200928	NULL	GDEhDisVCh_40054	B08	CEGS2	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAGCTTGCTCGCATACAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGGACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCTTGAACATGCCCTGGAGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCAGAGCCATCTGCAAGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCGAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTCGGGGAAACCTCAACACCCGGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACCGGGTGGGGCAGATCCTGCACCCTGAGGAATGCATGTATGCTGTGGGCCAGGGGGCCTTGGGCGTGGAAGTGCGAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCTGCATCGCTGAAAGGGCCTTCCTGAGGCACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATGGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCGTAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACGATGCCCAT	16503.0	single nucleotide variant	NM_000190.4(HMBS):c.331G>A (p.Gly111Arg)	3145.0	HMBS	HGNC:4982	Pathogenic/Likely pathogenic	1.0	Nov 16, 2024	118204107.0	-	RCV000001529|RCV001381874	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900	Acute intermittent porphyria|not provided	germline	germline	GRCh38	NC_000011.10	11	119089747.0	119089747.0	11q23.3	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA251822,UniProtKB:P08397#VAR_003645,OMIM:609806.0023	3.0	1464.0	119089747.0	G	A	-	-	-	-	-	-	SCV001580442|SCV002580038	-	-	331G>A 	Gly111Arg	NM_000190.4	2.0	1_Pathogenic	chr11	G	A	11-119089747-G-A	6.84775e-7	1464	11	119089747	G	A	G	R	rs118204107	11	118960457	11	118465667	111	HMBS	ENSG00000256269	ENST00000652429	ENSP00000498786	P08397	HEM3_HUMAN	c.331G>A	p.Gly111Arg	c.331G>A	p.Gly111Arg	principal2	Y	.	YES	Select	+	GGA	1	0	G	G/G	G/G	G/G	G/G	.	0.78662	.	.	0.83643	.	1.0	0.90580	D	1.0	0.97365	D	.	0.99291	.	.	.	.	3.3	0.90350	M	.	0.94316	.	.	0.96999	0.9995	0.97172	D	0.9923	0.99813	D	8	.	0.98269	.	0.48082	0.94829	D	.	0.99518	0.919	0.98524	P08397	G111R	Loss of ubiquitination at K115 (P = 0.0578)| Gain of catalytic residue at G111 (P = 0.1454)| Loss of sheet (P = 0.302)| Gain of phosphorylation at T109 (P = 0.3021)| Loss of glycosylation at K115 (P = 0.3418)	.	0.97743	0.9535314344380467	0.95309	.	.	0.73266017437	0.71847	T	0.990161	0.99956	D	0.572054	0.96612	D	0.58394	0.96555	D	0.997363984584808	0.91310	D	0.962504	0.98345	D	0.9799392	0.99090	0.9569918	0.98788	0.97612506	0.98780	0.9351936	0.97412	-13.752	0.92238	D	0.9837	0.91907	P	0.999922987888035	0.98892	0.33414197	0.77849	0.977	0.99166	.	.	.	.	.	.	6.030721	0.94396	34.0	0.9992551943463408	0.99043	0.950611	0.96428	D	1.05720967272792	0.97240	15.83048	1.01823975031208	0.98944	20.00481	6.17	6.17	0.99707	.	.	9.697	0.97951	11.780000	0.96090	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.983	0.59808	228	0.91137	.	.	.	.	.	.	.	.	.	.	.	.	1	264690	3.7780044E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1612612	6.201120e-07	0	1	1179086	8.481150e-07	0	0	75012	0.000000e+00	0	0	910	0.000000e+00	0	0	59924	0.000000e+00	0	0	29534	0.000000e+00	0	0	44876	0.000000e+00	0	0	63980	0.000000e+00	0	0	6044	0.000000e+00	0	1	1179086	8.481150e-07	0	0	90772	0.000000e+00	0	0	7038	0	0	84	0	0	118	0	0	2644	0	0	146	0	1	610	0.001639344262295082	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	1	11338	8.819897689186806E-5	Pathogenic/Likely_pathogenic	Acute_intermittent_porphyria|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.119089747G>A	ClinGen:CA251822|OMIM:609806.0023|UniProtKB:P08397#VAR_003645	C0162565|C3661900	176000	79276	Porphobilinogen deaminase, N-terminal	Gly	Arg	16503	single nucleotide variant	NM_000190.4(HMBS):c.331G>A (p.Gly111Arg)	3145	HMBS	HGNC:4982	Pathogenic/Likely pathogenic	1	Nov 16, 2024	118204107	-	RCV000001529|RCV001381874	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900	Acute intermittent porphyria|not provided	germline	germline	GRCh38	NC_000011.10	11	119089747	119089747	11q23.3	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA251822,UniProtKB:P08397#VAR_003645,OMIM:609806.0023	3	1464	119089747	G	A	-	-	-	-	-	-	SCV001580442|SCV002580038	-	-	331G>A 	Gly111Arg	NM_000190.4	2	1_Pathogenic	HMBS	ENSG00000256269	2803	200928	CCSBVarC005161	ALE00005161	331G>A	Gly111Arg	CEGS2	CegsMutGDEh1045	F02	GDEhDisVCh_40054	B08	2	CegsMutGDDh1045	F02	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	HMBS_Gly111Arg	11	11	119089747	G	A
359	CBS	1007G>A	Arg336His	ENSG00000160200	21	43062343	NC_000021.9:43062343:C:T	ALE00007311	CCSBVarC007316	NULL	NULL	263	GDEhDisVCh_40013	A06	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCACATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	358635.0	single nucleotide variant	NM_000071.3(CBS):c.1007G>A (p.Arg336His)	875.0	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1.0	Jan 02, 2024	760417941.0	-	RCV000409189|RCV002230729|RCV001584104	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880	Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria	biparental;germline;unknown	germline	GRCh38	NC_000021.9	21	43062343.0	43062343.0	21q22.3	criteria provided, multiple submitters, no conflicts	6.0	-	N	ClinGen:CA16041997	2.0	371147.0	43062343.0	C	T	-	-	-	-	-	-	SCV000486656|SCV000959121|SCV001524387|SCV001821464|SCV005871302	-	-	1007G>A 	Arg336His	NM_000071.3	2.0	1_Pathogenic	chr21	G	A	21-43062343-G-A		371147	21	43062343	C	T	R	H	rs760417941	21	44482453	21	43355522	336	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.1007G>A	p.Arg336His	c.1007G>A	p.Arg336His	principal1	Y	1	.	.	-	CGC	2	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.001	0.83643	D	1.0	0.90580	D	0.995	0.83178	D	1.0	0.99291	A	simple_aae	0.0	100.0	2.925	0.84244	M	-4.91	0.81626	D	0.95	0.96086	1.1016	0.99724	D	0.9540	0.98504	D	10	0.99415827	0.99926	D	0.73517	0.97869	D	0.953	0.99157	0.907	0.98057	P35520	R336H	Gain of catalytic residue at L338 (P = 0.0405)| Loss of stability (P = 0.1354)| Loss of helix (P = 0.1706)| Loss of phosphorylation at T333 (P = 0.2244)| Gain of disorder (P = 0.2413)	0.948369761403	0.94740	.	0.94045	.	0.81873	0.566835403442	0.48165	T	0.984555	0.99898	D	0.53957	0.95411	D	0.537279	0.95343	D	0.990762650966644	0.80848	D	.	0.78682	.	0.9192181	0.93070	0.808612	0.88669	0.9204993	0.93197	0.77624285	0.86636	-9.207	0.69097	D	0.4088	0.60017	A	0.999372264310919	0.96403	0.99964630	0.99571	0.995	0.99826	.	.	.	.	.	.	4.626477	0.7357	26.0	0.99946748011509989	0.99913	0.923345	0.89932	D	0.756729168526438	0.83252	7.992605	0.651208329114357	0.78584	6.92935	5.28	5.28	0.74083	.	.	6.848	0.75268	3.820000	0.40028	0.524	0.24207	1.0	0.71675	1.000000	0.68239	0.139	0.19953	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	109256	1.830560e-05	0	3	207478	1.445940e-05	0	3	236484	1.268580e-05	0	0	7152	0.000000e+00	0	0	17082	0.000000e+00	0	1	2316	4.317790e-04	0	0	9036	0.000000e+00	0	0	13384	0.000000e+00	0	1	42694	2.342250e-05	0	0	15680	0.000000e+00	0	1	42694	2.342250e-05	0	0	16154	0.000000e+00	0	0	30480	0.000000e+00	0	1	6190	1.615510e-04	0	0	13400	0.000000e+00	0	0	16718	0.000000e+00	0	1	89108	1.122230e-05	0	1	30578	3.270330e-05	0	1	30578	3.270330e-05	0	0	14866	0.000000e+00	0	0	34218	0.000000e+00	0	1	9564	1.045590e-04	0	0	17678	0.000000e+00	0	0	21544	0.000000e+00	0	1	102504	9.755720e-06	0	1	30496	3.279120e-05	0	1	30496	3.279120e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic/Likely_pathogenic	Homocystinuria|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Classic_homocystinuria	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43062343C>T	ClinGen:CA16041997	C0019880|C3150344|C0751202	236200	394	Tryptophan synthase beta chain-like, PALP domain	Arg	His	358635	single nucleotide variant	NM_000071.3(CBS):c.1007G>A (p.Arg336His)	875	CBS	HGNC:1550	Pathogenic/Likely pathogenic	1	Jan 02, 2024	760417941	-	RCV000409189|RCV002230729|RCV001584104	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3150344|Human Phenotype Ontology:HP:0002156,MONDO:MONDO:0004737,MedGen:C0019880	Classic homocystinuria|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Homocystinuria	biparental;germline;unknown	germline	GRCh38	NC_000021.9	21	43062343	43062343	21q22.3	criteria provided, multiple submitters, no conflicts	6	-	N	ClinGen:CA16041997	2	371147	43062343	C	T	-	-	-	-	-	-	SCV000486656|SCV000959121|SCV001524387|SCV001821464|SCV005871302	-	-	1007G>A 	Arg336His	NM_000071.3	2	1_Pathogenic	CBS	ENSG00000160200	359	263	CCSBVarC007316	ALE00007311	1007G>A	Arg336His	Edgotyping3	VUSMutGDEh010	D12	GDEhDisVCh_40013	A06	1	VUSMutGDDh010	D12	NULL	NULL	NULL	NULL	NULL	NULL	1	6	1	6	0	NULL	0	NULL	0	NULL	CBS_Arg336His	21	21	43062343	C	T
359	CBS	397G>A	Asp133Asn	ENSG00000160200	21	43066297	NC_000021.9:43066297:C:T	ALE00007332	CCSBVarC007343	NULL	NULL	299	GDEhDisVCh_40013	D09	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCAACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210441.0	single nucleotide variant	NM_000071.3(CBS):c.397G>A (p.Asp133Asn)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Dec 27, 2024	539326697.0	-	RCV000198043|RCV000243532|RCV001271170|RCV002277460|RCV002517162	MedGen:C3661900|MedGen:CN230736|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MONDO:MONDO:0003900,MedGen:C0009782|MedGen:C3150344	not provided|Cardiovascular phenotype|Classic homocystinuria|Connective tissue disorder|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43066297.0	43066297.0	21q22.3	criteria provided, multiple submitters, no conflicts	8.0	-	N	ClinGen:CA322517	2.0	212844.0	43066297.0	C	T	-	-	-	-	-	-	SCV000249680|SCV000318099|SCV001781419|SCV002566494|SCV003253633|SCV003829291|SCV004047250	-	-	397G>A 	Asp133Asn	NM_000071.3	2.0	4_VUS	chr21	G	A	21-43066297-G-A		212844	21	43066297	C	T	D	N	rs539326697	21	44486407	21	43359476	133	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.397G>A	p.Asp133Asn	c.397G>A	p.Asp133Asn	principal1	Y	1	.	.	-	GAC	1	0	C	C/C	C/C	C/C	C/C	0.092	0.31822	T	0.175	0.30260	T	0.002	0.09864	B	0.004	0.10086	B	0.18	0.41597	N	simple_aae	82.0	18.0	1.19	0.29976	L	-0.85	0.26376	N	0.366	0.40616	0.1499	0.84992	D	0.7877	0.92778	D	10	0.034464955	0.01658	T	0.145278	0.82700	D	0.278	0.59294	0.39	0.41134	P35520	D133N	Loss of phosphorylation at T135 (P = 0.1128)| Loss of ubiquitination at K137 (P = 0.1388)| Loss of disorder (P = 0.1525)| Loss of methylation at K137 (P = 0.1688)| Gain of loop (P = 0.2045)	0.697545007388	0.69254	.	0.55980	.	0.35874	0.361000359058	0.19511	T	0.725893	0.92217	D	-0.321866	0.06553	T	-0.265193	0.47972	T	0.0522171689290068	0.05824	T	.	0.82300	.	0.30224225	0.52773	0.12834401	0.30799	0.45696312	0.64167	0.11865663	0.28573	-3.439	0.15599	T	.	0.03823	.	0.674345435355313	0.66170	0.99031234	0.96780	0.442	0.67591	.	.	.	.	.	.	1.813498	0.23087	15.86	0.98950032076970107	0.49205	0.818522	0.73880	D	-0.412465040679833	0.24758	1.355855	-0.368838419897293	0.25613	1.429161	5.23	5.23	0.72532	2.86	0.52289	5.175	0.64936	2.553000	0.33357	0.524	0.24207	0.353	0.25871	0.021000	0.20883	0.005	0.06762	988	0.02004	3	5.990415335463259E-4	0	0.0	0	0.0	0	0.0	0	0.0	3	0.003067484662576687	.	.	.	.	23	109004	2.110010e-04	0	47	207474	2.265340e-04	0	47	236466	1.987600e-04	0	0	7154	0.000000e+00	0	0	17102	0.000000e+00	0	0	2320	0.000000e+00	0	0	9040	0.000000e+00	0	0	13026	0.000000e+00	0	1	42760	2.338630e-05	0	22	15690	1.402170e-03	0	22	15690	1.402170e-03	0	0	16188	0.000000e+00	0	0	30512	0.000000e+00	0	0	6208	0.000000e+00	0	0	13396	0.000000e+00	0	0	16366	0.000000e+00	0	1	89336	1.119370e-05	0	46	30608	1.502880e-03	0	46	30608	1.502880e-03	0	0	14888	0.000000e+00	0	0	34242	0.000000e+00	0	0	9566	0.000000e+00	0	0	17686	0.000000e+00	0	0	21262	0.000000e+00	0	1	102678	9.739180e-06	0	46	30526	1.506910e-03	0	46	30526	1.506910e-03	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Uncertain_significance	not_provided|Classic_homocystinuria|Connective_tissue_disorder|Cardiovascular_phenotype|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43066297C>T	ClinGen:CA322517	C3661900|C0751202|C0009782|CN230736|C3150344	236200	394	Tryptophan synthase beta chain-like, PALP domain	Asp	Asn	210441	single nucleotide variant	NM_000071.3(CBS):c.397G>A (p.Asp133Asn)	875	CBS	HGNC:1550	Uncertain significance	0	Dec 27, 2024	539326697	-	RCV000198043|RCV000243532|RCV001271170|RCV002277460|RCV002517162	MedGen:C3661900|MedGen:CN230736|MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MONDO:MONDO:0003900,MedGen:C0009782|MedGen:C3150344	not provided|Cardiovascular phenotype|Classic homocystinuria|Connective tissue disorder|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43066297	43066297	21q22.3	criteria provided, multiple submitters, no conflicts	8	-	N	ClinGen:CA322517	2	212844	43066297	C	T	-	-	-	-	-	-	SCV000249680|SCV000318099|SCV001781419|SCV002566494|SCV003253633|SCV003829291|SCV004047250	-	-	397G>A 	Asp133Asn	NM_000071.3	2	4_VUS	CBS	ENSG00000160200	359	299	CCSBVarC007343	ALE00007332	397G>A	Asp133Asn	Edgotyping3	VUSMutGDEh011	B04	GDEhDisVCh_40013	D09	1	VUSMutGDDh011	B04	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	6	0	NULL	0	NULL	0	NULL	CBS_Asp133Asn	21	21	43066297	C	T
100068252	KCNH2	684G>T	Trp228Cys	ENSG00000055118	7	150951689	NC_000007.14:150951689:C:A	ALE00007109	CCSBVarC007111	NULL	227956	NULL	GDEhDisVCh_40089	C09	CEGS2	ATGGCGGCCCCAGCCGGGAAGGCGAGCAGGACAGGGGCTCTGCGGCCCAGGGCCCAGAAAGGCCGGGTGAGGCGGGCCGTGCGCATCTCCAGCCTCGTGGCCCAGGAGGTCCTGTCCCTGGGCGCCGACGTGCTGCCTGAGTACAAGCTGCAGGCACCGCGCATCCACCGCTGGACCATCCTGCATTACAGCCCCTTCAAGGCCGTGTGGGACTGGCTCATCCTGCTGCTGGTCATCTACACGGCTGTCTTCACACCCTACTCGGCTGCCTTCCTGCTGAAGGAGACGGAAGAAGGCCCGCCTGCTACCGAGTGTGGCTACGCCTGCCAGCCGCTGGCTGTGGTGGACCTCATCGTGGACATCATGTTCATTGTGGACATCCTCATCAACTTCCGCACCACCTACGTCAATGCCAACGAGGAGGTGGTCAGCCACCCCGGCCGCATCGCCGTCCACTACTTCAAGGGCTGGTTCCTCATCGACATGGTGGCCGCCATCCCCTTCGACCTGCTCATCTTCGGCTCTGGCTCTGAGGAGCTGATCGGGCTGCTGAAGACTGCGCGGCTGCTGCGGCTGGTGCGCGTGGCGCGGAAGCTGGATCGCTACTCAGAGTACGGCGCGGCCGTGCTGTTCTTGCTCATGTGCACCTTTGCGCTCATCGCGCACTGGCTAGCCTGCATCTGTTACGCCATCGGCAACATGGAGCAGCCACACATGGACTCACGCATCGGCTGGCTGCACAACCTGGGCGACCAGATAGGCAAACCCTACAACAGCAGCGGCCTGGGCGGCCCCTCCATCAAGGACAAGTATGTGACGGCGCTCTACTTCACCTTCAGCAGCCTCACCAGTGTGGGCTTCGGCAACGTCTCTCCCAACACCAACTCAGAGAAGATCTTCTCCATCTGCGTCATGCTCATTGGCTCCCTCATGTATGCTAGCATCTTCGGCAACGTGTCGGCCATCATCCAGCGGCTGTACTCGGGCACAGCCCGCTACCACACACAGATGCTGCGGGTGCGGGAGTTCATCCGCTTCCACCAGATCCCCAATCCCCTGCGCCAGCGCCTCGAGGAGTACTTCCAGCACGCCTGGTCCTACACCAACGGCATCGACATGAACGCGGTGCTGAAGGGCTTCCCTGAGTGCCTGCAGGCTGACATCTGCCTGCACCTGAACCGCTCACTGCTGCAGCACTGCAAACCCTTCCGAGGGGCCACCAAGGGCTGCCTTCGGGCCCTGGCCATGAAGTTCAAGACCACACATGCACCGCCAGGGGACACACTGGTGCATGCTGGGGACCTGCTCACCGCCCTGTACTTCATCTCCCGGGGCTCCATCGAGATCCTGCGGGGCGACGTCGTCGTGGCCATCCTGGGGAAGAATGACATCTTTGGGGAGCCTCTGAACCTGTATGCAAGGCCTGGCAAGTCGAACGGGGATGTGCGGGCCCTCACCTACTGTGACCTACACAAGATCCATCGGGACGACCTGCTGGAGGTGCTGGACATGTACCCTGAGTTCTCCGACCACTTCTGGTCCAGCCTGGAGATCACCTTCAACCTGCGAGATACCAACATGATCCCGGGCTCCCCCGGCAGTACGGAGTTAGAGGGTGGCTTCAGTCGGCAACGCAAGCGCAAGTTGTCCTTCCGCAGGCGCACGGACAAGGACACGGAGCAGCCAGGGGAGGTGTCGGCCTTGGGGCCGGGCCGGGCGGGGGCAGGGCCGAGTAGCCGGGGCCGGCCGGGGGGGCCGTGGGGGGAGAGCCCGTCCAGTGGCCCCTCCAGCCCTGAGAGCAGTGAGGATGAGGGCCCAGGCCGCAGCTCCAGCCCCCTCCGCCTGGTGCCCTTCTCCAGCCCCAGGCCCCCCGGAGAGCCGCCGGGTGGGGAGCCCCTGATGGAGGACTGCGAGAAGAGCAGCGACACTTGCAACCCCCTGTCAGGCGCCTTCTCAGGAGTGTCCAACATTTTCAGCTTCTGGGGGGACAGTCGGGGCCGCCAGTACCAGGAGCTCCCTCGATGCCCCGCCCCCACCCCCAGCCTCCTCAACATCCCCCTCTCCAGCCCGGGTCGGCGGCCCCGGGGCGACGTGGAGAGCAGGCTGGATGCCCTCCAGCGCCAGCTCAACAGGCTGGAGACCCGGCTGAGTGCAGACATGGCCACTGTCCTGCAGCTGCTACAGAGGCAGATGACGCTGGTCCCGCCCGCCTACAGTGCTGTGACCACCCCGGGGCCTGGCCCCACTTCCACATCCCCGCTGTTGCCCGTCAGCCCCCTCCCCACCCTCACCTTGGACTCGCTTTCTCAGGTTTCCCAGTTCATGGCGTGTGAGGAGCTGCCCCCGGGGGCCCCAGAGCTTCCCCAAGAAGGCCCCACACGACGCCTCTCCCTACCGGGCCAGCTGGGGGCCCTCACCTCCCAGCCCCTGCACAGACACGGCTCGGACCCGGGCAGT	78140.0	single nucleotide variant	NM_000238.4(KCNH2):c.1704G>T (p.Trp568Cys)	3757.0	KCNH2	HGNC:6251	not provided	0.0	-	199472926.0	-	RCV000057955	MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:101016,Orphanet:768	Congenital long QT syndrome	germline	germline	GRCh38	NC_000007.14	7	150951689.0	150951689.0	7q36.1	no classification provided	1.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA005206	2.0	67244.0	150951689.0	C	A	-	-	-	-	-	-	SCV000089475	-	-	1704G>T 	Trp568Cys	NM_000238.4		5_Others	chr7	G	T	7-150951689-G-T		67244	7	150951689	C	A	W	C	rs199472926	7	150648777	7	150279710	568	KCNH2	ENSG00000055118	ENST00000262186	ENSP00000262186	Q12809	KCNH2_HUMAN	c.1704G>T	p.Trp568Cys	c.1704G>T	p.Trp568Cys	principal1	Y	1	YES	Select	-	TGG	3	0	C	./.	./.	./.	./.	0.0	0.91343	D	0.001	0.92967	D	0.989	0.90580	D	0.967	0.92348	D	0.99	0.97926	D	simple_aae	1.0	99.0	4.09	0.97213	H	-12.06	0.99815	D	0.961	0.99488	1.0985	0.99598	D	0.9596	0.98694	D	10	0.9944997	0.99947	D	0.969144	0.99810	D	0.978	0.99822	0.932	0.98955	Q12809	W568C	Loss of stability (P = 0.4456)| Gain of catalytic residue at W568 (P = 0.4528)| Loss of MoRF binding (P = 0.5446)| Loss of helix (P = 0.5596)| Gain of disorder (P = 0.5863)	0.98886297694	0.98861	0.9972078676784264	0.99718	2.6492091948	0.98441	0.855286061764	0.90395	D	0.984356	0.99895	D	0.57961	0.96960	D	0.594793	0.96910	D	0.999921560287476	0.99730	D	0.997504	0.98991	D	0.9647503	0.97717	0.9322216	0.97207	0.9689839	0.98134	0.9171487	0.96143	-13.304	0.90596	D	0.9995	0.99054	P	0.999995927144622	0.99831	0.99982637	0.99778	1	0.99985	.	.	.	.	.	.	5.13314	0.85933	28.7	0.99339366710749355	0.60149	0.980644	0.99849	D	0.826012729599631	0.87636	9.310873	0.71603862642492	0.83504	8.063544	4.44	4.44	0.53107	.	.	7.719	0.83758	7.635000	0.62975	0.549	0.27038	1.0	0.71675	1.000000	0.68239	0.994	0.71086	759	0.50583	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	not_provided	Congenital_long_QT_syndrome	no_classification_provided	NC_000007.14:g.150951689C>A	ClinGen:CA005206	C1141890	PS192500	101016|768	Ion transport domain	Trp	Cys	78140	single nucleotide variant	NM_000238.4(KCNH2):c.1704G>T (p.Trp568Cys)	3757	KCNH2	HGNC:6251	not provided	0	-	199472926	-	RCV000057955	MONDO:MONDO:0019171,MedGen:C1141890,OMIM:PS192500,Orphanet:101016,Orphanet:768	Congenital long QT syndrome	germline	germline	GRCh38	NC_000007.14	7	150951689	150951689	7q36.1	no classification provided	1	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA005206	2	67244	150951689	C	A	-	-	-	-	-	-	SCV000089475	-	-	1704G>T 	Trp568Cys	NM_000238.4		5_Others	KCNH2	ENSG00000055118	100068252	227956	CCSBVarC007111	ALE00007109	684G>T	Trp228Cys	CEGS2	CegsMutGDEh1047	F03	GDEhDisVCh_40089	C09	1	CegsMutGDDh1047	F03	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	KCNH2_Trp228Cys	7	7	150951689	C	A
359	CBS	5C>T	Pro2Leu	ENSG00000160200	21	43072189	NC_000021.9:43072189:G:A	ALE00007357	CCSBVarC007369	NULL	NULL	330	GDEhDisVCh_40013	F12	Edgotyping3	ATGCTTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	210454.0	single nucleotide variant	NM_000071.3(CBS):c.5C>T (p.Pro2Leu)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Oct 07, 2022	546530618.0	-	RCV002291590|RCV002354543|RCV002517994	MedGen:C3661900|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:C3150344	not provided|Familial thoracic aortic aneurysm and aortic dissection|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43072189.0	43072189.0	21q22.3	criteria provided, multiple submitters, no conflicts	3.0	-	N	ClinGen:CA324871	2.0	212839.0	43072189.0	G	A	-	-	-	-	-	-	SCV000249673|SCV001414142|SCV002657169	-	-	5C>T 	Pro2Leu	NM_000071.3	2.0	4_VUS	chr21	C	T	21-43072189-C-T		212839	21	43072189	G	A	P	L	rs546530618	21	44492299	21	43365368	2	CBS	ENSG00000160200	ENST00000398165	ENSP00000381231	P35520	CBS_HUMAN	c.5C>T	p.Pro2Leu	c.5C>T	p.Pro2Leu	principal1	Y	1	YES	Select	-	CCT	2	0	G	G/G	G/G	G/G	G/G	0.078	0.34068	T	0.1	0.41751	T	0.011	0.15925	B	0.01	0.14938	B	.	.	.	.	.	.	2.13	0.59147	M	-0.58	0.18181	N	0.307	0.34747	0.7958	0.94338	D	0.9120	0.97078	D	10	0.15923458	0.29574	T	0.570039	0.96102	D	0.350	0.66968	.	.	.	.	.	0.712588612948	0.70779	0.643778550969339	0.64143	0.370603087304	0.38293	0.568819642067	0.48444	T	0.4712	0.80251	T	-0.145556	0.28657	T	-0.0781074	0.64793	T	0.022499481216073	0.00962	T	.	0.54807	.	0.068961136	0.14930	0.047155548	0.06745	0.08198969	0.18693	0.055620138	0.09801	-4.34	0.28764	T	.	0.34710	.	0.618281999493075	0.64384	0.99575657	0.97868	0.29	0.55930	.	.	.	.	.	.	3.302017	0.45414	22.1	0.97256026390480366	0.33246	0.147932	0.26957	N	-0.405507600716291	0.25002	1.370859	-0.35267822433823	0.26107	1.459588	5.48	2.61	0.30175	0.667	0.26434	0.502	0.22382	5.488000	0.48816	0.59	0.31918	0.351	0.25855	1.000000	0.68239	0.594	0.31283	988	0.02004	2	3.9936102236421724E-4	2	0.0015128593040847202	0	0.0	0	0.0	0	0.0	0	0.0	.	.	.	.	4	108130	3.699250e-05	0	6	199858	3.002130e-05	0	6	229484	2.614560e-05	0	4	6982	5.729020e-04	0	0	16906	0.000000e+00	0	0	2236	0.000000e+00	0	0	8958	0.000000e+00	0	0	13282	0.000000e+00	0	0	42308	0.000000e+00	0	0	15580	0.000000e+00	0	4	6982	5.729020e-04	0	6	14630	4.101160e-04	0	0	30140	0.000000e+00	0	0	5918	0.000000e+00	0	0	13282	0.000000e+00	0	0	16568	0.000000e+00	0	0	84260	0.000000e+00	0	0	30390	0.000000e+00	0	6	14630	4.101160e-04	0	6	13496	4.445760e-04	0	0	33914	0.000000e+00	0	0	9328	0.000000e+00	0	0	17584	0.000000e+00	0	0	20898	0.000000e+00	0	0	98480	0.000000e+00	0	0	30318	0.000000e+00	0	6	13496	4.445760e-04	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Uncertain_significance	Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_provided|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43072189G>A	ClinGen:CA324871	C4707243|C3661900|C3150344	PS607086	91387	.	Pro	Leu	210454	single nucleotide variant	NM_000071.3(CBS):c.5C>T (p.Pro2Leu)	875	CBS	HGNC:1550	Uncertain significance	0	Oct 07, 2022	546530618	-	RCV002291590|RCV002354543|RCV002517994	MedGen:C3661900|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387|MedGen:C3150344	not provided|Familial thoracic aortic aneurysm and aortic dissection|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43072189	43072189	21q22.3	criteria provided, multiple submitters, no conflicts	3	-	N	ClinGen:CA324871	2	212839	43072189	G	A	-	-	-	-	-	-	SCV000249673|SCV001414142|SCV002657169	-	-	5C>T 	Pro2Leu	NM_000071.3	2	4_VUS	CBS	ENSG00000160200	359	330	CCSBVarC007369	ALE00007357	5C>T	Pro2Leu	Edgotyping3	VUSMutGDEh011	E07	GDEhDisVCh_40013	F12	1	VUSMutGDDh011	E07	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	CBS_Pro2Leu	21	21	43072189	G	A
359	CBS	395G>A	Arg132His	ENSG00000160200	21	43066299	NC_000021.9:43066299:C:T	ALE00007333	CCSBVarC007344	NULL	NULL	300	GDEhDisVCh_40013	E09	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCACGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	403744.0	single nucleotide variant	NM_000071.3(CBS):c.395G>A (p.Arg132His)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Dec 15, 2021	779011920.0	-	RCV000462847|RCV002261087|RCV002230758	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3661900|MedGen:C3150344	Classic homocystinuria|not provided|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43066299.0	43066299.0	21q22.3	criteria provided, multiple submitters, no conflicts	4.0	-	N	ClinGen:CA16616276	2.0	405373.0	43066299.0	C	T	-	-	-	-	-	-	SCV000543505|SCV001781423|SCV002541702	-	-	395G>A 	Arg132His	NM_000071.3	2.0	4_VUS	chr21	G	A	21-43066299-G-A		405373	21	43066299	C	T	R	H	rs779011920	21	44486409	21	43359478	132	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.395G>A	p.Arg132His	c.395G>A	p.Arg132His	principal1	Y	1	.	.	-	CGC	2	0	C	C/C	C/C	C/C	C/C	0.006	0.61594	D	0.008	0.68204	D	0.994	0.66535	D	0.79	0.57705	P	0.49	0.70511	N	simple_aae	51.0	49.0	2.935	0.84478	M	-3.25	0.65541	D	0.541	0.56785	1.0087	0.97328	D	0.9160	0.97212	D	10	0.589279	0.65997	D	0.45176	0.94344	D	0.578	0.82883	0.46	0.52616	P35520	R132H	Gain of helix (P = 0.0496)| Loss of phosphorylation at T135 (P = 0.0745)| Loss of solvent accessibility (P = 0.0907)| Loss of loop (P = 0.1242)| Loss of methylation at K137 (P = 0.1358)	0.836764147458	0.83391	.	0.63599	.	0.73395	0.43527340889	0.29894	T	0.967253	0.99615	D	0.16739	0.70669	D	0.018153	0.71300	D	0.932725667953491	0.59661	D	.	0.79194	.	0.5568161	0.70038	0.28145686	0.53918	0.5916314	0.71954	0.3635568	0.61499	-8.89	0.67063	D	.	0.15224	.	0.774217319791401	0.69728	0.99902403	0.99097	0.944	0.97378	.	.	.	.	.	.	3.141507	0.4257	21.5	0.99909611513952357	0.97950	0.542046	0.55639	D	0.0648471085697004	0.44570	2.749819	-0.15944612416243	0.32735	1.886283	5.23	2.32	0.27820	1.82	0.37615	0.323	0.19408	0.497000	0.19030	0.524	0.24207	0.015	0.19172	0.059000	0.22067	0.039	0.14199	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	109036	1.834260e-05	0	2	207514	9.637900e-06	0	2	236516	8.456090e-06	0	0	7156	0.000000e+00	0	0	17102	0.000000e+00	0	0	2320	0.000000e+00	0	0	9040	0.000000e+00	0	0	13056	0.000000e+00	0	2	42760	4.677270e-05	0	0	15690	0.000000e+00	0	2	42760	4.677270e-05	0	0	16192	0.000000e+00	0	0	30512	0.000000e+00	0	0	6208	0.000000e+00	0	0	13394	0.000000e+00	0	0	16396	0.000000e+00	0	2	89344	2.238540e-05	0	0	30608	0.000000e+00	0	2	89344	2.238540e-05	0	0	14890	0.000000e+00	0	0	34242	0.000000e+00	0	0	9566	0.000000e+00	0	0	17686	0.000000e+00	0	0	21294	0.000000e+00	0	2	102694	1.947530e-05	0	0	30526	0.000000e+00	0	2	102694	1.947530e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Uncertain_significance	HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Classic_homocystinuria|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43066299C>T	ClinGen:CA16616276	C3150344|C0751202|CN517202	236200	394	Tryptophan synthase beta chain-like, PALP domain	Arg	His	403744	single nucleotide variant	NM_000071.3(CBS):c.395G>A (p.Arg132His)	875	CBS	HGNC:1550	Uncertain significance	0	Dec 15, 2021	779011920	-	RCV000462847|RCV002261087|RCV002230758	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3661900|MedGen:C3150344	Classic homocystinuria|not provided|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED	germline	germline	GRCh38	NC_000021.9	21	43066299	43066299	21q22.3	criteria provided, multiple submitters, no conflicts	4	-	N	ClinGen:CA16616276	2	405373	43066299	C	T	-	-	-	-	-	-	SCV000543505|SCV001781423|SCV002541702	-	-	395G>A 	Arg132His	NM_000071.3	2	4_VUS	CBS	ENSG00000160200	359	300	CCSBVarC007344	ALE00007333	395G>A	Arg132His	Edgotyping3	VUSMutGDEh011	C04	GDEhDisVCh_40013	E09	1	VUSMutGDDh011	C04	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	5	0	NULL	0	NULL	0	NULL	CBS_Arg132His	21	21	43066299	C	T
359	CBS	532G>A	Val178Met	ENSG00000160200	21	43065521	NC_000021.9:43065521:C:T	ALE00007325	CCSBVarC007334	NULL	NULL	289	GDEhDisVCh_40013	C08	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGATGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	346587.0	single nucleotide variant	NM_000071.3(CBS):c.532G>A (p.Val178Met)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	Aug 28, 2021	370843514.0	-	RCV000279590|RCV002348095	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Classic homocystinuria|Familial thoracic aortic aneurysm and aortic dissection	germline	germline	GRCh38	NC_000021.9	21	43065521.0	43065521.0	21q22.3	criteria provided, multiple submitters, no conflicts	2.0	-	N	ClinGen:CA10650559	2.0	340088.0	43065521.0	C	T	-	-	-	-	-	-	SCV000436225|SCV002643179	-	-	532G>A 	Val178Met	NM_000071.3	2.0	4_VUS	chr21	G	A	21-43065521-G-A		340088	21	43065521	C	T	V	M	rs370843514	21	44485631	21	43358700	178	CBS	ENSG00000160200	ENST00000398158	ENSP00000381225	P35520	CBS_HUMAN	c.532G>A	p.Val178Met	c.532G>A	p.Val178Met	principal1	Y	1	.	.	-	GTG	1	0	C	C/C	C/C	C/C	C/C	0.001	0.78662	D	0.002	0.79703	D	0.992	0.64752	D	0.921	0.65630	D	.	.	.	.	.	.	2.175	0.60790	M	-2.95	0.61611	D	0.863	0.86054	1.0809	0.98908	D	0.9352	0.97862	D	10	0.9422097	0.93473	D	0.553969	0.95893	D	0.821	0.94259	.	.	.	.	.	0.934932621012	0.93375	.	0.75293	.	0.75889	0.720616936684	0.70086	T	0.970891	0.99682	D	0.253456	0.78768	D	0.259457	0.85967	D	0.885946810245514	0.53374	D	.	0.95022	.	0.8554229	0.87573	0.750115	0.85049	0.890812	0.90445	0.7249363	0.83561	-10.67	0.77889	D	.	0.67086	.	0.982448036761549	0.85931	0.99974710	0.99678	0.972	0.98934	.	.	.	.	.	.	5.073518	0.84654	28.4	0.99869772548365265	0.94730	0.872628	0.79381	D	0.570813450513661	0.71204	5.638769	0.48978012672503	0.67134	5.067084	4.51	4.51	0.54535	.	.	6.582	0.74004	5.618000	0.49151	0.513	0.23433	1.0	0.71675	1.000000	0.68239	0.378	0.26339	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	108644	0.000000e+00	0	5	206424	2.422200e-05	0	5	234216	2.134780e-05	0	0	7034	0.000000e+00	0	0	17010	0.000000e+00	0	0	2298	0.000000e+00	0	0	9016	0.000000e+00	0	0	13338	0.000000e+00	0	0	42454	0.000000e+00	0	0	15598	0.000000e+00	0	.	.	.	.	0	15954	0.000000e+00	0	0	30332	0.000000e+00	0	0	6152	0.000000e+00	0	0	13362	0.000000e+00	0	0	16662	0.000000e+00	0	5	88696	5.637230e-05	0	0	30446	0.000000e+00	0	5	88696	5.637230e-05	0	0	14700	0.000000e+00	0	0	34066	0.000000e+00	0	0	9488	0.000000e+00	0	0	17652	0.000000e+00	0	0	21288	0.000000e+00	0	5	101098	4.945700e-05	0	0	30364	0.000000e+00	0	5	101098	4.945700e-05	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	10064	9.936406995230525E-5	0	184	0	0	0	0	0	4652	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1432	0	0	4836	0	0	0	0	1	16332	6.12294881214793E-5	Uncertain_significance	Familial_thoracic_aortic_aneurysm_and_aortic_dissection|Classic_homocystinuria	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43065521C>T	ClinGen:CA10650559	C4707243|C0751202	PS607086|236200	91387|394	Tryptophan synthase beta chain-like, PALP domain	Val	Met	346587	single nucleotide variant	NM_000071.3(CBS):c.532G>A (p.Val178Met)	875	CBS	HGNC:1550	Uncertain significance	0	Aug 28, 2021	370843514	-	RCV000279590|RCV002348095	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Classic homocystinuria|Familial thoracic aortic aneurysm and aortic dissection	germline	germline	GRCh38	NC_000021.9	21	43065521	43065521	21q22.3	criteria provided, multiple submitters, no conflicts	2	-	N	ClinGen:CA10650559	2	340088	43065521	C	T	-	-	-	-	-	-	SCV000436225|SCV002643179	-	-	532G>A 	Val178Met	NM_000071.3	2	4_VUS	CBS	ENSG00000160200	359	289	CCSBVarC007334	ALE00007325	532G>A	Val178Met	Edgotyping3	VUSMutGDEh011	A03	GDEhDisVCh_40013	C08	1	VUSMutGDDh011	A03	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	5	0	NULL	0	NULL	0	NULL	CBS_Val178Met	21	21	43065521	C	T
3774	TP53	869G>A	Arg290His	ENSG00000141510	17	7673751	NC_000017.11:7673751:C:T	ALE00004877	CCSBVarC004877	NULL	214908	NULL	GDEhDisVCh_40053	D07	CEGS2	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACCGGCGCACAGAGGAAGAGAATCTCCACAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	133282.0	single nucleotide variant	NM_000546.6(TP53):c.869G>A (p.Arg290His)	7157.0	TP53	HGNC:11998	Benign	0.0	Aug 05, 2024	55819519.0	-	RCV000115740|RCV000213061|RCV000620742|RCV000148914|RCV000760102|RCV001357075|RCV001798340|RCV003935102	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MedGen:C3661900|MONDO:MONDO:0016248,MedGen:C5679802,Orphanet:213517|MedGen:CN221562|	Hereditary cancer-predisposing syndrome|not specified|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Familial ovarian cancer|Breast and/or ovarian cancer|TP53-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	7673751.0	7673751.0	17p13.1	reviewed by expert panel	21.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000468,UniProtKB:P04637#VAR_045411	2.0	127825.0	7673751.0	C	T	-	-	-	-	-	-	SCV001142524	-	-	869G>A 	Arg290His	NM_000546.6	3.0	2_Benign	chr17	G	A	17-7673751-G-A		127825	17	7673751	C	T	R	H	rs55819519	17	7577069	17	7517794	290	TP53	ENSG00000141510	ENST00000445888	ENSP00000391478	P04637	P53_HUMAN	c.869G>A	p.Arg290His	c.869G>A	p.Arg290His	principal1	Y	1	.	.	-	CGC	2	0	C	C/C	C/C	C/C	C/C	0.105	0.30652	T	0.178	0.42433	T	0.0	0.07480	B	0.002	0.10086	B	0.7	0.82410	D	simple_aae	30.0	70.0	1.015	0.25293	L	-2.03	0.50519	N	0.678	0.68361	0.8985	0.95638	D	0.9538	0.98498	D	10	0.119348556	0.22315	T	0.06596	0.69627	D	0.584	0.83221	.	.	.	.	.	0.97750202521	0.97703	.	0.22742	.	0.08274	0.204295560718	0.00594	T	0.562996	0.85270	D	0.0347643	0.56054	T	0.0915951	0.76176	D	0.0174106634616025	0.00477	T	.	0.48652	.	0.26072124	0.48797	0.26844433	0.52511	0.31317866	0.53727	0.2426277	0.49499	-8.733	0.66039	D	0.0696	0.08118	B	0.0232149184999856	0.30676	0.99985945	0.99820	0.1	0.27926	.	.	.	.	.	.	0.829403	0.12029	8.565	0.92403921287150259	0.22068	0.203159	0.32758	N	-0.808880781091665	0.12926	0.6420652	-0.82479844114957	0.13656	0.7232551	5.12	-1.23	0.08955	-4.5	0.05323	-0.383	0.07474	-4.225000	0.02284	-0.175	0.10912	0.0	0.06393	0.000000	0.08389	0.598	0.31382	432	0.80699	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	34	264690	1.2845216E-4	.	23	109402	2.102340e-04	0	32	208126	1.537530e-04	0	38	236944	1.603750e-04	0	1	7162	1.396260e-04	0	2	17112	1.168770e-04	0	0	2320	0.000000e+00	0	1	9046	1.105460e-04	0	6	13392	4.480290e-04	0	12	42768	2.805840e-04	0	1	15688	6.374300e-05	0	12	42768	2.805840e-04	0	2	16216	1.233350e-04	0	2	30522	6.552650e-05	0	0	6212	0.000000e+00	0	1	13416	7.453790e-05	0	6	16732	3.585940e-04	0	20	89556	2.233240e-04	0	1	30606	3.267330e-05	0	20	89556	2.233240e-04	0	2	14900	1.342280e-04	0	2	34258	5.838050e-05	0	0	9572	0.000000e+00	0	1	17692	5.652270e-05	0	9	21630	4.160890e-04	0	23	102748	2.238490e-04	0	1	30524	3.276110e-05	0	23	102748	2.238490e-04	0	.	348	1614132	2.155960e-04	0	17	64036	2.654760e-04	0	3	75040	3.997870e-05	0	0	912	0.000000e+00	0	4	60000	6.666670e-05	0	2	29606	6.755390e-05	0	1	44852	2.229550e-05	0	17	64036	2.654760e-04	0	1	6062	1.649620e-04	0	307	1180030	2.601630e-04	0	2	91088	2.195680e-05	0	11	65128	1.68898169758015E-4	0	306	0	0	174	0	0	8820	0	0	516	0	0	662	0	0	60	0	0	114	0	3	11328	2.6483050847457627E-4	0	9126	0	0	234	0	14	87108	1.607200257152041E-4	Benign	Familial_ovarian_cancer|Breast_and/or_ovarian_cancer|not_provided|Li-Fraumeni_syndrome_1|Li-Fraumeni_syndrome|not_specified|Hereditary_cancer-predisposing_syndrome|TP53-related_disorder	reviewed_by_expert_panel	NC_000017.11:g.7673751C>T	ClinGen:CA000468|UniProtKB:P04637#VAR_045411	C5679802|CN221562|C3661900|C1835398|C0085390|CN169374|C0027672	151623|PS151623	213517|524|524|140162	.	Arg	His	133282	single nucleotide variant	NM_000546.6(TP53):c.869G>A (p.Arg290His)	7157	TP53	HGNC:11998	Benign	0	Aug 05, 2024	55819519	-	RCV000115740|RCV000213061|RCV000620742|RCV000148914|RCV000760102|RCV001357075|RCV001798340|RCV003935102	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MedGen:CN169374|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MedGen:C3661900|MONDO:MONDO:0016248,MedGen:C5679802,Orphanet:213517|MedGen:CN221562|	Hereditary cancer-predisposing syndrome|not specified|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Familial ovarian cancer|Breast and/or ovarian cancer|TP53-related disorder	germline;unknown	germline	GRCh38	NC_000017.11	17	7673751	7673751	17p13.1	reviewed by expert panel	21	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000468,UniProtKB:P04637#VAR_045411	2	127825	7673751	C	T	-	-	-	-	-	-	SCV001142524	-	-	869G>A 	Arg290His	NM_000546.6	3	2_Benign	TP53	ENSG00000141510	3774	214908	CCSBVarC004877	ALE00004877	869G>A	Arg290His	CEGS2	CegsMutGDEh1021	A05	GDEhDisVCh_40053	D07	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	TP53_Arg290His	17	17	7673751	C	T
3774	TP53	535C>T	His179Tyr	ENSG00000141510	17	7675077	NC_000017.11:7675077:G:A	ALE00004860	CCSBVarC004860	NULL	214883	NULL	GDEhDisVCh_40053	E04	CEGS2	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACTATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACCGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	133272.0	single nucleotide variant	NM_000546.6(TP53):c.535C>T (p.His179Tyr)	7157.0	TP53	HGNC:11998	Pathogenic/Likely pathogenic	1.0	Oct 22, 2024	587780070.0	-	RCV000115726|RCV002288597|RCV004668781|RCV003460828|RCV000555493|RCV000663095|RCV000785312	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267	not provided|Hereditary cancer-predisposing syndrome|Neoplasm|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Ovarian neoplasm	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7675077.0	7675077.0	17p13.1	criteria provided, multiple submitters, no conflicts	9.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	UniProtKB:P04637#VAR_044939,ClinGen:CA000256	2.0	127815.0	7675077.0	G	A	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV000149635|SCV000629834|SCV000786200|SCV002582383|SCV002583045|SCV002647112|SCV004017964|SCV004206243	-	SCV005094438	535C>T 	His179Tyr	NM_000546.6	2.0	1_Pathogenic	chr17	C	T	17-7675077-C-T		127815	17	7675077	G	A	H	Y	rs587780070	17	7578395	17	7519120	179	TP53	ENSG00000141510	ENST00000714359	ENSP00000519626	P04637	P53_HUMAN	.	.	c.535C>T	p.His179Tyr	principal1	Y	.	.	.	-	CAT	1	0	G	G/G	G/G	G/G	G/G	.	0.91343	.	.	0.92967	.	0.999	0.90580	D	0.993	0.97365	D	.	0.99291	.	.	.	.	3.27	0.89959	M	.	0.88253	.	.	0.95034	0.9137	0.95855	D	0.9959	0.99906	D	10	.	0.99711	.	0.687476	0.97416	D	.	0.98989	0.974	0.99756	P04637	H179Y	Loss of disorder (P = 0.0303)| Gain of phosphorylation at H179 (P = 0.069)| Loss of catalytic residue at H179 (P = 0.205)| Gain of MoRF binding (P = 0.2633)| Loss of helix (P = 0.3949)	.	0.99252	.	0.82605	.	0.91438	0.641016483307	0.58644	T	0.996634	0.99995	D	0.5848	0.97289	D	0.602248	0.97246	D	0.998037993907928	0.93000	D	0.887511	0.68212	D	0.98132575	0.99195	0.9681046	0.99370	0.98394644	0.99385	0.9741499	0.99627	-11.575	0.82771	D	.	0.97478	.	0.995831084452488	0.91636	0.99997580	0.99989	0.992	0.99727	.	.	.	.	.	.	4.626865	0.73583	26.0	0.99779814712389325	0.86704	0.956447	0.97490	D	0.99384744462102	0.95527	13.73	0.94587491293266	0.97263	15.86703	5.59	5.59	0.84656	5.48	0.94220	10.003	0.9969	11.880000	0.98809	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.766	0.36402	434	0.80544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1614124	1.239060e-06	0	2	1180052	1.694840e-06	0	0	74946	0.000000e+00	0	0	912	0.000000e+00	0	0	60004	0.000000e+00	0	0	29606	0.000000e+00	0	0	44888	0.000000e+00	0	0	64048	0.000000e+00	0	0	6084	0.000000e+00	0	2	1180052	1.694840e-06	0	0	91096	0.000000e+00	0	0	6962	0	0	84	0	0	84	0	0	2210	0	0	146	0	0	610	0	0	24	0	0	94	0	0	466	0	0	2294	0	0	108	0	0	10680	0	Pathogenic/Likely_pathogenic	Adrenocortical_carcinoma,_hereditary|Ovarian_neoplasm|Malignant_melanoma_of_skin|Hepatocellular_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Li-Fraumeni_syndrome_1|Small_cell_lung_carcinoma|Glioblastoma|Carcinoma_of_esophagus|Squamous_cell_carcinoma_of_the_head_and_neck|Pancreatic_adenocarcinoma|Hereditary_cancer-predisposing_syndrome|Uterine_carcinosarcoma|Gallbladder_carcinoma|Malignant_neoplasm_of_body_of_uterus|Gastric_adenocarcinoma|Ovarian_serous_cystadenocarcinoma|Neoplasm_of_the_large_intestine|not_provided|Squamous_cell_carcinoma_of_the_skin|Lung_adenocarcinoma|Acute_myeloid_leukemia|Breast_neoplasm|Li-Fraumeni_syndrome	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.7675077G>A	ClinGen:CA000256|UniProtKB:P04637#VAR_044939	C1859972|C0919267|C0151779|C2239176|C0149782|C0006118|C1835398|C0149925|C0017636|C0152018|C1168401|C0281361|C0027672|C0280630|C0235782|C0153574|C0278701|C0279663|C0009404|C3661900|C0553723|C0152013|C0023467|C1458155|C0085390	202300|114550|151623|182280|275355|601626|PS151623	1501|88673|524|70573|360|70482|67037|140162|519|524	p53, DNA-binding domain|p53, DNA-binding domain	His	Tyr	133272	single nucleotide variant	NM_000546.6(TP53):c.535C>T (p.His179Tyr)	7157	TP53	HGNC:11998	Pathogenic/Likely pathogenic	1	Oct 22, 2024	587780070	-	RCV000115726|RCV002288597|RCV004668781|RCV003460828|RCV000555493|RCV000663095|RCV000785312	MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|Human Phenotype Ontology:HP:0100615,MONDO:MONDO:0021068,MeSH:D010051,MedGen:C0919267	not provided|Hereditary cancer-predisposing syndrome|Neoplasm|Adrenocortical carcinoma, hereditary|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Ovarian neoplasm	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7675077	7675077	17p13.1	criteria provided, multiple submitters, no conflicts	9	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	UniProtKB:P04637#VAR_044939,ClinGen:CA000256	2	127815	7675077	G	A	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV000149635|SCV000629834|SCV000786200|SCV002582383|SCV002583045|SCV002647112|SCV004017964|SCV004206243	-	SCV005094438	535C>T 	His179Tyr	NM_000546.6	2	1_Pathogenic	TP53	ENSG00000141510	3774	214883	CCSBVarC004860	ALE00004860	535C>T	His179Tyr	CEGS2	CegsMutGDEh1017	F04	GDEhDisVCh_40053	E04	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	2	0	NULL	0	NULL	0	NULL	0	NULL	TP53_His179Tyr	17	17	7675077	G	A
359	CBS	622T>C	Trp208Arg	ENSG00000160200	21	43065431	NC_000021.9:43065431:A:G	ALE00007323	CCSBVarC007331	NULL	NULL	284	GDEhDisVCh_40013	H07	Edgotyping3	ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGGCCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAGCCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCCTCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATTCTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGCCTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGACCGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGACACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTGAGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTGCTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCGGAGTCACACGTGGGGGTGGCCCGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTAGACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTACGACACCACCGCTGATGAGATCCTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACCATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTGGATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACCTACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTGGACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCGCAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCTGCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAACTACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAGGACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCAGCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAGAAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACGCTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGCAAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCGCACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTACCACAGCACCGGGAAGTCCAGTCAGCGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAGGAGCGGGACCAGAAG	404302.0	single nucleotide variant	NM_000071.3(CBS):c.622T>C (p.Trp208Arg)	875.0	CBS	HGNC:1550	Uncertain significance	0.0	May 19, 2024	1060500683.0	-	RCV000457277|RCV000786286|RCV002523288|RCV004601173	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3661900|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Classic homocystinuria|not provided|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection	germline;unknown	germline	GRCh38	NC_000021.9	21	43065431.0	43065431.0	21q22.3	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA16616544	2.0	405375.0	43065431.0	A	G	-	-	-	-	-	-	SCV000543507|SCV002779668|SCV005098245	-	-	622T>C 	Trp208Arg	NM_000071.3	2.0	4_VUS	chr21	T	C	21-43065431-T-C		405375	21	43065431	A	G	W	R	rs1060500683	21	44485541	21	43358610	208	CBS	ENSG00000160200	ENST00000359624	ENSP00000352643	P35520	CBS_HUMAN	c.622T>C	p.Trp208Arg	c.622T>C	p.Trp208Arg	principal1	Y	1	.	.	-	TGG	1	0	A	A/A	A/A	A/A	A/A	0.736	0.03762	T	0.611	0.07790	T	0.001	0.07480	B	0.01	0.14938	B	0.81	0.87956	D	simple_aae	19.0	81.0	-2.3	0.00097	N	-1.67	0.39882	N	0.872	0.86916	-0.1701	0.78328	T	0.4817	0.80121	T	10	0.5963807	0.66376	D	0.130833	0.81249	D	0.598	0.83995	0.449	0.50817	P35520	W208R	Gain of disorder (P = 0.0066)| Loss of catalytic residue at A207 (P = 0.0403)| Loss of ubiquitination at K211 (P = 0.0821)| Gain of MoRF binding (P = 0.2074)| Loss of helix (P = 0.2271)	0.67932339552	0.67407	.	0.90771	.	0.56147	0.789570093155	0.80342	T	0.871254	0.97197	D	0.425584	0.91246	D	0.373545	0.91137	D	0.322233869254172	0.25620	T	.	0.81278	.	0.6832646	0.76886	0.24170756	0.49388	0.6073497	0.72804	0.22218634	0.46880	-13.349	0.90769	D	0.6429	0.70578	LP	0.958914470719517	0.81571	0.99809340	0.98628	0.725	0.84761	.	.	.	.	.	.	4.034797	0.59767	24.1	0.84224246048942697	0.15402	0.964426	0.98650	D	-0.506990596234931	0.21596	1.162798	-0.204797255639327	0.31048	1.774259	4.65	4.65	0.57575	2.66	0.48641	7.785	0.84374	8.878000	0.78373	0.644	0.52462	1.0	0.71675	1.000000	0.68239	0.879	0.42046	988	0.02004	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	109320	0.000000e+00	0	1	207602	4.816910e-06	0	1	235782	4.241210e-06	0	0	7148	0.000000e+00	0	0	17086	0.000000e+00	0	0	2320	0.000000e+00	0	0	9042	0.000000e+00	0	0	13386	0.000000e+00	0	0	42762	0.000000e+00	0	0	15664	0.000000e+00	0	.	.	.	.	0	16110	0.000000e+00	0	0	30478	0.000000e+00	0	0	6188	0.000000e+00	0	0	13386	0.000000e+00	0	0	16726	0.000000e+00	0	1	89284	1.120020e-05	0	0	30582	0.000000e+00	0	1	89284	1.120020e-05	0	0	14884	0.000000e+00	0	0	34218	0.000000e+00	0	0	9528	0.000000e+00	0	0	17684	0.000000e+00	0	0	21624	0.000000e+00	0	1	101742	9.828780e-06	0	0	30498	0.000000e+00	0	1	101742	9.828780e-06	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	9690	0	0	114	0	0	86	0	0	2784	0	0	146	0	0	610	0	0	26	0	0	98	0	0	496	0	0	2898	0	0	112	0	0	14050	0	Uncertain_significance	Familial_thoracic_aortic_aneurysm_and_aortic_dissection|HYPERHOMOCYSTEINEMIA,_THROMBOTIC,_CBS-RELATED|Classic_homocystinuria|not_provided	criteria_provided,_multiple_submitters,_no_conflicts	NC_000021.9:g.43065431A>G	ClinGen:CA16616544	C4707243|C3150344|C0751202|C3661900	PS607086|236200	91387|394	Tryptophan synthase beta chain-like, PALP domain	Trp	Arg	404302	single nucleotide variant	NM_000071.3(CBS):c.622T>C (p.Trp208Arg)	875	CBS	HGNC:1550	Uncertain significance	0	May 19, 2024	1060500683	-	RCV000457277|RCV000786286|RCV002523288|RCV004601173	MONDO:MONDO:0009352,MedGen:C0751202,OMIM:236200,Orphanet:394|MedGen:C3661900|MedGen:C3150344|MONDO:MONDO:0019625,MedGen:C4707243,OMIM:PS607086,Orphanet:91387	Classic homocystinuria|not provided|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|Familial thoracic aortic aneurysm and aortic dissection	germline;unknown	germline	GRCh38	NC_000021.9	21	43065431	43065431	21q22.3	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA16616544	2	405375	43065431	A	G	-	-	-	-	-	-	SCV000543507|SCV002779668|SCV005098245	-	-	622T>C 	Trp208Arg	NM_000071.3	2	4_VUS	CBS	ENSG00000160200	359	284	CCSBVarC007331	ALE00007323	622T>C	Trp208Arg	Edgotyping3	VUSMutGDEh011	F02	GDEhDisVCh_40013	H07	1	VUSMutGDDh011	F02	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	5	0	NULL	0	NULL	0	NULL	CBS_Trp208Arg	21	21	43065431	A	G
3774	TP53	427G>A	Val143Met	ENSG00000141510	17	7675185	NC_000017.11:7675185:C:T	ALE00004857	CCSBVarC004857	NULL	214884	NULL	GDEhDisVCh_40053	A04	CEGS2	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTATGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACCGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	152371.0	single nucleotide variant	NM_000546.6(TP53):c.427G>A (p.Val143Met)	7157.0	TP53	HGNC:11998	Pathogenic/Likely pathogenic	1.0	Dec 13, 2024	587782620.0	-	RCV000132003|RCV000413546|RCV000409072|RCV000227179|RCV005025218|RCV001354661|RCV003474783|RCV001560552	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0010623,Human Phenotype Ontology:HP:0100013,MONDO:MONDO:0021100,MeSH:D001943,MedGen:C1458155|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|12 conditions|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501|MedGen:C3661900	Hereditary cancer-predisposing syndrome|Breast neoplasm|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|12 conditions|Malignant tumor of breast|Adrenocortical carcinoma, hereditary|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	7675185.0	7675185.0	17p13.1	criteria provided, multiple submitters, no conflicts	10.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000176,UniProtKB:P04637#VAR_044787	2.0	142657.0	7675185.0	C	T	-	-	-	-	-	-	SCV000187062|SCV000285196|SCV000492477|SCV001782984|SCV004017849|SCV004204253|SCV005425738|SCV005651061	-	-	427G>A 	Val143Met	NM_000546.6	2.0	1_Pathogenic	chr17	G	A	17-7675185-G-A		142657	17	7675185	C	T	V	M	rs587782620	17	7578503	17	7519228	143	TP53	ENSG00000141510	ENST00000508793	ENSP00000424104	P04637	P53_HUMAN	c.427G>A	p.Val143Met	c.427G>A	p.Val143Met	principal1	.	4	.	.	-	GTG	1	0	C	C/C	C/C	C/C	C/C	0.001	0.91343	D	.	0.79703	.	1.0	0.90580	D	0.998	0.88579	D	.	0.97926	.	.	.	.	2.455	0.71058	M	-2.25	0.50847	N	.	0.62079	1.0454	0.98016	D	0.9881	0.99654	D	10	0.879757	0.87142	D	0.825576	0.98642	D	0.659	0.87175	0.779	0.90338	P04637	V143M	Loss of catalytic residue at V143 (P = 0.1006)| Gain of methylation at K139 (P = 0.1054)| Loss of ubiquitination at K139 (P = 0.1099)| Gain of disorder (P = 0.1537)| Loss of sheet (P = 0.302)	0.955327548987	0.95447	.	0.56621	.	0.89720	0.527730584145	0.42654	T	0.964536	0.99564	D	0.327999	0.84922	D	0.233371	0.84724	D	0.972181141376495	0.69399	D	.	0.41321	.	0.6616419	0.75720	0.56417304	0.74526	0.6843735	0.76948	0.611134	0.77139	-9.866	0.73184	D	0.8446	0.81361	LP	0.88984778015431	0.75380	0.99986732	0.99835	0.808	0.89388	.	.	.	.	.	.	3.978604	0.58552	24.0	0.99770787119979165	0.85930	0.288039	0.39805	N	0.341173716038349	0.58060	3.998816	0.208646413129149	0.50071	3.225886	5.48	4.51	0.54535	3.29	0.59673	1.256	0.32628	5.997000	0.52497	0.599	0.40292	0.673	0.28467	1.000000	0.68239	0.829	0.39108	434	0.80544	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	16892	5.9199621122424815E-5	0	0	0	0	0	0	0	20	0	0	354	0	0	18	0	0	0	0	0	0	0	0	4092	0	0	20	0	0	0	0	1	21376	4.6781437125748506E-5	Conflicting_classifications_of_pathogenicity	Li-Fraumeni_syndrome|Adrenocortical_carcinoma,_hereditary|not_provided|Hereditary_cancer-predisposing_syndrome|Malignant_tumor_of_breast|Li-Fraumeni_syndrome_1|Breast_neoplasm	criteria_provided,_conflicting_classifications	NC_000017.11:g.7675185C>T	ClinGen:CA000176|UniProtKB:P04637#VAR_044787	C0085390|C1859972|C3661900|C0027672|C0006142|C1835398|C1458155	PS151623|202300|151623	524|1501|140162|524	p53, DNA-binding domain|p53, DNA-binding domain	Val	Met	152371	single nucleotide variant	NM_000546.6(TP53):c.427G>A (p.Val143Met)	7157	TP53	HGNC:11998	Pathogenic/Likely pathogenic	1	Dec 13, 2024	587782620	-	RCV000132003|RCV000413546|RCV000409072|RCV000227179|RCV005025218|RCV001354661|RCV003474783|RCV001560552	MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0010623,Human Phenotype Ontology:HP:0100013,MONDO:MONDO:0021100,MeSH:D001943,MedGen:C1458155|Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|12 conditions|MONDO:MONDO:0007254,MedGen:C0006142|MONDO:MONDO:0008734,MedGen:C1859972,OMIM:202300,Orphanet:1501|MedGen:C3661900	Hereditary cancer-predisposing syndrome|Breast neoplasm|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|12 conditions|Malignant tumor of breast|Adrenocortical carcinoma, hereditary|not provided	germline;unknown	germline	GRCh38	NC_000017.11	17	7675185	7675185	17p13.1	criteria provided, multiple submitters, no conflicts	10	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000176,UniProtKB:P04637#VAR_044787	2	142657	7675185	C	T	-	-	-	-	-	-	SCV000187062|SCV000285196|SCV000492477|SCV001782984|SCV004017849|SCV004204253|SCV005425738|SCV005651061	-	-	427G>A 	Val143Met	NM_000546.6	2	1_Pathogenic	TP53	ENSG00000141510	3774	214884	CCSBVarC004857	ALE00004857	427G>A	Val143Met	CEGS2	CegsMutGDEh1016	F04	GDEhDisVCh_40053	A04	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	TP53_Val143Met	17	17	7675185	C	T
3689	GCK	1142T>G	Met381Arg	ENSG00000106633	7	44145608	NC_000007.14:44145608:A:C	ALE00006696	CCSBVarC006698	NULL	214860	NULL	GDEhDisVCh_40037	D03	CEGS2	ATGCTGGACGACAGAGCCAGGATGGAGGCCGCCAAGAAGGAGAAGGTAGAGCAGATCCTGGCAGAGTTCCAGCTGCAGGAGGAGGACCTGAAGAAGGTGATGAGACGGATGCAGAAGGAGATGGACCGCGGCCTGAGGCTGGAGACCCATGAAGAGGCCAGTGTGAAGATGCTGCCCACCTACGTGCGCTCCACCCCAGAAGGCTCAGAAGTCGGGGACTTCCTCTCCCTGGACCTGGGTGGCACTAACTTCAGGGTGATGCTGGTGAAGGTGGGAGAAGGTGAGGAGGGGCAGTGGAGCGTGAAGACCAAACACCAGATGTACTCCATCCCCGAGGACGCCATGACCGGCACTGCTGAGATGCTCTTCGACTACATCTCTGAGTGCATCTCCGACTTCCTGGACAAGCATCAGATGAAACACAAGAAGCTGCCCCTGGGCTTCACCTTCTCCTTTCCTGTGAGGCACGAAGACATCGATAAGGGCATCCTTCTCAACTGGACCAAGGGCTTCAAGGCCTCAGGAGCAGAAGGGAACAATGTCGTGGGGCTTCTGCGAGACGCTATCAAACGGAGAGGGGACTTTGAAATGGATGTGGTGGCAATGGTGAATGACACGGTGGCCACGATGATCTCCTGCTACTACGAAGACCATCAGTGCGAGGTCGGCATGATCGTGGGCACGGGCTGCAATGCCTGCTACATGGAGGAGATGCAGAATGTGGAGCTGGTGGAGGGGGACGAGGGCCGCATGTGCGTCAATACCGAGTGGGGCGCCTTCGGGGACTCCGGCGAGCTGGACGAGTTCCTGCTGGAGTATGACCGCCTGGTGGACGAGAGCTCTGCAAACCCCGGTCAGCAGCTGTATGAGAAGCTCATAGGTGGCAAGTACATGGGCGAGCTGGTGCGGCTTGTGCTGCTCAGGCTCGTGGACGAAAACCTGCTCTTCCACGGGGAGGCCTCCGAGCAGCTGCGCACACGCGGAGCCTTCGAGACGCGCTTCGTGTCGCAGGTGGAGAGCGACACGGGCGACCGCAAGCAGATCTACAACATCCTGAGCACGCTGGGGCTGCGACCCTCGACCACCGACTGCGACATCGTGCGCCGCGCCTGCGAGAGCGTGTCTACGCGCGCTGCGCACAGGTGCTCGGCGGGGCTGGCGGGCGTCATCAACCGCATGCGCGAGAGCCGCAGCGAGGACGTAATGCGCATCACTGTGGGCGTGGATGGCTCCGTGTACAAGCTGCACCCCAGCTTCAAGGAGCGGTTCCATGCCAGCGTGCGCAGGCTGACGCCCAGCTGCGAGATCACCTTCATCGAGTCGGAGGAGGGCAGTGGCCGGGGCGCGGCCCTGGTCTCGGCGGTGGCCTGTAAGAAGGCCTGTATGCTGGGCCAG	44842.0	single nucleotide variant	NM_000162.5(GCK):c.1142T>G (p.Met381Arg)	2645.0	GCK	HGNC:4195	Likely pathogenic	1.0	Jul 17, 2023	193922266.0	-	RCV002281721	MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625	Monogenic diabetes	germline	germline	GRCh38	NC_000007.14	7	44145608.0	44145608.0	7p13	reviewed by expert panel	2.0	-	N	ClinGen:CA213719	2.0	36178.0	44145608.0	A	C	-	-	-	-	-	-	SCV004022350	-	-	1142T>G 	Met381Arg	NM_000162.5	3.0	1_Pathogenic	chr7	T	G	7-44145608-T-G		36178	7	44145608	A	C	M	R	rs193922266	7	44185207	7	44151732	381	GCK	ENSG00000106633	ENST00000403799	ENSP00000384247	P35557	HXK4_HUMAN	c.1142T>G	p.Met381Arg	c.1142T>G	p.Met381Arg	principal1	Y	1	YES	Select	-	ATG	2	0	A	A/A	A/A	A/A	A/A	0.0	0.91343	D	0.0	0.92967	D	0.997	0.70687	D	0.937	0.67258	D	0.99	0.97926	A	simple_aae	1.0	99.0	2.175	0.60790	M	-3.83	0.73614	D	0.922	0.92554	1.0491	0.98094	D	0.9188	0.97306	D	10	0.9870709	0.99042	D	0.795514	0.98394	D	0.963	0.99463	0.902	0.97846	P35557	M381R	Gain of MoRF binding (P = 0.0144)| Gain of methylation at M381 (P = 0.0225)| Gain of disorder (P = 0.0368)| Gain of phosphorylation at S383 (P = 0.1717)| Gain of glycosylation at T376 (P = 0.2722)	0.986712009296	0.98642	.	0.99995	.	0.98380	0.814544439316	0.84162	D	0.936668	0.98959	D	0.527074	0.95019	D	0.519329	0.94945	D	0.995235490642908	0.86959	D	0.955004	0.82826	D	0.98682237	0.99576	0.95436186	0.98636	0.9881108	0.99654	0.9653637	0.99237	-9.737	0.72444	D	0.9599	0.88016	P	0.997770718554719	0.93534	0.99981171	0.99752	0.997	0.99892	.	.	.	.	.	.	5.191984	0.87099	29.1	0.98589210283069695	0.43467	0.972335	0.99416	D	0.681140257682479	0.78280	6.863321	0.659791826520524	0.79230	7.062115	5.2	5.2	0.71681	3.45	0.62472	7.396	0.79204	10.997000	0.84758	0.751	0.87726	1.0	0.71675	1.000000	0.68239	0.992	0.67791	716	0.55914	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Likely_pathogenic	Monogenic_diabetes	reviewed_by_expert_panel	NC_000007.14:g.44145608A>C	ClinGen:CA213719	C3888631	.	183625	Hexokinase, C-terminal	Met	Arg	44842	single nucleotide variant	NM_000162.5(GCK):c.1142T>G (p.Met381Arg)	2645	GCK	HGNC:4195	Likely pathogenic	1	Jul 17, 2023	193922266	-	RCV002281721	MONDO:MONDO:0015967,MedGen:C3888631,Orphanet:183625	Monogenic diabetes	germline	germline	GRCh38	NC_000007.14	7	44145608	44145608	7p13	reviewed by expert panel	2	-	N	ClinGen:CA213719	2	36178	44145608	A	C	-	-	-	-	-	-	SCV004022350	-	-	1142T>G 	Met381Arg	NM_000162.5	3	1_Pathogenic	GCK	ENSG00000106633	3689	214860	CCSBVarC006698	ALE00006696	1142T>G	Met381Arg	CEGS2	CegsMutGDEh1044	B10	GDEhDisVCh_40037	D03	1	CegsMutGDDh1044	B10	VUSN2Hmut_GDN2h_09	C07	VUSMutpDEST2_03	A10	VUSmut_GDEh09	C07	1	2	1	1	1	1	1	1	1	1	GCK_Met381Arg	7	7	44145608	A	C
52861	F9	1324G>A	Gly442Arg	ENSG00000101981	X	139562009	NC_000023.11:139562009:G:A	ALE00004397	CCSBVarC004397	NULL	204394	NULL	GDEhDisVCh_40052	C05	CEGS2	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGAGATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATAGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT	25663.0	single nucleotide variant	NM_000133.4(F9):c.1324G>A (p.Gly442Arg)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Sep 11, 2013	137852267.0	-	RCV000011370	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562009.0	139562009.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255418,UniProtKB:P00740#VAR_017322,OMIM:300746.0068	1.0	10624.0	139562009.0	G	A	-	-	-	-	-	-	SCV000031602	-	-	1324G>A 	Gly442Arg	NM_000133.4		1_Pathogenic	chrX	G	A	X-139562009-G-A		10624	X	139562009	G	A	G	R	rs137852267	X	138644168	X	138471834	442	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1324G>A	p.Gly442Arg	c.1324G>A	p.Gly442Arg	principal1	Y	1	YES	Select	+	GGA	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	1.0	0.97365	D	0.99	0.97926	A	simple_aae	1.0	99.0	3.73	0.94777	H	-7.77	0.95858	D	0.927	0.99617	1.0406	0.97918	D	0.8991	0.96646	D	10	0.9946803	0.99956	D	0.913615	0.99356	D	0.933	0.98451	0.972	0.99735	P00740	G442R	Gain of MoRF binding (P = 0.0073)| Loss of methylation at K438 (P = 0.0888)| Loss of ubiquitination at K438 (P = 0.1557)| Loss of catalytic residue at K446 (P = 0.1868)| Gain of phosphorylation at T445 (P = 0.2542)	0.998199755148	0.99815	0.999816845241638	0.99981	1.79749068387	0.91559	0.781957983971	0.79185	T	0.940243	0.99046	D	0.629632	0.99865	D	0.666647	0.99864	D	0.999747335910797	0.98769	D	0.965103	0.90715	D	0.99552697	0.99973	0.9947084	0.99998	0.9957567	0.99977	0.99248934	0.99992	-13.463	0.91198	D	0.9389	0.90335	P	0.999681950866998	0.97477	0.99999270	0.99996	1	0.99985	.	.	.	.	.	.	5.154634	0.86372	28.9	0.99927308363601752	0.99164	.	.	.	.	.	.	.	.	.	5.59	5.59	0.84656	.	.	9.968	0.99105	11.850000	0.98052	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.999	0.91597	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	2	264690	7.5560088E-6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	7040	0	0	84	0	0	118	0	0	2644	0	0	146	0	0	610	0	0	24	0	0	100	0	0	574	0	0	2728	0	0	142	0	0	11340	0	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139562009G>A	ClinGen:CA255418|OMIM:300746.0068|UniProtKB:P00740#VAR_017322	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Gly	Arg	25663	single nucleotide variant	NM_000133.4(F9):c.1324G>A (p.Gly442Arg)	2158	F9	HGNC:3551	Pathogenic	1	Sep 11, 2013	137852267	-	RCV000011370	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139562009	139562009	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255418,UniProtKB:P00740#VAR_017322,OMIM:300746.0068	1	10624	139562009	G	A	-	-	-	-	-	-	SCV000031602	-	-	1324G>A 	Gly442Arg	NM_000133.4		1_Pathogenic	F9	ENSG00000101981	52861	204394	CCSBVarC004397	ALE00004397	1324G>A	Gly442Arg	CEGS2	CegsMutGDEh1021	G05	GDEhDisVCh_40052	C05	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	F9_Gly442Arg	23	X	139562009	G	A
3015	CRX	166G>A	Ala56Thr	ENSG00000105392	19	47836308	NC_000019.10:47836308:G:A	ALE00000381	CCSBVarC000381	5251	NULL	NULL	GDEhDisVCh_40040	D12	RC4	ATGATGGCGTATATGAACCCGGGGCCCCACTATTCTGTCAACGCCTTGGCCCTAAGTGGCCCCAGTGTGGATCTGATGCACCAGGCTGTGCCCTACCCAAGCGCCCCCAGGAAGCAGCGGCGGGAGCGCACCACCTTCACCCGGAGCCAACTGGAGGAGCTGGAGACACTGTTTGCCAAGACCCAGTACCCAGACGTCTATGCCCGTGAGGAGGTGGCTCTGAAGATCAATCTGCCTGAGTCCAGGGTTCAGGTTTGGTTCAAGAACCGGAGGGCTAAATGCAGGCAGCAGCGACAGCAGCAGAAACAGCAGCAGCAGCCCCCAGGGGGCCAGGCCAAGGCCCGGCCTGCCAAGAGGAAGGCGGGCACGTCCCCAAGACCCTCCACAGATGTGTGTCCAGACCCTCTGGGCATCTCAGATTCCTACAGTCCCCCTCTGCCCGGCCCCTCAGGCTCCCCAACCACGGCAGTGGCCACTGTGTCCATCTGGAGCCCAGCCTCAGAGTCCCCTTTGCCTGAGGCGCAGCGGGCTGGGCTGGTGGCCTCAGGGCCGTCTCTGACCTCCGCCCCCTATGCCATGACCTACGCCCCGGCCTCCGCTTTCTGCTCTTCCCCCTCCGCCTATGGGTCTCCGAGCTCCTATTTCAGCGGCCTAGACCCCTACCTTTCTCCCATGGTGCCCCAGCTAGGGGGCCCGGCTCTTAGCCCCCTCTCTGGCCCCTCCGTGGGACCTTCCCTGGCCCAGTCCCCCACCTCCCTATCAGGCCAGAGCTATGGCGCCTACAGCCCCGTGGATAGCTTGGAATTCAAGGACCCCACGGGCACCTGGAAATTCACCTACAATCCCATGGACCCTCTGGACTACAAGGATCAGAGTGCCTGGAAGTTTCAGATCTTG	105485.0	single nucleotide variant	NM_000554.6(CRX):c.166G>A (p.Ala56Thr)	1406.0	CRX	HGNC:2383	Likely pathogenic	1.0	Mar 14, 2024	61748437.0	-	RCV000085991|RCV001369855	MedGen:C3661900|MONDO:MONDO:0013449,MedGen:C3151192,OMIM:613829,Orphanet:65;MONDO:MONDO:0007362,MedGen:C3489532,OMIM:120970,Orphanet:1872	not provided|Leber congenital amaurosis 7;Cone-rod dystrophy 2	germline	germline	GRCh38	NC_000019.10	19	47836308.0	47836308.0	19q13.33	criteria provided, single submitter	2.0	-	N	ClinGen:CA227612	2.0	99596.0	47836308.0	G	A	-	-	-	-	-	-	SCV001566308	-	-	166G>A 	Ala56Thr	NM_000554.6	1.0	1_Pathogenic	chr19	G	A	19-47836308-G-A	0.000015733	99596	19	47836308	G	A	A	T	rs61748437	19	48339565	19	53031377	56	CRX	ENSG00000105392	ENST00000221996	ENSP00000221996	O43186	CRX_HUMAN	c.166G>A	p.Ala56Thr	c.166G>A	p.Ala56Thr	principal1	Y	2	YES	Select	+	GCA	1	0	g	G/G	G/G	G/G	G/G	0.099	0.30794	T	0.342	0.26683	T	0.96	0.55293	D	0.79	0.57705	P	0.88	0.91311	D	simple_aae	12.0	88.0	0.45	0.12695	N	-1.48	0.36173	N	0.438	0.47427	0.4105	0.89211	D	0.7832	0.92619	D	10	0.7588031	0.75956	D	0.1448	0.82655	D	0.717	0.89925	0.771	0.89713	O43186	A56T	Gain of methylation at K60 (P = 0.064)| Gain of phosphorylation at A56 (P = 0.1168)| Gain of disorder (P = 0.1351)| Gain of ubiquitination at K60 (P = 0.2033)| Gain of MoRF binding (P = 0.317)	0.943048806165	0.94200	0.7488543394443767	0.74695	0.194642975609	0.21532	0.776932775974	0.78428	T	0.750458	0.93094	D	0.16506	0.70452	D	0.106978	0.77205	D	0.232822149991989	0.21818	T	0.616438	0.54558	T	0.0958341	0.22359	0.11850957	0.28539	0.065878905	0.13993	0.09658436	0.22913	-5.289	0.39881	T	0.099	0.16823	B	0.198887365298175	0.49863	0.99460540	0.97586	0.355	0.61325	.	.	.	.	.	.	2.470815	0.31907	18.86	0.97445832218865325	0.34175	0.529401	0.54895	D	-0.213193754430928	0.32312	1.839698	-0.222386628528605	0.30419	1.733133	3.35	2.31	0.27741	1.71	0.36417	3.663	0.54347	6.143000	0.54151	-0.938	0.02114	1.0	0.71675	1.000000	0.68239	0.579	0.30914	912	0.21478	.	.	.	.	.	.	.	.	.	.	.	.	19	264690	7.178209E-5	.	2	109406	1.828050e-05	0	4	208106	1.922100e-05	0	3	236946	1.266110e-05	0	0	7164	0.000000e+00	0	0	17112	0.000000e+00	0	0	2320	0.000000e+00	0	0	9044	0.000000e+00	0	0	13394	0.000000e+00	0	2	42768	4.676390e-05	0	0	15690	0.000000e+00	0	2	42768	4.676390e-05	0	0	16218	0.000000e+00	0	0	30524	0.000000e+00	0	0	6212	0.000000e+00	0	0	13414	0.000000e+00	0	0	16734	0.000000e+00	0	4	89534	4.467580e-05	0	0	30608	0.000000e+00	0	4	89534	4.467580e-05	0	0	14902	0.000000e+00	0	0	34260	0.000000e+00	0	0	9572	0.000000e+00	0	0	17690	0.000000e+00	0	0	21632	0.000000e+00	0	3	102746	2.919820e-05	0	0	30526	0.000000e+00	0	3	102746	2.919820e-05	0	.	26	1614074	1.610830e-05	1	3	6082	4.932590e-04	1	0	74932	0.000000e+00	0	0	910	0.000000e+00	0	3	59996	5.000330e-05	0	1	29602	3.378150e-05	0	0	44888	0.000000e+00	0	0	64044	0.000000e+00	0	3	6082	4.932590e-04	1	18	1180048	1.525360e-05	0	0	91086	0.000000e+00	0	0	7618	0	0	108	0	0	84	0	0	3134	0	0	146	0	0	610	0	0	24	0	0	94	0	0	522	0	0	3242	0	0	108	0	0	12340	0	Likely_pathogenic	not_provided|Leber_congenital_amaurosis_7|Cone-rod_dystrophy_2	criteria_provided,_single_submitter	NC_000019.10:g.47836308G>A	ClinGen:CA227612	C3661900|C3151192|C3489532	613829|120970	65|1872	Homeodomain|Homeodomain|Homeodomain|Homeodomain	Ala	Thr	105485	single nucleotide variant	NM_000554.6(CRX):c.166G>A (p.Ala56Thr)	1406	CRX	HGNC:2383	Likely pathogenic	1	Mar 14, 2024	61748437	-	RCV000085991|RCV001369855	MedGen:C3661900|MONDO:MONDO:0013449,MedGen:C3151192,OMIM:613829,Orphanet:65;MONDO:MONDO:0007362,MedGen:C3489532,OMIM:120970,Orphanet:1872	not provided|Leber congenital amaurosis 7;Cone-rod dystrophy 2	germline	germline	GRCh38	NC_000019.10	19	47836308	47836308	19q13.33	criteria provided, single submitter	2	-	N	ClinGen:CA227612	2	99596	47836308	G	A	-	-	-	-	-	-	SCV001566308	-	-	166G>A 	Ala56Thr	NM_000554.6	1	1_Pathogenic	CRX	ENSG00000105392	3015	5251	CCSBVarC000381	ALE00000381	166G>A	Ala56Thr	RC4	RC4_Mut_GDEh1031	H08	GDEhDisVCh_40040	D12	2	RC4_Mut_GDDh1031	H08	NULL	NULL	NULL	NULL	NULL	NULL	1	5	1	99	0	NULL	0	NULL	0	NULL	CRX_Ala56Thr	19	19	47836308	G	A
3774	TP53	733G>T	Gly245Cys	ENSG00000141510	17	7674230	NC_000017.11:7674230:C:A	ALE00000547	CCSBVarC000547	6983	NULL	NULL	GDEhDisVCh_40053	E11	RC4	ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCGCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCTGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTGCTGGGAGAGACCGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGAC	27388.0	single nucleotide variant	NM_000546.6(TP53):c.733G>T (p.Gly245Cys)	7157.0	TP53	HGNC:11998	Pathogenic	1.0	Mar 14, 2024	28934575.0	-	RCV000013142|RCV000633397|RCV001271056|RCV000161025|RCV000492412|RCV004668714	Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MedGen:CN221562|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Breast and/or ovarian cancer|not provided|Hereditary cancer-predisposing syndrome|Neoplasm	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7674230.0	7674230.0	17p13.1	criteria provided, multiple submitters, no conflicts	8.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000369,UniProtKB:P04637#VAR_005972,OMIM:191170.0003	3.0	12349.0	7674230.0	C	A	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV000211746|SCV000581089|SCV000754619|SCV002582466|SCV002583127|SCV004931847	-	SCV005094412	733G>T 	Gly245Cys	NM_000546.6	2.0	1_Pathogenic	chr17	G	T	17-7674230-G-T		12349	17	7674230	C	A	G	C	rs28934575	17	7577548	17	7518273	245	TP53	ENSG00000141510	ENST00000714359	ENSP00000519626	P04637	P53_HUMAN	.	.	c.733G>T	p.Gly245Cys	principal1	Y	.	.	.	-	GGC	1	0	C	C/C	C/C	C/C	C/C	.	0.91343	.	.	0.92967	.	1.0	0.90580	D	1.0	0.97365	D	.	0.97926	.	.	.	.	3.31	0.90471	M	.	0.97825	.	.	0.98282	0.9027	0.95698	D	0.9951	0.99889	D	10	.	0.99908	.	0.698746	0.97527	D	.	0.99647	0.994	0.99935	P04637	G245C	Loss of disorder (P = 0.0891)| Gain of catalytic residue at M243 (P = 0.1067)| Loss of sheet (P = 0.3635)| Gain of glycosylation at S241 (P = 0.3988)| Loss of MoRF binding (P = 0.4981)	.	0.99461	.	0.84670	.	0.40547	0.733492791653	0.71968	T	0.995669	0.99992	D	0.581969	0.96996	D	0.598182	0.96946	D	0.999843120574951	0.99303	D	0.981202	0.94497	D	0.99146116	0.99833	0.95848596	0.98872	0.99206007	0.99860	0.9652241	0.99230	-12.643	0.88351	D	.	0.96519	.	0.99733005044816	0.93023	0.99997780	0.99989	1	0.99985	.	.	.	.	.	.	4.936062	0.81451	27.5	0.99710500832631999	0.81301	0.965009	0.98720	D	0.876726505775613	0.90522	10.46611	0.789079787513346	0.88964	9.808274	4.62	4.62	0.56895	5.29	0.92719	7.905	0.86513	7.687000	0.65653	0.596	0.33565	1.0	0.71675	1.000000	0.68239	0.975	0.56052	433	0.80635	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Li-Fraumeni_syndrome|Glioblastoma|Breast_neoplasm|Uterine_carcinosarcoma|Carcinoma_of_esophagus|Breast_and/or_ovarian_cancer|Prostate_adenocarcinoma|Pancreatic_adenocarcinoma|Hereditary_cancer-predisposing_syndrome|Neoplasm_of_brain|Brainstem_glioma|Squamous_cell_lung_carcinoma|Hepatocellular_carcinoma|Li-Fraumeni_syndrome_1|Transitional_cell_carcinoma_of_the_bladder|not_provided|Ovarian_serous_cystadenocarcinoma|Gastric_adenocarcinoma|Neoplasm_of_the_large_intestine|Squamous_cell_carcinoma_of_the_head_and_neck|Lung_adenocarcinoma	criteria_provided,_multiple_submitters,_no_conflicts	NC_000017.11:g.7674230C>A	ClinGen:CA000369|OMIM:191170.0003|UniProtKB:P04637#VAR_005972	C0085390|C0017636|C1458155|C0280630|C0152018|CN221562|C0007112|C0281361|C0027672|C0006118|C0677865|C0149782|C2239176|C1835398|C0279680|C3661900|C0279663|C0278701|C0009404|C1168401|C0152013	PS151623|114550|151623|275355	524|360|70482|140162|88673|524|67037	p53, DNA-binding domain|p53, DNA-binding domain	Gly	Cys	27388	single nucleotide variant	NM_000546.6(TP53):c.733G>T (p.Gly245Cys)	7157	TP53	HGNC:11998	Pathogenic	1	Mar 14, 2024	28934575	-	RCV000013142|RCV000633397|RCV001271056|RCV000161025|RCV000492412|RCV004668714	Gene:553989,MedGen:C1835398,OMIM:151623,Orphanet:524|MONDO:MONDO:0018875,MedGen:C0085390,OMIM:PS151623,Orphanet:524|MedGen:CN221562|MedGen:C3661900|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|Human Phenotype Ontology:HP:0002664,Human Phenotype Ontology:HP:0003008,Human Phenotype Ontology:HP:0006741,MONDO:MONDO:0005070,MeSH:D009369,MedGen:C0027651	Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Breast and/or ovarian cancer|not provided|Hereditary cancer-predisposing syndrome|Neoplasm	germline;somatic;unknown	germline/somatic	GRCh38	NC_000017.11	17	7674230	7674230	17p13.1	criteria provided, multiple submitters, no conflicts	8	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA000369,UniProtKB:P04637#VAR_005972,OMIM:191170.0003	3	12349	7674230	C	A	-	-	-	Oncogenic	Mar 04, 2025	criteria provided, single submitter	SCV000211746|SCV000581089|SCV000754619|SCV002582466|SCV002583127|SCV004931847	-	SCV005094412	733G>T 	Gly245Cys	NM_000546.6	2	1_Pathogenic	TP53	ENSG00000141510	3774	6983	CCSBVarC000547	ALE00000547	733G>T	Gly245Cys	RC4	RC4_Mut_GDEh1019	D11	GDEhDisVCh_40053	E11	1	RC4_Mut_GDDh1019	D11	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	TP53_Gly245Cys	17	17	7674230	C	A
14613	BRCA1	3G>T	Met1Ile	ENSG00000012048	17	43124094	NC_000017.11:43124094:C:A	ALE00003295	CCSBVarC003295	NULL	218379	NULL	GDEhDisVCh_40059	B03	CEGS2	ATTGATTTATCTGCTCTTCGCGTTGAAGAAGTACAAAATGTCATTAATGCTATGCAGAAAATCTTAGAGTGTCCCATCTGTCTGGAGTTGATCAAGGAACCTGTCTCCACAAAGTGTGACCACATATTTTGCAAATTTTGCATGCTGAAACTTCTCAACCAGAAGAAAGGGCCTTCACAGTGTCCTTTATGTAAGAATGATATAACCAAAAGGAGCCTACAAGAAAGTACGAGATTTAGTCAACTTGTTGAAGAGCTATTGAAAATCATTTGTGCTTTTCAGCTTGACACAGGTTTGGAGTATGCAAACAGCTATAATTTTGCAAAAAAGGAAAATAACTCTCCTGAACATCTAAAAGATGAAGTTTCTATCATCCAAAGTATGGGCTACAGAAACCGTGCCAAAAGACTTCTACAGAGTGAACCCGAAAATCCTTCCTTGCAGGAAACCAGTCTCAGTGTCCAACTCTCTAACCTTGGAACTGTGAGAACTCTGAGGACAAAGCAGCGGATACAACCTCAAAAGACGTCTGTCTACATTGAATTGGGATCTGATTCTTCTGAAGATACCGTTAATAAGGCAACTTATTGCAGTGTGGGAGATCAAGAATTGTTACAAATCACCCCTCAAGGAACCAGGGATGAAATCAGTTTGGATTCTGCAAAAAAGGCTGCTTGTGAATTTTCTGAGACGGATGTAACAAATACTGAACATCATCAACCCAGTAATAATGATTTGAACACCACTGAGAAGCGTGCAGCTGAGAGGCATCCAGAAAAGTATCAGGGTGAAGCAGCATCTGGGTGTGAGAGTGAAACAAGCGTCTCTGAAGACTGCTCAGGGCTATCCTCTCAGAGTGACATTTTAACCACTCAGCAGAGGGATACCATGCAACATAACCTGATAAAGCTCCAGCAGGAAATGGCTGAACTAGAAGCTGTGTTAGAACAGCATGGGAGCCAGCCTTCTAACAGCTACCCTTCCATCATAAGTGACTCTTCTGCCCTTGAGGACCTGCGAAATCCAGAACAAAGCACATCAGAAAAAGTATTAACTTCACAGAAAAGTAGTGAATACCCTATAAGCCAGAATCCAGAAGGCCTTTCTGCTGACAAGTTTGAGGTGTCTGCAGATAGTTCTACCAGTAAAAATAAAGAACCAGGAGTGGAAAGGTCATCCCCTTCTAAATGCCCATCATTAGATGATAGGTGGTACATGCACAGTTGCTCTGGGAGTCTTCAGAATAGAAACTACCCATCTCAAGAGGAGCTCATTAAGGTTGTTGATGTGGAGGAGCAACAGCTGGAAGAGTCTGGGCCACACGATTTGACGGAAACATCTTACTTGCCAAGGCAAGATCTAGAGGGAACCCCTTACCTGGAATCTGGAATCAGCCTCTTCTCTGATGACCCTGAATCTGATCCTTCTGAAGACAGAGCCCCAGAGTCAGCTCGTGTTGGCAACATACCATCTTCAACCTCTGCATTGAAAGTTCCCCAATTGAAAGTTGCAGAATCTGCCCAGAGTCCAGCTGCTGCTCATACTACTGATACTGCTGGGTATAATGCAATGGAAGAAAGTGTGAGCAGGGAGAAGCCAGAATTGACAGCTTCAACAGAAAGGGTCAACAAAAGAATGTCCATGGTGGTGTCTGGCCTGACCCCAGAAGAATTTATGCTCGTGTACAAGTTTGCCAGAAAACACCACATCACTTTAACTAATCTAATTACTGAAGAGACTACTCATGTTGTTATGAAAACAGATGCTGAGTTTGTGTGTGAACGGACACTGAAATATTTTCTAGGAATTGCGGGAGGAAAATGGGTAGTTAGCTATTTCTGGGTGACCCAGTCTATTAAAGAAAGAAAAATGCTGAATGAGCATGATTTTGAAGTCAGAGGAGATGTGGTCAATGGAAGAAACCACCAAGGTCCAAAGCGAGCAAGAGAATCCCAGGACAGAAAGATCTTCAGGGGGCTAGAAATCTGTTGCTATGGGCCCTTCACCAACATGCCCACAGGGTGTCCACCCAATTGTGGTTGTGCAGCCAGATGCCTGGACAGAGGACAATGGCTTCCATGCAATTGGGCAGATGTG	69739.0	single nucleotide variant	NM_007294.4(BRCA1):c.3G>T (p.Met1Ile)	672.0	BRCA1	HGNC:1100	Pathogenic	1.0	Jun 18, 2019	80357475.0	-	RCV000048405|RCV000111552|RCV000131890|RCV000763402|RCV001357041	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MedGen:C3661900	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Familial cancer of breast;Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43124094.0	43124094.0	17q21.31	reviewed by expert panel	10.0	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002562	2.0	55072.0	43124094.0	C	A	-	-	-	-	-	-	SCV001161632	-	-	3G>T 	Met1Ile	NM_007294.4	3.0	1_Pathogenic	chr17	G	T	17-43124094-G-T		55072	17	43124094	C	A	M	I	rs80357475	17	41276111	17	38529637	1	BRCA1	ENSG00000012048	ENST00000470026	ENSP00000419274	P38398	BRCA1_HUMAN	c.3G>T	p.Met1?	c.3G>T	p.Met1?	principal2	Y	1	.	.	-	ATG	3	0	C	C/C	C/C	C/C	C/C	0.0	0.91343	D	0.009	0.92967	D	0.924	0.51298	P	0.878	0.62305	P	.	0.99291	.	.	.	.	.	.	.	-0.56	0.54406	N	.	0.93850	0.5223	0.90822	D	0.7099	0.90000	D	9	0.9873682	0.99089	D	0.932498	0.99511	D	0.696	0.88959	0.996	0.99957	E9PFC7	M1I	Gain of catalytic residue at M1 (P = 0.0314)| Loss of disorder (P = 0.1193)| Loss of loop (P = 0.1242)| Gain of helix (P = 0.2684)| Loss of phosphorylation at S4 (P = 0.3332)	0.887736870969	0.88576	.	0.24402	.	.	.	.	.	0.280176	0.65093	T	0.398321	0.89744	D	0.334384	0.89616	D	0.996361911296844	0.89105	D	.	0.64967	.	0.90739095	0.91937	0.707353	0.82542	0.9052275	0.91737	0.64797	0.79185	-12.231	0.90483	D	.	.	.	0.999999926062728	0.99831	0.99954283	0.99470	.	.	.	.	.	.	.	.	4.144486	0.62186	24.4	0.99635003892177543	0.76291	0.062568	0.11864	N	0.34664899273018	0.58348	4.029269	0.312639291828477	0.56049	3.791295	3.83	3.83	0.43219	.	.	3.426	0.52638	3.191000	0.36784	-0.284	0.0639	1.0	0.71675	1.000000	0.68239	0.255	0.23438	469	0.78193	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1612162	6.202850e-07	0	1	1178330	8.486590e-07	0	0	74994	0.000000e+00	0	0	912	0.000000e+00	0	0	60018	0.000000e+00	0	0	29594	0.000000e+00	0	0	44826	0.000000e+00	0	0	64006	0.000000e+00	0	0	6024	0.000000e+00	0	1	1178330	8.486590e-07	0	0	91032	0.000000e+00	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_cancer-predisposing_syndrome|not_provided|Familial_cancer_of_breast|Fanconi_anemia,_complementation_group_S|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Pancreatic_cancer,_susceptibility_to,_4|Hereditary_breast_ovarian_cancer_syndrome	reviewed_by_expert_panel	NC_000017.11:g.43124094C>A	ClinGen:CA002562	C0027672|C3661900|C0346153|C4554406|C2676676|C3280442|C0677776	114480|617883|604370|614320	140162|227535|145|1333|145	.	Met	Ile	69739	single nucleotide variant	NM_007294.4(BRCA1):c.3G>T (p.Met1Ile)	672	BRCA1	HGNC:1100	Pathogenic	1	Jun 18, 2019	80357475	-	RCV000048405|RCV000111552|RCV000131890|RCV000763402|RCV001357041	MONDO:MONDO:0003582,MeSH:D061325,MedGen:C0677776,Orphanet:145|MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145|MONDO:MONDO:0015356,MeSH:D009386,MedGen:C0027672,Orphanet:140162|MONDO:MONDO:0016419,MedGen:C0346153,OMIM:114480,Orphanet:227535;MONDO:MONDO:0054748,MedGen:C4554406,OMIM:617883;MONDO:MONDO:0011450,MedGen:C2676676,OMIM:604370,Orphanet:145;MONDO:MONDO:0013685,MedGen:C3280442,OMIM:614320,Orphanet:1333|MedGen:C3661900	Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Familial cancer of breast;Fanconi anemia, complementation group S;Breast-ovarian cancer, familial, susceptibility to, 1;Pancreatic cancer, susceptibility to, 4|not provided	germline;not applicable;unknown	germline	GRCh38	NC_000017.11	17	43124094	43124094	17q21.31	reviewed by expert panel	10	ACMG2013,ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA002562	2	55072	43124094	C	A	-	-	-	-	-	-	SCV001161632	-	-	3G>T 	Met1Ile	NM_007294.4	3	1_Pathogenic	BRCA1	ENSG00000012048	14613	218379	CCSBVarC003295	ALE00003295	3G>T	Met1Ile	CEGS2	CegsMutGDEh1009	D10	GDEhDisVCh_40059	B03	1	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	4	0	NULL	0	NULL	0	NULL	0	NULL	BRCA1_Met1Ile	17	17	43124094	C	A
2803	HMBS	674G>A	Arg225Gln	ENSG00000256269	11	119092426	NC_000011.10:119092426:G:A	ALE00005172	CCSBVarC005172	NULL	200938	NULL	GDEhDisVCh_40054	F06	CEGS2	ATGTCTGGTAACGGCAATGCGGCTGCAACGGCGGAAGAAAACAGCCCAAAGATGAGAGTGATTCGCGTGGGTACCCGCAAGAGCCAGCTTGCTCGCATACAGACGGACAGTGTGGTGGCAACATTGAAAGCCTCGTACCCTGGCCTGCAGTTTGAAATCATTGCTATGTCCACCACAGGGGACAAGATTCTTGATACTGCACTCTCTAAGATTGGAGAGAAAAGCCTGTTTACCAAGGAGCTTGAACATGCCCTGGAGAAGAATGAAGTGGACCTGGTTGTTCACTCCTTGAAGGACCTGCCCACTGTGCTTCCTCCTGGCTTCACCATCGGAGCCATCTGCAAGCGGGAAAACCCTCATGATGCTGTTGTCTTTCACCCAAAATTTGTTGGGAAGACCCTAGAAACCCTGCCAGAGAAGAGTGTGGTGGGAACCAGCTCCCTGCGAAGAGCAGCCCAGCTGCAGAGAAAGTTCCCGCATCTGGAGTTCAGGAGTATTCGGGGAAACCTCAACACCCGGCTTCGGAAGCTGGACGAGCAGCAGGAGTTCAGTGCCATCATCCTGGCAACAGCTGGCCTGCAGCGCATGGGCTGGCACAACCGGGTGGGGCAGATCCTGCACCCTGAGGAATGCATGTATGCTGTGGGCCAGGGGGCCTTGGGCGTGGAAGTGCAAGCCAAGGACCAGGACATCTTGGATCTGGTGGGTGTGCTGCACGATCCCGAGACTCTGCTTCGCTGCATCGCTGAAAGGGCCTTCCTGAGGCACCTGGAAGGAGGCTGCAGTGTGCCAGTAGCCGTGCATACAGCTATGAAGGATGGGCAACTGTACCTGACTGGAGGAGTCTGGAGTCTAGACGGCTCAGATAGCATACAAGAGACCATGCAGGCTACCATCCATGTCCCTGCCCAGCATGAAGATGGCCCTGAGGATGACCCACAGTTGGTAGGCATCACTGCTCGTAACATTCCACGAGGGCCCCAGTTGGCTGCCCAGAACTTGGGCATCAGCCTGGCCAACTTGTTGCTGAGCAAAGGAGCCAAAAACATCCTGGATGTTGCACGGCAGCTTAACGATGCCCAT	171130.0	single nucleotide variant	NM_000190.4(HMBS):c.674G>A (p.Arg225Gln)	3145.0	HMBS	HGNC:4982	Uncertain significance	1.0	Jan 30, 2025	142459647.0	-	RCV000148511|RCV000498317|RCV003764896	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958226,MedGen:C5935575,OMIM:620711	Acute intermittent porphyria|not provided|Leukoencephalopathy, porphyria-related	germline	germline	GRCh38	NC_000011.10	11	119092426.0	119092426.0	11q23.3	criteria provided, multiple submitters, no conflicts	5.0	-	N	ClinGen:CA272881,UniProtKB:P08397#VAR_025574,OMIM:609806.0047	3.0	161253.0	119092426.0	G	A	-	-	-	-	-	-	SCV000589335|SCV002212600|SCV005408173	-	-	674G>A 	Arg225Gln	NM_000190.4	2.0	4_VUS	chr11	G	A	11-119092426-G-A	0.00033931	161253	11	119092426	G	A	R	Q	rs142459647	11	118963136	11	118468346	225	HMBS	ENSG00000256269	ENST00000652429	ENSP00000498786	P08397	HEM3_HUMAN	c.674G>A	p.Arg225Gln	c.674G>A	p.Arg225Gln	principal2	Y	.	YES	Select	+	CGA	2	0	G	G/G	G/G	G/G	G/G	.	0.63383	.	.	0.69466	.	0.997	0.70687	D	0.857	0.61060	P	.	0.97926	.	.	.	.	3.715	0.94651	H	.	0.67273	.	.	0.96431	0.9771	0.96803	D	0.9924	0.99816	D	10	.	0.88113	.	0.706346	0.97600	D	.	0.97773	.	.	.	.	.	.	0.96866	0.9562318792121636	0.95582	.	.	0.571098089218	0.48768	T	0.995598	0.99992	D	0.3198	0.84348	D	0.566532	0.95991	D	0.808724462985992	0.46674	D	0.912409	0.83895	D	0.90877837	0.92067	0.72923934	0.83811	0.9131859	0.92486	0.76490796	0.85942	-11.326	0.81474	D	0.6058	0.69064	P	0.997202798579699	0.92882	0.32941398	0.77714	0.932	0.96656	.	.	.	.	.	.	5.715775	0.93205	33.0	0.9994771199218434	0.99923	0.958528	0.97829	D	1.0246033594676	0.96431	14.71205	0.953043659807544	0.97480	16.22598	5.24	5.24	0.72825	.	.	9.732	0.98033	11.804000	0.96740	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.991	0.66489	228	0.91137	.	.	.	.	.	.	.	.	.	.	.	.	53	264690	2.0023424E-4	.	18	109348	1.646120e-04	0	38	208056	1.826430e-04	0	37	236886	1.561930e-04	0	0	7164	0.000000e+00	0	3	17112	1.753160e-04	0	0	2320	0.000000e+00	0	0	9046	0.000000e+00	0	3	13338	2.249210e-04	0	12	42768	2.805840e-04	0	0	15688	0.000000e+00	0	12	42768	2.805840e-04	0	1	16214	6.167510e-05	0	5	30524	1.638060e-04	0	0	6212	0.000000e+00	0	0	13416	0.000000e+00	0	3	16678	1.798780e-04	0	29	89542	3.238700e-04	0	0	30606	0.000000e+00	0	29	89542	3.238700e-04	0	1	14902	6.710510e-05	0	6	34258	1.751420e-04	0	0	9572	0.000000e+00	0	1	17692	5.652270e-05	0	3	21576	1.390430e-04	0	26	102744	2.530560e-04	0	0	30524	0.000000e+00	0	26	102744	2.530560e-04	0	.	528	1613954	3.271470e-04	1	499	1180022	4.228730e-04	1	10	74920	1.334760e-04	0	0	910	0.000000e+00	0	6	60000	1.000000e-04	0	0	29604	0.000000e+00	0	0	44894	0.000000e+00	0	5	63964	7.816900e-05	0	0	6082	0.000000e+00	0	499	1180022	4.228730e-04	1	3	91074	3.294020e-05	0	61	173884	3.508085850337006E-4	0	360	0	0	4502	0	2	9432	2.1204410517387616E-4	0	796	0	1	968	0.0010330578512396695	0	1848	0	0	280	0	7	17166	4.077828265175347E-4	2	9792	2.042483660130719E-4	0	6350	0	71	209236	3.3932975205031637E-4	Uncertain_significance	not_provided|Acute_intermittent_porphyria|Leukoencephalopathy,_porphyria-related	criteria_provided,_multiple_submitters,_no_conflicts	NC_000011.10:g.119092426G>A	ClinGen:CA272881|OMIM:609806.0047|UniProtKB:P08397#VAR_025574	C3661900|C0162565|CN376853	176000|620711	79276	Porphobilinogen deaminase, N-terminal	Arg	Gln	171130	single nucleotide variant	NM_000190.4(HMBS):c.674G>A (p.Arg225Gln)	3145	HMBS	HGNC:4982	Uncertain significance	1	Jan 30, 2025	142459647	-	RCV000148511|RCV000498317|RCV003764896	MONDO:MONDO:0008294,MedGen:C0162565,OMIM:176000,Orphanet:79276|MedGen:C3661900|MONDO:MONDO:0958226,MedGen:C5935575,OMIM:620711	Acute intermittent porphyria|not provided|Leukoencephalopathy, porphyria-related	germline	germline	GRCh38	NC_000011.10	11	119092426	119092426	11q23.3	criteria provided, multiple submitters, no conflicts	5	-	N	ClinGen:CA272881,UniProtKB:P08397#VAR_025574,OMIM:609806.0047	3	161253	119092426	G	A	-	-	-	-	-	-	SCV000589335|SCV002212600|SCV005408173	-	-	674G>A 	Arg225Gln	NM_000190.4	2	4_VUS	HMBS	ENSG00000256269	2803	200938	CCSBVarC005172	ALE00005172	674G>A	Arg225Gln	CEGS2	CegsMutGDEh1041	D06	GDEhDisVCh_40054	F06	2	CegsMutGDDh1041	D06	NULL	NULL	NULL	NULL	NULL	NULL	1	1	1	1	0	NULL	0	NULL	0	NULL	HMBS_Arg225Gln	11	11	119092426	G	A
71569	OTC	464C>A	Ala155Glu	ENSG00000036473	X	38401352	NC_000023.11:38401352:C:A	ALE00005245	CCSBVarC005245	NULL	205868	NULL	GDEhDisVCh_40048	A08	CEGS2	ATGCTGTTTAATCTGAGGATCCTGTTAAACAATGCAGCTTTTAGAAATGGTCACAACTTCATGGTTCGAAATTTTCGGTGTGGACAACCACTACAAAATAAAGTGCAGCTGAAGGGCCGTGACCTTCTCACTCTAAAAAACTTTACCGGAGAAGAAATTAAATATATGCTATGGCTATCAGCAGATCTGAAATTTAGGATAAAACAGAAAGGAGAGTATTTGCCTTTATTGCAAGGGAAGTCCTTAGGCATGATTTTTGAGAAAAGAAGTACTCGAACAAGATTGTCTACAGAAACAGGCTTTGCACTTCTGGGAGGACATCCTTGTTTTCTTACCACACAAGATATTCATTTGGGTGTGAATGAAAGTCTCACGGACACGGCCCGTGTATTGTCTAGCATGGCAGATGCAGTATTGGCTCGAGTGTATAAACAATCAGATTTGGACACCCTGGCTAAAGAAGAATCCATCCCAATTATCAATGGGCTGTCAGATTTGTACCATCCTATCCAGATCCTGGCTGATTACCTCACGCTCCAGGAACACTATAGCTCTCTGAAAGGTCTTACCCTCAGCTGGATCGGGGATGGGAACAATATCCTGCACTCCATCATGATGAGCGCAGCGAAATTCGGAATGCACCTTCAGGCAGCTACTCCAAAGGGTTATGAGCCGGATGCTAGTGTAACCAAGTTGGCAGAGCAGTATGCCAAAGAGAATGGTACCAAGCTGTTGCTGACAAATGATCCATTGGAAGCAGCGCATGGAGGCAATGTATTAATTACAGACACTTGGATAAGCATGGGACAAGAAGAGGAGAAGAAAAAGCGGCTCCAGGCTTTCCAAGGTTACCAGGTTACAATGAAGACTGCTAAAGTTGCTGCCTCTGACTGGACATTTTTACACTGCTTGCCCAGAAAGCCAGAAGAAGTGGATGATGAAGTCTTTTATTCTCCTCGATCACTAGTGTTCCCAGAGGCAGAAAACAGAAAGTGGACAATCATGGCTGTCATGGTGTCCCTGCTGACAGATTACTCACCTCAGCTCCAGAAGCCTAAATTT	103102.0	single nucleotide variant	NM_000531.6(OTC):c.464C>A (p.Ala155Glu)	5009.0	OTC	HGNC:8512	Pathogenic	1.0	-	72556268.0	-	RCV000083449	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38401352.0	38401352.0	Xp11.4	no assertion criteria provided	1.0	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224625	2.0	97210.0	38401352.0	C	A	-	-	-	-	-	-	SCV000115535	-	-	464C>A 	Ala155Glu	NM_000531.6		1_Pathogenic	chrX	C	A	X-38401352-C-A	0.0	97210	X	38401352	C	A	A	E	rs72556268	X	38260605	X	38145549	155	OTC	ENSG00000036473	ENST00000713758	ENSP00000519059	P00480	OTC_HUMAN	.	.	c.464C>A	p.Ala155Glu	principal1	Y	.	.	.	+	GCA	2	0	C	C/C	C/C	C/C	C/C	.	0.68399	.	.	0.79703	.	0.999	0.77914	D	0.977	0.73823	D	.	0.79708	.	.	.	.	3.045	0.86534	M	.	0.68685	.	.	0.97658	1.0684	0.98546	D	0.9775	0.99301	D	10	.	0.99964	.	0.852053	0.98857	D	.	0.99671	0.961	0.99597	P00480	A155E	Gain of disorder (P = 0.0333)| Gain of ubiquitination at K153 (P = 0.0745)| Gain of solvent accessibility (P = 0.1456)| Gain of relative solvent accessibility (P = 0.1571)| Gain of phosphorylation at S156 (P = 0.177)	.	0.99720	.	0.99469	.	0.79520	0.621513128281	0.55877	T	0.968815	0.99644	D	0.688779	0.99921	D	0.751607	0.99921	D	0.991701066493988	0.81897	D	.	0.77428	.	0.97490543	0.98676	0.9684529	0.99386	0.97490543	0.98676	0.9684529	0.99387	-10.817	0.78714	D	.	0.88956	.	0.999848517600571	0.98301	0.99867920	0.98905	0.995	0.99826	.	.	.	.	.	.	4.483666	0.70038	25.5	0.99572826724477315	0.72534	.	.	.	.	.	.	.	.	.	5.97	5.97	0.96929	5.17	0.91630	7.523	0.80833	5.893000	0.50860	0.599	0.40292	1.0	0.71675	1.000000	0.68239	0.997	0.79771	758	0.50788	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	not_provided	no_assertion_criteria_provided	NC_000023.11:g.38401352C>A	ClinGen:CA224625	CN517202	.	.	Aspartate/ornithine carbamoyltransferase, carbamoyl-P binding	Ala	Glu	103102	single nucleotide variant	NM_000531.6(OTC):c.464C>A (p.Ala155Glu)	5009	OTC	HGNC:8512	Pathogenic	1	-	72556268	-	RCV000083449	MedGen:CN517202	not provided	unknown	unknown	GRCh38	NC_000023.11	X	38401352	38401352	Xp11.4	no assertion criteria provided	1	ACMG2016,ACMG2021,ACMG2022	N	ClinGen:CA224625	2	97210	38401352	C	A	-	-	-	-	-	-	SCV000115535	-	-	464C>A 	Ala155Glu	NM_000531.6		1_Pathogenic	OTC	ENSG00000036473	71569	205868	CCSBVarC005245	ALE00005245	464C>A	Ala155Glu	CEGS2	CegsMutGDEh1028	E09	GDEhDisVCh_40048	A08	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	OTC_Ala155Glu	23	X	38401352	C	A
52861	F9	1228G>C	Asp410His	ENSG00000101981	X	139561913	NC_000023.11:139561913:G:C	ALE00004394	CCSBVarC004394	NULL	204387	NULL	GDEhDisVCh_40052	H04	CEGS2	ATGCAGCGCGTGAACATGATCATGGCAGAATCACCAGGCCTCATCACCATCTGCCTTTTAGGATATCTACTCAGTGCTGAATGTACAGTTTTTCTTGATCATGAAAACGCCAACAAAATTCTGAATCGGCCAAAGAGGTATAATTCAGGTAAATTGGAAGAGTTTGTTCAAGGGAACCTTGAGAGAGAATGTATGGAAGAAAAGTGTAGTTTTGAAGAAGCACGAGAAGTTTTTGAAAACACTGAAAGAACAACTGAATTTTGGAAGCAGTATGTTGATGGAGATCAGTGTGAGTCCAATCCATGTTTAAATGGCGGCAGTTGCAAGGATGACATTAATTCCTATGAATGTTGGTGTCCCTTTGGATTTGAAGGAAAGAACTGTGAATTAGATGTAACATGTAACATTAAGAATGGCAGATGCGAGCAGTTTTGTAAAAATAGTGCTGATAACAAGGTGGTTTGCTCCTGTACTGAGGGATATCGACTTGCAGAAAACCAGAAGTCCTGTGAACCAGCAGTGCCATTTCCATGTGGAAGAGTTTCTGTTTCACAAACTTCTAAGCTCACCCGTGCTGAGACTGTTTTTCCTGATGTGGACTATGTAAATTCTACTGAAGCTGAAACCATTTTGGATAACATCACTCAAAGCACCCAATCATTTAATGACTTCACTCGGGTTGTTGGTGGAGAAGATGCCAAACCAGGTCAATTCCCTTGGCAGGTTGTTTTGAATGGTAAAGTTGATGCATTCTGTGGAGGCTCTATCGTTAATGAAAAATGGATTGTAACTGCTGCCCACTGTGTTGAAACTGGTGTTAAAATTACAGTTGTCGCAGGTGAACATAATATTGAGGAGACAGAACATACAGAGCAAAAGCGAAATGTGATTCGAATTATTCCTCACCACAACTACAATGCAGCTATTAATAAGTACAACCATGACATTGCCCTTCTGGAACTGGACGAACCCTTAGTGCTAAACAGCTACGTTACACCTATTTGCATTGCTGACAAGGAATACACGAACATCTTCCTCAAATTTGGATCTGGCTATGTAAGTGGCTGGGGAAGAGTCTTCCACAAAGGGAGATCAGCTTTAGTTCTTCAGTACCTTAGAGTTCCACTTGTTGACCGAGCCACATGTCTTCGATCTACAAAGTTCACCATCTATAACAACATGTTCTGTGCTGGCTTCCATGAAGGAGGTAGAGATTCATGTCAAGGACATAGTGGGGGACCCCATGTTACTGAAGTGGAAGGGACCAGTTTCTTAACTGGAATTATTAGCTGGGGTGAAGAGTGTGCAATGAAAGGCAAATATGGAATATATACCAAGGTATCCCGGTATGTCAACTGGATTAAGGAAAAAACAAAGCTCACT	25690.0	single nucleotide variant	NM_000133.4(F9):c.1228G>C (p.Asp410His)	2158.0	F9	HGNC:3551	Pathogenic	1.0	Mar 01, 1992	137852278.0	-	RCV000011397	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561913.0	139561913.0	Xq27.1	no assertion criteria provided	1.0	-	N	ClinGen:CA255443,UniProtKB:P00740#VAR_017318,OMIM:300746.0095	1.0	10651.0	139561913.0	G	C	-	-	-	-	-	-	SCV000031629	-	-	1228G>C 	Asp410His	NM_000133.4		1_Pathogenic	chrX	G	C	X-139561913-G-C		10651	X	139561913	G	C	D	H	rs137852278	X	138644072	X	138471738	410	F9	ENSG00000101981	ENST00000218099	ENSP00000218099	P00740	FA9_HUMAN	c.1228G>C	p.Asp410His	c.1228G>C	p.Asp410His	principal1	Y	1	YES	Select	+	GAT	1	0	G	G/G	G/G	G/G	G/G	0.0	0.91343	D	0.0	0.92967	D	1.0	0.90580	D	0.99	0.78943	D	0.96	0.99291	A	simple_aae	4.0	96.0	4.53	0.99048	H	-6.96	0.93527	D	0.934	0.99866	1.0945	0.99425	D	0.9623	0.98787	D	10	0.9945991	0.99952	D	0.901637	0.99258	D	0.954	0.99189	1	0.99997	P00740	D410H	Loss of phosphorylation at S406 (P = 0.1578)| Loss of catalytic residue at G412 (P = 0.239)| Gain of disorder (P = 0.2964)| Loss of sheet (P = 0.302)| Loss of glycosylation at S406 (P = 0.3151)	0.999097391152	0.99907	0.9997216736224621	0.99972	1.79064612635	0.91462	0.733585119247	0.71981	T	0.959989	0.99474	D	0.708444	0.99934	D	0.779854	0.99934	D	0.999785840511322	0.98975	D	0.968703	0.88661	D	0.99075	0.99798	0.9907161	0.99983	0.99331653	0.99910	0.9909176	0.99984	-13.989	0.94345	D	0.9895	0.95768	P	0.999898921842201	0.98645	0.99999249	0.99996	1	0.99985	.	.	.	.	.	.	5.120913	0.85675	28.7	0.99416941699044747	0.63599	.	.	.	.	.	.	.	.	.	5.66	5.66	0.87274	.	.	9.968	0.99105	11.888000	0.99016	0.676	0.76753	1.0	0.71675	1.000000	0.68239	0.997	0.79771	924	0.18019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Pathogenic	Hereditary_factor_IX_deficiency_disease	no_assertion_criteria_provided	NC_000023.11:g.139561913G>C	ClinGen:CA255443|OMIM:300746.0095|UniProtKB:P00740#VAR_017318	C0008533	306900	98879	Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain|Serine proteases, trypsin domain	Asp	His	25690	single nucleotide variant	NM_000133.4(F9):c.1228G>C (p.Asp410His)	2158	F9	HGNC:3551	Pathogenic	1	Mar 01, 1992	137852278	-	RCV000011397	MONDO:MONDO:0010604,MeSH:D002836,MedGen:C0008533,OMIM:306900,Orphanet:98879	Hereditary factor IX deficiency disease	germline	germline	GRCh38	NC_000023.11	X	139561913	139561913	Xq27.1	no assertion criteria provided	1	-	N	ClinGen:CA255443,UniProtKB:P00740#VAR_017318,OMIM:300746.0095	1	10651	139561913	G	C	-	-	-	-	-	-	SCV000031629	-	-	1228G>C 	Asp410His	NM_000133.4		1_Pathogenic	F9	ENSG00000101981	52861	204387	CCSBVarC004394	ALE00004394	1228G>C	Asp410His	CEGS2	CegsMutGDEh1020	C08	GDEhDisVCh_40052	H04	2	NULL	NULL	NULL	NULL	NULL	NULL	NULL	NULL	1	1	0	NULL	0	NULL	0	NULL	0	NULL	F9_Asp410His	23	X	139561913	G	C
